0001065059-22-000012.txt : 20220311 0001065059-22-000012.hdr.sgml : 20220311 20220311115808 ACCESSION NUMBER: 0001065059-22-000012 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 114 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTRUS ENERGY CORP CENTRAL INDEX KEY: 0001065059 STANDARD INDUSTRIAL CLASSIFICATION: MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400] IRS NUMBER: 522107911 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14287 FILM NUMBER: 22731974 BUSINESS ADDRESS: STREET 1: 6901 ROCKLEDGE DR STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20817 BUSINESS PHONE: 3015643200 MAIL ADDRESS: STREET 1: 6901 ROCKLEDGE DR STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20817 FORMER COMPANY: FORMER CONFORMED NAME: USEC INC DATE OF NAME CHANGE: 19980629 10-K 1 leu-20211231.htm 10-K leu-20211231
0001065059--12-31TrueFalsefalse2021FY1.0020,000,0007.50.1070,000,0000.1030,000,0007.756.1108.0http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent00010650592021-01-012021-12-3100010650592021-06-30iso4217:USD00010650592022-03-01xbrli:shares0001065059us-gaap:FairValueInputsLevel1Member2021-12-3100010650592020-12-3100010650592021-12-31iso4217:USDxbrli:shares0001065059us-gaap:SeriesAPreferredStockMember2021-12-310001065059us-gaap:SeriesAPreferredStockMember2020-12-310001065059us-gaap:SeriesBPreferredStockMember2021-12-310001065059us-gaap:PreferredClassBMember2021-12-310001065059us-gaap:PreferredClassBMember2020-12-310001065059us-gaap:CommonClassAMember2020-12-310001065059us-gaap:CommonClassAMember2021-12-310001065059us-gaap:CommonClassBMember2021-12-310001065059us-gaap:CommonClassBMember2020-12-310001065059us-gaap:SeriesBPreferredStockMember2020-01-012020-12-31xbrli:pure0001065059leu:SeparativeWorkUnitsMember2021-01-012021-12-310001065059leu:SeparativeWorkUnitsMember2020-01-012020-12-310001065059leu:UraniumMember2021-01-012021-12-310001065059leu:UraniumMember2020-01-012020-12-310001065059us-gaap:ServiceMember2021-01-012021-12-310001065059us-gaap:ServiceMember2020-01-012020-12-3100010650592020-01-012020-12-310001065059us-gaap:ProductMember2021-01-012021-12-310001065059us-gaap:ProductMember2020-01-012020-12-3100010650592019-12-3100010650592020-06-300001065059leu:PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilitiesMember2021-01-012021-12-310001065059leu:PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilitiesMember2020-01-012020-12-310001065059leu:DeferredfinancingcostsincludedinaccountspayableandaccruedliabilitiesMember2021-01-012021-12-310001065059leu:DeferredfinancingcostsincludedinaccountspayableandaccruedliabilitiesMember2020-01-012020-12-310001065059leu:DisposalOfRightToUseLeaseAssetsMember2021-01-012021-12-310001065059leu:DisposalOfRightToUseLeaseAssetsMember2020-01-012020-12-310001065059leu:ReclassificationOfEquityCompensationLiabilityToEquityMember2021-01-012021-12-310001065059leu:ReclassificationOfEquityCompensationLiabilityToEquityMember2020-01-012020-12-310001065059leu:CommonStockAndWarrantIssuedInExchangeForPreferredStockMember2021-01-012021-12-310001065059leu:CommonStockAndWarrantIssuedInExchangeForPreferredStockMember2020-01-012020-12-310001065059us-gaap:PreferredStockMember2019-12-310001065059us-gaap:CommonStockMemberus-gaap:CommonClassAMember2019-12-310001065059us-gaap:CommonClassBMemberus-gaap:CommonStockMember2019-12-310001065059us-gaap:AdditionalPaidInCapitalMember2019-12-310001065059us-gaap:RetainedEarningsMember2019-12-310001065059us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001065059us-gaap:PreferredStockMember2020-01-012020-12-310001065059us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-01-012020-12-310001065059us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-01-012020-12-310001065059us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001065059us-gaap:RetainedEarningsMember2020-01-012020-12-310001065059us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001065059us-gaap:PreferredStockMember2020-12-310001065059us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-12-310001065059us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-12-310001065059us-gaap:AdditionalPaidInCapitalMember2020-12-310001065059us-gaap:RetainedEarningsMember2020-12-310001065059us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001065059us-gaap:PreferredStockMember2021-01-012021-12-310001065059us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-01-012021-12-310001065059us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-012021-12-310001065059us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001065059us-gaap:RetainedEarningsMember2021-01-012021-12-310001065059us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001065059us-gaap:PreferredStockMember2021-12-310001065059us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310001065059us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001065059us-gaap:AdditionalPaidInCapitalMember2021-12-310001065059us-gaap:RetainedEarningsMember2021-12-310001065059us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001065059us-gaap:SeniorNotesMember2021-12-310001065059country:USus-gaap:ProductMember2021-01-012021-12-310001065059country:USus-gaap:ProductMember2020-01-012020-12-310001065059country:BEus-gaap:ProductMember2021-01-012021-12-310001065059country:BEus-gaap:ProductMember2020-01-012020-12-310001065059country:JPus-gaap:ProductMember2021-01-012021-12-310001065059leu:OtherForeignMemberus-gaap:ProductMember2021-01-012021-12-310001065059leu:OtherForeignMemberus-gaap:ProductMember2020-01-012020-12-310001065059leu:ForeignMemberus-gaap:ProductMember2021-01-012021-12-310001065059leu:ForeignMemberus-gaap:ProductMember2020-01-012020-12-310001065059srt:MaximumMember2020-12-310001065059srt:MaximumMember2021-12-3100010650592019-01-012021-12-310001065059us-gaap:GovernmentMember2019-01-012021-12-310001065059us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001065059leu:WorkerscompensationfinancialassuranceMember2021-12-310001065059leu:WorkerscompensationfinancialassuranceMember2020-12-310001065059leu:OtherfinancialassuranceMember2021-12-310001065059leu:OtherfinancialassuranceMember2020-12-3100010650592018-01-012020-12-3100010650592021-09-300001065059us-gaap:LandMember2020-12-310001065059us-gaap:LandMember2021-01-012021-12-310001065059us-gaap:LandMember2021-12-310001065059us-gaap:LeaseholdImprovementsMember2020-12-310001065059us-gaap:LeaseholdImprovementsMember2021-01-012021-12-310001065059us-gaap:LeaseholdImprovementsMember2021-12-310001065059us-gaap:EquipmentMember2020-12-310001065059us-gaap:EquipmentMember2021-01-012021-12-310001065059us-gaap:EquipmentMember2021-12-310001065059us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember2020-12-310001065059us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember2021-12-310001065059us-gaap:ContractBasedIntangibleAssetsMember2021-12-310001065059us-gaap:ContractBasedIntangibleAssetsMember2020-12-310001065059us-gaap:CustomerRelatedIntangibleAssetsMember2021-12-310001065059us-gaap:CustomerRelatedIntangibleAssetsMember2020-12-310001065059us-gaap:SeniorNotesMember2020-12-310001065059us-gaap:FairValueInputsLevel2Member2021-12-310001065059us-gaap:FairValueInputsLevel3Member2021-12-310001065059us-gaap:FairValueInputsLevel1Member2020-12-310001065059us-gaap:FairValueInputsLevel2Member2020-12-310001065059us-gaap:FairValueInputsLevel3Member2020-12-310001065059us-gaap:PensionPlansDefinedBenefitMember2021-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001065059us-gaap:PensionPlansDefinedBenefitMember2020-12-310001065059us-gaap:PensionPlansDefinedBenefitMember2019-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310001065059us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001065059leu:PlanPaidMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001065059leu:PlanPaidMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberleu:PlanPaidMember2021-01-012021-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberleu:PlanPaidMember2020-01-012020-12-310001065059leu:CompanyPaidMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001065059leu:CompanyPaidMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberleu:CompanyPaidMember2021-01-012021-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberleu:CompanyPaidMember2020-01-012020-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2014-01-012014-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2016-01-012016-12-310001065059us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2017-01-012017-12-310001065059us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001065059us-gaap:EquitySecuritiesMember2021-12-310001065059us-gaap:EquitySecuritiesMember2020-12-310001065059srt:ScenarioForecastMemberus-gaap:EquitySecuritiesMembersrt:MinimumMember2022-12-310001065059srt:ScenarioForecastMemberus-gaap:EquitySecuritiesMembersrt:MaximumMember2022-12-310001065059us-gaap:DebtSecuritiesMember2021-12-310001065059us-gaap:DebtSecuritiesMember2020-12-310001065059srt:ScenarioForecastMemberus-gaap:DebtSecuritiesMembersrt:MinimumMember2022-12-310001065059srt:ScenarioForecastMemberus-gaap:DebtSecuritiesMembersrt:MaximumMember2022-12-310001065059us-gaap:CashMember2021-12-310001065059us-gaap:CashMember2020-12-310001065059srt:ScenarioForecastMemberus-gaap:CashMembersrt:MinimumMember2022-12-310001065059srt:ScenarioForecastMemberus-gaap:CashMembersrt:MaximumMember2022-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2021-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2020-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2021-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2020-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2021-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2020-12-310001065059us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel12And3Member2021-12-310001065059us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001065059us-gaap:FairValueInputsLevel12And3Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel12And3Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310001065059us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel12And3Member2021-12-310001065059us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001065059us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel1Member2021-12-310001065059us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel1Member2020-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:MutualFundMember2021-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:MutualFundMember2020-12-310001065059us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel3Member2021-12-310001065059us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel3Member2020-12-310001065059us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel12And3Member2021-12-310001065059us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2020-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2020-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001065059us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2020-12-310001065059us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2021-12-310001065059us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001065059us-gaap:FairValueInputsLevel12And3Member2021-12-310001065059us-gaap:FairValueInputsLevel12And3Member2020-12-310001065059us-gaap:PensionPlansDefinedBenefitMemberus-gaap:QualifiedPlanMember2021-12-310001065059us-gaap:PensionPlansDefinedBenefitMemberus-gaap:NonqualifiedPlanMember2021-12-310001065059leu:NotionalStockUnitsMember2021-01-012021-12-310001065059leu:NotionalStockUnitsPerformanceConditionMember2021-01-012023-12-310001065059us-gaap:RestrictedStockUnitsRSUMember2021-12-310001065059us-gaap:EmployeeStockOptionMember2021-12-310001065059leu:BoardRestrictedStockUnitsMember2019-12-310001065059leu:BoardRestrictedStockUnitsMember2020-01-012020-12-310001065059leu:BoardRestrictedStockUnitsMember2020-12-310001065059leu:BoardRestrictedStockUnitsMember2021-01-012021-12-310001065059leu:BoardRestrictedStockUnitsMember2021-12-310001065059leu:EmployeeRestrictedStockUnitsMember2020-12-310001065059leu:EmployeeRestrictedStockUnitsMember2021-01-012021-12-310001065059leu:EmployeeRestrictedStockUnitsMember2021-12-3100010650592019-01-012019-12-310001065059leu:OptionGroupOneMember2021-12-310001065059leu:OptionGroupOneMember2021-01-012021-12-310001065059leu:OptionGroupTwoMember2021-12-310001065059leu:OptionGroupTwoMember2021-01-012021-12-310001065059us-gaap:StockAppreciationRightsSARSMember2019-12-310001065059us-gaap:StockAppreciationRightsSARSMember2020-01-012020-12-310001065059us-gaap:StockAppreciationRightsSARSMember2020-12-310001065059us-gaap:StockAppreciationRightsSARSMember2021-01-012021-12-310001065059us-gaap:StockAppreciationRightsSARSMember2021-12-3100010650592021-10-012021-12-310001065059leu:StockAppreciationRightsSARSPerformanceConditionMember2020-12-310001065059leu:StockAppreciationRightsSARSPerformanceConditionMember2021-01-012021-12-310001065059leu:StockAppreciationRightsSARSPerformanceConditionMember2021-12-310001065059leu:NotionalStockUnitsMember2019-12-310001065059leu:NotionalStockUnitsMember2020-01-012020-12-310001065059leu:NotionalStockUnitsMember2020-12-310001065059leu:NotionalStockUnitsMember2021-12-310001065059leu:NotionalStockUnitsPerformanceConditionMember2020-12-310001065059leu:NotionalStockUnitsPerformanceConditionMember2021-01-012021-12-310001065059leu:NotionalStockUnitsPerformanceConditionMember2021-12-310001065059us-gaap:DomesticCountryMember2021-01-012021-12-310001065059us-gaap:DomesticCountryMember2020-01-012020-12-310001065059us-gaap:StateAndLocalJurisdictionMember2021-01-012021-12-310001065059us-gaap:StateAndLocalJurisdictionMember2020-01-012020-12-310001065059us-gaap:ForeignCountryMember2021-01-012021-12-310001065059us-gaap:ForeignCountryMember2020-01-012020-12-3100010650592017-12-310001065059us-gaap:TaxYear2018Member2021-12-310001065059us-gaap:StateAndLocalJurisdictionMember2021-12-310001065059us-gaap:SeriesBPreferredStockMember2020-09-300001065059us-gaap:PreferredClassBMember2020-09-3000010650592020-10-012020-12-310001065059us-gaap:SeriesBPreferredStockMember2020-10-012020-12-310001065059us-gaap:PreferredClassBMember2021-01-012021-12-310001065059us-gaap:SeriesBPreferredStockMember2020-12-310001065059us-gaap:CommonClassAMember2021-11-012021-11-300001065059us-gaap:WarrantMember2021-01-012021-12-310001065059us-gaap:SeriesBPreferredStockMember2021-01-012021-12-310001065059us-gaap:SeriesBPreferredStockMember2021-11-012021-11-300001065059us-gaap:SeriesBPreferredStockMember2021-12-012021-12-3100010650592021-12-012021-12-310001065059us-gaap:PreferredClassBMember2019-12-310001065059us-gaap:CommonClassAMember2019-12-310001065059us-gaap:CommonClassBMember2019-12-310001065059us-gaap:CommonClassAMember2020-01-012020-12-310001065059us-gaap:CommonClassBMember2020-01-012020-12-310001065059us-gaap:PreferredClassBMember2020-01-012020-12-310001065059us-gaap:CommonClassAMember2021-01-012021-12-310001065059us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2021-01-012021-12-310001065059us-gaap:PhantomShareUnitsPSUsMemberus-gaap:CommonClassAMember2021-01-012021-12-310001065059us-gaap:CommonClassAMember2020-09-012020-09-0100010650592016-09-300001065059us-gaap:PreferredClassBMember2021-11-012021-11-3000010650592021-11-012021-11-300001065059us-gaap:PreferredClassBMember2021-12-012021-12-3100010650592021-12-152021-12-150001065059country:US2021-01-012021-12-310001065059country:US2020-01-012020-12-310001065059country:BE2021-10-012021-12-310001065059country:BE2020-01-012020-12-310001065059country:JP2021-01-012021-12-310001065059country:JP2020-01-012020-12-310001065059leu:OtherForeignMember2021-01-012021-12-310001065059leu:OtherForeignMember2020-01-012020-12-310001065059leu:ForeignMember2021-01-012021-12-310001065059leu:ForeignMember2020-01-012020-12-310001065059leu:TechnicalSolutionsSegmentMember2021-01-012021-12-310001065059leu:TechnicalSolutionsSegmentMember2020-01-012020-12-310001065059us-gaap:SalesRevenueNetMemberleu:TenLargestCustomersMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001065059us-gaap:SalesRevenueNetMemberleu:SynatomMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001065059us-gaap:SalesRevenueNetMemberleu:KyushuElectricPowerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001065059us-gaap:SalesRevenueNetMemberleu:TenLargestCustomersMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001065059us-gaap:SalesRevenueNetMemberleu:SynatomMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001065059leu:EnergyHarborNuclearCorporationMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001065059us-gaap:SalesRevenueNetMemberleu:DominionEnergySouthCarolinaMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001065059leu:LowEnrichedUraniumSegmentMember2021-01-012021-12-310001065059leu:LowEnrichedUraniumSegmentMember2020-01-012020-12-310001065059leu:ContractServicesSegmentMember2021-01-012021-12-310001065059leu:ContractServicesSegmentMember2020-01-012020-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
leu-20211231_g1.jpg
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
Commission file number 1-14287
Centrus Energy Corp.
Delaware52-2107911
(State of incorporation)(IRS Employer Identification No.)

6901 Rockledge Drive, Suite 800, Bethesda, Maryland 20817
(301) 564-3200
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Class A Common Stock, par value $0.10 per shareLEUNYSE American
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐. No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐. No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes ☒   No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☐ Smaller reporting company☒
Accelerated filer☒ Emerging growth company☐
Non-accelerated filer☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The aggregate market value of Common Stock held by non-affiliates computed by reference to the price at which the Common Stock was last sold as reported on the New York Stock Exchange as of June 30, 2021, was $257.9 million. As of March 1, 2022, there were 13,673,933 shares of the registrant’s Class A Common Stock, par value $0.10 per share, and 719,200 shares of the registrant’s Class B Common Stock, par value $0.10 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement for the 2022 annual meeting of shareholders to be filed with the Securities and Exchange commission within 120 days after the end of fiscal year 2021 are incorporated by reference into Part III of this Annual Report on Form 10-K.



TABLE OF CONTENTS
  Page
 PART I 
Items 1.
Business
Item 1A.
Risk Factors
Item 1B.
Unresolved Staff Comments
Item 2.
Properties
Item 3.
Legal Proceedings
Item 4.
Mine Safety Disclosures
 PART II
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6.
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 8.
Financial Statements and Supplementary Data
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A.
Controls and Procedures
Item 9B.
Other Information
 PART III 
Item 10.
Directors, Executive Officers and Corporate Governance
Item 11.
Executive Compensation
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13.
Certain Relationships and Related Transactions, and Director Independence
Item 14.
Principal Accounting Fees and Services
PART IV
Item 15.
Exhibits and Financial Statement Schedules
Item 16.
Form 10-K Summary
Exhibit Index
Signatures
Consolidated Financial Statements
 



FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K, including Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7, contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. In this context, forward-looking statements mean statements related to future events, may address our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “will”, “should”, “could”, “would” or “may” and other words of similar meaning. Forward-looking statements by their nature address matters that are, to different degrees, uncertain.

For Centrus Energy Corp., particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following which are, and will be, exacerbated by the novel coronavirus (“COVID-19”) pandemic and any worsening of the global business and economic environment as a result; risks related to the war in Ukraine and geopolitical conflicts and the imposition of sanctions or other measures that could impact our ability to obtain or sell low enriched uranium (LEU) under our existing supply contract with the Russian government-owned entity TENEX, Joint-Stock Company (“TENEX”); risks related to natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan on the nuclear industry and on our business, results of operations and prospects; risks related to financial difficulties experienced by customers or suppliers, including possible bankruptcies, insolvencies or any other inability to pay for our products or services or delays in making timely payment; risks related to pandemics and other health crises, such as the global COVID-19 pandemic and subsequent variants; the impact and potential extended duration of the current supply/demand imbalance in the market for low-enriched uranium (“LEU”); risks related to our ability to sell the LEU we procure pursuant to our purchase obligations under our supply agreements including those imposed under the 1992 Russian Suspension Agreement as amended (“RSA”), international trade legislation and other international trade restrictions; risks related to existing or new trade barriers and contract terms that limit our ability to procure LEU for, or deliver LEU to customers; pricing trends and demand in the uranium and enrichment markets and their impact on our profitability; risks related to the movement and timing of customer orders; risks related to our dependence on others for deliveries of LEU including deliveries from TENEX, under a commercial supply agreement with TENEX and deliveries under a long-term commercial supply agreement with Orano Cycle (“Orano”); risks associated with our reliance on third-party suppliers to provide essential products and services to us; risks related to the fact that we face significant competition from major producers who may be less cost sensitive or are wholly or partially government owned; risks that our ability to compete in foreign markets may be limited for various reasons; risks related to the fact that our revenue is largely dependent on our largest customers; risks related to our sales order book, including uncertainty concerning customer actions under current contracts and in future contracting due to market conditions and our lack of current production capability; risks related to whether or when government funding or demand for high-assay low-enriched uranium (“HALEU”) for government or commercial uses will materialize; risks and uncertainties regarding funding for continuation and deployment of the American Centrifuge technology; risks related to our ability to perform and absorb costs under our agreement with the U.S. Department of Energy (“DOE”) to deploy a cascade of centrifuges to demonstrate production of HALEU for advanced reactors (the “HALEU Contract”) or to obtain contracts and funding to be able to continue operations and our ability to obtain and/or perform under other agreements; risks that we may not obtain the full benefit of the HALEU Contract and may not be able to operate the HALEU enrichment facility to produce HALEU after the completion of the existing HALEU Contract or that the HALEU enrichment facility may not be available to us as a future source of supply; risks related to uncertainty regarding our ability to commercially deploy competitive enrichment technology; risks related to the potential for further demobilization or termination of our American Centrifuge work; risks that we will not be able to timely complete the work that we are obligated to perform; risks related to our ability to perform fixed-price and cost-share contracts such as the HALEU Contract, including the risk that costs could be higher than expected; risks related to our significant long-term liabilities, including material unfunded defined benefit pension plan obligations and postretirement health and life benefit obligations; risks relating to our 8.25% notes (the “8.25% Notes”) maturing in February 2027; the risks of revenue and operating results fluctuating significantly from quarter to quarter, and in some cases, year to year; risks related to the impact of financial market conditions on our business, liquidity, prospects, pension assets and insurance facilities; risks related to the Company’s capital concentration; risks related to the value of our intangible assets related to the sales order book and customer relationships; risks related to the limited trading markets in our securities; risks related to decisions made by our Class B stockholders regarding their investment in the Company based upon factors that are unrelated to the Company’s performance; risks that a small number of holders of our Class A Common Stock, par value $0.10 per share (“Class A Common Stock”), (whose interests may not be aligned with other holders of our Class A Common Stock), may exert significant influence over the direction of the Company; risks related to the use of our net operating losses (“NOLs”) carryforwards and net unrealized built-in losses (“NUBILs”) to offset future taxable income and the use of the Rights Agreement (as defined herein) to prevent an “ownership change” as defined in Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”) and our ability to generate taxable income to utilize all or a portion of the NOLs and NUBILs prior to the expiration thereof; failures or security breaches of our information technology systems; risks related to our ability to attract and retain key personnel; risks related to the potential for DOE to seek to terminate or exercise its
3

remedies under its agreements with the Company; risks related to actions, including government reviews, that may be taken by the United States government, the Russian government or other governments that could affect our ability to perform under our contract obligations or the ability of our sources of supply to perform under their contract obligations to us; risks related to our ability to perform and receive timely payment under agreements with DOE or other government agencies, including risks and uncertainties related to the ongoing funding by the government and potential audits; risks related to changes or termination of agreements with the U.S. government or other counterparties; risks related to the competitive environment for our products and services; risks related to changes in the nuclear energy industry; risks related to the competitive bidding process associated with obtaining contracts, including government contracts; risks that we will be unable to obtain new business opportunities or achieve market acceptance of our products and services or that products or services provided by others will render our products or services obsolete or noncompetitive; risks related to potential strategic transactions that could be difficult to implement, disrupt our business or change our business profile significantly; risks related to the outcome of legal proceedings and other contingencies (including lawsuits and government investigations or audits); risks related to the impact of government regulation and policies including by the DOE and the U.S. Nuclear Regulatory Commission; risks of accidents during the transportation, handling or processing of hazardous or radioactive material that may pose a health risk to humans or animals, cause property or environmental damage, or result in precautionary evacuations; risks associated with claims and litigation arising from past activities at sites we currently operate or past activities at sites that we no longer operate, including the Paducah, Kentucky, and Portsmouth, Ohio, gaseous diffusion plants; and other risks and uncertainties discussed in this and our other filings with the Securities and Exchange Commission (“SEC”).

For a discussion of these risks and uncertainties and other factors that may affect our future results, please see Part I, Item 1A, Risk Factors, the other sections of this Annual Report on Form 10-K and our subsequently filed documents. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this report and in our other filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this Annual Report on Form 10-K, except as required by law.






4

PART I
Item 1. Business

Overview

Centrus Energy Corp., a Delaware corporation, is a trusted supplier of enriched uranium for nuclear fuel and services for the nuclear power industry, which provides a reliable source of carbon-free energy. References to “Centrus”, the “Company”, “our”, or “we” include Centrus Energy Corp. and its wholly-owned subsidiaries as well as the predecessor to Centrus, unless the context otherwise indicates. We were incorporated in 1998 as part of the privatization of the United States Enrichment Corporation.

Centrus operates two business segments: (a) low-enriched uranium (“LEU”), which supplies various components of nuclear fuel to commercial customers from our global network of suppliers, and (b) technical solutions, which provides advanced engineering, design, and manufacturing services to government and private sector customers and is deploying uranium enrichment and other capabilities necessary for production of advanced nuclear fuel to power existing and next-generation reactors around the world.

Our LEU segment provides most of the Company’s revenue and involves the sale of enriched uranium for nuclear fuel to customers that are primarily utilities which operate commercial nuclear power plants. The majority of these sales are for the enrichment component of LEU, which is measured in separative work units (“SWU”). Centrus also sells natural uranium (the raw material needed to produce LEU) and occasionally sells LEU with the natural uranium, uranium conversion, and SWU components combined into one sale.

LEU is a critical component in the production of nuclear fuel for reactors that produce electricity. We supply LEU and its components to both domestic and international utilities for use in nuclear reactors worldwide. We provide LEU from multiple sources, including our inventory, medium and long-term supply contracts, and spot purchases. As a long-term supplier of LEU to our customers, our objective is to provide value through the reliability and diversity of our supply sources.

Our global order book includes long-term sales contracts with major utilities to 2029. We have secured cost-competitive supplies of SWU under long-term contracts through the end of this decade to allow us to fill our existing customer orders and make new sales. A market-related price reset provision in our largest supply contract took effect at the beginning of 2019 – when market prices for SWU were near historic lows – which has significantly lowered our cost of sales and contributed to improved margins.

In October 2020, the U.S. Department of Commerce (“DOC”) reached agreement with the Russian Federation on an extension of the 1992 Russian Suspension Agreement, a trade agreement which allows for Russian-origin nuclear fuel to be exported to the United States in limited quantities, with an import quantity in each year. The two parties agreed to extend the agreement through 2040 and to set aside a significant portion of the quota for Centrus’ shipments to the United States through 2028 to execute our long-term supply (purchase) agreement (the “TENEX Supply Contract”) with the Russian government entity, TENEX, Joint-Stock Company (“TENEX”). This outcome also allows sufficient quota for Centrus to continue serving its utility customers. Refer to Item 1A Risk Factors - Operational Risks for further discussion.

Under a contract with the U.S. Department of Energy (“DOE”), our technical solutions segment is deploying uranium enrichment and other capabilities necessary for production of advanced nuclear fuel to meet the evolving needs of the global nuclear industry and the U.S. government. We also are leveraging our unique technical expertise, operational experience, and specialized facilities to expand and diversify our business beyond uranium enrichment, offering new services to existing and new customers in complementary markets.

5


Our technical solutions segment is working to restore America’s domestic uranium enrichment capability, to play a critical role in meeting U.S. national security and energy security requirements, in advancing America’s nonproliferation objectives and in delivering the next-generation nuclear fuels that will power the future of nuclear energy as it provides reliable carbon-free power around the world.

The United States has not had domestic uranium enrichment capability suitable to meet U.S. national security requirements since the Paducah Gaseous Diffusion Plant (“Paducah GDP”) shut down in 2013. Longstanding U.S. policy and binding nonproliferation agreements prohibit the use of foreign-origin enrichment technology for U.S. national security missions. Our AC100M centrifuge currently is the only deployment-ready U.S. uranium enrichment technology that can meet these national security requirements, albeit requiring one minor change in sourcing of materials.

Centrus is working to pioneer U.S. production of High-Assay, Low-Enriched Uranium (“HALEU”), enabling the deployment of a new generation of HALEU-fueled reactors to meet the world’s growing need for carbon-free power. HALEU is a high-performance nuclear fuel component which is expected to be required by a number of advanced reactor and fuel designs that are now under development for commercial and government uses. While existing reactors typically operate on LEU with the uranium-235 isotope concentration below 5%, HALEU is further enriched so that the uranium-235 concentration is between 5% and 20%. The higher U-235 concentration offers a number of potential advantages, which may include better fuel utilization, improved performance, fewer refueling outages, simpler reactor designs, reduced waste volumes, and greater nonproliferation resistance.

The lack of a domestic HALEU supply is widely viewed as a major obstacle to the successful commercialization of these new reactors. As the only company with a license from the Nuclear Regulatory Commission (“NRC”) to enrich up to 20% uranium-235 assay HALEU, Centrus is uniquely positioned to fill a critical gap in the supply chain and facilitate the deployment of these promising next-generation reactors.

The DOE has experienced a COVID-19 related supply chain delay in obtaining the HALEU storage cylinders. Since it is not possible to begin HALEU production without the storage cylinders, it would not be possible to complete the operational portion of the demonstration before the June 1, 2022 expiration date of the existing contract. As a result, the DOE elected to change the scope of the existing contract and move the operational portion of the demonstration to a new, competitively-awarded, contract that would provide for operations beyond the term of the existing contract. On February 7, 2022, the DOE issued a pre-solicitation notice for a request for proposal to complete the HALEU demonstration facility and to produce HALEU, noting that the “the Administration supports longer-term demonstration of production capability.” The pre-solicitation notice outlines a two-phase approach. Phase 1 consists of completing installation of the centrifuges – which DOE expects will take up to one year from contract signing – followed by one full year of cascade operations. Phase 2 consists of three optional, 3-year extensions to produce HALEU, so that the prospective contract could help support a total of one to ten years of cascade operations in addition to completing construction and centrifuge installation.

Centrus believes it is well-positioned to compete for a follow-on contract to operate the machines in our facility near Piketon but there is no assurance that DOE will award such a contract to the Company. Congress has not yet adopted a Fiscal Year 2022 appropriations bill for the DOE, and there is no assurance that the proposed program will be approved and funded.

The U.S. government has been operating under a series of continuing resolutions in Fiscal Year 2022. The DOE continues to support the HALEU program during the continuing resolution period, and has incrementally increased the government’s cost share ceiling as funds have become available.

Additional COVID-19-related impacts, delays in DOE furnishing equipment, or changes to the existing scope of the HALEU Contract could result in further material increases to our estimate of the costs required to complete the existing HALEU Contract, and delay completion of the contract. The Company currently does not have a contractual obligation to perform work in excess of the funding provided by DOE and, therefore, no additional costs
6

have been accrued as of December 31, 2021. If DOE does not commit to fully fund the additional costs, and the Company nevertheless commits to a plan to complete the remaining activities of the HALEU Contract, we may incur material additional costs or losses in future periods that could have an adverse impact on our financial condition and liquidity.

We believe our investment in HALEU technology will position the Company to meet the needs of government and commercial customers in the future as they deploy advanced reactors and next generation fuels. At present, there are a number of advanced reactors under development. For example, nine of the ten advanced reactor designs selected by the DOE for its Advanced Reactor Demonstration Program will require HALEU. In addition, the first non-light water reactor to begin active NRC-license review requires HALEU. The U.S. Department of Defense also plans to construct a prototype HALEU-fueled mobile microreactor in the next three to four years as part of a program called “Project Pele.” The U.S. Air Force also announced plans to deploy a microreactor at Eielson Air Force Base in Alaska. While the use of HALEU is not an express requirement of the Air Force program, the vast majority of microreactor designs are expected to need HALEU. On December 14, 2021, DOE issued a request for information related to a potential program to fund the availability of HALEU.

Advanced nuclear reactors promise to provide an important source of reliable carbon-free power. While there is no commercial market for HALEU today, we believe that by investing in HALEU technology now, and as the only American-based company currently pursuing HALEU enrichment capability and possessing an NRC license for such production, the Company could be positioned to capitalize on a potential new market as the demand for HALEU-based fuels increases in the mid to late-2020s with the development of advanced reactors. However, there are no guarantees about whether or when government or commercial demand for HALEU will materialize, and there are a number of technical, regulatory, and economic hurdles that must be overcome for these fuels and reactors to come to the market. Also, foreign government-owned and operated competitors could seek to enter the market and offer HALEU at more competitive prices. There is one known foreign government-owned entity which currently has the capability to produce HALEU, although this entity is currently subject to trade restrictions that limit the amount of material from this source which may be imported into the United States. Other foreign government owned entities which are not currently subject to U.S. trade restrictions, however, may enter the market. One such foreign government owned entity has expressed an interest in and potential capability for HALEU production but has not committed publicly to enter the market to enrich above 10% uranium-235 enrichment assays. This entity has indicated publicly that it would take six to seven years to be able to produce HALEU.

For further details, refer to Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - Market Conditions and Outlook. For a discussion of the potential risks and uncertainties facing our business, see Part I, Item 1A, Risk Factors.

Low Enriched Uranium

LEU consists of two components: separative work units (“SWU”) and natural uranium. Revenue from our LEU segment is derived primarily from:
•sales of the SWU component of LEU,
•sales of both the SWU and natural uranium components of LEU, and
•sales of natural uranium.

Our LEU segment accounted for approximately 62% of our total revenue in 2021. Our customers are primarily domestic and international utilities that operate nuclear power plants. Our agreements with electric utilities are primarily medium and long-term, fixed-commitment contracts under which our customers are obligated to purchase a specified quantity of the SWU component of LEU from us. Our agreements for natural uranium and enriched uranium product sales, where we sell both the SWU and uranium component of LEU, are generally shorter-term, fixed-commitment contracts.

7

Uranium and Enrichment

Uranium is a naturally occurring element and is mined from deposits located in Kazakhstan, Canada, Australia, and several other countries, including the United States. According to the World Nuclear Association (“WNA”), there are adequate measured resources of natural uranium to fuel nuclear power at current usage rates for about 90 years. In its natural state, uranium is principally comprised of two isotopes: uranium-235 (“U235”) and uranium-238 (“U238”). The concentration of U235 in natural uranium is only 0.711% by weight. Uranium enrichment is the process by which the concentration of U235 is increased. Most commercial nuclear power reactors require LEU fuel with a U235 concentration greater than natural uranium of up to 5% by weight. Future reactor designs currently under development will likely require higher U235 concentration levels of up to 20%.

SWU is a standard unit of measurement that represents the effort required to sort natural uranium between enriched uranium having a higher percentage of U235 and depleted uranium having a lower percentage of U235. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment deemed to be contained in LEU under this formula is commonly referred to as its SWU component and the quantity of natural uranium deemed to be contained in LEU under this formula is referred to as its uranium or “feed” component.

While in some cases customers purchase both the SWU and uranium components of LEU from us, utility customers typically provide the natural uranium to us as part of their enrichment contracts and in exchange we deliver LEU to these customers and charge for the SWU component. Title to natural uranium provided by customers generally remains with the customer until Centrus delivers the LEU, at which time title to LEU is transferred to the customer, and Centrus takes title to the natural uranium.

The following outlines the steps for converting natural uranium into LEU fuel, commonly known as the nuclear fuel cycle:

Mining and Milling. Natural, or unenriched, uranium is removed from the earth in the form of ore and then crushed and concentrated.
Conversion. Uranium concentrates (“U3O8”) are combined with fluorine gas to produce uranium hexafluoride (“UF6”), a solid at room temperature and a gas when heated. UF6 is shipped to an enrichment plant.
Enrichment. UF6 is enriched in a process that increases the concentration of the U235 isotope in the UF6 from its natural state of 0.711% up to 5%, or LEU, which is usable as a fuel for current light water commercial nuclear power reactors. Future commercial reactor designs may use uranium enriched up to 20% U235, or HALEU.
Fuel Fabrication. LEU is then converted to uranium oxide and formed into small ceramic pellets by fabricators. The pellets are loaded into metal tubes that form fuel assemblies, which are shipped to nuclear power plants. As the advanced reactor market develops, HALEU may be converted to uranium oxide, metal, chloride or fluoride salts, or other forms and loaded into a variety of fuel assembly types optimized for the specific reactor design.
Nuclear Power Plant. The fuel assemblies are loaded into nuclear reactors to create energy from a controlled chain reaction. Nuclear power plants generate approximately 20% of U.S. electricity and 10% of the world’s electricity.
Used Fuel Storage. After the nuclear fuel has been in a reactor for several years its efficiency is reduced and the assembly is removed from the reactor’s core. The used fuel is warm and radioactive and is kept in a deep pool of water for several years. Many utilities have elected to then move the used fuel into steel or concrete and steel casks for interim storage.

8

LEU Segment Order Book

Our order book of sales under contract in the LEU segment (“order book”) extends to 2029. For the years ended December 31, 2021 and 2020, our order book was approximately $986 million and $960 million, respectively. The order book is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries, and includes approximately $348.2 million of deferred revenue and advances from customers as of December 31, 2021, whereby customers have made advance payments to be applied against future deliveries. We estimate that approximately 3% of our order book is at risk related to customer operations.

Most of our customer contracts provide for fixed purchases of SWU during a given year. Our order book estimate is based partially on customers’ estimates of the timing and size of their fuel requirements and other assumptions that are subject to change. For example, depending on the terms of specific contracts, the customer may be able to increase or decrease the quantity delivered within an agreed range. Our order book estimate is also based on our estimates of selling prices, which may be subject to change. For example, depending on the terms of specific contracts, prices may be adjusted based on escalation using a general inflation index, published SWU price indicators prevailing at the time of delivery, and other factors, all of which are variable. We use external composite forecasts of future market prices and inflation rates in our pricing estimates. Refer to Part I, Item 1A, Risk Factors, for a discussion of risks related to our order book.

Suppliers

We have a diverse base of supply that includes:
•existing inventory of LEU (refer to Note 4, Inventories),
•mid-term and long-term contracts with enrichment producers,
•purchases and loans from secondary sources including fabricators and utility operators of nuclear power plants that have excess inventory, and
•spot purchases of SWU, uranium and LEU.

We aim to continue to further diversify this base of supply and take advantage of opportunities to obtain additional short and long-term supplies of LEU. Currently, our largest suppliers of SWU are TENEX and the French government owned company Orano Cycle (“Orano”).

Under the TENEX Supply Contract, we purchase SWU contained in LEU, and we deliver natural uranium to TENEX for the LEU’s uranium component. The TENEX Supply Contract extends through 2028. We typically pay for the SWU contained in the LEU, and supply natural uranium to TENEX for the natural uranium component. SWU pricing is determined by a formula that uses a combination of market-related price points and other factors. The LEU that we obtain from TENEX under the TENEX Supply Contract currently is subject to quotas and other restrictions under an agreement between the United States and the Russian Federation governing exports of Russian uranium products to the United States (the “RSA”). This agreement extends through 2040 under an amendment signed in October 2020 by the DOC and the Russian State Atomic Energy Corporation (“ROSATOM”). The October 2020 amendment provides quotas for shipments of Russian uranium products to the United States after 2020, and allocates a substantial portion of the quotas through 2028 to Centrus for use under the TENEX Supply Contract to supply LEU for use in U.S. reactors. These quotas will allow us to continue to supply Russian LEU to our U.S. customers through 2028. The terms of the RSA, as extended, were also adopted into law by the U.S. Congress in the Consolidated Appropriations Act, 2021. Refer to Item 1A Risk Factors - Operational Risks for further discussion.

9


The amount of SWU we must purchase from TENEX under the TENEX Supply Contract exceeds our current sales order book and, therefore, we will need to make new sales to place all the Russian LEU we must order to meet our SWU purchase obligations to TENEX. Although the quotas cover most of the LEU that we must order to fulfill our purchase obligations under the TENEX Supply Contract, we expect that a small portion of the Russian LEU that we order during the term of the TENEX Supply Contract will need to be delivered to customers who will use it in non-U.S. reactors.

We also have an agreement with Orano (the “Orano Supply Agreement”) for the long-term supply of SWU contained in LEU, commencing in 2023. Under the Orano Supply Agreement, we will purchase SWU contained in LEU received from Orano, and then deliver natural uranium to Orano for the natural uranium feed material component of LEU. We had the option to extend the six-year purchase period for an additional two years and have recently elected to take the additional supply in 2029. The Orano Supply Agreement provides flexibility to adjust purchase volumes, subject to annual minimums and maximums, in fixed amounts that vary year by year. The pricing for the purchased SWU is determined by a formula that uses a combination of market-related price points and other factors, and is subject to certain floors and ceilings. Prices are payable in a combination of U.S. dollars and euros.

We procure LEU from other sources under short-term and long-term contracts and have inventories available that diversify our supply portfolio and provide flexibility to help us meet the needs of our customers. We also have agreements to borrow SWU which we can use to optimize our purchases and deliveries over time.

Market prices for SWU fell substantially in the aftermath of the nuclear incident at Fukushima, Japan in 2011, bottoming out in August of 2018. While prices have been rising, they are still lower than market prices prior to Fukushima. Recent purchases of SWU and our long-term contract with Orano reflect these lower market prices. Additionally, prices under the TENEX Supply Contract have been adjusted to reflect lower market prices based on a one-time market related price reset that was agreed to when we signed the contract in 2011. The reset occurred in 2018, reducing the unit cost per SWU for our purchases from 2019 through 2028.

Technical Solutions

Our technical solutions segment reflects our technical, manufacturing, engineering, and operations services offered to public and private sector customers, including the American Centrifuge engineering, procurement, construction, manufacturing and operations services being performed under the HALEU Contract. With our private sector customers, we seek to leverage our domestic enrichment experience, engineering know-how and precision manufacturing facility to assist customers with a range of engineering, design and advanced manufacturing projects, including the production of fuel for next-generation nuclear reactors and the development of related facilities. Refer to Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - COVID-19 Update.

10

Government Contracting

On October 31, 2019, we signed the cost-share HALEU Contract with DOE to deploy a cascade of centrifuges to demonstrate production of HALEU for advanced reactors. The three-year program has been under way since May 31, 2019, when the Company and DOE signed an interim HALEU letter agreement that allowed work to begin while the full contract was being finalized. We have significantly invested in advanced technology because of the potential for future growth into new areas of business for the Company, while also preserving our unique workforce at our Technology and Manufacturing Center in Oak Ridge, Tennessee, and our production facility near Piketon, Ohio. The Company entered into this cost-share contract with DOE as a critical first step on the road back to the commercial production of enriched uranium, which the Company had terminated in 2013 with the closure of the Paducah GDP. The HALEU Contract, if fully implemented, is expected to result in the Company having readied the 16-machine cascade to enrich uranium to the 20% concentration in the uranium-235 isotope that is required by many of the advanced reactor concepts now under development. Centrus is currently the only company with an NRC license to enrich uranium up to the 20% concentration that is contained in HALEU.

In 2019, under the HALEU Contract, DOE agreed to reimburse the Company for 80% of its costs incurred in performing the contract, up to a maximum of $115 million (which was recently increased to $126.7 million, as noted below). The Company’s cost share is the corresponding 20% and any costs the Company elects to incur above these amounts. Costs under the HALEU Contract include program costs, including internal labor, third-party services and materials, and associated indirect costs that are classified as Cost of Sales, and an allocation of corporate costs supporting the program that are classified as Selling, General and Administrative Expenses. Services to be provided over the three-year contract include constructing and assembling centrifuge machines and related infrastructure, and training and qualifying the workforce for operation of the facility. When estimates of total costs for such an integrated, construction-type contract exceed estimates of total revenue to be earned, a provision for the remaining loss on the contract is recorded to Cost of Sales in the period the loss is determined. Our corporate costs supporting the program are recognized as expense, as incurred over the duration of the contract term. The accrued loss on the contract is being adjusted over the remaining contract term based on actual results, remaining program cost projections, and the Company’s anticipated cost-share.

Further, while we still anticipate completing construction of the cascade in 2022, due to a COVID-19 related supply chain delay in the DOE-supplied HALEU storage cylinders, production will commence under another contract that the DOE plans to compete later this year. The U.S. government has been operating under a series of continuing resolutions in Fiscal Year 2022. The DOE continues to support the HALEU program during the continuing resolution period, and has incrementally increased the government’s cost share ceiling as funds have become available. Currently, DOE has provided incremental funding, and increased the government’s cost share ceiling to $126.7 million. For further discussion, refer to Item 7, Management Discussion and Analysis, of this 10-K report.

Our HALEU Contract expires June 1, 2022, and although we believe demand for HALEU will emerge over the next several years, there are no guarantees about whether or when government or commercial demand for HALEU will materialize, and there are a number of technical, regulatory and economic hurdles that must be overcome for these fuels and reactors to come to the market.
Commercial Contracting

In 2018, we entered into two services agreements with X-energy to provide technical and resource support for the conceptual and preliminary design of its Tri-Structural Isotropic (“TRISO”) fuel manufacturing process. Both of these contracts have been completed. In August 2021, we entered into a new services agreement with X-energy to provide design services for detailed design of the TRISO fuel manufacturing facility and various support services for establishing their TRISO Research and Development Center. The task orders under the new agreement may include in-kind contributions that we are not currently, but may provide, at our discretion.

11


Competition and Foreign Trade

It is estimated that the enrichment industry market for commercial nuclear reactors powered by low enriched uranium (“LEU”) is currently about 57.5 million SWU per year. Our global market share of enrichment for the LEU market is less than 5%. Global LEU suppliers in our highly competitive industry compete on the basis of price and reliability of supply. The four largest LEU suppliers comprise over 95% of market share combined:
•ROSATOM, a Russian government entity, which sells LEU through its wholly-owned subsidiary TENEX;
•Urenco, a consortium of companies owned or controlled by the British and Dutch governments and two German utilities;
•Orano, a company largely owned by the French government that was formerly part of the French government; and
•China Nuclear Energy Industry Corporation (“CNEIC”), a company owned by the Chinese government.
The production capacity for ROSATOM/TENEX is estimated by the World Nuclear Association to be approximately 28.7 million SWU per year. Imports of LEU and other uranium products produced in the Russian Federation are subject to restrictions as described below under — Russian Suspension Agreement.

Urenco reported installed capacity at its European and U.S. enrichment facilities of 19.6 million SWU per year at the end of 2020.

Orano’s gas centrifuge enrichment plant in France began commercial operations in 2011 and the plant’s nominal capacity of 7.5 million SWU was reportedly in service at the end of 2016. Orano has reported that it has suspended planned capacity expansions beyond 7.5 million SWU.

CNEIC has emerged as a significant producer primarily focused on supplying domestic requirements in China. CNEIC’s commercial SWU production capacity is estimated to be approximately 10.7 million SWU per year in 2020.

All of our current competitors are owned or controlled, in whole or in part, by foreign governments, and operate enrichment technologies developed with the financial support of foreign governments. These competitors may make business decisions in both domestic and international markets that are influenced by political or economic policy considerations rather than exclusively by commercial considerations.

LEU also may be produced by down-blending government stockpiles of highly-enriched uranium. Governments control the timing and availability of highly-enriched uranium released for this purpose, and the release of this material to the market could impact market conditions. Given the current oversupplied nuclear fuel market, any additional LEU from down-blended highly-enriched uranium released into the market would have a negative effect on prices for LEU.

Our LEU supply to foreign customers is exported under the terms of international agreements governing nuclear cooperation between the United States and the government of the country of destination or other entities, such as the European Union or the International Atomic Energy Agency. The LEU supplied to us is subject to the terms of cooperation agreements between the country in which the material is produced and the country of destination or other entities.

12

Russian Suspension Agreement

Imports into the United States of LEU and other uranium products produced in the Russian Federation, including LEU imported by Centrus under the TENEX Supply Contract, are subject, through December 31, 2040, to quotas imposed under U.S. legislation enacted into law in September 2008 and December 2020, and under the RSA, as amended in 2008 and 2020. These quotas limit the amount of Russian LEU that can be imported into the United States for U.S. consumption1.

The RSA is a trade agreement between the DOC and the Russian State Atomic Energy Corporation (“ROSATOM”) originally signed in 1992 suspended an anti-dumping duty investigation of Russian uranium, and imposed quantitative limits on exports of Russian uranium products, including LEU, to the United States. Under an amendment signed on October 5, 2020, the RSA’s limits on shipments of Russian uranium product to the United States were extended through at least 2040. Additionally, under legislation passed by the U.S. Congress shortly after the amendment was signed, the material terms of the extended RSA were enacted into law.

Under this law and the RSA, imports of Russian uranium products will peak in 2023 at 24% of the forecasted U.S. demand for enrichment and then begin to decline, reaching 15% by 2028. Despite the fact that overall limits will ramp down, the RSA extension agreement explicitly sets aside sufficient quota in 2021-2028 for Centrus. The RSA and the legislation provide for a revision of the quotas in 2023, 2029, and 2035 to take account of SWU demand forecasts that will be published by the WNA in the future. Any quota adjustment or other change to the RSA could affect our ability to implement the TENEX Supply Contract through sales to customers who take delivery in the United States, which is our most significant market.

The actual size of the annual quotas allocated to Centrus for the TENEX Supply Contract are confidential, but a public version of the quotas shows that they represent a significant portion of the total quotas provided under the RSA in 2021-2028. The quotas provided for the TENEX Supply Contract are expected to be adequate to support the Company’s long-term strategic goals and to permit enriched uranium procured from TENEX during the remaining term of the TENEX Supply Contract to be imported to supply U.S. utilities, thereby securing a key part of the Company’s supply base for the benefit of its customers and providing the revenues needed by the Company to support its work on HALEU and other advanced technology projects in the United States.

For further details, refer to Part I, Item 1A, Risk Factors - Our future prospects are tied directly to the nuclear energy industry worldwide, and the financial difficulties experienced by, and operating conditions of, our customers and suppliers could adversely affect our results of operations and financial condition.

Other Actions Adversely Affecting International Trade
In 2018, in connection with the withdrawal by the United States from a 2015 multilateral agreement known as the Joint Comprehensive Plan of Action (“JCPOA”) the U.S. government re-imposed sanctions on Iran’s Atomic Energy Organization of Iran (“AEOI”) and a number of its subsidiaries. Waivers were granted to allow non-Iranian entities to continue to work on certain programs that, among other things, allowed affiliates of ROSATOM to continue work on nuclear projects in Iran. These waivers have expired or been terminated and as a result, the U.S. government could decide to impose sanctions on Russian entities that may be involved in nuclear work in Iran, including ROSATOM or its subsidiaries. These sanctions could affect companies owned by ROSATOM, including TENEX, even if they are not doing work in Iran. To date, no sanctions have been imposed or announced on TENEX or any other ROSATOM subsidiary involved in the TENEX Supply Contract, in respect to the work of ROSATOM or its subsidiaries in Iran.


1 The term “quota” is used herein for simplicity. The amounts of Russian uranium products that can be shipped to the United States are referred to as export limits in the RSA and import limits in the legislation, but from a practical perspective have identical effect.
13

DOE Facilities

We produced LEU through 2001 at the former Portsmouth Gaseous Diffusion Plant (“Portsmouth GDP”) in Piketon, Ohio and through 2013 at the former Paducah GDP in Paducah, Kentucky, which we had leased from DOE. We currently store our existing inventory at third-party offsite licensed locations under agreements with the operators of those facilities. The Portsmouth GDP and Paducah GDP were operated by agencies of the U.S. government for more than 40 years prior to the creation of the Company through privatization of the Government enterprise in 1998. As a result of such operation, there are contamination and other potential environmental liabilities associated with the Government’s prior operation of the plants. The USEC Privatization Act and our former leases for the plants provide that DOE remains responsible for the decontamination and decommissioning (“D&D”) of the gaseous diffusion plants. Further, DOE continued operations as well as cleanup activities, both during and subsequent, to our operations at the facilities.

We lease facilities and related personal property near Piketon, Ohio from DOE. In connection with a letter agreement that preceded the HALEU Contract, DOE and Centrus amended the lease agreement, which was scheduled to expire by its terms on June 30, 2019. The lease was extended until May 31, 2022. In September 2021, the Company and the DOE renewed and extended the lease until December 31, 2025. Any facilities or equipment constructed or installed under the HALEU Contract, or other contract with DOE will be owned by DOE and may be returned to DOE in an “as is” condition at the end of the lease term. DOE will be responsible for the D&D of any returned facilities or equipment. If we determine the equipment and facilities may benefit Centrus after completion of the HALEU program, we can extend the facility lease and ownership of the equipment will be transferred to us, subject to mutual agreement regarding D&D and other issues, including those impacted by DOE’s recent decision to competitively award a separate contract for operations of the HALEU cascade following the expiration of our HALEU Contract, which may be awarded to a third party.

14


Human Capital Management

Our employees in Maryland, Ohio, and Tennessee are dedicated to our corporate philosophy based in honesty, trust, and with the highest levels of integrity, safety and security. Every day these values drive how we operate our business; govern how we interact with each other and our customers, partners, and suppliers; guide the way that we treat our workforce; and determine how we connect with our communities. Our commitment to ethical business practices is outlined in our Code of Business Conduct. Each employee is required to acknowledge receipt, understanding of, and compliance with our standards.

Due to the highly specialized nature of our business we need to hire and train skilled and qualified personnel to design, build, and operate our state of the art equipment, and to perform a broad range of services to support our country and our customers. Our work requires that we attract people who are dedicated to consistently performing quality work and, for many of our positions, are able to obtain a security clearance. We recognize that our success as a company depends on our ability to attract, develop, and retain such a workforce. We are dedicated to promoting the health, welfare and safety of our employees. Part of our responsibility includes treating all employees with dignity and respect and providing them with fair, market-based, competitive, and equitable compensation. We recognize and reward the performance of our employees in line with our pay-for-performance philosophy and provide a comprehensive suite of benefit options that enables our employees and their dependents to live healthy and productive lives.

Safety in our workplaces is paramount. We take measures to prevent workplace hazards, encourage safe behaviors and enforce a culture of continuous improvement to ensure our processes help eliminate incidents and injuries and comply with governing health and safety laws.

We are committed to promoting diversity of thought, experience, perspectives, backgrounds, and capabilities to drive innovation and to strengthen the solutions we deliver to our customers because we believe this diversity leads to better outcomes. We proudly support a culture of inclusion and encourage a work environment that respects diverse opinions, values individual skills, and celebrates the unique experiences our employees possess. To ensure a diverse group of candidates is considered for each opening we enlist the services of a Human Resource Consulting firm that provides services and products related to Affirmative Action Programs (“AAPs”) and equal employment opportunity as required by the U.S. Department of Labor's Office of Federal Contract Compliance Programs (“OFCCP”).

Our values motivate us to promote strong workplace practices with opportunities for development and training. Our training and development efforts focus on ensuring that the workforce is appropriately trained on critical job skills as well as leadership attributes that are consistent with our philosophy. During the COVID-19 pandemic, we transitioned our headquarters staff to work from home. We have endeavored to maintain the highest levels of safety for our operations staff, who are in open offices, with enforcement of social distancing, face masks, and also 100% daily temperature screening. All non-bargaining unit employees of the Company, including those working from home, are either fully vaccinated (95%) against the COVID-19 virus or working with accommodations (5%).

A summary of our employees by location is as follows:
No. of Employees
at December 31,
Location20212020
Piketon, OH115 107 
Oak Ridge, TN101 105 
Bethesda, MD50 53 
Other— 2 
Total Employees266 267 
 
15

On January 16, 2020, members of the United Steelworkers (“USW”) Local 689-5 ratified a new collective bargaining agreement for the employees represented by the USW at the advanced technology facility near Piketon, Ohio. The contract term is through October 1, 2022.

16

Executive Officers
Executive officers are elected by and serve at the discretion of the Board of Directors. The Executive officers as of December 31, 2021, are as follows:
NameAgePosition
Daniel B. Poneman65President and Chief Executive Officer
Larry B. Cutlip62Senior Vice President, Field Operations
Dennis J. Scott62
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary 
Philip O. Strawbridge67
Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer
John M.A. Donelson57Senior Vice President and Chief Marketing Officer
Daniel B. Poneman has been President and Chief Executive Officer since April 2015 and was Chief Strategic Officer in March 2015. Prior to joining the Company, Mr. Poneman was Deputy Secretary of Energy from May 2009 to October 2014, in which capacity he also served as Chief Operating Officer of DOE. 
Larry B. Cutlip has been Senior Vice President, Field Operations since January 2018, was Vice President, Field Operations from May 2016 through December 2017, was Deputy Director of the American Centrifuge Project from January 2015 to May 2016, was Director, Centrifuge Manufacturing from April 2008 to December 2014, was Director, Program Management and Strategic Planning from December 2005 to April 2008, was Manager, Engineering from May 1999 to December 2005, and held positions in operations management and engineering at the Company and its predecessors since 1981.
Dennis J. Scott has been Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary since January 2018 and was Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary from May 2016 through December 2017. Mr. Scott was Deputy General Counsel and Director, Corporate Compliance from April 2011 to May 2016, Acting Deputy General Counsel from August 2010 to April 2011, Assistant General Counsel and Director, Corporate Compliance from April 2005 to August 2010 and Assistant General Counsel from January 1994 to April 2005.
Philip O. Strawbridge has been Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer since September 2019. Prior to joining the Company, Mr. Strawbridge served as an executive adviser at Court Square Capital from 2010 to 2013. Mr. Strawbridge served in various executive positions including Chief Financial Officer at EnergySolutions, a nuclear services and technology company, from 2006 to 2010. He was Chief Executive Officer and Chief Operating Officer of BNG America, which provided nuclear waste management services and technology to U.S. Government and commercial clients, from 1999 until BNG America was acquired by EnergySolutions in early 2006. 

John M.A. Donelson has been Senior Vice President and Chief Marketing Officer since October 2019 and was Vice President, Sales and Chief Marketing Officer from January 2018 through October 2019. Mr. Donelson was Vice President, Marketing, Sales and Power from April 2011 through December 2017, Vice President, Marketing and Sales from December 2005 to April 2011, Director, North American and European Sales from June 2004 to December 2005, Director, North American Sales from August 2000 to June 2004 and Senior Sales Executive from July 1999 to August 2000.

17

Available Information
 
Our website is www.centrusenergy.com. We make available on our website, or upon request, without charge, access to our Annual Report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed with, or furnished to, the Securities and Exchange Commission, pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable after such reports are electronically filed with, or furnished to, the Securities and Exchange Commission.
 
Our code of business conduct (the “Code of Business Conduct”) provides a brief summary of the standards of conduct that are at the foundation of our business operations. The Code of Business Conduct states that we conduct our business in strict compliance with all applicable laws. Each employee must read the Code of Business Conduct and sign a form stating that he or she has read, understands and agrees to comply with the Code of Business Conduct. A copy of the Code of Business Conduct is available on our website or upon request without charge. We will disclose on the website any amendments to, or waivers from, the code of business conduct that are required to be publicly disclosed.
 
We also make available on our website or upon request, free of charge, our Code of Business Conduct, Board of Directors Governance Guidelines, and our Board committee charters.

18

Item 1A. Risk Factors

The following discussion sets forth the material risk factors that could affect our financial condition and operations. Readers should not consider any descriptions to be a complete set of all potential risks that could affect us.

War in Ukraine

The current war in Ukraine has led to the U.S., Russia and other countries imposing sanctions and other measures that restrict international trade. The situation is rapidly changing, and it is not possible to predict future actions that could be taken. The Company has multiple sources of supply; however, the supply contract with Tenex remains our largest source. At present, sanctions have not impacted the ability of the Company or TENEX to perform under the TENEX supply contract. Recently sanctions have been imposed by the U.S. on exports of fossil fuels. Russia has imposed sanctions on the export of commodities but does not include the export of LEU. Additional sanctions or other measures by the U.S. or foreign governments (including the Russian government) could be imposed. Any sanctions or measures directed at trade in LEU from Russia or the parties involved in such trade or otherwise could interfere with, or prevent, implementation of the TENEX Supply Contract. While the initial sanctions announced do not affect the ability of the Company or TENEX to implement the TENEX Supply Contract, the situation at this time is unpredictable and therefore there is no assurance that future developments would not have a material adverse effect on the Company’s procurement, payment, delivery or sale of LEU under the TENEX Supply Contract.

If measures were taken to limit the supply of Russian LEU or to prohibit or limit dealings with Russian entities, including, but not limited to, TENEX or ROSATOM, the Company would seek a license, waiver or other approval from the government imposing such measures to ensure that the Company could continue to fulfill its purchase and sales obligations. There is no assurance that such a license, waiver, or approval would be granted. If a license, waiver or approval were not granted, the Company would need to look to alternative sources of LEU to replace the LEU that it could not procure from TENEX. The Company has contracts for alternative sources that could be used to mitigate a portion of the near term impacts. However, to the extent these sources were insufficient or more expensive or additional supply cannot be obtained, it could have a material adverse impact on our business, results of operations, and competitive position.

Economic and Industry Risks

Our future prospects are tied directly to the nuclear energy industry worldwide, and the financial difficulties experienced by, and operating conditions of, our customers and suppliers could adversely affect our results of operations and financial condition.

Potential events that could affect either our customers or suppliers under current or future contracts with us or the nuclear industry as a whole, include:
•pandemics, armed conflicts (including the war in Ukraine), government actions and other events that disrupt supply chains, production, transportation, payments and importation of nuclear materials or other critical supplies or services;
•natural or other disasters (such as the 2011 Fukushima disaster) impacting nuclear facilities or involving shipments of nuclear materials;
•changes in U.S. or foreign government policies and priorities;
•regulatory actions or changes in regulations by nuclear regulatory bodies applicable to us, our suppliers or our customers;
•decisions by agencies, courts or other bodies under applicable trade and other laws applicable to us, our suppliers or our customers;
•disruptions in other areas of the nuclear fuel cycle, such as uranium supplies or conversion;
•civic opposition to, or changes in government policies regarding, nuclear operations;
•business decisions concerning reactors or reactor operations;
19

•the financial condition of reactor owners and operations;
•the need for generating capacity; or
•consolidation within the electric power industry.

These events could adversely affect us to the extent they result in a reduction or elimination of customers’ contractual requirements to purchase from us; the suspension or reduction of nuclear reactor operations; the reduction or blocking of supplies of raw materials, natural or enriched uranium or separative work units (SWU), lower demand, burdensome regulation, disruptions of shipments, production importation or payment (including the blocking or restriction of transportation services or hardware); increased competition from third parties; and increased costs or difficulties or increased liability for actual or threatened property damage or personal injury. Additionally, customers may face financial difficulties, including from factors unrelated to the nuclear industry, that could affect their willingness or ability to make purchases. We cannot provide any assurance that events will not preclude us from making deliveries to our customers, increase our costs or that our customers, suppliers, or contractors will not default on their obligations to us or file for bankruptcy protection. If a customer files for bankruptcy protection, for example, we likely would be unable to collect all, or even a significant portion, of amounts that are owed to us. A default and bankruptcy filing by one or more customers or suppliers, or events (such as government actions) which prevent or limit our ability to obtain or sell material or services, could have a material adverse effect on our business, financial position, results of operations, or cash flows.

Our business, financial and operating performance could be adversely affected by epidemics and other health related issues including but not limited to the coronavirus disease 2019 (“COVID-19”) pandemic.

The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by the U.S. Government and has negatively affected the U.S. and global economies, disrupted supply chains, and has resulted in significant travel, transport, and other restrictions. The COVID-19 outbreak has disrupted the supply chains and day-to-day operations of the Company, our suppliers, our contractors, and our customers, which could materially adversely affect our operations. In this regard, global supply chains and the timely availability of products or product components sourced domestically or imported from other nations, including SWU contained in LEU we purchase, could be materially disrupted by quarantines, slowdowns or shutdowns, border closings, and travel restrictions resulting from the global COVID-19 pandemic or other global pandemic or health crises. Further, impacts of COVID-19 infections and other COVID-19 pandemic related impacts on our management and workforce, or our suppliers, contractors, or customers, could adversely impact our business. While we have taken steps to protect our workforce and carry on operations, we may not be able to mitigate all of the potential impacts. We anticipate increased costs related to, or resulting from, the COVID-19 pandemic, due to, among other things, delays in supplier deliveries, impacts of travel restrictions, site access and quarantine requirements, and the impacts of remote work and adjusted work schedules.

The impacts of the COVID-19 pandemic have been primarily affecting our technical solutions segment since much of the work required under the HALEU Contract must be performed on the Company’s sites and on our suppliers’ sites. As a result, our costs under the HALEU Contract have been impacted. Further, as a result of the U.S. Department of Energy (“DOE”) not supplying us cylinders as required under the HALEU Contract, operation of the cascade has been deferred and will be performed under a subsequent competitively bid contract that may or may not be awarded to us.

In the event that the COVID-19 pandemic prevents our employees or our contractors from working in-person at our site or, our suppliers are unable to provide goods and services on the schedule we anticipated, the impacts on our schedule and costs could be material. Again, while we have worked to mitigate the impact, we are experiencing increased costs as the result of the impact of the pandemic on their operations.

We continue to work with our customers, employees, contractors, suppliers and communities to address the impacts of the COVID-19 pandemic and to take actions in an effort to mitigate adverse consequences. However, the ultimate impact of the COVID-19 pandemic on our operations and financial performance in future periods,
20

including our ability to execute our strategic plan and programs in the expected timeframe, remains uncertain and will depend on future pandemic related developments, including the duration of the pandemic and any potential subsequent variants of COVID-19 and related government actions to prevent and manage disease spread, all of which are uncertain and cannot be predicted. The long-term impacts of the COVID-19 pandemic on us or on government budgets, our customers, contractors and suppliers that could impact our business are also difficult to predict but could adversely affect our business, results of operations, and prospects.

The continued excess supply of LEU in the market could adversely affect market prices and our business results.

Events related to the March 2011 earthquake and tsunami that caused irreparable damage to four reactors in Fukushima, Japan created an over-supply of nuclear fuel that continues to heavily influence market prices. In addition, reactor operators facing aggressive price competition from natural gas and subsidized renewable generation like wind and solar, have closed or are planning to close reactors, further reducing demand for our product and services. Despite the decrease in demand, some of our competitors supported by foreign governments continued to expand their capacity. Market uncertainty, and reduced demand, coupled with excess capacity and supply has adversely affected our ability to sell LEU and SWU and could adversely affect our business, results of operations, and prospects.

Our business is exposed to price volatility associated the procurement of SWU and uranium.

The Company is exposed to commodity price risk for purchases of SWU and uranium. Our earnings and cash flows are therefore exposed to variability of spot and forward market prices in the markets in which it operates. The supply markets for SWU and uranium are subject to price fluctuations and availability restrictions.

Operational Risks

Restrictions on imports or sales of SWU or uranium that we buy from our Russian supplier and our other sources of supply could adversely affect profitability and the viability of our business.

The majority of the SWU and LEU that we use to fill existing contracts with customers is sourced from outside the United States, including from Russia under the TENEX Supply Agreement, and we expect the arrangement to continue into the future. Our ability to place this SWU and LEU into existing and future contracts with customers is subject to trade restrictions, sanctions, and other limitations imposed by the United States and other governments and our customers. For example, our imports from Russia are subject to U.S. quotas. Given the quotas, restrictions, and customer limitations that limit our ability to sell SWU and LEU purchased under the TENEX Supply Agreement both in the United States and globally, there is no guarantee that we can make sufficient sales to meet our minimum purchase obligation under the TENEX Supply Agreement. (For further information refer to Part I, Item 1, Competition and Foreign Trade).

Further, currently evolving international events, including the war in Ukraine could result in new or additional sanctions or other U.S. or foreign government actions that could directly or indirectly limit or prevent our purchase, importation, or ability to sell material under our TENEX Supply Agreement. Even absent such restrictions, some of our U.S. and foreign customers are unable or unwilling to accept Russian SWU and uranium.

Geopolitical events, including domestic or international reactions or responses to such events, as well as concerns about national security or other issues, also could lead to U.S. or foreign government or international actions that could disrupt our ability to purchase, sell, or make deliveries of LEU, SWU, or other uranium products, or even to continue to do business with one or more of our suppliers or their affiliates. Our inability to meet our purchase or sales obligations, or to earn revenues from U.S. and international sales, would adversely affect our financial condition, results of operations, cash flows, and the viability of our business. All of these outcomes, individually and collectively, could cause us to incur significant financial losses, in addition to impeding or preventing us from fulfilling our existing contracts, or winning new contracts, and could adversely affect our profitability and the viability of our business.
21


We may be unable to sell all of the LEU we are required to purchase under supply agreements for prices that cover our costs, which could adversely affect profitability and the viability of our business.

We may not achieve the anticipated benefits from supply agreements we enter into. The prices we are charged under some supply agreements are determined by formulas that may not be aligned with the prevailing market prices at the time we enter into contracts with customers. As a result, the sales prices in our contracts may not cover our purchase costs, or those purchase costs may limit our ability to secure profitable sales.

We are dependent on purchases from our suppliers and other sources to meet our obligations to customers and rely on third parties to provide essential services.

We are currently dependent on purchases from suppliers to meet our obligations to customers, including purchases from the Russian government entity, TENEX. A significant delay in, or stoppage or termination of, deliveries of material to us under our supply agreements, could adversely affect our ability to make deliveries to customers. The recent action of Russian military forces in Ukraine has escalated tensions between Russia and the U.S. The U.S. has imposed, and is likely to impose additional, financial and economic sanctions and export controls against certain Russian organizations and/or individuals. Sanctions and export controls, as well as any actions by Russia, could adversely affect our supply and our ability to meet our obligations to customers.

We also rely on third parties to provide essential services to the Company, such as the storage and management of inventory, transportation, and radiation protection. Those service providers may not perform on time, with the desired quality, or at all for a variety of reasons, many of which are outside our control. An interruption of deliveries from our suppliers or the provision of essential services by third parties, could adversely impact our business, results of operations, and prospects.

We face significant competition from major producers who may be less cost sensitive or may be favored due to support from foreign governments.

We compete with major producers of LEU, all of which are wholly or substantially owned by governments: Orano (France), Rosatom/TENEX (Russia), Urenco (the Netherlands, the United Kingdom and two German utilities), and CNEIC (China). Our competitors have greater financial resources than we do. Foreign competitors enjoy financial and other support from their government owners, which may enable them to be less cost or profit-sensitive than we are. In addition, decisions by foreign competitors may be influenced by political and economic policy considerations rather than commercial considerations. For example, foreign competitors may elect to increase their production or exports of LEU, SWU, or other uranium products, including HALEU, even when not justified by market conditions, thereby depressing prices and reducing demand for our LEU, SWU, and other uranium products. This could adversely affect our business, results of operations, and prospects. Moreover, our competitors may be better positioned to take advantage of improved market conditions and increase capacity to meet any future market expansion.

The ability to compete in certain foreign markets may be limited for legal, political, economic or other reasons.

Doing business in foreign markets poses additional risks and challenges. For example, agreements for cooperation between the U.S. government and various foreign governments or governmental agencies control the export of nuclear materials from the United States. We are unable to supply fuel for foreign reactors unless there is an agreement for cooperation in force. If an agreement with a country in which one or more of our customers is located were to lapse, terminate, or be amended, our sales or deliveries could be curtailed or terminated, adversely affecting our business, results of operations, and prospects. Moreover, the lack of such agreements for cooperation between the United States government and those governments or agencies in emerging markets may restrict our ability to sell into such markets. Additionally, countries may impose other restrictions on the import or export of material or services.

22

Purchases of LEU and SWU by customers in the European Union are subject to a policy of the Euratom Supply Agency that seeks to limit foreign enriched uranium to no more than 20% of European Union consumption per year. Similarly, China has a policy of using Chinese sources of LEU and SWU. Such policies limit our ability to sell in those countries.

Certain foreign markets lack a comprehensive nuclear liability law that protects suppliers by channeling liability for injury and property damage suffered by third persons from nuclear incidents at a nuclear facility to the facility’s operator. The lack of legal protection for suppliers could adversely affect our ability to compete for sales to meet the growing demand for LEU or SWU in these markets and our prospects for future revenue from such sales.

Dependence on our largest customers could adversely affect us.

In 2021, our ten largest nuclear fuel customers represented approximately 57% of total revenue and our two largest customers represented approximately 24% of total revenue. Further, individual orders average $7.4 million. A reduction in purchases from our customers, whether due to their decision not to purchase optional quantities or for other reasons, including a disruption or change in their operations or financial condition that reduces purchases of LEU, SWU, or other uranium products from us, could adversely affect our business, results of operations, and prospects. Once lost, customers may be difficult to regain because they typically purchase under long-term contracts. Consequently, we may face reduced revenues and difficulty in selling the material we are obligated to buy, which could adversely affect our business, results of operations, and prospects.

The dollar amount of the sales order book, as stated at any given time, is not necessarily indicative of future sales revenues and is subject to uncertainty.

Our order book of sales is the estimated aggregate dollar amount of SWU and uranium sales that we expect to recognize as revenue in future periods under existing contracts with customers. It includes deferred revenue for sales in which we have been paid but still have a delivery obligation, which means we will not receive cash in the future from those deliveries. There is no assurance that the revenues projected will be realized, or, if realized, will result in profits. Our estimate of the order book is based on a number of factors including customers’ estimates of the timing and size of their fuel requirements and estimates of future selling prices. For example, depending on the terms of specific contracts, prices may be adjusted based on escalation using a general inflation index, published SWU or uranium market price indicators prevailing at the time of delivery, and other factors, all of which are unpredictable. Any inaccuracy in estimates of future prices would add to the imprecision of the order book estimate. From time to time, we have worked with customers to modify contracts that have delivery, scheduling, origin or other terms that may require modifications to address our anticipated supply sources. If we were to initiate such discussions in the future, we have no assurance that our customers would agree to revise existing contracts or would not require concessions, which could adversely affect the value of our order book and our prospects.

Our ability to operate the HALEU enrichment facility we are deploying under the HALEU Contract after the completion of the deployment is dependent on our ability to secure additional contracts and funding from the U.S. government or other sources.

In 2019, Centrus began work on a three-year, cost-shared contract with the DOE to deploy a cascade of 16 of our AC100M centrifuges to demonstrate production of HALEU with domestic technology. As a result of the on-going supply chain disruptions due to the COVID-19 pandemic and other factors, DOE has been unable to provide the cylinders required to begin HALEU production under the current contract. Consequently, operation of the demonstration cascade will be performed pursuant to a separate subsequent, competitively-awarded contract which may not be awarded to us. Although we believe we are well positioned to compete for the subsequent contract to operate the cascade beginning in 2022, there is no assurance that we will be awarded such contract.

Our goal is to be in a position to begin production and scale up the facility in modular fashion as demand for HALEU grows in the commercial and/or government sectors. However, our right to operate the facility we are building depends on the award of one or more follow-on contracts by the U.S. government, as well as continued
23

funding for operation from the U.S. government or other sources. There is no assurance that we will be awarded such contracts or that such funding will be available. Further, it is uncertain whether or when demand to support the scale up of the facility will materialize. If we do not secure the necessary contracts and funding and if sufficient demand does not emerge, we may not be able to continue or expand operations at that facility and may not be able to support providing HALEU fuel for the advanced reactors under development.

If we are required to delease the facility where we are deploying the HALEU cascade under the HALEU Contract and return it, along with the centrifuges and supporting equipment, to the DOE at the expirations of our contract, this would likely result in the termination of our NRC operating license and us laying off our Piketon workforce. However, if we are able to continue operating the facility, we would incur additional costs and liabilities associated with the facility.

If the Company’s operation of the Piketon facility were terminated, there can be no assurance that we could regain use of the Piketon facility or obtain a new NRC license in the future at the Piketon site or an alternative site, in which event we would be unable to begin commercial production of HALEU. We may also incur additional costs related to reducing our workforce or closing the Piketon facility. Failure to secure U.S. government or other funding to support the continued operation of the Piketon facility, and retain our NRC license, could have a material adverse effect on our business and financial condition along with our plans for future growth.

Our technical solutions segment conducts business under various types of contracts, including fixed-price and cost-share contracts, which subjects us to risks associated with cost over-runs.

The technical solutions segment conducts business under various types of contracts, including fixed-price contracts and cost-share contracts, where costs must be estimated in advance of our performance. These types of contracts are priced, in part, on cost and scheduling estimates that are based on assumptions including prices and availability of experienced labor, equipment and materials, and estimates of the amount of other contract work we expect to perform. In the event we have cost overruns, we may not be able to obtain compensation for additional work performed or expenses incurred. Our failure to accurately estimate the resources and time required for fixed-price or cost-share contracts or our failure to complete our contractual obligations within the time frame and costs committed could result in reduced profits, greater costs, or a loss for that contract. If the cost overrun on a contract is significant, or we encounter issues that affect multiple contracts, the cost overrun could have a material adverse effect on our business, financial condition, and results of operations.

Financial Risks

We have significant long-term liabilities.

We continue to have significant long-term liabilities, including the indebtedness under our 8.25% Notes, which mature in February 2027. We also still have substantial pension and postretirement health and life benefit obligations and other long-term liabilities.

Our significant long-term liabilities (and other third-party financial obligations) could have important consequences, including:
•making it more difficult for us to satisfy our obligations to lenders and other creditors, resulting in possible defaults on, and acceleration of, such indebtedness or breaches of such other commitments;
•placing us at a competitive disadvantage by making us more vulnerable to react to adverse economic conditions or changes in the nuclear industry;
•hindering our ability to obtain additional financing for future working capital and other general corporate requirements;
•reducing our cash resources for payments on our 8.25% Notes thereby limiting our ability to fund our operations, capital expenditures, and future business opportunities;
24

•placing certain restrictions on the ability of our subsidiary, United States Enrichment Corporation (“Enrichment Corp.”), to transfer cash and other assets to us, which could constrain our ability to pay dividends on our Common Stock or to fund our commitments or the commitments of our other subsidiaries, pursuant to the indenture governing our 8.25% Notes, subject to certain exceptions; and
•restricting our ability to engage in certain mergers or acquisitions pursuant to the indenture governing our 8.25% Notes also requires us to offer to repurchase all such outstanding notes at 101% of their outstanding principal amount in the event of certain change of control events.

The terms of the indenture governing our 8.25% Notes do not restrict Centrus or any of its subsidiaries from incurring substantial additional indebtedness in the future. If we incur substantial additional indebtedness the foregoing risks would intensify, however. Additional information concerning the 8.25% Notes including the terms and conditions of the 8.25% Notes are described in Note 8, Debt of the consolidated financial statements.

The Company has material unfunded defined benefit pension plans obligations and postretirement health and life benefit obligations. Levels of returns on pension and postretirement benefit plan assets, changes in interest rates and other factors affecting the amounts to be contributed to fund future pension and postretirement benefit liabilities could adversely affect earnings and cash flows in future periods.

Centrus and its subsidiary, Enrichment Corp., maintain qualified defined benefit pension plans that are guaranteed by the Pension Benefit Guaranty Corporation (“PBGC”), a wholly-owned U.S. government corporation that was created by the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). Centrus also maintains non-qualified defined benefit pension plans for certain executive officers. These plans are anticipated to require material cash contributions in the future, which may divert funds from other uses and could adversely impact our liquidity depending on the timing of any required contributions or payments in relation to our sources of cash and other payment obligations.

Further, earnings may be positively or negatively impacted by the amount of expense we record for employee benefit plans. Generally accepted accounting principles in the United States (“U.S. GAAP”) require a company to calculate expenses for these plans using actuarial valuations. The IRS and the Pension Protection Act of 2006 regulate the minimum amount we contribute to our pension plans. The amount we are required to contribute to pension plans could have an adverse effect on our cash flows.

Our revenues and operating results may fluctuate significantly from quarter to quarter and year to year, which could have an adverse effect on our cash flows.

Revenue is recognized when or as we transfer control of the promised LEU or uranium to the customer. Customer demand is affected by, among other things, electricity markets, reactor operations, maintenance, and the timing of refueling outages. As a result, a relatively small change in the timing, amount, or other terms of customer orders for LEU due to a change in a customer’s refueling schedule or other reasons may cause operating results to be substantially above or below expectations, which could have an adverse effect on our cash flows.

Results of operations could be negatively impacted if adverse conditions or changes in circumstances indicate a possible impairment loss related to our intangible assets.

Intangible assets originated from our reorganization and application of fresh start accounting as of September 30, 2014. The intangible assets represented the fair value adjustment to the assets and liabilities for our LEU segment. The intangible assets remaining on our balance sheet relate to our sales order book and customer relationships. The order book intangible asset is amortized to expense as the order book valued at emergence is reduced, principally as a result of deliveries to customers. The customer relationships intangible asset is amortized to expense using the straight-line method over the estimated average useful life of 15 years with 7 ¾ years of scheduled amortization remaining.

25

The carrying values of the intangible assets are subject to impairment tests whenever adverse conditions or changes in circumstances indicate a possible impairment loss. If impairment is indicated, the asset carrying value will be reduced to its fair value. Inherent in our fair value determinations are certain judgments and estimates, including projections of future cash flows, the discount rate reflecting the risk inherent in future cash flows, the interpretation of current economic indicators and market valuations, and strategic plans with regard to operations. A change in these underlying assumptions could cause the fair value of the intangible asset to be less than its respective carrying amount.

Centrus is dependent on intercompany support from Enrichment Corp.

Substantially all of our revenue-generating operations are conducted at our subsidiary, Enrichment Corp. The financing obtained from Enrichment Corp. funds our general corporate expenses, including interest payments on the 8.25% Notes, which are guaranteed on a limited and subordinated basis by Enrichment Corp. As a wholly-owned subsidiary of Centrus, Enrichment Corp. has its own set of creditors and a separate board of directors (the “Enrichment Board”), who are elected by Centrus. Current and future funding and support are conditional and dependent on Enrichment Corp.’s own financial condition and a determination by the Enrichment Board that such funding is in the interest of Enrichment Corp.

There is limited trading volume for our securities and the market price of our securities is subject to volatility.

The price of our Class A Common Stock remains subject to volatility. The market price and level of trading of our Class A Common Stock could be subject to wide fluctuations in response to numerous factors, many of which are beyond our control. These factors include, among other things, our limited trading history, our limited trading volume, the concentration of holdings of our Class A Common Stock, actual or anticipated variations in our operating results and cash flow, the nature and content of our earnings releases, announcements or events that impact our products, customers, competitors or markets, business conditions in our markets and the general state of the securities markets and the market for energy-related stocks, as well as general economic and market conditions and other factors that may affect our future results. Additionally, future sales of our common stock or instruments convertible into our common stock, in public or private offerings may depress our stock price.

Holders of our Class B Common Stock, par value $0.10 per share (“Class B Common Stock” and together with the Class A Common Stock, “Common Stock”) may make decisions regarding their investment in the Company based upon factors that are unrelated to the Company’s performance. Any sales of shares by holders of our Class B Common Stock would result in automatic conversion (with limited exceptions) of Class B Common Stock into Class A Common Stock, which in turn could adversely impact the trading price of the Class A Common Stock.

Our 8.25% Notes are not listed on any securities exchange. No assurance can be given as to the liquidity of the trading market for the 8.25% Notes. The 8.25% Notes may only be traded infrequently in transactions arranged through brokers or otherwise, and reliable market quotations for the 8.25% Notes may not be available. In addition, the trading prices of the 8.25% Notes will depend on many factors, including prevailing interest rates, the trading volumes, and the other factors discussed above with respect to the Class A Common Stock.

A small number of holders of our Class A Common Stock may exert significant influence over the direction of the Company.

As of December 31, 2021, based solely on amounts reported in Schedule 13D and 13G filings with the SEC, two stockholders with the largest holdings of our Class A Common Stock collectively own approximately 19% of our Class A Common Stock. As a result, these stockholders may be able to exert significant influence over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, such as a merger of the Company, or sale of substantially all of the Company’s assets. These stockholders may have interests that differ from, and may vote in a way adverse to, other holders of Class A Common Stock, or adverse to the recommendations of the Company’s management. This concentration of ownership may make it more difficult for other stockholders to effect substantial changes in the Company, may limit the ability of the Company to pass
26

certain initiatives or other items that require stockholder approval, and may also have the effect of delaying, preventing, or expediting, as the case may be, a change in control of the Company.

A small number of Class A stockholders, who also have significant holdings of the Company’s 8.25% Notes, may be motivated by interests that are not aligned with the Company’s other Class A stockholders.

Currently, a small number of persons who also are stockholders collectively own greater than 25% of our 8.25% Notes. As a result, these stockholders may have interests that differ from the remainder of the holders of our Class A Common Stock, and, as a result, may vote or take other actions in a way adverse to other holders of Class A Common Stock.

Our ability to utilize our net operating loss carryforwards to offset future taxable income may be limited.

Our ability to fully utilize our existing net operating losses (“NOLs”) or net unrealized built-in losses could be limited or eliminated in the event (i) we undergo an “ownership change” as described under Section 382 of the Internal Revenue Code, (ii) we do not reach profitability or are only marginally profitable, or (iii) there are changes in U.S. government laws and regulations. An “ownership change” is generally defined as a greater than 50% change in equity ownership by value over a rolling three-year period. Past or future ownership changes, some of which may be beyond our control, as well as differences and fluctuations in the value of our equity securities may adversely affect our ability to utilize our NOLs and could reduce our flexibility to raise capital in future equity financings or other transactions, or we may decide to pursue transactions even if they would result in an ownership change and impair our ability to use our NOLs. In addition, the “Section 382 Rights Agreement” we have adopted with respect to our common stock contains limitations on transferability intended to prevent the possibility of experiencing an “ownership change,” but we cannot be certain that these measures will be effective. We also may decide to pursue transactions even if they would result in an ownership change and impair our ability to use our NOLs. In addition, any changes to tax rules and regulations or the interpretation of tax rules and regulations could negatively impact our ability to recognize any potential benefits from our NOLs or net unrealized built-in losses.

Legal and Compliance Risks

Our operations are highly regulated by the U.S. government, including the NRC and the DOE as well as the States of Ohio and Tennessee and could be significantly impacted by changes in government policies and priorities.

Our operations, including the facilities we lease near Piketon, Ohio, are subject to regulation by the U.S Nuclear Regulatory Commission (“NRC”). The NRC has granted us two licenses for the Piketon facility: a license for a Lead Cascade test facility that was granted in February 2004, and a separate license to construct and operate a commercial plant that was granted in April 2007. Our license to construct and operate a commercial plant will expire on April 13, 2037. In June 2021, the NRC approved an amendment to permit HALEU production as a subset of the larger commercial plant license. We are currently performing work under a three-year contract with DOE for the construction of a cascade to produce HALEU. This contract is currently set to expire on June 1, 2022.

The NRC also could refuse to renew our license to construct and operate a commercial plant if it determines that: (1) we are foreign owned, controlled, or dominated; (2) the issuance of a renewed license would be inimical to the maintenance of a reliable and economic domestic source of enrichment; (3) the issuance of a renewed license would be adverse to U.S. defense or security objectives; or (4) the issuance of a renewed license is otherwise not consistent with applicable laws or regulations in effect at the time of renewal.

The NRC has the authority to issue notices of violation for violations of the Atomic Energy Act of 1954, as amended (the “Atomic Energy Act”), the NRC regulations and conditions of licenses, certificates of compliance, or orders. The NRC has the authority to impose civil penalties or additional requirements and to order cessation of operations for violations of its regulations. Penalties under the NRC regulations could include substantial fines, imposition of additional requirements, or withdrawal or suspension of licenses or certificates. Any penalties
27

imposed on us could adversely affect our results of operations and liquidity. The NRC also has the authority to issue new regulatory requirements or to change existing requirements. Changes to the regulatory requirements also could adversely affect our results of operations and financial condition.

In addition, certain of our operations are subject to DOE regulation or contractual requirements. Our facility in Oak Ridge is also regulated by the State of Tennessee under NRC’s Agreement State Program as well as applicable state laws. Our operations at the facility near Piketon also are subject to regulation by various agencies of the Ohio state government. These state and federal agencies may have the authority to impose civil penalties and additional requirements, which could adversely affect our results of operations. Further, changes in federal, state or local government policies and priorities can impact our operations and the nuclear industry. This includes changes in interpretations of regulatory requirements, increased inspection or enforcement activities, changes in budgetary priorities, changes in tax laws and regulations and other actions or in-actions governments can take.

Our operations involve the use, transportation and disposal of toxic, hazardous and/or radioactive materials and could result in liability without regard to fault or negligence.

Our operations involve the use, transportation, and disposal of toxic, hazardous and radioactive materials. A release of these materials could pose a health risk to humans or animals. If an accident were to occur, its severity would depend on the volume of the release and the speed of corrective action taken by emergency response personnel, as well as other factors beyond our control, such as weather and wind conditions. Actions taken in response to an actual or suspected release of these materials, including a precautionary evacuation, could result in significant costs for which we could be legally responsible. In addition to health risks, a release of these materials may cause damage to, or the loss of, property and may adversely affect property values. Additionally, we may be responsible for decontamination or decommissioning of facilities where we conduct, or previously conducted, operations. Activities of our contractors, suppliers or other counterparties similarly may involve toxic, hazardous, and radioactive materials and we may be liable contractually, or under applicable law, to contribute to remedy damages or other costs arising from such activities, including the decontamination or decommission of third-party facilities.

We lease facilities from DOE near Piketon, Ohio. Pursuant to the Price-Anderson Act, as well as the HALEU Contract, DOE has agreed to indemnify the Company’s subsidiaries who are party to those agreements, and other Company entities who fall under the definition of a person indemnified under the Atomic Energy Act of 1954, against claims for public liability (as defined in the Atomic Energy Act) arising out of or in connection with activities under those leases and the HALEU Contract, as applicable, resulting from a nuclear incident or precautionary evacuation including transportation. If an incident or evacuation is not covered under DOE indemnification, we could be financially liable for damages arising from such incident or evacuation, which could have an adverse effect on our results of operations and financial condition.

While DOE has provided indemnification pursuant to the Price-Anderson Act, there could be delays in obtaining reimbursement for costs from DOE and DOE may also determine that some or all costs are not reimbursable under the indemnification. In addition, the Price-Anderson Act indemnification does not cover loss or damage due to a nuclear incident to property located on the leased facilities.

Centrus and Enrichment Corp. have been named as defendants in class action lawsuits alleging damages resulting from releases at the facilities we leased in the past at the Portsmouth Gaseous Diffusion Plant, and the centrifuge facilities we still lease near Piketon, Ohio. These claims include allegations of damages that the plaintiffs assert are not covered by the Price-Anderson Act, which claims we and the other defendants have challenged. If DOE were to determine that the Price-Anderson Act did not apply, we would have to pay all or part of any damages awarded as a result of such claims, the cost to us, including legal fees, could adversely affect our results of operations and financial condition. Refer to Note 16, Commitments and Contingencies — Legal Matters, of our consolidated financial statements in Part IV of this Annual Report for further details.

In our contracts, we seek to protect ourselves from liability, but there is no assurance that such contractual limitations on liability will be effective in all cases. The costs of defending against a claim arising out of a nuclear
28

incident or precautionary evacuation, and any damages awarded as a result of such a claim, could adversely affect our results of operations and financial condition.

Our certificate of incorporation gives us certain rights with respect to equity securities held (beneficially or of record) by foreign persons. If levels of foreign ownership set forth in our certificate of incorporation are exceeded, we have the right, among other things, to redeem or exchange common stock held by foreign persons, and in certain cases, the applicable redemption price or exchange value may be equal to the lower of fair market value or a foreign person’s purchase price.

Our certificate of incorporation gives us certain rights with respect to shares of our common stock held (beneficially or of record) by foreign persons. Foreign persons are defined in our certificate of incorporation to include, among others, an individual who is not a U.S. citizen, an entity that is organized under the laws of a non-U.S. jurisdiction and an entity that is controlled by individuals who are not U.S. citizens, or by entities that are organized under the laws of non-U.S. jurisdictions.

The occurrence of any one or more of the following events is a “foreign ownership review event” and triggers the board of directors’ right to take various actions under our certificate of incorporation: (1) the beneficial ownership by a foreign person of (a) 5% or more of the issued and outstanding shares of any class of our equity securities, (b) 5% or more in voting power of the issued and outstanding shares of all classes of our equity securities, or (c) less than 5% of the issued and outstanding shares of any class of our equity securities or less than 5% of the voting power of the issued and outstanding shares of all classes of our equity securities, if such foreign person is entitled to control the appointment and tenure of any of our management positions or any director; (2) the beneficial ownership of any shares of any class of our equity securities by or for the account of a foreign uranium enrichment provider or a foreign competitor (defined in our certificate of incorporation as a “Contravening Person”); or (3) any ownership of, or exercise of rights with respect to, shares of any class of our equity securities or other exercise or attempt to exercise control of us that is inconsistent with, or in violation of, any regulatory restrictions, or that could jeopardize the continued operations of our facilities (defined in our certificate of incorporation as an “Adverse Regulatory Occurrence”). These rights include requesting information from holders (or proposed holders) of our securities, refusing to permit the transfer of securities by such holders, suspending or limiting voting rights of such holders, redeeming or exchanging shares of our stock owned by such holders on terms set forth in our certificate of incorporation, and taking other actions that we deem necessary or appropriate to ensure compliance with the foreign ownership restrictions.

The terms and conditions of our rights with respect to our redemption or exchange right in respect of shares held by foreign persons or Contravening Persons are as follows:

•Redemption price or exchange value: Generally, the redemption price or exchange value for any shares of our common stock redeemed or exchanged would be their fair market value. However, if we redeem or exchange shares held by foreign persons or Contravening Persons and our Board in good faith determines that such person knew or should have known that its ownership would constitute a foreign ownership review event (other than shares for which our Board determined at the time of the person’s purchase that the ownership of, or exercise of rights with respect to, such shares did not at such time constitute an Adverse Regulatory Occurrence), the redemption price or exchange value is required to be the lesser of fair market value and the person’s purchase price for the shares redeemed or exchanged.
•Form of payment: Cash, securities or a combination, valued by our board of directors in good faith.
•Notice: At least 30 days written notice of redemption is required; however, if we have deposited the cash or securities for the redemption or exchange in trust for the benefit of the relevant holders, we may redeem shares held by such holders on the same day that we provide notice.

Accordingly, there are situations in which a foreign stockholder or Contravening Person could lose the right to vote its shares or in which we may redeem or exchange shares held by a foreign person or Contravening Person and
29

in which such redemption or exchange could be at the lesser of fair market value and the person’s purchase price for the shares redeemed or exchanged, which could result in a significant loss for that person.


General Risk Factors

Failures to protect classified or other sensitive information, or security breaches of information technology (“IT”) systems could result in significant liability or otherwise have an adverse effect on our business.

Our business requires us to use and protect classified, sensitive, and other protected information as well as business proprietary information and intellectual property (collectively, “sensitive information”). Our computer networks and other information technology (“IT”) systems are designed to protect this information through the use of classified networks and other procedures. We routinely experience various cybersecurity threats, threats to our information technology infrastructure, unauthorized attempts to gain access to the Company’s sensitive information, and denial-of-service attacks, as do our customers, suppliers, subcontractors, and other business partners. The threats we face vary from attacks common to most industries, attacks by more advanced and persistent, highly organized adversaries, including nation states, which target us and other government contractors because we protect national security information. If we are unable to protect sensitive information, our customers or governmental authorities could question the adequacy of our threat mitigation and detection processes and procedures, and depending on the severity of the incident, the Company’s data, customers’ data, our employees’ data, our intellectual property, and other third-party data could be compromised. As a consequence of the persistence, sophistication, and volume of these attacks, we may not be successful in defending against all such attacks. Due to the evolving nature of these security threats and the national security aspects of much of the data we protect, the impact of any future incident cannot be predicted.

We have a number of suppliers and indirect suppliers with a wide variety of systems and cybersecurity capabilities and we may not be successful in preventing adversaries from exploiting possible weak links in our supply chain. We also must rely on this supply chain for detecting and reporting cyber incidents, which could affect our ability to report or respond to cybersecurity incidents in a timely manner. The costs related to cyber or other security threats or disruptions may not be fully insured or indemnified by other means.

A material network breach in the security of the IT systems of the Company or third parties for any reasons, including, but not limited to, human error, could include the theft of sensitive information, including, without limitation, our and our customers’ business proprietary and intellectual property. To the extent any security breach or human error results in a loss or damage to sensitive information, or in inappropriate or unauthorized disclosure of sensitive information, the breach could cause grave damage to the country’s national security and to our business. Threats, via insider threat or third parties, to our IT systems, are constantly evolving and there is no assurance that our efforts to maintain and improve our IT systems will be sufficient to meet current or future threats. Any event leading to a security breach or loss of, or damage to, data, whether by our employees or third parties, could result in negative publicity, significant remediation costs, legal liability, and damage to our reputation and could have a material adverse effect on our business, financial condition, results of operations, and cash flows. In an extreme case, DOE could terminate our permit to access classified information resulting in the elimination of our ability to continue American Centrifuge work or performance of DOE contracts, including the HALEU Contract.

The inability to attract and retain key personnel could have an adverse impact on our business.

The Company’s LEU and technical services segments require people with unique skills and experience in the uranium enrichment industry. It also requires people with U.S. security clearances. To train employees and obtain the required U.S. Security clearances for them can take considerable time and expense. The success of our business depends on key executives, managers, scientists, engineers and other skilled personnel. The ability to attract and retain these key personnel may be difficult in light of the uncertainties currently facing the business and changes we may make to the organizational structure to adjust to changing circumstances.

30

Changes in senior management could create uncertainty among our employees, customers, suppliers, and other third parties with which we do business. The inability to retain appropriately qualified and experienced senior executives could negatively affect our operations, strategic planning, and performance.

The potential for DOE to seek to terminate or exercise its remedies under the 2002 DOE-USEC Agreement and our other agreements with DOE, or to require modifications to such agreements that are adverse to our interests, may have adverse consequences on the Company.

The Company and DOE signed an agreement dated June 17, 2002, as amended (the “2002 DOE-USEC Agreement”), that requires the Company to develop, demonstrate, and deploy advanced enrichment technology in accordance with milestones and provides for remedies in the event of a failure to meet a milestone under certain circumstances. DOE has specific remedies under the 2002 DOE-USEC Agreement if we fail to meet a milestone or if we abandon or constructively abandon the commercial deployment of an advanced enrichment technology. These remedies include terminating the 2002 DOE-USEC Agreement, revoking our access to DOE’s centrifuge technology that is required for the success of the American Centrifuge project, the HALEU Contract or other projects, requiring us to transfer certain rights in the American Centrifuge technology and facilities to DOE, and to reimburse DOE for certain costs associated with the American Centrifuge project.

We have granted to DOE an irrevocable, non-exclusive right to use or permit third parties on behalf of DOE to use all centrifuge technology intellectual property (“Centrifuge IP”) royalty free for U.S. government purposes (which includes national defense purposes, including providing nuclear material to operate commercial nuclear power reactors for tritium production). We also granted an irrevocable, non-exclusive license to DOE to use such Centrifuge IP developed at our expense for commercial purposes (including a right to sublicense), which may be exercised only if we miss any of the milestones under the 2002 DOE-USEC Agreement or if we (or our affiliate or entity acting through us) are no longer willing or able to proceed with, or have determined to abandon, or have constructively abandoned, the commercial deployment of the centrifuge technology. Such a commercial purposes license is subject to payment of an agreed upon royalty to us, which will not exceed $665 million in the aggregate. While our long-term objective is to commercially deploy the American Centrifuge technology when it is commercially feasible to do so, DOE may take the position that we are no longer willing or able to proceed with commercial deployment, or have actually, or constructively, abandoned commercial deployment, and could invoke its rights under the license described above. Any of these actions could adversely impact our business and prospects.

DOE may seek to exercise remedies under these agreements and there is no assurance that the parties will be able to reach agreement on appropriate modifications to the agreements in the future. Moreover, even if the parties reach agreement on modifications to such agreements, there is no assurance that such modifications will not impose material additional requirements, provide DOE with material additional rights or remedies, or otherwise affect the overall economics of the American Centrifuge technology and our ability to finance and successfully deploy the technology. Any of these actions could have an adverse impact on our business and prospects.

Our U.S. government contract work is regularly reviewed and audited by the U.S. government and these reviews can lead to withholding or delay of payments to us, non-receipt of award fees, legal actions, fines, penalties and liabilities, and other remedies against us.

Our U.S. government contracts are subject to specific regulations such as the Federal Acquisition Regulation, among others, and also subject to audits, cost reviews, and investigations by the U.S. government contracting oversight agencies. Should a contracting agency determine that we have not complied with the terms of our contracts and applicable statutes and regulations, payments to us may be disallowed, which could result in adjustments to previously reported revenues and refunding of previously collected cash proceeds. Additionally, we may be subject to litigation brought by private individuals on behalf of the U.S. government under the Federal False Claims Act, which could include claims for treble damages. If we experience performance issues under any of our U.S. government contracts, the U.S. government retains the right to pursue remedies, which could include termination under any affected contract. Termination of a contract could adversely affect our ability to secure future
31

contracts, and could have material adverse effect on our business, financial condition, results of operations, and cash flows.

Our U.S. government contracts and subcontracts are dependent on continued U.S. government funding and government appropriations, which may not be made on a timely basis or at all, and could have an adverse effect on our business.

Current and future U.S. government contracts and subcontracts, including our HALEU Contract, are dependent on government funding, which are generally subject to Congressional appropriations. Our ability to perform under these federal contracts and subcontracts is dependent upon sufficient funding for, and timely payment by, the entities with which we have contracted. If the contracting governmental agency, or the prime contractor, does not receive sufficient appropriations, it may terminate our contract or subcontract (in whole or in part) or reduce scope of our contract or subcontract, or delay or reduce payment to us. Any inability to award us a contract or subcontract, any delay in payment, or the termination of a contract or subcontract, in whole or in part, due to a lapse in funding or otherwise, could adversely affect our business, financial condition or results of operations, or cash flows.

Changes to, or termination of, any agreements with the U.S. government, or deterioration in our relationship with the U.S. government, could adversely affect results of operations.

We are a party to a number of agreements and arrangements with the U.S. government that are important to our business including our HALEU Contract, the lease for the centrifuge facility near Piketon, Ohio, and the 2002 DOE-USEC agreement. Termination, expiration, or modification of one or more of these or other agreements could adversely affect our business and prospects. In addition, deterioration in our relationship with the U.S. agencies that are parties to these agreements could impair or impede our ability to successfully implement these agreements, which could adversely affect our business, financial condition or results of operations, or cash flows.

Our success depends on our ability to adapt to a rapidly changing competitive environment in the nuclear industry.

The uranium enrichment sector of the nuclear fuel cycle industry remains oversupplied, creating downward pressures on commodity pricing, with uncertainty regarding nuclear power generation. Changes in the competitive landscape may adversely affect pricing trends, change customer spending patterns, or create uncertainty. To address these changes, we may seek to adjust our cost structure and operations, and evaluate opportunities to grow our business organically or through acquisitions and other strategic transactions. We are actively considering, and expect to consider from time to time in the future, potential strategic transactions, which could involve, without limitation, changes in our capital structure, acquisitions and/or dispositions of businesses or assets, joint ventures or investments in businesses, products, or technologies. In connection with any such transaction, we may seek additional debt or equity financing, contribute or dispose of assets, assume additional indebtedness, or partner with other parties to consummate a transaction. Any such transaction may not result in the intended benefits and could involve significant commitments of our financial and other resources. Legal and consulting costs incurred in connection with debt or equity financing transactions in development are deferred and subject to immediate expensing if such a transaction becomes less likely to occur. If the actions we take in response to industry changes are not successful, our business, results of operations and financial condition may be adversely affected.

Item 1B. Unresolved Staff Comments

On December 20, 2021, we received a comment letter from the Staff of the SEC’s Division of Corporation Finance relating to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021. The SEC requested additional information pertaining to the following matters: (a) use of certain non-GAAP measures, (b) presentation as revenue in 2020 of certain amounts we collected from a breach of contract claim against a prior customer that filed for bankruptcy and (c) presentation as revenue in 2021 of amounts we received pursuant to a settlement agreement with DOE for pension and post-retirement benefits for employees at the formerly leased Portsmouth GDP plant. With regards to
32

(a) we have revised our disclosures on non-GAAP measures in Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations, beginning in this Annual Report on Form 10-K for the year ended December 31, 2021, in response to the Staff’s comments. As of the date of this annual report, we have not received notice from the Staff that its review process is complete.

Item 2. Properties

Our corporate headquarters is located at 6901 Rockledge Drive, Suite 800, Bethesda, Maryland 20817, where we lease 24,000 square feet of office space through October 2027. We own a 440,000 square foot manufacturing facility, including supporting office space, on 72 acres at 400 Centrifuge Way, Oak Ridge, Tennessee 37830. We also lease industrial buildings and 110,000 square feet of supporting office space from DOE at 3930 U.S. Route 23, Piketon, Ohio 45661. The industrial buildings encompass more than 14 acres under roof and were built to contain uranium enrichment operations using centrifuge technology. We also have a short-term lease for a small area of office space in Washington, D.C.

Item 3. Legal Proceedings

Refer to Note 16, Commitments and Contingencies — Legal Matters, of our consolidated financial statements in Part IV of this Annual Report.

Item 4. Mine Safety Disclosures

None.
33

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

The Company’s certificate of incorporation authorizes 100,000,000 shares of common stock, consisting of 70,000,000 shares of Class A Common Stock, $0.10 par value per share (the “Class A Common Stock”) and 30,000,000 shares of Class B Common Stock, $0.10 par value per share (the “Class B Common Stock”), As of March 1, 2022, the Company has issued 14,393,133 shares of Common Stock, consisting of 13,673,933 shares of Class A Common Stock and 719,200 shares of Class B Common Stock. The Class B Common Stock was issued to Toshiba America Nuclear Energy Corporation (“Toshiba”) and Babcock & Wilcox Investment Company (“B&W”) and has the same rights, powers, preferences and restrictions and ranks equally in all matters with the Class A Common Stock, except voting. Holders of Class B Common Stock are entitled to elect, in the aggregate, two members of the Board of Directors of the Company, subject to certain holding requirements. Additionally, the Company has reserved 1,900,000 shares of Class A Common Stock under its management incentive plan, of which 844,293 shares were available for future awards as of December 31, 2021, including 120,000 shares associated with awards which terminated or were cancelled without being exercised.

The Class A Common Stock trades on the NYSE American LLC (the “NYSE American”) under the symbol “LEU”.

As of March 1, 2022, there were 13,673,933 shares of Class A Common Stock outstanding. As of March 1, 2022, there were approximately 850 holders of record and approximately 14,360 beneficial owners of the Company’s Class A Common Stock. As of March 1, 2022, there were two holders of record of the Company’s Class B Common Stock.

No cash dividends were paid in 2021 or 2020, and we have no intention to pay cash dividends in the foreseeable future. The indenture governing our 8.25% Notes, subject to certain exceptions, places certain restrictions on the ability of Enrichment Corp. to transfer cash and other assets to us. This could act as a constraint on our ability to pay dividends on our Class A Common Stock.

There were no unregistered sales of equity securities by the Company during the years ended December 31, 2021 or 2020.


34

Fourth Quarter 2021 Issuer Repurchases of Equity Securities

On November 23, 2021, pursuant to a tender offer announced on October 20, 2021, the Company completed the purchase of 36,867 shares of its outstanding Series B Senior Preferred Stock, par value $1.00 per share, at a price per share of $1,145.20, less any applicable withholding taxes, for an aggregate purchase price of approximately $42.2 million. The accepted shares represent 97.4% of the Company’s outstanding Series B Senior Preferred Stock as of September 30, 2021. Based on the final results, the requisite consent of at least 90% of the outstanding Series B Senior Preferred Stock required to approve the Series B Preferred Amendment was obtained. On November 23, 2021, the Company issued a Notice of Full Redemption providing for the redemption of any and all shares of the Company’s Series B Senior Preferred Stock outstanding after consummation of the Company’s tender offer to purchase all of its issued and outstanding Series B Senior Preferred Stock. On December 15, 2021, the Company completed the redemption of all 980 outstanding Series B Senior Preferred Stock for aggregate cash consideration of $1.1 million. The purchase price per share represented a 15% discount from the aggregate liquidation preference, included accrued but unpaid dividends, of $1,347.29 per share as of September 30, 2021. These shares represented all of the Company’s remaining outstanding Series B Senior Preferred Stock.

Matters Affecting our Foreign Stockholders
 
In order to aid in our compliance with our NRC license, our certificate of incorporation gives us certain rights with respect to shares of our Common Stock held (beneficially or of record) by foreign persons. Foreign persons are defined in our certificate of incorporation to include, among others, an individual who is not a U.S. citizen, an entity that is organized under the laws of a non-U.S. jurisdiction, and an entity that is controlled by individuals who are not U.S. citizens or by entities that are organized under the laws of non-U.S. jurisdictions.

The occurrence of any one or more of the following events is a “foreign ownership review event” and triggers the board of directors’ right to take various actions under our certificate of incorporation: (1) the beneficial ownership by a foreign person of (a) 5% or more of the issued and outstanding shares of any class of our equity securities, (b) 5% or more in voting power of the issued and outstanding shares of all classes of our equity securities, or (c) less than 5% of the issued and outstanding shares of any class of our equity securities or less than 5% of the voting power of the issued and outstanding shares of all classes of our equity securities, if such foreign person is entitled to control the appointment and tenure of any of our management positions or any director; (2) the beneficial ownership of any shares of any class of our equity securities by or for the account of a foreign uranium enrichment provider or a foreign competitor (referred to as “contravening persons”); or (3) any ownership of, or exercise of rights with respect to, shares of any class of our equity securities or other exercise or attempt to exercise control of us that is inconsistent with, or in violation of, any regulatory restrictions, or that could jeopardize the continued operations of our facilities (an “adverse regulatory occurrence”). These rights include requesting information from holders (or proposed holders) of our securities, refusing to permit the transfer of securities by such holders, suspending or limiting voting rights of such holders, redeeming or exchanging shares of our stock owned by such holders on terms set forth in our certificate of incorporation, and taking other actions that we deem necessary or appropriate to ensure compliance with the foreign ownership restrictions.

For information regarding the foreign ownership restrictions set forth in our certificate of incorporation, please refer to — Part I, Item 1A, Risk Factors Our certificate of incorporation gives us certain rights with respect to equity securities held (beneficially or of record) by foreign persons. If levels of foreign ownership set forth in our certificate of incorporation are exceeded, we have the right, among other things, to redeem or exchange common stock held by foreign persons, and in certain cases, the applicable redemption price or exchange value may be equal to the lower of fair market value or a foreign person’s purchase price.

Item 6. [Reserved]



35

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with, and is qualified in its entirety by reference to, the consolidated financial statements and related notes appearing elsewhere in this report.

This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ significantly from the results discussed in the forward-looking statements particularly in light of the economic, social and market uncertainty created by the COVID-19 pandemic and the evolving events regarding the war in Ukraine. See “Forward-Looking Statements” at the beginning of this Annual Report on Form 10-K.

36

Overview

Centrus Energy Corp., a Delaware corporation (“Centrus” or the “Company”), is a trusted supplier of nuclear fuel and services for the nuclear power industry, which provides a reliable source of carbon free energy. References to “Centrus”, the “Company”, “our”, or “we” include Centrus Energy Corp. and its wholly-owned subsidiaries as well as the predecessor to Centrus, unless the context indicates otherwise.

Centrus operates two business segments: (a) low-enriched uranium (“LEU”), which supplies various components of nuclear fuel to commercial customers from our global network of suppliers, and (b) technical solutions, which provides advanced engineering, design, and manufacturing services to government and private sector customers and is deploying uranium enrichment and other capabilities necessary for production of advanced nuclear fuel to power existing and next-generation reactors around the world.

Our LEU segment provides most of the Company’s revenue and involves the sale of nuclear fuel to customers that are primarily utilities that operate commercial nuclear power plants. The majority of these sales are for the enrichment component of LEU, which is measured in separative work units (“SWU”). Centrus also sells natural uranium (the raw material needed to produce LEU) and occasionally sells LEU with the natural uranium, uranium conversion, and SWU components combined into one sale.

LEU is a critical component in the production of nuclear fuel for reactors that produce electricity. We supply LEU and its components to both domestic and international utilities for use in nuclear reactors worldwide. We provide LEU from multiple sources, including our inventory, medium and long-term supply contracts, and spot purchases. As a long-term supplier of LEU to our customers, our objective is to provide value through the reliability and diversity of our supply sources.

Our global order book includes long-term sales contracts with major utilities through 2029. We have secured cost-competitive supplies of SWU under long-term contracts through the end of this decade to allow us to fill our existing customer orders and make new sales. A market-related price reset provision in our largest supply contract took effect at the beginning of 2019 – when market prices for SWU were near historic lows – which has significantly lowered our cost of sales and contributed to improved margins. Spot price indicators for SWU have risen by approximately 65% to $56 as of December 31, 2021, since bottoming out in August 2018.

In October 2020, the U.S. Department of Commerce reached agreement with the Russian Federation on an extension of the 1992 Russian Suspension Agreement (“RSA”), a trade agreement which allows for Russian-origin nuclear fuel to be exported to the United States in limited quantities. The two parties agreed to extend the agreement through 2040 and to set aside a significant portion of the quota for Centrus’ shipments to the United States through 2028 to execute our long-term supply (purchase) agreement (the “TENEX Supply Contract”) with the Russian government entity, TENEX, Joint-Stock Company (“TENEX”). This outcome allows for sufficient quota for Centrus to continue serving its utility customers.

Our technical solutions segment is deploying uranium enrichment and other capabilities necessary for production of advanced nuclear fuel to meet the evolving needs of the global nuclear industry and the U.S. government, while also leveraging our unique technical expertise, operational experience and specialized facilities to expand and diversify our business beyond uranium enrichment, offering new services to existing and new customers in complementary markets.

Our technical solutions segment is dedicated to the restoration of America’s domestic uranium enrichment capability to play a critical role in meeting U.S. national security and energy security requirements, advancing America’s nonproliferation objectives, repairing broken and vulnerable supply chains, providing good clean energy jobs and supporting the communities in which we operate, and in delivering the next-generation nuclear fuels that will power the future of nuclear energy as it provides reliable carbon-free power around the world.

37

The United States has not had a domestic uranium enrichment capability suitable to meet U.S. national security requirements since the Paducah Gaseous Diffusion Plant (“Paducah GDP”) shut down in 2013. Longstanding U.S. policy and binding nonproliferation agreements prohibit the use of foreign-origin enrichment technology for U.S. national security missions. Our AC100M centrifuge is currently the only deployment-ready U.S. uranium enrichment technology in the U.S. that can meet these national security requirements.

Centrus is working to pioneer U.S. production of High-Assay, Low-Enriched Uranium (“HALEU”), enabling the deployment of a new generation of HALEU-fueled reactors to meet the world’s growing need for carbon-free power. HALEU is a high-performance nuclear fuel component which is expected to be required by a number of advanced reactor and fuel designs that are now under development for commercial and government uses. While existing reactors typically operate on LEU with the uranium-235 isotope concentration below 5%, HALEU is further enriched so that the uranium-235 concentration is between 5% and 20%. The higher U-235 concentration offers a number of potential advantages, which may include better fuel utilization, improved performance, fewer refueling outages, simpler reactor designs, reduced waste volumes, and greater nonproliferation resistance.

The lack of a domestic HALEU supply is widely viewed as a major obstacle to the successful commercialization of these new reactors. For example, in surveys conducted by the U.S. Nuclear Industry Council in 2021 and 2020, advanced reactor developers indicated that the number one issue that “keeps you up at night” was access to HALEU. As the only company with a license from the Nuclear Regulatory Commission (“NRC”) to enrich up to 20% uranium-235 assay HALEU, Centrus is uniquely positioned to fill a critical gap in the supply chain and facilitate the deployment of these promising next-generation reactors.

The DOE has experienced a COVID-19 related supply chain delay in obtaining the HALEU storage cylinders. Since it is not possible to begin HALEU production without the storage cylinders, it would not be possible to complete the operational portion of the demonstration before the June 1, 2022 expiration date of the existing HALEU Contract. As a result, the DOE elected to change the scope of the HALEU Contract and move the operational portion of the demonstration to a new, competitively-awarded contract that would provide for operations beyond the term of the existing contract. On February 7, 2022, DOE issued a pre-solicitation notice for a request for proposal to complete the HALEU demonstration facility and to produce HALEU, noting that the “the Administration supports longer-term demonstration of production capability.” The pre-solicitation notice outlines a two-phase approach. Phase 1 consists of completing installation of the centrifuges – which DOE expects will take up to one year from contract signing – followed by one full year of cascade operations. The second phase consists of three optional, 3-year extensions to produce HALEU, so that the prospective contract could help support a total of one to ten years of cascade operations in addition to completing construction and centrifuge installation.

Centrus believes it is well-positioned to compete for a follow-on contract with DOE to operate the machines in Piketon but there is no assurance that the DOE will award such a contract to the Company. Congress has not yet adopted a Fiscal Year 2022 appropriations bill for the DOE, and there is no assurance that the proposed program, which would go beyond the scope and expiration of our existing contract, will be approved and funded.

The U.S. government has been operating under a series of continuing resolutions in Fiscal Year 2022. The DOE continues to support the HALEU program during the continuing resolution period, and has incrementally increased the government’s cost share ceiling as funds have become available. Currently, DOE has provided additional funding, and increased the government’s cost share ceiling to $126.7 million.

Additional COVID-19 related impacts, delays in DOE furnishing equipment, or changes to the existing scope of the HALEU Contract could result in further material increases to our estimate of the costs required to complete the existing HALEU Contract, as well as delay completion of the contract. The Company does not currently have a contractual obligation to perform work in excess of the funding provided by DOE and, therefore, no additional loss has been accrued as of December 31, 2021. If DOE does not commit to fully fund
38

the additional costs, and the Company nevertheless commits to a plan to complete the demonstration cascade and produce HALEU, we may incur material additional costs or losses in future periods that could have an adverse impact on our financial condition and liquidity.

We believe our investment in the HALEU technology will position the Company to meet the needs of government and commercial customers in the future as they deploy advanced reactors and next generation fuels. At present, there are a number of advanced reactors under development. For example, of the ten advanced reactor designs selected by the U.S. Department of Energy for its Advanced Reactor Demonstration Program, nine will require HALEU. In addition, the first non-light water reactor to have begun active NRC-license review requires HALEU. The U.S. Department of Defense also plans to construct a prototype HALEU-fueled mobile microreactor in the next three to four years as part of a program called “Project Pele.” The U.S. Air Force also announced plans to deploy a microreactor at Eielson Air Force Base in Alaska. While the use of HALEU is not an express requirement of the Air Force program, the vast majority of microreactor designs are expected to need HALEU.

Advanced nuclear reactors promise to provide an important source of reliable carbon-free power. By investing in HALEU technology now, and as the only American-based company currently pursuing HALEU enrichment capability, we believe the Company is well positioned to capitalize on a potential new market as the demand for HALEU-based fuels increases in the mid to late-2020s with the development of advanced reactors. However, there are no guarantees about whether or when government or commercial demand for HALEU will materialize, and there are a number of technical, regulatory, and economic hurdles that must be overcome for these fuels and reactors to come to the market. Also, foreign government-owned and government-operated competitors could seek to enter the market and offer HALEU at more competitive prices. There is one known foreign government-owned source which currently has the capability to produce HALEU although this source is currently subject to trade restrictions that limit the amount of material from this source which may be imported into the United States. Other foreign government-owned entities which are not currently subject to U.S. trade restrictions, however, may enter the market. One such foreign-government owned entity has expressed an interest in and potential capability for HALEU production but has not committed publicly to enter the market to enrich above 10% uranium-235 enrichment assays. This entity has indicated publicly that it would take six to seven years to be able to produce HALEU.

The Company continues to review opportunities to improve its capital structure and to enhance shareholder value. As a result, pursuant to a sales agreement with its agents, the Company sold at the market price an aggregate of 1,516,467 shares of its Class A Common Stock in 2021, for a total of $44.2 million. After expenses and commissions paid to the agents the Company’s proceeds total $42.4 million. Additionally, the Company recorded direct costs of $0.3 million related to the issuance. The shares of Class A Common Stock were issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-239242), which became effective on August 5, 2020, and a prospectus supplement dated December 31, 2020 to the prospectus, dated August 5, 2020. At present, the Company has $5.8 million remaining available for sale under the prospectus supplement dated December 31, 2020, and may from time to time sell additional shares through the sales agreement at the then market price. The Company currently intends to use the net proceeds from this offering for general working capital purposes, to invest in technology development, or to repay outstanding debt.

In addition and in connection with the entry into an amendment (the “Voting Agreement Amendment”) to its existing Voting and Nomination Agreement with Mr. Morris Bawabeh, Kulayba LLC and M&D Bawabeh Foundation, Inc., the Company and Kulayba LLC also entered into an Exchange Agreement, dated February 2, 2021 (the “Exchange Agreement”), pursuant to which Kulayba LLC agreed to exchange (the “Exchange”) 3,873 shares of the Company’s outstanding Series B Senior Preferred Stock, par value $1.00 per share, representing a $5,000,198 liquidation preference (including accrued and unpaid dividends), for (i) 231,276 shares of the Company’s Class A Common Stock, priced at the closing market price of $21.62 on the date the Exchange Agreement was signed and (ii) a Centrus Energy Corp. Warrant to Purchase Common Stock (the “Warrant”), exercisable for 250,000 shares of Common Stock at an exercise price of $21.62 per share, which
39

was the closing market price on the date the Exchange Agreement was signed, subject to certain customary adjustments pursuant to the terms of the Warrant. The Company retired the 3,873 shares of Series B Senior Preferred Stock received by the Company under the Exchange Agreement.

On November 23, 2021, pursuant to a tender offer announced on October 20, 2021, the Company completed the purchase of 36,867 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,145.20, less any applicable withholding taxes, for an aggregate purchase price of approximately $42.2 million. On November 23, 2021, the Company issued a Notice of Full Redemption providing for the redemption of any and all shares of the Company’s Series B Senior Preferred Stock outstanding after consummation of the Company’s tender offer to purchase all of its issued and outstanding Series B Senior Preferred Stock. On December 15, 2021, the Company completed the redemption of all 980 outstanding Series B Senior Preferred Stock for aggregate cash consideration of $1.1 million. The aggregate purchase price of $43.3 million was offset by direct costs totaling $0.9 million. For additional details, refer to Note 15, Stockholders’ Equity, of the consolidated financial statements in Part IV of this Annual Report.

In the years following the 2011 Fukushima accident in Japan, the published market prices for uranium enrichment declined more than 75% through mid-2018. While the monthly price indicators have since increased, the uranium enrichment segment of the nuclear fuel market remains oversupplied and faces uncertainty about future demand for nuclear power generation. Changes in the competitive landscape affect pricing trends, change customer spending patterns, and create uncertainty. To address these changes, we have taken steps to adjust our cost structure; we may seek further adjustments to our cost structure and operations and evaluate opportunities to grow our business organically or through acquisitions and other strategic transactions.

We are also actively considering, and expect to consider from time to time in the future, potential strategic transactions, which could involve, without limitation, acquisitions and/or dispositions of businesses or assets, joint ventures or investments in businesses, products or technologies, or changes to our capital structure. In connection with any such transaction, we may seek additional debt or equity financing, contribute or dispose of assets, assume additional indebtedness, or partner with other parties to consummate a transaction.

Refer to Part I, Item 1, Business, for additional information.

COVID-19 Update

The Company has taken actions to protect its workforce and to maintain critical operations during the COVID-19 pandemic. Travel, operational, and other restrictions imposed by the U.S. and foreign governments may impact our ability to make future sales and may impact the ability of our suppliers, including our suppliers of low enriched uranium, to perform under their contracts. As of the date of this filing, our LEU segment operations have not been materially affected by the COVID-19 pandemic and we are working with our suppliers, fabricators, and customers to monitor the situation closely, including with respect to the impact of emerging variants. However, our technical solutions segment has been impacted by supply chain disruptions and increased costs as a result of the COVID-19 pandemic.

Further, the governments of states and counties in which we operate have from time to time issued orders imposing various restrictions, including prohibiting holding gatherings and closing nonessential businesses. Many of these restrictions remain in place and we continue to monitor and adjust as necessary. The Company has issued a policy requiring vaccinations subject to medical, religious and other exemptions as required by law. In some cases, state laws preclude us from fully implementing our vaccination policy. The Company has also continued other measures to protect its workforce such as expanded telework to protect our workforce, to comply with government orders, and to maintain critical operations. We are working closely with DOE and we are continuing to make progress while implementing measures to protect our workforce. Further, the actions taken by our suppliers and government regulatory agencies to protect their workforces may impact our ability to obtain the necessary supplies and governmental reviews and approvals to timely complete the HALEU
40

project. We are experiencing delays by our suppliers and increased costs from them as a result of the impact of the COVID-19.

For further discussion, refer to Part I, Item 1A, Risk Factors - Our business, financial and operating performance could be adversely affected by epidemics and other health related issues including but not limited to the coronavirus disease 2019 (“COVID-19”) pandemic.

Market Conditions and Outlook

The global nuclear industry outlook has begun to improve after many years of decline or stagnation. The development of advanced small and large-scale reactors, innovative advanced fuel types, and the commitment of nations to begin deploying or to increase the share of nuclear power in their nations has created optimism in the market. Part of the momentum has resulted from efforts to lower greenhouse gas emissions to combat climate change and improve health and safety.

According to the World Nuclear Association, as of January 2022, there were 57 reactors under construction worldwide, almost a third of which are in China. The United States, with 93 operating reactors, remains the world’s largest market for nuclear fuel. The nuclear industry in the United States, Japan, and Europe faces headwinds as well as opportunities. In the United States, the industry is under pressure from lower cost natural gas resources and the expansion of subsidized renewable energy. Eight U.S. reactors have prematurely shut down in recent years and several others could shut down in the next few years. At the same time, there are active efforts to develop, demonstrate, and deploy next generation reactors in the United States, many of which are expected to require HALEU.
    
The nuclear fuel industry continues to attempt to recover from the March 2011 earthquake and tsunami which caused irreparable damage to four reactors in Fukushima. As a consequence, approximately 60 reactors in Japan and Germany were taken offline, and other countries curtailed or slowed their construction of new reactors or accelerated the retirement of existing plants. While ten reactors in Japan have restarted and more are expected to restart, supply and demand dynamics for nuclear fuel continue to be impacted.

While the market for uranium enrichment is currently oversupplied, market demand is expected to grow as the nuclear power industry expands around the world. Over the past few years, prices for nuclear fuel, especially conversion and enrichment, have risen significantly. According to the World Nuclear Association, around 10% of the world's electricity is generated by about 437 nuclear reactors, and an additional 57 or so reactors are under construction. Recently, two nations new to nuclear energy generation started their first commercial reactors. New reactor builds have added new demand for nuclear fuel suppliers.

The recent action of Russian military forces in Ukraine has escalated tensions between Russia and the U.S. The U.S. has imposed, and is likely to impose additional, financial and economic sanctions and export controls against certain Russian organizations and/or individuals. The U.S. imposed financial and economic sanctions that, in various ways, constrain transactions with Russian entities and individuals. While the current sanctions and export controls do not affect the Company’s supply agreement with TENEX, additional sanctions and trade restrictions by the U.S., as well as any actions by Russia, could adversely affect our business. The Company is monitoring the situation closely and assessing the potential impact of any new sanctions and how the impact on the Company might be mitigated.

41


Operating Results

Our revenues, operating results, and cash flows can fluctuate significantly from quarter to quarter and year to year. Our sales order book in the LEU segment consists primarily of long-term, fixed commitment contracts, and we have visibility on a significant portion of our revenue for 2022-2026.

In 2021 and 2020, we benefited from collections of $43.5 million and $32.6 million, respectively. In 2021, we collected $43.5 million related to the settlement of the Company’s claims for reimbursements for certain pension and postretirement benefits costs incurred in connection with a past cost-reimbursable contract performed at the Portsmouth GDP, recognized as revenue within our technical solutions segment. In 2020, we collected $32.6 million from a customer in settlement of a supply contract that was subject to the customer’s bankruptcy proceeding, recognized as revenue within our LEU segment.

Based on our current order book and under current market conditions, we anticipate fiscal year 2022 revenues and gross margins in the LEU segment to be higher than 2021. Please see Forward Looking Statements at the beginning of this Annual Report.

With respect to our technical solutions segment, work under the HALEU Contract currently remains on schedule but we have been experiencing increased delays from vendors and increased costs due to the continuing COVID pandemic. We are working with DOE to minimize the impacts and to obtain funding for these additional costs. Additional funding commitments from DOE and a contract amendment will be required to complete the project. Refer to Overview above for additional details.

Our order book of sales under contract in the LEU segment (“order book”) extends to 2029. For the years ended December 31, 2021 and 2020, our order book was approximately $986 million and $960 million, respectively. The order book is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries, and includes approximately $348.2 million of deferred revenue and advances from customers as of December 31, 2021, whereby customers have made advance payments to be applied against future deliveries. We estimate that approximately 3% of our order book is at risk related to customer operations. Due to the nature of the long-term contracts and our order book, we have visibility of a significant portion of our anticipated revenue for 2022 and 2023 in the LEU segment. However, these long-term contracts are subject to significant risks and uncertainties, including existing import laws and restrictions under current contracts such as, the Russian Suspension Agreement, which limits imports of Russian uranium products into the United States and applies to our sales using material procured under the TENEX Supply Contract, as well as the potential for sanctions and other restrictions on trade with Russia or in dealings with Russian person and entities, in response to the evolving situation regarding the war in Ukraine. For further discussion of these risks and uncertainties, refer to Part I, Item 1A, Risk Factors - (1) Restrictions on imports or sales of SWU or uranium that we buy from our Russian supplier and our other sources of supply could adversely affect profitability and the viability of our business, and - (2) The dollar amount of the sales order book, as stated at any given time, is not necessarily indicative of future sales revenues and is subject to uncertainty.

Our future operating results are subject to a number of uncertainties that could affect results either positively or negatively. Among the factors that could affect our results are the following:
•Additional purchases or sales of SWU and uranium;
•Conditions in the LEU and energy markets, including pricing, demand, operations, government restrictions on imports, exports or investments, and regulations of our business and activities and those of our customers, suppliers, contractors, and subcontractors;
•Timing of customer orders, related deliveries, and purchases of LEU or components;
•Costs, future funding, and demand for HALEU;
42

•Financial market conditions and other factors that may affect pension and benefit liabilities and the value of related assets;
•The outcome of legal proceedings and other contingencies;
•Potential use of cash for strategic or financial initiatives;
•Actions taken by customers, including actions that might affect existing contracts;
•Market, international trade, and other conditions impacting Centrus’ customers and the industry;
•Armed conflicts, including the war in Ukraine, government actions and other events that disrupt supply chains, production, transportation, payments and importation of nuclear materials or other critical supplies or services; and,
•The length and severity of the COVID-19 pandemic and its impact on our operations.

Revenue

We have two reportable segments: the LEU segment and the technical solutions segment. Revenue from our LEU segment is derived primarily from: 
•sales of the SWU component of LEU;
•sales of both the SWU and natural uranium components of LEU; and
•sales of natural uranium.

Our technical solutions segment reflects our technical, manufacturing, engineering, and operations services offered to public and private sector customers, including engineering and testing activities as well as technical and resource support currently being performed by the Company. This includes the HALEU Contract and a variety of other contracts with public and private sector customers.

SWU and Uranium Sales

Revenue from our LEU segment accounted for approximately 62% of our total revenue in 2021. The majority of our customers are domestic and international utilities that operate nuclear power plants, with international sales constituting over one-third of revenue from our LEU segment in recent years. Our agreements with electric utilities are primarily medium and long-term fixed-commitment contracts under which our customers are obligated to purchase a specified quantity of the SWU component of LEU from us. Contracts where we sell both the SWU and natural uranium component of LEU to utilities or where we sell natural uranium to utilities and other nuclear fuel related companies are generally shorter-term, fixed-commitment contracts.

Revenue is recognized at the time LEU or uranium is delivered under the terms of our contracts. The timing of customer deliveries is affected by, among other things, electricity markets, reactor operations, maintenance and refueling outages, and customer inventories. Based on customers’ individual needs, some customers are building inventories and may choose to take deliveries under annual purchase obligations later in the year or in subsequent years. Customer payments for the SWU component of LEU average $7.4 million per order. As a result, a relatively small shift in the timing of customer orders for LEU may cause significant variability in operating results year over year.

Utility customers, in general, have the option to defer receipt of SWU and natural uranium products purchased from Centrus beyond the contractual sale period, resulting in the deferral of costs and revenue recognition. Refer to Note 2, Revenue and Contracts with Customers, in the consolidated financial statements in Part IV of this Annual Report for further details.

43

Our financial performance over time can be significantly affected by changes in prices for SWU and natural uranium. Since 2011, market prices for SWU and uranium significantly declined until mid-2018, when they began to trend upward. Since our sales order book includes contracts awarded to us in previous years, the average SWU price billed to customers typically lags behind published price indicators by several years. While newer sales reflect the low prices prevalent in recent years, certain older contracts included in our order book have sales prices that are significantly above current market prices.

The following chart summarizes long-term and spot SWU price indicators, and a spot price indicator for natural uranium hexafluoride (“UF6”), as published by TradeTech, LLC in Nuclear Market Review:


SWU and Uranium Market Price Indicators*
leu-20211231_g2.jpg
    * Source: Nuclear Market Review, a TradeTech publication, www.uranium.info

Our contracts with customers are denominated primarily in U.S. dollars and although revenue has not been materially affected by changes in the foreign exchange rate of the U.S. dollar, we may have a competitive price advantage or disadvantage obtaining new contracts in a competitive bidding process depending upon the weakness or strength of the U.S. dollar. On occasion, we will accept payment in euros for spot sales that may be subject to short-term exchange rate risk. Costs of our primary competitors are denominated in other currencies. Our contracts with suppliers are primarily denominated in U.S. dollars. We have a SWU supply agreement, nominally commencing in 2023, with prices payable in a combination of U.S. dollars and euros, but with a contract defined exchange rate.

On occasion, we will accept payment for SWU in the form of natural uranium. Revenue from the sale of SWU under such contracts is recognized at the time LEU is delivered and is based on the fair value of the natural uranium at contract inception, or as the quantity of natural uranium is finalized, if variable.

44


Cost of sales for SWU and natural uranium is based on the amount of SWU and natural uranium sold and delivered during the period and unit inventory costs. Unit inventory costs are determined using the average cost method. Changes in purchase costs have an effect on inventory costs and cost of sales. Cost of sales includes costs for inventory management at off-site licensed locations. Cost of sales also includes certain costs related to former employees of the Portsmouth GDP and Paducah GDP.

Technical Solutions

Our technical solutions segment reflects our technical, manufacturing, engineering and operations services offered to public and private sector customers, including the American Centrifuge engineering, procurement, construction, manufacturing and operations services being performed under the HALEU Contract. With our government and private sector customers, we seek to leverage our domestic enrichment experience, engineering know-how, and precision manufacturing facility to assist customers with a range of engineering, design, and advanced manufacturing projects, including the production of fuel for next-generation nuclear reactors and the development of related facilities. We continue to invest in advanced technology because of the potential for future growth into new areas of business for the Company, while also preserving our unique workforce at our Technology and Manufacturing Center in Oak Ridge, Tennessee, and our production facility near Piketon, Ohio.

Government Contracting

On October 31, 2019, we signed the cost-share HALEU Contract with DOE to deploy a cascade of centrifuges to demonstrate production of HALEU for advanced reactors. The three-year program has been under way since May 31, 2019, when the Company and DOE signed an interim HALEU letter agreement that allowed work to begin while the full contract was being finalized. The Company entered into this cost-share contract with DOE as a critical first step on the road back to the commercial production of enriched uranium, which the Company had terminated in 2013 with the closure of the Paducah GDP. The HALEU Contract, if fully implemented, is expected to result in the Company having constructed the AC100M technology and prepared the systems to enrich uranium to the 20% concentration in the uranium-235 isotope that is required by many of the advanced reactor concepts now under development. Centrus is the only company with an NRC license to enrich HALEU.

In 2019, under the HALEU Contract, DOE agreed to reimburse the Company for 80% of its costs incurred in performing the contract, up to a maximum of $115 million which was increased to $126.7 million. In addition, on March 4, 2022, the DOE informed the Company of their intent to fund an additional $9.0 million above the $126.7 million, as disclosed above. The Company’s cost share is the corresponding 20% and any costs the Company elects to incur above these amounts. Costs under the HALEU Contract include program costs, including internal labor, third-party services and materials and associated indirect costs that are classified as Cost of Sales, and an allocation of corporate costs supporting the program that are classified as Selling, General and Administrative Expenses. Services to be provided over the three-year contract include constructing and assembling centrifuge machines and related infrastructure in a cascade formation. When estimates of total costs for such an integrated, construction-type contract exceed estimates of total revenue to be earned, a provision for the remaining loss on the contract is recorded to Cost of Sales in the period the loss is determined. Our corporate costs supporting the program are recognized as expense as incurred over the duration of the contract term. The accrued loss on the contract is being adjusted over the remaining contract term based on actual results, remaining program cost projections, and the Company’s anticipated cost-share. The impact to Cost of Sales for the year ended December 31, 2021, and 2020, is $7.2 million and $10.6 million, respectively, for previously accrued contract losses attributable to work performed in the periods. As of December 31, 2021, a total of $19.1 million of previously accrued contract losses have been realized and the accrued contract loss balance included in Accounts Payable and Accrued Liabilities is $0.5 million.

45

Our HALEU Contract expires June 1, 2022, and although we believe demand for HALEU will emerge over the next several years thereafter, there are no guarantees that we will be awarded a contract to operate the demonstration facility plant or about whether or when government or commercial demand for HALEU will materialize, and there are a number of technical, regulatory, and economic hurdles that must be overcome for these fuels and reactors to come to the market.

The U.S. government has been operating under a series of Continuing Resolutions in Fiscal Year 2022. The DOE continues to support the HALEU program during the continuing resolution period, and has incrementally increased the government’s cost share ceiling as funds have become available. Currently, DOE has provided incremental funding, and increased the government’s cost share ceiling to $126.7 million.

While the existing contract ends on June 1, 2022, the DOE has unilaterally changed the scope of the existing contract and plans to compete the operational portion of the demonstration in a new, competitively-awarded contract, with operations to begin in mid-2022. Centrus believes it is well-positioned to compete for a follow-on contract to operate the machines in Piketon but there is no assurance that DOE will award such a contract to the Company. Congress has not yet adopted a Fiscal Year 2022 appropriations bill for the Department, and there is no assurance that the proposed program, which would go beyond the scope and expiration of our existing contract, will be approved and funded.

Additional COVID-19-related impacts, delays in DOE furnishing equipment, or changes to the existing scope of the HALEU Contract could result in further material increases to our estimate of the costs required to complete the demonstration cascade and produce HALEU, as well as delay completion of the HALEU Contract. The Company does not currently have a contractual obligation to perform work in excess of the funding provided by DOE and, therefore, no additional costs have been accrued as of December 31, 2021. If the DOE elects not to provide funding for production and the Company nonetheless commits to a plan to complete the demonstration cascade and produce HALEU, we may incur material additional costs or losses in future periods that could have an adverse impact on our financial condition and liquidity.

Commercial Contracting

In March 2018, we entered into an initial services agreement with X-energy to provide technical and resource support for conceptual design of its TRISO fuel manufacturing process. In November 2018, we entered into a second services agreement with X-energy to proceed with preliminary design of the TRISO facility. Under both agreements, which were funded by two separate cooperative agreement awards by DOE, we provided X-energy with in-kind contributions pursuant to X-energy’s obligations under those agreements. Both of these contracts have been completed. In November 2020, the parties extended the period of performance through August 2021. In August 2021, we entered into a new services agreement with X-energy to provide design services for detailed design of the TRISO fuel manufacturing facility and various support services for establishing their TRISO Research and Development Center. X-energy is funded under the current DOE cooperative agreement titled Advanced Reactor Demonstration Program (ARDP). The task orders under the new agreement may include in-kind contributions that we are not currently, but may provide, at our discretion.

Under the X-energy agreements, Centrus performs services pursuant to separate task orders that provide for time-and-materials based pricing. The cumulative task orders issued through December 31, 2021 under the three agreements provided for payments to us of $26.3 million and in-kind contributions provided by us of $10.4 million.

Prior Site Services Work

We formerly performed sites services work under contracts with DOE and its contractors at the former Portsmouth GDP. In September 2021, the Company and DOE fully settled the Company’s claims for reimbursement of certain pension and postretirement benefit costs incurred in connection with a past cost-
46

reimbursable contract for work performed at the Portsmouth GDP. Under the terms of the settlement agreement, DOE paid the Company $43.5 million in September 2021, of which $33.8 million was contributed in September 2021 to the pension plan for its subsidiary United States Enrichment Corp. (“Enrichment Corp.”) and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp. The payment of $43.5 million is included in revenue of the technical solutions segment for the year ended December 31, 2021.

Critical Accounting Policies and Estimates

Our significant accounting policies are summarized in Note 1, Summary of Significant Accounting Policies, of our consolidated financial statements, which were prepared in accordance with generally accepted accounting principles. Generally accepted accounting principles in the United States and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters that are relevant to our business are complex and involve many subjective assumptions, estimates and judgments that are, by their nature, subject to substantial risks and uncertainties. Critical accounting estimates are those that require management to make assumptions about matters that are uncertain at the time the estimate is made and for which different estimates, often based on complex judgments, probabilities and assumptions that we believe to be reasonable, but are inherently uncertain and unpredictable, could have a material impact on our operating results and financial condition. It is also possible that other professionals, applying their own judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts. We are also subject to risks and uncertainties that may cause actual results to differ from estimated amounts, such as the healthcare environment, legislation and regulation. Additionally, changes in accounting rules or their interpretation could significantly affect our results of operations and financial condition.

The sensitivity analyses used below are not intended to provide a reader with our predictions of the variability of the estimates used. Rather, the sensitivities used are included to allow the reader to understand a general cause and effect of changes in estimates.

We have identified the following to be our critical accounting estimates:

Revenue Recognition - Technical Solutions

Revenue for the technical solutions segment is recognized over the contractual period as services are rendered. The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer. For public sector contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay the Company for costs incurred plus a reasonable profit, and assume control of any work in progress. The Company’s private sector contracts generally contain contractual termination clauses or entitle the Company to payment for work performed to date for goods and services that do not have an alternative use. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. A contract may contain one or more performance obligations. Two or more promises to transfer goods or services to a customer may be considered a single performance obligation if the goods or services are highly interdependent or highly interrelated such that utility of the promised goods or services to the customer includes integration services provided by the Company.

The Company determines the transaction price for each contract based on the consideration it expects to receive for the products or services being provided under the contract. If transaction prices are not stated in the contract for each performance obligation, contractual prices are allocated to performance obligations based on estimated relative standalone selling prices of the promised services.

The Company generally uses the cost-to-cost input method of progress for performance obligations to deliver products with continual transfer of control to the customer, because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost method, the extent of
47

progress towards completion is measured based on the proportion of direct costs incurred to date to the total estimated direct costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred. For performance obligations to provide services to the customer, revenue is recognized over time based on direct costs incurred or the right to invoice method (in situations where the value transferred matches the Company’s billing rights) as the customer receives and consumes the benefits.

Use of the cost-to-cost method requires the Company to make reasonably dependable estimates of costs at completion associated with the design, manufacture and delivery of products and services in order to calculate revenue. Significant judgment is used to estimate total revenue and costs at completion, particularly in the assumptions related to internal labor hours and third-party services for which a vendor invoice or quote is not yet available. As a significant change in one or more estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its contract-related estimates regularly. Adjustments in estimated profits/losses are recognized under the cumulative catch-up method. Under this method, the impact of the adjustments is recognized in the period the adjustment is recognized. When estimates of total costs at completion for an integrated, construction type contract exceed total estimates of revenue to be earned on a performance obligation related to complex equipment or related services, a provision for the remaining loss on the performance obligation is recognized in the period the loss is determined.

Asset Valuations

The accounting for SWU and uranium inventories includes estimates and judgments. SWU and uranium inventory costs are determined using the average cost method. Inventories of SWU and uranium are valued at the lower of cost or net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The estimated selling price for SWU and uranium under contract is based on the pricing terms of contracts in our sales order book. For uranium not under contract, the estimated selling price is based primarily on published price indicators at the balance sheet date.

Intangible assets originated from our reorganization and application of fresh start accounting as of September 30, 2014. The intangible assets represented the fair value adjustment to the assets and liabilities for our LEU segment. The identifiable intangible assets relate to our order book and customer relationships. The order book intangible asset is amortized as the order book valued at emergence is reduced, principally as a result of deliveries to customers. The customer relationships intangible asset is amortized using the straight-line method over the estimated average useful life of 15 years, with 7 ¾ years of scheduled amortization remaining. The aggregate net balance of identifiable intangible assets was $54.7 million as of December 31, 2021.

The carrying values of the intangible assets are subject to impairment tests whenever events or changes in business circumstances indicate that the carrying amount of the intangible assets may not be fully recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset, or asset group exceeds its fair value.
Inherent in our fair value determinations are certain judgments and estimates, including projections of future cash flows, the discount rate reflecting the risk inherent in future cash flows, the interpretation of current economic indicators and market valuations, and strategic plans with regard to operations. A change in these underlying assumptions would cause a change in the results of the tests, which could cause the fair value of the intangible asset to be less than its respective carrying amount.

48


Pension and Postretirement Health and Life Benefit Costs and Obligations

We provide retirement benefits to certain employees and retirees under defined benefit pension plans and postretirement health and life benefit plans. The valuation of benefit obligations and costs is based on provisions of the plans and actuarial assumptions that involve judgments and estimates.

Assets and obligations related to our retiree benefit plans are remeasured each year as of the balance sheet date resulting in differences between actual and projected results for the year. The Company has elected the accounting option to recognize these actuarial gains and losses in the statement of operations in the fourth quarter. The alternative would be to amortize gains and losses into operating results over time. The Company’s treatment of recognizing actuarial gains and losses immediately is intended to increase transparency into how movements in plan assets and benefit obligations impact financial results. Immediate recognition of such gains and losses in the statement of operations may cause significant fluctuations in our results of operations. In addition, an interim remeasurement and recognition of gains or losses may be required for a plan during the year if lump sum payments exceed certain levels.

Components of retirement benefit expense/income other than service cost are presented in our consolidated statement of operations as Nonoperating Components of Net Periodic Benefit Income. These components consist primarily of the return on plan assets, offset by interest cost as the discounted present value of benefit obligations nears payment. Results also reflect claims experience, changes in mortality and healthcare claim assumptions and changes in market interest rates. Service cost is recognized in Cost of Sales (for the LEU segment) and Selling, General and Administrative expense.

Nonoperating components of net periodic benefit income netted to income of $67.6 million in 2021 and $1.6 million in 2020, including a net actuarial gain of $50.5 million in 2021 and net actuarial loss of $7.2 million in 2020. In 2021, the net actuarial gain reflected an increase in interest rates from approximately 2.5% to 2.8%, favorable investment returns relative to the expected return assumption, and healthcare claims assumption, partially offset by changes in mortality, healthcare costs trend assumptions, and claims experience. In 2020, the net actuarial loss reflected a decline in market interest rates from approximately 3.3% to 2.5%, partially offset by favorable investment returns relative to the expected return assumption, changes in mortality and healthcare claim assumptions.

Changes in actuarial assumptions could impact the measurement of benefit obligations and benefit costs, as follows:
•The expected return on benefit plan assets is approximately 5.50% for 2022. The expected return is based on historical returns and expectations of future returns for the composition of the plans’ equity and debt securities. A one-half percentage point decrease in the expected return on plan assets would increase annual pension costs by $3.2 million in 2022. However, the net impact of any changes in the expected return on benefit plan assets on the final benefit cost recognized for fiscal year 2022 would be $0 since the actual return on assets would effectively be reflected at December 31, 2022, under our mark-to-market accounting methodology.
•The present value of pension obligations is calculated by discounting long-term obligations using a market interest rate. This discount rate is the estimated rate at which the benefit obligations could be effectively settled on the measurement date and is based on yields of high quality fixed income investments whose cash flows match the timing and amount of expected benefit payments of the plan. Discount rates of approximately 2.8% were used as of December 31, 2021. A one-half percentage point reduction in the discount rate would increase the valuation of pension benefit obligations by $35.5 million and postretirement health and life benefit obligations by $6.9 million, and the resulting changes in the valuations would decrease the aggregate service cost and interest cost components of annual pension costs and postretirement health and life benefit costs by $2.6 million and $0.4 million, respectively.
49

•The healthcare costs trend rates are 6% projected in 2022 reducing to a final trend rate of 5% by 2026. The healthcare costs trend rate represents our estimate of the annual rate of increase in the gross cost of providing benefits. The trend rate is a reflection of health care inflation assumptions, changes in healthcare utilization and delivery patterns, technological advances, and changes in the health status of our plan participants.

Income Taxes

During the ordinary course of business, there are transactions and calculations for which the ultimate tax determination is uncertain. As a result, we recognize tax liabilities based on estimates of whether additional taxes and interest will be due. To the extent that the final tax outcome of these matters is different than the amounts that were initially recorded, such differences will impact the income tax provision in the period in which such determination is made.

Accounting standards prescribe a minimum recognition threshold that a tax position is required to meet before the related tax benefit may be recognized in the financial statements. As of December 31, 2021, the liability for unrecognized tax benefits, included in Other Long-Term Liabilities on the consolidated balance sheet in Part IV of this Annual Report was $1.0 million and accrued interest and penalties totaled less than $0.1 million.

Accounting for income taxes involves estimates and judgments relating to the tax bases of assets and liabilities and the future recoverability of deferred tax assets. In assessing the realization of deferred tax assets, we determine whether it is more likely than not that the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income in future years when deferred tax assets are recoverable or are expected to reverse. Factors that may affect estimates of future taxable income include, but are not limited to, competition, changes in revenue, costs or profit margins, market share, and developments related to the American Centrifuge technology. In practice, positive and negative evidence is reviewed with objective evidence receiving greater weight. If, based on the weight of available evidence, it is more likely than not that all, or some portion, of the deferred tax assets will not be realized, we record a valuation allowance. The more negative evidence that exists, the more positive evidence is necessary and the more difficult it is to support a conclusion that a valuation allowance is not needed for all, or some portion, of the deferred tax assets.

All available positive and negative evidence is analyzed quarterly to determine the amount of the valuation allowance. A full valuation allowance against the federal and state net deferred assets was first recorded in the fourth quarter of 2011 because of significant losses and other negative evidence.

In the second quarter of 2020, the valuation allowance on the state net deferred tax assets for the LEU segment was released due to a return to profitability that led to cumulative income for state income tax purposes. A full valuation allowance against the federal and state net deferred tax assets for the rest of the business remained throughout 2020 because negative evidence, including cumulative losses, outweighed positive evidence.

Centrus evaluated both positive and negative evidence that was objectively verifiable to determine the amount of the federal valuation allowance that is required on Centrus’ federal deferred tax assets. As discussed in Operating Results, Centrus has visibility on a significant portion of revenue in the LEU segment through 2026, primarily from its long-term sales contracts. Centrus considered both its achievement of sustained profitability and cumulative income in 2021, as well as the forecasted income to be significant forms of positive evidence. Negative evidence included uncertainty in and the lack of objectively verifiable evidence for profitability in later years when Centrus’ existing sales order book and supply contracts reach expiration in its LEU segment. In Centrus’ technical solutions segment, negative evidence included uncertainty in the future funding of the HALEU enrichment facility and thus, no assumptions for the future funding of the HALEU enrichment facility were included in the forecast model because it was not objectively verifiable. Centrus
50

determined that the positive evidence outweighed the negative evidence and supported a release of the federal valuation allowance. However, due to lack of objectively verifiable information in later years, it was determined that forecasted future income was not sufficient to realize all the deferred tax assets. Therefore, the Company recorded a $40.7 million partial release of its federal valuation allowance in the fourth quarter of 2021. As of December 31, 2021, the valuation allowance against the remaining federal and state net deferred tax assets was $414.7 million.

Going forward, the Company will continue to evaluate both positive and negative evidence that would support any further changes to the remaining valuation allowances. Such evidence in its technical solutions segment may include signing new contracts which could have a significant impact on pre-tax income, follow-on work related to the HALEU program, or abandonment of the commercial deployment of the centrifuge technology. Refer to Part I, Item 1A, Risk Factors for more information. Such evidence in our LEU segment may include renewing SWU sales contracts with existing customers and/or signing new SWU sales or purchase contracts with significantly higher or lower margins than currently forecasted. Additional evidence in the LEU segment may include potential deferrals in the timing of deliveries requested by its customers, which would impact revenue recognition timing. The impact of these and other potential positive and negative events will be weighed and evaluated to determine if the valuation allowance should be increased or decreased in the future.
51

Results of Operations

A discussion of the results of operations from 2019 can be found in Item 7, Management Discussion and Analysis, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed with the SEC on March 22, 2021.

Segment Information

The following table presents elements of the accompanying consolidated statements of operations that are categorized by segment (dollar amounts in millions):
Year Ended 
December 31,
 20212020$ Change% Change
LEU segment  
Revenue:  
SWU revenue$163.3 $151.5 $11.8 8 %
Uranium revenue22.8 39.0 (16.2)(42)%
Total186.1 190.5 (4.4)(2)%
Cost of sales113.1 92.7 (20.4)(22)%
Gross profit$73.0 $97.8 $(24.8)
Technical solutions segment  
Revenue$112.2 $56.7 $55.5 98 %
Cost of sales70.7 56.9 (13.8)(24)%
Gross profit (loss)$41.5 $(0.2)$41.7 
Total  
Revenue$298.3 $247.2 $51.1 21 %
Cost of sales183.8 149.6 (34.2)(23)%
Gross profit$114.5 $97.6 $16.9 

Revenue

Revenue from the LEU segment decreased $4.4 million or (2%) in 2021 compared to 2020. SWU revenue increased $11.8 million or 8% in 2021 compared to 2020. The volume of SWU sales increased 64%. SWU revenue in 2020 includes $32.6 million collected from a customer in settlement of a supply contract that was subject to the customer’s bankruptcy proceeding. Excluding this payment, the average SWU price billed to customers decreased 16%, reflecting the particular contracts under which SWU were sold during the periods. Uranium revenue decreased $16.2 million or (42%) in 2021 compared to 2020. The volume of uranium sales decreased (46%).

Revenue from the technical solutions segment increased $55.5 million or 98% in 2021 compared to 2020. Revenue in 2021 included $43.5 million related to the settlement of the Company’s claims for reimbursements for certain pension and postretirement benefits costs incurred in connection with a past cost-reimbursable contract performed at the Portsmouth GDP. Excluding this payment, revenue from the technical solutions segment increased $12.0 million or 21% in 2021, due to increased work performed under the HALEU and other contracts.

Cost of Sales

Cost of sales for the LEU segment increased $20.4 million or 22% in 2021 compared to 2020, reflecting the increase in SWU sales volume, partially offset by the decrease in uranium sales volume. The average cost of sales
52

per SWU was unchanged from 2020. Cost of sales includes legacy costs related to former employees of the Portsmouth GDP and Paducah GDP of $2.7 million in 2021 and $3.7 million in 2020.

Cost of sales for the technical solutions segment increased $13.8 million or 24% in 2021 compared to 2020, largely reflecting the increase in contract work performed. The impact to cost of sales is $7.2 million in 2021 and $10.6 million in 2020 for previously accrued contract losses attributable to work performed under the HALEU Contract. For details on HALEU Contract accounting, refer to Technical Solutions - Government Contracting above.

Gross Profit

We recognized a gross profit of $114.5 million in 2021, an improvement of $16.9 million compared to the gross profit of $97.6 million in 2020.

The gross profit for the LEU segment was $73.0 million in 2021 compared to $97.8 million in 2020. The decrease for the LEU segment of $24.8 million was primarily due to the payment of $32.6 million in 2020 from a customer in settlement of a supply contract that was subject to the customer’s bankruptcy proceeding and the decrease in the average SWU sales price, partially offset by the increase in SWU and uranium sales volumes.

For the technical solutions segment, we recognized a gross profit of $41.5 million in 2021 compared to a gross loss of $0.2 million in 2020. Excluding the settlement with DOE, gross profit (loss) from the technical solutions segment increased to a loss of $2.0 million in 2021 from a loss of $0.2 million in 2020.

Non-Segment Information

The following table presents elements of the accompanying consolidated statements of operations that are not categorized by segment (dollar amounts in millions):
Year Ended 
December 31,
 20212020$ Change% Change
Gross profit$114.5 $97.6 $16.9 17 %
Advanced technology costs2.1 2.8 0.7 25 %
Selling, general and administrative36.0 36.0 — — %
Amortization of intangible assets
8.1 6.8 (1.3)(19)%
Special charges for workforce reductions— 0.6 0.6 100 %
Other expense, net— 0.4 0.4 100 %
Operating income68.3 51.0 17.3 34 %
Nonoperating components of net periodic benefit income(67.6)(1.6)66.0 4,125 %
Interest expense0.1 0.1 — — %
Investment income(0.1)(0.5)(0.4)(80)%
Income before income taxes135.9 53.0 82.9 156 %
Income tax benefit(39.1)(1.4)37.7 -
Net income$175.0 $54.4 $120.6 222 %

53


Advanced Technology Costs

Advanced technology costs consist of American Centrifuge and related expenses that are outside of our customer contracts in the technical solutions segment, including costs for work at the Piketon facility prior to the commencement of the HALEU work in June 2020 and costs to continue to advance our advanced technology. Costs declined $0.7 million (or 25%) in 2021 compared to 2020.

Selling, General and Administrative

Selling, general and administrative (“SG&A”) expenses were $36.0 million in each of 2021 and 2020. These expenses remained flat year over year.

Amortization of Intangible Assets

Amortization of intangible assets increased $1.3 million or 19% in 2021 compared to 2020. Amortization expense for the intangible asset related to the September 2014 sales order book is a function of SWU sales volume under that order book, and amortization expense for the intangible asset related to customer relationships is amortized on a straight-line basis.

Special Charges for Workforce Reductions

There were no special charges in 2021. Special charges of $0.6 million in 2020 consisted of estimated employee termination benefits of $0.6 million.

Nonoperating Components of Net Periodic Benefit Income

Nonoperating components of net periodic benefit income was ($67.6) million in 2021, compared to ($1.6) million in 2020. Nonoperating components of net periodic benefit income in 2021 consists primarily of a return on plan assets of ($58.2) million and future impacts of the change in the discount rate of ($31.0) million, offset by interest cost of $21.5 million, as the discounted present value of benefit obligations nears payment. Nonoperating components of net periodic benefit income in 2020 consists primarily of a return on plan assets of ($85.8) million offset by future impacts of the change in the discount rate of $74.0 million, interest cost of $29.1 million, as the discounted present value of benefit obligations nears payment, and other actuarial items, which includes mortality and healthcare claim assumptions which net to ($18.9) million.
Interest Expense

Interest expense was $0.1 million in 2021 and 2020.

Income Tax Benefit

The income tax benefit was $39.1 million in 2021 and $1.4 million in 2020. The income tax benefit in 2021 relates to the release of the federal valuation allowance of $40.7 million offset by the effect of state rate changes of $1.2 million and state income tax expense of $0.4 million. The income tax benefit in 2020 relates to the release of the state valuation allowance against state net deferred tax assets for the LEU segment of $2.0 million offset primarily by state income tax expense of $0.6 million. The state income tax expense in 2021 and 2020, primarily relates to an accrual for a current unrecognized tax benefit offset by the reversal of a previously accrued unrecognized tax benefit.

54

Net Income

Net income was $175.0 million in 2021, compared to $54.4 million in 2020. The favorable variance of $120.6 million was primarily a result of a $66.0 million favorable variance in nonoperating components of net periodic benefit income, $16.9 million favorable variance in gross profit and $37.7 million favorable variance in income tax benefit.

Net Income per Share

The Company measures Net Income per Share both on a U.S. GAAP basis and adjusted to exclude deemed dividends allocable to retired preferred stock shares (“Adjusted Net Income per Share”).

On November 17, 2020, the Company completed the purchase of 62,854 shares of its outstanding Series B Senior Preferred Stock at a price per share of $954.59, less any applicable withholding taxes. (Refer below to Liquidity and Capital Resources for additional details.) The purchase price per share represented a 25% discount from the aggregate liquidation preference, including accrued but unpaid dividends, of $1,272.78 per share as of September 30, 2020. Since origination, the carrying value on the Balance Sheet was $43.80 per share based on values assigned in the originating securities exchange. The liquidation amount at origination was $1,000.00 per share.

The aggregate purchase price of approximately $60 million, less accrued but unpaid dividends attributable to the purchased and retired Series B Senior Preferred Stock, is considered for purposes of Net Income per Share to be a deemed dividend to the extent it exceeds the carrying value on the Balance Sheet, or $41.9 million.

On February 2, 2021, the Company completed the exchange of 3,873 shares of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (“Preferred Stock”) for (i) 231,276 shares of Class A Common Stock and (ii) a warrant to purchase 250,000 shares of Class A Common Stock at an exercise price of $21.62 per share, for an aggregate valuation of approximately $7.5 million. The carrying value of the Series B Senior Preferred Stock on the Balance Sheet was $1.00 per share par value. The aggregate liquidation preference of the Series B Senior Preferred Stock, including accrued but unpaid dividends, was $1,291.04 per share as of December 31, 2020.

On November 23, 2021, the Company completed the purchase of 36,867 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,145.20, less any applicable withholding taxes. The Company also completed the purchase of the remaining 980 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,149.99, less any applicable withholding taxes, on December 15, 2021. For more information refer to Note 15 - Stockholders’ Equity in the consolidated financial statements in Part IV of this Annual Report. The aggregate purchase price of both transactions was $43.3 million. The carrying value of the Series B Senior Preferred Stock on the Balance Sheet was $1.00 per share par value.

The aggregate valuation of all 2021 preferred stock transactions of approximately $50.8 million, less accrued but unpaid dividends attributable to the acquired and retired shares of Preferred Stock, is considered for purposes of Net Income per Share to be a deemed dividend in the aggregate amount equal to the amount by which it exceeds the carrying value of the Preferred Stock on the Balance Sheet, or $37.6 million.

The Company measures Net Income and Net Income per Share both on a GAAP basis and on an adjusted basis to exclude deemed dividends allocable to retired preferred stock shares (“Adjusted Net Income” and “Adjusted Net Income per Share”). We believe Adjusted Net Income and Adjusted Net Income per Share, which are non-GAAP financial measures, provide investors with additional understanding of the Company’s financial performance as well as its strategic financial planning analysis and period-to-period comparability. These metrics are useful to investors because they reflect how management evaluates the Company’s ongoing operating performance from period-to-period after removing certain transactions and activities that affect comparability of the metrics and are not reflective of the Company’s core operations.
55

 Three Months Ended 
December 31,		Year Ended 
December 31,
2021202020212020
Numerator (in millions):
Net income$116.2 $16.4 $175.0 $54.4 
Less: Preferred stock dividends - undeclared and cumulative— 0.8 2.1 6.7 
Less: Distributed earnings allocable to retired preferred shares31.0 41.9 37.6 41.9 
Net income (loss) allocable to common stockholders$85.2 $(26.3)$135.3 $5.8 
Plus: Distributed earnings allocable to retired preferred shares$31.0 $41.9 $37.6 $41.9 
Adjusted net income, including distributed earnings allocable to retired preferred shares (Non-GAAP)$116.2 $15.6 $172.9 $47.7 
Denominator (in thousands) (a):
Average common shares outstanding - basic13,873 10,322 13,493 9,825 
Average common shares outstanding - diluted (b)14,278 10,322 13,879 10,123 
 Net Income (Loss) per Share (in dollars):
Basic$6.14 $(2.55)$10.03 $0.59 
Diluted$5.97 $(2.55)$9.75 $0.57 
Plus: Effect of distributed earnings allocable to retired preferred shares, per common share (in dollars):
Basic$2.24 $4.06 $2.78 $4.26 
Diluted$2.17 $4.01 $2.71 $4.14 
Adjusted Net Income per Share (Non-GAAP) (in dollars):
Basic$8.38 $1.51 $12.81 $4.85 
Diluted$8.14 $1.46 $12.46 $4.71 
(a) For details related to average shares outstanding, refer to Note 14, Net Income (Loss) Per Share of the consolidated financial statements.
(b) For purposes of Adjusted Net Income per Share for the three months ended December 31, 2020, average common shares outstanding - diluted is 10,659,000 shares. No dilutive effect is recognized in a period in which a net loss has occurred.

Liquidity and Capital Resources

We ended 2021 with a consolidated cash balance of $193.8 million. We anticipate having adequate liquidity to support our business operations for at least the next 12 months from the date of this report. Our view of liquidity is dependent on, among other things, conditions affecting our operations, including market, international trade restrictions, COVID-19 and other conditions, the level of expenditures and government funding for our services contracts, and the timing of customer payments. Liquidity requirements for our existing operations are affected primarily by the timing and amount of customer sales and our inventory purchases.

We believe our sales order book in our LEU segment is a source of stability for our liquidity position. Subject to market conditions, we see the potential for growing uncommitted demand for LEU during the next few years with accelerated open demand in 2025 and beyond.

Cash resources and net sales proceeds from our LEU segment fund technology costs that are outside of our customer contracts in the technical solutions segment and general corporate expenses, including cash interest payments on our debt. We believe our investment in advanced U.S. uranium enrichment technology will position
56

the Company to meet the needs of our customers as they deploy advanced reactors and next generation fuels. We signed the three-year HALEU Contract with DOE in October 2019. Under the HALEU Contract, the Company is contributing a portion of the program costs. The program has been under way since May 31, 2019, when Centrus and DOE signed a preliminary letter agreement that allowed work to begin while the full contract was being finalized.

In 2019, under the HALEU Contract, DOE agreed to reimburse the Company for 80% of its costs incurred in performing the contract, up to a maximum of $115 million (which was recently increased to $126.7 million). The Company’s cost share is the corresponding 20% and any costs incurred above these amounts. The Company has received aggregate cash payments of $120.3 million through December 31, 2021.

The Company entered into this cost-share contract with DOE as a critical first step on the road back to the commercial production of enriched uranium, which the Company had terminated in 2013 with the closure of the Paducah GDP. HALEU is expected to be required by many of the advanced reactor designs now under development, including nine out of the ten reactor designs that were selected in 2020 for the ARDP. Our HALEU Contract expires in 2022 and although we believe demand for HALEU will emerge over the next several years, there are no guarantees about whether or when government or commercial demand for HALEU will materialize, and there are a number of technical, regulatory and economic hurdles that must be overcome for these fuels and reactors to come to the market. Assuming that we are able to win a contract from DOE to operate the cascade, our goal is to scale up the facility in modular fashion as demand for HALEU grows in the commercial and government sectors, subject to the availability of funding and/or contracts to purchase the output of the plant. At this time, however, there is no assurance that sufficient government or commercial funding or demand for material will be timely secured, that we will be awarded a contract by the DOE to operate or that we will be permitted by DOE to expand the demonstration cascade. For further discussion, refer to Part I, Item 1A, Risk Factors.

We lease facilities and related personal property near Piketon, Ohio from DOE. In September 2021, DOE and Centrus extended the lease term through December 31, 2025. Any facilities or equipment constructed or installed in leased facilities under contract with DOE, including the HALEU Contract, will be owned by DOE. DOE-owned property may be returned to DOE in an “as is” condition at the end of the lease term and DOE would be responsible for its D&D. If we determine the equipment and facilities may benefit Centrus after completion of the HALEU Contract, we can extend the facility lease and ownership of the equipment will be transferred to us, subject to mutual agreement regarding D&D and other issues, including those impacted by DOE’s recent decision to competitively bid the contract for operations of the HALEU cascade.

In the event that funding by the U.S. government for research, development and demonstration of gas centrifuge technology is reduced or discontinued, or we are not awarded a DOE contract to operate the cascade we are now constructing under the HALEU Contract, such actions may have a material adverse impact on our ability to deploy the American Centrifuge technology and on our liquidity.

We have taken steps over the last several years to reduce the size and volatility of our defined benefit pension obligations, including offering the option for pension-eligible employees to receive a lump sum payment upon termination of their employment. In the fourth quarter of 2020, the Company entered into an arrangement with an insurance company and transferred certain future benefit obligations and administrative costs from our primary qualified pension plan. In this transaction, we transferred approximately $30 million of pension plan assets to the insurance company in order to reduce our pension plan obligations by approximately $30 million. This transaction will save administrative costs associated with the PBGC and reduce the volatility of future pension obligations.

Capital expenditures of approximately $1 million are anticipated over the next 12 months.

We are actively considering, and expect to consider from time to time in the future, potential strategic transactions, which at any given time may be in various stages of discussions, diligence, or negotiation. If we pursue
57

opportunities that require capital, we believe we would seek to satisfy these needs through a combination of working capital, cash generated from operations or additional debt or equity financing.

The change in cash, cash equivalents and restricted cash from our consolidated statements of cash flows are as follows on a summarized basis (in millions):
Year Ended 
December 31,
 20212020
Cash provided by operating activities$50.0 $67.1 
Cash used in investing activities(1.2)(1.4)
Cash used in financing activities(9.9)(44.4)
Increase in cash, cash equivalents and restricted cash$38.9 $21.3 

Operating Activities

During 2021, net cash provided by operating activities was $50.0 million. Net income of $175.0 million in 2021, net of non-cash expenses, was a significant source of cash. Income included the $43.5 million recovery of claims for reimbursement for costs related to past contract services performed. The net increase is also the result of a $16.6 million increase in accounts payable and other liabilities and a $13.2 million increase in deferred revenue and advances from customers. These increases were partially offset by a $57.0 million reduction in pension and postretirement benefit liabilities and a $10.7 million increase in inventories.

During 2020, net cash provided by operating activities was $67.1 million. Net income of $54.4 million in 2020, net of non-cash expenses, was a significant source of cash. Income included $32.6 million on recovery of bankruptcy court claims. The net increase is also the result of a decrease in inventories of $25.8 million and a $13.2 million increase in payables under SWU purchase agreements. These increases were partially offset by a $32.7 million reduction in pension and postretirement benefit liabilities.
Investing Activities

Investing activities consisted of capital expenditures of $1.2 million in 2021 and $1.4 million in 2020.

Financing Activities

In 2021, net cash used in financing activities included the redemption of preferred stock for $44.4 million, net of direct costs, pursuant to a tender offer and net proceeds received of $42.1 million from the issuance of common stock pursuant to a Registration Statement on Form S-3.

In 2020, net cash used in financing activities included the purchase of preferred stock for $61.6 million, including transaction costs, pursuant to a tender offer and net proceeds received of $23.1 million from the issuance of common stock pursuant to a Registration Statement on Form S-3. See Common Stock Issuance and 2021 Tender Offer below.

In both 2021 and 2020, payments of $6.1 million of interest classified as debt are classified as a financing activity. Refer to Note 8, Debt, of the consolidated financial statements in Part IV of this Annual Report regarding the accounting for the 8.25% Notes.

58

Working Capital

The following table summarizes the Company’s working capital (in millions):
December 31,
20212020
Cash and cash equivalents$193.8 $152.0 
Accounts receivable29.1 29.6 
Inventories, net82.7 59.9 
Current debt(6.1)(6.1)
Deferred revenue and advances from customers, net of deferred costs(159.8)(131.3)
Other current assets and liabilities, net(67.1)(64.1)
Working capital$72.6 $40.0 

We are managing our working capital to seek to improve the long-term value of our LEU and technical solutions businesses and are planning to continue funding the Company’s qualified pension plans in the ordinary course because we believe that is in the best interest of all stakeholders. We expect that any other uses of working capital will be undertaken in light of these strategic priorities and will be based on the Company’s determination as to the relative strength of its operating performance and prospects, financial position, and expected liquidity requirements. In addition, we expect that any such other uses of working capital will be subject to compliance with contractual restrictions to which the Company and its subsidiaries are subject, including the terms and conditions of our debt securities and credit facilities. We continually evaluate alternatives to manage our capital structure, and may opportunistically repurchase, exchange, or redeem Company securities from time to time.

Common Stock Issuance

Pursuant to a sales agreement with its agents, the Company sold at the market price an aggregate of 1,516,467 shares of its Class A Common Stock in 2021, for a total of $44.2 million. After expenses and commissions paid to the agents, the Company’s proceeds total $42.4 million. Additionally, the Company recorded direct costs of $0.3 million related to the issuance. The shares of Class A Common Stock were issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-239242), which became effective on August 5, 2020, and a prospectus supplement dated December 31, 2020, to the prospectus. At present, the Company has $5.8 million remaining available for sale under the prospectus supplement dated December 31, 2020, and may from time to time sell additional shares through the sales agreement. The Company used the net proceeds from this offering for general working capital purposes, to invest in technology development, repay outstanding debt and retire shares of its Series B Senior Preferred Stock.

As previously disclosed in our Current Report on Form 8-K filed February 5, 2021, on February 2, 2021, the Company entered into an amendment (the “Voting Agreement Amendment”) to its existing Voting and Nomination Agreement with Mr. Morris Bawabeh, Kulayba LLC and M&D Bawabeh Foundation, Inc. (collectively, the “MB Group”) and an Exchange Agreement (as described below) whereby the MB Group agreed to support management’s recommendation on certain matters at the Company’s 2021 annual meeting of stockholders (the “Annual Meeting”) and Kulayba LLC agreed to exchange shares of Preferred Stock for shares of Class A Common Stock and a warrant to acquire additional shares of Class A Common Stock. Pursuant to the First Amendment to the Voting and Nomination Agreement, the MB Group agreed to cause all shares of Class A Common Stock owned of record or beneficially owned by the MB Group at the Annual Meeting to be voted in favor of (i) an amendment to extend the length of the term of the Company’s Section 382 Rights Agreement dated as of April 6, 2016, as amended to date, for two years from June 30, 2021, to June 30, 2023, and (ii) an increase of shares of Class A Common Stock reserved for delivery under the Company’s 2014 Equity Incentive Plan, as amended to date, of an additional 700,000 shares of Class A Common Stock.

59

In connection with the entry into the Voting Agreement Amendment, the Company and Kulayba LLC also entered into the Exchange Agreement, pursuant to which Kulayba LLC agreed to the Exchange, representing a $5,000,198 liquidation preference (including accrued and unpaid dividends), for (i) 231,276 shares of Class A Common Stock priced at the closing market price of $21.62 on the date the Exchange Agreement was signed and (ii) a warrant (the “Warrant”), exercisable for 250,000 shares of Class A Common Stock at an exercise price of $21.62 per share, which was the closing market price on the date the Exchange Agreement was signed, subject to certain customary adjustments pursuant to the terms of the Warrant. The Warrant is exercisable by Kulayba LLC for a period commencing on the closing date of the Exchange and ending, unless sooner terminated as provided in the Warrant, on the first to occur of: (a) the second anniversary of the closing date of the Exchange or (b) the last business day immediately prior to the consummation of a Fundamental Transaction (as defined in the Warrant) which results in the shareholders of the Company immediately prior to such Fundamental Transaction owning less than 50% of the voting equity of the surviving entity immediately after the consummation of the Fundamental Transaction. The Company retired the 3,873 shares of Preferred Stock received by the Company under the Exchange Agreement.

Capital Structure and Financial Resources

Interest on the 8.25% Notes is payable semi-annually in arrears as of February 28 and August 31 based on a 360-day year consisting of twelve 30-day months. The 8.25% Notes are guaranteed on a subordinated and limited basis by, and secured by substantially all assets of, Enrichment Corp. The 8.25% Notes mature on February 28, 2027. Additional terms and conditions of the 8.25% Notes are described in Note 8, Debt, of the consolidated financial statements in Part IV of this Annual Report.

2021 Tender Offer

On October 20, 2021, the Company announced the commencement of a tender offer to purchase all of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (the “Series B Senior Preferred Stock”), at a price of $1,145.20 per Series B Senior Preferred Stock (inclusive of any rights to accrued but unpaid dividends), to the sellers in cash, less any applicable withholding taxes (the “Offer”). The Offer was made pursuant to the Tender Offer Statement on Schedule TO filed by the Company on October 20, 2021, with the SEC. The aggregate liquidation preference per Series B Senior Preferred Stock (including accrued but unpaid dividends) was $1,347.29 as of September 30, 2021.

On November 23, 2021, the Company announced the results of the tender offer and the related consent solicitation (the “Consent Solicitation”) to amend the certificate of designation of the Series B Senior Preferred Stock (the “Series B Preferred Amendment”). 36,867 shares of the Series B Senior Preferred Stock were properly tendered and not properly withdrawn in the Offer, and corresponding consents have been delivered in the Consent Solicitation. Pursuant to the terms of the Offer and Consent Solicitation, the Company has accepted for purchase all of the Series B Senior Preferred Stock tendered in the Offer, for an aggregate purchase price of $42.2 million. The accepted shares represent 97.4% of the Company’s outstanding Series B Senior Preferred Stock as of September 30, 2021. Based on the final results, the requisite consent of at least 90% of the outstanding Series B Senior Preferred Stock required to approve the Series B Preferred Amendment was obtained. On November 23, 2021, the Company issued a Notice of Full Redemption providing for the redemption of any and all shares Series B Senior Preferred Stock outstanding after consummation of the Company’s tender offer to purchase all of its issued and outstanding Series B Senior Preferred Stock. On December 15, 2021, the Company completed the redemption of all 980 outstanding Series B Senior Preferred Stock for aggregate cash consideration of $1.1 million. The aggregate purchase price of $43.3 million was offset by direct costs totaling $0.9 million.
The effect of the Series B Preferred Amendment was to: (i) cease any obligation to pay dividends on Series B Senior Preferred Stock (other than the payment of accrued dividends in connection with a redemption or distribution of assets upon liquidation, dissolution or winding up), (ii) permit the Company to redeem Series B Senior Preferred Stock during the 90 days following the date of effectiveness of the Series B Preferred Amendment at a redemption price per share equal to $1,145.20 (plus any additional accrued dividends for the period from and including the date
60

of effectiveness of the Series B Preferred Amendment to the date of redemption), (iii) remove the prohibition on the declaration and payment of dividends on junior stock of the Company, which includes all shares of the Company’s capital stock defined as “Common Stock” in the Company’s Amended and Restated Certificate of Incorporation, or the redemption, purchase or acquisition of such junior stock, and (iv) remove the restriction on redemption, purchase or acquisition of capital stock of the Company ranking on parity with the Series B Senior Preferred Stock.

On December 16, 2021, the Company filed a Certificate of Elimination of the Series B Senior Preferred Stock of Centrus Energy Corp. with the Secretary of State of Delaware (the “Certificate of Elimination”) to eliminate the designation of the Series B Senior Preferred Stock and to return all shares of preferred stock of the Company previously designated as Series B Senior Preferred Stock to authorized but unissued and undesignated shares of preferred stock of the Company.

2020 Tender Offer

On November 17, 2020, pursuant to a tender offer announced on October 19, 2020, the Company completed the purchase of 62,854 shares of its outstanding Series B Senior Preferred Stock at a price per share of $954.59, less any applicable withholding taxes, for an aggregate purchase price of approximately $60 million. The purchase price per share represented a 25% discount from the aggregate liquidation preference, including accrued but unpaid dividends, of $1,272.78 per share as of September 30, 2020. These shares represented approximately 60% of the Company's outstanding Series B Senior Preferred Stock as of September 30, 2020. The remaining Series B Senior Preferred Stock outstanding after the transaction was 41,720 shares.

Commitments under Long-Term SWU Purchase Agreements

The Company purchases SWU contained in LEU from Russia, supplied to us under a long-term agreement, as amended, signed in 2011 with TENEX. Under a 2018 agreement, the Company will purchase SWU contained in LEU from the French government owned company, Orano. Refer to Note 16, Commitments and Contingencies, of the consolidated financial statements for additional information.

DOE Technology License

We have a non-exclusive license in DOE inventions that pertain to enriching uranium using gas centrifuge technology. The license agreement with DOE provides for annual royalty payments based on a varying percentage (1% to 2%) of our annual revenues from sales of the SWU component of LEU produced by us using DOE centrifuge technology. There is a minimum annual royalty payment of $100,000 and the maximum cumulative royalty over the life of the license is $100 million. There is currently no commercial enrichment facility producing LEU using DOE centrifuge technology. We are continuing to advance our U.S. centrifuge technology that has evolved from DOE inventions at specialized facilities in Oak Ridge, Tennessee, and near Piketon, Ohio, with a plan to deploy a commercial enrichment facility over the long-term.

New Accounting Standards

Reference is made to New Accounting Standards in Note 1, Summary of Significant Accounting Policies, of the consolidated financial statements in Part IV of this Annual Report for information on new accounting standards.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Not provided as a smaller reporting company as defined in Rule 12b-2 of the Exchange Act.

Item 8. Financial Statements and Supplementary Data

Our consolidated financial statements, together with related notes and the report of PricewaterhouseCoopers LLP, our independent registered public accounting firm, are set forth in Part IV, Item 15.

61

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Centrus maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed by Centrus in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported in the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosures.

As of December 31, 2021, the end of the period covered by this report, our management performed an evaluation, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control over financial reporting is a process designed by, and under the supervision of the Chief Executive Officer and the Chief Financial Officer and effected by the Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2021. This evaluation was based on the framework set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on this assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2021.

The effectiveness of our internal control over financial reporting as of December 31, 2021 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report herein.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

None.

62

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information regarding executive officers is included in Part I of this Annual Report. Additional information concerning directors, executive officers and corporate governance appearing under the captions Proposal 1. Election of Directors, Governance Information and Board and Committee Membership in the Company’s Proxy Statement for the 2022 annual meeting of stockholders, which will be filed no later than 120 days after December 31, 2021 (the “2022 Proxy Statement”), is incorporated herein by reference.

We have adopted a code of business conduct (the “Code of Business Conduct”) that applies to our employees, including our principal executive officer, principal financial officer and principal accounting officer, as well as to members of our board of directors. Our Code of Business Conduct provides a brief summary of the standards of conduct that are at the foundation of our business operations. The Code of Business Conduct states that we conduct our business in strict compliance with all applicable laws. Each employee must read the Code of Business Conduct and sign a form stating that he or she has read, understands and agrees to comply with the Code of Business Conduct. A copy of the Code of Business Conduct is available in the Corporate Governance section of our website at www.centrusenergy.com or upon request without charge. We will disclose on the website any amendments to, or waivers from, the Code of Business Conduct that are required to be publicly disclosed.

Item 11. Executive Compensation

Information concerning executive and director compensation appearing under the captions Executive Compensation and Compensation of Directors in the 2022 Proxy Statement is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information concerning security ownership of certain beneficial owners and management appearing under the caption Security Ownership of Certain Beneficial Owners and Management in the 2022 Proxy Statement is incorporated herein by reference.

Information concerning the common stock that may be issued under the 2014 Equity Incentive Plan (as amended and restated in May 2017) appearing under the caption Equity Compensation Plan Information in the 2022 Proxy Statement is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information concerning certain relationships and related transactions and director independence appearing under the captions Transactions with Related Persons, and Director Independence in the 2022 Proxy Statement is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services

Information concerning principal accounting fees and services appearing under the caption Audit and Non-Audit Fees in the 2022 Proxy Statement is incorporated herein by reference.

63

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)    (1) Consolidated Financial Statements

    Reference is made to the consolidated financial statements appearing elsewhere in this Annual Report.

    (2) Financial Statement Schedules

    No financial statement schedules are required to be filed as part of this Annual Report.

    (3) Exhibits

    The exhibits listed on the accompanying Exhibit Index are filed or incorporated by reference as part of this report and such Exhibit Index is incorporated herein by reference. The accompanying Exhibit Index identifies each management contract or compensatory plan or arrangement required to be filed as an exhibit to this report.

Item 16. Form 10-K Summary

None.

64

EXHIBIT INDEX
Exhibit No.
Description
1.1
3.1
3.2
3.3
3.4
3.5

3.6

3.7
3.8
4.1
4.2
4.3
4.4
4.5
65

4.6
4.7
4.8
4.9
4.10
4.11
4.12
4.13
4.14
4.15
4.16
4.17
10.1
10.2
66

10.3
10.4
10.5
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
10.14
10.15
67

10.16
10.17
10.18


10.19
10.20
10.21


10.22
10.23
10.24
10.25
68

10.26
10.27
10.28
10.29
10.30
10.31
10.32
10.33
10.34
10.35
10.36
10.37
10.38
10.39
69

10.40
10.41
10.42
10.43
10.44
10.45
10.46
10.47
10.48
10.49
10.50
10.51
10.52
10.53
10.54
21
70

(a) Filed herewith.

(b) Management contracts and compensatory plans and arrangements required to be filed as exhibits pursuant to Item 15(b) of this report.
71

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Centrus Energy Corp.
March 11, 2022
/s/ Daniel B. Poneman
Daniel B. Poneman
President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 11, 2022:
SignatureTitle
/s/ Daniel B. PonemanPresident and Chief Executive Officer
(Principal Executive Officer) and Director
Daniel B. Poneman
/s/ Philip O. Strawbridge
Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer (Principal Financial Officer)
Philip O. Strawbridge
/s/ Kevin J. Harrill
Controller and Chief Accounting Officer
(Principal Accounting Officer)
Kevin J. Harrill
/s/ Mikel H. WilliamsChairman of the Board and Director
Mikel H. Williams
/s/ Kirkland H. DonaldDirector
Kirkland H. Donald
/s/ Tetsuo Iguchi
Director
Tetsuo Iguchi
/s/ W. Thomas Jagodinski
Director
W. Thomas Jagodinski
/s/ Tina W. Jonas
Director
Tina W. Jonas
/s/ William J. MadiaDirector
William J. Madia
/s/ Bradley K. SawatzkeDirector
Bradley K. Sawatzke
/s/ Neil S. Subin
Director
Neil S. Subin
72

CENTRUS ENERGY CORP.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page
Reports of Independent Registered Public Accounting Firm (PCAOB ID 238)
Consolidated Balance Sheets
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders’ Deficit
Notes to Consolidated Financial Statements

73


Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Centrus Energy Corp.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Centrus Energy Corp. and its subsidiaries (the “Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive income, of stockholders' deficit and of cash flows for the years then ended, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable
74

assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Valuation Allowance related to Federal Deferred Tax Assets

As described in Notes 1 and 13 to the consolidated financial statements, as of December 31, 2021, the Company’s deferred tax assets were $464.8 million, net of a valuation allowance of $414.7 million, both of which a significant portion relates to federal deferred tax assets. In prior years, management maintained a full valuation allowance against federal deferred tax assets, and in the fourth quarter of 2021, management released $40.7 million of the valuation allowance against federal deferred taxes that most likely will be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient income in future years when deferred tax assets are recoverable or are expected to reverse. A valuation allowance is provided if it is more likely than not that the deferred tax assets may not be realized. Management evaluates both positive and negative evidence that is objectively verifiable to determine the amount of the federal valuation allowance. Sustained profitability and cumulative income, as well as, forecasted income, are considered to be significant forms of positive evidence. Negative evidence includes uncertainty in and the lack of objectively verifiable evidence for profitability in later years when the Company’s existing sales order book and supply contracts reach expiration.

The principal considerations for our determination that performing procedures relating to the valuation allowance related to federal deferred tax assets is a critical audit matter are (i) the significant judgment by management when assessing the ability to realize the federal deferred tax assets and whether a valuation allowance is necessary, particularly as it relates to forecasted income and (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating audit evidence related to management’s significant assumptions related to forecasted income.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the ability to realize federal deferred tax assets and whether a valuation allowance is necessary, including controls over forecasted income. These procedures also included, among others (i) testing management’s process for assessing the ability to realize federal deferred tax assets and whether a valuation allowance is necessary; (ii) testing the completeness and accuracy of underlying data used in management’s process for assessing the ability to realize federal deferred tax assets and whether a valuation allowance is necessary; and (iii) evaluating the reasonableness of the significant assumptions used by management related to forecasted income. Evaluating management’s assumption related to the forecasted income involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the Company; (ii) the terms of the Company’s existing contractual agreements with its customers and suppliers; (iii) the source and reliability of market related inputs; and (iv) whether the assumptions were consistent with evidence obtained in other areas of the audit.
75



/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
March 11, 2022

We have served as the Company’s auditor since 2002.










76

CENTRUS ENERGY CORP.
CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share data)
December 31,
 20212020
ASSETS  
Current assets:  
Cash and cash equivalents$193.8 $152.0 
Accounts receivable29.1 29.6 
Inventories91.1 64.8 
Deferred costs associated with deferred revenue143.3 151.9 
Other current assets8.6 7.8 
Total current assets465.9 406.1 
Property, plant and equipment, net
5.3 4.9 
Deposits for financial assurance2.8 5.7 
Intangible assets, net54.7 62.8 
Deferred tax assets, net41.4 1.9 
Other long-term assets2.3 4.9 
Total assets$572.4 $486.3 
LIABILITIES AND STOCKHOLDERS’ DEFICIT  
Current liabilities:  
Accounts payable and accrued liabilities$37.8 $50.6 
Payables under inventory purchase agreements37.9 21.3 
Inventories owed to customers and suppliers8.4 4.9 
Deferred revenue and advances from customers303.1 283.2 
Current debt6.1 6.1 
Total current liabilities393.3 366.1 
Long-term debt101.8 108.0 
Postretirement health and life benefit obligations114.9 130.8 
Pension benefit liabilities23.1 124.4 
Advances from customers45.1 45.2 
Other long-term liabilities36.1 32.4 
Total liabilities714.3 806.9 
Commitments and contingencies (Note 16)
Stockholders’ deficit:
Preferred stock, par value $1.00 per share, 20,000,000 shares authorized
Series A Participating Cumulative Preferred Stock, none issued— — 
Series B Senior Preferred Stock, 7.5% cumulative, 0 and 41,720 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively; aggregate liquidation preference of $53.9 as of December 31, 2020
— 0.1 
Class A Common Stock, par value $0.10 per share, 70,000,000 shares authorized, 13,649,933 and 11,390,189 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively
1.4 1.1 
Class B Common Stock, par value $0.10 per share, 30,000,000 shares authorized, 719,200 shares issued and outstanding as of December 31, 2021 and December 31, 2020
0.1 0.1 
Excess of capital over par value140.7 85.0 
Accumulated deficit(284.6)(407.7)
Accumulated other comprehensive income, net of tax0.5 0.8 
Total stockholders’ deficit(141.9)(320.6)
Total liabilities and stockholders’ deficit$572.4 $486.3 

The accompanying notes are an integral part of these consolidated financial statements.
77


CENTRUS ENERGY CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(in millions, except share and per share data)

Year Ended December 31,
20212020
Revenue:
Separative work units$163.3 $151.5 
Uranium22.8 39.0 
Technical solutions112.2 56.7 
Total revenue298.3 247.2 
Cost of Sales:
Separative work units and uranium113.1 92.7 
Technical solutions70.7 56.9 
Total cost of sales183.8 149.6 
Gross profit114.5 97.6 
Advanced technology costs
2.1 2.8 
Selling, general and administrative
36.0 36.0 
Amortization of intangible assets
8.1 6.8 
Special charges for workforce reductions— 0.6 
Other expense, net— 0.4 
Operating income68.3 51.0 
Nonoperating components of net periodic benefit (income) expense(67.6)(1.6)
Interest expense
0.1 0.1 
Investment income
(0.1)(0.5)
Income before income taxes135.9 53.0 
Income tax benefit(39.1)(1.4)
Net income and comprehensive income175.0 54.4 
Preferred stock dividends - undeclared and cumulative
2.1 6.7 
   Distributed earnings allocable to retired preferred shares37.6 41.9 
Net income allocable to common stockholders$135.3 $5.8 
Net income per common share:
Basic$10.03 $0.59 
Diluted$9.75 $0.57 
Average number of common shares outstanding (in thousands):
Basic13,493 9,825 
Diluted13,879 10,123 


The accompanying notes are an integral part of these consolidated financial statements.

78

CENTRUS ENERGY CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
 Year Ended December 31,
 20212020
OPERATING 
Net income$175.0 $54.4 
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization8.6 7.3 
Accrued loss on long-term contract(7.2)(10.6)
Deferred tax assets(39.5)(1.9)
Retirement benefit plans (gains) losses, net(50.5)7.2 
Revaluation of inventory borrowing4.8 — 
Equity related compensation12.1 7.1
Changes in operating assets and liabilities:
Accounts receivable0.5 (8.6)
Inventories, net(10.7)25.8 
Payables under inventory purchase agreements16.6 13.2 
Deferred revenue and advances from customers, net of deferred costs13.2 9.7 
Accounts payable and other liabilities(4.6)(5.2)
Pension and postretirement liabilities(67.0)(32.7)
Other, net(1.3)1.4 
Cash provided by operating activities50.0 67.1 
INVESTING
Capital expenditures(1.2)(1.4)
Cash used in investing activities(1.2)(1.4)
FINANCING
Proceeds from the sale of common stock, net42.1 23.1 
Redemption of preferred stock, net(44.4)(61.6)
Payment of interest classified as debt(6.1)(6.1)
Exercise of stock options0.9 0.3 
Shares withheld for employee taxes(2.4)— 
Payments for deferred issuance costs— (0.1)
Cash used in financing activities(9.9)(44.4)
Increase in cash, cash equivalents and restricted cash38.9 21.3 
Cash, cash equivalents and restricted cash, beginning of period (Note 3)157.9 136.6 
Cash, cash equivalents and restricted cash, end of period (Note 3)$196.8 $157.9 
Supplemental cash flow information:
Non-cash activities:
Property, plant and equipment included in accounts payable and accrued liabilities$— $0.3 
79

Equity transaction costs included in accounts payable and accrued liabilities0.4 0.2 
Disposal of right to use lease assets from lease modification1.0 0.2 
Reclassification of equity compensation liability to equity7.5 — 
Common stock and warrant issued in exchange for preferred stock7.5 — 
The accompanying notes are an integral part of these consolidated financial statements.
80

CENTRUS ENERGY CORP.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(in millions, except per share data)
Senior Preferred Stock,
Series B		Common Stock,
Class A,
Par Value
$.10 per Share		Common Stock,
Class B,
Par Value
$.10 per Share		Excess of
Capital Over
Par Value		Accumulated DeficitAccumulated
Other Comprehensive Income (Loss)		Total
Balance at December 31, 2019$4.6 $0.8 $0.1 $61.5 $(405.0)$1.1 $(336.9)
Net income— — — — 54.4 — 54.4 
Issuance of common stock
— 0.3 — 22.8 — — 23.1 
Purchase under tender offer(4.5)— — — (57.1)— (61.6)
Other comprehensive loss, net of tax benefit— — — — — (0.3)(0.3)
Issuance and amortization of restricted stock units and stock options
— — — 0.7 — — 0.7 
Balance at December 31, 2020$0.1 $1.1 $0.1 $85.0 $(407.7)$0.8 $(320.6)
Net income — — — — 175.0 — 175.0 
Issuance of common stock
— 0.2 — 41.9 — — 42.1 
Exchange of preferred stock for common stock and common stock warrant— 0.1 — 7.5 (7.6)— — 
Purchase under tender offer(0.1)— — — (44.3)— (44.4)
Reclassification of stock-based compensation liability to equity— — — 7.5 — — 7.5 
Shares withheld for employee taxes— — — (2.4)— — (2.4)
Other comprehensive loss, net of tax benefit— — — — — (0.3)(0.3)
Issuance and amortization of restricted stock units and stock options
— — — 1.2 — — 1.2 
Balance at December 31, 2021$— $1.4 $0.1 $140.7 $(284.6)$0.5 $(141.9)


The accompanying notes are an integral part of these consolidated financial statements.
81

CENTRUS ENERGY CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

The consolidated financial statements of Centrus Energy Corp. (“Centrus” or the “Company”), which include the accounts of the Company, its principal subsidiary United States Enrichment Corporation (“Enrichment Corp.”) and its other subsidiaries, were prepared in conformity with generally accepted accounting principles in the U.S. (“U.S. GAAP”). Certain prior year amounts have been reclassified for consistency with the current year presentation. All material intercompany transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts presented and disclosed in the consolidated financial statements. Significant estimates and judgments include, but are not limited to, revenue and related costs, asset valuations, pension and postretirement health and life benefit costs and obligations, the tax bases of assets and liabilities, the future recoverability of deferred tax assets, and determination of the valuation allowance for deferred tax assets. Actual results may differ from such estimates, and estimates may change if the underlying conditions or assumptions change.

Cash and Cash Equivalents

Cash and cash equivalents include short-term or highly liquid assets with original maturities of three months or less.

Inventories and Inventories Owed to Customers and Suppliers

Low-enriched uranium (“LEU”) consists of two components: separative work units (“SWU”) and uranium. SWU is a standard unit of measurement that represents the effort required to transform a given amount of natural uranium into two components: enriched uranium having a higher percentage of U235 and depleted uranium having a lower percentage of U235. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment deemed to be contained in LEU under this formula is commonly referred to as its SWU component and the quantity of natural uranium deemed to be used in the production of LEU under this formula is referred to as its uranium or “feed” component.

SWU and uranium inventory costs are determined using the average cost method. SWU and uranium purchase costs include shipping costs when applicable. Inventories of SWU and uranium are valued at the lower of cost or net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The estimated selling price for SWU and uranium is based on the pricing terms of contracts in the Company’s sales order book, and, for uranium not under contract, the estimated selling price is based primarily on published price indicators at the balance sheet date.

Inventories owed to customers and suppliers, included in current liabilities, consist primarily of SWU and uranium inventories owed to fabricators. Fabricators process LEU into fuel for use in nuclear reactors. Under inventory optimization arrangements between Centrus and domestic fabricators, fabricators order quantities of LEU from Centrus based on scheduled or anticipated orders from utility customers, for deliveries in future periods. As delivery obligations under actual customer orders arise, Centrus typically satisfies these obligations by arranging for the transfer to the customer of title to the specified quantity of LEU at the fabricator. Centrus’ balances of SWU and uranium vary over time based on the timing and size of the fabricator’s LEU orders from Centrus and the fabricator’s needs for working stock of LEU. Balances can be positive or negative at the discretion of the fabricator.
82

Fabricators have other inventory supplies and, where a fabricator has elected to order less material from Centrus than Centrus is required to deliver to its customers at the fabricator, the fabricator will use these other inventories to satisfy Centrus’ customer order obligations on Centrus’ behalf. In such cases, the transfer of title of LEU from Centrus to the customer results in quantities of SWU and uranium being owed by Centrus to the fabricator. The amounts of SWU and uranium owed to fabricators are satisfied as future deliveries of LEU to fabricators are made.
Deferred Taxes

Centrus follows the asset and liability approach to account for deferred taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences of temporary differences between the balance sheet carrying amounts of assets and liabilities and their respective tax bases. Deferred taxes are based on income tax rates in effect for the years in which temporary differences are expected to reverse. The effect on deferred taxes of a change in income tax rates is recognized in income when the change in rates is enacted in the law. A valuation allowance is provided if it is more likely than not that all, or some portion, of the deferred tax assets may not be realized.

Property, Plant and Equipment

Property, plant and equipment are recorded at acquisition cost. Leasehold improvements and machinery and equipment are depreciated on a straight-line basis over the shorter of the useful life of the assets or the lease term, if applicable. Refer also to Carrying Value of Long-Lived Assets below.

Intangible Assets

Centrus has intangible assets resulting from fresh start accounting as a result of emergence from Chapter 11 bankruptcy on September 30, 2014. The identifiable intangible assets relate to the sales order book and customer relationships. The order book intangible asset is amortized as the order book valued at emergence is reduced, principally as a result of deliveries to customers. The customer relationships intangible asset is amortized using the straight-line method over the estimated average useful life of 15 years, with 7 ¾ years of scheduled amortization remaining. Refer also to Carrying Value of Long-Lived Assets below.

Carrying Value of Long-Lived Assets

The Company evaluates the carrying values of property, plant and equipment and identifiable intangible assets when events or changes in business circumstances indicate that the carrying amount of asset, or asset group, may not be fully recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset, or asset group, exceeds its fair value.
Financial Instruments and Fair Value Measurement

Accounting standards define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, consideration is given to the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability.

Pursuant to accounting standards, Centrus’ 8.25% notes due February 2027 (the “8.25% Notes”) are recorded at face value and the fair value is disclosed. The estimated fair value of the 8.25% Notes is based on recent trading prices and bid/ask quotes as of or near the balance sheet date. Debt issuance costs are deferred and amortized over the life of the instrument.

83

The balance sheet carrying amounts for accounts receivable, accounts payable and accrued liabilities, and payables under SWU purchase agreements approximate fair value because of the short-term nature of the instruments.

Concentrations of Credit Risk

Credit risk could result from the possibility of a customer failing to perform or pay according to the terms of a contract. Extension of credit is based on an evaluation of each customer’s financial condition. Centrus regularly monitors credit risk exposure and takes steps intended to mitigate the likelihood of such exposure resulting in a loss.

Concentrations of Supply Risk and Other Considerations with the War in Ukraine

The current war in Ukraine has led to the U.S., Russia and other countries imposing sanctions and other measures that restrict international trade. The situation is rapidly changing, and it is not possible to predict future actions that could be taken. The Company has multiple sources of supply; however, the supply contract with TENEX remains our largest source. At present, sanctions have not impacted the ability of the Company or TENEX to perform under the TENEX supply contract. Recently, sanctions have been imposed by the U.S. on exports of fossil fuels. Russia has imposed sanctions on the export of commodities but does not include the export of LEU. Additional sanctions or other measures by the U.S. or foreign governments (including the Russian government) could be imposed. Any sanctions or measures directed at trade in LEU from Russia or the parties involved in such trade or otherwise could interfere with, or prevent, implementation of the TENEX Supply Contract. While the initial sanctions announced do not affect the ability of the Company or TENEX to implement the TENEX Supply Contract, the situation at this time is unpredictable and therefore there is no assurance that future developments would not have a material adverse effect on the Company’s procurement, payment, delivery or sale of LEU under the TENEX Supply Contract.

If measures were taken to limit the supply of Russian LEU or to prohibit or limit dealings with Russian entities, including, but not limited to, TENEX or ROSATOM, the Company would seek a license, waiver or other approval from the government imposing such measures to ensure that the Company could continue to fulfill its purchase and sales obligations. There is no assurance that such a license, waiver, or approval would be granted. If a license, waiver or approval were not granted, the Company would need to look to alternative sources of LEU to replace the LEU that it could not procure from TENEX. The Company has contracts for alternative sources that could be used to mitigate a portion of the near term impacts. However, to the extent these sources were insufficient or more expensive or additional supply cannot be obtained, it could have a material adverse impact on our business, results of operations, and competitive position.

Segments

Centrus operates two business segments: LEU, which supplies various components of nuclear fuel to utilities, and technical solutions, which provides advanced engineering, design, and manufacturing services to government and private sector customers.

Related Party

As previously disclosed in our Current Report on Form 8-K filed on December 31, 2020, on that same date the
Company entered into an At Market Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. and
Lake Street Capital Markets, LLC (the “Agents”), relating to the at the market offering (the “ATM Offering”) of
shares of the Company’s Class A Common Stock, $0.10 par value per share. Mr. Williams, Chairman of the Centrus
Board of Directors, also serves on the board of B. Riley Financial, Inc. Mr. Williams recused himself and took no
part in the selection of B. Riley or the negotiation of the terms of the Sales Agreement. Please refer to Note 15 - Stockholders’ Equity for a description of the ATM Offering in 2021.

84

Revenue

The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. Revenue for product and service sales is recognized when or as the Company transfers control of the promised products or services to the customer. Revenue is measured at the transaction price, which is based on the amount of consideration that the Company expects to receive in exchange for transferring the promised goods or services to the customer. The transaction price will include estimates of variable consideration until it is probable that a significant reversal of revenue recognized will not occur.

SWU and Uranium Revenue

Revenue for the Company’s LEU segment is derived from sales of the SWU component of LEU, from sales of both the SWU and uranium components of LEU, and from sales of uranium. Contracts with customers are primarily medium and long-term, fixed-commitment contracts under which its customers are obligated to purchase a specified quantity of the SWU component of LEU or the SWU and uranium components of LEU. The Company’s contracts for natural uranium are generally shorter-term, fixed-commitment contracts.

Revenue is recognized at the time the customer obtains control of the LEU or uranium. Customers generally obtain control of LEU at nuclear fuel fabricators. Centrus ships LEU to nuclear fuel fabricators for scheduled or anticipated orders from utility customers. Based on customer orders, Centrus arranges for the transfer of title of LEU from Centrus to the customer for the specified quantity of LEU at the fuel fabricator. Each such delivery to a customer is accounted for as a distinct performance obligation under a contract, and a contract may call for multiple deliveries over a number of periods. The contract’s transaction price is allocated to each performance obligation based on the observable standalone selling price of each distinct delivery of SWU or uranium. For certain contracts the customers may elect not to take control of the LEU or uranium and Centrus may have the right to enforce payment under the terms of the contractual agreement. The revenue recognition for these contracts is assessed when it occurs.

Utility customers in general have the option to defer receipt of uranium products purchased from the Company beyond the contractual sale period. In such cases, title to SWU and/or uranium components are transferred to the customer and a performance obligation for Centrus is created and a receivable is recorded. Cash is collected for the receivable under normal credit terms. The performance obligation is represented as Deferred Revenue on the consolidated balance sheet and the customer-titled product is classified as Deferred Costs Associated with Deferred Revenue on the consolidated balance sheet. Risk of loss remains with Centrus until the customer obtains control of the uranium product. The recognition of revenue and related cost of sales occurs at the point in time at which the customer obtains control of SWU or uranium and risk of loss of the product transfers to the customer, which may occur beyond one year. The timing of the transfer of control, subject to notice period requirements, is at the option of the customer. As such, deferred costs and deferred revenue are classified within current assets and current liabilities, respectively.

On occasion, the Company will accept payment in the form of uranium. Revenue from the sale of SWU under such contracts is recognized at the time transfer of control of LEU occurs and is based on the fair value of the uranium at contract inception or as the quantity of uranium is finalized, if variable.

Amounts billed to customers for handling costs are included in sales. Handling costs are accounted for as a fulfillment cost and are included in cost of sales. The Company does not have shipping costs associated with outbound freight after control over a product has transferred to a customer. The Company’s contracts with customers do not provide for significant payment terms or financing components.

85

Technical Solutions Revenue

Revenue for the technical solutions segment, principally representing technical, manufacturing, engineering, procurement, construction and operations services offered to public and private sector customers, is recognized over the contractual period as services are rendered. The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer. For public sector contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay the Company for costs incurred plus a reasonable profit and assume control of any work in progress. The Company’s government and private sector contracts generally contain contractual termination clauses or entitle the Company to payments for work performed to date for goods and services that do not have an alternative use. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. A contract may contain one or more performance obligations. Two or more promises to transfer goods or services to a customer may be considered a single performance obligation if the goods or services are highly interdependent or highly interrelated such that utility of the promised goods or services to the customer includes integration services provided by the Company.

The Company determines the transaction price for each contract based on the consideration it expects to receive for the products or services being provided under the contract. If transaction prices are not stated in the contract for each performance obligation, contractual prices are allocated to performance obligations based on estimated relative standalone selling prices of the promised services.

The Company generally uses the cost-to-cost input method of progress for performance obligations to deliver products with continual transfer of control to the customer, because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of direct costs incurred to date to the total estimated direct costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred. For performance obligations to provide services to the customer, revenue is recognized over time based on direct costs incurred or the right to invoice method (in situations where the value transferred matches the Company’s billing rights) as the customer receives and consumes the benefits.

Use of the cost-to-cost method requires the Company to make reasonably dependable estimates of costs at completion associated with the design, manufacture and delivery of products and services in order to calculate revenue. Significant judgment is used to estimate total revenue and costs at completion, particularly in the assumptions related to internal labor hours and third-party services for which a vendor invoice or quote is not yet available. As a significant change in one or more estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its contract-related estimates regularly. Adjustments in estimated profits/losses are recognized under the cumulative catch-up method. Under this method, the impact of the adjustments is recognized in the period the adjustment is recognized. When estimates of total costs at completion for such an integrated, construction type contract exceed total estimates of revenue to be earned on a performance obligation related to complex equipment or related services, a provision for the remaining loss on the performance obligation is recognized in the period the loss is determined.

The Company applied the practical expedient in paragraph ASC 606-10-50-14 and does not disclose the value of remaining performance obligations under service contracts having original expected terms of one year or less.

The timing of revenue recognition may differ from the timing of invoicing to customers. Progress on satisfying performance obligations under contracts with customers and the related billings and cash collections are recorded on the consolidated balance sheet as contract assets or contract liabilities. Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period.

Unbilled receivables are included in Accounts Receivable on the consolidated balance sheet and arise when the timing of cash collected from customers differs from the timing of revenue recognition. Those assets are recognized when the revenue associated with the contract is recognized prior to billing and derecognized when billed in
86

accordance with the terms of the contract. To the extent billings to the customer precede the recognition of technical solutions revenue, the Company recognizes a liability included in Deferred Revenue and Advances from Customers on the consolidated balance sheet.

Advanced Technology Costs

American Centrifuge and related expenses that are outside of our customer contracts are included in Advanced Technology Costs.

Pension and Postretirement Health and Life Benefit Plans

The Company provides retirement benefits to certain employees and retirees under defined benefit pension plans and postretirement health and life benefit plans. The valuation of benefit obligations and costs is based on provisions of the plans and actuarial assumptions that involve judgments and estimates. Plan assets and benefit obligations are remeasured each year as of the balance sheet date, or when lump sum payments exceed certain levels, resulting in differences between actual and projected results. The Company has elected to recognize these actuarial gains and losses immediately in the statement of operations to provide transparency regarding the impacts of changes in plan assets and benefit obligations.

Stock-Based Compensation

Centrus has a stock-based compensation plan which authorizes the issuance of common stock to the Company’s employees, officers, directors, and other individuals providing services to the Company or its affiliates pursuant to options, notional stock units, stock appreciation rights, restricted stock units, restricted stock, performance awards, dividend equivalent rights, and other stock-based awards.

Stock-based compensation cost for options and stock-settled awards are measured at the grant date based on the fair value of the award. The cost is recognized over the requisite service period on a straight-line basis over the vesting period.

Stock-based compensation cost for awards likely to be settled with cash payments are recognized over the requisite service period and accrued as a liability and re-measured each reporting period based on the trading price of the Company’s common stock.

The Company recognizes forfeitures as they occur.

New Accounting Standards

Recently Adopted Accounting Standards

In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20), which modifies the disclosure requirements for employers that sponsor defined benefit pension plans and other postretirement plans. ASU 2018-14 is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The standard is to be applied on a retrospective basis to all periods presented and early adoption is permitted. Adoption of this new standard did not have a significant impact to the Company’s annual disclosures.

87

2. REVENUE AND CONTRACTS WITH CUSTOMERS

Disaggregation of Revenue

The following table presents revenue from SWU and uranium sales disaggregated by geographical region, including foreign countries representing 10% or more of revenue, based on the billing addresses of customers (in millions):
Year Ended December 31,
20212020
United States$108.3 $115.0 
Foreign:
Belgium
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Revenue - SWU and uranium$186.1 $190.5 

Refer to Note 18, Revenue by Geographic Area, Major Customers and Segment Information for disaggregation of revenue by segment. Disaggregation by end-market is provided in Note 18 and the consolidated statements of operations. SWU sales are made primarily to electric utility customers, and uranium sales are primarily made to other nuclear fuel related companies. Technical solutions revenue resulted primarily from services provided to the government and its contractors. SWU and uranium revenue is recognized at point of sale and technical solutions revenue is generally recognized over time.

SWU revenue in 2020 includes $32.6 million collected from a customer in settlement of a supply contract that was subject to the customer’s bankruptcy proceeding.

Accounts Receivable
December 31,
20212020
($ millions)
Accounts receivable:
Billed
$23.1 $23.0 
Unbilled (a)6.0 6.6 
Accounts receivable$29.1 $29.6 
(a) Billings under certain contracts in the technical services segment are invoiced based on approved provisional billing rates. Unbilled revenue represents difference between actual costs incurred and invoiced amounts. The Company expects to invoice and collect the unbilled amounts after actual rates are submitted to the customer and approved. Unbilled revenue also includes unconditional rights to payment that are not yet billable under applicable contracts pending the compilation of supporting documentation.

88


Contract Liabilities

The following table presents changes in contract liability balances (in millions):
December 31,
20212020Change
Accrued loss on HALEU Contract:
Current - Accounts payable and accrued liabilities
$0.5 $7.0 $(6.5)
Non-current - Other long-term liabilities
$— $0.7 $(0.7)
Deferred revenue - current
$288.1 $281.7 $6.4 
Advances from customers - current
$15.0 $1.5 $13.5 
Advances from customers - non current$45.1 $45.2 $(0.1)

Deferred sales totaled $47.2 million and $38.7 million in the years ended December 31, 2021, and 2020, respectively. Previously deferred sales recognized in revenue totaled $42.6 million and $0 million in the years ended December 31, 2021, and 2020, respectively.

LEU Segment

The SWU component of LEU is typically bought and sold under contracts with deliveries over several years. The Company’s agreements for natural uranium sales are generally shorter-term, fixed-commitment contracts. The Company’s order book of sales under contract in the LEU segment (“order book”) extends to 2029. For the years ended December 31, 2021 and 2020, our order book was approximately $986 million and $960 million, respectively. The order book represents the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries under contract and includes approximately $348.2 million of Deferred Revenue and Advances from Customers. Refer to Contract Liabilities table above.

Most of the Company’s customer contracts provide for fixed purchases of SWU during a given year. The Company’s order book is partially based on customers’ estimates of the timing and size of their fuel requirements and other assumptions that are subject to change. For example, depending on the terms of specific contracts, the customer may be able to increase or decrease the quantity delivered within an agreed range. The Company’s order book estimate is also based on the Company’s estimates of selling prices, which may be subject to change. For example, depending on the terms of specific contracts, prices may be adjusted based on escalation using a general inflation index, published SWU price indicators prevailing at the time of delivery, and other factors, all of which are variable. The Company uses external composite forecasts of future market prices and inflation rates in its pricing estimates.

Under the terms of certain contracts with customers in the LEU segment, the Company will accept payment for SWU in the form of uranium. Revenue from the sale of SWU under such contracts is recognized at the time LEU is delivered and is based on the fair value of the uranium at contract inception, or as the quantity of uranium is finalized, if variable. In 2020, SWU revenue of $23.4 million was recognized under such contracts based on the fair market value of uranium acquired in exchange for SWU delivered. Uranium received from customers as advance payments for the future sales of SWU totaled $59.6 million and $44.4 million as of December 31, 2021, and 2020, respectively. The advance payments are included in either Advances from Customers, Current or Advances from Customers, Noncurrent, based on the anticipated SWU sales period.

89

Technical Solutions Segment

Revenue for the technical solutions segment, representing the Company’s technical, manufacturing, engineering, procurement, construction and operations services offered to public and private sector customers, is recognized over the contractual period as services are rendered. For details, refer to Note 1, Summary of Significant Accounting Policies — Revenue —Technical Solutions Revenue.

On October 31, 2019, the Company signed a three-year cost-share contract with the U.S. Department of Energy (“DOE”) (“the HALEU Contract”) to deploy a cascade of centrifuges to demonstrate production of high-assay, low-enriched uranium (“HALEU”) for advanced reactors. HALEU is a component of an advanced nuclear reactor fuel that is not commercially available today and may be required for a number of advanced reactor designs currently under development in both the commercial and government sectors. The program has been under way since May 31, 2019, when the Company and DOE signed a preliminary letter agreement that allowed work to begin while the full contract was being finalized.

In 2019, under the HALEU Contract, DOE agreed to reimburse the Company for 80% of its costs incurred in performing the contract, up to a maximum of $115 million which was increased to $126.7 million. On March 4, 2022, the DOE informed the Company of their intent to fund an additional $9.0 million above the $126.7 million, as disclosed above. The Company’s cost share is the corresponding 20% and any costs the Company elects to incur above these amounts. Costs under the HALEU Contract include program costs, including direct labor and materials and associated indirect costs that are classified as Cost of Sales, and an allocation of corporate costs supporting the program that are classified as Selling, General and Administrative Expenses. Services to be provided over the three-year contract include constructing and assembling centrifuge machines and related infrastructure in a cascade formation. When estimates of remaining program costs to be incurred for such an integrated, construction-type contract exceed estimates of total revenue to be earned, a provision for the remaining loss on the contract is recorded to Cost of Sales in the period the loss is determined. The Company’s corporate costs supporting the program are recognized as expense as incurred over the duration of the contract term. The accrued loss on the contract is being adjusted over the remaining contract term based on actual results, remaining program cost projections, and the Company’s anticipated cost-share. The impact to Cost of Sales for the year ended December 31, 2021, and 2020, is $7.2 million and $10.6 million, respectively, for previously accrued contract losses attributable to work performed in the periods. As of December 31, 2021, a total of $19.1 million of previously accrued contract losses have been realized and the accrued contract loss balance included in Accounts Payable and Accrued Liabilities is $0.5 million. The Company has received cash payments of $120.3 million through December 31, 2021.

Additional COVID-19-related impacts, delays in DOE furnishing equipment, or changes to the existing scope of the HALEU Contract could result in further material increases to our estimate of the costs required to complete the HALEU Contract, as well as delay completion of the contract. The Company does not currently have a contractual obligation to perform work in excess of the funding provided by DOE and, therefore, no additional costs have been accrued as of December 31, 2021. If DOE does not commit to fully fund the additional costs, and the Company nevertheless commits to a plan to complete the demonstration cascade and produce HALEU, we may incur material additional costs or losses in future periods that could have an adverse impact on our financial condition and liquidity.

Revenue for the technical solutions segment in the year ended December 31, 2021, also includes $43.5 million related to the settlement of the Company’s claims for reimbursements for certain pension and postretirement benefits costs incurred in connection with a past cost-reimbursable contract with DOE unrelated to the HALEU Contract. On September 7, 2021, after the final approvals for the settlement were received, the settlement agreement was signed by the parties at which time it became probable that there would not be a significant reversal of revenue. Under the terms of the settlement agreement, DOE paid the Company $43.5 million, of which $33.8 million was contributed to the pension plan in September 2021 for its subsidiary United States Enrichment Corp. (“Enrichment Corp.”) and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp. After receiving payment, at the Company’s request, the case was dismissed. Refer to Note 16, Commitments and Contingencies - Legal Matters.
90


3. CASH, CASH EQUIVALENTS AND RESTRICTED CASH

The following table summarizes the Company’s cash, cash equivalents and restricted cash as presented on the consolidated balance sheet to amounts on the consolidated statement of cash flows (in millions):
December 31,
20212020
Cash and cash equivalents
$193.8 $152.0 
Deposits for financial assurance - current
0.2 0.2 
Deposits for financial assurance - non current2.8 5.7 
Total cash, cash equivalents and restricted cash
$196.8 $157.9 

The following table provides additional detail regarding the Company’s deposits for financial assurance (in millions):

December 31, 2021December 31, 2020
CurrentLong-TermCurrentLong-Term
Workers compensation$— $2.6 $— $5.4 
Other0.2 0.2 0.2 0.3 
Total deposits for financial assurance$0.2 $2.8 $0.2 $5.7 

The Company has provided financial assurance to states in which it was previously self-insured for workers’ compensation in accordance with each state’s requirements in the form of a surety bond or deposit that is fully cash collateralized by Centrus. As each state determines that the likelihood of further workers’ compensation obligations related to the period of self-insurance is reduced, the surety bond or deposit is subject to reduction and/or cancellation and the Company would receive the excess cash collateral.

4. INVENTORIES

Centrus holds uranium at licensed locations in the form of natural uranium and as the uranium component of LEU. Centrus also holds SWU as the SWU component of LEU at licensed locations (e.g., fabricators) to meet book transfer requests by customers. Fabricators process LEU into fuel for use in nuclear reactors. Components of inventories are as follows (in millions):
 December 31, 2021December 31, 2020
 Current
Assets		Current
Liabilities
(a)		Inventories, NetCurrent
Assets		Current
Liabilities
(a)		Inventories, Net
Separative work units$8.8 $— $8.8 $17.0 $4.6 $12.4 
Uranium82.3 8.4 73.9 47.8 0.3 47.5 
Total$91.1 $8.4 $82.7 $64.8 $4.9 $59.9 

(a)Inventories owed to customers and suppliers, included in current liabilities, include SWU and uranium inventories owed to fabricators.

Inventories are valued at the lower of cost or net realizable value. In 2021, there was a valuation adjustment to reflect an update of projected timing and sources of inventory to be used for repayment of borrowed SWU inventory. There were no valuation adjustments in 2020. For details, refer to Note 1, Summary of Significant Accounting Policies — Contract Liabilities — LEU Segment.

91

The Company may also borrow SWU from customers, in which case the Company will record the SWU and the related liability for the borrowing using a projected average purchase price over the borrowing period. In 2018 through 2020 the Company borrowed SWU inventory valued at $20.7 million from a customer under an agreement signed in 2017 and recorded the SWU and the related liability using the Company’s average unit price of SWU purchases under contract projected to be used for repayment. The loan is repayable only with SWU. The cumulative liability to the customer for borrowed inventory was revalued to $25.5 million in the third quarter of 2021. The revaluation reflected an updated projection of the timing and sources of inventory to be used for repayment. In the fourth quarter of 2021, the Company repaid borrowed SWU inventory valued at $3.1 million to a customer and reduced the SWU and the related liability using an average purchase price over the borrowing period. The remaining liability to the customer of $22.4 million for borrowed inventory is included in Other Long-Term Liabilities. Cost of Sales for the twelve months ended December 31, 2021, includes the related expense of $4.8 million.


5. PROPERTY, PLANT AND EQUIPMENT

A summary of changes in property, plant and equipment follows (in millions):
December 31,
2020		Additions / (Depreciation)December 31,
2021
Land
$1.2 $— $1.2 
Buildings and leasehold improvements3.9 0.7 4.6 
Machinery and equipment
1.4 — 1.4 
Other
1.1 — 1.1 
Property, plant and equipment, gross
7.6 0.7 8.3 
Accumulated depreciation
(2.7)(0.3)(3.0)
Property, plant and equipment, net
$4.9 $0.4 $5.3 

Depreciation expense was $0.6 million in 2021 and $0.5 million in 2020.


6. INTANGIBLE ASSETS

Intangible assets originated from the Company’s reorganization and application of fresh start accounting as of September 30, 2014, the date the Company emerged from bankruptcy, and reflect the conditions at that time. The intangible asset related to the sales order book is amortized as the order book existing at emergence is reduced, principally as a result of deliveries to customers. The intangible asset related to customer relationships is amortized using the straight-line method over the estimated average useful life of 15 years. Amortization expense is presented below gross profit on the consolidated statements of operations. Intangible asset balances are as follows (in millions):
December 31, 2021December 31, 2020
Gross Carrying AmountAccumulated AmortizationNet AmountGross Carrying AmountAccumulated AmortizationNet Amount
Sales order book$54.6 $35.5 $19.1 $54.6 $32.0 $22.6 
Customer relationships68.9 33.3 35.6 68.9 28.7 40.2 
Total$123.5 $68.8 $54.7 $123.5 $60.7 $62.8 


92

The amount of amortization expense for intangible assets in each of the succeeding years is estimated to be as follows (in millions):
2022$9.5 
20236.6 
20248.6 
20257.6 
20269.9 
Thereafter12.5 
   Total$54.7 

7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Components of accounts payable and accrued liabilities follow (in millions):
December 31,
20212020
Trade payables$4.9 $4.9 
Compensation and employee benefits23.1 22.2 
Postretirement health and life benefit obligations - current7.0 11.6 
Accrued HALEU Contract loss0.5 7.0 
Operating lease liability0.9 2.4 
Other accrued liabilities1.4 2.5 
   Total accounts payable and accrued liabilities$37.8 $50.6 


8. DEBT

A summary of debt follows (in millions):
December 31, 2021December 31, 2020
MaturityCurrentLong-TermCurrentLong-Term
8.25% Notes:Feb. 2027
Principal
$— $74.3 $— $74.3 
Interest
6.1 27.5 6.1 33.7 
Total$6.1 $101.8 $6.1 $108.0 

Interest on the 8.25% Notes is payable semi-annually in arrears as of February 28 and August 31 based on a 360-day year consisting of twelve 30-day months. The 8.25% Notes mature on February 28, 2027. As shown in the table above, all future interest payment obligations on the 8.25% Notes are included in the carrying value of the 8.25% Notes. As a result, the Company’s reported interest expense will be less than its contractual interest payments throughout the term of the 8.25% Notes. As of December 31, 2021, and December 31, 2020, $6.1 million of interest is recorded as current and classified as Current Debt in the consolidated balance sheet.
The 8.25% Notes rank equally in right of payment with all of the Company’s existing and future unsubordinated indebtedness other than its Issuer Senior Debt and our Limited Secured Acquisition Debt (each as defined below). The 8.25% Notes rank senior in right of payment to all of the Company’s existing and future subordinated indebtedness and to certain limited secured acquisition indebtedness of the Company (the “Limited Secured Acquisition Debt”). The Limited Secured Acquisition Debt includes (i) any indebtedness, the proceeds of which are used to finance all or a portion of an acquisition or similar transaction if any lender’s lien is solely limited to the assets acquired in such a transaction and (ii) any indebtedness, the proceeds of which are used to finance all or a
93

portion of the American Centrifuge project or another next generation enrichment technology if any lender’s lien is solely limited to such assets, provided that a lien securing the 8.25% Notes that is junior with respect to the lien securing such indebtedness will be limited to the assets acquired with such Limited Secured Acquisition Debt.

The 8.25% Notes are subordinated in right of payment to certain indebtedness and obligations of the Company, as described in the indenture governing the 8.25% Notes (the “Issuer Senior Debt”), including (i) any indebtedness of the Company (inclusive of any indebtedness of Enrichment Corp.) under a future credit facility up to $50 million with a maximum net borrowing of $40 million after taking into account any minimum cash balance (unless a higher amount is approved with the consent of the holders of a majority of the aggregate principal amount of the 8.25% Notes then outstanding), (ii) any revolving credit facility to finance inventory purchases and related working capital needs, and (iii) any indebtedness of the Company to Enrichment Corp. under the secured intercompany notes.

The 8.25% Notes are guaranteed on a subordinated and limited basis by, and secured by substantially all of the assets of, Enrichment Corp. The Enrichment Corp. guarantee is a secured obligation and ranks equally in right of payment with all existing and future unsubordinated indebtedness of Enrichment Corp. (other than Designated Senior Claims (as defined below) and Limited Secured Acquisition Debt) and senior in right of payment to all existing and future subordinated indebtedness of Enrichment Corp. and Limited Secured Acquisition Debt. The Enrichment Corp. guarantee is subordinated in right of payment to certain obligations of, and claims against, Enrichment Corp. described in the indenture governing the 8.25% Notes (collectively, the “Designated Senior Claims”), including obligations and claims:
•under a future credit facility up to $50 million with a maximum net borrowing of $40 million after taking into account any minimum cash balance;
•under any revolving credit facility to finance inventory purchases and related working capital needs;
•held by or for the benefit of the Pension Benefit Guaranty Corporation (“PBGC”) pursuant to any settlement (including any required funding of pension plans); and
•under surety bonds or similar obligations held by or on behalf of the U.S. government pursuant to regulatory requirements.

The lien securing the Enrichment Corp. guarantee of the 8.25% Notes is junior in priority with respect to the lien securing Limited Secured Acquisition Debt, which is limited to the assets acquired with such Limited Secured Acquisition Debt.

9. LEASES

Centrus leases facilities and equipment under operating leases. Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company has facility leases with terms greater than 12 months, and the Company records the related asset and obligation at the present value of lease payments over the term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.

Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. Lease assets exclude lease incentives. Lease terms reflect options to extend or terminate the lease when it is reasonably certain that those options will be exercised. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term. The weighted-average remaining lease term was 5.3 years at December 31, 2021, with maturity dates ranging from December 31, 2025 to September 2027, and the weighted-average discount rate was 12.5%. Lease expense totaled a credit of $0.5 million in 2021 and expense of $2.6 million for 2020. Lease expense primarily related to operating leases for the years ended December 31, 2021 and 2020 includes a $2.0 million and $0.3 million credit, respectively, from DOE for true-up of prior years’ lease expense. Other amounts related to short-term lease expense were insignificant. Operating lease expense is included in Cost of Sales, Selling, General and Administrative Expenses and Advance Technology Costs on the Statement of Operations. Cash paid for amounts included in operating cash flows for operating leases was $2.4 million for the year ended December 31, 2021.
94


The Company leases facilities and related personal property near Piketon, Ohio from DOE under a lease which is classified as operating. The lease was amended on May 6, 2021, resulting in a decrease in the monthly lease payment beginning with the June 2021 payment. The Company accounted for the amendment as a modification and remeasured the remaining future lease payments through May 31, 2022, resulting in the recording of a $1.0 million reduction in lease assets and liabilities. In September 2021, the lease was extended through December 31, 2025. The Company did not remeasure the lease as under the terms of the lease amendment it may be terminated early upon completion of the work under the HALEU Contract which is expected to occur by June 1, 2022. Any facilities, centrifuges or other equipment constructed or installed under contract with DOE will be owned by DOE and may be returned to DOE in an “as is” condition at the end of the lease term, and DOE would be responsible for its D&D.

Operating Lease Assets and Liabilities

The table below presents the lease-related assets and liabilities recorded on the consolidated balance sheet (in millions).
December 31, 2021Classification on the Balance Sheet
Lease assets$2.1 Other long-term assets
Lease liabilities:
Current
$0.9 Accounts payable and accrued liabilities
Non-current3.0 Other long-term liabilities
Total lease liabilities
$3.9 

Maturity of Operating Lease Liabilities

The table below reconciles undiscounted payments for operating leases with terms greater than 12 months to the operating lease liabilities recorded on the balance sheet (in millions).
2022$1.3 
20231.0 
20241.0 
20251.0 
20261.0 
Thereafter0.8 
Total lease payments6.1 
Less imputed interest2.2 
Present value of lease payments$3.9 


10. FAIR VALUE

Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value of assets and liabilities, the following hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable:
•Level 1 assets include investments with quoted prices in active markets that the Company has the ability to liquidate as of the reporting date.

•Level 2 assets include investments in U.S. government agency securities, corporate and municipal debt whose estimates are valued based on observable inputs, other than quoted prices.
95


•Level 3 assets include investments with unobservable inputs, such as third party valuations, due to little or no market activity.

Financial Instruments Recorded at Fair Value (in millions):
December 31, 2021December 31, 2020
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:        
Cash and cash equivalents$193.8 $— $— $193.8 $152.0 $— $— $152.0 
Deferred compensation asset (a)3.2 — — 3.2 2.4 — — 2.4 
Liabilities:        
Deferred compensation obligation (a)
$3.2 $— $— $3.2 $2.3 $— $— $2.3 
 
(a)    The deferred compensation obligation represents the balance of deferred compensation plus net investment earnings. The deferred compensation plan is funded through a rabbi trust. Trust funds are invested in mutual funds for which unit prices are quoted in active markets and are classified within Level 1 of the valuation hierarchy.

There were no transfers between Level 1, 2 or 3 during the periods presented.

Other Financial Instruments

As of December 31, 2021, and 2020, the consolidated balance sheet carrying amounts for Accounts Receivable, Accounts Payable and Accrued Liabilities (excluding the deferred compensation obligation described above), and Payables under SWU Purchase Agreements approximate fair value because of their short-term nature.

The carrying value and estimated fair value of long-term debt are as follows (in millions):
December 31, 2021December 31, 2020
Carrying Value
Estimated Fair Value (a)
Carrying Value
Estimated Fair Value (a)
8.25% Notes$107.9 
(b)
$74.3 $114.1 
(b)
$68.6 
(a) Based on recent trading prices and bid/ask quotes as of or near the balance sheet date, which are considered Level 2 inputs based on the frequency of trading.
(b)    The carrying value of the 8.25% Notes consists of the principal balance of $74.3 million and the sum of current and non-current interest payment obligations until maturity. Refer to Note 8, Debt.

11. PENSION AND POSTRETIREMENT HEALTH AND LIFE BENEFITS

There are approximately 3,500 employees and retirees covered by qualified defined benefit pension plans providing retirement benefits based on compensation and years of service, and approximately 2,300 employees and retirees covered by postretirement health and life benefit plans. DOE retained the obligation for postretirement health and life benefits for workers who retired prior to July 28, 1998. Pursuant to non-qualified supplemental pension plans, Centrus provides certain executive officers additional retirement benefits in excess of qualified plan limits imposed by tax law based on a targeted benefit objective. Employees hired on or after September 1, 2008, who are not covered by a collective bargaining agreement that provides for participation do not participate in a qualified defined benefit pension plan or postretirement health and life benefit plans.

96

Changes in the projected benefit obligations and plan assets and the funded status of the plans follow:
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
($ millions)Year Ended December 31,Year Ended December 31,
2021202020212020
Changes in Benefit Obligations:
Obligations at beginning of period$757.9 $763.5 $142.4 $152.8 
Actuarial (gains) losses, net(28.7)56.7 (2.3)(1.6)
Service costs2.7 3.5 — — 
Interest costs18.1 24.3 3.4 4.8 
Benefits paid from Plan assets(51.3)(56.3)(12.4)(13.6)
Benefits paid from Company assets(0.4)(0.5)— — 
Settlements— (30.4)— — 
Administrative expenses paid(2.1)(2.9)— — 
Obligations at end of period696.2 757.9 131.1 142.4 
Changes in Plan Assets:
Fair value of plan assets at beginning of period
633.1 621.2 — — 
Actual return on plan assets57.8 85.4 — — 
Company contributions35.7 16.6 21.5 13.6 
Benefits paid(51.7)(56.8)(12.3)(13.6)
Settlements— (30.4)— — 
Administrative expenses paid(2.2)(2.9)— — 
Fair value of plan assets at end of period
672.7 633.1 9.2 — 
Unfunded status at end of period$(23.5)$(124.8)$(121.9)$(142.4)
Amounts recognized in assets and liabilities:
      Current liabilities$(0.4)$(0.4)$(7.0)$(11.6)
      Non-current liabilities(23.1)(124.4)(114.9)(130.8)
$(23.5)$(124.8)$(121.9)$(142.4)
Amounts in accumulated other comprehensive income (loss), pre-tax:
      Prior service credit$(0.9)$(1.1)$(2.0)$(2.1)

The current liabilities reflect expected contributions for benefit payments for the non-qualified plans and the postretirement health and life benefit plans in the following year.

The discount rates below, rounded to the nearest 0.1%, are the estimated rates at which the benefit obligations could be effectively settled on the measurement date and are based on yields of high quality fixed income investments whose cash flows match the timing and amount of expected benefit payments of the plans.

Plan assets and benefit obligations are remeasured each year as of the balance sheet date resulting in differences between actual and projected results for the year. These actuarial gains and losses are recognized in the statement of operations in the fourth quarter. In addition, an interim remeasurement and recognition of gains or losses may be required for a plan during the year when lump sum payments exceed, or are expected to exceed, the sum of the service cost and interest cost components of the annual net periodic benefit cost for that plan for the current year. There were no interim remeasurements in 2021 and 2020.

97


The defined benefit pension plans currently allow for a lump sum payment option to (a) active employees who are terminated as a result of Company reductions in force and (b) terminated vested participants who have not yet begun receiving their benefits and have been terminated as a result of a reduction in force by the Company, or due to voluntary termination or involuntary termination, other than involuntary termination as a termination for cause.

As part of the Company’s continued effort to reduce the size and volatility of its pension obligations and administrative costs, the Company transferred approximately $30.4 million of pension plan assets and approximately $30.4 million of related benefit obligations to an insurance company through the purchase of a group annuity contract in the fourth quarter of 2020.

Projected benefit obligations are based on actuarial assumptions including possible future increases in compensation. Accumulated benefit obligations are based on actuarial assumptions but do not include possible future increases in compensation. Effective August 2013, accrued benefits under the defined benefit pension plans are fixed and no longer increase to reflect changes in compensation or company service. Therefore, the accumulated benefit obligation equaled the projected benefit obligation of $696.2 million and $757.9 million as of December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, none of Centrus’ plans had fair value of plan assets in excess of accumulated benefit obligations.

Components of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income

The Company reports service costs for its defined benefit pension plans and its postretirement health and life benefit plans in Cost of Sales and Selling, General and Administrative Expenses. The remaining components of net periodic benefit (credits) costs are reported as Nonoperating Components of Net Periodic Benefit Income.
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
(in millions)Year Ended December 31,Year Ended December 31,
2021202020212020
Net Periodic Benefit (Credits) Costs
Service costs$2.7 $3.5 $— $— 
Interest costs18.1 24.3 3.4 4.8 
Expected return on plan assets(38.3)(37.5)— — 
Amortization of prior service credits, net(0.2)(0.2)(0.1)(0.1)
Actuarial (gains) losses, net
(48.2)8.9 (2.3)(1.7)
Net periodic benefit (credits) costs$(65.9)$(1.0)$1.0 $3.0 

Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss)
Amortization of prior service costs, net$— $— $(2.0)$(2.1)
Prior service credit(0.9)(1.1)— — 
Total recognized in other comprehensive loss, pre-tax$(0.9)$(1.1)$(2.0)$(2.1)
Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax
$(66.8)$(2.1)$(1.0)$0.9 

Net periodic benefit costs include service and interest costs of providing pension benefits that are accrued over the years employees render service. Prior service costs or credits are amortized over the employees’ average remaining years of service from age 40 until the date of full benefit eligibility or the average expected future lifetime of all plan participants, as applicable. Participants in the postretirement health and life benefit plans are generally eligible for benefits at retirement after age 50 with 10 years of continuous credited service at the time of retirement.

98

On September 7, 2021, the Company collected $43.5 million from DOE, of which $33.8 million was contributed to the pension plan in September 2021 for its subsidiary Enrichment Corp. and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp. Refer to Note 16, Commitments and Contingencies and Note 2, Revenue And Contracts with Customers.

Effective January 1, 2014, or for certain plan participants formerly represented by a collective bargaining unit, January 1, 2015, plan participants age 65 or older (“post-65”) have access to a range of medical plan choices with varying costs and benefits through a Medicare Exchange implemented by the Company. The Company provides an annual stipend for each of the post-65 retirees and post-65 spouses who enroll in the coverage through the exchange. Depending on the level of benefits elected by the participant, the participant may be required to make contributions in excess of the stipend amount.

The transition to the post-65 Medicare Exchange was reflected as a plan amendment that reduced plan obligations by $6.8 million as of December 31, 2014. This reduction in obligation was recognized in other comprehensive income in 2014 as a prior service credit. The prior service credit is being amortized into net periodic benefit cost as a credit over time. The post-65 Medicare Exchange stipend amount was increased for 2017. This increase in obligation of $3.6 million as of December 31, 2016, was recognized in other comprehensive income in 2016 as a prior service cost and is being amortized into net periodic benefit cost over time. The post-65 Medicare Exchange stipend amount was increased in 2018, as specified in a settlement agreement with the former collective bargaining unit. The settlement agreement also specifies the addition of catastrophic drug coverage effective January 1, 2019. The benefit enhancement for 2019 has been applied to all post-65 participants regardless of past representation by the collective bargaining agreement. The increase in obligation of $10.0 million as a result of the settlement agreement was recognized in net periodic benefit costs in 2017 as a plan change resulting from a legal settlement and is reported in Nonoperating Components of Net Periodic Benefit Income.

The defined benefits pension plans were amended in March 2019 making permanent the option for pension-eligible employees to receive a lump sum payment upon termination, regardless of benefit size, which decreased plan obligations by $1.3 million. The effect of these plan changes has been added to accumulated other comprehensive income (loss) as an unrecognized prior service cost to be amortized over the average future service of active employees starting in 2020.

Assumptions Used to Determine Net Periodic Benefit Costs
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
Year Ended December 31,Year Ended December 31,
2021202020212020
Discount rate
2.8%2.5%2.8%2.5%
Expected return on plan assets
6.3%6.4%——

The expected return on plan assets is based on the weighted average of long-term return expectations for the composition of the plans’ equity and debt securities. Expected returns on equity securities are based on historical long-term returns of equity markets. Expected returns on debt securities are based on the current interest rate environment.

Healthcare cost trend rates used to measure postretirement health benefit obligations follow:
December 31,
20212020
Healthcare cost trend rate for the following year
6.0%5.5%
Long-term rate that the healthcare cost trend rate gradually declines to
5%5%
Year that the healthcare cost trend rate is expected to reach the long-term rate
20262022

99

Benefit Plan Assets

Independent advisors manage investment assets of Centrus’ defined benefit pension plans and postretirement health and life benefit plans. Centrus has the fiduciary responsibility for reviewing performance of the various investment advisors. The goal of the investment policy of the plans is to maximize portfolio returns within reasonable and prudent levels of risk in order to meet projected liabilities and maintain sufficient cash to make timely payments of all participant benefits. Risk is reduced by diversifying plan assets and following a strategic asset allocation approach. Additionally, as the plans are frozen and funding status has improved, the Company has shifted the investment allocations to lower risk investments in order to minimize market exposure and will continue to do so based upon approved funding milestones. Asset classes and target weights are adjusted periodically to optimize the long-term portfolio risk/return trade off, to provide liquidity for benefit payments, and to align portfolio risk with the underlying obligations. The investment policy of the plans prohibits the use of leverage, direct investments in tangible assets, or any investment prohibited by applicable laws or regulations.

The allocation of plan assets between equity and debt securities and the target allocation range by asset category for the defined benefit pension plans follows:
December 31,
202120202022 Target
Equity securities45 %52 %40 -45%
Debt securities51 %42 %50 -55%
Cash4 %6 %0-5%
100 %100 %


Plan assets are measured at fair value. Following are the plan investments as of December 31, 2021 and 2020, categorized by the fair value hierarchy levels described in Note 10, Fair Value:
Defined Benefit Pension and Postretirement Health and Life Benefit Plans
(in millions)Level 1Level 2Level 3Total
20212020202120202021202020212020
U.S. government securities$— $— $13.0 $16.4 $— $— 13.0 $16.4 
Corporate debt— — 56.4 104.2 — — 56.4 104.2 
Municipal bonds and non-U.S. government securities
— — 1.7 2.1 — — 1.7 2.1 
Mutual funds (b)582.9 — — — — — 582.9 — 
Mortgage and asset backed securities— — 7.9 6.4 — — 7.9 6.4 
Fair value of investments by hierarchy level
$582.9 $— $79.0 $129.1 $— $— 661.9129.1
Investments measured at NAV (a)20.1 504.4 
Accrued interest receivable1.2 1.3 
Unsettled transactions(1.4)(1.8)
Plan assets$681.8 $633.0 


(a) Equity, bond and money market investments held in collective trusts are valued based on the net asset value (“NAV”) provided by the administrator of the funds. The NAV for each fund is based on the underlying assets owned by the fund, less any expenses accrued against the fund, divided by the number of fund shares outstanding. While the underlying investments are traded on an exchange, the funds are not. Fair values for the collective trust investments are measured using the NAVs as a practical expedient and are not categorized in the fair value hierarchy.
(b) Postretirement Health and Life Benefit Plan assets of $9.2 million are all contained within Level 1 mutual funds.



100

Benefit Plan Cash Flows

The Company expects to contribute $0 million to the qualified defined benefit pension plans, $0.4 million to the non-qualified defined benefit pension plans, and $7.0 million to the postretirement health and life benefit plans in 2022. There is no required contribution for the postretirement health and life benefit plans under Employee Retirement Income Security Act (“ERISA”).

Estimated future benefit plan payments follow (in millions):
Defined Benefit Pension PlansPostretirement Health and Life Benefit Plans
2022$52.1 $11.2 
202351.0 10.7 
202449.1 10.1 
202547.6 9.5 
202647.6 9.0 
2027 to 2031214.0 36.3 

Other Plans

The Company sponsors a 401(k) defined contribution plan for employees. Employee contributions are matched at established rates. Amounts contributed are invested in a range of investment options available to participants and the funds are administered by an independent trustee. Matching cash contributions by the Company amounted to $2.0 million in 2021 and $1.6 million in 2020.

Under the Executive Deferred Compensation Plan, qualified employees may defer compensation on a tax-deferred basis subject to plan limitations. Any matching contributions under the Company’s 401(k) plan that are foregone due to annual compensation limitations of the Internal Revenue Code of 1986, as amended (the “Code”) are eligible to be received from the Company under the Executive Deferred Compensation Plan, provided that the employee deferred the maximum allowable pre-tax contribution in the 401(k) plan. The Company matching contributions amounted to less than $0.1 million in 2021 and 2020.

12. STOCK-BASED COMPENSATION

The Company’s 2014 Equity Incentive Plan (“2014 Plan”) authorizes the issuance of stock options, stock appreciation rights (“SARs”), restricted stock units, restricted stock, notional stock units, performance awards, dividend equivalent rights, and other stock-based awards, as well as cash-based awards, to employees, officers, directors, and other individuals providing services to the Company or its affiliates. As disclosed in Note 15 - Stockholder’s Equity, in February 2021, the Company increased the available shares of Class A Common Stock under the Company’s 2014 Plan by an additional 700,000 shares. The plan currently authorizes the issuance of up to 1,900,000 shares. As of December 31, 2021, there were 844,293 shares available for future awards.

In January 2019, the Company adopted the 2019 Executive Incentive Plan (“2019 Plan”), which is subject to the terms of the 2014 Plan, under which participating employees are eligible to receive grants of equity awards such as notional stock units and SARs. Under this plan, the Company has granted awards that are subject to either cliff-based or performance-based vesting. The cliff-based awards vest after three years of service. The performance-based awards vest if the company reaches or exceeds a pre-defined net income target for the three-year award term. Equity awards may be payable in common stock, cash, or a combination of both, at the discretion of the Board of Directors. Compensation costs for awards that are likely to be settled with cash payments are remeasured each reporting period based on the closing price of the Company’s common stock. These cumulative vested costs are accrued in Accounts Payable and Accrued Liabilities or Other Long-Term Liabilities. Equity awards that are payable in stock are accounted for as equity and compensation costs are amortized on a straight-line basis over the vesting period.
101


In 2019, under the 2014 Plan, the Company awarded notional stock units to participating executives for the three-year period ending December 31, 2021. As the original award, at grant date, was expected to be settled in cash, the Company had recorded cumulative compensation costs in Other Long-Term Liabilities at December 31, 2020. There were 206,183 notional stock units (two-thirds of these awards) paid in shares in April 2021, with the remainder anticipated to be paid in April 2022. As of March 31, 2021, the Company reclassified these shares to equity as the Board of Directors approved settlement in shares.

In 2020, the Company awarded participating executives notional stock units and stock appreciation rights for the three-year period ending April 26, 2023. These equity awards may be payable in common stock, cash, or a combination of both at the discretion of the Board of Directors. The cumulative vested costs have been accrued in Other Long-Term Liabilities as they are likely to be settled in cash.

In September 2021, the Company awarded participating executives notional stock units and SARs. The awards granted will be paid in shares on or before May 1, 2024, provided that a defined performance condition is achieved. In order to receive the award, the total cumulative net income as reported on the Company’s Form 10-Ks for the years ending December 31, 2021, 2022, and 2023 must be equal to or greater than $160 million. The grant date fair value of notional stock units is determined based on the closing price of Class A Common Stock on the grant date. The grant date fair value of the SARs were determined based on the Black-Scholes option-pricing model. The Company has concluded that it is probable that the performance condition will be achieved and therefore has recorded compensation cost. Compensation costs for these notional stock units and SARs are amortized to expense on a straight-line basis over the vesting period.

Compensation cost for restricted stock units and stock options is measured at the grant date, based on the fair value of the award, and is recognized on a straight-line basis over the requisite service period. As of December 31, 2021, there was $0.4 million of unrecognized compensation cost, adjusted for actual forfeitures, related to non-vested stock-based payments granted, of which $0.3 million relates to restricted stock units and $0.1 million relates to stock options. That cost is expected to be recognized over a weighted-average period of 12 months.

A summary of stock-based compensation costs is as follows (in millions):
 Year Ended December 31,
 20212020
 
Notional stock units and stock appreciation rights$11.6 $6.6 
Restricted stock units0.5 0.4 
Stock options0.1 0.1 
Total stock-based compensation costs$12.2 $7.1 
Total recognized tax benefit$(1.5)$— 

The total recognized tax benefit is reported at the federal statutory rate net of the tax valuation allowance.

Board Restricted Stock Units

Non-employee, independent directors are granted restricted stock units as part of their compensation for serving on the Board of Directors. Settlement of these restricted stock units is made in shares of Class A Common Stock only upon the director’s retirement or other end of service. The restricted stock units generally vest over one year; however, vesting is accelerated upon (1) the director attaining eligibility for retirement, (2) termination of the director’s service by reason of death or disability, or (3) a change in control. As of December 31, 2021, approximately 192,000 shares of restricted stock units could potentially be converted to Class A Common Stock once vested and settled.

102

The following table summarizes Centrus’ board restricted stock units activity:
Shares (in thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 201974$3.09
Granted47$10.38
Vested(74)$3.09
Forfeited——
Nonvested at December 31, 202047$10.38
Granted20$25.13
Vested(47)$10.38
Forfeited——
Nonvested at December 31, 202120$25.13

Employee Restricted Stock Units

In 2021, certain employees were granted restricted stock units as part of their compensation. Settlement of these restricted stock units is made in shares of Class A Common Stock upon vesting. The restricted stock units generally vest after three years. As of December 31, 2021, approximately 4,000 shares of restricted stock units could potentially be converted to Class A Common Stock once vested and settled.

The following table summarizes Centrus’s employee restricted stock units activity:
Shares
(in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020—$—
Granted4$24.01
Vested ——
Forfeited——
Nonvested at December 31, 20214$24.01


Stock Options

The intrinsic value of an option, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of stock option awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, employee stock option exercise behaviors, future dividend payments, and risk-free interest rates.

The expected term of options granted is the estimated period of time from the beginning of the vesting period to the date of expected exercise or other settlement, based on historical exercises and post-vesting terminations. Centrus has estimated the expected term using the simplified method described in SEC Staff Accounting Bulletin Topic 14, Share-Based Payment, due to the lack of historical exercise and post-vesting termination information available for the Company since its reorganization. Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected option term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the option valuation model.

103

There were no option grants in the years ended December 31, 2021, and 2020.

Stock options vest and become exercisable in equal annual installments over a three or four year period and expire ten years from the date of grant. A summary of stock option activity follows:
Stock Options (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value (in millions)
Outstanding at December 31, 2019518$4.026.2$1.5
Granted————
Exercised(107)$3.43——
Forfeited/Cancelled————
Outstanding at December 31, 2020411$4.185.3$7.8
Granted————
Exercised(217)$4.17——
Forfeited/Cancelled————
Outstanding at December 31, 2021194$4.184.4$8.9
Exercisable at December 31, 2021144$4.373.2$6.6

Stock options outstanding and options exercisable at December 31, 2021, are as follows:

Stock Exercise PriceOptions Outstanding (thousands)Remaining Contractual Life in YearsOptions Exercisable (thousands)
$4.371443.2144
$3.65507.8—

Stock Appreciation Rights - 2020 Award

The intrinsic value of a SAR, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of SAR awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, expected term, future dividend payments, and risk-free interest rates.

These SARs generally have a defined term of three years from award and are automatically exercised at the end of its term. Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the valuation model.
104


A summary of SARs with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:

Stock Appreciation Rights (in thousands) Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value (in millions)
Outstanding at December 31, 2019—$——$—
Granted83.5$5.53——
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202083.5$5.532.3$1.47
Granted————
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202183.5$5.531.3$3.71
Exercisable at December 31, 202183.5$5.531.3$3.71

The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
20212020
SARs Granted (in thousands)n/a83.5
Average Risk-Free Raten/a0.14%
Expected Volatilityn/a94%
Expected Term (Years)n/a2.3
Dividend Yieldn/a—

Stock Appreciation Rights (Performance Condition) - 2021 Award

The intrinsic value of a SAR, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of SAR awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, expected term, future dividend payments, and risk-free interest rates.

These SARs generally have a defined term of three years from award and are automatically exercised at the end of its term if the performance condition has been met. Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the valuation model.

105



A summary of SARs with performance-based vesting granted under the 2014 plan in the year ended December 31, 2021, are as follows:
Stock Appreciation Rights (Performance Condition) (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value (in millions)
Outstanding at December 31, 2020—$——$—
Granted21$19.44——
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202121$19.442.3$0.64
Exercisable at December 31, 202121$19.442.3$0.64



The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
20212020
Stock Appreciation Rights Granted (in thousands)21.0n/a
Average Risk-Free Rate0.3%n/a
Expected Volatility82.8%n/a
Expected Term (Years)2.5n/a
Dividend Yield—n/a

Notional Stock Units - 2019 and 2020 Awards

A summary of notional stock units with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:
Shares (thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2019468$3.16
Granted125$5.53
Vested——
Forfeited(22)$3.16
Nonvested at December 31, 2020571$3.68
Granted——
Vested(319)$3.16
Forfeited——
Nonvested at December 31, 2021252$4.33
106


Notional Stock Units (Performance Condition) - 2021 Award

A summary of notional stock units with performance-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:
Shares
(in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020— $— 
Granted10$39.55
Vested — — 
Forfeited— — 
Nonvested at December 31, 202110 $39.55


13. INCOME TAXES

Income Tax Benefit

The income tax benefit is as follows (in millions):
Year Ended December 31,
20212020
Current:
  Federal$— $— 
  State and local0.4 0.5 
  Foreign— — 
0.4 0.5 
Deferred:
  Federal (a)(40.7)— 
  State and local1.2 (1.9)
  Foreign— — 
(39.5)(1.9)
Income tax benefit$(39.1)$(1.4)

(a) The income tax benefit for 2021 includes the reversal of a portion of the federal valuation allowance on net deferred tax assets. See further discussion below.

107

Deferred Taxes

Future tax consequences of temporary differences between the carrying amounts for financial reporting purposes and the Company’s estimate of the tax bases of its assets and liabilities result in deferred tax assets and liabilities, as follows (in millions):
December 31,
20212020
Deferred tax assets:
Employee benefits costs
$36.2 $61.8 
Inventory
18.6 16.2 
Property, plant and equipment
191.5 193.8 
Net operating loss and credit carryforwards
206.2 211.1 
Accrued expenses
0.4 2.1 
Long-term debt and financing costs
10.8 12.6 
Lease liability
0.9 1.5 
Other
0.2 0.2 
Deferred tax assets
464.8 499.3 
Valuation allowance
(414.7)(486.0)
Deferred tax assets, net of valuation allowance
$50.1 $13.3 
Deferred tax liabilities:
Intangible assets
$7.9 $9.9 
Lease asset
0.4 1.1 
Prepaid expenses
0.4 0.4 
Deferred tax liabilities
$8.7 $11.4 
Deferred tax assets, net$41.4 $1.9 

The valuation allowance reduces the net deferred tax assets to their net realizable value. The ultimate realization of the net deferred tax assets is dependent upon generating sufficient taxable income in future years when deferred tax assets are recoverable or are expected to reverse.

The Company has maintained a full valuation allowance against federal and state net deferred tax assets since the fourth quarter of 2011 to the second quarter of 2020. In the second quarter of 2020, the Company released the valuation allowance against the state net deferred tax assets for the LEU segment that are more likely than not to be realized.

In the fourth quarter of 2021, the Company released $40.7 million of the valuation allowance against federal net deferred taxes that are more likely than not to be realized. Centrus evaluated both positive and negative evidence that was objectively verifiable to determine the amount of the federal valuation allowance that is required on Centrus’ federal deferred tax assets. Centrus has visibility on a significant portion of revenue in the LEU segment through 2026, primarily from its long-term sales contracts. Centrus considered both its achievement of sustained profitability and cumulative income in 2021, as well as, the forecasted income, to be significant forms of positive evidence. Negative evidence included uncertainty in and the lack of objectively verifiable evidence for profitability in later years when the Company’s existing sales order book and supply contracts reach expiration in its LEU segment. In the Company’s technical solutions segment, negative evidence included uncertainty in the future funding of the HALEU enrichment facility, and thus, no assumption for the future funding of the HALEU enrichment facility were included in the forecast model because it was not objectively verifiable. Centrus determined that the positive evidence outweighed the negative evidence and supported a release of the federal valuation allowance. However, due to lack of objectively verifiable information in later years, it was determined that forecasted future income was not sufficient to realize all the deferred tax assets. Therefore, the Company recorded a partial release of its federal valuation allowance.
108


In addition to the partial release of the valuation allowance against federal net deferred taxes, the valuation allowance decreased in 2021 by $30.6 million due to changes in deferred tax assets since the beginning of the year. The Company continues to maintain a valuation allowance against its remaining federal and state net deferred tax assets due to significant federal and state net operating losses and insufficient future taxable income.

Going forward, the Company will continue to evaluate both positive and negative evidence that would support any further changes to the remaining valuation allowances. Such evidence in its technical solutions segment may include signing new contracts which could have a significant impact on pre-tax income, follow on-work related to the HALEU program, or abandonment of the commercial deployment of the centrifuge technology. Such evidence in our LEU segment may include renewing SWU sales contracts with existing customers and/or signing new SWU sales or purchase contracts with significantly higher or lower margins than currently forecasted. Additional evidence in the LEU segment may include potential deferrals in the timing of deliveries requested by its customers, which would impact revenue recognition timing. The impact of these and other potential positive and negative events will be weighed and evaluated to determine if the valuation allowance should be increased or decreased in the future.

The net deferred tax assets and related valuation allowance were increased as of December 31, 2020, by $39.5 million for previously unrecorded state deferred tax assets, net of federal benefit, in states where we have had historical losses and a remote likelihood of realizing a tax benefit. This increase to state deferred tax assets, net of the full valuation allowance, had no net impact on income tax expense for 2020. When a change in tax rate or tax law has an impact on deferred taxes, we apply the change based on the years in which the deferred taxes are expected to reverse. The Company records the impact of the change in its consolidated financial statements in the period of enactment.

The Company has federal net operating losses of $732.0 million generated through December 31, 2017, that currently expire through 2037. In addition, the Company has federal net operating losses and business interest expense carry forwards of $131.4 million and $4.1 million, respectively, generated after December 31, 2017, that do not expire. Centrus also has state net operating losses of $0.5 million, with no valuation allowance, and state net operating losses of $465.4 million, with a full valuation allowance, that currently expire through 2037.

Effective Tax Rate

A reconciliation of income taxes calculated based on the federal statutory income tax rate and the effective tax rate follows:
Year Ended December 31,
20212020
Federal statutory tax rate21 %21 %
Valuation allowance against net deferred tax assets(53)(26)
State rate changes1 (1)
Executive compensation1 2 
State income tax expense, net of federal benefit1 — 
Uncertain tax positions— 1 
Effective tax rate
(29)%(3)%


The effective tax rate for the year ended December 31, 2021, includes a decrease to the valuation allowance against net deferred tax assets of $71.3 million, or a change to the effective tax rate of (53%). Included in the valuation allowance decrease is the release of the valuation allowance against federal net deferred taxes of $40.7 million, or a change to the effective tax rate of (30%).

109

The effective tax rate for the year ended December 31, 2020, includes a decrease to the valuation allowance against net deferred tax assets of $13.9 million, or a change to the effective tax rate of (26%). Included in the valuation allowance decrease is the release of the valuation allowance against state net deferred taxes of $2.0 million, or a change to the effective tax rate of (4%).

Uncertain Tax Positions

Accounting standards require that a tax position meet a minimum recognition threshold in order for the related tax benefit to be recognized in the financial statements. The liability for unrecognized tax benefits, included in Other Long-Term Liabilities, was $1.0 million as of December 31, 2021, and $0.8 million as of December 31, 2020. If recognized, these tax benefits would impact the effective tax rate. As a result of changes to unrecognized tax benefits, the income tax provision (state tax, net of federal benefit) increased $0.2 million and $0.4 million during the years ended December 31, 2021 and December 31, 2020, respectively. The liability for unrecognized tax benefits in the table below relates to unrecognized state income tax benefits. Centrus believes that the liability for unrecognized tax benefits will not change significantly in the next 12 months.

A reconciliation of the beginning and ending amount of unrecognized tax benefits follows (in millions):
Year Ended December 31,
20212020
Balance at beginning of the period$0.8 $0.4 
Additions to tax positions of current period0.4 0.5 
Reductions to tax positions of prior years(0.2)(0.1)
Balance at end of the period$1.0 $0.8 

Centrus and its subsidiaries file income tax returns with the U.S. government and various states and foreign jurisdictions. As of December 31, 2021, the federal, Maryland and Tennessee statutes of limitation are closed with respect to all tax years through 2017.

Centrus recognizes accrued interest related to uncertain tax positions as a component of Interest Expense. Reversals of previously accrued interest for income taxes is typically offset against interest expense, but if the amount is significant, it is reclassified to interest income in the consolidated statement of operations. Centrus recognizes the increase or decrease of accrued penalties for income taxes as a component of Selling, General and Administrative in the consolidated statement of operations.

The impact of accrued interest and penalties for income taxes in the consolidated statement of operations was an increase to expenses of less than $0.1 million for the years ended December 31, 2021 and December 31, 2020, respectively. Accrued interest and penalties for income taxes, included as a component of Other Long-Term Liabilities, totaled less than $0.1 million as of December 31, 2021 and 2020.

14. NET INCOME PER COMMON SHARE

Basic net income per common share is calculated by dividing income allocable to common stockholders by the weighted average number of shares of common stock outstanding during the period. In calculating diluted net income per common share, the number of shares is increased by the weighted average number of potential shares related to stock compensation awards. No dilutive effect is recognized in a period in which a net loss has occurred.

On November 17, 2020, the Company completed the purchase of 62,854 shares of its outstanding Series B Senior Preferred Stock at a price per share of $954.59, less any applicable withholding taxes. (Refer to Note 15 - Stockholders’ Equity). The purchase price per share represented a 25% discount from the aggregate liquidation preference, including accrued but unpaid dividends, of $1,272.78 per share as of September 30, 2020. Since origination, the carrying value on the Balance Sheet was $43.80 per share based on values assigned in the originating securities exchange. The liquidation amount at origination was $1,000.00 per share.
110

The aggregate purchase price of approximately $60 million, less accrued but unpaid dividends attributable to the purchased and retired Series B Senior Preferred Stock, is considered for purposes of Net Income per Share to be a deemed dividend to the extent it exceeds the carrying value on the consolidated Balance Sheet, or $41.9 million.

On February 2, 2021, the Company completed the exchange of 3,873 shares of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (“Preferred Stock”) for (i) 231,276 shares of Class A Common Stock and (ii) a warrant to purchase 250,000 shares of Class A Common Stock at an exercise price of $21.62 per share, for an aggregate valuation of approximately $7.5 million. The carrying value of the Series B Senior Preferred Stock on the Balance Sheet was $1.00 per share par value. The aggregate liquidation preference of the Series B Senior Preferred Stock, including accrued but unpaid dividends, was $1,291.04 per share as of December 31, 2020.

On November 23, 2021, the Company completed the purchase of 36,867 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,145.20, less any applicable withholding taxes. The Company also completed the purchase of the remaining 980 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,149.99, less any applicable withholding taxes, on December 15, 2021 (Refer to Note 15 - Stockholders’ Equity). The aggregate purchase price of both transactions was $43.3 million. The carrying value of the Series B Senior Preferred Stock on the consolidated Balance Sheet was $1.00 per share par value.

The aggregate valuation of all 2021 preferred stock transactions of approximately $50.8 million, less accrued but unpaid dividends attributable to the acquired and retired shares of Series B Senior Preferred Stock, is considered for purposes of Net Income per Share to be a deemed dividend in the aggregate amount equal to the amount by which it exceeds the carrying value of the Preferred Stock on the consolidated Balance Sheet, or $37.6 million.

The weighted average number of common and common equivalent shares and the calculation of basic and diluted income per common share are as follows:
 Year Ended 
December 31,
20212020
Numerator (in millions):
Net income$175.0 $54.4 
Preferred stock dividends - undeclared and cumulative2.1 6.7 
Distributed earnings allocable to retired preferred shares37.6 41.9 
Net income allocable to common stockholders$135.3 $5.8 
Denominator (in thousands):
Average common shares outstanding - basic13,493 9,825 
Potentially dilutive shares related to stock options and restricted stock units (a)
386 298 
Average common shares outstanding - diluted13,879 10,123 
Net income per common share (in dollars):
Basic$10.03 $0.59 
Diluted$9.75 $0.57 
There are no common stock equivalents excluded from the diluted calculation as a result of a net loss in the period or options outstanding and considered anti-dilutive as their exercise price exceeded the average share market price.
111

15.  STOCKHOLDERS’ EQUITY

Shares Outstanding

Changes in the number of shares outstanding are as follows:
 Preferred Stock,
Series B		Common Stock,
Class A		Common Stock,
Class B
Balance at December 31, 2019104,574 8,347,427 1,117,462 
Issuance under public offering— 2,537,500 — 
Common stock issued for options exercised— 107,000 — 
Conversion of common stock from Class B to Class A— 398,262 (398,262)
Purchase under tender offer(62,854)— — 
Balance at December 31, 202041,720 11,390,189 719,200 
Issuance under public offering — 1,516,467 — 
Common stock issued for options exercised— 216,500 — 
Issuance of previously vested restricted stock units— 89,318 — 
Notional stock units paid in shares— 206,183 — 
Common stock and warrant issued in exchange for preferred stock(3,873)231,276 — 
Purchase under tender offer(37,847)— — 
Balance at December 31, 2021— 13,649,933 719,200 

Common Stock

The Company’s certificate of incorporation authorizes 20,000,000 shares of preferred stock, par value $1.00 per share, 70,000,000 shares of Class A common stock, $0.10 par value per share (the “Class A Common Stock”) and 30,000,000 shares of Class B common stock, $0.10 par value per share (the “Class B Common Stock,” and together with the Class A Common Stock, the “Common Stock”). As of December 31, 2021, the Company has issued 14,369,133 shares of Common Stock, consisting of 13,649,933 shares of Class A Common Stock and 719,200 shares of Class B Common Stock.

Pursuant to a sales agreement with its agents, the Company sold through its ATM Offering an aggregate of 1,516,467 shares of its Class A Common Stock in 2021 for a total of $44.2 million. After expenses and commissions paid to the agents the Company’s proceeds totaled $42.4 million. Additionally, the Company recorded direct costs of $0.3 million related to the issuance. The shares of Class A Common Stock were issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-239242), which became effective on August 5, 2020, and a prospectus supplement dated December 31, 2020, to the prospectus. The Company currently intends to use the net proceeds from this offering for general working capital purposes, to invest in technology development and deployment, and to repay outstanding debt.

As previously disclosed on Form 8-K filed February 5, 2021, on February 2, 2021, the Company entered into an amendment (the “Voting Agreement Amendment”) to its existing Voting and Nomination Agreement with Mr. Morris Bawabeh, Kulayba LLC and M&D Bawabeh Foundation, Inc. (collectively, the “MB Group”) and an Exchange Agreement (as described below) whereby the MB Group agreed to support management’s recommendation on certain matters at the Company’s 2021 annual meeting of stockholders (the “Annual Meeting”) and Kulayba LLC agreed to exchange shares of the Company’s Preferred Stock for shares of the Company’s Class A Common Stock and a warrant to acquire additional shares of Class A Common Stock. Pursuant to the First Amendment to the Voting and Nomination Agreement, the MB Group agreed to cause all shares of Class A Common Stock owned of record or beneficially owned by the MB Group at the Annual Meeting to be voted in favor of (i) an amendment to extend the length of the term of the Company’s Section 382 Rights Agreement dated
112

as of April 6, 2016, as amended to date, for two years from June 30, 2021, to June 30, 2023, and (ii) an increase of shares of Class A Common Stock reserved for delivery under the Company’s Centrus Energy Corp 2014 Equity Incentive Plan, as amended to date, of an additional 700,000 shares of Class A Common Stock. At the Annual Meeting both of the above referenced proposals were approved by the Company’s stockholders.

In connection with the entry into the Voting Agreement Amendment, the Company and Kulayba LLC also entered into an Exchange Agreement, dated February 2, 2021 (the “Exchange Agreement”), pursuant to which Kulayba LLC agreed to exchange (the “Exchange”) 3,873 shares of Preferred Stock, representing a $5,000,198 liquidation preference (including accrued and unpaid dividends), for (i) 231,276 shares of Class A Common Stock priced at the closing market price of $21.62 on the date the Exchange Agreement was signed and (ii) a Centrus Energy Corp. Warrant to Purchase Class A Common Stock (the “Warrant”), exercisable for 250,000 shares of Class A Common Stock at an exercise price of $21.62 per share, which was the closing market price on the date the Exchange Agreement was signed, subject to certain customary adjustments pursuant to the terms of the Warrant. The Warrant is exercisable by Kulayba LLC for a period commencing on the closing date of the Exchange and ending, unless sooner terminated as provided in the Warrant, on the first to occur of: (a) the second anniversary of the closing date of the Exchange or (b) the last business day immediately prior to the consummation of a Fundamental Transaction (as defined in the Warrant) which results in the shareholders of the Company immediately prior to such Fundamental Transaction owning less than 50% of the voting equity of the surviving entity immediately after the consummation of the Fundamental Transaction. The Company retired the 3,873 shares of Preferred Stock received by the Company under the Exchange Agreement.

On September 1, 2020, the Company completed the sale of 2,537,500 shares of the Company’s Class A Common Stock pursuant to the Registration Statement on Form S-3 that became effective on August 5, 2020, as supplemented by the prospectus supplement filed with the SEC on August 21, 2020. The price to the public in this offering was $10.00 per share of Class A Common Stock. The aggregate gross proceeds from the offering were approximately $25.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company of $2.3 million.

Shares of Class B Common Stock that are sold in the market are automatically converted to shares of Class A Common Stock. Shares of Class B Common Stock that were sold in the market and converted to shares of Class A Common Stock totaled 0 in 2021 and 398,262 in 2020.

The Company has reserved 1,900,000 shares of Class A Common Stock under its management incentive plan, of which 844,293 shares are available for future awards as of December 31, 2021. Refer to Note 12, Stock-Based Compensation, for additional information.

The Class A Common Stock trades under the symbol “LEU” on the NYSE American trading platform.

The Class B Common Stock was issued to Toshiba America Nuclear Energy Corporation (“Toshiba”) and Babcock & Wilcox Investment Company (“B&W”) and has the same rights, powers, preferences and restrictions and ranks equally in all matters with the Class A Common Stock, except voting. Holders of Class B Common Stock are entitled to elect, in the aggregate, two members of the Board of Directors of the Company, subject to certain holding requirements.

Series B Senior Preferred Stock

In 2017, Centrus issued 104,574 shares of Series B Senior Preferred Stock as part of a securities exchange. The issuance of the Series B Senior Preferred Stock was a non-cash financing transaction. As detailed below, the Series B Senior Preferred Stock was purchased by the Company in 2020 and 2021 and the designation of the Series B Senior Preferred Stock was eliminated and all shares of preferred stock of the Company previously designated as Series B Senior Preferred Stock were returned to authorized but unissued and undesignated shares of preferred stock of the Company.

113

The Series B Senior Preferred Stock had a par value of $1.00 per share and a liquidation preference of $1,000 per share (the “Liquidation Preference”). Holders of the Series B Senior Preferred Stock were entitled to cumulative dividends of 7.5% per annum of the Liquidation Preference. Centrus had not met the criteria for payment of dividends for the periods from issuance through final redemption of the Series B Senior Preferred Stock in 2021.

2020 Tender Offer

On November 17, 2020, pursuant to a tender offer announced on October 19, 2020, the Company completed the purchase of 62,854 shares of its outstanding Series B Senior Preferred Stock at a price per share of $954.59, less any applicable withholding taxes, for an aggregate purchase price of approximately $60 million. The purchase price per share represented a 25% discount from the aggregate liquidation preference, including accrued but unpaid dividends, of $1,272.78 per share as of September 30, 2020. These shares represented approximately 60% of the Company's outstanding Series B Senior Preferred Stock as of September 30, 2020. The remaining Series B Senior Preferred Stock outstanding after the transaction was 41,720 shares.

On December 22, 2020, the Company filed with the Delaware Secretary of State a Certificate of Retirement of 62,854 Series B Senior Preferred Stock, par value $1.00 per share, to effect the retirement of the Company’s Series B Senior Preferred Stock repurchased upon the completion of its previously announced tender offer to purchase Series B Senior Preferred Stock. Effective upon filing, the Certificate of Retirement amended the Amended and Restated Certificate of Incorporation of the Company to reduce the total number of authorized Series B Senior Preferred Stock by 62,854 shares such that the total number of authorized Series B Senior Preferred Stock of the Company was 41,720 shares.

2021 Tender Offer

On October 20, 2021, the Company announced the commencement of a tender offer to purchase all of its outstanding Series B Senior Preferred Stock, par value $1.00 per share, at a price of $1,145.20 per Series B Senior Preferred Stock (inclusive of any rights to accrued but unpaid dividends), to the sellers in cash, less any applicable withholding taxes (the “Offer”). The Offer was made pursuant to the Tender Offer Statement on Schedule TO filed by the Company on October 20, 2021 with the SEC. The aggregate liquidation preference per Series B Senior Preferred Stock (including accrued but unpaid dividends) was $1,347.29 as of September 30, 2021.

On November 23, 2021, the Company announced the results of the tender offer and the related consent solicitation (the “Consent Solicitation”) to amend the certificate of designation of the Series B Senior Preferred Stock (the “Series B Preferred Amendment”). 36,867 Series B Senior Preferred Stock were properly tendered and not properly withdrawn in the Offer, and corresponding consents have been delivered in the Consent Solicitation. Pursuant to the terms of the Offer and Consent Solicitation, the Company has accepted for purchase all of the Series B Senior Preferred Stock tendered in the Offer, for an aggregate purchase price of $42.2 million. The accepted shares represent 97.4% of the Company’s outstanding Series B Senior Preferred Stock as of September 30, 2021. Based on the final results, the requisite consent of at least 90% of the outstanding Series B Senior Preferred Stock required to approve the Series B Preferred Amendment was obtained. On November 23, 2021, the Company issued a Notice of Full Redemption providing for the redemption of any and all shares of the Company’s Series B Senior Preferred Stock outstanding after consummation of the Company’s tender offer to purchase all of its issued and outstanding Series B Senior Preferred Stock. On December 15, 2021, the Company completed the redemption of all 980 outstanding Series B Senior Preferred Stock for an aggregate purchase price of $1.1 million. The aggregate purchase price of $43.3 million was offset by direct costs totaling $0.9 million.

The effect of the Series B Preferred Amendment was to: (i) cease any obligation to pay dividends on Series B Senior Preferred Stock (other than the payment of accrued dividends in connection with a redemption or distribution of assets upon liquidation, dissolution or winding up), (ii) permit the Company to redeem Series B Senior Preferred Stock during the 90 days following the date of effectiveness of the Series B Preferred Amendment at a redemption price per share equal to $1,145.20 (plus any additional accrued dividends for the period from and including the date
114

of effectiveness of the Series B Preferred Amendment to the date of redemption), (iii) remove the prohibition on the declaration and payment of dividends on junior stock of the Company, which includes all shares of the Company’s capital stock defined as “Common Stock” in the Company’s Amended and Restated Certificate of Incorporation, or the redemption, purchase or acquisition of such junior stock, and (iv) remove the restriction on redemption, purchase or acquisition of capital stock of the Company ranking on parity with the Series B Senior Preferred Stock.

On December 16, 2021, the Company filed a Certificate of Elimination of the Series B Senior Preferred Stock of Centrus Energy Corp. with the Secretary of State of Delaware (the “Certificate of Elimination”) to eliminate the designation of the Series B Senior Preferred Stock and to return all shares of preferred stock of the Company previously designated as Series B Senior Preferred Stock to authorized but unissued and undesignated shares of preferred stock of the Company.

Rights Agreement

On April 6, 2016 (the “Effective Date”), the Company’s Board of Directors (the “Board”) adopted a Section 382 Rights Agreement, which was (a) amended on February 14, 2017 to, among other things, exclude acquisitions of the Series B Senior Preferred Stock issued as part of the exchange offer and consent solicitation from the definition of “Common Shares” in connection with the settlement and completion of the exchange offer and consent solicitation, and (b) further amended on April 3, 2019 to, among other things, (i) decreased the purchase price for each one one-thousandth (1/1000th) of a share of the Company’s Series A Participating Cumulative Preferred Stock, par value $1.00 per share, from $26.00 to $18.00 and (ii) extended the Final Expiration Date (as defined in the Rights Agreement) from April 5, 2019 to April 5, 2022 (as amended, the “Rights Agreement”). The Board adopted the Rights Agreement in an effort to protect shareholder value by, among other things, attempting to protect against a possible limitation on the Company’s ability to use its net operating loss carryforwards and other tax benefits, which may be used to reduce potential future income tax obligations.

In connection with the adoption of the Rights Agreement, the Board declared a dividend of one preferred-share-purchase-right for each share of the Company’s Class A Common Stock and Class B Common Stock outstanding as of the Effective Date. The rights initially trade together with the common stock and are not exercisable. In the absence of further action by the Board, the rights would generally become exercisable and allow a holder to acquire shares of a new series of the Company’s preferred stock if any person or group acquires 4.99% or more of the outstanding shares of the Company’s common stock, or if a person or group that already owns 4.99% or more of the Company’s Class A Common Stock acquires additional shares representing 0.5% or more of the outstanding shares of the Company’s Class A Common Stock. The rights beneficially owned by the acquirer would become null and void, resulting in significant dilution in the ownership interest of such acquirer.

The Board may exempt any acquisition of the Company’s common stock from the provisions of the Rights Agreement if it determines that doing so would not jeopardize or endanger the Company’s use of its tax assets or is otherwise in the best interests of the Company. The Board also has the ability to amend or terminate the Rights Agreement prior to a triggering event.

On April 8, 2020, the Company’s Board of Directors approved, and the Company entered into, a Third Amendment to the Rights Agreement (the “Third Amendment”). The Third Amendment modified the Final Expiration Date (as defined in the Rights Agreement) to be June 30, 2023.


115

16. COMMITMENTS AND CONTINGENCIES

Commitments under SWU Purchase Agreements

TENEX

A major supplier of SWU to the Company is the Russian government-owned entity TENEX, Joint-Stock Company (“TENEX”). Under a 2011 agreement with TENEX, as amended, (the “TENEX Supply Contract”), the Company purchases SWU contained in LEU received from TENEX, and the Company delivers natural uranium to TENEX for the LEU’s uranium component. The LEU that the Company obtains from TENEX under the agreement is subject to quotas and other restrictions applicable to commercial Russian LEU. Further, the ability of the Company or TENEX to implement the TENEX Supply Contract is vulnerable to any new sanctions or restrictions that might be imposed by Russia, the United States, or other countries in the future, including as a result of the war in Ukraine.

The TENEX Supply Contract originally was signed with commitments through 2022 but was modified in 2015 to give the Company the right to reschedule certain quantities of SWU of the original commitments into the period 2023 and beyond, in return for the purchase of additional SWU in those years. The Company has exercised this right to reschedule in each year through December 31, 2021. If the Company exercises this right to reschedule in full during the remaining years of the contract’s original term, the Company will have a rescheduled post-2022 purchase commitment that could extend through 2028.

The TENEX Supply Contract provides that the Company must pay for all SWU in its minimum purchase obligation each year, even if it fails to submit orders for such SWU. In such a case, the Company would pay for the SWU but have to take the unordered SWU in the following year.

Pricing terms for SWU under the TENEX Supply Contract are based on a combination of market-related price points and other factors. This formula was subject to an adjustment at the end of 2018 that reduced the unit costs of SWU under this contract in 2019 and for the duration of the contract.

Orano

In 2018, the Company entered into an agreement (the “Orano Supply Agreement”) with the French company Orano Cycle (“Orano”) for the long-term supply to the Company of SWU contained in LEU. Under the Orano Supply Agreement, as amended, the supply of SWU commenced in 2020 and extends to 2028. The Company has the option to extend the supply period for an additional two years. The Orano Supply Agreement provides significant flexibility to adjust purchase volumes, subject to annual minimums and maximums in fixed amounts that vary year by year. The pricing for the SWU purchased by the Company is determined by a formula that uses a combination of market-related price points and other factors and is subject to certain floors and ceilings. 

Milestones Under the 2002 DOE-USEC Agreement

The Company’s predecessor USEC Inc. and DOE signed an agreement dated June 17, 2002, as amended (the “2002 DOE-USEC Agreement”), pursuant to which the parties made long-term commitments directed at resolving issues related to the stability and security of the domestic uranium enrichment industry. The 2002 DOE-USEC Agreement requires Centrus to develop, demonstrate and deploy advanced enrichment technology in accordance with milestones, including the deployment of a commercial American Centrifuge Plant, and provides for remedies in the event of a failure to meet a milestone under certain circumstances, including terminating the 2002 DOE-USEC Agreement, revoking Centrus’ access to DOE’s centrifuge technology that is required for the success of the Company’s ongoing work with the American Centrifuge technology, requiring Centrus to transfer certain rights in the American Centrifuge technology and facilities to DOE, and requiring Centrus to reimburse DOE for certain costs associated with the American Centrifuge technology. The 2002 DOE-USEC Agreement provides that if a delaying event beyond the control and without the fault or negligence of Centrus occurs that could affect Centrus’
116

ability to meet the American Centrifuge Plant milestone under the 2002 DOE-USEC Agreement, DOE and the Company will jointly meet to discuss in good faith possible adjustments to the milestones as appropriate to accommodate the delaying event. In 2014, the 2002 DOE-USEC Agreement and other agreements between the Company and DOE were assumed by Centrus subject to an express reservation of all rights, remedies and defenses by DOE and the Company under those agreements. DOE and the Company have agreed that all rights, remedies and defenses of the parties with respect to any missed milestones and all other matters under the 2002 DOE-USEC Agreement continue to be preserved, and that the time limits for each party to respond to any missed milestones continue to be tolled.

Legal Matters

From time to time, the Company is involved in various pending legal proceedings, including the pending legal proceedings described below.

In 1993, the United States Enrichment Corporation, at that time a wholly-owned government corporation (“USEC-Government”), entered into a lease for the Paducah and Portsmouth Gaseous Diffusion Plants (collectively, the “GDPs”) with the U.S. Department of Energy (“DOE”). As part of that lease, DOE and USEC-Government also entered into a memorandum of understanding (“Power MOU”) regarding power purchase agreements between DOE and the providers of power to the GDPs. Under the Power MOU, DOE and USEC-Government agreed upon the allocation of rights and liabilities under the power purchase agreements. In 1998, USEC-Government was privatized and became the United States Enrichment Corporation, now a principal subsidiary of the Company (“Enrichment Corp.”). Pursuant to legislation authorizing the privatization, the lease for the GDPs, which included the Power MOU as an Appendix, was transferred to Enrichment Corp. and Enrichment Corp. was given the right to purchase power from DOE. The Paducah GDP was shut down in 2013 and deleased by Enrichment Corp. in 2014. On August 4, 2021, DOE informally informed Enrichment Corp. that the Joppa power plant, which had supplied power to the Paducah GDP, was planned to be decontaminated and decommissioned (D&D). According to DOE, the power purchase agreement with Electric Energy Inc. (“EEI”) requires DOE to pay for a portion of the D&D costs of the Joppa power plant and DOE has asserted that a portion of the DOE liability is the responsibility of Enrichment Corp. under the Power MOU in the amount of approximately $9.6 million. The Company is assessing DOE’s assertions including whether all or a portion of any such potential liability had been previously settled. The Company has not formed an opinion on the merits nor is it able to estimate the potential liability, if any, and no expense or liability has been accrued.

On August 30, 2013, the Company submitted a claim to DOE under the Contract Disputes Act for payment of $42.8 million, representing DOE’s share of pension and postretirement benefits costs related to the transition of employees at the former Portsmouth GDP to DOE’s D&D contractor. On August 27, 2014, the DOE contracting officer denied the Company’s claim. As a result, the Company filed an appeal of the decision in the U.S. Court of Federal Claims in January 2015.

On January 13, 2021, the Company and DOE reached a tentative agreement to settle the litigation. The settlement was subject to the approval by DOE, the U.S. Department of Justice, the Company’s Board of Directors, and the Court. On September 7, 2021, after the final approvals for the settlement were received, the settlement agreement was signed by the parties. Under the terms of the settlement agreement, DOE paid the Company $43.5 million, of which $33.8 million was contributed to the pension plan in September 2021 for Enrichment Corp. and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp. After receiving payment, at the Company’s request the case was dismissed. The payment of $43.5 million is included in revenue of the technical solutions segment for the year ended December 31, 2021.

On May 26, 2019, the Company, Enrichment Corp., and six other DOE contractors who have operated facilities at the Portsmouth GDP site (including, in the case of the Company, the American Centrifuge Plant site located on the premises) were named as defendants in a class action complaint filed by Ursula McGlone, Jason McGlone, Julia Dunham, and K.D. and C.D., minor children by and through their parent and natural guardian Julia Dunham (collectively, the “McGlone Plaintiffs”) in the U.S. District Court in the Southern District of Ohio, Eastern Division.
117

The complaint seeks damages for alleged off-site contamination allegedly resulting from activities on the Portsmouth GDP site. The McGlone Plaintiffs are seeking to represent a class of (i) all current or former residents within a seven-mile radius of the Portsmouth GDP site and (ii) all students and their parents at the Zahn’s Corner Middle School from 1993-present. The complaint was amended on December 10, 2019 and on January 10, 2020 to add additional plaintiffs and new claims. On July 31, 2020, the court granted in part and denied in part the defendants’ motion to dismiss the case. The court dismissed ten of the fifteen claims and allowed the remaining claims to proceed to the next stage of the litigation process. On August 18, 2020, the McGlone Plaintiffs filed a motion for leave to file a third amended complaint and notice of dismissal of three of the individual plaintiffs. On March 18, 2021, the McGlone Plaintiffs filed a motion for leave to file a fourth amended complaint to add new plaintiffs and allegations. On March 19, 2021, the court granted the McGlone Plaintiffs’ motion for leave to amend the complaint. On May 24, 2021, the Company, Enrichment Corp. and the other defendants filed their motion to dismiss the complaint. The court has not rendered a decision at this time. Meanwhile, the parties are in the discovery stage of litigation. The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the Nuclear Regulatory Commission’s regulations. Further, the Company believes that any such liability should be indemnified under the Price-Anderson Nuclear Industries Indemnity Act (“Price-Anderson Act”). The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions.

On November 27, 2019, the Company, Enrichment Corp. and six other DOE contractors who have operated facilities at the Portsmouth GDP site were named as defendants in a class action complaint filed by James Matthews, Jennifer Brownfield Clark, Joanne Ross, the Estate of A.R., and others similarly situated (the “Matthews Plaintiffs”), in the Common Pleas Court of Pike County, Ohio. On January 3, 2020, the complaint was removed to the U.S. District Court in the Southern District of Ohio for adjudication. The complaint sought injunctive relief, compensatory damages, statutory damages, and any other relief allowed by law for alleged off-site contamination allegedly resulting from activities on the Portsmouth GDP site. The Matthews Plaintiffs expressly contended that the ongoing and continuous releases that injured the Plaintiffs and class members were not “nuclear incidents” as that term is defined in the Price-Anderson Act, but rather “freestanding state law claims concerning traditional-style state regulation.” On July 27, 2020, the court granted the Company, Enrichment Corp. and the other defendants’ motion to dismiss the complaint because the Matthews Plaintiffs had opted not to proceed under the Price-Anderson Act which preempts state law. On August 18, 2020, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Sixth Circuit. On October 6, 2021, the U.S. Court of Appeals for the Sixth Circuit affirmed the lower court’s decision and dismissed the case. The Plaintiffs did not file a petition for certiorari with the U.S. Supreme Court; the Plaintiffs had to file such a petition by January 4, 2022 for the U.S. Supreme Court, and therefore, the lower court’s decision to dismiss the case is final.

On September 3, 2020, the Company, Enrichment Corp., nine other DOE contractors who have operated facilities at the Portsmouth GDP site and eleven individuals in their personal capacity some of whom are current and former DOE employees were named as defendants (“Walburn Defendants”) in a class action complaint filed by Jeffrey Walburn, Charles O. Lawson Jr., Kimberly M. Lawson, James A. Brogdon, Stephen Patrick Spriggs, Donald Slone, Vicki P. Slone, Victoria Slone Moore, Toni West, Carl R. Hartley, Heather R. Hartley, Vina Colley, Antony Preston, David B. Rose, Michael E. Groves, George W. Clark, Estate of Kathy Sue Brogdon (deceased), Estate of Jay Paul Brogdon (deceased), and Jon Doe(s), and Jane Doe(s), on behalf of themselves and all similarly situated individuals (“Walburn Plaintiffs”) in the U.S. District Court in the Southern District of Ohio, Eastern Division. The complaint alleged that the named defendants conspired and concealed nuclear incidents in violation of the Price-Anderson Act, the Racketeer Influenced and Corrupt Organization Act and other state claims. The complainants sought damages and equitable and injunctive relief arising from economic losses, property losses, and non-economic damages resulting from toxic and radioactive releases from the Portsmouth GDP. On November 20, 2020, the Walburn Plaintiffs filed an amended complaint to add two individuals to the complaint as defendants in their individual capacity. One of those individuals was Daniel Poneman, Centrus’ Chief Executive Officer. In the 78-page complaint, Mr. Poneman was referenced only twice, without any cited allegations against him; once in the caption and once referencing his position at the Company. The Company has notified its insurance carrier regarding the claim. On February 11, 2021, the Walburn Plaintiffs amended their complaint for a second time to replace two corporate defendants with two others (one of whom was a contractor to Enrichment Corp. and also to its
118

predecessor prior to its privatization in 1998 and the other a former DOE contractor) and removed four named individual defendants from the complaint. On March 2, 2021, Walburn Defendants filed their motion to dismiss. On July 14, 2021, the court put the case on hold until November 11, 2021, to give the Plaintiffs the opportunity to retain new counsel. The court conditionally granted the Plaintiffs’ local counsel’s request to withdraw as counsel and terminated the representation of the two other co-counsel. The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the Nuclear Regulatory Commission’s regulations. Further, the Company believes that any such liability should be indemnified under the Price-Anderson Act. The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions. On November 11, 2021, Plaintiffs filed a notice of voluntary dismissal without prejudice.

Centrus is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, other than the above, Centrus does not believe that the outcome of any of these legal matters, individually and in the aggregate, will have a material adverse effect on its cash flows, results of operations or consolidated financial condition.

17.  ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The sole component of accumulated other comprehensive income (loss) (“AOCI”) relates to activity in the accounting for pension and postretirement health and life benefit plans. The amortization of prior service costs (credits) is reclassified from AOCI and included in the computation of net periodic benefit cost. For further details, refer to Note 11, Pension and Postretirement Health and Life Benefits.


18. REVENUE BY GEOGRAPHIC AREA, MAJOR CUSTOMERS AND SEGMENT INFORMATION

Revenue by customer location, including customers in a foreign country representing 10% or more of total revenue, follows (in millions):
Year Ended December 31,
20212020
United States$220.5 $171.7 
Foreign:
Belgium
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Total revenue$298.3 $247.2 
* less than 10%

The U.S. government and its contractors, in the Company’s technical solutions segment, represented approximately 38% of total revenue in 2021 and 21% in 2020.

The ten largest customers in the Company’s LEU segment represented approximately 57% of total revenue in 2021. Revenue from each of Synatom and Kyushu Electric Power Company represented approximately 12% of total revenue in 2021.

In 2020, the ten largest customers in the Company’s LEU segment represented approximately 71% of total revenue in 2020. Revenue from Synatom, Energy Harbor Nuclear Corp. and Dominion Energy South Carolina represented approximately 14%, 13% and 10%, respectively, of total revenue in 2020.

No other customer represented more than 10% of total revenue in 2021 or 2020.

119

Centrus has two reportable segments: the LEU segment with two components, SWU and uranium, and the technical solutions segment. The LEU segment includes sales of the SWU component of LEU, sales of both the SWU and uranium components of LEU, and sales of uranium. The technical solutions segment includes revenue and cost of sales for work that Centrus performs under the HALEU Contract. The technical solutions segment also includes limited services provided by Centrus to DOE and its contractors at the Piketon facility. Gross profit is Centrus’ measure for segment reporting. There were no intersegment sales in the periods presented.

The following table presents the Company’s segment information (in millions):
 Year Ended 
December 31,
20212020
Revenue
LEU segment:
Separative work units$163.3 $151.5 
Uranium22.8 39.0 
Total186.1 190.5 
Technical solutions segment112.2 56.7 
Total revenue$298.3 $247.2 
Segment Gross Profit (Loss)
LEU segment$73.0 $97.8 
Technical solutions segment41.5 (0.2)
Gross profit$114.5 $97.6 

The Company’s total assets are not presented for each reportable segment as they are not reviewed by, nor otherwise regularly provided to, the chief operating decision maker. Centrus’ long-term or long-lived assets, which include property, plant and equipment and other assets reported on the consolidated balance sheet, were located in the United States as of December 31, 2021, and December 31, 2020.

120
 EX-4.1 2 exhibit_4-16x20211231.htm EX-4.1 Document


CENTRUS ENERGY CORP.
DESCRIPTION OF SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934
(as of December 31, 2021)

The authorized capital stock of Centrus Energy Corp (the “Company,” “Centrus” or “us”) consists of (a) 100,000,000 shares of common stock, par value $0.10 per share, of which 70,000,000 shares are classified as Class A Common Stock, and 30,000,000 shares are classified as Class B Common Stock, and (b) 20,000,000 shares of preferred stock, par value $1.00 per share, of which 2,000,000 shares have been designated Series A Participating Cumulative Preferred Stock,. The Class A Common Stock is registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, and trades on the NYSE American platform under the symbol “LEU.”

The following description of the terms of our securities is not complete and is qualified in its entirety by reference to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), the Company’s Third Amended and Restated Bylaws (the “Bylaws”), and the Rights Agreement (as defined below), all of which are exhibits to our Annual Report on Form 10-K.

Class A Common Stock

The holders of Class A Common Stock are entitled to one vote for each outstanding share of Class A Common Stock owned by that stockholder on every matter properly submitted to the stockholders for their vote, except for any amendment for the Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock or Class B Common Stock. Generally, all matters to be voted on by stockholders, other than the election of directors, must be approved by a majority in voting power of the stock represented and entitled to vote. However, questions governed expressly by provisions of the Certificate of Incorporation, bylaws, applicable stock exchange rules or applicable law require approval as set forth in the applicable governing document, stock exchange rule or law. The holders of Class B Common Stock are entitled to elect up to two directors, which right is subject to change based on certain holding requirements. Otherwise, the directors are elected by a plurality of votes cast on the election of directors.

Subject to the rights of the holders of any series of Preferred Stock outstanding at any time, the holders of Class A Common Stock and Class B Common Stock will be entitled share ratably, based upon the number of shares held, in such dividends and other distributions of cash or any other right or property as may be declared by the Board of Directors out of the assets or funds legally available for such dividends or distributions, with sharing equally in such dividends or distributions.

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company’s affairs, holders of Class A Common Stock and Class B Common Stock would be entitled to share ratably, based upon the number of shares held, in assets that are legally available for distribution to stockholders after payment of liabilities. If there is any preferred stock outstanding at such time, holders of the preferred stock may be entitled to distribution and/or liquidation preferences.

The Certificate of Incorporation does not provide for any conversion, sinking fund, redemption, preference, preemptive right, or right of subscription for the Class A Common Stock. Issued and outstanding shares of Class B Common Stock convert into shares of Class A Common Stock upon transfer to a party other than the current Class B stockholders and their respective affiliates.

Provisions of the Company’s Certificate of Incorporation, Bylaws and Delaware Law that May Have an Anti-Takeover Effect

Certificate of Incorporation and Bylaws. The Certificate of Incorporation and Bylaws provide that a special meeting of stockholders may be called only by the Chairman, the President, the Board of Directors


or a committee empowered by the Board of Directors to call a special meeting. Stockholders are not permitted to call, or to require that the Board of Directors call, a special meeting of stockholders.

In the event that levels of foreign ownership of the Company’s stock established by the Certificate of Incorporation are exceeded, the Board of Directors has the right to take certain actions with respect to such ownership. These actions include requesting information from holders (or proposed holders) of the Company’s securities, refusing to permit the transfer of securities by such holders, suspending or limiting voting rights of such holders, redeeming or exchanging shares of the Company’s stock owned by such holders on terms set forth in the Certificate of Incorporation, and taking other actions that deemed necessary or appropriate to ensure compliance with the foreign ownership restrictions.

Delaware Takeover Statute. The Company is subject to Section 203 of the Delaware General Corporation Law (the “DGCL”), which, subject to certain exceptions, prohibits a Delaware corporation from engaging in any “business combination” (as defined below) with any “interested stockholder” (as defined below) for a period of three years following the date that such stockholder became an interested stockholder, unless: (i) prior to such date, the Board of Directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; (ii) on consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned (x) by persons who are directors and also officers and (y) by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or (iii) on or subsequent to such date, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.

Section 203 of the DGCL defines “business combination” to include: (i) any merger or consolidation involving the corporation and the interested stockholder; (ii) any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; (iii) subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; (iv) any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or (v) the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation. In general, Section 203 of the DGCL defines an “interested stockholder” as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by such entity or person.

Rights to Acquire Series A Participating Cumulative Preferred Stock

Centrus has adopted a Section 382 stockholders rights plan and declared a dividend distribution of one right for each outstanding share of our common stock to stockholders of record on April 6, 2016. Each right entitles its holder, under the circumstances described below, to purchase from us one one-thousandth of a share of our Series A Participating Cumulative Preferred Stock, par value $1.00 per share, at an exercise price of $18.00 per right, subject to adjustment. The terms of the rights are set forth in a Section 382 Rights Agreement between us, Computershare, Inc. and Computershare Trust Company, N.A., as amended (the “Rights Agreement”).

The rights plan is intended to act as a deterrent to any person or group, together with its affiliates and associates, being or becoming the beneficial owner of 4.99% or more of common stock, with certain exceptions. The rights initially trade together with the common stock and are not exercisable. In the absence of further action by the Board, the rights would generally become exercisable and allow a holder to acquire shares of a new series of the Company’s preferred stock if any person or group acquires 4.99% or more of the outstanding shares of the Company’s common stock, or if a person or group that already owns 4.99% or more of the Company’s Class A Common Stock acquires additional shares representing 0.5% or more of the outstanding shares of the Company’s Class A Common Stock. The rights beneficially


owned by the acquirer would become null and void, resulting in significant dilution in the ownership interest of such acquirer.

The Board may exempt any acquisition of the Company’s common stock from the provisions of the Rights Agreement if it determines that doing so would not jeopardize or endanger the Company’s use of its tax assets or is otherwise in the best interests of the Company. The Board also has the ability to amend or terminate the Rights Agreement prior to a triggering event. Unless earlier terminated or extended in accordance with the Rights Agreement, the rights issued under the Rights Agreement expire on April 5, 2022.


 EX-10.1 3 exhibit_10-30x20211231.htm EX-10.1 Document
EXHIBIT 10.30
THE SYMBOL “[*****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED


TENEX Contract No. 08843672/110033-051
USEC Contract No. EC-SC01-11-UE-03127
Amendment No. 010

AMENDMENT No. 010, signed as of February 11, 2022 (the “Amendment No. 010 Effective Date”), to the Enriched Product Transitional Supply Contract, TENEX Contract No. 08843672/110033-051, USEC Contract No. EC-SC01-11-UE-03127, entered into on March 23, 2011 (the "CONTRACT") by and between United States Enrichment Corporation ("USEC") and TENEX, Joint-Stock Company ("TENEX") (formerly, Joint Stock Company “TENEX” or “Techsnabexport”). USEC and TENEX are referred to herein individually as a "Party" and collectively as the "Parties". Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the CONTRACT.

    WHEREAS, the State Atomic Energy Corporation “ROSATOM” and the U.S. Commerce Department have agreed to amend the Russian Uranium Suspension Agreement (as defined in the CONTRACT) (the “2020 RSA Amendment”); and

    WHEREAS, the Parties wish to amend the CONTRACT to meet the requirements of [******] Appendix 5 of the RSA, added by the 2020 RSA Amendment and to make other conforming changes;

    NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, which the Parties acknowledge is sufficient and intending to be legally bound hereby, the Parties agree as follows, pursuant to Section 20.04 of the CONTRACT:

    SECTION 1.     For Delivery Years after 2020, references in the CONTRACT to the “U.S. Consumption Quota” available to USEC, the “Initial USEC U.S. Consumption Quota Amount”, “U.S. Consumption Quota Amounts” available to USEC, “U.S. Consumption Quota Allocation” to USEC, or similar terms shall be deemed to also refer to the “USEC Export Limit Allocation” in the 2020 RSA Amendment.

SECTION 2.    The following provisions of the CONTRACT are hereby amended:

    2.01    The phrase “Incoterms 2000”, wherever it appears in the CONTRACT, is hereby replaced with “Incoterms 2020”. For the avoidance of doubt, wherever an Incoterm appears without reference to a year, it is the Parties’ intention that the term in Incoterms 2020 be used.

    2.02    The phrases “DES USEC’s Vessel St. Petersburg” or “DES St. Petersburg, Russia”, wherever either of them appears in the CONTRACT, are hereby replaced with “DAP USEC’s Vessel St. Petersburg, Russia”.

2.03    The text of Section 1.24 of the CONTRACT is hereby replaced with the following:

“DAP USEC’s Vessel St. Petersburg, Russia:
the Incoterms 2020 term applicable to the Delivery to TENEX under the terms of this CONTRACT of (a) empty Cylinders for EUP, (b) Sample Containers, (c) Overpacks, and (d) supplies that the Parties agree pursuant to Appendix D1 are necessary for the implementation of EUP Deliveries under the CONTRACT, e.g. seals, wires, ball-lock pins, etc.”
1

EXHIBIT 10.30

2.04    The text of Section 3.02(b) of the CONTRACT is hereby replaced with the following:

“To the extent not all of the Transferable SWU quantities in Row 3 of Table 1B are ordered to be Delivered before Delivery Year 2023 (such unordered portion of the Transferable SWU quantities being defined as the “Remaining SWU”), USEC shall order the Remaining SWU quantities plus Compensatory Purchases under Section 3.02(c) (together, the “Post-2022 Quantities”) for Delivery in EUP during the period 2023 through 2028 subject to Section 3.02 (d) and the following conditions:

•*** .

•***:

◦***; or
◦***.

•***.

•In any case, the total quantities to be ordered under the CONTRACT for Delivery within the period 2023 through 2028 under this Section 3.02 shall not exceed the Post-2022 Quantities. The Parties acknowledge that the amount of the Post-2022 Quantities are determined in accordance with the CONTRACT (as in effect prior to Amendment No. 010 to the CONTRACT) and Amendment No. 010 is not intended to anyhow affect the mechanism of determination of the amount of the Post-2022 Quantities as stipulated in the CONTRACT (as in effect prior to Amendment No. 010). With respect to the Post-2022 Quantities, Amendment No. 10 is only intended to amend and clarify the terms governing the period during which the Post-2022 Quantities are to be Delivered.”`

2.05    In Section 3.02(c) and (d) of the CONTRACT, the phrase “***” is hereby replaced with ***.

2.06    In Section 6.01, the following paragraph is hereby inserted at the end of Section 6.01(c)(i):

“The Parties acknowledge that this Feed Price is used solely for administrative purposes. Because USEC Delivers Natural Uranium as UF6 to satisfy its obligation to make a Payment in Kind for the Feed Component in the EUP Delivered to USEC (including the Feed Component in the Sample Containers Delivered to USEC), the transaction between the Parties is intended by them to be a sale of SWU to USEC, with return of Natural Uranium to TENEX. No pecuniary payments are made in respect of the Feed Price.”

2.07    Section 6.02 is hereby replaced with the following:

“The SWU Component of the EUP in any Sample Containers provided to USEC pursuant to Appendix E1 shall be paid for by USEC at the unit SWU Price applicable to the sampled EUP multiplied by the quantity of SWU in the sample, including fractional SWU. USEC shall make a Payment in Kind for the Feed Component of the EUP in any Sample Containers provided to USEC pursuant to Appendix E2. USEC shall not be obligated to make a pecuniary payment or Payment in Kind for the EUP contained in Official Samples not Delivered to USEC.”

2.08    Section 7.02(a) is hereby replaced with the following:
2

EXHIBIT 10.30

“(a)    Unless otherwise Agreed, [*******]

(i)[*****]

(ii)[*****]

(iii) [*****]

(iv) [*****]

(v)    In all cases, USEC shall not be obligated to document the Related Natural Uranium in any manner that would (x) violate the RSA or any implementing instruction, such as a statement of administrative intent, or (y) impair USEC’s ability to use the USEC Export Limit, any U.S. Consumption Quota Amounts, the U.S. Reexport Quota Amounts and other authority under the RSA or the Domenici Amendment (as defined in Article 8 or other applicable U.S. law), allocated to USEC, now or in the future, under this CONTRACT or the RSA for the purposes of delivery to its Customers either for consumption in the United States of EUP containing Russian-origin SWU or for processing of such EUP and reexport from the United States.”

2.09    The text of the first paragraph of Section 8.01 is hereby replaced with the following:

“The Parties recognize that the export of EUP produced in the Russian Federation to the United States is subject to limitations under the Russian Uranium Suspension Agreement, and the import of such EUP into the United States is subject to limitations under the terms of Section 8118 of the Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 42 U.S.C. 2297h et seq. (2008), as amended by Section 2007 of the Consolidated Appropriations Act, 2021 (such provisions, the “Domenici Amendment”). The authority to export or import subject to quantitative limitations under the Russian Uranium Suspension Agreement or the Domenici Amendment are referred to herein as, respectively, “export limits” or “import quotas” and collectively, as “quotas”. The Parties shall implement and interpret this CONTRACT in compliance with the Russian Uranium Suspension Agreement and the Domenici Amendment.”

2.10    The following new Section 16.05 is hereby added to Article 16 of the CONTRACT:

“16.05    All information marked as Confidential Information shall be sent only through secure channels, or with password protection, including, but not limited to, the Notice of Delivery required in accordance with Section 5.02.”

2.11    The following new Section 18.10 is hereby added to Article 18 of the CONTRACT:

“18.10    For the avoidance of doubt, this Article 18 shall survive the expiration or termination of this CONTRACT.”

SECTION 3: The Parties further agree to the technical amendments in Attachment 1 and to replace provisions of the CONTRACT listed in Attachment 2 with the word “Reserved.”
3

EXHIBIT 10.30

SECTION 4. This Amendment No. 010 shall take effect upon signature by the Parties. Except as amended hereby, the CONTRACT, as in effect on the Amendment No. 010 Effective Date, shall remain unchanged and in full force and effect.

SECTION 5. This Amendment may be executed in multiple counterparts, which taken together will constitute an original without the necessity of both Parties signing the same page or the same physical documents, and may be executed by signatures to electronically or telephonically transmitted counterparts in lieu of original printed or photocopied documents. Signatures transmitted by facsimile or by electronic mail via a Portable Document Format (PDF) file shall be considered original signatures.

IN WITNESS WHEREOF, the Parties hereto have executed this Amendment No. 010 as of the Amendment No. 010 Effective Date.

Signed for and on behalf of
TENEX, Joint-Stock Company
Signed for and on behalf of
United States Enrichment Corporation
(signature)

(signature)

John M.A. Donelson
(name)

Senior Vice President, Sales and Chief Marketing Officer


4

EXHIBIT 10.30
Attachment 1:     Technical Amendments

In addition to the modifications of the CONTRACT made in the main text of this Amendment no. 10, the Parties agree to following additional modifications of the CONTRACT:

Applicable Provision(s) of the CONTRACTModification
Section 1.16The following is hereby deleted: [*****]
Section 1.22
The text is hereby replaced with the following:
“Delivery Year:
a calendar year in Column 1B of Table 1 or any other calendar year (i.e., a consecutive twelve month period beginning on January 1 and ending on December 31, inclusive) in which USEC has a right or obligation to purchase SWU under this CONTRACT.”
Section 1.29[*****]
Section 1.44The phrase “DES A4” is hereby replaced with “DAP A4” in Section 1.44(b).
Section 3.01The last paragraph is hereby deleted.
Section 3.02
The phrase “period 2016-2026” in the first sentence of Section 3.02 is hereby replaced with “period 2016-2028.”

In addition, the phrase “Delivery Years 2023-26” in the first sentence of Section 3.02(c) and in Section 3.02(c)(x) is hereby replaced with “Delivery Years 2023-2028”, the phrase “in Delivery Years 2023-2026” in Section 3.02(c)(y) is hereby replaced with “in Delivery Years 2023-2028”, and the phrase “or in 2027” is hereby replaced with “or in 2027, and if necessary, in 2028”.

Finally, all text of Section 3.02 after the sentence “There shall be no additional compensation in SWU owed for the deferral of such excess.” is hereby deleted.
Section 4.05[*****]
Section 4.06[*****]
Section 6.08
The phrase “or in effecting a pecuniary payment for EUP in Sample Containers” in item (a) is hereby replaced with “, including a pecuniary payment for the SWU contained in the EUP in Sample Containers”.
Section 6.10The reference to Section 6.02 is hereby deleted.
Section 7.02(c)The phrase “under Section 7.02(a), Section 7.02(b), Section 7.02(h) or Section 7.02(j)” is hereby replaced with “under Section 7.02(a) or Section 7.01(b)”.
Section 7.02(f)[*****]
Section 7.02(g)
The phrase “under Section 7.02(b), Section 7.02(c) and Section 7.02(j)” is hereby replaced with “under Section 7.02(b) and Section 7.02(c)” in three places.
Section 7.03[*****]
Section 7.04
[*****]
5

EXHIBIT 10.30
Section 7.09
The phrase “, Section 7.02(h) or Section 7.02(j)” is hereby deleted in two places
Section 7.10
The text of Section 7.10 is hereby replaced with the following:
“All Related Natural Uranium Delivered pursuant to Section 7.02 shall be Conforming Material. [*****]”
Section 11.02The phrase “TENEX is obligated to sell to USEC under Section 3.01” is hereby replaced with “TENEX is obligated to sell to USEC under Article 3”.
Paragraph B-2(b) of Appendix B
The text of Paragraph B-2(b) is hereby replaced with the following:
“The nominal quantity of EUP (in KgU) to be Delivered by TENEX, its nominal SWU Component and Feed Component pursuant to the Order and if the EUP is to be imported into the United States under the USEC Export Limits, the nominal U-235 content of the EUP;”
Paragraphs B-2(h) and B-2(j) of Appendix B
The phrase “pursuant to Section 7.02(a), Section 7.02(b), Section 7.02(c) or Section 7.02(h)” is hereby replaced with “Section 7.02(a), Section 7.02(b) or Section 7.02(c)”.
Paragraph B-2(k) and all remaining text of Paragraph B-2 thereafter prior to the sentence beginning with “For purposes of Paragraphs B-1 and B-2,”
The “and” is hereby moved from the end of Paragraph B-2(k) to the end of Paragraph B-2(l), and the following new Paragraph B-2(m) is hereby inserted after Paragraph B-2(l):

“(m)    If the ordered Enriched Product will be imported into the United States for delivery to a U.S. utility, the date of approval of the USEC contract with its U.S. Customer by the U.S. Department of Commerce.”
Paragraph E2-2[*****]
Paragraph E2-3[*****]
Paragraph E2-5[*****]
Paragraph H-7AParagraph H-7A is hereby deleted.
Paragraph H-9(a) of Appendix H[*****]
“Note” at the end of Paragraph H-9 of Appendix H,[*****]
Appendix L[*****]
Appendix M[*****]


6

EXHIBIT 10.30

Attachment 2:    Reserved Provisions

The text of the following provisions of CONTRACT shall be replaced with “Reserved.”:

Section 1.18(iii)

Section 1.35 and Section 1.44 (f) and (g)

Section 3.02(a)

Sections 3.05-3.06

Sections 4.03(d), (g) and (h)

Sections 5.07, 5.08 and 5.09

Section 6.01(d)

Sections 7.02(h), (i) and (j)

Section 7.03(a)(iii)

Section 7.03(e).

Section 7.05

Section 7.06

Appendix E3

Paragraph H-9(e)(iv) and (v) of Appendix H

Paragraphs I-1, I-2(a), I-2(b), I-2(c) and I-3 of Appendix I

Paragraph N-5(d) of Appendix N

Appendix O1 and Appendix O2
7

 EX-10.2 4 exhibit_10-50x20211231.htm EX-10.2 Document
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC
11.THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
image_0a.jpg    The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers    is extended,     is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods: (a) By completing Items 8 and 15, and returning     ___________    copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE
RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR
OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
image_1.jpg
12.ACCOUNTING AND APPROPRIATION DATA (If required)    Net Increase:    $3,491,000.00
See Schedule
image_1.jpg
13.THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
CHECK ONE
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
52.243-2 Changes
X
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
D. OTHER (Specify type of modification and authority)
image_3a.jpgis required to sign this document and return __________________ copies to the issuing office.
14.DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT1. CONTRACT ID CODE
PAGE OF PAGES
1
11
2. AMENDMENT/MODIFICATION NO.
P00014
3. EFFECTIVE DATE
See Block 16C
4. REQUISITION/PURCHASE REQ. NO.
22NE000035
5. PROJECT NO. (If applicable)
6. ISSUED BY    CODE
EM-Oak Ridge
EMCBC
U.S. Department of Energy 200 Administration Road
Oak Ridge TN 37831
893035
7. ADMINISTERED BY (If other than Item 6)    CODE
OREM
U.S. Department of Energy Oak Ridge
Office of Environmental Management
P.O. Box 2001 Oak Ridge TN 37831
03011
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
American Centrifuge Operating, LLC
Attn: Charles Kerner
6901 Rockledge Dr, Suite 800
Bethesda MD 20817
(x)
9A. AMENDMENT OF SOLICITATION NO.
9B. DATED (SEE ITEM 11)
x
10A. MODIFICATION OF CONTRACT/ORDER NO.
89303519CNE000005
10B. DATED (SEE ITEM 13)
05/31/2019
CODE 079679750
FACILITY CODE

image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC
DUNS Number: 079679750
See Page 6
Period of Performance: 05/31/2019 to 06/01/2022
Change Item 00001 to read as follows(amount shown is the total amount):
00001 Demonstrate the capability to produce HALEU with 121,409,607.00 existing US origin enrichment technology, and provide DOE with HALEU for near term use in its Continued ...
Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A. NAME AND TITLE OF SIGNER (Type or print)
16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
Karen S. Shears
15B. CONTRACTOR/OFFEROR
image_5.jpg
(Signature of person authorized to sign)
15C. DATE SIGNED
16B. UNITED STATES OF AMERICA
image_5.jpg
(Signature of Contracting Officer)
16C. DATE SIGNED
12/06/2021
Previous edition unusable    STANDARD FORM 30 (REV. 11/2016)
Prescribed by GSA FAR (48 CFR) 53.243

ITEM NO.
SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(A)
(B)
(C)(D)
(E)
(F)
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 research and development for the advancement of civilian nuclear energy and security, and other programmatic missions. Line item value is: $121,409,607.00
 Incrementally Funded Amount: $121,409,607.00
 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2013 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721004 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2010 Allottee: 30 Report Entity: 471999 Object Class: 25233 Program:
 2721004 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2014 Allottee: 30 Report Entity: 471999 Object Class: 25233 Program:
 2721004 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2015 Allottee: 30 Report Entity: 471999 Object Class: 25233 Program:
 2721004 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2016 Allottee: 30 Report Entity: 471999 Object Class: 25233 Program:
 2721004 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2017 Allottee: 30 Report Entity: 471999 Object Class: 25233 Program:
 2721004 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2019 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721004 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2019 Allottee: 30 Continued ...
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC

ITEM NO.
SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(A)
(B)
(C)(D)
(E)
(F)
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 Report Entity: 471999 Object Class: 25233
 Program: 2721004 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2020 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2020 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2020 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2020 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 89-0319 Fund: 05350 Appr Year: 2020 Allottee: 30
 Report Entity: 471999 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2021 Allottee: 60 Report Entity: 302218 Object Class: 25233 Program:
 2721019 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2021 Allottee: 60 Report Entity: 302218 Object Class: 25233 Program:
 2721019 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2021 Allottee: 60 Report Entity: 302218 Object Class: 25233 Program:
 2721019 Project: 0000000 WFO: 0000000 Local Use:
 Continued ...
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC

ITEM NO.
SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(A)
(B)
(C)(D)
(E)
(F)
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2021 Allottee: 60 Report Entity: 302218 Object Class: 25233 Program:
 2721019 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 Fund: 05350 Appr Year: 2021 Allottee: 60 Report Entity: 302218 Object Class: 25233 Program:
 2721019 Project: 0000000 WFO: 0000000 Local Use:
 0000000
 Funded: $0.00 Accounting Info:
 05350-2022-60-302218-25233-2721019-0000000-0000000
 -0000000 Fund: 05350 Appr Year: 2022 Allottee: 60
 Report Entity: 302218 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 05350-2022-60-302218-25233-2721019-0000000-0000000
 -0000000 Fund: 05350 Appr Year: 2022 Allottee: 60
 Report Entity: 302218 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $0.00 Accounting Info:
 05350-2022-60-302218-25233-2721019-0000000-0000000
 -0000000 Fund: 05350 Appr Year: 2022 Allottee: 60
 Report Entity: 302218 Object Class: 25233
 Program: 2721019 Project: 0000000 WFO: 0000000
 Local Use: 0000000
 Funded: $3,491,000.00 Payment: VIPERS
      https://vipers.doe.gov Any questions, please contact by call/email 855-384-7377 or VipersSupport@hq.doe.gov Payment: VIPERS
      https://vipers.doe.gov Any questions, please contact by call/email 855-384-7377 or VipersSupport@hq.doe.gov Continued ...
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC

ITEM NO.
SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(A)
(B)
(C)(D)
(E)
(F)
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
image_6a.jpgNAME OF OFFEROR OR CONTRACTOR
American Centrifuge Operating, LLC
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 Payment: VIPERS
      https://vipers.doe.gov Any questions, please contact by call/email 855-384-7377 or VipersSupport@hq.doe.gov Payment: VIPERS
      https://vipers.doe.gov Any questions, please contact by call/email 855-384-7377 or VipersSupport@hq.doe.gov Payment: VIPERS
      https://vipers.doe.gov Any questions, please contact by call/email 855-384-7377 or VipersSupport@hq.doe.gov Payment:
      Oak Ridge
      U.S. Department of Energy
      P.O. Box 2001 Oak Ridge TN 37831 Payment:
      Oak Ridge
      U.S. Department of Energy
      P.O. Box 2001 Oak Ridge TN 37831 Payment:
      Oak Ridge
      U.S. Department of Energy
      P.O. Box 2001 Oak Ridge TN 37831
    NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA
FAR (48 CFR) 53.110
Contract No: 89303519CNE000005
Modification P00014
Page 10 of #NUM_PAGES#
The purpose of this Change Order is to revise the description and date of Milestones 9 and 10 and delete Milestones 11-14, and define activities. A not-to-exceed amount of $3,491,000 is authorized to implement these changes and is obligated with this modification. Changes are denoted in underlining and strikethrough.
A. Section C, Project Objectives, is deleted in its entirety and changed to the following:
“Project Objectives
The objective of the HALEU Demonstration Program is to demonstrate the capability to produce HALEU with existing US origin enrichment technology and provide DOE with HALEU for near term use in its research and development for the advancement of civilian nuclear energy and security, and other programmatic missions. While DOE will retain title to the HALEU produced, DOE is amenable to make it available to the Contractor for DOE R&D purposes. Title to UF6 by-product (tails) from the HALEU enrichment process will be retained by DOE. This demonstration consists of the deployment of a 16 machine AC100M HALEU Cascade to be located at DOE’s site in Piketon, Ohio, producing a 19.75% U235 enriched product by April 1, 2022. In order to fulfill these objectives, the Project will accomplish 14 defined Milestones. The Milestones to be completed by the Contractor are:
MILESTONE 1 - Rescind the License Amendment Request (License Number SNM-7003) to the Nuclear Regulatory Commission (NRC) for removal of enrichment as an authorized activity and for downgrade of licensed activities for the Lead Cascade by July 1, 2019. This activity is considered complete when the Contractor’s letter is submitted to the NRC. (Complete June 1, 2019)
MILESTONE 2 - Re-establish required site services under the Memorandum of Agreement for the Supply of
Services (Article 6, Section 6.1 of the GCEP Lease) by January 1, 2020. (Complete June 1, 2019)
MILESTONE 3 – Award Purchase Order for machine casings by October 31, 2019. (Completed October 22, 2019)
MILESTONE 4 - Re-establish vendor supply chain(s) of materials and equipment necessary for deployment and production of unobligated HALEU by June 1, 2020. (Completed June 1, 2020)
MILESTONE 5- Re-constitute the security program to support possession of C-24 technology and assembly/installation/operation of the HALEU Cascade at the DOE leased facilities located in Piketon, Ohio by November 1, 2020.
a)Obtain Security Plan approval from NRC.
b)Modify and implement Security Plan procedures.
c)Request security clearances for new personnel.
d)“Stand up” Piketon facilities for possession of C-24 technology and assembly/installation/operation of the HALEU Cascade.
MILESTONE 6 - Deliver sub-assemblies for 16 AC100M machines (Drawing no. 1007800 Rev. 3) to the DOE leased facilities located in Piketon, Ohio:
a)Transfer title of Contractor-owned machine components to DOE by December 1, 2019 or as mutually agreed by the parties.

Contract No: 89303519CNE000005
Modification P00014
Page 11 of #NUM_PAGES#
b)Initiate delivery of sub-assemblies for 16 AC100M machines to DOE leased facilities in Piketon, Ohio by December 31, 2020.
MILESTONE 7 - Complete reconstitution of HALEU Balance of Plant (BOP) and cascade infrastructure (e.g., utilities, controls, service module) by November 1, 2021.
MILESTONE 8 – Assemble and dry 16 AC100M machines for the HALEU cascade by November
1, 2021.
MILESTONE 9 - Install 16 AC100M machines for the HALEU cascade All systems except Mass Spectrometer, Distributed Control System and Fissile Material Storage Area ready for operations by December 1, 2021 March 31, 2022.
MILESTONE 10 - Complete operational readiness for operation of the HALEU Cascade on UF6 gas by March 1, 2022. Staff qualified for operations by April 30, 2022.
MILESTONE 11 - Obtain an NRC license revision for the Combined License (COL) to support production of 19.75% U235 by March 1, 2022.
MILESTONE 12 - Initiate operation of the HALEU 16 AC100M machine cascade by March 1, 2022.
MILESTONE 13 Operate the HALEU Cascade on UF6 and produce a nominal 19.75% ± 0.24% U235 Pinch Tube or P-10 sample(s) by March 15, 2022.
MILESTONE 14 –Operate the HALEU Cascade to produce a minimum of 200 Kg UF6 HALEU and up to 600 Kg UF6 of HALEU by June 1, 2022.”
B. Section C, Program Scope, is deleted in its entirety and replaced with the following:
“Program Scope
The Program will support the following major areas of activity and any other necessary activities to complete the Objectives and Milestones described in Section C.1.1:
−
Engineering/Procurement/Construction (EPC) of the HALEU Cascade
−
Manufacturing of the AC100M Components and Subassemblies
−
Plant Support and Cascade Startup/Operations
−
Regulatory Support
−
HALEU Program Management
−
Nuclear Safety Support
Each major activity area is described separately as follows:

Contract No: 89303519CNE000005
Modification P00014
Page 12 of #NUM_PAGES#
C.1 Engineering/Procurement/Construction (EPC) of the HALEU Cascade
EPC activities will include all the engineering, procurement and construction associated with reconstituting the Balance of Plant (BOP) and cascade components and systems to support the HALEU Cascade at Piketon, Ohio, including the vacuum, air, chilled water, and electrical systems and associated instrumentation and controls; the emergency power system; the distributed control system; the feed and withdrawal modules; the mass spectrometer, and the service module. Included also, are CTTF refurbishment; vent monitoring and centrifuge conditioning systems; and physical security modifications. Construction commissioning and Integrated System Test support is included. Also included is Program management of the EPC activities. Additional activities to be performed include:
•Complete punch list items found during integrated systems testing
•Complete the demobilization of work crews associated with HALEU systems construction/installation
•Complete modification process to the point of systems turnover to operations IAW ACD2-EG-
003, Nuclear & Commercial Modification Controls
C.2 Manufacturing (AC100M Components and Subassemblies)
Manufacturing activities will include all associated procurement and manufacturing of machine parts, components and subassemblies of the AC100M machines for the HALEU cascade, including the machine controls, upper and lower suspension, column, casing, and rotors (including balancing). Transportation of the manufactured items to Piketon, Ohio is included as well as program management of the Manufacturing activities.
C.3 Plant Support and Cascade Startup/Operations
Plant Support activities include all preparation of the facility for installation of the HALEU 16machine cascade, assembly and drying of the AC100M centrifuges, and installation and tie-ins of the machines to complete the HALEU cascade configuration. Cascade Startup/Operation activities include the Internal Readiness Review, and the Operational Readiness Review. cascade startup and operation (including maintenance), and production of the nominal 19.75% U235 sample, a minimum of 200 Kg UF6 HALEU and up to 600 Kg UF6 HALEU. Maintain and operate Balance of Plant (BOP) facilities. Also included is program management of the activities. Additional activities include: •      Assist engineering with integrated systems testing and final modification items for turnover
•Modify procedures for operation of the cascade
•Develop/modify training and qualification materials for the qualification of minimum staffing for cascade operations
•Implement maintenance program for upkeep of turned over systems and begin maintenance schedule in accordance with recommended maintenance intervals determined by engineering
•Implement surveillance program for upkeep of IROFS and begin surveillance schedule in accordance with periodicity intervals determined by engineering.
•Centrifuges will remain in the drying station for the remainder of the Contract.

Contract No: 89303519CNE000005
Modification P00014
Page 13 of #NUM_PAGES#
C.4 Regulatory Support
Regulatory Support activities include NRC licensing, safeguards and security, and permitting. Also included is program management of the activities. Activities to be continued include:
•Complete licensing actions to support systems Ready for Operations (except Mass Spectrometer, Distributed Control System and FMSA).
•Perform necessary licensing work to upkeep both the Lead Cascade License and Commercial Plant License and all license driven programs, procedures, and processes.
C.5 HALEU Program Management
Program Management will provide overall project direction of all activities and participants and management of the project including establishing a project Work Breakdown Structure (WBS) and baseline against which, performance will be measured using an earned value management system. The Contractor shall develop and provide a WBS that aligns with Contractor activities sequencing and execution of the HALEU Demonstration Program. Also, the Contractor shall develop and provide an integrated logic driven critical path schedule reflecting the WBS and which identifies contract milestones and deliverables. Formal status reports and meetings will be provided and held monthly with DOE to report and discuss schedule progress, milestone performance, cost performance, any variances, any concerns, and to identify action items. The Contractor will develop an agenda for these meetings and submit it to DOE at least seven (7) calendar days prior to the meeting. The formal status report is to be submitted at least three (3) business days prior to the meeting. The meeting date and the location will be mutually agreed upon between the Contractor and DOE. In addition, reports will be prepared and submitted to DOE to provide evidence of completion of project milestones. In addition, a weekly highlights report shall be provided electronically. Ad hoc meetings or conversations with DOE outside any formal meetings are to be utilized in a timely manner to identify and address any potential problems and concerns. Program Management will conduct activities that reduce overall risk to the program and assure a robust quality assurance program is implemented across the program.
C.6 Nuclear Safety Support
The Nuclear Safety Support involves the work related to the restoration of Piketon nuclear safety/nuclear criticality safety programs and processes. This includes the revision of parts of the Integrated Safety Analysis Summary (ISA) and Addendum 1, ISA supporting documentation, and nuclear criticality safety analysis and associated documentation. Also included is program management of the activities. Additional activities include:
•Complete Implementation of Nuclear Safety IROFS associated with ISAS and NCSEs to support systems Ready for Operations (except Mass Spectrometer, Distributed Control System and FMSA) and Staff Qualified for Operations.
•Complete documentation closeout activities associated with passive, active, and administrative
IROFS flowdown
•Perform license driven NCS and ISA functions

Contract No: 89303519CNE000005
Modification P00014
Page 14 of #NUM_PAGES#
American Centrifuge Operating, LLC (ACO) utilizes a fully integrated Earned Value Management System (EVMS) in the execution of capital projects. ANSI/EIA-748-B Earned Value Management Systems and the GAO Cost Estimating and Assessment Guide serve as the basis for the ACO EVM System. The system includes: Primavera P6 as the scheduling platform, Project Management Cost Processor (PMCP) as the cost processing, reporting and change control platform, Primavera Risk as the probabilistic risk analysis platform, and Oracle as the corporate financial system.
Major components of the system include:
•Integrated scope, cost and schedule Performance Measurement Baselines (PMB)
•Critical Path Methodology (CPM) used in evaluating schedule performance
•Probabilistic Risk Assessment (PRA) used in calculating project risks
•Formal change control process for both baselines and forecasts
•Monthly re-forecasting of project TEC and schedule
The EVM System and Project Controls are implemented and controlled at the corporate level of ACO and Centrus Energy Corp. ensuring continuity and consistency of its application across all projects in the Contractor’s project portfolio.”
C.Clause F.1 is deleted in its entirety and replaced with the following:
“F.1 DOE-F-1001 Delivery Schedule
The Government requires delivery to be made according to the following schedule:

Contract No: 89303519CNE000005
Modification P00014
Page 15 of #NUM_PAGES#
MILESTONE
Title
Date
00001Rescind the NRC Lead Cascade License Amendment
July 1, 2019
00002Reestablish Site Services to support the HALEU Program at Piketon
January 1. 2020
00003aAward Sub-Contract to Procure Machine Casings
October 31, 2019
00003bReceive all Machine Casings
September 1, 2020
00004
Reestablish the Vendor Supply Chain to Support the
HALEU Program
June 1, 2020
00005a,b,c,dReconstitute the Security Program for the Piketon Facilities
November 1, 2020
00006aTransfer Title of Contractor-Owned Machine Components to DOE
December 1, 2019 or mutually agreed upon date
00006bInitiate delivery of AC100M Subassemblies to Piketon
December 31, 2020
00007Complete Reconstitution of HALEU BOP and Cascade Infrastructure
November 1, 2021
00008Assemble and Dry 16 AC100M Machines
November 1, 2021
00009
Install 16 AC100M Machine in the HALEU Cascade All systems except mass spectrometer, Distributed Control System and Fissile Material Storage Area ready for operations.
December 1, 2021 March 31, 2022
00010
Complete Operational Readiness for the HALEU Cascade
Staff qualified for operations
March 1,2022 April 30, 2022
00011
Obtain NRC License Revision for COL
March 1, 2022
00012
Initiate Operation of the HALEU Cascade
March 1, 2022
00013
Operate the HALEU Cascade and Produce 19.75% Sample
By March 15, 2022
00014
Operate the HALEU Cascade and Produce a minimum of 200 Kg of UF6 HALEU and up to 600 Kg UF6 HALEU.
By June 1, 2022”
D.In accordance with Section H Clause, DOE-H-2061 Change Order Accounting (OCT 2014), DOE requires separate accounting for the incurred costs for this effort.
E.This modification will be definitized before May 22, 2022. If agreement on a definitive modification is not reached by the target date, or within any extension of it granted by the Contracting Officer, the Contracting Officer may, with the approval of the Head of Contracting Activity, determine a reasonable price or fee in accordance with Subpart 15.4 and Part 31 of the FAR, subject to Contractor appeal as provided in the Disputes clause.
The following definitization schedule applies:
    
    Action                         Date

Contract No: 89303519CNE000005 Modification P00014
Page 11 of 11
    Contractor proposal received               January 3, 2022
    Commence negotiations               April 1, 2022 Complete negotiations               May 2, 2022
Certificate of current cost or pricing May 4, 2022 data received
    Execute modification                    May 20, 2022

EX-21 5 exhibit21-listofsubsidiari.htm EX-21 Document

EXHIBIT 21



SUBSIDIARIES OF CENTRUS ENERGY CORP.


Name of SubsidiaryState of Incorporation
United States Enrichment CorporationDelaware
American Centrifuge Operating LLCDelaware


 EX-23.1 6 exhibit_23-1x20211231.htm EX-23.1 Document

EXHIBIT 23.1



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-239242) and Form S-8 (Nos. 333-257628, 333-218536, 333-200439) of Centrus Energy Corp. of our report dated March 11, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP

Baltimore, Maryland
March 11, 2022


EX-31.1 7 exhibit_31-1x20211231.htm EX-31.1 Document

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 
I, Daniel B. Poneman, certify that:
 
1.I have reviewed this annual report on Form 10-K of Centrus Energy Corp.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.     The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
March 11, 2022/s/ Daniel B. Poneman
 Daniel B. Poneman
 President and Chief Executive Officer


 EX-31.2 8 exhibit_31-2x20211231.htm EX-31.2 Document

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 
I, Philip O. Strawbridge, certify that:
 
1.I have reviewed this annual report on Form 10-K of Centrus Energy Corp.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
March 11, 2022/s/ Philip O. Strawbridge
 Philip O. Strawbridge
 Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer


 EX-32.1 9 exhibit_32-1x20211231.htm EX-32.1 Document

EXHIBIT 32.1


CERTIFICATION OF CEO AND CFO PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K of Centrus Energy Corp. for the period ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), pursuant to 18 U.S.C. § 1350, Daniel B. Poneman, President and Chief Executive Officer, and Philip O. Strawbridge, Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer, each hereby certifies, that, to his knowledge:

(1)       The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)       The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Centrus Energy Corp.




March 11, 2022/s/ Daniel B. Poneman
 Daniel B. Poneman
 President and Chief Executive Officer


March 11, 2022/s/ Philip O. Strawbridge
 Philip O. Strawbridge
 Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer


 EX-101.SCH 10 leu-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0002002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 1001003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 1004006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1005007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2104102 - Disclosure - Revenue and Contracts with Customers link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Revenue and Contracts with Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Revenue and Contracts with Customers (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Revenue and Contracts with Customers (Revenue from External Customers by Geographic Areas) (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Revenue and Contracts with Customers (Contract with Customer Asset and Liability) (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Revenue and Contracts with Customers Accounts Receivable (Schedule of Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 2110103 - Disclosure - Cash, Cash Equivalents and Restricted Cash link:presentationLink link:calculationLink link:definitionLink 2311302 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Schedule of Restricted Cash) (Details) link:presentationLink link:calculationLink link:definitionLink 2114104 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2315303 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2416408 - Disclosure - Inventories (Schedule of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Inventories (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2118105 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2319304 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - Property, Plant and Equipment (Tables) (Details) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - Property, Plant and Equipment (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2122106 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2323305 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2424412 - Disclosure - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2425413 - Disclosure - Intangible Assets Schedule of Intangible Asset Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 2126107 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 2327306 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2428414 - Disclosure - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2129108 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2330307 - Disclosure - Debt Schedule of Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2431415 - Disclosure - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2432416 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2133109 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2334308 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2435417 - Disclosure - Leases (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2436418 - Disclosure - Maturity of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2137110 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2338309 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2439419 - Disclosure - Fair Value Measurements (Financial Instruments Recorded at Fair Value) (Details) link:presentationLink link:calculationLink link:definitionLink 2440420 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2141111 - Disclosure - Pension and Postretirement Health and Life Benefits link:presentationLink link:calculationLink link:definitionLink 2342310 - Disclosure - Pension and Postretirement Health and Life Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 2443421 - Disclosure - Pension and Postretirement Health and Life Benefits (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2444422 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Changes in Projected Benefit Obligations) (Details) link:presentationLink link:calculationLink link:definitionLink 2445423 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Net Benefit Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2446424 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 2447425 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Assumptions Used) (Details) link:presentationLink link:calculationLink link:definitionLink 2448426 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Healthcare Cost Trend Rates) (Details) link:presentationLink link:calculationLink link:definitionLink 2449427 - Disclosure - Pension and Postretirement Health and Life Benefits (Plan Asset Allocations) (Details) link:presentationLink link:calculationLink link:definitionLink 2450428 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Fair Value of Plan Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2451429 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Estimated Future Benefit Payments) (Details) link:presentationLink link:calculationLink link:definitionLink 2152112 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2353311 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2454430 - Disclosure - Stock-Based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2455431 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2456432 - Disclosure - Stock-Based Compensation Stock-Based Compensation (Assumptions Used in the Black-Scholes Option Pricing Model) (Details) link:presentationLink link:calculationLink link:definitionLink 2457433 - Disclosure - Stock-Based Compensation Costs, Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 2458434 - Disclosure - Stock-Based Compensation (Options) (Details) link:presentationLink link:calculationLink link:definitionLink 2459435 - Disclosure - Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price (Details) link:presentationLink link:calculationLink link:definitionLink 2160113 - Disclosure - Compensation Related Costs, Share Based Payments link:presentationLink link:calculationLink link:definitionLink 2361312 - Disclosure - Compensation Related Costs, Share Based Payments (Tables) link:presentationLink link:calculationLink link:definitionLink 2462436 - Disclosure - Compensation Related Costs, Share Based Payments (Details) link:presentationLink link:calculationLink link:definitionLink 2163114 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2364313 - Disclosure - Income Taxes Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2465437 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2466438 - Disclosure - Income Taxes (Taxes by Jurisdiction) (Details) link:presentationLink link:calculationLink link:definitionLink 2467439 - Disclosure - Income Taxes (Deferred Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2468440 - Disclosure - Income Taxes (Rate Reconciliation) (Details) link:presentationLink link:calculationLink link:definitionLink 2469441 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details) link:presentationLink link:calculationLink link:definitionLink 2170115 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 2371314 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2472442 - Disclosure - Net Income Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2473443 - Disclosure - Net Income Per Share (Schedule of Income Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2174116 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2375315 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2476444 - Disclosure - Stockholders' Equity (Tables) (Details) link:presentationLink link:calculationLink link:definitionLink 2477445 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2178117 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2479446 - Disclosure - Commitment and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2180118 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2181119 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2382316 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2483447 - Disclosure - Revenue by Geographic Area (Details) link:presentationLink link:calculationLink link:definitionLink 2484448 - Disclosure - Segment Information (Segment Reporting Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2485449 - Disclosure - Segment Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 leu-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 leu-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 leu-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Supplemental Cash Flow Information: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Retirement benefit plans (gains) losses, net Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Repayment of borrowed SWU inventory [Member] Repayment of borrowed SWU inventory [Member] Repayment of borrowed SWU inventory Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Leasehold Improvements [Member] Leasehold Improvements [Member] Net income (loss) Net income Net Income (Loss) Attributable to Parent Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Pension and Other Postretirement Plans, Policy [Policy Text Block] Pension and Other Postretirement Plans, Policy [Policy Text Block] Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding Deferred Tax Assets, Net Operating Loss and Credit Carryforwards Deferred Tax Assets, Operating Loss Carryforwards Accounts Payable and Accrued Liabilities [Abstract] Accounts Payable and Accrued Liabilities [Abstract] Defined Benefit Plan, Interest Cost Interest costs Defined Benefit Plan, Interest Cost Income Statement Location [Axis] Income Statement Location [Axis] Accumulated intangible asset amortization Finite-Lived Intangible Assets, Accumulated Amortization Receivable Type [Axis] Receivable Type [Axis] Range [Domain] Statistical Measurement [Domain] Deferred compensation asset Cash Surrender Value, Fair Value Disclosure Segment Reporting, Policy [Policy Text Block] Segment Reporting, Policy [Policy Text Block] Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Proceeds from Sale of Property, Plant, and Equipment Proceeds from Sale of Property, Plant, and Equipment Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Contract with Customer, Asset and Liability Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions Restructuring Type [Axis] Restructuring Type [Axis] Stock Issued During Period, Value, Gross Stock Issued During Period, Value, Gross Stock Issued During Period, Value, Gross Employee Restricted Stock Units [Member] Employee Restricted Stock Units [Member] Employee Restricted Stock Units Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Other long-term assets Other Assets, Noncurrent Common Stock Ownership Enabling Preferred Stock Purchase Rights Common Stock Ownership Enabling Preferred Stock Purchase Rights Common Stock Ownership Enabling Preferred Stock Purchase Rights Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Expected return on plan assets (gains) Defined Benefit Plan, Expected Return (Loss) on Plan Assets Segments [Axis] Segments [Axis] Contract Termination [Member] Contract Termination [Member] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Retirement Benefits [Abstract] Retirement Benefits [Abstract] Decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Dominion Energy South Carolina Dominion Energy South Carolina [Member] Dominion Energy South Carolina Entity File Number Entity File Number Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Intangible Assets Class of Financing Receivable, Type [Axis] Class of Financing Receivable [Axis] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Pension plan assets transferred for annuitization Pension plan assets transferred for annuitization Pension plan assets transferred for annuitization Sale proceeds included in accounts receivable Sale proceeds included in accounts receivable Sale proceeds included in accounts receivable Options with exercise price greater than market price Options with exercise price greater than market price Options with exercise price greater than market price Amortization of intangible assets Amortization of Intangible Assets Deferred Tax Assets, Net, Current Deferred Tax Assets, Net Deferred Tax Assets, Employee Benefits Costs Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Discount Rate, Percent Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Contract with Customer, Liability, Revenue Recognized Contract with Customer, Liability, Revenue Recognized Operating Lease, Liability, Increase Operating Lease, Liability, Increase Operating Lease, Liability, Increase Other comprehensive income, net of tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Deferred revenue and customer advances – increase (decrease) Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits Industry Sector [Axis] Industry Sector [Axis] Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Board Restricted Stock Units [Member] Board Restricted Stock Units [Member] Board Restricted Stock Units Equity Award [Domain] Award Type [Domain] Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Exercise Price Range [Axis] Exercise Price Range [Axis] Local Phone Number Local Phone Number ASSETS Assets [Abstract] Subsegments [Axis] Subsegments [Axis] Actuarial (gains) losses, net Defined Benefit Plan, Amortization of Gain (Loss) Land [Member] Land [Member] Intangible Assets, Policy [Policy Text Block] Goodwill and Intangible Assets, Policy [Policy Text Block] Municipal bonds and non-U.S. government securities [Member] US States and Political Subdivisions Debt Securities [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Revenue Concentration Risk, Percentage Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Class of Financing Receivable, Type [Domain] Class of Financing Receivable [Domain] Preferred stock Preferred Stock, Value, Issued Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Loss on plan changes resulting from legal settlement Defined Benefit Plan, Other Cost (Credit) Technical Solutions Segment [Member] Technical Solutions Segment [Member] Technical Solutions Segment Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Accumulated Deficit [Member] Retained Earnings [Member] Audit Information [Abstract] Audit Information [Abstract] Debt Instrument [Axis] Debt Instrument [Axis] Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Subordination to credit facility, facility total Subordination to credit facility, facility total Subordination to credit facility, facility total Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Debt Securities [Member] Debt Securities [Member] Deferred revenue and advances from customers Deferred Revenue and Credits, Current Advances from customers, noncurrent, change Advances from customers, noncurrent, change Advances from customers, noncurrent, change Revenue from first customer over 10 percent Revenue from first customer over 10 percent Revenue from first customer over 10 percent Amortization of prior service costs (credits), net Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Subordination to credit facility, facility maximum net borrowing Subordination to credit facility, facility maximum net borrowing Subordination to credit facility, facility maximum net borrowing Stock Repurchased and Retired During Period, Value Stock Repurchased and Retired During Period, Value Accounts receivable – (increase) decrease Increase (Decrease) in Accounts Receivable Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Reclassification of stock-based compensation from liability to equity Reclassification of stock-based compensation from liability to equity Reclassification of stock-based compensation from liability to equity Other Significant Noncash Transaction, Value of Consideration Received Other Significant Noncash Transaction, Value of Consideration Received Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Tax Period [Domain] Tax Period [Domain] Company paid [Member] Company paid [Member] Paid from Company assets Retirement Benefits, Description [Abstract] Retirement Benefits, Description [Abstract] Sale price assets and property, net Sale price assets and property, net Sale price assets and property, net of auction fees and other costs Deferred Tax Asset, Lease Liability Deferred Tax Asset, Lease Liability Deferred Tax Asset, Lease Liability Summary of Significant Accounting Policies [Abstract] Summary of Significant Accounting Policies [Abstract] Summary of Significant Accounting Policies [Abstract] Net income (loss) per common share - basic Earnings Per Share, Basic Operating Lease, Expense Operating Lease, Expense US government securities [Member] US Treasury and Government [Member] Intangible Assets Disclosure [Abstract] Intangible Assets Disclosure [Abstract] Intangible Assets Disclosure [Abstract] Lessee, Operating Lease, Liability, Payments, Due Year Three Lessee, Operating Lease, Liability, to be Paid, Year Three Revenue from Contract with Customer Revenue from Contract with Customer [Text Block] Finite-Lived Intangible Assets, Amortization Expense, after Year Five Finite-Lived Intangible Asset, Expected Amortization, after Year Five Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Inventories, net Inventory net of Liability Inventory net of Liability Interest expense Interest Expense, Debt Stock or Unit Option Plan Expense Stock or Unit Option Plan Expense Defined Contribution Plan, Cost Defined Contribution Plan, Cost Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Pension benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Accrued loss on long-term contract Gain (Loss) on Contract Termination Postretirement health and life benefit obligations - current Liability, Pension and Other Postretirement and Postemployment Benefits, Current Deferred Tax Liabilities Deferred Tax Liabilities, Net Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Operating Lease, Payments Operating Lease, Payments Stock-based compensation paid in cash Stock-based compensation paid in cash Stock-based compensation paid in cash Preferred Stock, Dividend Rate, Percentage Preferred Stock, Dividend Rate, Percentage Payment in Kind (PIK) Note [Member] Payment in Kind (PIK) Note [Member] Advanced Technology Costs, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Cancellation of debt income for tax Cancellation of debt income for tax Cancellation of debt income for tax Class of Financing Receivable, Type of Borrower [Axis] Type of Borrower [Axis] Industry of Counterparty, Type [Axis] Industry of Counterparty, Type [Axis] Tax Year 2018 [Member] Tax Year 2018 [Member] Long-term debt, carrying amount Long-term Debt, Gross Entity Voluntary Filers Entity Voluntary Filers Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Belgium BELGIUM Stock Appreciation Rights Expense Stock Appreciation Rights Expense Stock Appreciation Rights Expense Long-term debt Long-term Debt Financing Receivable Portfolio Segment [Axis] Financing Receivable Portfolio Segment [Axis] Preferred stock dividend condition - minimum free cash flow preceding four quarters Preferred stock dividend condition - minimum free cash flow preceing four quarters Preferred stock dividend condition - minimum free cash flow preceding four quarters Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Cash Flows Provided by Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Provision for loss on contracts total Provision for loss Provision for loss Related Party Transaction, Description of Transaction Related Party Transaction, Description of Transaction Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Conversion of Stock, Shares Converted Conversion of Stock, Shares Converted Conversion of Stock, Shares Converted Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Total Liabilities and Stockholders’ Equity (Deficit) Liabilities and Equity Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other accrued liabilities Other Accrued Liabilities, Current Deferred revenue and advances from customers Contract with Customer, Liability, Current Lessee, Operating Lease, Liability, Payments, Due Year Five Lessee, Operating Lease, Liability, to be Paid, Year Five Deferred Revenue and Advances from Customers - Current and Noncurrent Deferred Revenue and Advances from Customers - Current and Noncurrent Deferred Revenue and Advances from Customers - Current and Noncurrent Scenario [Axis] Scenario [Axis] Defined Benefit Plan, Benefit Obligation, Increase for Plan Amendment Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Other Significant Noncash Transaction, Value of Consideration Given Other Significant Noncash Transaction, Value of Consideration Given Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Service [Member] Service [Member] Defined Benefit Plan, Plan Assets, Benefits Paid Defined Benefit Plan, Plan Assets, Benefits Paid Separative work units inventory Separative work units inventory Carrying amount as of the balance sheet date of separative work unit ("SWU") inventory. SWU is held as the SWU component of low enriched uranium. A SWU is the standard measure of uranium enrichment using a standard formula derived from the physics of enrichment. SWU costs are based on production costs and purchase costs. SWU inventory is valued at the lower of cost or market. Excess of capital over par value Additional Paid in Capital Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment Consolidated Balance Sheet [Abstract] Consolidated Balance Sheet [Abstract] Consolidated Balance Sheet [Abstract] Energy Harbor Nuclear Corporation Energy Harbor Nuclear Corporation [Member] Energy Harbor Nuclear Corporation LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Liabilities and Equity [Abstract] Stock Issued During Period, Value, Net Stock Issued During Period, Value, Net Stock Issued During Period, Value, Net Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Provision for loss on contracts utilized Provision for loss on contracts utilized Provision for loss on contracts utilized Accounts payable and accrued liabilities Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net Income (Loss) Per Share Earnings Per Share [Text Block] Entity Interactive Data Current Entity Interactive Data Current Option Indexed to Issuer's Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Finite-Lived Intangible Assets, Amortization Expense, Year Four Finite-Lived Intangible Asset, Expected Amortization, Year Four Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Defined Benefit Plan, Expected Future Benefit Payment, Year Two Defined Benefit Plan, Expected Future Benefit Payment, Year Two Minimum [Member] Minimum [Member] Other, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Liability for Uncertain Tax Positions, Noncurrent Liability for Uncertainty in Income Taxes, Noncurrent Gross profit (loss) Gross Profit Gross Profit Lessee, Operating Lease, Liability, Payments, Due Year Two Lessee, Operating Lease, Liability, to be Paid, Year Two Uranium inventory Uranium Inventory Carrying amount as of the balance sheet date of uranium inventory. Uranium is held in the form of natural uranium and as the uranium component of low enriched uranium. Uranium inventory is valued at the lower of cost or market. Deferred Tax Assets, Other Deferred Tax Assets, Tax Deferred Expense, Other Schedule of Stock by Class [Table Text Block] Schedule of Stock by Class [Table Text Block] Selling, general and administrative Selling, General and Administrative Expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Deferred Tax Assets, Gross Deferred Tax Assets, Gross Income Tax Authority [Domain] Income Tax Authority [Domain] Cash and Cash Equivalents Disclosure Cash and Cash Equivalents Disclosure [Text Block] Foreign Foreign [Member] Foreign [Member] Foreign [Member] Claim filed, unrecorded gain contingency, Gain Contingency, Unrecorded Amount Nonoperating components of net periodic benefit expense (income) Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Address, State or Province Entity Address, State or Province Deferred tax assets, net Deferred Income Tax Assets, Net Current Liabilities Liabilities, Current [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Receivable [Domain] Receivable [Domain] Company cost share portion Company cost share portion Anticipated company cost share portion of new government contract Stock issued during period Stock Issued During Period, Value, New Issues Operating Loss Carryforwards, Valuation Allowance Operating Loss Carryforwards, Valuation Allowance Restricted cash included in other long-term assets Restricted Cash and Cash Equivalents, Noncurrent Revenue Recognition, Policy Revenue [Policy Text Block] Schedule of Notional Stock Units, Activity [Table Text Block] Schedule of Notional Stock Units, Activity [Table Text Block] Schedule of Notional Stock Units, Activity Preferred stock dividend condition - minimum pension funding Preferred stock dividend condition - minimum pension funding Preferred stock dividend condition - minimum pension funding Debt Debt Disclosure [Text Block] Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Other financial assurance [Member] Other financial assurance [Member] Other financial assurance [Member] Stock-Based Compensation Share-based Payment Arrangement [Text Block] Senior Notes [Member] Senior Notes [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Inventories Inventory Disclosure [Text Block] Equity Securities [Member] Equity Securities [Member] Defined Benefit Plan, Expected Future Benefit Payment, Year Four Defined Benefit Plan, Expected Future Benefit Payment, Year Four Payments of Stock Issuance Costs Payments of Stock Issuance Costs Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues Valuation Allowance, Deferred Tax Asset, Explanation of Change Valuation Allowance, Deferred Tax Asset, Explanation of Change Deferred revenue, net of deferred costs – increase (decrease) Increase Decrease in Deferred Revenue, Net of Deferred Costs Increase Decrease in Deferred Revenue, Net of Deferred Costs Other Foreign Other Foreign [Member] Other Foreign [Member] Operating Lease, Liability Operating Lease, Liability Effective Income Tax Rate Reconciliation, Interest Expense, Percent Effective Income Tax Rate Reconciliation, Deduction, Other, Percent Document Transition Report Document Transition Report Common stock Common Stock, Value, Issued Preferred Stock Dividends and Other Adjustments Preferred Stock Dividends and Other Adjustments Inventory, Net [Abstract] Inventory, Net [Abstract] Weighted-average period in years of costs to be recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Customer Concentration Risk Customer Concentration Risk [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Basis of Accounting, Policy [Policy Text Block] Basis of Accounting, Policy [Policy Text Block] Other Postretirement Benefits Plan [Member] Postretirement Health and Life Benefits Plans [Member] Other Postretirement Benefits Plan [Member] Commitments and contingencies (Note 11) Commitments and Contingencies Lessee, Operating Leases [Text Block] Lessee, Operating Leases [Text Block] Separative work units net of liability Separative work units net of liability Separative work units inventory net of liability Accumulated other comprehensive income (loss), net of tax Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Inventory write-down Inventory Write-down Defined Benefit Plan, Funded (Unfunded) Status of Plan Defined Benefit Plan, Funded (Unfunded) Status of Plan Uranium owed to customers and suppliers Uranium owed to customers and suppliers Uranium owed to customers and suppliers Stock Repurchase Price per Share Stock Repurchase Price per Share Stock Repurchase Price per Share ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Retirement Plan Tax Status [Domain] Retirement Plan Tax Status [Domain] Legal Entity [Axis] Legal Entity [Axis] Auditor Name Auditor Name Cover [Abstract] Cover [Abstract] Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Deferred Tax Assets, Accrued Expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Debt, long-term and short-term, combined carrying value Debt, Long-term and Short-term, Combined Amount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Summary of Income Tax Contingencies [Table Text Block] Summary of Income Tax Contingencies [Table Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] Unbilled Receivables, Current Unbilled Receivables, Current Other Significant Noncash Transaction, Name [Domain] Other Significant Noncash Transaction, Name [Domain] Deferred revenue, revenue recognized Deferred Revenue, Revenue Recognized Other current assets Prepaid Expense and Other Assets, Current Preferred Series B [Member] Preferred Class B [Member] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Gross Proceeds from Issuance of Common Stock Gross Proceeds from Issuance of Common Stock Gross Proceeds from Issuance of Common Stock Financial Instrument [Axis] Financial Instrument [Axis] Entity [Domain] Entity [Domain] Total revenue Revenue Revenue from Contract with Customer, Excluding Assessed Tax Income Tax Examination, Penalties and Interest Accrued Income Tax Examination, Penalties and Interest Accrued Preferred stock dividend condition - minimum net income preceding quarter Preferred stock dividend condition - minimum net income preceding quarter Preferred stock dividend condition - minimum net income preceding quarter Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Proceeds from Customers Proceeds from Customers Uranium [Member] Uranium [Member] Uranium [Member] - Natural uranium or the uranium component of Low Enriched Uranium (LEU). Government cost obligation Government cost obligation Government cost obligation on contract Workers compensation financial assurance [Member] Workers compensation financial assurance [Member] Workers compensation financial assurance [Member] Employee Stock Option [Member] Share-based Payment Arrangement, Option [Member] Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Disclosure Items [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Deferred Tax Assets, Property, Plant and Equipment Deferred Tax Assets, Property, Plant and Equipment Separative work units repaid in period, value Separative work units repaid in period, value Separative work units repaid in period, value Common Stock [Member] Common Stock [Member] Investment income Investment Income, Interest Variable Rate [Axis] Variable Rate [Axis] Segment Information Segment Reporting Disclosure [Text Block] Transaction costs Professional Fees Operating income (loss) Operating Income (Loss) Defined Benefit Plan, Benefit Obligation, Administrative Expenses Paid Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Operating Lease, Liability, Current Operating Lease, Liability, Current Finite-Lived Intangible Assets, Amortization Expense, Year Two Finite-Lived Intangible Asset, Expected Amortization, Year Two Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Document Fiscal Year Focus Document Fiscal Year Focus Plan paid [Member] Plan paid [Member] Paid from Plan Assets Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Shares for Cancelled or Forfeited Awards Shares for Cancelled or Forfeited Awards Shares for Cancelled or Forfeited Awards Variable Rate [Domain] Variable Rate [Domain] Excess of Capital over Par Value [Member] Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation Depreciation Depreciation Payment of interest classified as debt Repayments of Debt Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Litigation settlement, amount awarded from other party Litigation Settlement, Amount Awarded from Other Party Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Increase (Decrease) in Deferred Income Taxes Increase (Decrease) in Deferred Income Taxes Preferred stock, liquidation preference per share Preferred Stock, Liquidation Preference Per Share Preferred Stock, Liquidation Preference Per Share Uranium inventory net of liability Uranium inventory net of liability Uranium inventory net of liability Collateral [Domain] Collateral Held [Domain] Separative Work Units [Member] Separative Work Units [Member] Separative Work Units (SWU) [Member] - SWU is a standard unit of measurement that represents the effort required to transform a given amount of natural uranium into two components: enriched uranium having a higher percentage of the uranium-235 isotope (“U235”) and depleted uranium having a lower percentage of U235. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment deemed to be contained in LEU under this formula is commonly referred to as its SWU component and the quantity of natural uranium used in the production of LEU under this formula is referred to as its uranium component. Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Government cost share portion Government cost share portion Anticipated government cost share portion of new contract Defined Benefit Plan, Lump Sum Benefits Paid Defined Benefit Plan, Lump Sum Benefits Paid Defined Benefit Plan, Lump Sum Benefits Paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Long-term debt, fair value Long-term Debt, Fair Value Stock Repurchased and Retired During Period, Shares Stock Repurchased and Retired During Period, Shares Stock Repurchased and Retired During Period, Shares Industry Sector [Domain] Industry Sector [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment Common stock and warrant issued in exchange for preferred stock [Member] Common stock and warrant issued in exchange for preferred stock [Member] Common stock and warrant issued in exchange for preferred stock Defined Benefit Plan, Plan Assets, Contributions by Employer Defined Benefit Plan, Plan Assets, Contributions by Employer Defined Benefit Plan, Accumulated Benefit Obligation Defined Benefit Plan, Accumulated Benefit Obligation Maximum [Member] Maximum [Member] Preferred stock dividends, undeclared and cumulative Preferred Stock Dividends, Income Statement Impact Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Total liabilities Liabilities Operating Loss Carryforwards, No Expiration Operating Loss Carryforwards, No Expiration Operating Loss Carryforwards, No Expiration Japan JAPAN Award Type [Axis] Award Type [Axis] Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Finite-Lived Intangible Asset, Expected Amortization, Year One Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Cash Flows Used in Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Lessee, Operating Lease, Liability, Maturity [Table Text Block] Lessee, Operating Lease, Liability, Maturity [Table Text Block] Consolidation Items [Axis] Consolidation Items [Axis] Conversion of interest payable-in-kind to long-term debt Notes Issued Total stockholders' deficit Beginning Balance Ending Balance Stockholders' Equity Attributable to Parent Deferred Tax Liabilities, Prepaid Expenses Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs Billing Status, Type [Axis] Billing Status, Type [Axis] Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit Operating Loss Carryforwards Operating Loss Carryforwards Deferred compensation obligation Obligations, Fair Value Disclosure Common Stock, Shares, Issued Common Stock, Shares, Issued Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Issued City Area Code City Area Code Accounts payable and other liabilities – increase (decrease) Increase (Decrease) in Accounts Payable and Accrued Liabilities Restricted cash included in other current assets Restricted Cash and Cash Equivalents, Current Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Equity issuance costs included in accounts payable and accrued liabilities [Member] Deferred financing costs included in accounts payable and accrued liabilities [Member] Deferred financing costs included in accounts payable and accrued liabilities [Member] Deferred Tax Liability, Lease Asset Deferred Tax Liability, Lease Asset Deferred Tax Liability, Lease Asset Schedule of Assumptions Used [Table Text Block] Defined Benefit Plan, Assumptions [Table Text Block] Entity Address, City or Town Entity Address, City or Town Gain on early extinguishment of debt Gain on early extinguishment of debt Gain (Loss) on Extinguishment of Debt Deferred Tax Assets, Long-Term Debt and Financing Costs Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Schedule of Expected Benefit Payments [Table Text Block] Schedule of Expected Benefit Payments [Table Text Block] Stockholders' Deficit Stockholders' Equity Attributable to Parent [Abstract] Aggregate Value, Preferred Stock Transactions Aggregate Value, Preferred Stock Transactions Aggregate Value, Preferred Stock Transactions Retirement Plan Type [Axis] Retirement Plan Type [Axis] Share-based Payment Arrangement, Nonemployee Director Award Plan, Activity [Table Text Block] Share-based Payment Arrangement, Nonemployee Director Award Plan, Activity [Table Text Block] Postretirement health and life benefit obligations Liability, Other Postretirement Defined Benefit Plan, Noncurrent Share-based Compensation [Abstract] Share-based Payment Arrangement, Noncash Expense [Abstract] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration Risk, Credit Risk, Policy [Policy Text Block] Accumulated Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Deferred costs – increase (decrease) Increase (Decrease) in Deferred Charges Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent Direct Costs of Stock Issuance Direct Costs of Stock Issuance Direct Costs of Stock Issuance Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Current Income Tax Expense (Benefit) Current Income Tax Expense (Benefit) Long-term debt, face amount Debt Instrument, Face Amount Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Net periodic benefit cost (credit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Government spending authorization Government spending authorization Government spending authorization on contract Deferred costs, additions Deferred Cost Additions Deferred Cost Additions Share-based Payment Arrangement, Expense, Tax Benefit Share-based Payment Arrangement, Expense, Tax Benefit Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months Defined Benefit Plan, Expected Future Benefit Payment, Year One Accumulated deficit Retained Earnings (Accumulated Deficit) Contract revenue portion after next twelve months Contract revenue portion after next twelve months Contract revenue portion after next twelve months Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category Ten Largest Customers Ten Largest Customers [Member] Ten Largest Customers Billed Contracts Receivable Billed Contracts Receivable Industry of Counterparty [Domain] Industry of Counterparty [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Technical Solutions Segment [Member] Contract Services Segment [Member] Contract Services Segment [Member] Components of Deferred Tax Assets and Liabilities [Abstract] Components of Deferred Tax Assets and Liabilities [Abstract] Net carrying value of assets retired Net carrying value of assets retired Net carrying value of assets retired Advances from customers Customer Advances, Current Exercise of stock options Proceeds from Stock Options Exercised Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Deferred costs associated with deferred revenue Other Deferred Costs, Net Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Provision (benefit) for income taxes Provision (benefit) for income taxes Income Tax Expense (Benefit) Defined Benefit Plan, Expected Future Benefit Payment, Year Three Defined Benefit Plan, Expected Future Benefit Payment, Year Three Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Deferred Tax Assets, Inventory Deferred Tax Assets, Inventory Equity Components [Axis] Equity Components [Axis] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Employee restricted stock units potentially converted to common stock shares Employee restricted stock units potentially converted to common stock shares Employee restricted stock units potentially converted to common stock shares Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Lessee, Operating Lease, Liability, Payments, Due Lessee, Operating Lease, Liability, to be Paid Concentration Risk Type [Domain] Concentration Risk Type [Domain] Preferred stock dividend condition - minimum cash balance preceding quarter Preferred stock dividend condition - minimum cash balance preceding quarter Preferred stock dividend condition - minimum cash balance preceding quarter Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage Inventories Inventories Inventory, Net Receivables Billing Status [Domain] Receivables Billing Status [Domain] Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax Segment Reporting Information, Revenue for Reportable Segment [Abstract] Segment Reporting Information, Revenue for Reportable Segment [Abstract] Stock-based Compensation, Policy [Policy Text Block] Share-based Payment Arrangement [Policy Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Preferred Stock, Liquidation Amount per Share Preferred Stock, Liquidation Amount per Share Preferred Stock, Liquidation Amount per Share Lessee, Operating Lease, Liability, Payments, Due after Year Five Lessee, Operating Lease, Liability, to be Paid, after Year Five Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block] Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block] Increase (decrease) in deferred tax asset valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Long-term debt, current Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Exchange of preferred stock for common stock and common stock warrant Exchange of preferred stock for common stock and common stock warrant Exchange of preferred stock for common stock and common stock warrant Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Preferred Stock, Par Value Per Share Preferred Stock, Par or Stated Value Per Share Entity Public Float Entity Public Float Revenue Benchmark Revenue Benchmark [Member] Unsettled transactions receivable Unsettled transactions receivable Unsettled transactions receivable Loss on contracts Loss on contracts Loss on Contracts Equity Component [Domain] Equity Component [Domain] Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months Lessee, Operating Lease, Liability, to be Paid, Year One Contract-Based Intangible Assets [Member] Contract-Based Intangible Assets [Member] Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Pension and postretirement liabilities - increase (decrease) Increase (Decrease) in Obligation, Pension Benefits Operating Lease, Liability, Decrease Operating Lease Liability Decrease Operating Lease Liability Decrease Statement [Line Items] Statement [Line Items] Maturities of Senior Debt Maturities of Senior Debt Uranium feed receivable Uranium feed receivable Uranium feed receivable Performance Condition, Minimum Net Income Performance Condition, Minimum Net Income Performance Condition, Minimum Net Income Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Net loss per share - basic and diluted Earnings Per Share, Basic and Diluted Deferred issuance costs Debt Issuance Costs, Noncurrent, Net Restricted and other common stock issued, net of amortization Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Related Party Transaction, Purchases from Related Party Related Party Transaction, Purchases from Related Party Domestic Tax Authority [Member] Domestic Tax Authority [Member] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Series B Preferred Stock [Member] Series B Preferred Stock [Member] Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] Share-based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of Allocation of Plan Assets [Table Text Block] Schedule of Allocation of Plan Assets [Table Text Block] Nonmonetary transaction, amount of barter transaction Nonmonetary Transaction, Amount of Barter Transaction Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Schedule of Changes in Projected Benefit Obligations [Table Text Block] Schedule of Changes in Projected Benefit Obligations [Table Text Block] Business Interest Expense Carryforward Business Interest Expense Carryforward Business Interest Expense Carryforward Counterparty Name [Domain] Counterparty Name [Domain] Lessee, Operating Lease, Liability, Payments, Due Year Four Lessee, Operating Lease, Liability, to be Paid, Year Four Amortizable intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Debt Disclosure [Abstract] Debt Disclosure [Abstract] Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability Schedule of Financial Instruments Recorded at Fair Value Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Tax Period [Axis] Tax Period [Axis] Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Other Capitalized Property Plant and Equipment [Member] Other Capitalized Property Plant and Equipment [Member] Geographic Distribution [Domain] Geographic Distribution [Domain] Schedule of Health Care Cost Trend Rates [Table Text Block] Schedule of Health Care Cost Trend Rates [Table Text Block] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Valuation Allowance Concentration Risk, Supplier Concentration Risk, Supplier Advances from customers Contract with Customer, Liability, Noncurrent Auditor Location Auditor Location Segment Reporting [Abstract] Segment Reporting [Abstract] Type of Restructuring [Domain] Type of Restructuring [Domain] Payables under SWU purchase agreements Accounts Payable Under Purchase Agreements, Current Accounts Payable Under Purchase Agreements, Current Average useful life of finite-lived intangible assets Average useful life of finite-lived intangible assets Finite-Lived Intangible Asset, Useful Life Customer [Axis] Customer [Axis] Disposal of right to use lease assets [Member] Disposal of right to use lease assets [Member] Disposal of right to use lease assets Pension and Postretirement Health and Life Benefits Retirement Benefits [Text Block] Use of Estimates, Policy [Policy Text Block] Use of Estimates, Policy [Policy Text Block] Payables under SWU purchase agreements – increase (decrease) Increase (Decrease) in Accounts Payable, Trade Schedule of Net Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Document Annual Report Document Annual Report Scenario, Forecast [Member] Forecast [Member] Equity Related Compensation Equity Related Compensation Equity Related Compensation Long-term debt, interest Other Long-term Debt Advances from customers, noncurrent Deferred Revenue, Noncurrent Title of 12(b) Security Title of 12(b) Security Other Comprehensive Income (Loss), Tax Other Comprehensive Income (Loss), Tax Proceeds from the sale of common stock, net Proceeds from Issuance of Common Stock Total Assets Assets Gain (loss) related to litigation settlement Gain (Loss) Related to Litigation Settlement Common Stock, Shares Authorized Common Stock, Shares Authorized Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Net income (loss) allocable to common stockholders Net income (loss) allocable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Document Type Document Type Stock Appreciation Rights (SARs) [Member] Stock Appreciation Rights (SARs) [Member] Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Retirement Plan Tax Status [Axis] Retirement Plan Tax Status [Axis] Advanced technology license and decommissioning costs Research and Development Expense Product and Service [Domain] Product and Service [Domain] Financing Receivable Portfolio Segment [Domain] Financing Receivable Portfolio Segment [Domain] Debt Instrument, Interest Rate, Stated Percentage Debt instrument interest rate Debt Instrument, Interest Rate, Stated Percentage Defined Benefit Plan, Plan Assets, Category [Table] Defined Benefit Plan, Plan Assets, Category [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Notional Stock Units, Performance Condition [Member] Notional Stock Units, Performance Condition [Member] Notional Stock Units, Performance Condition Cash [Member] Cash [Member] Significant Accounting Policies Significant Accounting Policies [Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Income Per Share Calculation [Line Items] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Table] Board restricted stock units potentially converted to common stock shares Board restricted stock units potentially converted to common stock shares Board restricted stock units potentially converted to common stock shares Schedule of Debt Schedule of Debt [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Geographical [Axis] Geographical [Axis] Effective Income Tax Rate Reconciliation, Gain on Early Extinguishment of Debt, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Average number of shares outstanding, basic Average number of shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic Net income (loss) per common share - diluted Earnings Per Share, Diluted State and Local Jurisdiction [Member] State and Local Jurisdiction [Member] Segments [Domain] Segments [Domain] Reclassification of equity compensation liability to equity [Member] Reclassification of equity compensation liability to equity [Member] Reclassification of equity compensation liability to equity Sale of Stock, Price Per Share Sale of Stock, Price Per Share Potentially dilutive shares related to stock options Weighted Average Number Diluted Shares Outstanding Adjustment Product [Member] Product [Member] Option Group Two [Member] Option Group Two [Member] Option Group Two [Member] Defined Benefit Plan, Service Cost Service costs Defined Benefit Plan, Service Cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Finite-lived Intangible Assets Amortization Expense [Table Text Block] Finite-lived Intangible Assets Amortization Expense [Table Text Block] Inventories owed to customers and suppliers Inventories owed to customers and suppliers Inventories owed to customers and suppliers Cost of SWU and uranium inventories owed related to the transfer of title from USEC to customer at fabricator whereby fabricator has elected to order less material from USEC than is required. Amounts owed are satisfied when fabricator orders future bulk deliveries. Intangible assets Amortizable intangible assets, net Intangible Assets, Net (Excluding Goodwill) Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Weighted-average number of shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Effective Income Tax Rate Reconciliation, Deduction, Percent [Abstract] Effective Income Tax Rate Reconciliation, Deduction, Percent [Abstract] Property, plant and equipment included in accounts payable and accrued liabilities Property, plant and equipment included in accounts payable and accrued liabilities [Member] Property, plant and equipment included in accounts payable and accrued liabilities Annual limitation of NOL carryforwards and tax credits generated prior to ownership change Annual limitation of NOL carryforwards and tax credits generated prior to ownership change Annual limitation of net operating loss carryforwards and tax credits generated prior to ownership change (that are not reduced by attribute reduction) Corporate debt [Member] Corporate Debt Securities [Member] Amounts Recognized In Noncurrent Liabilities Amounts Recognized In Noncurrent Liabilities Amounts Recognized In Noncurrent Liabilities Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Subsegments [Domain] Subsegments [Domain] Special charges for workforce reductions and advisory costs Restructuring Charges Property, Plant And Equipment, Net Capital Expenditures Property, Plant And Equipment, Net Capital Expenditures Property, Plant And Equipment, Net Capital Expenditures Concentration Risk Type [Axis] Concentration Risk Type [Axis] Revaluation of inventory borrowing Other Noncash Expense Depreciation and amortization Depreciation, Depletion and Amortization Collateral [Axis] Collateral Held [Axis] Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Finite-Lived Intangible Assets, Amortization Expense, Year Three Finite-Lived Intangible Asset, Expected Amortization, Year Three Accrued severance payments Accrued severance payments Accrued severance payments Foreign Tax Authority [Member] Foreign Tax Authority [Member] Accumulated Other Comprehensive Income (Loss) [Member] AOCI Attributable to Parent [Member] Approximate Number of Plan Participants Approximate Number of Plan Participants Approximate Number of Plan Participants Separative work units owed to others noncurrent Separative work units owed to others noncurrent Separative work units owed to others noncurrent Increase (Decrease) in Inventories Increase (Decrease) in Inventories Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding Other (income) Other Operating Income (Expense), Net Financial Instruments [Domain] Financial Instruments [Domain] Cost of sales Cost of Goods and Services Sold Debt Instrument, Periodic Payment, Interest Debt Instrument, Periodic Payment, Interest Document Period End Date Document Period End Date Common Class B [Member] Common Class B [Member] Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Restricted Stock or Unit Expense Restricted Stock or Unit Expense Advances from customers Contract With Customer, Advances, Liability, Current Contract With Customer, Advances, Liability, Current Fair Value, Inputs, Level 1, 2 and 3 [Member] Fair Value, Inputs, Level 1, 2 and 3 [Member] Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment Effective Income Tax Rate Reconciliation, State Income Tax Expense, Net of Federal Benefit, Percent Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Schedule of Income Per Share [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Income Statement Location [Domain] Income Statement Location [Domain] Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Notional Stock Units [Member] Notional stock units [Member] Notional stock units Property, Plant and Equipment, Net Property, Plant and Equipment, Net Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Property, Plant and Equipment Property, Plant and Equipment Disclosure [Text Block] Cash paid in exchange Cash paid in exchange Cash paid in exchange Separative work units borrowed in period, value Separative work units borrowed in period, value Separative work units borrowed in period, value Other long-term liabilities Other Liabilities, Noncurrent Defined Benefit Plan, Information about Plan Assets [Abstract] Defined Benefit Plan, Information about Plan Assets [Abstract] Defined Benefit Plan, Benefit Obligation Defined Benefit Plan, Benefit Obligation Distributed earnings allocable to retired preferred shares Preferred Stock Dividends and Other Adjustments Other Preferred Stock Dividends and Adjustments Accrued lease turnover - current Accrued lease turnover - current Accrued lease turnover - current Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Earnings Per Share [Abstract] Earnings Per Share [Abstract] Customer-Related Intangible Assets [Member] Customer-Related Intangible Assets [Member] Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] Deferred costs, costs recognized Deferred Costs Costs Recognized Deferred Costs, Costs Recognized Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity [Table Text Block] Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity [Table Text Block] Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross Accounts Payable and Accrued Liabilities [Text Block] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Separative work units valuation change in period Separative work units valuation change in period Separative work units valuation change in period Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Deferred revenue change Deferred revenue change Deferred revenue change Separative work units owed to customers and suppliers Separative work units owed to customers and suppliers Separative work units owed to customers and suppliers Exercise price of warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right, Exercise Price of Warrants or Rights Equipment [Member] Equipment [Member] Low Enriched Uranium Segment [Member] Low Enriched Uranium Segment [Member] Low Enriched Uranium Segment [Member] Effective Income Tax Rate Reconciliation, Uncertain Tax Positions Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Warrant [Member] Warrant [Member] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Pension plan obligations transferred for annuitization Pension plan obligations transferred for annuitization Pension plan obligations transferred for annuitization Allocated Share-based Compensation Expense Share-based Payment Arrangement, Expense Trade payables Accounts Payable, Other, Current Provision for Loss on Contracts Provision for Loss on Contracts Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Class of Financing Receivable, Type of Borrower [Domain] Class of Financing Receivable, Type of Borrower [Domain] Entity Current Reporting Status Entity Current Reporting Status Defined Benefit Plan, Plan Assets, Payment for Settlement Defined Benefit Plan, Plan Assets, Payment for Settlement Defined Benefit Plan, Plan Assets, Amount Defined Benefit Plan, Plan Assets, Amount Cash, Cash Equivalents and Restricted Cash [Abstract] Cash, Cash Equivalents and Restricted Cash [Abstract] Cash, Cash Equivalents and Restricted Cash [Abstract] Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Percent Defined Benefit Plan, Investments Measured at NAV Defined Benefit Plan, Investments Measured at NAV Defined Benefit Plan, Investments Measured at NAV Preferred Series A [Member] Series A Preferred Stock [Member] Expected defined benefit plan contributions for next fiscal year for qualified plans Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Provision for loss on contract noncurrent Provision for loss on contract noncurrent Provision for loss on contract noncurrent Current debt Debt, Current Counterparty Name [Axis] Counterparty Name [Axis] Gain (Loss) on Disposition of Property Plant Equipment Gain (Loss) on Disposition of Property Plant Equipment Common Class A [Member] Common Class A [Member] Cash, cash equivalents and restricted cash, start of period Cash, cash equivalents and restricted cash, end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Other Significant Noncash Transaction [Axis] Other Significant Noncash Transaction [Axis] Revenue, nonmonetary transaction Nonmonetary Transaction, Gross Operating Revenue Recognized United States UNITED STATES Common Stock, Par or Stated Value Per Share Common Stock, Par or Stated Value Per Share Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Compensation and benefits payable CompensationAndBenefitsPayable Compensation and benefits payable Current Assets Assets, Current [Abstract] Common Stock, Capital Shares Reserved for Future Issuance Common Stock, Capital Shares Reserved for Future Issuance Leases [Abstract] Leases [Abstract] Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] Accounts Receivable [Abstract] Accounts Receivable [Abstract] Accounts Receivable [Abstract] Income Tax, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Property, Plant and Equipment, Additions Property, Plant and Equipment, Additions Finite-Lived Intangible Assets, Remaining Amortization Period Finite-Lived Intangible Assets, Remaining Amortization Period Changes in operating assets and liabilities: Increase (Decrease) in Operating Liabilities [Abstract] Schedule of Notional Stock Units, Performance Condition, Activity [Table Text Block] Schedule of Nonvested Performance-based Units Activity [Table Text Block] Qualified Plan [Member] Qualified Plan [Member] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Entity Address, Postal Zip Code Entity Address, Postal Zip Code Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Accrued interest receivable Accrued interest receivable Accrued interest receivable Kyushu Electric Power Kyushu Electric Power [Member] Kyushu Electric Power Average number of shares outstanding, diluted Average number of shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted Option Group One [Member] Option Group One [Member] Option Group One [Member] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price Range [Domain] Income Taxes Income Tax Disclosure [Text Block] Accrued interest payable on debt Interest Payable, Current Provision for loss on contracts, noncurrent, change Provision for loss on contracts, noncurrent, change Provision for loss on contracts, noncurrent, change Provision for loss on contract change Provision for loss on contract change Provision for loss on contract change Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Share-based Compensation, Stock Options, Activity [Table Text Block] Share-based Payment Arrangement, Option, Activity [Table Text Block] Income Tax Examination, Penalties and Interest Expense Reduction Income Tax Examination, Penalties and Interest Expense Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Schedule of Net Benefit Costs [Table Text Block] Schedule of Net Benefit Costs [Table Text Block] Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental Stock Appreciation Rights (SARS), Performance Condition [Member] Stock Appreciation Rights (SARS), Performance Condition [Member] Stock Appreciation Rights (SARS), Performance Condition Finite-Lived Intangible Assets, Amortization Expense, Year Five Finite-Lived Intangible Asset, Expected Amortization, Year Five Average number of common shares outstanding, basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Assets and Property Sold [Table Text Block] Assets and Property Sold [Table Text Block] Assets and Property Sold [Table Text Block] Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments, Policy [Policy Text Block] Advances from customers change Advances from customers change Advances from customers change Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Auditor Firm ID Auditor Firm ID Class of Stock [Line Items] Class of Stock [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Government [Member] Government [Member] Entity Address, Address Line One Entity Address, Address Line One Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Axis] Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Investing Activities Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Provision for loss on contracts, noncurrent Provision for loss on contracts, noncurrent Provision for loss on contracts, noncurrent Redemption of preferred stock, net Payments for Repurchase of Preferred Stock and Preference Stock Payments for Repurchase of Preferred Stock and Preference Stock Loss Contingency, Possible Loss Not Accrued Loss Contingency, Range of Possible Loss, Portion Not Accrued Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Reclassification of stock-based compensation liability to equity Reclassification of stock-based compensation liability to equity Reclassification of stock-based compensation liability to equity Entity Shell Company Entity Shell Company Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Unrecognized Tax Benefits, Income Tax Penalties Expense Reduction Unrecognized Tax Benefits, Income Tax Penalties Expense Shares withheld for employee taxes Payment, Tax Withholding, Share-based Payment Arrangement Class of Stock [Domain] Class of Stock [Domain] Deferred revenue, additions in period Deferred revenue, additions in period Deferred revenue, additions in period Operating Lease, Expense Adjustment Operating lease, expense adjustment Operating lease, expense adjustment increase (decrease) expense Payments for deferred issuance costs Payment of Financing and Stock Issuance Costs Deferred Tax Asset, Increase (Decrease), Amount Deferred Tax Asset, Increase (Decrease), Amount Deferred Tax Asset, Increase (Decrease), Amount Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Preferred Stock Retired, Liquidation Preference Preferred Stock Retired, Liquidation Preference Preferred Stock Retired, Liquidation Preference Defined Benefit Plan, Plan Assets, Administration Expense Defined Benefit Plan, Plan Assets, Administration Expense Nonqualified Plan [Member] Nonqualified Plan [Member] Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Mutual Fund [Member] Mutual Fund [Member] Preferred Stock, Carrying Value per Share Preferred Stock, Carrying Value per Share Preferred Stock, Carrying Value per Share Statement [Table] Statement [Table] Mortgage and asset backed securities [Member] Asset-backed Securities [Member] New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Defined Benefit Plan, Expected Future Benefit Payment, Year Five Defined Benefit Plan, Expected Future Benefit Payment, Year Five Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Synatom Synatom [Member] Synatom Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Deposits for financial assurance Deposits Assets, Current Range [Axis] Statistical Measurement [Axis] Deposits for surety bonds Deposits Assets, Noncurrent Preferred Stock [Member] Preferred Stock [Member] Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net Repurchase of debt Extinguishment of Debt, Amount Deferred revenue Deferred Revenue Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Fair Value Measured at Net Asset Value Per Share [Member] Fair Value Measured at Net Asset Value Per Share [Member] Write off of deferred financing cost Write off of Deferred Debt Issuance Cost Inventory, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Preferred Stock, Cumulative Undeclared Dividend Preferred Stock, Cumulative Undeclared Dividend Preferred Stock, Cumulative Undeclared Dividend Adjustments to reconcile net income (loss) to net cash (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Preferred Stock, Liquidation Preference, Value Preferred Stock, Liquidation Preference, Value Scenario, Unspecified [Domain] Scenario [Domain] Conversion of Stock, Share Price Conversion of Stock, Share Price Conversion of Stock, Share Price Pension Plan, Defined Benefit [Member] Pension Plan, Defined Benefit [Member] Pension Plan [Member] Amounts Recognized In Current Liabilities Amounts Recognized In Current Liabilities Amounts Recognized In Current Liabilities Notional Stock Units [Member] Phantom Share Units (PSUs) [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Geographic Distribution [Axis] Geographic Distribution [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] EX-101.PRE 14 leu-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 image_0a.jpg begin 644 image_0a.jpg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end GRAPHIC 16 image_1.jpg begin 644 image_1.jpg MB5!.1PT*&@H -24A$4@ #M $" ( B'PT< 4TE$051X7NW: ML0T , @$,?9?^B-$A\(&=GDS7!4 P$^2G0 M1@_' 0 X&(X! @-,#HBV20Q2326H 245. %1*Y"8((! end GRAPHIC 17 image_3a.jpg begin 644 image_3a.jpg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end GRAPHIC 18 image_5.jpg begin 644 image_5.jpg MB5!.1PT*&@H -24A$4@ !'( !" ( ]T![' &DE$051X7NW! F,0$ #"H/5/;0A?H #@,#5< 9 GRAPHIC 19 image_6a.jpg begin 644 image_6a.jpg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end GRAPHIC 20 leu-20211231_g1.jpg begin 644 leu-20211231_g1.jpg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`_F5=G76< MJDL*Z? N8$]^KG5$R'(BV<.SBR%1)-=*@/MHE1Y\>4A32V5H)Q#A&DR(RX$B MH7;5RTK]N496914E)-.+BU5--<&FN*?*G$T;*WT=TK;Z/]+]?8#>UB(6V<\0G:6YW'&TIFL9OE,*&IG%GUF2EI1@>/ M1X=2IM*U,*F1I,AOCZA7/SA\V=YO>V\LC/L2ZM*L?B,?N=N#?MKYV;E_&W^_WDTO8_U<5&'=52:^,2<#6AGH 8@["? M]@>\/^$&R_\ 8NZ'K[?_ .?87][L_P!9$\W6?^3Y?]VN_(D>3>/JL?.< M #U[Q\DCZ5 4V/Q4?\?^F?['[I_36N!,+ZKOYAK/SV-\F\1A M^L)^>:7\U?\ E6BIN)5D

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

=NQ+G L:S&8JWL<8PU,8TUM@[4-N)D,Q7
M9+D>-!1'4VE"W74E1N=/52)VC6G$^7N[[A^&]5B_4C%:^!GVY9L(I18^[,6W
M0X;&D-)7 L,R>AK3,6_,2LG6*QA;,E]@O46[';6RMU"#EQ?(.5/2026?9KOG
MVFR27&QG+]R9)(2YZZL4TW$R"FIJF,XYS'3*K,$:C$<.,:.$2+%;SA>/DMU2
MN5"MTPBNPZ5DSI5ODO=_KC-KK+(;WL9JE4F0;D!Z_L<\IJ6U?233CC!MVCI4
M=W\L=!NL+2\DR0GS3\"'/L2[F.*[R9/V^/#)
MGA1.P                $*/NT=VKO45/ Z\:JN7ZC.LUI56N>9)6O$U88SA
MD]3\.%2UDII1O0+O)S9>4ZZDVWXL%"3;/RDH<;TWYJ;SO:39CH&ES<,Z]#JN
MS3XPMNJ48OLE.CJ^#C%53YQYU?.CF?
M@ZTOA2'&W$*4AUI:5-/-*4VXE2%*2=QAYF3@9,,S#G*WE6Y*491=&FO_ !1I
M\&JIIIESA9N5IV5;SL&Y*UEVI*491=&FO_%&GP:JFFF7,>C7:FN[::-J.SKV%*4XBER&&\B7&YY)I2G(_DM3"E'+_ &5N
M>WNK1(9KI'-MOHO179-).J7W,TU)=W&-6XMDTMB[KM[NT*&>Z1S[;Z+T5R4T
MD^I+[F::E'NXQJW%LW'&7&9@
M   '&HN:AVZ+O4O5M?!PU4-_;^R%6%=A:);3K9%5;KQ
M4$J=5QKMI5**?!R=6FHM&M_,G>KVCI48872]9R:JW7BH15.JXUV]-4HI\')U
M::C)%13(\DR#,+VURC*[NUR3([R8[87-[=SI-G:V4-G/IKJIEL3ZNVJIBI9O7L>[&_CR
ME"_!IQE%M237)IKBFN]%L+VQ^[T[M!@=G@.QIC+NYM:P(CMG8?FF5YUB3KJ8
M43+"BMI0ENUKY:FXMJ2$DT;SS#R?'ZDVFI2>6^])[EP98.H-/6,:*J_\[#DI
MT^Z3I&=.%7%_;44MO*_?,]TZ?+3]2DGK6+%=3X+WMODKE/NDZ1N4X5<9?;44
MI0V:;4       _C)DQX<=^7+?9BQ(K+LF5*DNH8CQH["%.O/OO.J2VRRRVDU
M*4HR2E)&9GP.)2C"+G-I12JV^"27:SK*481&64ROUOC9+6Q&ELL*7$>S6VC?*3][D"$FXCU",X41:8Z.#]9
M;L1-];OR-TZI)6Y-:/9DU9AR3IP]Y)=LI\U7XL6HKM;AEY@;TR=VZM)6Y26B
MV)-68R7;*?-5^+%J*[6]"Q@Q@    ;@]+NW&8]2-L5N4ULJ=/U]>2H
M==LS#&W?*)D&/^:VU3XL9Q:66\EH$R%R*]\C;5YDIA:_0>>2K+=G;KR]J:K'
M)MN4L";2O6^R<>]+EUQK6+XBNZG)J2GR2@GQ[6BR"JK[NEM(B_4B653;1&9]=/BKX+S
MCS(>[RR2IHGB0MXS@V692*7'B)M2D+=-NO-A/CRGGC@O'["NX\(KT%)\66EV>@
MG3IIIIK^0'!7?2;0WZCT:;B^.5'Q\3%OUS[RI1']/ZA'3K
M^S[@/_HD[^'AUS[Q1&6-6=?-+:1D7,K4^NL>P61D+,*/=.T;,AI=BS7+DN06
MY'K2'R-,94LB^;TDJ,N#+D=K:K-'$N1#3[,6(_>W8S.LM>:-)TCS+- MRH1>
M>[SEOZN]09E*EPTJSW8V%8PIM*UI-UF NRS97FA!\.-(=Q%LS\OD)?C_ )WB
M*EI>V=9^?A7U#F2W%TT?V-\H^F@&7VG\W[
MA?E=[SY(X@;J^YYV;L>OVB$8_B%D[6;%V])L,7H+"(\MB?1X[#C,KS#(8#[2
MT/1Y\:+/CPX[J#2XP_/2\@R4T0Z6X]4N/)',G1$4OME]&J;L+;V>WMK0%S=4
MX7;HJ:G'5K6RSG.71VXL^1'L%(4EY>,T460RDK*^FJ*V.W$KJJJAQJ^M@16B\6HT*#$;9C18[:?@E
M"$I21?80MBH8)[.]=L+[,ZGR+7F5UT)=FN!.EX3D+S)'.Q++DQ'$U-U"D(\9
M"&$RB0F6RE242HIK:7\#(R[1DXNJ.&JHJO\ 17-+K6/<31\B,M^+(M-C56NK
MF(A9&A^%G,TL*G1):$J-I]J.];)>+GR)#K*'$_,A)EP;)4MLFI686N:9;*1X(2H_JLILZ> XI2"Y=-ZGI(RR
M4KE1)42?L21%TN.LSF/(V>[,Y=^H?7;>&7H?*/)HM59U+KG3637_ *W/'+!B
MF;2X?Y*WK5YE"3X,^5%P1G\!UBJR2\3E\BH9U8T;+[&;XU_J9EY^)77]JN5D
MUC'X)ZMQ.EC/6V12F'%H<:;FKK(:V8IK2:#ENM),C(Q=2ETQJ4TJNAEFS+:XA1G[##K/!+[&ISK!.OU=O+SO',9>>BK(O
M-I]ML+)+AL)U+X.+)*O22ZO,<<
M-E*U$7@3BT-N&DC^)DE7'V&*E[XJ])UAS)Q.UN^8'6W1.<[5DML2[6J@HK<2
MJY')M6V87*_H,?AO(2XTXY"9EN?4RR0I*RAQW32?D1"C&/5*AW;HJE8;J9U\
MS/O1V%LU9C=W$FF*6_G.X,W6X3EFN+.FF90(Y'-4;$5)I4AAE#KJ
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MTVN07^0V,KA7^0N+2]FOB4Y1BCW7LM_5GIGF=
M:ETF7LXRC!\295Y+2XOQOF,KDM-&@C+EZ#BSJ5DKA)M&HOM,B/FTJS.)KM+V1WC*F9Q6E:ZUU=61M=,_H[VXG27(V*8U/))DI4&PD1),I]'Y+
M\> XRKX."M.P
MTE#3+#+2"2A"2)*4D1$7 M2H0?>]GB^.KP72F:JCQV\MCY9>XNS*0P294S'9
ME.=M)CR)*2(W8]=90&E,H7SZ:I3IHX\U\UK/-KL.DSM7LI-32T?MQ]Q23KG-
MJLM14$@R4F:SB-&N>HW? B6E;#\8B3Y'XFDSX+R^*]S7H.8&LN%MRJR#+9BL.(,G&)<]EY)\M
MCK;CU2X\D).B(A_;0Z05'9#(+C:NTXKLS4^"VS55'HC><93G68E'8L7JR:\R
MM,E-#10I3#TQ*5-JDN266DJ-!2"*KFJ,>JX%'055;1TM5
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M0I#E5DVQRI:F.V^:5MJ:;K)+3:%^)
MEXI(^#%VO9AZ$4N;+GPM"J5FO>>RX[;L3@6(-.^I&Q#5<&6\WZB%$Q;Y-D5[
M(EH-M)J-M2ZNM@J^;A2B,OAQP:KBRO9KXE.?,F/]NO$?U,Z9:+KU(-#]KC=A
MESZU&A2WOURR&XR>*M1M\)X37VC*$E]I(0DE?,1F*5QUFSO'D8 ]X7+/N#J=
M%H4.&3N<[/Q*B<921&;D*LAWF5O.+Y4GQ::F8_'(S+R/R6DN.#,R[6E[7J.)
M-LB)'T$?([BX:2[Y&I1N?>4$U)X22? CY
M5S\O-Y\D<0)YA1.Y!U[VV6_2X%HG!$N<_?N7Y;EKS27/R/U3IJZFC..LES_I
M/US=)M1\?DK(N?CQ6LKBV=)F3/9EQ0ZGK9FF4/(\9&7;8MDL+)2C2Y4X_CN.
M0(QFDTI)+B;1^<1\&HC22?CSR1<77[5/ YCR,[^Z#EI8ITMVHVV]Z,W*I&(8
ME!/YOSAV>64\JS9^3C_2T%?,+XF1?Y>?L/K;59HYER(+/;-ZW4O87L&AW-*M
MFWU]K*G/,LCK):4N0+NS.6S!QC'Y[*DK3)AS+!:Y3[*R])^-!=:6?"_%5>Y+
MICPYG2*JRVBAEIMI+#;3:&$-I90RA"4M(:2DD):2V1$A+:4%P22+@B^ M2H:
M\]J]ZU_6[0V=[3>3&=LZ>M36XC6/\>E:9?<**NQV$IE*D+=B,S'2D24H,E%#
MCNJ+\D=HQZI4.&Z*I62Z<]5G-U;R\R:]2/)8<+E+C:TFA^),C.DEQB0RI#\=Y
M"7&UI6E*B)M.JY@ID[BPNYZM]ELLQ7'K5]5KJ'8K,_$KMWP^K4Q5S8F0XA9R
MTL^#135U[D5UY*.$DZ:B+X"[3ZHU[RD^#+I..73.28]0Y%';4S'OJ6KNF&5J
M\E-,VD%BJ$8HUU
M&/F.     $S7LG[%G4/8?.]<+D.E2[!UQ)LSB$IPVEY%A=K!DUDE2$I4VDVZ
M6XLT^1^/Y9%S]A'M_P FM0G8U^_IS;]S?QW*GW]N2<7_ !93-T^2&I7,?<61
MIK;]QD8SE3[^U).+_BRF6@Q)8E*
M   !TK8VPL3U1@N4['SFT:IL3PZGE75U8.\&;<:,DB1'C-N-+R:PE-^*G&7%?=[*R+T6241N+BENGS!US<=^4+=R>-I5?9
MM0DU5=]R2HYM]J?L+LCVN(.[O,C7MSY$[=JY/&TBK4;,).-5WW9*CFWVI^PN
MR->+T 9>=CNM/L.N,/L.(>9>96IMUEUM1+;=:<0:5MN-K21I41D9&7)#!$W%
MJ4722->IN+4HMJ2?!DIO2_W/=M:(R6FQ;;N17^SM,2Y#<*R8O93]YEV&QWED
M@K?&+B:ZY93(M?R2EUC[KC"V4FACT'#)1[-V?YE:KH>3#%U:Y:.KZ#DPQ-8N7,K16Z24FY7+:?VT)/VFEVP;::
MX1Z7Q+7-+3(A6=5:16IM=80WT&:'XLR(^AQ
MM9?!2%$9?:)1V;UK(LPR+$E.S.*E&2XIQDJII]J:=42SL7K639AD6)*=BY%2
MC)<5*,E5-/M33JCDQ4*H              !H#VF]Q[K[UVK<>)=E+(U-<[5NC<>[WDG[,/1
M[4^3Z:.I',W[Z\O[V\GNM$8J(W$I)IO;#IVS;7R)6]]0K7J8;SA&2EDUZ;9'
MR2/4^!K/7J\[I>]XZ:O=^Q/XF/:M0CZ';5U_P JXR('F_F7%=U]-*@/.IBY7.O,*NHS9
M\(G5F08_9-M,OEY(\FHEPQ$ED7/Y<9)\'QP>=>6V9I0?
M/T249>E(V!Y79UW!WOA>[;Z+TI6I+OC.$N#]$E&7IBBY()=DS@      -&O<
MDS^PUSTLWA<5#SC%G7I$U04\RU<-WP)2_3)$0_+@C/C[!RE5T!3V
MZ08N]L#N#H.KD)7.=/9=5EDSU4+DJD(PTY&<3ER$^1&XA;5"M3AJY3X\FHC3
MR1W4W2#*2YES86A5   ")+WE,L^Y>L6,8RR]XR,SVM0QGV26V1NU-'1Y%XFLLN?%Y'J?KHYCR(V/>)S:7D':.JQ,W^:[ =;X]!9B)<\D-V>0R[+(;"6I')^G(E0
M9D)M1?#EMA!\?NG4M+V:G67,Q'KSV]NZF:81B^:8/C248GF%)6Y/C[A;&QVE
M.557<1J? F+K7[R+(C*EQ7D+X6VE1DHC,_\
M>WC'^\@X]Y YZ6/[M'O_ /\ L]_[V\8_WD#WD!TLR/UV]L[MEA>_=-9OF>&T
MM3C&&;/PG,;ZR;S?%+%YF!B^10+]_P!.'!M)4R4Z_P#=_IDE"%&9K_<+DRXE
M)DHD?>)W?(K?^TWB!Y-W*Q2U](W6L#P_.+TO5;03U*K#6'7?\
M-:)J9E[2D+,CX=)/'S&1E7NND#I'F6OA;%0J:>ZSEI9-W.SJO0XIUG"L>6HN3/E1\F9_$6\G63?B=UR-
M8?=-RW]5NE^R(J'":E9A:X7B45?FA*C^JRFLN)[:4K/ETWJ>DDH-*>5$E1J^
MQ)F7:VJS.))X-C^*1G5^)^B[F]Y(LW%M)4KDGC8
MP92/-)?!(X@6-1;G#BO2R>P+GRY07[GS#BRN;$S+?LQ
MXE5U?7+..JQC'J!NH@..)4IQQ$69;SGD^7B1?5'P
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MNI5(;?>VRXHNOM&8&E\^;W,:+Y2/_ /#1U+:E<&?S
MDGGYN*ME<6SI,R'[,F%-4O77.,U<9;3/S?9TZ,EY*4^H[2XI1U,. AQ9%YGZ
M5M96/"3^"25R7Y1CB\_:IX',>1+^*1V*^OO904U2XI/Y2?1^Y)I$?V*\S_R"O97-G29NS[2F)'C?3C';93/HJSS-\YRT
MS/P)3Q1[-K"VWE$GYR\FL/22?+XFDB,OE-(Z77[9S'D1=>\IFH23+SHX,0SX(D\\\
M/(D '0Y   "F-KY/\O'=K&93C?UD?:'92-?V1):]0EU.0[&.^
MN7S:0?!MM53[SAER2?%)\F1?$7;]F'H12YLNW3BZLR[I:.B/
M>3J*[(K?+93RS-?@K$\9O,ECNN*,EJ-3MC6LH(_W5K+DR^TKFXZ092CS+A@M
M2J4_/+XO24FG&J>F<(B4;G
M)^K/(S,DI^!<&H^?&M97-G29M-[06)'CW45N[4T:5YWLG,\D0ZILDJ=CUZ*G
M#$)0YY*4XPU(Q5WC["2M2^"^TSZ77[1S'D2DBF=BLY[S^7E;=AM?X>RZ3C&(
M:LB3)"2=)7H6N3Y%>/265-%SZ2SJZJ"YR9\J)PO@1$1G<65[-?$ISYDPWMQX
MH>(=+]'0EH\9%M16^5OJ\E*-TLMRB[R&&L_)*"3XUE@P@B(N"))?%1\J.E<=
M9L[QY&GOO5Y;]WZ4U+A"'2;RN+9UGR/S[*>'(KM+[;SM3!-R,JV3"QLGC3XKD0<,QN'.C*(S
M27FPW,S.2E)\F7F2R^!D?*\^*0AR)H11.Y!C[V^:R8F':'UVP^?TE]DF8YE9
M1TF1?G\5K*>EIW7"XY,EHS"<2?CQRD^?W!6LKBV=)D66ANEG:;=^%+V%IW'T
MR,5E6TRE5//-J3&'),?[R#K[R!STL?W:/?\ _P#9[_WMXQ_O('O(#I9P
M\GVL.[\Q]R3+P&GE273(W9$G9&%OON&2221N.NWJG%F24D7Q,_@0>]@.EEJ?
M$J0\:Q7&<<4Z3RJ#'J6D4\DS43IU5;&@FZ2C;:-1.&QSSX)YY^POL%N^+J5#
ML(X               !0\WYC<_#]Y;CQ:S8:?:N) C<&
M-5=B_5.2^!\T^U<3$H\H\@     EI]F/')UQVYG7+!*3"Q/5
M.7V<]WTS4V9V-ACU!%B^IY)2V\\[:FXDOF-265\%\#,MJ>3^/.[NN5Z/Q+6+
M<;];A%+^57U,V[Y*XT[V\)7H_$LXER3];A!+T^U7U,M:"4)+$
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MA*?:C^/J2:][SE0VU$9.2&DK>*0.RM_X.ZX?1;T58UB,:NW6L9I->X97NJ8K\YV8TY>J0I1'+@8M2SK&+6NIY\
M5QW+:5'DGR7).1$>&=>L
M;P+*
MA*:BNY*A)@-
MCFS@             TO[^=C9O6+K5EV>T+C+6:WF5L?(OXE^&5C3E;R+F
M79>FN_2[+==-=[5E$RUD5A7OTN:16$)::CYCCLERIO'&6$%Z<>+:O1TSX[23
M5Z<:6VDS\B,3+VAKOZQ[?Q]4E19$H]-Q+LN0?3+AV*374EV*21-_9>X/UFVW
MC:M.BR91<;B79<@^F7#L4FNI+LC)(VA&2F4@                      !4
MY]XC6EKA_;RRSE^.\=-MO$,5OZV<:5?2KGXO20,&MJQMPR\3E061)\Y=,NX>\)9\D_<
M9EFW.+[*PBK4H^E*$6_"2[R*@:O-3@  !(Y[5&LK+8?D+S2I!&Z_E%U!(F^3-39.'XFE*AL+ROTVYG[PQ[D56SC1G
M=F^Y*+C'X9RCP[J]S-D^4^EW=1WICW8JMG%C.]-]R47&/PSE'AW5[$RX")9D
MQ0      (^?=)QFPR?H_N1NM2IV12)P[)G&$M^9NU]'F^/2K91J\T^DF'5^M
M(-7"O@R:>/CR6!>9N-OW9KT54/W8,EUY.8
MMS'V5"[/E>R+LX^A-6_W8,E(&S#:@                   !IQ[@>6_J7TV
MWY:DX;:[##"Q)'BM:%N?KU;UF%NMI],R6LE,7R_)/V&@E>7R\CO!5FCA\B"G
MV@<1_6'MPB]6P:V\#UMF.1MOFV9H8EV*ZK#6TDY\$H?>BY0_XE]JD)7P7!&9
M5KK]DZ1YEIT6Q4   "#'WNRD_J=U^4DG_HRR;/B?4DG/IBDJJ\9.*3IE^:)\
MVDO>GS\WB2^/AY"M9YLZ3,I^S%>48KB3
M5/9N((SXCS44[\=LSX,U0G"X^')\7OC>HYCR)>Q2.Q4N]SO>M3O/L]91L2GM
MW&*:SIH>NJ>= =3)@V]M"GS[')+*O6TIQN2VNZLE0D.MF;W$AHE?#R2@CX+["MY.LFSNE1%?[WA<&FXYVHAY:M@_NS8>O,FNQ
MQYG);^U1K,5[3]FATES)BGK%+C8K>QHYF3SM1/I$,L^KX^*);#S7^:DU4KD6I
M5[&=HNJ)&Q3.QH5WB[O8;U5PB?65,ZMO=V7U?X8;AQ.HD'5%,\VD9;E+3?D<
M*DKB2IQEE?BY8OH2RV1-^L^SWA!R?WIPW3TG5_;Y[K9;VUQW(H.9Z[DTF0X)
M&KF[G.:-*4X)D$NZSEGZL],32FVS)222;M?C3R5&9*(T&
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MFW\IVFY5-+^0U/UV*XS2KCN?999,F1<D<2HE^7/SV!*(TD7V<&?QXKV5S
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M9&H=HQ5[WVMEVR\G\9&3Y_D*Y[D2,:U,1$O>C IJ.!ZJE.G
M!IZQB/"C$M1K]%E'D9GR8NDE%47(I-UXEW/"\<9P_#L3Q*.:51\6QJBQQA2.
M?!3-)5Q:QHT\I0?B:(IA%+F_67/!:%4K/>]!EYVO837N'-.FN-B.K(L]U'J^
M26;7*W1BA8ATPT9 -
M'B]:X]:96^LU)4IX\NR6ZR.,M1I2@OE@63*$EQRE""(S,R,SI7'6;.\>1NR.
MAR55_=VRT\B[@6-+ZWJ)P+7N$XOZ1>!$PY/CSLV6DR1\3<<1ER%&:OF-)I+\
MDDBYM+V"G+F6%.G.(_J/U7T!CJFC8?9U9B-I.8-*$J8M,DJV\CA-C1=E\:S);3QT^=:UI_HY:R+T3ML8L
MK.KMJ]DR0GE42"] >61FHR^J+X\&1%7M/V:>)TES)3?:X[ 8SM7K;BVO?O.,
MC/\ 3T$\5OZ)QU*)KF/,2W_U5R"''4HW'ZMZJ<:B..%SZ;?57N/-+;9RO+&&
MG"=@XY7NF2D-J-#MDZCT63))//L=X0!Z%TOAJVTMOXUJW Z>:2/+A=C#
MQFL:LGOF))^4B>3CA_ OBH_@7V"VDZR;\2HN1F(<'( '6LS*E\GC9.<=7**(3Q1_P!\&T:WE);;-5S81TI49EXJ,C+XD0NI_$927,N5"
MT*I&S[I.]:;5/6+)\+18,HS7<;/ZEX_5I7S)51N2(KF9VSK*?F*O8HC7$-9F
M1?4S6B^8O(A4MQK*O8CK)T1'=[+FI)=OLW96Z9L5PJ?#L8;PBED.-*)F1DF5
M2XMC8+BO1\?%%FV9_:0J7GP2.(=Y8W%N=RF'A_P#_ %Y[L4A%+F
MRYX+0JE;+WK">_EUU,I1._3GJ8R:49+]$WDYAD1ODV9_(;I(4WY\?'@T\_N"
MXL\GZ2G/F2I^V+>T=STIU Q2O1U.4'ZXT5W%9)I+E?>-9OD-E)9EMLJ4EN1,
MBV;,TN?G6U*0M1$:S(4KGQV=H\C?"=.A5D*9964R+7UU?%D3I\^=(:B0H,*(
MTM^5,F2GUML1HL9AM2W'%J2A"$F9F1$.AV*P
MRWZ[;FF<&)XEIQK7=QE!M$I9^B]F>1N5BS47'I)6XU@[9\$?GXD1F1$:3.O9
M7!LZ3YDG?M@8E^JG2W5*W&_3F90]EV6S"_.<*^],LN&*UPO4))EYT<&(9\$2
M>>>.2^8Z5QUFSM'D2 #HS5V QHL3S#KI>V<>!E+.2S77&9CCB2-##II78\>H1?83JBB=S
M '8WLEK/K'K^=G.P[9EMY3,EK&,5C/M?K#F-RTUYLU-+#/S<-)N+04B4I/T\
M-M9+=41&DE=HQ
M/Q%OS$Q-ZLVF'[-C]E\7K7I&&;(375.=N1FS6UCN>5L%JN@S
M924<%&K\LIH37@LD^'U\9_U%DN0TE4;_ #=VQ=Q-26X\:+>'D4C=I]I=2HF^
MY3BE1_=*5762K&'SFVI=P]46Y\6+>%DTC=I]I=BJ)ON5R*5']W&5762K"8--
M&CP    "V+[3O5BTT+I*PV!F]2Y5;#W.Y5W+M=.8]*SQ_"*YF0K%:N6TYR[!
MG61V#]A)9^1Q*7V&GD$ZP:4RE\K=L7="T:6?FPZ=0S.F5&N,+:KT1?4FU+N@:'+4,Z#AJ.:XRHU[4+23]W%]SE5SDN#XQ4E6/"5@;0-L
M            :K]U=ZO]2Y&,;RUN6WMN9.IVJ?28P4;?XFT_L
MBKW!JO7FTJ9!,5^?8?092U$]5+RJYVWKF)=3\JY-3-<2(<9)N2
M)&)G7SJC*S9:)/*ONR-,9L73Y+QCP7.",^"&LO-?1KVJ[8>3C1^TIB37V>72U6,2LFL+(G&;"IH/HHLE"OF1(967P(B(IA; T:[H>UL;$R4XY
M4T[LT^#3N.J378XQZ8OQ3)K>7.AWM VCBX>5'IS)IW;B?!J5QU46NQQATQDN
M],W=&9F<             !"W[WM3:2NO&KK>,EQ=75;@C1[-+;).$T]9X?E!
M5TIYTN7&&4*ANM<\>"G'TD9^1H(].^=%J[+;^-=C_10RTI<.^W.C\.37=5KP
M-)^>5J[+;F+>C7W4,Q*7#ME;G1ON7!KNJUX%881L(N@  !:T]F&HM:WJ#8S+
M#U?I+_<6:6]%ZB"2C[J9I,/H7O0,E*]1K[[I)G)F1?/Y%Q\.3E#Y/VKMO:\=JXV[-*>%<:AF6WU6KE/BRI
M2C[>B2X27HE1N*,.WMM#%WCI#P;C5O-MOKLW*5Z9THT^UPFN$DO"5&XHI^;G
MT7M3K]F,O!ML8A:8K=,+>.&[)94Y3WT-I9(*UQRY:)5?>5;GFG\ZPM?IJ/P<
M)#B5(3$O6-$U30&70<&U9B%QF&1SEH+Z6LCFJ
M-7QU*\56%S9.FW7TM8S_ )\B4ZTRG[/+DR(_1TO2-2UK+CA:99G>R)=B7!+O
MD^48^,FD>GI.C:GKN9' TJS.]DR[(K@EWRERC%=KDTBW9T-Z9TO3_5KM5,DP
M[S:&:*A6FQLEAH5](J3$;>*MQFD6ZVW(508\F6ZE#CA)7*D.NOJ2V2T,M2NV
M/M"SM+3':FU/4[U)79KE5F%71OC)MRHJI*8&P=EV-G:4[,W&YJM^DKT
MURJJ],(]O1"KHWQDVY455%;SC-C.P      . RO&*3-L7R/#+8SL6YA9,5+&O6Y0FN^,DXR7K392#[/=>,PZP;BRC5>6L/N-5\ER=BE^I
M@V8F6X?+?>^XLBA&7DUS*CMFW):0I919K3S!J-39F(7[EV_E[:U>[I>6FU%U
MA*G"Y;;?3->E<&OM9)Q["#6Z=N9FUM9NZ3F)M1=;   #+NB=*9MV$VEBFJ,"@KE7>33VVI$U32UP,?IFEI7<9+<.(X]"
MII87D\Z?)*<,DM-DIUQM"O5T31LW7]3M:7@QK>N2XOLA'[:8]J77>%:SQ-@V,>
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M99(JV2(= ?;)R^CS''MW=C*=FC:QJ4Q=87K*8MN
M3Y;(CK?:J+1Y#35A6626"^J5?'924D
M7,RW^F9(E^HCZDTFT?$KD8JBXG*BWS+*6H-08#HO :/6VMJ-FCQFC9X0@O%V
M?:3W4H^NN[N=X(P]::A
MP?6NN-@;"2]G-UE=VC!L-R?+2JCQ^@.HK%VIX_7SV:\YI99()CU_%3WI.>GR
M2'.*EII-MG67([%[2&FLTU3HW/YFPL-R?!LHRO9DA2*3+L>M\:N58_1XY1L5
MDU===1(,PH[]E/GDVKT_!1(Y)1_$DKK3?#D(\B4'(K*138_>W$2#+M)5536=
ME&K($5Z=.L9$&$_*9@PH4;]\3)?KI=9/EVL\NHJ.),QJ)8Y9#D6%K<4T"LANR[JL9;9-;B35
M(<0ELE+-*3N9RCTNC132=2UX+8J$!'N]:[W7M3:NJ*C7FI-IY]CN*:_L;!ZW
MPW ,IRBEC763Y%*CS:Y=C1T\V,W9M0,9B.NM*<\DM.M*\2)7)U[323JU4Z2J
MR1KVZM:7NJNHNK\:RN@ML8RR4K*\@R*DO:Z347$&91NZ.AR5R?=7-Q:<5'BU4Z
M23J3+=+, L=8=5=&89<5DVEN8."5]IDY5:UMG72D-RH-G!
ML+MQJ0TZE#J'DJ):4J(R*C-UDV=ER,C[QTWB&_M6Y9JG-V%KI,I@$RF9'2CZ
M^EM(KJ)=1>UBUEPB?4V#+;J"/Y'$I4VLC;6M)\1;BZH-55"I[OOI5V/ZNY4[
M)G8SD-QCU5.*?C>UL"AVLRC6W%>-^!8/V%8ER9A]TR;7D<>8;#K;K:E,K>:2
MEY5U&<9(IM-',8S[@_>5N!&Q#'MUY=9RDWS-(>M>+
M0,^[5Z;QRGB.LT5ON;%'FH3[IO/Q\8A91&M9;#CSA+-Y^/0Q'"-2N?)2>3^T
M=I.D6_ X7,NLBT*H    !B[>%A>56F-M6.+U=I=Y/$UMF[V-TU' GVEQ;9"G
M&K+[DK:VOJV),^5-FV9M-MI:;4KR5S]A:;-PC7Z)_!1$:
M3N+DETT352G%.I:$%L5"K3[AFF^Q.U>W6U\HQC1.ZLDQ9I[&:'';BDUCF]U3
M3(%#B5'729%7:5] ["F0Y-PS*=2IM:T\N&1*/CD7-MQ44FU4IR3;++.J\4+
M]7ZWPD6&8%A^*$WY)7Z98[CU=4>'FE*$K\/H^.2(B/_(0MVZNI41WT< J
M==LM ]DMO]N-Q9!6:)W/)I,AVE/HJ?)D:LS1VAD45/-8Q*HOF;5BE^[7J1ZK
MJVI#Y/5+&^VFJ'L,GRF*/,*&2[>:^R
MQQ@WBI+TV#8>ASR:+ZE['[U@B9FM(Y,C2T^E*W&&TCM"72Z]APU4J\9SHCM5
MU S8KJPQW/L M:!^0JIV3ACEJ>/2HZ/)#DBKS.C(H*HDN+P;T5]QI\F7/"2P
MCR- N5*,T4Z-&0(_N#=[,JAM8A5[FR^T6\DVF(^/XCB!9*]ZAK;_ #5S28FW
MD[CGE(X2HI!J)1IX,C2GCCH@N-!U,RIH7VV>SG8[)DYCMY&1ZVQ>VF%89!F6
MR/KI6P<@\C(WU5V.7$@LAE6$I))XEV?TT?P5ZB5/^/IJXER&VNR][>7>@=VPJ39.\;&RM+FU
MU=G-=4P:?+L\>D2K"?:KQYN!7UD.!/-QQ\S2RRRDU?!"1==45'FN"*=&V6]2
M(DD24D24I(B2DB(B(B+@B(B^!$1"U*A_H    *I?>'V_]IZ3V/E&8:YPR]R_
M3%_9SL@I+/%J^9=OX0S-D+ER,=R2% :D6%7%I7G?3BSG4G%?C>ER]Z_JMHN8
M335'S*;BZ\.1B/'_ '".ZV(U#>(5F\I,/WJ(J#4F-7U+:F6EJ2E1QV3-U!RA!"C9:%T!HO">N6KL
M>U7@;#I55,AV1/M)B6?O7(KV::5VF07#K#;:'9TYU*2(B+Q98;;91PVV@BMI
M2T;7&ZRUNLCKM=YI,Q^GHZZ3;7-K>1\N\=O=>-1'MIZT?LWJ6LE268#658_QM+W$UYD[
M>@NZ-Z'76;\12RBRIN,Y75RJ.T<;2E1-/JC.&;2E$A1H4HCKM1GXG2K1WK(>
MP'>'MTP6"RLGV?M.!826F9.+85C$>OJ)SC?HJ0B[K,!H:BLE18QFAU7UJ5,L
MF1.J\3+S+CIA'CP0JWP)B/;L]N>TT7:M;LWBQ 5LY,1V/AN&1WHEG&P-J;'<
MCV%Q:V45V3!G95+BO*CM(BK7'@L*HVH_P HS%Q;<5'BU4IR3;+#'7[#7M>:*TY@LJ.J).Q/6.#45FPM
M#C;B+:NQNNCVRG6W4H<;>E*,N/,Y)NFKX\\F./=PYT'4SN&O.F_=/N
M/EZ,KS2'FD:'--ANQVCNN3>0F&ZU#JR2S1QKI*[V\8CI)Q,=BOCG":67IK<8
M2?D1SA!41S1LL<]5^IVM.I^"GBN$M.6M_;?3R'F0CI8=V65MQ_2<-NONFTKL/
M!-TC<2[ZJ79TR?%QIW7Y-:IA79Y>V7])P6Z^ZDTKL/!-TC<2[ZQGV=,GQ<3V
M5:2W+@TIR%FFI]DXI*:6EM3.0X1DM.HU+)1MF@Y]:PEU#R4FI"DF:5I^*3,O
MB-6Y6C:QA2Z,S%R;4E]W;G']U+U=YJ3+T/6L"71FXF39DON[4X_NQ7J[SN>N
M^J79/:TV/"P+2.R+PI"FDILEXQ8U&/-&^1*9.9D]ZU68Y 2ZD_))ORFR-)&9
M'P1F5YI^UMQ:I-0P<+(G7MZ'&''OG*D%ZY(O=.VGN;5IJ&GX.3N2)W>E7M'5&L[:IV?V6?I,SRZNZ;]3G-K[#5/ FMY;1G#8^G*Y52]S)\>YW)N/V&J>
M!NX,S,X             #\.-MO-N,O-H=:=0IMUIQ*5MN-K2:5MN(41I6A:3
M,C(R,C(QPTFJ/BF<-)JCXID!W:_V:DY%?6><=7+NBQUNS>D3[#5>5ORH--#E
M.K-UU.%7T:+.^AAO+4?IU\QM+,<^2;DH:\&6]&;I\H5D7Y9NV9PMJ3;=F;:B
MG_HY).B[H25%V22HEH#=ODNLG(EG;5G;MJ3;=BXVHI_Z*:3HGV0DJ+LDE1*.
MV/[4/>IZQ1!
M-?Q\K=[NYT/$BHU^,[UFGIX7'+^37P-[>'%1K\9WK%/3PN.5/X-
M? E>Z7>TC1:=R*FVGV N:3/\VIG&;#'<&IH[LG!\;M6C]6/:VLZSCQY.5VT!
M?BIAOZ:/#BOH-?[Y5Z3C>T=G>55C2,B&IZ].%_-A1PMQ5;<)=DI-I.Q
MVS4VIPZVWBM+=:2MLY$?U&34E+BC'B[AT7'W#H]_2,ETA=CPES<9IUA)>B23
M:JJJL:T9X>Y-"QMRZ+?T;*?3"]'A*E7":?5":_!DDVJJJK&M&4L]Z:%V;UTS
M^TUUM''9-+<0'755\]+;[E%DU6EPT1[[&+1QEEFVIY:>#):2)QI?DT\AIY#C
M:8=ZWH6I;>SY:?J=MPO1?!\>F<>R4)?;1?PI\))232A-KV@:IMO4)Z;JMMPO
M1?!\>B<>R<)4]J+[^:?"24DTL.#R#QC8#KAUJVAVAV'7X!K:G=>\G67]M[;FI[FU".!IT&^*Z
MYM/HMQ^ZF^SP7.3X)-F0[:VSJFZ=1CI^F0;XKKFT^BW'ME-]G@N%AZ
MA9>/G6K=['?VLXJJNO6%E*)?J>DA_(6JWR\33Q]S-W2*.?B,8?E_LUW/>
M_0+/5_"I_%ZNG[!BC\N-D.[[[]'6.OTSZ?XO5T_8-H,'UU@&LJ=./:ZPK%<%
MHTFA1U6)T%700G'$)\"??8JXL9$F2HN?)USR<69F:E&9F8R7"T_ TVS]'T^S
M:L6?N81C%>EJ*57XOB93@Z;I^F6?H^FV+5BQ]S;A&"]+44JOQ?$[F+PO0
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MQWAXK?&=_P!AI>%O^D;IR]E*O!R19,ZD=+M3=0L5?K<,8:D%YM06%J+R)*GG'W4DX)$[4V=I6T\5V\->\S)I>\
MNR7M2\%SZ85Y13[FW)\22VT-DZ1L_$=K"3N9LTO>7I+VY^"7'HA7BHI^,G)J
MIM\,L,Q
M          "MWN3W/>T."]B=H:[@6V$U^'X?N3,<-@E+PZ*]*8QB@S.PI8CT
MF9(EDMZ0=3%2M;IFDEJ,U$1$9$5PK<7%/MH=')U+(9&2B)23)25$1I41D9&1
MER1D9? R,A;G<_T :@=[]RP-(=7-IY([,1&O,AQ^=@.'-$\VU+DY1F4.341'
MH*5J+UGZ2"](LEI+D_1A+/@^!W@JR2.&Z(@>]HW5\O-NU47-EQ5.4NI<4OLB
ME2EI\HR;K((3^)44%7S%Q*>:MIDIKDC(OH5'\#)(K772-.\Z17$M0"V*@
M
M                                                     &#^R6EZ
MSL+H[9&GK-YF(69X\]$J[&0A;C-3D6S69! C/.(1PIQM"D?
MYP\7<6CV]?T7(TBZTO?6Z1;^UFFI0EZ(S2;[UP/"W+HEK<6A9.C76E[^W2+?
MVLTU*$O1&:BWWI4*0&>X)E>L;=T[/@[>79FXRB^QK]U/FFN#337!G41:EF !FSKQHC,NR.V\4U
M-A,9PY]_,0NVMCCN/P<7QJ,ZT=YD]KX&A*(%3%$5\+I%<6CW-N:!F[EU>SI&"G[RY+VI4JH07
MQIR\(KX72*XM%XO"L0H]?X?BN"XQ%.%CF&X[38M115*):X]10UT>KKVW'"2C
MU74Q8J?-?!&M7)G\3$T\/$L8&):P<94Q[-N,(KNC%**^PB=&%AV-/P[6!BKI
MQK-N,(KNC!**^PCLPN2Z                                      #H
M6Q-6ZXVY0+Q?9V$8SG5 M9NHK/B4N N2TM^NFI3\$OL*;>3^XH
MA8ZAIFGZK8^C:E9MW['=.*E1]ZKR?BJ,\_4=*TW5\?Z+JEBU?Q_N9Q4DGWJO
M%/Q5'XFH#?M=]$FYI3TZ%B&^3ZI'IN; VL["]12C6:3K7D1
M? DD1$0Q)>6FR%/WBP5U5K_2WZ?![VE/"E##EY6;"4_>+3UU5K_2WZ?Q?>TI
MX4H;DX)KK M7X^QBNN<.QO",TEQ;[6^+[3-,#3<#2L=8FFV;
M5C&7VL(J*KWM)<6^UOB^UG%Z
M
M                       !5E]UCKA?ZNW];[245D^1&AB=:R8J[2/Y^)/MR'4M^1QW337+A2SGP(C2&CG1G)#DLB
M)3K*7"6Z[UE:JZQ.5+L9N%EGN]=1Z&M_5&IY?D26Y,
MS*)5''8:;,B-Q:/6,DGRA*SY2.BM2.>I$)?8'L5O3W"-NXQCE+B\Q<9,QZMU
MMJO&ENV#-:J<;?UUO;6#K<5$VR<882J;8OIC1(D9DS)+#27%*K1C&VCHVY,L
M9](.J-;U-T^QBLAZ%:9_DTEJ_P!BW\$G#BS+DFC:AT]:X^E#ZZ7'8BS88-24
M&\ZIY_P;-XT)H3EU.O85$J(W)'0Y
M
M                          #1[MWT(TSV[@M6.1MR,-V56PSATNRL=BQG
M+0HR"4<>MR6N>-F/E-+'=5Y(9<=9D,\J)B0R2W"7A>[-C:/NR"N9%;.HQ5(W
MH)=5.Q37!3BNQ-IK[62JZX-O#8&B[PMJYDIV=3C&D;T$NJG9&:X*Y%=B;37V
MLHU=8-LZ]F+M9CL^2C#[36VPZHB=RIV,R*R:_E)S+7NN*%+C12GH,R;FN0K;49&X<&I
M@1ZVH<\$$93>XQ\>QVT;N3]44E'X9HN-,\D=
MR9-U?I.]CXV/7C1N[/U12C'X9HGKZP=1=.=3L3=Q[6E,X]-ID&[T_P"DNRH[EQ^+HJ179&*45SHY
M-M[/C)3*0
M
M                                                    ZOF>$XCL
M3&[3#\YQVHRO&+ECZ>SI+N&U.@2FR,EH4IIU)^F^PX1+:=0:76G")2%)41&7
M*;7%1V$JPU]G>>:W;DN>HBE>^AS2C@$;A&;, K0X&0>B37*2^
MIL9+A*^)J,OE%17I=IUZ4=5QGV3M50YR'LNW3GN05Z5H4<*AH:#%GW$I/E;;
MDV:[E1>#A? _%I*B+[#Y^)
M4_:Y3=(0LG4M6F163DFT?B)>+S1&2XB*TLS-MI IN4IS=5X-5U7G^)V$YU?
MFEOQ;B1+9V0M7J+)/!),^3(OM'GVM:T>]/W5G+QIW7V1NP;^!2J>=:UW1+]Q
M6K&9BSNOLC=MM_ I5,HCTSU0
M                                           #HFRMF8+J##;C/]CY
M' Q;$Z)E+L^UL%+,C<<5X1X<.*PAV78V4UTR0Q&8;69)0DS'*3;HN8Y$*
M6Q_>QA1[5^'J;2CEG3L.K2U>Y[D9ULN>A*R2E:<]G3K[C>CH7W1ONXE+L2;>ZX@X*Y@$S%X2;"LR%^X@9 _D+-\_(99
M@RJR'*JG*=NH:4HU/22>*6GCP-L_*G.'0(8ME>2XO<9=^M>2.8]"JZ6;!@R6?0K)5E(GNNSB-M3#/H-MFDBY-
M3I']A#O"#FZ'#=#^G43M?2]NL+R;.,>PJ\PZKQO*/U4-%W.@SG+">W4U]O)7
M'7!0EM"(T>T8)1&9JY67V%QSQ./0Z!.IMF.IR
M
M                                                          !@
M3+>T_6K [-VES#?6I,?NF%J;E4]AGV-(M8:T<
M#'AY>Y]NX-QVGZWHVK5_1>5CY#7-6[D)M>E1
M;:]:,GCTCU                      -".^/>+&^GF#1$08D/)MNYE'EE@F
M)REN'7Q68ZB9D95E/TSS$MK'H#ZR0VRVMM^PD$;+2T)2^^Q@V^-ZX^T<)="5
MW5KR?NH/DJ0>*;]=2_<.WGU@NZROVKT;;G+(TJJZK4VVDNWW;?&#[DO9;^-%\UL#:/F+KNUK\+;N2R-(JN
MJS-MT7:[3?&W+G1+V&_C1?!JV[J7:V$[NUWB^T-=VR;C$\LKTSZ^0:4MRHSJ
M%KCSZJSC)6Y]%;U$YER-*9-2O3?:41&HN%'*O2M4PM:T^UJ>GRZ\6[&J?:NQ
MQ:[)1=5)=C3)>:1JV#KFG6M5TZ?7B7HU3[5V.,EV2BTXR78TS(P] ](
M
M           "M_[S>Y+.ZVK@ND(,YU&-X3C+&8WD%IUQ#4O+\G>FL0SG,$KT
MWUTV-PVE1EF7DC[R?(OROC<6EPZNTZ2?89LZ,^V1I/--(XCM??%/+$IHS2HVUD:%(625%6M133KR
M.LG0DIZR]B\*[/:II=EX>ZB.\\15V58VY(2_88EE$=EI=C23C)+:G$)]5+L9
M_P $%)BN-N$E)J-*:23\W*J\(1E&K.
MDI-/@3"=8LGS;-^O>GLUV+/;L\RS+ Z'+;JO<7\3(_2/%I1)X(ORU<\_#BO97!LZ3-[O:=Q
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M77K$RNMJI#BR3]?9XQ83K"'7+I0WH;B6D\H:=67@KI*ROM3E2[R?3%LH
MQ[-L/H46TE%N,[RY=4VN/2^RWRI\:KY17C6)JDY"IM[6AL
MH5S1V=A2W%;(;EUUK4S9-=95\MD_)J5"G0W69460TKXI6VM*DG]ABI:NW;%R
M-ZQ*4+T752BVFGWIKBGXHJ6;U['NQOV)2A>BZQE%M237:FJ-/Q18R]M/W*;[
M9%]4=>NPEN5EE]D1Q=;[(F&RQ)R.2PRIQ&)9:X7I-/W[[31_03N"7/67H/>4
ME3:WY!^7/F+?U&_#0-?GU99F1J>1#
M;NXI]69+A9O.BS<%GNSM7N++)LIFCF_OI-]IJ,,4,/   "P!['FX+15MN#0TZ6Y(J/NB'M7&
MXJU&::V5%L*[%Y>AS=;70K\%
MW--0N?#U6_@\20?D7K-WWV9H%QMV>A7X+[EIJW<_C=5OX/$L.C?Q(L
M
M          "G3[@&3O[ [H[RE1C7)7%S2-A,*.AWU22[AM3588J,P7P0V;D^
MG<4I!<<.K5SRHS,[N"I!%*7,MUX'B[&$8/AF%Q2;*-B&*8[B\612FVN"WQQ:G8^)QWB3]]4275FW806GEMQOUBQY;ZWX*UJ02C-QA2
MT-/N*+M.*DJ=IPG0N#X7F>+[$Q/'\XPNYAY!BN45<:XH[B"M2H\V#*1Y(4:%
MI0]'D-*Y;>9=2AYAY"FW$I<0I)6C33H^95.S@    I?]RLB?V)V\WQ8PB4MO&IY8=6>C\WCZ#Y(KN'""]!2?,N.X=CD;
M#\1Q7$H9^43%L/M(QI\*B0LO5S?:.)TCC7!&HX59 OLJ>>^)EPAN901TF9=&DH0^PW0QB4LC29)=(OFY/Q[W72B1Q G!R+K?U\RUA^/DNC]37*)!$3CDW
M7V*N2B4EM3*'&9I5:9D9]MI1I0XVXE:$F9$9"AU27:SM1%?KW.^CF!==&<4V
MUJ*/+I<'S#(GL5O,2DSG["'CV2OUTVYJW,?DS5/6":JU@5,TUQWW7?IW6"]-
M7IN);:KVYN7!\SI)4Y&Z7LO;/MLET_L[6%E+>EQM8Y736M$EY;R_NZGV!&N)
M"ZR,:_S+<--YC4V42$?$G9;BC+YBYZ7EQ3[SM%\"9P4CL
M
M                          !%A[P&T[+7O4B5CE0^['F;9S6BP.8^SYH<
M:Q]N+993=))Y)D2$3T8\U#=3\?48E.)XX,S+6/FSJ=S VH\>RVIY5Z-IO[VC
MG+X>A1?>I,U3YQ:K=T[:#QK+:GEWX6FU]Q25R7P]"B^]294Q$6"(X   4TV16W%+80K:JL8CALRZ^RKI+4R#-BNI^9J1%E,H<0HOBE22,5+5V
MY8NQOV9.-Z$E*+7--.J:\4^**EF]=Q[T;]B3C>A)2C)<&I)U37BFJHO?:4V
MG:^GM6[-)I,=>?:_Q'+9$5!&28W<:[G."DUZFVC)X
M](]0                  *(783&[+$-\;GQBX94S94>TL\KY*5)-)+-C)[,
MFY#7/Y4>6R:76E%R2VUI41F1D8A!K^/UA;O'I)7#9E+D)4YY%XD:>3Y^ YHP=F'   _F\\U':=??=;8
M88;6\\\\M+;3+3:36XZZXLTH;;;0DS4HS(B(N3 %,G2S/=3 )D@ER#V%V
M%K->A,L:TYLZX\--9M9I^[;
M2P?,H^M\LG+2VFT)]PS3%Q2]=-*+%"C)F*]XS"-LBE^MVN0ZE5S3]0_EFZ\7N[TD)
M0?JQCRJ/D.0*03J5H^:$P^9>1*(OW2/[#NY<(OT%)UJ3J?'Y?F\BX^TAS1@[,.  !3+[-39.Y>Z6V8]<^% BQX4..@U&EB+%:0Q'92:U*6:6FFR27)F?!?$Q:%4^H ?/*EQ8+#D
MJ;)CPXK7CZLF4\W'8;\UI;1ZCSRD-H\W%DDN3^*C(OM, +:4XAU-/2+0YW)F?'!EP1<&9];K]JG@D-DYYLL6LS+W4LJ4@R=
M5"=))EZ:B.M97%LZ3[C^_LH8)85.L=T;%DM.-0LUS'&<9K3<2I!248'56LV5
M*8)1\.1SDYN;/FDO$W&5IY,T&1+SXI"'(FT%$[@ =79S?"Y-@=3'R[%Y%H24
M+.M9OZIVP)+BFT-J.&B6J1XN+>023\?B:B(OM(5D"XJYC9*)N776<5J;!DH)9)42'XSZ5ER1'P8 Y,      ?
MAQQMEMQUUQ#332%..NN*2AMMM"34MQQ:C)*$(21F9F?!$ .NU^9X?;SG:RJR
MO&K.R96;;U?7WM7-G-.%Y\H=B1I3C[:R]-7P-)'\I_Y#'-&#LHX     !P;&
M38W)M7:*-D%'(O&//UZ9BV@.VK/I^IZGJUSLJW",Q%8     O2=6\/M, ZVZ(PR[;6Q=X[J; JVYC.(4V
MN';-8W7*LH2D+(ED<*:M;7)DDS\.3(C/@IL[9Q+N!MW!P[RI>MXMI27=+H55
MZG5$[]JX=W3]M8&%?5+]O#M1DNZ2@NI>IU7J,\CW#WP
M KN^[UTKOW@Q^
M\RN[J\;QFHL;_(+N:Q6T]+40W["SLY\I9-QXD*'&0X_(?=6?!)2DS%6QCW\J
M]'&QH2N9$Y)1C%-R;?))+BV5L?'OY=^&-BPE7>T?U1T)6,
MBCU3(:G>:XT=/9MI]JMJJKR/W$L2ZN)>P'"X<
M'-]URH;4DZ>4J06.X5$F-)=A665O1E,NRYDMI1.1ZV.ZV^MKAUYQAM3/KU(6
MW+B^1UD@G<>[T]]KJ?*C-[)VK 3+]-R)#>:QO5U%((C=9A-HDR:+7U/+2
MR1<>HM,IY*24XIQ7S"M[$/ Z<9'(93[9W=/$:IZ[?U _=1H:%O/LXGE&)Y';
MMI:(E$<>DJ[MZZL'5_YJ(C#[AF7Y/VX+OCK-E4&ARRYR3/=
M:0IYUF2Z[RZ9+F6E%'9?4Q,_5.9<.*G8W;5CA+,H1K3!=<)2'6DK43S:4(R7
M#FUP1N1I"3);$EKDU1I\&0A;$EA
M7SL2&UMK(E),A;--.CYE3F0V>\!$WC/E:SGZ[J-AMX'@V(YG>YOE6*_?43'H
M"KVPI8I,Y!8UOH12.+%H/-*7G%>"9'P2GSY75M=/;S.DJ]A _K#"MGYUE+59
MJ''\NR+,H,.5;,1L(CV,B^B08YM19<]G[KXF,,-?6H;6M)D1>J1&?Q%9M)<>
M1T5>PWGTCUZ[RS-RZGC9;B/8NEQ1W9&$EE%O-*U$S&C-*>?=-*$J6HFVD&?!$9GQ\" %*K4$.1NGM9KQF2LBHH+1J+")
M;[RO([B@AMF=<9F92(#9L_*N.V3_ $N0I[2Y',7V,F_%$[FL?=#*SPKJAV!O
MDJ)MTM7932QG#(C]*;E,!>+P74DHR2:VI=RA22/DO(BY(R^!]H*LEZ3A\BNE
M[4F)?K-W.P>Q4WZK.$XUG.6OH/TS1\<9=#C3=OV."T4.IRBXBUI?%.8BDP^NM2LC01)7Y>7)\\G=124%7N*;;J6[:RO9J:VOJXRGEQZV#$KV
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MIE/I3Y+4XHC4*WL0\#K[4C[H'KJ%#;<=E,XKD^)Y+:MMH(
MCY9HZNZ?N;!2N3X3%8?7\#Y(OAR5R#[3CI9L9[978[L:QV/PO0=CF5W=X%*9TJ=;.8NC&<9NK=:J218J5<8W.C3JA,?Z5"RB*6\HG6//AQ'6Y&/3U
M=IS%NM"RCD5W$QK'[W(YZB3!Q^FL[N:HS-))B54)^?)4:DH<4DB985\22HR_
MR']@MUQX%0IZ]):67L_NKH\K#]]3IFTF<]GJ_/<.R<3.?L*6ZKP-QPT^I1J4
M9*,TF7Y9^/)B[GP@_04EQ9AP//+Z0AP=\OBDC
M+XCCWD'PJ.EG?-4^XQNS7&L-OZ(VW.RG)E6VO\VP["\@NW9C>P=;YE*I9U-"
MBV$^ITHS(7M*6F>YYVI?DWF9
MYA<5&&ZTRS(GXEKD5Y8UKLJ7+I,6B-/,29CT1;_&1..MI61G^94I/Q3R7%VB
MCZQ'BRS69DDC4HR2E)&:E&9$1$1'8M'K?F]"%@&-Y%=P%?=1H3XIF(;4
MF6LC6[)==-:SZ5MPX'-&^)(G[3W4[9^J4YMMC:",QPAZU>G8?C^M+"594\>5
M]USCCW.6Y+C_ *S;$QYN;$.)5'(;/AM+\A!*0['='2[)/@CM%4XLFH%$[
M!5L]X3+/O_ME&H4.$;>#:PQ*B<:21D3SZRG+F;;=+O<*ZK=?NM>MM693;9FC*:&/?R\C^@Q"5.BG:W^475\
MXAF8V\TB0W&CV+;*5$DOE;(OB9&9])VY2E7L.4TD=UVG[T>IJJLF1]/ZWS/+
M\A-MUN'/S1-;BF,,/&7BQ+6W7V5W>V;+9_.J.;4%3A$22=09FI)67VL.?<1
M4E)V%]PSL*MYYBA]]#/FQ28U2,+43#!*4_+
M?5XI]>6^9N5?9MQ\#KQDRVOI;4N+:+U=AFJ<-94BBPZH:KVI#J4IE6D]UQR9
M<7DXD&:/O"\MI+\M\D\(2X\9((D$DBM6W)U957!4-3^[7??".IE4UC];$BYK
MN*[A%+I,-.0XU7TL!_UFV,BR^5'_ #T:N-UH_1B-J3*FFDR2;3?D^CM"#EZ#
MJY4]) %99KWE[\Y#80X"]@[(@MOI3(QO&$GCNL<=]?DHL::TE^KPZN=-H_%M
MZQ?5+>0DS6ZYPI0KTA Z<6V'W6H*EVW=U"5HU';)V1"HEGP=>.\78SJCE[%%9VN39!A]/8_
M=N5:BSZ19^$!EB22;&%3MW"7++";R/PYX^BA#)/'S(8>(O$)0C)>(3:+6.H-
MLX9O'7.+[1P&>J?C.55Y3(OK$TW.KY+;BX]C3VL=IU]$6VJ9S3D>0V2UI2XV
M?BI232H[9IIT?,J+B5Z/=IK=A:P[(0,KQ[,W9>V>IF)?
M?-G)MLEU_:U'YK949?9P5.XJ
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M$U>9F[ GR765N6,A@X5>OX&3#:6%V2^*CF*?-FR7>KOYC/5"L8Q/&(
M=?F&Z+Z#]96X]*>=^YL5JWR=;CY#E:HJVY#B9#S9E%@-N-/222I:G&6R2ISK
M"'5Q?(-T])7[.;W5[XY-/;CN;'V^XU);H;#KI(-9FLTJ4*_L0[D=.,C[=B^WAW U5CTO,,@U1-E4=2TN98SL3O\
M'9.,A?
MTS:'OR^)VTU5?CYUD]T=):V-4_);-S&ZJ
MC)UR!)C^HRA34_Y5>7S&1EQP?E6LKFSI)DV4JYNY[-9#9A-S+BWFK>;\T<^#K^Y='VUC+)U
M:ZH=5>F"XSFUSZ8KBZ<*MTBJJK548]N+=.B;6Q5E:Q>4.JO1!>U^/G$B?)9TWI;%*FK:=),2RV99V^0SYK!&DS>DT>+3\8C
MU;JD\I]--A,))\*\S_)&F=2\ZLV5QQTC#M0M)\'>0X%I?(:\WS=?:CTF
M7TED;*B07TT6>UF/YS;DMR_VBQAW+=>-(W(O
MT)^\:7KBSRL?SPW1;E_M&/A7+=>-(W(R]"?O&EZXLD]ZR^[+H+>UK6X?G$.7
MI+.K-;4:OCY-9QK/"KBP><)IFOK,S:CUR(LV0?Y"+&)!;6HR;;==<4E*ME;;
M\T]"UR['$S4\+.EP2FT[L\UU5FL94G
M&LWHI5+8>EX?4PUN>#]?;05.)6VW94MFPS,BK4E242&$*,C(N#\_5M,Q=9TV
M]I>8JXUZ#B^]=TEXQ:4H^*1YNL:5B:WIE_2NU27WT9)2CXI%*O
MLKUJV3USU=3GIVH
MP=*OW=RGL78=DHOX.J-:Q?!FO@\$QT "5/VT>C&1=@=C4.V<4_COE3V>;X;7\LMB9.X=2MZOGP<="QYJ56OZ:<7
M50BGSBG3WCY4]GF^%LH2F);@                   'X<;;>;<9>;0ZTZA3
M;K3B4K;<;6DTK;<0HC2M"TF9&1D9&1CAI-4?%,X:35'Q3(NM[^TCU@W!:SPZSCO0J_@_R6ZQZN8+XF:#,^1K37/*K
M;6K799.,IX>1)U?NJ=#;[?=M47H@X+P-6:]Y0[6UF[+)Q5[;?:
M[MO1SKQU9+Z_6^).3YG(CN-DW(
M9C3?IHE?1QY9%^>:K8L-MXN"<)?">-C[=V5H&V/;TZTWEM4=VX^JXUVI.B44
M^U0C%/MJ;.VUL7;FU?QFF67+,:H[UQ]=QKM2=$HI]JA&*?;4V\&6&8
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M)UA]WG2^Y+2OP[;52>DJP^A9DG1-RZK4G^'1.#?WRZ?OZT1M/:WG#
MHFM78X6KP^@YLG12<[?R5*7TQ#1$V4R)%
MI)4)^0LO)U"HK9G^;21U[4OM6=)+M,N>RUL2QOM.;2UO.E*DQ]>YK57%.VXL
ME+@5F>5\YQR RCRY;AG<8S+DI+Q+EZ2Z?)_8GB\N*9S#D;)>Z5EQ8KTNV7&0
M]Z$S+[+#,1A+)U+:E',RJKMK)E*5),W_ *BCII:%)+@R0HU<\),CZVU68ER(
MV_9+Q,YFSMWYUZ9F6/8'CN)D]R1$D\QR!VX4V232:E&O]12/DE$2?'XD?)<5
M+SX)'$"Q@+<[@    &O7;3+2P;K'OK)R>^GD0-4YK'KGOF+T[BVHYE-2J^3A
M?_WM8,_89?\ RE]I=HJLDO$X?(K1^UUB/ZU]T=7O.,$_#Q.'F.734J02R1]W
MXI;0*Q\S5\$&Q?6D19*X,R41<<&9&5Q<=(,Z1YEN$6I4.@[0UEANXL#R36^?
MU#5UBN4U[E?8Q%\(?9,S)R+85\@TK5"M:R4A#\9])>3+[:5%]G Y3:=5S',I
M\]E>ONQ.GFZW<7F3;)C[NG,Y-K3/J[UJY5W4QII/5-Y72HZ_*!=U+KZ3I'NY97^KO3N
MXJ/,T_KYL#!<4(B(S)SZ.9+SGP49&1$1?J9Y?'XV).=FS\*#",:Q)$@_ N#R^^DW#C*.?G5Y%A"%*\?@GA/E]J1WO/@D<0+#UE
M81:FNGVLYPF859"E6$QX^")J+#8)\<7,6;E:RE3:D+2N1
M/)MM)DI/"E%\2^TN8JLDO$X?(K#>UKB)95W0UK(=8.1$Q"MS++I:?3-:$'#Q
M:SJZU]:B^#1,7=Q%6E1_#S2DOW198^[A]@6.M&@7V"7B]4S(V8S
M,AY/*VDH5<3DH1X
MGL.*<:G7^\.7?J1U'[ WOKG&<=UM>8XP^EPVEM2\T0UAL-33B?F0_P#57R/3
M,N#)?'!D?Q""K)!\B!3V>\2._P"V4B^6VDVL&UCEMZAU?E\DNSETF)LMM^)&
M7K.Q"\$*^//!'7NOV?6=(\R>ONCOT^MO7?.MCP5M%E*HS.,X*TZ3*T
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M.NJ^T^"(BM6VW5\RJE0R(. 5^O>R+B7G/W_ )V\
MV9?3Q,$Q*N>\%\+^L>R.XN6R<,B;Y:^A@&:2\C^?D_$N/)>?)"!,UV*RS]1=
M!;JS!+ILOXYJS/+6$LO/R.QC8S9*K&TFW\R5O6'I((^2))JY,R(C,J,5627B
M=GR*DO2O2$?L)V3UMKFT:-W&7;-[(LP3RI*',6QB,[E9
M%RE-&
MCLI0RQ'89024(21)2DB(B(B%H53Z      !31[W92[G7<;?UHWS)<9V)-Q%A
M+*5K4[^H\:%@K#3:?F6XOQQY*2\>24?Y/P,A=P5((I2YDF43V/I#L6,[+[+I
MB2W([+DJ(C39241I"VTJ>CIDIVNTF0EEPS22R2DED7/!<\"G[[P.W09CPGV6
M=)5$UJ5G6T=AYFRRZAPJVHBT>'0I*4J,S8G+]+([%;#B>"/T)$9S]TEE^YU=
MY]B.>A$INJM.:PTCC#6'ZJPNEPNA0M+S\:JCJ^JLI2&TLE.N;22N1:W=B;2"
M29JL:IU&V?JH:L[Z='9=6GDV65+*XI0Q4Q:RGJ8Z6([22+EV0^OYGYMA,=YQE'6QX>68Y=UF(9M+C,
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M]C\LW/O"R@R;R77H+/M@6+!\0L?IK3(*?%:>'&]9?F<*MD_CVQZ2+Y?E?4-N8QE+_@9_#P^F
MIT\ESSY?'C@N:5Y/P#:I*DW4M/Y%E$_F-
MC]!&^/J&J?/4GUEH)1L14.O&DTM*%&*@POQN9-0CP*:
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M0V'0UN=O-85/,IRI7@6.NB.56>9]0=!WENXMZ>G!(M$X^ZZIYU]G$Y\_%(;[SJR);C[\
M*E;6M2N5&LSY-1_$[>:I-E1-*7?H(6-R6Y26S^")4Z09?!0I7)5E3L1VBJ(
MD7%,[                                             &!.S6_<:ZS
M:7S';V3-E-101&X]%1I?*._DF46;A0Z&BCN>#BVRES5DI]Q*'#CQ&W7C2I+9
MD/#W)KN-MO1[VK9/M*VJ1C6CG-\(Q7I?-T=(IRIP/ W/N#%VQHE[6,I=2MJD
M8UHYSEPA!>E\W1TBG*G I7;EW'L#?6P[[9NR[Q^]R:^?,U*69H@U53-^J*[(Q79&/8O6ZM
MMN$NM:UJ&OZCYDV][6UDJ?J;)[68]+LK.IJF%R;/!["5*=8_=S&O9EB#^T4H2BO0YP?7L,L
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M8WZEM8[@6/R7%H1D&:6K4A59$>],TN?=]?'C/SIGBI"CB17$H43BDQ=.-#%=Y;GL;3T*[JMQ*61\2U!_;W)
M5Z5Z$DY2Y>S%T=:%+C8.P,PVIF>0[ SV]FY'EF46+]I<6T]TUN//OJY2PPW\
M&H<"&T26HT=HD,QV$(;;2E"4I*'>?GY>J9ES/SIRN95V3E*3[^Y=R7))<$J)
M))$*-1U',U;-N:CJ%R5W+NR^Q=R7))<$DDDDCIHM"R   "Q=[1/=F[R
MIXNK.TKMZTL*VI>FZ=O+)[U9SU331E/6N!29+AF_,^Z:UHY=::S4IN&R^QY$
MVS'04@O*C>5[*?ZL:G-RN1A7'D^;C%>U:;YOI7M0[HJ4:T442/\ )_?%_+?Z
MJ:K-SN1A7'E)\7&*K*TWS?3'VH5Y14HUHHHGO&\S?X
M                              09^]UD\R)A?7_#$+65??Y1GF3R6RY]
M-4S$:G'*J"M7SD7FAG-I!)^4_@H_B7V*K65Q;.DS*WLRX_60.M&9Y"PV@[;(
M=NW<>QD\))TXE)C.*M5D)2B^)M1ESI#J>?B2I*OW.!Q=^-ZCF/(EV%([  0U
M>]'GE95:+UOKOU657F8;(3D33"C-3J*+#J&UC6,A*4J+TU'9Y/!0E2N24DUD
M1&9PRWZ'4.FL&)PDJR78MME!MDM"5N
MM89C;U6KY.?56TAW.$&?'R$KQ\OCXA97%L3Y'->RUB7W;H39F9.-^#V5;274
MM'^;,WJ[%<9IEL/$:2-PD_7Y#+1XJ/X&@S(B(^5<7G[27@2TN+\;YC*Y+31H(RY>@XLZE9*X2;1J+[
M3(CJ6E69UER(W_91Q+Z_-C"
MW4EP7DI"EESQR1U+SX)'$.99"%N=P -6^W/5S$^UNJ+#!;LX]9D]=Z]K@&6J
M8)V1C.2$SXMJ<-"3?=I+4D)8L(Z?]*SPM)$ZTTI':$G%U[#AJI4_QZ]W#TUW
MZB:VS)Q39>K\@1(#V]RW]1N
MKN_,D2OTI$75>8P8+OJ>D;5I>T\F@J727P9FIJRLVE$DN#69>)&1GR72"K)>
MDY?(KO\ M&8HG(NXE3;J0:CP/7V3<(G%6F5U$FR:_-F
MDS-=#7R^.3)//V\E\I][:K-'$N1&![*.(G/W%N'.5,^;>,:XK,92ZII2TL2<
MRR2/8MFEWGTVGG(^%/)+X>:D>9$9%Y$=6\^"1UAS,V>]YD!S#D3 BD=@   BY]WO+CQWJ)(HT/>"\]V/AF,K92ZI"GHU>=EFBS4VDE>
MJRU(Q1HS\N$)6:#Y\O$CJ6E[1UER-4/9%Q3YNP.2^/^4AWO/DCB!V3WN\DFQ<1Z]X>VI7W=>Y'L'))2269).;B
ME9BM77J-'V*4EC,Y/!_YI&?^4<65Q;$R/+J_[<^T>U&MG]FX?G& X[4Q\FM,
M75 R5>0IL52ZJ)63'I"2JZ2PC?3.(M$$G\YY^CW,=#-_?<_=?UMT.C8-7.F<67*2(N#XXX'2WQG4[2Y&EWLD45?(V%OC)7$H.UJ,-Q"BA+,R]1-?D5W
M:6%FE)>F9FAQV#!CX%IG53
MSGB7W%U7N,B=:(G\WVGDUHR_XK2IRKIZK'\;C,_$_!:&+*KFJ)22^UPR,SX^
M'%U^UZCF/(R_[H.6EBG2W:C;;WHS:"^5^+CN,WBD1'5^J7YM\?!7*V$GY)\>%U;*
M]IOP.LN1U;V3,?KF-7;KRI"&_O>USZBQ^4YX%ZI5V/XZ5E!1Y^1J]-4G)9!\
M<$7)?:?[G-[FCB'(FV%$[@ 14^\#GE9C?59G#WG656^Q\]QNMKXAF?K_ $&.
M..91:63:24DO1B/UT1A9GSPJ8@N/CR56TO:J=9^Y
MAN$5,KA7#\R(FXOLACD?)((XK$VK4?P49^M_F\?-VO/DCB!-3M[7L#;.K-A:
MSL_2*)G.'W^,F\\1FB')M:V1&@V!>*'%)=K9RVY"%$E1I6V1D1\<"BG1U.Y4
M3Z>9Y8:%[=ZHN;GSJ3I]@IP;,&9/*4P:[(WI.$9(4UO_ #BJ6[-Q\RX,TN1R
M41>22%U-=4&4EP9O7[NO:!6>9_6=<,-GG(QK7,QJSSER$XI;=QL*3'4W$I5$
MV1H?:Q&ME&E1)4?[_EO-K23D9/'2U&BZGS.9/L)#.KG2"-KSI3G&K,DKV6-E
M[ZP:[E9V](;)N33V]WC\R+B&/.*<22FU8,F8A2DJ\D(LER5I,T+(4Y3K.O8C
MLEPIVD*GMJY]*U5W/UW!LE.UT?,7[W5E_&=,VG3?R",XW40'D&9$:RS2MKB-
M)_YR?A\2(5KBK ZQX,RA[HW:1[?&YF=283+=GZ]U-92J9A->HY+.5[$=6<"\
MMHZ8_E]:Q5J+[L@<$OE29#K2C1)(AQ;CTJKYL2=7X$U/M]]5F.L&D(,:[A-M
M[1V F#DVQ9)I+UX,DV'%4N(DM*W$G'Q2'+6VOQ,TKFO27$GX+22:-R75+P.\
M51>)BSW=\ID8]T_GU3#Q-(S?8V$XM*3YJ0;\>,JTS+T4DDC)P_J,1;6:3X+Q
M09_N<'S:7MG$N1!%U'Z59[W!_E!_4?*\0QC^3O\ 53[T_6M5RGZ[];?UE^B^
M@^Z*NRY^F_5A[U?4\/\ 2(\>?FXKRFHYG/0Q_^CW,=#)V
MNL6HI^AM"ZTU):V4*WM,+HWH-E95OU'W?*L)MI86\U<'ZIF/).(F38*2WZC:
M%FDBY(C%&3ZI5.Z5%0JJ=VKJ7L_NKO Z_P#?4Z9M)[ H"?SW#LG$S@:]B-)\
MR<<-/J4:4D:2-)E^07CP0N8<(+T%-\67!\9H86*XWC^+UJ4HKL;HZFA@(0@F
MTHA4\"/7Q4I;(U$VE+$=)$DC,B+X"T?%U*IS@
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M'V93#,F.ZAZ/(:;?8>;42FW67D$XTZVHO@I#B%$9'^Z1B^/L*QE[.TOJE+SB*FAP.QV$['3Y):E6.6Y!88W'>>+GP=<@
MQL*=2UR7+927./RS$=_.K/N2U+#TM-^ZA8=VG>YR<%7T*VZ=U7WD:?/74;D]
M4PM)J_GHNH3TG5L;4
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MN[/: U!@VI<:,GX.(T[<678FUZ+MW>2G
M')^07K[?FZ;;MQ]7EIV&[=3X2A[U
M&<7UG)R!;2? TL3;<:-J9D4?)0K65Q;.DSG/92Q$X&FMO9PMGTUY/LBOQQMU32D+D1
ML.QN+/;6EQ1\/1T20DR+@G$K+DSY)*\^*1S#D32"B=@   C!]R#I$SV/P
MD]CZ]JVBW9@M:[](Q'0AMW/\:C>I)>Q62HB+U;F&:ENU3BC^+JUQU'XO)6U4
MMSZ71\CK)5])59=:=8==8?:<9?9<6T\RZA3;K3K:C0XTZVLB6VXVLC)23(C(
MRX,7)3+>7MGXC^J/2[3S;C1M3,BCY+ETTS)"?6^_\KNI5:[P@U? Z),0B,S-
M1DGGX?DE:W'6;*L>1V#W$H]X;LQC.8SL.Z
M]85=0[M&'7@QWZJ.M;:[*IAV,YRT;I:=K;K?,SR[B+B7.YL@+)HC;J#:>3AM-&558L;J%*4
M9E.?7/G,KX(EQIC1D7[I]+KK*G<);"M(F08IDEG(*)45.;(BL5,VON);IE%@1,DK(T4FY3JFVF7H2
M4+/AXE([W8-\5S.L73@664+0XA+C:DK0M*5H6A1*0M"B)25)4DS)25$?)&7P
M,A;E0PON[L+J+KQB[^5;5S"NQ^.EEQ=;3I=;E9-D+Z>21"QZ@:<^OM)#CA>)
MJ2DF&>?)YQMLE++E1-!$VV;I-(\D(2M7,X]+H$ZJI%][W67$BNT!@
M;+W)R9N=9=8QR=27IE!8QZFI7EL\&I7K?>$]*5&:2+P41>7)^-6RN;.LS9'V
M><250=3YE\ZWPYG.T,LO673X\EP:R#18FTT7!%^;:G8_),N>3\EJ^/'!%UNO
MVO4HUS9WVI]3;,@QG9,/7>77U%=*:2M7T,#8$*H]"QD^)^FW$*UQ.
M-&-:OL>E-I+\HQS9?%HXF:]^T3VMP[7KV5]?=B7L/'(>7W[.6:^N+>2U$J'<
MFE0H-+=8S)G2%I:A3+B-70W8!+-++KS3S?D3SK*'>;L6_:0B^PL5B@=S3/MQ
MW7U9U3Q6QULU$XN0^25OH2I
M,=+KGP+O&#D_ X;IZ2._VWNZG:O>.W+O LRKH6R<&DNV^59'ETJ.FDD:O8L7
M9TN%!@3H,1<6QJK"S5]- JI*52$-I/T'VX\9:"[W(1BJKF=8MMF\/N::TL-F
M=/MCM5$90N$24+5S$Q69/>(B+E1MD7)$9CI;=)
MG:7(@<]MGLU0];=]F[F\PJ_7NQZ',Z1=&6T:ZRKKB!#M:B?"M*NQC,S*^RKI3$Z!.B2
M$$XQ*AS(SCL>5&?;42D+0I25)/DC,A:E0Q-N[L!JCKSB4G,=J997T$-#+ZJR
MI)YE_(\DE,I(RK<:H_51,MIKBE)(_ B:9(_-YQMLE++E1>-;[LF2X24I=F2'5I2
MA*DH3=QCTJA3;JRT[[?^)%A?3C055Z/HJL,);RU9&2O)P\ZL['-$/*-?SJ]5
MF^2:?W"1P2?E(A;3=9LJ+D:2>]7EOW?I34N$(=)MS*-ER\A6V2EDX_$P_&I\
M)U!D1>"F$2LO86HE'SYI09$?!\=[*XMG6?(_?LJXE]WZ0VOFJV_!W)]G1\?0
MI7JDIV)B&,5DQIU)*(FC9^JRY]!*29F:T+(_R2"\^*7@G<6U',IJ57R<+_\ O:P9^PR_^4OM+M%5
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M5#/G8W5DZ1?*S';6KCYE<)(U%RDY.B%4N956[.;[V1W^[#4=?AF.V[](
M:?U^TI#\V-"ENI>G6UJ;2_H6+>Z5%^KLG_+T(<1AMM;JVHOK*N8Q4(\2DWU,
MLX]5.O\ 4=9](8AJJN>:G6->P[:Y;D>Y.VXU&],HWF<]1L?$K&O<=A/5Y96<7.*V53R63;
M<852V-DIEI;9D;3L8R(^4B[@ZP12?!FW7M-]4/Y4-BR.P&;5IOX-JZR0UB3$
MQLEQ\CV0EMN6Q*X7Y&]$PN.\W+49DDE3WHOBI1-/('2[*BZ5S9S%5XEF,6Y4
M([O=)UQ:;$Z?9L[3L.RY^O[G']B_1LH);C]=2/R*Z^=+DR\$5F/W4J:L_M].
M,HBY,R(5+;I,ZRY$+'M?]HL9ZZ[HNJ/8%DW2:^VU5UM%:WTETF:W'P/974O6G#I
M66[-R2+!=..\NAQ:&\Q(RS+)C9>+<''Z4W42)/D\:4.R%^$2,2B4\ZVGXCM&
M+DZ(X;2YD*'63W%>VFW^TZZ.AQFLSC#]CY$A9ZTD&N)7ZVQ&(3<5RYKLPBP'
M)=6U2UJ6W;"1*CR8\Z1Y>G&;?D-D565N*CXHZJ3;+$$Z;%K84RQG/)CPH$61
M-F2%DHTL18K2WY#RB0E2S2TTV:CX(SX+X$*!W*:W6:%(W+W3U/(L&525Y9O.
MLS2X86:U&_%C9*O-;MIU2%*<\7(<)XEJ)7)$9GY%]HNY<(/T%)<67,Q:%4
M                                            "LI[XF-2HN^-09BM
MMTH5[J-S&H[IF7H+E8GF606DMMLO3(R=::S1@U_.KDEI^"?M5&_SIQI1US$S
M'7HGB="[JPN2D_ZQ?8(P>>F+.&OX>:T^BYA]"[JV[DY/^L5?5ZX31IHT@
M  ?=5ULZYLZZGK([DNRMIT2MKXC*36[*G3I#<6)':21&:G'WW4I21?:9CO:M
MSO7(V;:KVZ)>ME_P"J('W54U=7ZOK_
M ';70H'K^GZ7K?1QFH_J^EYN>GZGI\^/DKCGCD_M$[K4/=6HVJUZ8I5]"H?0
M:S;]U:C:K7IBE7OHJ'(BH5
M                 "L'[WF,3(/8O6.6G'<15Y%IR'3,25>H;3]KC&8Y7(LV
MVU+6I"51X&2034A))(O,E'\5&8C7YT8TX;@QLNGXJYB**??*%R;?P*,FHKAZ67.'C7,W+M8=K^EO7(PCV\9245P[>++_ ()VGT%
M                                       #CK>HJ[^JLJ.[@1+6FN8$
MNKM:R>PW)A6%=/8O9UG'@9CC#;JC=7!JYUQ)8KLHJ89>1-*2E(81C32:B0
MRHW#Y-LU(,S/_I':MM\Z'7VEWF5-<^VQW-WQD*;K8-58X-"FOH^]9I0I]Q]Q"7"H2
MFY<^1W2H;FDCUV4+4@B5P1&1%7A.$8T;XG22;9.GI3"G=;Z=U5K]]E
M#$K"=C/69YG@E"AK)KC(;)ZUA(KL
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MD@M6>/932VF/7M<]SZ4^HN8+]=90W#29*)$B')6@S(R,N?A\1QRX@JQ=B?;
M[&Z@RBSDZVQ>WV]KTY;DG'[W$&VYV4PXJWUG$@7N*QG"N_O>(V1>;\)B1$<(
MB62VU*-I%S&Y%\^#*;BT8W:PSW)KF QB*Z#NH[1NH7&;I+2-NN)CB&C0Z:VG
M6;7Z>EC,*0M9<+\4'Y&7VJX/FMOGP./:\3<;J=[2.P+_ "&FS+LU'CX=A=?*
M8GJUQ#M(L[+;1)B.&EY'65UMQM[!PB4X],9PFQM(==F^-)6YYKKHDNU?B
M5F4UT9!F;+OKLSS01-J9><3ZSMQ&ZG\;F4W'N-0*7 /<9U]$).>0JUS+<%O(;N'$I4DG>*1UVQS*?,2R9FWZT=EA9EXF\
MC[2X=R"Y'/2V66NN6EH'7C2F!:;KKAW((^%5\^.Y=O0D5JK2?;W5GD-K-*O;
MD3$PVG[2W>-#?K.J0C@C6H^5';R?4ZG=*BH1,>YIU+[2=CMXXO?:IUHO*,&Q
MC7%701[$\TU]2(7?/7V16MPI$#),KIK-!E&FQ&C4;/IJ](C2H_CQ5MRC&/%\
M3K)-O@2=].-57>D^LNH=9Y-7_=.2XYCDAS(JOZROL/N^^OKJTR2YA_754B76
MROI[&X=3ZC#KK:N.26HOB=.;K)MCOH0XVI*T)47";3JN9R5F.QWM0[[U
MA=VEGJ"N=W'KQ3[\BL.J=ALYY4P3/S:@W>-O.156\N/Y>DE^J^H^I\/44Q'\
MO23<1NQ?/@RFXM)GW2/M1]E=LWC5WN):=2XS*E%+MK'(YT;(<
M\MFUFEQXX%#"G2E,S)!F:%.6DF*ML^5^DZ1$E7#NQ7+BSE1?:6)=$:!UCURP
M2'@&KZ%NJK&E%)M+.0;NX9K1IW'\#PGN#A$$I"TN0
M<(I=Q45.MYUSS<=)6.,QZIY+CBO)3A*-)G\35^Z*C=M\Z'7VO$V6TQ[8/:3?
M.31LHW]8W.N\;=4TJSN\WMU9+L>WB(-:SB5=*_/GRX;QK,TFY:NQ29\S<2T_
MQX*Z.Y&*I'FJ
MD7T^(<77AR++V!XTUA>#89
MAS!))C$\4QW&F20I2T$U15$.K;)*U_.M)(BEP9_$R^T6[XNI4(C/=)ZP=D^R
M.9ZG3I_7BLPQ;"\8R$YDX\PPF@1%O\DM813(B8.4Y/225J^[J"(LW6FE(42B
M2:C-'!5;>6WF55+=E6VZ(4VUR
M6R57-_>-/-L:N0L\=8A&OT'EH2LS3R9D9GTFU*55R.4J(W.'0Y     -->_6
MO-I;:ZOYUK74&-GE&79=/Q.$JN3=45"M%-79157UH^F?D5I3UA$;=0EI3:GB
M4M#JB(C'>#2E5\CB7%<#0GVP>E>]^OVWL\V!NK T8?'D:[/+COQ);#,J+*9=CR8TAI#T>1'>0IMYA]EQ*FW676U&E25$:5),R,N !7L
M[<>T;E4:^M5'224(7),R\:\+JY2YG1Q[C0>@U;[AVJRD4&%85V]PR*PXXEV'@%5MV!3K6
MM9+=4R]B"/NF4EQ:2,U-K6E1D1\F*E;;YT.OM>)D?!/;Q[N=@+V/;9OC^08O
M&D+;8G9GNR]FQ[*/'0HU*25-8O66;2UI0:O33]&EE2S(E.((S47#N0CR.>EL
MGPZB=%M4=3*MV;4>>9;+M8R8][L6ZA,,S4L&1^I58Q7I5(1C5*X9\N(0Z[(D
MJX-]YQ*&D-4)3MFE<-U
M32>A(DU$+Z[*+AE!I_6',+-*)&0W2E+;;>4P],_-14N%YLPF66C,_3(4Y2ZG
M4[)45#/PZG)!-[HG5S+-R]D^MRL!K_5M]K5-GKJSG$RM4&F1AME^L#N0W1MD
M1E%@X_DLIYQ15/V=Q/4GY7+*ZLGG94A1<)-YY7B1)X(J3;;JSNN!DD< ^>7
M$BSXLF#.C1YL*;'>B3(2ME^.^RLTK0HC2I)F1D9& *
MY/;CVE\_Q[([;,^LL!K,,'L7WIYZZ=LX\3*L34X:7'H--)N)+$;):5I2EG'(
MWTV#;?BT:)"B-Y=Q"ZJ4ES.CCW&DV-:T]PO6D>10X1A'VMW*WOD17>PJJPP
M.%/D-'<9IMRY?DY"^VDR2^IJA5*LM=EUSI7;5+@%:=OG%UKC-*;$JTIT&L.5D5M
MCUA75"?K[.5!@121.DH4:GGF4$2?BM/Y1<1I55Y'+Y$'WM\]!^R6G^SN)[-W
M!K9&)XOB-'E\B)9KS/!+TW+NXQ^;C,.(B!B^4W4]2UQ;M]?FMDF4$V9FHE^!
M'6N3BXT3XG2*:?$L+"@=P
M       (W_<_ZPV?8_KN_+Q"O78[&U//D9OBT&,SZT^\JR@N1LLQ>"DN7')-
MG7(:E,--I-V1,KV&4_%P:\\RMM7-P[?''JU+$D[MM+BY1I2Y!>,E222XN4(IM=W=@Z;9-Q6+/6>E+*%E5I/E,
M.?16^:13^JP_&X;ID34B7%LD-VAJ-Z/\
M\;A24Y-KA*XN-N"[VG2U*DY=T8T?QE6VP)4DNP
M                 (WO<\ZLV7970!S<.@.6.R]3S)N88E7QVS=F7]8]#2SE
MF+0VTDI3DRU@Q69,9M"3H8UYYD[8N;CT'KPX]6HXK=R"7.2I2<%
MXR232YN44NTUKYH[5N[FV]UX<7+4\23N6TN:Q5I_[RD.)41LR
M4Q$\*)Q7CMGRHVQI[*7?[NO6WV2Z%QJZ6G!)PE6
M                                                           '
MSRXD6?%DP9T:/-A38[T29#ELMR8LN+);4S(C28[R5LOQWV5FE:%$:5),R,C(
MP!]
M             /XO1X\CTOJ&&7_0>1(9]9I#OHR&N?3?:\TJ]-YOR/Q47"BY
M^!@#^P  #^2F&%NM/K9:6^P3A,/*;0IUDGB23I-.&1K;)TDD2N#+RX+D ?U
M
M   !"IWF]J"LW#=7>W.O,FGQ+8=N_(M,JP6T<=E3KJJL4^NC&5MO5[T]6T!PM:A-N4[4N$+DGQ=4VWKVBS<-4Q+]FG:X/H=.=
M)JL)+QC)HQC18UD>4S45N,T%WD5BXI*&X%%53K>:M:R6:$HBU[$A]2EDVHR(
MD\GXG_D'FV,;(R9^[QK<[ESNC%R?P)-GEX^-DY<_=8MN=RX^R$7)_ DV2=]9
M?::[";BM*ZVVO4SM'ZZ\F9$Z3DT9#6?6D8S\G(-+ACROO"JF*(B2IZW1#0R2
M_-+<@TFT>R=M^5FOZO=C=U2$L+3^;\2/KKN[GJ2EZSNK)Q!*>?<^)\)0@D-H0A,D](TC T/ AINFVU;QH+
MUM]LI/[:3[6_0J))*46C:-IV@:?;TS2[:MXMM>N3[92?.4I=K?H5$DED\>F>
MH                       &K_:GMIJWJ3@:H\XRR[C6Y]U:9M7!^EY[;O3JK=N/
MQ[DE2J7=%575)\%55E.;@YS8ZEPYUQU,'$-8SYF.K:B+)"/2MLKB.,91=O/--
MD3Y+D-1'%*7X1VD*- C;KOF1NC6KDE"_+$Q'RMV6X/%1?&D4G0B]
MN#S/W9KMV2MWY8>$WPMV&X5(>5
MYO2)%]:O/.K/X>3CKDM3BU<%]IF9C"I9N9.3E.[=]OJI^AD1&L%W#1PBEWN#2
M)J9$6WA-F2'L@PR:[Z;]I5-K4GZAAQ!2H*UDE?J-FA]R1FS-^:?NRT[$DK&K
MPC65MNJDON[;YRCWI^U'MJJ286G;QM/'DE8UFW&LK3=5)=L[;YRCWI^
MU&O&JI)R"C/#88                        !#=W>]J3&MXVUSM31,VGP'
M9]HZ[8Y%C%DEV+@^:V"S4Y*LFW83$A[%\DG*/R==;9G
ME=C:W=GJFB2A8U*3K.#X6[C[7P3Z)OM:3C)\6DVY&F-\^4V-KMZ>K:#*&/JD
MW6<)<+5U]LN"?1-]K2<9/BTFW(@)V5TX[1:DL)$#-]';#B-QU^'WQ3X_,RG&
MWN5I;;./DV,(MZ)TW5+3PCZCU"\B(TD?P&BM1VAN;2KCMYN%D)+[:,'.'JG#
MJC]FI'_4]F;JTBX[>=@9*2^VC!W(>J<.J'V:G0:30V\VO*35L^Y'(U]_1,'
M@W!-.[)=W"L8>F59+[@VCM;R;UG4+LZ]PO5.&T.O]>X] Q;#\:B'"IJ2M0I,:*TMYV3(=6MQ;C\J9-EON/R'W5K>
M??<6XXI2U*,Y%8&!AZ7APP,"W&UB6U2,5R7:_%MMMMNK;;;;;),Z=IV%I.%;
MT_3K<;6':5(QCR7&K\6VVVVZMMMMML[F+PO0
M
M
M
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MY31J9D,+(VGV'%MK)2%*([O SLK3UBUK^BX^KV517K
M=6ON9IN,X_P9II/M2J3FVWK=G<6AXVLV517[=6ON9IN,X_P9J23[4D^TS8/9
M/<
M
M
M
M                                                 TO]Q&_GXUTJ
M[#6-0:OL22C,S(B,QA^_P"_
M/&V;J%RWPD['3ZIRC"7V),PKS&R+F+LC4;EMTD['1ZKDHVY?R9,I9"'1"8
M    "T?[)N16%GUBSFAF.*=BXQN.Z:JC4OGZ>%;XKB5B]#0CQ(DMHLE/O<\G
MRJ0K[./C)GR:R+EW;5^Q/C&UF2Z?!2A;=/AJ_62H\D,FY=VM?L3XQM9LNGP4
MK=N5/XU7ZR8X;<-S
M
M
M
M
M   :S]R=/)Q2YN4?;BO7**7K,8WGIMS5]JY^GV4Y
M7IX\G%+FY0]N*7IE%+UE'H0M(,       6Q_9VUQ.PCJ(SD=E'4P_M+8&3YI
M!]0S)TZ.&Q5X;7>31\>FV])Q>3(;,RY6V^E?)I4CB4OE'I\\+::R+BI+*R)W
M%^"E&VOLP;7>G7E0EOY-:;G7E0E6&T#:X
M
M
M
M
M                                               5,OV[J<]6P8-
MZ'DS;5%PM3?&5N7=%NKM]E/9YQJXKQK$U2   &W/3?J/G/;?:,'%:.-+KL&I
MI,*;LC-_1_>.-4"W3-<>.ZX7HR6C*]H;4S=UZG
M'%LIQPH-.]<[(1[EWSEQ48]_%^RFUF&S-H9^[]5CB6$XX$&G>N]D(=R['.5&
MH1[7Q?LIM71<4Q>BPG&,>PW&*]FIQS%:2KQVAK(Y&3,"HIH3-?7Q&^>5&EB+
M'2GDS,SXY,S,Q,/%QK&%C6\/&BH8]J$812[(Q5$O4D36Q,6Q@XMO"Q8J&-:A
M&$(KDHQ227J2.?%KJX4])9:C] ^@W?TI[K]'=#]Y[
MRG1T]O5U<*>DI[=HX70M_,,B?ZW9-NRJC,SI!,54C!J*_P!<6"S,OFQ6_P A
MV'C6P*BG0KDDIL:V<\H^32:4>)")6YH;&EEW);=N9L(J3I%VXSLO\"4[L+L8
M_APD_50AQNJ&P)9ER6VKN="*DZ1=J,[+^;G.]"[&/X<)/NX4-'1A1@IL+I"'
MU:.[K9?83(]VMU*)3!3*'66%8NOM^\Y=77[7*O"AL:,A,D
M
M
M
7                           #_]D!

end



GRAPHIC
21
leu-20211231_g2.jpg

begin 644 leu-20211231_g2.jpg
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M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HK,\93>,K?PQ>2_#[3=,N]9$6-/M]9OI+:U9R0,R2112. !DX"$L
M0%RN=P^4_P#@BO\ MK?M!?MW_LR>+_BU^TOI_AVS\2:+\7=>\-?8?"MK)%96
MT%BT,:I'YK-(_P Q_8M_X)H^-/
M@QI_Q2;0F\4>*Y_C'J-TMI;Z2TC6]K;6\-FKS2W,\J7$@(4K''8ON(,D>>E^
M&OQK_:O_ &-_V&?''[2'_!6KQY\.=1USP;;:AK5^_P ([&[CT^/3(85,-O']
MM"2374DBN!E44M+&@Z%F /IVBOSU\8?M[_MP_ G]@+PO_P %:_C.WAR[\':G
M%I&O^-/@YI'A]A/H7A;4YH4ADM;\R^9/J-M%:@AEQ,BQPX5Q]^^&O$>
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MHHH **** "BBB@ HHHH **** "BBB@ K\]/^#;3_ ),]^*W_ &+.\U/3GNX(GR.7A2:%I!C/ D3Z]J^9O\ @EC_
M ,$]_BE_P3F^''BSX6^+OVC=$^(&F^)_'6J>*Q-9?#Z71;BUO;]XWFCW-J5T
MKP@HVU=JL-_+''(!A?M\_P#!"[_@GS_P4,\0ZK\5OBM\.=1T7XF7T$(L?B=X
M7UZZM=4T^:"-8[>5%\PP/Y81,*\9'&1AOFKX*_:@\=?MB_$K_@V9_:G^!/[2
M7BRX\6>/?@;\37\ WWC+#&;Q)IFE:WH]P;]V))8FUF=69LLP@)D):;^T)XR\3>$?\ @HMX7?X:^*+\7&D>&/$OP=<^
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M-7:* /$_VT? O@G0?V6/&^L:'X.TJRN[?1'>"ZM-/BCDC;[(<*@ 8;>A]:W*Q_$O_(7T?\ Z_3_ .@F@#2_L[3_ /GQA_[]"C^SM/\
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M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
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M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%9-G:VK>,KR!K:,HMI&50H,
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MP#D\XK_]<#5S3O^0?!_
MUQ7^0JGXQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "% $U%%% !1110 4444 %8]E_R.
M][_UY1?S-;%8]E_R.][_ ->47\S0!L4444 %%%% !1110 5F^,?^18O?^N!K
M2K-\8_\ (L7O_7 T 7-._P"0?!_UQ7^0J:H=._Y!\'_7%?Y"IJ "BBB@ HHH
MH **** ,>R_Y'>]_Z\HOYFMBL>R_Y'>]_P"O*+^9K8H **** "BBB@ HHHH
MS?&/_(L7O_7 U_]>47\S6Q6/9?\CO>_P#7E%_,T ;%%%% !111
M0 4444 %9OC'_D6+W_K@:TJS?&/_ "+%[_UP- %S3O\ D'P?]<5_D*FJ'3O^
M0?!_UQ7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /*/VY_P#DT?Q[_P!@
M%_\ T-:[KX7?\DS\._\ 8"M/_1*5PO[<_P#R:/X]_P"P"_\ Z&M=U\+O^29^
M'?\ L!6G_HE* -VBBB@ K'\#_P#((E_Z_9O_ $*MBL?P/_R")?\ K]F_]"H
MV**** "BBB@ HHHH *Q_$O\ R%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@
MF@#8HHHH **** "BBB@ HHHH Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O
M_0JV* "BBB@ HHHH **** ,?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\
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M]<#0!R_P"1WO?^O*+^9K8H **** "BBB@ HHHH S?&/_(L7O\
MUP-7-._Y!\'_ %Q7^0JGXQ_Y%B]_ZX&KFG?\@^#_ *XK_(4 34444 %%%% !
M1110 5CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S0!L4444 %%%% !1110 5
MF^,?^18O?^N!K2K-\8_\BQ>_]<#0!_]@%__ $-:[KX7
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MW_KRB_F:V* "BBB@ HHHH **** ,WQC_ ,BQ>_\ 7 U47\S
M6Q6/9?\ ([WO_7E%_,T ;%%%% !1110 4444 %9OC'_D6+W_ *X&M*LWQC_R
M+%[_ -<#0!_]<#5S3O\ D'P?]<5_
MD*I^,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%% !1110 4444 %8]E_P CO>_]
M>47\S6Q6/9?\CO>_]>47\S0!L4444 %%%% !1110 5F^,?\ D6+W_K@:TJS?
M&/\ R+%[_P!<#0!_]<#5S3O\ D'P?]<5_D*I^,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%%
M !1110 4444 %8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L4444 %%%% !
M1110 5F^,?\ D6+W_K@:TJS?&/\ R+%[_P!<#0!:MX=U%+NU2\A"&6$2QDH[+
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M8K'\2_\ (7T?_K]/_H)H V**** "BBB@ HHHH **** ,?P/_ ,@B7_K]F_\
M0JV*Q_ __((E_P"OV;_T*MB@ HHHH **** "BBB@#'\2_P#(7T?_ *_3_P"@
MFMBL?Q+_ ,A?1_\ K]/_ *":V* "BBB@ HHHH **** "L?P/_P @B7_K]F_]
M"K8K'\#_ /((E_Z_9O\ T*@#8HHHH **** "BBB@ K'\2_\ (7T?_K]/_H)K
M8K'\2_\ (7T?_K]/_H)H V**** "BBB@ HHHH **** ,?P/_ ,@B7_K]F_\
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MC#(^HLZ_03_@OU^Q[_PN+]GFT_:4\(:7YFO_  \W?VIY29>XT>1AYF<&/@A8I*NGW=W]I\17<76UTV'#W#Y_A8K^[4GC?(@[U_1[H.A
MZ/X8T.R\->'M.BL]/TZTCMK&T@3;'!#&H1$4=E50 !Z"OG^-7EF"IPPN'HPC
M.6K:C%-+HKI=7^"\SQ.+7E^$A##4*48R>K:BDTNFJ75_EYENBBBOSH^%"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M*'BCPIX7\;Z%<>%_&GANPU?3+L*+K3M4LTN()@K!EWQR JV&4$9'! /:OSY_
MX-F=&TKPY^Q)\2_#VA:?#:6-A^TEXSM[.UMXPD<,27,*HBJ.%4*  !T K]!_
M$OB?PUX+T*Y\4^,?$-CI.F64?F7FHZG=I!! F0-SR.0JC) R2.M?G!_P;&?%
MOX6^-OV5_BOX:\(_$71-2U(?M$>,-2.G66J127'V*:Y@:&Y\M6+>2X9=LF-K
M9X- 'V%>_L%?L6
M:5,K;6UNL<$2 A8TA#??+.WRS_P;Z_##XK_ /_@DWJUSX&T2[UG3M4\8^*M>
M^!OAW7;]H#)H$LS?V5"TDG^ICN&C:X#G^"[$G.ZN8_;@_P""XW_!+3QA\&_ WAZ7[+\5;NQTO4KQ_$LH8B3P_;2V-O*J6^5*WLQ8%E)MHP
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M8:':7>DM'/JU]<0&&U7_]]+69X5US4;73I(X?#=S
M.#_]]+1_PDNK
M_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\
M"2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+69KF
MN:C/J.FR2>&[F,QW)9$9ES(=O05U=8_B7_D+Z/\ ]?I_]!- !_PDNK_]"A>_
M]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\
MWTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\ T*%[
M_P!]+1_PDNK_ /0H7O\ WTM;%% '*>%=_\ ?2T>!_\ D$2_]?LW_H5;% &/_P )+J__ $*%[_WTM'_"
M2ZO_ -"A>_\ ?2UL44 8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM;%% &/
M_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2UL44 &[F,QW)
M9$9ES(=O05I_\)+J_P#T*%[_ -]+1XE_Y"^C_P#7Z?\ T$UL4 8__"2ZO_T*
M%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>
M_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0
MH7O_ 'TM9GA77-1M=.DCA\-W,X-S(Q=&7 );I^%=76/X'_Y!$O\ U^S?^A4
M'_"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+
MJ_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__
M  DNK_\ 0H7O_?2UF:YKFHSZCILDGANYC,=R61&9_P#?2UL44 8__"2ZO_T*
M%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>
M_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 _]]+1X'_Y!$O_ %^S?^A5L4 8_P#P
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M2ZO_ -"A>_\ ?2UL44 8_P#PDNK_ /0H7O\ WTM4?$NO:G&+J%6B(
M,KLN%]S735F^,?\ D6+W_K@: *EEXCU5+.)%\)7C 1* P9<'CK4O_"2ZO_T*
M%[_WTM:6G?\ (/@_ZXK_ "%34 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2U
ML44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_W
MTM'_  DNK_\ 0H7O_?2UL44 ]_P"O*+^9K8H Q_\ A)=7_P"A0O?^^EH_X275_P#H
M4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\ A)=7_P"A
M0O?^^EH_X275_P#H4+W_ +Z6MBB@#F?$NO:G&+J%6B(,KLN%]S5FR
M\1ZJEG$B^$KQ@(E 8,N#QUJWXQ_Y%B]_ZX&KFG?\@^#_ *XK_(4 9O\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM9EKKFHKXINKI?#=RSO;1JT 9=R@$\FNKK'LO\ D=[W_KRB_F:
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M$WP6^&/A3P!J2KJ_A77=_CWQ+=';=:_:7+"2^N'8Y+3^8H,08G:KE22]KB96A5T2_PW]Y^5_=7=M_RGUW#F-IY2_:8B5HU-EZ7][TO[J[N_8K
M_P#!!;]EF_\ @C\ [S]HSQ-X)NI-=^(07^RY2@!@TB-CY>,\CSI,R'LR+">U
M??/_  DNK_\ 0H7O_?2U8\)Z+I/AKPKIGAS0-/BM+'3]/AMK*T@7:D,*(%1%
M'8!0 !Z"M"OE\SQ]7,\=4Q,]Y/[ET7R1\[F&,J9AC)UY_:?W+HODC'_X275_
M^A0O?^^EH_X275_^A0O?^^EK8HKA.,KZ;>3WUJ)[BPDMF+$>5*1GZ\58HHH
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M_D6+W_K@:N:=_P @^#_KBO\ (53\8_\ (L7O_7 UR_Y'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "
MN)_:*^/WP\_9@^#>N?&WXGZEY&E:+:F0Q(1YMU,?EBMX@?O22.551TR)+> Y6+/!;G/,J#NP.&A6DZE;2G#67GVBO.6R[*[V3.S
M!X>%63J5=*<=7^B7F]EVU>R.U_8'^ 'Q"N=8UO\ ;A_:?T[9\3OB-"GV;2Y
M2OA71 0UMID0/*-C:\O0EL!AN#EOHGQC_P BQ>_]<#6E6;XQ_P"18O?^N!K+
M%XF>+KNI+3HDMDELEY)&6)Q$\36_]
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M_F:V*Q[+_D=[W_KRB_F:V* "BBB@ HHHH **** ,WQC_ ,BQ>_\ 7 U47\S6Q6/9?\ ([WO_7E%_,T ;%%%% !117C'[0CC(VN67Z:^&OPX\%_"#P!I'PP^'6@PZ9H
M>A6$=GIEC /EBB08&3U9CR68Y+,222237F/[#?[*+?LN_"ZY;QGK?]N_$#Q=
M?-K/Q$\42?-)J.I299E5L ^3%N*(N ,;FVJ7(KVJNO'5Z2C'#4'>$.O\TNLO
MTCV7FV=.,K4U%8>B__]<#6E6;XQ_P"18O?^
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M+_U^S?\ H5;%8_@?_D$2_P#7[-_Z%6Q0 4444 %%%% !1110!C^)?^0OH_\
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M HHHH *Q[+_D=[W_ *\HOYFMBL>R_P"1WO?^O*+^9H V**** "BBB@ HHHH
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MKXT^5"BBB@ HHHH S?&/_(L7O_7 U_]>47\S6Q6/9?\CO>_P#7
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M?Y"IJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH \H_;G_Y-'\>_P#8!?\ ]#6N
MZ^%W_),_#O\ V K3_P!$I7"_MS_\FC^/?^P"_P#Z&M=U\+O^29^'?^P%:?\
MHE* -VBBB@ K'\#_ /((E_Z_9O\ T*MBL?P/_P @B7_K]F_]"H V**** "BB
MB@ HHHH *Q_$O_(7T?\ Z_3_ .@FMBL?Q+_R%]'_ .OT_P#H)H V**** "BB
MB@ HHHH **** ,?P/_R")?\ K]F_]"K8K'\#_P#((E_Z_9O_ $*MB@ HHHH
M**** "BBB@#'\2_\A?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH
M**** "L?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*@#8HHHH **** "BB
MB@ K'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_ .@F@#8HHHH **** "BB
MB@ HHHH Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0JV* "BBB@ HHHH
M**** ,WQC_R+%[_UP-7-._Y!\'_7%?Y"J?C'_D6+W_K@:N:=_P @^#_KBO\
M(4 34444 %%%% !1110 5CV7_([WO_7E%_,UL5CV7_([WO\ UY1?S- &Q111
M0 4444 %%%% !6;XQ_Y%B]_ZX&M*LWQC_P BQ>_]<#0!(=.BO-/U&TDMKZTG3
M='/#(I1T8=U9201Z&OYPOV[_ -EK6/V.?VHO$_P0ODE;3[2[^T^';N7K=:;-
ME[=\_P 3!?W;$<;XW':OZ2*_-[_@XR^"_P -]9^"/A/XZ7>N65AXLT?5SI=C
M:R'$VK64H+R1* ,L8642 G"JKR;O]I3Q?I?EZ_\ $/;_ &7Y
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M,; PZ9HUML:>0#SKR=OFEN92/O22.2Q/09P,  #N:**\ZI4G6J._\ 7 UI5F^,?^18O?\ K@: +FG?\@^#
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MJ9ZHZ%74]U<'O7*U^R0X3X:J04XT;IZKWI[/_MX_4X<-9!4@I1I73U7O2_\
MDC]?_@=_P<#^,/V@/B_X<^"W@+]ASS=6\2:K%96F?B.2L>X_-*^--X1$#.Q[
M*A/:OTIK\J_^#=O]CW_D._MI>,M+_P">FB>"_.3Z?:[I<_\  8%8?]-Q7ZJ5
M^:\3TVWK<^!XAI9?A\>Z&$A91T>K=W\V]MO6X44
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M9VD#SW=UI_\ !4_XZVWQ
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MZ_\ 7 U*-8H_VF,*J@*/\ A#-%X _[Y\V('"CK)'%Z5]55C^+?B'X \ VWVWQUXYT?18=N
M?-U;4XK9<>N9& KKP.)KX/%PKT?BB[K_ "^>S.G!UZV%Q4*M+XHNZ_KS/Y;Z
M*^@/^"FWPQ^"WPT_:]\2G]GKXB^&_$?A+7I?[6TU_#.KP7D.GO,S&:T8PLRH
M4E#[5[1M'[U\_P!?T%AJ\<5AX5HJRDD[/=7Z,_;NY]5?\
M!'S]CW_AK;]KW2_^$DTK[1X3\&;-;\2^8F8YMCC[/:MV/FR@94]8XY?2OW^K
MY5_X(^?L>_\ #)/[(.E_\))I?D>+/&>S6_$GF)B2'>@^SVK=QY41&5/2227U
MKZJK\7XJS7^U,UER/W(>[']7\W^%C\HXCS+^TBC"CZ_K\]/^#;3_DSWXK?]G.>
M-_\ TKBH ],T_P#:[^-7[8/[=7Q2_8__ &5/'VE^#?#?P,TS38O'WCFYT!=4
MNM1\07Z22P:;:122+$D$$43-<2,&D:1EB7RMID:K^SI_P5E\)ZG^R;\;OB]^
MU3866A>+?V9M?UK0?B]INA!OL]U<:>&:*[L$E8OY-Z@1H8W8L'9HRS;=[>*_
M\$#=/U#1?VQO^"@FC^)U9=:_X:FU&ZF648*OA/_P %CM?\#P3OI;^/_ ,"F $JTECJA?4L8X!6'E_8\T ?HKXP_;W_
M &X?@3^P%X7_ ."M?QG;PY=^#M3BTC7_ !I\'-(\/L)]"\+:G-"D,EK?F7S)
M]1MHKF">;S4$,N)D6.'"N/OWPUXCT+QCXPQL(EMK-(
M,?4NF/PKZ6_X)D:+XE\.?\$W/V??#WC*.5-6L?@EX5M]3CFSO2=-(M5=6SSN
M# @^X- 'N%%%<9\9O@9X0^.>F66D^+]4UJUCL9VFA;1=6DM&9BNTABGWACL:
M .;_ &Y_^31_'O\ V 7_ /0UKNOA=_R3/P[_ -@*T_\ 1*5\S?M6_L4_"?X?
M?LZ^+O&FB>)/&$UWIVDM-!'?>*9YH68,HPZ,<,.>AKW_ .%?@71T^&'AQ!=7
MN!H-F!F[;_G@E ';T5C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ?F'_P<
M2?L>_P#("_;2\&Z7_P \]$\:>2GU^R738_X% S'_ *8"OS4^"'P?\9?M ?%S
MP]\%_A]9B;6/$FJ165F'SLC+'YI7(!(1%#.Q[*C'M7]('QG_ &C!74]F4&O@C_ ((J_P#!-7Q%\(?B
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M+/BIJ'@_5#][3/&7AF^L)$_WF:(QC_ONO
M:OAY^T=^S[\7 @^%OQQ\(^(FD^['HOB.VN7SZ%8W)!]B,U<\0_!_P%XMT]M)
M\5Z,NIVK?>MM0Q-&?JK@BO(/'7_!*;_@G]\12[^(OV:- B>3EI='C;3G)]=U
MH8SGWJ>;)ZFZG#YQG^%H?F*^5U-U.'S4OTC^9]#45\F/_P $C_AYX54O\!_V
MJ/C3X V?ZFRT;QT\]DOH&@G1MX'H6JE-^R-_P4T^'QW_  W_ &]O#WC&%/\
M4Z?\0? XML#^ZUQ92&1_J0#1]3P53^'B%_V]&47^"DOQ#ZIA)_PZZ_[>4E^2
MDOQ/S!_X+!_L>_\ #)/[7VJ?\(WI?D>$_&>_6_#?EIB.'>Y^T6J]AY4I.%'2
M.2+UKY5K]8O^"CO[.'_!2/\ :$^!!\._%;]E/P9KM]X9N6U.P\5_#WQD^;9%
M0^>@L[[$TRR(/N(=Y9(R VW:?R=K]DX=QLL7ED54E&4X:-J2E?LW9Z77>SO<
M_4\BQU;N/*B(RIZ222^M?E3_ ,$@OV.!^UY^UQIL/B736F\)
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MFPQSW)$]R5E:?\ P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M
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M?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:@ \#_ /((E_Z_9O\ T*MBN4\*^%=.U#3I)II[D$7,
MB@)<,HP&K3_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?
M_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_
M\"VH_P"$'TC_ )^;W_P+:@";QC_R+%[_ -<#5S3O^0?!_P!<5_D*Y_Q+X2TR
MQT&ZNX;BZ+1Q$@/"]*ELXI6N;S+1*3BZ;'2@#=HK'_X0?2/^?F]
M_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:
M@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BL>R_Y'>]_P"O*+^9H_X0
M?2/^?F]_\"VK,M?"NG2>*;JP:>YV1VT;*1<-NR2>IH ZNBL?_A!](_Y^;W_P
M+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@
M#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8K-\8_P#(L7O_ %P-0_\
M"#Z1_P _-[_X%M5'Q+X2TRQT&ZNX;BZ+1Q$@/E2V<4K7-YEHE)Q=-CI4O_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-
M[_X%M1_P@^D?\_-[_P"!;4 ;%?&?QZ\4^)/^"CWQRO\ ]C'X1:U<6?PH\(7J
M#XT>,-/E*_VI<*VX:#:R#J21^^8'Y<$'&-LNI^VC\4_&?BOXB6'[!W[(VMW*
M_$3Q+:_:/%7B-;EWB\&:*<"2[E((Q<.K!8DR&^96^4M&3[9^S]^R=\)OV:OA
M1I?PA^&=I=V^G:;%^\F:Y/FWD['/ _AJP\&^$-%M
MM-TK2[..UT[3[.()%;PQJ%2-%'    %7ZQ_^$'TC_GYO?_ MJ/\ A!](_P"?
MF]_\"VKR6W)W9YC;;NPLO^1WO?\ KRB_F:V*Y2U\*Z=)XINK!I[G9';1LI%P
MV[))ZFM/_A!](_Y^;W_P+:D(V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ .;^/?[,/P"_:>\,?\(E
M\>/A9I7B.U52+>2\@Q<6I/5H9T(EA/NC*37YG?\ !5S_ ()*_$+X=?"!_CC\
M,_C=KWC#PSX&LR!X<\6O]JU#2-.:0;Q;W8&Z:WC)W>2X B0.RL26S^JO_"#Z
M1_S\WO\ X%M576_A=X2\2:-=^'=>@GN[&_M9+:]M)[AF2:)U*NC ]05)!'H:
M]C*LZQN55X2A*\4]8O5>=K[-KJK,]3+75HRA*\4]GJO.U]FUU1_+S7:?
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MNX;BZ+1Q$@/E2V<4K7-YEHE)Q=-CI4
MO_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%
M5]-TZ#2K46EN\C*&)S*Y8\^YJQ0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !114=W)/#:RS6MMYTJ1L8X=X7>P'"Y/ R>,T 245^:OQ"_X+@_
MM(_"W]MGQ7\"=8_X)1?M):Y;>'_!^GRR>&_"'A.PU9DGENKO&IK79J#S3N69)$A9I8MA1C)&@^=2T4@!^C-%%% %'Q+;^);K0K
MFW\':M8V&IO'BSO-3TY[N")\CEX4FA:08SP)$^O:OF;_ ()8_P#!/?XI?\$Y
MOAQXL^%OB[]HW1/B!IOB?QUJGBL367P^ET6XM;V_>-YH]S:E=*\(*-M7:K#?
MRQQS]3T4 ?-OBS]AWQWX%_:W\5_MG_L?_$[P_P"$_$OQ'\.66D_$K0_%?AB;
M4]+UJ:Q#+I^IJMO=VTL5W!'(\+?.R31$*1&R^96G^S9_P3H^!WP&_9G\9?LX
M^)TD\;I\4M4UG5_B[KFN0+'-XMU/5MW]H3S)'A8D=6\M(T/[N-$7&&&WA2WMXECC10J(BX"@<  #
MH*=10 4444 >4?MS_P#)H_CW_L O_P"AK7=?"[_DF?AW_L!6G_HE*X7]N?\
MY-'\>_\ 8!?_ -#6NZ^%W_),_#O_ & K3_T2E &[1110 5C^!_\ D$2_]?LW
M_H5;%8_@?_D$2_\ 7[-_Z%0!L4444 %%%% !1110 5^ /_!8/]CW_ADG]K[5
M/^$;TOR/"?C/?K?AORTQ'#O<_:+5>P\J4G"CI')%ZU^_U>,_ML)*TE^
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M]_Z\HOYFMBL>R_Y'>]_Z\HOYFMB@
M HHHH **** "BBB@#Y _X*H?\$X-)_;=E\">-=.NH;'4?#.M);Z_=EMKW&AR
M-NGC4]Y$908P>!YLGK7U?X3T72?#7A73/#F@:?%:6.GZ?#;65I NU(840*B*
M.P"@ #T%-\8_\BQ>_P#7 UMAX49N\87LO7*M5N
MO'6FVOBVV\6ZR]E%9>'W9_MMW"RU.>&8[7*A&]1HH ^/?V]?C/_P %
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MV:Z-/=/U_P"#N-&2G3=X2UB_S
M3\UL_OV:"BBBN$XPHHHH Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0JV
M* "BBB@ HHHH **** ,?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\ Z":V
M* "BBB@ HHHH **** "L?P/_ ,@B7_K]F_\ 0JV*Q_ __((E_P"OV;_T*@#8
MHHHH **** "BBB@ K'\2_P#(7T?_ *_3_P"@FMBL?Q+_ ,A?1_\ K]/_ *":
M -BBBB@ HHHH **** "BBB@#'\#_ /((E_Z_9O\ T*MBL?P/_P @B7_K]F_]
M"K8H **** "BBB@ HHHH S?&/_(L7O\ UP-7-._Y!\'_ %Q7^0JGXQ_Y%B]_
MZX&KFG?\@^#_ *XK_(4 34444 %%%% !1110 5CV7_([WO\ UY1?S-;%8]E_
MR.][_P!>47\S0!L4444 %%%% !1110 5F^,?^18O?^N!KYRU[_@LO_P3=\,:
MY>^&O$/[1$MGJ&G7$?AGX.U/X@^/=?MM*T71K*2[U/4;M]L<$*#+,3
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MH **** "BBB@ HHHH **** /*/VY_P#DT?Q[_P!@%_\ T-:[KX7?\DS\._\
M8"M/_1*5PO[<_P#R:/X]_P"P"_\ Z&M=U\+O^29^'?\ L!6G_HE* -VBBB@
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MJ*\>_8H_:NT[]K#X2'Q!J>BMH?C#P_>OI'C[PK."LVCZK%\LL94\^6Q!9"5D]CT\KRJMFU5TZ4HII7U;5_2R9^QGC'_D6+W_ *X&
MKFG?\@^#_KBO\A7X!7G_  6H_P""F6H6KV5W^TKOBD7#K_PANC#(^HLZ?'_P
M6P_X*;Q1K%'^TQA54!1_PAFB\ ?]N=?0_P"H.FK
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MV\-3ZL;+48R6MYO.4"+RRV4596!!!Y!%?MO"F*Q5;*XTL3%QG#356;CT>NOE\C];X;Q
M&(JY=&G7BU*&FNC:Z/\ 3Y#M!T/6/$^N67AKP]ITMYJ&HW<=M8VD";I)YI&"
M(BCNS,0 /4U_1[^PA^RSH_['/[+OACX(6*1-J%I:?:O$5W$.+K4IL/<29_B4
M-^[4GG9&@[5^6W_! 7]CW_A<7[0UW^TIXOTOS- ^'FW^R_-3*7&L2*?+QG@^
M3'NE/=7:$U^U-?)<=YK[;$1P--Z0UEZO9?)?GY'S/&.9>UKQP<'I'67J]E\E
M^84445^?'Q(4444 %%%% &/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S-;% !
M1110 4444 %%%% &;XQ_Y%B]_P"N!JYIW_(/@_ZXK_(53\8_\BQ>_P#7 UR_Y'>]_P"O*+^9K8K'LO\ D=[W
M_KRB_F: -BBBB@ HHHH **** "LWQC_R+%[_ -<#6E6;XQ_Y%B]_ZX&@"YIW
M_(/@_P"N*_R%35#IW_(/@_ZXK_(5-0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %?-__!5'4OVN=)_99AO?V$[#3+OXJ+XZ\/CP
MM:ZXP%C,3J,(G6YRR_N?L_G;\,&VYVG=MKZ0KCOC;\ /A#^T7X7M_"'QB\&Q
MZM:6-^M_IDJ7MV?A7]IO]C7Q1HK7=W';)XL^&]U_P )9H1=V"J7\B*+4H%R06>6Q6&,
M9+2X4D 'N]%%% !1110 4444 %%%% !1110!Y1^W/_R:/X]_[ +_ /H:UW7P
MN_Y)GX=_[ 5I_P"B4KA?VY_^31_'O_8!?_T-:[KX7?\ ),_#O_8"M/\ T2E
M&[117@G_  4.^.VK_!CX(#3?"M\]MK'B6Z-C;7,38>" *6FD4]FQM0'J/,R.
M0*\;B'/,'PWDE?,\5\%*+DTMWT27G)M)>;.7&XNE@,)/$5-HJ_\ P/F] ^.W
M_!0[X(?!C5Y_"FFK=>)=8MF*7-MI3*((''5'F;C=V(0/@@@X(Q7F'@#_ (*M
M>#+&8Z?XL^$6I6MJ]P[M$E&/:R?XO7\C]@/A;\6_A
M[\9_"T?C'X<>)(=1LG;9(4RLD+]TD1L,C#T(Y&",@@UTE?EE^QI\=M8^!7QN
MTK48[YUT?5KJ*QUVV+?(\+MM$A']Z,MO!Z\$=&-?J;7]/^%_B!#C_(Y5ZD%"
MO2:C4BMKM74HWU2EKHVVFFKO1O[_ (?SI9SA'.2M..DET\FO)A1117Z4>\%%
M%% !6/XE_P"0OH__ %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$T ;%%%% !1110
M!\B?MG> _%_[)'QEB_X*1? C0I[RSBMH['XV^%+%>=8T=AN;4<[NZ+
MR542;OJ3P#X\\(_%#P5I7Q%\ Z[!J>BZU8QWFF7]LV4GA=0RL.XX/(."#D$
M@BM2ZM;:^MI+*]MXYH9HRDL4J!E=2,%2#P01P0:^,_A7O#_A2PO)_P O
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MT/1]4!U/PI;>)+7R;R72)G*-1M'3Z*EQL'_?-5/^'5>A^'SYGPK_;;_:!\*[?]7:67Q&:>
MU'UBFB;=_P!]5^,NCE=1W5>2_P 4/U4I?D?E3I9=-W5:2_Q0_P I/\CZKHKY
M4_X8T_X*!^%/F^&__!4W69(D^[9^+?AOIVH^8/1IBRN/J!F@^&O^"S7@X_\
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M/K;6UC;Z <=Z_->)J&75,QY:?$;XH>9Q;>(+FP
M&A:))Z$7EX!]<%!Q7H?P6_X)Q?L4? 2X35/ 7[/VARZHK;SK>NQ-J5Z9,Y,@
MFNC(R,3R=FT>U>W !0%48 Z 5\[[7*J'P0E4?>3Y5_X#&[_\G/"]IEM'X8.;
M_O/E7_@,=?\ R8^3C\,_^"LGQ[^;XA?'GP+\&-'FZZ9X#T9M8U3R_P"Y),?CO>^+?B[K\9W#5OB9XFGOPI/4+ I2'9
MZ*RM@8%?3]%)YMC(JU%JFO[BY?O:]Y_-L3S+%)6I-07]U _
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M5:E>K*I-WR_Y'>]_Z\HOYFMBL>R_Y'>]_P"O
M*+^9K8H **** "BBB@ HHHH S?&/_(L7O_7 U_]>47\S6Q6/9?
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MHV-P+FUFO1]D-U<+',D4@B^T"+?#&VSOKVN;^+?PM\+?&?X>ZE\./&-NSV6HP[3)'P\,@(9)4/9E8 C
ML<8.02*^1X\X=J\5\(XO*J4K3J17+?;FC)3BGY.44F^B/-SC RS'+*F'B[.2
MT]4TU^*/Q_HKU?X[_L:?&[X%:Q/'J/A:ZU;1U
M<*J=N5Q=V_+NGT:NGT/Q*M@\5AZWLJD&I=K?U?Y">"?#]_XK\9:3X7TL$W.I
M:G!:V^#CYY)%1?U(K]D:^-_V4O\ @FQ8P:/=>*/VE-($EQ?6IBL-!BNB&LP?
M^6TDD;?ZW^ZH)"\YR3A?3O[(_:5_9?\ G\-SWGQ/\$0]=-NG']N:;&.T;]+I
M0/X2-W0 *!FOZL\'LBSWP_RFMC4Z2AS6=2DES)/F;O'FDOM0
MBKL_1>&,)C,FPTJN(INU2VVKBE?XH[]>EVNJ1[U17'_"+X[_  Q^-^E/J/@#
MQ$DTT'%]IEPOE7=FV<%98F^9<'C/*D@X)KL*_HC!XW!YCAHXC"U%4IRU4HM-
M/T:/MJ56E7IJ=.2:?5!11174:!6/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z
M?_030!L4444 %%%% !7"_M)?L]?#S]J7X,ZU\$OB;8&73=8M]L=Q$!YUE<+S
M%AP0<@D'NJ*NG4J4:BG!V:=T^S1=.I.E-3@[-:IGS/^P3^T+\
M0GU36_V*?VH+\'XI_#F)5&HR$A?%.C9"VVJPD\N2-JR]2'P6^9F5?IBOC#_@
ML'K7PQ^#'A;P?^U-#\0QX/\ BAX0U.1_ .K/HUY<0:P NZXT>Z>WB=5CGC+[
M1*5&=V&"F0BY\._^"Z/_  3N\3>!=)U_QQ\8I_#6LW=C')JF@W'AC5+EK&UE\+W79WCT5_6K
M9?B,;2CB\-2;4MTHMVDM[67POIV=UT1]5^!_^01+_P!?LW_H5;%?(?A7_@M)
M_P $T--TZ2"]_:4V.US(X'_"':R>"V0>+.MW0?\ @LO_ ,$W?$^N67AKP]^T
M1+>:AJ-W';6-I!X)UII)YI&"(BC['RS,0 /4UQO)LW2N\/4_\ E_D:< 4444 %%%% &/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_
M /7Z?_036Q0 4444 %%%% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\
MU^S?^A4 ;%%%% !1110 4444 %8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7
MZ?\ T$T ;%%%% !1110 4444 %%%% &/X'_Y!$O_ %^S?^A5L5C^!_\ D$2_
M]?LW_H5;% !1110 445QGQ^^/_PK_9D^%NH_&#XQ>)H],T;34Y8_-+R)_C?\;_AC^SI\,M3^+OQ
M?\4P:1H>DP[[BYF.6D8_=BC4%1>237S'\(/@A\4/^"@/Q&TO]J_]L7P
MM/HW@+2;@7?PK^$%^./]C5=43I),PY2$Y"@\C&=]CX(? #XJ?MM?$W3/VP_V
MV/#$FE:!IDI+:/>,7W_FE\HZ7;]*4X9=%TZ;O5>\E]GRB^_>7R75OY _X*G_\ !-_2
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M ()B_P#!.+2_V%?B!\2=3O;N*_O=:U5X/#UWNW20:&LF^!&/:1R"R>K0;]^/P?/_+<^N=!T/1_#
M&AV7AKP]IT5GI^G6D=M8VD";8X(8U"(BCLJJ  /05;HHKXAMMW9\BVV[L***
M*0@HHHH *S?&/_(L7O\ UP-:59OC'_D6+W_K@: +FG?\@^#_ *XK_(5-4.G?
M\@^#_KBO\A4U !1110 4444 %%%% &/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY
M1?S-;% !1110 4444 %%%% &;XQ_Y%B]_P"N!JYIW_(/@_ZXK_(53\8_\BQ>
M_P#7 UR_Y'>]_P"O*+^9K8K'
MLO\ D=[W_KRB_F: -BBBB@ HHHH **** "LWQC_R+%[_ -<#6E6;XQ_Y%B]_
MZX&@"YIW_(/@_P"N*_R%35#IW_(/@_ZXK_(5-0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A_QR_X
M*7?\$^_V9OB%#?$UK;Q3W6@^(?%-O;74,+9/*',:R&,G
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MXU\?^*G;0OVGY_#ND>(K7Q!XCNKI[C=>WK0R26S&*UEO7($C@9*C /..: .._;G_P"3
M1_'O_8!?_P!#6NZ^%W_),_#O_8"M/_1*5\^_M=_M=_LT^.?V:?&/A+PE\8]'
MO]2O]':*SLX)6+RON4[1E>O%>W_"SQGX6?X8^''76X"#H-F0Q;@T =-16;_P )CX8_Z#4'_?5'
M_"8^&/\ H-0?]]4 @(;G' (!KDK?X]?&#]GN=-$_:G\-?VCH@<1V_Q$\.6K-!@G -Y;J-T#>K
M*-I)P >37LO_  F/AC_H-0?]]4RX\4^$+NW>UN]3MI8I4*21R#$=3F?S+WPY"/$OW8UO)=]A?\ ;=;W(^4@G^%B",@98YK*AQ+/!5HX
M;.Z?L)MVC.]Z,WTY:EERR?2%11DWI'GW)ACW2DJ>+CR-[/>#]'T?E*S[7/:J
MQ_$O_(7T?_K]/_H)K'^(?Q[^$GPK\-R>*O&_C2VL[1#A.&>29^R(B@L['T ]
MS@ FOF7QM_P5:\&3:[:R>$_A%J5Y:6=P7$U_J<=L\@QC[BI(!_WU4\0\><(\
M*5%2S3%QIS>O+[TI6[N,%*279M688W.,MRZ2CB*JB^VK?W*[/LJBO ?@A_P4
M6^!?Q=U*+PYK!NO#.JSD+!!JI5H)W/14F7C/LX3)P!D\5[9_PF/AC_H-0?\
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M]TI[J[0FO@.VMY;NXCM8 "\KA$#,%&2<#)/ ^IK^C+]@WX&_#W]CW]EKPO\
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M#8Z9)#=ZI%&QNI6"L>Q;@T =-16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4
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M_P#%[XP^(18Z99X2"",![B^N&!\NVMX\@R2N0<*.  6)"JS#P#X _LX_%?\
M:R^*.G?MI?MR^'C8)IS^?\+/A).=]OX*0!+?, K?,/W?&0&"I%4_9
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MF@#AQ4O_"8^&/\ H-0?]]4
M:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^
M&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 $-E_R.][_ ->4
M7\S6Q7,VGB704\6W=Z^J1")[6-4DSP2"_]<#5S3O^0?!_
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MWAJ.RAC?680RQ*"">AQ4O_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
M"8^&/^@U!_WU0!I45#8W]GJ4 NK&X66,D@.O3-34 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?+?_!7_ ,8>)8_V
M.KC]GCX>:I)9^*_COXFT[X9>';B$_/;_ -K2&*^N1W'D::E_<9'(\C/O7KGQ
M1^)GP-_81_9=O?B)XS$^A_#[X:>&85G&F:7/>-8:=;(D*!(8$>1E1 H.%.U0
M6. "1Z!>Z1I.HW-K>ZAI=O/-92F6REF@5FMY"I0NA(RC%69.;;'/Y\1Q)!XAT&ROTC;=&E[:I*$/J P.#5
MVB@#Q#]MCX?> =+_ &4O'.H:9X(T>WN(M#=HIX-,B1T.Y>0P7(->F?"[3=.'
MPR\. 6$( T*SP/*'_/%/:N+_ &Y_^31_'O\ V 7_ /0UKNOA=_R3/P[_ -@*
MT_\ 1*4 :_\ 9VG_ //C#_WZ%?.G[?G[=>G_ +#?_")_\68A\4?\)1]O_P"8
MR++[-]F^S_\ 3O+OW?:/]G&SOGCZ1K\Z?^"_'_-)_P#N/?\ N.K[OPTR;+>(
M.-L)@,?3YZ,_:SY96C
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MJZ%CI\O)Y)K\W*^K_P#@G=I7[3&A^$?$?C;X*Z!X
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MJ_9/\._M?_LO^)_@G<6=M%J-W:?:?#MZ\8'V748LO ^ZE\1_&-PR66G0[C''R\TA(5(D'=F8@#L,Y. ":_-;X[?ME_&[
MXZZQ/)J/BFZTG1V8BVT+2KEHH$3L)"N#,WJSYYS@*.*^$XY\5LG\-ZE)S3J8
ME^]"$6D[)_%)OX8W5EHVVG963:\G-.)75OHOS/%_P#@BY_P
M3JTO]HOXU^+?%O[0W@,W/A7P3!<:1?:/J,;(+G5ID>)H6Q@@P1EW."&21H2"
M*^W?A_XX\:?\$O\ Q[IWP!_:*U>?7O@AK=X+7X=?$O4%#S>&Y&^YI6IOCB(#
MB.(-?^'&HRZO\ #_7KW1;J>Z:YFN-+NW@>29L;G)0@DG S
MZU]G_LL?M3^'_P!J_0+[]E3]JS0K#75URQ>"">\@41ZI&!N:&55P%E &Y)%P
M/.(U@,?AI4(U;1@G)25^EI67+-MOET:E\+>J1V4?$O"<0
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M:-T]5[T-G_V\>[#AK.ZD%*-*Z>J]Z/\ \D?JU_9VG_\ /C#_ -^A1_9VG_\
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MO1G!0GY=K,@YW3:9Z
MN$R3,\?1]K0I\T=MXK\VF?IOX+LK.72I&EM(F/VR49:,'C=6O_9VG_\ /C#_
M -^A7Y2Z'_P9NF>3=_PL;&-QSC_ )!QK5T7_@Y1U'Q!K%IH
M6C_L+7-W=WMRD%K:V?Q!,LTTCL%5$0:;EV)( 4RCDD 5X]^S'^R=\2?C!\4+;]MK]NC2+8^+ A;P#\.EQ)8>"K5N
M5)4\2WS#!>0C*D#&"%$=O]EK]D[XF^/?B=%^VU^W*EO>_$*:(CP=X.C?S-/\
M#6;OJ2N"K6I9?3=##N\WI*:_&,?+O+[6R]W?CJ5:>
M"@Z-!WD])27_ *3'R[OKLM-X?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ*\D\P
MA_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH R/%UC91^&KQX[.)6$)P5C (JWI
M^GV#6$!-E"285R3&/05#XQ_Y%B]_ZX&KFG?\@^#_ *XK_(4 ']G:?_SXP_\
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M>_\ 7 T 3:?I]@UA 390DF%Q&TB
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M\BQ>_P#7 T 3:?I]@UA 390DF%_\ 8!?_ -#6NZ^%W_),_#O_ & K
M3_T2E<+^W/\ \FC^/?\ L O_ .AK7=?"[_DF?AW_ + 5I_Z)2@#=K\Z?^"_'
M_-)_^X]_[CJ_1:OSI_X+\?\ -)_^X]_[CJ_3O!O_ ).1@?\ N+_Z9J'Y9XU?
M\FRQ_P#W"_\ 3U,_.FBBBO[J/X&"OZ*HI8IXEG@D5T=0R.C9# ]"#W%?SJU^
MR,O[*?[0O[+\K:S^Q)\3O[0T!&+R?"SQS=//9!>I2RNB?,MCZ*QVDG+,>E?S
MSX\Y?@\Q_LZG4Q$:53]]R&?%H$27+$XS:W/$=PI/"D;6;^%2.:]TK^7THMI]S^K>>B?
M)_[=G[">L?%36)?C'\'+6.36Y(U&LZ,7"?;=H $L9) $@4 %20& !!W9#?#_
M (C\$>,_!^I-H_BSPGJ6F7:MM-M?V,D3Y^C &OV0K'\2_P#(7T?_ *_3_P"@
MFOPOC3P)R+BG-)YAA:[PU2H[S2BIPDWO+EYHM-[NTK-ZVO=OY#->$,'F&(=>
MG-TY/?2Z;[VNK/OJ?F5\"?V-/C=\==8@CT[PM=:3H[.##K=DLM.AVB23EYI"2SRN>[,Q)/89P,
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MQM<#J?+P.2*_-4@@X(K^*_&[(:^1\;3:4O8U(0=-RE*>BBHRBI3N:G;6MD^I)/<_:90HG6+]YY"Y^
M\\FT( .?FSVK\RR;"XK'9OA\-AG:I.<8Q>UI.22=^EF>!A:=2MB80I_$VDO6
M^A^I'C[P!X+^*?@S4OAW\1/#5IK&B:O:M;:EIM]%OBGC;J".QZ$$8((!!! -
M?'_@_P :>/?^"4OC:Q^#_P 9M+[MFFN? L\C?)87KX@D#I*C#*LK#A@0001P0:G%X1X9J47S0E\,N_EY-=5T]+-SBL*
M\.U*+YH2VEW_ ,FNJZ>EF2T445QG*8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\
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M2;1\TKXZN[EG8]VKQ=F7U7!K#0?O3W
M_P /7[]O2YU5%%%?D1^8A1110 4444 9OC'_ )%B]_ZX&KFG?\@^#_KBO\A5
M/QC_ ,BQ>_\ 7 U]_Z\
MHOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "BBB@ K-\8_P#(L7O_ %P-:59O
MC'_D6+W_ *X&@"YIW_(/@_ZXK_(5-4.G?\@^#_KBO\A4U !1110 4444 %%%
M% &/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,UL4 %%%% !1110 4444 9OC'_
M )%B]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U]_Z\HOYFO'/CM_P4/^"'P8U>?PIIJW7B75[9BES;
MZ4RB"W<=4>9N-W8A ^""#@C%>7^%?^"K?@V7Q=+J7BSX0ZE8VD\2QF2PU2.Y
M= #][:R1 _3/YU\!F'BGX?Y7CW@L1CX*HG9I*4DGV-6XAR7#
MUO93K+F^;_%)K\3[+HKF_A;\6_A[\9_"T?C'X;^)(=1LG;;(4RLD+]TD1L,C
M#T(Y&",@@UTE?<87%8;&X>-?#S4X25U*+333ZIK1H]:G4IU8*<&FGLULPHHH
MK/-RR;:V=HV3TO>Z7R&:\7X3+L0Z%.#
MJ26^MDGVO9W??0_8K3O^0?!_UQ7^0J:ORR^!'[97QN^!.KP/IOBFZU71U8"Y
MT'5+EI8'3N(RV3"WHR8YQD,.*_2GX2?%+PM\9_A[IOQ'\'7#/9:C#N$QQD9!!KZKP_\ %#(^/X3IT(NE7@KRIR:;MMS1:^))M)Z)IM76
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M?%UN;.^5_2,-\LX/)&PEL6;=0T,Z8>/G!P#M)'(->._\ ")_MN?LA_O/ .M3?&OP)!_S M #G:PWGA54=:]#^SLBSK7+JGL*K_P"7562Y6_\ IW6=EZ1J\MMN
M>3/._M+/LCTS*E[>DO\ E[2B^9+_ *>45=^LJ3E??V<$?3M8_B7_ )"^C_\
M7Z?_ $$U_/717[A_Q+E_U-/_ "A_]V/PC_B9;_J5?^5__N)_1917\Z=?HM_P
M0'_YJQ_W ?\ W(U\QQEX*_ZI<-U\V^O^U]ER^[[+EOS3C#XO:2M;FOL[VMYG
MU/!7CC_KAQ-0RC^S_9>UY_>]KS6Y82G\/LXWORVW5KW\C]%J***_"C]]"BBB
M@ KP7X[?\$\O@A\:-7G\5Z0#/^[7ONH?LA? BY^$W_"G=
M-\&QV&G))Y]K>6C$7<%T!Q;DTGV373L<>&R/*<)&4:5%+F5G>[T[7=V
M>(?"[XQ^-OA-XRM?V??VEKY9+RX.SPCXU*[;?7(QP(I2>([D< @GYB1U)5I/
M;ZY[XH_"WP3\8_!MUX%\>Z.MW8W(R#TD@D'W98VZHZ]B/<'()!\H\!?%+QM^
MSGXLL_@A^T5J[7ND7DGD^#O'TW"70_AM;QCPDP' !_'/A^TU71]5M7MM1TZ^A$D5Q$PPR,IZBOCC0?$/CO_@DM
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M0 453\0^(O#_ (2T2Z\3>*MN:Z\-@L1B[N"]U;R>D5ZMZ?+=]$=.'PE?$W<%HMV]$O5O3]7T/HWXP?&WX2
M_ #P76E!7^&?P_N#MD^+WCW3"^F:/W,2@X()!.0&4(2:^
MF@ H"J, = *ZO:X# _PE[6?\S7N+TB]9>LM/[IT^TP>$_AKVD^[7NKTB]_66
MG]T\._9H_P""?WP(_9OUJ;XC"'4/&/Q OLOJWQ$\9W)OM4N'(PVQWX@7MMC
M.W 9FQFOD+_@MQ_P3G\4_'GXS?#SXP_!71!)K'BG5;?PMXFV1DJA8_Z-?28_
M@1/,21ST5(AVK]+JQ_$O_(7T?_K]/_H)IX/.L?@\P6,4N:5FM=K=O1=%LK#P
MN;8S"XU8KFO*UM>W;T71&;\#O@]X/_9_^$'ASX+> K7RM)\-Z5%96F5 :3:/
MFE?'5W=.VOFZ3XDTJ6RN\*"T>X?+*F>CHX5U/9D![5U5%5"]_Z\HOYF@#8HHHH **** "BB
MB@ K-\8_\BQ>_P#7 UI5F^,?^18O?^N!H N:=_R#X/\ KBO\A4U0Z=_R#X/^
MN*_R%34 %%%% !1110 4444 8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,UL
M4 %%%% !1110 445S?Q2^+?P]^#'A:3QC\2/$D.G62-MC+Y:29^R1HN6=CZ
M<#). ":PQ6*PV"P\J^(FH0BKN4FDDEU;>B1%2I3I0D_ #_@H3\$?B_?VG@[4_M/AO6)@L5M!JK*8+A^@2.93C<>P<+DD 9)
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M+ QR21SCZ_DGB3QQEU'@S'1RC$JI7Y>7]U>?*G)*;VMCYK/
MLWH0RJLL-4YIVM[NMKM)W:NE97W:/E/KUHHHK^"3\=/5_P!C7X[ZO\"?C;I>
MIK?LFCZK#UX(Z,:_36^^(GP_TO/]I>.M&M\=?/
MU.),?FU?D-X*\,W_ (U\8Z5X/TN$R7.J:C#:0(O=I'"#^=?J#8_L6?LL:=C[
M/\$]&;'_ #W1Y?\ T-C7]5> &9\5U$P<*][63[7Z?B;]]^T3\ --R+_XX>$8B
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MUX!Z,*\GK_.S/I7?@OQEX4FD8VMCJ=I=6ZGH'FCD5\?A E?# !)P!7Z5?
M\$\?@3J_P8^"!U'Q78O;:QXENA?7-M*N'MX H6&-AV;&YR.H\S!Y!K]5\ \O
MQ^*\0*>(HI^SI0FZCZ6E%QBGYN332_NM]#Z+@VC6J9S&.?'^BZ+<:G_8O]FP:MJD-N]W
MY?V[?Y8D8%]N],[^&>B^(H[/^Q?L
M1U6P25[;?]OW^6Y&Z/=L7.TC.U<]!7YWXKK!/@#&+%N2I_N[\B3E_%A:R;2>
MMKZK2Y^D>$3QR\0\$\&HNI^\MSMJ/\&I>[2;6E[63UMH?I[9WEIJ%LE[874<
M\,@S'+"X96'J".#4E?.UY_P2^_9!+IVW&Z\&^,+NV8-Z@2/(
MH_ 8J/\ X9%_:N\%?-\(_P#@H+XI\I/N6?CC0+76?,']UIGVN/\ > S7\9_V
M5PWB/]WS'D_Z_4IQ_&DZW]=C^VO[6XFPW^\9;S_]>:T)_A55#]?F?1M%?.7]
MI?\ !4GP&,7?AOX3>/;5/NFQO+O2[V3Z^9F$?A1_PVQ\>?!O'QF_X)_?$2P"
M?ZV;P?<6VOHO^UF$IQW]J/\ 5+,*O^ZU:-;_  5J=_\ P"<9&?C"OZ2X!\)
M^%,?PEAJ^=6+TJ24?=C-)>ZHVLM5KK>Y_,GB%XO<6Y?QAB]*#;]]RO=Z.ZTM8_0K0_P#@O%_8UHUK_P ,K>9NF>3=
M_P )SC&XYQ_QXFKG_#_C_JT[_P OO_[AK\Z:*^P_X@WX;_\ 0#_Y5K?_ "P^
M+_XC5XF_]!__ )2H_P#RL_HLK'\>^ ?"/Q.\)WG@CQSHD6H:;?1[)[>4?DRD
M._&/[(_B.T^%7QKUB?4_ U[,(/"?CBYY:Q)^[9WK=L#A9>F!Z B/W]'21
M!)&X96&593D$>M4/%?A3PYXY\.W?A+Q=HT&H:=?PF*[M+A,K(I_D0>01R" 0
M017A6D>(?%O[%&M6_@[Q]?W>L?"V\G$.A^(YLR3^'F8X6VNB.6@[+)VZ=/E'
MQD*U?@R:I8B3G@'I&;;D:CUI_#.\;27E*4\K?+-WH]'UAY/O'L
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MGLUOQ)YB8DAWH/L]JW<>5$1E3TDDE]:^JJ^5?^'U/_!.6#_D+_&S4M/ X=X(G7J4)WD[_#+_+H?3]%?.EE_P5K_ ."<
M]^%,'[56@+O.!YUO=1_GOB&/QK4L_P#@IW_P3\OPI@_:U\&+N;:/.U01\^^\
M# ]^E<3RS,H[T)_^ R_R.1Y?CX[T9?\ @+_R/=Z^8/\ @K-XU_:U^$G[+MQ\
M;_V2?B5+H>H>$[L7/B.TCT6RO1>::WR.X%S#)M:%MLF5VC9YI;.!CO+3_@H;
M^PE>C,/[8'PX7YMO[WQ?:1\_\"D''OTJUJG[7_[#/C70K[PWJG[5'PKU+3[^
MUDM=0M&\=Z=)'-#(I5XW'GJ<;IKJM4?BU_P^T_X*=?\ 1S/_ )9FB_\ R'4-C_P6D_X*7Z;"
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MT?&#XK:MX7\&^-[1=WA?PU(;>_UW3UFVX3S&Q@O(W+2N<#+N68]R:_-^)*
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MOC'_ )%B]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH ***
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MM[J2.>VOH3'-$X8@JZGE6!Z@]#7\L_2%XJH8O+<+EV7XB,X.XY)->
ME_\ "S/VT?'?R^"/@!H/A2W?_5WWC/7C.Y'KY%L-R'V.:\N_X)'^'-2M/!?C
M+Q7-&PM+_4[2UMV/1GACD9\?A.E?7M?WGXH6X.9&_$5H>'?V'/V<=&O1K&M^#9O
M$>H?QW_BC49;YY/]Y7;RS_WS7KE%?<4^#.&U-5*]#VTU]JM*59I]U[5SM_V[
M:W0]>.58&_-.'.^\FY?^E-V^11T#PSX;\*6(TSPOX>L=-MATM["T2%!_P% !
M65\6OA;X6^,_P^U+X<>,;=GLM1AVEXSAX7!#)*A[,K $=CC!R"171T5[];!8
M/$8.6$J4TZ4HN+C;W7%JS5NS1V2I4ITG3DERM6MTMV/RS^._[&?QN^!6L3IJ
M'A:ZU;1U!_&?C#4UT;PGX2U+4[M
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M_M;2Y]-_X94\OSDV[_\ A.7?N^T?
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MQ_ICE6?8/-)RH6=.O#XJ4])Q\[7:E%])P0M%=6MS&'CE1A@JP/!!JU17ASA"I!QDKIZ-/9H]II25F?/"2^*_V&]76W
MNFO=:^$5Y<8CF.Z:Z\*2.WW6ZM):DGKU7/\ >_UGO^DZMI>O:9;ZUHNH0W=G
M=PK+;75O('CE1AD,K#@@CO3[^PLM4LIM-U.SBN+>XB:.>">,.DB,,%64\$$'
M!!KX._:$^.?B/]CKQYKOP/\ VD/ Q6*
MAP]3YYZT7HEUB^ROO%]OL_X=OSW_ ."P?['O_#)/[7VJ?\(WI?D>$_&>_6_#
M?EIB.'>Y^T6J]AY4I.%'2.2+UK]5/^"/G['O_#)/[(.E_P#"2:7Y'BSQGLUO
MQ)YB8DAWH/L]JW<>5$1E3TDDE]:_/?XR:/=?'K4M.UCXH^(-0UB[TW45NXKG
M4+MYW;'WHR7).QL#(_V17LOP)_;+^-WP*UB"33O%-UJVCJX%SH6JW+2P.G<(
M6R86]&3'.,AAQ7G8GZ67#^:Y9@\%B,+4A=M5974N7E=J;M9^VD?6ZU?9]S]3:J7OA_0=1W?VAHEI/O.7\ZV5MWUR
M.:QOA)\4O"WQG^'NF_$?P=<,]EJ,.X1R)QV96!!['&1D$&NDK]:PF
M*H8S#0Q&'FI0FE*,ELTU=->36IZ5*K"I!5(.Z:NFNQ@7OPI^%VI;O[1^&V@7
M&\8?SM'@?=]?LX_L\ZCN_M#X#^#)]R[6\[PO:-D>AS'TKLZ*ZU6K1V
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M'DM:C4DW47P-ZOWO_D=_P/JLMXDGAVV[L****
M0@HHHH *Q_$O_(7T?_K]/_H)K8K'\2_\A?1_^OT_^@F@#8HHHH **** "BBB
M@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV* "BBB@ HHHH *
M*** ,WQC_P BQ>_]<#5S3O\ D'P?]<5_D*I^,?\ D6+W_K@:N:=_R#X/^N*_
MR% $U%%% !1110 4444 %8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L444
M4 %%%% !1110 5F^,?\ D6+W_K@:TJS?&/\ R+%[_P!<#0!=1;7/*45+WFMXJ+24=KW;OI;\PXQS?%/'/
M!TY.,(I7MU;5]?*S6AJ>&_&WC+P=J:ZSX3\5ZEIEVK9%S87LD3Y^JD&ON#]A
M/]NS6?BIK,7P<^,=U')K4D;'1M9"!/MNT$M%*  !(%!(8 !@""-V"WP75SP_
MJ%]I.NV>IZ9?75K<072207%E,8YHV# AD8;T\1AJDG
M2NN>FV^6<>NFRE;X96NGW5T_G,IS?%Y5B8SIR?+?6-]&O\^S/U]\:_$OX>_#
MBR_M#Q]XVTO1XB,JVHWR1%_]T,"OV,_V=_!=[_;+> H];U-F#2ZIXEF:_GD8?Q'
MSB5#>ZJ*]/M[>WM($MK6!(HXU"QQQJ%50.@ '05_>'L>,LP_B5:6%CV@G6G_
M .!S4()_]PIKS[_L'+FE;XI1IKR]Y_>[)?\ @+/%3!^W1\3?]==^%/AI82?P
MQ)_:^HQCW)Q >/3!J2S_ &(O .NW2:K\:_'/BCQ]=HVX)K^L.MJC?],X(BH4
M?[))%>TT4UP;E%9\V8.>*E_T^DYQ_P#!2M17RIH%E>&GK6;J/^\[K_P'2/\
MY*9'@_X?^!?A]8?V7X%\':9H]O@!HM-L4A#>YV@;C[GFOF?]NO\ 83UCXJZQ
M+\8_@[:QR:W)&HUC1V<)]NV@*LL;,0!(% !4D!@ 0=V0WU?7YT_\/^/^K3O_
M "^__N&OJGX.5O%;(ZV587!^TI4N5^[*G3=-OFY)0YG%7TELFK74E9Z_+\:<
M1<&\/X2EAL\K>RC5YN2T)RUA:[7)&5K_74\%\2>!_&G@[46TCQ;X2U+
M3+I&PUO?V,D3Y^C &O1/@1^QI\;OCKK$":=X6NM)T=F!N=>U2V:*%$[F,-@S
M-Z!,\XR5'-=;K'_!>?\ M;2Y]-_X94\OSDV[_P#A.%$*W-4S1RCV]C67X\C_!(^]OA+\+?"WP8^'VF_#CP=;LEEIT.T/(
MP%?
M.G[?G[?G_##?_")_\6G_ .$H_P"$H^W_ /,>^Q?9OLWV?_IA+OW?:/\ 9QL[
MYX^BZ_.G_@OQ_P TG_[CW_N.K[OPTR;+>(.-L)@,?3YZ,_:SY96C*W-5A%Z233NFUJOQ#_ (?\?]6G
M?^7W_P#<-4X/^"\7DZW/K/\ PRMGSH5C\O\ X3GICOG[#7YZT5_5_P#Q!OPW
M_P"@'_RK6_\ EA_(G_$:O$W_ *#_ /RE1_\ E9^BW_#_ (_ZM._\OO\ ^X:_
M1:OYTZ_]O*Y[+17SH?^"HO[,.JDCX>67C;Q>?X!X:\$7LN_P"GFI'2?\-T
M_%/Q#Q\.?V _BW>9_P!6WB'3H-)5O?,KM@>]?D?^IG$\?XN&=/\ Z^.-/_TX
MXG[%_KMPM+^#B55_Z]J57_TVI'T917SG_P +M_X*-^)_^1>_8I\->'%;[DOB
M7XB0W/XE;5 1].M']@_\%3_%'_(2\??!OPM$W3^Q]+U"^F0>_GD(3].*/]5J
MU/\ WC%X>'_<:,__ $U[0/\ 6NC4_P!WPF(J?]P9P_\ 3WLS\7Z***_T1/\
M-T*_1;_@@/\ \U8_[@/_ +D:_.FOT6_X(#_\U8_[@/\ [D:_,?&3_DV^._[A
M?^GJ9^I^"O\ R:6YGE2
MXD!"E8X[%]Q!DCSTOPU^-?[5_P"QO^PSXX_:0_X*U>//ASJ.N>#;;4-:OW^$
M=C=QZ?'ID,*F&WC^VA))KJ217 RJ*6EC0="S 'T[17YZ^,/V]_VX?@3^P%X7
M_P""M?QG;PY=^#M3BTC7_&GPZ>L6GJ>3FN29?G-
M.*Q$6I0UA.+<9P?>$EJO-;-:236AXE\"/VUO"GQ&\5'X-?%WPQ=_#WXD6X N
M/"6ON +L_P#/2RGX2ZC."1M^8@$@$#=7MM$HKY(
MB7L+^(^7=V$O:2"9?FC;(!XX. &!'%>)?\)I^U/^PO\ Z-\4H]2^+/PM@XC\
M5V4._7]"A'_/W$/^/N)1UE'S  LQ'RI7L_V;E7$'O96_95WO0E+23_Z)_:>;<.^[FJ]M06U>$=8K_I]3CMYU*:Y.LHTUJ?4M?CAXY\1Z
MEXO\::OXKUB1FNM2U.>ZN&?KODD9C^IK];?A;\6OAO\ &OP?;>/OA7XQLM;T
MFZ'[N[LI<[6P"4=3AHW&1E& 8=Q7YJ_ME_ C6/@5\;M5TY[!UT?5KJ2^T*Y"
M_(\+MN,8/]Z,ML(Z\ ]&%?R%])G*,UCE>#K.$E"C.<:B::<9245'F6ZMRRCK
MLVENSS^-']$KASDS^&?$MS V?4
M!V=1^ Q7]Z>'5#C?)."<%0GAJ=1*%TI594ZB4I.233IRBVDTK.4;;/5'[%D<
M,VPF4TH.G&6G63C))NZ5N5K9]T>ST5XK_P ,Y_M">%_F^'/[8NO[%^[;>*M'
MM]3WCT,C;6'U S2?;?V^/"/_ !\Z)\//%T"]/LES<6%T_P!=^8Q^%?:_ZRXV
MA_OF75X><5"JOE[*UT5XJ?VH_BWX9X
M^)O['OC2S"_ZR7PU-!JZ#W_=%>._M7FG[6'[?OA5_@[>>%_A5<:UIGB;5)5M
M98=3TF:TGLK8AC+*I8;=W 08;(\SFWKH8XC/,NPU"52V8IKXEZ]:*_E#,/'SQ Q6/=;#U(4J=]*:A&2MV\%%%% !6/XE_Y"^C_ /7Z
M?_036Q6/XE_Y"^C_ /7Z?_030!L4444 %%%% !1110 4444 8_@?_D$2_P#7
M[-_Z%6Q6/X'_ .01+_U^S?\ H5;% !1110 4444 %%%% &;XQ_Y%B]_ZX&KF
MG?\ (/@_ZXK_ "%4_&/_ "+%[_UP-7-._P"0?!_UQ7^0H FHHHH **** "BB
MN;^+?Q2\+?!CX>ZE\1_&-PR66G0[C''R\TA(5(D'=F8@#L,Y. ":PQ6*P^"P
MT\17DHP@G*3>B22NV_)(BI4A2INR_P"1WO?^O*+^9K\ROCM^
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M?!_UQ7^0J:OAKX"?\%2O$VGZG;>'OCSH5K=:_PCQUPYQO
MAI5C7R_5:%FBO.OB;^U7
M\#?A5>?V+KWC..]U7COV3RX\[&/^V5KE/^%B?M>_&/Y/AK\+[+
MX?Z1)]W6O&C>;?,O]Y+-.(V]I,@^M=F+XKR?#XB6&H2=>LMZ=)>TDG_>:]VG
MZU)07F:5SZQK6C>'=.EUCQ!JUK8VD"[IKJ\
MG6*.,>K,Q  ^M>1:U^VGX*U74I?#7P(\&ZW\1-5C;:ZZ!:E;*%O^FMU( B+_
M +0#"DT;]BWP=K&HQ>)/CSXUUOXAZI&VY/[=N2EE"W_3*UC(1!_LDL/:O7=%
MT/1?#FFQ:-X>T>UL+.!=L-K96ZQ1QCT55  _"N;_ (R_-?Y,'3?I5K?I2@__
M  -_'NG^';!O#RO=Z5X0
MT-'N;ME;:)0\Y.&<("=J9#;0 ,XKX<((."*^CO\ @OQ_S2?_ +CW_N.K\Z:^
MF_XD?P?BOEN&XDIY]/#U*JDIJ=#V[DX3E!2YO;T4M([1BHI622LV_P"8_$GQ
M!IG)8.VCZ3=1WVNW)7Y$A1MPC)_O2%=@'7DGHIKX?HKKR?]G'@\!FE'$XKB3V
MM.$E)P^I\O-9WMS?6I63>^CTNE;=?%8;Q=I4<1&I4P'-%.[7M;7\K^S?Y']%
ME%%!(4%F. .I-9G]QA17%>-/VD_V>OAUO7QU\DNG!@OO$%O'(3Z!"^XG
MV KS'5_^"H/[&]K>-I/A;Q_J/BB_7_EQ\+^'+R[=OHPB"'/LU>U@^&^(,PCS
M8;"5)KNH2:^;M9?-GAXWB;AW+I F39AE']HK%147+V-
MDIPDU;VOQ1C)N.^G,E?6U[.W\P?2#SK+LX_LUX23DH^VNW"<8N_LKFMKO^VO"+_6F?AY@HX-48T_WEI3YY2?[ZI>\%R):
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M]_[CJ_1?"C.Z6*X_P="E@Z-)/VFL(SJNNI^;>+N15L+X>
M8VO6QM:LU[/2_+;=6O?R/J>"O [_ %/XFH9O_:'M?9<_N^RY;\T)
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MR*\U/PK&4"M;V-W!>V\%;?4XYL[TG32+575L\[@P(/N#7BS_\ !)OQ]XS_ &:?
M"7_!/GXV?M*6GB;X >#[^P":'_PBKP:_X@TC3ITGT[1M0OOM30-;Q-% DDD-
MO').EO&O[D[V?[7AAAMX4M[>)8XT4*B(N H'   Z"@!U<9\9M$^.6MZ991?
M[QOHNAW:3L;Z76M,:Y66/;PJ@$;3GG-=G10!\D_M6^#?VT[#]G7Q=>?$#XS^
M#]0T6/26.HV5CX<>*::/_P#8!?\ ]#6NZ^%W_),_#O\ V K3_P!$I0!+]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XUF>%;7Q3
M)ITC6&J6T:?:9 5D@).[=R:ZNL?P/_R")?\ K]F_]"H /L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8
MHH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\
M&LS7+7Q2NHZ:MUJEL[MOZ+*_G3K^KO #-\?F=''PQ4N=TU12DTN:W[VT7+XI*-O=3;Y
M;M*RT/Y%^D/D^7Y76R^IA(G>OT*^Q>-_^@W9?^ Q
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MV,_C=\"M8G34/"UUJVCJY-MKNE6S2PNG8R!M[*I!J7:W]7^1!X9T;5_$7B.PT'P_8375]>7D<-G;6X^>61F 55
M]R2*_1G2_P!M3PU:Z@FA_%235? >HNVU;?Q9XN:7;WEM*,2VUW LD;CT*L"#7]9>#O 7%W#>25<B_1^&,GS+ X257F4)3M[LHWT6U]4T]7U]4<]X:\0
MWOC/3AJ_A#X@:'JMHW2YTYUGC/\ P)&(K1^Q>-_^@W9?^ Q_QKSOQ+^Q'\!=
M6U(^(/".D:AX.U4_(<#ICL YK^>A-5%ZN$_9S7I%5'YL^F^M8ZC
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M:+7Q)-I/1--JZU3?HY+Q!A,Y3C!,?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&MBB@
M#'^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HH Y3PK:^*9-.D:PU2VC3[3("
MLD!)W;N36G]B\;_]!NR_\!C_ (T>!_\ D$2_]?LW_H5;% &/]B\;_P#0;LO_
M  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+
M_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% ',^);3
MQ:F@W3WVK6KQ"(^8B6Y!(]C5FRL_&ALXC%K-F%\I=H-L<@8^M6_&/_(L7O\
MUP-7-._Y!\'_ %Q7^0H S?L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MB
MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V*"0H+,0 !R30!C_8O&
M_P#T&[+_ ,!C_C7PG_P6[^(WQ4\#^'_AWX6L_%D<>GZM=ZG7GB_Q"21'H/A&U-[,6'9F
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MY6^\K'[]X'<5*C',%FN9JDOW7+[:HM?XG-R^TDO[M^
M7ROT+'_#9U['_P ?WPF^(ML>I$_@&48'KPYX_P */^&W?#T?_'YHOBVW[XG\
M#W R/7C-5?\ AZE^QM-SIOB_7KT= ;7P;J)RW]T9A'/^-'_#S[]G.;G3_#?C
M^['/P&^,%UC[QM_A[.=OURPH_P"'B^FR\6'[&/[0-T?XA;_#0G ]
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M;)0>CS.3(_XL:ZS[%XW_Z#=E_X#'_&O"_^&>?V_P#Q-SXK_;XL](B;
M[]IX:^'-I^DTS[Q^5'_# 7B;7_F^(O[-"GCZ,(1VC2I56EZ)TZ)?V@?AEX,W#Q;^T?X"TPKU
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M]VE%;WMIHM-=S^)O%U8Z/B'C5C'%U/W=W!-1_@T[63V(FCX]J^H:*_SO_URXAA_N]54?^O4*=+\
M:<8OYWN?Z1?ZE<.3_P!XI.M_U^J5*WX5927RM8\/\&?L$_LY^ -C>&_@9X'#
MQ_ZN:_T%;R13ZA[C>P/OFO3M(\+:[X?LUT[09-)L;=/NP6>G")!]%7 KHJ*\
M7&9GF68RYL76G4?]Z3E^;9[>"RO+,MCRX2A"FO[D8Q_)(Q_L7C?_ *#=E_X#
M'_&OYZZ_HLHK] \./$?_ (A_]:_V7VWMN3[?)R\G/__/Y6MUOI^=^)?AI
M_P 1$^J?[7[#V'M/^7?/S<_)_?A:W)YWOTMK_.G17]#7C'_D6+W_ *X&KFG?
M\@^#_KBO\A7Z=_Q,;_U*_P#RO_\ <3\L_P"):?\ J:_^4/\ [L?G'_P0=@UN
M;_A:O]C7L,./[#\SSHMV?^0AC'IWK]"OL7C?_H-V7_@,?\:V**_"N,N(_P#6
MWB2OFWLO9>UY?=YN:W+",/BM&]^6^RM>WF?OG!7#/^I_#-#*/:^U]ES^]R\M
M^:47\S0 ?8O&_\
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M7$)-HQVXJQ110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!Y1^W/_R:/X]_[ +_ /H:
MUW7PN_Y)GX=_[ 5I_P"B4KA?VY_^31_'O_8!?_T-:[KX7?\ ),_#O_8"M/\
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M?9O]B?\ !3'X,\Z/XM\$?(O\ EAJUH=#U9P.BJ\9-OTX+/DGKZU-^P'^P
M'_PPW_PEG_%V/^$H_P"$H^P?\P'[%]F^S?:/^F\N_=]H_P!G&SOGCZ+K^;N/
MN.Z&:\6XFMA%3Q.$ER4MI1OOV9_37A[P#7RCA##4<8ZF
M&Q<>?G=.KWJ3<;Q3G1E[KCO&5MNZ/G"'_@HUX:\"S+I_[4GP(\=?#&;<%DU#
M4]'>^TLL3C"7=L&#\]]@'2O9?AG\%I&TRZCD_YZ;KQ 3J!TPJ]/I7QE_P %=?&7[2WB/_A7
MVC?M(_"#1O#MUIO]K?V?JWA_7!=6FKA_L?F%(V'F0>7L3B0DMYHQ]TU]AP#P
M9DN=<6X:A5Q%+$X>7/S14ITYZ4Y->[+DF[22;]FYJVK?+<^+\0N-L[R/@_$U
MZ.'JX;$QY.6;C"K3UJ04O>CSP5XMI>T4&WHES6/2/^'_ !_U:=_Y??\ ]PU3
MT/\ X+Q?V-:-:_\ #*WF;IGDW?\ ")K\]:*_I'_ (@WX;_] /\
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M>-=,TU1J-O=Z7;ZCJ$<+3-(CI+Y8=@6QY46<=-P]:^+@"3@"OT'_ &,?V+?
M^F? J*Z^./PTTW4-7UVX-Z8=4L5:>R@*A8X@Q&Y"0"Y ((+@'E:_3?!' 9]B
M>-HXG+(Q?LH3<^>ZA:47%)N*;NVTUH]KVLF>]PG1QE3-E4H)>ZG>][6:M9V_
M#T/IJVN;:\@6ZL[A)8G&4DC<,K#V(ZT^O&+G]@WX"6L[7G@4>(O"5PYR9_#/
MB6Y@;/J [.H_ 8IG_#.?[0GA?YOAS^V+K^Q?NVWBK1[?4]X]#(VUA]0,U_9/
M]K\3X;_>*?;?V^/"/_
M !\Z)\//%T"]/LES<6%T_P!=^8Q^%*?VH_BWX9X^)O['OC2S"_ZR7PU-!JZ#
MW_=%>._M1_KAEU+3%T:U'_'1JV8I)M4E6UEAU/29K2>RMB&,LJEAMW)_C<\FK0P'#DX3FU>=722C?:,5MS=9WDO/O?;\OMKX?\ _!5KP;8S'3_%OPAU*TM7N'=KFPU2.X=0QS]QDC!Q_O5]
M3?"WXM_#WXS^%H_&/PW\20ZC9.VV0IE9(7[I(C89&'H1R,$9!!K\?Z]7_8T^
M.VL? KXW:5J,=\ZZ/JUU%8Z[;%OD>!VVB0C^]&6W@]>".C&OB^!O'KB*&O/@[+EC<13<5RNK2IQCS\UI2=6I3YE[KTBVV
M[7LM3X?C?CO)N"<-3>,GRSJ\W(N633Y;*K#2+).MQJ%TL2D^@W'YC[#)-
M?%7[!O[5W[5G[97@:\^&O@W6M%\-+X.MK2'6/%NHJ]]?W"3F<0^7&RK&65(2
MK,_)P#G)-?0VC?LG_ _P'))\3/C/KTWBO4[9/,NO$7CO41+#;C_920B*) >F
M0=O8U]CG=+C;*\UEE$LL='$P4.?VM2#A!SA&:C%T95'5:4E?EM&^G/=-+]GR
MCB:AQ'E<,PRQ7HS3:G.\8Z-J6C7,[--/1+31V*LW[6?BKXFRMIO[+GP;U/Q.
MI8K_ ,)-K"MI^DQGIN#R /-CNJA3Z4U?V7OB9\6&^V?M0?&N]U.VM97B3_@HI\(Y]5D\!_LU^"]?^*VN6X$?V/P7IY:QMCT
M7S;Q@(HX_P#;7>!5#_A7?_!0G]H3]Y\3/BEI'P?T";[VA>"%%]K#(?X)+U_D
MB?\ VX?3I7?3\*\QQ4%6XKQ?+!Z\E2]*#7EAH.OV3_P!C+PH(=>UWPQX*LC'N6U4J
MMQ=8_B$:@S7#>X#&OSN_X*X_M+Z+^TE_PK[5O"'P[\4Z9H6G_P!K#3==\0Z2
MUI#K/F?8]S6RL=S(@1,L0.9 ,<5]_?"#]@_]FCX.:K_PE6G^!3K_ (B=Q)/X
MH\77!U+4)9/^>GF396-O>-5KQ'_@KU^R;^T!^U#_ ,*]_P"%%^ /[<_L/^UO
M[4_XFMI;>1YWV+RO^/B6/=GRI/NYQMYQD9_9/"W$<#<-\7X.&'O&$.=>UJ.%
M&E!>SFO=IJZ5W[JAS]JQ7]9_Z[<&?]#+#_P#@ZG_\D?R1_J+QM_T*\1_X(J?_ ")\
M]5_13#!!;)Y5O"D:C^%% 'Z5^,/_  Z;_P""@/\ T0+_ ,NK2O\ Y*K]H:_G
M?Q\SS)LX_L[^S\33KUO;F2O:ZO;:ZON%%%%?SL?TD%%%% '\Z=%?HM_PX'_ZNQ_\
M+$_^[JK:Q_P08_LG2Y]2_P"&J_,\E-VS_A!L9_'[=7]U?\1D\-_^@[_RE6_^
M5G\#?\05\3?^@#_RK1_^6'YY5^BW_! ?_FK'_.L)F&883DHP]IS2]I2E;FI3BM(S;=VTM%^!]%T44
M5_)Y_784444 ?.G[?G[ ?_#M.W-+VE6-^6*BM(
MS25DDM%^)^;L'_!!WSM;GT;_ (:IQY,*R>9_P@W7/;'VZKG_  X'_P"KL?\
MRQ/_ +NK[^LO^1WO?^O*+^9K8KT_^(R>)'_0=_Y2H_\ RL\K_B"OAE_T ?\
ME6M_\L"BBBOS$_4PHHHH **** ,WQC_R+%[_ -<#5S3O^0?!_P!<5_D*I^,?
M^18O?^N!JYIW_(/@_P"N*_R% $U%%% !1110 4444 %8]E_R.][_ ->47\S6
MQ6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 %9OC'_D6+W_K@:TJS?&/_(L7
MO_7 T 7-._Y!\'_7%?Y"IJAT[_D'P?\ 7%?Y"IJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \H_;G_P"31_'O_8!?_P!#6NZ^%W_),_#O_8"M/_1*5PO[<_\
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MWVDHUH_.4?922]*F0<@D5\R>(_VB/!=WJ33>$_AEJ5A:%L
MBWO_ !-'=.!Z;UM(A_X[7D]%?TKQ#]&#P)XKJJKFF31J36G-[7$1E;LY0JQD
MUV3=C^'\;XI\=9C)2Q&*4GW]E13^]4TSZ<^!/[=?P0^"^L0>*]1_9/NO$NL6
MS![:YU7QRHAMW'1XX5L,;NX+E\$ C!&:_07]@/\ ;\_X;D_X2S_BT_\ PB__
M  B_V#_F/?;?M/VG[1_TPBV;?L_^UG?VQS^+U?HM_P $!_\ FK'_ ' ?_'?A[BJO#F6QPTH>S:<9U7K*I"+;YIRYGRMJ\KOMLC]&\)/$/B_-
M.-<)E>)Q"="?M.:*ITHWY:4Y*\HP4M&D]^EMC]%J***_F@_L4**** /D+_@K
MAX:.-DS^$#U\,5][?\%5OVJ_"WP!^'VB_#
MCQC\'V\5V7CJ&_4O'KWV%]/>U-LR2H?(EW-NG!'0#9@[@Q%?F*?CV,\>$_\
MR?\ _M=?AGB+]%SQB\0,\7$G#&7?6>/)4?*W%-:J+B[Q<7HWV=F>B5J>"?#.H>,_&
M6E>$-)C9[K5-1@M+=4Z[Y'"C]37D_P#POO\ ZE3_ ,GO_M=>C?LR_MT>%?V?
MOB"/B/K?P);Q)?6L)72D;Q,+5+5V!5I2/LTF]MI('0+DGDX(^3R?Z%'TA\1F
MM&GCLG]E1_P"AH\:_^%;T45^Z_ZC\(?]
M -/_ ,!1_4/]D99_SYC]QXO_ ,,)?![_ *&CQK_X5MQ_C1_PPE\'O^AH\:_^
M%;/>89%C_P"SGEC4DO;7E&+Y7?V5K2MRRV?PMVTO:ZN4445_3I_.
MY]F?\$CD_:JU'_A8/AW]F6?PIIPO?[)_M[Q#XG624Z7<>XVA@FJ3_=WG"*525Z4
M-ZGQI6=K1<59:IO4_MGPAX9RK,O#[ XC'*59?O+0G)NE&U:IM3^!NZO>2E*[
M=FEH9_A;PEX5\#Z)#X:\%^&M/TC3K<8@L-,LT@AC'^RB */P%:%%%?BLYSJ3
M[>[/W&$(4H*$%9+1):)!1114E!6/9?\CO>_]>47\S6Q6/9?\CO>_P#7
ME%_,T ;%%%% !1110 4444 %9OC'_D6+W_K@:TJS?&/_ "+%[_UP- %S3O\
MD'P?]<5_D*FJ'3O^0?!_UQ7^0J:@ HHHH **** "BBB@#'LO^1WO?^O*+^9K
M8K'LO^1WO?\ KRB_F:V* "BBB@ HHHH **** ,WQC_R+%[_UP-7-._Y!\'_7
M%?Y"J?C'_D6+W_K@:N:=_P @^#_KBO\ (4 34444 %%%% !1110 5CV7_([W
MO_7E%_,UL5CV7_([WO\ UY1?S- &Q1110 4444 %%%% !6;XQ_Y%B]_ZX&M*
MLWQC_P BQ>_]<#0!_\ 8!?_ -#6NZ^%W_),_#O_ & K
M3_T2E<+^W/\ \FC^/?\ L O_ .AK7=?"[_DF?AW_ + 5I_Z)2@#=HHHH *Q_
M _\ R")?^OV;_P!"K8K'\#_\@B7_ *_9O_0J -BBBB@ HHHH **** "L?Q+_
M ,A?1_\ K]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH ***
M* ,?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*MB@ HHHH **** "BBB@#
M'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_ .@FMB@ HHHH **** "BBB@
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MJ.ZM+6^@:UO;:.:)QAXY4#*WU!ZT?VCPK5_BX"W_IRG5_,/[-XLH_P
MLPA+_KY0YO\ TW4I?E\C\N_^"S/[0OP3^/MM\,[OX-_$G3/$*:=_;/V\:?,2
MUOYGV'R]ZD!EW;'QD<[3Z5\-U^@7_!=CP1X,\)W7PQO?"WA'2],FOO[;^VS:
M?81PM<;/L&W>44%\;FQG.-QQU-?G[7]F^%#P4N ,&\(I*G^\LIM.7\6=[M**
M>M[:+2Q_$WBZL='Q#QJQCBZG[N[@FH_P:=K)N36EKW;UN%%%%?HA^;'[._\
M#9O[1'Q$&SX _L(>,[J*3B/5/'EY!H4('_/0)(6>1?88)%!\ _\ !3'XG\^*
M_CEX!^&UI)_R[^$/#TFJ7:I_=9[PA W;G_#7]E?]F_X/^7)\-O@C
MX:TJ>+&R]ATJ-KG\9G!D/XM7?T5R8SB;B#'TO95L3/D_D3Y8?*$;17W';@N%
MN'P]I_R[Y^;GY/[\+6Y/.]^EM?
MYTZ*_H:\8_\ (L7O_7 U)*^;>R]E[7
ME]WFYK9^^<%<,_ZG\,T,H]K[7V7/[W+RWYIRG\/-*UN:
MV[O:_D%%%%?,'U04444 %8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L444
M4 %%%% !1110 5F^,?\ D6+W_K@:TJS?&/\ R+%[_P!<#0!_]<#5S3O\ D'P?]<5_D*I^
M,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%% !1110 4444 %8]E_P CO>_]>47\
MS6Q6/9?\CO>_]>47\S0!L4444 %%%% !1110 5F^,?\ D6+W_K@:TJS?&/\
MR+%[_P!<#0!WF?SIT5_0IX'_P"01+_U
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M3\8_\BQ>_P#7 UR_Y'>]_P"O
M*+^9K8K'LO\ D=[W_KRB_F: -BBBB@ HHHH **** "LWQC_R+%[_ -<#6E6;
MXQ_Y%B]_ZX&@"YIW_(/@_P"N*_R%35#IW_(/@_ZXK_(5-0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'E'[<__ ":/X]_[ +_^AK7=?"[_ ))GX=_[ 5I_Z)2N
M%_;G_P"31_'O_8!?_P!#6NZ^%W_),_#O_8"M/_1*4 ;M%%% !6/X'_Y!$O\
MU^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%% !1110 5C^)?^0OH__7Z?
M_036Q6/XE_Y"^C_]?I_]!- &Q1110 4444 %%%% !1110!C^!_\ D$2_]?LW
M_H5;%8_@?_D$2_\ 7[-_Z%6Q0 4444 %%%% !1110!C^)?\ D+Z/_P!?I_\
M036Q6/XE_P"0OH__ %^G_P!!-;% !1110 4444 %%%% !6/X'_Y!$O\ U^S?
M^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%% !1110 5C^)?^0OH__7Z?_036
MQ6/XE_Y"^C_]?I_]!- &Q1110 4444 %%%% !1110!C^!_\ D$2_]?LW_H5;
M%8_@?_D$2_\ 7[-_Z%6Q0 4444 %%%% !1110!F^,?\ D6+W_K@:N:=_R#X/
M^N*_R%4_&/\ R+%[_P!<#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ K'LO\
MD=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@ HHHH **** "LWQC_ ,BQ>_\
M7 UI5F^,?^18O?\ K@: +FG?\@^#_KBO\A4U0Z=_R#X/^N*_R%34 %%%% !1
M110 4444 8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%% !111
M0!F^,?\ D6+W_K@:N:=_R#X/^N*_R%4_&/\ R+%[_P!<#5S3O^0?!_UQ7^0H
M FHHHH **** "BBB@ K'LO\ D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@
MHHHH **** "LWQC_ ,BQ>_\ 7 UI5F^,?^18O?\ K@: +FG?\@^#_KBO\A4U
M0Z=_R#X/^N*_R%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!\6?M,_\ !(=OVZO%?BCXC?M-_M:_
M%O1]3N+VXM_AYH_PX\=3:5I?A&QC8I:SQ01J!)/'7[:WCV]\57GPE\:>*/#Y\=-!)/=>(M)T=ROVTXR]Q
M)N6>$,-SR>0-Q9RS'Z*_:6^*GCKQ?J\W[)7[,^O"U\?ZUIH?7/%$48EB\":5
M-N0ZG,#\K7;A9%L[8\RRJ9&'DPS,.D_9W\!_L\?LQ?"^P_98^"M]INFZ1\-M
M"M()=*-^KS6,$OF,D]TQ.?,F9)I6D?YI'+NS/GI%:)%'*8I
M_.D,(XD@
M\0Z#97Z1MNC2]M4E"'U 8'!H ^WNH'9\QR)&J
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M UGX-ZK=:QX&T>[E7QOJ\:R7.F12,$6Y(5064G '0=J]L_X5-\*_^B:>'_\
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M// &G?&3X+VNG^!M'@BN_&\L=U'#ID2K,GV9CM-$_P"^I/\ XBNZ
M_P"%3?"O_HFGA_\ \$T'_P 11_PJ;X5_]$T\/_\ @F@_^(H X7_AN[]D/_HO
M&B?]]2?_ !%'_#=W[(?_ $7C1/\ OJ3_ .(KNO\ A4WPK_Z)IX?_ /!-!_\
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MD_\ B*[K_A4WPK_Z)IX?_P#!-!_\11_PJ;X5_P#1-/#_ /X)H/\ XB@#A?\
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M^B\:)_WU)_\ $5W7_"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\
MQ% '"_\ #=W[(?\ T7C1/^^I/_B*/^&[OV0_^B\:)_WU)_\ $5W7_"IOA7_T
M33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\ Q% '"_\ #=W[(?\ T7C1/^^I
M/_B*/^&[OV0_^B\:)_WU)_\ $5W7_"IOA7_T33P__P"":#_XBC_A4WPK_P"B
M:>'_ /P30?\ Q% '"_\ #=W[(?\ T7C1/^^I/_B*/^&[OV0_^B\:)_WU)_\
M$5W7_"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\ Q% 'E_@W]N;]
MDNVTN2.Y^..D1L;N4A9!*I(+<'E.E:W_  W=^R'_ -%XT3_OJ3_XBN-_8*^'
MG@#6?@WJMUK'@;1[N5?&^KQK)'
M_P#P30?_ !% '"_\-W?LA_\ 1>-$_P"^I/\ XBC_ (;N_9#_ .B\:)_WU)_\
M17=?\*F^%?\ T33P_P#^":#_ .(H_P"%3?"O_HFGA_\ \$T'_P 10!PO_#=W
M[(?_ $7C1/\ OJ3_ .(H_P"&[OV0_P#HO&B?]]2?_$5W7_"IOA7_ -$T\/\
M_@F@_P#B*/\ A4WPK_Z)IX?_ /!-!_\ $4 <+_PW=^R'_P!%XT3_ +ZD_P#B
M*/\ AN[]D/\ Z+QHG_?4G_Q%=U_PJ;X5_P#1-/#_ /X)H/\ XBC_ (5-\*_^
MB:>'_P#P30?_ !% 'FGBS]NC]DFX\.7D-O\ '+1Y':$A402DD^P" M%MKB'0W:*>WT
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M'_Q%>)^!?AYX F_;R\=Z--X&T=[.'P1IY% '9?\-W
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MAC EB85)))7DUM_\ "IOA7_T33P__ .":#_XB
M@#A?^&[OV0_^B\:)_P!]2?\ Q%'_  W=^R'_ -%XT3_OJ3_XBNZ_X5-\*_\
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M&^!?AYX F_;R\=Z--X&T=[.'P1IY%>V?\*F^%?_1-
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M/_B* /-/%G[='[)-QX'YY_AQH+N^B6C.[Z/ 2Q,*DDDKR: ,#_ (;N_9#_ .B\:)_W
MU)_\11_PW=^R'_T7C1/^^I/_ (BNZ_X5-\*_^B:>'_\ P30?_$4?\*F^%?\
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M"_#SP!-^WEX[T:;P-H[V'__  30?_$4?\*F
M^%?_ $33P_\ ^":#_P"(H X7_AN[]D/_ *+QHG_?4G_Q%'_#=W[(?_1>-$_[
MZD_^(KNO^%3?"O\ Z)IX?_\ !-!_\11_PJ;X5_\ 1-/#_P#X)H/_ (B@#A?^
M&[OV0_\ HO&B?]]2?_$4?\-W?LA_]%XT3_OJ3_XBNZ_X5-\*_P#HFGA__P $
MT'_Q%'_"IOA7_P!$T\/_ /@F@_\ B* .%_X;N_9#_P"B\:)_WU)_\16=XL_;
MH_9)N/#EY#;_ !RT>1VA(5$$I)/L G->E_\ "IOA7_T33P__ .":#_XBO+OV
MU_AO\.])_93\0P7(/TH T;#]NS]D5+&%7^
M.VB@B)003("./]RIO^&[OV0_^B\:)_WU)_\ $5O_  T^%GPQN/AQX?GG^'&@
MN[Z):,[OH\!+$PJ222O)K;_X5-\*_P#HFGA__P $T'_Q% '"_P##=W[(?_1>
M-$_[ZD_^(H_X;N_9#_Z+QHG_ 'U)_P#$5W7_  J;X5_]$T\/_P#@F@_^(H_X
M5-\*_P#HFGA__P $T'_Q% #_ (=_$SP'\6?#B^+OASXFMM6TUIGB6\M2=A=?
MO+R LAIV@:/:V-N&+""SMUB0$]3M4 9JU0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\7_ !7_
M .#?#_@DE\,_V(_AE^SA:Z=\,OB%=2W/C#P[+K
M^HW3ZC-)'%&9&NKBXDN4($$179(NQDW+M8DGZ1HH \'_ &8_^";?[*G[)LFD
M77PU\/\ B74[GP[;M;^&+GQSX[U7Q ="A9#&T>GIJ-S-'8 QDH?LZQEE)5B0
M<5[Q110 4444 %%%% !15#Q1XHT'P7X?NO%/B?4%M+"RC\RZN61F$:Y R0H)
MZD=J\U^ ?[=O['7[4^N7GAO]F_\ :/\ "?CB]TXXU"#PQJJ7GV0X8XE,>1&2
M%; 8@G:<=* /6:YOX6_"GPC\'O#L_A?P7#.EI<:E<7T@N)S(WG3/O/_B=XHMM%T6Q0O>ZG>DB&W0 L
M7=@#M4 $EC@ #)->':+_ ,%@?^"6/B&&6[TK_@H/\(GMX"!<7/M%\3:'> FTUGP]JL-[:3XZ[)H69&_ UM4 %%%%
M!1110 4453\0:_I'A;1;GQ%KUX+>SLXC)1_ W]O7
M]C/]IGQ;>> _V>_VE/"7C36-.?*/[M^'QDH0.17K
ME '-_"WX4^$?@]X=G\+^"X9TM+C4KB^D%Q.9&\Z9][G)[9Z#M72444 %%%%
M!116/X]\?^#OA?X5N_&_C[7H=+TFQ3?>7]P&\N%>[,0#A1W/0#DT ;%%?-^B
M_P#!83_@E?XACFGTC_@H-\(Y8;< W-RWCBS2&$'H7D9PJ?B17N/PT^*WPN^,
M_A.#Q[\'OB3H'BS0KDD6VM>&M8@O[24C&0LT#,C=1T/>@"+QO\*?"/Q!\1>'
M/%'B.&=KOPMJ37VDF&T
MFYUW6+GR;6S@::YEV%MB*,DX4$G@= ,UY3\&_P!OW]BW]H?QY>?"[X%_M+^$
MO%OB+39&CU/1M U5;JXLF4L")T3)A(*,/GV\J1UXH ]?KF_A;\*?"/P>\.S^
M%_!<,Z6EQJ5Q?2"XG,C>=,^]SD]L]!VKI** "BBB@ HHHH **S/&/C+PS\/_
M  U=^,/&.JI8Z98H'N[N1&98E+!!:-_P %A?\ @E?X@,QT
MC_@H+\)9DMEW74W_  FUHL<"^KNSA4'NQ% 'TA7-^-_A3X1^(/B+PYXH\1PS
MM=^%M2:^TDPSE%68H4)8?Q#!Z4OPL^,?PB^.?A2/QW\$_BIX;\8Z'*Y2+6?"
MVN6^H6CL "0)H'=">1QGO71T %%%% !1110 445!J>I66CZ;<:OJ4WEV]K \
MUQ)M)VHH+,< $G !X'- $]%>/?"S_@H'^Q3\I':@"_17S?I?_  6#_P""6>M7-Q::9_P4 ^%$KVBDWG_%
M9VH%N!G)D)-_@5\7O"_C713)L&K^$O$%MJ
M5J6QG;YMN[IG!SC- %WXD?#[PY\5? NI_#OQ=%*^FZM;&"\6"4HY0D'AAT/%
M:6C:5::#H]IH>GJP@LK:." .V2$10JY/6VGV
M_\ !0G]B3XL_%.X^!WPR_:;\):]XRLY
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M%[B9MJ1J6!_VG?"6J^-X)?+N?"-
MCJ8DU*W;%5_;R^%ZZE82R1W]C)XMMTE
MM71BKK*K,#&5((;=C:0
M);74X8F.2%9[>1PIX/!(/!H U_B1\/O#GQ5\"ZG\._%T4KZ;JUL8+Q8)2CE"
M0>&'0\5I:-I5IH.CVFAZ>K""RMHX( [9(1%"KD]S@"K-% !1110 4444 %%%
M>+Z%_P %%/V'/$_Q;;X!>'OVG_"5YXY1PLO@ZWU(-J<9PI^>VQYJ##*22H #
M G@T >T5S>F?"GPCI'Q1U3XP6<,XUK5]-@L;UVG)C,,1)0!.QR>O>NDHH **
M** "BBB@ HJ#5-2LM&TVXUC4IO+M[2!YKB3:3M15+,< $G !X'-?/LG_  5O
M_P""8\'BFZ\#W7[=?PR@UFPG>&_TNX\501W%K(C;765&8-&5.0VX#;@YQ0!]
M$UB?$CX?>'/BKX%U/X=^+HI7TW5K8P7BP2E'*$@\,.AXK#^"?[3'[.7[2FD3
MZ_\ L[?'SP7X\LK5@MU=>#O$]IJ:0,>BR&WD?8>#PV#P:[>@"MHVE6F@Z/::
M'IZL(+*VC@@#MDA$4*N3W. *LT44 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$M0\4SM\9?!OPX\;Z1XN^&T.G3-JFB2#5-0E>:[CV@6]ND?A/J.JP:O-]BEM+*QL#%>7;I.$8
M6\,AV//CRPP(W9!H ^[_ (9_\%0OB-Y;*X2(&0H)IEP,;^03]?5^8G[?'[0?P(M?^#@
M7]AB>X^,_A5(]/\ #?CTZA,=?M]EJ+_1%%B96WXC%P<"+=CS"1MSD5[OJ_\
MP2;\?ZK\<;KXS1_\%8OVJK6VN?%;ZTO@RU^(%HNCPQM"+.\M8Y89_$OB))XI4#+(IU&8$,#P01Q@]J^_OCG\3OAS\'_A1KGCSX
MJ^.](\.:+9Z;.USJFMZC':P1XB8X+R,!G .!G)Q7Y4?\&QW[?_[#/P$_X) >
M%/A[\;/VP?AIX4\1Z5XAUR6^\-Z_XVL;748TDOY9(R+6243/O4@J%0EL\9-
M$GQ9\/:9_P $>O\ @X,^#-E^S%:KX=^$_P"UM!/O["-_JEM"LUUI^EJ+*Z%W- '6-VF-M%YQ,2R,R2;/D;PI\+_B=_P5__
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M^A:I91S-#/!)\*KI][#X8U2W2T.N3:>D<8MW:*-Y0CA7C6
M[@$OEMYH3[7_ &9/^"IO[,?_  4 \;6'@_\ 8:\5WOCO1X[&:[\;^+K71+VR
MLO#L#0,+> S7,,8:_EG:/;;J"RQ1SR/LVH' /IZBOC_X"?\ !*+Q[\#_ (PZ
M#\6-4_X*M_M3>.+?0[W[1+X3\:^/[2ZTK4AM9?*N8DLT9T^;. PY4'_ML_\%"?V=/^"?EKX"U?]I/4=5TW2OB#XXMO"VG:Y:Z>)++3;N=&9)KV
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M/%FM:#\>KWPQ:VK6.K6QCT&7681.D,HCWW5Q*D0D95AMF61D";T9U%;WAO\
MX*E?$;1OV]_ O[%7[2G[$?B'X9V?Q+M2\7V&H-J\NG0BXN;:[M+
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M+Q/8?M,_MI?M3^4LGA#XH_'^<>"-6B6D G:WO=/M]S:>9$*[ \KOEU5D0B01_8U?F#_P6*_:-_9^
MA_X*#?L"ZF_QO\)&V@^+U_J%Q>&[KQEX_P#%FF:%H]B@:]U76+^.UMK=2P4%Y9"%0%B!R1R0
M.]?C_P#\&T_[?O[#7P;_ &2_C%H?QA_;!^&?A+4-0_:.\2ZUI^F^)_&]CI]S
M=:?/#8+#* -#_@HUX6T7_@C_ /\ !8K]G#]L']D_
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M=S>-H_ K?#4Q12:U)XPDFC@BT.$;UBEFD>6)D4_F.8PKA=_3O^"AGQ5\
M!_MN^ OV)OVH_P!E9?"U[\5-#O[_ ,!>*_!WBV7Q!ITDUE$TUS97S2:?9FSF
M6-=P*^=&=R#?SQ\9?\%+577_ -@_X7_\% /V!/V/ETOX?_!C]IG1/B;:^%O#
MW@X:-<>*_#EG;>3/K)L%ACDBWR.P1I$#_9$6X.U3A?L/]EW_ (+%_LC_ +?'
MBSPWX)_86\27_CV\U!5O?%]P/#][:6_A'3Q&SL]]+-$D:W#R*MO% C,[O(9
M#%&[@ ^LJ*^._"/_  2;\?\ A7XX:7\9I_\ @K%^U5JMMIOBN#6G\&:I\0+2
M31[Q([E9SI\T(LPS6C@>4T88$QDC<#S7V)0 445XK^WA^WO\!?\ @G-\&[#X
M]_M(MK^NVMH9)&M-3;:\J12-&K, 2P1SWVF
MOI3]E7_@IMKO[6O[('Q,_:;\$_L[?V;JWPQ\8:]X>U3PAJOBU0+N?241[EHK
MN.V8#=N98PT8!*C"
M-?LYEDM=7_LNSN5NY[>125FA66[6+S$)4O%*H)*,!X'_ ,$UOVM/@;^S/\ /
MVP/V)/BYXIFL/B\GQU^(5WIWPWBT^:35M4M+NW5[:ZMH57]Y;LJLYGR(HXU\
MV1TC(<@'TE\6_P#@NKH_PT_X)3^"O^"IVD_LB>*--[6TUA-5T>RCTV_#V\MS/;^)?M$RP"0+]HV0XE8Q[@J,I)
M&X9^S_\ @N#^TG^SQ0>([9XETT*\1O2ZN
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MW[(MIIO@_P"$_P"T%X:^)F@Z5X>\%_V+/X[TO24<3ZBMBL$9/E&DCWO%
M9O,%,;1E@#[%OO\ @HE\7?A+^U[\+OV5/VJ?V2?^$8C^,UO?KX&\4^#_ !A)
MX@M[:]M(5FELM30V%M]CD\MAAXGN(R<_/M5G7ZMKX_\ V7/^"U/['O[>^L^%
M?!7[#NOZGXX\1:TT%UXFTU_#UY;)X0TX?/VO_!Q+_P % +OP]I=I<:A'X:\%&Q@N
MK@P122G2(&"/(J.T:LX7_;N_;G^"7_!.O]GVY_:9_:%M]>;P
MM9:Q8Z??3>'M)-Y+;-=3+$DSH&7;$I;+,3GH%#,RJWR;_P $N/A[J'CW_@KQ
M^VM^W'X.OK;5/AOXSNO!^B>"_%.G3K-9ZY-9Z-#]M:VE0E94A*/VS?@Y\9?&W@S]GN+2/%'P;^*>M>!-2\,:IXO!M]1O\
M2TMWN)(KR.U.R-O.94W0\E!NV!B5\D\6?\%X=%T+_@CEI'_!8+0?V0/%.L>'
M]5^T"Y\-6_B.QB_LHIK+Z1$UU<2$/LEN%3!@@F9?,^90 6KQ;_@EW^UG\#?V
M2?BK^VO^R/\ &_Q3-IGQ0US]K'QEXE\+> (]/FEU77]-U*&W>RGLH%7,RR)$
MSEP0D<9$DC)'EQ\DP?'+X4M_P9.S_"RY\9VUKXAAG73X]*OE:"2ZN6\>"]\J
MW\P 7+"V83,(B^Q#EMM 'ZD^/O\ @KAX]^#_ .T-\(_!7QF_88\4^%OA?\:O
M%UKX4\%_$_4O$]I]H;6;M";.*XTA5,]M%.P.QI724*"9(8V!0?:M?E3_ ,%R
MOVE/V>-1^&/[#&O:;\<_"-S9_P##7/@#Q%]JM_$5LZ?V1;+>)<7^5UC:TD(67R_.8[V#/*[# (  /KJBL[PAH,OA7PGI?A>XUZ_U
M633=.@M7U35)A)$]%N?$?BG7+/3=.LXC)=W^H7*0PP(
M.K.[D*H]R<5^/?\ P0K_ &]OV'_A;^T=^W'J/Q2_; ^&7A>#Q3^U-K^M>&9O
M$GCFPL%U;3GNKDI=VQGE43Q$$$.F1@CU% %S_@NKX4T/_@DS^UE\#?\ @L!^
MRGIL7A*]\0?$FW\&_&G0M#C%O9^,-/N8I+C=[G6&218E@*I&H>22/S(A)\%?MWZ-XA_X+Y?M9?!O]G#]G7P?K-S^SE\
M*O'$?C#XI?%[4-)FM=*UV[@4I#I>DR3*GVUO+>>-YH@\:_:0^2$'F'_!:_XT>+?^"K'[/V@ZG\*?V@]+\.:K\,OBGXG\ )KEGI-]INF1V-
MUITC>1,\6\Q[B$!*!(69=LF]0#[!^!7_  6O_9O^)/[)7Q+_ &F/BMX3UOP)
MJWP9\77'A/XF?#ZX:._U&QU^.X6VCL+5HB%O6GG=887&P.Y(8(%8C7\4?\%'
M/C'\$/VD_A#\#/VIOV.Y?#.E_&Z^GTWPCXD\*^,6UYM*U..-)%L]7@%C EHS
MJ^!)!-=1ADD^;8ADKY%_X**^&/"_[5W_  2L\4?M ?\ !*;]E'3;#PSX*^(_
MAOQKX97P[X&_L67X@Q:3.9;JYALU@BEFMHQ*/*=TWRFUN#&I4Q-)]._LK_\
M!./$4UG+XA\)2:!>0-X1L=ZF_N-2N&B$$(AC$B
M1X=OM$YB2/*IM
M:3P9I7Q M(]'LTDN3.+"&$V99;5 ?*5"Q(C &XGFOL2@ HHKR3]N/]M#X1?\
M$_/V:]=_:K^.NGZ_<^%_#LUI'J2^&]+^V7*"XN8[='V%E 0/*I9F8  '&3@$
M ^&OV3X9X?\ @Z#_ &O[W2-.MIKX?!/PN;=+B4Q)))]CTS"O(J.44E4!8*Q
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MV_X- OBG\/-7\76^G:U!JNKV0T_4@T#3W-QXE$\4,#. EQ(8VW%8FW\06\FZSMH9/M%Q\
MKG]W%@AWZ(>&(/% 'Z[T5\E_M&_\$X]>_:[^)TOQ\\!_\%2OVB_ >D:WI]JU
MAX?^%7C^TMM#$:PJHGMT:UESYH'F,PN!-?:DT,2QFYN9%50\TA7>[  %F8X&<4 ;-%%5M9UK1_#FD
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M84_9E\5?M7_&73-=O/#/@^V@GU:W\-:;]KO2DMQ%;J4B+*" TRLS,RJJ!F)
M4U\3?L)Z;I_[37_!>'XR_P#!0[X)ZS;Z_P#"NZ_9]\-^'-+\56+[[6\O[PV>
MH?9T?H98H($:5/O1&>,.%+ 4 ?2/[(7_  4"\4?M:?$#X[?!FP^!%MH'B[X&
M^+(?#U];7GBXS:?JUS)$\J21W*6@DBB*J#EH2WS#* @BO+/#G_!;>R\1?\$R
M/&W_  4CL?V0_%-U:^!-?U;2M<\(:?XCL'EMS83"*:YDN)FB'D[C_P LHY9
M.1&PR1XU^Q%^U5\"?V*?^"L/[;'P<_:7\;'PSXH\=?$?0M?\!:#/I]Q-=^*+
M2;3V5/[.AB1GO9-Q">7$&?<2,?*VWYC_ &=OCY\++#_@VB_:R\&^)O$T>BZN
MWC+QM;+I^L+Y!>YN[L&"VCD/[J:9CN 2)W.4?LI- 'WGXZ_X+9>/?A=X2^#O
MQ_\ B5^P#XIT;X+_ !4U#0=+NOB1=>+K03:/?:I$K1.-,\O[3-9*[,GVF3R&
M<)O6$J\7F??-?C1_P5@_:$^ ][_P;Y_L[?8?C)X7N&GOOAL8([?7;=W?[)';
M/= *KDDPJK&08^3!W8K[H_:3_P""?FI_MI?$"#X]?#;_ (*A?M > =%U'2+>
M*QT;X0>/[.WT29$W8N8P;:7<[[OF<.0=HQ0!]7T5SOPC\!7?PK^%OAWX:7_C
MW7?%4^@:+;:?+XE\47:W&I:JT4:H;FZE55$DTA7<[!5!9B<"NBH *_,;_@CI
M!##_ ,%I_P#@I"(HE7_BLO!1^5<:[N[J98XH8D4LSNS$!5 !)). !DU^/7_!*_P#;J_8I^&/_  6+_P""@7BK
MXF_MPL;;5Q9P:G'=&VEFE5)Q$SJ&V$XW ]* -
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M\#IKEEX.UG2WE5+61&AE>%'AV1K>YL[F)$^VPW B=8L1I(S@+Y8W
M(69\1_\ @J%\7O@)KOP@\1_M"_L2ZEH'@#XT>++'PYH>LZ3XK.IZWX?OKY2U
MFFL:8EDD5L''WC!=W/EE6!!( ;YH_;9^'OP+_P""E'_!)#]HK0O^"27[-&B6
MFA:AHFC3:#XJ\*> 1H9\XQOGV
M;]D/_@OQ^RO^VC\/?"/@KX'+JNK_ !U\00V]GK'PH_X1V^2;P_J *I>SWLYB
M\F&QMCYDK3%\LBA$!F=8J /O>BOC_P"/G_!*/Q[\!
M[?7+SSXO"?@GQ_:6NE::-BKY=M$]F[(GR[L%CRQKZ\L['/%FFG1_%
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M0T?PUI[R
M:K (=4=[-";R,*5"2G'[Q=I(PV1@XJ_7&67[17P(U+XY3?LS:7\7?#]U\0;7
M09-:O/!UKJD&]#L]/MVE:5H+&V2)"['+-M4 9)
MY)ZFKE9/@CQIH7Q"\,VWB[PTM_\ 8;L,;SOK998I "" R."#R >1VJ
M>UM;:QMH[*RMXX888PD,,2!510,!0!P !P *DHH HR^%_#,]W>:A/X=L7GU"
MV%O?SO:(7N80"!'(<9=<$C:./,B ,X ;/&<&J_[0G[
M4'[.O[)W@RW^(G[3/QL\->!-"O-133[35O%.KQ6<$UTZ/(L*O(0&++
M:XNKR7:6V1QHQ+':I.!V!KZ H **** "BBB@ JEK?ASP]XFMX[3Q)H-EJ$44
MRS117UJDJI(OW7 8$!AV/45#XQ\:>#OAUX7OO''Q!\6:9H6BZ9;F?4M8UF_C
MM;6TB'62660JD:CN6(%4OA5\5OAS\&M=M?M.C:WILOF
M6]Y#D@21M_$I(.&'!ZCB@#H*IZ+X=\/^&[>2T\.Z%9V$4LS32Q65JD2O(WWG
M(4 %CW/4UX'X_P#^"M__  3#^%?CC5OAK\1_V]/A9HOB#0=0EL-:T?4?&5K'
M<65U$Y22&5"^4=6!5E/(((/(KU7X#_M$_ K]J'P"OQ3_ &=?BUH/C7PV]W):
MIK?AS44NK9IH\;XQ(A(++D9';- '9T444 %5M8T;1_$.F3:+K^E6U]9W*;+B
MTO(%EBE7T96!##V(JS10!%8V%CI=E#INF6<5O;6\:QP6\$81(T P%51P !P
M.E5W\-^'9-1GUB30;)KNZMOLUS=-:H9)H?\ GFS8RR* .P
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M-?"#XQ_"WX__  ZT[XN_!7QYIOB?PQJXE.E:]H]R)K6\6.5X7:*0<.HDC/_C+I=GJVBV<=WX@LH$EN6T6VD4M'/?&!
M'%C&R@L'G,:E06!P": /1-'\.^'_  \)UT#0K.Q%U.T]R+.U2+SI3U=MH&YC
MW)YJY5+PYXC\/>,/#]CXL\):]9:II6IVD=UINIZ==)/;W<$BADEBD0E9$92&
M#*2"""#5V@ HHHH @U32M,US3IM(UK38+RTN8S'<6MU"LDVMHECCB0=%55 "@>@J>B@"HV@:$^KG7WT6T-^U
MM]G:]-LOG&'.?+WXW;,\[(_B[X?M/'?BN.>3P]X/DU2/^TKZ*&&2>65
M+<'S/+6.*1C(0%^7&<_!K]KC]F[]H+Q+J?@GX1?%W2]6UW1K6*ZU30
M"7M]0MK:3B.X:UG5)1"YX67;L8\!B:]&H **** "BBB@ JGKGA_0?$^GMI/B
M31+/4+5F#-;7ULDL9(.02K@C(/2G:YKNB>&-&NO$7B76+73]/L8&GO;^^N%A
MAMXE&6=WO:VJ1FXD/5W*@;V]SDUYQ\9OVVOV3_ -GK7KCPO\9?
MCMH.A7]C8)?ZK;7$[.VEV;L52ZO/+5A9P,58":?9&=C8;Y3CTG0]#4U% %;2-'TCP_IL.BZ#I=M9
M6=LFRWM+2!8XHE_NJJ@!1[ 4CZ'HDFL)XBDT>U;4(X#!'?-;J9DB)R4#XW!2
M><9QFK5> ^.?^"J/_!.'X9_',_LT^/\ ]M;X'-&NO$7B'5K6PT^PMGN+Z^O9UBAMX44L\CNQ"HBJ"2Q(  )->?_
M  5_;!_9C_:+UJX\-_!/XU:'XAU"WTY-1^Q65R1+/8NVU+V%7"FXM6;Y5N(]
MT3'@.30!Z31110 4444 %%% ": .EUK0M$\2:;)HWB+1[6_LY<>;:WMN
MLL;X.1E6!!Y&:L0PPVT*6]O$L<<:A41%P% X  '05YE^S!^VG^R=^VEX:O?%
MW[*?[0/A?QY8Z9.L.IOX>U1)I+)V!*K-%Q)#N"L5WJ-P!(SBK7QJ_:V_9L_9
MUU6ST#XT_&+1M!U&^LI;ZVTVXF,ER;.(@2W;0QAG2VC) >=@(DR-S#- 'H:/H5G:3ZA-YM_/;6J1O">-HYH9D#)(A&"K \$$'!!J'1-"T3PUI<.A^'-'M=/LK=2(+.
MRMUBBC!.<*B@ 'Q!<:/:O?V\316]Z]NIFB1OO*KD;
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M4#:CKOB'4H[6V@R0J@O(0"S,0JJ,LS$  D@5R/[+G[QV=A<:]JD=O]LN78*D$*L=TT
MK$@!$#,<]*[.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _-O\
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M!EG\"XOA_!XL@MVCMO&%[+JRW[W%JQ ^UV]K%!#$+M=?\%T?B#X#\
M"?\ !)CX^6_C;QII6D2:S\+=9L-(CU+4(X&OKJ2U=(X(0Y!DD9F "+DG/2NC
M_P""6GQ9^&WB/_@EK\$O&'A3QII^M:?H/P6\.P:Q+H+KCPAI;>5::?9W-O+#,\%M%#'#N"F%6FDF=$EEE*G]DOAQ-X
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M"?BGPGX86]\*_#SQSX=BL#K&EKNWWEE/!//%>G033'"QJ4)(#$B7]I3P!X8_;7_X+2_LJ_%G]FOQ'IVO67P,T/Q5K'Q0\7^'
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MVTU*SA?YKVVNDN3''Y8M[HFL6@8+/&258%6 :-U=61T8!D=&5@"I%=C7Q1_P &]_[*'Q1_8Y_X
M):^!OA;\8=!O=%UK4;_4]>/AO401/HMM>WDD]O:2J>4E$+1M(AP4DD=3RIK[
M7H **** "BBB@#\V_$'P[\!>!?\ @Z*\$7O@GP7I6CR:Q^R7JMWJS:7I\=O]
MLN#KTF9I?+4>9(<\NV6.!D\"OM;X[_LFPW^F6\]QY8DNC:S(T2)/$;M!:P3/;Q(9/(TRTNY ISM
M_M%#W%??E?)__!(#2=1\:_L]^(_VU/%-C+%K7[17CW4?'JK=(1+#HLI2TT.W
M)/)5-)M;%@. &E? Y-?6% !1110 4444 >)_\%'?AWX"^)7["GQD
M60H3\-[4!UQE?F?D9R*]._X*._$+P'\-/V$/B]KWQ#\::5H=E-\-M=MH+K5]
M0CMTEG?3;C9"AD8!I&P=J#+-C@&O&O\ @WP^(/@3QO\ \$@?@9IW@[QGI6JW
M.B>!K>RUFVT_4(YI+"X5Y T,RH28G!4_*V#Q0!-^TG^Q=_P3!_8<_8Y\=_M
M>+OV'_A9XD;P1X4U#6[W5?%G@33]2U37]06-Y ;FZGA:6XN;FX95+LV6>4 8
M& /3/^"6W[*S_L7?L!?#']GO4M+MK36=,\.)>>*HK6V2*,:S>.UY?A50!0HN
M9YE4  !%4    <-_P4E3_A?'QL_9_P#V"+4>=:>-OB"/&?CVW^\C>&_#1BOV
MCE4?P3ZFVD0<\$.X[''UO0 4444 %%%% !7YM_'3X=^ O!O_  E:7>ZY\$?%T^LW6G:?' ]],)';S9F109'S(YW-DG<>:_22OS$_:K_ &@_
M@1HO_!RE^SK9ZQ\9_"MK)I7P;\4Z?J@N-?MT^Q7DK2>5;S$OB*5_+?;&V&.W
M@4 >O_\ !=3X;_M)ZI^SW\/?VD_V9?!\7B_4_@'\6]+^(VM?#^>?RQXCTVPB
MN!/%&<$&:,2^<@P2#&656D5%/G'[(G[4/PU_X+9_MM?!_P#;L_9BU)]#\$_L
M^^'==@\46VL74,>M:CK.NV,,']E26D;L\=G;)$9FN),1S3H@A#B*1U])_P""
MV.I^,=+\(?!*X\1)<#X)K\<='?\ :!F@1FAC\/J)&B^W@O*_B1^SK\&K?_@MM\#_ -K/_@G+XKTD^(O%EOK"?M%V7@C4(KC2K_PY
M]A9K?4=06W)CBFDN_)2)FPUQ($?"NI2"RUC3X[F)9!:3*'"R*0& 9@&'(R?6O1Z\X_:[^
M(7@/X8?LR^._%GQ'\9Z5H.F1>$]11]0UC4([:$,;67"[Y& W'' SD]J /FK_
M (-PO^4)OP#_ .Q&(/&VO?)=;M?'NJ0V,T/
M@^&-%\/7FES3LICL886F:&:(CRYWN"^)'?(!]>_\$K?V3O&G[$7[!O@+]G#X
MB>++'6-"]N]4GTEV:QMIKV^N+UK2T+ $VT'VCR8R0,I&#M7.T?0E?''_!
M!OP'\%K!O#WAKQ_!K_P!LU^WB&F2W6D[+:.X+.! TKJRH
M'P788&217WI^U=X(_95^)7P-UGP5^V;I?@V]^'U["#K,'CJ:WCT\!#O61GG9
M5C9"-RR AD(W @C- 'P__P %LO%LGP)_X* _L(?'WX\3?^I-JM?;_ ,6OB%X#^%GPZU?Q
MS\2_&FE>']&L;*1KS5=:U".UMX1M/WI)"%'XGFO@C_@U4^(/@3Q'_P $4OA1
MX'\/^,]*O=:\.S>((]?TFUOXY+G3FE\0ZG-$)XE):+?&Z.NX#)#\
M@6WD51@&F?\ !LUX_P!5U+]EGXQ_ BTUF;4O"/PB_:/\4>$_AW=R3F58]$C>
M&X@MT3,/*BO-?BBD$ TZW*JTDU^NQEA$*DL46O:O^"2__  3XT+_@
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M CMD[UA<'("/$&NV7P5^-
MND_$G0],;29$U#Q!X"U(\S]XD274:,!(T,?W [A!<_X*
M-=-#!&V'=E=MNV-R #]*J*** "BBB@ KSOXM?LM?!CX\?$?PK\1?C+X.LO$W
M_"%PWA\/:+K=I'=6%M>7/E*U]Y$BE6N4CB,4'?"K]D_P1\/_P#@Y!\0?$O]D_PC9>%_#=A^SK$?C5:^';9;
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MIV]E8V5N\]Y>7?_!/S_@GU\+/^"5W
MQ:\(?$KX+^&[C2M+^'VK:IJ7BO4M(MWUF^UH6\DJZH]V$$LNHRW15_,SN>23
M8 5;97IW_!*_X*?$WX;?\$N_@U\#/VHK%M0\0V7PSL;#Q-I>N1B8QH\/%C.K
M@AO*A9+=E.1^[(Y%?&?CS_@O_P#\$/H?B'7;1K!=0LK:1HI+[RYPLD$!DBFVF548H@&?B=^R=X-L?"]MIGP"O[OX[1>&[1+6QO&O+IX-*CN(X@$^U2R
M0O-@@,R6"N>@)^@?^"G?_!5O]F3_ ()C^ -)N_C%\1-'L/%7B^Y-IX/T?4FG
M9&;(62^NEMHY9DLH-P:1TC9VX2-6=@*\1_8#_P""M?\ P2G\2_$O2OVJ'S)/E!Q\YXYK])*_-3_@Z(^*_P ,?!G["GA3POXL^(.BZ=JEQ\:/"=[;
MZ9>:G%'<26T-ZSRSK$S!C&BHY9P-HVG)K]&_"WBSPMXY\/VOBWP3XET_6-*O
MH_,LM3TJ\2XM[A,D;DDC)5QD$9!/(- &A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 54U?0-"\011PZ]HEI?)#*)(4O+990CCHP# X/N.:MT4 %%
M%% !1110 4444 %%%% %33= T+1I[BZTC1;2UENY/,NI+:V5&F?GYG*@;CR>
M3ZU;HHH **** "BBB@ HHHH 22..6-HI4#*P(96&00>QJOI.CZ1H-BFF:'I=
MM96T9)2WM(%C1BW]_;ZK?:/:
MS75F6^R7,UNK209Z[&(RN>^*M44 %%%% !1110 4444 %1W5K:WUK)97MM'-
M#-&4FAE0,KJ1@J0>""."#4E% $5E966F64.G:=:16]O;Q+'!!!&$2-%&%55'
M     '  J6BB@ HHHH **** "BBB@"NVCZ2VK+K[:7;&_2V:W2],"^U6*** "BBB@ HHHH ****  @,"K $$<@U4T;0-"\.VK67A
M_1;2PA9R[0V=LL2ECU8A0!G@<^U6Z* "BBB@ HHHH **** "JFI>']!UFXM[
MS5]$L[J:SDWVDMS;([0-Q\R%@2IX'(]!5NB@ HHHH **** "BBB@ JEJWAOP
M[KTUKR6,WG64EW:I(UO)C&]"P.QL<9VB@ HHHH **** "BBB@
MHHHH I:+X;\.^'$FC\/:#96"W,[3W"V5JD0EE8Y9VV@;F).23R:NT44 %%%%
M !1110 4444 %5]/TC2=($JZ5IEO:B>9IIQ;P*GF2'J[8 RQ[D\U8HH ****
M "BBB@ HHHH *KZAI&DZN(EU73+>Z$$RS0"X@5_+D'1UR#AAV(Y%6** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDIENKNZE+R2N>K,QY)KZA_X*+?!OXA_#WPUX8UOQ/\8]=\76*-5M
M)2B,NW8!RX5^O]ROE.OX\\<.(LZS;BYX/%TY4J=&,>6FW%VW4A7@9CRVWXU?3$5I;>(1%> W&&9D0Y_O5\UX79]FV0\:826!3E[6:A*":7/&
M3M9W:6E^9-M)-7;2NQ:;:S6.G
M6]E<7KW,D,"))<2@;I6  +G'<]?QKU,LQ^88R4EB<)*A:UN:5.5_3DE*UO.W
MD=&'K5ZK?M*;AZN+O]S9^.=6
MUS_A9?B'0-0NK*.]U""WB_LVPOKJT99H;(RRF25%8"50=^8XI*]:T+]A;PAX
M6_:6^ _[37[$'Q=\20_#.#7=2F\7^"]&\?7>H^%M3LKCP]J<5IJD$$EQ)"CI
MN
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M_2OC[QU\*_$?_!>7_@DM\9OVZ[SPCR#C[\4$#$C "@'W5_P44^&FB_M"?&WX"_LW6VN>(=-U/6?&UQX
MAUZ\\->)[W3)D\,Z1;&6]C=K26-GBGN[C2[-@>@O"P(917RK^WW\-[+0?^"_
M7['7P8\->-/&6E>#O'NA^)9_&'A72_'.IV^GZK)IUAN?\$0?VB/%/\ P4?\*R_\%)/'^D7%O/)X#T/X?Z(+F+8);FS@6[UZ
M^A':.XU.X$&>XTF,X'4\%_P5'F3X=?\ !?3_ ()__%_Q1_HV@WD_C#PZFHR<
M1+J%UIWD6\!;H'DDNHPH/+'.,X- 'Z$_&+X7^#_B#\(-5^'_ (BMKL:<=*EC
MB-AJ<]K/!MB95>.:%UD1U'(8,"" FP7,\KRW,CN\-7VHZI>W4H2.&"&!Y'9B>  %->?_\ !-;P1XA^&G_!
M.GX!_#GQ=ITMGJV@_!;PMIVJ6DR%7@N8=)MHY8V!Y!5U8$>U 'R7_P '"7A>
MTM_$'[''Q#M=7UB&^?\ ;2\!Z--;PZ[=+936DDUU<,'M!)]G=_-MXF$IC,@"
M !L<5]T?&?\ :.^#7[/XTB#XH^+GM;[Q#=26WA[0]-TRYU+5-6EC3?(MI8V<
M1\WEVN"=H H ^R_@W^VU
M^RO\>_"_B?Q=\-_C-IKVW@>Y>W\;V^MQ3:3>>')54LRZA:7Z0SV)VJQ_?QID
M*Q&<&O*->_X+=_\ !*WP[\,&^,U[^V+H,_AM=;NM*&HZ9IM_>%Y[;RO/D2.W
MMWD>W0S1!KI5, +@>9GBO#-2\$Z[X8_X.E-/\1?"&)K:P\2?LH&^^+45MQ%<
MF+59K6QGG[&?,5O&A/S>7 P'R[J\]_X(T^!O!V!\QR ?I7KG[1OP&\-? G_AI[7OB[H%I
M\/#H<.LIXQFU)!I[V,JJT4ZRYVLL@=-F,ERZA020#Y?XG_X*K_\ !/OX=^)4
M\&_&3]I72OASJD^GQ7UG8_%33KSPI)>6TA*K+;C5X;;[0NY64F+=M((;!XK\
MVK?X4>+?C1_P:L_L_P!WX3\:9B(2C8B:0L< 'W."",@U\:_&
MW_@K[\)?A1_P4J\,?L%7&E>($B7P;J>O>,M<3P7J5RBO&T,=I:V@@@=K@%FF
M>6:-6C0HB;]Q=4M?'KQ'_P %X[3XP:_;?LR_#/\ 98O/ :7N/#-UXU\1>((M
M5DM]J\W*6T)B5]V[A"1C%>8?%*26/_@YI^$;ZBT:2M^R5K/F;&^7>-88L 3V
MZ_A0!]>_'3]LW]GC]G.\DTKXF>*]5?4(-)_M6]TGPOX0U37KVQT_F74LB11H"PB<1J+E
M&VAI69O*/^"IW[(/[+/[%?\ P;W_ +6?P._9:\=>(O$.F6WQ(TB_\2R>(KZ"
MX%GKD^LZ!)<0VY@@ABC14,):.-=J2-(O#!E !]\:O_P63_X)?>'_ !1X[\&:
M_P#MI>#K#4?AK!'+XR@O;B6%;/>=H2-WC"74@;Y6B@,CHWRLH/%2:I_P6$_X
M)L:)XQ\$^!-8_:KT6UU#XB0Z?)X5,^G7JV\S7T$=Q:0SW!@\FRGEBEB=8+EX
MI=LBDH,BN&_X*L?#'X;^$/\ @C#\Q8V
M\&X#/EQDDHN<*22 ,U\C_P#!5GPGX6TW_@U%^'4.F^';&W2S\"_#*\M$M[5$
M$5Q+-IGFS*% P[^=*6;JQE@?M+Z+<_$.
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M*T"H95964J""!\C_ /!$;X?_  ]U7]JW]OG6=2\':3=:A=_M/ZUIM[/<6,-/@;
M<_M=^%A=:#X'.M>,;>ZO;C3TL=(G$<32-=2+&BR W$4;1I)YT4DBJRH_ T/^
M">^H?L*_!?\ X)X>$M7_ &0_B7%_PHKPYI&H3Z'XJ\0:I<+%'9Q7ERUU/+/?
M!'6-9Q<'<^U JC;\@6E^#WPQ^&WAS_@G9X=N= \":/9RQ? &VTZ.YM]/C606
M9TM9#!O W>67)'
M_B=>V/B[Q#IDFH^%]'\4>$=5T1M?M(UW//ISZC:P1Z@BK\Y:V:0;06^Z,U9^
M/W[?/[*W[,EWJMC\7/'^HQ/X>L8[WQ.?#_@[5M;30+:0%HY]1?3;6==/C90S
M*]R8U*J6!*@FJ'QQ\$?L0_%GQK\%_P!IGXK:+H?B;7M$\1)_PI/Q!:7SRR&[
MU.) TEF(9 MRC01B=R0Z)%;M-@"/+G\:^ =,L/#DAN--N)UAM+Q1J&DW-Q);M;QI;*WF%%2WC4!5*9 /T
MO^&_Q)^'_P 8O 6D_%+X5>,M-\0^'->L8[S1M;TB[6>VO('&5DCD0D,#_/(Z
MBOG;]M75_P#@G%XE_:I^ G@[]J?XO6UG\4= \>+J?PA\+V.OW27=SJ.O^"F/[!'PT^+^M_ 7QM^U/X3LO%OAKP_
M-K7B'1OMK2-IEI%-# WGO&K)%*99X8T@9A-(TBA$8UM_LD_MR?LI_MU>$=6\
M;?LJ?&"S\5V.@ZL^F:XB6-S9W.GW:C)BGMKN**:(D<@L@#8.TG!Q\>_$'PQX
M;UK_ (.H? ^H:QH-E=W&G_L87-U8S7-LCM;3CQ)<1B6,L"4<)+(H88.UV&<$
MUY9I?BCXB_"7]OG_ (*[>)_@'#+;^)M(^$W@_6/#<6GI\ZZJO@R]GCF11]Z7
MSCOXY9CZF@#WC_@L)^VI^R#XI_X)]?'_ .'Z_&#Q&-0T/P3X@L;3Q#X3L=>B
MTFS\2PV$_P!FT^?6;"(6*S_:C#$;2:X^:5DC>,L0M<)I&L_\$Y-0_P""!7[-
MGPU_X*7_ !?M_#7@W7/A5X)N+2WCU^ZM+^_N[:SLYHEMTLR;F?#A-PC5L;@?
ME.UAD_LXZG\)?'G_  :4ZQ)X$-A?6$/[*'BA=55"K[=:ATN^>]:3TF%\LLA)
M^;<0W<&O*/\ @H*EM#OA:8V/.UO,T]3CWP6'YT ?K?\8OC
MM\)_@#H%IXB^*_B]--BU'4$T_2+2*UFNKS5+QPS):VEK;H\]W.55F$4*.Y5&
M.W"DCFO@)^VK^S'^TPWBJU^$7Q0CN-0\#70M_&NAZWI5WH^IZ!(4+K]LL=0B
M@N;965696DC56"L03M./CS]JWXV:9\,O^#C7]G+P]\;=52R\(Z[\#O$.G?#>
MYU)PEK'XKN+U1ZEX9M+N:AX2U:ST7Q+=@LH@T_5
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M/J/[4W[1GP__ &1?V"-).I1:;JM]%J+:?&T\=U+J%Y#+,LA&
MY7:)5B+ Y**J?= %4/\ @Z3M?%%W_P $/OC$OAE965)_#[ZDL.=QM1KEB7Z=
M@=I/^R#GC- ':>$]?_:HT3_@EOXR_;UM=#_MW]H;QC\'K_Q9HNF);FYCT66:
MQ:\T_1+&W8']U;*8$:-1FYGC>1RS2#'R3_P3:\'?L_\ _!3GX8>+OB/^SU^T
M?X[/Q73]G/P2=4^(/==L=)@5-%\;)->
M^(CJ=OJ-KPDDDT6EVY4@8>5264R2":, _2W]JCXQ>+?V=OV1/$7Q)TZ&._\
M%]EH,-AX;M)""NH>(;MH[+3[\+_ +,Q^&-U#J'B*#5KK3K+Q/XJMS'!$FLW=NZR&V4?Z1(I
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MQ!-["0#@9^SO^"/7QHU']O/PAX@_P""H7B'PW-IG_"S=,T;0?"EAI3ZA;2:;X%U>]TR]TG5KBRN;.ZBL)S%-%- Z2(ZGD$-UKXF_;"F
M3X?_ /!T%^RKXY\5?Z'I7BWX+>(O#FCW]Q\D,VH0B_G: .>-Y6>$!>I,J#JP
MS]L_\%!O'/AWX;?L)_&+QKXJU&.VLK'X9ZV6>1L&21K*5(HE'\4DDC)&B#EG
M=5 )(% 'DG@']F#7M2_X)M^ -<_9W\7:MI/Q6T?X;V&N^#_&&IZO /V&OCY\,M0^&WB=C''=*'M+M%!>U
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M:._8,_9?_:P\<^'/B=\;O =Y?>(_!UI
$?$&E>([_2[_13.T;2RVMS8S0R
MP2L8D&]!7HQ!H?#'_ ()[_L]?#CXPZ?\ M ZM/XO\;>-=$LY[3PUXB^(_
MC;4-=FT*"8!9EL4NY7BM6D4;7EC1977Y6=EXKT+XV?'SX+?LW^"6^(_QX^)V
MC>%-$%W%:QZAK5\L*S7,AQ';Q _-+,Y!"Q(&=B. :XWX6?M__L8?&KQA8_#C
MX:_M'^&-0\4:C>-:VOA.2]^SZN9%MIKHAK&8)<1CR()I-SQA2(VP: /7IX(;
MF%[:YA62.12LD;J"K*1@@@]0:Y+X!? ?X5_LQ?!OP]\ ?@EX4BT3PIX6TY;+
M1=+A=F$,0)8Y9B2S%F9B29C./LW^LQCYMV,;?FSCFHM9_X*&_L0>'?C8?V;=;_ &H/!]M\01=&
MV'@J755&J-* 6VK;?ZQOE5FR%(*@MTYH [+]GW]GWX1_LM?"32_@9\"O!\&@
M>%M&DN7TW2K8DI ;BYEN9<9Y^:6:1O\ @59G[4?[)/[.G[:7PLE^#'[3GPML
M/%?AY[R.\@MKJ26&:SNH\^7RNKEH+
MEXRH*-<)*4(###!)?B?\0O%MMI'A^"W$]QJU[N6&&+:
M7\QSCY%"@DLV  .<51^"'[0?P3_:4\&Q_$7X"?$S2O%N@3-B#6M$N//M9N2#
MY%KO]I7P7K6N-X*UR'6O"R6'CK6=
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MDC8>)_#+]BG_ ():= T:(V\$?LO10 5XG^TG_P $[/V/?VN?BIX1^-GQ
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MXDU7QKXW\-ZMXD_:"U:[T6Z\,>,-3T(^(O#[Y"3Q"&2-;N$2&4I/YKL9)"7?/O GP2^),&NZM\,/%,GAS
MQU9Q65Q"=+U-!EKZP]Y%8A!&+=-0:[-XB!%" +,,+\O0D5S/PF_X)R?L9_!3]
MEB__ &)/ WP<\SX4:E:3VMSX'\0^(=1UFR$,TCRR1QC4+B9H5,CM)B-EPYWC
M# &O;J\K\2_MM_LI^$OVG_#G[%^N?&S2%^*7BR"XFT3P7;B2>[>."UDNY&E\
MI&6V @B>0&9DW  +N+*" >9_L5_\$;_^">W_  3^\;2_$;]FGX)SV&M_9YK;
M3=0UOQ'?:J^DVTI!E@LQ>32"U5\89HP'<<,S#BL_]KS_ ((B_P#!-;]N+XV6
M_P"T5\?_ -G]KCQFD,<%_KN@>(K_ $F;5(44(L=U]CFC$^$ 3>?WFQ53?M4
M>U>'_P!K3]GGQ5^TYX@_8UT#XDP7/Q+\+>&[;7]>\+K97 >TTZ=U2*$;#0/#GA_3HK'1=%TNV6&
MWL[:-0J11HO 4 5YC^TA_P $^OV5OVM?B5X,^+OQY\&Z_JOB#X>ZD-0\%7NG
M_$'6],32+L,I^T10V-Y#$)?D4%RI8@8)(XKVBB@#Q&Z_X)V_LH7O[5UG^W!=
M>$O$K_%&PT==)M/%!^).O_)IPD,OV+[-]N^SM;F1F>.HX4\8ZYJ'Q%UW4!K"PQ>5"+BWN[V6"01
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MSZE=>(8Y8# ZWES)?#O@WP_>^+/%VO66E:5I
MMK)T[68-2T<:EXZUFXN])DAE,D<5E=279FLH-S'=# Z(YPSAG
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M).OX>_8J_9U\*?!;Q#\ _#OA/4[+0?%USYNM32X
M%[/-(H"M*TQI_#;XD?M->%]+U?0V1?$44
MEVTD6B,XW*+^>-6BL25(;%P\?RD-TYK?U']LS]E+2O@W=_M$7?[07A4^ K"]
MDM+SQG#J\* (OV2?V-?V>?V&/A1!\#?V8/
M">I^'_"5G*\EAH5[XMU358+(O(\CB :A:Z']H+X&?#
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M7.@ZF^GZY8E&BN=
M/N5 ;RYH9 LD19&21-R@/'(DB%D=6(!YI\'?V!OV??@[\7/^&@@OB?Q=X]CT
MM],L?&/Q"\87VN7VFV+D%[:S-W*Z6:.1E_)5#)_&6KUSQ+X'_ -GO
MX?\ A>"U\(^&?#EMH6DZ1(/-1+&"!8$B?=DR?NU 8MDL22AR.*XKPC_ ,$S/V<]$\6:+XR\?>)?B3\1KGPU?17OART^*/Q1U?7[
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MQW_ /PN#X2_]%1\.?\ @[@_^+H_X7!\)?\ HJ/A
MS_P=P?\ Q=><_P##NW]B3_HV_P .?]^'_P#BJ/\ AW;^Q)_T;?X<_P"_#_\
MQ5>K[+@S_G]B/_!5/_Y:>3[;C;_GQA__  ;4_P#E)\@?\%V?&'A+Q7_PJS_A
M%O%.G:E]G_MSS_[/OHYO+W?V?MW;"<9P<9ZX/I7Y]5]Q?\%FOV=O@C\ _P#A
M6_\ PISX;Z;X>_M;^V/[1_L]&7[1Y7V'R]V2?N^8^/\ >-?#M?V;X3K!1X P
M:PDI.G^\LYI*7\6=[I.26M[:O2WH?Q+XNO'2\0\:\9&*J?N[J#;F,,DC&/U"=23UOSQC'TM
MRSE?K>]CT\MGGLY2_M"%.*TM[.M^:$+>5KGYN?\%TM:_:9_9>_:2_9T_X
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MF2^O'NXR.IT=N>Q^6/\ @HC96DO_  .OV*K3]JS]JC3IH/&WBG3-,\)V$=VC+<0:!X;A?3;5)@
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M$IO%O\ ]FZ7HV@QS+;B_O;Q(+AT66=Q%"D,$SR,K$A$4N/BK_@I3\6O
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M/3N4QBS_ ,'0
M'_*"[XZ?]-/@O\ MYP_\$_/!?["OC3Q=XNU;X,,QB2*)C(Z6T1
M*3%Y[MX&C$6!%(TD:OC^*_\ @JEXR\+^*/V7?"G[17_!-_Q/X2\4?'/QD%UKD =-2;5))([.0EODN'CC9Q$V'(P0.1F_P#\%R?C
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M2O CE-PDG?@':&@8@*Y<=I_P58\V?%/
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MDMJWB*_A@3S96(FCM$LF\F\0VRQ'3O)\G[8K
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MO\4=4\/9OX_"MQJGARQT]KFX2#6QD$@(W(]ND>-\B*?6_VK?VZ_V3?C+_
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M";POJ%ZWC"PO=0GO(+FP^RPRMZ7
M^SIIGP'^$NJ^)/%/[3]E3:E<"&X:V\J%T 2.*
M9I';"97+U/\ LT_\%#?B#^T1XW^/'[-\G[.-IHGQF^ UYIUMK/A,^-?M.CZH
M-1M7N=.GM]3-G'((98XV+%[57C&/D8G \$_X*"?\%(?'?PD^.G[,GPI_:5UG
M4?@'\+?B];:SJ/Q!\:"3R;[3I(8?,L- >_4,-,FD#Q"YFB/F!MRPS1A6EK@?
M^"1?Q,^ OA+_ (+@_MF_#?XWW@BRU71M3^TW]I:Z%.;K4)7
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M^'=:\16NJ?VA:Q+&T=_#/; (T+[&+Q?'>ZY"O\ 9Y_LV*%Y'+/\ENMQ)Y2RMA"%'/7'[,65
M[9ZE9Q:CIUW%/;SQ+)!/#('21&&596'!!!!!'!S0!\-_M9_&:[_:&_X+$?!7
M_@FG!,7\)^%_!MW\7/B7IZG,>JM;7'V71K27'6**^VW;1G(=X[8D87GC_P#@
ML]J7[2'[*O[6?P _X*E^!/@QJOQ/^&GP':.-6#MQM5 K,B2/)'5O\ PGJWPF_X.H],\?\ B")AI7Q6_9,O-+\.W3C"
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MN"A,$>J--YDTL0Q*L<3RLJ^=(TGZ8_\ !.K0=9F_9PB^-_B_39;7Q!\7]=R*@6.8P-$0?
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MS*ES;>%=R>#_
M -K[X?S_  ]^-\B!MB6&F26]Y?3,1PLL^DP&TB)_NR#G=M+O^"O?[('QPT?_
M (*Q?!KXF_LOV;V.E_M.^#-0^"GQ=FL%:/[-I83[7+=J5Z3KIT5RT9&,#35
M*]: /M__ ()H^'!XD^ FL?M0>(=%$.J_'OQ7>^.[R.XM]L@TRZ5(-'@D!&=T
M>CV^G(RGHXDX&2*^4_\ @T8@AA_X(UZ T42J9/'FOM(5&-Q^T 9/J< #\!7Z
M8Z3I6F:#I5MH>BV$5K9V5ND%I:P(%2&)%"JB@YTNT\6#PE\03#(R M'F'1@<'MD
M<5Y-_P %6/B_-^P3^U1^SG^W9X>+/B/:?"?XLP1'$>IZ-J:3S65S..A
M:PNH9)8W^\JW,\8.)F%=QX&^+G@']M[_ (*&>#OBM^SEXA@\4_#[X/>!?$ME
MK7C[1V\[2+_7-5GTQ(-/LKI?W5XT-O974D[PLZ1&6!"VYBJ^+?\ !RWX/U+X
MR?L]? +]F[PI T^O_$#]J7PMIVEP1#+QHL5Z\UP?1(T&6;^$')XYH _2"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#XO_P""O7[)O[0'[4/_  KW_A1?@#^W/[#_ +6_M3_B
M:VEMY'G?8O*_X^)8]V?*D^[G&WG&1GXN_P"'3?\ P4!_Z(%_Y=6E?_)5?H%_
MP5F\:_M:_"3]EVX^-_[)/Q*ET/4/"=V+GQ':1Z+97HO--;Y'<"YADVM"VV3*
M[1L\TMG Q^4'_#[3_@IU_P!',_\ EF:+_P#(=?OG G'7&F7<-4L%EL<,Z5)R
M2]HJO/>4G-WY9);RTLMK=;GP&;?1UR+Q!S6MG=;$U(SJ.*E&,XI+EC&*LG1D
M]5%/XGKVV7KO_#IO_@H#_P!$"_\ +JTK_P"2J]H_X)Z?\$]/VP?@;^V#X0^*
M7Q2^$/\ 9>@Z7_:'VZ^_M_3Y_*\S3[F%/DAN'=LR2(O"G&9!:H^V*/,C!6!R\6:T
MTXOEO*W-KI?2^^ARX;Z+O#W#&+I9LL54;H3A42E &W4=K:VUC;1V=E;QPPQ($
MBBB0*J*!@  <  =J^:?@Y_P4'\=_&O\ 9P\6?M*>'?V-/%]E8>%-7US3I-$U
M+Q#I27]_-I%U^'46IM:CXIZY?)INDZNL32D*R7-^B$.
MHF,4-O(RXCG<;F4 ]@\-_#OX?^#;R?4/"'@71M*N+H8N9]-TR*!YAG/S,B@M
MSSS6Q110!4UKP_H/B33Y=)\1:):7]K.H6>VO;998Y!UPRL""/K7S!_P63_9P
M^,_[5G_!-_X@_LC_ +-?P[@U/Q#XUTJWTW3//U.VL;'3TCN[>9GE:1@P79$P
M58TH>%O@OX67QI\+;?PUXKM?#-AINOQ[K6:626W
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MU&@"IK?A_0?$U@=*\2:)9ZA:EUVM4C>Y?\ O2,H!<^YR:NUY?\ MA?&
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M$KR6CS1@+*T;$H7 7.W.%Z  ZJJ=WX=\/W^K6VOWVA6*]W@=Y(8$1I6W2,J@%VP!D^IP /PJI'
MX7\,Q:_)XKB\.V*ZI+"(I=26T07#QC&$,F-Q7@<9QQ5ZB@ HHKSGPY^T5HGQ
M!^.>L_!7X8:,=;3P=(D/C_Q"MT([/1;N2 30Z>I"L;F]*/#*\*[5AAE5Y'5G
MBCD ,?\ :O\ V5-/_:'/@_X@^&-=C\/?$7X9>(3KGPZ\5M:^<+*Y:)H+FUG0
M,K2V=U;O);SQ!E)1PRLKQHR^C:99WGB[P=!:?$OP?I\5U([
M6U\4VFMZ=8R>(I='EB@N7TB.YN4$\2S-+%YEP8%E:,^62H#M]+_L[?'7PC^T
MS\$O#GQX\":7J]CI7B6P%U:V&OV'V6^M2&9'AGAR?+E1U967)P5/)H T/AM\
M(/AI\(OA3HWP/^'?A"UT[PIH&B0Z1I>BC=+%'911")(F,I9I?D4 LY9FY+$D
MDGHHXXX8UAAC5$10%51@ #H *^+?VJ_^"R6B?LC?LO\ B/\ ;0\)=<^
M&VB?$*^\,6^L^&-;LI+BY6VOWTW[:8+EH2L4EY#,B;&DR@BDSMD^7UGX[_MQ
M7'[-_P"Q;>_ME?%7X%:S9Q:?96]U/X,BUFRDU-Q.46&WB(D\F:Z>22.)8$(O!6DW\>GD'3X[W38I5MB  #&&4[,8'3'2M8
M 8 KS[]FOXP?$7XX_#6T^(7Q%_9T\2?#*>_B2:U\.>+KVSDU!(V7(,R6DLJP
M-C&8V;>N<,%(('H- $([70+:_P#"5[8F6+4;A)GBB>&XFB8*PA8!QD9P#C(S]#^'?$7C
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MI'[5GQPCM&D\ 6%]IWPJ\-6TGFII1O J7FK3N0 ]Y-"B0(BY2WA\T!Y&G:QNY+>9X/AW>.C,C%25
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M3"8U48P<54TUE=7Z:1R:C+AIY 2H)4-
MA$)&?+C0'I7R]_P0%_8]_P"%Q?M#7?[2GB_2_,T#X>;?[+\U,I<:Q(I\O&>#
MY,>Z4]U=H37[4UZ'&6_X5]54
M5\/[?*_^?$O_  /_ .T/D/;9=_SYE_X'_P#:GRK_ ,/@?V8O^B??%7_PVU[_
M (5]/Z%K%KXAT.SU^QCE2&^M([B%)XBCJKJ& 93RK8/(/0U;HKGQ%3"32]C3
M<>]Y,,TNJQ:A(9+56Y\R&WDE=<;8=QVCE.+/[ \/\ B^\T3Q2?'5A (Y%U
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MES2D$1)<1C O$GPX\%?"?X
MG6/Q)\63^,KK3S>7>IV$$R66D6L=E=7'FJ9K@O/.Q6+RXE$;2LYV 'VQ7YD_
ML2_\%"?C'_P4"\,Z?J?PM_;@_P"$9^..B_$VUC^*'[-?B#P_HMLND:+!KB1Z
ME9VR7%JM_(\>FJ[?:Q'Y;OXW:=J&CP6-BUM/M*\9AW*( 4;;XN
M_P#!2GXP_P#!,*V_X*<_"S]H>UT?QKJ'@9_'^B?!UO"FG77AB?2?*-Y#I,LK
MVXU)[E[0*IN4NXE,[Y$2)\H^>_\ @HU^U;XR_;]_9-_8$_;(^#'QE\1^"/#_
M ,4_VH/ VF:IX,L8;6:W@U+[=8\1;9L]M_9(T
M7_@HY^SC_P $X;O_ ()H_$+]CC6/$'Q!\*^%;_P=X$^(>D:[I@\*:OIS1R06
M&H7$\MTMS:)#$Z++ ;=IF6#,:.7VK@_M9_\ !*;XY? K_@FA^R;^SU^Q[X%'
MQ)UW]F7XX>$_'.L:%%JMOILOB);)[R;4#;R7;K%&TES=M(JN_"$C+, " ?I)
M\/\ 0/$OA;P?9:!XP\>7?B?4K9&%UKM]96]O+=DN2&:.W1(EP"%^50,+GJ2:
M_/K6?VB_^"H_Q<_X*U?&'_@GI\+?VC_ /A70-$^%^E^(-"\5'XG3PSL8X9)HQY;RB/9O\LL@?<$>10';\W=#^)WC+X6_\'+?QIU?0/@K
MXA\9:;;'-<:?;
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M,^"[*HQW/C&'_@L/,O!>OZAKFC:C##;ZI]G-EYJ:??3NLT4MNDDD94*5&!
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MO[.MO\VC!.%_P4=^$O[7?[0'[8'[('QL^$O[&7B_
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MXN],CO=3UB2U@\I)/*C$C);H8U:66)>$#"O%_P!B_P#9#_X*#_"K_@A#\,])>6[.MQW2Q3RM//#%;PQM,-V^3S2N#Y0.
M0+OQK_X)R?MU_$W_ ()2_LK3?!GX<_\ "&?M'?LGGP]?Z%X4\4ZSI\UMK<^G
M6$5M=6@N+2ZE@$*1D)=C*H55?Y/\
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M^/OC=X9:3PMIEK:2VMO>S6YNH[Y_-B9KB2(G:D2"1(XDXB+2!D\6_; _9D_;Y^*'[*W[''Q3\+?LFK?>.?@+\4_#6O^*OA99>
M-M/^VR:=:61MYMEW,\=H9PP!V"1E <8=MK5TG[1O[+7[8G@#_@HU\*/^"P?P
M8^!1\1:BWP_F\#_&[X1:'XAM#J2:1+.]S!Z\L023+) EN2BA3S)NC\E_8,^-'_  69_;SM/BN^D_MF
M?#[PN?@[^UKJ_A'4+H_"^&9/$&CZ<+))]/2(R%K*(*TDRR%Y[B1[HH9XEA5F
M]V\/_LX?$_\ :1_X*7Z'_P %+/B5\$M=\):!\*?A9?>'_AOX2UNYL1KFM:I?
M.[7=Z\<-R\-K"+<_9HHYI5=WDD=Q$BJ7PO\ @B1\#/VK/V\#V_P 2/VD/$_Q&\*ZG?^(M$OH9M/U,VJQ6TBZ??W$D=PH@+,"OEX/#D\$
M^M?VH/C$G[._[-'Q$_: ELTN5\"^!=7\0M;R$[9196*/B++J_C'Q?K5Q_KM3U+4M3NKB2XE/=MC1IGTC4
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M(&J:9(3ID>LF65M.T> 2$2/''/JLERC[1EM'5VVF0(0#RS_@Y ^#6@?L[_\
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M,#W(K\P/B)_P4._;X3_@AS;_ /!:/X?_ +0FEP^)F":]/Y?'/AV7PSJ2V]N[_:KG[)J$L]CNV?O0L+Q+RX95.Q/@C]F
M/0_VKO"'[-GASP3\7?\ @W]^(GC'PM?ZJOC"^T'PU\<[1/">H7\]T;Z.YM_#
MK2K';6P=TD33Y4V1E$:2-I@TA /2O^#AW4?BIK?_  2"^#'B+XT>,=)U[Q#J
M?QU\)W][J6B^%)=$MV2=;V6)/L4MY>/"Z1ND;YG?(M'U">TN=/OD3?Y3+/
M!=VS.NX*V'&]1@]_\/\ ]O+]LNY^'=CHGQ&_X)/?%N'XF)9I#J>F:;K?AT^'
MY+T* TL>J/J8"VI;+;C$957@1.P 8 Z#_@G/_P ?_P"T"?\ JY+Q'_Z(L:^?
M_P!B?XD:G\(/^"_7[5_[&&G3%?#/C3PAH7Q3TK35.(K+43!9Z?J4J#^]YB'O7UA^Q!\!?'7P#^#5Y:_%S5--O/&WC#Q;J_BWQJ^B,[6,&HZC=O<-:
MVS2!7>"WC:*V21P&D6 .54L5'R[^Q#\*]3^+W_!V\%K>:NJ_]>]RD,)/0OO'5&% 'Z!T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !537M#T?Q/H=[X:\0Z=%>:?J-I);7UI.FZ.>&12CHP[JRD@CT-6Z*:;
M3NAIM.Z/-?V2_P!EKX8+L
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M>LQ6%Z]O/Y,@P2DBX;*[09%"R#&5="!M-^''P^T?[!I&E0&.T@,\DSG+%GDDED9I)I7=F=Y9&9Y'=G=F9B3N444
M97C70=8\3^%[SP_H7BZ\T&YNXQ&NKZ?#$]Q;*6&]HA,KH)-NX*S*P4D$JV,&
MC\)?A+\/?@9\/M.^%WPM\.1Z5HFEHXMK9)'D=W=VDEFEDD+/--)([R22R,TD
MDCN[LS,2>CHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end



XML
22
R1.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Cover Page - USD ($)
 $ in Millions

12 Months Ended







Dec. 31, 2021


Mar. 01, 2022


Jun. 30, 2021





Cover [Abstract]
 

 

 





Document Annual Report
true

 

 





Document Transition Report
false

 

 





Document Period End Date
Dec. 31,  2021

 

 





Document Fiscal Year Focus
2021

 

 





Document Fiscal Period Focus
FY

 

 





Entity File Number
1-14287

 

 





Entity Registrant Name
Centrus Energy Corp.

 

 





Entity Incorporation, State or Country Code
DE

 

 





Entity Tax Identification Number
52-2107911

 

 





Entity Address, Address Line One
6901 Rockledge Drive, Suite 800

 

 





Entity Address, City or Town
Bethesda

 

 





Entity Address, State or Province
MD

 

 





Entity Address, Postal Zip Code
20817

 

 





City Area Code
(301)

 

 





Local Phone Number
564-3200

 

 





Title of 12(b) Security
Class A Common Stock, par value $0.10 per share

 

 





Trading Symbol
LEU

 

 





Security Exchange Name
NYSEAMER

 

 





Entity Interactive Data Current
Yes

 

 





Entity Filer Category
Accelerated Filer

 

 





Entity Central Index Key
0001065059

 

 





Current Fiscal Year End Date
--12-31

 

 





Entity Common Stock, Shares Outstanding
 

13,673,933

 





Amendment Flag
false

 

 





Entity Current Reporting Status
Yes

 

 





Entity Well-known Seasoned Issuer
No

 

 





Entity Voluntary Filers
No

 

 





Entity Public Float
 

 

$ 257.9





Entity Small Business
true

 

 





Entity Emerging Growth Company
false

 

 





Entity Shell Company
false

 

 





Document Type
10-K

 

 





ICFR Auditor Attestation Flag
true

 

 
















































XML
23
R2.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Audit Information

12 Months Ended



Dec. 31, 2021



Audit Information [Abstract]
 





Auditor Name
PricewaterhouseCoopers LLP





Auditor Firm ID
238





Auditor Location
Baltimore, Maryland


















XML
24
R3.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




CONSOLIDATED BALANCE SHEETS - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Current Assets
 

 





Cash and cash equivalents
$ 193.8

$ 152.0





Accounts receivable, net
29.1

29.6





Inventories
91.1

64.8





Deferred costs associated with deferred revenue
143.3

151.9





Other current assets
8.6

7.8





Total current assets
465.9

406.1





Property, Plant and Equipment, Net
5.3

4.9





Deposits for surety bonds
2.8

5.7





Intangible assets
54.7

62.8





Deferred tax assets, net
41.4

1.9





Other long-term assets
2.3

4.9





Total Assets
572.4

486.3





Current Liabilities
 

 





Accounts payable and accrued liabilities
37.8

50.6





Payables under SWU purchase agreements
37.9

21.3





Inventories owed to customers and suppliers
8.4

4.9





Deferred revenue and advances from customers
303.1

283.2





Current debt
6.1

6.1





Total current liabilities
393.3

366.1





Long-term debt
101.8

108.0





Postretirement health and life benefit obligations
114.9

130.8





Pension benefit liabilities
23.1

124.4





Advances from customers
45.1

45.2





Other long-term liabilities
36.1

32.4





Total liabilities
714.3

806.9





Commitments and contingencies (Note 11)
 

 





Stockholders' Deficit
 

 





Excess of capital over par value
140.7

85.0





Accumulated deficit
(284.6)

(407.7)





Accumulated other comprehensive income (loss), net of tax
0.5

0.8





Total stockholders' deficit
(141.9)

(320.6)





Total Liabilities and Stockholders’ Equity (Deficit)
572.4

486.3





Preferred Series A [Member]
 

 





Stockholders' Deficit
 

 





Preferred stock
0.0

0.0





Preferred Series B [Member]
 

 





Stockholders' Deficit
 

 





Preferred stock
0.0

0.1





Common Class A [Member]
 

 





Stockholders' Deficit
 

 





Common stock
1.4

1.1





Common Class B [Member]
 

 





Stockholders' Deficit
 

 





Common stock
$ 0.1

$ 0.1





















































XML
25
R4.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
 $ in Millions

12 Months Ended






Dec. 31, 2020


Dec. 31, 2021





Preferred Stock, Par Value Per Share
$ 1.00

$ 1.00





Preferred Stock, Shares Authorized
20,000,000

20,000,000





Preferred Stock, Shares Issued
 

104,574





Common Stock, Shares, Issued
 

14,369,133





Series B Preferred Stock [Member]
 

 





Preferred Stock, Par Value Per Share
$ 1.00

 





Preferred Stock, Dividend Rate, Percentage
7.50%

 





Preferred Stock, Liquidation Preference, Value
 

$ 53.9





Common Class A [Member]
 

 





Common Stock, Par or Stated Value Per Share
$ 0.10

$ 0.10





Common Stock, Shares Authorized
70,000,000

70,000,000





Common Stock, Shares, Issued
11,390,189

13,649,933





Common Class B [Member]
 

 





Common Stock, Par or Stated Value Per Share
$ 0.10

$ 0.10





Common Stock, Shares Authorized
30,000,000

30,000,000





Common Stock, Shares, Issued
 

719,200

























XML
26
R5.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 shares in Thousands, $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Total revenue
$ 298.3

$ 247.2





Cost of sales
183.8

149.6





Gross profit (loss)
114.5

97.6





Advanced technology license and decommissioning costs
2.1

2.8





Selling, general and administrative
36.0

36.0





Amortization of intangible assets
8.1

6.8





Special charges for workforce reductions and advisory costs
0.0

0.6





Other (income)
0.0

0.4





Operating income (loss)
68.3

51.0





Nonoperating components of net periodic benefit expense (income)
(67.6)

(1.6)





Interest expense
0.1

0.1





Investment income
(0.1)

(0.5)





Income (loss) before income taxes
135.9

53.0





Provision (benefit) for income taxes
(39.1)

(1.4)





Net income (loss)
175.0

54.4





Preferred stock dividends, undeclared and cumulative
2.1

6.7





Distributed earnings allocable to retired preferred shares
37.6

41.9





Net income (loss) allocable to common stockholders
$ 135.3

$ 5.8





Net income (loss) per common share - basic
$ 10.03

$ 0.59





Net income (loss) per common share - diluted
$ 9.75

$ 0.57





Weighted-average number of shares outstanding:
 

 





Average number of shares outstanding, basic
13,493

9,825





Average number of shares outstanding, diluted
13,879

10,123





Product [Member]
 

 





Total revenue
$ 186.1

$ 190.5





Cost of sales
113.1

92.7





Separative Work Units [Member]
 

 





Total revenue
163.3

151.5





Uranium [Member]
 

 





Total revenue
22.8

39.0





Service [Member]
 

 





Total revenue
112.2

56.7





Cost of sales
$ 70.7

$ 56.9









































XML
27
R6.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Cash Flows from Operating Activities
 

 





Net income
$ 175.0

$ 54.4





Adjustments to reconcile net income (loss) to net cash (used in) operating activities:
 

 





Depreciation and amortization
8.6

7.3





Accrued loss on long-term contract
(7.2)

(10.6)





Retirement benefit plans (gains) losses, net
(50.5)

7.2





Revaluation of inventory borrowing
4.8

0.0





Equity Related Compensation
12.1

7.1





Changes in operating assets and liabilities:
 

 





Accounts receivable – (increase) decrease
0.5

(8.6)





Increase (Decrease) in Inventories
(10.7)

25.8





Payables under SWU purchase agreements – increase (decrease)
16.6

13.2





Deferred revenue, net of deferred costs – increase (decrease)
13.2

9.7





Accounts payable and other liabilities – increase (decrease)
(4.6)

(5.2)





Pension and postretirement liabilities - increase (decrease)
(67.0)

(32.7)





Increase (Decrease) in Deferred Income Taxes
(39.5)

(1.9)





Other, net
(1.3)

1.4





Net cash used in operating activities
50.0

67.1





Cash Flows Provided by Investing Activities
 

 





Capital expenditures
(1.2)

(1.4)





Net Cash Provided by (Used in) Investing Activities
(1.2)

(1.4)





Cash Flows Used in Financing Activities
 

 





Proceeds from the sale of common stock, net
42.1

23.1





Redemption of preferred stock, net
(44.4)

(61.6)





Payment of interest classified as debt
(6.1)

(6.1)





Exercise of stock options
0.9

0.3





Shares withheld for employee taxes
(2.4)

0.0





Payments for deferred issuance costs
0.0

(0.1)





Net cash used in financing activities
(9.9)

(44.4)





Decrease in cash, cash equivalents and restricted cash
38.9

21.3





Cash, cash equivalents and restricted cash, start of period
157.9

136.6





Cash, cash equivalents and restricted cash, end of period
196.8

157.9





Property, plant and equipment included in accounts payable and accrued liabilities
 

 





Supplemental Cash Flow Information:
 

 





Other Significant Noncash Transaction, Value of Consideration Given
0.0

(0.3)





Equity issuance costs included in accounts payable and accrued liabilities [Member]
 

 





Supplemental Cash Flow Information:
 

 





Other Significant Noncash Transaction, Value of Consideration Given
(0.4)

(0.2)





Disposal of right to use lease assets [Member]
 

 





Supplemental Cash Flow Information:
 

 





Other Significant Noncash Transaction, Value of Consideration Given
(1.0)

(0.2)





Reclassification of equity compensation liability to equity [Member]
 

 





Supplemental Cash Flow Information:
 

 





Other Significant Noncash Transaction, Value of Consideration Given
(7.5)

0.0





Common stock and warrant issued in exchange for preferred stock [Member]
 

 





Supplemental Cash Flow Information:
 

 





Other Significant Noncash Transaction, Value of Consideration Given
$ (7.5)

0.0





Preferred Series B [Member]
 

 





Cash Flows Used in Financing Activities
 

 





Redemption of preferred stock, net
 

$ (60.0)





















































XML
28
R7.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
 $ in Millions


Total


Preferred Stock [Member]



Common Stock [Member] 


Common Class A [Member]




Common Stock [Member] 


Common Class B [Member]



Excess of Capital over Par Value [Member]


Accumulated Deficit [Member]


Accumulated Other Comprehensive Income (Loss) [Member]





Beginning Balance at Dec. 31, 2019
$ (336.9)

$ 4.6

$ 0.8

$ 0.1

$ 61.5

$ (405.0)

$ 1.1





Net income
54.4

0.0

0.0

0.0

0.0

54.4

0.0





Stock issued during period
23.1

0.0

0.3

0.0

22.8

0.0

0.0





Stock Repurchased and Retired During Period, Value
(61.6)

(4.5)

0.0

0.0

0.0

(57.1)

0.0





Shares withheld for employee taxes
0.0

 

 

 

 

 

 





Other comprehensive income, net of tax
(0.3)

0.0

0.0

0.0

0.0

0.0

(0.3)





Restricted and other common stock issued, net of amortization
0.7

0.0

0.0

0.0

0.7

0.0

0.0





Ending Balance at Dec. 31, 2020
(320.6)

0.1

1.1

0.1

85.0

(407.7)

0.8





Net income
175.0

0.0

0.0

0.0

0.0

175.0

0.0





Stock issued during period
42.1

0.0

0.2

0.0

41.9

0.0

0.0





Exchange of preferred stock for common stock and common stock warrant
0.0

0.0

0.1

0.0

7.5

(7.6)

0.0





Stock Repurchased and Retired During Period, Value
(44.4)

(0.1)

0.0

0.0

0.0

(44.3)

0.0





Reclassification of stock-based compensation from liability to equity
7.5

0.0

0.0

0.0

7.5

0.0

0.0





Shares withheld for employee taxes
(2.4)

0.0

0.0

0.0

(2.4)

0.0

0.0





Other comprehensive income, net of tax
(0.3)

0.0

0.0

0.0

0.0

0.0

(0.3)





Restricted and other common stock issued, net of amortization
1.2

0.0

0.0

0.0

1.2

0.0

0.0





Ending Balance at Dec. 31, 2021
$ (141.9)

$ 0.0

$ 1.4

$ 0.1

$ 140.7

$ (284.6)

$ 0.5























XML
29
R8.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Cash, Cash Equivalents and Restricted Cash

12 Months Ended



Dec. 31, 2021



Cash, Cash Equivalents and Restricted Cash [Abstract]
 





Cash and Cash Equivalents Disclosure
CASH, CASH EQUIVALENTS AND RESTRICTED CASH
The following table summarizes the Company’s cash, cash equivalents and restricted cash as presented on the consolidated balance sheet to amounts on the consolidated statement of cash flows (in millions):
December 31, 
20212020
Cash and cash equivalents
$193.8 $152.0 
Deposits for financial assurance - current
0.2 0.2 
Deposits for financial assurance - non current2.8 5.7 
Total cash, cash equivalents and restricted cash
$196.8 $157.9 

The following table provides additional detail regarding the Company’s deposits for financial assurance (in millions):

December 31, 2021December 31, 2020
CurrentLong-TermCurrentLong-Term
Workers compensation$— $2.6 $— $5.4 
Other0.2 0.2 0.2 0.3 
Total deposits for financial assurance$0.2 $2.8 $0.2 $5.7 
The Company has provided financial assurance to states in which it was previously self-insured for workers’ compensation in accordance with each state’s requirements in the form of a surety bond or deposit that is fully cash collateralized by Centrus. As each state determines that the likelihood of further workers’ compensation obligations related to the period of self-insurance is reduced, the surety bond or deposit is subject to reduction and/or cancellation and the Company would receive the excess cash collateral.
















XML
30
R9.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Inventories

12 Months Ended



Dec. 31, 2021



Inventory, Net [Abstract]
 





Inventories
INVENTORIES
Centrus holds uranium at licensed locations in the form of natural uranium and as the uranium component of LEU. Centrus also holds SWU as the SWU component of LEU at licensed locations (e.g., fabricators) to meet book transfer requests by customers. Fabricators process LEU into fuel for use in nuclear reactors. Components of inventories are as follows (in millions):
 December 31, 2021December 31, 2020
 Current
Assets		Current
Liabilities 
(a)		Inventories, NetCurrent
Assets		Current
Liabilities
(a)		Inventories, Net
Separative work units$8.8 $— $8.8 $17.0 $4.6 $12.4 
Uranium82.3 8.4 73.9 47.8 0.3 47.5 
Total$91.1 $8.4 $82.7 $64.8 $4.9 $59.9 

(a)Inventories owed to customers and suppliers, included in current liabilities, include SWU and uranium inventories owed to fabricators. 

Inventories are valued at the lower of cost or net realizable value. In 2021, there was a valuation adjustment to reflect an update of projected timing and sources of inventory to be used for repayment of borrowed SWU inventory. There were no valuation adjustments in 2020. For details, refer to Note 1, Summary of Significant Accounting Policies — Contract Liabilities — LEU Segment. 
The Company may also borrow SWU from customers, in which case the Company will record the SWU and the related liability for the borrowing using a projected average purchase price over the borrowing period. In 2018 through 2020 the Company borrowed SWU inventory valued at $20.7 million from a customer under an agreement signed in 2017 and recorded the SWU and the related liability using the Company’s average unit price of SWU purchases under contract projected to be used for repayment. The loan is repayable only with SWU. The cumulative liability to the customer for borrowed inventory was revalued to $25.5 million in the third quarter of 2021. The revaluation reflected an updated projection of the timing and sources of inventory to be used for repayment. In the fourth quarter of 2021, the Company repaid borrowed SWU inventory valued at $3.1 million to a customer and reduced the SWU and the related liability using an average purchase price over the borrowing period. The remaining liability to the customer of $22.4 million for borrowed inventory is included in Other Long-Term Liabilities. Cost of Sales for the twelve months ended December 31, 2021, includes the related expense of $4.8 million.
















XML
31
R10.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Property, Plant and Equipment

12 Months Ended



Dec. 31, 2021



Property, Plant and Equipment [Abstract]
 





Property, Plant and Equipment
PROPERTY, PLANT AND EQUIPMENT
A summary of changes in property, plant and equipment follows (in millions):
December 31,
2020		Additions / (Depreciation)December 31,
2021
Land
$1.2 $— $1.2 
Buildings and leasehold improvements3.9 0.7 4.6 
Machinery and equipment
1.4 — 1.4 
Other
1.1 — 1.1 
Property, plant and equipment, gross
7.6 0.7 8.3 
Accumulated depreciation
(2.7)(0.3)(3.0)
Property, plant and equipment, net
$4.9 $0.4 $5.3 

Depreciation expense was $0.6 million in 2021 and $0.5 million in 2020.

















XML
32
R11.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Intangible Assets

12 Months Ended



Dec. 31, 2021



Goodwill and Intangible Assets Disclosure [Abstract]
 





Intangible Assets
INTANGIBLE ASSETS
Intangible assets originated from the Company’s reorganization and application of fresh start accounting as of September 30, 2014, the date the Company emerged from bankruptcy, and reflect the conditions at that time. The intangible asset related to the sales order book is amortized as the order book existing at emergence is reduced, principally as a result of deliveries to customers. The intangible asset related to customer relationships is amortized using the straight-line method over the estimated average useful life of 15 years. Amortization expense is presented below gross profit on the consolidated statements of operations. Intangible asset balances are as follows (in millions):
December 31, 2021December 31, 2020
Gross Carrying AmountAccumulated AmortizationNet AmountGross Carrying AmountAccumulated AmortizationNet Amount
Sales order book$54.6 $35.5 $19.1 $54.6 $32.0 $22.6 
Customer relationships68.9 33.3 35.6 68.9 28.7 40.2 
Total$123.5 $68.8 $54.7 $123.5 $60.7 $62.8 
The amount of amortization expense for intangible assets in each of the succeeding years is estimated to be as follows (in millions):
2022$9.5 
20236.6 
20248.6 
20257.6 
20269.9 
Thereafter12.5 
   Total$54.7 

















XML
33
R12.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Accounts Payable and Accrued Liabilities

12 Months Ended



Dec. 31, 2021



Accounts Payable and Accrued Liabilities [Abstract]
 





Accounts Payable and Accrued Liabilities [Text Block]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Components of accounts payable and accrued liabilities follow (in millions):
December 31,
20212020
Trade payables$4.9 $4.9 
Compensation and employee benefits23.1 22.2 
Postretirement health and life benefit obligations - current7.0 11.6 
Accrued HALEU Contract loss0.5 7.0 
Operating lease liability0.9 2.4 
Other accrued liabilities1.4 2.5 
   Total accounts payable and accrued liabilities$37.8 $50.6 

















XML
34
R13.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Debt

12 Months Ended



Dec. 31, 2021



Debt Disclosure [Abstract]
 





Debt
DEBT
A summary of debt follows (in millions):
December 31, 2021December 31, 2020
MaturityCurrentLong-TermCurrentLong-Term
8.25% Notes:Feb. 2027
Principal
$— $74.3 $— $74.3 
Interest
6.1 27.5 6.1 33.7 
Total$6.1 $101.8 $6.1 $108.0 

Interest on the 8.25% Notes is payable semi-annually in arrears as of February 28 and August 31 based on a 360-day year consisting of twelve 30-day months. The 8.25% Notes mature on February 28, 2027. As shown in the table above, all future interest payment obligations on the 8.25% Notes are included in the carrying value of the 8.25% Notes. As a result, the Company’s reported interest expense will be less than its contractual interest payments throughout the term of the 8.25% Notes. As of December 31, 2021, and December 31, 2020, $6.1 million of interest is recorded as current and classified as Current Debt in the consolidated balance sheet.
 
The 8.25% Notes rank equally in right of payment with all of the Company’s existing and future unsubordinated indebtedness other than its Issuer Senior Debt and our Limited Secured Acquisition Debt (each as defined below). The 8.25% Notes rank senior in right of payment to all of the Company’s existing and future subordinated indebtedness and to certain limited secured acquisition indebtedness of the Company (the “Limited Secured Acquisition Debt”). The Limited Secured Acquisition Debt includes (i) any indebtedness, the proceeds of which are used to finance all or a portion of an acquisition or similar transaction if any lender’s lien is solely limited to the assets acquired in such a transaction and (ii) any indebtedness, the proceeds of which are used to finance all or a 
portion of the American Centrifuge project or another next generation enrichment technology if any lender’s lien is solely limited to such assets, provided that a lien securing the 8.25% Notes that is junior with respect to the lien securing such indebtedness will be limited to the assets acquired with such Limited Secured Acquisition Debt.

The 8.25% Notes are subordinated in right of payment to certain indebtedness and obligations of the Company, as described in the indenture governing the 8.25% Notes (the “Issuer Senior Debt”), including (i) any indebtedness of the Company (inclusive of any indebtedness of Enrichment Corp.) under a future credit facility up to $50 million with a maximum net borrowing of $40 million after taking into account any minimum cash balance (unless a higher amount is approved with the consent of the holders of a majority of the aggregate principal amount of the 8.25% Notes then outstanding), (ii) any revolving credit facility to finance inventory purchases and related working capital needs, and (iii) any indebtedness of the Company to Enrichment Corp. under the secured intercompany notes. 

The 8.25% Notes are guaranteed on a subordinated and limited basis by, and secured by substantially all of the assets of, Enrichment Corp. The Enrichment Corp. guarantee is a secured obligation and ranks equally in right of payment with all existing and future unsubordinated indebtedness of Enrichment Corp. (other than Designated Senior Claims (as defined below) and Limited Secured Acquisition Debt) and senior in right of payment to all existing and future subordinated indebtedness of Enrichment Corp. and Limited Secured Acquisition Debt. The Enrichment Corp. guarantee is subordinated in right of payment to certain obligations of, and claims against, Enrichment Corp. described in the indenture governing the 8.25% Notes (collectively, the “Designated Senior Claims”), including obligations and claims:
•under a future credit facility up to $50 million with a maximum net borrowing of $40 million after taking into account any minimum cash balance;
•under any revolving credit facility to finance inventory purchases and related working capital needs; 
•held by or for the benefit of the Pension Benefit Guaranty Corporation (“PBGC”) pursuant to any settlement (including any required funding of pension plans); and 
•under surety bonds or similar obligations held by or on behalf of the U.S. government pursuant to regulatory requirements.

The lien securing the Enrichment Corp. guarantee of the 8.25% Notes is junior in priority with respect to the lien securing Limited Secured Acquisition Debt, which is limited to the assets acquired with such Limited Secured Acquisition Debt.

















XML
35
R14.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Leases

12 Months Ended



Dec. 31, 2021



Leases [Abstract]
 





Lessee, Operating Leases [Text Block]
LEASES
Centrus leases facilities and equipment under operating leases. Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company has facility leases with terms greater than 12 months, and the Company records the related asset and obligation at the present value of lease payments over the term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.

Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. Lease assets exclude lease incentives. Lease terms reflect options to extend or terminate the lease when it is reasonably certain that those options will be exercised. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term. The weighted-average remaining lease term was 5.3 years at December 31, 2021, with maturity dates ranging from December 31, 2025 to September 2027, and the weighted-average discount rate was 12.5%. Lease expense totaled a credit of  $0.5 million in 2021 and expense of $2.6 million for 2020. Lease expense primarily related to operating leases for the years ended December 31, 2021 and 2020 includes a $2.0 million and $0.3 million credit, respectively, from DOE for true-up of prior years’ lease expense. Other amounts related to short-term lease expense were insignificant. Operating lease expense is included in Cost of Sales, Selling, General and Administrative Expenses and Advance Technology Costs on the Statement of Operations. Cash paid for amounts included in operating cash flows for operating leases was $2.4 million for the year ended December 31, 2021.
The Company leases facilities and related personal property near Piketon, Ohio from DOE under a lease which is classified as operating.  The lease was amended on May 6, 2021, resulting in a decrease in the monthly lease payment beginning with the June 2021 payment. The Company accounted for the amendment as a modification and remeasured the remaining future lease payments through May 31, 2022, resulting in the recording of a $1.0 million reduction in lease assets and liabilities. In September 2021, the lease was extended through December 31, 2025. The Company did not remeasure the lease as under the terms of the lease amendment it may be terminated early upon completion of the work under the HALEU Contract which is expected to occur by June 1, 2022. Any facilities, centrifuges or other equipment constructed or installed under contract with DOE will be owned by DOE and may be returned to DOE in an “as is” condition at the end of the lease term, and DOE would be responsible for its D&D.

Operating Lease Assets and Liabilities 

The table below presents the lease-related assets and liabilities recorded on the consolidated balance sheet (in millions).
December 31, 2021Classification on the Balance Sheet
Lease assets$2.1 Other long-term assets
Lease liabilities:
Current
$0.9 Accounts payable and accrued liabilities
Non-current3.0 Other long-term liabilities
Total lease liabilities
$3.9 

Maturity of Operating Lease Liabilities

The table below reconciles undiscounted payments for operating leases with terms greater than 12 months to the operating lease liabilities recorded on the balance sheet (in millions).
2022$1.3 
20231.0 
20241.0 
20251.0 
20261.0 
Thereafter0.8 
Total lease payments6.1 
Less imputed interest2.2 
Present value of lease payments$3.9 

















XML
36
R15.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Fair Value Measurements

12 Months Ended



Dec. 31, 2021



Fair Value Disclosures [Abstract]
 





Fair Value Measurements
FAIR VALUE
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value of assets and liabilities, the following hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable: 
•Level 1 assets include investments with quoted prices in active markets that the Company has the ability to liquidate as of the reporting date.

•Level 2 assets include investments in U.S. government agency securities, corporate and municipal debt whose estimates are valued based on observable inputs, other than quoted prices.
•Level 3 assets include investments with unobservable inputs, such as third party valuations, due to little or no market activity.

Financial Instruments Recorded at Fair Value (in millions):
December 31, 2021December 31, 2020
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:        
Cash and cash equivalents$193.8 $— $— $193.8 $152.0 $— $— $152.0 
Deferred compensation asset (a)3.2 — — 3.2 2.4 — — 2.4 
Liabilities:        
Deferred compensation obligation (a)
$3.2 $— $— $3.2 $2.3 $— $— $2.3 
 
(a)    The deferred compensation obligation represents the balance of deferred compensation plus net investment earnings. The deferred compensation plan is funded through a rabbi trust. Trust funds are invested in mutual funds for which unit prices are quoted in active markets and are classified within Level 1 of the valuation hierarchy. 

There were no transfers between Level 1, 2 or 3 during the periods presented.

Other Financial Instruments

As of December 31, 2021, and 2020, the consolidated balance sheet carrying amounts for Accounts Receivable, Accounts Payable and Accrued Liabilities (excluding the deferred compensation obligation described above), and Payables under SWU Purchase Agreements approximate fair value because of their short-term nature.

The carrying value and estimated fair value of long-term debt are as follows (in millions):
December 31, 2021December 31, 2020
Carrying Value
Estimated Fair Value (a)
Carrying Value
Estimated Fair Value (a)
8.25% Notes$107.9 
(b)
$74.3 $114.1 
(b)
$68.6 
(a) Based on recent trading prices and bid/ask quotes as of or near the balance sheet date, which are considered  Level 2 inputs based on the frequency of trading.
(b)    The carrying value of the 8.25% Notes consists of the principal balance of $74.3 million and the sum of current and non-current interest payment obligations until maturity. Refer to Note 8, Debt.
















XML
37
R16.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits

12 Months Ended



Dec. 31, 2021



Retirement Benefits, Description [Abstract]
 





Pension and Postretirement Health and Life Benefits
PENSION AND POSTRETIREMENT HEALTH AND LIFE BENEFITSThere are approximately 3,500 employees and retirees covered by qualified defined benefit pension plans providing retirement benefits based on compensation and years of service, and approximately 2,300 employees and retirees covered by postretirement health and life benefit plans. DOE retained the obligation for postretirement health and life benefits for workers who retired prior to July 28, 1998. Pursuant to non-qualified supplemental pension plans, Centrus provides certain executive officers additional retirement benefits in excess of qualified plan limits imposed by tax law based on a targeted benefit objective. Employees hired on or after September 1, 2008, who are not covered by a collective bargaining agreement that provides for participation do not participate in a qualified defined benefit pension plan or postretirement health and life benefit plans.
Changes in the projected benefit obligations and plan assets and the funded status of the plans follow:
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
($ millions)Year Ended December 31,Year Ended December 31,
2021202020212020
Changes in Benefit Obligations:
Obligations at beginning of period$757.9 $763.5 $142.4 $152.8 
Actuarial (gains) losses, net(28.7)56.7 (2.3)(1.6)
Service costs2.7 3.5 — — 
Interest costs18.1 24.3 3.4 4.8 
Benefits paid from Plan assets(51.3)(56.3)(12.4)(13.6)
Benefits paid from Company assets(0.4)(0.5)— — 
Settlements— (30.4)— — 
Administrative expenses paid(2.1)(2.9)— — 
Obligations at end of period696.2 757.9 131.1 142.4 
Changes in Plan Assets:
Fair value of plan assets at beginning of period
633.1 621.2 — — 
Actual return on plan assets57.8 85.4 — — 
Company contributions35.7 16.6 21.5 13.6 
Benefits paid(51.7)(56.8)(12.3)(13.6)
Settlements— (30.4)— — 
Administrative expenses paid(2.2)(2.9)— — 
Fair value of plan assets at end of period
672.7 633.1 9.2 — 
Unfunded status at end of period$(23.5)$(124.8)$(121.9)$(142.4)
Amounts recognized in assets and liabilities:
      Current liabilities$(0.4)$(0.4)$(7.0)$(11.6)
      Non-current liabilities(23.1)(124.4)(114.9)(130.8)
$(23.5)$(124.8)$(121.9)$(142.4)
Amounts in accumulated other comprehensive income (loss), pre-tax:
      Prior service credit$(0.9)$(1.1)$(2.0)$(2.1)
 

The current liabilities reflect expected contributions for benefit payments for the non-qualified plans and the postretirement health and life benefit plans in the following year.

The discount rates below, rounded to the nearest 0.1%, are the estimated rates at which the benefit obligations could be effectively settled on the measurement date and are based on yields of high quality fixed income investments whose cash flows match the timing and amount of expected benefit payments of the plans.

Plan assets and benefit obligations are remeasured each year as of the balance sheet date resulting in differences between actual and projected results for the year. These actuarial gains and losses are recognized in the statement of operations in the fourth quarter. In addition, an interim remeasurement and recognition of gains or losses may be required for a plan during the year when lump sum payments exceed, or are expected to exceed, the sum of the service cost and interest cost components of the annual net periodic benefit cost for that plan for the current year. There were no interim remeasurements in 2021 and 2020.
The defined benefit pension plans currently allow for a lump sum payment option to (a) active employees who are terminated as a result of Company reductions in force and (b) terminated vested participants who have not yet begun receiving their benefits and have been terminated as a result of a reduction in force by the Company, or due to voluntary termination or involuntary termination, other than involuntary termination as a termination for cause.

As part of the Company’s continued effort to reduce the size and volatility of its pension obligations and administrative costs, the Company transferred approximately $30.4 million of pension plan assets and approximately $30.4 million of related benefit obligations to an insurance company through the purchase of a group annuity contract in the fourth quarter of 2020. 

Projected benefit obligations are based on actuarial assumptions including possible future increases in compensation. Accumulated benefit obligations are based on actuarial assumptions but do not include possible future increases in compensation. Effective August 2013, accrued benefits under the defined benefit pension plans are fixed and no longer increase to reflect changes in compensation or company service. Therefore, the accumulated benefit obligation equaled the projected benefit obligation of $696.2 million and $757.9 million as of December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, none of Centrus’ plans had fair value of plan assets in excess of accumulated benefit obligations.

Components of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income 

The Company reports service costs for its defined benefit pension plans and its postretirement health and life benefit plans in Cost of Sales and Selling, General and Administrative Expenses. The remaining components of net periodic benefit (credits) costs are reported as Nonoperating Components of Net Periodic Benefit Income.
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
(in millions)Year Ended December 31,Year Ended December 31,
2021202020212020
Net Periodic Benefit (Credits) Costs
Service costs$2.7 $3.5 $— $— 
Interest costs18.1 24.3 3.4 4.8 
Expected return on plan assets(38.3)(37.5)— — 
Amortization of prior service credits, net(0.2)(0.2)(0.1)(0.1)
Actuarial (gains) losses, net
(48.2)8.9 (2.3)(1.7)
Net periodic benefit (credits) costs$(65.9)$(1.0)$1.0 $3.0 

Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss)
Amortization of prior service costs, net$— $— $(2.0)$(2.1)
Prior service credit(0.9)(1.1)— — 
Total recognized in other comprehensive loss, pre-tax$(0.9)$(1.1)$(2.0)$(2.1)
Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax
$(66.8)$(2.1)$(1.0)$0.9 

Net periodic benefit costs include service and interest costs of providing pension benefits that are accrued over the years employees render service. Prior service costs or credits are amortized over the employees’ average remaining years of service from age 40 until the date of full benefit eligibility or the average expected future lifetime of all plan participants, as applicable. Participants in the postretirement health and life benefit plans are generally eligible for benefits at retirement after age 50 with 10 years of continuous credited service at the time of retirement.
On September 7, 2021, the Company collected $43.5 million from DOE, of which $33.8 million was contributed to the pension plan in September 2021 for its subsidiary Enrichment Corp. and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp. Refer to Note 16, Commitments and Contingencies and Note 2, Revenue And Contracts with Customers.

Effective January 1, 2014, or for certain plan participants formerly represented by a collective bargaining unit, January 1, 2015, plan participants age 65 or older (“post-65”) have access to a range of medical plan choices with varying costs and benefits through a Medicare Exchange implemented by the Company. The Company provides an annual stipend for each of the post-65 retirees and post-65 spouses who enroll in the coverage through the exchange. Depending on the level of benefits elected by the participant, the participant may be required to make contributions in excess of the stipend amount. 

The transition to the post-65 Medicare Exchange was reflected as a plan amendment that reduced plan obligations by $6.8 million as of December 31, 2014. This reduction in obligation was recognized in other comprehensive income in 2014 as a prior service credit. The prior service credit is being amortized into net periodic benefit cost as a credit over time. The post-65 Medicare Exchange stipend amount was increased for 2017. This increase in obligation of $3.6 million as of December 31, 2016, was recognized in other comprehensive income in 2016 as a prior service cost and is being amortized into net periodic benefit cost over time. The post-65 Medicare Exchange stipend amount was increased in 2018, as specified in a settlement agreement with the former collective bargaining unit. The settlement agreement also specifies the addition of catastrophic drug coverage effective January 1, 2019. The benefit enhancement for 2019 has been applied to all post-65 participants regardless of past representation by the collective bargaining agreement. The increase in obligation of $10.0 million as a result of the settlement agreement was recognized in net periodic benefit costs in 2017 as a plan change resulting from a legal settlement and is reported in Nonoperating Components of Net Periodic Benefit Income. 

The defined benefits pension plans were amended in March 2019 making permanent the option for pension-eligible employees to receive a lump sum payment upon termination, regardless of benefit size, which decreased plan obligations by $1.3 million. The effect of these plan changes has been added to accumulated other comprehensive income (loss) as an unrecognized prior service cost to be amortized over the average future service of active employees starting in 2020. 

Assumptions Used to Determine Net Periodic Benefit Costs
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
Year Ended December 31,Year Ended December 31,
2021202020212020
Discount rate
2.8%2.5%2.8%2.5%
Expected return on plan assets
6.3%6.4%——

The expected return on plan assets is based on the weighted average of long-term return expectations for the composition of the plans’ equity and debt securities. Expected returns on equity securities are based on historical long-term returns of equity markets. Expected returns on debt securities are based on the current interest rate environment. 

Healthcare cost trend rates used to measure postretirement health benefit obligations follow:
December 31,
20212020
Healthcare cost trend rate for the following year
6.0%5.5%
Long-term rate that the healthcare cost trend rate gradually declines to
5%5%
Year that the healthcare cost trend rate is expected to reach the long-term rate
20262022
Benefit Plan Assets

Independent advisors manage investment assets of Centrus’ defined benefit pension plans and postretirement health and life benefit plans. Centrus has the fiduciary responsibility for reviewing performance of the various investment advisors. The goal of the investment policy of the plans is to maximize portfolio returns within reasonable and prudent levels of risk in order to meet projected liabilities and maintain sufficient cash to make timely payments of all participant benefits. Risk is reduced by diversifying plan assets and following a strategic asset allocation approach. Additionally, as the plans are frozen and funding status has improved, the Company has shifted the investment allocations to lower risk investments in order to minimize market exposure and will continue to do so based upon approved funding milestones. Asset classes and target weights are adjusted periodically to optimize the long-term portfolio risk/return trade off, to provide liquidity for benefit payments, and to align portfolio risk with the underlying obligations. The investment policy of the plans prohibits the use of leverage, direct investments in tangible assets, or any investment prohibited by applicable laws or regulations. 

The allocation of plan assets between equity and debt securities and the target allocation range by asset category for the defined benefit pension plans follows:  
December 31,
202120202022 Target
Equity securities45 %52 %40 -45%
Debt securities51 %42 %50 -55%
Cash4 %6 %0-5%
100 %100 %


Plan assets are measured at fair value. Following are the plan investments as of December 31, 2021 and 2020, categorized by the fair value hierarchy levels described in Note 10, Fair Value:
Defined Benefit Pension and Postretirement Health and Life Benefit Plans
(in millions)Level 1Level 2Level 3Total
20212020202120202021202020212020
U.S. government securities$— $— $13.0 $16.4 $— $— 13.0 $16.4 
Corporate debt— — 56.4 104.2 — — 56.4 104.2 
Municipal bonds and non-U.S. government securities
— — 1.7 2.1 — — 1.7 2.1 
Mutual funds (b)582.9 — — — — — 582.9 — 
Mortgage and asset backed securities— — 7.9 6.4 — — 7.9 6.4 
Fair value of investments by hierarchy level
$582.9 $— $79.0 $129.1 $— $— 661.9129.1
Investments measured at NAV (a)20.1 504.4 
Accrued interest receivable1.2 1.3 
Unsettled transactions(1.4)(1.8)
Plan assets$681.8 $633.0 


(a) Equity, bond and money market investments held in collective trusts are valued based on the net asset value (“NAV”) provided by the administrator of the funds. The NAV for each fund is based on the underlying assets owned by the fund, less any expenses accrued against the fund, divided by the number of fund shares outstanding. While the underlying investments are traded on an exchange, the funds are not. Fair values for the collective trust investments are measured using the NAVs as a practical expedient and are not categorized in the fair value hierarchy.
(b) Postretirement Health and Life Benefit Plan assets of $9.2 million are all contained within Level 1 mutual funds.
Benefit Plan Cash Flows

The Company expects to contribute $0 million to the qualified defined benefit pension plans, $0.4 million to the non-qualified defined benefit pension plans, and $7.0 million to the postretirement health and life benefit plans in 2022. There is no required contribution for the postretirement health and life benefit plans under Employee Retirement Income Security Act (“ERISA”).

Estimated future benefit plan payments follow (in millions):
Defined Benefit Pension PlansPostretirement Health and Life Benefit Plans
2022$52.1 $11.2 
202351.0 10.7 
202449.1 10.1 
202547.6 9.5 
202647.6 9.0 
2027 to 2031214.0 36.3 

Other Plans

The Company sponsors a 401(k) defined contribution plan for employees. Employee contributions are matched at established rates. Amounts contributed are invested in a range of investment options available to participants and the funds are administered by an independent trustee. Matching cash contributions by the Company amounted to $2.0 million in 2021 and $1.6 million in 2020. 

Under the Executive Deferred Compensation Plan, qualified employees may defer compensation on a tax-deferred basis subject to plan limitations. Any matching contributions under the Company’s 401(k) plan that are foregone due to annual compensation limitations of the Internal Revenue Code of 1986, as amended (the “Code”) are eligible to be received from the Company under the Executive Deferred Compensation Plan, provided that the employee deferred the maximum allowable pre-tax contribution in the 401(k) plan. The Company matching contributions amounted to less than $0.1 million in 2021 and 2020.

















XML
38
R17.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation

12 Months Ended



Dec. 31, 2021



Share-based Payment Arrangement, Noncash Expense [Abstract]
 





Stock-Based Compensation
STOCK-BASED COMPENSATION
The Company’s 2014 Equity Incentive Plan (“2014 Plan”) authorizes the issuance of stock options, stock appreciation rights (“SARs”), restricted stock units, restricted stock, notional stock units, performance awards, dividend equivalent rights, and other stock-based awards, as well as cash-based awards, to employees, officers, directors, and other individuals providing services to the Company or its affiliates. As disclosed in Note 15 - Stockholder’s Equity, in February 2021, the Company increased the available shares of Class A Common Stock under the Company’s 2014 Plan by an additional 700,000 shares. The plan currently authorizes the issuance of up to 1,900,000 shares. As of December 31, 2021, there were 844,293 shares available for future awards.

In January 2019, the Company adopted the 2019 Executive Incentive Plan (“2019 Plan”), which is subject to the terms of the 2014 Plan, under which participating employees are eligible to receive grants of equity awards such as notional stock units and SARs. Under this plan, the Company has granted awards that are subject to either cliff-based or performance-based vesting. The cliff-based awards vest after three years of service. The performance-based awards vest if the company reaches or exceeds a pre-defined net income target for the three-year award term. Equity awards may be payable in common stock, cash, or a combination of both, at the discretion of the Board of Directors. Compensation costs for awards that are likely to be settled with cash payments are remeasured each reporting period based on the closing price of the Company’s common stock.  These cumulative vested costs are accrued in Accounts Payable and Accrued Liabilities or Other Long-Term Liabilities. Equity awards that are payable in stock are accounted for as equity and compensation costs are amortized on a straight-line basis over the vesting period.
In 2019, under the 2014 Plan, the Company awarded notional stock units to participating executives for the three-year period ending December 31, 2021.  As the original award, at grant date, was expected to be settled in cash, the Company had recorded cumulative compensation costs in Other Long-Term Liabilities at December 31, 2020.  There were 206,183 notional stock units (two-thirds of these awards) paid in shares in April 2021, with the remainder anticipated to be paid in April 2022. As of March 31, 2021, the Company reclassified these shares to equity as the Board of Directors approved settlement in shares. 

In 2020, the Company awarded participating executives notional stock units and stock appreciation rights for the three-year period ending April 26, 2023.  These equity awards may be payable in common stock, cash, or a combination of both at the discretion of the Board of Directors.  The cumulative vested costs have been accrued in Other Long-Term Liabilities as they are likely to be settled in cash. 

In September 2021, the Company awarded participating executives notional stock units and SARs. The awards granted will be paid in shares on or before May 1, 2024, provided that a defined performance condition is achieved. In order to receive the award, the total cumulative net income as reported on the Company’s Form 10-Ks for the years ending December 31, 2021, 2022, and 2023 must be equal to or greater than $160 million. The grant date fair value of notional stock units is determined based on the closing price of Class A Common Stock on the grant date. The grant date fair value of the SARs were determined based on the Black-Scholes option-pricing model. The Company has concluded that it is probable that the performance condition will be achieved and therefore has recorded compensation cost. Compensation costs for these notional stock units and SARs are amortized to expense on a straight-line basis over the vesting period. 

Compensation cost for restricted stock units and stock options is measured at the grant date, based on the fair value of the award, and is recognized on a straight-line basis over the requisite service period. As of December 31, 2021, there was $0.4 million of unrecognized compensation cost, adjusted for actual forfeitures, related to non-vested stock-based payments granted, of which $0.3 million relates to restricted stock units and $0.1 million relates to stock options. That cost is expected to be recognized over a weighted-average period of 12 months.

A summary of stock-based compensation costs is as follows (in millions): 
 Year Ended December 31,
 20212020
 
Notional stock units and stock appreciation rights$11.6 $6.6 
Restricted stock units0.5 0.4 
Stock options0.1 0.1 
Total stock-based compensation costs$12.2 $7.1 
Total recognized tax benefit$(1.5)$— 

The total recognized tax benefit is reported at the federal statutory rate net of the tax valuation allowance.

Board Restricted Stock Units

Non-employee, independent directors are granted restricted stock units as part of their compensation for serving on the Board of Directors. Settlement of these restricted stock units is made in shares of Class A Common Stock  only upon the director’s retirement or other end of service. The restricted stock units generally vest over one year; however, vesting is accelerated upon (1) the director attaining eligibility for retirement, (2) termination of the director’s service by reason of death or disability, or (3) a change in control.  As of December 31, 2021, approximately 192,000 shares of restricted stock units could potentially be converted to Class A Common Stock once vested and settled. 
The following table summarizes Centrus’ board restricted stock units activity:
Shares (in thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 201974$3.09
Granted47$10.38
Vested(74)$3.09
Forfeited——
Nonvested at December 31, 202047$10.38
Granted20$25.13
Vested(47)$10.38
Forfeited——
Nonvested at December 31, 202120$25.13
 

Employee Restricted Stock Units

In 2021, certain employees were granted restricted stock units as part of their compensation. Settlement of these restricted stock units is made in shares of Class A Common Stock upon vesting. The restricted stock units generally vest after three years. As of December 31, 2021, approximately 4,000 shares of restricted stock units could potentially be converted to Class A Common Stock once vested and settled. 

The following table summarizes Centrus’s employee restricted stock units activity:
Shares
(in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020—$—
Granted4$24.01
Vested ——
Forfeited——
Nonvested at December 31, 20214$24.01


Stock Options

The intrinsic value of an option, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of stock option awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, employee stock option exercise behaviors, future dividend payments, and risk-free interest rates.

The expected term of options granted is the estimated period of time from the beginning of the vesting period to the date of expected exercise or other settlement, based on historical exercises and post-vesting terminations. Centrus has estimated the expected term using the simplified method described in SEC Staff Accounting Bulletin Topic 14, Share-Based Payment, due to the lack of historical exercise and post-vesting termination information available for the Company since its reorganization. Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected option term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the option valuation model. 
There were no option grants in the years ended December 31, 2021, and 2020.

Stock options vest and become exercisable in equal annual installments over a three or four year period and expire ten years from the date of grant. A summary of stock option activity follows:
Stock Options (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value          (in millions)
Outstanding at December 31, 2019518$4.026.2$1.5
Granted————
Exercised(107)$3.43——
Forfeited/Cancelled————
Outstanding at December 31, 2020411$4.185.3$7.8
Granted————
Exercised(217)$4.17——
Forfeited/Cancelled————
Outstanding at December 31, 2021194$4.184.4$8.9
Exercisable at December 31, 2021144$4.373.2$6.6
 

Stock options outstanding and options exercisable at December 31, 2021, are as follows:

Stock Exercise PriceOptions Outstanding (thousands)Remaining Contractual Life in YearsOptions Exercisable (thousands)
$4.371443.2144
$3.65507.8—

Stock Appreciation Rights - 2020 Award

The intrinsic value of a SAR, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of SAR awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, expected term, future dividend payments, and risk-free interest rates.

These SARs generally have a defined term of three years from award and are automatically exercised at the end of its term.  Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the valuation model. 
A summary of SARs with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:

Stock Appreciation Rights (in thousands) Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value            (in millions)
Outstanding at December 31, 2019—$——$—
Granted83.5$5.53——
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202083.5$5.532.3$1.47
Granted————
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202183.5$5.531.3$3.71
Exercisable at December 31, 202183.5$5.531.3$3.71

The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
20212020
SARs Granted (in thousands)n/a83.5
Average Risk-Free Raten/a0.14%
Expected Volatilityn/a94%
Expected Term (Years)n/a2.3
Dividend Yieldn/a—

Stock Appreciation Rights (Performance Condition) - 2021 Award

The intrinsic value of a SAR, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of SAR awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, expected term, future dividend payments, and risk-free interest rates.

These SARs generally have a defined term of three years from award and are automatically exercised at the end of its term if the performance condition has been met.  Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the valuation model. 
A summary of SARs with performance-based vesting granted under the 2014 plan in the year ended December 31, 2021, are as follows:
Stock Appreciation Rights (Performance Condition)   (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value            (in millions)
Outstanding at December 31, 2020—$——$—
Granted21$19.44——
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202121$19.442.3$0.64
Exercisable at December 31, 202121$19.442.3$0.64



The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
20212020
Stock Appreciation Rights Granted (in thousands)21.0n/a
Average Risk-Free Rate0.3%n/a
Expected Volatility82.8%n/a
Expected Term (Years)2.5n/a
Dividend Yield—n/a

Notional Stock Units - 2019 and 2020 Awards

A summary of notional stock units with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:
Shares (thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2019468$3.16
Granted125$5.53
Vested——
Forfeited(22)$3.16
Nonvested at December 31, 2020571$3.68
Granted——
Vested(319)$3.16
Forfeited——
Nonvested at December 31, 2021252$4.33
Notional Stock Units (Performance Condition) - 2021 Award

A summary of notional stock units with performance-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:
Shares 
(in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020— $— 
Granted10$39.55
Vested — — 
Forfeited— — 
Nonvested at December 31, 202110 $39.55

















XML
39
R18.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes

12 Months Ended



Dec. 31, 2021



Income Tax Disclosure [Abstract]
 





Income Taxes
INCOME TAXES
Income Tax Benefit

The income tax benefit is as follows (in millions):
Year Ended December 31,
20212020
Current:
  Federal$— $— 
  State and local0.4 0.5 
  Foreign— — 
0.4 0.5 
Deferred:
  Federal (a)(40.7)— 
  State and local1.2 (1.9)
  Foreign— — 
(39.5)(1.9)
Income tax benefit$(39.1)$(1.4)

(a) The income tax benefit for 2021 includes the reversal of a portion of the federal valuation allowance on net deferred tax assets. See further discussion below.
Deferred Taxes

Future tax consequences of temporary differences between the carrying amounts for financial reporting purposes and the Company’s estimate of the tax bases of its assets and liabilities result in deferred tax assets and liabilities, as follows (in millions):
December 31,
20212020
Deferred tax assets:
Employee benefits costs
$36.2 $61.8 
Inventory
18.6 16.2 
Property, plant and equipment
191.5 193.8 
Net operating loss and credit carryforwards
206.2 211.1 
Accrued expenses
0.4 2.1 
Long-term debt and financing costs
10.8 12.6 
Lease liability
0.9 1.5 
Other
0.2 0.2 
Deferred tax assets
464.8 499.3 
Valuation allowance
(414.7)(486.0)
Deferred tax assets, net of valuation allowance
$50.1 $13.3 
Deferred tax liabilities:
Intangible assets
$7.9 $9.9 
Lease asset
0.4 1.1 
Prepaid expenses
0.4 0.4 
Deferred tax liabilities
$8.7 $11.4 
Deferred tax assets, net$41.4 $1.9 

The valuation allowance reduces the net deferred tax assets to their net realizable value. The ultimate realization of the net deferred tax assets is dependent upon generating sufficient taxable income in future years when deferred tax assets are recoverable or are expected to reverse.

The Company has maintained a full valuation allowance against federal and state net deferred tax assets since the fourth quarter of 2011 to the second quarter of 2020. In the second quarter of 2020, the Company released the valuation allowance against the state net deferred tax assets for the LEU segment that are more likely than not to be realized.

In the fourth quarter of 2021, the Company released $40.7 million of the valuation allowance against federal net deferred taxes that are more likely than not to be realized.  Centrus evaluated both positive and negative evidence that was objectively verifiable to determine the amount of the federal valuation allowance that is required on Centrus’ federal deferred tax assets.  Centrus has visibility on a significant portion of revenue in the LEU segment  through 2026, primarily from its long-term sales contracts.  Centrus considered both its achievement of sustained profitability and cumulative income in 2021, as well as, the forecasted income, to be significant forms of positive evidence. Negative evidence included uncertainty in and the lack of objectively verifiable evidence for profitability in later years when the Company’s existing sales order book and supply contracts reach expiration in its LEU segment.  In the Company’s technical solutions segment, negative evidence included uncertainty in the future funding of the HALEU enrichment facility, and thus, no assumption for the future funding of the HALEU enrichment facility were included in the forecast model because it was not objectively verifiable.  Centrus determined that the positive evidence outweighed the negative evidence and supported a release of the federal valuation allowance. However, due to lack of objectively verifiable information in later years, it was determined that forecasted future income was not sufficient to realize all the deferred tax assets. Therefore, the Company recorded a partial release of its federal valuation allowance. 
In addition to the partial release of the valuation allowance against federal net deferred taxes, the valuation allowance decreased in 2021 by $30.6 million due to changes in deferred tax assets since the beginning of the year. The Company continues to maintain a valuation allowance against its remaining federal and state net deferred tax assets due to significant federal and state net operating losses and insufficient future taxable income. 

Going forward, the Company will continue to evaluate both positive and negative evidence that would support any further changes to the remaining valuation allowances. Such evidence in its technical solutions segment may include signing new contracts which could have a significant impact on pre-tax income, follow on-work related to the HALEU program, or abandonment of the commercial deployment of the centrifuge technology.  Such evidence in our LEU segment may include renewing SWU sales contracts with existing customers and/or signing new SWU sales or purchase contracts with significantly higher or lower margins than currently forecasted. Additional evidence in the LEU segment may include potential deferrals in the timing of deliveries requested by its customers, which would impact revenue recognition timing. The impact of these and other potential positive and negative events will be weighed and evaluated to determine if the valuation allowance should be increased or decreased in the future.

The net deferred tax assets and related valuation allowance were increased as of December 31, 2020, by $39.5 million for previously unrecorded state deferred tax assets, net of federal benefit, in states where we have had historical losses and a remote likelihood of realizing a tax benefit. This increase to state deferred tax assets, net of the full valuation allowance, had no net impact on income tax expense for 2020. When a change in tax rate or tax law has an impact on deferred taxes, we apply the change based on the years in which the deferred taxes are expected to reverse. The Company records the impact of the change in its consolidated financial statements in the period of enactment. 

The Company has federal net operating losses of $732.0 million generated through December 31, 2017, that currently expire through 2037. In addition, the Company has federal net operating losses and business interest expense carry forwards of $131.4 million and $4.1 million, respectively, generated after December 31, 2017, that do not expire. Centrus also has state net operating losses of $0.5 million, with no valuation allowance, and state net operating losses of $465.4 million, with a full valuation allowance, that currently expire through 2037.

Effective Tax Rate

A reconciliation of income taxes calculated based on the federal statutory income tax rate and the effective tax rate follows:
Year Ended December 31,
20212020
Federal statutory tax rate21 %21 %
Valuation allowance against net deferred tax assets(53)(26)
State rate changes1 (1)
Executive compensation1 2 
State income tax expense, net of federal benefit1 — 
Uncertain tax positions— 1 
Effective tax rate
(29)%(3)%


The effective tax rate for the year ended December 31, 2021, includes a decrease to the valuation allowance against net deferred tax assets of $71.3 million, or a change to the effective tax rate of (53%). Included in the valuation allowance decrease is the release of the valuation allowance against federal net deferred taxes of $40.7 million, or a change to the effective tax rate of (30%).
The effective tax rate for the year ended December 31, 2020, includes a decrease to the valuation allowance against net deferred tax assets of $13.9 million, or a change to the effective tax rate of (26%). Included in the valuation allowance decrease is the release of the valuation allowance against state net deferred taxes of $2.0 million, or a change to the effective tax rate of (4%).

Uncertain Tax Positions

Accounting standards require that a tax position meet a minimum recognition threshold in order for the related tax benefit to be recognized in the financial statements. The liability for unrecognized tax benefits, included in Other Long-Term Liabilities, was $1.0 million as of December 31, 2021, and $0.8 million as of December 31, 2020. If recognized, these tax benefits would impact the effective tax rate. As a result of changes to unrecognized tax benefits, the income tax provision (state tax, net of federal benefit) increased $0.2 million and $0.4 million during the years ended December 31, 2021 and December 31, 2020, respectively. The liability for unrecognized tax benefits in the table below relates to unrecognized state income tax benefits. Centrus believes that the liability for unrecognized tax benefits will not change significantly in the next 12 months.

A reconciliation of the beginning and ending amount of unrecognized tax benefits follows (in millions):
Year Ended December 31,
20212020
Balance at beginning of the period$0.8 $0.4 
Additions to tax positions of current period0.4 0.5 
Reductions to tax positions of prior years(0.2)(0.1)
Balance at end of the period$1.0 $0.8 

Centrus and its subsidiaries file income tax returns with the U.S. government and various states and foreign jurisdictions. As of December 31, 2021, the federal, Maryland and Tennessee statutes of limitation are closed with respect to all tax years through 2017.

Centrus recognizes accrued interest related to uncertain tax positions as a component of Interest Expense. Reversals of previously accrued interest for income taxes is typically offset against interest expense, but if the amount is significant, it is reclassified to interest income in the consolidated statement of operations. Centrus recognizes the increase or decrease of accrued penalties for income taxes as a component of Selling, General and Administrative in the consolidated statement of operations.

The impact of accrued interest and penalties for income taxes in the consolidated statement of operations was an increase to expenses of less than $0.1 million for the years ended December 31, 2021 and December 31, 2020, respectively. Accrued interest and penalties for income taxes, included as a component of Other Long-Term Liabilities, totaled less than $0.1 million as of December 31, 2021 and 2020.

















XML
40
R19.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Net Income Per Share

12 Months Ended



Dec. 31, 2021



Earnings Per Share [Abstract]
 





Net Income (Loss) Per Share
NET INCOME PER COMMON SHARE
Basic net income per common share is calculated by dividing income allocable to common stockholders by the weighted average number of shares of common stock outstanding during the period. In calculating diluted net income per common share, the number of shares is increased by the weighted average number of potential shares related to stock compensation awards. No dilutive effect is recognized in a period in which a net loss has occurred. 

On November 17, 2020, the Company completed the purchase of 62,854 shares of its outstanding Series B Senior Preferred Stock at a price per share of $954.59, less any applicable withholding taxes. (Refer to Note 15 - Stockholders’ Equity). The purchase price per share represented a 25% discount from the aggregate liquidation preference, including accrued but unpaid dividends, of $1,272.78 per share as of September 30, 2020. Since origination, the carrying value on the Balance Sheet was $43.80 per share based on values assigned in the originating securities exchange. The liquidation amount at origination was $1,000.00 per share.
 
The aggregate purchase price of approximately $60 million, less accrued but unpaid dividends attributable to the purchased and retired Series B Senior Preferred Stock, is considered for purposes of Net Income per Share to be a deemed dividend to the extent it exceeds the carrying value on the consolidated Balance Sheet, or $41.9 million. 

On February 2, 2021, the Company completed the exchange of 3,873 shares of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (“Preferred Stock”) for (i) 231,276 shares of Class A Common Stock and (ii) a warrant to purchase 250,000 shares of Class A Common Stock at an exercise price of $21.62 per share, for an aggregate valuation of approximately $7.5 million.  The carrying value of the Series B Senior Preferred Stock on the Balance Sheet was $1.00 per share par value. The aggregate liquidation preference of the Series B Senior Preferred Stock, including accrued but unpaid dividends, was $1,291.04 per share as of December 31, 2020. 

On November 23, 2021, the Company completed the purchase of 36,867 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,145.20, less any applicable withholding taxes. The Company also completed the purchase of the remaining 980 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,149.99, less any applicable withholding taxes, on December 15, 2021 (Refer to Note 15 - Stockholders’ Equity).   The aggregate purchase price of both transactions was $43.3 million. The carrying value of the Series B Senior Preferred Stock on the consolidated Balance Sheet was $1.00 per share par value. 

The aggregate valuation of all 2021 preferred stock transactions of approximately $50.8 million, less accrued but unpaid dividends attributable to the acquired and retired shares of Series B Senior Preferred Stock, is considered for purposes of Net Income per Share to be a deemed dividend in the aggregate amount equal to the amount by which it exceeds the carrying value of the Preferred Stock on the consolidated Balance Sheet, or $37.6 million. 

The weighted average number of common and common equivalent shares and the calculation of basic and diluted income per common share are as follows:
 Year Ended 
December 31,
20212020
Numerator (in millions):
Net income$175.0 $54.4 
Preferred stock dividends - undeclared and cumulative2.1 6.7 
Distributed earnings allocable to retired preferred shares37.6 41.9 
Net income allocable to common stockholders$135.3 $5.8 
Denominator (in thousands):
Average common shares outstanding - basic13,493 9,825 
Potentially dilutive shares related to stock options and restricted stock units (a)
386 298 
Average common shares outstanding - diluted13,879 10,123 
Net income per common share (in dollars):
Basic$10.03 $0.59 
Diluted$9.75 $0.57 
There are no common stock equivalents excluded from the diluted calculation as a result of a net loss in the period or options outstanding and considered anti-dilutive as their exercise price exceeded the average share market price.

















XML
41
R20.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Commitments and Contingencies

12 Months Ended



Dec. 31, 2021



Commitments and Contingencies Disclosure [Abstract]
 





Commitments and Contingencies
COMMITMENTS AND CONTINGENCIES
Commitments under SWU Purchase Agreements

TENEX

A major supplier of SWU to the Company is the Russian government-owned entity TENEX, Joint-Stock Company (“TENEX”). Under a 2011 agreement with TENEX, as amended, (the “TENEX Supply Contract”), the Company purchases SWU contained in LEU received from TENEX, and the Company delivers natural uranium to TENEX for the LEU’s uranium component. The LEU that the Company obtains from TENEX under the agreement is subject to quotas and other restrictions applicable to commercial Russian LEU. Further, the ability of the Company or TENEX to implement the TENEX Supply Contract is vulnerable to any new sanctions or restrictions that might be imposed by Russia, the United States, or other countries in the future, including as a result of the war in Ukraine. 

The TENEX Supply Contract originally was signed with commitments through 2022 but was modified in 2015 to give the Company the right to reschedule certain quantities of SWU of the original commitments into the period 2023 and beyond, in return for the purchase of additional SWU in those years. The Company has exercised this right to reschedule in each year through December 31, 2021. If the Company exercises this right to reschedule in full during the remaining years of the contract’s original term, the Company will have a rescheduled post-2022 purchase commitment that could extend through 2028.

The TENEX Supply Contract provides that the Company must pay for all SWU in its minimum purchase obligation each year, even if it fails to submit orders for such SWU. In such a case, the Company would pay for the SWU but have to take the unordered SWU in the following year. 

Pricing terms for SWU under the TENEX Supply Contract are based on a combination of market-related price points and other factors. This formula was subject to an adjustment at the end of 2018 that reduced the unit costs of SWU under this contract in 2019 and for the duration of the contract.

Orano

In 2018, the Company entered into an agreement (the “Orano Supply Agreement”) with the French company Orano Cycle (“Orano”) for the long-term supply to the Company of SWU contained in LEU. Under the Orano Supply Agreement, as amended, the supply of SWU commenced in 2020 and extends to 2028. The Company has the option to extend the supply period for an additional two years. The Orano Supply Agreement provides significant flexibility to adjust purchase volumes, subject to annual minimums and maximums in fixed amounts that vary year by year. The pricing for the SWU purchased by the Company is determined by a formula that uses a combination of market-related price points and other factors and is subject to certain floors and ceilings. 

Milestones Under the 2002 DOE-USEC Agreement 

The Company’s predecessor USEC Inc. and DOE signed an agreement dated June 17, 2002, as amended (the “2002 DOE-USEC Agreement”), pursuant to which the parties made long-term commitments directed at resolving issues related to the stability and security of the domestic uranium enrichment industry. The 2002 DOE-USEC Agreement requires Centrus to develop, demonstrate and deploy advanced enrichment technology in accordance with milestones, including the deployment of a commercial American Centrifuge Plant, and provides for remedies in the event of a failure to meet a milestone under certain circumstances, including terminating the 2002 DOE-USEC Agreement, revoking Centrus’ access to DOE’s centrifuge technology that is required for the success of the Company’s ongoing work with the American Centrifuge technology, requiring Centrus to transfer certain rights in the American Centrifuge technology and facilities to DOE, and requiring Centrus to reimburse DOE for certain costs associated with the American Centrifuge technology. The 2002 DOE-USEC Agreement provides that if a delaying event beyond the control and without the fault or negligence of Centrus occurs that could affect Centrus’ 
ability to meet the American Centrifuge Plant milestone under the 2002 DOE-USEC Agreement, DOE and the Company will jointly meet to discuss in good faith possible adjustments to the milestones as appropriate to accommodate the delaying event. In 2014, the 2002 DOE-USEC Agreement and other agreements between the Company and DOE were assumed by Centrus subject to an express reservation of all rights, remedies and defenses by DOE and the Company under those agreements. DOE and the Company have agreed that all rights, remedies and defenses of the parties with respect to any missed milestones and all other matters under the 2002 DOE-USEC Agreement continue to be preserved, and that the time limits for each party to respond to any missed milestones continue to be tolled.

Legal Matters

From time to time, the Company is involved in various pending legal proceedings, including the pending legal proceedings described below.

In 1993, the United States Enrichment Corporation, at that time a wholly-owned government corporation (“USEC-Government”), entered into a lease for the Paducah and Portsmouth Gaseous Diffusion Plants (collectively, the “GDPs”) with the U.S. Department of Energy (“DOE”). As part of that lease, DOE and USEC-Government also entered into a memorandum of understanding (“Power MOU”) regarding power purchase agreements between DOE and the providers of power to the GDPs. Under the Power MOU, DOE and USEC-Government agreed upon the allocation of rights and liabilities under the power purchase agreements. In 1998, USEC-Government was privatized and became the United States Enrichment Corporation, now a principal subsidiary of the Company (“Enrichment Corp.”). Pursuant to legislation authorizing the privatization, the lease for the GDPs, which included the Power MOU as an Appendix, was transferred to Enrichment Corp. and Enrichment Corp. was given the right to purchase power from DOE. The Paducah GDP was shut down in 2013 and deleased by Enrichment Corp. in 2014. On August 4, 2021, DOE informally informed Enrichment Corp. that the Joppa power plant, which had supplied power to the Paducah GDP, was planned to be decontaminated and decommissioned (D&D). According to DOE, the power purchase agreement with Electric Energy Inc. (“EEI”) requires DOE to pay for a portion of the D&D costs of the Joppa power plant and DOE has asserted that a portion of the DOE liability is the responsibility of Enrichment Corp. under the Power MOU in the amount of approximately $9.6 million. The Company is assessing DOE’s assertions including whether all or a portion of any such potential liability had been previously settled. The Company has not formed an opinion on the merits nor is it able to estimate the potential liability, if any, and no expense or liability has been accrued.

On August 30, 2013, the Company submitted a claim to DOE under the Contract Disputes Act for payment of $42.8 million, representing DOE’s share of pension and postretirement benefits costs related to the transition of employees at the former Portsmouth GDP to DOE’s D&D contractor. On August 27, 2014, the DOE contracting officer denied the Company’s claim. As a result, the Company filed an appeal of the decision in the U.S. Court of Federal Claims in January 2015. 

On January 13, 2021, the Company and DOE reached a tentative agreement to settle the litigation. The settlement was subject to the approval by DOE, the U.S. Department of Justice, the Company’s Board of Directors, and the Court. On September 7, 2021, after the final approvals for the settlement were received, the settlement agreement was signed by the parties. Under the terms of the settlement agreement, DOE paid the Company $43.5 million, of which $33.8 million was contributed to the pension plan in September 2021 for Enrichment Corp.  and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp.  After receiving payment, at the Company’s request the case was dismissed. The payment of $43.5 million is included in revenue of the technical solutions segment for the year ended December 31, 2021. 

On May 26, 2019, the Company, Enrichment Corp., and six other DOE contractors who have operated facilities at the Portsmouth GDP site (including, in the case of the Company, the American Centrifuge Plant site located on the premises) were named as defendants in a class action complaint filed by Ursula McGlone, Jason McGlone, Julia Dunham, and K.D. and C.D., minor children by and through their parent and natural guardian Julia Dunham (collectively, the “McGlone Plaintiffs”) in the U.S. District Court in the Southern District of Ohio, Eastern Division. 
The complaint seeks damages for alleged off-site contamination allegedly resulting from activities on the Portsmouth GDP site. The McGlone Plaintiffs are seeking to represent a class of (i) all current or former residents within a seven-mile radius of the Portsmouth GDP site and (ii) all students and their parents at the Zahn’s Corner Middle School from 1993-present. The complaint was amended on December 10, 2019 and on January 10, 2020 to add additional plaintiffs and new claims. On July 31, 2020, the court granted in part and denied in part the defendants’ motion to dismiss the case. The court dismissed ten of the fifteen claims and allowed the remaining claims to proceed to the next stage of the litigation process. On August 18, 2020, the McGlone Plaintiffs filed a motion for leave to file a third amended complaint and notice of dismissal of three of the individual plaintiffs. On March 18, 2021, the McGlone Plaintiffs filed a motion for leave to file a fourth amended complaint to add new plaintiffs and allegations. On March 19, 2021, the court granted the McGlone Plaintiffs’ motion for leave to amend the complaint. On May 24, 2021, the Company, Enrichment Corp. and the other defendants filed their motion to dismiss the complaint. The court has not rendered a decision at this time. Meanwhile, the parties are in the discovery stage of litigation. The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the Nuclear Regulatory Commission’s regulations. Further, the Company believes that any such liability should be indemnified under the Price-Anderson Nuclear Industries Indemnity Act (“Price-Anderson Act”). The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions.

On November 27, 2019, the Company, Enrichment Corp. and six other DOE contractors who have operated facilities at the Portsmouth GDP site were named as defendants in a class action complaint filed by James Matthews, Jennifer Brownfield Clark, Joanne Ross, the Estate of A.R., and others similarly situated (the “Matthews Plaintiffs”), in the Common Pleas Court of Pike County, Ohio. On January 3, 2020, the complaint was removed to the U.S. District Court in the Southern District of Ohio for adjudication. The complaint sought injunctive relief, compensatory damages, statutory damages, and any other relief allowed by law for alleged off-site contamination allegedly resulting from activities on the Portsmouth GDP site. The Matthews Plaintiffs expressly contended that the ongoing and continuous releases that injured the Plaintiffs and class members were not “nuclear incidents” as that term is defined in the Price-Anderson Act, but rather “freestanding state law claims concerning traditional-style state regulation.” On July 27, 2020, the court granted the Company, Enrichment Corp. and the other defendants’ motion to dismiss the complaint because the Matthews Plaintiffs had opted not to proceed under the Price-Anderson Act which preempts state law. On August 18, 2020, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Sixth Circuit. On October 6, 2021, the U.S. Court of Appeals for the Sixth Circuit affirmed the lower court’s decision and dismissed the case. The Plaintiffs did not file a petition for certiorari with the U.S. Supreme Court; the Plaintiffs had to file such a petition by January 4, 2022 for the U.S. Supreme Court, and therefore, the lower court’s decision to dismiss the case is final.

On September 3, 2020, the Company, Enrichment Corp., nine other DOE contractors who have operated facilities at the Portsmouth GDP site and eleven individuals in their personal capacity some of whom are current and former DOE employees were named as defendants (“Walburn Defendants”) in a class action complaint filed by Jeffrey Walburn, Charles O. Lawson Jr., Kimberly M. Lawson, James A. Brogdon, Stephen Patrick Spriggs, Donald Slone, Vicki P. Slone, Victoria Slone Moore, Toni West, Carl R. Hartley, Heather R. Hartley, Vina Colley, Antony Preston, David B. Rose, Michael E. Groves, George W. Clark, Estate of Kathy Sue Brogdon (deceased), Estate of Jay Paul Brogdon (deceased), and Jon Doe(s), and Jane Doe(s), on behalf of themselves and all similarly situated individuals (“Walburn Plaintiffs”) in the U.S. District Court in the Southern District of Ohio, Eastern Division.  The complaint alleged that the named defendants conspired and concealed nuclear incidents in violation of the Price-Anderson Act, the Racketeer Influenced and Corrupt Organization Act and other state claims. The complainants sought damages and equitable and injunctive relief arising from economic losses, property losses, and non-economic damages resulting from toxic and radioactive releases from the Portsmouth GDP. On November 20, 2020, the Walburn Plaintiffs filed an amended complaint to add two individuals to the complaint as defendants in their individual capacity. One of those individuals was Daniel Poneman, Centrus’ Chief Executive Officer. In the 78-page complaint, Mr. Poneman was referenced only twice, without any cited allegations against him; once in the caption and once referencing his position at the Company. The Company has notified its insurance carrier regarding the claim. On February 11, 2021, the Walburn Plaintiffs amended their complaint for a second time to replace two corporate defendants with two others (one of whom was a contractor to Enrichment Corp. and also to its 
predecessor prior to its privatization in 1998 and the other a former DOE contractor) and removed four named individual defendants from the complaint. On March 2, 2021, Walburn Defendants filed their motion to dismiss. On July 14, 2021, the court put the case on hold until November 11, 2021, to give the Plaintiffs the opportunity to retain new counsel.   The court conditionally granted the Plaintiffs’ local counsel’s request to withdraw as counsel and terminated the representation of the two other co-counsel.  The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the Nuclear Regulatory Commission’s regulations. Further, the Company believes that any such liability should be indemnified under the Price-Anderson Act. The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions. On November 11, 2021, Plaintiffs filed a notice of voluntary dismissal without prejudice.

Centrus is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, other than the above, Centrus does not believe that the outcome of any of these legal matters, individually and in the aggregate, will have a material adverse effect on its cash flows, results of operations or consolidated financial condition.

















XML
42
R21.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Accumulated Other Comprehensive Income (Loss)

12 Months Ended



Dec. 31, 2021



Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
 





Accumulated Other Comprehensive Income (Loss)
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)The sole component of accumulated other comprehensive income (loss) (“AOCI”) relates to activity in the accounting for pension and postretirement health and life benefit plans. The amortization of prior service costs (credits) is reclassified from AOCI and included in the computation of net periodic benefit cost. For further details, refer to Note 11, Pension and Postretirement Health and Life Benefits.
















XML
43
R22.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Segment Information

12 Months Ended



Dec. 31, 2021



Segment Reporting Information, Revenue for Reportable Segment [Abstract]
 





Segment Information
REVENUE BY GEOGRAPHIC AREA, MAJOR CUSTOMERS AND SEGMENT INFORMATION
Revenue by customer location, including customers in a foreign country representing 10% or more of total revenue, follows (in millions):
Year Ended December 31,
20212020
United States$220.5 $171.7 
Foreign:
Belgium 
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Total revenue$298.3 $247.2 
* less than 10%

The U.S. government and its contractors, in the Company’s technical solutions segment, represented approximately 38% of total revenue in 2021 and 21% in 2020. 

The ten largest customers in the Company’s LEU segment represented approximately 57% of total revenue in 2021. Revenue from each of Synatom and Kyushu Electric Power Company represented approximately 12% of total revenue in 2021. 

In 2020, the ten largest customers in the Company’s LEU segment represented approximately 71% of total revenue in 2020. Revenue from Synatom, Energy Harbor Nuclear Corp. and Dominion Energy South Carolina represented approximately 14%, 13% and 10%, respectively, of total revenue in 2020. 

No other customer represented more than 10% of total revenue in 2021 or 2020.
Centrus has two reportable segments: the LEU segment with two components, SWU and uranium, and the technical solutions segment. The LEU segment includes sales of the SWU component of LEU, sales of both the SWU and uranium components of LEU, and sales of uranium. The technical solutions segment includes revenue and cost of sales for work that Centrus performs under the HALEU Contract. The technical solutions segment also includes limited services provided by Centrus to DOE and its contractors at the Piketon facility. Gross profit is Centrus’ measure for segment reporting. There were no intersegment sales in the periods presented. 

The following table presents the Company’s segment information (in millions):
 Year Ended 
December 31,
20212020
Revenue
LEU segment:
Separative work units$163.3 $151.5 
Uranium22.8 39.0 
Total186.1 190.5 
Technical solutions segment112.2 56.7 
Total revenue$298.3 $247.2 
Segment Gross Profit (Loss)
LEU segment$73.0 $97.8 
Technical solutions segment41.5 (0.2)
Gross profit$114.5 $97.6 

The Company’s total assets are not presented for each reportable segment as they are not reviewed by, nor otherwise regularly provided to, the chief operating decision maker. Centrus’ long-term or long-lived assets, which include property, plant and equipment and other assets reported on the consolidated balance sheet, were located in the United States as of December 31, 2021, and December 31, 2020.

















XML
44
R23.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Summary of Significant Accounting Policies (Policies)

12 Months Ended



Dec. 31, 2021



Summary of Significant Accounting Policies [Abstract]
 





Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation and Principles of Consolidation

The consolidated financial statements of Centrus Energy Corp. (“Centrus” or the “Company”), which include the accounts of the Company, its principal subsidiary United States Enrichment Corporation (“Enrichment Corp.”) and its other subsidiaries, were prepared in conformity with generally accepted accounting principles in the U.S. (“U.S. GAAP”). Certain prior year amounts have been reclassified for consistency with the current year presentation. All material intercompany transactions have been eliminated.






Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts presented and disclosed in the consolidated financial statements. Significant estimates and judgments include, but are not limited to, revenue and related costs, asset valuations, pension and postretirement health and life benefit costs and obligations, the tax bases of assets and liabilities, the future recoverability of deferred tax assets, and determination of the valuation allowance for deferred tax assets. Actual results may differ from such estimates, and estimates may change if the underlying conditions or assumptions change.






Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

Cash and cash equivalents include short-term or highly liquid assets with original maturities of three months or less.






Inventory, Policy [Policy Text Block]

Inventories and Inventories Owed to Customers and Suppliers

Low-enriched uranium (“LEU”) consists of two components: separative work units (“SWU”) and uranium. SWU is a standard unit of measurement that represents the effort required to transform a given amount of natural uranium into two components: enriched uranium having a higher percentage of U235 and depleted uranium having a lower percentage of U235. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment deemed to be contained in LEU under this formula is commonly referred to as its SWU component and the quantity of natural uranium deemed to be used in the production of LEU under this formula is referred to as its uranium or “feed” component.

SWU and uranium inventory costs are determined using the average cost method. SWU and uranium purchase costs include shipping costs when applicable. Inventories of SWU and uranium are valued at the lower of cost or net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The estimated selling price for SWU and uranium is based on the pricing terms of contracts in the Company’s sales order book, and, for uranium not under contract, the estimated selling price is based primarily on published price indicators at the balance sheet date.  

Inventories owed to customers and suppliers, included in current liabilities, consist primarily of SWU and uranium inventories owed to fabricators. Fabricators process LEU into fuel for use in nuclear reactors. Under inventory optimization arrangements between Centrus and domestic fabricators, fabricators order quantities of LEU from Centrus based on scheduled or anticipated orders from utility customers, for deliveries in future periods. As delivery obligations under actual customer orders arise, Centrus typically satisfies these obligations by arranging for the transfer to the customer of title to the specified quantity of LEU at the fabricator. Centrus’ balances of SWU and uranium vary over time based on the timing and size of the fabricator’s LEU orders from Centrus and the fabricator’s needs for working stock of LEU. Balances can be positive or negative at the discretion of the fabricator. 
Fabricators have other inventory supplies and, where a fabricator has elected to order less material from Centrus than Centrus is required to deliver to its customers at the fabricator, the fabricator will use these other inventories to satisfy Centrus’ customer order obligations on Centrus’ behalf. In such cases, the transfer of title of LEU from Centrus to the customer results in quantities of SWU and uranium being owed by Centrus to the fabricator. The amounts of SWU and uranium owed to fabricators are satisfied as future deliveries of LEU to fabricators are made.





Income Tax, Policy [Policy Text Block]

Deferred Taxes

Centrus follows the asset and liability approach to account for deferred taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences of temporary differences between the balance sheet carrying amounts of assets and liabilities and their respective tax bases. Deferred taxes are based on income tax rates in effect for the years in which temporary differences are expected to reverse. The effect on deferred taxes of a change in income tax rates is recognized in income when the change in rates is enacted in the law. A valuation allowance is provided if it is more likely than not that all, or some portion, of the deferred tax assets may not be realized.






Property, Plant and Equipment, Policy [Policy Text Block]

Property, Plant and Equipment

Property, plant and equipment are recorded at acquisition cost. Leasehold improvements and machinery and equipment are depreciated on a straight-line basis over the shorter of the useful life of the assets or the lease term, if applicable. Refer also to Carrying Value of Long-Lived Assets below.






Intangible Assets, Policy [Policy Text Block]

Intangible Assets

Centrus has intangible assets resulting from fresh start accounting as a result of emergence from Chapter 11 bankruptcy on September 30, 2014. The identifiable intangible assets relate to the sales order book and customer relationships. The order book intangible asset is amortized as the order book valued at emergence is reduced, principally as a result of deliveries to customers. The customer relationships intangible asset is amortized using the straight-line method over the estimated average useful life of 15 years, with 7 ¾ years of scheduled amortization remaining. Refer also to Carrying Value of Long-Lived Assets below.

Carrying Value of Long-Lived Assets

The Company evaluates the carrying values of property, plant and equipment and identifiable intangible assets when events or changes in business circumstances indicate that the carrying amount of asset, or asset group, may not be fully recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset, or asset group, exceeds its fair value.






Fair Value of Financial Instruments, Policy [Policy Text Block]

Financial Instruments and Fair Value Measurement

Accounting standards define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, consideration is given to the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability. 

Pursuant to accounting standards, Centrus’ 8.25% notes due February 2027 (the “8.25% Notes”) are recorded at face value and the fair value is disclosed. The estimated fair value of the 8.25% Notes is based on recent trading prices and bid/ask quotes as of or near the balance sheet date. Debt issuance costs are deferred and amortized over the life of the instrument. 
The balance sheet carrying amounts for accounts receivable, accounts payable and accrued liabilities, and payables under SWU purchase agreements approximate fair value because of the short-term nature of the instruments.





Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentrations of Credit Risk

Credit risk could result from the possibility of a customer failing to perform or pay according to the terms of a contract. Extension of credit is based on an evaluation of each customer’s financial condition. Centrus regularly monitors credit risk exposure and takes steps intended to mitigate the likelihood of such exposure resulting in a loss.






Segment Reporting, Policy [Policy Text Block]
SegmentsCentrus operates two business segments: LEU, which supplies various components of nuclear fuel to utilities, and technical solutions, which provides advanced engineering, design, and manufacturing services to government and private sector customers.





Revenue Recognition, Policy

Revenue

The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. Revenue for product and service sales is recognized when or as the Company transfers control of the promised products or services to the customer. Revenue is measured at the transaction price, which is based on the amount of consideration that the Company expects to receive in exchange for transferring the promised goods or services to the customer. The transaction price will include estimates of variable consideration until it is probable that a significant reversal of revenue recognized will not occur. 

SWU and Uranium Revenue

Revenue for the Company’s LEU segment is derived from sales of the SWU component of LEU, from sales of both the SWU and uranium components of LEU, and from sales of uranium. Contracts with customers are primarily medium and long-term, fixed-commitment contracts under which its customers are obligated to purchase a specified quantity of the SWU component of LEU or the SWU and uranium components of LEU. The Company’s contracts for natural uranium are generally shorter-term, fixed-commitment contracts. 

Revenue is recognized at the time the customer obtains control of the LEU or uranium. Customers generally obtain control of LEU at nuclear fuel fabricators. Centrus ships LEU to nuclear fuel fabricators for scheduled or anticipated orders from utility customers. Based on customer orders, Centrus arranges for the transfer of title of LEU from Centrus to the customer for the specified quantity of LEU at the fuel fabricator. Each such delivery to a customer is accounted for as a distinct performance obligation under a contract, and a contract may call for multiple deliveries over a number of periods. The contract’s transaction price is allocated to each performance obligation based on the observable standalone selling price of each distinct delivery of SWU or uranium. For certain contracts the customers may elect not to take control of the LEU or uranium and Centrus may have the right to enforce payment under the terms of the contractual agreement. The revenue recognition for these contracts is assessed when it occurs.

Utility customers in general have the option to defer receipt of uranium products purchased from the Company beyond the contractual sale period. In such cases, title to SWU and/or uranium components are transferred to the customer and a performance obligation for Centrus is created and a receivable is recorded. Cash is collected for the receivable under normal credit terms. The performance obligation is represented as Deferred Revenue on the consolidated balance sheet and the customer-titled product is classified as Deferred Costs Associated with Deferred Revenue on the consolidated balance sheet. Risk of loss remains with Centrus until the customer obtains control of the uranium product. The recognition of revenue and related cost of sales occurs at the point in time at which the customer obtains control of SWU or uranium and risk of loss of the product transfers to the customer, which may occur beyond one year. The timing of the transfer of control, subject to notice period requirements, is at the option of the customer. As such, deferred costs and deferred revenue are classified within current assets and current liabilities, respectively. 

On occasion, the Company will accept payment in the form of uranium. Revenue from the sale of SWU under such contracts is recognized at the time transfer of control of LEU occurs and is based on the fair value of the uranium at contract inception or as the quantity of uranium is finalized, if variable. 

Amounts billed to customers for handling costs are included in sales. Handling costs are accounted for as a fulfillment cost and are included in cost of sales. The Company does not have shipping costs associated with outbound freight after control over a product has transferred to a customer. The Company’s contracts with customers do not provide for significant payment terms or financing components.
Technical Solutions Revenue

Revenue for the technical solutions segment, principally representing technical, manufacturing, engineering, procurement, construction and operations services offered to public and private sector customers, is recognized over the contractual period as services are rendered. The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer. For public sector contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay the Company for costs incurred plus a reasonable profit and assume control of any work in progress. The Company’s government and private sector contracts generally contain contractual termination clauses or entitle the Company to payments for work performed to date for goods and services that do not have an alternative use. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. A contract may contain one or more performance obligations. Two or more promises to transfer goods or services to a customer may be considered a single performance obligation if the goods or services are highly interdependent or highly interrelated such that utility of the promised goods or services to the customer includes integration services provided by the Company. 

The Company determines the transaction price for each contract based on the consideration it expects to receive for the products or services being provided under the contract. If transaction prices are not stated in the contract for each performance obligation, contractual prices are allocated to performance obligations based on estimated relative standalone selling prices of the promised services. 

The Company generally uses the cost-to-cost input method of progress for performance obligations to deliver products with continual transfer of control to the customer, because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of direct costs incurred to date to the total estimated direct costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred. For performance obligations to provide services to the customer, revenue is recognized over time based on direct costs incurred or the right to invoice method (in situations where the value transferred matches the Company’s billing rights) as the customer receives and consumes the benefits. 

Use of the cost-to-cost method requires the Company to make reasonably dependable estimates of costs at completion associated with the design, manufacture and delivery of products and services in order to calculate revenue. Significant judgment is used to estimate total revenue and costs at completion, particularly in the assumptions related to internal labor hours and third-party services for which a vendor invoice or quote is not yet available. As a significant change in one or more estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its contract-related estimates regularly. Adjustments in estimated profits/losses are recognized under the cumulative catch-up method. Under this method, the impact of the adjustments is recognized in the period the adjustment is recognized. When estimates of total costs at completion for such an integrated, construction type contract exceed total estimates of revenue to be earned on a performance obligation related to complex equipment or related services, a provision for the remaining loss on the performance obligation is recognized in the period the loss is determined. 

The Company applied the practical expedient in paragraph ASC 606-10-50-14 and does not disclose the value of remaining performance obligations under service contracts having original expected terms of one year or less.

The timing of revenue recognition may differ from the timing of invoicing to customers. Progress on satisfying performance obligations under contracts with customers and the related billings and cash collections are recorded on the consolidated balance sheet as contract assets or contract liabilities. Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period.

Unbilled receivables are included in Accounts Receivable on the consolidated balance sheet and arise when the timing of cash collected from customers differs from the timing of revenue recognition. Those assets are recognized when the revenue associated with the contract is recognized prior to billing and derecognized when billed in 
accordance with the terms of the contract. To the extent billings to the customer precede the recognition of technical solutions revenue, the Company recognizes a liability included in Deferred Revenue and Advances from Customers on the consolidated balance sheet.





Advanced Technology Costs, Policy [Policy Text Block]
Advanced Technology CostsAmerican Centrifuge and related expenses that are outside of our customer contracts are included in Advanced Technology Costs.





Pension and Other Postretirement Plans, Policy [Policy Text Block]
Pension and Postretirement Health and Life Benefit PlansThe Company provides retirement benefits to certain employees and retirees under defined benefit pension plans and postretirement health and life benefit plans. The valuation of benefit obligations and costs is based on provisions of the plans and actuarial assumptions that involve judgments and estimates. Plan assets and benefit obligations are remeasured each year as of the balance sheet date, or when lump sum payments exceed certain levels, resulting in differences between actual and projected results. The Company has elected to recognize these actuarial gains and losses immediately in the statement of operations to provide transparency regarding the impacts of changes in plan assets and benefit obligations.





Stock-based Compensation, Policy [Policy Text Block]

Stock-Based Compensation

Centrus has a stock-based compensation plan which authorizes the issuance of common stock to the Company’s employees, officers, directors, and other individuals providing services to the Company or its affiliates pursuant to options, notional stock units, stock appreciation rights, restricted stock units, restricted stock, performance awards, dividend equivalent rights, and other stock-based awards. 

Stock-based compensation cost for options and stock-settled awards are measured at the grant date based on the fair value of the award. The cost is recognized over the requisite service period on a straight-line basis over the vesting period. 

Stock-based compensation cost for awards likely to be settled with cash payments are recognized over the requisite service period and accrued as a liability and re-measured each reporting period based on the trading price of the Company’s common stock.

The Company recognizes forfeitures as they occur.






New Accounting Pronouncements, Policy [Policy Text Block]

New Accounting Standards

Recently Adopted Accounting Standards

In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20), which modifies the disclosure requirements for employers that sponsor defined benefit pension plans and other postretirement plans. ASU 2018-14 is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The standard is to be applied on a retrospective basis to all periods presented and early adoption is permitted. Adoption of this new standard did not have a significant impact to the Company’s annual disclosures.































XML
45
R24.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Revenue and Contracts with Customers (Tables)

12 Months Ended



Dec. 31, 2021



Revenue from Contract with Customer [Abstract]
 





Revenue from External Customers by Geographic Areas

The following table presents revenue from SWU and uranium sales disaggregated by geographical region, including foreign countries representing 10% or more of revenue, based on the billing addresses of customers (in millions):
Year Ended December 31,
20212020
United States$108.3 $115.0 
Foreign:
Belgium 
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Revenue - SWU and uranium$186.1 $190.5 
Revenue by customer location, including customers in a foreign country representing 10% or more of total revenue, follows (in millions):
Year Ended December 31,
20212020
United States$220.5 $171.7 
Foreign:
Belgium 
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Total revenue$298.3 $247.2 
* less than 10%






Contract with Customer, Asset and Liability

The following table presents changes in contract liability balances (in millions):
December 31, 
20212020Change
Accrued loss on HALEU Contract:
Current - Accounts payable and accrued liabilities
$0.5 $7.0 $(6.5)
Non-current - Other long-term liabilities
$— $0.7 $(0.7)
Deferred revenue - current
$288.1 $281.7 $6.4 
Advances from customers - current
$15.0 $1.5 $13.5 
Advances from customers - non current$45.1 $45.2 $(0.1)


















XML
46
R25.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Cash, Cash Equivalents and Restricted Cash (Tables)

12 Months Ended



Dec. 31, 2021



Cash, Cash Equivalents and Restricted Cash [Abstract]
 





Schedule of Cash and Cash Equivalents

The following table summarizes the Company’s cash, cash equivalents and restricted cash as presented on the consolidated balance sheet to amounts on the consolidated statement of cash flows (in millions):
December 31, 
20212020
Cash and cash equivalents
$193.8 $152.0 
Deposits for financial assurance - current
0.2 0.2 
Deposits for financial assurance - non current2.8 5.7 
Total cash, cash equivalents and restricted cash
$196.8 $157.9 






Schedule of Restricted Cash and Cash Equivalents

The following table provides additional detail regarding the Company’s deposits for financial assurance (in millions):

December 31, 2021December 31, 2020
CurrentLong-TermCurrentLong-Term
Workers compensation$— $2.6 $— $5.4 
Other0.2 0.2 0.2 0.3 
Total deposits for financial assurance$0.2 $2.8 $0.2 $5.7 


















XML
47
R26.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Inventories (Tables)

12 Months Ended



Dec. 31, 2021



Inventory, Net [Abstract]
 





Schedule of Inventories
Components of inventories are as follows (in millions):
 December 31, 2021December 31, 2020
 Current
Assets		Current
Liabilities 
(a)		Inventories, NetCurrent
Assets		Current
Liabilities
(a)		Inventories, Net
Separative work units$8.8 $— $8.8 $17.0 $4.6 $12.4 
Uranium82.3 8.4 73.9 47.8 0.3 47.5 
Total$91.1 $8.4 $82.7 $64.8 $4.9 $59.9 
(a)Inventories owed to customers and suppliers, included in current liabilities, include SWU and uranium inventories owed to fabricators.
















XML
48
R27.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Property, Plant and Equipment (Tables)

12 Months Ended



Dec. 31, 2021



Property, Plant and Equipment [Abstract]
 





Property, Plant and Equipment

A summary of changes in property, plant and equipment follows (in millions):
December 31,
2020		Additions / (Depreciation)December 31,
2021
Land
$1.2 $— $1.2 
Buildings and leasehold improvements3.9 0.7 4.6 
Machinery and equipment
1.4 — 1.4 
Other
1.1 — 1.1 
Property, plant and equipment, gross
7.6 0.7 8.3 
Accumulated depreciation
(2.7)(0.3)(3.0)
Property, plant and equipment, net
$4.9 $0.4 $5.3 

















XML
49
R28.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Intangible Assets (Tables)

12 Months Ended



Dec. 31, 2021



Goodwill and Intangible Assets Disclosure [Abstract]
 





Schedule of Finite-Lived Intangible Assets [Table Text Block]
Intangible asset balances are as follows (in millions):
December 31, 2021December 31, 2020
Gross Carrying AmountAccumulated AmortizationNet AmountGross Carrying AmountAccumulated AmortizationNet Amount
Sales order book$54.6 $35.5 $19.1 $54.6 $32.0 $22.6 
Customer relationships68.9 33.3 35.6 68.9 28.7 40.2 
Total$123.5 $68.8 $54.7 $123.5 $60.7 $62.8 






Finite-lived Intangible Assets Amortization Expense [Table Text Block]

The amount of amortization expense for intangible assets in each of the succeeding years is estimated to be as follows (in millions):
2022$9.5 
20236.6 
20248.6 
20257.6 
20269.9 
Thereafter12.5 
   Total$54.7 


















XML
50
R29.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Accounts Payable and Accrued Liabilities (Tables)

12 Months Ended



Dec. 31, 2021



Accounts Payable and Accrued Liabilities [Abstract]
 





Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Components of accounts payable and accrued liabilities follow (in millions):
December 31,
20212020
Trade payables$4.9 $4.9 
Compensation and employee benefits23.1 22.2 
Postretirement health and life benefit obligations - current7.0 11.6 
Accrued HALEU Contract loss0.5 7.0 
Operating lease liability0.9 2.4 
Other accrued liabilities1.4 2.5 
   Total accounts payable and accrued liabilities$37.8 $50.6 

















XML
51
R30.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Debt Schedule of Debt (Tables)

12 Months Ended



Dec. 31, 2021



Debt Disclosure [Abstract]
 





Schedule of Debt

A summary of debt follows (in millions):
December 31, 2021December 31, 2020
MaturityCurrentLong-TermCurrentLong-Term
8.25% Notes:Feb. 2027
Principal
$— $74.3 $— $74.3 
Interest
6.1 27.5 6.1 33.7 
Total$6.1 $101.8 $6.1 $108.0 

















XML
52
R31.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Leases (Tables)

12 Months Ended



Dec. 31, 2021



Leases [Abstract]
 





Lessee, Operating Lease, Liability, Maturity [Table Text Block]

The table below presents the lease-related assets and liabilities recorded on the consolidated balance sheet (in millions).
December 31, 2021Classification on the Balance Sheet
Lease assets$2.1 Other long-term assets
Lease liabilities:
Current
$0.9 Accounts payable and accrued liabilities
Non-current3.0 Other long-term liabilities
Total lease liabilities
$3.9 
The table below reconciles undiscounted payments for operating leases with terms greater than 12 months to the operating lease liabilities recorded on the balance sheet (in millions).
2022$1.3 
20231.0 
20241.0 
20251.0 
20261.0 
Thereafter0.8 
Total lease payments6.1 
Less imputed interest2.2 
Present value of lease payments$3.9 

















XML
53
R32.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Fair Value Measurements (Tables)

12 Months Ended



Dec. 31, 2021



Fair Value Disclosures [Abstract]
 





Schedule of Financial Instruments Recorded at Fair Value

Financial Instruments Recorded at Fair Value (in millions):
December 31, 2021December 31, 2020
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:        
Cash and cash equivalents$193.8 $— $— $193.8 $152.0 $— $— $152.0 
Deferred compensation asset (a)3.2 — — 3.2 2.4 — — 2.4 
Liabilities:        
Deferred compensation obligation (a)
$3.2 $— $— $3.2 $2.3 $— $— $2.3 
 
(a)    The deferred compensation obligation represents the balance of deferred compensation plus net investment earnings. The deferred compensation plan is funded through a rabbi trust. Trust funds are invested in mutual funds for which unit prices are quoted in active markets and are classified within Level 1 of the valuation hierarchy.
















XML
54
R33.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Tables)

12 Months Ended



Dec. 31, 2021



Defined Benefit Plan Disclosure [Line Items]
 





Schedule of Changes in Projected Benefit Obligations [Table Text Block]

Changes in the projected benefit obligations and plan assets and the funded status of the plans follow:
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
($ millions)Year Ended December 31,Year Ended December 31,
2021202020212020
Changes in Benefit Obligations:
Obligations at beginning of period$757.9 $763.5 $142.4 $152.8 
Actuarial (gains) losses, net(28.7)56.7 (2.3)(1.6)
Service costs2.7 3.5 — — 
Interest costs18.1 24.3 3.4 4.8 
Benefits paid from Plan assets(51.3)(56.3)(12.4)(13.6)
Benefits paid from Company assets(0.4)(0.5)— — 
Settlements— (30.4)— — 
Administrative expenses paid(2.1)(2.9)— — 
Obligations at end of period696.2 757.9 131.1 142.4 
Changes in Plan Assets:
Fair value of plan assets at beginning of period
633.1 621.2 — — 
Actual return on plan assets57.8 85.4 — — 
Company contributions35.7 16.6 21.5 13.6 
Benefits paid(51.7)(56.8)(12.3)(13.6)
Settlements— (30.4)— — 
Administrative expenses paid(2.2)(2.9)— — 
Fair value of plan assets at end of period
672.7 633.1 9.2 — 
Unfunded status at end of period$(23.5)$(124.8)$(121.9)$(142.4)
Amounts recognized in assets and liabilities:
      Current liabilities$(0.4)$(0.4)$(7.0)$(11.6)
      Non-current liabilities(23.1)(124.4)(114.9)(130.8)
$(23.5)$(124.8)$(121.9)$(142.4)
Amounts in accumulated other comprehensive income (loss), pre-tax:
      Prior service credit$(0.9)$(1.1)$(2.0)$(2.1)






Schedule of Net Benefit Costs [Table Text Block]

Components of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income 

The Company reports service costs for its defined benefit pension plans and its postretirement health and life benefit plans in Cost of Sales and Selling, General and Administrative Expenses. The remaining components of net periodic benefit (credits) costs are reported as Nonoperating Components of Net Periodic Benefit Income.
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
(in millions)Year Ended December 31,Year Ended December 31,
2021202020212020
Net Periodic Benefit (Credits) Costs
Service costs$2.7 $3.5 $— $— 
Interest costs18.1 24.3 3.4 4.8 
Expected return on plan assets(38.3)(37.5)— — 
Amortization of prior service credits, net(0.2)(0.2)(0.1)(0.1)
Actuarial (gains) losses, net
(48.2)8.9 (2.3)(1.7)
Net periodic benefit (credits) costs$(65.9)$(1.0)$1.0 $3.0 

Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss)
Amortization of prior service costs, net$— $— $(2.0)$(2.1)
Prior service credit(0.9)(1.1)— — 
Total recognized in other comprehensive loss, pre-tax$(0.9)$(1.1)$(2.0)$(2.1)
Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax
$(66.8)$(2.1)$(1.0)$0.9 






Schedule of Assumptions Used [Table Text Block]

Assumptions Used to Determine Net Periodic Benefit Costs
Defined Benefit Pension PlansPostretirement Health
and Life Benefit Plans
Year Ended December 31,Year Ended December 31,
2021202020212020
Discount rate
2.8%2.5%2.8%2.5%
Expected return on plan assets
6.3%6.4%——






Schedule of Health Care Cost Trend Rates [Table Text Block]

Healthcare cost trend rates used to measure postretirement health benefit obligations follow:
December 31,
20212020
Healthcare cost trend rate for the following year
6.0%5.5%
Long-term rate that the healthcare cost trend rate gradually declines to
5%5%
Year that the healthcare cost trend rate is expected to reach the long-term rate
20262022






Schedule of Allocation of Plan Assets [Table Text Block]

Plan assets are measured at fair value. Following are the plan investments as of December 31, 2021 and 2020, categorized by the fair value hierarchy levels described in Note 10, Fair Value:
Defined Benefit Pension and Postretirement Health and Life Benefit Plans
(in millions)Level 1Level 2Level 3Total
20212020202120202021202020212020
U.S. government securities$— $— $13.0 $16.4 $— $— 13.0 $16.4 
Corporate debt— — 56.4 104.2 — — 56.4 104.2 
Municipal bonds and non-U.S. government securities
— — 1.7 2.1 — — 1.7 2.1 
Mutual funds (b)582.9 — — — — — 582.9 — 
Mortgage and asset backed securities— — 7.9 6.4 — — 7.9 6.4 
Fair value of investments by hierarchy level
$582.9 $— $79.0 $129.1 $— $— 661.9129.1
Investments measured at NAV (a)20.1 504.4 
Accrued interest receivable1.2 1.3 
Unsettled transactions(1.4)(1.8)
Plan assets$681.8 $633.0 






Schedule of Expected Benefit Payments [Table Text Block]

Estimated future benefit plan payments follow (in millions):
Defined Benefit Pension PlansPostretirement Health and Life Benefit Plans
2022$52.1 $11.2 
202351.0 10.7 
202449.1 10.1 
202547.6 9.5 
202647.6 9.0 
2027 to 2031214.0 36.3 






















XML
55
R34.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation (Tables)

3 Months Ended
12 Months Ended





Dec. 31, 2021


Dec. 31, 2021





Share-based Payment Arrangement, Noncash Expense [Abstract]
 

 





Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
 


A summary of stock-based compensation costs is as follows (in millions): 
 Year Ended December 31,
 20212020
 
Notional stock units and stock appreciation rights$11.6 $6.6 
Restricted stock units0.5 0.4 
Stock options0.1 0.1 
Total stock-based compensation costs$12.2 $7.1 
Total recognized tax benefit$(1.5)$— 






Share-based Payment Arrangement, Nonemployee Director Award Plan, Activity [Table Text Block]
 


The following table summarizes Centrus’ board restricted stock units activity:
Shares (in thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 201974$3.09
Granted47$10.38
Vested(74)$3.09
Forfeited——
Nonvested at December 31, 202047$10.38
Granted20$25.13
Vested(47)$10.38
Forfeited——
Nonvested at December 31, 202120$25.13






Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
 


The following table summarizes Centrus’s employee restricted stock units activity:
Shares
(in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020—$—
Granted4$24.01
Vested ——
Forfeited——
Nonvested at December 31, 20214$24.01






Share-based Compensation, Stock Options, Activity [Table Text Block]
 

A summary of stock option activity follows:
Stock Options (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value          (in millions)
Outstanding at December 31, 2019518$4.026.2$1.5
Granted————
Exercised(107)$3.43——
Forfeited/Cancelled————
Outstanding at December 31, 2020411$4.185.3$7.8
Granted————
Exercised(217)$4.17——
Forfeited/Cancelled————
Outstanding at December 31, 2021194$4.184.4$8.9
Exercisable at December 31, 2021144$4.373.2$6.6






Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
 


Stock options outstanding and options exercisable at December 31, 2021, are as follows:

Stock Exercise PriceOptions Outstanding (thousands)Remaining Contractual Life in YearsOptions Exercisable (thousands)
$4.371443.2144
$3.65507.8—






Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]
 


A summary of SARs with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:

Stock Appreciation Rights (in thousands) Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value            (in millions)
Outstanding at December 31, 2019—$——$—
Granted83.5$5.53——
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202083.5$5.532.3$1.47
Granted————
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202183.5$5.531.3$3.71
Exercisable at December 31, 202183.5$5.531.3$3.71






Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]
 


The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
20212020
SARs Granted (in thousands)n/a83.5
Average Risk-Free Raten/a0.14%
Expected Volatilityn/a94%
Expected Term (Years)n/a2.3
Dividend Yieldn/a—






Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity [Table Text Block]

A summary of SARs with performance-based vesting granted under the 2014 plan in the year ended December 31, 2021, are as follows:
Stock Appreciation Rights (Performance Condition)   (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value            (in millions)
Outstanding at December 31, 2020—$——$—
Granted21$19.44——
Exercised————
Forfeited/Cancelled————
Outstanding at December 31, 202121$19.442.3$0.64
Exercisable at December 31, 202121$19.442.3$0.64


 





Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions [Table Text Block]
 


The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
20212020
Stock Appreciation Rights Granted (in thousands)21.0n/a
Average Risk-Free Rate0.3%n/a
Expected Volatility82.8%n/a
Expected Term (Years)2.5n/a
Dividend Yield—n/a






Schedule of Notional Stock Units, Activity [Table Text Block]
 


A summary of notional stock units with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:
Shares (thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2019468$3.16
Granted125$5.53
Vested——
Forfeited(22)$3.16
Nonvested at December 31, 2020571$3.68
Granted——
Vested(319)$3.16
Forfeited——
Nonvested at December 31, 2021252$4.33






Schedule of Notional Stock Units, Performance Condition, Activity [Table Text Block]
 


A summary of notional stock units with performance-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:
Shares 
(in thousands)		Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020— $— 
Granted10$39.55
Vested — — 
Forfeited— — 
Nonvested at December 31, 202110 $39.55



























XML
56
R35.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes Income Taxes (Tables)

12 Months Ended



Dec. 31, 2021



Income Tax Disclosure [Abstract]
 





Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The income tax benefit is as follows (in millions):
Year Ended December 31,
20212020
Current:
  Federal$— $— 
  State and local0.4 0.5 
  Foreign— — 
0.4 0.5 
Deferred:
  Federal (a)(40.7)— 
  State and local1.2 (1.9)
  Foreign— — 
(39.5)(1.9)
Income tax benefit$(39.1)$(1.4)






Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

Future tax consequences of temporary differences between the carrying amounts for financial reporting purposes and the Company’s estimate of the tax bases of its assets and liabilities result in deferred tax assets and liabilities, as follows (in millions):
December 31,
20212020
Deferred tax assets:
Employee benefits costs
$36.2 $61.8 
Inventory
18.6 16.2 
Property, plant and equipment
191.5 193.8 
Net operating loss and credit carryforwards
206.2 211.1 
Accrued expenses
0.4 2.1 
Long-term debt and financing costs
10.8 12.6 
Lease liability
0.9 1.5 
Other
0.2 0.2 
Deferred tax assets
464.8 499.3 
Valuation allowance
(414.7)(486.0)
Deferred tax assets, net of valuation allowance
$50.1 $13.3 
Deferred tax liabilities:
Intangible assets
$7.9 $9.9 
Lease asset
0.4 1.1 
Prepaid expenses
0.4 0.4 
Deferred tax liabilities
$8.7 $11.4 
Deferred tax assets, net$41.4 $1.9 






Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

A reconciliation of income taxes calculated based on the federal statutory income tax rate and the effective tax rate follows:
Year Ended December 31,
20212020
Federal statutory tax rate21 %21 %
Valuation allowance against net deferred tax assets(53)(26)
State rate changes1 (1)
Executive compensation1 2 
State income tax expense, net of federal benefit1 — 
Uncertain tax positions— 1 
Effective tax rate
(29)%(3)%






Summary of Income Tax Contingencies [Table Text Block]

A reconciliation of the beginning and ending amount of unrecognized tax benefits follows (in millions):
Year Ended December 31,
20212020
Balance at beginning of the period$0.8 $0.4 
Additions to tax positions of current period0.4 0.5 
Reductions to tax positions of prior years(0.2)(0.1)
Balance at end of the period$1.0 $0.8 




















XML
57
R36.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Net Income Per Share (Tables)

12 Months Ended



Dec. 31, 2021



Earnings Per Share [Abstract]
 





Schedule of Net Income Per Share

The weighted average number of common and common equivalent shares and the calculation of basic and diluted income per common share are as follows:
 Year Ended 
December 31,
20212020
Numerator (in millions):
Net income$175.0 $54.4 
Preferred stock dividends - undeclared and cumulative2.1 6.7 
Distributed earnings allocable to retired preferred shares37.6 41.9 
Net income allocable to common stockholders$135.3 $5.8 
Denominator (in thousands):
Average common shares outstanding - basic13,493 9,825 
Potentially dilutive shares related to stock options and restricted stock units (a)
386 298 
Average common shares outstanding - diluted13,879 10,123 
Net income per common share (in dollars):
Basic$10.03 $0.59 
Diluted$9.75 $0.57 
There are no common stock equivalents excluded from the diluted calculation as a result of a net loss in the period or options outstanding and considered anti-dilutive as their exercise price exceeded the average share market
















XML
58
R37.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stockholders' Equity (Tables)

12 Months Ended



Dec. 31, 2021



Stockholders' Equity Attributable to Parent [Abstract]
 





Schedule of Stock by Class [Table Text Block]

Changes in the number of shares outstanding are as follows:
 Preferred Stock,
Series B		Common Stock,
Class A		Common Stock,
Class B
Balance at December 31, 2019104,574 8,347,427 1,117,462 
Issuance under public offering— 2,537,500 — 
Common stock issued for options exercised— 107,000 — 
Conversion of common stock from Class B to Class A— 398,262 (398,262)
Purchase under tender offer(62,854)— — 
Balance at December 31, 202041,720 11,390,189 719,200 
Issuance under public offering — 1,516,467 — 
Common stock issued for options exercised— 216,500 — 
Issuance of previously vested restricted stock units— 89,318 — 
Notional stock units paid in shares— 206,183 — 
Common stock and warrant issued in exchange for preferred stock(3,873)231,276 — 
Purchase under tender offer(37,847)— — 
Balance at December 31, 2021— 13,649,933 719,200 

















XML
59
R38.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Segment Information (Tables)

12 Months Ended



Dec. 31, 2021



Segment Reporting Information, Revenue for Reportable Segment [Abstract]
 





Revenue from External Customers by Geographic Areas

The following table presents revenue from SWU and uranium sales disaggregated by geographical region, including foreign countries representing 10% or more of revenue, based on the billing addresses of customers (in millions):
Year Ended December 31,
20212020
United States$108.3 $115.0 
Foreign:
Belgium 
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Revenue - SWU and uranium$186.1 $190.5 
Revenue by customer location, including customers in a foreign country representing 10% or more of total revenue, follows (in millions):
Year Ended December 31,
20212020
United States$220.5 $171.7 
Foreign:
Belgium 
36.6 35.8 
Japan
34.6 23.4 
Other
6.6 16.3 
Total foreign
77.8 75.5 
      Total revenue$298.3 $247.2 
* less than 10%






Segment Reporting Information

The following table presents the Company’s segment information (in millions):
 Year Ended 
December 31,
20212020
Revenue
LEU segment:
Separative work units$163.3 $151.5 
Uranium22.8 39.0 
Total186.1 190.5 
Technical solutions segment112.2 56.7 
Total revenue$298.3 $247.2 
Segment Gross Profit (Loss)
LEU segment$73.0 $97.8 
Technical solutions segment41.5 (0.2)
Gross profit$114.5 $97.6 

The Company’s total assets are not presented for each reportable segment as they are not reviewed by, nor otherwise regularly provided to, the chief operating decision maker. Centrus’ long-term or long-lived assets, which include property, plant and equipment and other assets reported on the consolidated balance sheet, were located in the United States as of December 31, 2021, and December 31, 2020.


















XML
60
R39.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Summary of Significant Accounting Policies (Details)

12 Months Ended



Dec. 31, 2021



Average useful life of finite-lived intangible assets
15 years





Finite-Lived Intangible Assets, Remaining Amortization Period
7 years 9 months





Concentration Risk, Supplier
Concentrations of Supply Risk and Other Considerations with the War in Ukraine    The current war in Ukraine has led to the U.S., Russia and other countries imposing sanctions and other measures that restrict international trade.  The situation is rapidly changing, and it is not possible to predict future actions that could be taken.  The Company has multiple sources of supply; however, the supply contract with TENEX remains our largest source.  At present, sanctions have not impacted the ability of the Company or TENEX to perform under the TENEX supply contract.  Recently, sanctions have been imposed by the U.S. on exports of fossil fuels.  Russia has imposed sanctions on the export of commodities but does not include the export of LEU.  Additional sanctions or other measures by the U.S. or foreign governments (including the Russian government) could be imposed. Any sanctions or measures directed at trade in LEU from Russia or the parties involved in such trade or otherwise could interfere with, or prevent, implementation of the TENEX Supply Contract. While the initial sanctions announced do not affect the ability of the Company or TENEX to implement the TENEX Supply Contract, the situation at this time is unpredictable and therefore there is no assurance that future developments would not have a material adverse effect on the Company’s procurement, payment, delivery or sale of LEU under the TENEX Supply Contract.    If measures were taken to limit the supply of Russian LEU or to prohibit or limit dealings with Russian entities, including, but not limited to, TENEX or ROSATOM, the Company would seek a license, waiver or other approval from the government imposing such measures to ensure that the Company could continue to fulfill its purchase and sales obligations. There is no assurance that such a license, waiver, or approval would be granted. If a license, waiver or approval were not granted, the Company would need to look to alternative sources of LEU to replace the LEU that it could not procure from TENEX.  The Company has contracts for alternative sources that could be used to mitigate a portion of the near term impacts.  However, to the extent these sources were insufficient or more expensive or additional supply cannot be obtained, it could have a material adverse impact on our business, results of operations, and competitive position.





Related Party Transaction, Description of Transaction
Related Party      As previously disclosed in our Current Report on Form 8-K filed on December 31, 2020, on that same date theCompany entered into an At Market Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. andLake Street Capital Markets, LLC (the “Agents”), relating to the at the market offering (the “ATM Offering”) ofshares of the Company’s Class A Common Stock, $0.10 par value per share. Mr. Williams, Chairman of the CentrusBoard of Directors, also serves on the board of B. Riley Financial, Inc. Mr. Williams recused himself and took nopart in the selection of B. Riley or the negotiation of the terms of the Sales Agreement.  Please refer to Note 15 - Stockholders’ Equity for a description of the ATM Offering in 2021.





Senior Notes [Member]
 





Debt Instrument, Interest Rate, Stated Percentage
8.25%




















XML
61
R40.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Revenue and Contracts with Customers (Narrative) (Details) - USD ($)
 $ in Millions

12 Months Ended
36 Months Ended






Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2021


Dec. 31, 2020


Sep. 30, 2021





Revenue, nonmonetary transaction
$ 23.4

 

 

 

 





Advances from customers, noncurrent
45.1

$ 45.2

$ 45.1

$ 45.2

 





Deferred revenue, additions in period
47.2

38.7

 

 

 





Deferred revenue, revenue recognized
42.6

0.0

 

 

 





Separative work units borrowed in period, value
 

 

 

20.7

 





Separative work units owed to others noncurrent
22.4

 

22.4

 

$ 25.5





Provision for Loss on Contracts
0.5

7.0

0.5

7.0

 





Provision for loss on contracts, noncurrent
0.0

0.7

0.0

0.7

 





Litigation settlement, amount awarded from other party
43.5

 

 

 

 





Accounts receivable, net
29.1

29.6

29.1

29.6

 





Gain (loss) related to litigation settlement
43.5

32.6

 

 

 





Revenue, remaining performance obligation, amount
986.0

960.0

986.0

960.0

 





Deferred Revenue and Advances from Customers - Current and Noncurrent
348.2

 

348.2

 

 





Contract with Customer, Liability, Revenue Recognized
59.6

44.4

 

 

 





Provision for loss on contracts total
0.5

 

0.5

 

 





Provision for loss on contracts utilized
7.2

10.6

19.1

 

 





Maximum [Member]
 

 

 

 

 





Government cost share portion
126.7

$ 115.0

126.7

$ 115.0

 





Pension Plan, Defined Benefit [Member]
 

 

 

 

 





Gain (loss) related to litigation settlement
33.8

 

 

 

 





Other Postretirement Benefits Plan [Member]
 

 

 

 

 





Gain (loss) related to litigation settlement
$ 9.7

 

 

 

 





Government [Member]
 

 

 

 

 





Proceeds from Customers
 

 

$ 120.3

 

 




































XML
62
R41.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Revenue and Contracts with Customers (Revenue from External Customers by Geographic Areas) (Details) - USD ($)
 $ in Millions

3 Months Ended
12 Months Ended





Dec. 31, 2021


Dec. 31, 2021


Dec. 31, 2020





Revenue
 

$ 298.3

$ 247.2





United States
 

 

 





Revenue
 

220.5

171.7





Belgium
 

 

 





Revenue
$ 36.6

 

35.8





Japan
 

 

 





Revenue
 

34.6

23.4





Other Foreign
 

 

 





Revenue
 

6.6

16.3





Foreign
 

 

 





Revenue
 

77.8

75.5





Product [Member]
 

 

 





Revenue
 

186.1

190.5





Product [Member] | United States
 

 

 





Revenue
 

108.3

115.0





Product [Member] | Belgium
 

 

 





Revenue
 

36.6

35.8





Product [Member] | Japan
 

 

 





Revenue
 

34.6

 





Product [Member] | Other Foreign
 

 

 





Revenue
 

6.6

16.3





Product [Member] | Foreign
 

 

 





Revenue
 

$ 77.8

$ 75.5





















XML
63
R42.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Revenue and Contracts with Customers (Contract with Customer Asset and Liability) (Details) - USD ($)
 $ in Millions

12 Months Ended






Dec. 31, 2021


Dec. 31, 2020





Deferred costs associated with deferred revenue
$ 143.3

$ 151.9





Provision for Loss on Contracts
0.5

7.0





Provision for loss on contract change
(6.5)

 





Provision for loss on contracts, noncurrent
0.0

0.7





Provision for loss on contracts, noncurrent, change
(0.7)

 





Deferred revenue
288.1

281.7





Deferred revenue change
6.4

 





Advances from customers
15.0

1.5





Advances from customers change
13.5

 





Advances from customers, noncurrent
45.1

$ 45.2





Advances from customers, noncurrent, change
$ (0.1)

 

























XML
64
R43.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Revenue and Contracts with Customers Accounts Receivable (Schedule of Accounts Receivable) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Accounts, Notes, Loans and Financing Receivable [Line Items]
 

 





Billed Contracts Receivable
$ 23.1

$ 23.0





Unbilled Receivables, Current
6.0

6.6





Accounts receivable, net
$ 29.1

$ 29.6


















XML
65
R44.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Cash, Cash Equivalents and Restricted Cash (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020


Jun. 30, 2020


Dec. 31, 2019





Cash and Cash Equivalents [Line Items]
 

 

 

 





Cash and cash equivalents
$ 193.8

$ 152.0

 

 





Restricted cash included in other current assets
0.2

0.2

 

 





Restricted cash included in other long-term assets
2.8

5.7

 

 





Total cash, cash equivalents and restricted cash
$ 196.8

$ 157.9

$ 157.9

$ 136.6



















XML
66
R45.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Cash, Cash Equivalents and Restricted Cash (Schedule of Restricted Cash) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Restricted Cash and Cash Equivalents Items [Line Items]
 

 





Restricted cash included in other current assets
$ 0.2

$ 0.2





Restricted cash included in other long-term assets
2.8

5.7





Other financial assurance [Member]
 

 





Restricted Cash and Cash Equivalents Items [Line Items]
 

 





Restricted cash included in other current assets
0.2

0.2





Restricted cash included in other long-term assets
0.2

0.3





Workers compensation financial assurance [Member]
 

 





Restricted Cash and Cash Equivalents Items [Line Items]
 

 





Restricted cash included in other current assets
0.0

0.0





Restricted cash included in other long-term assets
$ 2.6

$ 5.4



















XML
67
R46.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Inventories (Schedule of Inventories) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Inventory, Net [Abstract]
 

 





Separative work units inventory
$ 8.8

$ 17.0





Uranium inventory
82.3

47.8





Inventories
91.1

64.8





Separative work units owed to customers and suppliers
0.0

4.6





Uranium owed to customers and suppliers
8.4

0.3





Inventories owed to customers and suppliers
8.4

4.9





Separative work units net of liability
8.8

12.4





Uranium inventory net of liability
73.9

47.5





Inventories, net
$ 82.7

$ 59.9
























XML
68
R47.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Inventories (Narrative) (Details) - USD ($)
 $ in Millions

12 Months Ended
36 Months Ended






Dec. 31, 2021


Dec. 31, 2020


Sep. 30, 2021





Inventory, Net [Abstract]
 

 

 





Separative work units borrowed in period, value
 

$ 20.7

 





Separative work units repaid in period, value
$ 3.1

 

 





Separative work units valuation change in period
4.8

 

 





Separative work units owed to others noncurrent
$ 22.4

 

$ 25.5



















XML
69
R48.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Property, Plant and Equipment (Tables) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Property, Plant and Equipment [Line Items]
 

 





Property, Plant and Equipment, Gross
$ 8.3

$ 7.6





Property, Plant and Equipment, Additions
0.7

 





Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
(3.0)

(2.7)





Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment
(0.3)

 





Property, Plant And Equipment, Net Capital Expenditures
0.4

 





Property, Plant and Equipment, Net
5.3

4.9





Depreciation
(0.6)

(0.5)





Land [Member]
 

 





Property, Plant and Equipment [Line Items]
 

 





Property, Plant and Equipment, Gross
1.2

1.2





Property, Plant and Equipment, Additions
0.0

 





Leasehold Improvements [Member]
 

 





Property, Plant and Equipment [Line Items]
 

 





Property, Plant and Equipment, Gross
4.6

3.9





Property, Plant and Equipment, Additions
0.7

 





Equipment [Member]
 

 





Property, Plant and Equipment [Line Items]
 

 





Property, Plant and Equipment, Gross
1.4

1.4





Property, Plant and Equipment, Additions
0.0

 





Other Capitalized Property Plant and Equipment [Member]
 

 





Property, Plant and Equipment [Line Items]
 

 





Property, Plant and Equipment, Gross
$ 1.1

$ 1.1


























XML
70
R49.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Property, Plant and Equipment (Narrative) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Property, Plant and Equipment [Abstract]
 

 





Depreciation
$ 0.6

$ 0.5
















XML
71
R50.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Schedule of Intangible Assets (Details) - USD ($)
 $ in Millions

12 Months Ended






Dec. 31, 2021


Dec. 31, 2020





Finite-Lived Intangible Assets [Line Items]
 

 





Amortizable intangible assets, gross
$ 123.5

$ 123.5





Accumulated intangible asset amortization
(68.8)

(60.7)





Amortizable intangible assets, net
$ 54.7

62.8





Average useful life of finite-lived intangible assets
15 years

 





Contract-Based Intangible Assets [Member]
 

 





Finite-Lived Intangible Assets [Line Items]
 

 





Amortizable intangible assets, gross
$ 54.6

54.6





Accumulated intangible asset amortization
(35.5)

(32.0)





Amortizable intangible assets, net
19.1

22.6





Customer-Related Intangible Assets [Member]
 

 





Finite-Lived Intangible Assets [Line Items]
 

 





Amortizable intangible assets, gross
68.9

68.9





Accumulated intangible asset amortization
(33.3)

(28.7)





Amortizable intangible assets, net
$ 35.6

$ 40.2





















XML
72
R51.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Intangible Assets Schedule of Intangible Asset Amortization (Details)
 $ in Millions



Dec. 31, 2021 


USD ($)






Intangible Assets Disclosure [Abstract]
 





Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months
$ 9.5





Finite-Lived Intangible Assets, Amortization Expense, Year Two
6.6





Finite-Lived Intangible Assets, Amortization Expense, Year Three
8.6





Finite-Lived Intangible Assets, Amortization Expense, Year Four
7.6





Finite-Lived Intangible Assets, Amortization Expense, Year Five
9.9





Finite-Lived Intangible Assets, Amortization Expense, after Year Five
12.5





Finite-Lived Intangible Assets, Net
$ 54.7






















XML
73
R52.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Accounts Payable and Accrued Liabilities (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Trade payables
$ 4.9

$ 4.9





Postretirement health and life benefit obligations - current
7.0

11.6





Compensation and benefits payable
23.1

22.2





Provision for Loss on Contracts
0.5

7.0





Operating Lease, Liability, Current
0.9

2.4





Other accrued liabilities
1.4

2.5





Accounts payable and accrued liabilities
$ 37.8

$ 50.6





















XML
74
R53.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Schedule of Debt (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Debt Instrument [Line Items]
 

 





Long-term debt
$ 101.8

$ 108.0





Senior Notes [Member]
 

 





Debt Instrument [Line Items]
 

 





Long-term debt, face amount
74.3

74.3





Long-term debt, interest
27.5

33.7





Long-term debt, current
6.1

6.1





Long-term debt
$ 101.8

$ 108.0




















XML
75
R54.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Debt (Narrative) (Details) - USD ($)
 $ / shares in Units, $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Preferred stock, shares issued
104,574

 





Preferred stock, liquidation preference per share
$ 1,000

 





Subordination to credit facility, facility total
$ 50.0

 





Subordination to credit facility, facility maximum net borrowing
$ 40.0

 





Senior Notes [Member]
 

 





Debt instrument interest rate
8.25%

 





Long-term debt, face amount
$ 74.3

$ 74.3





Long-term debt, current
$ 6.1

$ 6.1






















XML
76
R55.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Leases (Narrative) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Leases [Abstract]
 

 





Operating Lease, Weighted Average Remaining Lease Term
5 years 3 months 18 days

 





Operating Lease, Weighted Average Discount Rate, Percent
12.50%

 





Operating Lease, Right-of-Use Asset
$ 2.1

 





Operating Lease, Liability, Current
0.9

$ 2.4





Operating Lease, Liability, Noncurrent
3.0

 





Operating Lease, Liability
3.9

 





Operating Lease, Expense
0.5

2.6





Operating Lease, Expense Adjustment
(2.0)

$ (0.3)





Operating Lease, Payments
2.4

 





Operating Lease, Liability, Decrease
$ 1.0

 





Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]
Other long-term assets

Other long-term assets





Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]
Accounts payable and accrued liabilities

Accounts payable and accrued liabilities





Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]
Other long-term liabilities

Other long-term liabilities




























XML
77
R56.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Maturity of Operating Lease Liabilities (Details)
 $ in Millions



Dec. 31, 2021 


USD ($)






Leases [Abstract]
 





Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months
$ 1.3





Lessee, Operating Lease, Liability, Payments, Due Year Two
1.0





Lessee, Operating Lease, Liability, Payments, Due Year Three
1.0





Lessee, Operating Lease, Liability, Payments, Due Year Four
1.0





Lessee, Operating Lease, Liability, Payments, Due Year Five
1.0





Lessee, Operating Lease, Liability, Payments, Due after Year Five
0.8





Lessee, Operating Lease, Liability, Payments, Due
6.1





Lessee, Operating Lease, Liability, Undiscounted Excess Amount
2.2





Operating Lease, Liability
$ 3.9
























XML
78
R57.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Fair Value Measurements (Financial Instruments Recorded at Fair Value) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Cash and cash equivalents
$ 193.8

$ 152.0





Cash and cash equivalents
193.8

152.0





Deferred compensation asset
3.2

2.4





Deferred compensation obligation
3.2

2.3





Fair Value, Inputs, Level 1 [Member]
 

 





Cash and cash equivalents
193.8

152.0





Deferred compensation asset
3.2

2.4





Deferred compensation obligation
3.2

2.3





Fair Value, Inputs, Level 2 [Member]
 

 





Cash and cash equivalents
0.0

0.0





Deferred compensation asset
0.0

0.0





Deferred compensation obligation
0.0

0.0





Fair Value, Inputs, Level 3 [Member]
 

 





Cash and cash equivalents
0.0

0.0





Deferred compensation asset
0.0

0.0





Deferred compensation obligation
$ 0.0

$ 0.0





















XML
79
R58.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Fair Value Measurements (Narrative) (Details) - Senior Notes [Member] - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 

 





Debt, long-term and short-term, combined carrying value
$ 107.9

$ 114.1





Long-term debt, current
6.1

6.1





Long-term debt, fair value
74.3

68.6





Long-term debt, face amount
$ 74.3

$ 74.3




















XML
80
R59.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Narrative) (Details)
 $ in Millions

12 Months Ended






Dec. 31, 2021 


USD ($)




Dec. 31, 2020 


USD ($)




Dec. 31, 2019 


USD ($)




Dec. 31, 2017 


USD ($)




Dec. 31, 2016 


USD ($)




Dec. 31, 2014 


USD ($)






Gain (loss) related to litigation settlement
$ 43.5

$ 32.6

 

 

 

 





Defined Contribution Plan, Cost
2.0

1.6

 

 

 

 





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
50.5

(7.2)

 

 

 

 





Pension plan assets transferred for annuitization
30.4

 

 

 

 

 





Pension plan obligations transferred for annuitization
$ 30.4

 

 

 

 

 





Pension Plan, Defined Benefit [Member]
 

 

 

 

 

 





Approximate Number of Plan Participants
3,500

 

 

 

 

 





Defined Benefit Plan, Accumulated Benefit Obligation
$ 696.2

757.9

 

 

 

 





Gain (loss) related to litigation settlement
33.8

 

 

 

 

 





Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment
 

 

$ 1.3

 

 

 





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
(28.7)

56.7

 

 

 

 





Pension Plan, Defined Benefit [Member] | Qualified Plan [Member]
 

 

 

 

 

 





Expected defined benefit plan contributions for next fiscal year for qualified plans
0.0

 

 

 

 

 





Pension Plan, Defined Benefit [Member] | Nonqualified Plan [Member]
 

 

 

 

 

 





Expected defined benefit plan contributions for next fiscal year for qualified plans
$ 0.4

 

 

 

 

 





Other Postretirement Benefits Plan [Member]
 

 

 

 

 

 





Approximate Number of Plan Participants
2,300

 

 

 

 

 





Gain (loss) related to litigation settlement
$ 9.7

 

 

 

 

 





Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment
 

 

 

$ (10.0)

$ (3.6)

$ (6.8)





Expected defined benefit plan contributions for next fiscal year for qualified plans
7.0

 

 

 

 

 





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
$ (2.3)

$ (1.6)

 

 

 

 



























XML
81
R60.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Changes in Projected Benefit Obligations) (Details) - USD ($)
 $ in Millions

12 Months Ended






Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
$ 50.5

$ (7.2)

 





Defined Benefit Plan, Plan Assets, Amount
681.8

633.0

 





Pension Plan, Defined Benefit [Member]
 

 

 





Defined Benefit Plan, Benefit Obligation
696.2

757.9

$ 763.5





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
(28.7)

56.7

 





Defined Benefit Plan, Service Cost
2.7

3.5

 





Defined Benefit Plan, Interest Cost
18.1

24.3

 





Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement
0.0

(30.4)

 





Defined Benefit Plan, Benefit Obligation, Administrative Expenses Paid
(2.1)

(2.9)

 





Defined Benefit Plan, Plan Assets, Amount
672.7

633.1

621.2





Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)
57.8

85.4

 





Defined Benefit Plan, Plan Assets, Contributions by Employer
35.7

16.6

 





Defined Benefit Plan, Plan Assets, Benefits Paid
51.7

56.8

 





Defined Benefit Plan, Plan Assets, Payment for Settlement
0.0

(30.4)

 





Defined Benefit Plan, Plan Assets, Administration Expense
(2.2)

(2.9)

 





Defined Benefit Plan, Funded (Unfunded) Status of Plan
(23.5)

(124.8)

 





Amounts Recognized In Current Liabilities
(0.4)

(0.4)

 





Amounts Recognized In Noncurrent Liabilities
(23.1)

(124.4)

 





Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position
(23.5)

(124.8)

 





Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit
(0.9)

(1.1)

 





Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
(0.9)

(1.1)

 





Other Postretirement Benefits Plan [Member]
 

 

 





Defined Benefit Plan, Benefit Obligation
131.1

142.4

152.8





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
(2.3)

(1.6)

 





Defined Benefit Plan, Service Cost
0.0

0.0

 





Defined Benefit Plan, Interest Cost
3.4

4.8

 





Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement
0.0

0.0

 





Defined Benefit Plan, Benefit Obligation, Administrative Expenses Paid
0.0

0.0

 





Defined Benefit Plan, Plan Assets, Amount
9.2

0.0

$ 0.0





Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)
0.0

0.0

 





Defined Benefit Plan, Plan Assets, Contributions by Employer
21.5

13.6

 





Defined Benefit Plan, Plan Assets, Benefits Paid
12.3

13.6

 





Defined Benefit Plan, Plan Assets, Payment for Settlement
0.0

0.0

 





Defined Benefit Plan, Plan Assets, Administration Expense
0.0

0.0

 





Defined Benefit Plan, Funded (Unfunded) Status of Plan
(121.9)

(142.4)

 





Amounts Recognized In Current Liabilities
(7.0)

(11.6)

 





Amounts Recognized In Noncurrent Liabilities
(114.9)

(130.8)

 





Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position
(121.9)

(142.4)

 





Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit
(2.0)

(2.1)

 





Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
(2.0)

(2.1)

 





Plan paid [Member] | Pension Plan, Defined Benefit [Member]
 

 

 





Defined Benefit Plan, Benefit Obligation, Benefits Paid
(51.3)

(56.3)

 





Plan paid [Member] | Other Postretirement Benefits Plan [Member]
 

 

 





Defined Benefit Plan, Benefit Obligation, Benefits Paid
(12.4)

(13.6)

 





Company paid [Member] | Pension Plan, Defined Benefit [Member]
 

 

 





Defined Benefit Plan, Benefit Obligation, Benefits Paid
(0.4)

(0.5)

 





Company paid [Member] | Other Postretirement Benefits Plan [Member]
 

 

 





Defined Benefit Plan, Benefit Obligation, Benefits Paid
$ 0.0

$ 0.0

 





































XML
82
R61.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Net Benefit Costs) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
$ 50.5

$ (7.2)





Pension Plan, Defined Benefit [Member]
 

 





Service costs
2.7

3.5





Interest costs
18.1

24.3





Expected return on plan assets (gains)
(38.3)

(37.5)





Amortization of prior service costs (credits), net
(0.2)

(0.2)





Actuarial (gains) losses, net
(48.2)

8.9





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
(28.7)

56.7





Net periodic benefit cost (credit)
(65.9)

(1.0)





Postretirement Health and Life Benefits Plans [Member]
 

 





Service costs
0.0

0.0





Interest costs
3.4

4.8





Expected return on plan assets (gains)
0.0

0.0





Amortization of prior service costs (credits), net
(0.1)

(0.1)





Actuarial (gains) losses, net
(2.3)

(1.7)





Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement
(2.3)

(1.6)





Net periodic benefit cost (credit)
$ 1.0

$ 3.0























XML
83
R62.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Pension Plan, Defined Benefit [Member]
 

 





Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax
$ (0.9)

$ (1.1)





Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
(0.9)

(1.1)





Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax
(66.8)

(2.1)





Other Postretirement Benefits Plan [Member]
 

 





Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax
(2.0)

(2.1)





Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
(2.0)

(2.1)





Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax
$ (1.0)

$ 0.9



















XML
84
R63.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Assumptions Used) (Details)

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Pension Plan, Defined Benefit [Member]
 

 





Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
2.80%

2.50%





Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets
6.30%

6.40%





Other Postretirement Benefits Plan [Member]
 

 





Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
2.80%

2.50%


















XML
85
R64.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Healthcare Cost Trend Rates) (Details)

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]
 

 





Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year
6.00%

5.50%





Defined Benefit Plan, Ultimate Health Care Cost Trend Rate
5.00%

5.00%





Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate
2026

2022


















XML
86
R65.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Plan Asset Allocations) (Details)


Dec. 31, 2022


Dec. 31, 2021


Dec. 31, 2020





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
 

100.00%

100.00%





Equity Securities [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
 

45.00%

52.00%





Equity Securities [Member] | Scenario, Forecast [Member] | Minimum [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
40.00%

 

 





Equity Securities [Member] | Scenario, Forecast [Member] | Maximum [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
45.00%

 

 





Debt Securities [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
 

51.00%

42.00%





Debt Securities [Member] | Scenario, Forecast [Member] | Minimum [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
50.00%

 

 





Debt Securities [Member] | Scenario, Forecast [Member] | Maximum [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
55.00%

 

 





Cash [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
 

4.00%

6.00%





Cash [Member] | Scenario, Forecast [Member] | Minimum [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
0.00%

 

 





Cash [Member] | Scenario, Forecast [Member] | Maximum [Member]
 

 

 





Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage
5.00%

 

 





















XML
87
R66.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Fair Value of Plan Assets) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
$ 681.8

$ 633.0

 





Defined Benefit Plan, Investments Measured at NAV
20.1

504.4

 





Accrued interest receivable
1.2

1.3

 





Unsettled transactions receivable
(1.4)

(1.8)

 





Fair Value, Inputs, Level 1 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
582.9

0.0

 





Fair Value, Inputs, Level 2 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
79.0

129.1

 





Fair Value, Inputs, Level 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Fair Value, Inputs, Level 1, 2 and 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
661.9

129.1

 





US government securities [Member] | Fair Value, Inputs, Level 1 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





US government securities [Member] | Fair Value, Inputs, Level 2 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
13.0

16.4

 





US government securities [Member] | Fair Value, Inputs, Level 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





US government securities [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
13.0

16.4

 





Corporate debt [Member] | Fair Value, Inputs, Level 1 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Corporate debt [Member] | Fair Value, Inputs, Level 2 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
56.4

104.2

 





Corporate debt [Member] | Fair Value, Inputs, Level 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Corporate debt [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
56.4

104.2

 





Municipal bonds and non-U.S. government securities [Member] | Fair Value, Inputs, Level 1 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Municipal bonds and non-U.S. government securities [Member] | Fair Value, Inputs, Level 2 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
1.7

2.1

 





Municipal bonds and non-U.S. government securities [Member] | Fair Value, Inputs, Level 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Municipal bonds and non-U.S. government securities [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
1.7

2.1

 





Mutual Fund [Member] | Fair Value, Inputs, Level 1 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
582.9

0.0

 





Mutual Fund [Member] | Fair Value, Inputs, Level 2 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Mutual Fund [Member] | Fair Value, Inputs, Level 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Mutual Fund [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
582.9

0.0

 





Mortgage and asset backed securities [Member] | Fair Value, Inputs, Level 1 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Mortgage and asset backed securities [Member] | Fair Value, Inputs, Level 2 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
7.9

6.4

 





Mortgage and asset backed securities [Member] | Fair Value, Inputs, Level 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
0.0

0.0

 





Mortgage and asset backed securities [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
7.9

6.4

 





Pension Plan, Defined Benefit [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
672.7

633.1

$ 621.2





Other Postretirement Benefits Plan [Member]
 

 

 





Defined Benefit Plan Disclosure [Line Items]
 

 

 





Defined Benefit Plan, Plan Assets, Amount
$ 9.2

$ 0.0

$ 0.0






























XML
88
R67.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Pension and Postretirement Health and Life Benefits (Schedule of Estimated Future Benefit Payments) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Pension Plan, Defined Benefit [Member]
 

 





Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months
$ 52.1

 





Defined Benefit Plan, Expected Future Benefit Payment, Year Two
51.0

 





Defined Benefit Plan, Expected Future Benefit Payment, Year Three
49.1

 





Defined Benefit Plan, Expected Future Benefit Payment, Year Four
47.6

 





Defined Benefit Plan, Expected Future Benefit Payment, Year Five
47.6

 





Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter
$ 214.0

 





Other Postretirement Benefits Plan [Member]
 

 





Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months
 

$ 11.2





Defined Benefit Plan, Expected Future Benefit Payment, Year Two
 

10.7





Defined Benefit Plan, Expected Future Benefit Payment, Year Three
 

10.1





Defined Benefit Plan, Expected Future Benefit Payment, Year Four
 

9.5





Defined Benefit Plan, Expected Future Benefit Payment, Year Five
 

9.0





Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter
 

$ 36.3






















XML
89
R68.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation (Narrative) (Details) - USD ($)
 $ in Millions

12 Months Ended
36 Months Ended





Dec. 31, 2021


Dec. 31, 2023





Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
700,000

 





Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
1,900,000

 





Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
844,293

 





Weighted-average period in years of costs to be recognized
12 months

 





Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
$ 0.4

 





Board restricted stock units potentially converted to common stock shares
192,000

 





Employee restricted stock units potentially converted to common stock shares
4,000

 





Employee Stock Option [Member]
 

 





Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
$ 0.1

 





Restricted Stock Units (RSUs) [Member]
 

 





Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
$ 0.3

 





Notional Stock Units [Member]
 

 





Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
206,183

 





Notional Stock Units, Performance Condition [Member]
 

 





Performance Condition, Minimum Net Income
 

$ 160.0



























XML
90
R69.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation (Stock-Based Compensation Costs) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Share-based Payment Arrangement, Noncash Expense [Abstract]
 

 





Restricted Stock or Unit Expense
$ 0.5

$ 0.4





Stock or Unit Option Plan Expense
0.1

0.1





Stock Appreciation Rights Expense
11.6

6.6





Allocated Share-based Compensation Expense
12.2

7.1





Share-based Payment Arrangement, Expense, Tax Benefit
$ (1.5)

$ 0.0




















XML
91
R70.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation Stock-Based Compensation (Assumptions Used in the Black-Scholes Option Pricing Model) (Details) - shares

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
0

0





Stock Appreciation Rights (SARs) [Member]
 

 





Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
 

83,500,000





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
0

83,500





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method
 

2 years 3 months 18 days





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
 

0.00%





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
 

0.14%





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
 

94.00%





Stock Appreciation Rights (SARS), Performance Condition [Member]
 

 





Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
21,000

 





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method
2 years 6 months

 





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
0.00%

 





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
0.30%

 





Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
82.80%

 























XML
92
R71.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation Costs, Rollforward (Details) - USD ($)
 $ / shares in Units, $ in Thousands

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
144,000

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 4.18

$ 4.18

$ 4.02





Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
0

0

 





Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
$ 4.17

$ 3.43

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
4 years 4 months 24 days

5 years 3 months 18 days

6 years 2 months 12 days





Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
$ 8,900

$ 7,800

$ 1,500





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
$ 6,600

 

 





Board Restricted Stock Units [Member]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
20,000

47,000

74,000





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
20,000

47,000

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
(47,000)

(74,000)

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
0

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
$ 25.13

$ 10.38

$ 3.09





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
25.13

10.38

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
10.38

3.09

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
$ 0

$ 0

 





Employee Restricted Stock Units [Member]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
4

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
4

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
$ 24.01

$ 0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
24.01

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
$ 0

 

 





Stock Appreciation Rights (SARs) [Member]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
83,500

83,500

0





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
0

83,500

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
0

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
0

0

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
83,500

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 5.53

$ 5.53

$ 0





Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
0

5.53

 





Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
0

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
0

$ 0

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
$ 5.53

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
1 year 3 months 18 days

2 years 3 months 18 days

 





Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term
1 year 3 months 18 days

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
$ 3,710

$ 1,470

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
$ 3,710

 

 





Stock Appreciation Rights (SARS), Performance Condition [Member]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
21,000

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
21,000

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
0

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
21,000

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 19.44

$ 0

 





Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
19,440

 

 





Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
$ 19.44

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
2 years 3 months 18 days

 

 





Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term
2 years 3 months 18 days

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
$ 640

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
$ 640

 

 





Notional Stock Units [Member]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
252,000

571,000

468,000





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
0

125,000

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
(319,000)

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
0

(22,000)

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
$ 4.33

$ 3.68

$ 3.16





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
0

5.53

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
3.16

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
$ 0

$ 3.16

 





Notional Stock Units, Performance Condition [Member]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
10

0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
10

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
$ 39.55

$ 0

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
39.55

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
0

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
$ 0

 

 







































XML
93
R72.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stock-Based Compensation (Options) (Details) - USD ($)
 $ / shares in Units, shares in Thousands, $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Share-based Payment Arrangement, Noncash Expense [Abstract]
 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
194

411

518





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 4.18

$ 4.18

$ 4.02





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
4 years 4 months 24 days

5 years 3 months 18 days

6 years 2 months 12 days





Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
0

0

 





Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
$ 0

$ 0

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
(217)

(107)

 





Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
$ 4.17

$ 3.43

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
$ 8.9

$ 7.8

$ 1.5





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
144

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price
$ 4.37

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
3 years 2 months 12 days

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
$ 6.6

 

 



























XML
94
R73.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price (Details) - $ / shares
 shares in Thousands

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 4.18

$ 4.18

$ 4.02





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
4 years 4 months 24 days

5 years 3 months 18 days

6 years 2 months 12 days





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
144

 

 





Option Group One [Member]
 

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 4.37

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options
144

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
3 years 2 months 12 days

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
144

 

 





Option Group Two [Member]
 

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
$ 3.65

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options
50

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term
7 years 9 months 18 days

 

 





Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
0

 

 





















XML
95
R74.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes (Details) - USD ($)
 $ in Millions

3 Months Ended
12 Months Ended







Dec. 31, 2021


Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019


Dec. 31, 2017





Increase (decrease) in deferred tax asset valuation allowance
$ 40.7

$ 30.6

$ (39.5)

 

 





Valuation Allowance, Deferred Tax Asset, Explanation of Change
federal net deferred taxes that are more likely than not to be realized

changes in deferred tax assets since the beginning of the year

previously unrecorded state deferred tax assets

 

 





Operating Loss Carryforwards
 

 

 

 

$ 732.0





Operating Loss Carryforwards, No Expiration
$ 131.4

$ 131.4

 

 

 





Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
 

71.3

$ 13.9

 

 





Provision (benefit) for income taxes
 

39.1

1.4

 

 





Liability for Uncertain Tax Positions, Noncurrent
1.0

1.0

0.8

$ 0.4

 





Unrecognized Tax Benefits, Income Tax Penalties Expense Reduction
 

(0.2)

$ (0.4)

 

 





Income Tax Examination, Penalties and Interest Accrued
0.1

$ 0.1

 

 

 





Federal Statutory Income Tax Rate, Percent
 

21.00%

21.00%

 

 





State and Local Jurisdiction [Member]
 

 

 

 

 





Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
 

1.00%

(1.00%)

 

 





Operating Loss Carryforwards
0.5

$ 0.5

 

 

 





Operating Loss Carryforwards, Valuation Allowance
465.4

465.4

 

 

 





Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
 

 

$ 2.0

 

 





Tax Year 2018 [Member]
 

 

 

 

 





Business Interest Expense Carryforward
$ 4.1

$ 4.1

 

 

 





























XML
96
R75.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes (Taxes by Jurisdiction) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Current Income Tax Expense (Benefit)
$ 0.4

$ 0.5





Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability
(39.5)

(1.9)





Provision (benefit) for income taxes
(39.1)

(1.4)





Domestic Tax Authority [Member]
 

 





Current Income Tax Expense (Benefit)
0.0

0.0





Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability
(40.7)

0.0





State and Local Jurisdiction [Member]
 

 





Current Income Tax Expense (Benefit)
0.4

0.5





Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability
1.2

(1.9)





Foreign Tax Authority [Member]
 

 





Current Income Tax Expense (Benefit)
0.0

0.0





Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability
$ 0.0

$ 0.0




















XML
97
R76.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes (Deferred Income Taxes) (Details) - USD ($)
 $ in Millions


Dec. 31, 2021


Dec. 31, 2020





Components of Deferred Tax Assets and Liabilities [Abstract]
 

 





Deferred Tax Assets, Employee Benefits Costs
$ 36.2

$ 61.8





Deferred Tax Assets, Inventory
18.6

16.2





Deferred Tax Assets, Property, Plant and Equipment
191.5

193.8





Deferred Tax Assets, Net Operating Loss and Credit Carryforwards
206.2

211.1





Deferred Tax Assets, Accrued Expenses
0.4

2.1





Deferred Tax Assets, Long-Term Debt and Financing Costs
10.8

12.6





Deferred Tax Asset, Lease Liability
0.9

1.5





Deferred Tax Assets, Other
0.2

0.2





Deferred Tax Assets, Gross
464.8

499.3





Deferred Tax Assets, Valuation Allowance
(414.7)

(486.0)





Deferred Tax Assets, Net of Valuation Allowance
50.1

13.3





Deferred Tax Liabilities, Intangible Assets
7.9

9.9





Deferred Tax Liability, Lease Asset
0.4

1.1





Deferred Tax Liabilities, Prepaid Expenses
0.4

0.4





Deferred Tax Liabilities
8.7

11.4





Deferred Tax Assets, Net, Current
$ 41.4

$ 1.9































XML
98
R77.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes (Rate Reconciliation) (Details)

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Federal Statutory Income Tax Rate, Percent
21.00%

21.00%





Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
(53.00%)

(26.00%)





Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
1.00%

2.00%





Effective Income Tax Rate Reconciliation, State Income Tax Expense, Net of Federal Benefit, Percent
1.00%

0.00%





Effective Income Tax Rate Reconciliation, Uncertain Tax Positions
0.00%

1.00%





Effective Income Tax Rate Reconciliation, Percent
(29.00%)

(3.00%)





State and Local Jurisdiction [Member]
 

 





Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
1.00%

(1.00%)






















XML
99
R78.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($)
 $ in Millions

12 Months Ended






Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Income Tax Disclosure [Abstract]
 

 

 





Liability for Uncertain Tax Positions, Noncurrent
$ 1.0

$ 0.8

$ 0.4





Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
0.4

0.5

 





Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
$ (0.2)

$ (0.1)

 


















XML
100
R79.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Net Income Per Share (Narrative) (Details) - USD ($)


1 Months Ended
3 Months Ended
12 Months Ended







Dec. 15, 2021


Dec. 31, 2021


Nov. 30, 2021


Dec. 31, 2020


Dec. 31, 2021


Dec. 31, 2020


Sep. 30, 2021


Sep. 30, 2020





Stock Repurchase Price per Share
 

$ 1,149.99

 

 

 

 

 

 





Preferred Stock, Liquidation Amount per Share
 

1,347.29

 

$ 1,291.04

$ 1,347.29

$ 1,291.04

 

 





Payments for Repurchase of Preferred Stock and Preference Stock
$ 1,100,000

$ 43,300,000

$ 42,200,000

$ 60,000,000

$ 44,400,000

$ 61,600,000

 

 





Conversion of Stock, Shares Converted
 

 

 

 

0

398,262

 

 





Preferred Stock, Par Value Per Share
 

$ 1.00

 

$ 1.00

$ 1.00

$ 1.00

$ 1.00

 





Exercise price of warrant
 

21.62

 

21.62

$ 21.62

$ 21.62

 

 





Exchange of preferred stock for common stock and common stock warrant
 

 

 

 

$ 0

 

 

 





Preferred Stock, Liquidation Preference Per Share
 

$ 1,000

 

 

$ 1,000

 

 

 





Preferred Stock Dividends and Other Adjustments
 

 

 

 

$ 37,600,000

$ 41,900,000

 

 





Aggregate Value, Preferred Stock Transactions
 

 

 

 

$ 50,800,000

 

 

 





Common Class A [Member]
 

 

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

231,276

 

231,276

398,262

 

 





Series B Preferred Stock [Member]
 

 

 

 

 

 

 

 





Stock Repurchased and Retired During Period, Shares
 

980

36,867

 

 

62,854

 

 





Stock Repurchase Price per Share
 

 

$ 1,145.2

 

 

$ 954.59

 

 





Preferred Stock, Liquidation Amount per Share
 

 

 

 

 

 

 

$ 1,272.78





Preferred Stock, Carrying Value per Share
 

 

 

 

 

 

 

$ 43.8





Preferred Stock, Par Value Per Share
 

 

 

$ 1.00

 

$ 1.00

 

 





Exchange of preferred stock for common stock and common stock warrant
 

 

 

 

$ 7,500,000

 

 

 





Preferred Stock Dividends and Other Adjustments
 

 

 

$ 41,900,000

 

 

 

 





Warrant [Member]
 

 

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

 

250,000

 

 

 





























XML
101
R80.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Net Income Per Share (Schedule of Income Per Share) (Details) - USD ($)
 $ / shares in Units, shares in Thousands, $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Income Per Share Calculation [Line Items]
 

 





Net income
$ 175.0

$ 54.4





Preferred stock dividends, undeclared and cumulative
2.1

6.7





Preferred Stock Dividends and Other Adjustments
37.6

41.9





Net income (loss) allocable to common stockholders
$ 135.3

$ 5.8





Average number of shares outstanding, basic
13,493

9,825





Potentially dilutive shares related to stock options
386

298





Average number of shares outstanding, diluted
13,879

10,123





Net income (loss) per common share - basic
$ 10.03

$ 0.59





Net income (loss) per common share - diluted
$ 9.75

$ 0.57





Exchange of preferred stock for common stock and common stock warrant
$ 0.0

 





Preferred Stock Dividends and Other Adjustments
$ 37.6

$ 41.9


























XML
102
R81.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stockholders' Equity (Tables) (Details) - shares


1 Months Ended
12 Months Ended






Sep. 01, 2020


Dec. 31, 2021


Nov. 30, 2021


Dec. 31, 2021


Dec. 31, 2020


Dec. 31, 2019





Class of Stock [Line Items]
 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

0

(398,262)

 





Stock Issued During Period, Shares, New Issues
 

 

 

1,516,467

 

 





Common Stock, Shares, Issued
 

14,369,133

 

14,369,133

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
 

 

 

217,000

107,000

 





Preferred Series B [Member]
 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

(3,873)

 

 





Stock Repurchased and Retired During Period, Shares
 

(980)

(36,867)

(37,847)

(62,854)

 





Preferred Stock, Shares Outstanding
 

0

 

0

41,720

104,574





Common Class A [Member]
 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 





Common Stock, Shares, Outstanding
 

13,649,933

 

13,649,933

11,390,189

8,347,427





Conversion of Stock, Shares Converted
 

 

(231,276)

(231,276)

(398,262)

 





Stock Issued During Period, Shares, New Issues
2,537,500

 

 

1,516,467

2,537,500

 





Common Stock, Shares, Issued
 

13,649,933

 

13,649,933

11,390,189

 





Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
 

 

 

216,500

107,000

 





Common Class B [Member]
 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 





Common Stock, Shares, Outstanding
 

719,200

 

719,200

719,200

1,117,462





Conversion of Stock, Shares Converted
 

 

 

 

398,262

 





Common Stock, Shares, Issued
 

719,200

 

719,200

 

 





Restricted Stock Units (RSUs) [Member] | Common Class A [Member]
 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 





Stock Issued During Period, Shares, New Issues
 

 

 

89,318

 

 





Notional Stock Units [Member] | Common Class A [Member]
 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 





Stock Issued During Period, Shares, New Issues
 

 

 

206,183

 

 



























XML
103
R82.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Stockholders' Equity (Narrative) (Details) - USD ($)



1 Months Ended
3 Months Ended
12 Months Ended










Dec. 15, 2021


Sep. 01, 2020


Dec. 31, 2021


Nov. 30, 2021


Dec. 31, 2020


Dec. 31, 2021


Dec. 31, 2020


Sep. 30, 2021


Sep. 30, 2020


Dec. 31, 2019


Dec. 31, 2017


Sep. 30, 2016





Class of Stock [Line Items]
 

 

 

 

 

 

 

 

 

 

 

 





Preferred Stock, Shares Authorized
 

 

20,000,000

 

20,000,000

20,000,000

20,000,000

 

 

 

 

 





Preferred Stock, Par Value Per Share
 

 

$ 1.00

 

$ 1.00

$ 1.00

$ 1.00

$ 1.00

 

 

 

 





Preferred Stock, Shares Issued
 

 

104,574

 

 

104,574

 

 

 

 

 

 





Preferred Stock, Liquidation Preference Per Share
 

 

$ 1,000

 

 

$ 1,000

 

 

 

 

 

 





Common Stock, Shares, Issued
 

 

14,369,133

 

 

14,369,133

 

 

 

 

 

 





Stock Issued During Period, Shares, New Issues
 

 

 

 

 

1,516,467

 

 

 

 

 

 





Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
 

 

 

 

 

700,000

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

 

 

0

398,262

 

 

 

 

 





Preferred Stock Retired, Liquidation Preference
 

 

 

 

 

$ 5,000,198

 

 

 

 

 

 





Conversion of Stock, Share Price
 

 

21.62

 

 

21.62

 

 

 

 

 

 





Class of Warrant or Right, Exercise Price of Warrants or Rights
 

 

$ 21.62

 

$ 21.62

$ 21.62

$ 21.62

 

 

 

 

 





Payments for Repurchase of Preferred Stock and Preference Stock
$ 1,100,000

 

$ 43,300,000

$ 42,200,000

$ 60,000,000

$ 44,400,000

$ 61,600,000

 

 

 

 

 





Common Stock, Capital Shares Reserved for Future Issuance
 

 

844,293

 

 

844,293

 

 

 

 

 

1,900,000





Operating Loss Carryforwards
 

 

 

 

 

 

 

 

 

 

$ 732,000,000

 





Common Stock Ownership Enabling Preferred Stock Purchase Rights
 

 

4.99%

 

 

4.99%

 

 

 

 

 

 





Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental
 

 

0.50%

 

 

0.50%

 

 

 

 

 

 





Stock issued during period
 

 

 

 

 

$ 42,100,000

23,100,000

 

 

 

 

 





Stock Repurchase Price per Share
 

 

$ 1,149.99

 

 

 

 

 

 

 

 

 





Preferred Stock, Liquidation Amount per Share
 

 

$ 1,347.29

 

$ 1,291.04

$ 1,347.29

$ 1,291.04

 

 

 

 

 





Common Class A [Member]
 

 

 

 

 

 

 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 

 

 

 

 

 

 





Common Stock, Shares Authorized
 

 

70,000,000

 

70,000,000

70,000,000

70,000,000

 

 

 

 

 





Common Stock, Par or Stated Value Per Share
 

 

$ 0.10

 

$ 0.10

$ 0.10

$ 0.10

 

 

 

 

 





Common Stock, Shares, Issued
 

 

13,649,933

 

11,390,189

13,649,933

11,390,189

 

 

 

 

 





Stock Issued During Period, Shares, New Issues
 

2,537,500

 

 

 

1,516,467

2,537,500

 

 

 

 

 





Stock Issued During Period, Value, Gross
 

 

 

 

 

$ 44,200,000

 

 

 

 

 

 





Stock Issued During Period, Value, Net
 

 

 

 

 

42,400,000

 

 

 

 

 

 





Direct Costs of Stock Issuance
 

 

 

 

 

$ 300,000

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

231,276

 

231,276

398,262

 

 

 

 

 





Sale of Stock, Price Per Share
 

 

$ 10

 

 

$ 10

 

 

 

 

 

 





Gross Proceeds from Issuance of Common Stock
 

 

 

 

 

$ 25,400,000

 

 

 

 

 

 





Payments of Stock Issuance Costs
 

 

 

 

 

$ 2,300,000

 

 

 

 

 

 





Common Class B [Member]
 

 

 

 

 

 

 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 

 

 

 

 

 

 





Common Stock, Shares Authorized
 

 

30,000,000

 

30,000,000

30,000,000

30,000,000

 

 

 

 

 





Common Stock, Par or Stated Value Per Share
 

 

$ 0.10

 

$ 0.10

$ 0.10

$ 0.10

 

 

 

 

 





Common Stock, Shares, Issued
 

 

719,200

 

 

719,200

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

 

 

 

(398,262)

 

 

 

 

 





Preferred Series B [Member]
 

 

 

 

 

 

 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 

 

 

 

 

 

 





Preferred Stock, Liquidation Preference Per Share
 

 

 

 

 

 

 

 

$ 1,000

 

 

 





Preferred stock
 

 

$ 0

 

$ 100,000

$ 0

$ 100,000

 

 

 

 

 





Direct Costs of Stock Issuance
 

 

 

 

 

$ 900,000

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

 

 

3,873

 

 

 

 

 

 





Payments for Repurchase of Preferred Stock and Preference Stock
 

 

 

 

 

 

$ 60,000,000

 

 

 

 

 





Stock Repurchased and Retired During Period, Shares
 

 

980

36,867

 

37,847

62,854

 

 

 

 

 





Stock Repurchase Price per Share
 

 

 

 

 

$ 1,145.2

$ 954.59

 

 

 

 

 





Preferred Stock, Liquidation Amount per Share
 

 

 

 

$ 1,272.78

 

$ 1,272.78

 

 

 

 

 





Preferred Stock, Shares Outstanding
 

 

0

 

41,720

0

41,720

 

 

104,574

 

 





Warrant [Member]
 

 

 

 

 

 

 

 

 

 

 

 





Class of Stock [Line Items]
 

 

 

 

 

 

 

 

 

 

 

 





Conversion of Stock, Shares Converted
 

 

 

 

 

250,000

 

 

 

 

 

 

















































XML
104
R83.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Commitment and Contingencies (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Loss Contingency, Possible Loss Not Accrued
$ 9.6

 





Claim filed, unrecorded gain contingency,
 

$ 42.8





Gain (loss) related to litigation settlement
43.5

$ 32.6





Litigation settlement, amount awarded from other party
43.5

 





Pension Plan, Defined Benefit [Member]
 

 





Gain (loss) related to litigation settlement
33.8

 





Other Postretirement Benefits Plan [Member]
 

 





Gain (loss) related to litigation settlement
$ 9.7

 




















XML
105
R84.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Revenue by Geographic Area (Details) - USD ($)
 $ in Millions

3 Months Ended
12 Months Ended





Dec. 31, 2021


Dec. 31, 2021


Dec. 31, 2020





Revenue
 

$ 298.3

$ 247.2





United States
 

 

 





Revenue
 

220.5

171.7





Belgium
 

 

 





Revenue
$ 36.6

 

35.8





Japan
 

 

 





Revenue
 

34.6

23.4





Other Foreign
 

 

 





Revenue
 

6.6

16.3





Foreign [Member]
 

 

 





Revenue
 

$ 77.8

$ 75.5




















XML
106
R85.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Segment Information (Segment Reporting Information) (Details) - USD ($)
 $ in Millions

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Segment Reporting Information [Line Items]
 

 





Revenue
$ 298.3

$ 247.2





Gross Profit
114.5

97.6





Low Enriched Uranium Segment [Member]
 

 





Segment Reporting Information [Line Items]
 

 





Gross Profit
73.0

97.8





Technical Solutions Segment [Member]
 

 





Segment Reporting Information [Line Items]
 

 





Gross Profit
41.5

(0.2)





Product [Member]
 

 





Segment Reporting Information [Line Items]
 

 





Revenue
186.1

190.5





Separative Work Units [Member]
 

 





Segment Reporting Information [Line Items]
 

 





Revenue
163.3

151.5





Uranium [Member]
 

 





Segment Reporting Information [Line Items]
 

 





Revenue
$ 22.8

$ 39.0






















XML
107
R86.htm
IDEA: XBRL DOCUMENT








v3.22.0.1




Segment Information (Narrative) (Details)

12 Months Ended





Dec. 31, 2021


Dec. 31, 2020





Ten Largest Customers | Revenue Benchmark | Customer Concentration Risk
 

 





Revenue
57.00%

71.00%





Synatom | Revenue Benchmark | Customer Concentration Risk
 

 





Revenue
12.00%

14.00%





Kyushu Electric Power | Revenue Benchmark | Customer Concentration Risk
 

 





Revenue
12.00%

 





Energy Harbor Nuclear Corporation | Revenue Benchmark | Customer Concentration Risk
 

 





Revenue
 

13.00%





Dominion Energy South Carolina | Revenue Benchmark | Customer Concentration Risk
 

 





Revenue
 

10.00%





Technical Solutions Segment [Member]
 

 





Revenue from first customer over 10 percent
38.00%

2100.00%
























XML
108
leu-20211231_htm.xml
IDEA: XBRL DOCUMENT




    
    
        
            0001065059
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
        
        
            2021-06-30
        
    
    
        
            0001065059
        
        
            2022-03-01
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
        
        
            2020-12-31
        
    
    
        
            0001065059
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesAPreferredStockMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesAPreferredStockMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:SeparativeWorkUnitsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:SeparativeWorkUnitsMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:UraniumMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:UraniumMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:ServiceMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ServiceMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
        
        
            2019-12-31
        
    
    
        
            0001065059
        
        
            2020-06-30
        
    
    
        
            0001065059
            
                leu:PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilitiesMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilitiesMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:DeferredfinancingcostsincludedinaccountspayableandaccruedliabilitiesMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:DeferredfinancingcostsincludedinaccountspayableandaccruedliabilitiesMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:DisposalOfRightToUseLeaseAssetsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:DisposalOfRightToUseLeaseAssetsMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:ReclassificationOfEquityCompensationLiabilityToEquityMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:ReclassificationOfEquityCompensationLiabilityToEquityMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:CommonStockAndWarrantIssuedInExchangeForPreferredStockMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:CommonStockAndWarrantIssuedInExchangeForPreferredStockMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredStockMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
                us-gaap:CommonStockMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
                us-gaap:CommonStockMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:AdditionalPaidInCapitalMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:RetainedEarningsMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:AccumulatedOtherComprehensiveIncomeMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredStockMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
                us-gaap:CommonStockMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
                us-gaap:CommonStockMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AdditionalPaidInCapitalMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:RetainedEarningsMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AccumulatedOtherComprehensiveIncomeMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredStockMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
                us-gaap:CommonStockMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
                us-gaap:CommonStockMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AdditionalPaidInCapitalMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:RetainedEarningsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AccumulatedOtherComprehensiveIncomeMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredStockMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
                us-gaap:CommonStockMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
                us-gaap:CommonStockMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AdditionalPaidInCapitalMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:RetainedEarningsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AccumulatedOtherComprehensiveIncomeMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredStockMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
                us-gaap:CommonStockMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
                us-gaap:CommonStockMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AdditionalPaidInCapitalMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:RetainedEarningsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AccumulatedOtherComprehensiveIncomeMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeniorNotesMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                country:US
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                country:US
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                country:BE
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                country:BE
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                country:JP
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                leu:OtherForeignMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                leu:OtherForeignMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                leu:ForeignMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ProductMember
                leu:ForeignMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                srt:MaximumMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                srt:MaximumMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
        
        
            2019-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:GovernmentMember
            
        
        
            2019-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:WorkerscompensationfinancialassuranceMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:WorkerscompensationfinancialassuranceMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                leu:OtherfinancialassuranceMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:OtherfinancialassuranceMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
        
        
            2018-01-01
            2020-12-31
        
    
    
        
            0001065059
        
        
            2021-09-30
        
    
    
        
            0001065059
            
                us-gaap:LandMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:LandMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:LandMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:LeaseholdImprovementsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:LeaseholdImprovementsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:LeaseholdImprovementsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:EquipmentMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:EquipmentMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:EquipmentMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ContractBasedIntangibleAssetsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ContractBasedIntangibleAssetsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CustomerRelatedIntangibleAssetsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CustomerRelatedIntangibleAssetsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeniorNotesMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
                leu:PlanPaidMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
                leu:PlanPaidMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
                leu:PlanPaidMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
                leu:PlanPaidMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
                leu:CompanyPaidMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
                leu:CompanyPaidMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
                leu:CompanyPaidMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
                leu:CompanyPaidMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2014-01-01
            2014-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2016-01-01
            2016-12-31
        
    
    
        
            0001065059
            
                us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
            
        
        
            2017-01-01
            2017-12-31
        
    
    
        
            0001065059
            
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2019-01-01
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:EquitySecuritiesMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:EquitySecuritiesMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                srt:MinimumMember
                srt:ScenarioForecastMember
                us-gaap:EquitySecuritiesMember
            
        
        
            2022-12-31
        
    
    
        
            0001065059
            
                srt:MaximumMember
                srt:ScenarioForecastMember
                us-gaap:EquitySecuritiesMember
            
        
        
            2022-12-31
        
    
    
        
            0001065059
            
                us-gaap:DebtSecuritiesMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:DebtSecuritiesMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                srt:MinimumMember
                srt:ScenarioForecastMember
                us-gaap:DebtSecuritiesMember
            
        
        
            2022-12-31
        
    
    
        
            0001065059
            
                srt:MaximumMember
                srt:ScenarioForecastMember
                us-gaap:DebtSecuritiesMember
            
        
        
            2022-12-31
        
    
    
        
            0001065059
            
                us-gaap:CashMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CashMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                srt:MinimumMember
                srt:ScenarioForecastMember
                us-gaap:CashMember
            
        
        
            2022-12-31
        
    
    
        
            0001065059
            
                srt:MaximumMember
                srt:ScenarioForecastMember
                us-gaap:CashMember
            
        
        
            2022-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USTreasuryAndGovernmentMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CorporateDebtSecuritiesMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:USStatesAndPoliticalSubdivisionsMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:MutualFundMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel1Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel2Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:AssetBackedSecuritiesMember
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:FairValueInputsLevel12And3Member
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:QualifiedPlanMember
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:NonqualifiedPlanMember
                us-gaap:PensionPlansDefinedBenefitMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsPerformanceConditionMember
            
        
        
            2021-01-01
            2023-12-31
        
    
    
        
            0001065059
            
                us-gaap:RestrictedStockUnitsRSUMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:EmployeeStockOptionMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:BoardRestrictedStockUnitsMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                leu:BoardRestrictedStockUnitsMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:BoardRestrictedStockUnitsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                leu:BoardRestrictedStockUnitsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:BoardRestrictedStockUnitsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:EmployeeRestrictedStockUnitsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                leu:EmployeeRestrictedStockUnitsMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:EmployeeRestrictedStockUnitsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
        
        
            2019-01-01
            2019-12-31
        
    
    
        
            0001065059
            
                leu:OptionGroupOneMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:OptionGroupOneMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:OptionGroupTwoMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:OptionGroupTwoMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:StockAppreciationRightsSARSMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:StockAppreciationRightsSARSMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:StockAppreciationRightsSARSMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:StockAppreciationRightsSARSMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:StockAppreciationRightsSARSMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
        
        
            2021-10-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:StockAppreciationRightsSARSPerformanceConditionMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                leu:StockAppreciationRightsSARSPerformanceConditionMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:StockAppreciationRightsSARSPerformanceConditionMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsPerformanceConditionMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsPerformanceConditionMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:NotionalStockUnitsPerformanceConditionMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:DomesticCountryMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:DomesticCountryMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:StateAndLocalJurisdictionMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:StateAndLocalJurisdictionMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:ForeignCountryMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:ForeignCountryMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
        
        
            2017-12-31
        
    
    
        
            0001065059
            
                us-gaap:TaxYear2018Member
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:StateAndLocalJurisdictionMember
            
        
        
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2020-09-30
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2020-09-30
        
    
    
        
            0001065059
        
        
            2020-10-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2020-10-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2021-11-01
            2021-11-30
        
    
    
        
            0001065059
            
                us-gaap:WarrantMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2021-11-01
            2021-11-30
        
    
    
        
            0001065059
            
                us-gaap:SeriesBPreferredStockMember
            
        
        
            2021-12-01
            2021-12-31
        
    
    
        
            0001065059
        
        
            2021-12-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
            
        
        
            2019-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassBMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:RestrictedStockUnitsRSUMember
                us-gaap:CommonClassAMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:PhantomShareUnitsPSUsMember
                us-gaap:CommonClassAMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                us-gaap:CommonClassAMember
            
        
        
            2020-09-01
            2020-09-01
        
    
    
        
            0001065059
        
        
            2016-09-30
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2021-11-01
            2021-11-30
        
    
    
        
            0001065059
        
        
            2021-11-01
            2021-11-30
        
    
    
        
            0001065059
            
                us-gaap:PreferredClassBMember
            
        
        
            2021-12-01
            2021-12-31
        
    
    
        
            0001065059
        
        
            2021-12-15
            2021-12-15
        
    
    
        
            0001065059
            
                country:US
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                country:US
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                country:BE
            
        
        
            2021-10-01
            2021-12-31
        
    
    
        
            0001065059
            
                country:BE
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                country:JP
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                country:JP
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:OtherForeignMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:OtherForeignMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:ForeignMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:ForeignMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:TechnicalSolutionsSegmentMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:TechnicalSolutionsSegmentMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:TenLargestCustomersMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:SynatomMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:KyushuElectricPowerMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:TenLargestCustomersMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:SynatomMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:EnergyHarborNuclearCorporationMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:DominionEnergySouthCarolinaMember
                us-gaap:SalesRevenueNetMember
                us-gaap:CustomerConcentrationRiskMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:LowEnrichedUraniumSegmentMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:LowEnrichedUraniumSegmentMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        
            0001065059
            
                leu:ContractServicesSegmentMember
            
        
        
            2021-01-01
            2021-12-31
        
    
    
        
            0001065059
            
                leu:ContractServicesSegmentMember
            
        
        
            2020-01-01
            2020-12-31
        
    
    
        iso4217:USD
    
    
        shares
    
    
        
            
                iso4217:USD
            
            
                shares
            
        
    
    
        pure
    
    0001065059
    --12-31
    true
    false
    false
    2021
    FY
    1.00
    20000000
    0.075
    0.10
    70000000
    0.10
    30000000
    P7Y9M
    6100000
    108000000.0
    http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
    http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
    http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent
    http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent
    http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
    http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
    10-K
    2021-12-31
    1-14287
    Centrus Energy Corp.
    DE
    52-2107911
    6901 Rockledge Drive, Suite 800
    Bethesda
    MD
    20817
    (301)
    564-3200
    Class A Common Stock, par value $0.10 per share
    LEU
    NYSEAMER
    No
    No
    Yes
    Yes
    true
    Accelerated Filer
    false
    true
    false
    257900000
    13673933
    238
    PricewaterhouseCoopers LLP
    Baltimore, Maryland
    193800000
    152000000.0
    29100000
    29600000
    91100000
    64800000
    143300000
    151900000
    8600000
    7800000
    465900000
    406100000
    5300000
    4900000
    2800000
    5700000
    54700000
    62800000
    41400000
    1900000
    2300000
    4900000
    572400000
    486300000
    37800000
    50600000
    37900000
    21300000
    8400000
    4900000
    303100000
    283200000
    6100000
    6100000
    393300000
    366100000
    101800000
    108000000.0
    114900000
    130800000
    23100000
    124400000
    45100000
    45200000
    36100000
    32400000
    714300000
    806900000
    
    
    1.00
    0
    0
    53900000
    0
    100000
    11390189
    1400000
    1100000
    719200
    100000
    100000
    140700000
    85000000.0
    -284600000
    -407700000
    500000
    800000
    -141900000
    -320600000
    572400000
    486300000
    163300000
    151500000
    22800000
    39000000.0
    112200000
    56700000
    298300000
    247200000
    113100000
    92700000
    70700000
    56900000
    183800000
    149600000
    114500000
    97600000
    2100000
    2800000
    36000000.0
    36000000.0
    8100000
    6800000
    0
    600000
    0
    -400000
    68300000
    51000000.0
    -67600000
    -1600000
    100000
    100000
    100000
    500000
    135900000
    53000000.0
    -39100000
    -1400000
    175000000.0
    54400000
    2100000
    6700000
    37600000
    37600000
    41900000
    41900000
    135300000
    5800000
    10.03
    0.59
    9.75
    0.57
    13493000
    9825000
    13879000
    10123000
    175000000.0
    54400000
    8600000
    7300000
    7200000
    10600000
    39500000
    1900000
    50500000
    -7200000
    4800000
    0
    12100000
    7100000
    -500000
    8600000
    10700000
    -25800000
    16600000
    13200000
    13200000
    9700000
    -4600000
    -5200000
    -67000000.0
    -32700000
    1300000
    -1400000
    50000000.0
    67100000
    1200000
    1400000
    -1200000
    -1400000
    42100000
    23100000
    44400000
    61600000
    6100000
    6100000
    900000
    300000
    2400000
    0
    0
    100000
    -9900000
    -44400000
    38900000
    21300000
    157900000
    136600000
    196800000
    157900000
    0
    300000
    400000
    200000
    1000000.0
    200000
    7500000
    0
    7500000
    0
    4600000
    800000
    100000
    61500000
    -405000000.0
    1100000
    -336900000
    0
    0
    0
    0
    54400000
    0
    54400000
    0
    300000
    0
    22800000
    0
    0
    23100000
    -4500000
    0
    0
    0
    -57100000
    0
    -61600000
    0
    0
    0
    0
    0
    -300000
    -300000
    0
    0
    0
    700000
    0
    0
    700000
    100000
    1100000
    100000
    85000000.0
    -407700000
    800000
    -320600000
    0
    0
    0
    0
    175000000.0
    0
    175000000.0
    0
    200000
    0
    41900000
    0
    0
    42100000
    0
    100000
    0
    7500000
    -7600000
    0
    0
    -100000
    0
    0
    0
    -44300000
    0
    -44400000
    0
    0
    0
    7500000
    0
    0
    7500000
    0
    0
    0
    2400000
    0
    0
    2400000
    0
    0
    0
    0
    0
    -300000
    -300000
    0
    0
    0
    1200000
    0
    0
    1200000
    0
    1400000
    100000
    140700000
    -284600000
    500000
    -141900000
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The consolidated financial statements of Centrus Energy Corp. (“Centrus” or the “Company”), which include the accounts of the Company, its principal subsidiary United States Enrichment Corporation (“Enrichment Corp.”) and its other subsidiaries, were prepared in conformity with generally accepted accounting principles in the U.S. (“U.S. GAAP”). Certain prior year amounts have been reclassified for consistency with the current year presentation. All material intercompany transactions have been eliminated.</span></div>
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts presented and disclosed in the consolidated financial statements. Significant estimates and judgments include, but are not limited to, revenue and related costs, asset valuations, pension and postretirement health and life benefit costs and obligations, the tax bases of assets and liabilities, the future recoverability of deferred tax assets, and determination of the valuation allowance for deferred tax assets. Actual results may differ from such estimates, and estimates may change if the underlying conditions or assumptions change.</span></div>
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash and cash equivalents include short-term or highly liquid assets with original maturities of three months or less.</span></div>
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Inventories and Inventories Owed to Customers and Suppliers</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Low-enriched uranium (“LEU”) consists of two components: separative work units (“SWU”) and uranium. SWU is a standard unit of measurement that represents the effort required to transform a given amount of natural uranium into two components: enriched uranium having a higher percentage of U</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and depleted uranium having a lower percentage of U</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment deemed to be contained in LEU under this formula is commonly referred to as its SWU component and the quantity of natural uranium deemed to be used in the production of LEU under this formula is referred to as its uranium or “feed” component.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SWU and uranium inventory costs are determined using the average cost method. SWU and uranium purchase costs include shipping costs when applicable. Inventories of SWU and uranium are valued at the lower of cost or net realizable value (“NRV”). NRV is the estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The estimated selling price for SWU and uranium is based on the pricing terms of contracts in the Company’s sales order book, and, for uranium not under contract, the estimated selling price is based primarily on published price indicators at the balance sheet date.  </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inventories owed to customers and suppliers, included in current liabilities, consist primarily of SWU and uranium inventories owed to fabricators. Fabricators process LEU into fuel for use in nuclear reactors. Under inventory optimization arrangements between Centrus and domestic fabricators, fabricators order quantities of LEU from Centrus based on scheduled or anticipated orders from utility customers, for deliveries in future periods. As delivery obligations under actual customer orders arise, Centrus typically satisfies these obligations by arranging for the transfer to the customer of title to the specified quantity of LEU at the fabricator. Centrus’ balances of SWU and uranium vary over time based on the timing and size of the fabricator’s LEU orders from Centrus and the fabricator’s needs for working stock of LEU. Balances can be positive or negative at the discretion of the fabricator. </span></div>Fabricators have other inventory supplies and, where a fabricator has elected to order less material from Centrus than Centrus is required to deliver to its customers at the fabricator, the fabricator will use these other inventories to satisfy Centrus’ customer order obligations on Centrus’ behalf. In such cases, the transfer of title of LEU from Centrus to the customer results in quantities of SWU and uranium being owed by Centrus to the fabricator. The amounts of SWU and uranium owed to fabricators are satisfied as future deliveries of LEU to fabricators are made.
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Deferred Taxes</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus follows the asset and liability approach to account for deferred taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences of temporary differences between the balance sheet carrying amounts of assets and liabilities and their respective tax bases. Deferred taxes are based on income tax rates in effect for the years in which temporary differences are expected to reverse. The effect on deferred taxes of a change in income tax rates is recognized in income when the change in rates is enacted in the law. A valuation allowance is provided if it is more likely than not that all, or some portion, of the deferred tax assets may not be realized.</span></div>
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at acquisition cost. Leasehold improvements and machinery and equipment are depreciated on a straight-line basis over the shorter of the useful life of the assets or the lease term, if applicable. Refer also to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Carrying Value of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> below.</span></div>
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Centrus has intangible assets resulting from fresh start accounting as a result of emergence from Chapter 11 bankruptcy on September 30, 2014. The identifiable intangible assets relate to the sales order book and customer relationships. The order book intangible asset is amortized as the order book valued at emergence is reduced, principally as a result of deliveries to customers. The customer relationships intangible asset is amortized using the straight-line method over the estimated average useful life of 15 years, with 7 ¾ years of scheduled amortization remaining. Refer also to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Carrying Value of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> below.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Carrying Value of Long-Lived Assets</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company evaluates the carrying values of property, plant and equipment and identifiable intangible assets when events or changes in business circumstances indicate that the carrying amount of asset, or asset group, may not be fully recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset, or asset group, exceeds its fair value.</span></div>
    P15Y
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Instruments and Fair Value Measurement</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accounting standards define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, consideration is given to the principal or most advantageous market and assumptions that market participants would use when pricing the asset or liability. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to accounting standards, Centrus’ 8.25% notes due February 2027 (the “8.25% Notes”) are recorded at face value and the fair value is disclosed. The estimated fair value of the 8.25% Notes is based on recent trading prices and bid/ask quotes as of or near the balance sheet date. Debt issuance costs are deferred and amortized over the life of the instrument. </span></div>The balance sheet carrying amounts for accounts receivable, accounts payable and accrued liabilities, and payables under SWU purchase agreements approximate fair value because of the short-term nature of the instruments.
    0.0825
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Credit risk could result from the possibility of a customer failing to perform or pay according to the terms of a contract. Extension of credit is based on an evaluation of each customer’s financial condition. Centrus regularly monitors credit risk exposure and takes steps intended to mitigate the likelihood of such exposure resulting in a loss.</span></div>
    Concentrations of Supply Risk and Other Considerations with the War in Ukraine    The current war in Ukraine has led to the U.S., Russia and other countries imposing sanctions and other measures that restrict international trade.  The situation is rapidly changing, and it is not possible to predict future actions that could be taken.  The Company has multiple sources of supply; however, the supply contract with TENEX remains our largest source.  At present, sanctions have not impacted the ability of the Company or TENEX to perform under the TENEX supply contract.  Recently, sanctions have been imposed by the U.S. on exports of fossil fuels.  Russia has imposed sanctions on the export of commodities but does not include the export of LEU.  Additional sanctions or other measures by the U.S. or foreign governments (including the Russian government) could be imposed. Any sanctions or measures directed at trade in LEU from Russia or the parties involved in such trade or otherwise could interfere with, or prevent, implementation of the TENEX Supply Contract. While the initial sanctions announced do not affect the ability of the Company or TENEX to implement the TENEX Supply Contract, the situation at this time is unpredictable and therefore there is no assurance that future developments would not have a material adverse effect on the Company’s procurement, payment, delivery or sale of LEU under the TENEX Supply Contract.    If measures were taken to limit the supply of Russian LEU or to prohibit or limit dealings with Russian entities, including, but not limited to, TENEX or ROSATOM, the Company would seek a license, waiver or other approval from the government imposing such measures to ensure that the Company could continue to fulfill its purchase and sales obligations. There is no assurance that such a license, waiver, or approval would be granted. If a license, waiver or approval were not granted, the Company would need to look to alternative sources of LEU to replace the LEU that it could not procure from TENEX.  The Company has contracts for alternative sources that could be used to mitigate a portion of the near term impacts.  However, to the extent these sources were insufficient or more expensive or additional supply cannot be obtained, it could have a material adverse impact on our business, results of operations, and competitive position.
    SegmentsCentrus operates two business segments: LEU, which supplies various components of nuclear fuel to utilities, and technical solutions, which provides advanced engineering, design, and manufacturing services to government and private sector customers.
    Related Party      As previously disclosed in our Current Report on Form 8-K filed on December 31, 2020, on that same date theCompany entered into an At Market Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. andLake Street Capital Markets, LLC (the “Agents”), relating to the at the market offering (the “ATM Offering”) ofshares of the Company’s Class A Common Stock, $0.10 par value per share. Mr. Williams, Chairman of the CentrusBoard of Directors, also serves on the board of B. Riley Financial, Inc. Mr. Williams recused himself and took nopart in the selection of B. Riley or the negotiation of the terms of the Sales Agreement.  Please refer to Note 15 - Stockholders’ Equity for a description of the ATM Offering in 2021.
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. Revenue for product and service sales is recognized when or as the Company transfers control of the promised products or services to the customer. Revenue is measured at the transaction price, which is based on the amount of consideration that the Company expects to receive in exchange for transferring the promised goods or services to the customer. The transaction price will include estimates of variable consideration until it is probable that a significant reversal of revenue recognized will not occur. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">SWU and Uranium Revenue</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenue for the Company’s LEU segment is derived from sales of the SWU component of LEU, from sales of both the SWU and uranium components of LEU, and from sales of uranium. Contracts with customers are primarily medium and long-term, fixed-commitment contracts under which its customers are obligated to purchase a specified quantity of the SWU component of LEU or the SWU and uranium components of LEU. The Company’s contracts for natural uranium are generally shorter-term, fixed-commitment contracts. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenue is recognized at the time the customer obtains control of the LEU or uranium. Customers generally obtain control of LEU at nuclear fuel fabricators. Centrus ships LEU to nuclear fuel fabricators for scheduled or anticipated orders from utility customers. Based on customer orders, Centrus arranges for the transfer of title of LEU from Centrus to the customer for the specified quantity of LEU at the fuel fabricator. Each such delivery to a customer is accounted for as a distinct performance obligation under a contract, and a contract may call for multiple deliveries over a number of periods. The contract’s transaction price is allocated to each performance obligation based on the observable standalone selling price of each distinct delivery of SWU or uranium. For certain contracts the customers may elect not to take control of the LEU or uranium and Centrus may have the right to enforce payment under the terms of the contractual agreement. The revenue recognition for these contracts is assessed when it occurs.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Utility customers in general have the option to defer receipt of uranium products purchased from the Company beyond the contractual sale period. In such cases, title to SWU and/or uranium components are transferred to the customer and a performance obligation for Centrus is created and a receivable is recorded. Cash is collected for the receivable under normal credit terms. The performance obligation is represented as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on the consolidated balance sheet and the customer-titled product is classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Deferred Costs Associated with Deferred Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the consolidated balance sheet. Risk of loss remains with Centrus until the customer obtains control of the uranium product. The recognition of revenue and related cost of sales occurs at the point in time at which the customer obtains control of SWU or uranium and risk of loss of the product transfers to the customer, which may occur beyond one year. The timing of the transfer of control, subject to notice period requirements, is at the option of the customer. As such, deferred costs and deferred revenue are classified within current assets and current liabilities, respectively. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On occasion, the Company will accept payment in the form of uranium. Revenue from the sale of SWU under such contracts is recognized at the time transfer of control of LEU occurs and is based on the fair value of the uranium at contract inception or as the quantity of uranium is finalized, if variable. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amounts billed to customers for handling costs are included in sales. Handling costs are accounted for as a fulfillment cost and are included in cost of sales. The Company does not have shipping costs associated with outbound freight after control over a product has transferred to a customer. The Company’s contracts with customers do not provide for significant payment terms or financing components.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Technical Solutions Revenue</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenue for the technical solutions segment, principally representing technical, manufacturing, engineering, procurement, construction and operations services offered to public and private sector customers, is recognized over the contractual period as services are rendered. The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer. For public sector contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay the Company for costs incurred plus a reasonable profit and assume control of any work in progress. The Company’s government and private sector contracts generally contain contractual termination clauses or entitle the Company to payments for work performed to date for goods and services that do not have an alternative use. With control transferring over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. A contract may contain one or more performance obligations. Two or more promises to transfer goods or services to a customer may be considered a single performance obligation if the goods or services are highly interdependent or highly interrelated such that utility of the promised goods or services to the customer includes integration services provided by the Company. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines the transaction price for each contract based on the consideration it expects to receive for the products or services being provided under the contract. If transaction prices are not stated in the contract for each performance obligation, contractual prices are allocated to performance obligations based on estimated relative standalone selling prices of the promised services. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company generally uses the cost-to-cost input method of progress for performance obligations to deliver products with continual transfer of control to the customer, because it best depicts the transfer of control to the customer that occurs as the Company incurs costs. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of direct costs incurred to date to the total estimated direct costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred. For performance obligations to provide services to the customer, revenue is recognized over time based on direct costs incurred or the right to invoice method (in situations where the value transferred matches the Company’s billing rights) as the customer receives and consumes the benefits. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Use of the cost-to-cost method requires the Company to make reasonably dependable estimates of costs at completion associated with the design, manufacture and delivery of products and services in order to calculate revenue. Significant judgment is used to estimate total revenue and costs at completion, particularly in the assumptions related to internal labor hours and third-party services for which a vendor invoice or quote is not yet available. As a significant change in one or more estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its contract-related estimates regularly. Adjustments in estimated profits/losses are recognized under the cumulative catch-up method. Under this method, the impact of the adjustments is recognized in the period the adjustment is recognized. When estimates of total costs at completion for such an integrated, construction type contract exceed total estimates of revenue to be earned on a performance obligation related to complex equipment or related services, a provision for the remaining loss on the performance obligation is recognized in the period the loss is determined. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company applied the practical expedient in paragraph ASC 606-10-50-14 and does not disclose the value of remaining performance obligations under service contracts having original expected terms of one year or less.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The timing of revenue recognition may differ from the timing of invoicing to customers. Progress on satisfying performance obligations under contracts with customers and the related billings and cash collections are recorded on the consolidated balance sheet as contract assets or contract liabilities. Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unbilled receivables are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the consolidated balance sheet and arise when the timing of cash collected from customers differs from the timing of revenue recognition. Those assets are recognized when the revenue associated with the contract is recognized prior to billing and derecognized when billed in </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">accordance with the terms of the contract. To the extent billings to the customer precede the recognition of technical solutions revenue, the Company recognizes a liability included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Deferred Revenue and Advances from Customers </span>on the consolidated balance sheet.
    Advanced Technology Costs<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">American Centrifuge and related expenses that are outside of our customer contracts are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Advanced Technology Costs</span>.
    Pension and Postretirement Health and Life Benefit PlansThe Company provides retirement benefits to certain employees and retirees under defined benefit pension plans and postretirement health and life benefit plans. The valuation of benefit obligations and costs is based on provisions of the plans and actuarial assumptions that involve judgments and estimates. Plan assets and benefit obligations are remeasured each year as of the balance sheet date, or when lump sum payments exceed certain levels, resulting in differences between actual and projected results. The Company has elected to recognize these actuarial gains and losses immediately in the statement of operations to provide transparency regarding the impacts of changes in plan assets and benefit obligations.
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus has a stock-based compensation plan which authorizes the issuance of common stock to the Company’s employees, officers, directors, and other individuals providing services to the Company or its affiliates pursuant to options, notional stock units, stock appreciation rights, restricted stock units, restricted stock, performance awards, dividend equivalent rights, and other stock-based awards. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation cost for options and stock-settled awards are measured at the grant date based on the fair value of the award. The cost is recognized over the requisite service period on a straight-line basis over the vesting period. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Stock-based compensation cost for awards likely to be settled with cash payments are recognized over the requisite service period and accrued as a liability and re-measured each reporting period based on the trading price of the Company’s common stock.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Company recognizes forfeitures as they occur.</span></div>
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">which modifies the disclosure requirements for employers that sponsor defined benefit pension plans and other postretirement plans. ASU 2018-14 is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The standard is to be applied on a retrospective basis to all periods presented and early adoption is permitted. Adoption of this new standard did not have a significant impact to the Company’s annual disclosures.</span></div>
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents revenue from SWU and uranium sales disaggregated by geographical region, including foreign countries representing 10% or more of revenue, based on the billing addresses of customers (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.988%"><tr><td style="width:1.0%"/><td style="width:61.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.824%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.686%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      Revenue - SWU and uranium</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">190.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenue by customer location, including customers in a foreign country representing 10% or more of total revenue, follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.631%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">      Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* less than 10%</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>
    108300000
    115000000.0
    36600000
    35800000
    34600000
    6600000
    16300000
    77800000
    75500000
    186100000
    190500000
    32600000
    23100000
    23000000.0
    6000000.0
    6600000
    29100000
    29600000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents changes in contract liability balances (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"/><td style="width:56.423%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued loss on HALEU Contract:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term liabilities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - current</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances from customers - current</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances from customers - non current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    500000
    7000000.0
    -6500000
    0
    700000
    -700000
    288100000
    281700000
    6400000
    15000000.0
    1500000
    13500000
    45100000
    45200000
    -100000
    47200000
    38700000
    42600000
    0
    986000000
    960000000
    348200000
    23400000
    59600000
    44400000
    115000000
    126700000
    7200000
    10600000
    19100000
    500000
    120300000
    43500000
    43500000
    33800000
    9700000
    CASH, CASH EQUIVALENTS AND RESTRICTED CASH<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the Company’s cash, cash equivalents and restricted cash as presented on the consolidated balance sheet to amounts on the consolidated statement of cash flows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:65.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits for financial assurance - current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits for financial assurance - non current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">157.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table provides additional detail regarding the Company’s deposits for financial assurance (in millions):</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:37.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deposits for financial assurance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The Company has provided financial assurance to states in which it was previously self-insured for workers’ compensation in accordance with each state’s requirements in the form of a surety bond or deposit that is fully cash collateralized by Centrus. As each state determines that the likelihood of further workers’ compensation obligations related to the period of self-insurance is reduced, the surety bond or deposit is subject to reduction and/or cancellation and the Company would receive the excess cash collateral.
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the Company’s cash, cash equivalents and restricted cash as presented on the consolidated balance sheet to amounts on the consolidated statement of cash flows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"/><td style="width:65.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits for financial assurance - current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits for financial assurance - non current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">157.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    193800000
    152000000.0
    200000
    200000
    2800000
    5700000
    196800000
    157900000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table provides additional detail regarding the Company’s deposits for financial assurance (in millions):</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.298%"><tr><td style="width:1.0%"/><td style="width:37.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deposits for financial assurance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    0
    2600000
    0
    5400000
    200000
    200000
    200000
    300000
    200000
    2800000
    200000
    5700000
    INVENTORIES<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus holds uranium at licensed locations in the form of natural uranium and as the uranium component of LEU. Centrus also holds SWU as the SWU component of LEU at licensed locations (e.g., fabricators) to meet book transfer requests by customers. Fabricators process LEU into fuel for use in nuclear reactors. Components of inventories are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:24.994%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.921%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Liabilities <br/>(a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Liabilities<br/>(a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separative work units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uranium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Inventories owed to customers and suppliers, included in current liabilities, include SWU and uranium inventories owed to fabricators. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value. In 2021, there was a valuation adjustment to reflect an update of projected timing and sources of inventory to be used for repayment of borrowed SWU inventory. There were no valuation adjustments in 2020. For details, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> — </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> — </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">LEU Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company may also borrow SWU from customers, in which case the Company will record the SWU and the related liability for the borrowing using a projected average purchase price over the borrowing period. In 2018 through 2020 the Company borrowed SWU inventory valued at $20.7 million from a customer under an agreement signed in 2017 and recorded the SWU and the related liability using the Company’s average unit price of SWU purchases under contract projected to be used for repayment. The loan is repayable only with SWU. The cumulative liability to the customer for borrowed inventory was revalued to $25.5 million in the third quarter of 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The revaluation reflected an updated projection of the timing and sources of inventory to be used for repayment. In the fourth quarter of 2021, the Company repaid borrowed SWU inventory valued at $3.1 million to a customer and reduced the SWU and the related liability using an average purchase price over the borrowing period. The remaining liability to the customer of $22.4 million for borrowed inventory is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for the twelve months ended December 31, 2021, includes the related expense of $4.8 million.</span>
    Components of inventories are as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:24.994%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.921%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.059%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Liabilities <br/>(a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories, Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current<br/>Liabilities<br/>(a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separative work units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uranium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(a)Inventories owed to customers and suppliers, included in current liabilities, include SWU and uranium inventories owed to fabricators.
    8800000
    0
    8800000
    17000000.0
    4600000
    12400000
    82300000
    8400000
    73900000
    47800000
    300000
    47500000
    91100000
    8400000
    82700000
    64800000
    4900000
    59900000
    20700000
    25500000
    3100000
    22400000
    4800000
    PROPERTY, PLANT AND EQUIPMENT<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of changes in property, plant and equipment follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.362%"><tr><td style="width:1.0%"/><td style="width:44.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.064%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions / (Depreciation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, gross</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Depreciation expense was $0.6 million in 2021 and $0.5 million in 2020.</span></div>
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of changes in property, plant and equipment follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.362%"><tr><td style="width:1.0%"/><td style="width:44.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.064%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.292%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions / (Depreciation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, gross</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    1200000
    0
    1200000
    3900000
    700000
    4600000
    1400000
    0
    1400000
    1100000
    1100000
    7600000
    700000
    8300000
    2700000
    300000
    3000000.0
    4900000
    400000
    5300000
    600000
    500000
    INTANGIBLE ASSETS<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Intangible assets originated from the Company’s reorganization and application of fresh start accounting as of September 30, 2014, the date the Company emerged from bankruptcy, and reflect the conditions at that time. The intangible asset related to the sales order book is amortized as the order book existing at emergence is reduced, principally as a result of deliveries to customers. The intangible asset related to customer relationships is amortized using the straight-line method over the estimated average useful life of 15 years. Amortization expense is presented below gross profit on the consolidated statements of operations. Intangible asset balances are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:27.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales order book</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The amount of amortization expense for intangible assets in each of the succeeding years is estimated to be as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.918%"><tr><td style="width:1.0%"/><td style="width:72.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    P15Y
    Intangible asset balances are as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:27.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.618%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales order book</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>
    54600000
    35500000
    19100000
    54600000
    32000000.0
    22600000
    68900000
    33300000
    35600000
    68900000
    28700000
    40200000
    123500000
    68800000
    54700000
    123500000
    60700000
    62800000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The amount of amortization expense for intangible assets in each of the succeeding years is estimated to be as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.918%"><tr><td style="width:1.0%"/><td style="width:72.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    9500000
    6600000
    8600000
    7600000
    9900000
    12500000
    54700000
    ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Components of accounts payable and accrued liabilities follow (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"/><td style="width:70.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade payables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement health and life benefit obligations - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued HALEU Contract loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">   Total accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Components of accounts payable and accrued liabilities follow (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"/><td style="width:70.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade payables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement health and life benefit obligations - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued HALEU Contract loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">   Total accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    4900000
    4900000
    23100000
    22200000
    7000000.0
    11600000
    500000
    7000000.0
    900000
    2400000
    1400000
    2500000
    37800000
    50600000
    DEBT<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of debt follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:34.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.25% Notes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb. 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest on the 8.25% Notes is payable semi-annually in arrears as of February 28 and August 31 based on a 360-day year consisting of twelve 30-day months. The 8.25% Notes mature on February 28, 2027. As shown in the table above, all future interest payment obligations on the 8.25% Notes are included in the carrying value of the 8.25% Notes. As a result, the Company’s reported interest expense will be less than its contractual interest payments throughout the term of the 8.25% Notes. As of December 31, 2021, and December 31, 2020, $6.1 million of interest is recorded as current and classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Current Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the consolidated balance sheet.</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 8.25% Notes rank equally in right of payment with all of the Company’s existing and future unsubordinated indebtedness other than its Issuer Senior Debt and our Limited Secured Acquisition Debt (each as defined below). The 8.25% Notes rank senior in right of payment to all of the Company’s existing and future subordinated indebtedness and to certain limited secured acquisition indebtedness of the Company (the “Limited Secured Acquisition Debt”). The Limited Secured Acquisition Debt includes (i) any indebtedness, the proceeds of which are used to finance all or a portion of an acquisition or similar transaction if any lender’s lien is solely limited to the assets acquired in such a transaction and (ii) any indebtedness, the proceeds of which are used to finance all or a </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">portion of the American Centrifuge project or another next generation enrichment technology if any lender’s lien is solely limited to such assets, provided that a lien securing the 8.25% Notes that is junior with respect to the lien securing such indebtedness will be limited to the assets acquired with such Limited Secured Acquisition Debt.</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The 8.25% Notes are subordinated in right of payment to certain indebtedness and obligations of the Company, as described in the indenture governing the 8.25% Notes (the “Issuer Senior Debt”), including (i) any indebtedness of the Company (inclusive of any indebtedness of Enrichment Corp.) under a future credit facility up to $50 million with a maximum net borrowing of $40 million after taking into account any minimum cash balance (unless a higher amount is approved with the consent of the holders of a majority of the aggregate principal amount of the 8.25% Notes then outstanding), (ii) any revolving credit facility to finance inventory purchases and related working capital needs, and (iii) any indebtedness of the Company to Enrichment Corp. under the secured intercompany notes. </span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 8.25% Notes are guaranteed on a subordinated and limited basis by, and secured by substantially all of the assets of, Enrichment Corp. The Enrichment Corp. guarantee is a secured obligation and ranks equally in right of payment with all existing and future unsubordinated indebtedness of Enrichment Corp. (other than Designated Senior Claims (as defined below) and Limited Secured Acquisition Debt) and senior in right of payment to all existing and future subordinated indebtedness of Enrichment Corp. and Limited Secured Acquisition Debt. The Enrichment Corp. guarantee is subordinated in right of payment to certain obligations of, and claims against, Enrichment Corp. described in the indenture governing the 8.25% Notes (collectively, the “Designated Senior Claims”), including obligations and claims:</span></div><div style="margin-bottom:6pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.5pt">under a future credit facility up to $50 million with a maximum net borrowing of $40 million after taking into account any minimum cash balance;</span></div><div style="margin-bottom:6pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.5pt">under any revolving credit facility to finance inventory purchases and related working capital needs; </span></div><div style="margin-bottom:6pt;padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.5pt">held by or for the benefit of the Pension Benefit Guaranty Corporation (“PBGC”) pursuant to any settlement (including any required funding of pension plans); and </span></div><div style="padding-left:49.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.5pt">under surety bonds or similar obligations held by or on behalf of the U.S. government pursuant to regulatory requirements.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The lien securing the Enrichment Corp. guarantee of the 8.25% Notes is junior in priority with respect to the lien securing Limited Secured Acquisition Debt, which is limited to the assets acquired with such Limited Secured Acquisition Debt.</span></div>
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of debt follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:34.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.25% Notes:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb. 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    74300000
    74300000
    6100000
    27500000
    6100000
    33700000
    6100000
    101800000
    6100000
    108000000.0
    0.0825
    6100000
    50000000
    40000000
    50000000
    40000000
    LEASES<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus leases facilities and equipment under operating leases. Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company has facility leases with terms greater than 12 months, and the Company records the related asset and obligation at the present value of lease payments over the term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. Lease assets exclude lease incentives. Lease terms reflect options to extend or terminate the lease when it is reasonably certain that those options will be exercised. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term. The weighted-average remaining lease term was 5.3 years at December 31, 2021, with maturity dates ranging from December 31, 2025 to September 2027, and the weighted-average discount rate was 12.5%. Lease expense totaled a credit of  $0.5 million in 2021 and expense of $2.6 million for 2020. Lease expense primarily related to operating leases for the years ended December 31, 2021 and 2020 includes a $2.0 million and $0.3 million credit, respectively, from DOE for true-up of prior years’ lease expense. Other amounts related to short-term lease expense were insignificant. Operating lease expense is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales, Selling, General and Administrative Expenses and Advance Technology Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on the Statement of Operations. Cash paid for amounts included in operating cash flows for operating leases was $2.4 million for the year ended December 31, 2021.</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company leases facilities and related personal property near Piketon, Ohio from DOE under a lease which is classified as operating.  The lease was amended on May 6, 2021, resulting in a decrease in the monthly lease payment beginning with the June 2021 payment. The Company accounted for the amendment as a modification and remeasured the remaining future lease payments through May 31, 2022, resulting in the recording of a $1.0 million reduction in lease assets and liabilities. In September 2021, the lease was extended through December 31, 2025. The Company did not remeasure the lease as under the terms of the lease amendment it may be terminated early upon completion of the work under the HALEU Contract which is expected to occur by June 1, 2022. Any facilities, centrifuges or other equipment constructed or installed under contract with DOE will be owned by DOE and may be returned to DOE in an “as is” condition at the end of the lease term, and DOE would be responsible for its D&amp;D.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Assets and Liabilities </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities recorded on the consolidated balance sheet (in millions).</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"><tr><td style="width:1.0%"/><td style="width:35.831%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification on the Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzEtMy0xLTEtMjE0Mzk_682ca39e-ddb4-44ff-885e-e76715c51242"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzEtMy0xLTEtMjE0Mzk_cf88ec72-257b-42ff-8c0a-ba51e5bea0dc">Other long-term assets</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzMtMy0xLTEtMjE0Mzk_0e06c5ff-04b0-4719-9080-f90f2f55fae3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzMtMy0xLTEtMjE0Mzk_232f8de0-d59b-483c-9d70-bf50c50acb2c">Accounts payable and accrued liabilities</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzQtMy0xLTEtMjE0Mzk_37b14eee-69b1-4cf1-b3e3-ed9545245a62"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzQtMy0xLTEtMjE0Mzk_c55b774d-d560-4efd-af1f-64c96418fbbd">Other long-term liabilities</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating Lease Liabilities</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The table below reconciles undiscounted payments for operating leases with terms greater than 12 months to the operating lease liabilities recorded on the balance sheet (in millions).</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.134%"><tr><td style="width:1.0%"/><td style="width:78.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    P5Y3M18D
    0.125
    500000
    2600000
    2600000
    2000000
    300000
    2400000
    2400000
    1000000
    <div style="margin-bottom:3pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities recorded on the consolidated balance sheet (in millions).</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"><tr><td style="width:1.0%"/><td style="width:35.831%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.892%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.746%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Classification on the Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzEtMy0xLTEtMjE0Mzk_682ca39e-ddb4-44ff-885e-e76715c51242"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzEtMy0xLTEtMjE0Mzk_cf88ec72-257b-42ff-8c0a-ba51e5bea0dc">Other long-term assets</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzMtMy0xLTEtMjE0Mzk_0e06c5ff-04b0-4719-9080-f90f2f55fae3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzMtMy0xLTEtMjE0Mzk_232f8de0-d59b-483c-9d70-bf50c50acb2c">Accounts payable and accrued liabilities</span></span></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzQtMy0xLTEtMjE0Mzk_37b14eee-69b1-4cf1-b3e3-ed9545245a62"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2Yzg2YjY2MWM4ZjRmZTU4Y2Q4Mjc3ZTRiOWMxYWExL3NlYzoxNmM4NmI2NjFjOGY0ZmU1OGNkODI3N2U0YjljMWFhMV8xNjYvZnJhZzo5ZjdlYjE2ODQwNWE0NzZhOWI2NDBiODJkY2E4NzFkMS90YWJsZTpmMmU4Mjg4MGM3MDU0ZWM3OWNlNTkzMTM4MmVlYmNmNC90YWJsZXJhbmdlOmYyZTgyODgwYzcwNTRlYzc5Y2U1OTMxMzgyZWViY2Y0XzQtMy0xLTEtMjE0Mzk_c55b774d-d560-4efd-af1f-64c96418fbbd">Other long-term liabilities</span></span></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The table below reconciles undiscounted payments for operating leases with terms greater than 12 months to the operating lease liabilities recorded on the balance sheet (in millions).</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.134%"><tr><td style="width:1.0%"/><td style="width:78.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    2100000
    900000
    3000000.0
    3900000
    1300000
    1000000.0
    1000000.0
    1000000.0
    1000000.0
    800000
    6100000
    2200000
    3900000
    FAIR VALUE<div style="margin-bottom:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value of assets and liabilities, the following hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.3pt">Level 1 assets include investments with quoted prices in active markets that the Company has the ability to liquidate as of the reporting date.</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.65pt">Level 2 assets include investments in U.S. government agency securities, corporate and municipal debt whose estimates are valued based on observable inputs, other than quoted prices.</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;padding-left:9.83pt">Level 3 assets include investments with unobservable inputs, such as third party valuations, due to little or no market activity.</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments Recorded at Fair Value (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:30.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.580%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation obligation (a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The deferred compensation obligation represents the balance of deferred compensation plus net investment earnings. The deferred compensation plan is funded through a rabbi trust. Trust funds are invested in mutual funds for which unit prices are quoted in active markets and are classified within Level 1 of the valuation hierarchy. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There were no transfers between Level 1, 2 or 3 during the periods presented.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Financial Instruments</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2021, and 2020, the consolidated balance sheet carrying amounts for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounts Payable and Accrued Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (excluding the deferred compensation obligation described above), and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Payables under SWU Purchase Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> approximate fair value because of their short-term nature.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying value and estimated fair value of long-term debt are as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"/><td style="width:36.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.732%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.25% Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on recent trading prices and bid/ask quotes as of or near the balance sheet date, which are considered  Level 2 inputs based on the frequency of trading.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the 8.25% Notes consists of the principal balance of $74.3 million and the sum of current and non-current interest payment obligations until maturity. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8, Debt</span>.
    <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments Recorded at Fair Value (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:30.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.580%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation obligation (a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>(a)    The deferred compensation obligation represents the balance of deferred compensation plus net investment earnings. The deferred compensation plan is funded through a rabbi trust. Trust funds are invested in mutual funds for which unit prices are quoted in active markets and are classified within Level 1 of the valuation hierarchy.
    0
    0
    193800000
    152000000.0
    0
    0
    152000000.0
    3200000
    0
    0
    3200000
    2400000
    0
    0
    2400000
    3200000
    0
    0
    3200000
    2300000
    0
    0
    2300000
    107900000
    74300000
    114100000
    68600000
    74300000
    PENSION AND POSTRETIREMENT HEALTH AND LIFE BENEFITSThere are approximately 3,500 employees and retirees covered by qualified defined benefit pension plans providing retirement benefits based on compensation and years of service, and approximately 2,300 employees and retirees covered by postretirement health and life benefit plans. DOE retained the obligation for postretirement health and life benefits for workers who retired prior to July 28, 1998. Pursuant to non-qualified supplemental pension plans, Centrus provides certain executive officers additional retirement benefits in excess of qualified plan limits imposed by tax law based on a targeted benefit objective. Employees hired on or after September 1, 2008, who are not covered by a collective bargaining agreement that provides for participation do not participate in a qualified defined benefit pension plan or postretirement health and life benefit plans.<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in the projected benefit obligations and plan assets and the funded status of the plans follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health<br/>and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Changes in Benefit Obligations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Obligations at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gains) losses, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid from Plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid from Company assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Obligations at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Changes in Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Unfunded status at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(121.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts recognized in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">      Current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">      Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(121.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts in accumulated other comprehensive income (loss), pre-tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">      Prior service credit</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.9)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.0)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.1)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The current liabilities reflect expected contributions for benefit payments for the non-qualified plans and the postretirement health and life benefit plans in the following year.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The discount rates below, rounded to the nearest 0.1%, are the estimated rates at which the benefit obligations could be effectively settled on the measurement date and are based on yields of high quality fixed income investments whose cash flows match the timing and amount of expected benefit payments of the plans.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Plan assets and benefit obligations are remeasured each year as of the balance sheet date resulting in differences between actual and projected results for the year. These actuarial gains and losses are recognized in the statement of operations in the fourth quarter. In addition, an interim remeasurement and recognition of gains or losses may be required for a plan during the year when lump sum payments exceed, or are expected to exceed, the sum of the service cost and interest cost components of the annual net periodic benefit cost for that plan for the current year. There were no interim remeasurements in 2021 and 2020.</span></div><div style="text-indent:13.5pt"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The defined benefit pension plans currently allow for a lump sum payment option to (a) active employees who are terminated as a result of Company reductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> force and (b) terminated vested participants who have not yet begun receiving their benefits and have been terminated as a result of a reduction in force by the Company, or due to voluntary termination or involuntary termination, other than involuntary termination as a termination for cause.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As part of the Company’s continued effort to reduce the size and volatility of its pension obligations and administrative costs, the Company transferred approximately $30.4 million of pension plan assets and approximately $30.4 million of related benefit obligations to an insurance company through the purchase of a group annuity contract in the fourth quarter of 2020. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Projected benefit obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are based on actuarial assumptions including possible future increases in compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accumulated benefit obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are based on actuarial assumptions but do not include possible future increases in compensation. Effective August 2013, accrued benefits under the defined benefit pension plans are fixed and no longer increase to reflect changes in compensation or company service. Therefore, the accumulated benefit obligation equaled the projected benefit obligation of $696.2 million and $757.9 million as of December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, none of Centrus’ plans had fair value of plan assets in excess of accumulated benefit obligations.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Components of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income </span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company reports service costs for its defined benefit pension plans and its postretirement health and life benefit plans in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The remaining components of net periodic benefit (credits) costs are reported as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Nonoperating Components of Net Periodic Benefit Income.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:45.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health<br/>and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Periodic Benefit (Credits) Costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of prior service credits, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gains) losses, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit (credits) costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(65.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:45.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.875%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of prior service costs, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss, pre-tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:2pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net periodic benefit costs include service and interest costs of providing pension benefits that are accrued over the years employees render service. Prior service costs or credits are amortized over the employees’ average remaining years of service from age 40 until the date of full benefit eligibility or the average expected future lifetime of all plan participants, as applicable. Participants in the postretirement health and life benefit plans are generally eligible for benefits at retirement after age 50 with 10 years of continuous credited service at the time of retirement.</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">September 7, 2021, the Company collected $43.5 million from DOE, of which $33.8 million was contributed to the pension plan in September 2021 for its subsidiary Enrichment Corp. and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 16, Commitments and Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> Note 2, Revenue And Contracts with Customers.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective January 1, 2014, or for certain plan participants formerly represented by a collective bargaining unit, January 1, 2015, plan participants age 65 or older (“post-65”) have access to a range of medical plan choices with varying costs and benefits through a Medicare Exchange implemented by the Company. The Company provides an annual stipend for each of the post-65 retirees and post-65 spouses who enroll in the coverage through the exchange. Depending on the level of benefits elected by the participant, the participant may be required to make contributions in excess of the stipend amount. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The transition to the post-65 Medicare Exchange was reflected as a plan amendment that reduced plan obligations by $6.8 million as of December 31, 2014. This reduction in obligation was recognized in other comprehensive income in 2014 as a prior service credit. The prior service credit is being amortized into net periodic benefit cost as a credit over time. The post-65 Medicare Exchange stipend amount was increased for 2017. This increase in obligation of $3.6 million as of December 31, 2016, was recognized in other comprehensive income in 2016 as a prior service cost and is being amortized into net periodic benefit cost over time. The post-65 Medicare Exchange stipend amount was increased in 2018, as specified in a settlement agreement with the former collective bargaining unit. The settlement agreement also specifies the addition of catastrophic drug coverage effective January 1, 2019. The benefit enhancement for 2019 has been applied to all post-65 participants regardless of past representation by the collective bargaining agreement. The increase in obligation of $10.0 million as a result of the settlement agreement was recognized in net periodic benefit costs in 2017 as a plan change resulting from a legal settlement and is reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Nonoperating Components of Net Periodic Benefit Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The defined benefits pension plans were amended in March 2019 making permanent the option for pension-eligible employees to receive a lump sum payment upon termination, regardless of benefit size, which decreased plan obligations by $1.3 million. The effect of these plan changes has been added to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as an unrecognized prior service cost to be amortized over the average future service of active employees starting in 2020. </span></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><span><br/></span></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Assumptions Used to Determine Net Periodic Benefit Costs</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:45.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health<br/>and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The expected return on plan assets is based on the weighted average of long-term return expectations for the composition of the plans’ equity and debt securities. Expected returns on equity securities are based on historical long-term returns of equity markets. Expected returns on debt securities are based on the current interest rate environment. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Healthcare cost trend rates used to measure postretirement health benefit obligations follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:73.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate for the following year</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term rate that the healthcare cost trend rate gradually declines to</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year that the healthcare cost trend rate is expected to reach the long-term rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Benefit Plan Assets</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Independent advisors manage investment assets of Centrus’ defined benefit pension plans and postretirement health and life benefit plans. Centrus has the fiduciary responsibility for reviewing performance of the various investment advisors. The goal of the investment policy of the plans is to maximize portfolio returns within reasonable and prudent levels of risk in order to meet projected liabilities and maintain sufficient cash to make timely payments of all participant benefits. Risk is reduced by diversifying plan assets and following a strategic asset allocation approach. Additionally, as the plans are frozen and funding status has improved, the Company has shifted the investment allocations to lower risk investments in order to minimize market exposure and will continue to do so based upon approved funding milestones. Asset classes and target weights are adjusted periodically to optimize the long-term portfolio risk/return trade off, to provide liquidity for benefit payments, and to align portfolio risk with the underlying obligations. The investment policy of the plans prohibits the use of leverage, direct investments in tangible assets, or any investment prohibited by applicable laws or regulations. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The allocation of plan assets between equity and debt securities and the target allocation range by asset category for the defined benefit pension plans follows:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.192%"><tr><td style="width:1.0%"/><td style="width:47.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.995%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Target</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Plan assets are measured at fair value. Following are the plan investments as of December 31, 2021 and 2020, categorized by the fair value hierarchy levels described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 10, Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:29.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension and Postretirement Health and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal bonds and non-U.S. government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual funds (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage and asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value of investments by hierarchy level</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">582.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">79.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">129.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">661.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">129.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments measured at NAV (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unsettled transactions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">681.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">633.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Equity, bond and money market investments held in collective trusts are valued based on the net asset value (“NAV”) provided by the administrator of the funds. The NAV for each fund is based on the underlying assets owned by the fund, less any expenses accrued against the fund, divided by the number of fund shares outstanding. While the underlying investments are traded on an exchange, the funds are not. Fair values for the collective trust investments are measured using the NAVs as a practical expedient and are not categorized in the fair value hierarchy.</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Postretirement Health and Life Benefit Plan assets of $9.2 million are all contained within Level 1 mutual funds.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Benefit Plan Cash Flows</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company expects to contribute $0 million to the qualified defined benefit pension plans, $0.4 million to the non-qualified defined benefit pension plans, and $7.0 million to the postretirement health and life benefit plans in 2022. There is no required contribution for the postretirement health and life benefit plans under Employee Retirement Income Security Act (“ERISA”).</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Estimated future benefit plan payments follow (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.269%"><tr><td style="width:1.0%"/><td style="width:37.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.283%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Other Plans</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company sponsors a 401(k) defined contribution plan for employees. Employee contributions are matched at established rates. Amounts contributed are invested in a range of investment options available to participants and the funds are administered by an independent trustee. Matching cash contributions by the Company amounted to $2.0 million in 2021 and $1.6 million in 2020. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the Executive Deferred Compensation Plan, qualified employees may defer compensation on a tax-deferred basis subject to plan limitations. Any matching contributions under the Company’s 401(k) plan that are foregone due to annual compensation limitations of the Internal Revenue Code of 1986, as amended (the “Code”) are eligible to be received from the Company under the Executive Deferred Compensation Plan, provided that the employee deferred</span><span style="color:#221e1f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the maximum allowable pre-tax contribution in the 401(k) plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company matching contributions amounted to less than $0.1 million in 2021 and 2020.</span></div>
    3500
    2300
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in the projected benefit obligations and plan assets and the funded status of the plans follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health<br/>and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">($ millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Changes in Benefit Obligations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Obligations at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gains) losses, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid from Plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid from Company assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Obligations at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Changes in Plan Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Unfunded status at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(121.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts recognized in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">      Current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">      Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(121.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amounts in accumulated other comprehensive income (loss), pre-tax:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">      Prior service credit</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.9)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.0)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.1)</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    757900000
    763500000
    142400000
    152800000
    -28700000
    56700000
    -2300000
    -1600000
    2700000
    3500000
    0
    0
    18100000
    24300000
    3400000
    4800000
    51300000
    56300000
    12400000
    13600000
    400000
    500000
    0
    0
    0
    30400000
    0
    0
    -2100000
    -2900000
    0
    0
    696200000
    757900000
    131100000
    142400000
    633100000
    621200000
    0
    0
    57800000
    85400000
    0
    0
    35700000
    16600000
    21500000
    13600000
    51700000
    56800000
    12300000
    13600000
    0
    30400000
    0
    0
    2200000
    2900000
    0
    0
    672700000
    633100000
    9200000
    0
    -23500000
    -124800000
    -121900000
    -142400000
    400000
    400000
    7000000.0
    11600000
    23100000
    124400000
    114900000
    130800000
    -23500000
    -124800000
    -121900000
    -142400000
    -900000
    -1100000
    -2000000.0
    -2100000
    30400000
    30400000
    696200000
    757900000
    <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Components of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive Income </span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company reports service costs for its defined benefit pension plans and its postretirement health and life benefit plans in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The remaining components of net periodic benefit (credits) costs are reported as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Nonoperating Components of Net Periodic Benefit Income.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:45.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health<br/>and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Periodic Benefit (Credits) Costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of prior service credits, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Actuarial (gains) losses, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net periodic benefit (credits) costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(65.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:45.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.342%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.875%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Amortization of prior service costs, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in other comprehensive loss, pre-tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    2700000
    3500000
    0
    0
    18100000
    24300000
    3400000
    4800000
    38300000
    37500000
    0
    0
    -200000
    -200000
    -100000
    -100000
    48200000
    -8900000
    2300000
    1700000
    -65900000
    -1000000.0
    1000000.0
    3000000.0
    -2000000.0
    -2100000
    -900000
    -1100000
    -900000
    -1100000
    -1100000
    -2000000.0
    -2100000
    -66800000
    -2100000
    -1000000.0
    900000
    43500000
    33800000
    9700000
    6800000
    3600000
    10000000
    -1300000
    <div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Assumptions Used to Determine Net Periodic Benefit Costs</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:45.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.323%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health<br/>and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div>
    0.028
    0.025
    0.028
    0.025
    0.063
    0.064
    <div style="margin-bottom:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Healthcare cost trend rates used to measure postretirement health benefit obligations follow:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"/><td style="width:73.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate for the following year</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term rate that the healthcare cost trend rate gradually declines to</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year that the healthcare cost trend rate is expected to reach the long-term rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr></table></div>
    0.060
    0.055
    0.05
    0.05
    2026
    2022
    0.45
    0.52
    0.40
    0.45
    0.51
    0.42
    0.50
    0.55
    0.04
    0.06
    0
    0.05
    1
    1
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Plan assets are measured at fair value. Following are the plan investments as of December 31, 2021 and 2020, categorized by the fair value hierarchy levels described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 10, Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:29.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension and Postretirement Health and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal bonds and non-U.S. government securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual funds (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage and asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair value of investments by hierarchy level</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">582.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">79.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">129.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">661.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">129.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments measured at NAV (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unsettled transactions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">681.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">633.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>
    0
    0
    13000000.0
    16400000
    0
    0
    13000000.0
    16400000
    0
    0
    56400000
    104200000
    0
    0
    56400000
    104200000
    0
    0
    1700000
    2100000
    0
    0
    1700000
    2100000
    582900000
    0
    0
    0
    0
    0
    582900000
    0
    0
    0
    7900000
    6400000
    0
    0
    7900000
    6400000
    582900000
    0
    79000000.0
    129100000
    0
    0
    661900000
    129100000
    20100000
    504400000
    1200000
    1300000
    -1400000
    -1800000
    681800000
    633000000.0
    0
    400000
    7000000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Estimated future benefit plan payments follow (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.269%"><tr><td style="width:1.0%"/><td style="width:37.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.283%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Postretirement Health and Life Benefit Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    52100000
    11200000
    51000000.0
    10700000
    49100000
    10100000
    47600000
    9500000
    47600000
    9000000.0
    214000000.0
    36300000
    2000000
    1600000
    STOCK-BASED COMPENSATION<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company’s 2014 Equity Incentive Plan (“2014 Plan”) authorizes the issuance of stock options, stock appreciation rights (“SARs”), restricted stock units, restricted stock, notional stock units, performance awards, dividend equivalent rights, and other stock-based awards, as well as cash-based awards, to employees, officers, directors, and other individuals providing services to the Company or its affiliates. As disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 15 - Stockholder’s Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in February 2021, the Company increased the available shares of Class A Common Stock under the Company’s 2014 Plan by an additional 700,000 shares. The plan currently authorizes the issuance of up to 1,900,000 shares. As of December 31, 2021, there were 844,293 shares available for future awards.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In January 2019, the Company adopted the 2019 Executive Incentive Plan (“2019 Plan”), which is subject to the terms of the 2014 Plan, under which participating employees are eligible to receive grants of equity awards such as notional stock units and SARs. Under this plan, the Company has granted awards that are subject to either cliff-based or performance-based vesting. The cliff-based awards vest after three years of service. The performance-based awards vest if the company reaches or exceeds a pre-defined net income target for the three-year award term. Equity awards may be payable in common stock, cash, or a combination of both, at the discretion of the Board of Directors. Compensation costs for awards that are likely to be settled with cash payments are remeasured each reporting period based on the closing price of the Company’s common stock.  These cumulative vested costs are accrued in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounts Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accrued Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Equity awards that are payable in stock are accounted for as equity and compensation costs are amortized on a straight-line basis over the vesting period.</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2019, under the 2014 Plan, the Company awarded notional stock units to participating executives for the three-year period ending December 31, 2021.  As the original award, at grant date, was expected to be settled in cash, the Company had recorded cumulative compensation costs in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at December 31, 2020.  There were 206,183 notional stock units (two-thirds of these awards) paid in shares in April 2021, with the remainder anticipated to be paid in April 2022. As of March 31, 2021, the Company reclassified these shares to equity as the Board of Directors approved settlement in shares. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2020, the Company awarded participating executives notional stock units and stock appreciation rights for the three-year period ending April 26, 2023.  These equity awards may be payable in common stock, cash, or a combination of both at the discretion of the Board of Directors.  The cumulative vested costs have been accrued in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as they are likely to be settled in cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In September 2021, the Company awarded participating executives notional stock units and SARs. The awards granted will be paid in shares on or before May 1, 2024, provided that a defined performance condition is achieved. In order to receive the award, the total cumulative net income as reported on the Company’s Form 10-Ks for the years ending December 31, 2021, 2022, and 2023 must be equal to or greater than $160 million. The grant date fair value of notional stock units is determined based on the closing price of Class A Common Stock on the grant date. The grant date fair value of the SARs were determined based on the Black-Scholes option-pricing model. The Company has concluded that it is probable that the performance condition will be achieved and therefore has recorded compensation cost. Compensation costs for these notional stock units and SARs are amortized to expense on a straight-line basis over the vesting period. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Compensation cost for restricted stock units and stock options is measured at the grant date, based on the fair value of the award, and is recognized on a straight-line basis over the requisite service period. As of December 31, 2021, there was $0.4 million of unrecognized compensation cost, adjusted for actual forfeitures, related to non-vested stock-based payments granted, of which $0.3 million relates to restricted stock units and $0.1 million relates to stock options. That cost is expected to be recognized over a weighted-average period of 12 months.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of stock-based compensation costs is as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"/><td style="width:63.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.335%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional stock units and stock appreciation rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 39.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The total recognized tax benefit is reported at the federal statutory rate net of the tax valuation allowance.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board Restricted Stock Units</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-employee, independent directors are granted restricted stock units as part of their compensation for serving on the Board of Directors. Settlement of these restricted stock units is made in shares of Class A Common Stock  only upon the director’s retirement or other end of service. The restricted stock units generally vest over one year; however, vesting is accelerated upon (1) the director attaining eligibility for retirement, (2) termination of the director’s service by reason of death or disability, or (3) a change in control.  As of December 31, 2021, approximately 192,000 shares of restricted stock units could potentially be converted to Class A Common Stock once vested and settled. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes Centrus’ board restricted stock units activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:59.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.09</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.38</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.09</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.38</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.38</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.13</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employee Restricted Stock Units</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2021, certain employees were granted restricted stock units as part of their compensation. Settlement of these restricted stock units is made in shares of Class A Common Stock upon vesting. The restricted stock units generally vest after three years. As of December 31, 2021, approximately 4,000 shares of restricted stock units could potentially be converted to Class A Common Stock once vested and settled. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes Centrus’s employee restricted stock units activity:</span></div><div style="padding-left:36pt;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.105%"><tr><td style="width:1.0%"/><td style="width:50.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.342%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24.01</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24.01</span></td></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The intrinsic value of an option, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of stock option awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, employee stock option exercise behaviors, future dividend payments, and risk-free interest rates.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The expected term of options granted is the estimated period of time from the beginning of the vesting period to the date of expected exercise or other settlement, based on historical exercises and post-vesting terminations. Centrus has estimated the expected term using the simplified method described in SEC Staff Accounting Bulletin Topic 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, due to the lack of historical exercise and post-vesting termination information available for the Company since its reorganization. Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected option term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the option valuation model. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There were no option grants in the years ended December 31, 2021, and 2020.</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options vest and become exercisable in equal annual installments over a three or four year period and expire ten years from the date of grant. A summary of stock option activity follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.011%"><tr><td style="width:1.0%"/><td style="width:40.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value          (in millions)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.02</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.6</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options outstanding and options exercisable at December 31, 2021, are as follows:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.859%"><tr><td style="width:1.0%"/><td style="width:21.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.891%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable (thousands)</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.65</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Appreciation Rights - 2020 Award</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The intrinsic value of a SAR, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of SAR awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, expected term, future dividend payments, and risk-free interest rates.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These SARs generally have a defined term of three years from award and are automatically exercised at the end of its term.  Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the valuation model. </span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of SARs with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"/><td style="width:36.319%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.222%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Appreciation Rights (in thousands) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value            (in millions)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.47</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.71</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.71</span></td></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.467%"><tr><td style="width:1.0%"/><td style="width:61.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.327%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs Granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Appreciation Rights (Performance Condition) - 2021 Award</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The intrinsic value of a SAR, if any, represents the excess of the fair value of the common stock over the exercise price. The fair value of SAR awards is estimated using the Black-Scholes option pricing model, which includes a number of assumptions including Centrus’ estimates of stock price volatility, expected term, future dividend payments, and risk-free interest rates.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These SARs generally have a defined term of three years from award and are automatically exercised at the end of its term if the performance condition has been met.  Future stock price volatility is estimated based on the Company’s historical volatility. The risk-free interest rate for the expected term is based on the U.S. Treasury yield curve in effect at the time of grant. No cash dividends are expected in the foreseeable future and, therefore, an expected dividend yield of zero is used in the valuation model. </span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of SARs with performance-based vesting granted under the 2014 plan in the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:37.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.539%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Appreciation Rights (Performance Condition)   (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value            (in millions)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.64</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.64</span></td></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.467%"><tr><td style="width:1.0%"/><td style="width:61.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.327%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights Granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt;margin-top:5pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Notional Stock Units - 2019 and 2020 Awards</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of notional stock units with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.590%"><tr><td style="width:1.0%"/><td style="width:58.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.16</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.68</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.33</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Notional Stock Units (Performance Condition) - 2021 Award</span></div><div style="text-align:center;text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of notional stock units with performance-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:</span></div><div style="padding-left:36pt;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.590%"><tr><td style="width:1.0%"/><td style="width:51.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.742%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.55</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.55</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div>
    700000
    1900000
    844293
    206183
    160000000
    400000
    300000
    100000
    P12M
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of stock-based compensation costs is as follows (in millions): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"/><td style="width:63.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.335%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.978%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional stock units and stock appreciation rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 39.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized tax benefit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    11600000
    6600000
    500000
    400000
    100000
    100000
    12200000
    7100000
    -1500000
    0
    192000
    <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes Centrus’ board restricted stock units activity:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"/><td style="width:59.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.09</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.38</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.09</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.38</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.13</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.38</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.13</span></td></tr></table></div>
    74000
    3.09
    47000
    10.38
    74000
    3.09
    0
    0
    47000
    10.38
    20000
    25.13
    47000
    10.38
    0
    0
    20000
    25.13
    4000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes Centrus’s employee restricted stock units activity:</span></div><div style="padding-left:36pt;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.105%"><tr><td style="width:1.0%"/><td style="width:50.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.342%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24.01</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24.01</span></td></tr></table></div>
    0
    0
    4
    24.01
    0
    0
    0
    0
    4
    24.01
    A summary of stock option activity follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.011%"><tr><td style="width:1.0%"/><td style="width:40.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.189%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.193%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value          (in millions)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.02</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.6</span></td></tr></table>
    518000
    4.02
    P6Y2M12D
    1500000
    0
    0
    107000
    3.43
    411000
    4.18
    P5Y3M18D
    7800000
    0
    0
    217000
    4.17
    194000
    4.18
    P4Y4M24D
    8900000
    144000
    4.37
    P3Y2M12D
    6600000
    <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock options outstanding and options exercisable at December 31, 2021, are as follows:</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.859%"><tr><td style="width:1.0%"/><td style="width:21.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.891%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable (thousands)</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.65</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div>
    4.37
    144000
    P3Y2M12D
    144000
    3.65
    50000
    P7Y9M18D
    0
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of SARs with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"/><td style="width:36.319%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.222%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Appreciation Rights (in thousands) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value            (in millions)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.47</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.71</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.71</span></td></tr></table></div>
    0
    0
    83500
    5.53
    0
    0
    0
    0
    83500
    5.53
    P2Y3M18D
    1470000
    0
    0
    0
    0
    0
    0
    83500
    5.53
    P1Y3M18D
    3710000
    83500
    5.53
    P1Y3M18D
    3710000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.467%"><tr><td style="width:1.0%"/><td style="width:61.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.327%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SARs Granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div>
    83500000
    0.0014
    0.94
    P2Y3M18D
    0
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of SARs with performance-based vesting granted under the 2014 plan in the year ended December 31, 2021, are as follows:</span></div><div style="text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:37.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.539%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Appreciation Rights (Performance Condition)   (in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value            (in millions)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.64</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.64</span></td></tr></table></div>
    0
    0
    21000
    19440
    0
    0
    0
    0
    21000
    19.44
    P2Y3M18D
    640000
    21000
    19.44
    P2Y3M18D
    640000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.467%"><tr><td style="width:1.0%"/><td style="width:61.763%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.327%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Appreciation Rights Granted (in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (Years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div>
    21000.0
    0.003
    0.828
    P2Y6M
    0
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of notional stock units with time-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.590%"><tr><td style="width:1.0%"/><td style="width:58.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares (thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.53</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.16</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.68</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.33</span></td></tr></table></div>
    468000
    3.16
    125000
    5.53
    0
    0
    22000
    3.16
    571000
    3.68
    0
    0
    319000
    3.16
    0
    0
    252000
    4.33
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A summary of notional stock units with performance-based vesting granted under the 2014 plan for the year ended December 31, 2021, are as follows:</span></div><div style="padding-left:36pt;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.590%"><tr><td style="width:1.0%"/><td style="width:51.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.742%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares <br/>(in thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value (per share)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.55</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.55</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div>
    0
    0
    10
    39.55
    0
    0
    0
    0
    10
    39.55
    INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Income Tax Benefit</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The income tax benefit is as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.356%"><tr><td style="width:1.0%"/><td style="width:54.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.589%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.509%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Federal (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:40.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The income tax benefit for 2021 includes the reversal of a portion of the federal valuation allowance on net deferred tax assets. See further discussion below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Deferred Taxes</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future tax consequences of temporary differences between the carrying amounts for financial reporting purposes and the Company’s estimate of the tax bases of its assets and liabilities result in deferred tax assets and liabilities, as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.944%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits costs</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and financing costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(486.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net of valuation allowance</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease asset</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The valuation allowance reduces the net deferred tax assets to their net realizable value. The ultimate realization of the net deferred tax assets is dependent upon generating sufficient taxable income in future years when deferred tax assets are recoverable or are expected to reverse.</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has maintained a full valuation allowance against federal and state net deferred tax assets since the fourth quarter of 2011 to the second quarter of 2020. In the second quarter of 2020, the Company released the valuation allowance against the state net deferred tax assets for the LEU segment that are more likely than not to be realized.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, the Company released $40.7 million of the valuation allowance against federal net deferred taxes that are more likely than not to be realized.  </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus evaluated both positive and negative evidence that was objectively verifiable to determine the amount of the federal valuation allowance that is required on Centrus’ federal deferred tax assets.  Centrus has visibility on a significant portion of revenue in the LEU segment  through 2026, primarily from its long-term sales contracts.  Centrus considered both its achievement of sustained profitability and cumulative income in 2021, as well as, the forecasted income, to be significant forms of positive evidence. Negative evidence included uncertainty in and the lack of objectively verifiable evidence for profitability in later years when the Company’s existing sales order book and supply contracts reach expiration in its LEU segment.  In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Company’s</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> technical solutions segment, negative evidence included uncertainty in the future funding of the HALEU enrichment facility, and thus, no assumption for the future funding of the HALEU enrichment facility were included in the forecast model because it was not objectively verifiable.  Centrus determined that the positive evidence outweighed the negative evidence and supported a release of the federal valuation allowance. However, due to lack of objectively verifiable information in later years, it was determined that forecasted future income was not sufficient to realize all the deferred tax assets. Therefore, the Company recorded a partial release of its federal valuation allowance. </span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the partial release of the valuation allowance against federal net deferred taxes, the valuation allowance decreased in 2021 by $30.6 million due to changes in deferred tax assets since the beginning of the year. The Company continues to maintain a valuation allowance against its remaining federal and state net deferred tax assets due to significant federal and state net operating losses and insufficient future taxable income. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Going forward, the Company will continue to evaluate both positive and negative evidence that would support any further changes to the remaining valuation allowances. Such evidence in its technical solutions segment may include signing new contracts which could have a significant impact on pre-tax income, follow on-work related to the HALEU program, or</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">abandonment of the commercial deployment of the centrifuge technology.</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Such evidence in our LEU segment may include renewing SWU sales contracts with existing customers and/or signing new SWU sales or purchase contracts with significantly higher or lower margins than currently forecasted.</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additional evidence in the LEU segment may include potential deferrals in the timing of deliveries requested by its customers, which would impact revenue recognition timing.</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The impact of these and other potential positive and negative events will be weighed and evaluated to determine if the valuation allowance should be increased or decreased in the future.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The net deferred tax assets and related valuation allowance were increased as of December 31, 2020, by $39.5 million for previously unrecorded state deferred tax assets, net of federal benefit, in states where we have had historical losses and a remote likelihood of realizing a tax benefit. This increase to state deferred tax assets, net of the full valuation allowance, had no net impact on income tax expense for 2020. When a change in tax rate or tax law has an impact on deferred taxes, we apply the change based on the years in which the deferred taxes are expected to reverse. The Company records the impact of the change in its consolidated financial statements in the period of enactment. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has federal net operating losses of $732.0 million generated through December 31, 2017, that currently expire through 2037. In addition, the Company has federal net operating losses and business interest expense carry forwards of $131.4 million and $4.1 million, respectively, generated after December 31, 2017, that do not expire. Centrus also has state net operating losses of $0.5 million, with no valuation allowance, and state net operating losses of $465.4 million, with a full valuation allowance, that currently expire through 2037.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Tax Rate</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of income taxes calculated based on the federal statutory income tax rate and the effective tax rate follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.514%"><tr><td style="width:1.0%"/><td style="width:64.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.230%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance against net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax expense, net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The effective tax rate for the year ended December 31, 2021, includes a decrease to the valuation allowance against net deferred tax assets of $71.3 million, or a change to the effective tax rate of (53%). Included in the valuation allowance decrease is the release of the valuation allowance against federal net deferred taxes of $40.7 million, or a change to the effective tax rate of (30%).</span></div><div style="text-indent:13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The effective tax rate for the year ended December 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2020, includes a decrease to the valuation allowance against net deferred tax assets of $13.9 million, or a change to the effective tax rate of (26%). Included in the valuation allowance decrease is the release of the valuation allowance against state net deferred taxes of $2.0 million, or a change to the effective tax rate of (4%).</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accounting standards require that a tax position meet a minimum recognition threshold in order for the related tax benefit to be recognized in the financial statements. The liability for unrecognized tax benefits, included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, was $1.0 million as of December 31, 2021, and $0.8 million as of December 31, 2020. If recognized, these tax benefits would impact the effective tax rate. As a result of changes to unrecognized tax benefits, the income tax provision (state tax, net of federal benefit) increased $0.2 million and $0.4 million during the years ended December 31, 2021 and December 31, 2020, respectively. The liability for unrecognized tax benefits in the table below relates to unrecognized state income tax benefits. Centrus believes that the liability for unrecognized tax benefits will not change significantly in the next 12 months.</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:59.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.266%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to tax positions of current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus and its subsidiaries file income tax returns with the U.S. government and various states and foreign jurisdictions. As of December 31, 2021, the federal, Maryland and Tennessee statutes of limitation are closed with respect to all tax years through 2017.</span></div><div><span><br/></span></div><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus recognizes accrued interest related to uncertain tax positions as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Reversals of previously accrued interest for income taxes is typically offset against interest expense, but if the amount is significant, it is reclassified to interest income in the consolidated statement of operations. Centrus recognizes the increase or decrease of accrued penalties for income taxes as a component of S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">elling, General and Administrative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the consolidated statement of operations.</span></div><div style="text-indent:11.25pt"><span><br/></span></div><div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The impact of accrued interest and penalties for income taxes in the consolidated statement of operations was an increase to expenses of less than $0.1 million for the years ended December 31, 2021 and December 31, 2020, respectively. Accrued interest and penalties for income taxes, included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, totaled less than $0.1 million as of December 31, 2021 and 2020.</span></div>
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The income tax benefit is as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.356%"><tr><td style="width:1.0%"/><td style="width:54.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.589%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.509%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Federal (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    0
    0
    400000
    500000
    0
    0
    400000
    500000
    -40700000
    0
    1200000
    -1900000
    0
    0
    -39500000
    -1900000
    -39100000
    -1400000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Future tax consequences of temporary differences between the carrying amounts for financial reporting purposes and the Company’s estimate of the tax bases of its assets and liabilities result in deferred tax assets and liabilities, as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.944%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.080%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits costs</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and financing costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(486.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net of valuation allowance</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease asset</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    36200000
    61800000
    18600000
    16200000
    191500000
    193800000
    206200000
    211100000
    400000
    2100000
    10800000
    12600000
    900000
    1500000
    200000
    200000
    464800000
    499300000
    414700000
    486000000.0
    50100000
    13300000
    7900000
    9900000
    400000
    1100000
    400000
    400000
    8700000
    11400000
    41400000
    1900000
    -40700000
    federal net deferred taxes that are more likely than not to be realized
    -30600000
    changes in deferred tax assets since the beginning of the year
    39500000
    previously unrecorded state deferred tax assets
    732000000
    131400000
    4100000
    500000
    465400000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of income taxes calculated based on the federal statutory income tax rate and the effective tax rate follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.514%"><tr><td style="width:1.0%"/><td style="width:64.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.230%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance against net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax expense, net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
    0.21
    0.21
    -0.53
    -0.26
    0.01
    -0.01
    0.01
    0.02
    0.01
    0
    0
    0.01
    -0.29
    -0.03
    71300000
    13900000
    2000000
    1000000
    800000
    200000
    400000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.204%"><tr><td style="width:1.0%"/><td style="width:59.213%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.266%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to tax positions of current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    800000
    400000
    400000
    500000
    200000
    100000
    1000000.0
    800000
    100000
    NET INCOME PER COMMON SHARE<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Basic net income per common share is calculated by dividing income allocable to common stockholders by the weighted average number of shares of common stock outstanding during the period. In calculating diluted net income per common share, the number of shares is increased by the weighted average number of potential shares related to stock compensation awards. No dilutive effect is recognized in a period in which a net loss has occurred. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On November 17, 2020, the Company completed the purchase of 62,854 shares of its outstanding Series B Senior Preferred Stock at a price per share of $954.59, less any applicable withholding taxes. (Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 15 - Stockholders’ Equit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">y). The purchase price per share represented a 25% discount from the aggregate liquidation preference, including accrued but unpaid dividends, of $1,272.78 per share as of September 30, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Since origination, the carrying value on the Balance Sheet was $43.80 per share based on values assigned in the originating securities exchange. The liquidation amount at origination was $1,000.00 per share.</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aggregate purchase price of approximately $60 million, less accrued but unpaid dividends attributable to the purchased and retired Series B Senior Preferred Stock, is considered for purposes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Net Income per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to be a deemed dividend to the extent it exceeds the carrying value on the consolidated Balance Sheet, or $41.9 million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 2, 2021, the Company completed the exchange of 3,873 shares of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (“Preferred Stock”) for (i) 231,276 shares of Class A Common Stock and (ii) a warrant to purchase 250,000 shares of Class A Common Stock at an exercise price of $21.62 per share, for an aggregate valuation of approximately $7.5 million.  The carrying value of the Series B Senior Preferred Stock on the Balance Sheet was $1.00 per share par value. The aggregate liquidation preference of the Series B Senior Preferred Stock, including accrued but unpaid dividends, was $1,291.04 per share as of December 31, 2020. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On November 23, 2021, the Company completed the purchase of 36,867 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,145.20, less any applicable withholding taxes. The Company also completed the purchase of the remaining 980 shares of its outstanding Series B Senior Preferred Stock at a price per share of $1,149.99, less any applicable withholding taxes, on December 15, 2021 (Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 15 - Stockholders’ Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).   The aggregate purchase price of both transactions was $43.3 million. The carrying value of the Series B Senior Preferred Stock on the consolidated Balance Sheet was $1.00 per share par value. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The aggregate valuation of all 2021 preferred stock transactions of approximately $50.8 million, less accrued but unpaid dividends attributable to the acquired and retired shares of Series B Senior Preferred Stock, is considered for purposes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Net Income per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to be a deemed dividend in the aggregate amount equal to the amount by which it exceeds the carrying value of the Preferred Stock on the consolidated Balance Sheet, or $37.6 million. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted average number of common and common equivalent shares and the calculation of basic and diluted income per common share are as follows:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:76.102%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator (in millions):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends - undeclared and cumulative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributed earnings allocable to retired preferred shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income allocable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator (in thousands):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,825 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares related to stock options and restricted stock units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,123</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per common share (in dollars):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">There are no common stock equivalents excluded from the diluted calculation as a result of a net loss in the period or options outstanding and considered anti-dilutive as their exercise price exceeded the average share market price.</span></div>
    62854
    954.59
    1272.78
    43.8
    1000
    60000000
    41900000
    3873
    1.00
    231276
    250000
    21.62
    7500000
    1.00
    1291.04
    36867
    1145.2
    980
    1149.99
    43300000
    1.00
    50800000
    37600000
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted average number of common and common equivalent shares and the calculation of basic and diluted income per common share are as follows:</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"/><td style="width:76.102%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator (in millions):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends - undeclared and cumulative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributed earnings allocable to retired preferred shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income allocable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator (in thousands):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,825 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potentially dilutive shares related to stock options and restricted stock units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,123</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per common share (in dollars):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>There are no common stock equivalents excluded from the diluted calculation as a result of a net loss in the period or options outstanding and considered anti-dilutive as their exercise price exceeded the average share market
    175000000.0
    54400000
    2100000
    6700000
    37600000
    37600000
    41900000
    41900000
    135300000
    5800000
    13493000
    9825000
    386000
    298000
    13879000
    10123000
    10.03
    0.59
    9.75
    0.57
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in the number of shares outstanding are as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.497%"><tr><td style="width:1.0%"/><td style="width:49.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.893%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.893%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.897%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred Stock,<br/>Series B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock,<br/>Class A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock,<br/>Class B</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,574 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,347,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance under public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock issued for options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Conversion of common stock from Class B to Class A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398,262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase under tender offer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41,720</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,390,189</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">719,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance under public offering </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,516,467 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock issued for options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Issuance of previously vested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Notional stock units paid in shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock and warrant issued in exchange for preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,873)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,276 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase under tender offer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,847)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,649,933</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">719,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
    104574
    8347427
    1117462
    2537500
    107000
    398262
    -398262
    62854
    41720
    11390189
    719200
    1516467
    216500
    89318
    206183
    3873
    231276
    37847
    0
    13649933
    719200
    20000000
    1.00
    70000000
    0.10
    30000000
    0.10
    14369133
    13649933
    719200
    1516467
    44200000
    42400000
    300000
    700000
    3873
    5000198
    231276
    21.62
    250000
    21.62
    3873
    2537500
    10
    25400000
    2300000
    2300000
    0
    398262
    1900000
    844293
    104574
    1000
    62854
    954.59
    60000000
    1272.78
    41720
    62854
    62854
    41720
    1.00
    1145.2
    1347.29
    36867
    42200000
    980
    1100000
    43300000
    900000
    1145.2
    0.0499
    0.005
    COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Commitments under SWU Purchase Agreements</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">TENEX</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A major supplier of SWU to the Company is the Russian government-owned entity TENEX, Joint-Stock Company (“TENEX”). Under a 2011 agreement with TENEX, as amended, (the “TENEX Supply Contract”), the Company purchases SWU contained in LEU received from TENEX, and the Company delivers natural uranium to TENEX for the LEU’s uranium component. The LEU that the Company obtains from TENEX under the agreement is subject to quotas and other restrictions applicable to commercial Russian LEU. Further, the ability of the Company or TENEX to implement the TENEX Supply Contract is vulnerable to any new sanctions or restrictions that might be imposed by Russia, the United States, or other countries in the future, including as a result of the war in Ukraine. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The TENEX Supply Contract originally was signed with commitments through 2022 but was modified in 2015 to give the Company the right to reschedule certain quantities of SWU of the original commitments into the period 2023 and beyond, in return for the purchase of additional SWU in those years. The Company has exercised this right to reschedule in each year through December 31, 2021. If the Company exercises this right to reschedule in full during the remaining years of the contract’s original term, the Company will have a rescheduled post-2022 purchase commitment that could extend through 2028.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The TENEX Supply Contract provides that the Company must pay for all SWU in its minimum purchase obligation each year, even if it fails to submit orders for such SWU. In such a case, the Company would pay for the SWU but have to take the unordered SWU in the following year. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing terms for SWU under the TENEX Supply Contract are based on a combination of market-related price points and other factors. This formula was subject to an adjustment at the end of 2018 that reduced the unit costs of SWU under this contract in 2019 and for the duration of the contract.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Orano</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2018, the Company entered into an agreement (the “Orano Supply Agreement”) with the French company Orano Cycle (“Orano”) for the long-term supply to the Company of SWU contained in LEU. Under the Orano Supply Agreement, as amended, the supply of SWU commenced in 2020 and extends to 2028. The Company has the option to extend the supply period for an additional two years. The Orano Supply Agreement provides significant flexibility to adjust purchase volumes, subject to annual minimums and maximums in fixed amounts that vary year by year. The pricing for the SWU purchased by the Company is determined by a formula that uses a combination of market-related price points and other factors and is subject to certain floors and ceilings. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Milestones Under the 2002 DOE-USEC Agreement </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company’s predecessor USEC Inc. and DOE signed an agreement dated June 17, 2002, as amended (the “2002 DOE-USEC Agreement”), pursuant to which the parties made long-term commitments directed at resolving issues related to the stability and security of the domestic uranium enrichment industry. The 2002 DOE-USEC Agreement requires Centrus to develop, demonstrate and deploy advanced enrichment technology in accordance with milestones, including the deployment of a commercial American Centrifuge Plant, and provides for remedies in the event of a failure to meet a milestone under certain circumstances, including terminating the 2002 DOE-USEC Agreement, revoking Centrus’ access to DOE’s centrifuge technology that is required for the success of the Company’s ongoing work with the American Centrifuge technology, requiring Centrus to transfer certain rights in the American Centrifuge technology and facilities to DOE, and requiring Centrus to reimburse DOE for certain costs associated with the American Centrifuge technology. The 2002 DOE-USEC Agreement provides that if a delaying event beyond the control and without the fault or negligence of Centrus occurs that could affect Centrus’ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ability to meet the American Centrifuge Plant milestone under the 2002 DOE-USEC Agreement, DOE and the Company will jointly meet to discuss in good faith possible adjustments to the milestones as appropriate to accommodate the delaying event. In 2014, the 2002 DOE-USEC Agreement and other agreements between the Company and DOE were assumed by Centrus subject to an express reservation of all rights, remedies and defenses by DOE and the Company under those agreements. DOE and the Company have agreed that all rights, remedies and defenses of the parties with respect to any missed milestones and all other matters under the 2002 DOE-USEC Agreement continue to be preserved, and that the time limits for each party to respond to any missed milestones continue to be tolled.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various pending legal proceedings, including the pending legal proceedings described below.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 1993, the United States Enrichment Corporation, at that time a wholly-owned government corporation (“USEC-Government”), entered into a lease for the Paducah and Portsmouth Gaseous Diffusion Plants (collectively, the “GDPs”) with the U.S. Department of Energy (“DOE”). As part of that lease, DOE and USEC-Government also entered into a memorandum of understanding (“Power MOU”) regarding power purchase agreements between DOE and the providers of power to the GDPs. Under the Power MOU, DOE and USEC-Government agreed upon the allocation of rights and liabilities under the power purchase agreements. In 1998, USEC-Government was privatized and became the United States Enrichment Corporation, now a principal subsidiary of the Company (“Enrichment Corp.”). Pursuant to legislation authorizing the privatization, the lease for the GDPs, which included the Power MOU as an Appendix, was transferred to Enrichment Corp. and Enrichment Corp. was given the right to purchase power from DOE. The Paducah GDP was shut down in 2013 and deleased by Enrichment Corp. in 2014. On August 4, 2021, DOE informally informed Enrichment Corp. that the Joppa power plant, which had supplied power to the Paducah GDP, was planned to be decontaminated and decommissioned (D&amp;D). According to DOE, the power purchase agreement with Electric Energy Inc. (“EEI”) requires DOE to pay for a portion of the D&amp;D costs of the Joppa power plant and DOE has asserted that a portion of the DOE liability is the responsibility of Enrichment Corp. under the Power MOU in the amount of approximately $9.6 million. The Company is assessing DOE’s assertions including whether all or a portion of any such potential liability had been previously settled. The Company has not formed an opinion on the merits nor is it able to estimate the potential liability, if any, and no expense or liability has been accrued.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On August 30, 2013, the Company submitted a claim to DOE under the Contract Disputes Act for payment of $42.8 million, representing DOE’s share of pension and postretirement benefits costs related to the transition of employees at the former Portsmouth GDP to DOE’s D&amp;D contractor. On August 27, 2014, the DOE contracting officer denied the Company’s claim. As a result, the Company filed an appeal of the decision in the U.S. Court of Federal Claims in January 2015. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 13, 2021, the Company and DOE reached a tentative agreement to settle the litigation. The settlement was subject to the approval by DOE, the U.S. Department of Justice, the Company’s Board of Directors, and the Court. On September 7, 2021, after the final approvals for the settlement were received, the settlement agreement was signed by the parties. Under the terms of the settlement agreement, DOE paid the Company $43.5 million, of which $33.8 million was contributed to the pension plan in September 2021 for Enrichment Corp.  and $9.7 million was deposited in October 2021 in a trust for payment of postretirement health benefits payable by Enrichment Corp.  After receiving payment, at the Company’s request the case was dismissed. The payment of $43.5 million is included in revenue of the technical solutions segment for the year ended December 31, 2021. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On May 26, 2019, the Company, Enrichment Corp., and six other DOE contractors who have operated facilities at the Portsmouth GDP site (including, in the case of the Company, the American Centrifuge Plant site located on the premises) were named as defendants in a class action complaint filed by Ursula McGlone, Jason McGlone, Julia Dunham, and K.D. and C.D., minor children by and through their parent and natural guardian Julia Dunham (collectively, the “McGlone Plaintiffs”) in the U.S. District Court in the Southern District of Ohio, Eastern Division. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The complaint seeks damages for alleged off-site contamination allegedly resulting from activities on the Portsmouth GDP site. The McGlone Plaintiffs are seeking to represent a class of (i) all current or former residents within a seven-mile radius of the Portsmouth GDP site and (ii) all students and their parents at the Zahn’s Corner Middle School from 1993-present. The complaint was amended on December 10, 2019 and on January 10, 2020 to add additional plaintiffs and new claims. On July 31, 2020, the court granted in part and denied in part the defendants’ motion to dismiss the case. The court dismissed ten of the fifteen claims and allowed the remaining claims to proceed to the next stage of the litigation process. On August 18, 2020, the McGlone Plaintiffs filed a motion for leave to file a third amended complaint and notice of dismissal of three of the individual plaintiffs. On March 18, 2021, the McGlone Plaintiffs filed a motion for leave to file a fourth amended complaint to add new plaintiffs and allegations. On March 19, 2021, the court granted the McGlone Plaintiffs’ motion for leave to amend the complaint. On May 24, 2021, the Company, Enrichment Corp. and the other defendants filed their motion to dismiss the complaint. The court has not rendered a decision at this time. Meanwhile, the parties are in the discovery stage of litigation. The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the Nuclear Regulatory Commission’s regulations. Further, the Company believes that any such liability should be indemnified under the Price-Anderson Nuclear Industries Indemnity Act (“Price-Anderson Act”). The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions.</span></div><div><span><br/></span></div><div style="text-indent:13.7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On November 27, 2019, the Company, Enrichment Corp. and six other DOE contractors who have operated facilities at the Portsmouth GDP site were named as defendants in a class action complaint filed by James Matthews, Jennifer Brownfield Clark, Joanne Ross, the Estate of A.R., and others similarly situated (the “Matthews Plaintiffs”), in the Common Pleas Court of Pike County, Ohio. On January 3, 2020, the complaint was removed to the U.S. District Court in the Southern District of Ohio for adjudication. The complaint sought injunctive relief, compensatory damages, statutory damages, and any other relief allowed by law for alleged off-site contamination allegedly resulting from activities on the Portsmouth GDP site. The Matthews Plaintiffs expressly contended that the ongoing and continuous releases that injured the Plaintiffs and class members were not “nuclear incidents” as that term is defined in the Price-Anderson Act, but rather “freestanding state law claims concerning traditional-style state regulation.” On July 27, 2020, the court granted the Company, Enrichment Corp. and the other defendants’ motion to dismiss the complaint because the Matthews Plaintiffs had opted not to proceed under the Price-Anderson Act which preempts state law. On August 18, 2020, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Sixth Circuit. On October 6, 2021, the U.S. Court of Appeals for the Sixth Circuit affirmed the lower court’s decision and dismissed the case. The Plaintiffs did not file a petition for certiorari with the U.S. Supreme Court; the Plaintiffs had to file such a petition by January 4, 2022 for the U.S. Supreme Court, and therefore, the lower court’s decision to dismiss the case is final.</span></div><div style="text-indent:13.7pt"><span><br/></span></div><div style="text-indent:13.7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On September 3, 2020, the Company, Enrichment Corp., nine other DOE contractors who have operated facilities at the Portsmouth GDP site and eleven individuals in their personal capacity some of whom are current and former DOE employees were named as defendants (“Walburn Defendants”) in a class action complaint filed by Jeffrey Walburn, Charles O. Lawson Jr., Kimberly M. Lawson, James A. Brogdon, Stephen Patrick Spriggs, Donald Slone, Vicki P. Slone, Victoria Slone Moore, Toni West, Carl R. Hartley, Heather R. Hartley, Vina Colley, Antony Preston, David B. Rose, Michael E. Groves, George W. Clark, Estate of Kathy Sue Brogdon (deceased), Estate of Jay Paul Brogdon (deceased), and Jon Doe(s), and Jane Doe(s), on behalf of themselves and all similarly situated individuals (“Walburn Plaintiffs”) in the U.S. District Court in the Southern District of Ohio, Eastern Division.  The complaint alleged that the named defendants conspired and concealed nuclear incidents in violation of the Price-Anderson Act, the Racketeer Influenced and Corrupt Organization Act and other state claims. The complainants sought damages and equitable and injunctive relief arising from economic losses, property losses, and non-economic damages resulting from toxic and radioactive releases from the Portsmouth GDP. On November 20, 2020, the Walburn Plaintiffs filed an amended complaint to add two individuals to the complaint as defendants in their individual capacity. One of those individuals was Daniel Poneman, Centrus’ Chief Executive Officer. In the 78-page complaint, Mr. Poneman was referenced only twice, without any cited allegations against him; once in the caption and once referencing his position at the Company. The Company has notified its insurance carrier regarding the claim. On February 11, 2021, the Walburn Plaintiffs amended their complaint for a second time to replace two corporate defendants with two others (one of whom was a contractor to Enrichment Corp. and also to its </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">predecessor prior to its privatization in 1998 and the other a former DOE contractor) and removed four named individual defendants from the complaint. On March 2, 2021, Walburn Defendants filed their motion to dismiss. On July 14, 2021, the court put the case on hold until November 11, 2021, to give the Plaintiffs the opportunity to retain new counsel.   The court conditionally granted the Plaintiffs’ local counsel’s request to withdraw as counsel and terminated the representation of the two other co-counsel.  The Company believes that its operations at the Portsmouth GDP site were fully in compliance with the Nuclear Regulatory Commission’s regulations. Further, the Company believes that any such liability should be indemnified under the Price-Anderson Act. The Company and Enrichment Corp. have provided notifications to DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions. On November 11, 2021, Plaintiffs filed a notice of voluntary dismissal without prejudice.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, other than the above, Centrus does not believe that the outcome of any of these legal matters, individually and in the aggregate, will have a material adverse effect on its cash flows, results of operations or consolidated financial condition.</span></div>
    9600000
    42800000
    43500000
    33800000
    9700000
    43500000
    ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The sole component of accumulated other comprehensive income (loss) (“AOCI”) relates to activity in the accounting for pension and postretirement health and life benefit plans. The amortization of prior service costs (credits) is reclassified from AOCI and included in the computation of net periodic benefit cost. For further details, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 11, Pension and Postretirement Health and Life Benefits</span>.
    ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The sole component of accumulated other comprehensive income (loss) (“AOCI”) relates to activity in the accounting for pension and postretirement health and life benefit plans. The amortization of prior service costs (credits) is reclassified from AOCI and included in the computation of net periodic benefit cost. For further details, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 11, Pension and Postretirement Health and Life Benefits</span>.
    ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The sole component of accumulated other comprehensive income (loss) (“AOCI”) relates to activity in the accounting for pension and postretirement health and life benefit plans. The amortization of prior service costs (credits) is reclassified from AOCI and included in the computation of net periodic benefit cost. For further details, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note 11, Pension and Postretirement Health and Life Benefits</span>.
    REVENUE BY GEOGRAPHIC AREA, MAJOR CUSTOMERS AND SEGMENT INFORMATION<div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenue by customer location, including customers in a foreign country representing 10% or more of total revenue, follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.631%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">      Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* less than 10%</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The U.S. government and its contractors, in the Company’s technical solutions segment, represented approximately 38% of total revenue in 2021 and 21% in 2020. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The ten largest customers in the Company’s LEU segment represented approximately 57% of total revenue in 2021. Revenue from each of Synatom and Kyushu Electric Power Company represented approximately 12% of total revenue in 2021. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">In 2020, the ten largest customers in the Company’s LEU segment represented approximately 71% of total revenue in 2020. Revenue from Synatom, Energy Harbor Nuclear Corp. and Dominion Energy South Carolina represented approximately 14%, 13% and 10%, respectively, of total revenue in 2020. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">No other customer represented more than 10% of total revenue in 2021 or 2020.</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Centrus has two reportable segments: the LEU segment with two components, SWU and uranium, and the technical solutions segment. The LEU segment includes sales of the SWU component of LEU, sales of both the SWU and uranium components of LEU, and sales of uranium. The technical solutions segment includes revenue and cost of sales for work that Centrus performs under the HALEU Contract. The technical solutions segment also includes limited services provided by Centrus to DOE and its contractors at the Piketon facility. Gross profit is Centrus’ measure for segment reporting. There were no intersegment sales in the periods presented. </span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the Company’s segment information (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.549%"><tr><td style="width:1.0%"/><td style="width:62.795%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.003%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LEU segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separative work units</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uranium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">190.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical solutions segment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Gross Profit (Loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LEU segment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical solutions segment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company’s total assets are not presented for each reportable segment as they are not reviewed by, nor otherwise regularly provided to, the chief operating decision maker. Centrus’ long-term or long-lived assets, which include property, plant and equipment and other assets reported on the consolidated balance sheet, were located in the United States as of December 31, 2021, and December 31, 2020.</span></div>
    220500000
    171700000
    36600000
    35800000
    34600000
    23400000
    6600000
    16300000
    77800000
    75500000
    298300000
    247200000
    0.38
    21
    0.57
    0.12
    0.12
    0.71
    0.14
    0.13
    0.10
    <div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the Company’s segment information (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.549%"><tr><td style="width:1.0%"/><td style="width:62.795%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.003%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LEU segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separative work units</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uranium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">190.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical solutions segment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Gross Profit (Loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LEU segment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical solutions segment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company’s total assets are not presented for each reportable segment as they are not reviewed by, nor otherwise regularly provided to, the chief operating decision maker. Centrus’ long-term or long-lived assets, which include property, plant and equipment and other assets reported on the consolidated balance sheet, were located in the United States as of December 31, 2021, and December 31, 2020.</span></div>
    163300000
    151500000
    22800000
    39000000.0
    186100000
    190500000
    112200000
    56700000
    298300000
    247200000
    73000000.0
    97800000
    41500000
    -200000
    114500000
    97600000





EXCEL
109
Financial_Report.xlsx
IDEA: XBRL DOCUMENT

begin 644 Financial_Report.xlsx
M4$L#!!0    ( $!?:U0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04
M    " ! 7VM4'19I)N\    K @  $0   &1O8U!R;W!S+V-O&ULS9+/
M3L,P#(=?!>7>NFG9D**N%Q GD)"8!.(6)=X6K?FCQ*C=VY.6K1."!^ 8^Y?/
MGR6W*@CE([Y$'S"2P70SVMXEH<*&'8B" $CJ@%:F,B=<;NY\M)+R,^XA2'64
M>X2ZJM9@D:26)&$"%F$ALJ[52JB(DGP\X[5:\.$S]C-,*\ >+3I*P$L.K)LF
MAM/8MW %3##":--W ?5"G*M_8N<.L'-R3&9)#<-0#LV']^>IW7+8Q+
M))W"_"L90:> &W:9_-;Q:^'47W1=02P,$%     @ 0%]K5)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>	+]O6N[!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" ! 7VM4AW0IP\L%   R&   &    'AL+W=O_V:@
MM=.8-O#\^HA^FWX\?,R*:S&6X:_ -]OK6J]&?+'F26@6KT
M7[(_O-MJU8B7:".C+!@81$%\^,M?LD2^W?0RS)L#)KN 21FYD['9:C*-?>&_
M!6@"P1-+=F1YPU#$B? :Q*57A#F,%A :X^%W7#6($3//S/)(;1G:+1
MWWR->\JYF^*Y:,[_'JVT45#W_R"0K1-D*X5L74J0]!+H1D-&<9SPD"S$3BI3
M-'4XCE&)0.BT3W3:U>@\* X2D7;X94HXUIJ'&N/4.7'J5.,T%RJ0OJU- BTC
MBAB5(&75^-N'#R45T3UQZU;C=AMH#Z;O47!%;N%A8??A6"64>B=*O?]%*QX5UE,)T!CRK!(KET)M7LE8JET#8W@F[K0*PUGL :14W#;B%5D:
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M6,7I+5?8ZH3E;L)P$X"EDA_$&[)\C58R+")= O!M^@,CDIL&PV7]F#!]MA,&GA'\ P=KD)L$HFD"XQH%]GL"-[
M(5]%,4$[5P)WI ;J?(]M3E>4C=3M?MN^Z@^5S$*A=_AFOW"-;C
M_F%-'O*BP6]* ,JV4BP7?X;K]C%!V10>]G:I>H&/%V\02A!+NC$W 59ID_!+
MA&']*8:5#O@ UV!2/IEIG12[5 GFO<1V_;G"NY7V"S]E",MNKC+)*$Q6"1).
M*%=ZM]+V8)ZLPL"#HI*\2$SFTNZ6TG2EQ$/0W*3:/A9
M%V<#QRDYM'#/SF4J*?DT@FV8+>;? <%LK0SL>%RHF"6 90WGYC+N5I+QY1;J
M&B6$PY02RM7;K7K$\[HKE.N2>.K4OV)$C6\79)3X@8'=P\@8 >J<
M[AXOB60)WJ5J:IX=LMH"20^K-?'L'OIPWGIZ>CH0'Z7'P,W\]<-I^AVW]:5)
M*-80ZC2ZD"IU.* ^W!BY2X]L5](8&:676\%]H>P+\/M:2G.\L0.<_IM@^!]0
M2P,$%     @ 0%]K5(4*P6X? @  = 4  !@   !X;"]W;W)KICV8Y"!6;1^S
M+TOWW\]V0L:D$O$2^^R[C[_G^"ZMT;S9$H#8NY+:SJ.2Z'@?QS8O07$[P"-H
MM[-'HS@YTQQB>S3 BQ"D9)P,A[-8<:&C+ UK6Y.E6)$4&K:&V4HI;OXL06(]
MCT;1:>%9'$KR"W&6'OD!7H!>CUOCK+BC%$*!M@(U,["?1XO1_7+F_8/#-P&U
M/9LSG\D.\#;T@D)"3)W W_(8'D-*#G(Q?+3/JCO2!Y_,3_3'D[G+9
M<0L/*+^+@LIY=!>Q O:\DO2,]1=H\YEZ7H[2AB^K&]_D4\3RRA*J-M@I4$(W
M(W]O[^$\X/9"0-(&)$%W+$L]1@S8SW=C0_":F&:"=.:/]37LBX7>'B
M*%M4A2"VULWO=?>4QN2P?C/.6\2R0207$*.$/:&FTK+/NH#B?T#L]'2BDI.H
M9=)+7$$^8./1#4N&R:B'-^Z2' ?>^-HDV8_%SI)Q3^)G#W[2X2FM$#C4G,"56_GFY@C.6;3;;'FG33MKT*FF/PBBV7GVDKA^0C.]Z
M9,PZ&;.K9&PPO_C(^@E++DDH-'##GESSD%Q_^-#BLTI08 ZAWBW+L=+4%$6W
MVK6415-)_]R;?N2..0AMF82]"QT.;MU%F:;&&X/P&.IJA^2J-$Q+UQ;!> >W
MOT>DD^$/Z!IM]A=02P,$%     @ 0%]K5#$%W[OS!@  5QX  !@   !X;"]W
M;W)KT6E?;NP^D^F&# :A)3Q\#NOS_G9>,$.X9*W0]+ N/QX_',/#/VS9&+[]F6
M4@F>DSC-;GM;*7?O!X,LVM*$9'V^HZGZ9%+Z?^6$^H)#XF]%CUG@&^5*6G'_/7SZN
M;GM>CHC&-)*Y"J(^#G1&XSC7I'#\J)3VZCGS@UM;]0#*[HF^UA^X<)P5_\&QE V4<+3/)$^JP0I!PM+RDSQ7
MAF@,@'[' %0-0)<.P-4 7"RT1%8LZYY(,KD1_ A$+JVTY0^%;8K1:C4LS;=Q
M(87ZE:EQ/OF'7@#
M6 H^L3A6EL]N!E)-G \?1-4D=^4DJ&.2>QKU 897 'D(6H;/+A_NM8"IA),LXS*S*$0UPIQH=#O4DBR+2#I"D3Y _VQ9P<2JQFL
MIBI5A86J/,@.$SC&_='-X-"T2"DU;$H%J)9IH?1KE+X3Y32*^%Z!4M$7485P
M&=,KD%)I UEJ&C6F1^,^/,%H%0KM((,:9. $^3$]*,-QP:C5>($QY1CVO7'S
M[P2D.2+T&]9N@0QKD*$3Y#U=4^5":K]YINQ)LHQ'C$CUQ9');9Y%RI\%58O9
M4]M"0@,6]'$?GX"W2 6P/[:C'];HAT[TG^66"I5;RB @EB H(0Z-R4>-W2T!
MFC+#+N..:G@C)[RO7)+X G@C8VH_#/JGVV^1\L*&)[<@CFN(8R?$N5 T*N3+
M%9C') >I0O]!1?U.\9N\ D_VF!H;4 )CPTT9OVN[H:=3O'?&77<\8\I1%>LK
MOA94OH E3U?V3.Z946UD)XM0T!]VX&Q0$3P3^Y*D&Z;RDF/;*QVMJ?W&W!5
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MNK0F2&222&B .R/4AJ:9!KF9IEUCG DZ9'()'INUFDTL[,;::%;82E\S'CRB(%D=_(
M'6VPFIB0NT6:7IX!D-G]^($)U"K5%?^:Z)";Z$Z+D'-&M7";)1]8I%"G336W
M(3>WE0GA'$)+MZ.Q-@.ZCY!8K:J]=DB,;.?1]RV-5>F1_ $6-+&+2=7:C>0J[>>KA6063J@W6("([EOL!/RC'W1$!#B2V
MM^_8I"7H>T8;4HDU4^XHL/L!UN2%W>2E"LA]LH^+\X:5S0X51)./KM'(-UIX
MFYSO#;O:.:R)"[N)JXF3EV<./%%NL%6U4O@>JL[*N
MQN0XKQ^<+L4FU$$.N'&XYV:X,C=D+?]SV=WDJ&OH0X/+;'(8==;I6),9OJ2O
M:K0M1;9HQL_OOXT0'/Y9G%G(%_"VBB9KZL"7=6$6,4<7AC7983?9S<5K$;R@
M10D_!?]^HLF2BO]_-JUH2L%GVJ4:>>$Z5ML.C?3@G=K5)=)&IHD$
MNXG$L.G=13;5J1K_VE3MZU3MNU/U!3;US91[:E/?3-Y>5YWNZ[3LN]-R3L^J
MA)S%)+O02WV=2GWWC<5/6U0G-__,U46)NMNL04/C_L/6+[]R_43$AJ49B.E:
MC5+%B#*!*&\QRQ?)=\5%X))+U3(4CZI=4R;(!=3O:ZY*R.HEOUNL[Y(G_P-0
M2P,$%     @ 0%]K5/$]MKV? P  = T  !@   !X;"]W;W)K[%!L/,^)EA_-I,CY0]\1AC 7ZD2<9G1BS$_JUI
M\C#&*>(#NL>9?+*E+$5"#MG.Y'N&4:2=TL2T+HV!8/(ID7YB[G_\$'R\NUTM/JU78+FX
M6WSPUR!XOUY_"L#K#6(X$S$6)$3)&_ O^!RLP.M7;\ K0#)P3Y)$O@D^-84$
M4>',L)ATF4]J7Y@4VN">RL ,,+\3:R%S%C. *!H.'3#9"5!%]0%>TXQ
M=%P/.DX[Q[CD&'=R!)@1F?X2G!0&?+W'Z2-FWSJZ>E+.,?DK73WIV[->">)=
M![(BSR3"600>D, WBB:4PB6WH3:<[MCCPTK
M?XBS4.+J$K8U2S&!6ZO);&"E7K#;OENM."R5PM6B@ROD>3K
M6]#MTX+=1DWR2L-AMXC_20N.S]Z1U@VN:M] 79O#-=N@D6XQFJ GGT&
M8M;.M2EF.WWF0C$;384:Y&%R>\HLS6>B4"_:4(U5D&G'FEBEW+]"=/].I\,!^@A+W1(M4_Y/N?K':H!(QEJLK_
MZ+VV'0U07"@ML[HQ$&1<5)_THPY$IP&>]C0@=0.RVV#<&&&<:%S>,JAG;ZX?GQ8/'Z_N[E\OKU!BV?X
MN+]]>%Z@QV_H\>GVQ^7S'1B@$_2RN$%'7[XBM:(Y4X@+]+R2A:(B4Y@" XU7I%/KZZ(M\<;
M%@(C AV %T?WGSDP0F;((=E?^.>_IZEIBE,^@T3!7/%IVH^+9N;A;>Y
M(-$\",^&FRZTPVH\"TACM<4V;MC&7K9KJ322;TC1E#G'KFH^[[P5S\-@OL/F
ML!I'P=3--FG8)EZV/W*I%%KG\HUK=)3"Q5<7X<1^-QX'DQU"VRJ:!9.H^^>F
MG3:T4R_M9;*A(F8)TBQ>"9G*Y6^4\AA2'D.P3B"YQ#++N#(9D(LEBB'RSHA/
M+5(2X!UO7#9S-_^LX9]Y^1>02X'K&"V98#E,6 --$T@Z7.FL,[]L_^V1%9P1SM
M^!!9/HSZ5B(>M3HQ\GKQJ%=)%75/6^-K)]K:JNO)!/=0DI:2>"D?I) -*&"NI6!"*S-[!91K\(C+
MA,?H%5:?R7?L8UVF#F_(B>7.R;0WJ]7..=K@WOG12ASV:]R=T PJ@X;;B1LZ
MAG]W!>XQVL9K50[[9>Y.;  .ZD]=3Q(GGZUB)PY I]6DA[#5.NP7N[ONW(59
M .F!?4YH33_TZ"2,[S XSW)LL6I'#?I5[8/J -&$K%I[M%A2U41=P,NX%;)4-^Z7M"?8Q
M+ =90%#\Q[]0PC<\866=74!Y'*?4/#-:$1=9D?;J,K:ES"XC'$;38-;C0BMX
MV*]X-Z9@X*^%!E!&21^>;1= *UIR$W887\'6V$>.]&KSJ,N^B@86>BV&>3$OO"WHDGVB.8A[ E/
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M*GB1'>1TFYA#?V+>[[2]S2#$.C:JK;:.!GI$(^R=XKO;8-IOTEEQAFSM#?^[<._)   &    'AL+W=O9A8LN'U'>NWSF4SMZX^%$L*97H/4OSXKRSE'+U
MI=Q<49
M7\N4Y?11H&*=941\7-&4OYUW@L[FPA-;+*6ZT+LX6Y$%G5+Y;?4HX%NOWF7&
M,IH7C.=(T/EYYS+X,HFQ6J E_F3TK6A\1DJ5%\Y_J"^WL_-.7R&B*4VDVH+
MGUB$I]_93"[/.Z,.FM$Y6:?R
MB;_]3BN%8K5?PM-"_X_>*ME^!R7K0O*L6@P(,I:7?\E[98C&@F#0L@!7"_#N
M@JAE05@M"+6B)3*MUC61Y.),\#OUVCZ#'_NOMX_3]'##9I<3G]'-W\\?)^B4_1M>HV.?CM&OR&6
MHSN6IN"#XJPG 8+:J)=4M[LJ;X=;;A=@=,=SN2S0UWQ&9]L;] ![K0#>*'"%
MO3M>TZ2+PN $X3X.'( FAR_O>^"$M3U#O5_89D]2+-$-)$>!YH)GZ&%%!9$L
M7Z!+%;!,,EIX;A/5MXGT;:*6V]Q#@K,\X1EU^:!<.]1K51Z_7@3#^*SWVC1+
M*3-HR,11-ZJ%ME#%-:K8J_SE[#\0L9#DLD"20Y8G/$]82E%>PT5'*2^*8_6S
MNI@H,UU3:'&)8R4E2.?(9)Q(=E_]067
M! _P5Y*NRWC@L FQOB?1G#UZK>0'Y3]DI>H-K\_6\C' 3_0$=0@Q$'OYR6DO;%G"
MCD&'T.FH+7T"PQ9!Z(5_6R%$1]=T@Q5L=UO%HT46%>+0F>1_*AS%R@-5"X0-/OW]!J+9*E4H,L!*4E 6R\P&H5-TXX=NH4V5$[
ML&JN2RIL*P:!X:T@WL,/$%[^@4^Q'6^ED2XV[
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MBQGH:_O5"2LT)&A[0OE4K8=]&";
M2_H-*JF NH1:AF1L^ ;[^6:Z)&!2],;D;\[HV^7FSVG<+S]@*"Y=4U'K\%!KV"OWLM6F>%&(%_Z14@L( #?.^=H%J
M%U4^"I:H85K][M3#9JYP9.MA2^&@+;[#QAFBG]\F!T,_@3PE0A<::&P8GSEU
ML1DLB(>V,@ZQ<-!6#$/#=*%_7OP9;:@:2[RZ. ; \< ZA7&);:F\K8MATG O
MDP(V^7&BS[FD5D(IM=+E'B:-=#TK$X:X)BZR.=\S XKOS-F09#CP-A/3]6J5
MZMD'6K>ZLX!&J'S. R7<=]H2&EX+_;RF&WTT98LN(?QRJ.U[5+\
M2WY$_[JCV0L5__89VC!<./Y$AT:&F2(_,WV20R,G*^U2K5NJY6 @,MP5^;GK
MFA4K#@VNPBO44SSUL %X#*6:&JK3R /<%1G>B?!GNLL00^0GAL]R5V@??>RV
MG)%C#&IW5N,YEI\N,^U#.;,2.,2%IK)'_F=7_Z<+
M3:F._//,9[G0,-/4Y.N#$ZQ.\.+:>RKJ\>/"($ALBB/>,*+57IE0]
M=D!7AS@F-D4Y/O@/.V)3C6/_%/!+1P:3:M/F4_/3P:Y=>XTW+3(J%OH%
ME +I%J%\9Z&^6K_D&PO=V]R:W-H965T&UL
MK5G;;MLX%/P5PEA@6Z"Q35FRG"(QD.@:;-,$<=I]6.P#(],Q44ET*3I.]^N7
MND2V1)HTVKXDECQG>#@\I,Y8%SO*OA5KC#EXS=*\N!RL.=]\'(V*9(TS5 SI
M!N?BFQ5E&>+BDCV/B@W#:%D%9>G(&H^GHPR1?#"_J.[=L_D%W?*4Y/B>@6*;
M98C]N,8IW5T.X.#MQ@-Y7O/RQFA^L4'/>('YE\T]$U>CEF5),IP7A.: X=7E
MX I^C.&L#*@07PG>%0>?03F5)TJ_E1#AYS?VL)J\F,P3*K!'T[_)DJ\O![,!6.(5VJ;\@>YBW$S(*?D2
MFA;57["KL>YD ))MP6G6!(L,,I+7_]%K(\1! #P68#4!5B_ CFJM?01
M1_,+1G> E6C!5GZH"J**%DM(\K)V%YR);XF(XW/O[O/B[M.-?_48^&#Q*/[=
M!I\?%^ N%%=WWE_QW2<_>%C\"?P@O/%N'L$9^++PP;L_WH,_ ,G!+4E348/%
MQ8B+;$K.4=*,?%V/;!T9^9%RE"K"/'W8O:AMS!A>@@6GR3?PSRW.GC#[5\'D
MZYD\FF5B]W1IFIM>BHH"7.G8@U]EO]:QAWKVX#7!@H*N@(']DG)&HZ;:PK;:PK6I@^\C U_B9Y#G)G\$U2E&>8("XF$\R!!/X
M 5AC>*XJV9IS6G&6Q_[+_&PRF0X%]N6P1&68/9QV,;Z,&0]G74R@PL N)I0Q
M4SATNJ"H!KF'>=OC'BB6F>#!:!V5)ZW*$ZW*G\73E51+J%*SCIT=#.C80[NG
M90UR#C7H*6E$!$9$:$1$IR0;ZV@Z MJM@+96P/I\($6Q%1MDN65EP6XP(W2I
M$M26 F7W-Z?O&.O7B B-
MB$B1BN/VBR/6\734GK9J3_5JKQ'#A>A:^'J-TR40[33 V2:E/S &'+UB96LP
M/34-MTW#U:91/UN2SK.E/I@^@%P<4N))*9)1I>+*NDF[P7.->\J("(R(T(B(
MC(C8,)V.N+-6W)E6W =<<$82WFPE^J9UV.MBC56:GLL+/['&THDE
MPZ26PY M2O4C,D,$-",R0Z)>%8R]/5\M]:T/W?)1VSF%R\.Y
MY<#]3;G
M][244+889[9LB%0P^8R&9E=DAH1F2'0DZTE?]I.M$=Q[(Z@W1P\X*7\I(2N2
M5*U$N0FJPCY[JA:A;/=$KU=_MV(T RE!3R0E_ ?@%.#O6_%)N1*R=Y'*S8-F
M(V6&!&9(>$HVD9DGUD*Z2[#W4M!@IGZJO8<*,V+)A6XT-;X9$I@AX4GI1&:B
M6 OI*KSW3U!OH'[>N33$!NL"=5ZK4=D("/$*]>]1[&:@4=R;_#@OEILQK
M<*Y.7YD*]K=^H #);D;%9,MN496[-9-^'XZ58SH]L4<';W;*=XFWB#V3O  I
M7HDH,;A8*5:_GJLO.-U4+WN>*.:S";LF3Z
MZR4*M1T&G6 GF/-U89T@&@TJML8%VIOJ6M,J:E$R7J(T7$G0F ^#<>?BLN?T
MO<)[CEMS;PXNDI52G]WB*AL&L2.$ E/K$!C];G&"0C@@HO&EP0Q:E\[P_GR'
M_L+'3K&LF,&)$A]X9HMA*D2QH^PK77[O0#2C;&J
M;(R)09939MEHH-46M-,F-#?QH7IK(L>E
M.Y2%U;3+R*VD+0S,9(;9SP 1$6W9)CNVE\E!Q"FF(70[QY#$2>< 7K>-ONOQ
MNO\=/7P/&20J019N]NKMZ/7\W>+!A>G1PJ9)&"9XQ)ULQP61*+GTSL@I8J38.;9^RL?2CYF!!Y35^3KP-/.&2
MRD0(JGCS] +HPF"Y0MU>&C?$T.;_-^9'T#GOAF?NWT_"F  J93AM4/^#G$MB
MR)F@8.B(/-MG5*5:.R)QF/CO+TPDA;0S2\A;/SR%I;*D]0\)=51/&JJGX?G>
MXZNTNN49'1[+,N[:(+G(T#(N"&[-=.95]QQL]E 0#R;Z5PEEO8GXE9+K9TO4
MY1[)!^KAJ.EB$1]J_:__KI-0A\,Y,@;
M'/ESV,W=>>PK\^A>HRU1K_USXLC2/:U[;BMM7ZQQW:A_J-?/W6NFUUP:$)B3
M:1R>]@/0]1-2+ZRJ?-M>*4N/@)\6].JB=@JTGRME=POGH'W'1]\!4$L#!!0
M   ( $!?:U08UM$*B 4  'X-   8    >&PO=V]R:W-H965T&ULG5=M;]LX#/XK1*XX;$#/29RTR;:V0-MUN %;5RSM]N%P'Q2;B;7)DBO)
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M B!_243K^CKY)Y]XDZ)O\P+WM/EP2P_\Y73IO
MB0G_?D?WM-,]#;JGOQ>Z'PA??KBXO'[W_O7% LY)C:T=%$;E#FHKM*Q+$!Z4
MS(C^F(,RF6 2.Y :?(' U0AF!5IXVJ]V0CH'X<*6=BHS964TF>#];RYNDLZ>
M4,XT1AS9$2O:7+(@S29PDV3P'F:
M3&C3%&:3Y!E,9[1]1#/T<0#7QE/V]^#9.!D'55-^ILF,7H?3H'A*0GMP\(Q>
M3\33/DPP&THG1;K+2."/JZM*21KM4T@S55-E<_BSQD\EQ5(JZ8.?S8;('Y)M
M22]*_B>6JMG-2D+V
M]EF&=&PHXR*LB=CQ\T_D6,F@R3QU>SX*"";452X\LGXBW2>:9("2NNLZ!L#4
M-L-[G-JRAB4R%?/ 24O)W99-A2R-M<%+#D,GDL!UA,4/;1X$%@J:^4:U0%IS
M]$(JBBN!I0"0S4M#0,G#13PTV=I"KK5<423)^&F6F5I[1GYEJ$(YG"VSSJDU
M==,.*3\;5$)CG1+H&T()*]$4^Q$[4(2>GD1=VCI=@ 5Y:1@
MT:DV]+F(Y]T$^G*X>!?<_U7%.
M3Z*16%O$P %'*8E50I9GP>,8!/R9,$2G>PA#DF8O7.<\MX[6\570UH;#-7"R
M-MD]1C_"V)AO9<@#Z>)T*"JC%2?0%VP@;LKJLE:QA>W@DEX?UIIXL/(NI+MP
M8+24RYK87UL>"YGJ/M*!L+IJE=SDY;O7GK*:^3
M8-#VFS4<.!./U=J2_U_AV;_''I:2^4^0:$(MN767+/<8%/F1U]DOT(/Y]LNE
M$./(=W.>?3R%Y.A>RF=.Q_F'&/T^J]KI M)O]'PZ>Q"=UP(
MA:ZK=;]!170JX[T1^=[X[7G<'2SN7DSP2\57D "7#[<&;?+096[8NQ.3B^MP
M\W<0VF6\'G>SW<_%:;Q3[[;'/Y.WPJXE77<4KDB46L/! &R\[<>!-U6X82^-
MIWB&SX)^D-#R!EI?&>KBS8 -=+]<)_\#4$L#!!0    ( $!?:U00*,?.W@(
M &8&   9    >&PO=V]R:W-H965TMDP#'M0;"86*DNN)#?MWX^2$S<=UA88]B*+%'EX
M2(ET?ZGTG2D0+3R60II!4%A;'461R0HLF0E5A9).YDJ7S)*H%Y&I-++<.Y4B
M2N-X+RH9E\&P[W53/>RKV@HN<:K!U&7)]-,8A5H.@B18*Z[XHK!.$0W[%5O@
M-=K;:JI)BEJ4G)=O3?XQG%I-O;@,IDI=>>$TWP0Q(X0
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M#\8LCZ0>%WB1MW- 9FLC+FD2>WY2SI
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M.$NHYQS:3YC,;^\>%G_7L-BN;Q^6!YS$I&3L7(MM?!80F5- [Y&N#1-
M*_3VNV\FV>#T)T<]1ZC7Y
MX,4EMAZ;%5K(^YRJP? DN"G)Z[$_P ;M>A_(2NA'V[6^V)X$C]2$W*'!H#"Z
ME.S;@6 )?^@$2.&!%N57',E2!7[>!&,G%#+OD@+B4P DH33&>OF9E"AD5CI:
MQB?I(AN_BU 7R$86RZ[ \@1:*W4A6Z'4ENT%K3AJ=N9>HJ+#Q$KR2.YCGZ)U
M_Q[I7C7*F&HM6_<\ULYQ6($3U2(?*S]R74"#OC8E&'(<5I'B;P*P(!$=H62)
M5:= R0HYRL$(MB@XK$4$CXG%)SK27> :BDHSQ(K/9UA;XUAJ*DD\]3XKSBA9
M!D]4"Y1T,@DE0'>#C2S2%S5(F5:"MI28619!912YT>76VA3OL(=A,,HWG,'Z>&5L(B7XQ?U^,3X("P=B@X45F1*
M.SE*P,9K.TZ\:<-5N3*>$AB&-;UTT+("K5?&^/V$'1S>3O-_ %!+ P04
M" ! 7VM41*Q>1.8"  !G!@  &0   'AL+W=O
MLY.&(HT)B2]^.=\]]]Q=[C(Y*/U@*D0+C[609AI4UC87463R"FMF0M6@I)=2
MZ9I9NNI=9!J-K/!&M8B2.'X?U8S+8#;QLHV>3=3>"BYQH\'LZYKIISD*=9@&
M@^ HN.&[RCI!-)LT;(>W:.^:C:9;U*,4O$9IN)*@L9P&Z>!B/G+Z7N$+QX,Y
M.8.+)%/JP5U6Q32('2$4F%N'P&C[B0L4P@$1C1\=9M"[=(:GYR/Z1Q\[Q9(Q
M@PLEOO+"5M/@/( "2[87]D8=KK"+9^SP1[8U7=&1.#FLMV
M9X]='DX,SN._&"2=0>)YMXX\RTMFV6RBU0&TTR8T=_"A>FLBQZ4KRJW5],K)
MSL[2/%=[:0ULV!/+! *3!9!0[[& -6<9%]QR-)/(DC=G$^4=\KQ%3OZ"/$C@
MDY*V,K"4!19_ D1$L^>:'+G.DQ<1+S$/83AX"TF<#%[ &_:Q#SW>\#]CA^]I
M9JRF#^C^!:^CWNO(>QW]M]:$,NLHBQ/*I1+4Y?":2_I6A:"V,V\N@.J&=8:ZKYU;8MAJ5N 1TL K&(4?
MNM6YI\9G;>.2,ZP;H9X0(4.))22O"R
MMP"5";[SB ;>46MI[;3/PA@&@_!]7X&K=+V\(P+2%QR$,@;B<.P5KQO4A"!W
M() F01_Z$VE\@"0\9?07#L_"-'
M2:8L#29_I'07J)T"O9=*V>/%.>C_+;-?4$L#!!0    ( $!?:U1XS(9>7@<
M ,D5   9    >&PO=V]R:W-H965TC@9C=X/*ZE,[_*'E>2T+N(?P1WWG\&W8:9FI"HQ7U@@'\XO>U?CT^I#V\X8_%2S\VK,@
M2S)KO]++Q]E%;T2 0$,>2(/$?P]P UJ3(H3Q+>GL=4>2X/ISJ_UGMAUMR:2'
M&ZO_4K-07O1.>F(&<]GH\+M=_ K)GB/2EUOM^:]8Q+V3XY[(&Q]LE8010:5,
M_"\?$P]K B>C9P0F26#"N.-!C/)6!GEY[NQ".-J-VNB!365I!*<,.>4^./RJ
M4"Y"(^61-*+SZ8&- _/LJ\\%A#/S]@O+#3ODA
M*S]\(VFO2'VX_BRNVO 7=H[1@R#G5F-F>+&O##I8:XQ5?W JD!"H,G =*5LK
M(_%)AL:IL!0WC7-@@OC-FN+=9W#5CI63P>3H1_$O&\"?BI\A&Y".8W'GE,E5
M+;78$S_]<#(93\[PZ?AP,-U>^&@"./!!O!^,Q>1X<,0/T^G@6'RV@570PIX8
MC\:#D[6WD\%H)8RY&$I8QR.4%[5" ^/\%3$;% RM;.8]*/!^+*"U_:A2%P9$A@W#*S#] 7B%K,&Y96K<%H
M6D6^L)E6A:1BY'>1(%DFUPUF5*L[1^N7!/U!Z@;8@$TIAB.Q/'HL0WW^>F.K
M6IHE^^[XS..WVKK .A,@>,2:[@%+#:+-0&CP'D4EFA0\$<:9@A[8LH&V.=L4
M)=;W:#R%UC.P<'DKBOOLM:U0[HL]BI44_R39G:S(@MPZ8@5C($^!36IR+;U7
MUT)\U7 =^ZP'-4T E*Z[^%"B4[
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M:";Z]]4_8!A)7U7@5(XFWF#4.#5O"M;X!8%VELKMO-J9JFUJ;:7=1JO92*=^K!(^=RI;
M]1E28#B="VQCSNRB;CT/MVM5FWG]E%2D85=6;64W;_$@)7.E:1IJ:N)F[VC4]9-8N6EN5E53850&@>3BU)>F
M@KW#U5XY#U25Y5?ZAET("V*>VX9;SI)&<%:12U]V#66_,=Q"I2C1202M8@&,
M,UE3?+;AT+8DG@8B#Z75: P;2@"_6![HTD=9% [0CY1;[9B6=&_W7'K'_&R"
M#Q@"B!Y]T>6_@P>K'\BDIVRM);LR#XC,XK13-RXO<:"*T>1 NK-Y$S:U38&;OUY$C%QG-B5(04.9A+WMF/?1L80J#9#
M<31$5V3+"+4])EN2!)$5%/?\M<:7DMG.^]N "%G=Z=LFMJX"-?*UH'B
M--_CE;<4U,WZV6^G3>)+%KC!AQV!\=]55?P%SU<4#]CD8F=.-?8YC^VJM.MX
M5UA/HZKW9_]O%?/L*;!_M$*M3BM!<]XCEW,;BTZ&P\E<=?7T+MTW7:?E7V($
M+=G%-DTQ^\E#=]>_W+3>($"^D2GPT1XL($$#A\?^RE'1TC0BS!LS2WS6Z=P:
M^?$'9VS4)D=TC8$X,FMH9EL-D^NN7[,/=6502CUO+?MC<#](<,?>S&KM@>J%_)L1UM:35N8%MC'8H=[??)Z+>?[:6Q5_G\XBNVZ'1JN
M7:_AV%OP)2+]3L80CS=MW6IW3WD5K^=6V^,EYR?I"JP>..K.470T.#[JQ3K4
MO@1;\V5=9D.P%3^6(-'_M &_SRURFE[H@.[V]O(_4$L#!!0    ( $!?:U1H
MU>2J8 <  "T2   9    >&PO=V]R:W-H965T/9<*>VN1J7W]8?QV.6EJ+C+3"TTWJR-K;C'
MK=V,76T%+X)2I<:SR>1B7'&I1]>7X=F#O;XTC5=2BP?+7%-5W.YNA#+;J]%T
MU#[X36Y*3P_&UY*
MK>M=,XID9<0SAOG3964
M@:"2.O[GSRD//85WDV\HS)+"+.".C@+*3]SSZTMKMLR2-*S110@U: ._-7(V/\7*^;9
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MH[(,,QO3$N^5Y*NVZ$/#O63 >L4?Q6'PW$I'?M;65'L7!VC%T?2":F*#B-2H52^.;2F07Q_[BSNC^4KM6"ZLQ[*@
M-J @# 1;BUNI%%M1MPJ;2R>*V%\%Q9PC"8IRL>[5..'O4E4:53!9U18UC_'#
MMY*5I!Y:[0(V&H6<[@_;>!L87!2G' V#A030M-6Z08DMLD63GV=SMA/<.FI!
M\):H5FBQEKM.8F]A8S26)J% 5I !KC==(0YUSBF92U'[^!1/WN[GX@A7(5UN
M&K2 I7P3H.DL.__GX:Q[X[FBV6&Y%07J@+2]F63G6"-*4BB."(6=J^CLD2M"F.\Q7\DP_J/.I#I)5 3#H0
M) #D\^Y!#.@$OAT5$[VJ=B:F-,IM=
M,.E:7EIZH \[ 4X2)DQ7QFZY*\$,L@@):J/M0]L7,"?9-8YL[N6=05V'&IT-
M&J4M];)(4.H84^H
MW9!RP5^8\\ :A(:)H+G89Q%T24Q  K6"!T<%:')?#L,8";X
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M1V,;
MJPME6:.;11B^=!HASFX)Y^65\;U/ >K.<*H]V*.O%?C5FM+P(=0I3@ZXG#,B
M-%R8*//LAE[^,ZG
M2$S[2Q^BX]XG?"7L)OQ0@05&F8U?\]W3[K>01?P)8"\>?TCYS"TV$'TQKJ$Z
MR=Z>C^(72'OC31U^$%@9[TT5+DO!P2PD@/=K8WQ[0PZZ7XBN_P902P,$%
M  @ 0%]K5%LJD18T!@  Z X  !D   !X;"]W;W)K&ULI5=M;]LV$/XKA-<-*9#*MNRD:9H$<)(6*]!N0?KV8=@'2J(MHA*IDE0<
M__L]=Y1DI\W+L'VQ)9)W]]S;<^+)VKIOOE0JB-NZ,OYT5(;0'(_'/B]5+7UB
M&V6PL[2NE@&O;C7VC5.R8*&Z&J>3R>&XEMJ,SDYX[GH^FH7[C6JS+0POCLI)$K]5&%S\V5P]MXT%+H6AFOK1%.+4]'B^GQ
M^9S.\X$O6JW]SK,@3S)KO]'+N^)T-"% JE)Y( T2?S?J0E45*0*,[YW.T6"2
M!'>?>^UOV7?XDDFO+FSU51>A/!T=C42AEK*MPK5=_ZXZ?PY(7VXKS[]B'<_.
MYB.1MS[8NA,&@EJ;^"]ONSCL"!Q-'A!(.X&4<4=#C/)2!GEVXNQ:.#H-;?3
MKK(TP&E#2?D8''8UY,+96ZF=^"*K5HD/2OK6*40\^)-Q@'(Z,LX[1>=14?J
MHFDJ/E@32B_>F$(5=Q6,@6J EO;0SM-'-5ZJ/!&SZ;Y()^GT$7VSP=49ZYL]
M[>JE]GEER5LO_EID/CA4Q]^/V)@/-N9L8_[_P_F$HL6[:_%E\?[S&\$Z;UBG
M]B*42C1.YPI/,J#FVZH0F4*#Y KU78BEL[5 V4/C2DC4O??H;>M$(W4A@A5P
MUOBE3M@);D%RIE9,N
M+S?D>^OA'Y!V38UM;9HV0&BM0\F2);I0^4 ALHX<6R$HAMQ^KVY4)5!.DH/H
ME9!.1?@6 NPRG",?$"RG"%2ECL5OOQREZ>'K7K['K4U>M0528FY@C[,<47QO
M;0!,SI'GN#+Q=/'S,6UD]L+6B.)&E!&0Z%,!K)7^WFJ*)(%%K&C;J<8Z=CJ&
M^"ZN]#%< /$Y^9B(E;U1SG":0+@FWR"2>>NZP.?6P0(;14[JUG":*Z0Q0YV5
M%A@TFA%\4.TYEP:18"%2*S;QR-Q2U(2\6R!VY;.[&Y4?XLR?#VII[U/LV
M+V,^M2NX-#>,2E+E8K] J7$X0X 4TFIL7\><%80[$6^UD2;7\/2= 1.TT>BU
MRJD;"JKQG:[>0RQKC>:"_N?' AREZ@PN]CSUT\ID*)P^4;W'GVR S<=W%QR5
M8W$A?E!H3K@)N-\)J:O9LD1_BFBT_3UG:=^;WJ0)I.'SO#>I0(E./B;
MHRPQ=&4>_*YF"7I(-/_TUJ:S']:I[7WVYX^?D"YS2J]BH]DX1GKNQ]C
MW$F3V0/[M$,Z/J%1BJ>,H9- _!P]:JQ,5L@_<]+]HDW5>F$0AVU1"B4=\1H*
M^6&3#?02;2U;FHBPY6R[0AJ%DUFFP3@8[Y"G/SX3NRH:B417MZ%%%<1-?(&A
M#75.O:!#3S DTK76SUQ#%4,'\@J)U$N-0]1,.-B774CDP=^]O5*[GA)3*"14=DME.V
M8D_=$AGU/CU95X7RN=,9<48&IGT>X7=6,+U0!4Y\_/I97+4(,%A3+%9.Q2\$
M(9O&V5MFU]U!F:E<8NQU><*R+S$%7M!@%48&3-U8@8/_48P,]V1=_#!X*VM6
M40$S.]6']-W(]?^%X"YZVY$BWPQV=WD3S?EOSQTEZ<&OX@]+/%@9]YNE+2(HJ$T=Z3J*[_
M=EUF,SX,@Q\.F#B)=YCJ&8>B2Q0[1T=QM:)-S'3^CJ%E8\V+_EVC$QU_'*D\@Z[ '($^"-#]UU3N-#T)E3C:1^*S<-\G\GCG]E$KM^([%KD!C?$B
M,JP.U[A%O+ULC\<[X ?I5AI8*K6$Z"1Y>3 2+MZKXDNP#=]E,AMP,^+'$E=1
MY>@ ]I<68+L7,C!<;L_^ 5!+ P04    " ! 7VM41V_=_]P5  !@0@  &0
M 'AL+W=OOWZ^JNIM-F;Z"62"Q+*J/ZJKJ
MJJ\.^?5-4?ZHUL;4ZNO.9GE^6;UT539VEN+DM5-9N-+F_?FJRX^7TO
MWG,/OJ:K=4T/CMZ\WNJ5N3+U]^UEB7='?I4DW9B\2HMW^GL^.\XRUY4Y+[)_I4F]_GWO9$\E9JF;K/Y:W/QA['FFM-ZBR"K^J6YD
M['2TIQ9-51<;.QD4;-)<7O5/RX=@PLGPG@DC.V'$=,M&3.4[7>LWK\OB1I4T
M&JO1+WQ4G@WBTIR$6OSA-U651U:>JT-.!ZK?XP.JO7_,G'
M=&G46Y.;95I7KX]J;$S3CQ9VD[>RR>B>3>*1^E3D];I2%WEBDNX"1Z#8DSUR
M9+\=/;CB.[.(U#@>J-%P%#^PWMBS8]9[VM[;'?,@7IGJD69;EE[_N=L
M#N9 A_[W@=TF?K<)[S;Y_V7Z(YM+;AZ\7GRX^
M?U-_7)Q]_/8'?_+QP_L+]?;B\\7[#]^NOJU-:92F_]MM6?Q,H?4FNU7CP70X
M5&:SS8I;8RJF3FC&FT5QC5F)FM^J/QN=I"OEJ:T^\S71>*:Q]
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MW_B6#\$28A@I9U[4H20UWF29K(F=RQ5.2KJE5Y YGZ9>Z[IE!LM+EW6Z2+YJU
M;,B6JJK6=@WVXF2RCK0_5?^/"
MBL.1B=1,>'
M:CJ+CO%[-#Y4!W$T.X2&L1&!]E1@ZPB?TMK_^1\GHWCTFW_]D$,;357;8?%)
MA'--HC$&3]0$FSL+#?5)$[4LBPWSUXGK8!KSEMB>=P;=]#(F"GJFGL/FZ?S6
MSQ[R\&$T/;Q#&0!3+1:@\L\.QCQA=^A9 NB0D@/C2V)^DOX:NR]X$A_2S].[
M$W>$8Z![K5AFI[-H9$43CV,P1L022)PY<<9G>:7>Z[14USIK#"\2ZG2_W&?C
M,1:=C6)L<^=()'.V64V9*W<5[7H@Z42=3$'+[C3'WP7P2)G.&SG:> KIQ[-H
MIK#75)%T=H1#8CP6,9Z(&,=>C'^C($;W">)!WNV(Y9AT67AW&G#N>]XU&7;8J&CEJ:1;'*T[^P8MJQ3EFJYVD&KV(@
M]/.F+,F\! ]I+>9.\'H<#64/OIJ?X>H6/1.)OOA0J.-K%$^(-LAA:*E]S@&(
MZL6BV329)N-;P("6##I*LR9+>4UN .^-.B![->J4OVUY6S(/!$
M,&M\'+L3D4GDV&/Q%0.\4GVG0AQ"[HNU@=U 5SG)7WD'HF]%S^@A&?PN*!#S
M[SS$2L&066IH4=MZG)$G:*:T1EXL?K6[5,?[*RLDS3_!K4"3>!+"K(1E=KM<3A
M*D18M242]#.8H"U8;VA5+ZD[<@G]<-1Q!+1"KW\'X708/E.BC,;&Q'O,/+Z06:WV>!GC]-H[
M4?:AHB?L1BV)X6VGR61&1 @@LX -L0?RFM24-?.^A >-X$@]UB3?$?L(?8EW3
MA9<^3Q$1:+E^7B#./'C!@+P;PYBWGV',;@9;1!4!+GMG'PS [#:X6IJNNV7A
M+J,@5)8!V'*@#VT")0BM'!X'6;@C?,NAL]IJ&7'">5N(J5EX[[K\M8OF4JT C/2]]' NA.(.+]OC) 4/B Y+'13
M(38ZJY@/3I\L2>S+CW^KV$6D>4,&8XE9'"#R@<3N5KBHS ILC*79^F$EAC-6
M$W9C#-V%)@QW!^'>"A_E%0P-7;INT+U/:,?%#8(H@O@H,("/3"N-N.(^.XD#
M,BNA^6P,%XZJ-3S12HSUMBD7:S@!$? *'VSY)M+QV:E"A_OM$\V0VW/Y<#06
MNIG69.*(N#Q.PQ=9P]D-.. JG6<4JP&E,IHH<74%&H?9#8@[ "*_N"_P@HMD
MA03S' (NG+]59\VJ@8$:#>/Q@ !2V;0T58J7*0'#Y:J#^"V-+"X=V8K +%X.)
MX\1F-G_4=>J]GOQ D']U:,\G0(E.+@X'<8P%1ECO"2(01D:_EK@!!_[>S$TO
MB0?G[LBB+]TLRC[G4?:59&E,AA(5Z8
M5T-WJWH3)ZRT/:FSIU_,@X\4OC[&'G'X=,P^R>T&L[T1L,2_$OWN"N=;47.^
M)J2Y+^0F?OM(^_&8NF?5>T%W19>$.'+(/'UZP,_"F[D4@Z7#"A'D]2N [.A<
ML>/4G>"A$E&XBH@SA=[AR
MIJA$N*I?SSDC@.E2KT++N%N'D=0EC9D, 1" -P4@4*"*4!'BR4I\
M!?"IT$KPJ0@CC#JLE$BU@LB?#M5-BJ7C8+VY('EMN?D+%U$(4E\>[+Q8"6E%3+_G@,P^H&W.BJS2^U
MZ9L.8$_#[=D?.,==-?,*>DJ!S$5>8G7FP7E1;B,!3*/!L0PS:I3?,0
MA>KB"U>1I/=C99SKH69C4;S8E HJ,3, !W=W1
M\#?BY,O9E-_%OQU*8 P[0JB1XBE5DL,AGF^@G MM[]AB7:242^*S7V-O@4,.
M'@:F24(OK3[Q])+0E(!YJ@I*3MQ6!EO=C3I T9?ER,E+TJ2JTRUEIHF9G YS
M234Y35O.Y>26?5AM<
M_IS&7C5[CH#U@]T'=[)38/-&_S [.=T.>)=DFIQ9""3EPE]UT
MUVPXY7(=@IL@@J0M@DJ*P!84P_@21]N?!6:B-]2))T186G53)T$4)50\YN%]
M I:7M,3VP GA0M\G*J5$)^=EO0.#4RT>R+?Q+G:V^+IT8^P.]W*U*Q4^GHM?
M13UQ@&/+$Q_8=EE"@265DQYF+ S5+_!NULL[GZ)\-H_^'KX(;2?LG"D:EM($
MF_O*5\J"ZCQ;&PSZJ>SF<4N^IK03;V8E?PI[6DF>D4&(W'9&*I9S'2-=FI4ND\Q>^BWH
M:?V Z(JU+X^T,PA=#ZA;/$1$$>A;F/:L[V/@7?5[ $:+B(\#.V,5HRU+""2$
M,5V110]V%,WT43*6^K4H6?4FNJN=7 (GS]D(REZ?= F'PL*#61; 76YT+A;2
MN)0W(Q)9Z*5'@2W2YMP5):!-7]J\V19Y-Q?<%;WC)25I!Q:D)<9=GU[3'"-$
MMA*58XO66HE6)A1"%:AE8BMTSZISLEASW+A 'WIL#):=]T80#L];&.\F<9IJ
MIX10U71#I(HEZ=>S(*/YO1+JWQGAIGDH&K*G;
M\K)8G0U#=6M%?!73A8$$:!"ST?U-S!S::Q9-R07L:/>$E9+4*XUOAW5SV'"9
M=5$RYMRECR^)G;[1Y0^,9UM&$]?UK
MKDJ=-!S1PLQ0GRA;,*R%?ZSJ3UDDK3J%TI*1.>/E+D$XX(Q^C-J;&.2R/N!2
M$71@5Y!N$OJ0%E[Y"3.E5 7559%S-"R%_H89RQ$,Q_6:5+#BEWJX.MS@,J4G[>K&#F>0 7JA>V;$I%1&@?G(5O7LUN&6^V
M+.3Z4UG\9:220ZU/M+#M?2)Q(T)%[.F*_2X>I4^J=;JL;=4H%*FU:Z@$!L _@
M417)A5*+3$N+!O7\<*NM=0$VOY?\NY&:NG6:; 6P%^$L%:DIR9VV90BF',JBAOO8MXV!;*9:KN
M]4%LHK_)IA=W?/5DJN >1O@Q&:J7>/L"ZW0)G\;T*0V9TI IAIR3J9C@R0S_
M^>$+%0^'ROWL]$.5OI,KH5QH6^F,U/O6$-A&,IN7;&7Y>"W6\HNQJ8VL@FKJ
M.H6>(!:X==8RX6][S%U(0NE#+,)]E__D&??W4S_]>QP6C79K=1\YX13;UY%]
M'=O:1A_F[/OM>W05P<= _1G9A)+JK^?$8RX_Q3/NI+X[(OR?&NYZ(WM9
M<7?1]&04G=X9?M]K=_0GV*P5 1/N7.$[.->+'YS"OY="ZA>8]30>N^?=1MY0
MHZ&C.TH)[@M%H7B.3T4LHU.**<7TG
M(.S,EI=:K,P1+EL^:L"F$/1[[EHQ.3>I;4_702S=N%0@"Z_XOIJ=X"&]CDF9
M:$9,0M#T5I7,PK#]BVXE3/A%-S^^$7($+<[#U)@]L#CX?*([]R='XEF]7
MSM-<9ZZ#L%>Y%"7I"@5[=/XD=9D@_W6>
MP%:[_JP>6QWQG7Z&J0T"B?W3L+FG9*_-\$N^U&41M;/%F\"01-TEV]]>^)76/7V=,!:,]8M,^,[8\]
M#_L825:#X.*W^4^J%B94$
MH3R?Z2GG79J-],:S:KHVH,Y%LGXJY&"WM'V/,$*58UC />+[9 [ZE(^5K>]+
MYT?!M_XW!G$<_6T#_@9-7LL? /!/_9]/.)._&M .E[^]\ EA('W)(C-+3(6=
MFNXA3N>_9R!OZF++?T-@7M1UL>%?8=;!?AJ SY<% B;[AC;P?U3BS?\!4$L#
M!!0    ( $!?:U3:";]0F \  -H[   9    >&PO=V]R:W-H965TV//R+0HR6]YF[$=YR[7)O'$23J=F_L D9"$
MAB)5@+3C_OI[=@%0I"3:;IJ^Y*X?$DLDL=CW?79!/;DIS$<[4ZH4G^99;I]N
MS:RQ%"M<>*NGLY(N[#][LI!3=:7*]XM+
M@V_[-954SU5N=9$+HR9/MT[C1VIX?^*#5C6U\%B3)N"@^TI>7Z=.M/C&D
M,I641$'BS[4Z5UE&A,#&3Y[F5KTE+6Q^#M1?L.R092RM.B^R[W5:SIYN'6^)
M5$UDE95OBYM_*B_/ =%+BLSR_^+&/7O8WQ))9#@[G.W5_YR>NAL>"X
M:\' +Q@PWVXCYO*Y+.6S)Z:X$8:>!C7ZP*+R:C"GRJ+)*/
M>V>0*Q7GQ1RVMI+4]62_!'5Z9C_QE,X]82WKD.D-NV2=2:/VQBSKI;R%:Y7BU!B9
M3Q5][HG719Y(.Q,7GT@/2OS[=&Q+ \?YSQV[C^K=1[S[Z MH^AY*[]Z?'ZZO3=RS>OQ;N98M(RO_W[WXX'\=%C"]W%(W'Q4Z7+6_$R
M3R GHD!<9C(7._30H/^8'Z$K_#U^O"MD5_ZK7" C))KE$88"P=;4KT[?VD"XASB&1G520@EN:97KTJY?[XF\(&HR
M:S^W4(8S$7$C;Z1)<2W5USI5>2H4Q+R6&=G5,=$3$I<+R& <&6_]L%):<8.$
M0'_)\"MWRT*H^2(K;I7"MV(RT8DRO!^$+0O3(J]S9J.2F14+4^"CSJ?"*G.-
M599HE4OKB (+H",)FAG4IFPD3BT(VR0KB 6=PQE+)>(#L2?834)M=V+O&=]">B'35'L['?7[O7Z_[VE'[(T+>C*IC(%-LMN[_*I:D([B
MWLD*E5/F$JE SN)GI9 ;94.C&/\)1@NU+9>8L
MC*?N]-CSRG:K%M*4.M$+1!*\I_8^ ;F$RO14DU2@!P=4Q,L4V:MDHLHYA!,3
M6X,8O'I3$+'34E1&XKVW,YA=,"]-9&J(IS?Z?9'HR\0$$
MK3?BU%^\1H1#*.<7S:<];;J/@"B9(:.4N%72L&@^B+Q'K1%NKM=.NXD7 ;X/
M%&.)(?4I40J/242GVD/=1E)-10[8@Q@IYM"J-%-\(Y=A:Q$/>\2#VX#-%X6X
M\WO.Y:T8@R=YR^Z&6$Q<&/D<1DFE1[M+NC'6N%/=&A5MT
MY:R@+I\/;,G5:1F_@>$K4*G*XFB*8"V&*HHTDUKS+)
MP4-6 D7'/K$@D\14+N.=)DE1$6N77I_DJ*?^_G=:CI$K2^W,^8:=[KLBG^Z]
M@V%:MU>M5*NF82=?MQP#M"NV8&W:.I+RE/UH1>6\9$Y:^MEI1@K""%1N]JA0
MD\H03L6U3Z#>[;U".?^XO+/,L8U1[[.WMU-(2JFJ8#D:
M7K!!KUA_ETW!R"K7?7:O4 ,&_<->?#S-;/O
MJP@LPFJVE\'XVZ&]VJ4[7Z:P7W3CO7F_S2CED
M%0Q#3E!?,)'^LCS*]:'Q>"+7*E "_8A]>]
MX?-MXVHYB>6U&:KVC0:V;;AG0'TY:7*L8#D%![T5SCM'/0][WL,%/4SF=SFP:^^S
M3*+UN4K00Y#YN7?;(T:(H7F1JBQJ]HZ,_&#F)*MJ7] E"0?_&'. \K6R#<<:
MGA$<+[@'FX !._OA$.BY%WAD&*^69\JCOY7]YI5[C@IG8W, V
ML:?Y Q&$HM5I=J@"<:XGNZZ5@ENU^
M- H1P&U9WMA[S51@,/VQLC5X2DH*+'R.0N\,F;%2]!FF:VB:E2D07:5NE>R@/
M1DZ#1HG1>( (HK$7U!M&F_6YPZ9@465;< )\@.7N>[>XC\0,549ZB
MK1N+JSH-!WYIG=X6<1P=XL\A_G^[68']Z$"0 URU/)DT2O_>\(,I;*J.@X2!%V@FY>@-BN5HBO!J]=NQ'64>FJEGM.TL-
ML$JU\-L&H>IJ2SC*^#V-GW'1C&VU'^_@8PJ+P2S8@OMRCJ,B=Q7[L9@5-R@+
MIE?G7(82B?.<)>@YXQFQ0Z=YJ4ILCM2*L/S3WH.
M>:"$^&30F&K1D@Z]H1?-D!*+DH9-K+\Q%U9HRR>H#F,F-9+E-.#0IS.1RS*D
MM](-_SA+\13N'-N8RGJE $R3\W6Y,AV@0"&/Q)63@K)6.2LJBQW11WWODZ0X
M]4GR'USNGE,XOJ "]X$+W,Z"AK%$89>"+#"]UM_%)^)H)+:'4?_$4<)3HR-
M--2$8_'!+=LY&NWZ9UZXJH.+(9V$OW?M@ERZ)!JVP<7MP4$4#^MM1D>[X:'/
MW"=N4+WP>:4K][C>#>L26!TNWQ@$,L[[-3GG-\HF'+&M$=_#$L/:P._!(37Z
M"@+*UI9[<%!]X2B"TP7WW X?ZFB"/XZB?AR\?-6?/]O3:\).EV\\CB#5::A'
MYU8G2[B+OLLAC1Z-;]%_$&@$?K$,"BEWT^S6UJ/S=;#W
M7-YRK;5-3!AZ9X*#\.*YJT/:SZ;\@E8P-FNJS#:?MR;
M4-C!)(J\DX&3'R0L$3$-/,!.P((A]6AOF5I52T2,*U"T*>;\Q%A-=D8(VQ<2U2CC^6#S0Y7,UGKWKLTFP [M_9[
M'UV!FN&^^E;<:I717-E</SC,T]YR=D'!LUQ5QY;C!+O]K$Q!7%=V2=0+M.Q!EB.7,+W.B_"4
M/]'S2^L!UZ96L)YL]:.5CLV55MP<*YZN>2<*LU4W_Y)Y3G^0C=%Q9:X%]_VN
MJ\=T>%I41C1GND04X@-,PT"YYZ\.]A#%7N?K#7&=;'W9"QWPHY52<1^TO A1
M<#B>_TA.7_@;D^G4Z-FA+'+^NBY(MKLQT7;ZH2&G(S
MQHTP]2 ^%MNH=P.TUNA\T=36)7:U<*[^#7( 8L;](X:RHV%W(=X_I\XURQY
M^6ZN"?;&,7$-W@^BH=@^BHX_AVN$_2Z3.?H]N([12(T\UZ,(GXZCD\"-.S'<
MN&;$:X9'8DCVH?E'.UR*YJYY6E]7]U#NN7&C7?7B%>\,3MT4;J?AW0]QUD"C
M*6R3AI./)"496>)A='@@#OJ"+!OTZ_@[;8Z'WKKQT)[SBE,^Z^Y":C1C_=U1
M&O;\:L!9$S_\*@1F_5Q_V2[QT=3R2"8 L^:[$IR'W=L*M $[9U46A L2IJ'J
MP/5%TD]T^$29WV_X,P&!_QT$L%;Z6Y71'>#P.3,X;K\N4P/NE=<%^,6JYC'8
M'2!A8X[:E .^JJJ[UM9V]KG'0U3D[8/H8+VR+BO9?97I-ZG!#$^_#Z"B^OQ9O7$598>V(I9F5[X@E/MRI#SXWE!Z71KU.FZ]T
M;GH#9RU8[C^*8?K!9BL1E.]+)W$=(93[7E#N>\NG%+C?C^+1-_S*,2>4#\ML
M2W=/FO?X[8,=CB-'FYSF>;%GW=Y;C33SMJ]"".^EPU.VIT/QI^P_CC072\H_71WI4@'F]*M^E6.Y@G@GL.X8;[G"K)MIX&-+T+]CFV$
M/P3^34^ 1X?'A!'CP]IZ\2#@QWM/K78&@UV_^IXCL@. 4)J7=(_ PD'P,#X)
M-#__(/A@P/.:X6;;/PB;/= 3/J] _"J'^ T/,,5J+H[[L,5)='#PQ8\P:\J;
M?OFWW_B]Y5R9*?^JE(^:\]+]]+*^6O]P]=3]7G/YN/O5ZRMIIBA;(E,3+.U'
M1P=;[H6M\*4L%OSKS7%1 L/QQYF2L!D]@/N3HBC#%]J@_CGOL_\"4$L#!!0
M   ( $!?:U2*H'WD$@X  'DK   9    >&PO=V]R:W-H965T/S
M^>J]3LGIY$)]6%]WJ]*>C"^;,G6[E6'U3Q:?O.XM=Y3271
MFU$?2QO;WBOHKEAVR+*53+TSZFTZ*S=.31R?8N?7SN@A]:&1].!#;.P8<9\
M^X.8RY>RD,^>6+,3EE:#&GUA47DWF-,Y&>5#87%78U_Q['4>FTR)C_*+_*ORB9?:Q:EQI57B'S=+5UAXQ#^/'+&HCUCP$8MO5.%7
M=O_\XI>WM^+CS=]N/X@6M\]5KE:Z$!\W2FA_N<#E9;BLG9!.K$R*J'+B5.=P
MCC2%G[NSQ^+O2EIO$0%]JFRI;*U3^IB*%Z6U*B\>BU#O0B +Z>3J
M;)!X-)F)TVAR?39(_G1^/;DX"XM>'ZIDQ"NB,_H2319G?.J ^H!F7ANXEY:)
MUKKS[B%=E0?Y)^V/84OU1*M!WS(/*P!&
M$U16V.1O+%6Q4RIG#F-I[9W.UT)FILP+QU*N= X6-1BWBB7"_6UIM\9A-ZF?
M=KXPV5;F=ZSIJQ^<4*[0&=DGR,ZJD\XSH@L7A//FTW*I4UUHW+7* 0VAU#Y5
M[*\>'_'@ ;=]>4CUL;C-MJFY@Y:#<1U4Y_ Y$O-+.-5(7$:31W"8SW!X _5%
MCR:7(J);[RR2FRWNQF*;RKQ@!J%RO476*41T'<&9H^LY=O\,Z]):R?H#BGAI
M8O ";V+%0]D[:1,'3HGV+(HFD;B)8UN"7_4%693T1S$RPXTW)E]_7RB;05-+
M?W*P%.A[_J,I#HYF8/:-@NYKU=V!R+4@WGYAIYKB-/KK48Y87"Y 9'%]/9F+
M7WL<]W01+2@J3Q>/+B?3LSX:8W9MV+W/\4?B8@II1B*:XX3.[I:E'T/[AIFJBK.1N((4(W&-3R\?WV %D>;>P5VEWM,<_0T= EJ/)E?$2K2_JBW(2"SH
M/I;A8$*'/K&PL8P#* P$MB@,W=:6%Z >2O6?DN0C>FK"I!$+/HS"[3:<#)$%
ML"<*(B?D@N46&]9PZ^!XKERM=*SI%K;P<0'<$#XKCQUW '\G=ALU$(26V(D-
MD([W R+H$JDY+FBI"3 89 C0(#8(5BKR"OQAF<1Q:3\8RC66N*(&3/)MQV@_
M)+/3M(]!UA!2BC]*:1$Y)G2E56]N/^'H-6-&L9$%ZS-#$H-W_J[2.[J(_& *$F-9.8-*:K[[
MA)Y% WR/*(U64%DYTWW,L"\&N_=#N'T! 6V)Y.!/ Y6E =O())HJ:[9SKM:2
M?ZC/.E'>JCAC!^S-S)1"Y]F?M=$!7.@,NN<[!8DQIH54(4&CD)8?;H>FM*=<;
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M4&A)" ^ F(B?S(YRV5@D)2/-5UQ0
MYW[*$7RAY7/C2O!]H5IQ%-0>(J_24CMEFPI-B4?FOA>7D':M(L+[*2 FCR8=
M;)$I?$E?ZX(<]Z@NX,@R0;5*ET,^[2'S[=ED/+@W4:B3.7D%.!++.S&:3U'9
M5GDLV"=&[EDC<@<:B*9.6*JUSO.6=Y.5N@4+Q;D&5G.E5E4NT-TQZ32C BTF
MTOSLW=SM(4('AJ,;)UG5'6"KO)N('PUSY'N,KE_LH,-:6F*C2M /
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M/H0UQ$'ERWUG5=D\4)9C404PZ.-94!HH2!E]@Q&\7V(WAB3^(J;,B9/
MM=H3/-*1=K6!B&I([J=-J$9R9_#MZ;
MTP\U.G'1$L!/SW+@M$[8PYKQ(:LWXZ (WHIGQFT"X:#[(>M
MHZOY;#*MG3 ,.[B\\OW4GNM&5V.?LQJ(X@I>M1JP^56GW.FFRZ\R1B(KP!2+7U>=8GZF$?21#-::)424#;1XM)5%T8TU1T6Y6;XY:$'ZT0O75-4 4,,R'"DJB*EI$]EC#__P[5Z__TJ%0L06EQ>-A('<\ 3H?@:Z
M7:V\4OAQQWLZ_X9]-*>VI)Z5-0%(N5&F<>FAKQ,AE3U)C)*'O*VXM=6#!EJI
MZE/K6V$$?9_')J\.SJFI8,EW_J-OSEH5F$.@?GHQ/Q.GL\NS\%R$25:U5R1.
MHS-Q^T7%)7,.R<@7_1G@+.PYA*HA>,:FZJ'*IZH?Y7T^%5)]5MV/6G:J93V=
M79]!T-,Y?7X/\F2XBJ'O@?F"*:
M3ZZ_19S9Y?_!%/T=73!$*R4]A/$%\=V$% ';NSJD;N*8)IL\GRJ 1YP_PNPR
MC&([02@R>BE#TE-_G959M\;=(*EL3,K*\7.NRLQUG]-ZW%F-[
M>S]J'C8175\+AKTMPJYV&R;IGT?QHZV/-.=\TWHZ,^:)R"AJY?K^TC3R&6E$
M3[^.KZ3)_ZHEU3@4^6T&N^U"O^G0V#@N/_GA)0YJ-;U')"^ZCY;12M(0&=R>
M>M?"Q2$ /FL5Z"-Z=MEP_NP*@2"A'8[6(#E[GZ@JP&/?+;*)/>
M2J([-^)&S@](FR<.PUQ\\YL6SV7J8:N'A/CRN'=VVQN)J=G\+;SN@3%46+-94G!TQ1J'K6ZMJ3AE4TARN7
M3B=:^TFG']E:AA\W#R($(?II\F(@U/7#TLQ6B\AE[T696/2(__@ZO??P+
M'N\2[>7AT.P'B5;=-Q9OI;U+N8O$WT>54^VN5*C3/*:G.M-%2 8 7'H5"%9C
M+D.0D/)X, LIO+::BC6Z:GRY]A%Z...?[]=M0FO*5 Z45M0/<@UG\C!->EWM
MO@U-Q@0F]:^B! /67?G!@10\G1J9,N'=EKIK+#>K%3U4K^>;>]W,&(U.40TN
M0AAHUPXQ'GSS,[8X16;'52]<3:EYT.0'9JW>L1 4Q],F^-
M1OA5G" S6)8I)Y,#H0]U^D$H1&F^'HL?N>'RD]B;A+(IO?L5GI(]@.ON/.G
M$$3^"(4PWFC9]9J?.^P_SQ,W#A&M5 8>&.%X4
M%*:0*?8-R#10(C _7 'TO;]WWGH=,E-VS2]]TEP#[NW?C*ROUN^5WOC7*9OE
M_J74MV$HFJH5MJ(ZOS@1UK_HZ7\49LLO5RY-49B,OVZ4!"K1 MQ?&5-4/^B
M^FW;9_\&4$L#!!0    ( $!?:U0(J?V(/P<  *T4   9    >&PO=V]R:W-H
M965T+.
M# :+_4!+M$V4$E62BI/Y]7-(2K*<-':ZN[-?;#W(>\\]]_!>4J<;J;[J-6.&
M/.2BT&>]M3'EV\% IVN64QW(DA5XLY0JIP:W:C70I6(TKQD0F[.>E&O>7#'5VMC'PS.3TNZ8G-F?BUO
M%>X&K96,YZS07!9$L>59[R)Z>SFTX]V WSC;Z,XUL9$LI/QJ;SYF9[W0 F*"
MI<9:H/B[9U=,"&L(,+[5-GNM2SNQ>]U8_^!B1RP+JMF5%+_SS*S/>M,>R=B2
M5L+D4/YGAIZ?JKDAB@[&M;LA0O5S08X7MBDS(W"6XYYYOP&>?]8I#)GY)8I
M,E]3Q4X'!I;M^T%:6[GT5N(7K$0Q^20+L];DNLA8MFM@ $@MKKC!=1GOM?B>
MI0%)HCZ)PSC:8R]IXTR0%>]=4%;Q8Z6V4Y%\7"VT49/'O/?:'K?VALS\\
MS./Q+U+KD_UT'C!V_85\O+GZ_.F:W%[?$5Q\^GQ#YC]?W%V32ZIY2@JXX]Y=
M"3^XR"%Q[>+BFJ14I)6@AF5D\4@R?L\S!-_,H$+(E"X$(T:V4XU,OZZER)C2
M=HY9,[)QDH8->L\45B@IJGP!;W+I/6E[U9U/L.JUH85SEE7*_EE#@,AE%H"@
M%ID;P45ES>\)IN_F/_.+$#$!14C[" ^@+:5AA>%4-/,5\^0@?@\M8L52N"OXGIG.,K8.SUYLU3]=X8N,1T !94U"4
MII52#-%_+F#QGCE0T<0I._3Q7<$[+1X="L$<,,M:I5)88#:"<=R?CH8=VKG1
M.VS/@0)O+G%1<*G(+8H;LW[)W 5(C86J>.HY]DJ!G:/9:!B,9GTB& !;$+0L
M!??RV'"SMIIP>:0/#)P<_IG$T>4>NOU73
M@'SIAO(4@6)H)1K)L7DC\>@G,*Y3616&+)7,'0]TM5)LA7P1P6$U\TDJ78"L
M2*$1:$%4#B5-4U59352&5$5)>>;5SXI,]UV\43^>Q,%DV@%!':-S5AJ?G"3T
MR0G(')9!D^(K7CBW/E\I5>K1NKNGHL+[PCV]I(+:X7/73#>P>C1,@FG8\;1P
M@L5X-Q%\:\U7A5>2-=%Z@FW-(!QN;%;9 ]@K5LR3V66!YHXK9+<#TON.^F$8
M!F''O9^^I?-)5L !S8^*1'(U#M!PA7-Q>'WOH!0BC.-XTE:6K862W
MR)!MPYTD]XNU[TJ81..'HO 06P]KJ)3::[]3:\NVFL/A L&A([.<;6$U0-B#
M+0%8-I9,Q@#WY41:UU)8BF%H)ZN0D$)6HV#6$..6]0>V4!6V-"3V_6K?JFYR
M:0-)^M-)\I\OZCXIJ:JA'T4[J2;'=B'&X;LG4]S3Z-V)X_28GY XL0MBW %Q
M):!*W,]E.@E&VW1\^4Y:EX[Y0R7RY67\A-N6]:<+ZOOUZ97^
M7U_&ZN4=SX!K^*R.8>=4E[&H*6/=SA,GAS7:[3S)N#\=3_Z.SA/UH^$HL#WP
ME;WG2PRUS;-O%=9F)QKY//Q81WTD)X>K
M^$*:-<'.%OL9=_31;3-*_H?KY.4J^6.+9G=E"^%9*5NG?H.V$\[S$C *@^E_
MVZMH"H;5DU:UE4
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M%P  7T,  !D   !X;"]W;W)K&ULY5QM;]PXDOXK
M0FZPR #M]ELR23:9 ([M9)(9QT:<3 YWN ]LB=W-6!(UHN1V[Z_?IZI(BNIN
M>W9G]A8XW)>D)5'%8KT^5:3\:F7;&[?4NLONJK)V/SY:=EWSU_U]ER]UI=S4
M-KK&D[EM*]7ALEWLNZ;5JN"7JG+_Z.#@A_U*F?K1ZU=\[ZI]_'?WWSA,;S@%^-7KGD=T8KF5E[0Q?OBQ\?'1!#NM1Y1Q04_KO5I[HL
MB1#8^,W3?!2GI!?3WX'Z6UX[UC)33I_:\JLINN6/CYX_R@H]5WW9?;*KG[1?
MSU.BE]O2\;_92L8^/7J4Y;WK;.5?!@>5J>5_=>?ED+SP_.">%X[\"T?,MTS$
M7)ZI3KU^U=I5UM)H4*,?O%1^&\R9FI1RW;5X:O!>]_K45I7I(.7.9:HNLE-;
M=Z9>Z#HWVKW:[S %#=S//;DW0N[H'G*'1]D%*"Q==EX7NA@3V =OD<&CP.";
MHP?SC^?_F9W H+Y9\M2F*0V&VSF_T=FL
M6VHBUZAZG1G'EY]ZYXRJLX6]U6U-=/;LJM9%AE^F6PO-2?;!&CRY[FQ^$RD\
M_LM_/#\Z.GC)0_CWX'F0K=N7
MM6[#Y$2D1J1VJO;,V0UF62 5A=)LIFD2ZZ"3V=HS*^Q]J4V'N]>=ZK2;$ U9
M=FY[S$Q^#*72P'D/->D)+O.R+^!P;$@T(X)V6-U*M33^RTU+!B&ZV;T>VYJ%
MJ56)>RL0#*%F9NQ-Y@Z$])' L8TTC
M]+OEQ>,IN$0*+GJ(+M1_T: FR?0=F15IJUM"
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M!)$BDEJ=A^AZ=, B%>]C0Q\\+PU9'#D;EC;&1&>-U'W<9)^KTWC8K6P:!GU^NST\3\2?:
MCL$>A6N!?.,1 !2_C0U_K[/#9A"=+K7'D8/=P,N!1
MR-I1"J>%KI8F%W]K5,LIO5)%ZD-I*B\,\"DQPG'&V?*6U&BD+7W-M<%
M^$;K8OD>8$[!Q:V]HE)>F-U62
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M9F1"U.%F8SU\\>)X1ZNSAF@!KCD@",$[H,>>%*H5112U;3E6T[!^P(0WF',226,S.?]]QV
MYR#BLLZW8QM !]4I,&X(EC
M0PT/H_2
MBZ61V$^./3CGO9P'4T2MN#DEU;<(OQ3._L: EZPW5Y7^)XRVMBO('53JW#1P
M"H1-9PI#A<=&VS#(?X/2=#" JP07P\6,*V7]"E9I6_.WZ(:>9\\"UYPCPR;Q
M3SRT%@_V!7G4 Z>?.CMIV*7O)BR+@%Y:0=&;C+* MF[2B]3!J\=MNZ@)40PW
M[5(;D;)F^M[
M1K_>MNA618$=6J.2Z>POJFI>GI'G,^IG]7K,]Y!)2X YITB$]820PB54_Y LE?_=B^@.ERQ+3CUL<1MB$V"'?M(H0
MYKG?/J2YU5(+>B(@L"$DHL;-P,9VM,T#=Q]61Y8RHPB)_']+:15,.=UUG*4W
M6RZU[3)OE/!"VYB:IY E$HKM:$S+"1MR]?L&5+%6 1WNX&'"F+Q>"_"HJ9?3
M$!ZBA:2,.F$4>+/MB;O!A8X/)NQ_8]@@_5$VXRPOE:F\F29ZBMW(,^.:G@+F
M2^[)T?3YT%)!-T8*O$6X$@Q;DD]3]V!&[*002)KZ7HN[R$C>:I095S_?/3F>/AV('P8$H<:E0G63C#:%H#Y3C$!VE\4#)DGDV3LHH
MW_5- U$B4ZF*/$CBO4" F5X'57%SQ.0$[6S92[IP>L&D@LUPBUD:H3OV\6")
M%\BY1S]PQ'@QLNC)UMK%D)VY\W5H&EJH%8RR2"IBV^B68U[2,O+BV0ALI+CL
M<+GX48*DV)@+OM- D=U1?N2WXO#U(K3FI-JO%"R!RNIPSD^
M@&1KWE9!D"(A9FL?$F37$9P:,L\V=$G"X85%3\4/%IM.\$"MYQDB
M@8!]U(A#Y9?&9"1"WL_WP=D_NB:EH/X8'D/^ETMC80C*=?+DEB.\6.T@)Z?U
M#82J*K7PO5M@%+T@/ZR8 7)RUI3'P"&27WC+@W XGP'S^^?U?08CTV\O
MEO<;B1ZC*
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MM-T]GZ)-&]E_= BRJY
MV#P.VIJD@N<3#]YQ,EKHSH&B5BUU+PP
MD%VWL;-QUDMS+U*-O1W2
MRA\!5X*6BF^ OWGB[PFV(HA(=+[U-6,^:B@8/9_P&!11XJL>?$THA'3]^!;'
M:3K=T\G14WH]IDSHJU2K?QMHVU92V, #79I/4D]L?X8=<#YF(OM,M '22@,V
MQ$$(IPU]Y'%^$ENMV*FT_XA]@UB=K#$JPFAT4P5B5P*4!LSW7K4OO10[0-K?@(
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M%)G^_&CEN1NZOO_ST9^&DKZ?R 7ZSG"T#KS=";9Z1(I%#-?
M3K-?U(K<[T,+^?UL2-P(+!?A_L3G\9,IY>U%07>N.]TL(8\K14GL)KMN6K.@
MS?@S$D2174L_Y%<\,]G5-+F&)HR2Z^S"LIE\MK7)OB)"@BGPE'V:9C\!')<:
M"OY)2R1-[_T*\X"Z2[XXJ3N+E';5\B$$,*"@G^S-E* $:%_ /)0NL_-I]@X(
MB[+@.VU;@.NOTX ]!JCQ,R9;PZAU6&GVF XAT@[?]^FX#R@XKE1?[AQ&.OY
M5;C5CUVX5EANN$%^I9>JG/N2KG*ZO$T.=^S -ZG=;5K$O[O)$]!!3,UBMHG-
MPNEY_4OF-1L%/)<"\[.44L7RBU;9]
MTV67[4+5?LMY VF+YD(C(UT/,^RQ56AXK\.G8=&IS/G\F1K!9#4@H3)H3(1@2;[YY02>I4JH$G<^@
M,OCG%>)!I2@LC<_0G2Y)V.=W.N]9$I>R:\4G)HBC9\_WZ)/4@3.X/'VF(.0\
M.$?)(=9B:SKJON(]FW#@CP!QSML&20LC4POZN OEO:E>9F3 0T-:CJ%+1RW7
MD3RID(I]WH2(U7_,53LW6/UW1BQ!1\=\5K3BH^:V>M=+$
M.TQ1R0XU!^V*:I*Q6HVGF)XT'XXOI?TZ#RGPU%=ACVT]Y#AN
M0";)]MZS&7PBB KG;GS$&_E#WI('R>$1$CR=C=G JRK-H\/$W_NCJ%*/41_+
MAZ?$,M.F3_"GS882-:^.@GRW<^_#W:*A57KX9+O_U?3))A#>6]J2,'%GRL&%
M$]TF'Y\ENF5!-+3QW]Z/-DS(0
MV=[ LFP+18L2AK?T>)BHQY^ECAU8WZ\>Q?=H0WAU;\3I_]_FUDG>_5]L3@UF
MNJ._/!1A]*D,C(!:$;&M'<(O+(1['BAUPK'>\6[1/"Z=CE6[
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M   9    >&PO=V]R:W-H965TZ"EDT64/S3R%*?]ZW>D%-4!VO1E>[%X).^[
M[SN2G\<'ZS[["I'@62OC)TE%5'](4Y]7J(4?V!H-KY36:4$BB$E:
MI=EP^#[50IID.HYS&S<=VX:4-+AQX!NMA?LR1V4/DV24O$SP 7=C-:&$2I,9O)21,.94N.5R7GT726YXUNE" L8$T5
M.EA8S<=;A;X_(:Q,;C7"R8WU_G2<$I<,B6G>P<];^.P'\*,,;JVARL/2%%B\
M!DB9:T\X>R$\S]Y$O,)\ .>C,\B&V>@-O/.^ ><1[_R_:, 9W/$[L24\B&?X
M:[;SY/A:_?T&C8N>QD6D+Q]O'F]G#\@K6#]?+>UBL;S?WR^OE
MW7;U:0FK.XZ7#+_>;D_AH4+P5B%PS=H:-%&S.*)H(\7\%479452!(IS\^LME
ME@T_SM:+51R./I[R*P[I'LBVSU'2%TX#!@OHMC$DS1[8:J#NWKTP!=26^XPD
M'>I I4*AJ(HK2I8(.S182H):">,'D;S0UI'\*N+#9^JUDXSIT3W)/*CRY.$D
M=UA(8JK2,[%<">]E*5E&PO=V]R:W-H965T
M,[2#)EN2+TF6!' <-TG77&#'+89A#[1,6T0D426IN/[W.X>49*=)W(=A+Y9)
MGLMW[N3)6JI'G7!NX'N6YOJTE1A3'+?;.DYXQK0O"Y[CR5*JC!EX:K=2%F(C.=:R!P47YZVAL'Q>9?H+<$7P==ZYS^0)7,I
M'VEQO3AM=0@03WEL2 +#SQ,?\30E00CC6R6SU:@DQMW_M?2/UG:T9R5>\-B'*/ @[(3!'GE18V9DY44_,7/""ZF,R%>[!GNX_<3SD@-N521L
MGG*HN?X>SK51F$#_[('2;:!T+93N?_/X?B&3\9?Q[6P,YW_!Y?CN
MP7 R'GIP,_QT-X'1;/IP=S.>3&%X>P'3\>7-^/8!KF\_WDUNA@_7=[>-T?--
ME6A<02KCRB4BC]-R09ZJ#S7N 2,?8:KG$,LR-VJ#E8G=0*-%1!MT#@!]F"$-
MR"48:5B*%%:1AZPI-@$-[U%0)M(4%>D/Q_ 79\IE#F#<>39'('7LZ:<#LUP8
M/)T:9KB&=Q"&';^'WV 0^ /XZ! = _:8E2@SB/I^'Z*>?PB?6,%RB+JX#B._
M"W%T'/3]"!XLOMJBP0 Y!CV4_+"+F_0='2(U?KL#/X3?(.5:@TE0-!G\
MD'"8^5,?5O*)J]Q&E^4+$$:CEW*;.5)I\BDR<1C)#%%M?OWE, P&?Z @'B>Y
MB%&CEFE)[M>@799X6_>B_:PHE/PN,&EXNH'H\."%CTF%=1OI#X.#:MWQ+4C#
MM4&X3^VU,]JS=OT/1@^"-[5W?C"Z,M;#_.9JM8$KIN98
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MIDOEANU.K;FY;(W PS7]Y(368+E65,X]5>FB/X1]L0P"$(<0;T^SKW]4ZJ^9[AHW+MHO/^,BP_/
MZN0=#")$\0Z.:/SM4]TE_.\[?OCA>8C1M*!KYS&*Z-LHO!AQ%BK3FJ-+F VM
MV4;.IH(=#R^;!C ;NDW#A?;BU=QFJ8<;RO6PM= QFYA9&%?8U@I\698_\F^)CDB@CP?"FE
MJ1>DH'F>GOT+4$L#!!0    ( $!?:U1*!S;S#!P  "E;   9    >&PO=V]R
M:W-H965T,DS:[
MG6F[F3C9?MC9#Q )26@H@B5(.]J__IXG %*4;'>_)*9( @<'Y_$[#_#;>]]]
M"CMK^^+SOF["=\]V?=]^?7D9RIW=F[#TK6W@SL9W>]/#9;>]#&UG344O[>O+
MZZNKKR[WQC7/OO^6?GO7??^M'_K:-?9=5X1AOS?=X;6M_?UWSU;/](?W;KOK
M\8?+[[]MS=;>VOYC^ZZ#J\LX2N7VM@G.-T5G-]\]NUE]_7KU"E^@)_[I['W(
M_BYP*6OO/^'%3]5WSZZ0(EO;LLZ>M _Q;W_.Q7+Y\5
MY1!ZOY>7@8*]:_A_\UD8D;WPZNK$"]?RPC71S1,1E3^8WGS_;>?OBPZ?AM'P
M#UHJO0W$N09WY;;OX*Z#]_KO;WDW"K\I;MVV<1M7FJ8O;LK2#TWOFFWQSM>N
M=#847^A??_GVLH>I<8#+4J9YS=-9(^+42
M_OKZ[(@_V')9/%\MBNNKZ]69\9Y'1CRG\9[_]XSXU\TZ]!W(T[_/S/MEG/=+
MFO?+$_.^-L$%G#7-M."I#L6_Y/\/]G-?O*Y]^>G?]/O6- >Y^9=%<;]SY:X FNJA
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M3N+->\@2 3J3+6R<%P4+MFG8M\S.
M?F?ZPFPVX*-@!!!0DA;97=D@_ 5>JUPH:Q]8YOK'J.=R9,G&1/P^5%M=%>G;
MHE@/0 K(=N/[ O<6A^W] NBZL\U@Z;7.UC1=Z4,/>P1+ >!P9^J!V B_M.*P
M\>$6'NIL#UPA;NRLJ8%E>*=V&Y2BQFY*?$/VQV1SU V($^7. V(1MV@*_ IM8.GJQ4&$@)?>>V
ML)%DOX:.I((WM+.VV#/L@ ' Y(9SG'L9.??R[))^:D ?>M\=GLJIL\,B_/XZ
MM*:TWSTCQ>_N[+,XEQ.US:__<4\*6KPAE&@[?N)V:-O:X=7/_O["DH>#YP8P
MXF[81S_S\X\?H[<35\%,N_<%&G[?X%9\702QD6#U$5Z#E*)?U%%N?_LX\IDR
M"QB>WSX6@#H,6J.F,EU%+^($>VO"(!:!K!^8/;9S@=3 ;D#A>C6GM$!R0&AV
M8;PM4-*(A<3A&MQRV'I='W@N?[2((RZ %T,],R14H+ M>#MTA5MR$Q^+Z^(ML'9I'M?;L[!%?2+MD(7'BVQ(]T!X@'+A,#U_:8%C(W,"[0I+,A>7X/
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M,S^%@ =;3%>;8I47 )0:,#M@!Y[0#P)>SX9V(N,,K 9@?=S+6I"5)PO@6!
MVT0BQ**7(XL>U*(O5,PX[! L/\)"8LISPHZES,U,N3'K3JA=%F_3!:IJB2)
M]@N-ZV:P-7,OD  U0UEC. $R4O+K'XF52=\\@)<]R"L#JZY#",/8XPE
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MCALYA>"@]K/.#E;6 RCP;F*"^0!
M8;HQWVE-,3"<(R;D'$]/$-(@*Q#?C2_8QA 1XB!K0( HD8S,3-%O?CVV@J&.9\\
M^FM4L;^>585WG0>CW&- 5AO!IAAJMNAEGJIU_\541;K;QKLVWE5UZ2K&=Z:$
M6X$"?8)2R^)GP%EVYVO@_AXW0MPD#K,'G05:0,B.!ZTPA"H=>[6&HJ[.8#GB
M LE'T<8,,!GJG835XB9VA,LW0\TI&?E)=DNDO4:B"' M4"AR./L>]QC$('@*
M1%5!_TF@%*VQ;[87/X/R5> L:=I.
M/W7\:&-W&(NDN\(N3@21AT8_MH'K'89T79_G?PU&Q?PHQ6O@L+>6\DSD_':F
MQ;U9K6#7FD_=T/8E@
M\^1CGF2H*P?#3-(\N0^0EX*[L69P=)=4(P%^#0(GVK%ZP<9_P9FGEQ"#KOYZ
M]8UX!'@@H4V9G4UL9[%""D3\>9UYU*,?4@!46+;P#"B3]Z2-(5K;\]8*:R#G
MI8N<#F:'V5BPZR''&,/'TG7EL,?$1DEW*"2R[#Y&9*44!@V^D,PG[.2V\T.[
MR'T'[ BE*"396XM3G1L+ FC@44T\BH*!PV1OBZNSGTO"E20FF&&(>5F B#B@
ME5SEA@#6V+>3[)(*BTUE;B)O, K@H-CE,).H 4?C=L/\S
MZ>7S,\YG365=PB'H9P_A,,U(([(7!-*V(=
MRE.JG%3X#153DUMJ^K*%9&]P''4"1\
M#5W $#@+?D9[OIB&OZ^6UR_^%^T%,*,"QKVUZVY I']]=?VR^"*K9O.3O^*3
M*27>3=E4:L8N1;=Q4X!5L<8W391ECXGYR.8;)E.IJ=^L<F-(>3+BKAV8!Z=9W,
MS/7YHI)O<)$B8N]=^ 0;AWG)7BZ>:&*>,!OW/*2Y].\._RY)&J?.  Q_<*DB
M:1*$@5TE,P'2"-I%%0XR%-0Y0$G9K>I-S'>:F*-<%C]^[J730D+M/D$@A5Z
MRX#,8JL/%<%AS"V[?8DDW1]&[ =)I#&Y@J5U13D?0J
MI5V!EYRI=%I1[FVY:S"#"$%X/4CIG >62#ZPA07075A,(%I UKA^N..VS4*"
MRV;88,*R(W,(7I2L!DRW18UN(B $[%!!T#/8@'R2]J/T&&,$=N6Y!893H74% .9 ]=!2;FG=Z7'@VE!&G!:VW&3Q[!F
M3"WTU-CEF+4]'#EAH'ZM,3MS !K9@MAY8S("NLK2*VQ>B(,UD;]]E6%YDFIT(BUV]$S.!Z/+#49=BSQ3*P
M.5%E.<423:X]R(%E;JKB=B1B<<.F=7IS8\NS.7V+0(#S"L'=<"(1^#ZUU$;00&O&
M)M/21GR@S3%9&)"# TPPF6UG;6H(FG@"XI9(6[#9:I#;$">'H$[>B:? ,OY4
M,]!/B@HGHGW+;M9S2,@^M>TS0YU @%K+*@5'ZI77]N E),Z7A49?1 A;)5CD
M2RSB+5*-6VSH9<;CS(RB,8P.71K*X/WM,$Y:XVH:'=Y T_00_-D?<$AE3+5>/N9[N!Q9*^Y
M!V7!!7$R@C4B/363YW.\H?C_)@0OU29RO$\G8T3.DO?HQ%D==+<
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MY:W%.*6S&*=^L*=/TO^#6\9C89R[DADERO74UR(A#[BC\FPV:#%1GI@5
MSEV[F"&3S<+Y3/OQ<9_U 4WE$-*)L&@-M,O&WX_?QSQ@
MX]"+<3BE1UGL^'4Y!P;\I2!1>M9'4I,?VE&NP>LH_X0&\^R45\5,
MO8(J)2S*B$SH%J=ULBR8E)Q$[\DX82VOAND;;A\A4W[-ZG
MASC9%4;%RMG$5Q9OXHSKE,-"CUE@TT5]&LKR:HX'1BL@AWWH'&)E6[0)39^=
M J(;BN/(<=-^:3 _34,^F+93?\5UBZWDX.+3L2EN/=*?B2_3PP1A/G-)DL85
M&-VGD1!,^'FF:%I
M$S^NN?-H*40DOT X[GHY7(L)FHY='(<1.;H%+I8[.Q*#Z'DQ$$#=X:+47U1:
MLDXZ,BX2D,%,X./Y$3FBBT*4HZ'V)83K!@50>;V?0K_
M<6@M6B9T:R4 37F\J)4C?^ZDO8;B(3V$I_LW/BFM9Z-Q5^G4&J;DA%H1W#R=
M,$/[0KI4I'(N!C7O:%'?19M.J*(N:K-&#^&;\[/A1:^6-5VCO>(GX%DF
MH$S3YZPWU'?QO@KF@D/O.Q>R7'/J>Y7T5W/&E#_(5FV.3*.M-M):**
M$ ?C9T11E9/<$!YF!CZVN^+F]DWQU=57%ZNKBQ=7%ZLOY>R9I".T$2NSML1$
M7503^IK8BR?5)PF^N8S^]),#_>@--@O20Y25
MM]ZIBT>$2X?.#@\OZ61J1)/)*@_B;$(ZVB]IY
MM1OM-'F?"@&/R]?3L<%TRB?M<8-LK?%"_C
M$1DKWQ6:% ?FDFVRR*D3BVFH8PI]HM?Z3\Q0WL!B$%%R[<9MA.RZTH+5K@B95J(EBZ#'6
M)<,WI,QA9F:.5.?4[.=XF#Z&LCK_F9)WV6=K_M'C)R'>C3]>@Z>]GL[0QT\Z
MF>[OZ5LY/V,G[6OY5@Z1D?N\V.27O:RHG>R^%+ MN'!_L +R^6&KQIT[W:OX
M11[]B \>"PE/^90/O<">:]1WJO=SOY*@ICGK#T=?5
M@.W29XU&G]M9$N/RNM,L163O8HA+AIX_MQ6).6Z1I@,69+QJ((D.CL2LH\ Q
MW8,:+$+-Y:W4Y3IW]E5K^I0F];^S99?O#(TA#Q8Y;)V=0Q'[)!GPQ+$M52JY
M!XJ0LMMC7Q0L(,4G\_RG.+)\ O6(Z0.R#")F\@?;3./F::UT?3C,X&&CZ/+M24^6/$
M#XG?!H@U.G(FQ#]MLN?O:>P1G=&I=G%DTS@K:C2>N(6(CNHNG&:@+R90*8=,
M&9ZZ@MT#D=),YK3+-_=Q&%#B9L&8M:/PHFOR]&2-3<\[D,6H&5 VK\H:@X?A$[QT:N@R+/KQD69B>ZJ:@4!?- !]A931D$R3X,,ULKLMN$-R=
M?X" _,_%V,Q.\?3D8Q+Y89;3>8>D,R>+A[#VC768-M*DJ?17G#5"Z5,/J_/?
M9/C5WH^^&-KY!OXNM7IZY.S3_T$D&K8 N["
MP\2O&.:^O;E]378(7[K]2'<@-%Z,+=T%S!"1P&O%&A>(? E%C+ *_/XW:1G[
MXG98][YU9?%R]>+B^BI^\7/O*ZO$Z8<68Z;'P!>V
M#A,0(V E6RA]+('275IKD:HO?PK32?IM R3">N0@,/5Z8 K/[;794?M=>HJF
MQH^O[=8UE$/@[H4?8+>H5W+U@KYE>\6R&S\%YH*HIV8WR!S ,CH?OVS!Y@ +
M5ZGF_)@A)3[9@]!-F*%%2NRJJ@HPRBI,A.>"C3
M-'+V579TWM5?9E\OIJ/B^(UFRCXV/7_(./X:OP-]PU\_3H_S1Z1_,=T6<4YM
M-_#JU?(E1#0=?Y>9+T#^Z%O(:]]#P$%_ I8%#(P/P/V-][U>X 3QZ]C?_S]0
M2P,$%     @ 0%]K5'<<,9'\ P  T@D  !D   !X;"]W;W)K&ULM5;;3-2OX+7?WZVN#7=R@Y*+DR@JMR/#E
MM#5/QA=];Q\,?A-\:X_NR6>RT/JSW_R43UL=3XA+GCF/P+ \\$LNI0<"C;_V
MF*TFI'<\OJ_1WX71N]6T-6I1SI=L(]V-WK[G^WP"P4Q+&ZZT
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M3'@Q%3[Q[B :4+AGMF:*NCWLTV[4HU_!SI!_G R <*<=-*@S'@[A,>Q'
M?:H+>_Z5IH@Y&D2)7]]TCBRA:YT?29TQ]T350_+(G3T1>7=28A=(-D)7O? ?
MB)BF/@$D,DRBX?\@XMTQ;Q_O356TM#>,4OJ>T)P6W0)H)'QB&OO--/9/#LKS
M$W]&96:#
M%7R(F7E%KP=1OTV_:'6>-5!59:56Q3E>9N43[^^^&:5)^D/ &7H$+&VDL>3P
MSYM*GU,-B%J/1F%8TE$27 9HGWG^4.D17EJ'P3CV"W.-I6K0+I:7O134.7CV
M^B$@EK2BF+2?ZZWXZ#L+G"+\3=AJ'JM/;G/:_+#,J^_TP;SZV_G(3"&413\O
MX0I-T$FF^H.H-DZOPU=[H1U(A]L5?KJX\09XOM3:U1L?H/F-F_T-4$L#!!0
M   ( $!?:U1;72AF0@,  &P(   9    >&PO=V]R:W-H965T,DL7F)%;.QKE'1
M2:%-Q1QMS2*QM4'&@U$EDRQ-]Y**"17-)D%V9F83O712*#PS8)=5QD H,7?> Z/'-1ZCE-X1P;AJ?49=2&]X=[WV_B[D
M3KG,F<5C+;\)[LII-(J 8\&6TIWKU7ML\PD _"*D&JP)G%#^I5PX
M0Z>"[-SLF-GR-?@[G%XMQ363J)P%ICB+([SM("'$'.UO#/LJV>CS!/(9^[S5D:=;;XJ_?
ME:$?_/7_OPS?#^4)/QI4301>/=1WP(8U/!M[KU
MG3RV-U'\1@N.CH]U53/UZ^6+4=;;
M?VLA#V7Q=\ '93&W90GGS$((I;R$VLV[R[6R6@K.O&S.)%,YA0S?&J>!57KI
MO6U2MHX>U/O.%R;X+PBWA5="41=(20UM=\= -,!JCJ:C@K^EMY7\"_D.] [Z
M\<@_AUF!$.\:Y
M\-]G*@Y'QX2D0BR8X4%U R7Y4^5_DB(/)<27]EU]U&KQYA)-M4'RC88+&FH)
MPD,SB869L@,!5_:65EF\=V\_C ?PF3(P'7.:J]]2XNV9M(D(
MR9T)4*%9A#GGP5*'-<.@DW:C]+"9(+?JS1S^Q,Q"* L2"S)-XWUZXZ:9;@LAPY%TVZ'80?%9A*ALN1)IPDMMA@Q6VL:U2TLM*FXHY4LTYL;9"7
M(:B2"4O305)QH:+9)-ANS&RB&R>%PAL#MJDJ;I[G*/5V&F71WG KUAOG#&M*2CE*)"98568' UC,0+E-*#*(W?.V;4;>D##^=[^I=0.]6RY!8OM/PA2K>91J,(
M2ESQ1KI;O?V*NWKZGE=H:<,(V]:7#2(H&NMTM0NF#"JA6LF?=N=P$#!*7PE@
MNP 6\FXW"EE>43EM!%KX
M<,>7$NW'2>*([->38D>9MQ3V"B5C<*V5VUCXK$HL_P4DE%*7%]OG-6='B9=8
MQ-#+3H&E+#O"ZW5U]@*O]T:=SZ?PC9[ZS_.E=8:>Q*\C[+QCYX&=O\)>4*>4
MC430*S@XSY>.\2C(-^#8UKS :40=9M$\8C2[T%6M%4&MYXN#^^(&@5M8:4FM
M1=FQVX]CH!/$:HFF.\7_+"E<-,80KI,'V;?G]*;# FMNN.^LT'[0
M*$&)GL H'M'X_MV(9>Q3IV?#."61QP.OL#B'>\.5:"H8L;A'3CD,>_$9Y$-R
M3\E"DS[<:<.E"DX,&J="LPS=@H="-
M_M-77.S%LJ"Q!6%IO&P'X%I6[]5G*Y#NRVUH^8-TPW]
MEFB\ ZVOM'9[Q6_0_;^S/U!+ P04    " ! 7VM4!V3=_KP"   ?!@  &0
M 'AL+W=O%*@L;U-)@GX\70Q?N 7QPW9F\/3LE*J3MG?,VG0>P*0H&9=0B,'@]X
M@4(X("KC?HL9=)0N<7^_0__LM9.6%3-XH<1OGMMR&HP"R''-&F%OU.8+;O6<
M.+Q,">-7V+2Q0V+,&F-5M4TFN^*R?;+'[3WL)8SB-Q+2;4+JZVZ)?)67S++9
M1*L-:!=-:&[CI?IL*HY+]U)NK:933GEVMM3T?K5].H:E8-("DSE\IHNW
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M965TKS]*=GS9U@3#7FR1(C^2XD=IMK?N@2I$#X^U-C1/
M*N]W5UE&186UI-3NT/#.QKI:>A;=-J.=0UE&IUIG8C"89+54)EG,HN[6+6:V
M\5H9O'5 35U+][1";??S9)@<%!_5MO)!D2UF.[G%._1_[6X=2UF/4JH:#2EK
MP.%FGBR'5ZMQL(\&?RO']#?Q-JYEK4DO+;ZDRI]-4^F"92XD8WV'^W^#^SJB0D65E/\
MPKZUO>"(14/>UITSR[4R[5\^=N=PY# =G' 0G8.(>;>!8I8WTLO%S-D]N&#-
M:&$12XW>G)PRH2EWWO&N8C^_>&>\-%NUU@A+(O0$+^XE2_1REGG&#U99T6&M
M6BQQ FLHX(,UOB)X;4HLOP7(.+$^.W'(;B7.(MY@D4(^? 5B((9G\/*^VCSB
MY2?PWEI;[I76($T)/Y9^HZC0EAJ'\'FY)N^8,U_.A!WU84I;+A
M.'8#;Y11'G]_SUQ\+H7/\?3A'A\]K+0M'KX\UX>SX<(<7]%.%CA/>% )W5=,
MCALM0RCFLI:F0 +I@@HV5O.$>E-G"LK:-\; LBJ9NM/1<**N<5__*.(E_83G[6D+?W&L'41Q(GCS#''&/7'&9XG3D46?(,LW9_/Z
MD2]JPI]DT-FXSS/HOF*>M(?//);'L;&+S8\$J.^(1JP!E$45O#QC4%,4B&7H
M]Q-*Q_L$2%[5L=_>POH<'YEP@D_XDH^;ESE,N%6\&,&T78SAHEU,V.82.&E^
MJS:>NST4['-H8^S;(_4$L#
M!!0    ( $!?:U0VE-S2TP(  %D&   9    >&PO=V]R:W-H965TC)2*RNXQ+D&LZIKIC%*@L9R'$R3X:SO[+W!
M#XYKL[<&%TFFU(O;?"_&0>P$H<#<.@1&KU>\1"$<$,GXO<4,.DKGN+_>H7_S
ML5,L&3-XJ<1/7MAJ')P'4&#)5L(^J/4-;N,Y=7BY$L8_8=W:#M( \I6QJMXZ
MDX*:R_;-WK9YV',XCS]P2+<.J=?=$GF55\RRR4BK-6AG36ANX4/UWB2.2U>4
M1ZOIEI.?G4SS7*VD-3!G&Y8)!"8+H$.]P@)N..%NS8GH\@2K7..
M\BW%K*5(/Z!(4KA3TE8&KF6!Q;\ $>GM1*<[T;/T(.(5YB'TDB^0QFER *_7
M):'G\7K_FX1?T\Q835_2\P'6?L?:]ZS]#U@?J<&*%;&I$CZOP)J;I1$IX'TL)V>9D\/V^H1>WI*):BO
MX9A+^CJ%H$8S)T.@ F&=H>Z*Y!XQ+#0K< =IX CZX<7VZ>BIU5G;JD2&=2/4
M!A$RE%ARDI+V0L))PQ3FBJJ EFND\6"A0B9LY;T$+SL/4)G@2X]HX"LUD];.
M>A#&D"3A69?>F^GM]1,)D+ZR()0Q$(>GWO"^04T(<@D"J?>[T#=D<0%IV(=[
M6U&<[Z4FH=N4T^LT)I'O?6?17KO7J)=^J!GP^&WG=Z?=
MW)RVX^*O>3MT[YA>QNXPBZO\GD#U!+ P04    " ! 7VM4<_TG0WL"  !9!0  &0   'AL+W=O
M*P95PNO
MTKJ9!8'**ZR)\D6#W*R40M9$&U5N ]5()(4+JED0A^%Y4!/*O73N;!N9SD6K
M&>6XD:#:NB;R:85,[!9>Y.T--W1;:6L(TGE#MGB+^ENSD48+!DI!:^2*"@X2
MRX6WC&:KD?5W#M\I[M2!#+:33(A[JUP5"R^T!2'#7%L",;\'O$#&+,B4\;MG
M>D-*&W@H[^F7KG?32T847@CV@Q:Z6GA3#PHL27E@BGWA5WG
MFYB,>:NTJ/M@H]>4=W_RV._#0< T?"4@[@-B5W>7R%6Y)IJDJB37&4VT.YU=*L4A.GTS5F&F[-41)7>%$,UX+K2L$G7F#Q+R PQ0T5QOL*5_%1XAIS'Y+H/<1A'!WA)4/'B>,E
MQSI>4Y4SH5J)\'.9*2W-[?AU!#X:X",''[T"_W\G7]K HP0[A#/5D!P7GIDR
MA?(!O72Y'QK++6P#I6!FGA2<4FZN!6/FAJNSF7Z>-4*99#F/>[=N.;<=:67PUH'OFD:XYQ5JNUTDDV2W\5EM:@H;V7+>
MB@W>(7UI;QVOLA&E4@T:KZP!A^M%M]O$7MOW=\UD"LO-DF\&9&33*]/_B:3 [@34>)TX@W/2SQVU7IR?$K^'X ^%1(7"3>?1_>(
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ML%9#9;)O-:!6)Y>O,C)J.R<*Q>: %33=D&S
M8N7\_(AK6L!M_Q#A4>B.=:Q?>_?I_%T?9GNCK$&WB0/;0\QL/]7&W?&;<-6/
MPI_7^P_*C7 ;93S'7K-KGOYQEH#KAW2_(-O&P5A:XC$;S9J_:^C"!3Y?6TN[
M10@P?BF7/P!02P,$%     @ 0%]K5&E9,*ZT @  6 8  !D   !X;"]W;W)K
M&ULE55M3]LP$/XKIPQ-($UY<=K1=6VEE@X-"20$
MC'V8]L%)KHV%8Q?;:=F_G^VDH8BVT[[@\[T\SW-'?!UMI'K2):*!EXH+/0Y*
M8U;#*-)YB175H5RAL)&%5!4U]JJ6D5XII(4OJGA$XOAS5%$F@LG(^V[59"1K
MPYG 6P6ZKBJJ_LR0R\TX2(*MXXXM2^,I0"E:AT$P*
M4+@8!]-D..NY?)_PR'"C=VQPG612/KG+53$.8B<(.>;&(5![K/$".7= 5L9S
MBQETE*YPU]ZB7_K>;2\9U7@A^4]6F'(<# (H<$%K;N[DYCNV_?0=7BZY]G]A
MT^3VSP/(:VUDU19;!143S4E?VCGL% SB P6D+2!>=T/D5*!MEMLY,+BE3\$AYC7"#5-<*[<2-AM,'FG'49Z/(6!:7
M&^4MXJQ!) <0$P(W4IA2PS=18/$6(++R.HUDJW%&CB+.,0\A33X!B4ER!"_M
M>DX]7OKOGN=,YURZMC7\FF;:*/N9_#["T>LX>IZC=X#CWKZ>HN8(<@&73%"1
M,\KA2EB&NIGP'>92V0$!-?"J:-^\CS*Y5SO4*YKC.+#/4J-:8S#Y'THX9<)^
M6IS;5Z+/AF#'C56&JAOY.T\,U[A&#DE[DO9,X4$:RWD\.M4:C1["!=4E4%%
M[@Q\KMF:TYN=>T/5D@D-'!>V- [/
M^P&H9H\U%R-7?G=DTMA-Y,W2KGY4+L'&%U*:[<41=#\FD[]02P,$%     @
M0%]K5)KR ENR"   Z!H  !D   !X;"]W;W)K&UL
MK5G_;^(Z$O]7+*Y[ JD;2$("]-I*+;M[KU+;5VW;/9V>W@\F&/!M$G.VTR_O
MK[^9<9(&&EANM1+"B6//=W]F)CE]5OJ[60EAV4N6YN:LL[)V?=+OFV0E,FX\
MM18Y/%DHG7$+MWK9-VLM^)PV96D_& SB?L9EWCD_I;D[?7ZJ"IO*7-QI9HHL
MX_KU4J3J^:SC=ZJ)KW*YLCC1/S]=\Z6X%_9Q?:?AKE]3F7$UQ/"[Y)\6P:UPPUF2GU'6^NYF>= 0HD4I%8I,!A>!)3D:9(",3X;TFS
M4[/$C!%:K^JY]]$J4^$]!*5&OIG
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M'+_/4KGD&,B&_4'V9P_BQ;++5"7?_VSSQ'[EV)=BZ9C@K&:H&0PR!-1J"
M&R.LN\==BP*]R(SEMC"H I&"A88M5 KG_82]LV<9;W>TJCWBND<0Z6F*K'OL
MWX)K%RU *Q'93&CR]ZYYC /\&S2N&LJVV/-DP[C<@@F6,L]EOD25UD)+-6='
M;!2-O F.<>A%,/K#P!OB& 7>F%TDMN!:\I1UEP"%(#@$C!'FF.6 K-U@[(UZ
M+(J]$5Q[88]U?2_NL7NAGV0B6 )V,"R ITC[[W\;!W[PCWJ\RJW0PMARF3_V
M0*^A%\+B(1L"\_IDKKF6P)XX@]PXA"A!R]:IRM8\?ZUW
M#VCYP(MZ[R0#S+8I^<[4<]V0-FPOO9@#>DEP-T<89N(%T@K8Q_$%F_@]_)^\
MW[CE' &Q]^:6>!)[0>D:/_3!,,XMS;.$EK@@74[8%RXU>^)I02=N(Z;;_1Z'
M(1"- Q_8O%,)?9Y":K*%SAD$=9,>B#1FXPADV=Y6V3
MS(!7Q- [6\Y!-XZ<&\?.C6'MQE_HB&"7(_;:;LLM(XQE9[M)PW*/^29DO-MX
M!+Q#C+0C5'"(BM*5CP+AU9""]R)3!:JJ1:*6N?P+*,H-=$HEG\E46BG Z=-"
M:X27QB32(NLTQI$W<#SH:-ZJ_&/2LA'E\WM..CI&_A!E S\,2FG_'P50ZB0I
MLB+E"+X* %1#8&108*T0*<%!,H=[P;J()[UC0&KQT?*7$\@14D%U52&(%G.
M-5*GY(1BHCBE6GC$]F2LJ,Y8T<$9ZQ:@K0+4*6'38:EI+P$CYE)\!5M'AZ=B] ;54>U9H1N.";7#45LZA8C55OY%R8Y L>6(5Q7%@("Z
M^O>K_Q_4(<,Q;AA#MJS+$$@IMX?$!D!('-780I@" ]EJ4)VJUJQ+0=M6QQY\
M,+O7B'T_,@]*Z=1L\]P6$K;#IP-/!YW;SGE0EI)]4^8VO$9[US#](T!NI=IZ
M5)T3NBX;],BFAV<+W)"#\#1K\"?K!KQ S$ #\%X,KX _Q%'QI7/P +*-<_
MP-_PPW8L[G'7J';7Z&!WE3I/$?TI!SUHK,J^@MB'9O3]S!R#!.EC&#-+]#71
M+TI79H)3@]V>--NZTK<6L]41NYE2&J?^E2A@;GM%O\;>X .+T#'7*E]^Q-!R
MZ^T*"E7&'A<%>3NV%7;-119.4<3#'WF!1=QP>
M^U+["E=5+QH [YX@';O&AU-A\CX<$"LQ)(X9Z":62A/0SEY=#+QU-2L)I8Y.
M5J\L%4\BQ3+/)-"A.52^56!X'XA0'_2-=NQ^OW'X^[02AS;+GVL4@/GE&)1C
M6*:+-K1INWKT[CVV5$]"YR2!$=#15/U/6XKT0\KHT(8.6U!H& 30I& ,^
M^AAN(S8<>3&;0+=#*:6\(PP9808*!B$L](+M^7N&] -UTMH6B#4%[ 59(XZ3+OO*N[&JC5]RY@I:U5&
MEY!.YT+C GB^4(#2Y0TRJ#]NG?\/4$L#!!0    ( $!?:U0\^Y-P:@<  !4A
M   9    >&PO=V]R:W-H965TXB!
MK"SJQ2]I$L#Q[MX5N+9!-MVB*/J!EFA;B"2Z(ATG]^L[0[U8=FS9SFYZMQ]B
MO7&&,YQGGAE1N5S)[$'-A=#PE,2INFK-M5Y<=+LJF(N$*TLN1(I/IC)+N,;+
M;-95BTSPT @E<=>Q[5XWX5':NKXT]VZSZTNYU'&4BML,U#))>/9\(V*YNFJQ
M5GGC+IK--=WH7E\N^$Q\$OJ7Q6V&5]U*2Q@E(E613"$3TZO6B%V,F4<"9L3G
M2*Q4[1S(E8F4#W3Q0WC5LLDB$8M DPJ.ATE2[\*%,]5_ A#46X0W[<+,^"SL_A)YD&7,WA
MPQ/%0\#OHXG2&2+^CX;9O6IVS\SN[9L=F2!;D, <)+H>",9J4+97QO_\]3"29
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M08F*>AF#GY=::;2#M.WD%Y\-H(V!L"1C1Y);LU6WA<'%OD#;0" OH-8 @6$%@>&7]6CY$HSJ
M3:QYKS^99IOMV*#93Z,[A>^\>@XZ2DKKJ,K0HLZ*!%]B3YXAP0HB, \6]#I!
M;RITYYF:=K&[:=\7Y9U;_DN:7M/B(9I[$T*O6>80
MHS,+6]+3*?U_8#NKV\[(=M?JL\/$ODNJ(:^9O=[$L8_NBQL(?"_XSPT*BWJ@
M,#L+RCHNVP\81ZWSJLB6=[S(%EZ;94FFFNP3\%C9D8+8AM-CC\PF_TEZ#:3=$=H/?(A&'
MYO;A@L!JNW_LK4K"K&.7]^6F5XN: ?7M*Q6(]]PD5HX#85RL8
M.U>@\PT5DEUOB7L+"69$FPTM;$_^S[AX;9@I([;5\PY3\0ZAIH1RU@GEO#$3
M[\FK+R+H9IN_;8+>FY][6-MAEFUX= ]KVY;[G7F^B[0'CC78>KI!VPY6 WJZ
M1=LEEO%1$\K6'Q"8>\(^6+$E7=O[.KEA/S#?!@VGN_; _\8.OMB%?=,M6*\W
MH/:,]2H4,:=LW0YNFYTY3J>0/K!'YV/72"][^[:+DPG[$G4FN9F-.YX!@S&H#/IU+J\H(FJ/X3XOHO4$L#!!0
M   ( $!?:U0#Q&PO=V]R:W-H965T_7WV,GI+0%KKH/A#B>]WEFQCY::O/#SID=/>:9LL>-N7.+PV[7)G/.A>WH
M!2OL3+7)A
MC3Q](/@J>6G7WLE[,M'ZAU]-GC>(,TZ$,SX6]+0QQQ1 'NTM%PK%HW8M)QK9]U'70XZF[227SK)09
M;Y$9Q?19*S>W=*E23E\*Z,+ VLIX9>59O%/B!2<=ZD=[%/?B:(>\?NUU/\CK
M_Z?7="%MDFE;&*9OIQ/K#'#R?8>*0:UB$%0,MJBX0_FD1<:DIW2N\X56K)SU
MJS7EEX\H+LO4.F/%4^G:]"U$G>[YT=%9II,?WS?%?[?J^SF3+)4X*)F4LDE:
M$I:F.D,A(KU2 4]9AM*P[4/ZFX4ITT4(-N<3-G7 _:-'YX4Q<.&0KCAE(S)J
MTJ^_',11_''M[$FUJ
M#7J=47NK\*@34ROJC-M;Q;?ZX\Y^NR*Z?AN29J"(VOXEZ@S:._*^7^=]_]UY
M7WD5,&.K-E\\"-DZO">5![
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M#;CMG\#>FFF(Q!NCHDZO,FT3&KIKMX*G9:WBF?R
M\F[V61@$QE+&4[#B4(;SB"GO.^7"Z46X8TRTPXTEO,YQ163C"; _U=JM%EY!
M?>D\^1=02P,$%     @ 0%]K5"KDHGEH P  2 <  !D   !X;"]W;W)K&ULC57;;A,Q$/V5T8J'5BI[39J+DD@-!<%#442Y""$>
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M>Q,Y+EU1[JVF74Y^=O6>ZOY.EJI!V*"&^YIIA(N/;"O07"X22R&<85+V<.L
MES\!E^5PIZ2M#;R6%59_ R3$;2"8GPBN\V<1;[&,H+SB
M";S73$LN]^9,[K>;K;&:^N/[,_BC 7_D\4=/X-_3L:DZ@:!V\%AR'\OILXCN
M6,Y-RTI<1G3N#.H#1JN/-<+1MQQ6P ZHZ02![)HMQ:'(%+-Q/2^KTQ!_=/S
M!$H+QO$P?M,23,E$V0GF#PFY4H_STF]67'0.G@<)+4'W8!X!_,_ 3@DZVF8.
M7Y'I4'=?+/>7PONN(7)6:;C@DCI8"(IC+N<^.3WR"\@FXSBE[W@4CV!#!Q.U
M)AAJ__*!>!QXA;(R\!(Z@B\%7-=XZ@>$/,[@.I[ +:=B\JUGCJ=B,Z)8
MNJ8&J^@NL=P!M'_BA(P4D_@:1ED\.R?WE^M)O^-5*U&A-HY],8X+QSZ>PBU*
M1>=T4&QKU1FBZB3?]'4ZSZ(!NBJ-)0LB2@)#^K/B:C0K8'8US<>P49;*QHG(
MKU 3)[=WUDCR20%Q"\E2K2MDJ"X94"I*.V2RD]P:N&"74$RO(9]-_XO2J0^(
MU'0R@RR]RO+B/$7_=(837E%;,.UDK[TD2E,:IRY-:3R>49D"Z N8Q9-Q6)W
M8P7AC[IC>#Q7OP%02P,$%     @ 0%]K
M5$[5_3:9 P  -0@  !D   !X;"]W;W)K&ULI5;?
M;]LV$/Y7#AJP)8 0B9)LR9EMP$X[M \=C*;;'HH^T-+9(B*)*DG9SG^_(R6K
M#I 8*_9B'BG>=]_]XGE^E.I)EX@&3G75Z(57&M/>!X'.2ZRYOI,M-O1E)U7-
M#6W5/M"M0EXXI;H*HC"J-)JW@IG]'_<+Z3+UNN
M\4%6_XC"E LO\Z# '>\J\UD>/^#@S\3BY;+2[A>._=W)Q(.\TT;6@S(QJ$73
MK_PTQ.%"(0O?4(@&A%]4V#Q$B @;B/!Z$QP'5U%?(?Y'<3,ARB,V!6\>'0X=GCQSSB\,D:);6>L
MVV D;+C"QL#7U58;187S[8KA9#2<.,/)6X:IGXJ.\.4.' G8/L-#Q;6&KR[>
M\ 5/!M85??KV6N2OPMOFO=H+ %=
MDH<:J$NUX4TAFCW0 7 -.UE1H^I[V%![H%)8]&Q]>)!U37WTZF[-*][D!&"
M$H;.3)\T-@,6)OXD32#SXR3UDR@%YC-&TC2"CUIW3K.C>E'0=MM*Y,203%M2
MO_Z212SZ'2)_$J?^) S'D\&^=I$4A$)$Z8T"V=INUX G5+G0='K68&'JAR\0
MF@,5@7T;*"+Y)=Y.R7K(S=K60R^N1M5XEOD1L;\9A%O8="HOZ748_##H%N<'
MW$PC/YLDMZ/Z>7T[:E$("?-36ACSXUGHLVP&*9OY]-C^UY@Q?\*F%.3T?\0L
M(H3+J(^F*6)49@JCW(J]C:X11H_*V
MW&VY*&RY#@4Z\@BG%(+X=4^H@.'(E>+4LH-7A("GW%6_\[ =B[E7N8G]+(UO
M(:)P1^ETQ+V:1JK +$E_*HWL1S9B?YK,_%D#2Q-U=DU
MIG_5Q]-Q)J[Z4?#C>C]0/W&U%Y35"G>D&MZE-()4/Z3ZC9&M&PQ;:6C,.+&D
MN8[*7J#O.RG->6,-C/\4EO\"4$L#!!0    ( $!?:U202MY*FP0  #4+   9
M    >&PO=V]R:W-H965T-R2#*UN2
M;\D< TF:=AU:+$B<%<.P!UJB):(2J9)4'/_[G4-*LMLFVLOV8HG4N7S?N?DL
M=TI_-CGG%I[*0IJ+06YM=3X:F23G)3.!JKC$+UNE2V;QJ+.1J31GJ5,JBU$T
M'L]&)1-RL%JZNUN]6JK:%D+R6PVF+DNF]U>\4+N+03AH+^Y$EENZ&*V6%'CD5_SHB!#".-+8W/0N23%X_?6^EO'';ELF.'7JO@D4IM?#!8#
M2/F6U86]4[M?>1&26/MREN+7K 61O!129L;N)$I3[\V,$)H';ZHQ7<5
M]5I\PY, XG (T3@*>^S%'=_8V8O_A>\=KY2V0F;'S(=X_;)<2U; MWC'5:99E8L$
M+K'ES',9Z7>RSHE,@;U'7#T;[%Z#; PVU1&"^T\/P&0*M692U"48AC4 J3 L
MRS3/F.4I0
M;KCN"H9^QO @!8&_M\C!P"L$L0AB>H;38 QO/>)SP F5$?%X%LP@G@8+^(U5
M3$(\P7,4!Q/X'=%IH,_A#"VLE<48M(SG<]283X-I5T2OOXLI^ES,@I">9^,C
M28QKRP\*E33%>(CJ@3QR9]\$>=\;8NM =H'VM? ?!#&*B  2F8?!_'\(XOH8
M-_D[\TF+)O,@@I\!B]-@M:!I)-S3C=.N&Z>]C=([&)[KNWYSO7U'17ZM2HS+
M_J6E+Z,/-0VOC'.=5Q32C_SOWIP@U)L]5_BSV
ME3\-,<0/355&$08]/L->\$'W->HK=,V37+I>-ZJH"=4!:AA&F(KI#//?GZTV
MMN^TPJ3=:K45%DX^X.'T&#?*SV-$\0K.J SZ7$\(_\DXB$X;HY4W2DT]<76)
M)F:P?B;0OB$8SA4,"<,FDP)V:.@G%DU=)E/',:6OR=Y&+T)!ED5(O73GJ&)!.G3=H&..-)VTPF_"2__]51@;E)_-T"&
MSN^WU^/@N:X=':TR./ RM[ 9/^G\5M/==COAI5^%#N)^H?S(=":P9@J^1=5Q
M,,>.U7Y)\P>K*K<8;93%Z>I><]QKN28!_+Y5RK8'T$"*)*MW+P3QX L>S#&V!/#2B8++/:!ZJY6$V:3&I)M
MQ?OU>ZK8:DF)+,SHP>X+69=35:>*?;;RX2'61$E]:ZR+'X_JE)8_C4:QJ*G1
M<>B7Y/"F\J'1";=A,8K+0+J438T=C8^/WXT:;=S1^9D\NPOG9[Y-UCBZ"RJV
M3:/#TP59O_IX='*T?G!O%G7B!Z/SLZ5>T(S2E^5=P-VHEU*:AEPTWJE U<>C
MR\7A;\;F@5MZX5>S+W_H%OKLN/1\=L$%DJ$DO0^/=(4[*6!<&,/SJ9
M1[U*WKA]O9;^L_@.7^8ZTM3;KZ9,]<>CTR-54J5;F^[]ZA?J_'G+\@IOH_Q5
MJ[SVW?A(%6U,ONDVPX+&N/Q??^MPV-IP>OS,AG&W82QV9T5BY:5.^OPL^)4*
MO!K2^$)39*T,S[1T6GY2)K&3^CY62L;KU+=517KJ1R5\ ()O=VC]=V
M7XP/2KRD8JA>GPS4^'A\ZQZ'UR+OS3/R)H\4D(2JC52U5EE3$6-2&6<2
MO;+(G%(9E[1;F+DEI6.D%/F/:
M1$P;J'OBFN0(3AH?DOF?EC*XHV!\N<_RP^K>9\/5OU0CD3S@P=O>@[<'14Z]
M*\BED V[-_%AH&;M' -A(X?<93XLV!$A5J]VWM8[* O?D9>^7X6P(Q-L8C1957E1)
M#06N'=,L?>181.V*K'BSK"$=VX!5J=8)3!>QITB<;A23@N(HB0%;P=LEBZ[:!(5"B6R*Z(6QME1S
MK-,/Y#I-4]\LM7L2?QL0G5E"4/1M*$@@C@+Q!U7[%:&"!H)&?@B!' UH$X@_
M7_UV]6\XQTF)K6U05H<%?.W$0>$DL8$1< ^V<*KU(XDCP!#2&'3HT'-C31+>
M2EMV^M I8F.'/LTP]JYT0NQPYJYT]]K!6@IV]+
ME)6@4#'$%JB2C2PNYP%CMMZ[D8N=+"7OYLV%;QI?FL1I,F^3*CWEP!E7V+:D
M[Y;?7'UAJ$K>(8FQ)3I\GU [)@?8&="EG%IXQ,JAM<+\%UD-YR8OS;9O+WFY
MR8S.FZ&: .H=O;W&T@22("&C)&6Y:F"SJH)OULCX'(ZE#N*U<8_>9H)%<(JZ
MV[AV9V4B=39(252$U.6<&O 29,RC9 R,L\0&Y\KH$B.'O&.":1_RK[6Q&5EF
M4;,#HW8.=5O GM)+('15P:<_FW:]'<_K[\JDKV+&JD:Y)HP[7+:MZPI52Z]Q
MDO*85A"^?)5KF[M0&V WY0KNJKH$(-8O7G4?__-OI^.3]APAX/2A0_!D@8$_YHB3NB$$T(1/WX+;$Q<[@C97M\W6U@AX]IMV0>A
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M,G/XP'ELHP=9AT?J)ZWY>EF/(TY.8$142P?CMC9@4@@)U*:)9*O/S7;C!('>6F-#1XTF:W&\>:87#XJL,
M5NTM&FOL %57?[0\A BEH?OMU!#+WPX2&\QGY$.5_+ZOY/<'2VQ&SD G&Q?5
M?VZE,/Y[0.YI+_?TH-Q+FB>$ N>>-L\7UU)%.!OB6/Z/T3_N/4)/\[66S/'_!0MTM^'!C
MJ<+6X^%['%A#_BJ4;Y)?RI>8N4_)-W)9$T;=P OPOO) MKMA!?VGN?/_ U!+
M P04    " ! 7VM4+DCZ^I$%  #C%@  &0   'AL+W=OQZ20[P:BOE:*P0QS'ZT0TB%OCD7ZW$.,1W\LP
MB-E"H&0?152\3UC(CP\MW#J]> DV6ZE>=,:C'=VP5R9_[!8"GCJY%3^(6)P$
M/$:"K1]:7_#](_&4@I;X(V#'Y&R,%)4EYS_5PS?_H>4H1"QD*ZE,4/@YL"D+
M0V4)LK>BH>)_H^.F:S30JM](GF4*0."*(C37_J6.>), 7L7%$BF0*H*W0L*;J;@
M-IVAFRETF\[0RQ1Z316\3$$O9B=UEO;TC$HZ'@E^1$))@S4UT,NEM<'!0:PB
MZU4*^!J GAR_L .+]PS1V$=3'DL!2YT !KE%4ST[$PFZ^4Z%H"H$;M'-C$D:
MA,DM^HQ^O,[0S:=;] D%,7H.PA!B)1EU).!2UCNK#,,DQ4 N8, $/V W7'-'O)EVX>8JZVU[6'V!V*>1SQ&,)'O",(M#BA.KN8 B:UZ&F+
M*CD>QL1M=T>=@P%'-\?1M>+XXA]HO&()6@L>97L+HEOC6NV%8+$T04F-#LZ@
M='MMG$-)PZ%;PPM"I"PT,PI5+,VO6"HQ[^7,>U;F,[9FP,^'4I M!?7]0/D^
M43MWQT3 3=MNTJMS[U=I3>M"[J#=-R/V+R+.!O"[XILX^->8)R9>'3!I
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M,"-Q"C,C@VYM0PP'U:IC$O*G/1JVW%J4&JV[W4NN*BP\#V%N-*ZH<-)VEH1%WO+&JU:G9%J(RY:#^PO?^X
MAGDOP?^7G%UO*NJ=IT$(._7D:) Z3XYE=D7O@>W-QS-]"Z)]A/YZ9M&2B;]M
MI\ZBPA-[A?_*#TS$*E."GQ*)DBT5#.VXN'10(O5"BXE7+=G33*Q_+H:K4=#,
MUOR*K3+SHK83>VU?9+=5BY!"KH5D!-]]-&$QC&0C)Q=5FMBK]$<+%JG74==M
M#RYXH*BCQ%Y'?]E,[V0Q/N15$@]J( J6G%F%^M:\:K&J]&$\/9S*U0ZYS=P8&IC;XM
M39#N!].[DOQM?B/[1=]#5MY/\/T4&][/\/T\O6\MS*?7O\]4; (XRH=L#5-!
MGPT^%>F-:OH@^4[? "ZY!)YZN&749T()P/&ULI9=1CZ,V%(7_BH7V859J 1L"R2J)-)-LVZTTZFA&TSY4?7# "6C!3FUG
M,BOUQ]<8 B0XWI2^3(#<RX**A9-)N?_D>2+)2(F%
MR_:$JF^VC)=8JE.^\\2>$YQJ45EXR/V)+^?L((N9K"YXR_D>[\@+D:_[)Z[.O+9+FI>$BIQ1P,EVX=S#
M3VLTJ02ZXO><'$7O&%11-HQ]K4Z^I O'KQR1@B2R:H'5QQM9D:*H.BD??S=-
MG?:>E;!_?.K^DPZOPFRP("M6_)&G,ELX4P>D9(L/A7QFQU]($T@;3%@A]%]P
M;&I]!R0'(5G9B)6#,J?U)WYO%J(G4'W, M0(T*4@NB((&D%P*0BO",)&$.J5
MJ:/H=5ACB9=SSHZ 5]6J6W6@%U.K5?R<5OO^(KGZ-E", T!2M&
M)5<;(90'F8&5OCOA MR=JK:#SNR2:&.?@2O+VMP]^$C^ !R"A[SHE![+N:>5 DJ'U[2N'VHW:(K;@/PJ#QF
M GRF*4D-^I5=#Y&E@:>6KET_=%J_!V3MN":)"P+X T ^@B9#_T^^OEWN6]($
M[=,0Z'ZA_6DPY:B%D196,'E;HMG4#>;>6]^NH2J,7=16G;D*6U>AU=4KS25)
MP8O$D@A+RDG;;S(V92V<]OTCWYUUB&8W,VRGZ&X1X:BF#4>UW/;:'.
M%K+:NB%BQQHX&C:-LN\^CGN/8)/14#7IO:SGOCK:0#MNGCA+#XD$?SZ2"]]1"=JQ9 C_?0[##E9P-*V@ 5>&U]A0=97%J.,5LO/*$/M[
M@$8=NM!H=*$AEWU)A@U4>ST)"A P@Y4UO^,MU?;:?->SU@7
MUU=J"JUGQJY-/<(^8K[+J0 %V:J6OALK8[R>"NL3R?9Z3MHPJ<8:?9BI29KP
MJD!]OV5,GDZJ&[2S^?)?4$L#!!0    ( $!?:U3_1WCV/0,   4+   9
M>&PO=V]R:W-H965TR!<54ZK1
M:YIP-7%BK3J-$8FE*40+V;R(YHXGB&B"0VU,4'@
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M*_U"BAVS=0V?%70OE$(P+FY3'6UF<%CB\#K],]9,IE^2&=1S]@O._@:_5_RS:$1Y2A592I/F[ E_VVD^Q5[E:^+PT@V@OA'$/\S('^KR=QJF:;7K]RO7"HXE?(;F(\O"&Y_
M0M[!W%:3N/HR0%'B,RJWU&B ];7MO^" Q);KK.;V8[&_SGBN;:+&Q;&ULC571;MHP%/T5*^I#*S$2$J!=!9%*4+5*[81 W1ZF/9CD0JPZ
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MH&"B>M+G.H<683 \00AK0OA50E03(M=HY&QA,E#T19-*K9@&.?X"?7$-]B!]>&G
MM=M9Y38\X78.:9]$@QX)@W#004^^3@_>TGW,K0DO;,(+G5YT0N_8=H_\E ;P
M<2^IT"[+6R:H2)G8MC/[N_/!$^1GF".W/]EJJ*]I*
M;.S$[.'>QV'4QQ3W[0 KT.4;4 -YXW+8N!Q^ZO)1K"N?K^XPJ:14"H3I\EG)
MC5H6QN],5HBK-J(_[G8Y:ER./G79[N.P1 9T&1Q^#_/XAR$[0>Y-^Z^#:
M2_.!JBW#'<1A@[2@?XDJJKJ(JHF1.W>6U]+@V73#'.]N4!: [S<2-V(]L==#
M\V\0_P=02P,$%     @ 0%]K5,@>6U*P @  ) @  !D   !X;"]W;W)K&ULI59=3]LP%/TK5L0#2"R?30HHK33:3F,:$J)C>YCV
M8)+;QL*QB^VT[-_/=D*6TM!%VDOB&Y]S[[D?M9ONN'B2!8!"+R5EW(C .>65%(O]/W$*S%ASC2UW^[$-.65HH3!
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M2B+,^CSX_0O%=-T
M_UWZ8G#TX'*?[NGVM3T,VQZ&UE]TI(>V\@?M^/E50]&-@E+^.A(H:@-%-M#H
M7X$RLX"_@?H:6+M*K"MS6FVGP67D7J3>MMNG&C7NHN*PQ>RI'+4J1T=5=N;/
MZB0LHU6N+3UQ7!4@].]*""T;82FA7WP=X:(CRW?#-]*/8_:DQZWT^#^E4\[6
M'Q2(\HCX^$!8>%#W0TSLCOO%)ZWXY*CX;UQA:G6?'PR(G1JQGUV?]*1G:)(#
M\3VH>.Q>[J/F@U"+'E24N,F;4GB=$];U2*!%5"P/:!_<9-)8.':QG9;]^[6=$-(+6;0K^I)X
MXCESSHPGMH=K+IYD!J#02TZ9'#F94LL+SY-Q!CF6+E\"TS,I%SE6VA0+3RX%
MX,2"N1$SBO'^[((E/F
M@S<>+O$"9J#NE[="6UX=)2$Y,$DX0P+2D?,EN)@$H0%8CY\$UK(Q1B:5.>=/
MQKA*1HYO% &%6)D06+]6, %*322MX[D*ZM24;OU2%: ""
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M%46WN1);:]7JLBG];=,/P@-T6D72V]C!>MOR=YVZ;F_S/N=*7"3O,]'T/A''0\RGGZM4P-XKZ!CG^ U!+
M P04    " ! 7VM4RJX,Z?<"   2"@  &0   'AL+W=O##%@U;$S
MVT#[[6<[:69(8(P\@!V?__'OG!Q?ACO&7\4:(0G>2D+%R%E+6=UYGEBL40F%
MRRI$U4K3U0U7@I<(BHPHX"CYTP,0[U2MR.,S?S[4?E;&NGJU:DEB)(6Y,]
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M_P!02P,$%     @ 0%]K5#*E>R6I @  ?@<  !D   !X;"]W;W)K&ULG57?3]LP$/Y7K(B'(K'\3HM0&HG23>,!A*C8'J8]N,FU
ML7#LS'9:^.]G.VGH(.TJ7A*??=]WW_GL<[KEXEF6  J]5)3)J5,J55]YGLQ+
MJ+!T>0U,KZRXJ+#2IEA[LA: "PNJJ!?Z_MBK,&%.EMJY!Y&EO%&4,'@02#95
MA<7K#"C?3IW V4T\DG6IS(27I35>PP+44_T@M.7U+ 6I@$G"&1*PFCK7P=5\
M8ORMPP\"6[DW1B:3)>?/QK@MIHYO! &%7!D&K'\;N %*#9&6\:?C=/J0!K@_
MWK%_L[GK7)98P@VG/TFARJESZ: "5KBAZI%OOT.73V+X"H@Z@#1>T!\ !!W@-CN3)N*W88Z^H*?%'(W.SM$9(@S=$4IUP63J*1W>D'AY%VK6A@H/A I"=,>9*B7ZR@HH
M!@ANCA-$XR,$GDZ\SS[<93\+CS+.(7=1%%R@T ^#(4&GP_T!^/PX? &UAOM#
MT?_))NIK&5F^Z#^U?+U ][IA_+I>2B7TQ?I]A#ONN6/+'1_6BMNS82\R:AA1
M$BVYT#Q0F(-1@R"\N$ ;3!L8VLLVP-@&,-UHDX6^.TF]S8"LI)>5?$*6T+/D
M)%&SY(.HR V&-8U[3>-/:#(*L&UU>8G9&M[4#W-O7Z8[+-:$241AI:'Z1.F2BK;;MX;BM>U_2ZYT-[7#
M4C^0((R#7E]QKG:&"= _N=E?4$L#!!0    ( $!?:U2:7SM6]P,  "T1   9
M    >&PO=V]R:W-H965T4:1(017YD26'\\D!EAS%32.'YF1:U\3I-8OMY7_RXCR0@E 'W.9/(?[+)8UP+^5BH>9LD:04BC]!,_9@M12H#]
MA@24):!J0K"?V4
MZCPU60BM"*%^=<""X4@!' 7@^N>6QGJK%#C[#R\9D>_!V9PH3)F^.@=?[N?@
M[-U[\ [0"-Q1QO1VR)&C-!I3T_&SF:_2F5'#S!"!.QZIC03744""PP*.II%S
M07LN5ZBUXISX-O!@!R 7P1I L^>GNRUPO'QIO:2>]ZJE_7ZKP\&-(J'\OV6R
M;CY9-YFL^YK).N"#X+)VC]*J_:2J^"G04!5D\C2RL,2'-<>U,/IYW#ZK7"FOK\-MPPK$H YT>[H4VSF[Y@1
M(ZG]:(C3D M%?V?/*B0ZARSJH*B7HYUYEL?M'[,Y1$[U!3F]P GKWF!'
M!9A3&7.)&>"K*N6G&0^.Z;BV5T]GF-,9OD@\TT/Q?-*M<(9CJC3DZT?=_;26
MMH+4:FE8HZ5N/;J+'-W%6Z2MT=4!N3@"TK.KTCB.Z=H7]6"A6W0#MQ5N60^U
MEN[6[6"_ JT^JM< KM2J8"NX6[-XW^](N"2BS3,A*BJBTULT+!H"]$YBTEG9
M\GI"&U47O3WH$'+15N";^DJK-6>ERP;G-N I.@5L;Q6W1+^S;3@+P$T8"_Y
M# [Y+%44]@_[?T$5A1W#=C]^M2J.W;1[_%4\#O(:;:*P7/@RSWV1*NIWHIH,+A4+O#O58*6=G#[WZW(H4G@@XA%Q:*T,FD
MD)5^AD&@PF-1N\?^JS9$[#L^_:W?&ULG53=;]HP$/]73E$?0.I(")1.58C$1Z?MH1,J
MZO8P[<$D!['JV*E]0/O?UW9"QBI TUX2W_E^O_MVLE?ZV12(!*^ED&8<%$35
M71B:K,"2F9ZJ4-J;M=(E(ROJ36@JC2SWH%*$<12-PI)Q&:2)URUTFJ@M"2YQ
MH<%LRY+IMRD*M1\'_>"@>.2;@IPB3).*;7")]%0MM)7"EB7G)4K#E02-ZW$P
MZ=_-AL[>&_S@N#='9W"9K)1Z=L*W?!Q$+B 4F)%C8/:WPQD*X8AL&"\-9]"Z
M=,#C\X']B\_=YK)B!F=*_.0Y%>/@
48G10N.[%4E^#F"/0Q\/
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M D;*3'JW=9F1O.74Z/652XY.&;K#SL7ISSA0Z53'4^*,E>!N2MJD)(OUG% ZFVA/E'(-S4#?$Y-W_2%0
MY#KKN2.SD]QM?,K2$=!(IH8YCF5FJ;?X<@PFSV(Y[ZG4S91K=+P.,/[E?LH9
M ;F]A)2#DB\N?]3O'N[7]YM^8(/_X6+D\C?_NB]KY.&6PJ,#=S_@B^5?;?RU
MPO9A]_$]-YSA9E%C 9JN=XK%NWLLVAM7W7W9TYGWW_9
MN0L7/TL#<=]J5=UUD#LK[G\^P:;R61W
M(GWO!_8,."3;V-ZXO>(\_JWQ;A_\3\7[A_'H%TH5TNK?
ML/40'PUT'8N6JNA/%$7B\BXM7OO-R:+@+(28=TF5STT6I4YP#5G2%8;,)B@:
M+N=]XXVF>Q?;,NUO]O7\(?J4-JZZ+9>@$*"9(4"FS+4A$]QK
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M*#/LC?&(X O9<9 JQ=92G"BA=&'PZ'O3C\>0,)JD$<_QB^KQ_
M%D,\N?- PC8\KTUK@QI,1P,')JPW@^J=][L_A?YPH5P21%E)VQG7[\+W QT+"%14K+$
M-G-8<[,$LV1 I%P1 9IE2AM R:G2*82!]QNH.0S0:;W*82297FRP.>NL!G.E
MW=8,'5$4&$*C,&0)2V=,[^^%CX)N/:S:_HU7DL.<"UQP97'*DI7&D8+0B*0P
M>I,LB5PP5)ZF/,^M=_AO5U(<$[!DFJ$G!_;&_EX[BH+NA7/6?0F[AU7(5CI?
M$0RI47!=/M:35K>H'A@2R9F DQJ<*\DPF%4XURSGEA7GQF#)V1R=0><,OV0P
MF<]YPG35"<^77/ ,)EB31I/U3'.Z8%5$(CG&XG=<>*VMNE5URB61"^TXY>Q >%OETFVN,"5)D
M!LQ70F#85)H)FV97J:?97RNNF3T]Y#:]I]MJ".L'Y!"0RK!Y0 ^MY+U$O4K2
M?F*L.#RJ-S#H1UU+V\\8^.@_!IY+[ HI<='$-F,(JJ1XUP6R9(5PC;1D6"F6
M@*H5$R$ MZ&7K@GE&3+BTIQAVR@+"!52=P9U18*K5J+@3V$+8V=;?:9\H8E3H#E[9G)$1L9ZQ+K4*\/= VVG5WOK6&T6]#2\O;\VXM<#+?
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MH96YTZ4VNT5&G1YDQ3G73,GWP
M\@5]@G^53%_^[<5WAX?BRB353.6E2*R2I4I%Y70^$;^FRGT2AX=AU:4IEE9/
MIJ4X[AT?BU^-_:3GTG]?ZC)3+^,Y+X[\[R^.F,B+D4F7+U^D>BYT^O<'^DG:
MZY^=GAR?]-+1:?_T9/1$C/CLY>S8Z.U%)_U]],'F$Y7Z/*Y>9^ON#F]W>TZ+$BK')2W!B<;+_
MT1/8(%.JS^6AS/0D/T\@BK)A;_P^,9FQYP][_+_G],WA6,YTMCS_::AGRHD;
MM1"W9B;SGSH.%CITRNJQ7^CTO]5YOP_F^=>%E^84YV0Z5U&Z(!)8O1S<#&\_
MW(G!S>#V]6_B\MWM^^XJ^]\@XU>#N\O;Z_?#ZW'V>G@]N/OF
M.;\=O+Z^&PYN!U<(O=N[#Q?GFXN;U
M0%Q<#HG]_K.3TV^>_T?2"3,65RI1LY&RXJ3?(_YI9D5
M,E]V^-?^\_ICORU^:FS\HO[L0"0&"<&5K+M'\D" H4[/_U^XJ;2*OTG,;&9R
MSU!'%-**N%\3]ZQV!9E]FPZ$=L*J
M"&5I0":A[$VX @;)!?!)99'207SP.9G*?*+$15+2UQ2W'5*5
M1()-5>JU4UJ9DCIRWG[SVQWB? ;N$YF+ KR.C9V)"NLM+W#+V#CYT
M@^_\5
M@([]3^="(V@08-JJ(A*4E?_R7-'6B8K\&&WRI7L-Y<*
M[C*&\D$%?%SG"8+;6,E(!NB8%F=9$S@4LNKS5(](4] )Z?@BSZ%#, #6
M2_+!G\G;^KW#?VP6*=^>/VT+UGO -H7!U&2(:/;UK9##QLJY!$_96+D2DZ<42HR$.\\R"_:))?Q&EAYJ/7DRN)HKNQ0S62+V ,@&D)LM
MA:M&,UV6GC;#3K/+,0_X4%MFJ0.O2E11\L=P= ]O[)-AX?ZH8JZL M1!Q^NN(--L%<'0 ?$ /4G9B BB7SJL^TVV6,
M?41<.UX02.RS0 =;"&0ZQ':&-:,L\J1B"K-51GJV[278 Z9_KR!^$!A0 A1R
MBBU?3DE>(M[:X_EE^ ^-9F<;*:*$XWU.WHB55_MCA6TCJH*]:&':]O%(Z#M@
M)!"X^4=:BX6!^$@Z[P )%";!/Q$G=H.@Q+'KBG?D#0OME(?XFH+GA>A'VQ=9
M!6\CXX-],J-#/>G*F.^W^M%]P-Z[1G4DA_7I*'A;RV($"'NBM!7+0 %:7(++
MSOHIVS$20;+5(18:@3UJ.87'1W@[?!!Q[XU<%<$&><4="LC$BE)E*,Y@?%?!
M6Z!BG0+1'!/T.)"B&+1Z5)4QQF#3J0CXYY=X)S,15.$ "(V97!)CJ4+M;",H
M*_'*2)0$U"[5C@3-1&U"0E5R\(TK8B-3$\(O(>=29QQ5A+-KO)HU)N'[&A%)
M$I*R%=5.V7*+D.L;[X,S7H=@FE/2"4XW-UF5EQ+)#1+IO/DUTXCD-" ?1$7*
MJ7P(6NC(^R+ (P+G6O4FQV.I"4K^O'>:*DM7W!,Q]&<]-/@&YU Z8;MOM W*
MU-K97(XY]:F8O _(]7ZS4EL#G/V56^@821-7**$7A %O49T.'I/8*",.;KUM<1YI'34&NHU&ZSI3B
MVIQBI>UF :D2 "O7AK[&9EM-D0L@HZ]74-PX2J)E9U=2WSFU;5^*%,9?"9US
M3P27WGE-$N]'FBURQ-EL]Y8_<[/B_YW:>$8A)^IP9)7\=,BYXUQF"[ET#_[*
MJY[_C3<2,O/PE7ICY*X9MW%[ZSAJ+:C/W'"SKD?"&LL0N)P%T/+6G3?M9!#'
MS['38J?=06)KS8,.ZJ=Y9K(7.TE%5I=VT
M,=1^I.!!6:(4SVAWJ'HJ7=/X+!3#_4HE8J'L;\:!CO>
MV?RH)>9B\I5F\DIS$.*YGH.X"L+X@4<;A:62
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M>_KXA\A% +[Z;GA=C6O],3..B-V0@*H*ZN)2'J+J6)_
M:TTZVF# HP10KH=\)=VC66]U&7YK91G* >/H3O@8'N5=BD=F(T>I-B^W1,E6
M7Z;.(_OFHCLONK,Y^C2&N@L+!4#/H X,XB4*4NE^N"
M>;@7HJE7=,^S,W',LY.3VDW;CK'BLAPYX7ZU=5&T*Q+N0Q+;EH^08@(JNZ_)
M G"'4(PU<$H98*;LQ+L7&<1D<2K%\\5Y#,OUMG.W.ELHQX-RF9'WA5(,60X-
MYX0O0^JQAA!AV!QMK8L[N+ZV_#RS
M5,TE:W-E%QCGAS H@(*J'N*^(LP:O(!<#)TI2793[=T7*GEH]
M"L^,9).E<[(&?II4$FI""^NBC[G&R1 D6$8 %8ZI!R;,,Z=[:ZK)=%W(+FIM
M,?$%7V=K5=B.0D#B5]53TL^=>4[,U'WVVM H&:W_>",@=@+?MI*'<'L;K7JF
MF/IBT,=_:5&[A9XF_MKJ5-9/N0_0&5Z5(. N$C]N^,,/J>Z!E/']'@& 3$W!
M-^ZUPYX\/5Z=_X6FEJL.6+Z4O4-)GXHQ>4O;/NF(@Z\OL<(WB^!E4TQ#$5V.)MDDU(_*(__#R:A0;
ME Z/ BJ+>@D%(S=.E?-/+J YE#$5E)V2VX]IMM1F_8\_L]OWQL\72NJSLHEV
M!+\Z84K?]Y_&E>%>HY6<9/JQM7XSTKJ6)HY7Y@2KUMYX2S52Y8(>
M%%; 1^IY*WHBXGF\SI.NO]MK?RZ&EEY^Q(>?XJ9[T6T_]5OI=]?)Q=[W/@#$
ML%$JQX-VG(I81C(&;$)2^_+>ALJ:[PT]DB(8)D@>!?GA%^&W
MF6N<^J31BECF-4QO@^_2Q2MG0R[)T&3DWI''E6W-G%8ZB$[;7_T5\22^5/)2
MJ_;IH5-#]$+9(?FS_CUJ-W,U*7)8?K4P69^SK5_-ZO$VD\7#W::.UQ/M_K'>
MJD7H=G[LQR,KU/SE3(9Z+.7\OH/LQG79UKOXR+E,T_#G-I''^M45\=WK[B\@
M]LNU_2ZUY5@K)Q-*XGZI'0?P1)?-="G.]0V'KPGV(:C^J Q*D13R\+0H3VE89++/:A_<<,/7[EDX#:+1? 3X2V2
MUN-=B3RE)V">'W;-N1+ZP+-@%)XVTZIU5.I'8R%C\TT5%9>K]QCKI%9RD_9O
M0YK:>B(R,_/W_G)UT&A]CV6_WNG^LT%6RTO@_
MSW[_?XKB?YYOOVZL]_SP)'8'C1=EA$$,C4_MP5'C78C]#XU4]DX:[WKEA_9'
M*(KJFA>]TU'9/CP:-!AA[(N#Y5,BG+% :*$LM870EA16$5F0*$4$X840\=?#
MI]8Q;F@0A>).B[U5YY^&1RX DVF1;8.$Y7
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M"Y&E;/OQX\\&VS']L=(6)GD.U!CBC/!*&0*2D6@9ETY$"N_7S?<;32: >\=>!_C=QZ[^-KMOUQGS>'X7CC
MX\$K>[QUO,'VSP_9_O$^:[YKBH/C[9.#W3VQS]Z*YK'G![O;[:UWS;/]=QMG
MKWFKLW_>.VN=-$7K9).UCE\>;[W:)PW3K5>O#UOHF;[$]LG_<.6Z^>WG4
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MA,YV/.V5@Y7&&+'Q[F>#IZE]AMJ)YOA1[M^5^_F-XYF[]QY%OX9R#UGV+SMP^"C6[XF5WA!K4(#=
M+$Q!4@!TK2"@O3:V4)*):()W)/&59^F>Q7HQHC_;ZI?X3?]1P-\3,+LI8!&2
M9D(4U'-3"!]CX8B710I1 \HC00@KS[(0YB;?-WC_7GB4\*TDS&](V$70QD92
M!",SY<8?X(0OO+;2)L/R3T3F_6_(]V4)/MO,QK#;'DMWV \HDITC*"^=@8]_^$-E%OESB"'B?Z"SC!^?G96#KR,S%Q\/NG\>'>!U> Y>
M_[R#]Y/-XPW2/$9->+?/4=)G^\>M3NL8I7+\YU'SA27[[_[L'^R>=IJ[G0];
MKS;.#TXV1?,$GW6\^0FUZ+SU;D\VV=[YP?H'AO=C^SN3:_[GSR-W$CI;)WMG
M6^_>BOW=ULG^\>$HOQ=JT5'SO$D/=C^<'^QB>W?WY?[YP='_G*-6M+-6; RJ
M=IU_>&^M\I%*7DB6L3WP6%B9$-M1BO#0='O;)]'L-U-M<=GA2A-R@FMWO4E3OI2O.&KB1NK?'6%-3$
M5 A.2.%B" 5-Z-LA*T R$+.9^!5=]_SO]AJ#DG*Q_$)CI"'22.^2L5HHPAQ2
M$"ZD#%8SJIFJ[ >YL!\W5(?_O>JLMS^V Q+#;<041),]DY->]]'03$\O_ V]X#B<;4#P$%KA#^900V1(A>7(
M33B+3#F[\HRLTI\U-#^F$S<,S16=>+0RLU.4PQN*(FB*) 13..LB.B,"G1&F
M;4&5I F%FCB1"" _8&6^C2/"">$\28 T6'"/9-DZ)8/2VDO"HGG$D3FIQ\:G
M&ZY,1!;BK$F%-%HA"_&^ .]-3 9(?4XI'()F3IIS=#$1;9(M4
MT2)H5!)A#"N,UE! 5(%3:0T FAS^7229=G3C0C->ME'_XNOVQQ@VD7UV#]NN
M$]?Z_3CH;\<3P*/=P[637CEHGU=SR>,8"+VF-7E&^FD8EJ,(Y7SU9-1<;XXN
M@R.[?[6;YQLCO.?)P:N7)ZTY?!D2;J5G-W
M\[QU_!9U8U^VUH_PF1MG6^N'H_W=37ZPWFKO'V^2UO':E\&13_ML[ZQYW&0H
M=WIP_(%LX?/V=S?$UCKJXG'XT&1_ME%76?-EGJC:N)BH8LWS-?:> DLQ<%+@
M>$>B&GU OX:CL@B!]"'3!B"9LFIYE_#(%VA"HJ".6!+0;Q*(*MF1"@8R2XZ$
M"/UU-"GDETKSNM<]W(WER7IT@\ELY252J#DC1>NX.4&*TS8^8=0\>?FAE27]
MKDD.=C?I_N[A)Y0LV=]]B2/ZX,,!(D/S8M3O]DAK_8/WCK'%;K_["
M\S=E:_?#)]0(WL(V?,VQM1[!P;!0),D!?99 "LL\,A#T5XADUC.E5YZI57HG
MKG$/"O H^3M)?O]F2"-IX1FCA0>#XU\%58"AHJ"(X$Q!2$@J5IY18E;O9AWN
M$NVZ+MZMTU@BVG.7C7Y%OOD%^@W6_N-I%'_-79/VF=M%Y\
MR1GVT>8
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M,#I%)>JW3TX[><5(]=U1F77QZAJ'U;,^-OWW)]=O,7[\YV=.FM#O#E$O\+7CUQ\OGC(DVL=]=5^
MX\1Q:YG7.@41"0,6#>=!>B3JRC,Q-C%$<;( W35>@328=)8J.+F\T>3([7H@
M1Z6JUQ]6VC?^\@3A;5C&9Y,5/D_W=M8O+K\X=/$Y7__5WG3,X4"S;A')Z\1#[.I&W\,^+"STT[;MP?-F#-V&J%]
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M8S2.*B*6: 0]K^4(*.(M2$&H#A\(O-+@6;W)I?I01DQ3H CA&'/"]#XB0+5(F@6 1F"
M7C:YU,7$W"'[]U$N]XAC/[(JK+X"NB?^?"TN3VX?ER<_$Y>_C*),5O]]/8QQ
MBG_>.8HJO7?&,FN,1/60%D!++:B(EJ/K&\D<9D?NJB3]&?K!5HAI\
M;/LXUHU.'*)>G$*>I?P8R'_HRU8BZS-4;QZ"0'#0P$>LI.>2_ !YTY
M3*"\!H-]T>1X7Z/[FAP5DP14I$0G(4CD)I=59-X(#SP9<+4?CWLE=-O#DV4<
M@V!D4BYR+8@0%IR3D5)M-4$K+)2%VH_!^Y'=7,8=U4Z"UCRBX1-6*^#:$\YX
MDI&H"/6V@UY"DZ'&0JVSU.O(% +/?"$>58=MKK//;N5WYS&7\^
M62\L9H)",42DH&;M]^O_.8R_@)*!'S2**TH
M="1 K  )EAG&T!3%'/RB=D'@ZG.8B=KI3?Y%RB527DUL%*BZAFA$(*F=(5$;
M'L;AO\7+$R0_DR=XG??KF)P%3X/D@KD8)C&W7!Z!I@\&5*=\X#WFD?
M=O$^'KLCYP%#_ZBJ!3M>S-E_/D+G^S_#N![[OFR?YN\^>P@XTK'C!J,W'OG^;%1'+B/16("L4
MCGT86C(7>T)B2C:$0 'YG$C&>:.TEHP8$-8G]8"P9'T2R4_CI2/=0]_K#_KM
MB8K@EQ,5.1VK"'21,E4JTEEN($D@45Z&H*6U(G(#3BM0#*S628+7#PA(:J B
M,+Z, ,%CX#PXZY*E0N92@H1X19GFW,O@V4,"B+E*?SX>J>-.,AW1"8V"
M*^J2MH0&+XT'[FLQ@S0MZ6]'G_,%JJOSD:V4F>9@]*)W"$5)H0YP77/'.$8#5X
M(R+$P*)-23X@G+A2>!(=S7=0XH6#S7Y_F#W1C3-_!-W#^+)7WFMRT5R (F1?
M@@6M*0>1$C4Z$0M446UHU.$A!2D64BGF@A1&VVBYTC(80#Z)]$(020P7()FE
MXY6V]Q/C_E%=N,P?_(SUO2Y^[']C'<',%]],,?Y.K>#>$4#6KT6,UGF?% ?M
MO"4$@7QII'-E0'Y'-'=_\OP3Y:>H$GB(NB$1[E[@10SQ,74E&;G#<270 >M69)U4@C_EXT:R%4U86@\P;:
M:*=?P&E[ )VZB$GF9-V P@E26$^,)IH 0$CHQHMQB8"E$--V'$"[&\,&E+ET
M]PSB,#.1#PN!*>YCM6)/:F+ 6@>.4P;,($=>&OFL>3\\&7;RG@P5C<[GE?$H
MW^UCW.SZWLD,DM!F(C)53/0Z64!ZI"3NV D=O[^"#=6
M*06>)$T%079#G"N1XMJC[B1)AOR%B.2&"I24(D!N)A7(BR?
M5.="Z>RSH565F4V/442Q2$%#Q:SNBD
M3GE/7!>#%TD'JGA,1H2ED458;1&
M&O'PJ/AL-"(7HJ8$$@ 3E'G(VUKJI)5-Q@9J:Z01"T*J9R(FIEU4(0$7@0MT
MJB%((_ _4 $244Z76%.C#*T%(;'S3[#*)=*B1Y)#F1), FCN
MM+7<,AY=O;)S'S#UG;\>Z10L4UIJ:;3PPJ&/ZVT4U'#K@ZU%O9)'PKP >D13
M, J&1>
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M11=<:"[1YY/,D$0\&$MT'1(EOJ,BN6][)6Q?=C]V6C:@U879Y+67$4>
M. @IO3$^14\#  CPS-3?Z"RKNLS% *5$@TLR1:0I@L=HM(D*6&:QA*@4EP-=
MEDQ3YK.QGI6,JA@L!RD,UTX@D>62IY@$U:8.%=$>GJ;,9TTAT<88ZZS22LC$
M7$S@\D8\P1/'X@)G6&>Q;>=R=F-9Y8]-.&N?S&*KM]DL/D!:R'GRGDB3,Z4-
MDTD"#T11K[#S%S?:/*>NG^(4IU5>"@O!4R*,C^ 4=KTB'&UJ=NTR/E)[KY;T
MCFA![5P2P2U-G#C\O^Q! 812'X )YKF<0[_=57>OS%I55?:KV9#7/>CV
MU[KAY45)_NWH8_MC+K_??SYZ'0^ALU$U?RN]R%?%\A2[>W1SAN55[V,LN[DI
MLS468;41!)O79WV^=B.@W99<8N\G\M-0;X97Y /
M]M=CRO//SV,7_UA*ODACD$ZI0'UTN:2, 8-\D"?2"R]HQ8R:U01'EA4S").A: \J3P@)>+2SL^BQBEU_:#&%Y _PAA.__*
M.0H?H9/3$[[^[6>_(>_%'\3"T[P9)F-L+C\?7FD.3V70&N.=-0(EHP35%+G) 2)3CQ*D$D)RS\V*WBN
M[6@$FA(D4,'ES27Q;PL:";(D/%B0=H&]Z3K+;XKC3_API.YWM5 /@F\O$HXE*4"K!@-=(M2B)WC B%W_D?W-_R^=?\7-?0S?49$Q[
M@Y LG:'(<85('E75>F=U2B996HMI^P42T?S]EZB=DC+O6:VCD()9:6+(92:X
M=0K_+3Y'6@ QSH3])*E-9%9)G>L3)@!%'':@=5&RP*A9-@S,6_(=]3IA\^2T
M['VL0@EU*:S#C+>2&2:-YSF$9Q*EEG,3>.#:*K&TH'@_,IL_2AJ=$!LC$Z"\
M< IL#NT!(X[*2(,CRX:2]SX6IPB;8 *PD!S*",ER-$K9!"*HO#N2]7[)8//R
M8$V@4MM$?*12)(=0*7)=5J<%K0K6)!OJL 1ET>0T?WC4@:!+CYZJ2)4'Q98/$\;+)\>KC
M]GD,W[RX)I 9.)>*>.^DBT*(G 9MHN+"YHVB*.@E&UV+(;[IC3XJI2<4H9%;
M@Q8O9R,G&0E+!B!GB2V^^%ZVN^U!?-W^F+<]Q6XX;+O.9/?TYZ,F'/?*<8V.
M+RHU= BF!YHT
ML#HT%;39CBT2[KJ!OV![V36&['JH) 3<>= @E]$8>B@SEALQ2Y+@E2<9;$PQ8$]'J$:$77WB+
M4?9AJEML< F$\^24R$OHJ.34!*H4CRS__A7>$TA^-
M7L>/L7-=1IX1$F[.'E!$RN2$+GL/5,^),,#Y4I;!O4?6 LCM2F.-4@\(;M@@FLN
M!$E@&4,<3(H#!03'&A3,6$1^3MO<
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M3=CT8B-/O=0T4@-P.A1GQ8(GTB,
M21J77)Y4)KD"FN V>4:%E!+HN,J+F.@3%8_Z-!594W%K6>.I4ZML"!Y9;T@B
M[VK)J7$4M E@A8Y><#>N6*HN9*T>93T=6:O;RUI-3]8!QZITQ*%_@QX/=4K+
MX"4322%I'>\Q3O6%K/6CK*OI<4RK#;,^@31$."E<,M)S)A,/.?K/
MKU4BKO=\Z[R;71R?PWSUS=78@]%.],.R/6C79B].'8AB OE1XE3P:!T!'4D,G-/H\UZ<
M"Y^/LEB2F5[."8!153XXET)H)5V(@@AM-%6* !TOEV&+*)EKNWSL^-@%?.G/
MNPI&:*2>#]GEG,_#@&>/"
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MM-&>:Q=$2,EZI9T)#I)//#+]J%:+HE:ULN06F%4T$WC- ?EJ.U;ICE
M1I0S81^1< *!!"!0=\KE;-\&C3%0F9$APC1\*"T "Z=YM00HEF@)'+]0$IC
M/3P-FN*^*MHD1HF+EG)AN7%,*^6M#HQ#XN2!8-#W"D MGP9-L78.=TEH[UU"
MX@-,.)<]?A&]"D%J48.J'X\:-.?($7)H99)U*7I!=;"H1R9[85+[J&4-YE'O
M46CWR^X9-JTN=4)9T)PGY15B4,ZP-,X" 6F#X#J*5(.];!_5: '0B*2@& 0I
M S,B9W%RIKCFSFKN$^%UV$RB]G[]BUYYVBOQ8"WS3UPDGJ?(/#->2!5,E%P"
M4B+I+4C^0+RRAZ=!T\,@KE62+)A!@;-UZ^O-P99
M%I5WWAL'2(:"L2(H=/.ME#[H1!Z(5_;P-&B*D2')E>;HRVMM1$(0X@@X#HAE
MWC"HPYYH]??KZXU!R3A#G(B[1Q.J0;W=?[O/RJ=$4I\D<*A"13)BDA;(2A A6Y1DR
M\!J=M8KBI-
M#Y6DI5&PI#E-2B0-3BI+K:#2"T6\A8>!2O/. 5D*5(HN!FN3HQ%0I?"G<$XF
M()I$PWEX( [; U:E*>XJXM"V<!BK-.RMD*5")
M"&.3\,XXC;\(@&'1&Y.X4U&K]+A'X;*KTE37J*&O!@H9=Q+)4).8 VN41Z B
M%&JP9?T\I+=X48I%@29 VAV"LUPZU"?G+#61RURQ43 ;K%Q\:'K4IT7"I\AC
M+DYF&8EXIYC\ I
M>OM99;0 !\X:RAP15"J0DM0@W>A1:>Z?"7&J3 R*$!]$,.B@.<>X5R9%!S(\
MD%CV?%W]6VOPHB -:!V") YI3]XME#MMPK&LY'J+23!-IE"7):1&4$TJ!(=%K8ZG-\QAB4O?Q$6F6QN^>XG0\85P"
MZH9443@"SBL0!#A/R(=]'59L/&K.?#"'1@B$RA2B<2(!-SX7F-;2$061BKCX
MF%/_1([JX'/P'V*H76JBU=X*RX"S: 7SR@4#$"!$RD%<[!ZQT,CSJ#]SC>/H
MJ(@CFB6CA-!Y(V<6O=0JV!"HH@\#?^;KDM<9?R371 0F*$0C$G7@\JYRZ*=;
M1Y,D#V1R_:'IS_3PQQ 2I: &;1@1@@C'"1%410\TI. >R J-^29GU!E_E :K
MF>>*4R444^"0^R0ND/LPPWD=]FIXU)]YQGRTXCQX&06A(B4#TG*1?&2@922F
M!BOE[TUDR^;$3S'OF4>?\KHP*[U +;*H.6!X!'!2:*46'X0>E6CN2.0U-\X;
MK1A8X0S^ESC7UA&B#23)%A^):B*R*09?'-/24^2IR%V9(=8Z*U*N/J<$2/5
MUCO4:I11PUATP1..)E]S%)@.AAH5/')&'6M0E6)FN^?^: O@+&=S#K\P#F^'
MT,EO&O(Y-1G/J />.Q>M)%$H1&!G.>7<$A2AHI(\*L>4E*/5Z_ZGAOHA/)>!
M1 B!20$T:XJ+(*@4'&(N[;>>'S?9@WNQ%67M$Y3ALWYTXA"%,L!3H+,SZ/D/
M>]WV8 8^7/_*=MN,WGJ[[2]E^!/;;7O*0E# N;1)4"9M%$;XF CQBI%@KLN0
MUUZ&;V*9>N4)='U\T>N&=CZ^.'+E4Y,K%R:BZZ6,B50$$X"*&(W67%$M(=1@
M(N,+<7X&U/Z@;/L!.EF70MW>V:L)9#).U2"^
M^PVQ;)R<=GJC&"NA;)W.9EC-1"1HO"PQCCNEO4#Q&.X@)L; F,"3JU(.J*V1
M2#+P/>_A5U\;*K,4"K73HQ;)!B5=#$1*@0Z_D9(QEJ1/3 L>>666R(596FB?
M6*($(2^()P+!MTI%CQ7 )J%5(.U
M4',7XFS0+TH#.H'@&H1(VA !A(A$99(@1]$Y.\2CD2$#U
M;7]M.#CJE>WS&/:Z(997(@55_/WY:.,LEK[=CV]0[>.5[9#SJ!B?^*KL#4^W
MNK$FXX"1G#D3P*E2(VL36T%.W\K10(!-$U&>J\%&BO#
M!(D\T92YB"4U6$=W'\+?_=2KR:C6.1\N,"^M!Q$9=.STMHV]7ZK#=/CP:
M]'?6MG=J$CPFCJ"-U2FF\489SFJ1!R0US"D^II_U#![/14:+$$)&(N64!:I\
MMIV(L]HY3D!3G058NVC*G,?:% ,JUE@7DDH4G$ 0Y'GY+J9=YS5R!@N
M@HSF;]> AFBIY1&D$3RA0"5$(%:#]T+2&JP 6 0YSBBHG%R>I4D!11.DM@8H
M$0I!,$D>8#PI2BFYQ[%V=Y6FY/Y5FCMO76+$2R*B\99(D(D(I&XIA7.7V?S-2RYN9RW:
M$D0R$="\:,JC9U,#1+.%U&NLXE>*@YYDR^+R(D>KC)>\KPV.?E@6 RZ
M=A[N?67USL2I13ZM9=!&*2F%8,IR!$E) M>:LN!H?9W:N21;S\6/I0E=(^.<
MHR*/*VX% Z*4,,QS3D/]_-C['U'3S(&*W$O+35(N"3#"<967J (B7!!4UF#W
M@OE+8WK6AC,FG4C2)6J$<-X%RI5PB><%Q-K4,V-F7NL/9C)>B/=,1XO>)H',
M"HS3U HN(@X<3VS-N7G=EHI,CY)3A_R._J##)H#7RE#%'I);4U6$-Z *)
M8N_E$%_20:2A+-*:.[KE+6VV?6]D[@+9Y/IQ<'H>I1N'8_V
M!VW_HC?L#LK1,HXW;XU7Q%@;B!-,"Q.4IDD&&GU*--1I>FJQI#D73L]RE1,G
MHB<)!R-1$&A"B5)N)+4QU2D;X'O2K'8I6NN&UST/G3^'9;L?VGY9K2)7T@6'
M7:PC$51H)SU"KA/ @\WE]I=HE,Y+KG,9KX%%,."<5YH+RAQ$2S3C3NL8C0&Z
M1./U9:^,[,*B"5"@]90,/.M4I*+90PIS+R 001'$0
MC%DO$&H=?H&B!:]1DD"K/6ZI7I!9S2LQ7CV]S,*0!+ZJ"ES@'RD"DX0P88-%
MGXRJ&E0_1_U]4[WO=>7%K_FXM0V?&2,&"M4%(Z9/44B@:PJ2\PD4FT;WP
MIKM3E%MG$DV/HL2@-8#G0'A ES\90#,1D'YR[#8_R7:\WWZK/_C,7ZS"*"I\
M#,&H*'+9?DZ=DI)Z&U0@4*=J"(L 6?/W"UV@@3/E DD+9 "4=M4<0I3J9R8P&O1QQM-8DX47OY*37
MK8ZOS7RXT3L,-WJ%3OS,.OS F(G(Q;GP2,4#\$BB9B$DSA.39KGP\QV4):K]
M,N*FH1R)>9Z]B$EH8L!3;Y0US(00F:G5@N6% =#YBY5Z)[4"9/A4(^='1^M/B)7=
M_Z2&U#I(28*F3##)C=(&,#P6";, :[7/T7'(K:;0U6.)Q-[G49;PDQ33)-1U1#")E/,._P#-% ZAD
M58WFM><^<.8_L>TAEPA)T1DB!/I5)N1M'6G05E"FE5]::/$1:D#2HGRII'F_P>*Y")13*FR4%$@: PI-^82(JQT0
MQY5+MA053)-*M5?A]X<(3/MG525WL:K8W;VIK97Y:,&M3G(0)$2
M)(<.;Q+>YIUW@C5.<&]L(A.28"">L1"?-*.G&*X6INH],IKLYI&IJ"4-:*LUXT"0:*T*RP*0"S60@
M1',FR7+-(-QWAL0!SO+Q4V%"SIZ'Q'$$,%BS.5H=/ J;_*K
MP-0AN#Q_R@
M=-8D''3141Z$T\Q1Z4CT1G(7B19I><;<#"4WG_7"1#F %#2Z@"(2:S12X2@\
M<\9[J>M0X/B6DOOSS7+9.&*<=")ZK%DE%+=!4AXF:^4MN+F,N
M<@+"1F8D2H[RY" 8HC0BI39YEX7ZC[EJCXS!42PGR[J7,0;J$".E$Q1D B&M
M \>59<9R#LP0MZO**AZ[_N@$RB_7:$ G]K?CQ]@=QE;\GEQOA?M-..Z5
M+X;]0>\DEM>4J?L:RL/8'UP>G%;^PE?>]V8&Q<53;YR\C#CE@J4T$:62=T(+
MYQCGTGHIK0@NU6I=X$(J\\ZH"_C=HP+/2H'!,6IH?4Q#>]3[%\5.99*3,106EF!7>6"Q�Q:I2: &
M4&VU,S5BC0NIS ^56LR%)R>2ES3YY"/A@CGJN'?11A"!&,%J50U[(97Y(5&+
M^2@P,@A(1E%P47C+K]$0+&6
MI[VQ4&>H5O-!]A.;S@X>@%EK]/NPJ-2STJI01$KI ^.,2FH"\ DL&!BB, Y$NH:
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M\6Z#WNG3?*?<_@(Z[G!]RA\K].!TWY\>O'';Z'=
M/^W Z&F[BX0M%M5%OTWN[GH#9%35 S[&'5ZM"30;AYS)I52[Y]F*S2RV-/JGN7%R=,.A,;N%)=AV^5>^V/%;[R
MQ8M/7H6=#AI]I*:A\0]2_>^W4PBAW3U\2AJTNLOGQSRI^N(K??^USLZ/O3B.
MK>B53R\>D%"[B@0G[<[HZ?_>Q?'6;[3BI\9V[P2Z__O7/G3[11_U,8U/[+?/
MXU.!'5Y]^C1^/XVWJ:0S>5_*;FSL[F5FM^KV!O]0;OH'^$
MRCSH=7]MK*^^6&TP(H6=7ZL77I&_;*#X^P:V3PX;_=+_L8)6\)*AO3^DJ\>G
MARL-Z R^<>0Z7&E^>O9#$,OQPI4G\^@GQ#&5,@0D(]$R+I&2TZ\FLC2ZD!E8B.VGZST_
MS,0E!QY6)BFE_*^16^]]?,VV/^[SYC <;WP\>&6/MXXWV/[Y(=L_WF?-=TUQ
M<+Q]+TG^)R/X=5?(OSKS\X!ZWQTQSVR
M]6[_T\%Q\_Q@_>5)ZWR3--45+\NR).GZ7P;'[#FR\Z_MA5>2L$
M6FNU]M9>-[8WWFQM[S;>[&WO[*VU=AN[6PTT6KMHF1J4-[:V&U3^,_S2V'KY
M[5>ZCCOJ&]QQ+B^Y^Z^-QA4;?&E_UU[LYE>BEHM%-\ O>V5C")U(X075!=-*<0IX$XRO/UJ.O
MO-C__@=5Y#=.?VUD07P7Z*:L@^IN;&4.-.&6(SW7V6GW<]P!1PHZJ=UA%8V8
MX1C9J*(,+_%AK>I9#TOMT8+O?WKO2/+:$5WX1&,A@DZ%!7!%- X"!XTF/:(%
M+]">&[TX1IQ^J?9?A]Z9*\]V/&SW!WG'C!8>>5@*1)KG'T1S_2UK[6Y^POOQ
M]U:2R)35!42!RI1K--FL4<)3[%H?($;$S1=Y(F[8;XSG!AMYPGWUUIIU/<9U
M[Q$M:UI;#7CZ9W.GA7>&-?D
M7L9UWE_T,@^DBGY/]B9^T0O7:12^@\]QYT$\+7L?\WUJRI]>MMVK/=5ZU1PU
MS[W$L8U8\++=>O57&X_SUCJV:=VSYOI?>%WK0VOWP^2:O_!9LGNPVR/[YYOG
MK?,/YUN[;^7^NTUR\.[/HWW$C=:K3<2,_4^M=\BPV%NZ]9?Y]'IW;=#<(6>O
M=S?/6NM-^1[ *"&%+)*UI!!1V0(40Q01P5)0A%LB,N?JP"N*JYRBC@E3&)]T(93419[%+9 X>:\26&["
MRC/)"A2*MO3;#D)=,/I"@ZL;/FT/\$G^[_E]I=/_K&"TT4N-]E5P_6460W=L
MLQ?FS3>W=QH;)Z>=W@@=FNOCKM'JK?YR4P7N/,_TM0G"!8[JSR$,,W-,70NA
MC/W^Y-=K; "M)9[^E$=Y]MY(J7@,4#@3*#H!G*)'*6W!E1!1@C-@T\HS90E%
MH?H/G1@.8V.];'^,OS9VAFV$"$/(ER#YZ^SC !.YO< _M\K=WJ=ZLKB?$IYX
M'YU1/G)7<,9\YEYHUKAF17+),.!T>Q'V!^4JILR5;Y!BDW6I,E
M9>0_-3G#WG,5C$W*%)QKGT,[K@!+0R&YLC9P:E1"63:A''6@&[Z4Y;V)\DT/
M9=4Y:)^.7:L')2>\[_O$M.'20.%]#C9;((6CDJ"8-'516.H)67G&B*&WC[]=
MCVSP>YG0F;<1SL"]5D9X@&J$T"W?!R8MEX05,D2%?@A+A8-DBJ0%9=0$+P1'
M+LH)_>4^Q_KK'M+R-T>][H,-LK/W-$9M)+>%Y-[K,XI/X;]#&&Y95+#Z6,31.AV5_"-U!8]!K
MX!F5HT79/]TOV?W,<[%K?O#TEC'F!E]=2CSE2M2L.F?EM.
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M=W!YF5G7:/<;T/@4.YWB0[?W"9L9H8\]'_! ?QC+7QO0
M;X28VM57W<;V$+TI0>2%J*Y(&*6VVF@T]O'/.\8LWJ$UR!:A_U.O_-__L%J(
MW_[FV:GZW^PZ?76.L9K93RF\0R7Y=]:1G8F*;%8:4DN;]#,Q1__IO:;6LP2Q
M-PW)_0\,]=N2HUBW-\!O_C-L9Q.#EJ7*
M=2*LO D$<(FQF$?3K*:1[EESCV3_I+XP@95P:O
MT(!.YQ+!KD*;BY,3\)[7T>P:BEWA9A<.9D:V?#@O[6L$/-H]K$X]+:./51"9
MLD:U;*W?^"?>#UW11G_HCQK](VP%MG=8=?D$QV
M0^.?;/R.#AU:/.Z.\0WR^=6I>%%NQ>0^51F4JA%5(Z$_:%C2"##J9WB>/4Z\
M&)8E-F&[:G^.)PU@,'R <''^WB<<)5Y#$9G,\:"(_C22'W2EK9"2B7GF&
M!G,A\6(.XWZ\PF?L_[+:N*E]XY_WL+;GLH=S!T\ ],$AYIY$
M@J49(J,NA/=0"!-I88CTA9;.Y^FBZ(UZ1,Q:(F8]\;&*]'5R>?H&>(_X6$(&
MN0P9.JWZ%9WBZ\>Z)\@L.)3R@MRA&AR@GTPRCP4[X;D+=N5P\9AV?LT
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M3#/A;$'P^JZKL7XZ[[&DU(T.D_\H3;
MH.D7/,&RH%,BNLB;OA="IE08XV61%'->1XK'[!5'9/EY0NMK@:NE&*UW]R:O
MU=J?S:E_7UEE@>>8TM\$*W]MM&^;@91GGZHY)U2UG(HTZ#6&_7&@$]]T7)(V
MG]FO(IX7\SMYWB<_JS/*#__4QD?G"&H77ZV7?=&/[7ZENEWH^C9T>6WI=*+KO0=/[J0G QI5A-JF7WNBKS
MA%>V<[2XBUJ1[779ZS1ZB$U7E.5S*&.(/?@YU4T0<66U[@Z4#O"VQ=99)XZJ
M!)%_4MG86]W)^QEHIO+2WE_RBW]^RTD:M^L@6;BBDJE=GHRG+$_QV9!/0BVN
M$HE#U6(8AO9@TJ[5F>9O;/I4KN6G]_SP5"5RDJ;([=C:7>.MX[?GS4_O=0P\0B0%LS8OJ">BL)X)_.B\8B8E*^+W
M(P[+.K:K6;3^4>QT+N>[_OF5%/EO3A7]DXMZ:-
M']#XC!>&YZ^NW3/GS71R"F&_AS>ODFBR'S&!B?C0O2_5G?[7Y,Q_++*>,&[#+OM\0@>]L/*]2'-B>/6,J]U"B(2!BP:
MSH/T+"6%\/I^LQK2BI,5!!/?/D%'^(^50MXHC^LE"M<-*I@,H*1*:@@_,HS)O6J
MO1C<%V*6:8E5(K ""?TJB)LMEY^)3VU4N]*6W>J1VT-!Y5;
M@"!S.]4@#TXU]LE[J5EPB;K"2J^1X$ ./'-6>!]10XAUSL+*,\I_59K_:CF_
MH1_C!?K]"_/^F1U<,O@[KO4?)T9K:G]EA-SV[L]O?_?>9[U8_?NLIOE7,5O?
M>K'7W&CM[C0V6R^VMM]L;:_E/>V>[S>V-UYN;&^T7FPL?&+6F^QW3?*:KJ8Z
M?V\QK;<>Y\ ])@0FPC7H%/N;I[3C9##7SHE4K"7QI<=#Q[
MC3> ;NWFYN9EONO:N/';EP[O2P2@1MZ?ZCLZ]Z7 'O?1O/+BT]Q'\^I6J*>]
M<23J:1ES*O/'>&-SU,\-J5I /E\"#IN"/.S.^ZF.?QZ5GR.)A[%P980/1:63
M3Z'S"14T;[DWFUUK=G:GK#RU2F90FTVO$GJ[0G(+/SES0REK/SU\
MCV]T;_L,?!\ZJG=Z@_A\E[E!!_[#8=D;=D,Q:6+FU"G]MGQ2_)%773CQKFWO
M-C9_YF4G%B!;#/I-AE)'H=]9T2<+\G_HG?^NKLV/+?*_U8N/&Q>BG^P6\K2:
M)LIGK3S;1/>DWZ!?,/<[J9'!3!,9ELPV5L@@'LG"989)O="T;O_A>DN*\K,XX-S_G)FY_)?UTG':Z\9]A>S#Z%<_H5"F"
M51KJ.%6QTX[E!5RR$AR,JS_V\[8@,^QO#_?V-H/#K\RR-L_IA6\#?XIQ^IVD]0
MM1OE W*<8#A>^9'YUUH7.J-^N^)=+R^+ [SH=<.X%$4^![%HV!E4IVR=QO%3
M'CG9$F.20DS2CYSLVYAD'JZH4V4X[W8G\;.?XW+]>@<2FB!@$&("0
MS/[T=_W6L >0E.11@W5?O=,.!6SL8>TUK]^ZUV/N+,] #^M'^_=ZS':><7BO
MQWST!AYSU2I C9BSD Z3G[9.>0T7NQX)T%".'TAM.0JX0W@A\*@0)KE78.XL
M,WJT3\SHLZ5O)9YR
M?Z"?_T"#)8_]&W9%>5$@)88=?9EZ\Z J?2B[A:"==O=
MQ]:^ 3JY&7K>+4N7N[E+O3!9[I/@*C[V'M^0H_W6=1.I-MV[]VOX'7E:MHX+
MT$?9L_=NTC/$X,ET6DXL^^[8,/RRGP$/#R?II_A%[P7BS1:(CQ^0.+RO+KF(
M?WP2J,T=VY' -  4[^KNWO=QQ_G#H\_)'^Z8-!7^\$FUZI]//M[60*[F]*^R
MD_.:E)!9N6!T?UIP7M;93ZYVI)T@3BM_9R4E)+%I-MK6BH(;<33WK.F+L*;#
M>]7E$M;T237S=VQ'C*,PLX"KCSA-E["/-VBW)I#]W4BS2L1V[G9+.7)P;VVC)S15_=,^P[S+ /$?W];+7E=\Q"$I[Q2<7E=VQ'?$>J['4_G^?MZM[V
MN[NLX8K&W?8*E?91?+^7G3>W?N!+-@/@B6XZ'Y\
MINJU6W _7M/D\N4]"-^=OAPTT%_^Z_$'I17>2P\MM.(F4.R WU0W?B]1[O"E
M>427YD+WV=;6I'%D^_#SM^W=W[O,>W6P(>=R.,FT@^5A2GM)C\]M[41UH/M&
MK%??RJ]- \]/7KT]>O5TY]\G)_]Z\=O/V>LW1V^>_7IAW]28>+],V^FUN6_N
M._WFXC[,(_1TKGHNH[#%?*%I\HC_*)=TH),K3/PKH!A=QWD S4#[9(\R@;H:
MD:RK$;CN,BSU )]OS_.VV*F:YAU.QO<&[_B!_1^M?S<:=L]=7FMK\-=2XI(=
M[#^S/N-1+W#?!_QHLL2?]P\?_+!+1IWTZL8'1$7&Y93UQ$IYO
MB/74MC_9>=,67=;UDUF6^\V2H6UG1O9S7I/(+Q5'1N0Y_
M'+NJI$6M_7Y>5M7PMV[6]%4Q_'6RZL:>UGVC;[D5?/):BR:G1^+XD@
M\]9.?!?7>-M1C5=8SK/)TMP6J7R5KF/WV)L/TTUKZI5-FV;.0W2T)M$PC@<
MNAY$Y!CF@CLH_!HWB,\OJYME5A%AZ#W$G9\V5=6^4*(]/_OO%TYW]0Z7,[VESZ.SFY83'
MS.L5*+1SQH0PV&G5C&D;DEM.FF3=X"U7T_A-+;E]]#?=IA]UIR.F@J%H'[ K
MO[]K:>,=CW3JF@59%*S2@S=,2:)HU =OE'/3AOC2$#.1@D Z;+E0='\8,C\^
M0GHI!UO$&8[+"MF*-(%FS'R'WNP<;1WM*LV^+1%&ROJ6;F$__T)B\^!JTN0Z
M1=EW_W[V^_<9FP7*X\N.\R,Z8("MF&NWV%3&ZL')O(+TIHF>&KM@.IWIR$CI(S(B1'S%*W$ RS.Z(+ +[+,HN[\#S
M8ET'L\'\RKIWX?"%>'_-6[HTJ"/,'+&!V9]]_DX(;]GU->TDZ/&7'#O>B BN
M^TGEF$X+,L+;E7Q=KK+=@9'G!O29QNLB_.BB;;@\M=NPH" B*\G2RL9Y_:[M%\M)Z?@!;DU7X[_P+O9:
M]HV^&R["@N0YL+^Q(IIMT>/"\;60#!C\NZ!)KQBN:9XSUUH2M1$=T+LXZ@UK
M,T;21<3.4L)Q9;8S>5'>!P>9^;
M)2B-QB )A%R_(BMZ.0@[?-*66! *#?^=QL>+Y9P^#*TD,Z4KP*$34]A98PI&
MKG1%+B#6 ;=A'H/1Z:WLW&&C)Q CB[[M>EJ0O;)0W'1B3V0<*1V%>ZC7+X!E
M72N'NE86%5]X"%H6#3@FWBQL]?[AX8'G2Z_[#A4O((]"0QA66K)>L;*,3S5"*TFO9$7AKG
M;5M:IKQGLS3X7&4:*P1#\C)R G41X8[TSI;$B_DW>L2SD1_I:5*?L7$M=&7^
MDET&N0)&ZBS;F?YYN^1F>&E,&JAQU]JXQY2,0)G6%ID_)_G@4_^)BZAF8;/+
MN,7\INW"!T(:+W\2.]_Q1=6UEM)O "L.Y!']C?6R;U:HJPC^9M$4:A.[3==*C8I
MF,& M9SS?S@R1D_KDO01R*4)*@67HG+S]9GG?S2F*& 6Y[.&70)CL,8.SH:.
M1"Q8+5<:0N\@QD1/P3#"FS"_V$H*JF+&JJ+-C^P 6D+38Z5YMYGYI@N7_295J: ;'?Z#E1;QT(Y_J\HKU
M)E#,F.R\6%D+EB:KT?0?;%UY!J@E#$IOIK.8))!SQ2Z(&6J_,Z.CV2\;TU\F
MYBQ3#8RG3UHW,UL95&D%1SLAG7>8W"CX'GCB86=Y-H#?@6/V,Q2WA
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MRP*?-:\5^(7XKFA)8*9,5[03YFO?)G/;J%+"/&A\EFL"UA<%,
M5P4N&[LT9C#!>YX8I&)P$V\ABFB%E:EMC[]4Y=2%BQ=>2R:M7 *S?K)[\/!O
M.$"7LA_Y_;$Z])*Y
M::95#V>N>+3"GIGG]D\:E:]R8_\S
M+I_7W$E5^6=?%MQOS?N/1OXX2+ ZKPATD*D39[R"SGC+5-3;YB-N)/$1L!,=
M!"2)N6QY]RRO>F?7L@0J]RG[FW0F@Z>'VH_<#M-OVKB"<\OWO-.;3&(A55'U
MU(7>^<#7AO<+-RD[WM8YV],K?N6XHKEF/Y')X8O,8R5!K=GZC+0[)F>5(>:B
M'.?L6EA "59!:5$6NCZ7['04^4I85YYU\QRLJY^/(>*FF4U,=UHF?60M^-AK
MRO$+/9"_[NWN[V'X3-B.]^IO>"\X-;X[%W\)/!:N4P7:V"1>X)W<4ZL-1*#Z\L*8:JU47[_Z44T#OC3=-K!&2@"=IF_
M9P%#3!1\P*(2.DEV@\/>["(7TW?$_(VOTG:ZLOY>- D(.@/"\XT;TP?W#)X]&B8\K8JYXR"]T@S)V2OQ;
ME*!TS= AEI#<():*S;L,J0?1B>(L>$C93KB;1&4416A1JEL6Y.6:Z8]TI+-=>_X 55:V,P%^1/KH9TB KB^9* -66]?*<-FL]?EP8W*2+J>
M/8".5 0G$M>Q#?I=7,P*/:Y!4-\B2YEX2>G.Z:\L5M0?LLS?D:FN$>#?ZU(@
M5I S$;TZVA*["P'5\%L24\VG4[<>4QW8;'T;/-BQ^MB(*+ 7]8*+]=(%\V5]
M1!'3&\?1@SJ2Q+'/T#&:/]:!#'V
M/UXPYS(-LSKQ>EBT]0J3&)>%!$'1YZ';X$MECP"[V,PJVW*-_-\W&IAC:'K>
M0R!N!H1M?")$LX <[&O)R()@G,R07V0*?SZ9N,527+K3[7OE70(;8['J\.7
ML,8_>':(Y+B+8K@0%TX$5=W4T09NBMUZDA/WT6DY@2KNX55B1C!V(7B-=\NY
M]@@;(3J/8'1BV[!73U+5DI\Y=%2YU!K;
M)[V>V7?AR*O\O.NMEC@Z?U'_8RXE-VY3>#?-I'T4$DL_#WP^?UFH.A
MF +)5_(WO0*O9(2F7;&277)6Y(_!M"4Z*@N^TH68PAB!CP?TQY\>9;3%1:6.
M6;T9&FF;Y?\AM1C>:@)!249
M,'2=)$F*OD/L=_H@U(+TAGQ.?Y*BDF."X]J0"TWL<,:6ENK-\TJ=^@N%-
MGE1Y.>_4Q6#G1"98R4MCRWV1=TL6EF=R"W/8(Q!YYS[\CRB$^O%-PM>6OHMWF9TVW+9Z/L7S1X/WFW$E_!2SJ+;DZD2G\YF97-*#LE&Q+;
MCNO2>[\*N$V@V6V2HY#T6*<1VC+X3^4]NCM,_9[)1[FA>-+GAP:*\D;/ZV?'
M9@CLKJFMMR;I;_^A)OWEMEG!(NG/3'"ZJ#0HF0&:
M\*OYOOM'7RJ\^A&IUKPCKW!IG\O2KBGVRO,015-VNG.6M3<56MZ>P^[)/*0
MP4E'DJ+(BF;2LVJSF[WA,[83-'_&!.&/T1FE<287
M$!ZAK6F\S&Q4Y_X(QH>-*TP_7B.N[17.7ME
MV '5GJI.1?^%J,=*+0++(>E*2XFQP&CA>RVHF\S82BMGH-[.BQC,LV/U8BUI
M/0N6_7EQ5D:>)9J4ZI+F&0BW\*+;9DK!;O:6-K[A#6*E'"8-*_J+@MGWQ=FT
M]"!M1X51)76==8^R):KI6 V+OXZ4M"B (^-?2I[(MH52AP-KB3S+5C0STC#6
M6>D72ZV^(>]]TFWPR5UQ
M%Q_\Y5I6=;5E"0;71Z_MT5^^H'?L:BL0U6GWRZ@GE];#?M%4UOU+U;;-6_*3
MBL /8[+7&FQ?PP++\#RT'$O)
M@\:PENL$QYAYMZ:]JU)GSU1]H?;$HCEWH=A@I%4^ZO61@AJ$\ZLXV8/4OG%3
M[TQ;Y]1_!OV0J[XT]\]B/K)$7["6A(-\S#*N9:-O^)]"*=NY#TY9Q=*FS1,E
M::( &-U\%5(>$B'10%:YQ9:(4=1#&BE9Z+
MMDE:,MS:NQGT1=H^B55I(Q368_9_DA*!U$_^+.2Y
M'(?#_XJ:W77= 75UT):?-\%'U[E3UJS_D7V7?W_EV@BC8;TDG;=!X(-L:E',
MI^D527*0H@(8-LB@]FNY2.V6G-1C(0,IC '=?3?^7J*$7$C&.I\$4(87RA+@
M7'U*JW1PJ(TR^@O)]9'FA]4]K!7QM<49M4-'/1.48_,6EH:?-=^#3A.I. 54
M=RO*HXKMV]3'VZ=\!"?<2;Q;Z(P#>GB=9_NES/F
MAJ5'5<7M+ F]&G6?]%(,H70Y7(WAQ\47
M(6V$R&5.-X&,=8ZG\W$+<9I[,KH"J7@0OR'QNS=-*TN80U@AY$J_?^NN]ZWE_7G52Y]3Y2CW/
M%MCXS\^#CYFN6J'!!LVAY(I#O@:32=YQ'0WMC8S'15/F>1@,/O)?(=E %[)C
M^8FW,9#'2&2>L+:NWP->R6?"FV+
M=B?1:LY/+YFBHR"YS%+7>(>)]R1(^2B34/7-+CX"YG8AXY;YA!2I!+JB33_8
M.SADRIGE9T[2C)PF[<;A9*^F '.#&(AD \1%/_:A^-P[UCH4=*-6X>D-"8C#G.4:7G*
ML$A[B:USXF#57/.Q(W7'ROH/]O8/6;??!_P(*CPT9,U?DUN)O6#=NL:EI'72
M5:++3 OLHEBF#))J*T@M5VA"B,A:%5)6Y%B.>XVLEG.LRV$O !K4W66-
MY$6=G1!S0_8GD>?>:%LMR+%H BZJ!O$QNTSRY(I-9266V/.:'$EPPX_1.R1#*LG1.P.0C$]HK%''B>6FF+BG#).?*3M^M[
ML/?#G@3BH;W E0_6G"=YK(,$QS_[9IGS@B.+FK3%#.F;/OBPOKSPR8,G,B_T
MXY- QIH@^LZDSO?1I.,,3JE2?"U/KQ7I7 #,H) ,HP_&9, > Y-)\R]8X=/3
M[WKD@)08?6UWDA(@-J"0OX^2J*5(.B\NU6^!%S2>^J6K53\0N2H.IV8[60">
M0GR(@UO7Z<5,*FQ\$/P.*PF_^XK>(1S)!Q74B9:VP5W@3<6O:;[/G1,9[6!M
MXH,PEGP,U5P?FW!)-J3WL"$M;"'*0UUVGJS33:^Q635ULV,01DNW9 2,:4.1I&?@R
MSB-[FDL0+><,.ZVU(A^9RO+-Q1D?WL#T[-O"?DXNYQIPGFBI&U(BFM97&'L/
MDS>,-_"54);-8&Z+*E_%]GS;<&$&LPQ\A>^^-ZM]*87 >##W\[]IN@)K*R-.
M:F%^A%&&$ZR;FE@7JOI,AS1[UE>C&TZ"YL0-W8TQB[/4.MA#XLZ28EW.L(J<
M$#IA,B;*R%7GPQ]QT$.&^997%%2DJ0Q*L)32ST-E"/C&I
MD%J,!.8H\3'[6?,:G_J\QI?P3WI!ZY][^M)KI]VL7](TS]ET)?/SP6[V;U*
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MC2EALBBF4=A&YG2/_WBE[8G]4"HB[.VJ[3
M>(#>JYV#!P]I5923YZTS4!B"$>,1VIA/ZZ/'>N
MIN%X)41RXGK0,OW?-[S%>FV7;&I4U8/M79*"Y8.32$CT4* .F*ZRW5)W:0D(
MYB9+<'6G[IQ+K/&\*/DZ;D0:@*#:F7!DR&%!/Z%U)@X(7#.8O[N1G3)DT4
MCP(1PWX"\"B+^*K8C157B+"]8WB6R.4(ZNEIOK!
MD[FD9XKP8F:CP:RL ?%(/I"3R"11OP1)D\5
MK(FU=5BBCK+8%A$(PI3]#KQ=3E
MV@7ALM#2&3N&.;>G"0XXT(=L(('ZUE+/6O&L^#W.^5/8+T\QN[J @V0!RQFT
MQ68AY#O*'NSP"#[^TVTXLU@5,O@9A$;]3*5X9N:JA9T:]K1!I1_"U+5(/-*1
M\*UN\W3%Y:#M' *A*6G3D>LI(.QTC>;"CYQRF,8<0$
M/!V#-^T\BJZ&[!0WRSLW ;PU."[-1 --6)R/^8HQAR [["BBRN6-GX%54S:%
MG#-F2PJ,N#W8%.3_8DBF%# A@%LQ"*E@L3DN78-BCK/N)/]C["2$:6AZ=]DA
MC2*$=QPCF<%E?,] %/H=0_>(D1NT]G\D+ QZ[XB9
M6#@H6?%]F,IH^-$-#%-][7NLC(O8=CZ9M+TX&XC*GKJ)8[_2 [&9]G>S%U.F
M,4_#\#>4+):E/GAJD9(AR7G)ZF]$C9 Q_:#@SABG$TN'82&'=Y&XM)JD$:K"
M1KXP,MQ6NOY]Q W6;@$W8F":6>\J!+#)1W0";/N O3I(N8AYJ
M\7-@'UR?*^&M,TW1)[L&)$/9]RC8H,$W[:03GW;LCO9I!X-"AXVE&1YT5UI2
ML=O*@\>NPPQ;44+L(^?HX&YVA'"?ZYRB4[6"U7J11[I;=SIS RWT0@)I$G-%
M?R&E0A@F:SYM(+HC^RE5_K2T\0Z?1FKF2JK9.N_4&GCM4+N
M7SG!T:ZSN"2F94N:6=W4.Q4>R\[9PVRGX-U1"DGSVZOC'7-S*J2!;FQW$W;V
M6K?6Z_5IEM-3-^7MXI0?;GNGZ7=B4K,CJ"%;?;5P:42* 9D1/IRTC9V'@7/A
MHHHG 1($#$8L^ZBD+O>Z/:(U-)Y%?]L&R0+92_J(^6GN#RT[*EMPJ(GE9M5U
MTS-O\4?F$=Z3$R%I]ZPD-HG47#_$3[F43!Q5>?:2(*=TRJ;%*CL/$!B14'$[EF*UP*/;/>A5M_P=1T4:I
MDA%^_J':BZW0]\Y&F9/>E5 HD8NKK/Q
MJ>-(2PEUT]MSB78S3TG>PQ1I/5&',%6MF@+) ^=!"6.]=+PR3#D!+%_3P^KF
M7!3N/ KS&>S]CH!.3]8L4^X9%LS=S*? ;;0$)TQ SY%9R4@BK_O11
MH@=Z<+^!KU% PX'^"_TY(DF$+0WHL+/8B/4#$4$CZY$UDC\ B+=&*G?=[2B3NX_,>(95W0QR1-41A.?:WQ
M2.R '&JG/B-P9&" 7'26],F<]6U1>0 B4J*QU9@->Z74TXESXLT2L-*0,&)
MS.+-Q9Z30"&9,/*]<=:Z, 82V( +PKD9VU];Y2 F"!DL":<^4=B)"7H]/ (U0*Z^0Q:*U(%TT
M3-=SAB+OT5HKMBQJH\:,L(FN\:>84$!+JA1$K[@P2$.,4>
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MMWFS'GTAM\Q5#CS=KOT?A/*TCY!POP3,P[!+;M^!7(W\;]Z![*=BP;
MKM@ W$G4]KK8>E[WI_,Y3V?([^YN:L,0TBF?2!,+L=TYT><]9Q(0"W]T\#=#
M49%<-=_QM=:HZ4F?P'8E($U7@J^19K*::[49L^FD7^\M8H ZT4CIQS_?J:& !KP ]")_$(
M*4MM1\$"0?4#_ ?GCD&?UEG,&FL)G(5>DS@B0T;-8)VWEV[2QQIYWUSNQ>-O
M(_?B XV6WR/*#D"1M]QO8(OB@C*]PRB]FL YQ=E@4FAOF(9S!E1C1E XIFSD
M;T\,=_-?^7_R=S.4"HVR8S+HBWR4'0&N@/8X5R@!1B2HXA9$[:"=T@8/FX?8
M-S?H6Y3.^0J8(^T<$M>]O/WM*)3N19[;PA&S(W;MT>^0A>@[40WY&$=.^*'J)00]$R60>QY/MP3-PM[GG:S%S4G%-C@#%H?<.Q*;IE73\H%;S[X
M'>#I"S.$M,B-S*#856;K_/V+Z"6/6<>X@F:RQA!IJO_8>;#[!*\CDPB><>5J
M" A@A+_\%RW@.@W_Q%H,F_KDMF_JDYNPJ9)@.:R(S&[IEEXKG3(NXH C<;R%
MV,3>[N/]_;\AYBA#[/KRYM\;P_@H\X@I20K8J9^Z80(
MW7J1.T>(J_*=JSQ*@R\)OS_$3SU$X%9573@NKKJ_PR4;L'E9!V=$%%18P?VH<3_;UC7=D;@4R=*ZSV
MVD_I+I?225H@HRK-D:6$!+;@6_6NU,M]E]W B3I:!T.-H&\LD7&Y#G\OC:\'
MS4W*-H7\-[>PHK4YZP9Z[@RYS=#+)>TL[5U!#[>GH9E 0G]$]^52,FB&$XL+
MWL* P4\KE4)1GI\'Q*8[5%8>;T1G*.)-_+T&8H3.W?1_= )ZM;D5;B#>>&1Q
M.7E8VOP=?/;V^H;-O<.1$[ KJ157G"#!1A"X#[?H%+6I9AX/"):AV5GKCL-<
M&06&)7E_FL:7(E"MZ#^VQ] _=D?34.^38:CW2V_RAZ8U:6T&O9#'0OZ^W
M[]EO.Q;S5RO*'F^. ZM_/D%F[8C7#Q9M(?
M3_OKL$"?5GW3HNKR-$\P9KR%Z=[G\DP1VAK\_OP6GL"CFW ":,\ T*,"RE';
M@%.[.2Y=-'E8J&&40,IRBL>=$7$AIGW-(NZ>
M2#^"2+U'KZRE-'CU'1N[QV<]$\9&RCBV]'%!GOVGTO
M]=+B^K82QVZ>5U4V(6T2M:L+5U5NRCI2LS7FT"HR\!N2BA84:FNT,\EM+-[B1S
M'&63625&"4KHS$#I\@K82(!HM=K.>:?YN&&5.?W@B\7"66+93F7
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MZR1'<:H F:" RVKL1G70)DS-;SMW;32"#5JA_QM0J)05)&6))8?\"JO=DI:7;*X-8^W6D\S:F?C>T8,9/_CAR>Z!GS.-75CJ
M@WV$W:>B:'8*VAX"Y)LA.+6:*0E],XN=*W9Y3F9Z@Q9= IYE#,V'S1?R#\2L!H.DH.VI*V[0MD(BID#GAL/LC3*<,*=>"\544K-43%4 (TD
M2I^WHV&0"K[Y6P'%@PAH!5MWSKH1T[PCK4URDI3GI W@A7W:"EKKU8VSP!-<
M&&9G\N12C]MT ]R, ,Q$PB*5*#<%)^4#]YQ;I9T23-403WZ@
ML) U=VC3--#O/#C7S>)3OS4D('X@-JH3)B7T.MG5]U>%?+DGT(\BT'E92..M
M!&HBTI,%KR+*>9"T'M(][@_F2QY,L$8TZ%"K)=H!4[1 ZS>K6@^%\U%X1BQC
M33$7BZ^1UER;PBLB%,0E*,U,/,/Z$!R?^Y.]"LK5 @T9!\;F* %.N3 >NF'+
M;YFKBU24O)PK3#UWCQ*8!86O9+6EG*ZD1&6@O;!W'0"?OHTN&_G<=PHEKPIU$&@L98JDN09@:;UY]MNS__'>
M_N?T'IE@:ZBKAN9\0L?;9,=(B?<.._XM5,W?7=_F[UIQ9)OV6LXR:0SC:VDV
M57")[1M5KVPHBI&A+R(US"2[36PM8BT1Q#"B7/\9MNZV"BQEXS_)"$W-]@I>8
M]KX#F+@>%DV9^I2FE@SS1MW+TK+4V55BX2.S[B\^SJAL&MF3P2/S9]\L\_B;
M"4JS-J2K [*4;[V]!@CCK]TKV+ Y^J$6UE5&KB"[*-Y+@U': WMN@$3E^YJE
MHW^W#)U+7[T^BH$MX)_R\UNGE1_VHG70,P4_APB_4,<);3+CCIJ7UI" WKTY>'[TY^=7/\)MM/ .J338W[+ZZ>CNC/XZ-
MSJ3'W4<0!X??-#S"@8)* )"X>KM'"W#MV9!V#M:/QVP%XUMM&B;%"6:7W"WM
MLD@_<2V6OD64Q=D$/J7M6NG@S742 MQTYBO[.NC4<:@ZDN.IT&:M=;F13N>@0I*:"%WN.IGLXO=.T./H.C,]O) @PW78E7[&:\3NJ8QCCI
MW@5ZGZEP-8OJ\ 9F*MP6'3B%"X!6AVZ(Z 3B-=\/4+%@I7.SOCXD/2L<; BJ
M#3N.T@>9(W*S(B1IPHY"'Q=Y<\G]P[A#594H(]P012%51;0FB4
MVGDM]TL%B*XHC8ZT>\BU)N)&&L $^FDVU_#T H_P U:8T\RJH+
MY[2@06"JP=QA<_BM:@>^@:DW*-C;*JZ"V :17W2WC^QIG^5C5N3 L;$R1K-N
M37.E0SW1-E6D5SS8S8*1OOES@7]<:*K3"4Y2S?/:F^R("7SVXSB0$]
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M5& C3YC%#E/ZF._ L;]&Z;'H)7VY$HT)O@3YS(LWS$"G0FERGM43]W
M2R5;AJ]M^$[(-,O18V^'4\+TB92O A%053S.T95<.QJ=Z_\!L2\N2*T ]KG$
M."J14C*" '^+,,ND#M6>E0*L/C4S0)KVJ5 HS^#F[AP7V7AV/\2"MP:IXBPMI_VI2S^K
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MV=='P@7FE_10A]^RBE3KW"3LE)@@VFD7ZJ\YDZU%W44N"0/O]YLP)\9V3(3G,7,YCO?G[[)797%*XOV-J_%QI[W$
M18?PQ^YE>.C6 H*14.<0,'T6M)&QR[(%C1Y%U!"*R>Q AOE8-
MP,SM^%[F-'X^RWY^^E(6F=XHTCVF3$HKM."61D2(KY:=^K3-@(($#5%4FPJ?
M(9U]4>K5W7^T,\\G,X#4V;4,_:@C1R2>18U^"I6DX\ P!2%+J?5<']I'-
M,0E=YQIH!8^\ / -0M/#W@*[/BL@:7+.KLU:&P1A=%'QZNRW5\<9\7-7=YL6
M) @UF]=D$T^Z6+BU3HQ
M!J7\KV^U?[NX2-3/C)2&;MEMW5:K.KEA>KR)4%[S]=9F!5M+.TY6644;W<(;
M5K;%#HI+5\%L%;>_A$34A9YK)S2FP(*8T63I#U,+12<5C$5N^YA_\6R,#SR+
M8PV+OD9$^GK/0JZ"I7>I$)QH#I[3386SNQ' ;+6.F91NQ5Z_ED+:4?:SUJRR
MR5H@J,1J*;!&GI&<);%RO5W:L]=&\!)6]D#SXK5/%>+)D-D$?Y Z@ P)B/XS
MJ.29:@9RJW^U85-QH]8'K_V=-F3U=V_D%-9+^HV?.F!YB2!]^W
MJP?%X-RB5JB*,Q3[R75K-X9QF)ZHT66)RW==&D35UL-78R8Y
M=Z::-&0G_4?XB)-;R7+?*QS^,A1]2G7^ /'UW4P:ETPF;>^*K007-@*-DDJMU3"\$S*DZ":6Y(7
M<3 B&G6B GLWI[%<#1\+OEI!/_IX).GD.UJ)4ZAFJ4A3V6158:=:QFSP1BLG
MJVBJB_-Y^=9XULAWIG@+4/E1#:>)PO,%8*XJ;25'5T+P/]Y8]FY4Z>-]+\KP
M:1/T8U#5M+Y(4X_%)@W1%EK;\Q(P$MG_@?3"[LA',!U+5^XL7QDE3$&O-N*-
MT"*BE"'YQ$^NZR4[[O"4&[*"QP:[ @F$0'#K3M%1#: &G%1%O(?+E69]
M6U2&^\KYK&-9&#.):7.=9-RJQP*!2U/U(]!/3%"=99)F\1$4_M7%\XV8X@>K
MZYX<[WI@:?_ NQR?2#YVXL$_;R)_3DAL8]_N_^PH_JST4Y&6<#YE0ZA7,OJ\
M=F"VG'J8>WUN0>H5D,:0 ZK!?W5;OFG+G==JX=+#+[IFV38+NL968OCFU8O7
M)R'7&!'_M50!0 ;L9C\U/E>L"^9$G-NE:B(,H!<^(4SA\P8;DTMEPMK6;-\9
M79=_9G(9&GGC.BEJE?9ZJBO
M:/%YR\8[L!5#NH-$A32"EW?O),,^=I=RM,HO=,ZJKS@QRGKG72G-M99M.>XC
M[+=S$PE1X>THHT=X -V .E^U-2S;?QU'9#0;8>L$.D@!:Z@W(**W+=Y;59,UIL[$/A=<]&(M%XH8H
M5EUKSVR\6%$-F!,GL<%\?",]+]!+'S[>#9$M+A8C;A? -$^K9HQ2!MDH,>[2
M?KH1I(,]1FNOM+]-G3W\VV[VLXS"/@$/UJ&(A6AIK5%3IE).9M?S,3M?76#C
M7+.U)*M67<%EKAGK'H9$F/@TQ@A)/XUQV[)3A?[PX=]"1809L-H][:H(; _6
M<)2N@K5S[11P 0C/-<]M#9UGGWF*(BK 0VY5<9$EY1C?U%(? $7::=&+QDF/!OCL^
MQZ:-NS]H&?]/R*OI5-/KEPG^CZ:\DGK_,ZHHZ@"]?T\"-XL$K$31Y]4P2T?Y
MY'D=SGH=X,E76W#2>,O 0+XC]_KS/UX(I'9_]-=Q],=DO>6^=XOB[+PPY6 3
MX,[Q;\]>',=-.(UH$F(YYE!R[,.^:H.?!U=1=:_]H-^DE0"3?)%S!QNH:BI
M_RXU4(FJK+OS%HUM_*X?:<:*ENR.G=1V)CCW\M/!D^#FEU]2=?+%W.,]02:'
M(M,U8!]%L?2 71M@I :0Z@E458Y8+MG1Y=A2KM2(YTC%P8\W+#;N0:7Z#G%C
MK,Z7(=_ N_J7__H6XPJBB&A@A2FS0W@.46:[7F;=9"RG(/-C[%C?=(S!R>!']DJ.,H&&G7X[5MMS'8^Q.
M\SJVZ*.B,JVJ] D$_*[_!D(DC,9OATJ[/S20)>]3Z$#*<=7SN'9J^X]VM69U
M%KVC:;T2F.[XTB/NBHG4,3VY]W06'4]Z[%8-#3J8R4>Z"&_^N;,4Y^V1N%LA
M>?)1+8('.H8K@$0TS8&DVZ37>EQQ \#UZZOZDEX==&:L6^QF7F'0"+8G&0%V
M7)>AJ7/)^L1$/5_V]X(83"^UI%?L;4A&N371$NG-)ETM8G C\]YP+2%<1.M6
M&0-?P/CFQB3(OR9U?,1M*]4A&5EG<:UJ/*
M@C$0%RHM\T!XPJ*Q^'6R8NNV+#R3HO^=63F]>S^I:#YHT81A(A)-7_I2W.!K
M417KA"CQT7XN7@FD11=$3SOC2GO#1$9>MVPF[Q9E)?)47(D[0__L;O9S9/Q X6/=DA70C+VR,^)5/
M(NE#[-!C4J8\(PHI!V!<.]E)$U*4+\?:C1-*++.TKY?2TZ( TS+('>N:R][2
M4K"+$!"5BA*OO])GY&G\^B*9=HI\>W2*)IL!FMB3*)KZ=@/8H&0SXA5&6Q$O
MUA8A!8Q:T.9O5!D9B[815UWVYZ?3;R_X>G"C@J^W(+/F*L;^W>.;YOKQ@B5E
M89_#(Q179W%?];GR8%(?K%ZS#Q[>&V7O7(P1&;FZ1CZ2->AP^*()PQ]H[
M+W[8!U&YT[+3AG&NSB<)[#%MZFNW6,J !WM[3S0Y9F*_&)AVD&<&J\PXWE9+
MK"^*D?,FAGI&=I,8QP%D=0W5$A@RI/CYD]M"+5 S! .:U"1MM/AUC_4Q^Z>O
MX-5>DP'+9O&/G0>[3_ ZB6NV!Y21HT8#(Q!7O9%$>MOMBS="M=S"$E5BA=O2
MRN S OZ3TE&>E@Q#%G49V#\\/(@6>T1>3J^,[S8:UP^I0F'[F'/)"M0)XPCLL$DQUQ-A=G@^X__!LH0/H%/'7=HEPZ
MJ__4L''#B?V5$2[/K)\8([1YI@"4KJX W*X:*AVSZ=TJ]X
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M,8G3)A'FJ)SY'?HB'<(
MVYRZF#=7)]RX6W]5\\>G;RPG^0XWY1
M]6S)*!^:$@P:"RJ,.QC9J++VB4H*H H
M/".XPP!EJ.%>-$\8>?A&8AXDHN'-=AK807C *
M'LD+KOJ+$ $%?X=-"S"KT<8C$1Z'T+@@],GYI,=C9E[8%:XVELAN69\UU9GX
M0FSFO!*==>R3L%4C96#M=&1QX<.)83%,$2?:]L4#87Q6G$89M!' &2X-U1[U
M>D6#)^*9T2?)HJ2M&J'&.WPXE% :L7+7DIKLK(GX2$1!XU]7>MRVM*@&(=Z9
M"SS"]%< PT41-2&$Z47;Y=?P]52@2]X;YS^B]J]F8;Z-A^K\IV1G]>SU>^5K <^D_9KE;X IT>HQS'/"!-U'R#'LZ=H6L<.]F\/T9/0-IJ1,HU
M'OHY* "/NZK.R;6I%
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M60MRUH,]Z5(@MT1&/(\::Q/;6Y95U-  4'DOTLP2(,G$;,7<N-F@4
MY[5/R>B#M)>#AQ)]BLMJB'G_V4N4.8 =BD46BG:V0XN'N)5YT3U8O\7$O#UI
M6ZYV;>N6?5O+3N)/:))0FVZ-P%QGNO4D])A)2D;"<@4,-/[J)A:B; &O8CO]
M!+;L!YW'%)+0(YW*M_UVL3,RO"K+$I>^IRJ.CAN>9."@">3AR)K\10T^/72/
MTB(63/O8PB;P 70_$ULTG4#=!9N@3_MLSGM!4/*WI'6G>U,D"+$5'LW
M:)@$ 2P)V/Y O:@0:'=? A!@)QFC K[=<_H6@TB21B HFTHQ";IPEVZ186U.
M&WAY+!S"%\^+I&8-Q,YNK%(:?UK-)-%*.%:SND]I_72;YX?;9?/<**BA?_:
M4CC.%P@+1)"9-S^:<6G:OYNC99 3/]JO>;NJN'\[A+G$BWP#&=9EZ7:6/GC>
M)&C2BUE9-5VSF*T4EYD&G#7T+I!+P&27,J#78U&O 0P;M*NK?!'!:><>I#D;,['TV*\PJQUJ)EKT=SS@W$M;@*D[."IQ_5SVO/<+&"
MEX%(H+' JVK#45\],*#:6:]@'Q*C(7M1B1VW/3)0M"4L#1[#H[+_J"JP"2>=
MA&I',@?9RODRLE8J&.RXD?9/
M/]G3Z/_6HY?@,RS7CCWI'P.V.T',@U2)4^D^72Z6FG"&3JTL7A KY*[($)8E
M%Z;Z)?!#Q,/OLI[\M/=9/XKQ!,>;8)@6TD#]*
M5MT"KG_IE>W:59+KA7P1./[*JDA+"'73ER'7I5T&?6,4)67 P".I.N;62[X_
M8Q?U./"5A4QZ4FRR=B&$,MDOKW03 0(N14]8N&8!Q.Y9L\XSN+BO6XIC(FI5
MPTM?KF1D9D%LW&L[(VY;I3*WD]1Q:01-3&C,\:?C>#'\2#V&L.
M'#>+G@ [4MM4J=)>."2NLF$P2-[2=8VL,'.D=A%_6&J,PFV7KM'#99,&.6\\
MQO[, :(7ZF0US94:E.'I8CU;WI44!_W9*\LR-\5I[(3KL$G+H+[&TOE>%L@U
M4E9JX96UQ)6Y/#O-RW9D/=29BX]B[5 6CF-?\O;SG^J.%;S==*_E:ZQ*LB-!
M3IJYQ7")8%FX9H&-+/+5#CV^$[\5B9>XM;><7XC(=GTIE\$G[2PBU$I78][=
MX/MJKI6MTH#3'M\5BQ4^*_]1+ISF;.2S.^T->"WDJ-($U+VH6[LKZ.S2^9[AG=8U_]&WYM9@\:7=
MS$*-HIQV?"&K_+R[RWT6WIJ3$KK&&KX%[S7GU5
MF  PX+V9D&6M("'6S5EP#T+X$ NK3Y?6*#*T*CCW2:]>Y?1)2M:7,<(YYTSM
M,&L2!84V\&'/$ZE)@-ONF')IF3V@+DSP)83'O-6#X0?"%58?NVR%M2AKM8]#
M$2UK$5>JIJ(S%O$LSDZ%T+<="GJ=#'F7<^=,^F8<7R>65XS\AEK8_]'D=3^&\6%K5\+_1S>S_[;(3Y,;QZ4J!78 !9]>=:K-K
M4SIY?GSL0SEWF1= M5-BQ?WG3N-]%S@"6K"TC2:/"&L/1HA(;W\VI>D% *HV["[5*F./%YWKVS
MMG_ M8#?AVQR0-4LZ9;BFV!) /QV>!CRM7\X1#7[ME[;$-*9&("^=<4
MNEW?T>MW^9X?DY,#C*>9"FA]%
MBZWR1>?^8?_XD4B-F,KJ'V7-4^:7-N1+#;*.^'OR9_5$/GRP^V1O'\[(94O_
M?V$?5C_E+OLI_[XLUO_V\'#W\:/#K7_>V]W?^K>+ACW8_>'!P6(^'UZEX+=F-*>YS7^##M:R\-8\TN]E_:W9Q=Y_9O67&@^!\%$CT
M%_8#-G7#\H%=.ES\O"R*RGWQ4,;FM?];^5.ROD^F%>5*G(7I4S9M,1],'5]F
M@ZY*'8A(7V%WKK3D3]FZ6[AO>Q]R:]9SV"831YKK1>O^BM?I4F6 %QT2./YY
M%9JY;,E;Z>7@\C&N? ?WL@T[VV)1-VIK]_X
MM_)D]QY_YI/]+,?ZP?Q* ;G9QW1PKWY\R>U]PQA/P7E[
M,]PNH1=45C0] C:V$W?-+W/PZ-$G6>^?8:=ND?KS#9+'ISEWKI$\F'O^G2.G
MEP6@USOY?:WP\V!S[VMS'MZNVIROGI949[_D=8]\A?U'!L8[YSAGJ \WT WG
M*J1VX$^6O_7[Z[<^HPS!PRI[].1PYR':T4BV/;I_G(,G5HJ@$66JA"H\JTX,
MR1(>TC'*/GO]UHH?-Z'X^7+!]=I9*4#UQ78,8%)VOD3=T(BM!O6^).Z3K]VC
M&W7MKJ>T[=E[-^F9YB4YLMV&]_'9)O;DK@#0A:UK=.LD*:UR5G?GY*_3)YDE=>TDM2T+D$3$!D9J6;9FLZSQVE
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M_L& SUPO=M'0@LUF>2<(_U4/:"H(I-
M&.3XX2X : 65]X]&NSW%9;^_MF%B&/2I6Z!II)?V7/(FW3"X$AB@G =[>X<8
MT.(C])T?1J&M-O G@.R>(2"#^'8U.&D_7DV>XE4R_RA;Z^I+OSX>Q4=K7F]SAQ_-:<6 V&1@
MSG+:GS(> R-C\MC1G+CUGWU+1]7A1O'[O](KZ($HI?H\BA'PWA,&-8VF]\-P
M($6#B%#_F.8#I0/_N_8C1V/M\03#IV1D&8<&?E83_3@7)H6E[!\>'@ZFM/=0
MBNUGV&H/@J4U_+;O\W1V+AH[3QJY"1 .8SJ[P@$U!_ [+Z7X3S8\-EP1SPL__\>N<*UVF7O*ZJ,+-OBV=, .M\1_*YI,2NF?P8906H\1KX&7?;DLC^<9Y"X#*)MBD1=G98);3E/HN&C[FEP8ILF5', 51+EX;^-2(
MVVA))Z<$W"C*Z)C8@G6F>X]TIGN[V3]=I!NM*U-!T=JHA/STV\\F#PTGV??W
M]/VET#HXYO[;IDES8F"DJ*F!HJ#1%Z1)7X4^OITNA 61@)-'\^#EY), N#38
M,!P"3:MBM>S192K4K<=16;<_+[F.%UDZ>LLB/?9PJT1YS2V"+QILJ"P]64LD
MDDN,R^0GO^E3?NCXJR^;<_M&+"@VJWM;1Q1%B@>]6'>"Z C"X;>F7GD7[8H$]M'2QZW\N6/>8]83B>M9RN/!YNMGZX"HI<-,I]
MRM:GIVP]OD_9^J^CL[RL.$_G1[CZ^.6'RL-OO8\!>'8
MC;D/$AD5Y^?GNQ/I$R&M>'=):C)$VYS[SOOC4.1@?95[;O2+IF:$0@?X-;U*_G D.LN)9'TJ;\E1,4YCI[3HUH/\*2/?8^?4;;HVZ[/!:GUM32!T5D^^"[_'N/N/_RN\!U_HB']<&A/
M1'_>/WQ 1GD>.K]\AQ&N:6I!A\S1M68,M&EMEH>CDGX?C-UL
MR_:Y>VU3PUM*;WR&G=C.].\OY@?G@3,PN>#:>V3UB>#:)U2Q#?S>9X%[R%(
MHD.!BO#P& 35<.P5@IB_X$$A?:NVOBZ2YB9^4L$S(]F
M\_)@F^CP1I=E)L8F!HM[ @CIH@L>7>
M0RRW^:)$%P(V'=C/)B$Z_ V4![S_4IO=(&B'D:<]8VSGDZBWB9#56!IRU*9W
M2M /JYT#N!]]>03+7Q##T4?!XTBWY#I^][W?<5%JB!"
MNZ4.1]H<-_+LV,47-HE1S+$,WX^02R.U@]>&1[P-1Z&*DKVCR7?_%@K4_7IDLNK%SKJ@-!EYU[X,#WG0>64+M?NV7#?;SC/WWLL//_%-! T
M-Q5G;BC=G$@ICQD<+=RN##9 8IFT:;-RC+Y1K;Y1.%*,ZU-M<&%O0*Q+1VE_
M"4?, G!>_**ZB60W:;17)Z^/WIS\FG8*EC/NG'N'[LC2G$)CO1BNGGMX15\$/NJKVS:0NNN5S7-
M.^[95JGL/4L$'@Z:_MHZZ5Z"F,ABE&HD?%*#CFDKL_U$7?H2WB*];F;\C\><1_(%NB
MG%QA1?"BJK@A(M>F5?!@+0&%(4I M3)RLT0#B7R@AY7LP'G35@59Q]H3D/VA
MWK(J2M A]$W719VLH(;%[2O!M+P1UG%CT;2_5])QU>PF(4(TJ@Y&W4;*D[[?
MZ^;>1SICTO2W1S;YK*F<245W*1A!P$KZ,7&#/AAN\,ZU A8].3AXY/VB7W\*Z=[L
M_["[S\2VT$Y3W!)U[EBF3XD+K-L&J?7[_2A6(/(U>S:FHJ+LVAY852HP9C
M1[X5)F)]W.,*DBR7_U9=4YLNSOU?<#V-:$RH1*:/[]2E-"GTJ?E,5TW$OB>D
MCR$D[EI,.^_/@DX=F64 41*E3IH3>Z?^EY5 E";'; B'>DQ
MBIW(6NJL5/MF$S7<'_.7/&:)3G-$<;M?@?2S"DJDM7$L&XEPWQ_-ESR:UIWV
M5;YL($:#;R8Z,'V _S)>^9L3O3=N"CZU$! F':[O1MKRVN1\,] "[L_U2YYK
MX29E9X>6GY(:S$X#=)-=1K)/STYTL/@$V9T6)#-"_/)SD-:'/3O=.8G\-JW]^THG\^VE
M61S>J#3J^QOR^6Y(ZH@+*0XDBOR5.*_-N7;/M[[>J7"$ H&"4RY-%.^G5J?_
M2"SK:NF!]]M]%<%.! UH=?$ZP6VI/=,EOYN$_H(+F,QS^?DKFD9V[)L_YU61FXZJ9<%-W2VTI)>K7YN?!Q41:6_!V
MN9JH 1G]IH>SRW&1:SDLD,2Y5WV7???Z[>_?C[**":< 1$6!@&]+1]S1\B/[
M?)3%)@&F8BZOV&V:.D9;)V#96?].2,%-1SLD&^_Q&.
M>-@B+HK!T<,:2"[;PE(Y?A1O;?1T)P9J$LQA5YX]4I664\'Q3SEQ#@[0 T1(
M#NXC'!@]4>1S4B=XH40J'((LZS]ZNGM10DRU&D71B7G.>.G; DM1Y%V68WE_
M?4:.]5: DDE3^/A
M>NTX UT>=9(6U&N-(8W*F8V2DU$Z7POD=V'D]UM^MU/A\0=/>@_ 2*U(OH;8
M$C^#PDUSW&I)&:$51Z%]<2:P4Q 9-CC3<5Z_ R5/4#W3+*6.1R/V]F%^NMO^
M^(C_Y-[G2*X9H #:1/H3*AG*) %)'RZG(4L ]4%ME@0=C0UFB\V?;RB77 ^4+XY*N9GL8P\X>NQD^]]
M?38_&Y)'<$(1%4F079@,G8B/K$>!CM$EP?>0\Y,&W\,E,7MD:T >Q)%WLVP*
MN/";$H7_B"CVIL6GT65-(N0;Z=,PAO)/T@/=HI186N1MF[F\6J)"3-A)2;?;
MQ4@"Z_D^6BS2$C<[*]L>274=7UXNY[:&%,1X:F$VWC
M0)6@:\O8/JV:,6BZ7[+Q".JS!7.%.=GN5=YRVPU;MV4[OD560?9/V?:3]I1D
M\G]RGZ*=9SZ9EC2*%L[459(G.0 W0(Y.[4Y9E,>G[9_'0SI;)WD>N'\JO5TQ
MC'G:F'*M-.DQ8DW$;L\ [^(%\RBBI4AX6U&8;8K?*0P>OA[GXO(,>+0B7^TL
MFQWZGSC5(4UJ'#B$-:TBR(-0L!))#\7+XEMB7 >[MBG?(DZ6SU[4D@(I?K&1
M[>CZU#%#Y$EB+"G9\1F9JA=UDA;*_V9]A3@T6*_D.2&KDVAUJ=69T$58AX)=
M!6DJ&UT;FPOWE%0W7CXG.%E6ZWF0YZ/ '**5AY,@&D/M;8Z$.5!(1XRS(#-:
M9,6L7_)_D#K(#1,RU'LA8U!38Y@JDO-7"O*:RS+<&D\4_FKX&($^$?]!&=2D
M+5DI>=ZW>')DV6/)U2OKJ5N+]*]_SC,[&T($S0!@"HHQ<=:)5#D/J"VAM"8A
MLJ$%8JED$3>W#-]S)S)0$CB[I5MTFJ"Y-#+TLY <,T8]:^I$UIT[UB,URF*^DX%-W,U(-DU/=0%2C3"H:I:8<&Q)H-K'#0L96-"#]C=8O
M!@_SVN(/.C4G)YUUL)%Z4O/NA("*]W'3(47U XNVG.=MZ;D?6V)]*\@ZDJSB
ML6\Z=RH0/(SC,H>RJ%_@/?0%HB'3^I]'8$268BVUNJ@=%:V%'MV2V8V#UEM<
MIY?/;'!^@G3@CHUW$.8HLA^VSB IG.!RC8BIY&$PWW4+4O0I[.4E+SW@,YJJ
M\_3DF==R< E%*F ;23F:K*J2ZXBE4O^2_1F%BVW?)S5V@@"I1]TAE=^UK%N
M2<'J2?93XZLTBW&'FM!Z&6>FTBF/RR)JP06S MP#-D+$1,BR+H*=\1%$?VMN
MRPMUFYV)5\CRR-X3Z !,IZ1[P!F1JS6K4[#&C#
MM M&HAG?!]2'S-78%[A\8N.:-#P2;?U;2E#OO)HN4 ;I(: ?'.E(D
MF;C/7)K1'3[ HB?7#&S.?Y45IS)$\ZK26V5"4>62E_?>9H^TK]O.C]^ZI!"!
M.27GF0ZT4T]4 _4B(A*%,X.[3CTI>5&T#+!R%:;/0K%A=<.GX,#Y6H-0Y/,S.2B4MR]>D+4 ;FK#X,U)8 U@,KPOO.XD!@>
MK OJ*JY4V^.K2#Y4&MT47^*;61!"!1$^&U"A2! ZJ%Z*.4,7;MLQ_2O9# ;
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M4HZYP:\_$($<=,%U9@C/M[^KSOBYV-^MSB+XA/@+BH$!=4E12GNVC0$BO=
M3X&V@7O<@M";-H^Q*XD/UERQ+KJ*1?JDR-.C$43?8D4J...[12/,@IZ#KV,@
MV!)9V(56&PAW\MUP&N#0NVD/8O*#^?*4B$5R?P=/.L2B)XJOH.!R<;0@":3<
M$(7CXJMB# /@GB@]MC  4S4$
M!>_B-D5)?.%KZ#3;QD2E-7JG"7-IG,2$G885;KG:]X2OW!XJQ/(:)W28/
M87#.( .L2\$H<^_+SJJLXQK>D.M0AMB:'M 2,%?BW*TYJ/V:(2K7LFT4#V8+
M;,@1X" %<(1-1+,G!8FE;9%@+T K3?#_D!H@RJ28D,+,(O%MF TTZ7CE_)I?
M*O.MC97+Z:H#TY$:FT$HQ2!EXA NA_F5+0V!A>*]BEZ)]:*UF.LND'E#9@S^
M9IU)JGR3[^R<0M
MEEZK6%.(;SL&YL^N0>69(".LDY5EQ,@!QR3(_@&C'=KU!4(5S$+Y'&RH'.A!
MP)'VI52TW6-@*/N1.D$Y7P4BE$RXD3@6A=(JQIAN+J+/M2EN)%B!FQ@(I4";
M(,"11&3?N3AS5CQU(U# *,S45%%+, III;'F0?\NFF#/2@ J2@Y5"DU*;,6E
M096TWF04L;)-BS/@F\PSOCI_+P"E7D"57)C48J
M1OH'?G.+@3I1\#JFQ$JG<%-\@1]^U>5L$3]G+:F.7+S>:Y;FN:2NLEC3&-3S
MI%AZ+2XRIQ%%A5]Q2A7=6 NS6YSH]E]@OF/>8+MHHZ.@^A6V-%;#!P,M-\(Q
M"VCL:F1XHD>)]L/)OUDI%A=]8K'0@CFY])8?,1KHO-X6D^JM8)&M\9#U[.M(
MOQF6NJ4E:=']?\/I:I-@;\8XNG,,P@UKFU;900RX[CHR8B0.).6>R-I]XFE;^P?$1JWHJ-W5D0F6B'81S";A_5 SC \4^QVQ>5F7M54]!MR_#KZ
M03,];%%-5(?";_Y=C6E1=VE/7E\T;F)B<9'@Q*,XR2C. $:[5/QG_>LT/VM
M65**8@D=:D.O)W3< 15 ]DZ[I@WWS1Q':TE_@+(5URFR>-!67 K# *#"*GBT
M2?_(3H@G--EWS[G^^_L1S;S+B0__73RCWPFKI]]_)T5DTDB_NM\<%+D*7=1&
M<=#D7Z13%'0:+ [/F^QGA_S?K%\JI.;W7
MR(S$HWD^H_\#H2+I,:4LW><)5M>2V"Y"GC13[AWZA,HC-QX6VH!YOT
MN!Z59.7Z<6"3#CB=A2 ^GMGA *I\\D[RH*"07)%7B^WYFFQ)%V%LHG6?DE34\']]"#6.IK;X.B6"E>Q)Z#C(Q<7%$,"E?
MPK;]]D(S!S]>%CE7&5M>@RI9H<2;LCU55FC(78*?S@-;:S\7,
M)XZ1K8C;T^5Y36-7>8L;RN:#9-!'D^Q9+<3?XD9#Z3[LTO2!>F3(N-OSR7B/
M&FD&)^S@MBL%QUM4)6;:T@VT=3/MO612-B"F5?FYG+8ZB[K(V3*69I"UXY!-
MBK(FH&DF-Q)L-63+N=9R$MD+P\75*M(#"MJD+"2FM 2D3MJOP3?^L?_VH -6
M#*.5;BJ;6 V,/%X\R2OU[-F@@4Y]>H0IWXR,TFK_UV".:+\V7$6Y?5W(1S=/
M:6AN- W-;#2]PMS]1+RW.7;T5&,9$]_YVIIR!NZT%?/Q?0%^=[ _
M4C2.VJ\\!5OO?;)]/,DQ$2]155\7.SK?*?^_'[_6[/5L6J<=4U'2AFYW[[EB
MG$[IX6/FY!JJ)UU- !%":)
MGNUR%;U7=!>PDKR1Y=H1(I8 U9;R)1"?_ERJ(I/@:',(
M(W[?+IUR9:MI3]R-DO?"CBG99@@$*;,CXD*0,QJK)T+H8+D.R@/C9#1C(]BV*%\MSE +0>I5'(*8>DS+
M==".J!>W=#XG+6 RH>]/6(QMVD3+S5-IY0$.$#\P]66=$FPDLJR?,]UBPGA3
M8OHI8-2@&@VV3D/R=17=4Z9G?B+:ZJ>4VFTOG1B,9':-4$P4P&2PI4-"UV_FZEW
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M_N=A-VS"+$G"#M_A1$7PX-,&BE&GJ2_<4B5J.JVF_'#7>P:%<*&S]1+YRB'1;-7(^9)W!<7*@(O9!0F+&!X^$,),>[+
M2HH0F;O[&!Z?,3.7*$([)9.G.=^1B(1R]QB[/4QI6).H8$+W83L?MGMPH\)V
MUW.MO%80-P7Z !WA(D/R,GX5.K#PSS85_X[ U52)DY75H  C:/Y1*+@S9ZA;
M<3HF&
M#SFHE;&J:"ALZ,M#SV!J"V'CJLY!4U,[G@BDC%I6Q*5B(P%V$6M/BSN"1\8<
M%E'?,;S\VZOCJ-L+V42N[B1.TB,2NY)>8/+L2QISV=2A:4 D\DJ_M>MD[8>/
M=YAO@\Q5ZI@3ZZ73.V:A6V[+'4#0_#;::'><:J-:BT$T.5*B[7@B):-U29*5
M*)@ AQEO\C"12\I(*IX2DD*>,572]2R3;85IQL!R[)%2Y;""P"X/09NVE3C,:W(MFX
M"R2=2$[UK8N,\*UBT\3%0$ %]>S2 S6 1^F I9=7-_WCFEX-<+)#8"_B5NSA
MJ>!VCK( H!TO9[]=L2,N
M64/$%_="_+R0N89S.@5TT)S7 9^3%'^ M;;][4\%?L-RZ&ML?JJM;3L&YHA2
M+JW-0T*XB<$S6&,R<1DAR;/^"[5A;4("-XLY%,S24,HURMANZQ1#UCNB(P^Z
M[\$7(B*=)9[%D9"HT!,IW2D!OR7R,*(W7)E1Q]#T\UV(@K"#Z>)HPK> W
MX;8"<2!-MV(W2UIC=BZL(CO&X6&N
MW@(X'!=Z&CBQ!"@X<<.'GB2R94EX;"B4\T@/9-X6$4_3;J08:\@1?4T=MR[1
MQ3@5)"HJC3KH\G<9#CYIF#&?E\NE*[(AI)7E$OQ?]MZ$R6TKRQ+^*XANNS]I
M IF=B]9R3$6D);M:-;:ED>3R='SQQ01(@IFP0( %D)E*__KOG;N]^T P%Y?D
M7*SIB6Y9(L&'M]QWEW//D8I:;NU(L?F_(+87&5_CC9^Y5^58'2D.WSIC8 _;LOUL_6R>0;&
M,WLE8BZ]H^B'7^18^W;*"(IQ7OI=OYX&:BI7>^DA2QU>9!(.L[N^L,^?[1X\
M_CK[J24R4$U$DSL%IO9RTJV19#C8.WC*O2)P71TPP+509BKV3-":<.Z"4RC%
M;56TX^AI7BJ[2F*.'"/G)US$5.=^*+-^XRGD2YQ#GA>"_.[BY??NFF\.'
MWL0)W1^[+R9GX[;%7ZXX:8?(P-Y&M?K]QS>N5A^&L$6M7D2@PR:G1'G$^>%*
M9-<:WD4_/Q]C>ZA+45"SQ9\"],!%LJA)"$^IT70.<(XXKI4\9#2(.C79NNJ980]1:&6DHH_YEM3_G
M:I]0Z7I$QTD35S'*$ LOQ1#)<:C&WK185JND=U^!6M.V"W8?X85'EWU9U<^Y
MJDFFCD"/,:PC8K[B7!HSFZ'395W[U&4ULC&0HALHR>6V_!1WAAT3MH9$S[)/
M+%'14E9/U/.^^5)NC>761[>JW/KE.'[Z*U6KLF,=R0-F2Q%T*H#(3)NMOXM8
MNA=B6N%/J1+NX)]W518W%PV"I@?Q/-F$:*N+OD=/&\%[4JSCE"%'U0:<+IB0
MC!IZ%)*!?W\!-9DFC+1%VUZ7F OGP"G/4_)7BT0]B)$X7?T+MO-SY?MOCU;QS9TB.*D,UQ<9SP?E"EG^F^BFGP
M"7IQ!G_'0BL[&WD66B)HYR*NT)76HP38-H<3ZQ4R!)2':/@1JVQ_;__KB(7W
M'UEVZ&1=PK7AM&_E,[G(:,M+26.8YKA;I5&_Z\F>]Q[$?]55$8"(<3HHQ)1J
MFF3D*NI%CL><,36*]YYM(A#R$S5ZS6GX2TGP7SR%GLV/X,]_X%F,I^FE73;BZO0SS>).M.&>29LE=:KJ3Z]##3.;U$Z"[V0] //7,_ B,#MWS%V15;22D]DL^1>[#
M>R*#1#MQ-] OTDZF2&L3ZVP*9R6K6DW6 D8@O\+ZT2X=DL]@;NGBV*9GM]'W
M=MQ!VF11PB2*;N 8S3 :I7=%SEU[\3B,P4\8[-SU>DBFB7S
M4"&>S3VN\VJJ3,A]*9\EZ)CKIUJUL0=+[0/M7#LLH^U3!N^?H>=K16=)^^NY
M"[TO]:K:RJM:5^&'23ERL^>/FPS;.5WV5CY.!^73$!0323L?_+=U(M W"%;D
M6ZFINN-'T@"\9H2D)Y+S&*SW+>;QW3LVDPJL>"CN/?CH[>Z-&P?$R#T
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MZ9,2EGZ.EI50J2N]^ 37ZD&M-C6D]3SLZA,$U=W*NP<%
MRS'#;2!2BL.]'#W%C_CNW)C-A#R*.Q.J3CKGF?Q!Q7K)H^'O##L<'$^TXF&W
M_QR,D#BF!*(K:@*J]B=@?>/%-X=S0%&3BMJJ>]J?5$MQ#3Q#Q^"GR9(NT*KR
M&V\N]2'"X 0K#(Z-/B,8\YA]A/M*.YPO%4\9'?O61K@W03_G_
ML*5VL+VR1;DZ:6<$81SRS@B=5S"'\W7-:06$4H_I&A=2F*?9?_S[_O.];^3O
M@/$0ZSK3<:A KJS=[SR"?[[ZX>-;63^\#:;0$FK3HNNH6XM.G G\1=4/5T=1ZGGJ81W]3E?@;']P*N/#JZW+3O-JU00NVY%UQ8QQ3!A
ME2PR>[EWU-W3+-F0H8464],#B=;', UY=]TPFH!W:13 #%)MC)]W&"S%U5/7
MULQ=%6CU81=AB P83A/=_!&GQ1@N]?0V/LQI/SQS$ZNE^1E_S"U][^%#@_)5
M[HBQ7/Z7^BE4UX%;>2?!"1)'=%+T%=$T; R10L(D\1M?'W,H.VMD)DC,#4,\
M X\D5VH5L;J1&F;3"),'*Y?@$Z>9L0BJ^Q2=C4AI:2'A3"HHY%R%OLD'$QZ$Y<04T-5VAP\1:EA1:B1%YI$]1)F9+(*48G?BQEG0R/
M*U;<_'K'#=?[DS)]YQ=UN+?"C9@@?=A7WS8%9)22^:.0#K5%NA9E#2[Z US*$"],1:'Y:T(_T2)7/:E*V;E.>MX9-$M8X++BFY8CF>#.,Z
M2+J73JJ>U?O&_I$WFK:"-41P8)Y,,',SROU?,!5YIHUS*;,>.C_C-#AXILM(
M)75-'D/#K36"2E@)I(5DS;40T3'S [E-30MJ$<-P,<"%C8BK#$4!*M+R!IUK'8/66HMJ^,#,Q/N>?'#O]K;W=\CA0IN6M4"UMCWY)[G_=0>,Y..L6J,GTY]W.9C'M(J
MB.JMBLMQP"%!4-61^*=DP>065@P(]SNOETQU$'<>,Y"Z/.88#4;2D0V"4MM[
M- OD>YU$4] V-56W\7T"N)4M\5O6E-D C45R;Y?_GNI7JRMC0DF;[R*65
MR$!N[*Q1R![E7MAIQQR3FV%.AT^3&.%PBH1*?X=]A#X6S=+[1GAQ$4=1-4D2
M%[U2#OP!^_ZV^/-'4AB,E-BC1FS@3))>YD?@7GRSJPEYQM0V1X..:T;,ZEV_
M,H]H?EZ64RG:[.<#F-1W('LR/[SKR_Z^J"LS/F[
M9%3*/BYMBY=NC8(Y\5:1\96*Q/&1/,!3B%6F$&!*$\A^BJD&*;?1-^A*3M28
M-2'C;6*4$B\$2S_8H50-QQW/3;0CR:X[TZ:J3I1P@O
M_KQEK">WJHQU,Q9::R_"B!^6.KH[8;^62L*O(+MQXZ/GD<"I='K)"$F82O5C
MXB[,R3,IJ:2?*WO0K.+_E(KUM.A+L91Y@IP98(_TBKRC%"Z;'H5:*&\))/%K
MT^HMMK_2QDQ4DBN7JV?1KBABIP3RP,*J"T]'T[,Z;E =TN88&^Y=]U#D&C4#I#+D=_WT#&9JOH87Z.?+]% V)\XAO']Z
M_4-OF:R69QEY)]8V(I)VO*]^S3+VF@?"M8(_-TH:&)LH'U0/ 6>EHOIQ"]BC
M_&9TUOB^L81<[SKDF#KJG7C6A\\.]*"]:H@YM:0I>#^=]:[DP_5K.D='A2>1'0)7,6+CN"P.Z4NSGK)4! D77 %
ME[YH97GI^MS:2,@L)#;L\=[7[D:&3[ Z=YYNN%0$A$#A2Q:N:Y'54WT/Z6S:
MS=X4/;&QRL$8C@N11\L:2;&)9#)61DERZVP3B>Z)RZ&#J@U6*]'/D5=(Z II RE\1@2T_L)@EBV*@(AKI4_(Z:[2F;K4
M]-\:U_]"_^$'$I3&E,&/KBM*>]]E\LG7"2,/74@GX9^)WI[;H&9;A5#2+!4(
MLS7U3*3ZT9!3:F^E7+BO3ZJ6/OF^;%#"+4MG<2?#?A_?L.:N2G=+FL [:Z%6
M;7$UR)9 U)_9MKT6#T9DJW_)2-8%S/:$REQ
M]D-9A#,EN@\ RSK)=^W+U9])&3WW'N5#8)8^FMOM4!$7S0C5"RH2BON:N$-&
M?N4H[*8:/_$TO/!KPF5<_\%TG9"T!.F@\S/W#Y$\/\1S@V'_^[HI)9=N)XG2
M,81ZXV9B;7%8 IZUVE0((_>.-+),UHS2Y=WFB.0M^%KK3%(,KBH7?$DN!N30
M["1[2;>!BAL.NJZRS8A<,5'/C97/R)42!0%+LQI3,V"M%#2XQ#LF^S!P4/V*7J0[G#1O.#A@1E=!F?:$NB?)3IZ2N,!J3[N.&;G+Z#$P8!G%XK4&X[ ;=8A 3Q@=:0^-!$/A7=O?Z;RA,>W25
M7ZCZ6$RFN! K@JIY(P=$&J+P?A3-M5WB;"'NXJ!DH"5+/U34=_T2\[<$U3/6
MJY.V$Q>2^,\Q:UH@/ZW:.C+5VW]94O1H17OC.T)E114K/H;G;Q&R^64(R>5J<5\4P7-=W@*2W_
MAIHR BKJ_"*M+"M)1:]M<[:X'\ E#=[8CT51I>';3U4Q",C%I%B%# )DQC51?:P!5UX4V;"H:DJ\*B)E&T
M]'7Q(43QLV.ZT(4:A9IT@>3! 48W++'N_7LB%E-!84@BLJ ACN9R;K
ML$E7"'SCBR0?0%YOK&S@65NUY1(OMJ/_%2>,9P;%PCMDJ*!9KG
M5=Z!<_*#VO7*=8B2N(&0,@7/ M6-.VROB2WB>O.=7VG"QV<;3;726"(FK?=K
MP>M !JE0JD+J$(;:S'I1-,(D6BWH6:_FE%V9(I]/9$TL.M5"XBIGBCLT:],Z
MTI,C5I=*3]S]):95AZ6V(QSLP*#OB:9">X3(8Z>TZ_;I]BG) M6:
M:4$<;;!.Y6DQ7-[)2 -^XG^P1S >QF@RZ=,P,"N''3
M&\Y*JH)%E5C^*\VS2C.;3^RJ3JXT\^;XFZOSV./;YY/BSQI"+-.3T:H54!
MKYBI)<+7%^'PGX]"T1)>9^V1YH6@09!=5P];MI_ UP07BQKD2K\]!^(K9CL(
M!Q&3%V)I;4B584(NRS1!O[.)#V[AP
M$'!0.P%&-N(2<@(Q'F8='N:!FROMMAE.?1)H>*4E6O/">;9R^;%E&;7@_@@E
M-[G>H/XA_FN]9$2#!;7)Q9ZP*9_*#>&MOL6S];G:#3*>E+,\5/<*Q<0KL5W!!
MFV+!R#0JR,P*(?6=$N!4O&5$L^N*]8O@A$^R?X6/H, Y&4UGZ^9([8FZ5:UL]054LW7Q\/'LY;DMCJ\IECD
MSM 4.[U13!CH>RDH";6[*MQH\SDWV701UJU&50FR1PZGV#_^Q;,8F/"-Z2:<
M-85/,!@T3))5QXG4>&AP(+>$7ZB)J*,K75F>S:X#
M8ZLHQW\$)X8K@3+R7*%3(YB4E0SY5%C5[6XH>R"V44MA_DC-&8Q7K
M1+C^PVQ(SH[9$\1QI40U
MC>_*CF0]/B$^ &+ZE-4 _DC(Q9H8XK4QFR]BZ@6:"X>[NL4%']>A1-R?E&'.'S *6,*XMN-R"$0%'L)E4:R1-&&1QU&;:(Q'(C%4NF>2
MB-6)4OQ<.'9B5OLX+<0\8D4(Z4DH.B@:#
MB@I,%((U)N9-\%F//Z!INFQUZPJ_AQ/:S:AK)
M_S:>%$& W&&JXXG9.8S(CX?1/Q.7B;-NU(N&-3JH.^_1P5.B8E)7*H 01'(-
M'5WB#I#:T3S,<7L&;TFHT8!"4 C;ICE$!2",D#Z;D$V%74\"B7CF)CFE& <^
M&]PV\J&,4 &I#?'B7+9S&3I*OV,G)FT=&YHF/.)!\3!#WVSZ]@2T87I/KZ 8
MSRIUNU!*8%N?5QY.;O+H[CKS_A
MRQ"(8>31G_&%*G&=!DL6MB&=X]I)U[2UWFQMU3#E&.V]LEEW<8_/A8E/>34R
M]>"UYF]"IEMAZ:([P-9/7U"U32*F6#.A77JO1O[![,%U
M+'OA3C"GY<-IQ=*\L8L:,%2&&A\^Y%ES;RV$"@!QFX6.W2V5(@KMWR#RB*:1FI*'_Y4-_ GS@"]E-)Q5HZ5B=.FP?!3+*CZ7P:D00C
M:ID M8N:ZV(B9. :$-FWV,.5+XGSF9J+R/+(M,F#'Z9<-NGD7,LEE_QI\:$R
MOUNO&VZ[@=<47.^F)(1SQZW4Z(!9@IZ4^96:GHC=8]N=45J,W9!QRWVZZ.U6
M.AC;]&$IRAWW@CD MG#$!R+L&P@R1/A>9'=L"7_P]1$#)Z*#O?@V_5\^^2JD
M"O-/OBC,7R^/O$60^^VE8>I?;C*'''4'+/)/_=%:.)1!^[]D1>!>SK5.[:XO2(0[RH(F+[;,X;!^H
M1PPDM;'V\J$!>0U?X4QL+T:2WX]:R*K5FOK&+HXUPNTF.1,L/+]9A&[%\=H(
M9\.N)BIJ;PC-\'CX^8HUC%XF;-X(NB#\YWZME3
MV^=$D&VY*H0A&(*$V:9616)6MN^F+WOG7]\[/U&/X\UNF:,5P1-6V>%>-@-.
MYRQLG15 �X3G6:Q7.6[9O@_2?W'%TKLY)">E'D(WV -M&V4!NVQ=,DON9U
M']F?34H^XJE/E1F/R?,X0RZW[.!FW8A28#V+!<"^YQ9D2(@O;WS7TXM'TREI
MX1R+,R1\4F%1'$>2:%;8S>XI'\>]#XG,Z[9W11/6Y@ _*U#QXDEU\0?2M;G
M ]I,"XX/ O?DETJQ58J??ZD4_]4V&YWU+6;%P(CB3/XQOEB*-G6$3TFS Z$(
MYYH XU^])#O!>P\2I]7\_!K9B4_YO3^08XG:B23$(UJE['ON6KB;C6C?%U5-
ME&(.P4,96H:;1[IH-,<+U,82BWG"3C$APD&.7WWV,3SSI DO>'QN/#VOWAOA
M8G_>$^OO12TX$?GCE1$N@4RK_,Y=OT-?NW=1AX<*R<*_QBVCPY7+XXKY+@3Y
M("M3V JY)@G[)ON"_6/4Y4-Z0)D!KAXLX?&4MXTK2N?YBK7)Z/L&>E*,!^TN%C'9]-0=(,^*VFM(CBG=7NOP$6URM9^
MR5V/MGO?<'ESFQX[[+2]^)' B.JBN_DF^)"P&(7%%#T&_>HVV^IG'Y8O#@:-
M[]+B7ADE+9=^)+ H9L#H3*W.R?.?H0AS['J*RY4T\M#>[K5?)^YTW2E6RI&X
M1;M.M<@K$+E\= _.BE7A)-.TRL]_367 Q;)NS\MRY)]&;8W?<+X9#E^+_A7L
M2MAAX:J8">LU,FPDQS--FA[=T9D8!"Z#J#QX<)
MA#YX.),CH--@7QG[Q]_?S5ZN302B1/NB;,QUYWYL:$%BW__&=BLHTTBW[P*_
M(^]'4Q+WJ6@-"Z< 5V2%%]9@CI&#= E=T>D]H(K^1;T%QZ\>FTSY3N.TD_MK
M;FYC.4;8]9+WNUTT*&@E9GY:+-E142J'B[9(5";P5HIM8KA0ZK82+(6(:9^%
MH"EX0LT'4Q&DD1+E9-4X EAD+#K1N:%+SW].VGQ7(E#-% S J^._Z&UL'PQI
M,$:9B?G+S!F&7F)&822S8L_C< .I;FK;;<+MX+':3NF-!^*1**1'K@HB[N/W3JR9F9U5L0%UPZBR!LGM.'O;>^V
MJ5A+*V8TT_9JK4B!!"2E]F08/TNOB0)HFS-U059V7=LIJ%DQ"51<.2GG7*@=
MO^KM/&+3+JL6[U4L.&$Y/[<<7 H/-A!(/9<.]C0&S:O8,V
M.P VMT9&Q+GB,0+43NY<.0B>A0>*Q=_R($H\\L"\"OMQ1RE.&P9C4];!1XGW
M[L@E(5QM/CX*1U"\T].JP-&I&/M(#L-P9^3Z];B9_AJ)1)?V,BQ)2IJ)*'3G>Q5HP:1N7
M!^N2E>BH-7)DW8UEP2]Q+N[(V0D+94J]PIR6D4D:1K/*52U]V-0.XR-(C6Q)3R+Z1]ZG>47^@]^>1NFH+7232V?.'3,?M0
MGD?0OT9V&3=SS-=9A&:,9
MHBMR(J(!92S[TT/>;3Y$\\8+8]-B;EC0E5&("E""OA&Q,6/BQ(O5HVC7+\>(
M5-G"SBH_AA\DKMI<0+:4-R";79&!*X'L*]7_%D\/TUC.XK[DW[QX(W.HE&YG
M:52)RG?$>84RD;@^D/NF1@R.H(W:&1A.L03V:F3VA,!,7'K2UY-K5](-=MEJ
MXH:&.T.FVD@8RKIUYNY%Y-X+/F;5)JAW
M\2E)=,<=BG-M]O&.3KXE&SA(QE@402;,JJ^S-O$Y!Q>4G&7G+H?#B#8S]A!2
MPSK3%XE69E,4Q 6LWH?IH9E9'E=3XAUO6 J0\XA12?R.2F5@5J/."6;TO
M%^W,>$O(U>=$6/RB=6!YC3=)_I$"71[Y/?4C+I=G<(K?J=%XZTZL<:WK*9G&X^ZFWV2'B"&C7"FVF4(AYK+G-9R,NB=5=ZRD5]T Z>6
M^=B9PR^;:RK$V)],*,2V#U,Y]7T[K0J3$+OD%>]Z:*2).-76MZ?L%;[X,$]U$M67F+&V)%M#4%9JLR7.
MC;/XEYM3,7B<2E_W3^4GN^L#MYKV5'"4+K)7-D5
MS NQ.U# HM81@+"-K77\YW%K#IS%A09]E1)R>4/^3HA 1B;?2;L]
MP8R5ZR529K+IA71*/&ZD2I&G9Z*)[*LG3QYC!6KF2^0J\?$Q:)]7$%HBSCT2
M[PDSMX/)B'HS& GEVG2L)-I)]_X5#/#9":A\I5W?/6%>%ES:@G\1-E>;&\T>
M)2.H/*MJ'@J0O=;RCB],7-6$Z35=XCRN\;:GQ)PK^&<_B!_-5Y,C$)#%C+JN
MQ:2%8N.1'8R^M&;#(2&,8W]/TA'A+;G>>^U8Y=9=.;KF&J-86++IGR7LJI>5
M%VC[6"3*=0/=))SPCXYTFT2>FP$+'Q;[93D^7&?8S7YLN[(E]+G3UK3?'OFM
MRP*B_*+WHL^F3["S+EH'+OF_1>! <>;$HD?>^-A7I$DW^N-YBL"3$)N28*?4
M]&;R6!?Z@P/O;)#2YXH$IQYCS3PU.=Z27G"0KI;/'IRH.]V-^SMHEH8N4M3/
M0_FD4IFFCHC.T6LG^9@B^ ?;Q3?U>-)!QK=8M $5."PR-AU _F*]B9C5]2[U
M>IG!X>G*:5DM^>8#JY;0*'*%S.2*10$J5?C0^EE5)GDJ,RT*SUG?\66_%$*Z
M;9$W1&I<>!RE.92['^O\O4BO'$V#09';^:U]=I,E:,8>K?L)VCA4)26H"FT.
MY:@Z!8A-&4>W["P=.^T='&SR3U4*)KA6W%M:)!\L6,9@0!6JO4+,6(K&?1_H
M<>?Z@*%>I&-2D9SUJMP0-,D'FSD6)?H"'><7@/*I:F!?=83ZC+]ZA>4(%^0I;DC/M)1$=F/K
M%9TAW3O?A^^5V0MF?O5HJG=*4V7^(ERAEU&QS9R]8S
MD(\.FU/2?=IB)(K:\4(<&[AE8Z $9J/@VY+\22DN9^_=!RF[9;;W F9 =U52
M:5 =D2_=2+$DM'^K2D(W8_;=]A[ 0_X(<,C=K*!<"_)P@Z>Q9A5$43C O+$K4-.3D+4S-W4A"K>6-Q[WQ'S0I!>E-AE
MRW?U)?/9/$S*ABS%<$4WEU 7"1\]5K(/?W6&IX50CN1:<,:2%>:6%V?"Y>)*
M@EQ5M[M@YU6]&R9E@1PF3O?:''!,\L-YZV@*:2+<)$:!F%9J->-%/R5TZZN3
M,G>F8$\JU,JRB\[")^&F,PL0)RY4\3 -_P!%0K3@$EZ#&[%TGYR>8!>4HP
M/=:E "X1=#_DB)7$O/MI,%%##V[PD-P%(/9%G2KRW#C&3 %5%(BL>W]G#Q]+
M)'+T7!I93#ZI;SE^]0\?,_**>11XJ(ME3T@C^XV?Z%
MD[=%U$ORW1B#O%[1=5B@BZ<_X@:0]^I6H@63I'8NMO:K$Q.=DF.Y*9]Q/J*6
M$>4VTO*%O47BVN<(5"HEFB,"T)B]HT7>(%SE0MH&PN(*IWF8'DZT9:Z[5TU>
MU69:LYJ<%$T3LA($+9;H8X>Q6BS+6;D1L_B47OA(72]%?T?&P  @ER'"Q)Q[R_I!7$@[($DE9P!/3*+E?X
M0T3$4@9V$#.6H+H@/V\)([YN#*=QW+5GJ6UCJ.U4N<^U[EO$5&2")C:H'R%(
M)%/,1?:.2P54S574LV$!D5=B5U[_B?OR"!$-RX?_FQ2![&__98::(%"O'
M^YV<6#+-83BY*P\LSC=>^#^Y(\Y1&,]MTH1Z*_P!1O57<")G@%.MC2$'.5%J2[-RPGIXS  L!AP+X(0U[:V8
MMEE> ?4P(-/CPV!?)B%2X*L&FAK/5@IN32D&-4&^.*9GXF9I
MJ!0 !IS5.CA,];G)%5L4J2,(&X/*_ .17[.W>@J4Q#_Z#?G@]K^65(JFNH>&
M\OI-SM7L?_Y;M?]D^NS)Y,F3_>FS^:-Y^?C9=/;LX.G3\M'D^72_*/;_[\'!
MO_V!FJ!O
MKNI]',[P/Y_'^R#&H.QUD[TLIR6%.P=[P.H>[.=,R4H9D9EB@:A+$3>Q7#GA
MQ/#DB(L2P@Q#:KZL3BL5!7[A",6_EPHZ>_;<[X@CDRJ4X8/(/.WO[?POBW_F
M58_FIW.X(6S?;-B'^S3L/:O9_^]UL*DEZL*;3_S?]L1_\J?D:>_*Y4H>)[/
MS0"(GH2^G'@[G&V/O8%+=D;DC5:)+L6"Y>/^DI&&@Q*Z")835>2_'1V]0>=W
MS[P6D&. JX8,EK+@2%$-)HE>U#VA6*"YMF*
MTF==8-ASZ1\-]^QJIPMN):-$XL6&#[HV,]&N#*M":R^RE5ZC\N4;:JX(4? O
MS((+![?W.H5?2E2'![>J1'5=CK7/;C%QBC47C8HV84O7G6N:IP!KXV3CA-!]
M]_2BV^Y3#/_JM*OT0C]:TY6SWWTP"78 CX*].Z?BSEQ,.#R7%^:YX#-OHZ_S
MVGR=S_RB%[Y6'NS$<46-5.P:;RAACMXS%UPP^_G0)[1+,/8HB*= Q#Z1ZD;2
M9Q GXB$P7B)/7#;O,@WW!D08KL[GJ%B+CSVXL)V+8N9N$ZT]U2K.VS.)\_W]L,/3C\$_^&X
MS%YVQ/+W+H1[9?9L+[A5WX*HHI\5>?9CT9TC013.U3.TB)T1KE3%IK.#1WEX
MIZS'#Z'L6!+(KD5M+D2ORX(PIYQC>3U=M>R\'CRE% HX^XOLT:.]Y!%MB_)=
MLYX#6TT]/)I&]Y57Y,^$=,C_6 Y;\?0@A(@=.QIAHCQN])Y\;/0['6#M<1P90-C C$$&B?#])%>P_^H]_WW^R]PV_
M.)>"NY:0_C-6N<;W-2-%#NE(+M,%OZS[+SY3[/SLEAB]0V?Q;X?5X^30&T;T85]=S;[M
M[Q['3K3,*/0#6_*^;@*7P9HZ0[[A7]
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M57@M1&G3I._G'39T#;5_-$ 7;Y<KWR5-SC=L_W6S8WH!JS2);UTW^_^RYV9__P
MPXO$"";_:F(?]"%JJ&9F8
MRQY+_1$?JP53XCU[O!=%Y*"'!U(M[4AUG\/5\V1O4[%^8&*B4S4RSLO'!JNV
M.9H+?V)X.=W?_?)3RS!CZI0E@"[-V;*H9K&,3PGUO5SE J1(Q>@R)CXAYI?A
MDQ1\V,*TEVQFA8U"$L^,\!.TO.+?G^T>//XZ0^*J'[U<^/:3YN6ZP UKG%O^
MEE65$95E"AYU3$/#4=A->;LP^(AQ8R"?MM:\/ZD,V YB5Q7J('K;U0BH&=,1
M9T+^?73_WM^]]3Z>P;!;UDU'85()]%Y?U&QZ! #H!"^EGUY=@QD7:+0JON!=CK4LAE'/L&YY(9E5\Q,7&ZB4Q^AKJ9:*NFCA+7STZ
MV#U01ESY_N/OIZFX]SCV4\/V=+8
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M!6H&YFF$^P)@&*_X-'BDOY6D(:EDM5)'4MH<=8S#00 S?$QOP;7MI]5
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MJP*Y)F/FM=-M^4WVX.""G20/O-;\3U
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MX8T6]]#]= A"3(LL93=0K50.C\NGY;HKN&14?J!2]N*$CD@=RN>7G]J0*FS4OC=\5)K^;!13DM:S)"FQOW6GN5
MX3"D-T'DQE+/- +=))("G+PY9D5A-H_.-I8)R(S?;'/T2AH=-7L*XBT1MT93
MQ)W/+5+2T?T.9Z-5Q@28(>TXK-4]FX//:L&81/YXXECP8"Q?E*;&KJU%=C7P
MZ*.]6P(>?;*;9?_O[4*/OA6TT__W>YB]OA0LKU.P?/PIP.B/#F\2C'Z#9^?I
M+01>?_8>]=O;AG+-]J_W2;IG%J>I9_F!"2Z>0BF:?ETWD:-)[JW>"9Q6#=6-
M$*1W:."9G&=6#Z'P4:*N2QJV& _+@/BF)5&"Y;(L".<1[OB2^W^U3[_[Y$U<
M=V'90)T<5TOZ:8GE!*#2G;IE@40WJQQ6"ZE7%_Q:GNA$0WH7.@;K6*F5N!D*
MU"A,128P*%]I)4P_*^/A?2 1Q+;!$)'95 19AK+6*K\3XM36F,7$=?&<@\SO
M9]HM+U[_X]7+G?WGX>%AT<+WC=^TQ$N[?&8:Z)P1063V\P=@M4JHC!N ]'MY
M@Q_D#=[9&UBBC8;/>1+>G0E(:O_&"OFW"-#10]\
MG@ T(A1.U2//KTHT@YAMP$PUQYM2H"H9H))GFDAP@5NN8OD=XDNDOJ2BFU!:
ML$13!MYN-WL;>T4D=;+Q-OGV=\GUK\-OV%^%DI3P3/;X:H *IE2)GBPT;%@4J:R
M47LKI"'CV3;*V)GLW40-TWC=>K[9D28YKML)]%_+%:FH";L(SH%D+5#F(E(.
MT-EF=*]XFMBXTZ,@=+@G2V&I#?\2+IE$N/TKC&Q[=8(=%QN,H
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MUHEGT\;4E:*&2U"EEIKXKAE\21PLC$=)7.^X,UAJ*.NO8.;&M;%\FD5XM;#I))^QHFHE+*D#2RH75
M.VV1NNB.2T@ I!LZ_'R8/Y$G&\L#'.SM/^="9W"N24!>$/PJ:35X,GCK_'(KQX_V=X%W:/1.N/T@^".,9]'
MZV/(*H2I>7;MJM)M.U"O?!,*6CM,>$56%R4[X^&<)(?5T)O+*[3_O/G!_;Q=P3DH'\^LH>J5_'VW5$,#PKNG/:_
MS0)P->TUHBGAA^Z$'7CL[@MUN2;$G<_*K5)=_+FIF+6$PAC*XRWH;_Z)#IZ*
M4XIPJA#AJ'@!C8")!O!N,X'3Z["B87G$+-TD$8J>2ECX(M$C(*;#.#7_7+;QT=S]/@>?@<^'C[XH!P8T\$CY;Z/1'AK,+\(>5B:7+8]'# ?7M$TX'74U
MMRM7XPI".T("#E^;=.V'DJO"I^L:V1U*V8HW>(+"6^X:_H[;-GA?X9@T.K!?
MVXFJGQHY+^<_%PN5BB*!3-$NE82%(8-F(8@Y+:W/?9AF\D=9(9%PBSFYL3)]
M)Q^1RLC G>12-):/YBST#F6A^3%_0 KKSU?A>GJK>N5OG3UZO^&I(0A"(]!)
M@<[,*QJ7?EVM:%?K-;?%E'BS(?$+MON;(MR?Q4GVM^#S(:/^LIH#?!T.WAOD
M#7G\2PAZHZC%92IC-[(?@4%IG!(UD&4R0J*9,*O[[#]O4Y^*/+(8;A.3)Z),,S2\:[7RG=:*?!W4B4HR-H6#9A-.@ETE<
M0VG="R_C[A;\#+Z]@\NEG+D$IG,9Z4*P6Q6*A^H_TI[;N$QV,Q&QI63J"5Y#
M%,0)F9\*6%J&U?+JK&S(+LBDC#W_U.;EU'C5U94QB]9Z64OAR94.&N23*"/E
M]>1H[+%F,!"]7U/Z,ON%_%QS%N/\G"]5XU'*#V$VD[2[G).=@\/'X:W:%42^
M0SQ&IZX0*3HDNAY_G
M9_/RC'0#\7G)%O&3>Q+7M:2U+ETN$NLT(Q6KQ>EI)B/"1?4;1K1X*M6
M,+W33RM^RS\W:=K9?(
MX#:81$5#@!6D8&WB, \T>6'7'/7Q^IM*3H;)'+6=/ +C]*W>QFXQ8MEGS)X:
MYY_>OC!W@1J5<+ QH/ ?83F30UW V/-8\LS=%QQ2AR&I#\S&D9+C+J0Z+I9Z
M__KHA0TCA]34+K5Q+? *A\,4!L^F?;S0?=7K^>!.GBFHI\ !C8D).*$&.]1:
M0C*UX8B1512"&;UUY2PB_([ZQ6VH\?5K2OQ'FEZH)\U[D"
MR@Y*ZSI\9(YGG1&,$X^;E,D3E8B%-[5+O@PRJ[-RP6QVC/#!]#E=XE.GGRB]!
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MYUHU,/$*ED7U)+6COX)@N&IGN>D&!">0,U["_H]6EU[H\N)[.251P%.(
M-VY:5A1!%SVM=<] #A:UCWSV8;-K.B\WOU:\FT2Y&L\@L"Z7(JX_#N!$]@^>
M[#XU[KU[N?>87#W.VT944 4C0R XB@AH6Y%^];H+_LT)-2?]<\TH!4+GL^]K
M@ 4[WQDDZ7\2."7+6EFQK8WI9%!WU\^BB:B=U=6QNNV2.&$@KA-^]5:IEQ\;=
M'-P3TKUL9D+[CN E)WLZ3F5#&QBWH)B(H@-JB9Z+[ >5C?ERDG2Y>-1T1N$7,R$26S?EL8]=
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M*"HNJFG7ZIK(>:@ !F>IP"%KB6ME#?A1S0E
M]67-CBKBA)[*.D6- 5LQ-:KI@H2[\+LJ&%! K^T1W[)D>W94%_V'XL][(K@J
M[@ J5L FCF'X[$M*M3APAUX:<38M)X*_/H4L@&_.2U9#+Q4F[XKX  (AI.;I
MNV.YG)=Z?NCP/J\0(X"N*78<[X=]K>;?7LN#@[GF#=]FZ8]
M$U)G5QI5T;6=":4+M%(:@SQ2^8B1Y"APBYQ6];2\TR39Q4&U,WR1"%1^(ZA%
MX: **$U+ZXT,,KC-E T+.X<>A)V?HWMQQF/(7E'4E.UEWLUI[9Q?HUIF$&0VCH122)#A1YZ;)8K*>" JB
M#TG2@N<\F-A@)7.CFHMO)BP"*;!F1Q*_,T=VJT0T?5E^X"+Y2I"MNJS4* :2
M&IX3C+P5OD]M0>.N*TH_<$86Z?\/#MG-7M-^V_KJI5*J2Y^04+"/#I_1?!OOD&=_RNCZ,X
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M]L:&FX 2?HW&
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MDJ25))]_*4G^]4SCV-$#[Q]7XW-7=OD:[N%W78]L^A#GO1
M#OGJT:$+:4D_>#X'2-8@K)
MY9&-_+J2M\C.2)JK9?B<.^JIR"-$?3-M"H2,D^/DUX'$[1J0"K2[]"#RC\'G)1(YF>98^_4>P<59\44^L]6B6I3+[&
M-V/L(J$:&Z)I2@ /\]=HFD\YBUC =JH*6+I;BFFP,BI>&0F@*,E9'E=3U@ L
M[K-XG8+PJ+A)F(TI]^[9M6Z(=88"*.R&]#0W4YD)E"YWI:3Q2=58FDN2PE:<
M6QQ4MW"P6/\)I$+5._71N2UXR5JDX0^H*?P*[K<,!*OKCO\EP@SI+,6O
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M1UEN/8CJ>O.R\FG3BWXM%%>O^6W>+@#)/L
M-146J]5:&A[JL%8H1,<)&TJ,4I59UFB>A>BG(R9*Z&,PZ[\!M-I+Z ^M/8@?
MI_K&GNVAZKOU,OIFL6&.TP%%1!E8ZF5CM][Q0_X].\CYH$>0]:29Q8V!">MF
M&_$A[[@11XU33D+L30=5EQ+$;"GT*.X()4S#GS4;>%Q@D-!NY=%( KQIR:=B
M]R^Z6+O9CZ(CS[%$8C X>L)[+.M"S-595!1456NE,77@I);+
MBGPL?S>>E$!JQSY]W+R]\QZ %X;SJ](&XE).VRZ$$:<5\!]AJK'S6/##U 9E
M4QD\)X8CGRPW<3-!Z8^<-3:]9)[-U^L5A%[O[@FR$'4;UWW+;RAQ %HC'?"8
MBZL+.#O&)22)?V2Q@D]UW"@7T/L+&D?Z!4J-8+^B(;9(P>AKJ0SO
MSU#,[-M-T(I>,W>%5 GH$I#5D$--G.O%O!SK.+\W^<"C*7#7XGD2A@9TO,8^
M>=23BK(DI&E?_KUH&*Y(['/<*438ZL=/ARW>"<.5"8:%!]4DYU<@B="12%-L
M$PD[X,5),-8< B1=)YPFSYX?.OL=][;6H? 2*:>P2C!)P]L9WZPYL*ESF"GLFO!P QX[-)"G4A*/[:O21Y%+8K^K<4;L*$D"T
MPWE;4XU(!?>.^1BP]%A4JT:@HXH_HK#Z&[64->49P5I4%_8[ZMVF#)4M&X7.
M2\PDA^U*7R14.@.\$9R'
MO9P0!S!0WAUH,76Y(ZN0)C7IK!T2$]C+C"_@0F+QN.-\QV?:\O][B-?^Z /,
M":[-_WW[1^Y/'5U"=@B2IAT4:Q?+%:_.%/%B),D-SL3TA.ONX2FKDW^N$3O3
M6>C731BT5MN*-4G+=QTI:>(8S(H%J$ZU#][O&BOA2VB!FMI=\
MDZP#_?[?RHYV&EE&CKO;^1R3X'/'E,)S30FJK&=J1,O"1B.*:]51
M)5/1;SHM:VEZ9,C3RO5$&SA>94H%(5 V(P-GV;9@*@OJ_6-JU*X<.27TD5SS
MEWP:J9P_.\>T3_L-*YNDM":EI4'O*[OAH)/=W3TC,(NDL],#*7+]HDSO@,">
M"O\"PQW7#9?,UYB*,(3>&9&"YG@ST*@(CP5VDV+ZX9@>LB/3-Z?_]\T?-9F&
MDO';*L]*T7;B"KY(SHJR3U1J7_TWL55BR2
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MH;GC9_@=<_&UAXFJ! 26%E$@*"5
M3L)-Y).C*5/9@H*-"=@P5B!C_!PLLG^^E/_^K4KYWZT\Y&M+(;RE7%)_QW./
MKRF(.2T1-N5)@H3>3I 1:%^8D\ KE+/F-5!\R(*EVM 47X58JEMQXE__B$<0
MKWKX._S?ST11=;4%O%&**LPV(W,2-72R>1X(8QSURRZ$C%U5GS,*1V2!<0]_
M+&<^WSI0O%>\,43%%?#3;![3_1O6J"PQ##>WG%7FJ6
MQ,[*/>>;D%P.\O#!'?TQ)NV2[::%L-CW_ 89N$6(7$B4,*?D2]ASOS&SL6XR
M/%V4[B] /^D,[@UGT$\Z+U01 ?M0?DIFL3# 5)O(JQ0)F(7=.WZ&3?:D:#X
M734]5PH( JY=^E+N,-_G(_0MU;Z%@5=]8V?:N-N>0E#Y1\E+&$\K/
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MN2"] 7Y8,&?GUA')RD/<2BI)1VL;U1^93 #<.C:&-4J2;-CC)9GL^'CC0'M8TD?EVVFILSPZXFIH=!(ANZM%;+
MXIQVSD",?HF:M.G[H(N4]'TLI0M3(54M5*D(V**5!K9TFU!/UZ*P;3?< 2PH
MMSDZ+.B-NM\[V8/]A[=M<@:;THZ8Y;3F='^X6C7'V7!O)3N(PZ3;5*M]T09R
M5[E DPB()&'[:-$BG+]Y&/S$28R>P&@..MPBF/=&/;!F=KM6,]NYT0W^X."V
M;6\"R Y=I)51BOH+&HFC%7M7*ZIK'5<@3V94FN@-:.=*1:2B1*-!7*[SM$,S
MR6Y424+*44OTW'L;9^C@F^K12ROSE&M,N?[-J
ME_2?2P2'P?VKRWF8G^=8AF1E=O:?W2!>,81?3SZ3=,Q5AI#.SOZCW7W:I2[!
MH91=FS>BBZBV RR_+,]G6![7+^*"'_:,">#$^>A!ZV[%3"(,4W(=_.%C2W$E+TY81\AA/RO4$P-VJY+H.5>*]H]=>@W>$2!(B0
MU1*RQTNO% IXU@GC2(O8N^Z<-;S:^;E]:\V7&6H+ZQ7):P%_%.*4VN$@_'IS
ME5%X'[[97A;^LDR??IG>6#Y9A \9K]=ZAL;6*R17:"VDR^C+@?I#5^IHR*CB
M7'JO5>'4V!@"+=;3:BE6(/FR?G_D^C$+0:4 3@!J_GYEQOBDAO"+ZF2HXF?=')0=7L?02MQX+?<#*IV]D [9/24>)MJ)Z)+K4A1T>P\8S^
M1L=V*;@=RRDQ"I#@;5=XV;ON2:D5^UFLUSNJU9H)B\&:$BZB'>,NZRYT 5/:K%VBI32V #D0
M2A[BQHL7BSXC^)G#+B)B/\/U4NOHSECKJ !9&4>[.6%M.'['BGR.ZFP9$:G,
M@;G^)_3\7"@TYBOQ^Z[#*[V(QUO8X%C@^>IWNCX28"F;@K8;/&_X]>33,79/
MF$BTZC E&Z8S*RK/1'#6HK79=^..3ND]OO+T\%9]T@XI>MN@3I=:MLX[A354
M^DXPTR;%R7)&IAWPGA\SK*;'ZCEA\B/1:@[8'CZ\XM8_%"CRA&#'L![*3N.!
M'<3*73;44L#W'38"[]>0X+;LB+TI=\3,EGP"96#DUNJ63<.!C^
MB)K,[,L+?2_+0:E*Y.@A+L#@=UQF7SW=?61M'TL%.P@!&F/46OTKWQX
MUW(%8D-4[2R7]> -SFH@U!U4D*ZGJ%0TL7%%S(FR5=W*MCZ2ISS(+9&#\;](
M_=47MA@WBK0V#;Q_59U1^L2D_>-S-0_^^; SA[<2.W-K;!M!LFV_>N)ULNSD
M:8"59C*DH_$D[-,H".ET,[?8/!'%?$=BEV )S4=DNEOF_PF!&=JD]ND
MCD8ZCXB:CPLRQ20\F:V7H '8S?A7VW&B& FA76L>OL0>^5K>KCPEWC,A920=
M#[FL,636]0R79IUV,/;@\A;EQ[HXAET/'M3,R8YN*()"B$B8?,6)8)ZTID1X
MI.T-E/>0]LA0E%P@1OPM_$J,#*F:M6Q7;J/$Y1;.2?[ X!^9
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M:;EQ5%IX:H@R'Y]8/ N6WI8KD*?Y8?16BD,_W,TO^BZ2,SPW*B=,Z7
M--%D(($E:LCNOXG&AQ0(PQQZ3VOPH$DU4TU#]+1"04$DT==+(6P]"X&)*(@#
M=,KHF,WA[F:O@_I8(3-SANC!;
MGJ3(I2-\HKEE;@JNNM@;810SSNTN8O4!,5.Y9$M.,N_T!5^D&7Z9M'G#]L/@
M\JR:2XJU_@S[X<^7YWETM_(\=^4\P[Y':J\+TCH;ARG2/&S[1MA:,^G]TU/I
M1+\YO2U\-]7*JC?GRG[W\\C?RG6#ZXH31$::KFD:DFM:E,&)F(7;RR6NM,+#
MS^%KI('H4\4)72/[]I/#HOZ#*@H;+JC\)?($G)9JYJOC\L4C"5D7^RD>3V5
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M80 ^7E&J6V".J9].U/3-YH/FZKF/X=5:HV;>@
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M4ABP9=L\QYR-!"R6;%M1!TFV+9*,/7_AJ_^#)[E/]%$EZ* EY#LO%8JR/\J@,3>^!<@,Y
MRG[PO*VJCHPUJSV HF<@A?C5\]V]R)]--7\\)!T(E9]!8EN3L!Q]++'.47 %
MT2W;9-F6T[9C+EUR47%B6(]1 V\_Y)(#')8[!XA;Q]-K J+7'/56[0 )IF]9
M.5RO8'KGFS1=/EX0('Z=U6&BB=6ZZF8[P?:NSF,LQM!:[:,6^3J2ZRQ9^:]#
M1D774J DTQH!#^'Q2[&;O=+\S,WZ8Y=,*
M"*I6%7R=/ST=VIJ8XY"D!@B8%A-"Q$>//ARCZ0GB60'PUG*$YEW!WX8SQA4J
M"0@(OZ26
M8GDFP@LWI'C*>WR9
M.7(K9FBM\X^.&R1YJ)46;F4NKD6$A"9G]OFTYA
M3K9/@<. (\C)L/V-(P(3OPI6?[)F%HRPPI0%B1GMY,SWU ,TKNI2B%&F .+Y
M[K[7C;G",*)(5E=R5L5VZNA7PLFL"2_N(<1W9'<><1-LG[T1M 
MQ%NY<;$1]Z+6Y>Z-*C!\^M3 GP_"\/AN01ANHMPY"-V#EQ*BR3[[^[HILWU-
MI:;/C==&%
M^[I4^)P"GJ"4);TC#@L&N2-I=N?"F:;JD^H0=;X3HFC2 E!V4A)S>60\7N%!5<=%@[UMCOG+P2W$+"Y:7:R[F81*!C\-KPF
M1D,,IE&G$"5$C5B4IY9D!4T:B7M#[C$*[KT",]UJ62TE=M)*BS%2)Q7'4R]:
MDY-\6\:*?KA2OV?EUO]6Y=;=C#Q")/.TMDKSK 0B,=&E+JC#UCC5RLY^QAI*
ML70GFFC$V DQZ=*.X0GQQ<8R>=.RHE V/ 091/,J:!,4IT55$^PM>Z$L)YQ=
MQ8]:'.U^/64*_ST#&9RPL
MH:"D>C)%Y4'BNLTG4[4E&"@]TDL5"C50!JIA43UOT\Y1NJ(ISW(/@J[/=]1>
MQHPX520@V=E1'R *FV*X5 *5GJV=MMEJ
MGRWY@M9=KM83Q)\)I/^Z 5E ,
M^WD9IGC6+HF2>^/(,TW+LJMD0M!G:)F5ERB!K1A!$^W\Z"@E\E]2:EZL@PK\
MG9$4SG'K.\]Y3]!=@/O60G_@&S:V2!YO0(SV5.('G& D)>[XJ7."-,I$N6-Y
M.=;QS55&.&P;[(?YNFNJ_H08HOZYKI:\1+B[!7RH>H$ZD\D1'.HHBO:\^QAW\(?3*%^=G
M;ZS!7_4Z":7FEQ65KORQ1P0W6%BH![L3)H>!^ZV__/
MCLA$N=-S"2W>/*(\T(Q@WH(RP%5<=_"E<2'>DMPP8
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M*!<#!XEC>R>XWWBA(T42O14DT2#H[5FC4
M(R?#(>']<3;#X1>+IMR5H50@LZ
MKWPJ-QPF3T6'>KBG630S1:Z2$YI?D_/U58C7#Y,RRQ8#YAP^^>;^7B1.N^.H
MM6MZ(6^"E>FR=^@E,H#"+\%?OM-S5.!84,O!4'?<82
M(@A^7)&5':OV3NNB6O E8(A"
M;:70YBZOZA6"]A6L'Z?&3.1K$V@8WJ7A6K-VCBR+GC^X\Z7F8C67)[>JYG(S
M)T@W'I5 +5F%+3FH0%D9VRBEC6C;LXL:6_!Q+)9%E0;#7ST*%H1)
M3=3>5YLG+#R7?>2O#@]WGT5D;-''&X$W?_I-S;#H.:((F]HQ"1$SZ4.P"J\=
M#:7A^^]6A&[Z+G9UO6B[Y:ZQ+ W_02F7& GP/.:8:62SDDX%CTO;0&A4E G%
M+;[R%R#YN^DA/RE1S=*S'KD)PGVW,N\L5^I\BWF[M,/]T<;*^Q>A+8(D[%
MTJ:"A-J%X6PKW.,3COCWD(>&/?F.QDBP]G?NE496]S./_Q),;R1GOIA"-,D0
M6,M+13G+X(U3=$Q7?2329N(-6&ZWCB$VG59+:EB_2<3(WZXX2D4^I=;9 V*3
MK[5-^/-49\P:CSB0/5Y7X!I01"W!V<-,KB3#0;/7E<>HW5#6X PQDG72JQ5JHU3AUF^.V/\D.G;7U:.D.M0(!ZBI\52 ($16(NO_+J>
M'4M )#^7B_1#)6R 99[P](1[;%5PIRRH>7IA3A GDAMQ;W*CFWEUR^5>N2LE
MM42O*_4)3Y,0WG$!BFXW9P*1V%@7>^N$ H:*+%H-"5?A0E/HY.G0T9I5U.>.
M1FX=&<[G"G*21D(NZVH+1.WKDU1DUP]2&M.8
M%E-R8JZ[/7@\+/EP&A=M%EMZ?A$("\;L#L&6C9\9MQ6WEJ=P76J;I85GIJ&-
MG\NED,NM1^R-3?'S97-:!8/#CFU='E=]75@51' T-,.Q;(C,UO0FS6YD/''G
ML%LS&:[K_XIV419LC/Z7=II.(^ZQ6*W?NMONK_/TGH*>!C'P*:=]B_H<-;8U
M3$0#B<6. 3Q)_3P  <@JS_WS'HVC!O,
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M;*CNE[P.[B''SSC(_,%%*@0[=]P")5+X&CE+,K=TLQEFQ'EPX8>%>?)9,["\+@&OHE!2A0-K)@=/+*XTN07RN2U#3&Y
M+MINVU>Q0&=M_%#P&"N!6]GNY1ER,M$<3=H6%)951/S5C-DHP:MR7&_[43!I
M,-AU^& <^Y-@: B@&R:[_08-E!?.-[2='OKKI"%7PE92L^D
M$],2YTFO$9,/\JLE7&BZ"@X.8$@\@-B&X^K--Z64TVS#H-JXQ_=HGMY0\9'2
MK"Z^[OBABE,0HR^M.V7DAQ8USF;/[>'Z^.'6U3GXL^RU:/W)M"N^5E-5^Y4
M7'+1MQZ'A-#$?$'UF&17U7/14*)WIKVJ6TB#HE3
MZLH]),$^C4F<\>W'7A,1VR[^;>Y9#"=LFL8G15D@L #"!-GB2A0+]0#BB56X
M/R0=3RT,G/0 )[?YC,1MN9J>E(E5,&<9?1&4U<+/] _5>)AAD5M4*7P;N.7\
M$2VQWN?[X^<^Z048F$O-O*?V5G/O%MFB[H<[FN^/I)@@VXZ9WDJ4($/466M=2=N9O4^BPQ74GN"XQF6@)(N4N4SGDP
M]IRQJ?B1CA4IJ!/>I?<=Z7)*CY2=M&OC21WA28IEAR(+8Y@Q/S2=A_#'?Z[;
ME?3O2%]0;)LC_4]?IA5M@4$ $]>%,[B2LQ4+%O;Y((^X2LH:8^/N<"P\3B%0X*#],$S%:1!Y2_Y]*AY!2DGA0JP$1IS ".^NE
M\7FK)T"6.][^6AE1VCPW@L2.;?*JQ,^F'[V,7B?=_]1QMIUG)QOEV4EOC-Z+
M6GN>'1C;8EO8Z/:FEJVL!RDCR)D$A;(GKT/:LRU2O61&QYAJ_DS)T*.PNU?9
M/\*%)K?TW7TDLR65=A2"-_=^NW?1_Y_DU6X5^Z]G4*"R8QT
MXO,8Y@[,N)W>KQGQTW"M
ME<3\WBB9L)/[\Q#SR'>YGC. .
M[$T,&IVM4K"1GY.*H*A&;?YV+='@0%XUD;WG=$.X%4ZJI50"$H7:]*F$VE@@
MZA/2ME7Z^6A!F..DF4K@AH;16:X8*PT855*>8EKVPBN. 4V$0%M!QH9[R?"B
M,49;$3;)#C:,):>TS.70%V*T@^,^7P>?NIJ31=I_K&*V%$L\S?[CW_>?[WTC
M5"W020'W]KIF_ 9^77TA\6*$H.[X&$BO54F65,\E.@DO7DA@>K]Z_,BA?+>U
M"M_?#<2(:
M38BK&C^UZF5;_DJL@[S1Y%PBSRTSM_FZHG&&%P?IV=+>$I%?-*2_8]/? ::R
M/_[>9!R@^B[NHE+W5E%6Q''#0,&(&*4M$P&,D;_9$5"RV NE7>)F9*=']ZGH
M/+**D%IO0.P,J.C8 X8/&6#(X)))-ZH12GGWB#BC2;+UU$(C]AQ9S.(X?)Z)
M9P8@W0@YHZ*N)4(8QD ^'<,5?<=M>RSV]^U>_(%BD, 8!#@X=^^F?S*P#!1"\)!X@B2?BV7&+0*&.
MS%\>E4<%+R\J9)AOFC:JI1A^RVR=2#J]5%[ROV2W"Z3HS
M_E!E%8SY_$NN)0L\7A'IA:(2
MT+^X)BE%F)ZUEX\)Q()C5+Z(J=*^TJH.9[+>DO+C"F&:$<4$Z%S8QJJ*$#?M
M1+)2(1A<=?K%BXA5DAVEA8EPL#\E,EI9CV;!=LJKIE(WPWLI_Y+F36&],L<:)O..@
M?%/-GU#&HN**(HN8%\LRC4]R$G+6DM,IDFO3D\B2(/3[H[&/S02RPUH8UE]H
M,*,U]E*TK3HJ%J;+9YH5GA)!<*H2&2_+1WNE5:HD%@&[R@<0(FM*U8D0UR02
M=;$UHW_2Z(,4'0;<1AZ7""%9L_\UT";6V>39.Z1TBOL=[CSF_=2E(TR<=B[[
MP)!00Y/?G"T#H-[IV LM!ZBR?:&<.VS?DAXBO5I.E@#_J#J!<
MR6-AB8!E%1AA#D$P'VV,AL50!'8R4=5!FOB:ET&<D*:;YD4)JK5CZ[3X.>1&"A@];O_MF[AES:)UY79!&[#3U AK:B/GG
M>63$.-\:1'R'E*:L2%#)AP3.,M$J5:B67E! 1NX8IKJZ#V1M@:RPSRVR)W>N\
M+%_2UG;T20)S^R $6S/Q@DOA^NL"KU7&Q7*MYR:7^1^X^U4V0;IEAFYR+/%]
MY*ID4>EBGK 9OUEL+N3W:8!^5;1[\%:$C9,WK>+.75K]@VT9+,@IYG?>RL71OUBTH#V%$*962
M.T7%DRD0B+W^O1FX;X3Z@J#G!KB,VQ.J=;AJ)[O97&'1Y>>OX
M5*@4O>)X:ST+ 7T0DQ26EP%$7K<7#A E )P@X-F>W$?(P1,PZ45K3LC #OTM
MO,=[U PKL[!':IZ:<=>"F92=BXBOH1;;.3[2E7+9?
MHK>31/W8>R#[E7353)?   @L>Z-%!%!N []\]*:J0:BZG%>1"8%*QXX#![NR0-:XM,6+X'<\'AO*PX X>@JH<'EZX5B6O=(M>@W9M+50
MT0$MTE>E>\VHB!N^2+514&'CU7-X:7KI(LC#I9@&WE?PRM]4- G55YZUY0'E
M)$=>CVA#3QZ_XC!^. ^G7*?T?79#N"1I0>_6J-4[$-<00@>E/V2Y>!1VZ-SY7WR#FY8QYM/T^"!Y<7Z;*A
MU@C3&W](3Q,EM*OP5P$I\-4P3:0[E%_;R_*(I"3+^H9T+9A%A*HJA<3/GO""
MR>QB40!/CS^@.6F>&*'7X@2R!+)\]A?\%]]B/EAQ6[$.(RF[D#:DL(VSC-)WF;L&Q T)\&_HCOML.WR[I=_#R;;FF& 0R
MI*950F<442;PCM3,U!UZ,>&NK'[LDI[1E&&DRLHA,Z2!-JCV215.6L7*OU^)
MF3ZC"?D#34BMA?,AK2&]LHNZ8\\'^V"+0,?\2B1*5QZB$!&]L29G=OO<3S6@Z4VH_)\5 R6A*?,A^[ER_4S)N
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M40\1@:/^(Z]1)0%22VQ217)+B.:*\KU*S\NAX$2A2;.1BDHAY8GN4M01:6F
M8R\2]R#12%.]<_<71_W)Q&1ROLJ
MYO9%WNR7G4FH!;+FCT##CY*0)SH:K,Q/L#;BY3(<>>/$JQQIM4^(BWU1(R,K
M+2)$!H[/9Z ;.&F$O9/C;9%4R7I(FY-AX3(%DF>P,M5M#6O?XQXJVIJC'3W"
M15L<)[H&FHIT/,\QL\-E7%L8;D"B+B!C%<54L "#F&.
MM$@57@%)D@;*:(7G56CF7QC(#G_R EJ^7BHJT+##VX\TCBMIEJG(,A%<>MA^
M*_+X,0<"'152@0\*196T$F^J[%DPAS:R\R%Z;AM:#"\%&V%F4':CR4M0J,H4
MYFZVP5[/)I6[<,BST K@$@?B=CGN+7;)$"$]!]VB0VY-G,8)!_N\N.+E(HIB
MRI/QA5I7=JZ+@';BQ$EV\;LU#,1741$76P>>67B)*LP(KT
M9#%=GGZ;J]V!QM8AXU@+2SPDS2TI2M\HT\P7D(+F(\&.Q)13QF4@]:@W6-:S
M+M+(S3Z7.#F#GC9BO%ZA%N8X66SG9FG-H65]J
M=YJ5NM0^#,=HQ<:4"V[>U:"IV3PTK\A)6@\DBF06ULL:JB/@EPK[$Z;."@3V
M JK:)_%0@]R&9(3BJC0I(MA0"!/)-;H+,)1^')SD8N_&#[R8PX&+M26%,>T8
M+]I-K!UI";5B+"6-6C1V]J3)@5C8^-[K;.T5BU$M&G35:ZL4]LL8I=((9RA&B(N
M_1)[QV(#CH+?F(L[*EGM3'E%GB%L$>] EA7UG4Y91'=_(X:5"'(_ECN<#ZH!
M?4=6P27R&["&\2EA4\.Z:E0K;1L>%.G4YNHT8
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MM 8&7HN!/0:%^8R7SF]!)?]\+!',
M^"/H#8;5O/Q'YF#1\K=XE9NB9=2$9WR]A_LNJKUNA4]#<4<>C,9[D<),S (QKD!07*BLL4L4"U[\;"
MKI,PXIW_'I6"=3&"CV/!+!&QBHG4W(R.7RWNIRI2^Y)P]J8C4QQT"5^>_LQ7
MIQ0)=#1?NOCY6R'^\Q6JLOO/XQ@MHM^BEM_E<0OPF*'G4"59\ES[(?Q9R
M== U6^T.BM8D@O\_DA\64MF:2W\;=FPL ]-RW[2
ML,M_ZW>?-NH!)FN9[>Y@^Y.U3;O3VL%DF];31ETZV:9I]]MK#?N:*)=3+_ '
M,N-__=+ZI9!K]*9I6,1?!66,]Z"EV5;
ML (-AX[[$^OB!Z-+,4O796P\7D;[!X3)\H5KWLQUH&/1DK>&*:OV]#ECG,XD
MJT59SQ7 ]78^;3LWQJI+H];9E5J;U6V9K7($> KI
M;K#:;:HK-U7]?E4]GS:>S^=(Y3DQ^T%^H&5T)XDOS>].C@2HK?Z7=-ZFA:[R2W*
ML=@@)W>\@^93'1?U\5;_>"_:9GM]F77"!WN,9[>!ME'[#8[GJDWV@8SU/I!G
MHD);5FMC;:*V<_9\2 /;[-5G5.TSNK";FTCV^GSV?CZUK^#(0U_+5_PK]43A
M!=![:@Q!3NS7/8]Q\;K6U\"[9V%*:81K^5M)IZEI6Z8:*[3/8%;G)KDCHKD.AO'$E6/Y$[\8FIPF%#]^G+J.$)+CC=<
MJM?<6-[5Z7#[UTD&]1E5^XPNK-83'.GU^>SQHJ.."SU%3X\>66)<8.?5C2.(
MSO8R<^/U5YOXVYM7D]AT!RINV->4?!J4?-%\0DIK3<0U$5=IX0#'3W2E'@LE
M;^LB_WGQ);NIX+GMF(AZEI6=5-H/;7J4(5(
M[L1OHNS#G%!]&W4Q1Q?T&-;?4W***J6RJ
MD-;,4C/+>3*+]>14@)-AENU$-[Q.'%@\_._(N_OK?\+_D6-I:_I7&B?>^)$O
MTPM&+(!C:)D=&HKO_C!Z_5=U$L\9:GN$9$E"HA'?> G,P%U.6G;916?I:IZZ
M"WM:\CH+-,91.#626V9H_;B-$7,CYL1L9+QHFVT#/N][86"$D7%AOWQE>(%A
M-VT+B&\Z^,DQKT3PP_#?S'\0TC[))^X@V$[ <,IMI?'C .<$_X2T/S"GG$;_5H#$<@ AGPF@ML\ASF3&$*?/-
MD./'VFE8W9<-6/085\-'9# @HDSJ.Y&:3@41&RZSO>-#;&
M,(&(>=-A&L7T//^3"U+-@4_.6!#C\$XP,F9AG$0L\2(^[I %;.S!\R[\G1@W
MC7#F'K)B$"#QPHOW7G(+_#9SXH0>O)0?0UF4\1]0*7QV"J\["4WW6Q@E\31,
MX>U?WW];S$P_!LLVF?@BVI0ZA >S#<".SQ^_#Z*Z'_WUL5MSZ#+;PH%E_H&%M>^F/[5.1R&
MU 'KN$KAH)KAWCK!1"I67"SE>4&I9#Z;..ZC$ F:3"+@C PVG?GA(X,'A53*
MPSP!Z3=GE+H._V]XZH5M]A0?20;"YUZTYGZ >9T;^JPK[EIYW=QN+T,C4#,G
M#.!E"2HIR9T7C1QB/!B0Z]!YD '!_:*GJ9JYX[2:FC(O=7UF,4S(
M<=TH9:/LZYC\"@,[21)YPY0,7/SL"GE]+5XWC8\P_HB!JN,#20:%G_%S8&'C
M^@FA<8Q045@U1&]6,_)&G?^E\6L((!\0$HQ."
M7\!]X]G:_Z\WOW0]<;_&HWHCY\U1 F#?OAP21D5MNNC&X>*,G#F+U?&B
M$H\#EZGE1VXK+N7ZCZO5E(9QOPH:L,K!4D*5[Z Z0&\TY[2,9MZ'D'.1D)/B
M_=6F-35T+-!TU$;N$Q01-+YWL49/$0@DXEY=(1/(E#"YOQ#Y^"E!G
M$S&2U@I:;DSN-^8+/YPPD5 ))=<=/@L@1[=49%?%
M"?R/>C8$?=?A1$D("+QA!&%BN/#0)(R(MP"9),%>C& "3F0X4U1QT823-!B_
M>K-P"P'!)V#3XHU9H4$SM]G+%2V^0N4:H$LW=-<[LYB]D?]X._+BF>\\OO$"
MVC%ZZ:WXH/ GX#<+%V[T0?ZS,*]!:-DV2D(9NB4^+(QODXSOPATB_ZT#/_87
M_]PTK86_+1MV8/;LWI-&7?[%=J==SW4'(K*@V7:+&MJT%KQ/7<4H;U]P-SQ[%\E\8U^0U/^,M>%FV!75,
M_5I!:^<>UWC\88O/CHBO?%AB3O*;E:!WJVE/SL6/+*4_(FE22>
M1]45/-TGMG78Y=D>81+K$=:@N!K=.8&+ER]X10,?G8@8I#.K1V%O7 NG3J3?
M^Q'5!4,J?D2;]P>JCVC?7'28]G%'*,V/T'UVPWR?8BXG+&"1XU/DC#.:>H$7
M)Q$%GI]9R[)6UVS61>[J,ZK/Z+GWEWW;LM_6QU0?4Y76>UB#70OO$D-'VK ^G@V.9U 7GGRBE<]/N%FB"Q3E>J7VXF;&7 _,?O<6
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MJ]=YID6ZA3TZL%%3QO)V>F,8;)O'/_>>8Q_>9WO
M4>T%E_H&%M>^^ 2.LM,XC5C6;+U\IU6KE!]9JY3K7*N48]R$]99<[ YCR+GK
MLUKH!=G7=+''NQY@FL3=B
MU! ^C0PWC0$26(2-XY/(<7FC=VPK3WN!F&H01%#?>-$;OH'>!#\=\30YW"=9
M@<^ K^#+W[R?+ D#8^RXGN\EC\8L\N"1)*1?W7 *P[C4FEYVL?_;U>'!&OTEC L,++:;;V]^_8LSG;V]HO^TWK[*6.Z> ;N]P*K_BNR VICC
MWB+-<[+#@8G@Y-"_=D2;U23$8F7O3UEE
M[ZN2RMY'MAD;+7VNJ#G","@[,:*;9;84F0&X68.7B['-R(TL:(XP')&X^!DE
M3 1ZW[!9PJ9#($:[:;6-V/%AR61F&<,P!/B.#<<8IX$KYWWSQ^_BJ3N0)%-F
M@.AD$1=)V7L-SF5/G9D29%P+!FEUZ\UBF@P?$AZ#(1T#.1@W^1(WW!@Z($KG
M&:IRA+(I?(L*N==:A=P_5(7<[_,50!/ 7X)@X/0B L5@P5KF$:QE#"0
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MKOF4G>MWS'ZV<]EZG[1_+WKM3/-LE.W9P+2VNV=9#2
M^ZA7OTJ-U%)0% 0206"09"4=A*5D"OI!>UX]6+ ^^2(WL&)I^L%_HKDI)="8
MC<@]@A*"J[Z.[X?WW"T'$J:MN]PR<8:OLO&8N22'X@0%%DDM+M&XWFR9=DZ'
MX(]I4Y6\R95LM;052VJN6!+_3-F"G(GC!8 )_ F41B,V9A&I7_ 9(<>EJ8K.
M3.$MY<)6\P*)GW\.DB+C6TKV@+1[W#=:,4S@XG[(#U# N!
MJ:9!Q-QP$I"YK.]>_O0B=L-LWV (:KV$>(K=4&_@
M=S+ 05LG3OV$H\2+KNX)+QD./A<\R>1JP#2ZYF#%V""18YQ=B"^20,0P[14O
MS-6DN7^#4POH1W_$+*
MZC6$VIMHK(R"Q&=$A?#761J!G<$UZZ[=Z'?:DK;PB@V%39J ?AU0=,,-S E^
M>0?_"#" X9NBRANB2@RJ0(GG\O.F@4@N#D"2=@8-PVT4WN&J20L]L
MP(F;3>WSYHGK#!FA%.@-%=\9J)P/=%T(*O&+KN:2Y]BPA'!@>Y/(@U^D<-3Q
M:R0"O;BX7 %4#;P(IQN)$<,_(M? 0&#]Q4;PNLS8P5.-%V\J,%],X85X!4?V1#:/4B1X-NR'LS\626J(/$FBK
MT>^UGBZH&P;8N.(@7E@Y<%(J9>$5%="%O'+AO3+L%D)X5YO$M0\X:ESA]*=P
MO$(E +JX\.!Y!^ PBIR KJT4,-B=)N+CRE'01H4=8)'KZ7""-YU=.YM]@SOP
M @V#,N?E//ST3%'7.B.W'R6D.A:!/LN5G\7BI[##:N^Y'%DE5]?\_OKB5X@E
M>P#S:L_)W_?,%>+7DN+WI%E0:X/A;%5&ZW]];X (P-]L(AI;90;5'KP:POBM<:
M@Z8:4, 77:%,R;L(#WYS(E Y_LGI!52EJR!(R<29A5%21*UY)8^<( E@?>RX
M(F9!:.&M_,7-_H#V="$L?QAY:>?[_/ZKZ#W*G%-KY?O0R@7C9S0BC%7V;^1I>5+\;\-'&9BT7'GGC+H.8W*=OM63*:TG
M$?RYN=M.7@DC8DDU9R6_$^/\1% Y%CU?,PBDF[T%U@
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MWOC5FW4HZ%D5_I]4K'?=$F3U)"L]
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M:G-DO[/QQ<]&RS^.3GI_NG=TJ]0]>4LQ)3[/*%GRZ;:&F-HBRUIA+J-+]2S//I9;M4\'92@I9[>
M=CF8ST8[*)!\\].M>HV??8MQ_ +FB,3($YS@U;M$JTGNF$CN";[(FN1JDMOS
M%45-4/*_:WUQ3<'56;76>JD+7!%P3< 56;?7LIVKD-077%%R!5;=[3XVF
MK^_\\JL]M-U53_$04SR'ZCOO61!.L?60J+^3W(8IC#>*7QD7SO.*\%2E.DP]
MQAICG%ONTQ5,QIDP%5LMRLMK?2PNJ62V>V9)3A8U":K3,RI^2LU&RS[^.D"G
M?DJM1GM0\U+%3VG0Z-N=.M>I2H)WY/ET87(QG+OZ6(L8CS?_W6HW[%Y=2*+J
MI_04\5N?TB%4V>./'#OU4VHV+/N)J34GZ(RLQSBB,4[<06AGW36T=EL7GRE#
M/>M AF[#$;;7B9Y9M;O2#K)ZC/-V&+XKUS
M;1>VV>FL'[]9DUM-;L\SILSF\3N<:YH[)IIKFIVZ5-C^XC6X:[Q.HC[F7*^.
M.3A@F=LZO? ,26Y#1;0FMYKO'5]?(]5CU-=(
M)==(O&K4A_&8N8D1CI^1%]V@JR<]?*B^@3K+,;9Z ]6J./_4UT]'[RBS3;N^
M?JI);I]K:YO-XV^U49/<,9&<;6XE=&:
MYFJ:V[,R>LB;3%)&7R>8E@'_._+N_OJ?\'_DIZ=.-/&"2_[*&PQ?$G_!+@M=
M^$\QA4NDF#<6OXW:ZB8.5NYA#_-?G5?&QS R1BQQ/#\V(N8[>!>0A(8C*M+.
MEZ)M&)1[@@_)G=_-U&G -UX"^^^NL9@O8<(,J[W;.2V=0:-2^V',EZ?[)B]V
M#KA)F.>4W&*IXX ZZ!#!C;W "5S/\6$R\(!HW)[F-&#.F\(7;V&#!")Y_SUPV'<*3+:MAV$V[V5 \ND[5:"\V
MK&:CVQDT8,GB4=,POH3\">^.&8SGH7F( VXX"6"A\%Y@.#A!+Z1_W]]Z[BW\
M!?MZ^D!3QJT#7W3=%'/1=G!B?_W/8?3ZK_/C>J/_^L6SNFZ_.^QV+;<_;H]9
MI^^.^G:OQ]K#@6LYCO5GQ_ZE9#(:TN-9>./'K8LPJT ?O=*[U\_>OU-OY"6/
M!AR7<>W,D+>-[RP.T\AE\=RJEV^)OCK1%]9JF9WM$__&+$9HZTVP@#X$0:;&"$,
M@UR,R9L-7# \3'-PB+]P#3C+;')Z9UQ@BY\LP;\D+ KH=R"))()5PVPP.]05
M[UQ__>>G]Y?6@&B'?S/[5H/6XK,[YN.F/#1<8!Z +L,UYY&AM9-0K!SHTAH_ZU_#CL+-ID.0^'#N^6 R.[@5W\+4P
M>D2P=0&4$-TVYY$CXJTA\STX7WYFM!?4R,L8AN%/1&K\^^!,()I"OP\( 3CIT[D/V")-9+'2._I2O$1\C*0YHS2AW^6G/HA#,F9& KN)I
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MLU&FT5\BPAE_NT).O1:LQO'N_=VF-3"-WX,1X_9 _A4NW>4R
M/"&JL6X$R4L#E1:??\5)3,SK+__1
MMZW>6SXA49G$B\4,8&KQ+.3Z)^P%5_6"Q^+DG2&HJ_@*+)EK@G'N&T3&.#5
M;GAZ CLU05%$8B>3-K@LNVFVU,* )\-T*"DQ$;5B94/RL%I\-#>Z'<1HQ"7+?'!C?N35^??_-
M%/P#ZT%EQ!4>S2&3ALD(+8PI?D2\7,1UP'M$M]@(PGO!EB.TI<(9DI*NV02P
MP:A-R9% "YX;A"#P'G8:-">?3X>KL4WE[[GZCM-&,[,@'& !'AIM_ 6;9+Z#EER^#P#,@RGGFOWI(
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MA$HGSMDD=^XXC8@G1EX,FF+LH>M'78E\:A0HT+"I5 '&E>?/#)D\<3MB@" 3*3
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M -$)$[B*MQ(!2D.A[+KB+=(8-;1U06PY'KH!\;Y-[8ZV*]R*&\&\/)\?6_LD=K =Q?U%0@V?<(,#MF%\B7B?1Y5)&&S1)?0Q]?8!;"S^.GIO\Q+G,BHGARS8%
M9A>"U8"21EG_W][]>BVT*D6J>0H5VU]"E*?L3)1!!+D;7]B-PG%8BA3(Z%67
M[*."KT!=D)\V/M(FN$([08GEC0BJN,^".Y&X&L-_$N$"GG JX/\*$[*08L;(L1L#><3C1^%NX_=FTM!$/\QTJ(ECO/#A%\!B9'+)B[LR
MM"-)WFF:/ZAT(VZ]D4]QF$C3% ,5>)!@,#EA,$+WO'N+6@M!'[R(A'@;G^/2?* A0M\( '(SZ&SHQ
MR&@L^2'D1/SJS0JIN5/^7F_SU PI+CL#+%1=, ;<=V8Q>R/_\1;0%#27QS=>
M0$/12V_SD8K(V84X<%HL_UDP?;]E-MO$]R([47Q80())/Q6"T_EOW8YI]UH+
M?VZ:UL+?E@UKM4W;ZCYIV.6?[+6>-NK2R>(>=-8:]KG%2!961QEL7-#D[1S-
M[ROY5M]4I!G?[QM ]R
M/&>C<4HL4&["YV+!NF4?*DAL W-PS&VM3_UXVNU-P&#[U=!/6C'X)%(3-G.@
M;PK-0H?+,MJ-49BBUUDN\&S5_.UO4+6YN=4W!T^KBKB]+:IX&<^:66IF$0Y1
MRVP=*[.4UWRJW/WRAAD!7Y5S]FI>73ZY^_7WO.P CZ/'9'IW'6Q7D:XE/@$_!V%PR;40E1U_3^ETF"'FC3%8-=&*,^"C
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M1;@A!7U43M'SH*"BAK?,.9S7L #_V'0F UAGD50^0,%P?Y(R]:*M22,EA48
MC&["-:T&C[U&N4.5-2@],^(9,*J,DRK@I"I7( 6W[4P,9E7I, 5/5LF3U1YI
M/OGO?&<33V5^WO-)AZY$Z*(C[UJ9=I#+A-32
M6)Y[]'9KMT=OW#!6L73T:[Z@&UK0)['20^:ETQ%5:X](B/W@9/25R.B0&S1D
M?GA_VB@R!!,U4QTXIN2J"'4U/L5R2[*P'5@%<7);6?3'M44[O?,-[#6G93W7I=OERW:C3B/:_!\4]5QO4J"%(JK$LE8K-4
M=ZJ6PGT4L@(J_JEOVIV7!BY]!VEOYY=TU:]4TM41Z.I_B*0ID.GJODZ-D)R9+?V0JOU
M81K##.)8IAA'O"]C0/&2U(^"VC6IAE%E(9/E+614@\D08Z&QU0QFML98^-]U
MTICI/0"H28"GWAABK+L*>L?T5I\BL'^RV] ?41+V'TQUS;@5+2YXWG<:\TR]
MXI;)MF64U-(2-LA93
MLLV"2-#]%*A6!]1PH;A?U!%KO4W3&KM1@SF/)DJ]*3?UP0_D)J*9[JHDZI3]0Y\[LG-R(P5-:JSRB
M%$'%E)?,D#6PG9CCP^ !'0Q-EAB.MQV2R^=]Q:C="@Z.C5-4Y
M70W88MY:@1JF8)X?FZJE:S.=:^YRY"G[V\S).LH-6+K<;[DTNMC!W/JL+R(Q
M$;($$%^0Q/E^88#3(]EDDG<51F BC-"ZD ,_6(V.U6VTNSW> #V6"'.-F4'&
ME9';.-5$?@^;DK
M5%2IB/P[F'_:UCZBFK'XC_FU8WD$Z@BHY[W2-/4.ZUK%$3V7D1=.R/:B=!_N
M>8?A.$7)I1U2V2KB6^:/,;,GRX&,RW(@C8N/'BA#7T+3:+5:EW9K8+?M5[(9
M$XH^X'K0HQ@U@\(WK]()-ION-$0B&*_/( 4 =F=*9S.??XAG)16[K6*3.3[K
M["WJJSS#'H[83CS?]APKS6@%(4!@.!X)?-'86;0GC:G#M&JHN.&,)&#.-[**
MF>_K37C$*"<@?TZRP7F#
M.$7G(^I05 ^ M(^LB6.N'SN /()_FL"AW6%?,1".V$_,#T66-(I6>9LL4N4DY_0O_P&*#K8
M_LB&48K:(F<(H"=\1O[1EG]7T+A;Q7\C'1U_<5
MD4*"W8X]7AU"O(*G_"54BMU5'KM_BTSCMS"*@/+>.??.D-TVC'^DOO,X=(S/
MGWD/P=]$RUOQ *P9^,KAFMFGP#6-"TS_8:)!'%^=F/9O[XQ?@3%F:I*$#X'Q
M0:@:VG0N*"2\E4Q$J1V4HID5/&$MZ;TZ"D<5
MA-18=#K<4"+K9_E:>$OK<"RD)JJ?O'R.*ZKQR";8^0_Q\\OO/WYWB+TN$U';
MP+D+J9WIA?.&\7(&K;YM?$?HB#4BY@+%H:5>
M@;+C&UWD>=!N*+=Y*OJ0A_0@5V&2^U!TEB4A\/)-F8"<9P.K;7S@G>6 R;%;(TC\;V :ER\%
M[=Q )[Y>L]D L%Y%A',RH4X3+DT3'IQ]FO"JN@1@)P=,=LP5?7"QP?4C%ZT:
MDI5(T<:I)'L;UXBU;'2'-:9$Q/DP*7$EBY'_^!_DP(4
MW1$L&P1:G_.
MZ%_P;UZ%H6BP<4^1D#AB)[C=(/X#_8OZAH PU F+V\*P-B_D=B[C%33$_.7:
M1L+@SBV%W'%D%C2 @,!T@?6$88!R03@$N4A3=0J%GU/,K"$_,B;M 5O>NVZ*
M,O<-Z'2ON$7$T &&6A6*G=CA90-7S@Q)=_@J:\0NW;WP-# U+'+D\8;-Y.^4
M>XDU,#!+7M:H
5XS8<-_43"EO]1KIA
MB=$^*G_X=\9K;L[7F:O^;?H9I,#XBF[$3<^GS0
M5S^!SP"',SDH8#:_XTF$C/*]J9>H)K_#1ZYRDP.75CG+URVN]!\97-PG1%6PWRWQU@%]A&KA"1 H]2WC1Q\5J
MAEA&7)4>]GUU;:JY85\NB!Y9UM1(%R/1Q;.5&B%CYU1FQ.L\Z1;J[PXXU[RT8I?/+'
M5^&]+:@R81DY*-/RYL,UGT!VE;7 6%M_=W,&7>EF\F+@5J/5[IGV0 C/&S9+
MQ V&F.>17\FNXM(OX1U?+SK$5K&IU.&5;Z]0<50%.5"Z1X!F.,7]N("1W$S0
M"/!:/'"C/:![X,DOQM$!HX"PNCHW;$!$@Y&8T\E7TD09BVH0H%89+]@I0_BIS[0%I#Q%,-H:+ @/$LY+ F=C$V
M;IT[C(=A@?0X9H96V4;.>Z1S=O%7=61E+\_?$P(C(6-PEV<1BM?9&;47^063
ML:U?8:NQ,VAMV_IE] ]>29'/1IR.\OD8@Y[9?EDP)Y4?=@-QL00-WNF1/ZCT
M^)(M&H+^ ;EB4'L5!R#&)X#0:'\RH[MX
MENNH!W(]V ID_;VFG5+WV%:G;*0B=DW"-^1B=NDJBC2GH>]-.!%0,YW'3(,AS6N5X.-Q?>03H^ -7EV8"%4H
M1]EXWKSGW\E1=X3W^ F8QZFB=FZNIR"O=)VM@0_*X%)\[][CG)#.0(DEU_4,
M/:*Y>V-@U_F=9C?7XF9PKE,EY04")D+=:2IU]=UDHNZS4I=
MUQW,X;(Y(0O%3[)"1M*RYLAT0(A+H0PE$GV+.:6&%W<*0 V*K,ANZ$2ZGJF".>'NA(W
MZSCY[XS<4J#PYHT)[,X4S<)(P-:<5M/0.C9$/#(D]B3ZT9V$OGP94W"7VULM
M')KW>UIK\/Q&%*Y((B?X*6ZE9DZ$%QB9-;U*OSEI>S;3W+IEFAOW3CA%*OB
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MW'J[S:(#Y__;BNN&ST +'+A_\QC=_%&/!#7W]=!TK*
MYU- LGB:%.^"P'!K3+!':< -  HB=J6*_Q58(JQV8R%0!@_:4ZA:6Z)SKK@#
MP. /#'0#$743Z*L
MW#)7I;[3?9=#'9?9@[PM]_GJ$*)PW;R],4\RQF3FF0@415N)8H?(XPCHY*53
M(Z7@R F *+JS8%KIA&EI7EP[D!\HI&7BQT3,IJ \'L02A8^.#[:WZMFF15C=
M@>4G,KKQ@YA2?&&]Q+G9+U_)U&4Y#J^G)_(6>-*;M.D(FZ>S,!"N%\1FF,LH
M=?DU.TH-6AI.0-[I3YX%><=-I*A+8Y6LH
M$WA0J3=60:?JE&(:*Z>]\FF(.F"@[04AC_V(B+]9%O$E,K["WU*\,#C*% :/(+ICS!=LFBS#'.D
MRJ_.3^.[-\) =##9J)Z"R!D/,-#NF_>3)>CV^7KKA0WI8<WKEK?I]K[L)E- QSE;7'NT&UVXE&QQ[/^5W%K7@BI*9ZVM&*
MG3^($E#-R$NK8=Q0RSCNT ,%G%QVF/J2;> W"J,X&BUJ90M+%'::;H6B+8!)
M:KTL8TDRF^:?>:/_^L6SNFZ_.^QV+;<_;H]9I^^.^G:OQ]K#@6LYCO5GI_/+
MP>'I$VR7T;LR#WJF!V.)\CWY;_364;S0'0_'_V\L_B/^^SW/]D[1TW,U#-/$
M^(VG GWWXI]'K9VO@HDLM8<:\,93!P,UT=T%W,0#ND1@72Y?YCL&3UKV\-*>
MR]RY.XESNM3\-8U62Q",
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M3N1F\FLOO/A.JNS
ME/I"9\+E2.T)_8TIA=!EB_0H(X.[8\5GT6>8!A1"-,JJ6/*;OWQ\Z?6MQ\:P
M-.:F9*Q]'8]!)\L2>/CO&?Z+W_G](U[5SR*/@I!"#"$*[WE8*ZR28H-'L
M#&5=6#IL6;J4 @@S8HU3>.B.ME^4JA6!:#,'BRA[LWQ"Q5.I0+P_%XY*E5A7
M,_-%F>';IZXS<48+_-%X7+NPGA8*AX 5[%"J%F?,5K"KU(@W"!G"[K?\WS+'$S9O+%
MGBR\@T'(8,G&MU+-EH*0_GN$J04)XQ6O<2L%Q?$;G\S\5MZD1HD;*9;L-.:5
M\ZS.2/Q7F6?)^$I&]YK?XU>(0O9EXE@6=BC'HN.\8+899K $EFLHC$1
M>?O+]D).?(8U0;,\K871"E@BCW99EAPEV\Q%C2*KHBW*E&(Q#)GDJ#D]0/+"
MT#,?RUF_$]739;);@)>KL'BJN4&SB1L;G"R6:.4YJG@7G5"N#TLP=PD+_:J5
MG+#@+G OE@I)W:0H<9?*O_6WVRG7$O"./"??*,8P5VQ^'#E3AE5L-<=7EFT/
M9Y\P(HH;!)Z0TJ2^1A,G\/[/R14^^0%<,+IW'OE;5,O9N+C^>O/U%2PCWQ*B
M&D)H3L!MK*W;(DDJR8]"+B.EW>_;$SCJ1X$,J[=\"$$C)HF1>;:HENYL2.#9&;Q(U"3]X7
M&0CIWE.R<2MT;IO&)F9^RUJC_"N/F"(# R.ELKW9C+:U=%G0,",JYT^9<:5F
M*@5!W6'<%SPH*G,)!8P2Y'BN@5"A'D'A^(FF/_D<"B\T-IOGCIRSO8K<
M5:A[S07KBG;P^@H)2S
M\;>K[S^,3Y\^[41R]UH5P4^K"?BI^9KFO%@RCX97$F#&KY0L==KMK#[E;MTD
MA#.U-:'<&NKG)VQ;%:*SH!ZH7K95O_%"ZQAVE)39[!Q*/B9*J(ESF*ASP*LK
MYI :G+DI76?&14RU/!W?HA  %W; ,HT/OBC'D_=V9@16IKT=)$ 5=[Y:^\C=
MQ)PSI6?L-[)WXEMO=M *N@LJEL#)/SQJM35EQ2 PS>P5G714$7[1JI%7N@"K
M$>^(104H^#8OEL3SF>>='7I1"OIF84)9_5/.U)+11L)5@$F%=HC;U['JAZ7F(;\C>J0"
M6LM*^PLF0KXT837<,_6IW& >$A.6Y)EK8THUR+,*#KYS#]_[X !CR2,RIEA.
M';WG@H47S(-*G:,UXU \!\V+>V'0P4(5?^);1OY%'$Q+YP;NJ)5CS^%1?/:"]9JUT_CG@VIM"5N[?V]Z?* &D;U
M;TR8)2Z*:L%AT =6LL^M$$T;I>010,BY'WFJH@3$T7E:PPK63Q^G>
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M"SV\FXA/L)("L&]710"V0 !*R"(IANHG0%FN15$]PV IJYR&
M^-\*)E:E\H;5!DS\IER96J+J1R82IFXPVKRL >2I UZIAW^ A-7#'3 J+T+9T?I)NMA)\\VF?^_AR3D"^M5Q;2+
M:[V>45F5IRT07@4I^'A)J+2$YGJU#3.=E_DQN^>U9X.RH+/ZT*MUZ!=VU7!C
M)U*O)I]=Q<^7 8(1R_,J"P\1?:%B*I:Q::_Z^IP/ Q.MJL&$U)1K2JD6I5!Z
ML+1B?,S'5>GTZ#:C&%Q4%,3Y\0FC=_B!L(*# UT1:(X>W<,SAQPB@9><<%B]
MJ63D=1Q'LMWUTBEB1R9L'P?[Q3!0,9]4GD2.2^4<5+!3&#WRFO.4RQEA3NF4
MIRJ70R+6/^!?Y=!6[T-7
M?_A?Q0M+MF1UMR.M*JU(T6,V'A'A*;Q)31S^['Q
MDE%1*%_P(JUB+TKSIOOQGL5NY,WFH_:74,DZ1-+$_?IEK[>O]B9
MQX:*<\*OKR+W%C2V^#4;39SH]V-"[ C#:S_QHP7
M3=-J9KUU7QE7JI'*IQC;)8/A>4/-XE2+58,[Q(N9G8_LB#),UZ87/SD_X2@+C)\:U:$G/)P%/??Y\;5PLMHK!7)1X
M#G1>:.NKDEZO>3KTK;;]>M0;]#J]SH@]M 1076DQ
M\=]E3#P&)E/3LX22+S\IQA^DMV_9#AQM0@GBDW
MK7;E@:+5/Q6@L&N@. &@X/^T>D0O@]=B17^V+NT'X*>N94O ^''K12.C%#;>
M/6(:_;,!PEX$$'.UR#/WHRR@\8CM5TMK'EK=1>@!6HY[*Y_JO:HX<'2:IP(<
MK1HX3@S:#I0.KCK..E?1U/OKGK'(Z7HTA
M?$6R!B$6U(:M15,K_S&P7E17;#Z]2.8=+P8\=;6F:S\BL&ES[6<.OI091\M4
M]?ZU0M_8[VL6>;[1XQ!8JT5[0[=VC6XG@&Y6NVTWVZ@6#=IVY_5=NS/H]9M_
M$LJ58IL&9/B?'(8:"NFH]L&*58
M_^V;,VG;"U!FN\L\2*A
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MJ2@W*29J2R?. MA9!T765'&V!C:MLP:;TU%R=A"W4X--E;KVE"7?XP
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M(QNU@,;2?4!^R#JU:"TELUI5*DHO[QA\X&O2!W$P>S
MI 9PC1B[Z%S;K&O:5=/EL9G'HSGH $ZT+@?]2S WVNV.F3P @7YF" 2: U5C
M__R%SGLV'*ZQ%-[,&[,S<6A@O\-:A@< DQ@OA/G
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MHY_&59K"$_H6JYNX'NZUW*_L2E\)!BE='<_%]Q'$;C\DJG+[Y@:.6SY.AZ+
M^[+?G,"9O7UV\GB$G[#RZJ,6E7F-0$4\INV6"2=JV>U023=#"X%TGI#,)N?,3=6/
MSD8^*OG>W!8 #0
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M^)_-KHN?G@6Q0'WBBV\IX[ :U&V5EB4W&75JD&Q3C!?GF#>
MJQ/,SSG!_)14A+J2YM'F,)7H"&VK:2
M8[103U Y1IU:4S@#;*SKDYXC-K9RV,@1K;T=;"3>/=N-WHMDV&JQL#G)T%Y=
M?H1[UMH"J,_VL,^F%9SW-M_Q,1:3GTTKITDK,MS&<5UWB\&%.G
M+KUVPEAI[S\]KL;*'6-ENU."E26%<;E*VM'==#T)#,>CC6X5'N>TT8486:B3
M2S!9X^3IXN3^DP5KG-PK3MHK<+([9[JWCP\L=^O5/S:PK$WWRL%LG7EY0I&V
M74K)MG+:Z(!@-NMI6X39G@#&KVX2$F(,C@]EK86E>Y^50F5U%B8B:,OKUO;Z
M*0-DG3EZV@!I-U< 9+^02ZKY-X\'(>UFC9!50L@3:O5EU^FLIX:0 UN4]?D3
MN333]4NJ5\17N3##/C._FPH :P0\71VQ[J=S
M2KY*:I?7YKO\YOK?-;3T.GJ/-;3U:GL!\
M['\Z,;7#KM6.LS/>ZGY;E71?;0-H6P_-KF5C4\T'GXRU!V>RPGC3R]'V:[MM
M4P!MU0!Z=@!:=QD[60!MHV;:)P"%3S+0*L/@86WO5[_V?NDHJD/2=JG:KCI5
M/W."^Z-JP]C=*=78LZU3VJ#75F^Z$,6[6LM*Q4N[E&;5E[TT9I
M-88] \-:=8YHY3!,!R",&+6MA1&C&/13VO;,/J*:1\O6>RKKJ&]0UC5=JP[^
M]CJ?/!+PK[MD5M*D?4;>JV5G=:HN>ST./N^]B+D):&?(F5_'8P^ P/@$7YX&
M6:.\)_3$[/5V$^F_L$P4!T+1-A,336NLV!M6[#][LU84=^?^HD8I33O72HIX
M%!CZ^M8))B#\ ZZ'A+Z&#<21[(&Y*0IS>)K )-Y"+Z?-^^C*#N!6UI/D8OBJ
MXI!P0ITN6_O/5ZPA8<=U,^Q<+3:A/WR8SOSPD?A_SO7%17)7IBD6KM^NXN"]$WC,-]Z9QKNP=%7]8&&PD/#\]
MZ1BOL6>OV%,GVYT0]I0X2/K-O.7#$83W#O12#.(
M>#(L04(9X%#Y[P__3KWD$1MWH_\4S*9O_B:HT]]1087UW2S51YU3NI*KTW%.
M''6L/.H V%PJY%&^VN\L3B+/310 X6W/'/Q<* C FQWTQ*"*\QMC5 ;[(V/Q
MJ[U U,+J!S5$G:(SN$YD.86+(VO0LNR.U6YU^EVK]WK4&_0ZO<$(?<*MO"F&
MH(* 1#A0BB(?E$_XAL').H@1FV'(%CW#\XU':H38,T+4/9!.2(DI<]MTFP6W
M#44I9S#P5%6BNR-KI_:Q5!,HZB#J4P"*YJ#3M%JM9A_^V>]W7M_C#WWV<&3-PYO]*F)+7>9G>9F?05WFYYS+_)R0I&W7H?XG)FG!
M;F^^ON]9=K_+):T,Y/*B.#%4JD!9Z=1FGR+2#RJ2%QK\V\B8Q 6N2)GL/%DJ
M=VJ-_QDX5+=;.@4(\ZJT::/2--W:;GA)"FI -YI]"!7-YW;I"*?-+[L>#>]STB9(3WPYCM
M&\3K*'#KNV\YRM9'P(_@H WC:V&S1V%3IS^64=:U5UU:L9
M /?(>S"N%RFU /)>X/'O1N'#(R\^0=HVQMU@90OL"V2UKQ;!R2SR?)&U85LU
MFNP73>J$AJ-%DTQ!T -SR%!N][+H8NRC!G\=%)77O-*6Y3G(PC.+0XP13I:/
MPE\&\(B8ZW&U[SONP'RT\FZ;J:W9HAQPL.*0=;"N,Y,2/TN'% )UI&QMW9S2'=HUU^\.Z_:=%
MU%BWUX*P=J$@[()("P*&3J$>[!)(;)1B8F-/H+C53D0[+_=:(]1S$*I.RS@A
MA.)%[.WNZXG+9CX#;%'-WD:1,TZ:G[CJ=)(3 KBRO+/.
M7+F@(JI]=9,PG_A5* T$^AIH3(Z .F^<3ICQ=<9P_L&D87S^?)WA74[3*@>^
MM>\P#UT]J.)ZU@FEOW9V$&L_]48CG]5(] PDTF&D6*']MW"4%4.VJ)O/'+*
M-@,_8F_$^[.ABONTCZ:-S2OA1ET<_)?RPFE:KV;8I3J?3;@]&5@X^"FY?R< K
M4*78J<3%QCOGWAFRVX;QC]1W'H<.JA -7NGK+\YT
M]O:]? (0 K:!OMO@H?*'2(11*^R(Z_8:B/8'1'51]G, (EN$8C^XO%G#VB"S
M2'?1D&63FZ,:,TX!,^H@XZ/%C#7# NU"6. "UT:612]\&T786+OEW(K+HFR+B^UM+Q4KUG8N+J\U%F5EZH%RI,%2LNL14I51FP>AM^),BDMY])J _.]MCHC_J_->;$6?L]@
MN?J^JOEG*+)!SE-Z_!BE:?')K7
MIG
?#0/)EIXF,J/-AV5D>KH;3JPK#P^G$?.X,':I%3&C&A;['+PW&BF%B
M608D-L91."7YMD94\]B+8;E+@IOQYI+[\BFS!,[CZU0_]7&@-&"7>D1T;O&]LV^=P.X8^$S0,4Q.V^
M!;,;KT_,/'AHZQ!+OT3*?=.S\^2\Z#9 J0R;HVXD-
M(X'X.!73G[O*<@Y8!4A$X
M??1*6HCP4QH!+^)5NXKT<V\T:)O]?NOEXFNCEPLO=WIF9[#XYZ9I+?QMV;!@*]C6>L,*Q66+2LK:
M>C3?P^WC-M+ 03"@N)*PD;^/63624)(0D;00$%Y'G8&$FE?*V5:^_B@^:;:#I\
M_^9+3/W3/D[%N!JCW?3\HQ' E1#/2^IZ/>
M=#KWU3,
M/'X(3%QJJ[ R'9;5,D2NRI+]EM1FC[W]GMQ N-D JMTB/TR_M^T;7%R97J-J-W_%I^?"-NOG;86R MEO-WOR")>G>,
M/DL&>8IFW/O#HE./)A1W[B3B#>'NNC'IXS]>7_T4KV0GYDV+P+<
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M>MU#=]LKX3<=++ZR8.E=O:O#%T'WWNEM\67\-YOMO0\?=UN;[P&=F.KO;'YG];>3NQ >W?GW=;&^M[F1NO/K?9Z^\W6^KO6[E[\Q7;L
MZWS.@9^A]B=91AIWR4O!54YO=5]=BE5%;G?'ZT>/5:N2RQ=Z7?VGJ_
MZX.%=Y*NE0]S266M]7XJJ>PM)&K=>>5NHKM^-"95,JCRMNC65*;?#Y>9?M]7
MF7ZG@C__+/K'/\JL=M\JLO7+^S?K.W^TMC9:_U6[VNNW3LL)GF?HG]O5#
M2D574!DLT4A*:"2UG$NH&89>8<(,]4A_V2A+<,3_@G&FNI565Q_'GCA?O%X_
M=464JJFS6VZEVK(<^>?<;/2^O<,?ONV3[5-WM/GM\UMUM'.TB?
M_K1-/Q]]./Z\]Y'NX[_I]I$EG_<^%#N?ML_V/VV>O2/MSOY%[ZQ]O$W;QUNX
M??3GT<[;??CY^"/:>=O^NK.Q1=KX(]P_ZAQM?_KS;:]L?_M<_>OP\\7
M/?3YTU^=[;=;=.?MW^?[>UNPO?&AL_-I'^WL[9^U/WTXVG[[3V?[T]_?M]\H
MN/_IK\'GO1[QV_N[3_4_?NOSF?<^6:.3HX^[VWA[;>QOQOK
M\9G;\//;SX<[>W\=Q>^X^+P7QV[O_>+^4DBR5OHV$>B
M@LL4DX_>EE$VR?]U$XVHHC:G/TZZ>O/)GLD:_@P(_DI^P#]T1Z>:/KN'W@]O
M?F19USAE4#P0*!".H!!U@>+YJ9XG.JMR!LZ[ETD^HWX;533OC3($6^T(UZ%T!L].&S]V>E]SWOC
MLX4'1A$>*N^-MX#'[K!GOQ[V.BDMY:CP8VO#A\(6P[R=/%N\T)4UB?)VDZ!:C1)YI !9M6N40;*5UUXV_'Z4.:?7B3C/U]FIM
MQ"EOR#C\<+8_^=:A_N9;.AWP^*HR>JIC6=8S3\O63F_D9N0R'90NTVO++I?I
M3N/K@^D:S;^D1R>AC.'O4_72,?K]UU%]][GJ*N6#X@_PU:1J>\GWWEUMUN"*
M,.]==?W8*ZZ?HG3]O$KO&TPMY?_;1'135T^9#Q4-B?E:P9#])J*\Z5
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M-W8[%8,JAN>M5,%HNFCP295-G ^AHJU,)D^(3"(5-(4)EM1=?^A!
M44%FK, :TH\?J^0KV^[Q9<&M,G_\(-%YD6+S1E0PN '?O2K?/ 9I@M4MH%@Q
M5GI0XB0]&/C!X'A4V3PME,DCN_&%DLUN_N1*[E2XO2PQ-O)]#N8KZLVA:><:
MH=S2)R>1*M-/I<>A*BNFUE=;.Y'+)L-9=!)K%J5_R9^EO6 P)KJ):I]2EF6C
M?K[+E(*O>VL=-6&X1+NE*!M42JT?_W]-9?CIVO'E)I"^?&0QCLEZ.K_@M[+R
MT>%P9)3]/"R6,OS%M"?%+^ZZ4^)-V
MI;*BK>!=VH]:@\L""AW]?3#9'N,$QL:7T:C]T[2!I1=B+T\[5W7,5 &&](Y)
M$88I63-^9-FIIG#:SVRHN$SU\5YG Q*U=.406$P_>IH
M&N-;=)PX7];K*TC":\T8L]Z=]JOO.P5OU<"M1A\'5P[
M5S?^TAM-ZC7M2>NT(FM7<4M:SV6[TD4=>SC]YDG?_)D^+G>[5XE$=2LRVC"1
M:I&DZ+>4&-J6I50B),:&MCY.S%@QB"L&MM,;C)YYLSY6V\IH-G2EFL>M^:8[
MIWHX^::%XKRL7I>^/!6&*:LXQP&.S2Z.2TU^K)U/NNQ2%+Q* OF[CXLWU=&\
M^A5I]:=E/3)MKM1@7Z8G2^WEEQVN6*/<@[NC&GN)@-(OEA,'U5*<^$+BK%<+
M0E\NR.]>?RUEAS^+N]]@9%RE@2N_?F[TG4\#7&W0E;TUK8FN%3"3';F2*G+,B>Y/*&9Q@>RX /W9J ,GI_V32.(+IE#!IIVU(^^&[9ZMCC?CK:=-7;2Q_(U/@Z'S_8>94Z
M<9KL_=2Q9$J5KJ;DB^J4FCD^--7T&FA[Z?Y)%ZQ&'J;)]IZ(9WJS+P?@]]C&
MU,CYV+
M*>=*!;;Q>>0LMM*K$5^+ ;:(/N,H11U1#5(TB^($QC9%'AC5/([//^U>UA:.
M38T&606G5TD$ODJ?FL+^3(,F;#>B@G*XXF!VW.@$YU(95:)FK%D6*KVGL!7^
MX=%-99KCM'4NM_]72W#_L3Y/AVGC:2I'NYR<*Z;-H/)\OTJ3?N3M
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MOHU<9:4/IRBWG(B;3L=W#TISUXE^W^J<2.IOGCUE OFU6C/*N5Z:U#MWGZN:0L?D$S&[K2_8G[:>K&=131K
MB^%XEAM/'XM!^,^$T-=3 =[1AMX9K_$_1W[JC?'1\9X^:ZV7^V]#^OMC6[*T
M N,LF\K?68735N?1B-P8:Z^N/Y!==$;B)N?L<;!&8N5[W+E;_Z*;I^I*F=.MR6]6368@O_(LBNBHNWQ^MD,/T^VKMZ2O^LG*3[W6G26=\R+"@
M/:NMK6[2GW%=EX?JKZ95X92/6,<]O=-9V#Y]$-\R&/[H6UY-%VH.D1IB\^/V
MWB]!%D8C./7%L>V^=#;]B\++?H^9?-E&C.GUN#=(DNEK$J/?XR,3ETL)^BR:R2/,[/OXY/8EOK$3^L')UI=)517ENV1U)FK$JJH(7
MOJ?@A47/'5LAR7V9]'6O7_XJ60!V!,8DV_H#GQP B\:BF#C"XI@GQ9A^<]R+
M#QEU/HY&MV3M*=TTWY"Q2KPR2I?'DV,-&$>W7(Z56/]6;7W=: J4_YAXFLNO
MBNWHC;>?V(YO"GQ:F?23"+5+EW%Y,!SUY: * QF]W+_BC:RV_&F )7=FR0*3'H\[N1KI
M:K;?$S_+:?Q7Z4(95N;9R'74T?9K&5RW>%PFSPF59IWJ7GQ(0GA_>D$M8J'2
M*5PN2MTIM6\Z"#:]WM?*U7YZ8&2MNA=2SA3>^,/B*^2JXO515IH21V6
M1Y=3ZVLLQ:X>=53S>_4P8+P22DHH$7H%+ O99>KH&)F
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MO_UZ[3B5@U*.1!SIGJYK^/T;>_]S=I'F[0=V[E_].'P
M\X9E^\KZR]C[/@OR?CZK 7.?5-+X7)#%KOWKV?
MS?DV?[[\.*OH_E?0NU[E#T1I'G^)9E_/BWZM!^
MD1@9FYY1=,;M'4.(;YHP6959:V]P?SI_[$5][.6)/%Y+RH24,O"QI6%M0Z=^
M7E/AY@G;'ZMMT\G7_UA_M]Y^L]G:_??FYH*TZX_4Q%^22Z$Z 4JAZV^M/&/DS">=6TA//RAI59IL^7;U!HX9D-'7S48@OU[H@WZO/Z[N[T[GR+)(BW70&/-Q)W98N?3?M-
M8/,"1_.A$R_>L[YGLK;#S+ :LILVFE?X6
MJX(U'BDI$T\9595^2$'1WW3G2L[1J^K]1@, 6T^")?YUISY.]ZV?GMJLSHU.
M#_[L5U>A6J?=HCH[.!VXE:N'"5XH(@C$02)$I1.26:NYU-AR1P)67[8NSQ"<
MM\6Q[@S^WPI@XQ.%TP$XT/KD=5I+ZUV7_MJ\7$A_ZJ*?(I']QB3(.L(I#E/\
M)'_LDX>]K?') ]G9^\H^'_]SO/-V^ZR]MPG;J830QOY9_*[O^WM?S[:/M^#.
MQD?-_Z&J8S2_J?M\_V+V#[\\>SST9^=]M%'W'XS
M6Q[I '\^LF?;9?FB]M?VQM_H\]OVX?[%7T?MC8/XNS^/MS_%S^WMP_]<_#W<
MWAV51SK:A-L77[\X904SG #L'044$@\DM0@P1BA)\RBH6EE#BJQ.*AJ-%\(U
MN\1M^&T)"-0IY#(3/5LFPD12R+&1S F*F%?0*Z%Q7-::*&)-R43PMDRT/GRC
M^_T4W%3R46:A95GH_"H+$>&<3:CWG&.2T"I4$!IJD&@
MDFN"@C")>+!:17?EG1]@_[[4STU-\8S5NM1"QFJ=6)T1"9J; !WD0#(4L2HM
M!$H0#+R/\Z6EA,[:$JN\05A]:5Z@K6Y*&M%+N>=OI0UN:GD];;ZI2QN,1_L\
MTDSFEZ7X97]."V@BN#:0(N5!\@F;&+.@7&4 6NLU(%B'Q1?64MY$QJ$S9?F'YBD
M_["]094&O6>+\NY5>85J,@_@ !8@+'>='<.Y_.%-"J:A!*7YJ_H%S[EW?,K^8,R\;)
M?0F#]RE3;>$V4^;8@5_ONG(>JI1MV5]Y&P(ZF),)5G.$F++ 2>O3H:8$VB -
ML I6FQ \)')E3=[=79G="0U&;%TB(2/V'A [(QFP) )+G,(08/( 2@TD)QIP
M%+1A3#)NR,J:>+9.!J2:+A?V>L.4PNWN  %\QH;R#C2*VO1G*G-;%GFBLI3\3R\9%S7%LR0
M<7T77,^Z(Q 52A,)$+)16WCK@(:$@N U<8(+$92)N(:\ME"C>\?U0U^GG,KW
M,'H$2.]_35BRLON^GC% I;6DJ'EEESDOW84ZJS*9=/YQ)
M09&MIOOS2SDJYLG76WMAF7Z*YA*B7$ECH
M&:!2"&#BS@.P(LHS10TW?&6-W?T8)'LX&HS5^CP<&:LU8G7[*E99D,0J2X&W
MD@)*+0-21M3R0'E@W"HF2=0?=[7B;$GE=-RF,2]
MJX3Q%%063[O7M=GHN0WKG,TI!.R$@LHBH&6*V4:8 R.(!I8@C+$,BCJXLH;O
M[E'-@1(-QFE="B'CM#:@&-52+:ME3?L/LC5R?U\
MK5YX&;9)?3Z$:NBWRL),>_ILPD"9<)8CG(LIE1!_=W#QA2-$*"("0"]QNOWE
M@$*( \:P,DBQ@ A?6:-HE3;(/,ENA*:JA S5&J&Z?16J"DEM(5$@3DR$*E(<
M*!XPD)Q1SY12. 4]/\L[%\V6!M5%BTZO>P!2;;Y\U>)![V!FCV5]FF#DL81!
M(V$5P 8[0+E/F9NX!9PCIAR1"CJ:3A9R[,%S!FFM5S S2.M3 R/W'G&6$F(
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M#%#NTJU5,PWQR+4)I8Z_G26G#ZF"7D_FH7UR21D>KH5/;$YJ60=AH$+
M#S 5+E6_=4#%N0."0^\4(E1I6DJE)@4HY"BBIDF+C-S[1^Y\.A/DHRD#X@1%
M(T<9#J14"%CF-#,(&ALG:PVC1L7_O32/TE0QN%;O>[J6U&O9TT%LD>\/2O?2
MX/3DI%/$?^4;2O>J*Z9F8B=.Q%[OS7@:HOVS.YZ$3$M+T=+6?$8TRH1%!D8K
M1]&41T%+()EF@'/K3!#:<4M3SO=\4>DY([8./9$1>T^(G1$2SAF'A=4@DJL"
M5) R X$&B%/, \$>,5E+B')V4-S]6O.H&8E<;.T_-LX=R*F.93IU&#L-;> FR4!]0&%Z5$"I%C&A+N
M").>KZP12'(]VF>-VKK./3)J[P6UL[E1%),<6P.P3P<>G#.@$,> ,$IAY%K$
M+5Y9PY*LX@:A]J4Y)L;Q8,KKK4AD9W36@
M>S:T4A-A>7# 2:@!Y=$84(02P$1 P0=%8;I"2W@-$'[O)BG8
MLO?A8:1%'/"].-[)U,FTLQSMS"<>\T^UT\(F=,I5
MV"!TOH@[Z>][@V'?#XM^&0G<.O2Z,SPL(QDZ1? MX[L^%,-6S\2VZC0A.93A
M@9*S7IV9C3@-7>_^J.8C%:.Q&Y"C4K/60.<&BJDLA8?D LS^@.3ZP(7#&0 J !]4@!Z8D!1"$,
M.;%4"A.Q3&"N"?/@NL-W!PF!8X%QUT./EV'>U%@69IJ!JKG(1%03$>'Y@G)$
M"@\#BBL(!T IP\ 82P!AD 2+/74AW0NK(6@R>R<:#-\:2\5D^-XG?&A'^B_5\WZ*)]RTR^]R6?."2QJG1!(14W9(BQX!1P0,D*&9$!AA@JC/'\HV+9XW;![EQD7%[!]S.5J\7
M6AMA&:#$D?@'Y$"E>M+<28ZD$,)Q4^+V&=ZY:+9HF*TZEYT/#WZZD2V5&CAG
M/LNF)QYAFV*]:>" &JF!@=@#88- 6,C M$CA5]G1\*RA6NOA189J/5"=O99A
MI(2.$&"QA2!=PP0:>P,8HTY:#^.FKB-4ZRN5E'T*2UW'R-4<@FN]?9%@_U/V+#.NE83U[
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M[VNQR_$L-4Y:52[7][J_T]\=ZJ%W_Z2677[W2-K#S)V^=[>Q]C'W?/V]?'-#M@R_,&((42J6-H0]?ES6;D)1$6*/
M7Q2U]F?4F9P&E[PRQUE7N(>6;YFAL:B6'FUW\F7N_/56A'QL4G&BDR9JO3D]
M/NW$'[_YUB5?[59\%5>1;Q6#P>G4XL@A'K.BU7&CK(I_0$MI"$Y2RQ(E*ZV,
M]YC?U%]ZE9A+-EYIA5[_6 _CMYP-7X?BS#MPX?N]['A9CIVGKY['?MGS+Y)K
M8[B/UI8S-*I9*H'6AH XB0IR#[&$.E5RC2H._]Z@2(\+)F><<4VI
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M4^T*2K21B@N,:&T;?(Z*;#!\E[I,7"](1@]
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M1CBC.#6<&QA18P*@S'(@*0X &Y<Z?H-6TJ-A4$S%2BQ7@ME
M.'-<",L@]C(+YP?#YXQPA@(RJJ4 S*N4>$L+H(V0@#@>HK%#@Z>A:?BL,S;U
M*=1,WCRS?E#J!:M/BG1OOQ?;=ZF(<[3IO=_.7X^CE+Y+=][KPFUUWU03D?EG
M:X_/*:$]-\ KJE+BOP 42554M'9"B2 \C/H 4;@J&F2Z9]=:4^_;9Z#6
M!=09H>!8T)!&9: 9BD+!80VTC4(^RGIC/4=.I! 3R>Y>WJAY+K8GHQ36[2CL
MT[OQ7A_OW/%Q.2IFI],WTE&R5
M,_*N-QBT_7 G[.FS3%/+T=1\[D#AJ9(XJHI@(4X%U0A03!,@G)48!2:0(,DC
MRAIDYV1_1&/]$1F^]PS?697A)>?*0.!N^2/ZKT<V>^4N3-S9X-]
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MUO_&O[=C8W=;.GZV=]YL?UO>VXAM:Z^V-V.KM]Q\V_[W9WMWZ9[.U
MU8[_WFQ()WXINJWXV$X$V^!5RY]9GWCUL"(&=WFAMQ590/]Z3:-O3H'5#>:2
M7R]!7W)Z['!'GPS\Z_$/O[MB<-+1YZ^+;MGL\D._CYXU8HI%ZGFU?&EFCZI>$VB50'GMRW 57?O:CQZ+\"J2]%:/_?%K$M_N
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M7[?WMF#[4WS>T0%K[WV$;;Q)/^]9O+-AS[;?3#Q,IC^/M]/GJ7D4?JT^;WT2!WOTYV-
MPZ/VQ=^P_3;VXNAKZM?Y?R[&WJ7-X?;1)MR^^/J%:"6$2.7GO6* *J6!E%(#
M#@V$S+$ J5E90YS4YF!Z0N[U3$U-ZML2U"0Y\881+336U!AON+546R=2^DB'
M2$E-<$Q--_!T9VIZ &HZOTI-3C!LH,2 "IYJU:M(4E0(H AD6 GCA=.1FAAJ
M5,3Y<[E9>T-0?NSK;G%Z_%PNT]9/11PSJ+E'4 1*H2$*0]D@:MK&%\]^#Y?+VVN5#6D@5N
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M*4MLM&]6UI DM44 YX.R9X7VV@_*,MIK1/M,UBW#O7/:1$N!&!X-AY236JL
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M[7@TIGBTG"2R*VLXAV8\9]#>0SAP!FV=H)U1' A!P:4B %*O =WU*&9XB/;4[+KK%8%C%@=Y!
M7;R(0^':U<5H3MY6,Q+I:OW*?&3&NA5C7:F"0B?"5!H,X;Q9P
MHQS&GDCB4./@F[T8Z\>]V-0+7>*R%U*Q$MT]*%(% 3T8^.S->'"],3TC.V%K
M,A_KY71DHEJ.J."2=AP(#%*;2$,>$)7%F3V9WQG%%;
MN\S(J*T9M3/R EH7+),<>!ED1"UC*64L H((JN*$66:CO.#/T9]Q??AH^>^B
MZWQW^!JH^6H]CWMU]<27!X?Q,>&7K^\PQK_MK[5]^[4YALI#WY0,NS'
M83_MQT%[4\W+2IJ88SV,WW_W,F4M1UEH3F@8*@2)^@(H8U+(
MNPA QCT&8(ZCWF 0^I2"I:RQC7]OD%&4?1I-%QN+<9SQNB1>9R2&0L@C&"4&
MM48EO#H@12# >\JQ]-9#2%;68&TQ&@UR8%20@PV/ MT9'OI^RU<>NU>MKK]=
M+.B+,'!JUP[EX.^<^.0V[1YL=6WO>.P\;?MA5A'UL!*>5Q&<&R$8!BQP!"B,
MAH\R-/Y! ]*:L6!Y?2HBNRR:B^@:5,0@]C?^M"RT,X27A/!L]*M<;9.MF
M21(B1I>#C:O6YO
M(DHB*DYZ7=\=#E)@1M5A5N%U$"I*G46W[7[-KI+G /;[\Y5D
ML#\VV&<43PA:&9I,&I9J\A#M@0K* 6F%H898&QA=64--P7J^X[(5<=KW@^&<
M9LD76A[&O3*>@!$_;7B3:6A)&F+SMU=H<%3!  C2 E#G$="680"5C5-#G!V.,QRT;C*:A)@&Q0D#+
M^-#K^Y%Z: WUV2T3G.>SX'M0%N,CX'%YT*)[&L=O=$;O>M]>FKK-
MLV%?QRDHNKI_OC7TQX-VKYM:V>^5%_XSX=V.\.9SDV**C. NY?]*Q$VFB^;0Q8P^8I$N9#1H@,9Y*"21P@JF5#7R/4[.F7.]+0<
M/%\UPU:($(U@JNCTXNE
ME#D]/NW<-=?ZTS6E'E.I3&9I-TW2QGB.*G+;'>JA+T^TCT]BVS+/+<=S\YE0
MD=9:".\!PS0=[ 05K:HR':H.SJ9C'2AR89=GCN':Q4C&\+UB>#8O*O:$(Y;\
M([TGQNIYD!A3H=19GC=[\:>
M#%JZT^E9G;*M#WNMOA\6282<7&J5PZA*JFBY/,\/?(Z9G0X%X
M0BWE('!. *4F,GRP @CBL9&(,\M%(XV5S/#WL!H\PMIY+P!"4L75@!W0R#,@
M!"0.4ANPI2MK%"T((VT0PS^T*_6QSW:G#93XF^->M_*@'O8ZSO?G;).?#_Z:*3%NA>[TVY/'>G5NE#8S-S+,?=\#FHK
MB5,4!A!L--ZRW3WH*?[F>[N
M@>YFHPT%M$0P"935"% I%%#.66 9)IQH*J2(=,=JJS7V4,?_XX:,5S8MJ:QN
ME\4-GC'581*[Y'JG26#.]O@NW_!(K7QAQL&)[T]L@G12\?K:DXHZCFH?\QFU
MWJ)N^A6@R*A&0O)V;@AP$"!-]@!R@4$1D,.+,3.P^"TH65%(U971H@&>>Z?
MAH;;*#HITN@NX5W/C4 7=?'9$>A]J[C1NLH4NA2%;L^G_'/$6X*@!=X&!FA
M'$B!+0C0:XVTEH)%':=6Q7P>L2=3V1;O1MAKE]#;">5>--BY!-S(O3!="SW"%+C>$(P>/]FR
M2-ZR;K)ES2=P"M :!;D #-&47XX$8*A%0*B@-,*(*2A3,,JK^%*#-JU\<;%^
MG-\UU"+CO$DXG\VSS;BC4C%@N8HXM]$V-A2%:"]KK@EAO*R:KEY)W"0+^44=
M%%_C9'RIMU<>58N,YF*.JC)+U4)H,('!0(),
M:?#AJSBQ#4)Z*4A^&Z:0X7$BH_*/JB6F_]O:U2Q'-WOQ 9&($Q+W#GU+VY1D
M4G?/DV>KVQO&IT<$M&)CBHC"@[[NM$YT?Y@\8L-#/_ )G64LK4XI%T+1U5U;
MQ#<-QCE(!JO+=7TF?I:F.B/D1
M;6+S(I2O_1V8#I>_TUPBEV\;7N?-?G@Y7?KHS$<=$%T\,^
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MN^GD7-YR>\(AM#?M[).,7KMIYQJ3J:(Y%[/3]Y0NN).OVWCKHGUTLV1G(S[W[4>\/W:G[9UT/K]-;K/.47O#TNWCK>0Z
M.]K9.#R.W]W9_Y2>9UG[*'[N?,8%=_S/U\]'!S2V';8O#L[WC_Z&L82CV(IT([YU=IY^'*030O#J'9!#*5GJ_*GQQA
M98N.;W4OM7E4GMGO02O/TK1@6?I"#8V^R#,6J
M6%0!OE&K8L.?Q)50E(6 RX(>^K@7FW=1_N*YQ,T^!?4[/1'QYXY//Z0GI7:GCW.B.#!-)<(::)%N<-BX,4E-'=!*8.68L0+AE36Y(&WRDY?$&;OW
M)R$S=N\#NS/*4AOLH64TY3S7@"J#@30Z $$8J
M[_B>/O/9/;X;&]]_6+(0%QI0C RD<*HL0 J:@$PD@+N9+*&;NR
M1N**N0,%9>=#DY%;NVC(R+T7Y)Y/(??H[R^*:*ZICJM5> &H(Q 8%P3@!@HK
M#!+6I//T!?5X'@6X+\WS\*$L!YI.MUK&=WTHAJV33GQ@ZY>#J*D'OY8N"3]X
ME4Z[L@_B0<\U0FR0^Z.:E/=Q3M;M\%3W"]T96SN9FVZK*D:6$:$\<(;B
MR$V0 ..# G$J@XY_6,3HRAJ#=U(5V17QO(\T!K'#\:>,WP?4%B/\RN"-Q22
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M*=2N\4?/GW:/9^;#9&+ROK#Z"1(X#X^ )WS!KK
MRE(GSUB_/5,4-RQ6):.W!O3..($X=B+0X  3-N59IA1H1AG 05N-K'5&N<77
MW)Y\G&OSA<36Z.2HN$LTRA-V13.5IZR,L)^OD);#6YL+V48$HF3HU@O=&W;PPB4EC[H^RJ'>_98/*;4&)LZHQG;ZVN7C9TEB0O.:8ZX-JV7
M(EW#Y1A0J!70'$9C1TGNJ*/QYU3BCM\]J4?V5308OP_HJLCXO1-^9TO%:.4Y
MX@$$11"@G"&@ DH7ZIGD4"B(2+(9R+.-?GVJPF-R8[?OH^0X]57Z,/=-=VW\
MEM#O';?LZ2 VT/*FW7C#]G>X.7=\'VL4)=9+BLF5P0_5'/7]L->&/_N
M39J:3&S+$1M:($R8HCXXP"V1@!*L@%((1G:3VE'C)!&T'F++'I$& [G64)@,
MY(< \HQ"T7&>2% *8)(L#(2B0I%" DUI4,YX#TTJKKO J9D](XT(V3BI!'LI
M4'HI>Z0.>E^40>^/QEZ3".D765TB=6V>3>7^^Y@G''])*KT_F7ZDKM*DR=L5355
MFHQF*R4_V#%QG,K+!YFXEB0N,B=&4F82(10!2KA(7- *H+$7@%ENE40L",17
MUKA84*(HAXL\#Q@_I!K),*X)QC/Z0WCHA!844(TTH!9A8&"4(\0(KN-,6JW]
MREK VI2" B5'&#ND4/6!)V*CJ$%I2&R4Z.Y\&VHBL@PK@W&L[E+3#"6
M$@@T\090KC'0B$<8"R\9%8)AG2*Y[EXZL*'.#"R;KB7>W*0XX%V\%CP^"BJG"7L_FJ\_SC\.4D[H"7>M3Z8L<]=RW,462!#,.$8!$$4MH")*$*.)
M!4I$LL&4X0!=F8*UKFK+-T;*$W)VO&3TWT==XXS^^T+_C'*AR&*K- 28^HA^
MC"707#' -8LD0*QB*0:=+\JCTE#TCW3-N"'C5?@J0?5\^_U>7F+
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M3TI?;TN?O.FANI&3I:I:(NSG%S@!-G0-)
MGS&;S@C+BY?/NR1*AF[]7L4,W=JA.Z/&H9,L6 A32<0 :*19((WP0!/LK+-*
M&.%6UC!I%'2?F2J\KBBK\\
M*;^RQM&=!79.
M#GIZ'B"M745DD-X9I+-G@]C&V= ,*)K2RK)T2Y(%"#1%UFL;"'>V02!]$7Z(
MS3/?M\6@/,@H?0^M7NF5>'$9G)IRB%&:(CO5'(PGQV7N68I[MK_/I[06EA.%
M)! T6$"Y9,"XE'..!20)U3I@D?(YK)LM'78/=3\^[GLQ/#ST'=<*O7[+
M'Y]T>N?>MX;Z+-^Q>I0CC ^^HX?>[?7V]-FG-#>]3AK(/WO]1&HB6F'*_,H:
M;LJ5C>Q\:+ZLN#66(PD?ZV%LT]GP=2C.O ,7OM_+&+^U[V+[>WSFV1>+G1<&
MDE2<+Q49C4"7G$$0C->*<2H]Y2M1<4B,\.\YF.)1CC@&I029U.DJ1C%%N6#7
M(TF1G?!GT8TSD*Y8=*M3UW&CR;;&?>E37X.[@SB)4$\X_C W&JFX[Q$M"I E3= >6T!
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M'O@/>N@W0_ VAQ0NN$0T3>
M/:XG'\ UF =J=W)E'F@X#\Q>=%:2.$$UP!0:0(U00%(30,#$.D94D*F0&UY4
M2"F?S=V[H^QF.N=5R_B#HMM-?K1T)[I$4>N7=F_H6V3.)'CN/OXEV \322''
M1K(( <2\B@I(:,P8T401:[YL/0#I90Y;CL/F"]Q;8Z"$*$4VX@"HQPI$^]D"
M'.*D$>94E+#Y$3EQ0@0A&!134&J$5)10KIZQSU@==ZK+[=DIE(E^.R.?S
MWR%$(=(0 V9I)'*4LEHP%8 T2C#-I#)01")7?%769%P^E1/-S'J9]>98SWA$
MF*!00.4I#TY"P9EGPDCHHQYRE34*.8&9]9K$>C/R57)O2% *&"F2?'4<2*DT
MT,8KC^)4&N1KLD;S(>YK$KOD>J>FX^LI#?BXK7P11L3NZ\K)8
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MH%6&Q+4OPU5T[6L_>BQ"T;91MWKLC[^277OSS]V#K+^#X%\R^YBH?G
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M?EQ2K)(<2:?XRL=BI_+33KPFYTF_5&_(WI/K;P(98A@6GFGE*>'(!*$@V,??J%6D!"<
M!1*2E/Y*I*( @2350EA AA CFYB"]Z5Y5M[TCH][Z6M3[;-TP/-=]_LI(C"E
M#Z_.@?PH84>97GRF5'OVK5Q+=(P+"(VET?A.OA6GA+:2^JC6L5&DQH
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M7NXZ0O2\EY!4M2E9
M_BLAJ41N41J!D\E[5C;L:Y\K*"4R(]N$:"]V-=GM(2VEB4E]&GV]DJ_GBKAYVDBJ>__K:)LR0YI$:D[:HMK-J+
M=M5^LFK;('K"(@U"L6+ZK!NK:.S#".=6[>DNT9:UD]-)ZO_;>>5#UW;'[6K$
MU4@G))D-.['W\="?^/ZH^\UW=OIV<.H[?_]K,!I=7B_Z\:_5P0"(:6;^RRL?
MY3\I?'230B/7J=MT@S5N7]F^N4JO>++5S/O$T]_=O@,P^0.I14/$+3F(
MKH4G+W0O]='68V!$UI\:0-X<;W1B&>H'7/7F:CONPZT9<"
M.:DI4[EA-&,9:)R:$86)NFY5\B0HGPQZ0("C(@MWC;QU[RIO7??3Z3ORZ6 7
MWK6=[7W[NO_K<^_SQ\^G>P7].]BY.NOMO#G_LU=ZZ =F#M^P>?.[N
M'KRCGSX>9I\_OO_RZ?0_O;V+K7P/KMW_^ E_NCC,=N>]=5\^Y3 C&&N,>#XY
M@7GT/K_9ZW[^>)COOK+9YX-M]OG+?[[L';R[^._%3NFIVQ[OPMAV+[X>.45%
M\$'%7ILREFJT2 >)D:#&;NX.9\%FY81G'PV"+%A$"4!XDDH0+9W.>,*YGEF8KY
M&*NJAMW"30LWMPTW01&+88966D>5]L:#E),KDUM*@\I)"S=W!C=[<]*-M4PZ
M!^),#L8AX#8T*(5T7+ &<$\X;<6>5:.//MS
M@DX05C%&">+Q!\TL"#J9#\@:+64FC::6/7M.,[:D?,6-&Y*UJ-.BSFU+.<0Y
MPG/KN>8@Y8A,:J6,-CDFFDB.12OEW)T-9[Y2CE(2F^!3.TH:$SPT@D\8"DS3
MC&2&,1]BI9Q6JVKQYL%(.;_>.;>5>;*^0@LO<=:HSS#.:(VRY"VWB#E
MK"!9'BA3XMGS/.=+&HO=BYBS/'A&W5?7L/89[3/:9ZQ1NZLUCN>YI+&93QVN
M!J>7A]<^L$3WU>LN/'5XHHZ9+*-YX"IPF034-A+G;.][X<'VGE79"$(^5IAJA6$DF=!61P+&GLN!8VK&/>^A,O
M5+%Z^LVEXIR#(A $IIGQ,C,VXSG-%=98B9M7V6KI]U;H][Q!OQ?;1PZT \>X
M VU .425D4@%G"'/&=<:$Z-RU]+O$Z!?G@L+-!M8%E7Y6,572YKE6: >!\94
M2[]K0;][3?Y[L7N4N8P1ABTB)E>(4B^1QM8@%H0*6@O",6_I]PG0+^56D9Q(
MB;.<2A*T,R*PH+!0C&F5M_2['O0[PW\/CS(0D[G !L6^38ARC)$D*D<^LZ .
M>2&MHBW]/@'ZS3/!AT/E; 4A/3
M;@0B4@1$,^"S4L!ON3<8A&:,X7_/GC/Z^YVX6B)=7R*EDGEKO%4NSX \,XEI
M<#P0K8T/RM*6R:X%\4Z=[[OG<=Y'L9Z_]@X8K-(8468
M,%20,U.JJS_:C*$A7L+^:06/
MU>#9X8QW;/_5]I'-M+8F,$1RX1 -0B#-+4.&.V*<(U*;U5GGVB8TZTO7*_>.
M79.N6_J]&?W.6.>^'CDGE?,\0SZU8'! OTIPC3#EN2(T(RKC,14R;VGW\=+N
MRCUC+4^^2YK>F^')NT=<*4^ @)&S)(]9/P;)7 .!)YUM]G8RM"=ZY($:G1]VQC[],PC!#Y]8^ME-4ME7X'G[64[[>W]6
M;HO;ZKOW?MP=+L&M%JYN!%>?9M/1#MX=>4P9Q2Y#(#<"6FD9,]'R# EN7,ZH
MBT)'K,R\6$OL(1?T>>1D?.]^MNL2;ZM$K(:HFUZX@T\@@G@OE<-(&@Q$G0N&
MI"8$.0W[RR@(#5JTT7M/@+IOQQ/74O>=4O=,!MO!\9$12@L2/")*&D2#-DC!
MUB)&\BQW>?3(L):ZGP!UWXX_KJ7NNZ7N)N_^LG44@I$XUQQQ)3VB%'XH+X#$
MB6&&68NI::G[P5+W313L%7CL6@7[SNEY?Z;>R\Z1(R(G3(($SJE&%!@W<&NN
M$0)'.64R)Q8AABW
M.:*,4B0],&O,@N>98U@'F;IJ+/8HO,^:K[^;0_
?M"1_\A$&*\^=2]LRT_&\2/6-S>'[WKTH-N1M#Z:WY\>'
MZVX_YP%O#[@C6NPEO<.%^.- _6E%F) AP$$S6^#@\"@/*C"16R2(
MY  '1""MG  )PL')G8PL'#P$.9J2#KT<^)T;1V$H]LQI1X =(
M6Y.A7 B?(9HR!
M=& "!;(G)CZ1\#KHKM\CG/C91X!@!81,D$O.O)5"6
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M/G^VA%?GN%:Y-2C/8T-NJBC20><(-!6<\< XB_6^< NO=QBNVR)HBZ!S"&H
M/*EG06 ;*#98*6XPT9QH$NT+N$70NT\YKAQX@FL1!=3,&0P(ZG-DF"0HUX3Z
MS'G-@V\%U!9!6P2]7P3-,Y/C#(0;H$M,K/:Y4@*(5X78>T"U"'KW6=HE@N+,
M,\J-0")C@*!,"J2==2BGF0!,#510^^RY9)M9"Z$MA+80NM*)WR1YC@CCN0/U
MD#J@31-B,6@@5ZJYTR'C/\'0GY4,;<%T)3GN)9A::KT. L11CJ-"'QMI.ZR1
MXX1G.C>9$.39ZM6#6@MDZ3?PF\B#+A2=&ZH -5<1)JX1T/C><
M9UQ*VLJ#=V>3G,_2S^'$Y; 7R)N,(@H;@0S-'0(Y4/B8$QI^!=IV3[+=*Q=\5FI513M5 RJ-;5"58=2QC^XSV&>TS;O\9
M3R1R<;G4N.?'G6XJ%-1I6S]<)F@P*W*N,B*HX-3DRBC-' =U36E0$91,0=6X
M"JK&"Q('GQ$@'>;!)P="<6^I,@8!&<(EPPP:2@
MEAIIG%6>8IDKZY3.6@)>$P(^G"5@3C!GTG)$%#!?2@UH_\)QI)AT/&2!69VW
M!/P$"!B'8)02C(N@J#),.>Y"8F:"P1H%2QVBV&5( O,%.I6>JDR+S.EGS[%8%L764NFC
MH=(\EI#/7(9UQBE6V(0<1&?*B+9>LX!;-KL&U)LL596UZF+WR^[YWO$18X)H
M 0JNI\(#HZ4$*2PH7A*D,-M=8RLQ(:CF7F68D\XKD
MS%"/KY246T:[4D:[X- 6)D@0AC*0B'&.:*8#,C9@%+#F6M!,<>+6C].V%?TO
MK>@_"+$W^NF@7Q;K;ZOTWZXW[$8EAF!ZZ9M6]EB1['&^X"43E&N# = R2DS,
M?_'(R!!0R(,U3&!&A6MKAST!POY=+]FO$G9+P#P>W%D//#E
M# ?DJ02B#E@@XX-'-&Y\"8?^NYZSERG?$E>U)4<,]@QP
M5Z$@= [*,F5(22N1YCJ3'H0PXMOF-T^!L'_7T]82]GU;P>8]<-23X*TER D!
M$C>(5LAHXU%N,K" 9-RJ/WCF0NST8ODR[
MDO[:ZKO&7Q^+'6KEEM6 WL74>Q?MA(?DR '(2 *FOS'OWVZ3>DO0-27IWEJ0UK+BS3J,\UQ[!P6!(9L2CS&3.=^ J2^,@]?R[GOFJ3M'$F+Z-PQ.9(VDX@*ER%E"6Q;;C*KLI 9)YX]
M%YNL)><'1LXWJ4NW I_?7(&ZEK#OFK"_SA(VR[#T7CN$<\80-4PC*7V.-%"[
M]M(Y[G@D[!74L&MI>@U9],J\?:TTOBX47OO_SGK*U';DO?ZDO?MY.^UY'W'Y#WGXW-*:)H3
MX-+,@J[A&4?2$(4L,&RB!'7&^9:\GP!YWTX67TO>=TS>\_Z^G&O'K44J#[$^
MM8O-MYU$2D7O@#*8QPH-AGSRG=S%LM^^$0\KVG];5\^H[Y]()S3UG-0+O.D)11SS:4
M(HDQ0R:C!'-+N%UAF'Q+X&O,J5?@W6LY]7V8P^>3_?(02/(31GJGM4>.N8"HH 8II0PRNQS#D)M,NF!A2-/8L80D7GL< D4GTFJ/'8^P*:VQ/[XB7VE28"_2>PM4=^0
MJ.?<@L'E2CKI4!Z+B%',!8CK5"&!'<."2);+-@WPL1/TRBI_MMQ[?0A]+BW0
M C;C&,_#J%0(5#.)M# .>1^D9!IG7K1-NYX"L:\T/[ E]O4@]@4G(F-&.!DH
M]_38NX/!@?[Q,>[,H!>7\?5@F+9K >
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M-N1M#Z:WY\>'ZV_\+]F]KV!W!>C>SJ>'"_0 PV$HTM^!-3#&.
M,O?1U(B1S9E%5&*/0'(UR#**B=2&8K:Z&D=MT-/ZXL'*O8DM'CP(/)BO6)I)
MJV.R$B.Q1)+,#9(Y%8B3P+UDF>!9&_/\%/!@Y1['%@\>!![,93 *ZHU7E".;
M9011Z@A2PDB4F< D=2'0%=9 ;/%@??%@Y4[)%@\>!![8^9+'1GBC)>)8*T2U
MHDAEFB+0)J6RGDI&VK:F3P$/5N[9;/'@0>#!7(XDED9:QV"3M4SE3##2A'/D
M+*'64&.H;&L7/5@\N(D_9 7NSTLJ+]XN,K0(9
M1-1RAI3+*.+46VY/0/'ZY.B<=['>
MCS-U9S2:Z+[U'=UWG9)ZZA*N0S\:#[MV[%U1S35AP"A=6OP].(N73O,Q8;Y/
M)E;D/GVM*84\;MV2XM-M3-AM@F"^6+V54J9=;I$#C1@TH) AZ0A!W$HL<=QE
MT^9H/04JOYT6CBV5WP^5S_E%7>9#1H-"F&*"0. 52'G/D&>4&T9]#B3?4OD3
MH/+;Z>384OG]4/FTT
M=+PAE;?4?!-JOFCX*HMV;U+(H*S)4$ZH VIF%*E=]S+AGWG&%8I@2H@'G2 FA$%,^SX15PN1M?_6G0.6W
MT]BQI?)[LK#-EV;U%F3O5&C=2HRHL3G2WD=V;K"Q5DB,5U>:M:7S]:7SE2==
MMG+Y'=5][Z4^.'G1QO="*1W=21:P9#YX>HF,X?.2R)&TQ,SW>J6907C =G
M?\0%&PUZ75=_>26^_=0A>[OPMGSM_G:/"[0NP+]\96[B0E6&><)]P*#&&245
M#IR(0$3LQ.(D.=JY =['C'H_'+4E]5?=EWO6_N))GBN9,T0S8F(+7X9,+C@B
M0>;"&)$Q\1-K:D4U]R&1_%I:&4,IUE('
MSRG)G5/>*?M;"-XB]0V1>G?.4NZH,R9HI)D*@-2*(Z69C,.4Y9L@ZEL6NH3F2F0](Y19;S1TFU($L
M3;--T>)TB],M3C\TG+Y)9B3)-57,\Z"PHUH2J34GQ#ON.(65I)<#]24)D2UB
MKP"QO\XBMA "U!PND3(QZI?G-@86>"2"]IQKK0@#Q":2;O+?3V-L ;,%S"<&
MF#,BDQ0:X0&=*9$
M.66=LS[H5K"]%\2>#[2S+F14T("($!I180F2S %,]!M$V
MQ>C]+H>QBH=G2Y0X?%0]SIG>EBT.SCQ(Q^I,ZUG;!W2"=V^[MLN7#0:PP>IK94OIPQ&=S88=>/N_S&,74BZW_R?W[MN?%))&F6QUO@(
M$_&LNNMD.*WSD 4_Q#][[K\]&S?\ZLQ&FWCYK+/K]BEY_*6SN;
M^"H>D9;NY?;>P?O##YWMO>WW;SYU7NZ_?[MXL.YG:'O[!]L?.@?[,*B]#_M_
M[;S:.MA^U7F]L[>U]W)GZZ_.AP/X8!?&_^%F('#=XY!GS^Y]#3IXL]/Y<+B[
MN_7^4V?_=>?#SIN]G=<[+[?V#CI;+U_N'^X=[.R]Z;R%Y7FYLWV3A2B8P][D
M% 9F5Q"4/\O]7^A1=[0?M@#U)OUQ#,,'++/GQ<\#>-.+'H@']RT'7&Q5V4O=E_UNGNOWH$,L28IR$@>Q*6SB++#
MB7]VCV'P.:S \V^S\/<; DNS/\LOT%_ZS
M,QA&WMZIOBSD@?++?VQTOI]T[0F( [8W<3Y=J0OR&9520:>\9:,3JW:=%8L?
M1S0QHZ[KZN%YYQ D?!CMASC&."B@[9,XUC2PP;#8NFIXQM?,4B=
MF>K'=_T(1NE!;#D;>I!6X$7=?ERF&' - G[G>W=\TCGVL!2ZUSN/P_=G<3BZ
MAH%JU/'(P+UQ4H>;'Z8KEOYXL[7UMAK+)JSP<*SA6K@3%O##-+82T0S9Y%2VB''F.1$6R&L6Q\@ACV+2%#OVB/
MV )(Z@*%5T/N$L"I,0-0X'\F72!KH.0^B.T)V<8#^.NKATTL5ZVHC#@:34Z+
M8H> #'K"!IB)P),?.QXL 'C^N;[DZ*JX[#H)PGO'HT!
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MEO8P1+B=/O"$\6#8:M61M+\?$6Z#VZ
MP$K=5LP0E8)X;8,CU@B*O9",V""U(M1[+X)>'RBH=KM;"@_-O_>_)S&A\W(R
M&@_@L!57?)BIJE&5T0DD0BLY K8TZ[W%2) YOQ8LO-C&[
MQN8M\4Q$/Q+*-R5;4BL!!-#XA&?/ 2!O)_C@>B>NE%O/>GX\7>=B]>O%!JFU
M7>L5K/5FL:Y13XS$%I%;QRX14?D"XH[4!Z.VDT(=FHS2ZD>'F@,<')Y/"3,2
M%ER5U!C0< K5[>SD?-2U"1%\;0C;["1G74U[TV]@TX&B$[$:OSB6I#G #*LE9\-Y5%LMZ?)<[&Q\\#XG[T !V6--2K*J48M!I
M*T6U/F;).ANUW&.?+@/,'Y\,7,$5FD\[FPQ!7QSY\F%3&;9[=E:HF?'C[R<1
M\2.[MM'7O3G#W6%+YY\:QQ3UY&B6&*?!%)B33"@P&MC-OH\.%Y-)RXKDVN^W*2:7"G$3GAH&Y$6PK DNX56GEB@-'V4MIC#WXR
MFF@-6-BUT1QUPY5IHV#?RE?WQS$2HK8[-^SO6/PYZL!0XF+'B(:.&0R^IG%M
MI)=5+XE6F8*RJJ=M_'S9JD'!GZ=Z"&+P7.'/92E+4SHNRH$F4W*@HJ7 ^E/7_&%%6*>LTU7R2@
M[I)7!FV&Y49L=EY/_XCP:N/I3CPG"E]AXGO%P1@EVNA/;"^Z%.#XV^+VPW1*
MIE 2&ZN<5IU8]' 8+4B%Z<_X\??H3Z@<24F^@)G#D;+-(6TT_RB/:ZDT@YG?' #WE%Z,S;POG4)/!QA4K
M26ZZN)N=AML.D*&BQJ5 _"VB831WPNM._2P$Q1U/$@F<7Z"&RKXY?5,-/7$<
MS:UHGH5+;ND#ETZ\/>DL\3UE!Y\TJ\W.BVK0%N@9Q(5" OSF"]9P7*@[Y=RC
M57OHFS;8YFI'C;F_.]^[O5YB!"5FS4PC8=F@!+;S>629!<89N!OT%V#(
MG^A>B*)AX=:PT2>S,0N#->PM8P?S&%DY30#69QG)/,@9'_$EL4ES/O^X)E1,
M=:>ESUG":),D6\%^--]6'*;!=LJY++GQ5+OHAYD[@0] XNG#C3@7[1A%'%%"^YA#Y+IJT5W\;S;.F%(=%!1'$(T/R3!1RL!+X@U2Q$"\V_C2MO) H[_>#@>@PHW/8Z/=\5;?1<_R
M6=1'6Q:Q>[#[X\CA($DF&))6&40I-4@*[!!5ECF/E15*K@^+J'9SHY/V,Z%'
MO:,//$AL.K>S>FZ^FEL-X$-76$*UA:\*-3(9'3<[?WG Q9B&UNF>1F@HK2[Q
M,:? 1>!] 'N+#W718V>[A9&DGYQ\0QV'A>(0(]C&D.BD,9R4$0FE^'V23/-A
MTBL"K,J/2OPH\;<7!Y5,DQL1IIJ&W_<1=0"81H.(N;?L?4E/_*,[!B2SUPK-
M*!E8JJ:?Y/)!_QC]!)$
MGT5TQ1APM_]U.#D;V^1(^1"S"XK6!5EL78!I(9QVXZIT0S?YGI:-*3J,:\OP
MG-NGB#V;VDAZA4'FI'LV*I[>N'3^V2D>I.BY7A@SQK/73UUVTRDF@=A-K'<;
MTY2.F#PQNR8->TC3.U(,:?EPKQC>U)$YR]L*3^:4N4V=6Y7#&W%EP*IUE9\2<-;*K[\!J>XKXCE:R_R ]5(#J:Q QU?&"$*A^74
MP)-P/E',V<_5EYAG]W-FE>PB,?FCT!X*ZTBRW=21%[8[M)/3&.QDTS[T]CP1-[Q4)2\9'<:5OTHU:FT$M.*"77X:@RQ"5$RGT))A5E% %E"^N^#
M2<\5AFGK$S@5&7!E0!K,I( HP"J PD;0>937&OZ5;LP;+)26WDSR<^W9.-7#
MK_"@6*XFN4G25A6LIAGY7H2M?8S\JPJ?K!2.QD0:=Q3A+)=X1&IG_2!%5I]V
MQ^,Z%+9I 9P^NHP$@WF4<0FC,K*^5/RF^?/PR-,8-:G=-YT"M@>3437+I"WD^$HAA,T''0SIWEC/K#ATBIE
M_4E4[N<*E64Z\QA+9G (5&989I89QO+<>17RRRI*TGEF\\J;\11K=F(4$2BZ
M[^',IMH)[FT=O5^7+4/DR3&?;;+WZNOYWA>;[7WY=+YWL7U$&,4!$XLL+#JB
MSC&DO" H2$8]%8%HDCU[+C?)8LW(_UW6O7) ]J^]&4ZBQQ$V2W3^WBB+$6_]
MWYV]>.4T[V8X3^2VBFB>ALC5D *$7N=ISP<2-RXK9<3&^V:"B".,QD,\U*X.
MZ"U@R73=/_7H:^=_)D49KR3HI[ Z/;PT?#>>-WA^I SK9R++2R]C IK:.%-;
M7YI.A&Y]7F\0E?>K>/+THOGRM8KF6SM<7Q[H=Z6,F?3E*P(A$M^O:MT4\DM4
M&C>F'Y[I\Z1&)BJQ=AC-J#-1WZG607%1%7TS$+7R\XF,Y
MR2%,,J89]=R"Y0=8RZ@[K2ZBI^X/H.:D[(#D"3I"2J=-ZDXJ1962EXXKZ;_.
M"])U+L]F9_O'N"R=$A.&BH$T90+=KRQ^Y34^!J)5KZ]C\Z=U8.HB(G52 -+34;Z^.\[V+KS]VHV3^
M:N>(<  N@04RC') -:^0]-@AK$$[(L8QE8?UPK&T>><)Q](QWT\A\R^;VOIH
M6K3MHX[A])W#K\.8<'N_]7ZO]N2P:#6%_PX:Y>:^S\P@>),+ROM)Z.JT #()ET[+BK8%765 (:B
M$A-3"..@0"R?U :1H3[KNEY9!0E>L5&6_JLL^ 74%FE494)G%1%;5<1+[[65
M\2DB5K]\4^4DB?,]C3!T!@\:#4 B*WPC*<'C_,_.R>![#"W=*+T"Z6Q4F%P<
M@X/MO>W_EFY&N'4R[ ""'L-,V4>
MC430R"J*%S781Y5'[^<)K4Y7 M'=%WD1=ZQ"6/@+TL(@
M#G&)>RFE#EQA(8NEP]S %QO7K"(YO3QE
MAG6V7,&38IVRZ:.'\P=J9LC#**/#&>]WCJ-JVB\DZ;\7KZGL7,78FY?\8WHR
MRME$;\SY['OK-[KNL'#WZ$+O]E5R?6+]YC&++2[1Z66_YQY-N
MSY>J "SDS#+J?A_HUOJ8PYDVHJPK=\UC5X_C\O>79%)3<;*\QO3MF'_8C;I/
M,_.Z-(\,?=R^XK>"MI-1.2)U9W^#)CJTJ)3O =06"^=F"Q
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MG,H-&"T2Z*!"D>'"9738J?,51SO-1
M_+(O.^*$+\%L3P\X-ID, K.,G#;O*5[X?&YT\/+N;L-+M'EB@F
M!8
M.Y\MT!TE@Y>E#:;@9E%>>!WU>HG^7P?DS<*L^PI4^"*- ,5N6\\\';LF3N1F>G;S,-:__GHY
M,]NMXXCYTQX;A0-[Z@:HXI:*=1O$[.?X[Q28?\3F;G=WA9N* 2"J-+U!VLR[]0GKLR%'Z4".*7Z5D^PM)'U_?%@
MW)TQ:=5NK_C''!2 HO>VR$Q-=2+7*H&C: @V !S&K(,ZS>:251A9T63R7A-0
MDPX>ANB5/6;JN?3C=.AZQ.G<]LR=FKZ\;ZHEQ%WJ57"00DG
M1R*S@1,<4'"91Y2I@%1&#+*PM%I@1QE9J/1NG<\IYH(YK"@5L?./ITK@C J?
M9]D:E7,HM_V!:_M-2V4=QE4 Y-2Y%R.EN^-DR:QMK:6I[K0[3K)K,G\"7)U4
M+I_"]IJ:Q]:2[4P>E.5<"AZ]83D84J5F0M+=F$"*"W:LX5PTDJDZ/<9RW(5
MH5\:>@>]>L*P*MVBLFQZ07*D-6T,S4IOTR'-I#V-I[7CRLCK%.1:-Z*;JZ@[
M38&:G?N"<;_(VAH55NZ4BY!*$/TH*_ND(D3EO(:5Z[">S_%@X*Z8S,&R41=E
M^"JWY[3'#PPWVH#*,L3-<<>X]%[IZZXVKRP+E'I:5SV;BKI'.BU]U8:IN7/Q
MO=%^/;"@,BT)[+\?Q?F&HE55JN^P+-5W&08]FC"S)I$NTYRB3Z8T+:: W?=<:)RA9:.P$:1RM22
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MYI_X<9$U!C#FYTKK5\&W]3I,PTJ*PK/-<_LZNE7*-K)3)&EN8%':+QE3BO*
M@Q2V\7."*#JSE2TQ=I&OC&;N-JCD1^-*FFR6XHD\Q&_CPGF#N=)/DJ:)39-=V-0V&)2F>>0
MJN2 5'HV;O#6J1A=,3@WC72IY%KCSP=EMEESOU(,4T$;B\69JQKT)=O[9^/P
M-#A?Y%^U2#R-#*TAH"#=2T@G'H9&56L[]+IJ5ZH;R305*X@Y=)M%/\'4H*97
M5M"N$*QQ1W%8^_&=O2I(/1W;XF1>,I[TGD;;U-&:61'KVJES,NZ]6 P'2]K(
MSB9+50F.U6% Z4S5BE_:Q&GKZ_5=[9$I'59&,U5!F:P6\8K-5+' \BP7G*3AI4\*Y3)=9
M/$&UVEF21TQKF#-H+>:"U^=_JB5&DY(OCU9MGFO*]HT&5#'O*]6$3E5=*[/3
M8SX)6V4"+]! ;[YO4T@M.OJN-VUSE@RPC?Y-"<$V._]:O&J)QE-&")H;H
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MBDJA:0UA>-]3T;=IK]1:_5IJ<(F]4&:MNN7J19VK2L%9?FO^X?KJNIN,F:&?QRS3S\C,5=_C
MT?)8@41#11&,Z@3.'.^Y*(GQLMB BO$MC60H6L_5NS UGT\SL'?"XKB*LQ0I
M>)2JN2W@:SWNY6=T8Y9A31\YX]"XA*BF2S"M.U9)S9NP[8U:
MCNC&/,51]#:==2L?TG7X?@*IRA8Q&^.3&/"HX,95X^"%R1?3WK@!SVB&^LQU
MQAXT4CZ+G/MY6:!BD56QG$$,LI^>YIF;DK'DNJRJE'9'LR7]ID.J6A_,V O2
MF$IA[/)]KC3FRY#^,GZ\I'OO\D6I'"25;R^6'H@86![)OT>#1I66/RH;EL8;
M"A-3TSX JVA/_,PQJ*6E:$J)J% $N/VC.BV-%@\)-DLS)+QI"Z(;P()_]@Y0X?.4EI8/8\D5R=;
MO^[ &-Q@6-/#8%B4QJR*R)Q'+]8W#5I+LH9NC>8"[*8=_YH2ZW1?BD3P1B&-
M0B]97DYCT< V:Z*.J6+^>S&QR9DK6@R.IY>C:D6F[Z\K=L'8W1>@PT*SZ#;Y
M>S&DT3^CMZ2!;B7$-,26R>FDE 1L! $T.2O/[A3Z$W)/X;[*="]+VC=',-]+
ML43>J%W/7CM[:5F5>>;D%^=IV?E/%LA45J%?R\C1Q#UC/AB?GS6DJZ+^_1S;
M]647A9J^'_:K!VB7*0N. %F/ZT>B?,!C6WU<'"0Z7A4^W09HR\]0V4H]=1X )IZTKZ!;48O
M3*-U1!5G4[D@4UT5OU ([['MV=3'NBR"*&KM1;/7J0-N>D>!Y&6:9".<[FTE
M;T85N6AI?O5>7>KIJ"(;*A(N)9]2LHD!*F5T2E%9J2DP7B-L8@KIC>:+]4<-
MO^TTKK9ZQ&C>#ZQ'C6XRE:5J?)^&@:UUB$II1>T.VJT4)X24%4[46!_RI8&]0#PSI;-J7C=O*(IMAWU9N'$N%FR99["DMGD=I_:9S79V
M65?478@"C "P5538*>%IFGI0'[0%LE^?HD97']>K8PU_K_K/8RU.]MZ/0(:W
M)UM]]VI:JW([59CS3[E%V/E1,$X8111B+*.($JN1%)8AJ7"F,/R7YWP>5W.L
MM;!<>TDQY2H8H22!7VTNB,9JH3395E7V*L5JP)$Z/B\B>Z^L578K4NU2XKMZ
M3K-K$+37#HZEH\300*@"NJ6:Q,OA$QON+;8N+B2\-T46=\/D>#8,N*BJ6#FL
M4Z;>9!R];4G9G4RC,AH:V)H+WYY(J%26Y,#4"C'*/%$&9$;'#BC#FA$JUE+;%V'
MLK$=E?\O&>W*;$=_>M8;G/O275A<["O+7-%6TE4W=L[*K8ZMBHL;SF8W_&2Z
MX:DO67UCO*$(_IIICU)]WS0*3EU5S7C\VF0_C8.H!Y&B,(KBO_.-&,OJ[[6K
MK+BA]CA$N_QE#9K6AW-NEW2Q+UTJC)V,
M*SU8V-22N8Z<*YTXU4GJ16F[+K!#/=!QO5)*/];!N75#6NDXVLVF+[;.KU_WVF/HM%WF.]?Y2>GS<#2#\
M-/;]1%S ;W=2SY;N-__DN2P^,IX(1[5!% 0Y!+\(I$1L?IGC8*7V(=/Y^E2/
M2J7Q4%'XH+FUC]?-4&5>IBI2\/(X_X*QV,;\"V(N0Q8FXY/!,!G($O%7;3FK
MCBK]XBF5<6X^M*!FJALQ/+YK4^"[:Q2AK+OSP/)T 7H #ZM0TOE:T$V[78RA
MB$@#S^QUD\?\K-%+MTAPA,?'?,BB?GX:9&R7"Y\6?\0J6MZ6-1^+$**-NBM0
M=),W;YG_?&/&DZ>_%]UZTPRB!ROZW8&]1XBMGCR=:7/9BSL?LU/\PV6'+ 4C
MQ:B#*X)]T-7"1E+A=K$[BU_.UN%)WB2+R[HI,Q?20JA+':-ZA4J==I'BH
M47=<1\55<0S)<0F[K^.D4)Q@Z;&L;_T6I:BIE_)Q;F9JVG+U9I9;ECKMG9>Q
M*]5V%D[MZ&>K):-04YQZG
M"SKM[26I1+"IP7?'J4U-$6!9YJO_3N;D[0ILL"!;=3?UM\-!T65+8H%$N\)"O3C'40/G]3EFGZ^X>)&0_. #(%9@!_
M_[CU6?YT3F4!DX&+H5^%?E#&*A8-=:?51XHDHD(7&)8&J=%9=.A>Q[16B,US
M!K;2D-;8\BC9%5WVJERI,A_5)J[6+4.Q PP1UC(:?$JQ/(5S=T^KJFU5+9-Q
MBN&9O=SXXVX_15T650[J?AB8%?TP"D%S5-)B'%(A U7QH$F:A&D,!U4!E%*:
M3&W0>O48&E6AHCZ1@M*U*RNWQ#*L,9YVG%JR;;EF09<820[;6X_ =6?Z$C:C
MR)$)X:
M9;'6^ CG^;-[#5RZ#WF Q!:PV__9WCO<[FSMO>J\W-\[>+_U\N!#Y^/.P;\Z
M+P\_'.SO;K__\! B05YU1_KX.-I9*T)>AXIK#\$X6Z[3Z^'@-+:DCUDY=?S3
MB_,W?I B[+MV*Z8T'<0@U?41^W=+L7] /YW"OZ?OR.Z;'0;/S/:^O.A^.@!Q
M_N#PXO,K$/L_?LIVR:,:Z(R
MR_*%C@"6J*"=EDI@RI35C 4FA2:22"FD7J8EK)WT>)!J:\5"$Y*9$66>[']>E*^67'*8ULVN>Y:@,];4\^4X<$9_^[SN":
MAA%OS!HHZC!?YV(V09EZ5P?XQ43*TW@)B%+_^.-2>CW50Q!;$(B.?T2(7V!^
M?R[=HW%95K;DL3$5#\4 :7TV\G]4O_P)JP*BV/D?W7Y:\733G^4+2\8],+BZY+C<+RII(Q,9SR$_[GJQ24_VDS\Z)]CM_@=W(DYO?3K;!-?
M^MW/'HOYIB2_]MB?OY)+?CN#O=YC_YG6MUACV,5X9/[O,Z#X6FIP\?3^D75P
M.@75\^I+U<*EY.Q'O'C)N9K;]6+#5TW^,I[7GS/9),U\BB[>[7Z,YVJVL:NI
M9A6+,[VT))A(($=2[QW.:29SQ:6VU"MN
MG,EY$$OU .=M]U3W1O_W&6(_T0JJC,58AJK2#+9_E#+:5ED&_D#_  J$A8-G
M\ >J%WSZ^._1YX,!W3UX?[IWL84_OWG=^T2VL[V+J"-\[NV=OOO^B7S*]CY^
M8O \^KE;WO/??Y^84]?;_W+\8^\-S/35?[Y^^OB?+Y\.WN7[;_[=A;&2SZ]>
M? $] G_^\A7TC)/3_U[LC'<_9#_^.M@>[W[9SG8OOAX1CZT1AB&L'$84.X4D
M(P(I+['+M44K\]H84\S/V=!5$S[.X
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M\EV+F6LG;?Q;PTM_0]18LAZ/#Y\RH[T@SA*?.YRD
M3/)->G][].0UUE3HH557?\Y#0E!.4IYA3@T5.=,8]!Z9A]YJJX^:DHT,0N38J>UIMH2V6JKZTC)<]IJM#+PD#L$6 P_I"!(G+>-;?UUI_S]_]H$$L!.Q,8,&[W-#<>RFDCT'7E)HLX\&W
MXLC:@9A=$$>$YM8[1Q"1EB(: D-*XH RE3$&(&7R8)\]%^+W36XW)9@'I.\^
M81"0(+%B[IW*-:,R%X:&C.RQCJK;(EXGX+Z+^HB_PS)9-?M]S,U0GM
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MQYVS0;-ZYXME5F&?'VNM6A)KU<*:U@O13\79JH8^
MH\[?;I*=')2E"I.@"*&26D644)P:%@PQ/#,W%N#>Z&[_K\%H]+XX=0>#O[KC
MLDC^AU0J-QZ49YT"*&$ /\9_]">GR W&J'SL@Y?G?KV(T=>+W:VCS/HL4[E!
MF(!,1@EV2$N;(1>8\CJW*D_Y"^32B)"R:,Y\PT\][00%1V94;T:D.-T93<[.
M@)#JUIRIC.%W/8(OS!<_K:17/:,NI6=T_^MP_(?D^>J+_]!-P*>',M@<'OMK!9"N
M&JRXD_I'#[E4DKJ6<:-9':ESC2S97TDH7>4R/ZS*0=?;@_LIN52"Z^*C'M7"
M9@_@3&/R" _UW_\VK59XKT6Q&D)+^0@4K[_'$+M:SAK6_<=ZN" S[[>2GM0LDN;YK;-D4U\6Y]=NA;+D+*N2"
M49$):HW0BN:4**>L<]8'?;1SO2"%X@!6[JRIKCEZ\):.PG-U=OKIX!W>?;5[
M_OE@!^^>1L_5U^_[;SYW/UU\S3Z_.OFZ^^H3WOMBS_?.YSQ7IY]/]EX=?M^]
M^'=O]\OA>?)<'6S1SZ?__K)_\/[K_IMWW_>^')*]BYT\Y8=W9SU7P1&1$X=1
MCCV+$?>QR[FBR%)N9>XT(=:D5+[%2(0'GW_9PLXCA1V22YIQ8B1S@F+F5>:5
MT(2Q7.9P=-@WB8(Z?]?_N(ZUHLU^O&]!J]JQ!M:]G R'
MR>'40MX-(.]P0=(BS&94L( DR%N(>D.0M)(AP0/(7C@+.6S.<[ZR8I!K%#C9
MTNFJ)9.63E=&I_.BB2;8!-@4Y"0-B!*@6),'ACQGD@?+'6A&C[&:P(KL7&G\
M1*ZY9++$GOH[]5Y_5<-\L@'A-Y[_NG" WX[W7I6D5IW@*0?8\^.6!_P*#_BT
M(*L)R0GGF(%F:B6B62I(9B221G#/E0H\UJ$@ZF'GYSRP]/$63%LPO25QN@73
M%8+IO$!MM;>P/P$%XPVB@3E0?!U'-O?8>JJTB25H 4P7)>H63&_3"%G=7$Z[
MB&ZXAUX$*^YGL"0AZ=&-\OH:'&;7B3);BWZJ,ZC!WI-CNUW7J:T5%W@G7=$#SP!>L[QH^_>P^/M./8"MT.1FE<
M-O(-5[:.+U^O3Q-_*=J_EZW4._Y'[/&>>KN7%Z:;RJ#S-+U)-9+R 65?^?*-
M:;AIGJ.)*?J]SP>9IR=6PZ0/"^Q2D_3X^+@G:7AG^CPM:0II
MC^^++>//_3@M7(K9+K8IM;&WZ8/I3IWY?FIX6^3YG)YU>W5"50R9'PQ3OULW
ML)/XCO3=YF^%X,TF!EX5.#^'@D^HN;R7X[?W6UB0EE
MW6F_RGM)EWL(+=>7)9W'7//Q5M]5ZWC>MEI_]>DH)XQBS23*F& Q3H< %_NZ7[DVH^H5[G*-XF@OY)7Q/@F
M);^65'-%P@V[A50=LLEN)57G5@:+-VFN'M!@Z?4>VZ8KW4FZTGIF@;2934^B
MF?SM9R[]_-(',?V72YL64MB(VNTQN,1M'Z\:^MO[8/.Y6(_CLI
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MYL,UF')..TY0K@('W,D/,4^AQ9V'A#M_OTF5Y5_Q
M:\TBT @F#+]54-3SDY_ 4&&-:+'HIE@TGYV.B1*4$40\P0@XAD5*$HE,1IA@
M"GMI4B[&H@RTD&]X%S"T+@:G>U2F]P9]9-=4H4X=<3N] 2S3V ]/5Z1#MT4&
M;C3%]>8I=ZA#SS"0,!A&$^V@7X=-P2AL%8#<+/4:NC^\0Q=^.&BYRXVXRV+M
M$RR,PQGCB'D,&K8 -5L&IY%3G#@0#8(T>8P#E@23/Q]9'8(6F1XO,OVNEGT#
M9&H1Z$8(M*!KY]QKY7,$:@A!%#1N)(6E2!%MLZAIBR"CC4^TZ-.B3ZMK7V+R
MVZL!J56[?PV6Y@0C2H(&J5:C()R*I4HTTH$&1 )Q5#M0R0-;#DO75[M7B$CK
MXL.^QSB/5[$?T+"1UX$Z)4FTWN'66GI/WN'J4);-H%I8OA$L+U:0TL1)0F+Q
M*$4\_+ "&:ES1%3(A-%8$!IK=4KY^\4Z6]],BS8/1%MMT68U:+.0ML^$I[EU
M2%D*:$,)"(&.,P1;94GPS)N01;3!OZ^=MFC3HLT=H5(XD"0S*32EN6,"QJ=OG2-8&==/+_WF6K@OA69G*E5
M7MUX"CZNH(,D8*(H@7>51=\>^G3K0@U(+00U1<*^1Y#:)ZA4:C5GW]-?"95U]Q
MGE%06)'E.$>4\X TE1I)8W.;$Y!:,:BOL33-&J'/DVI+<[FFVH\]W^>TU=:J
MV%H5[\ECNM=&VOT:*ML%Q=1X+(RG!EGU_]E[\Z8VDF5]^*LH>.]]8R:"XM3:
M7>6)< 1C&%^?L&!LP_C /T2M(-#"44O&\.E_6=4M(21A! @0=H?#&$N]U)+Y
MY%J9# S3@ &0,3#LS#03,IA*
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M/+?8)>-_1@,F->G=0GIT9^OLMU8 J87&G'F+5!E+\^CD@_RQ_2&<$NBBJ+7=J,.3Z/3G(V+UN $$* -
M5-)OP>!Z\&^C #;OZW9):C?:**7Z#/D?14,?][WOI)X3  " &H-AO -^=%O#
M3B7M8O.B8]^-SX*A%">]_B 6S/7]SGJCA H8?*FTSM+
MO8S2\V].9L0@<0U&;:E^B_=3_,?UW>D#\L?O#=A'8*+4<0GX16TT_H)YW,E@
M$_S5&_8G1W6AB[+WTW= TP'PW+V0>UE!C3%"=W2K"_8@:(T)H,'6WS5@\J6.
M3[4D7PBYK_:/B+:YXYE#1&B'.,D\,BS3B%OL<)[G7&=N[:V2RQ;DRW(VU^2P
M-'+8W3H[RA3EH&IK%!Q0 L>"(2UD3+NT4B@GJ,21'++;$BXK!"1?#!*D.$!=@%W8--]PL8].O^I4%Q%Q9$M$- Y#0.-2.D3"&X'R!,Q/
M(6?9/J_J2_=R(#;/ .ZZ^?DSI9\2OMZYI7933<^,_A&-<09*J#-
MNY9ZI!1V2) @%<6* +Z ;
M77W6K>NT2^'5I/17#(:T4>DI]39
M>$Q*-9Q=+]@-+BI\V?KZO!^;9Z\W+DY:]F1$LLMEBO(58W9PI\ @DZVY8Z?3
MJC?TL*B@LW35 ,^$ZILH([_#LX9@*Q8G<&.$VO3D^%7+ZD&O'^'9?].M-#$]
M&"%%@H>*MR[7)P AP/C@+OBHW8[7E&L04>&;[KX-19CO;)__G=5;ZK NQ%"^C+O(78 +%ME#^?##NTQZUDL@7U;W1
M!HWOJJSNC9%14FK?\8KHO!SI+:4A7@R!!:X'U;H1*)SDJRVSTEX7UVR=
M1J!!)G_3[>%(1(\] 'HPZ2V-LTC>B%X4TS>EXO4$XN-#"V@P#F:]T0H3?/JA
M6_E"XU1&'@BX]44#F3N];J?7]0/=O]R#*13E$-[W8QW#Z>/<*:"65MC@+..>*!"J1#",@);8@26< X%L-B<\I$C/I,)__X!%7/
M)?Q9,JZ0;4S-8TJV2=M,873_O9278TX=;QV?:ZU)>U'W[L7NWAEI[FW3W;UMWMS;/S)>
MY-[*&*BW&>*I<@H3!S'*K=*K;T5:O7C]C6%+ 7\6'/KX(@9Y7/E*0I&
M!<0SH9 ,%*-@L36.$Y.+L/:6\Q^!GTX CA.O;(]+T^ RT,!OM&MR_T9;'VKQMSZK2Z:'(!I^=^
M^PZ\IE2?/6]/NC'7I?$E;G%R,_[TJ3^?)V*]I7T[6H1BO AC\W4<3(YV_QSO
MV/7=ZZ!M=X?1/Y.L-WSV&=_OR/^?]'@"2+Q\*VDLQZ ]+Q2;Y=DK+JGQS
M_UOR0_1"2#;JH%=ZD&RZ\KS?^A:]AH6/?J!K57Q]RNQ-F4C)M5OI,D.87PDU
M49R.WQ*%8C]FZR1]_Z_DYP4COUW$J53!]D_Y=A!\R;9&M_ >B)
M'CP V$;5BCINU]\]>.)$QZP7"6A6/7E6;!%7(=0[[E:T2@LS#Q&KQ?J)G7V[
MW<8NX,FU^7^;T4TW,L'&EP ..7_>[EW"(*P&
MH\KYTB<)U[7"\#@=08)+.@E;(T0"Y+H*8^'"$Y@NTD6A+]<;[=X%\MU^RT:G
M_,@G,AI#>O_XM5%(5)9$[%A0>M\WJD'&T,W-#-(8_1I=W1W:=ERGZJXRSI>"
M>'!?MQ>=B1V ;EM&$G4, E1Q-Z.^[C1.
M0'(8[[O54T%M L*(-E83?KLFG(L3W[U!/?'9L-W75 0RM1W#H1&_VWXPB)'.
M44IL%>=LPR;%J&*O?Q8WUG@0IC':T?:5=ZG=GB"[-+"(^6-?ZPMPZZUE;YZ+
MC9-#.>[ <.R\O\E-ZVD;JO@LK&K?MSIFV*^"NJ/MBF0F\?]&"HM1C\CGT;>?
MB"I9SN=E'N1();+CIP_/XU,U$.[W5F?8N;Z]>)FHMY\O8O=[:VCP1A(6>QF+'*)>).YTAY:I$5
M3DK+2" X7WM+R&UEH<9.ZQ2O5-Z +6/!6BPD-TQ)*H+0S.&,
MV R(8I&DR)HD'DD2>_M'R@BG#)?("4-BI6N!C*0>8:U9SKRR+![*(C2[ZW#@
MR^;-@:+3U'T@2IYZVBPOU^=+OVRK0*N#,)^KANI84#?O7RP2RITS#!EWC7;KM
M-N$U*>.% ;8>% KXR:8](H0=<"=:],K:T=95N6:V#1>!;>V3V^ E5_Y=E>WY)7I-5W3E=84-H+Q:/;(\@$U
MW$2+I%S;8GB>Q$^E/8TH:@67_$N9<+7>>%_E-L7Y;3I0_%K)QFH!"V]_/_?=
M8D5W9*/Q9>3H2C;$*!=VPC]VPZ"= IIK/UV5N D;XSLFY6I=&Y[ 5/8$7EWR
M5'*P)X8*?5W>/4R!IPF[M50ZDC#\&FVE&UEN_=%IH\8-K*DF,%;#HY*>XO^Z
MFZ33<:0P=].WB :7YQ/&N?]NH]Y_,S,U1N0GCM+'=\!:=..C=+EN=()V7>EIE?CQ0_%;)7S5+EEXZ]I45.*4LRZ@CO<_/.<"V)*
MZ=V]SH6**7&)71MZPJ(;\X(;]L>H=6-;XV!>5G%+$5UK^T,8[VV45WH QLF:
MXVE=T^R-"8WS95:3."J?/6A8P_8@N>/GX4+\3\Q[C8[*4O[,"U),1AZOW78E
M:;7@TC)O]J76X9XNVAN,O9H*=)@X#+U(L0$@WA>KF_2#;L7[@U:[SG!9V$R^
MVCYR@AMJTTAGB3DFD:,B05;$;<4X#LW[M[8I74:HI8DD4L;NU?Y1S;077
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M4#I@P3&G(I..N5@B]8Y(S?#UN(*#1V
M-28+OHAG7-OZ,AW#BQ&M,.QW6\5).K#XWV'KO,P]C$F#Z;Q/\BBF CG?6T7R
M'!6V=SX^]#85>P&)UG:5,R*^ !Z>LN=' 85QA#<]-A;W&A]P'CN3HJ-JG,L2
MS^GVXM'<@9^;J  X<.'C<<&BG-;HZCGNJ1LNLH;K^2J]9IP$DY0/?2,5LC>N
MWY02+$N%N-2.RS-1OAB?W(\AO\KO4CJ/S6691]%U*7[8]_%4Z3J\=#(J6,[W
M6N\9J3FW'&;8:'P(Z:G7XT_5W6VI(PI'W-0*D]4W.!A/V7R=%-JDHT1QG&N;+L%% 3_O_R)
MN?T>*]/C=>]WJ1B7O>[V/L+JLI E3'D(=)[==GTL=G6"/,9 1GIP#9/5!KI3)^8#571_F
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M*L$#8HXXPQCH742NO55WMLJX2/9M69PH*1FCE;XH&#VDI[-)S]\?N_4B5'!^#)9+>J?0 *^&X])-E#C
MHS\&M:VIXXFFK>R>-F?[9X]>V&!M[/U823P"#SOHOG^\*RYU62'G69LQD'>\<4!_>>T^7Y;Q&9\-P5>S%#9O !A>=&\/CP]/"DN=<^V]W[L[V[
M]>?IX=?FQ<'>V>5_KLZ^-R^.+,VP,#E## @&<<(S9$ !0U@[X!).,V:S4FUI
M@8GG-J/:X#-/G666*,LX [TZ!*^)EZ#=*Y$KMI9*)YY'VNT//2#2YI?_6V_$
MGXWM3_L?_@&S>&?O2V-S9ZOQ>?O+WN"TSR0)S,>76(1=B=[.,Q+;:+D>8YDQ:EE$G^31UKJ1S>"^528SG8U.Z
M;]+SBE0, 1Y2S'?5 3FLE^%4?TT55;XZ*)(M.QB%6W6J2!HK7EP7KHDYY;UV
MR^FR!FJ9F%&<>)^B$]7QG;D7%]%>&NFLZ?D!QETT?@/-ME*!B]_?W,K*,*=C
MD):#WOD;<;/A[E@;J.8_TC!B@=WH=6SK\\*_&?WR!VBK8.M=OFEUTWJFF_ZH
MGEZI)?$%4_T]T_O*KRLIGM!C?_Q*R?E3##;'BPTH-5.MUGA.A^?;&CF/+U4SE\[I
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M?ZX^#)I?IMK+TQ#-JPSAH!7B'&NDF<7(>N$G5[E.')>.*A+>@?
MB-[3LJ\&MQKG<"VMC
MMJV@&[=U6UPY<+NWCFJM]S^5CKI5!@J+JI77*#\R-HGJ)Y\,&B6]SE=:QZM&
M[[=J5YD8;!(^]9#6O+A[7FC,Z6*Y9):B4*F22(@Z:&5(AI1$3+
M3(:095[%\RZWG:]=&-3F8\>3*F53K[S5(?'+,^_RVCO7S/NDS#NEDV2YQ%+E
M!.42U!&N@D4Z2(O@\2W*,E3R([Z%]K*A^T4V]+F_J&/P<8ASR9!RFJ),P2Y9X./ ]-I;
M<6L>[DOP[:HX,HA\!D_&_ #D7BHFLWA:RCV#<-6"52ZI*L&#P7:YWC"FBXPF
M^%H2"_LS^IS"(*FY
MYRC+-$=<,X^TS"D*/#",71:LL3&XE\W1Z)XF9W\Q;>5AEN[R^/B%G5PUHM>(
MOG1$7V;DLD;T9T/T*4U?>9G98#V .1CGG#J*I",:4^H$QB,.73S+88B[[/!?]T3$]8'6YNG9]]BG66F*C; !F"#$
MGC_>(&E9+ ]I-=7,.<_UJST>455N*B9+%95]+L'0/-9]=UMW3W>71WS!@PQ+
MK4CTO$<>%-^@2C[DR /+-QA_V-F$'YXB8!L8RRE?A5UN)>QQ]^R3,B[^Z(\M;G:VY?NX^][C':\_W.,CCN9UR@FKB635R_
M5*+*UU[_S/=3:=-8RBD=W7^Z'/[Z$,-/4J.!F(H4X3%C+X
MPHHGR_N=K*L56M^]0U>^W_MYG(+PG,.M?SH'7P_X[M8FWNG\^_3@ZP=R".\X
M[/S[!-YUMK/7;N^T9IR",.:_SG:^'IXM#9@>O_Z>Q^W>D<=/Z"
M>7TBNU_WZ8TS7%?-B^;5AR/!&
M_O%:#CK4I[AJ 'SM /@SIC@]%\9=3F*"\1E9I%1!B-&+-9"
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MT]Z.S M.-):(2!J3<#%%BC./ZV5-B_*<9ATCLZ9?G >"=>8:XM1@I$BBBC,J A5>:B?FZV2LZ
M?;ATOGT=(;(:P6L$7ST$KQ7TAX/WE%?,2^RHR4VL.AFU=.N15,H@YK7GA%I'
M:#:_O%L-WC5XKPA$U>"]0L5 :O7[:1%\VC7*U^ETC>(W@-8+7_O&7!N\I_[AG/MP'ID &QY\XH$IR2
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M@,QVRP(0 N(!"5<8.(7<73V Z]O7-P%.Z2)=,OHHPFFO"Z^(UW_]=(O7_=']\5?I^^Y93"_^8WCC?5&T 9V6P/K%;]'*.UX/P"T[9TU!C"&
M(@#$1^D#>G,1Y84=%J!U .!O-/ZZOC-*S82@\74MX&,0#[Z=A-^P\''>W:%M
M>QV?!4I>+][^;!4AQ]!2%:#9BTK2+PTN>_M'!!:6:YDA8W3L%0D_ $\D <0C5B\*FP8E6HQKX#/;4KAW?.X.6\N1= ^,RICBG,)UV-&
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M<4,#]489M[2RCS7RU,3-1:E;LOJ.U,J7+!$V$,82@$+A$7
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M3!UF0_1*+ZO[4,VK/S>OCL5HK<$_BD^GHT$S$*$\?WQDMV;-7X(U:WUW>+76=Y=DE\YXK+'6BN8*:4$PXB!(@5$M1UGFM6&9$BS+DU05
M*\2I2VU]2S>H6!D']0\:ZSPP-%"7?7V&!5H5R%Z9K@N3>%V#]+U ^M.,IU\(
M;"1E"F4^CWT5B$?*,XNPPHZP#%MJP/)19(.\YLJN2^?*UY'%4>-SC<_/ZT*>
M.,9=F\!+1.TI?Y76.=9&@ F%!%-6A""EQ&Y^R*<&[1JT5P2:
M:M!>,="N'2"/0^GI@!\5)CA#&=)9U*VERY&13" L&*,^T(SR+&71O.JN"35,
MUS!=P_0SM;RI?1^/P>;15>#=@W:*P)--6BO&&C7OH]'>JBGDS]R2P7LBD(F!18]<0#3N47$*&,S
M16V(7:"$JG'Z"5I&SC2'7*#OUVPOGNOIC(:((I#"RFV,LUJJKEV(R"=HVG7G
MEOV@6>2=?7ZF^@)9DSO#P?1S.>4954I8YR4EDKL\%SY;*TL[SZ[LB] J3/SF
MGF0;JI2XM(:J\)SXC=2W7ZKNJ6Z4YA
M$V.KT;*S9FC')ILPU^&YBZU!X?GG_5[LO!DWH]4!>BHWNS?L6W^CU==E?(+Q
ML0=IO$'R*..E?HCPX/?I([+K6_^CU'#LZ3Y
M3-Q5*6OX^A9M0,T<#FZ_95Z/Q9=0X!296M6)GR?]T6C.];%'!B3@&=(!!OM&
MMR_T9;'VKYNJ*^BMDPLX/??;=V Q16&N>K5 M]N7(-;);N@=?5EVF2T%=1+3
MH=_K7"MYZ]=MT*TN_,TFVZUV._;8!BMFW)EVU(A[U M\I !>)N4@?E.^*@J
M89$4BPE=0X,U QO:. <]XR2^[AR40-!'OOGI>\OFXI6F0R1\"Q;8\4E2&6X,
M[&[=T::>]NT>?4)[VYM'V5*
M""E5A@(V.>(R9$@1E0,?.>8XT]I)M_86=,K9U(K2PJ\ZU)8\H,=< "0!=GI4
MD/5QW_NDW18 D*6M _N<)[HO6<$OP@PEZ4_0:1*P^1_%F 4B%8[(/Z2GC9BB
MJ(9C1TK"A*Y^BRZ>-&XP'F &K:+\.)D+O6X[LO'@)+Z@O,@..\-2J$P,%YX[
M2-]5ZQ$?/F:L:Z:*=D;?5ZP%]]R'M8RV)"B19<);C@78IHIG+#S2FJ468JD]>X2I$5H2BP)A G%F,J3S
MC*&,,$.T,@PV#%A*W'I::\1256/TP4D+I,5_A[H_* W9N*M/K;S=4ZU\:BWW
M3O%<\E"I2E36>915(_O%?+
M+5>D/J@/_#U$ZN-K?.:'/O[.(H, 7ZC@D(V-P@SIU#
M4@N-G+"Y59)IR_W:6S;G'-!-[@?RFQ"GI;!T0WL/61F%[[VUPY*9.KK5C9_>
M+L^ VN]#L\OMRU#+JF50Z]4^/993@T3L>85
MG5<,LS%6_>:K-JWBAG][M036;B29QL=>]QCM^7YG5;Q&&RNV3.^2SQR4:>"8
MEW6GC6SAP85O@Z+=@3M.BH;O1NJ:Z1T^#IP4-P#2?S_WW<+?%[N>6M[^,])<
MWIWH[K$?"=X:Q1;0N.'?YI%1V*3\4P?J->)!,B1)8/!?H2EGCG(;ZR/<6G2H
M K*Q3OV#L.^#?9)IDTAF968 :G9L29
MM)+$B&*CT:AX9V<(BD#++H%9;N9F_]WO@38RN/R[K;N#S:[;_N^P=1XU[ZU6
M8=N]8MCW>_"^/]L]>_;2U+^W/:9^H."+'7K =MY_NCH\/<:[[_]I[>X!!WS=
M9KM;9^)PZZ\V/%<G%A]N[71VMS[QPZ\?1'-OY^1@S_+=O?99
M\^L^S*'=_L]5\[)Y<:0TY[EP''F./0(]2B&C T:YQM8((@FV?#HNKYF2!*C-
M$&8Y#;G*K+8TXYCFE!B!UQH>(.4\TG8?%/ZW?W_>_7O[\][!>N/OCYL[>XW-
MG:W&]J?]#W\WMW?V1HQ4D< #@L3SB'JN3_C.<;]]*7+\I8GP^$A[[@..G0E9
M[,>: Q%J8QW23G-F.+74BVFB6LG\@;7QZXWSN/7)WO*C
MS0?AW&[W+HK&;W!E)4"*W]_F*MF,0T8IZ>@Z#)42G6 -VOJ\\&]&
MO_SA6@4,Y_)-JYMFDF[ZXV:B47S!5))3>E_Y=17*R>4&RVB,YE1%>JH75X&>
MC13HFNO7>(/<^MV/'DNR#9SQ!SWVQZ^DZDD&"RC[LH.=DT\\
M(@Z 0_^@*Q=? +Z19XLMP!V5H.ZLT39[Z9S,Y)*+GB<#5RV4@#MIE21A%^-;
MM_8O^/G78Q/&&L5ZT?A7X[[8'F1'E2HO<=1G71/-V^..QL7QUV
M/N'#]Y_@NWTP*RQ\_L_)8>??K1VZ?=FS=%_9&Q1>NFAT(+N8;3&DY'<.ISDPF!-5:YYX)3):1W
M"AB3*9/!WT4+\M8*XE*1?/@R[.4;:\+?])KNT:K<][O?4N)QL6M_J0?=7N8
MLS8_7[>'('+IJL,&XR),EY01XFL3=D70*H/,Z9LSC4.+( 5FU.)
MN' 4&1^#O";+7&#.DXS$',)'-SC[0<^%%RIP4O/JN"J'M$I0286TC%.2R4"(
M8K%ICV,@J_B3&&DUX]Z/<:=4#.=PQFS.D60\("XE03((CC3V# =J;698;*ET
MVVF:GX%QGR(2\\N#@6FTPK8KW1L;NT &W6X-K$>!'^GS8Q<"8S
M+'&&LN MXB%XI%50*',:Y]9RV,544RU;(?[_Y8.!36U/X,/^YT=)JZ8 "+N&=>9ID*FKM,,^^4M;4M\0*0U)RQ)3 60BG,D-2YHX8
M^"XGJR;4GRI:\6KLC'3F]!%6Q2_AZ,@]J*O22"4LXS+S4@=-;# @[+#+6&U5
MO 0 S;8[Y43ECML<.<,%XL(P!#I)AJPQP5I-,Q&K',SK=OKS.#I_3EZM%,>?
M9YMJ?_13Y$0S)C)LK1'&<\Z%)D3ZC''%I7-$Y[6>^"(P/>./=I1PQ3P"%=X@
MK@U'TKJ 2*88"%E0ZQE=-9C^A?S1\\_O_/VC/(&8]W3C\N3_&7[G=1
M@]<3@-?^K(ZI/'748\0S$S.;C46:9PH1S3)%&?=9D&MO\SG!M%?4^.*U9E37
M"/,L)8/JW)VG@YOI]& LO*"!((Z=1=PQBC0#"QN@EW3]:.)7=WPZT,3FH.OR^'3_O&-:-"!HEXKCG8>]@@C2VH3S@V
MU>#&K.?T4'%Z'Q9X"-99E-=5ZP NAQ+1]E6?*919,*X)SA6+*+#)>
MB-C-Q6.NK79:QZ.8>#50H@Z>_3AXUO6WG.M8T/9<1M_X%:O[,7\='UKW8QD+
MM"KB8/4#C3N^1OC[(;R=L?0RE0OM"$=Y[@Q8>B0@'3MWN4QSISWS&4G= V8/
MV[]:#]H2F/1U%+6KX;J&ZQ=J]/(CS'ZGSV,+GNW8C\:U!L.^KP,A]X;Q*45=
M,8,]"PI)3ASB*@](!BV0UI+E6=!&>AS-^=DC$36,_U3QW5HTU*+A]47#:TW^
M_B)@VE?#5:">1_W=Z'C4W0@D+<;(@>S.8DVL8[GXY\
M3C2@,4:PJ!9QKBC2P4D4TXB9Q,1*::(..)LQ/&YFFKK34Y+\AO?9=!N4Y8K0
MH"CEL.V*JEBDS8A@J,FP29N.1YN^@,^GWO0%-ITV-X^,(!D-(@-$L#BFB>=(
MTRQ'\#=CWF34>A(W?;;=^M2FXXTIU_!,&\C'-(!\Z'V+-H[D:V]?NC=D]O2]
M(=_W>NX"=@U4IP_=@>X>MT#\;!:%'Q2KV!WRTX@A&.A ]'#O P&&N&CN;>+F
MUC\GNU$?>O_7"7QWN;O5/MWY^KD]RQ .=*##=O,TZD^;WYM;GRYVOFYST(/*RMMC52^J<%P3<4,G*F[T0/5J
M=5,&7NCW.JF!\;M>!\9VF8[FYG\4C;[O]8]UMPK^)EFES\_;H*JE__<"W.J+
M$YB,[@\:VEI0( >I)7R1NCG[\T'5(0K'ALF$KZ?7.'CKY/L:'O;R>#00H[MG
M_>'YP%ZN5^WH0]O;0=D6OM<=-??2\9/X Y:I;"??FIKCN!]SU5.^B,VE&TE=
M;9A>[RQV#M=E_=T'JW'KO<=VWK7+?;
ME_%^#=\4PW;J9.U\NP5J;2NVANZ-V]D7=X]T=&GY69SJ2>N\N#G681&'E>8T
MZ.NXS2AN>:/C!R<]U^C!B].W'L;?20_6\)$^]G"G#\-VH]T*J3WU$Z/H7RU0
M9/Q'6(AI%-U/X_@(P[BAH^V;DXHMZ(3'F&0@9F)7?>
M(.T)0]YR2C/OG-#YVELBIG&P$9<,R&LR6V-L60#Q@))7Q YRKF%\NW=1GNZ,
MK4=#"^BU.^*N9+XEB@&>'I1ESB.A1&]"28T;3TTT7^P)\%=,2KN=?(J]: [^
MTO+WXL@1)GA.<@3B*RL[LFBF.0HV.)9+;ZGPL^)+$&LR)4+(>":"CN5.0/9E
M(8 R*[,9^3N-5$:W-< @H%$_?G1K>]H%^S8OT*YVKMB^9691M@ECVD
MS2W--YA\6#_:'SU6;:@%^Z;>[SLA\B<8:_; I[[$6"563]"0-R/R%Z>!U[2N
MDBS&L8_M24S$JO6&E=&*62#H,=D=MC'3&?:77XZ;'9J7U[KZ/N[X%UNSA58L
MG=MLO-/]_F6T=D"Q'4X4RW[D"OQ2*SEYVF[2/J@7\P&+N0-*\,*T^$NN4,VX
M->.NX&+>PKC/?1;[)4+_7Z8\G_<],?)J,Y4>VVOTWO-?E42D1Q=>)$)83&(?
M*24YY5IK'H3'-$BM\XR+11.1IAUW23AL?[?M85RT49AMA6++#W/EC5*2#F.*
MT-?/ISM;_[3*9\,[][;QX=8G=@!C.-S:QKM;9WCWW4Q*4J>Y]^G[X?LFWOGZ
M(:,25IR[4.3@_/X'N^"W_G=O)C 3/L-=+<0ZVAK8:V)X*V'X0G)A2W2;VMAKG[PMQT\CTE0N:909EU
M''%J ]*!*R0R*G,F0V8XP!P36&,SP(/
M4DCMLRPP;C'31)"%3[O7ING30-NK'-.,>54'/%\0E9HS 4]L)5,^V2F+:VEYZ>@:?<0B[+)?;2(N:MCJ$\X%W-.)(24U -K09= .PE
M-J>*2LW -0/7EL#3L^QTD,JPX'$\\$]8X(@SRI"TP2"68QR"8Y1G/$7?'VT(
MU"R[NBR;::%9'CPQV',KFEFFGY*SP).
MI$,2U&/D5>8RS:073-2*=S3U#E&H%/*L%,@*#^)66QOZ_
M-(\50CG>H"O$LTLZ"56R'MV@8F4\Y/,/A.WU!KK]P-A$7=7Y&19H5
M.L.^CD23&KIKZ'Y^Z*X-YZ>'\CC5;$Y0+ 04:D5OAJ''##PQ25@;O
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MQR3*KIH=\]B",O.FN"J6R*,3X)\C$6=6%N[ ^_'
MJ>EY\_0SV!46[^ZU6[M;)QT8,]G=._Y^L'=\N?/^\'3WR[2-LG]QV#G@.UOQ
M^W^W=JX^B=VO(#_CM5O[8G?K+WCW!QA[4_SG:G,FMY+D3ALK*^.4&*
M@6@-1F@I=?">!5#I'E_ >?42XU<:98!YV(.*P\R9Z\]W^N9EP.< =*N]BUZ-
M.??"G.T9S&&>@*7E+#)64\25Q,BX #^LR(,+.K!X;CU;6OVJND35PIC#ZX)4
M*X@Y)WWO:]2Y%^K,MN3!@DKG9$!4$QF=L1S)('(D--.":>Y%<&MOY4H5R_A%
M-!U1:SJKASI_]8;]&G3N!3JS9?'RW,G=DX
MQ )I;"4*PDANK''P)Z:=+ZTK8*WUW">Q9_+G_6JN5%.N,Q>?;X%6!=A7YLCG
M#X!]QP]J[+X7=A_,>LFP\ :[#&D5RU-F#+ [)PPQ(ZFVBBB>B==_V'/I?+J<
ME,5Q@N)U[MD="8L+Y.C\*$4QL0C)K 2)G1$K P]>2.LDS7//C;)$:W)$1+XV
MD_7X=+E2,U"3[U\>G!Z+ [IS=M#9:>^<
M;E\UMS8O#M]-9^3]V3Z(8[CZW-YY__D$T N>\>]61*8#"@A$]VESKWG1W/KS
M[#]7\(S-(YP9)HADB%!N0VLE<;D+U.=!8@G[-YVTM_GNW>[^SMZ7QM^;!YM_?MQN;.YL->##S_O;
M6XV/'S;__/#QP]Z'[2^S/+-PHN[NR/OWN*
M/-0X6''[U_?(0[VS\*^:N72.!5<2T?-8*FHA0V7+6]\QOM]@9/V&EOC8]9CP
M$-Q#5USMQ8I2Z58/Y3TG_*LM')Y'75-'@5A:D>\Z2O_"7\^GWM_$A"
MS[3T>[0_?^7F>^^3O"OIT5J94,64BK\[./']=\-^'^!MA=Q9#]/J2W?6>:NY
MMP^?P;5?=SIP/=ZY^D!WWW_N-*_LU2Z\X^!J\Q+&?]F<=F=U/L"[FQ=@ 9 #
M"F/<^\2:IP?\\/W!U_H4/'"Q1;I#G2J.X2TCF'FP#
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M2W+VE':"@R0R=Q:1$"CB$E0423UPMJ)F3&KW)_&_VU^
MW-YOO(/KX[HWVKVB]EL\O?+1[WUK19#ZJ]?_""N^VQUMP"J5(7H-B#.;=IPQ
M8;5,=8$Z6$Y1C:@T769[%K#N\4F6(:K_%JNH2-:,NCU&G5 ."F6 L
M&&1)IA'7#+0"&@(BSG(-0"N\-$M1^FN_Q;W8;/?<]_4@5@!M>UWX<6[H9>V4
M>&J]8+ST'^/*C\R1R]H8>0CBV-D4#J\S&IQ&S'"%>(B(D[$,>9JQX#SU@H2H
M&JQ2*+5V,ZRH:E#SZG)Y=4H[L,"-FGF%B"?1)Y$GD G8'0M;=T
M@Z\0K_X*?H/D4YMW;J3V&CRY=A"7?O;,5HTX#T&,2I'0>KRZM+TPYJ7ETJKTYI!\I9KKR1B!+F09.W
ML9&T-8A0RG.GN-(LC]K!*CGY?B[?P?QC2[>4A5GX\.E2.T7=7G-AI3/6GZ/G
MW:)+LRJXOC(U8Q8Y1%^#_$- ?OOBXW33.R>"2>!
M!D(P:V]9_O,WO5N07U?\G%"-UC5:O^2YI!JMEXK6S9MHS0(W#(@98445XEKF
M2'K"D8Z2URGC&+=K;P6>D^I3H_5S5OJZM4#-@WJ3+ECX*\,O7_A+/GWAKRUO
M!BM8V.MTL\*4\W;SZ@-I7OW3@6?3G:U/$5/$[MZ?IX=;EAV<[K/#KY];AYV_
M.CN74Y64.H KI_M7.U\/X=H#'.\]W#L337CGSI5K[>RY]N'[?W<.OAZP_UQ]
M^KZ[M7D4 ICI4FKD'0%(L,$"&N0&"9Z)+)<<:(9,5_;R6'%).9 1_)32:PN_
M&^I\%AP6F$V77MK:_G/OSJI=#R+]N06][A[>S>EHH;T"*T-3[CF53&+,3!9R
MS)W2N='/6  LTN9J%?AZ ;($<7BD".448X.\SD/,/+%(Y3Q'1.98YB9S8%B\
MB@I?FXUBV.GH_F4L\.5@>Y?=F/6/N5-]YH)>V091#^K5ROA&1A9KJGJ?QZH-
MM6"KUOM\1S> >9=?SRN6":-/4'Q,"/5:!ENO;#G8Q:K%+:^,V3(O_0F*Q346
M+(;VJZS%W/IF2Z2E5[$H33T8]G^46_F+%Q!\=\=YV+J&X.UK]['7/49[OM^I
MB:LFKNQTQOXXLTBI'-'RX"5IH4%?:A_>;,1
M17K^F/6X#QL]:DT?\X)ZD*][D,^4A#,&J E?2_4(%*^/(/M294GZK:YMG4_T
M:BHC"$]QV*"N.?F+U)S\__\_20G]X]4?DZFI[C51W3TR"K#&GA I# F!2TPD
MML((P9CS*C#F%\W_BC&4#]UBT!_&XB%_:>LW.S'%8'72!QX84ZG2!TZ;M'FU
M<]KN[&P=?S\X/8;//_"#TP]BYWU3''[=QKM;_SYK=@Z^[[2FTP>:5P=73;K[
M]0"N^:NUN_7YY.#TI-4\/<,'5^WVP1[,K_/I\A#F'\N<[DQEWVNA%,\902(V
M7.$D]TAZGB&GGMJJEMM6>+YH]5\NZ)G:NMI:2ZE!TA*-.,\RI)2U2/!@J&-$
M2KMZLNZY77NK9SE_B'XW7PP>83@OT?=1G^5[+IT_NKJCISOBX")9V!'<22=]XA3X9!1WJ*,6A8L26?[YFMN]3'I%0R3U9A<
M8_*+87(-QO<$XVE'%PY4$F$MRG%0B(N,(V5CGUT-6X6)IJ"IK[TEF-0UAFHX
M7BWHJ>%X)7PGM8J\!%2>4I%%\)10KA" ,$6>P9HES0V2W.S1J3
M:TRN,7FEUN2%,;D&XWN"\;0K.X2<6TH)LEKB6(4S0UH2'ALS:)II%Q@U4466
MOZWX7OM)#N=H>ZW;YLM+H-#9JS[A<-7<1:
M5G]YTQ_&NE94IE+AF\/C(1 *(PVC"^\BQ>@&RS!R^K)Q"3=&VBA:16I;!O^B&P<7
MJ;,L>J5-[YM?;\"H&V&8[FZ-J!BFEAJ]3S9TKRA[\J4ZW6/;0P?SJ)YM8?:7
M<>C?='OHTP1NWI6&HQOPGF%[L)Z^?=?K ,]>IM,(^1\%?'?>ZP_2,ZL!^>_G
MOEOXQD4+1FM\H^V+ FX%1F\-BL1,<8-@!V;F$"\#<#P^Z0T'Y>1!F-XV+/AX
MILS->MJUF8HOZXW_694@1NCU8?OA+=\';P!?D.L-4/605Z\Q/)S/]T7SXD@Y
MQ;ED&@6N/.(J,TA*:Q!U7F/XQ0KGYUM?HY)SD2;&--6*M&FCX'21NVVY XE
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M$"C^XZZ%2)>1/ZJ)W[ELE5B.U3-_;\1W38ZCE+KG_1[8"2Z-ZN*D%5L"QM,&U07$<+>HQ&$KI!>W/;RY/U[H
M=LMW(XX" 'B@QM'2P1OCF !#/1!,>GJ_5"J*81S9C2?'Y?^MM:R)39V!^5&Y
MZ8K+>"SV>=XKI_^F[]MPY3?_QZ@^8?(43-Q5&6#X^A9M8/K#P>VWS-3(>?X$
MOH0DBDVMSL3/D_[UH:9CCPPHO6=(!QCL&]V^T)?%VK]N%FAM=='D D[/_7:+
M[PH2?P,-;KG+]X$QT2RW$QV+PSC'>PH/'!XG$CUU-M!(L1NB9I=V/K&
ML>^FEIQPM^_"72F[E*+DK#7^
M B+F2&@]*V[F2K"1Q)F11COJ;X=[W^^<;OH&NXV*ES))@M
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M?-SW@-A1!ZBJF(V>/>NVV
MNM]@9+W^9>-\V+KSZ%8 '@(%>GVD:2\ Z_"N:=RN
M8#M>-;*,DB?%5K=T2[_;PT3YS>K[:A1,747S.PKWXZ$& V;@1P[?&\(^KO)(
M-3*Z -HRE^7:C];-7,8[XNX/6LF*GS!E*RVJ%]9G=R .9>;#\5@2%8_?<:U"
ME)0!]G2QF-?@WNZ!61G?^&W"9[#E"[!\=*D )H7C75NW.J"1S/@!TBOOTA9_
MK];R+M_ _9P \V:QR&@6V97[Z((W5;_UD3)A""!S4!K4?
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M>8)&8#^,/]'M,**._8TO&Y7^GC9V129;Q9,%19;:.'?AWKC9VHPG
MY^GV?7YO7/7TO7$_>M@EOWN>@G3=XX\^RL_5Z45Z,&J[+0Y/7?L WK>[]>EB
MY^LVWKDZ/-G]"L_9^K,5LZP/Z#;?N?KK++;0OJ%9QNQL^D^KN7? =[8VR<'>
M)[;3V18P9MQ\_X$W.Y]/#_:.6?/KI^__N?ITM;.W?>2QP@+( WE* ^*@]B,E
ME44YM<9J827+['1/6<$IIP$[F668&R%A$Q2F%A-#E%5.3_\X]P$,GF SK PQ5*AHAZTD5J:8]!# *%'R2&-L54IA
ME!?G"3)+.=4;$7YU_48C<< X33,J+]/7C)+GCKLPK)$7=-#7<1 H#JAR?4;I
M50)J>F1,URP]9B-/,^BJUQIM]>S2!0^7%HWCOM>#D2>1T"ICMG2+33JLRT2^
MY%H?*[T)>Z?BJ0T]J+)*?'+NC_-:R_&-TTS'XRY'_'%B8#$-"DSE%JC1H^S3
M\<"B'"\C#'T?/>+7"895PNUC\^->B[0N*:B2?GT_6NZT/Y?L6(
MWJO1^N\IV:JZ%Y1IN+7U#=BB-)D_CD<5WQ_:*>'CO-3FX+6P 3Y27#]=DGR^
M$Y.YB)&?5I5ZJHM>5YOVY=CWFW(S!B<]N'#TQ%&NA?_N^[95>%=RCXL3MZV4
M^=UNA0D*'BD397_NB&2OU:CV2P'\WDTEO1ES*,F-WQ%0+KV
MC1OV8Q;^+R?#MR]VKHZ/-"RTD#1#L14\XHYR9$!;0@XD6) JD]3'8/QU.>^1
M"$Y'%XH(EG,RZ!,*=JK^H(V8]YOR-8_'G#5]CXB,\<6?#\I/XS&&:P2?H3'7
M*DK74S_RS@1Q+7C^YF'.2G8OVMNJQAB/XU0'<5;I%,ZS4QL\[^QRY]3BG;TF
M@7<=V4QC$7*. BAH5&0K KEG-,."&L\5H4%1RH$@%%6YRL <
M"(::#)M$#GA$#HM4J:S)X5[DL/?I*/>9Y<+'RC8 _9P0B13E& EC0&(%2A0.
M]SJA76_J2[L,]H^$\80H+A&W)/(XSI"RC*-H10NF0\8]6,QT(YMS'/NV+*]H
M#,0-FQ8*YWU8\CX8+F-S#W2,&2MU9$J4ZDQ,KYX]_%=B27S']3D+_3+R)<9)
MQW27IE!-5[O383'HO*(#@L\.*[AYU3QB-F.4&8DR8D#AM?!#,V=19IS/I5;$
M&100%PS9%P.F.:>10TTXCK:/+D-G;RP-A+8S-,2-0S
M9CL8C2&GU#+71R&!*C^JM&QVMTM,Z0\]&IZG6%H,(Y0 4YW,AG 4VYBV_A:,.RFW]:ZNP*YRQ8+G64!82H[X_V/OS9O:2++UX:^B<-S[1G>$D\E]K)) 2 (D$" @QQ- JU15N3U/GG/R+(E0
MI!,W2%OK@S;*65=)MWQ)Z78LGUXEGBYS$/SR0EKY^H2TKO2D\HF>/$X>[-7X>_!::.30?!7\VL<=#NO&WO'S>Z%T#7V>!X?HXR\+2[G
MZ3C?/3<:U?'%Z,MP!"K!E5/RZV#%X5*T+N(
MUP#)PO8KQY#Z2'-\[C)R^9XZV!IEQ:DZ-^(-.M6[^C&^\L$]JJ.8'E_'K;:?
M/TJ=;H^$O^] "9G:Z ]I.]"E@1B*2"0:>,\F081BT'4Y(4(19GHN3DQOU
M75AGPU&>A\Z<@\2+(]>-QKO.Y:,<\GKR?-/V1R>@U<*M%^7,<=!E< 00E.NC
M\M&2GW@>/.XB[*P^''N&AI **T<#I&5.GA;*TY&
M\&>?V(FG_]_FG]L?H5%U\JD+BCD_',WV)>^'O7QJ6N%]A+.-QB;TXH+E7C?\
M>4J RB&@CH6Z\+K(@86@0%8/K5S1^J!.Y0..NC'^O F973+YC0^!N]\[]:%M
M_C!/S*C'O0BJVO,;&A&;GR,MZX^MIUCR5R0]<-6OJQ
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M%%&A'.C4><@]MLA90:)PT>+@7[VM?25:WKUQOZ?
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MC$@:1Q#WB2#'(D,Q&,$%Y<+*8A)<[9![(9Q2/(#@(D%6C DX*9&$)/=&Y)5[LF.]#C)$2MZV,]Y$V:SYMS.L'1M^6%\707BEW6,O(H!*N+A
M8N)A$0J7(N"/L]8L')1,.*&@L:J5=9X5A75EW2D'OL>3P3/GCM5_WG59G63(_6>6N;QC5I-=M]J'M^&8K
M5O$0H^13.8AJ'  T/WCXICR*XRRU4W=>Z[[[/#QV)=T@C-_&8U?I#8.OOGQK
MC]W%'_ND/1H7%#)R8,V=#@:?IY!9Q,3KQ,1K@UW&0>Y;P[@+;][_'EO?XDY%
M@\]$CNRRW?V#TYVS7[\/?+>[*WM8EWZ/O3@_9'D 7__747Y,+=
MYI0<^<63W2_OSG;^V/T"\B?9W<AQ5F4E<.+
M=:&=@VA[^]^[A6V68IM9OVA+M.?,,J0C"< VR2.MDP.M55E+58J,NNN"GA_C
M*..%R&S\5FRSJ/Q6V&99MCGNQ5CX9BF^>3?#-\1Y3(VRB+A@.WL2OBF2#?+\HTHTLTZ\\*N+-H]"-+.+-6M%-\UN1;I:CFUG',*H-E]P%1)-BB$>FD68@
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MB"CK2VKN]7W5=7W9!>
M2R%,BO!W '.@A?;['WM;_[1VSG+;6LW=_2.\T_[P=>_3
M1[9#M\DA7/O/V;OONU\V/[NHK 4=$ EJ# (Y2R.;E$!5^-(W5:K^SW?=]R$K;SGCT]SWX?]NOX<]"X7-JP*PX#6
MW']]4ZK&'NV!$,2B=W^\_X+;9RT0M;#6+.-SRJU='.5?ZJ+D/G
MJH)XO5SFIYE9_SQ3W6HCY!>KU'=3/,K$:KT4M,OQAIA:P>B>EC!=J"=5_0[Y
MR[V,Y4(HNCP^9H/EH1BMB/%*'%4XA-_?8EVJ=!2"]-]AMPI6RJCK5TBIJFJ.
M$-&O@3B8* ES7"^QQAA0"9,!8%8'FRA/].JBMZZ!;
MWZKHLS$;UA5[JEBY2VNWE.*[9J$9,34ZZU&*[]+J8].""3++E^:[43":$J2B
M)" A)HRUE-Q1KV.0S@I)0,L@H%]U8-/LA4I&.ZV(HJ[I^[H10.:J=J'! .X"^:;3'0MTU68&
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MG=_KJO+J+9J_-3LB_MB^H:T[8SJM<'*)MLT/2
MC\&;U/P1 SJ+O77*0WP[EZY1-!\Y;+_C.W]\:!W0=SA7SSG8_] ^^+)#X9\X
M. MM>/[WP_WMLYV9:+Y_X'M'WP__^.?+P9?WN7K.\>X?A\V=LP/XU_JR2P_H
MWOZOK9W]G=-+=5?/=G[L[A]]#C0J3AA'VBN'N!(!N:0L8L8K0A5GSOC:7Y+0
M7]8H&KLP5&&HZQA*6IZ\XX1*Y[E,TE*L35(A$15PHJ0PU+HRU.[?$PSUI7):
M5.3**$11"\-@G8ZU3A:$*0ZU%WQXAS\$2#%68:#DFFBKU&@A-
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M?(Y8*[V8.]@^B9U^
MG3^GSJ7WD_VY%-*Z4I=3ABF&:=*$I?]+@?-#P7G:]R5$PF.("BD1!.S'"B,7141)*T(2UMX$5N#\ N"\2F>1
M(E"O'+93CB)<..:HIDA$"@*UE0I990DB6$1C@S+4^R)0/W/(KM*OHD!VU9"=
M]JF0)EFL@D*@!'G8:0E UL6(7(J\@BV3+%RJW1!*$+S@^G T^X'
M("%[E>7W!\\/A>>JLGL3$K!<2
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MZ-LCQ$P4G>^!>&DJBH(9*I1C&J7HAI.FPT24LH$+31%A%C0ZQR/2.A$4@XQ&>.%$3@%,-UCAI,))3X23
M5A7U4O2Z1[9#S<3!1*T<2:#)"9MKNUB/G#$)62Y$T D3O\+H\4)8A;">6%A/
M(:S')JRI0!^I9+1$D!RIE^/F24+:&884]C9QYH(*JPO<*X15".N)Q2T5K>^A
MB&DJDBD%QJ.+"K% />)28&0BT#[F@6(;*7!67#>UKW(,^]? NE8ULOGO1B/^?K;0S@^\ZV;,?'1C==<>M):]AO=.*@T>Q\B_U!
M&^YL1-OKP*CV-QI7O_($GMMH]AL)%C!<&QS#4CXZ;MA&SSK7; QZL+#@_ORK
M^DZ_87MQ]!+X?K/3: \'0]L:702IJO']N.F/*RIMG,#4Q_J6_PZ[HQLRJK[%
M!JR"KQ&ZEPL?YR_XENWWFZD)7_K>'!S#%_^,WV*K07*G\QA\ ]:L&WWG&]4RFYR?MXW+RW :+J,E1=B&.%]3;_^?Z_WK[?+WK6XMDH76(LPBC-/W
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MPE0R\2A49?3B^BK9J"Y-:4?U-28WN%!77L8;Y,IKUSV6D U%]9T,\'<+[]K![UQQG?[7/!(MN&ZU&^'TE6;&BQ0)-^.>GVFUG*?M.+
M+9N--;_D.4!L@\P1%!R(L_D)EQVQUN2_?_V1S*8HLC(5HXDA+7F&B_?NFT'[0N;E>WSN9S!GAU^VCG;W?^*#[?>
M?=^E[_'!V:_-@R_;^'#_UZ^'^T?\H+WS':Z=':V[I"]_0]?=[YLLL.M
M#U]V_OAWYM'3?A67!MM_V?LW X<2*4(2@88Q#')B KC4!"
M8J6"DM(G_>HMP6K#K"B=Y#(;WT/FA[U%QHX5@U%N3&]@\]!X]09V_?[EEDW.
M43B\;0MG+4O94 !=Q)AA! ["UU8C3:)!FUB-A%-$\
M6 =3]NJMXG=WFUESQE[8T:\PV8MELLB)PP8'SC#W.&EO=-#6Z"@BQEPMZB)8
MI-%[H;;=:6G4<)PH#B@(JC._)604TT@FF$(:,%4Q@#1*^ 9YYMQ6I-'"X87#
M5\KA11I="65/2:,AY;PU."(5D,^%<:^WL-[
MPBU$3KM)2_8 V3H7X&5Z>UZ^L'(_AFMWXU=H26A4SM;YU")[U%8.:&.OY4YH
MN&;XE^U_K;V7^]FQIYNR.4!7/LW=3K\)"PA>,_+.
MI8UFYV0XZ#?<^.7Y*:D7_SN,'7]:>5S5S9CRL)IQ=+[K.IGKV!XEX=(FC+64
MW%&O8Y#."DF(UR1H6K,EW -2: Z>$R8JSDD E5WSZ(1+5AH-6CM3AJ0@GM9Z
M=%?Z[#_F.IWCCS;RB)\X+*F76G_0'U^#1=SQS1/;FHP=^)]'LJU?.%S_;GT<
MZR^3(9B=81N%[@"-GO3D=\K#_QQCW_ZG8S^9X=Z7=Z>'GW[_NM-^_V-OZY_6
MSEEN6ZNYNW^$=]H?ONY]^LAVZ#8YA&O_.=L6N_N;GZV)P1KF$69:(&ZU0BYZ
MA7P.JQ3)"J;D%7:7L;]A16!Y*?2'[3SYOJJ6-:@^AN^C\7\W\X%M[ \:)_:T
MBANY<+/-KJN#9JO1SCZ?S<'I1N-#=LQM#+KWY&I[CH@E76TS!AKZ=2,OMG/>
MG&',]0D@NIDWEPIMN:V<<)5+;M5&(KV63DJ@_L13%-K#!J!4Y,YX8BWY3%3F
M]_.[[MM;=^: O1I?0C8:C?]W*=CL,H]QG3RS1&L,0^VEU-@*BJ.A3#@>B?V\
ME7D,PS]T06B7*>RO"-S:[6QV0A5)\E<7V"P.FKW*@?O7V(FI.>A?5)W;AW?_
MVNKZKX_-76]\WSF=YJX89
M<-?ISMF['Y])P$0%-\KOS&.4R' 1$!5&JF TE3Y,2Q(J\:B(BCK:"$@2SN7T
M )PPKX@+5+]J1-@23K*S20\TJ;=_;>_^_6YOM[&YN]7X:^_O_0_;^^\^;.]L
M[^XW_F][\\_]_ZNN_/GN]^W&K]N[V[^_V_][)B;QV;JPSR>=FX?X\I1$ G )
MU,'>3SF-U( (R)2#.10IP>8TCDBK7-XO @E:IXTKQ0S8YEWL32.*4?7(X(0YT19PBU^]9:\%QK/21FR?M+JG
M<:0PU;Q8R:/?*KW'G8+R!+MX%=@9@"D[^<.:,QLG-;%64:@Y.+'[K5EI8!?L
M.O[JA,)T*20HO_,4E+%*[@6T? /5K8X%NLN*Q,%K+B+U$0NN \GYW92$Q6^D
M=8SCLB+O-PJ.[O:\Y
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M_&1,];T@YH4,U[I&GS_FN"V8KN"Q(V77F+*J5+*HG'9-L9KR)
MKHC;OU"'QR+-A.WCS2(KZ4X.AJNHC7Z79Y1&/EXC'Z@V_$,!;+Z#]MZD.2D?
M/QPU.Y41OYM&J4OOE(1\4>_\1\U\<,]YUA^U;TNY'3+F"0]$>9=K_5FKK<3*
MZR2E2XXL'D15J?4COLX:Z(S5>GV<#&]IL!ZYXW_?_?*>[<"[#ML[='=K!Q_L
M'W[=^_3[U]VS\.5@?Q,?T.W3PZUW8O?O:7?\3?B^/SWXZJ H]=@[J@/-
M#$1,8:!'8:"I@"">:S!*JU @F"$>&4;:884H<88*YT3R"AA(L@U1&*@PT!-A
MH$!AZPR)4IH"!RYR(M# B)'$2DWTPK5F"@.MGH&FH\@U;!.$*8X\C0KQ)!C2
MVF5!R'L9,;:$B5=O":<;O#!08: GPD"1&ZNC\H8GSA-5EHT8Z)D9CN'(J[=4;Z@9/IIQH5B2#NY5&%KT'.!YXG<)
M^-K$4B"&2I$IJ+TS:J?$"&.%5KE2+^-2
M(*X)19;'!'])$P.6DCG_ZJV0#(.:2!:Q# 1Q"AFM2#SB]R6G?=9P%<;
M:6F@G%.-N=%58JS@HJ;PN5>>+;#U%O@^''RG]F#OF3; O(@$"WMP2 D9QVR6
MH1-506H?%:CR<]*;/0I\7X1ORM]U4#ETL#^X.A[@.N99U!BZ?LSSL"K[37PS
MFHG?8"(*TRS%- >SI1@TU\YSBIR+!''%+=+:4R2\L(HX; 7#65"XL["_?H<6
M!;,/J*<7S-X!LU/2@P*
M]?.E,#N9HB8U?\#J.XN];L'RDEB>5M1=LH(;&4'(SX=VA$5D950H4"*B C@G
M)UX!;C4E])>"Y^>+YQ4H[ 7/CX#GJ;U9 7"-9#GU!Z, :J:0QHX@%@R71&O'
MG5Q'/+^(8_AWXPRWM]?AGZ[U<+UT^/%4%(5@:=+QL_$7F#D3N$#2.U #)//(
MT)PHSX@HG,[9NT&))WIE!6R*S7\-4?L 6GQ![5U0.R4J.)H(YBP@061"G'.#
M7# )D41< #G08:=>O:6K*ZE74+N&J'T /;Z@]@ZHG5;8A4U&$^$0UB3G2*81
M.0[RON6)).6BY8IEX]N=O?P+:-<7M ^@K!?0W@6T4UNMQ(J1@$$7#SP'YW"&
MM' ".*).<
M) A4 -#9$]/(26.1)J"T81_@?[ .!;F3BUXQ^*\QA &JEH.X:"5AW$OG(K;.
M!-A!C,7"A14($07"*X7PE%0A#.,,"!B%H#SB41-DI$_(:XT5)XJIG)]=R +A
MYPKAQ&(4+FE..>8V89V$92\07B6$9[1Y)X+E6B#/'4 XV8 T
M)AXQ9Z+4CK"HL^5\7M!^@?"S@'!@WL)^JY57E#-*;'2@SY,H81NF,XCO)%.5T8(T1+*G5RJD02 #%0!#KK&;:
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M2T)YYS*4=<+4.$%0"%HBKJ1")BB- +F :.&3?I#P^[))
MWS>RO_^Y/\Y;NW.V>_:>?W;8FL!L0-1ZB[B%_=E1&I TRGA"5;08ETWZ!2#\
M00+R"\(? .%^ N$?OW\&X2L*S1-*DF;/6VR088FC)*QUPFDN[>HL!"M$^(MP
M'-@,[6:GV1_T  3?8B/^.(F=?JS]"![>9^#)*!0/F2A_;W <>Z-2N(6-EF.C
MTQFC  &I0D@-\H:3!G%A'7(V&,1%=B;(X(C-T)TM>EJ@N[;0
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M%_PQT3YE)9":)Y /?*[@@T&E\!A9'2.RPBD:4I)8&4II8+
MS"SA*4:W\;/'CT"Y>^_
M,>-G-#LA=@9OD*G:^"C6O]]ML]?X9EO#6%G]+K)]9EN@BT?-3@?:/<B?FQNJHO,FY
M]!-5FF:KCF:!,*D,M2O?B0NB5X3H*7,8H>(!E(/3$?JGG9ZQ2-X;9\
M1&-4H!OQ'2@B&M*D=:$(^\YC1%P;8E[OI//<>!0!CHB+1)$5E.74
MGR$D1;R0V:5?SBDP5A#\;!#\ ": @N!5(7A*TR>>\QBH!@03!IJ^#,APQY%B
M&N:24,TI??66DCGU? J"GPV"'T#-+PA>%8*GM'F2)"'934?8(!"W)"(;(@5M
MWK/ C./4Q2N*?#X>@E_$L?ZE2I\O[!S_@3-TWL0^%V;%4@SP]N3#9U1X&7#R
ME$L$TT81ERF3C_,(E#HJDX_$<%B!@LQ1X4LYP&*>V=6(.]
M#P%AT-<1CZ  & 7B W'4>*Q%TKD\N)!S?' *>)\%>!] 8+W 93V MX5@7=*9T\!BR ,
M0Q@G#F(SP-@JHQ&3N:H.]RII?(7._BC@?1$G[Z4"YWKHZA/S4+R!5LU%8O84
M7B7J+,C^,5*'N!(6.9T$,I$Q;(.24:AUC QZ,H< +ZG*:(^L4* -8RNROJY!C4D4JB(["E)J;3PV[ZZ7(EVWY8?3[JA3?Z>? K'9!
M)D1<=H[3FB+#8/IXQ(SK9 +ANFS++P#:=U7S98'V8T/[4I5-_)E)[7S*U;"L
MIX@;&Y&6.1%N)"D)ZJ*081VA_2(.[4N5S74]PY^S0QA8Z6HJ-WWV>3
M[CGB3+(6*:!78?(@J_8'ZT5_X+MQ\?V=.0]-BHJ[U$,
M.H'F3R6R.;DFB%E"4>T4MV(=L5V2]2^9K']^X\ESHAA0>6
MY8$I>X9A'G-K&<(^92CM(>EM.A8F4>QAOE",^?S<@EIJN!3(R!23
MT(I01W)@/%]%6HO";X7?UJGC2_';K:UNA=\>DM^F;6\AP)8D"(K&.L0Y)LB%
MG$6 ,TDB-IA3E?F-K,+IK_!;X;=UZO@R_'9[*V/AMX?DMRF;8K""!"TQ"E1(
MQ!.HISI*B9BE5C+"';&DBK2\G+1,
M9@YS')?$$1:0TXZ M"P]LL1QY 137G-G:,XE\-P2_Q3J>:[4N[J$%VHY_ZH9^IX
M0GI0MVBD"(0<(N5/J]A5RSXLPYBYBT=KM=I"_
MV:KUS/-/K($9"";"%V*Z(S'1V31N$DMA@D1:2B FKAG2R@BDJ>;)&P-Z=.W6
M.QN$67)!/0N\WI/MI.!U-7B=,I]8$!BLC FIZ!/BVD9D& -!@E(;37939:[V
M4UV!GT,![%H"]GXL#@6PJP'L=*ET$A2.L*,:YR/B1#%D?71(6<*V'O2TPM@5P/8Z"
M!-#M"<_EGC#2'$?D;)(I$$ZI.X'UBJ5<*UQ6N>X0(WL)UJ^:ZG>GRE$I'
MSSQ*D6K$M7+(6O@1"1&46<]#3IE[UW#>0G:%[)XZV=U_.&\ANU63W92)29ID
MJ&<19:=>Q"6AR"F2$/X!8GL+V:V:[*8]:0R5
M/C&% DP@XL(F9 G+A<Z#O0Y'=0_O9/(42">,8RQQ8Z?VP/6S9
M00R-[N X]F"0VB>]>!P[_5QGL=F!_XZ-GUK=?O_GUPVX@@;VQT7@Y?S2"0N,
M[SU&Z:XP&+&T\E%;>0-XGU1FST5\X?[J-;N]!KSA6]/'AN_%T!QVKP@_;W,^;]-4OZ[BO'_ZL5]^Z-:CW_7
MR_&W;G_P6[4BBXBUG(@E9@X*!/,,JZ"0XD:#%NDTLDIQY PG"7M&3< Y1&L)
M;7(9C*Q6<;Q)/RQ$]=R):F7V_$)4CTU4T\Z05@A%DD(\R@!$E3BRSD7$I2(>
M_I"B,GPMX[MB>FRB^CB=G8Y:AC5!*H>ZO!V]$-5C$]5T:1Z1%)61H40]J'X$6^2XHBA@3345)MB8
M?<363:*J+''_&EAX[KG5MV[?[K ->/"7+-^3AF["LH%LU9B3-]G<:(9I$6OOU_KO>OM\O?MSHV(0MU;?\X-N:$S39Z,;6B'S3BCQ/X%4/%*[VF&^8U
MU,\5MQJN/DQKG-C3=LSG /E#((,&S";Z[Q"F/S7AQEPZN4ZYF*^=  ?TXJ#9
MB_F>QG&TK<'Q*"%CBA?/K&YJ=JI[4K?5ZGZ'I=&PU
M5_F-SO;K;YTV8ROT@S:-&0OOS-%>OJ Z7\E//E^#,@H.+U9K*B^49+XN_)HN/=\+IFJS0B!9&-*,%[AL/DZN/MQO]?+Y=SR4LHF%KD(<@.8SNJM)[WNEWH>ZKLN\%ZAL@&+%Z:UNJ'7A'N.;'.$^WSH%\=-G$S'
MFF_.!E1^Z^A5E8@$CZZ; RT>M:9M3_/*[\7_#IMYQ')G;%WG/0Q[>4C&78,%"R/1
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M)&+[I-4]C;':(>M-/?9@FJL='6C0G]_/DJ&6A(XN@-JLD36A:+7XTCNVW3(:9(0;Y])MO8-5WW=Y0[QZ2NS%9&0VK=OD3BM"'DU7M5>$8MO&5C^(=N3B3P5]V9B[+)^Q=M_+W;VP1) W;3LZJ;
MERLJ=X9M%+H#-'KRD[?='/[G&/OV/QW[R0SWH$T'7_SWG;./_+"]?;J[]1[:
M(,X81S;BA"2A
MVKN@8B3XU5LV+S-J[9X#&&B-I-+)W6-2Q%^_1;-W 8*R!&0<]0YH[C%C"VZ]J=5.I&YK_*U@,OGJ^$Y3LJ%>%IF\6J)[YI#D O\(LH
MX>?J[YP1?U3AZY(QYD+_!C8!L7.L3/O6,!MOL_VMW\Q6W30<@/*7KX"FD15B
MF.N\3@#Q59\N9G<]QG_BQ.$ISH ;9GMZ)7/6DQ&7F8KML7VNL3D\&H+>3S%A
MK[/7=6]X,1[]1C82UB: Z]64W.#:/IIVCF+OO FUC%1;@($EX-I,
MH[*H.N:5D5UC9&J '2#6XI"]=LX:,9L*X\@N? V\,N$LLP7>-;'A-4$C%QT:
M?7JQ+9:M;_[6!\_?__I9\6@((PI9F0SBBE/8^AA%DDDE%55$YH-U:>0&G=G[
M&N-M+R_691;"73/FE86PTH5 =[8./BML0?QD E&8&Y0!FF4@B5@B*F%"HDKN
MU5LEU!ROU8N%4%E(MT!E;SN@+49>7[9>OLYZ^
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MET='>49L,$KR:=XHPTJQ-[R2RJ?36*[5TVGLO8WL8F.P8-SME=' YM44VD;XN3'$?Q:^#U308B$/
MWI$Z>4Y-(RM[(RN65Q>L*./VUV6IZO\JJ:J2,/,F_&>6K,Z'=&8H5QL#_IC#
M\!,(C"-%N#_CS'OU&E@H-\9Z+X"#[(VU73E"3NKR]P*9%S)<=Z5H]@S'+=M%
M%BD)OTB'7]K X56 \9F.35E4*UE4#Y2*Z9[2O"S4Y[D:[$^_C?7SRERWR&):
M((?.W5;9 R7Z*8U\X$;>M53!DTBE]/>DA?=.I4K7+#CVY55C7>)0V'#*!39,
M2&4X5ES#+TJD4%A@;YQ6T>ZGK1WMG:_'+3?L]TOGNYN
M'>&#]O:/O3_^W3K<^N?+3GN''6Y]/=W=^OWKWG2D:_O@^P[=;1YNP7UG!WAO
MZT/S8'^;'[3_^;K[:>?TX"Q\W=M_!VUX+_YS]GX4Y;H]V/FRC7?.OG[F#H?H
M5$!2A( X90DY;A+"QG*E&5%!5(&NZ@J7N5(0>HU@6BBHHB";6 K$4,X4XQPG
M:RAU5"?)++%4^XJ"\)B";N6@4BCH#A1T>IF"HM(\Z!"1==(BS@)'3BN)%!44
M6(DX:T&&F5>.I5!0H:#UI" 28=^4,A ?'1>,U9307PH]
M%7IZ(O2DC;0T4,ZIQMQHFOWM@HNPGJ7URK-52TB%GE9#3].2DY%2NT"0E40@
M[AQ%QJ2$A &9U[H('Z\E/3UM$_."YJ]WD\DGKC8G/\^RP.ME,!I/15'7EB:=
MCS,6HT"!56!S0%$3C7CP"8'>EA 6-F FM6<^%_+6V4J* (#EQ3A80."7%J0&@P*D].9,%905.$G9+R#590^WQ1^P!FB8+:
M.Z!VVOZ0I D8,XN8]!1Q[22R4:9GJ.:
M3Q?56R]=?7N<7+(7!\->IW$Y9="M=/=%3:3K1TW+9$!_ .5]/#(.X.1XZ >&&>92\GY2"2(%WJ.4K!T"=$U.M8H
M^'U(-;[@=W7XG5;J8?8D(P91$4$]<#$@DWA$F I-L8J&B@#X57-<)PI^UQ:_
MZZ7/7P??
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M>1"F#2:, B438UZ])7-RMST*>E]$U/_N J5?EC7!7*XRP$YRJ&(\
MY\8C[RG-]? <,KD4.GRNHB8RT*1>O95BCHJUM)UW=1AZY'.?PJ:%35?/I@]I
MLBILNAHVG1*7K0@B$6Z0PBHAGB1&-C*):#34$1-C<"R+R[B0:2'30J9+CLQZ
MF0P+A:Z$0J?MA890ZHV7R#A.$ ?] ED7*-**)4&I")RX^11Z/]5-%S.(W2ZM
M0N'PPN&%PQ_1<%PX?#4V%SS<
M<]#6ZEBVW_@0??>H R\)^8[1([KMDUX\SM6SO\7&NX[OMF/CIWQV>W59Y >J
MN%>>\4#/>!&%"F^([,Y'MG/CNN_L.U+*8SRH!%DE5'CROH>7 QN>P>)Z9FMH
M_99*(:@GL;C6(T:WDOTNB7ZUY)?EOLF-C9WGK#_ZY?=/][CPR^[7V;M/(>MW4_OSW;_@*N?
MX/K6^Q\[9]"O3]"&,WC_'SOX<.M#>X?NB/^<;<_F#E<68^,IDH+FS!Q:($>#
MK:)LB-3&@LZ4?7OOR.ZY;2'(AL*=*8%.&ZI"H-(IY9+$-B'-)D29>
M(HV3=(80)8G)!+9XD/,:>3'?/@O:_4!\45WYKSE9STJ^LT=PPBTT]R1I[MV,
MDZ^Q(G&J(K*)&<0#%\A($Y%T/!D/0KXU,>=R6(&/[QHY)12.> #7TL(13Y4C
MIB.]@C/*> 6R#ZW\KCC2D5LDJ!) $($'6KFNKDF^E\(1BQS4G6?X?6I>%66)
ME"7R=+)&/55-:[\[L*U&[]+!?+7#N9SVJC7#?@ #>R/92UW+]:U<^G^
MKS=1K+].NK!$>2&,%OGQ=O+CSFR6;L,%]8H@28Q&G&"&K&04YC>QR).TH('<
M5<=<%E'K<5!0F+$PXR-KXH49'Y(9IP\9& ^,)(T$MQZ846;KFS9(QF2%"; S
M!K4FN>W*&EK3-103%90)AP31"G$9'#*,.Q2T#5XI;I7E\ZTS9;LMV^W+W6X?
MQXFI4.4#4N6T4U+P0A)'#6*2Y,3E3" =742@BHK()8G6;_YB@>+YO_?YZU_U\J'%$R0)0,$$_A
M'*$5AV\JG%S I-D!D(PQ,H)(A9!Z_0,Z*G!G]S/&!
M4)*!K(X1%XD@C@U!+CB#O)8T"-BEA**OWDJYH4OJM$*ZA72?U!%%(=TU(=TI
MA8!:'91U&DDB)>**1V0\ULCH2+S 3(*.<%>%H'!NX=S"N0]OIRZG^CE9*$?#NCMLPU#XJQ)/TG.#
M^0W)*B?-[(1EF_C*28;<-$7TR@),M4T=0-P:AG@>O9Q-Z\V<23/VQU^ILG]U
MOS7SB,-CJO.P\5/ZC<&Q'31L#^[TOC>,H=&%48=/8^,TVEZ_$=LGK>YIA,[T
M(@S%>9ST1N.OV91B#?A@5!>J?F8=D#?YU//G57$@ZI>&A2OV*,+CV[;9R6VL
M7PS-'C\[];KM1OX.QT"P@V:K>E*P@YB_E8:MUOFH1%@I3==L-0>GN3'Y>^,7
MQ!\GT0^@+6DX&$+C6LT4!S!-^1D6'G&2V+SDFC#).4&:A6Z?MRL_O!Z3(_BD!^\[';45,).@I><3
M M,Q\3R;8"ZKO@O<^-Z$1Q-\,4!Y?VEVAMUA?S3LT+OSE3"HVC?NX<4S-Z8.
M5  TH^?8FHP6@< -T!DM7Y[/D6"$FOG!;WJQ!6_X%D>I5T<;Z,1=(S;!%[=8
M!\0Q'%Q]R[P,L@_,HA5$C9X:U8F?Q[V+D[RCB%POVJ^HFM@WMO7=GO9?_>LR
M5P%130[@=-^OGH'ZY]2$UINYRO[PC@;O'>6"6&=D(H%%BQ..SK!7X\44P^8
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MDCM#8HR,)_OJ+0>\7%%.&A9B*Z^!:@/1E]?)=Q!8\LSWFFZ8
MR630K664D=!723@@MUR049[N2OS(DD=_Z/H@)=K>:6.[ P+T<26!_-;MG6Q4
M LTR2V[E]7#*DEO9DH,V?>:!1^.E0S@$!KJJB\A$KQ$(""EQII)+$J2:.75V
M9U=Q.1JOO-#[M:[U&ZS<;COV^AO+
M&PF>BG%A.R60/+/[W;\M: Q _B1+J(2_S@ITAJV/O0&P[ZR"7+%M[($JVXLG
MO=C/"EC(F+5C@38_UMG>T4BSSQO&ZZGWB-=S'IP57BER [JM;'3X*5L+:*48
M#I 4U7^17WYN'(-RGRT7L=_/J+2-7BX1D FF#>HPT'W];'_IV4->W?_BJ[$"CV3ZI-YFZBQ/2^T9C?T*4KVTM
M,3\9_@\];<&,-F$+#M5@1@O"&[1O;#N WHQT\U@W9OQA_P34^MSFXVXC=GHP
MGF.3@^^.+!KCYE9VE5$[-QI;,;\L][!;?[\%"[R5WWG>SSA2-D;]F!CZU],?
M--KV%&Z$-OYW"(VL9(JV_1HOY(RJV (T#5J0IV'4MW&?;1NTKL$%:S\_ .7)
M!]+HU":+,.UM$MIM%MJ_?=[>V/P?%$N<2I#70]1&/
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M?U7R6=X]:\'R&BFR;M;'$.?0V]X="%/
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MCG?4NVJ#SBA-C4]6Y'JY@KNDA6=4)!8X:!>579Z8,#K*!AU#E=YE-GU;%^+$K4$-&)[D"@F"+H_(>*$
M4 LXZT6_]F*]W1Q>_)BL6VU^&:83N^84*6DX2$
MDIAYZZ.CYE4C F^>Y#VZ-[PNQ\ -D[]"WZJ91 ,S7M858":FO)'G/$-C*]:;
M:)PO6^64_?TG58><47++.N18WD\!:LKNI0[Y_11-OY?&PB;Z=!I[;R.[V!C<
MD"'EQG3WYM44VD;XN=%]?!:^#Y3U?*$(D9%A!MK[%=J;J3-N=[68(O
M9+CNNLS8,QRW+, OL*86ZO!+&SB\"C ^T[$IBVHEB^J!\MB=]_DJ'9/H-4ID
MM]7L^^KXLF<'<2JDYA9AY4]A^2P8'7JE:;DSS#OB:@,-V (VY+
M'PQH+MDW,@*,OI]- ..9_0 3>VXV1O2)FHGJ".W/I[MTG?T\!/<
M\\O_]\$N ]^Z(G1P9O?7O+SOM[;.#3_]\G5MSQ46FM;2(!AD0QTDC&P5%@B06
M3<(X>)OS]\RZ(/WO(NQ]ZTII!9-78_*.V;4*)M<-DU-9!P36CFBGD(BYVH?X
M_]G[UJ8VCJW=OZ)R[0_956[MOE^R3[F*V$X..1'$-HY?_(7J*P@+Q"L)V_#K
MS^J9D1"2P( %"-$[.PY&FIF>[G[6K==Z5N3(&H41]4XEK)RG@F5,SM>8%4P^
M%B9_LCJJ8'+%,#G+N20Q%X%@@V(2#G$M)'(,!Q2CEF =Y<0<4?3D:F'R)^EY
M"B97#9,S>M+1@&EP#AE!*.(A1&22!U/6JP"8)$P*>1,]N:06KNOE0+\=>YQZH75G$?$G,G%U\DA31)8"V T$&\L32[E2I[YE*V[F0<_Z-93@+BJ
MGG(!XI*!.&,3$$>P(%:C$)5%/$J%C!(8"45CD,$3JE4&(B] _%F204T)G6,9
M+)-VVTF['>OA6N3PQVMMRZJVK4J-;ZK=Z_OERNHF2[:?6CV0GRBG"X[O4=^S
M2:%/#5%@SA9NB.34F;_>%C2@,\WR1YE
MBLK($I*2.\23MLB0)%&TVJ84J=6>7Y<&?#ES570K@B5L=-TU5+KEM)2WJ^:4ELOO;EGM3>S9R
MJ]7>Q&ZM==B8.;ND+]TY ,1",HDIP156W#ME#6>V?R^>_X1;__QOK?]:1
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M@$1;A[!U!'$<(=4]_AJ'HYICMTZJZJ?6:_CKX'22_#3#
MI#I#I#IN7'+33JCM\>TK4LGJ$*L;3GW5>VP0AR=]N'G3Q36?<@WBUV[\UO"Q
M5L2@QS7?8;[RJQUT9_-[V#^N$C^J5Q^<5A-;=5JI9F_0'7ZI^+AS
M/+].3K]NT_4E][ZMFNP,3U/J^FZ^F[?#@TF[ES(.AMU4M;Z9SI^S56.:\0FBA7V9
M_8A]L 2J+^2G]'TM ^P)O  HZ'9KHR%4SV'%BMW]8@JS\Y(&_?/,$YIO?5KW
MHAF.[*A9[NY1[I$3P^46F/F3X4$W50[.Y96Z&$*U/#!4F--FAL=?&EZ>[>YQ
MO8)U]EQVG?I59E >TKIDO;3H+P=[YW]-N&&-C@JMF9[RLAY39YT&AS=SX@F'_-#=S
M[E6[82H?:DPH?RU(8!P'@,Y1O>JGPSK%,M;IEB]AIPTRA^S,THSL<A#WJW3Y:J#K*ZKS$DRA+G<(F,*KBZ-O
MF83WZFS4>@/DKD3UOIRZ5]T>*\]NO8DSTON#LTDJP?52OA83PU];5T_^RN7+
M*=4FYD[Y;+3T&C;<'N1M1XW6>TC15].H.5_.J'WG6PLBWO2(3Z\!.K
MVL;<;*PE#W')%(4+OUJR&TMVX\HQ^3U1Z.9X4FNGLCT>]1#H,8*I;V=K?J[<
M!W2)V6"XM6!N!GE8*S4YMSLT3I(&K[VE/GAN/-&$$6RPYE@3RGRX>^H<_A;=_=P$W_^]'L7GL.WWW3@]^\/
M._1M[C___7-W)NQ\]/[P\\Z?A]N?=L\Z?_S9[1R^[^U^VH1WVN>=\S\/M_[H
MG._N?*%;Y[\?+4K -"*%*+Q D>*(./4)66\C$E)@S)BC*6>!\?E#X[HCR2QD
MEIDT60$%KS9,[C<+M&.$L&H>MBC@&QDCT,JD[)ZL4N;-L
MN3-SW)4X%EQ8@S 3 ?'D&;(&>\2P5MYC&2.C+UX)6N1.D3NK)W>LU5)*RR(3
MG"LI7(@<7RY,TOW%TR0G,B K!WKFJW^8JR9V'+%K))R3==+92D$4_(P/7:2)NZ:MEW@$G@O+<<07&OJ>4
M<1,#848ZZHOL6AG9-6,S8:IP"H$BG++-9() AGN,&/=&JT!$M&:AK_:X!3N/
M 8DWEX_9[A396?#::VG,@,]$/-C=0B8)Q@PQG$MC=')22<-="=ZLB$!84$!C
M>22<*(0U38BK9) 3*612\22C2]PJ!4X4^5EC9K$ 6%\_Z::E0D5ZO.CZS,L7
MG)$:#&OMI%-1$)>"B(D3IE@)P:R,])CM1F"4U)1$)"P+N0#8(.N,0-P*L"@4
M#S0R,"=^.@13I$>1'E.,ZM%8YP4&64X6 B$TX49V15I,=L((7[
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MGD>1%3>0%;,Q#4>X9%ICY FFB&.FD'-@.EQF0
M#F ?2&H$?$2-LNX>2-.6>$C0I#(UE;8,K([0/\UUNV.0/.]/!=K
M$5W+%EVS!Q?6">)Y1$)9@7BB&ND8&-)$.F-=-%&;(KI65G0]]7LL8 &\ 8?>
M%:0[C]](\$(T;:>F-V\5-5I$M98WY/
M)X1*]S1)U1U_[8X H/X&T[;5'\46@5?Z/8__GSS^>Q[@M<-Y0NT9#6WKFC#I
MMG13U+3)':F6KB=%,NP^NC,*K)MX]$H<.MUL>GX!BPONVLMQ
MB7]?Z?29V;VQ)&JRHVX(O?@X;_Y7MCU;]T_KMKYS1\O>F;*JRJZA-]>0FINRHI>RH)UW5
M-?O.BT\Y/[8_M%O[?1C1<14 N)K1YDDC
MI\,PDSMB+#62)*P8-ARNMLP[*PB+D<9HFXS4N;0W)'ZM
MJM=3[B3V??1KZGZ/ 9W'07^22B*?Z 'M.)/D\^$[TOGTN;=[> #C>H>W=WJ'
MVV_VOV_]L7F^=7C0RYDFVSO[XO.'N4R2HZTW'[]_/OJG"\_K;;UY)^ ]^/:;
MMS"^#MW^XY_#SSN;8OM-KW>)X^>\(SJ'NWN^:LA9>I>^*T"M"[Y+0BYAA&W!P/')N37":LB"<#\QQ+Z1?
MG#!7A-ZC"[VS*:%WOKMG=3!<)@SR#B0?Q\(CFS1#4D6A30C:AB+TBM K0J_B
M;\0^)H6C5%[R0*VES'#C13)*QNCUTBV](MQN)=QFJPQ)XM[!RB!O;4*<4(E,
M8A1IS@45Q-LD]8M7A+77E82Z2+8BV6XDV216(=KUE<;44R58D
MV^J\]RTD&U4Z48)=-(1QP[2C2DIO5*#,)H:7;[,51W4I$F][.CIWOK$7P'#S
M(2D0=C9D3AD,$H]AQ)+16!FBDXS%42U"KPB][*@RE[CRWB7FN*7)PN\2O!USK=WWGW;] ]%FI<2 V
MT.S!/D^I=QO:O)NE-#QV:?O2Y8 /CDN=C$O1+6
M/1S>Q\>0F]^WWG3$GD],"Q\8DC11Q*4"Y!-/D>(>XQ24L)@]3,1JE9!>[)MB
MWUQVZH)B+$DOP;3A3G#MC,56F,"9BCSQ$JYZ;+GV\;)RV?&OQF*^O2+6GI>'81>Y8B]51[+F3043!A+8_"&RO8\L_""IZ7@^>9U":,
M8Y3$,A2QR7RC7B+C4\PV!TAGC;UFRTMM*GA>63PS)9.@03O'"4_>&"U,Q$IQ
M;8B7/)4@R./B=C9K)R5N3;04":(, E>!(^V"S6<^X.U137GV%<02?(4"VI4%
MK:%1>N>]=A8\_* -#Y)@9X3P026\_!., MK;@78F(850+QFL2\V+QRDQR&E)
M4!"1*YR7I$NIP6U]Q&7$TPJ1J-02O,$NI:!7G46&^HUM;:40JTH
MFF>3+9@4A!M.D1,Y<9;*@"Q@%X$0%EZQ["?;8CJO/YZ3=IHXY;01CEMOC8L^
M$!,I\2X(18LKO)IXGLLC8%8E)L"SBIPB1E&+B6'I//<6AY@![#5\X8?FN9EBK*\N07*WZ_P,TV6C\SR
MJ?)OAM$.@-)W3VROY?K'85CQP<):H1NPQ52D['=)55QK2<8#3\GF?K"<\RB$
MMB$%@ -CH,FP+V?E*RGA/LZ=E8/_Q[#B$5F;!5SR!AFC'/)!F #>!3B*R_,G
MEM/Q][%2C]<;SQ0+3E*0&DQ1X;WUF@8FM8HV:=@&)4"PHGB>.2O75GL?&$>$
M&XFX B@[1C&21' I!:$1NX+G]<>S,"1RFA0C2?*DK!/2$,.)\%QB;ZYHX5D\
MC8?"[>Q9N0C6"J$ MR2 'C8Z(2.B0)8K$@5F5-#.<>,T
M22]>T38IF%UCS(+)S A55@>.0<\&!5J7>&*)(O)I9G#\HEP#=A8I!W
M'.QFJQ0RVB>DF2!>I0AN4"AV\_KC&7-M,MF8=@K^@ZW5-'JM4^X)JF1*Q0]>
M33S/'90#4)WS..7D4P!TP!)9#XZP8U[Q;%*;J J@UQ_0/DIFN)7"^\23)CI1
M9XV6'G0V)M841_BQ@3MS4 [8M#1&CP+-C&@6?M+,6&29M)8;"U:5*I[P>H/6
M)L5"<(8)!Z!USA =P1"S2G-J@A'%$WYLT,Z>DW-FK7 !&2D"XIA:9)+42%"I
M-6'VUTFD^\_[%7=T,]+DGYD06&2/14!P9[%YB4B(L
M)2I"$M(P7ZR$QQ0XN_,M/@1Q,B2-M+?9NM<JHGGFT%KYS!V3)-)4:<1C
M!%]=IHBH,2FG-^-8"!N> YX](U+'(#'V(1^G6.<<95[J%)T5H225K2B>MRYI
MY_T]'[P+DAH4!(N([*W@>67Q;)4*06 '[KSAB3.G
M=*98BL%SL*V;-BM%/Z\>GB_IY_T]8R7A2GD$RYD;ZL&\6B$C(AHS'"TSE"R/
MO+;@>67Q+)TSC$KC%8T@U*W5+BE&$^6&:\9YT<^KB>>YPVYLC5!"H4"3 >_9
M:V2IH6SKQ8\+\=_
MGC_LYA@\)H;R42?B@C!D$U&(!$^LU%8+20N@UQ_0TDF#DU,\2,>EM!I'K[0A
M)J>2K"^>,TG/%>,I11 =-)&/&Y$S-%&A.+
M -P2$R4R/?HJZN&'+AA_C*/P_F"T;_=C5?IM,PY:^;5B6%3S7?)Q+@LH$FW
M1*00M>/),NU#3L,2#DL;"8_%\5]% >7GCLTUYEZ#6$+$<8RX9@)I1@-21E.7
M6%)8++U)?,FO6ST\&^4--]0R&@VG7KJ@K0TV1,(L9SX4@V-%\3QS<&Y]5"Y)
M@AS)7:8\\TC'8)%DQI) L8L!%SRO/YZ]BA([K&C2DG/EK!4T>J%D,"$028K?
MOR('Y$WE*!4\$>H,[!L!OC\S@-M@#,(X.LX3]CCC5OV\TU\PN[*8%4QA'B@G
M-FK8#&#0\TXAA&1WUFFA-BMV\_GB6RAI%/9.,2"ZIM Y\X,0X
M^,!4,\:*'[R:>)X_ #)M\ ?1S +1D+'@1
M.28\)6V%83SY2*T2$>O2(NS13\QFJKV-]5P;)Y'CF?>,4I]YSP(B)#'+81U9
M3BTMGO Z@S:RZ%-F0S?"A(+GZ[!#2AJ/
MP!GBR$GKD2!@2[G 1-4[40IQDBK:\9
M(ZU^:G6/O\;A*%.A#UONK'70C0,[\ =GK5[\&GN+.=%_-(,W[N"^4+ ]7A[!
MXOGZUVWS,V[^^BLBSQ>_]VWDN3),,0RF."%DQ!G N+7&(:&9IXM!X[F:,ABY,0QVAX! OC;NE2-X;C(R='
M%JE:I.I,QZ\D+988;"+,L=..!B-2[H6=;%*I)(FNJK2=R=F(U(## S(V$%OE
M8&&DB8U(4O,]R57.D/1?(6YI0D(A.>8R4X2%MMD-8N(H6#I-9[X?0U/$M%WA9Y6^3M
M0\A;!7>(1HMHI.;,1NUE)%Y$EY)UGI4F,2LJ;^?2!I/+>2 W
M#&DLL-':T!2NJ=^B4%N<(_;O-.ZR!^OF'9>*S *#'<:_I\84\9AK+1-
M@I;0Y&.G)\_VM)&<<1X-PH'G.EV:":Z-0THY(Q53+"4P[*0DUYRP%X ]',",
MHTIXDH+#G%.-C7&&)\>MEMP*63JQ/CK 9C(2-?4LY*Q_%[U"W 6"=/0>Z42"
M,3XQY=B/XE3/A0EGD@AI8=M;8V_FG]8J_N$7.#69B2%0QD1>B?
MNEZ<$Q9WDD8W3:8NHRRC+*.\QU*$GXMV/.4Z!1:2 4TBN,**>Z? ^&95/SH?
M@H_)_LCL[L73!1;!E#CN--)X8P2RN!@%M_;N9ZQN#5:<5)Z =^\U& 7>(>."
M1$HG+G0,WI/PXA7%2^M*MS+^=8'[,KI+,!HE*5",,L,\^Y'
M3D"!^SW#?<8'8(R %)82,.]V?0
MHG+#^\$I."!=0-X D-$:1!^[7RV8/H\=^2CW*/=8BWL\=W[M91CNC9P:BZD+
M*544]ZT4]Y=Y.STIKR*+&KGD.>+)QM&H
M!^;S: !WJ:?\:AK[!XICEGN4>ZS%/=:2F.>7!S&IX(JVE9593T
M'97TVV]_[;P]_ZO.:#OK[+P[WWZWQTG@,1<3T.SI[V7+]W.$9_CWJ'\>SUI$=?(FC2\S6![&7$\ZR
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MCT]M+?KO/'M+E4&WN1F3L[:M1^OM9FK^;N$Q]=V>-#ZO=?_-IS;8#^GSI?W7N1&NR)K
MM-?]HY.Q)O(@94;]2J ,N@[V=>M?MW 6".C4Z(+'3$2NF'%&!4VT#)YQKJ*Z
M>Z#G;36V&'X'@3:(;X].>OVS.'@]'F8^X]J"8?S>S>[#;K2#B2.!GZ@C\?E_
M#K _^N?8?C*GVS"FW4/_K7/^D7\^>GL&3@&,Y_/!UIO>P>ZG?PZV/GV$L;_-
M;%3G^^?C]SU'(S8LDU4[0< -, R9W&4\DN@(]LX$D5Z\FG^\V3C;<\JFA!U'F&:R'6XH>).>
M(XU)$@03F22%;71E=<[,;H(OH!OOJ&P,W697X> U%Y'ZB 77@62F?24#4T9:
MQWC95:NQJW:_[W&OM(1_$6B('%^V$5EL+))<@O9P =8NTSXOB%#,BJ>3RV;T
MP849W9>2HVMH#@:RH3+>4A[;S)*,/R#+N!R&2 ?_$$,I[VXG<; &&/%
MGE4>X$X.A^S (W_K]?V7Y[?+SSKGF]_V8I2!6 MBTR6N5^/K*#?? C];SZX\9_X>!;2Y-=F"9;IGEPX]VT*^]F
M)C!9?\94FRA]Y<>X3:[\[+K;4M/FDMWIMM<_DNJ[W?7:P>JV4/)&M_U!1M(M
MTANNR5&J-]$J45DU9L5%:*>Q=K*!<9.\I76=EUM$PH;K0_OTX[A--3G97KFW
M"O='IK:]X13<_!SWUN__2#G$-WSQVY")@_&8;, T<,UEX$8HK)GV7#LAHO#+
M;-'/1UN?_NR"G4BSS0CW.]K:.8#G][J?
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MQ"XCN@>,9VH#(0ZI)$@F&"N),&&>T)
MH#CZ: .3)(IL._STV6.).]S6=E"Y[(AB1DK\8<5LB"QY+LKOAE6!5U7!7L31
MK<31[GQ @E@CG9>(*L<19T0A[9U!/GD54C)$!S J*.$E&6*=T%5XC;X5%G(*?8"UER(B @V A@=?PXA63J]<>YH=L6]>2<#P6@\CV
M"/;N3!73LGB^5J92=)I09'C2/Q[V!YGOB6/RRY=_3^K]+U5:5S6D%:564S<]
M;%^44$]_L^&5LJ-:_#NPH7[AQ!!MO-)QB,*E)I6IVJII-
MRL*7C_=CIE.Z(*UJ]4^:9WRUW5Y5=PJFWHG->[$+KY-9K8[###O6F"PL#FIZ
M+GB1O @GL5J)FA@KQG:KD\><6;!\)HZY_$X-J]=XTFSU KDW4/]6W =WJNJ^
M@9R>YCC(>_=U?PA/]/W]XTS.56@.KJ(YV#K<_[9'. T2.XMDB!B!ULS-;:E
M026BD]$@9BV83M?1'-24!>367!@^&<_A8_6G%,0B[+PZRE,UR,AX/:]ZPO %?3C$4330(:(FSK&W@
M/G[Z@DR:UQK9[RB,[^?LL#ML#4_=(=B@EJ.JDNR3CD^J[5.)<$O
M">_3R5 ;^9UI/(CZ[W"L\:J[C0Y 665] >"(^_WCV JGE7JQQ\>9G^_2$*<>
M/::?W,P5V\?PQ??Q:SP^S0\+E?HB1LN7%:/B458YH?5+_GI#*Y*_-*&YS$^/
M8$]U&\7F8M.R.7,Z#/I'EW30Z2T78,*A6;UHOFZ\$*WQ/%]#+ L#C"3=XWZJ
M1G1DOW>/3H\R7V+_6Z7>3P:9*^+[96.D(9N<6KU[H<2]XZ,)]:2
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M^K"QL[F]->=1WISC<2&QY8_'-?,>CC'G"6%:1QXU;#KN&+=SO_^
M928AAKN!RKWTO9,XJ.S;/!K[S0["<,S.#((UTXA]!?L6'+]Z$#6!7;]R^ZO;
MH)HG>GPEZ.UOL=?+_\U^X/?4]7%0/0]>=M0?7+H]K'\>!A@3
MPT8;9ST!"_D5KAJ.N=+&B@1\[6[V9^&>O6[C-P_AQI6@JGWD>]9ZU1U_!3NG
MU_4WV%I;_5%L$=%"K0]Y'@_Z/3!0)INLWE^/J:=?YBG[/;K!J1V<5:KVY:4)
M[Q[[0:Q6MZ(8GT08QMS=J?6Z9T%S;^0KCF 7?VAVW576Y00T3=0A1]::#7NE
MCU@_;+EA SS'##?19-.Z;F-015RR9OOM;$[9;>0=OU6QFF^GCWUHA9GY7K^0SLY;\&/?\NTW^WLNL)RX[I$R-(";*7)!O9 Y(21$
M#:I3XLRNB/%+C!>$'NJ-4MN>E?_B3\&$/Q[USJX3S:2LHP[1*)FB!L[JM_S'D]Y/8SG_>W_P!UP[*MOJ"I/_^];^GB*4Y?TG-_(G46)5>Z-9\HM"P5=8FU9*855?1]-X\
M;OUICQOC@YC+QH<-8"\WID?^="JH<[5);BZ9Y"];WPZZ_J!U.5*6;SB*@Z-)
MG&IBE;QL3)?ZJLDARB@;I1#1<#,[7&B;
M5[9P-O;;K7'X$ 9[4HUE>C(.X/KJ_A-+^R(Z-_5JL5N9U;[73:FQRV$[39G_
MS2_SZ5'5<27KRNEO-_?.G[>JXVIXS"#&UED^Q*X\F=HV;[3LW(VGK^^FIN-*
M_0J#W'HF6XV#W+4EQE W5(EH?+IV7#7.J?B&1W:P#W\;DQE78T!Y#/4#JN5K
MCQVTYIDY=.IB9G6M<%1UW*F,TL8URK[*R_QTFS]PW>,FM)I:#IR1EZTF!)C=
MBG=;^05G.V6(^_.AALFOFLG">UX7U]0/IWO;R/Z355F%VYZ:G6[:^N
M=> ;C[IQ^*@S!%!8K0FJDQC^ZA_OHQV0':LR4;,R;"(XIJ18$RRJT=F$S"M9
M,YSHF>-P^2QF"M!'68:<-_VR6KD_6'X\RD-ISI#Z7QMGO5$*C;BY3:S]&78E
M(C/3\XA=B7Z":W]!T/='0=R9H&\DA%,N,'@I%7T$>%$R!&RL\A(S8EJ ,4
MX,[O=_/#JJ=7MDEE_;6"'46P:C/VF^S#&>,BFSV5H7/9>@S92NU7+S*E_Q<(
MC973_"LJN?.2S"X@KFVLN\4 N&,!",?/+Z%L?@6>8383:U!^.HP/_!@'4K6#?1!+@
MIPUP"GI-3*IR-K(L /?"=BMA!W*D%E@3X3&^Q>1".HYR=7*_RLLAKHE4 8F2
MH_]U"DL]IF8,V1-M3)/A%2Y4=?K5SVD2JIZJ=?HJOL>
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M+VD[.)1L#+N=Q-H?BM]J[7$>>DM0Z$AYTL(3'
MJ)5BDBAA RE[]TGLW:TW';JG)'6&A8BLH!'VKA3(9;W[H*0
MUGCOUOMN6!OF5PKXVVPPRN#9-*H@I0([2SIJDR B!,QT\%*6#?9$-ICG>Q&4
MF[*"(TLYB$1K K+:!J2Y#A&VF_2YM?;5K,4+=MDE6R';E6 B5#9&=^[X9%KY
M9QUO6[79$F$4\'>[/U;P61+><^7-O>W&.I8/[FOSJ_P]ZBFZ+/[!W;*_!'1Q0'2<*/7Z_OJVTWJZ-PNK:K$?CO+IZHKUEK],I[[MR"+94 \80I"3@D4?(I<*YVP3D^BL_I&:WAZ=)03-\?538WIN.A(>9BC
M:G63]>%,E_6K7=N5:[.N6%LS?)09?NLR36^)HOD;:I6/'5V[IU LG/\/&N:;?R
M]6Q(OC0.MGR"7)T>;DSMIO?59GI;'WX]^9A7PW[Y)?-E?=X)7W;/.V>?WWS!
MVY\^]^"9M'/T_DOG33C<.O_(MM[\?K35G66_? ??_;VW1=\?=L[__ (>HH!Q
MPOOMGGW^X]VW+=IA6SL>=S[MTD5-^CBW$GOLD%4!(QXD1[_P>*UP_S\8">W% E32J,B>N\B>^1Z#VB8',B0A:U)"
MW,> '#<2"1N<4DPP[44^(URE[F2%T']5C84"UN6"=;8/L2,1*ZY0Y#G'*6J)
MG"0S#ZIYWSX9DY$7D7,7D3/?
M1]!S[TC*E/5.^CK?WC*2D-#!$"&L_.*/:5,UV8@Q+$Y%+&+[+F)[OJVB
M5H8$0R6B@8);IXQ 1I. &",J8JVPB+3J4$#GY/;]U'/_3/+"TG#YR-&A(E^+
M?+UO,[C(U_N1K[-A,T.L\P&C2&75:TLA*R-%-'&+-0/]2,"'50O,XB)>K[+7
M9W@*29TWOVS/^P;WF'IA!J\4^J&._=[TK?Y]T#\J
MZOQGU?G^A;MT_NX;\D?6_
M[Q5#3\-A*3)Q363B8SHNRY*$TZ7\J?L]!G0>!_TB(6\K(<^F)>3^'B'2^Q73E3W^GZK6=9K!?;H[Y+7,
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M'W9;F>G.PN'[QB8AE@:3TF7-R8
M2D@_JE%?4P-E,Z!A]*FHA:INO:]A>(/38:/C6ZXRIJXRS9JM\NL3XA0B;2SH
M73B%A&D#,)=/TZ/;6MSMMM<_DG.Y_,&J-L8W&^P-:3AN04KQ).A(:LNOXMP:
M'?1/X4YA.!=7?D;S\:DA=6QM-*2.57_CUIL<$_@]\T/_4_%#_W("AG]ETEV>
MK,7'R>R:T^1[I3!YNJPI*Q*HOXHIY7AL<<_U^"+F)OPW=YB%A\3*S^;<+_1P
M Q4&:\><5)XS3#0#>
M'?#PZ]S]X61=ZW;G$Y>7/5%KL@G<][;>O#_8W@F]+; C.W]LXNV= _C[5J^S
M<]#KT$W<.7][]OGP"]_Z,!NX_XBW_G@K8#RT0SO?=@_?B6WX>X=^_+[]Q\=S
M^/MY9^?/H^V=??(_YYM31YL?R=;A_IZP%(O$*#)"*L1E4D@3PU'T1(5 /4DY
M@5_-U_!==_Y.@?$"E?QF31?,O';0SFC]J$SP1#+F4-7_D%AE-"2+$8DM(
MDBJ%?.K19GK)JO\)>OW_5.;H\_'NK\Y2?NJJOU[)HOKO)$7>S:G^R!T/$5,4
MHJ2(.R^04YP@%6UDTF'F-5GHYM\DT%S\_&>B^R^#LNC^I:-V1O>G%(0GEB%!
MM4%O*FP>\7S6EO
M8!?\ ,W%7K@AFF?L!:P#CL8$1*C"B$OOD6%@]'L788M$IVE0-T3S2Y!=RCLG V9*164)K?+C']6P*-D#
M/R-P=N?,!V:(Q?E$4K"H,+^]$H405;F$ZW V,)7M@
M+6 Z8QXD"3I)PS9R4CZD=D)R5]X&E($3^?/L")P]QQ%!7.I&8,(Z?R08*F
M#IQ0;2F3N7EF"1,\N++_25"6]('U >V,ZH=MD 0#T&I!*.*6"*2EQ2AJS8*F
MQB27 +2B35@)")3T@751_25]X">DR/Z9@21\HNK^D#SP4:F=TO] Z.?#V$;/6Y.IRB9P('JE N*'4I,!4KB!]YA26#/ND&>&(BYP0IIR@22E@L%'(JE;'#+$^@_.\[HS>.&^M>#R+7=X]:8JW+8^A9_DBOZGEB@*Z+EAH3Y
M-GS.%9,I#&(0:TKG87MEB9#'V[%P(2^?9I1NO?ERMG7H2>=P%^?^-58F+3A6
MR%IC$0\)7#JB.*)1.VVEMH[$%Z_X2K(BWU44/10E[L3.6+23"_'M0N);OQ<-
MV M&&)0BZY._UMXUJ@' WY
ME*' %I\L?+&FS&][V65/@
M5E*^T. ^(QK<2^T 8F-+>P1N#)1-%Y)(+
M9A<7UA#\B''H]3XN^[)UOGO>.?KSL'/XD79V-O#6T3NQO0//V.FPK3>;WSKG
M?\*UF[SS>C;N]8YM'7;.=H\Z9UL[N]_!.*6?WWP16V#,=LX]/&<#[KO+=@_W
MO\UQYYYW]BA5EJ; D-1)(*Z= [>*"<28 )]*6T_QL@^_2XSZ%C'JNR%U16/4
M!W->1]Q/,DBO%<=?:
M!I9&F:(UV(*,\8I9&Y6P1!OF?$C)_2#?YB&-A"N*XXH9,8"))<%E*05VQ&DI!W4JB><9D\,1&FV VA>8.
M\>0CLMD;P$Q@:P7V3MW;Z<(3C#&4@KJ'M#]D,B.8LP#SHY9[@68FF'%,\V
M&'&70XJ[87%%4Q4*2F^'TAFC0=(D@Y(!69_9>@T U$IF4,#:61D8HSEP>--C
MB1]6T]U;H==*E;_5-2?-9E[?8K=O_K+5
MS7\[>]D:Q!,P"3+4<]5:*W[W<3AL:MA:*>'L74"NRG6I6J7KVTNJ![>LEG45(5PN;8MEYZ%UNFP*IR "W_K@?Q''_Q!
MOY?KC>I+\HWS%X[Z(?9>MKX==/T!O*'OG0;XDFT=5Y9!]8[#X>E1O;[-%_)U
MEPLP)L\=7HRM&GKK:[\'LK('0O#E19'&I<%/WM7% _NUVQ\,7[;2:7:P6K 3
MNK#VH752BU3X)%[_T7OY_$JK %WODHSW._
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M@M]5M\T6%4A.6,]9 ].W7E2)#8U
M\(OKFSK@Q2)E,LC))FR$5K47XQ_0'N-HAV>#HX:YUU8P_,\=/!UZHT
M&>QMN$-VP/-7*SS"7%;0;;>V^BUOAP<3@0=P&4P]M%O?'P8#FB76LU?/"N1P--R["F/^G1X<=/FA;)BJ5>HT@BSU:+9OLF&=?>X
M_M:4Q?$#$=KL)Y[KW6"'=//5OPYBGOZOL2ES:[SLJ:N:@ *^N,2Z8;]W.KKZ
MDCGGY>'=E HS!+.9N9OZ\V!2&'0"1CYRL%F^H*J\_%?;^V;/AB_^<^FE $-H
M>@9G7_[J)9A4ZTXO6^TX<$*XL0D'J2VW0AG!G4S,\62M9IS7/A1< ]Y(CEUF
M+FO#,0W"!8Z]=]HDHBVQDDMLV'4EI/HQ-2;@HV(B..Z/=WD%M^%XZU>E_"U
M"*!A424_0";P0]35MJP(4* *7$1;-:)
MB5H)HRS>_O<4Q*H]/L[_ 2L9%%ZO,MEJH]8V[ D@3E/_=%!-_=C:R#<%H=6%
ME1K%XV95)K;*V AI).6#U9\O=OFK.6F\G5*$OK (?7\O&FRBDPP%0@CB06)D
M= "_&UN/D_&O<\[Y7>'\X@IY^L.Q/W39N-9M3,A=RL8Y;E.Y_$IL0MM:L'LH&R=4
MW\=@B;Y;Z?PC#);!4C^9P<+,FIMM@^=:D#\=3FN5FORK:O+?CAW/O[,[6&;F
M8F;>QR/;K6([K^'B'+_.%ME?W529:;O9N'K&T[6QOS^(^]FDW)Q$63@J;G"8NGTZ A_MN(KESR>%$%/J418G=P3P&JU/"CR9
MR%7$%AMNA3544RKA_?.!,C'WR);G/WO8?[^ >F^"5OF6?_WC[K7,VZY<5Y5K'>;X^'#M[AS_F4O,DT$#A)91AWBVFCD#+8H
M!4ZI4-3(H%^\$N0'/5U*&L<]I''<#76+TSC<7$RGPOG&*5C:F5PN?#P&?3$5
MZ/F[!V\[-C@K>_-]!ND4 AM,SJ1P7+KDM_&1VV\6;N,@A5V*:D.L8H8\)RHE[-.4=[<3!$;V4JPU3Y7\-IX,[1=)U[XY11'64!W,]!-4AS?G6^]Z>QQJJ.DWB)C:40\"/A)<(I(8#Q8#T*:
MNA>O2%N4,LK"N'2MG^N3\1QD03(4#"GN#37*2.Y$S6";MYR;M.1RTC,7?W2S-)^F3_O+8IF8.$VT.AZV;QQPGUUW]>Y_/@7N\YQ2*+!U4FK4S:
MDYJTY^"K7Y\4^7.MNYXG%Q9EFF-)C+!6"66:8=XM;!95TR57S
M*G;G/'Z"O: &8^1D[DWODD*&6XX843D28+G&],4K3G[ I5/LXWMP^.^&NI(N
MN4YXG8T"R)!PXE0"5"U!G$:";&0,42\B3]89'TU.ERSYS?>8+GFG2%Q)EUQ'
M>,ZH4Q8PIU98Y#'SB-L0D354H.!E3$I8R[A\\4JT64F7?*ATR3O:KB5=[:6@,2=@58N$.>(2!(H1/A<]>**\(2F*TEOB\=(E
M?Q*;)5UR'2![=AFRQDH%[B\H?8D!J"1*Y##.M.U@"1CJK NR0+8LT:!^A%1(.ZI1L+G?H0R)&?[B%24E
M7?(13D]6SEXLZ9+WBM-1^RIE-L#4(.D82EW
M'U3(F,01CE@(;CA)F5.#F-(E].$]_KO!KN1+KA=@WUT&;(J1)18UBDH+Q*5,
MR'+B$ O4$L^-H4*6A,E[3IA<1DN?DC"Y'OC8E8_*A,B;O:+Z6C,D51MW^9=1A$K!S6B+0AYE,@$?D-(O(
M.*,-Y\XD15^\TFU34B;?3G7(6YI[W,Q#XQXW3<$8>,BA?YH?5+G(4\[S[$=/
M2_BLDO=\1XNA]I^WT]1N:*14\:EO)XR^S_G4S'AK!?,(X\109AU'3B6,0"H)
M!L8![(4$/C5?DD_]; .DL_=DB]%%\Z'F#W%V?P9*!=T-_F11_^6>Q..,O&QPM
MEB1D2EB/>. 464D8\EA3ZI-2,7?R9DMJR/!LD?AH_O)RX'G97R;%8;XU[&8<
M9B%XL@9L5"\DV*@ZMREBAB%%A:5$O>@ -]A,AI7_B,"NMX_#V^TGT\.-./_]J
M*M)4?3;!46D*/]T4?N?C'F.Y.Y)*ZK86YBXMZBEI2Z*6WO$ER'(*)X*D,!+-0DMX>
M+5IQ]OG-E^^=PW?@0/USM'7T%F\=O?N^N[,!SE6';N]L?ON\LWNV=?CYJ/-Z
M-EKQYY?MG;=G6V\^?M_ZM$MW=][1SV]@3&\V.8Q!= Y_ZVT=PCL<[7ZK>J"_
MOJ!%@'_W+/&)R:@1)8(C+CA'3M.$1*2>"DVBQVZ9\?IGFU5SNX/MNT'U@0ZV
MYS&[+@?;#P?#[C0,O^P1%P5QQB I0S[7AI^LH@XQI81CPBCBV!+/M9\["A?&
M'"D62H8 JLU@;B/1W-#@I+2$)BLE+IFGSP6=6U-*LFZRS(CRL.[2R(2XN;^_5P(.Q.@]#O2662EHHBRWWN=*X2Z@E"ZBWN( [9!.RV\5W!7K2G'D262:)3)8%;=Z0-UW-Z@6]_#)
MP/"2[GN[9SAFTCF H3,:@;:S60MFW0<_JI@S(_"+5P(7$-Z;=Z@2&/N!>F&\
MY9$2Y[S3C#&'-=,6R^(=/A=P7O8./^XY6'X?)$5!"H8X$2(WN(1=YA^M-^_QPX+RD.;_L4<:L$4(BC:,%<.J$#.8<&?[_V?OR
MIS:2;-U_I<+OWA<]$4YU[DOW"T?0#?9UQPC:-FY?_ N1*P@+B9&0,?[KW\G2
M@M "$@@0J&9B/(!455F9YWSYG9-G"D%D&8$TJ]#T#LI:.
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MIWT9*&>NC#3MP4YMR\T;[C&4HI!C4TNQRJ&KJ6ADV80;UHKB;7\Q9B_==!''2+XP;^@:R/B8>^9'7'O2Y]@EN
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M_;_<][> .WT'I:\2(JXE1'PXE(R0& Q%SH.-R#U+R#H=$>>2!*RB/F9_S[L%L(2C?A,Q,-;"@-!0L(:+
M,["/1K"?]["\(<'75I4V<=_-_W$S(PRN2<[NDAG!9(T1L_)(>\)KE"X6:;_D
M(\W\A]YYL+!H:O4Y#-5@85>N&296F7#QTH+*YQO"OY0$SM^*^21TO+3-B
M,QY9U6$G9G-:J2U9+TX)X[A63$3)/7?:1V]2C(IXKR+W^52(F*E3H>4;/,VK
M+;#SGQY8QN];7;#N2E_G7G8O[1_;UN @:+?=^EX6'AA687_9YT(_OF[O@BV]
M\Q-L9E;_\@'#LS$\!ZYM-NL_ZZS^#MYF_]O/@\;DN=#;;W6:*W'4^=Z^A_M\
M@/?,[_3Q>._+YY_UG_[BZXG_L;>_VR@#[J\Z^)+='-@$8JFBXV4U L1#3NI*EK'HQXBRX_\R#%Q]/EJ]:^M'ZR=1@$
M(9%IBS!)'G'A!7+8">19EA7&E1:VTN6G;Q>TL9/V7YO:P^U=W_V[.7W;E@Q2
MJ-9K8JK?X)$F/NIY>K; 5]7ODWH!?QX
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MZ)1W6 T[K91X026>8*>")4.Q<>9&X#XSV5B.Q(J A7+26")]KARBF5;.,6P547D#+.N'/"EW
MG8H4K3:W)3:W@RF&*JTPB:N$L-? 4'7DR#(14$P\ZES$1PJVRB/YC74AW.5(
M_F[JN.;AH)6O=#F%G6"CR5-JO$](^D01YY0CC2U'2EGXQ7.N.%OE4?W&*NQ-
MM0;N9#A69?%>H'KN7NVG='?[X) F9Y+1#(&LNWP J<%L5!$ER;F O30&K5^]
MH356%4U_K.[#=R2U?-7>G3$EO=Y]^*4T'WX\I;L<5[JC0X.]M=A%I$A,L"LX=YK9@ DC+D@G
MJ'>,SJPBM![!Z97[=P7@XJ4?70-V6DW:
MAOE';XEH)U5$^[(DUI(0#3$L6J$Y2[ A"ALM-LIZSP5)*.YG:U02!/#,4X,I&HJ&+:'SBF_4ZF8Q73
M_B+U\_.8?GZ^.!0J:64-1Y3P7)^'8:2Q#PB$0'%-2#2Y.2.I@MH?+ZC]CKRV
M"FI?8ZWSXUIW>9@\US%PAA@Q 4DI\%A64Z2*:A]L'V4#
MRY49SH-Y&!C.@]Z6#&SGT.[E!Y7&\YA9/?G1\T*?=;*K[T@9^A;T7AJ3A@%,
M55;UJU;YC!/+WK50;S8^GG
MA,&F^5+[^W5SGUZL[E_>Y83_A.GEFB=;8:>ZE!&-?
M4!P-9<+E&(T;]I-F[/WVR1_'T /L3[,Y6KF!C#=M[_=LS[+7%^%NMW?:E]']
M_.;[,+ _FG#-,Y7&K_][C/WI/RW[Q?3V3C_P@Y///_/S=D_^^5;?_WB\^^7C
M<7W_X&+ORP'[^N4]V=O_< D2R[,O9F__&ZGO[[#Z]H>?((V')LCH%),H:)63
M,&Q$CCF%J+18.9X2%8Y#;$I!DQ]X]C<3%@!<@.
M&K#;JY4O>B UN>WZ.7SQ^U TBM-VB,UN<=X&:(1-X!3N6WXCV4:G_%HLVJGX
MM/6Q6QSUZPOD[\;3LV;[,L+H>YG!E%=03'B1"4P!,@I/!N;1;+8ONK]=5Y.Q
MN3NUG:-&JW2PB)D[TE+ZM\2-\O.CWP=T'7J/\@(F=LWQ>_^/?+QKA_/@WA6MDS6L.:/LQ@]4*WO<4C>BN1
M,E-??6*^9":47\VD2P? Z(L=4)1PS4&ZC+-XU3WLG\6\+>I 7N2%-VWB\"SI
M&@YC^&5>3LD3G ^N;,G6:Y";<.)3DHU!,:/BEY*QM'MPP]#]U^8D]+1^M97'
M8!-Z>LRL+?.NT^YV7XK7@,&H+G:WMRX/?H*==EK'!W0';+9FXV"__F-W^XC7
M][]=UK=W+O<^37H-PLG!SRU_#N_X\>1@_QC>Y:_C^L\=O+=]]&-O
M__U%??^]F.A]>@G/._0R AF2%M&4ZSO9Y)"3V"#JB I,>,7(0@=;FQ"?/G D
M%Q\;W6_H;2?"3_8\;DXQC[OB[<:&-,W%V]8@V'V5>+NZX*:WMM$IG;)C3K$L
M\UGDW^=)CMWS+/DC\,U07Z'OK>C[80I] 5^%YCBA8+1&G#B##$X1N2@XE491
M^/C5&S#>^13Z_O<&1CF=19_Y[C_M)HARLW%^67'=BNNN _:NCNK.PMZAX%_)
M?86^RZ/OYRGTE<0(Z2-%+EF).'30@[6/6" ,X29XS:)-7F@PT"-A[,$4QC*24I.F_
M8Z<4W):/Q9_M5FCD3_]5H#([JBA58.Z[W37 9AVBG@@=1#TUAL&65_%*-D-V$^:@
M78)1>;_\A3(4ZW5Q<=SPQ_!2OMD+\"5;].&U?*VQ<*[^%_)U?\*+=7K=4H'4
M[Z/GEB_8?X=RQ,7WD8G]&EYF8//DF*_71>KE0EY%&.[?9WW\[+Z&^0M%)Y\)
MI'PFT!AX2(M.?D#M1L?=XK!UHQ)DCYD=<>]+GV"6[3B;8+AD9QF5EAX7N=[_EN!5A^
M<.EP'F"@I1*548:U8K==>-L]'HEDMYS+T=,&<8PP"EBG6,;R#608IOUU_JP3
M\X=9@*^N&LEW?R3PM+S!YU'?$!Q9*ZZ+:]YP,M-IM/K?6HG@#X2/YWWJK-TM
M5_NW3LQK\3T.@@@'+&SLJD$((KZZQ+INN]D[GW_)O$WP$7P&)U]^_A(\/'+-"14?EZ ^
MK636:F>\8\91;IC43%O'/*.6FUS2K\^OX9H8MC))53HQ%Y+'@G+.K; >+H*K
M8Y(V"L)O=E00FAQ-DJ8@- ]"&6T)YE(1E00+EO5#TF$*YX2D3U'M*R(^.QQ]
MC*:,6,H64+SO #555/JUJ/3WAY'R8)1AB.;BC=P;C1RQ H%@2"QU4-R'=8]*
M+_G95@&,!1CTY2B*_*)Q?CR^NZ'^AI$+I64R,PPRGX@K/\MQY0-\SCMMWC8G
M@EU+OOMZX>#SF5/TN%'AAM8$9W>)"F>JQKE+8JYFYFIE17GK
M'3RZF9TF_UH@98'=D+&PBE2/90Y,5YU:LH&/W(0 AEMJ2^/-B658LM(5<]ZX
M1+$7F$?M#196),R)(3*ID.:TCV=/6$'Z9;=-X/ WNOOE,]G=#B?UD_?XZ_X!
M/CC=_;;[KL[K],-/&*?8???YQW1]@2.PI^$Y^Y_Q+JU?UD\^-G=//C;@^QC>
M]V>N6_!U^QO<[VWC?W^^O];[9&_[Z-!+DC0S!BF-,>(R)*2U9<@&DQ3AVCJ]
MZ!%5%3[S$%6P[J2I:UY;^F4WZ'L\7;[6 N7](1:YBH/F"%,1AC21%&DO
M6;(V8197W0)E8W6Y:M!W%P#S4EL6(Z."F(U9< XL#=<).L8URX)
M$IFR+#)Q6U>^1^2EU[-5*_JYU)95GZ*?#LAFT!0C$85#/%>&MAQS)(*+@3M#
ML0FOWM!;:EM5:3,/P#SOJ92K[P)]7?46*L9:J>6":CG!))6A5D1+D>*"(FY)
M0B98CFB*C!"IHN7BU1MB:GPZC:;2S*J5WA-,VB:X.X<@=S.Y(Y
MA-C5-'.N/)D+:NT$_Z161A^D0DI8AK@/(3LQ)?+4&L6Y)X956KL&#+2:M US
M9+YM=U)L !S^^F<^RVDV*Z?F"^"BHU6MZ.A*-[;/4W34<,?+KK \&0ET-&BD
MF9<(,U"'@%T03JYX8]M8+\%SH*.WL-&!8O;R*7TK[/PX:W3*.ZR&G59*O* 2
M3[!30[CA,6"$G0)-SNUP=(3)Y8XEJB7HLU65$C\].ZTF;$@]ZM8^IM
M%HI T6KS6V)S>U@BJ$&
M@ZEPQ",6M4$\8H.LTK"Y$>V%9);9I%=W(K^Q#H2[G,C?31G7/!:T\I0NIZX3
M7#3P*(T."44A@(LR1I$U7"&N(V4T1H>I7NE)_<9J[$TU!>YD-SZE5FY:V]1'
MT\_=3^/Z^?F0"IM,4AI1(C58B"8@FSA'+% ;H\>"2W)[I<1*.5?8-?6.G'9U
ME?@'*CFFI->[IKZ4NGN/IW37-L7,8;T53$@DF0"ER_NA%CB"TC$7,0\@BRP7
MX)>W[(F;<*(SUKMW=3;S8!X&-O.@,@@#LSFT>_E!I=T\9E%/?O2\P&>=3.H[
M$H:^\;R7IONM5P;U4F#DIPQJ:6B2$2"("05F=* *.:4H,L(EFR*5Q)LJQ/W9
M&]3W( )C2K=05'ME*R^HB9-11R:86=Q87KA"
M_:-4F[U'E=IYNQ?7R3-+M,9.>%7\&^IX=XOS-J!SKE,.]YU1^K]?[7U0?Q:^
M&T_/FNW+"*.?*$:;*=3"=69O:T+Q^UUU>8'N%H];SE;A&I?J+N5L):FIAZAC
M*FN,JI477:4UK.G##%8_2M%5\SS+/>9RE\7.5-WGNS336E6IP6)5T3%4,)OZ%DZ(.>3JYLR=9KD)MPX#2_@O2@2M+R]:)?B&'^8O.+
M7F;1I!]?L^6]_1&,DH,?NU\^P+.^-@^^O+\ >_OX*XSYX/2OTX/]#V3:8G][
MNK?]F>^^^_!C]V0'G@?O=?K/\<')%MT]?7L*US<.3K\>[V[_,UDT">]M^T-E
MG8]"[D),?2C NRY_=7;W/XJ
MMXBL"H[,[O5Y3Q!>'0;/ZO69ES"OX/M!_[(7U5_^D=#WPQ3Z9B^?DM0AY@&"
MN:4$68(I,@P[+:6C.J3L+V6W-)BO8OH>&GV?(3D>MN'=Q2_E%V&[N9_>)8;[I-$[2P0 W 3P.:5(B\T$.>14/9@"F63MHZP
MH! .Q@'*8HL,K#SR"CO,N:0T^!R((ZJDE4>$V.>$I-O#?M,'N=_T$IW:GL?*
M/2I3Q8_"5(I+[NNX2,!JY\"UD"#\\I1Y%D&5AT3U
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M6[DES.K[QW#? [Z[_?[GPQ_
M[+W[P'?AFOK);F-O^P.M[W_C7_?_:NQ^V85Q?_B1N6M]>^MRJN_P_LYA2M%P
MJ@EB(==0C3PA+01'3NL0#.4.4_?J#4A"5;7JT=/B[Z:-JTN+7UP9)S)URPTY
M[\L!J1
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M]M4;2J> 9"75 BJ'PD@EOB7#0N6DX$9S;BM:YW5OD<5P N?CJ&D"C'N68HZ51F
MTPFD"6=(@8D:# >#E*WZ$&%C/05WX 'W5-AUCBRH%'HU"CW!%@((BQ*)(P-J
MC3A.%-D4&&)1:2JMEU'8ASI$>(9NA$T+.ECR!.$9$8;)J(,*1Y; D:-I[P#C
M25GID:2$ 8Y(A:P7(/P.1PPVA_'4@-61\W%6)"U8.K:@"13RZ["R0%@4?A<997 2I<@TV-H#@Q>[^,^('*@-C!0CS;8H8
M",Y]B#(AG=N \N 9,CYRQ 0%NN Q5IA4'H/*8[#BT(*774WK\;1Y@B]@P;R.
M5J&HDT2<*
M>K*##Y-6G %#0"*YG'W$\L%A4D@EAC$)AC '9@"OL44R&V\N0IE_SX+8:/4[
MLEZK)S>0:EX6F6QWR[:^OW5B;AGP/0Y*O WVGK&K!MLLOKK$.MA4>^?S+YE5
MJ>Z1-;^0ZT7Y#-L%H?[/-"WO9??7K]6I\C18:
MG\')EY]?P_(NA?UNJ(2QX("+;7">L.D8R8F::,@_-4-3U^G
M0J*_C#6>+D:=I_]5%ABEI%]7].:RHG=O^/LPA49'0#Y6;'0 O&/O6L)W57AT
M;N'1[6^'40ME.5A;8';EX N>FVH+CZC3#,%"CM-Q!EN\[S\9[&^?G.-'E9@$7,^:BDX>Q5I.QG.N0
M40H\-HF<3\^Y\RX0)KE+C*=DE+:S$RC>[[Y]0M_ABS[B.#O^^NYK8Y>^9WO[
M<-\O'_#NR0?X^6OSX.3XV]?3G3]S[U/$ZZ*T[?P^7MV<.+%+C#L
MK]L?Z.XV_'SZ3V/OW?KBLG]3%=)E4?T@3\QPSCQ@C":BV"+G\
MHD5!*X]SZ33!U/PCCO_[?XC$OT_JVI(H4VH87ER_5NG#O#<4K!TL_M=]5F.)
M55@KE)OOEKT;U*VI6[;"P-5@X+5C7G_H G7""(E,P@%QB2FR4EE$&,:&8 (R
M=$-4^--AX":$H3ULSMHS@KB91"Y7-E71$)6PS>6TM5/$<,:C8])C G&3@E@6'-*)*<153,@2#3]I%87DS :N\GE(%63VZ$?!
M]]3*=X:I
MIP&DXX9"F<_>H[.I\/ 2Z,BJ:^U6$+(@A$S2%!URM<6 DC/9(1)9KGMA4 (9
M4.BR4("ZJV4E-3QLH5&'<$A@W6?C8'SH/RRRI1\XQ
MX$@F4*2CEPAC:JDWT@5&9YXKW8 <6J"$VJP\AY;6
M!+[;76\;K%EL0/?-H3537WT6Z9P'.?U\9RK]?)F8M54G1#Z+>5NT,-IC9I(^
MEXG#&Q<1^6>OT\G[Y(,T\%M6E![2B?8(&<_/,/2C[V'M__LVP@39YGU.DUY:
M/N.L5WRFAS&];IAPNGHG'.%6.V_@_Z0VU(F $W<&+#_FW6W5IL6DI3/ DCFF
MS:U'R/*9FCN#TG _ZO3#Y>Z[#Q2>0[Y^J>/=G\?'>^_>7^Y^^7AZ0+\V#K[4
M+W:W=[]]G728GNS\_+K]'G_=/H!W^@?&_8'MO=OA!R?OR==W7T^^GOYU?/!S
M"]?IQ^;UM)T/%_7]@\- 2<2),60(V$SX->MXA+RB$)0*
MGUXJ/AGM)=;&!.PX55P'J4@2@42?$@GAEJ;=%3X]%3Y=CN/3M\/@E*?$2D2"
MXMF=$Y$SRB'!D\("UM*XM<2G3:#_X_SOTWFNE&1;H6BV_30/W. LB E@HM8(
M[WCT. %3PM(&DG+#6*8%R>4R5TZ<*@!: H#&TI=.=G#]Y[=#(XF0A!H$FTE$
MG.CL3R86K-[C&URCOH$I=6K'2,BE<< (+%3$G7#GAP=AQW+)@
M&$UTY6RB4MKEE/;RNM+2 'KJ;$(\@KYRK3FR/#F$([> MI9'$;+23@>!5,E"
MC^8Q:G?@HU:5-C0/= *-5EOGO%2,$^IL-%A1YI2*46M+*A?+.H+1YRD&84EB
MFAB772PY@C4!@_ JYE 0&16V6(L;NO8\>Q=+I=!#A;961TEZ?V=PH#JXR'1U+O@ZG]6CF+?10<26L)XHI29#R)2,G<9ELKKH5?
MI<6_3!#$7/?H('3.G>&:Q/F<^X
M%4YZW?.<%Q34QO3E 95AT[KHNQ/&<*R>A6O'$RK4?WQ
MH)>3^B%-+F%+!1(V.<2CC,C88!$3DC&L -;UZAQ,U1'6DP:];(3G>^5!+Q5;
M>5+(^C;E-!-!!VV308*IW!TUMX*WU(,]'7R0SB2*]:LWI#;="KXZX%IO-5_&
M/%E!G$QEGJRIPD^XS8Q2BAAED'7>YU-M"3_%B%BN5V@QE:JLRU0S][!.UNCL
MZ[E1D_M$UVR$=;7RZ)K*NEI+Y-JY*%&KI"MU7-]^3PX-T4YK&9!RFB#.I48F
M"HV\9]9(II6VJ\LIJ#PLZXL!*P_(J3!@;3&@/HX![%!&IX*4%@6E-.)$*J2Y
ML,BFY*/E42O_(EL*W,=X>6F'^LM8-BL(XJDLF[7$AA]7_.#]C]WMNCCTU)LH
ML4(<$X:X33E65WL4E9",F,B(2_TBDO>W;=8F^*?"B=4?#W@[XGG+'95:T6+R:Q^@E:ESUA]LRL-7>LH'TY:+^%&RNO3Y=IOGJ9
MX0!1QC9@M;7)?@F(Z *_O]OFH 2]S26N;1
MG_Y;)S9A&-_CH"3VX/1B[*K!6/#5)=:!_/;.YU\RJ[+W4\@&P6IB[L?^/1ZU
M53FS1Q&Y3K3?D$TPVM]L\\)>=E_]>GUI8%W&9W#RY>?4UF/1/=;=:8>BC:L1N
MU=/@9.LP0"3Z'[AX?A%CJ]PAO.UT+@&0"WL*1."\6^XRJ=&"
M+:(!&T9JG?N_"3)T#.SR/P[VGW+IL
MMS^0QGEWL+GT(WNO9!$>T>TUSV%3F[4537[[]4OHTZ!$#?=Q=MD^#9+7F%&K
M;WT  U*K[]- :H;S!QFLGO]QU:?A3=6- 4Z;$MJFK4\/2-&N;0
M,O,49GPI)SNG9\WV)5C1 ^.]"]/0/9^P(JIZZ2^\7CK+W?V8$EQAQ;U3-H?Q
M4Q.,#\''9&T.Y7#X^TMQP]*][:^-
MO7=OO]7??19?MS_@K]N?^=X^W!O&6-_?8;M?ZN2 _G/RM3'IACW(8^0'7SY<
M?-UO?MO=_OAM=_](U.$]X/]_U/<].?@)UWW9/;W6VF%8V"1YGB1ER$4<42X1
M@)QD%%F*@Q#>"R;]JS=,OL22U/0:X=1C
M6Q!K1QO?M[[# -J=R]E$L4HR>7!F-5J!"H&60J#I'@\*&Z.8%XBIF! G+B'#
ME4$J$HX=Y\"4^*LW1-?D&F6"5-E@SX5:5(IZ9T6=H J")QU*'54*J$*2$4P:
MT-O@L 9 QOBK&E;Y^5!6?Q/KW&6,Q3N
M01^>;TV-=: /PU7Y.Z\)V#<[PQ6I4&HIE)IN^*!-8%@Y@21S!'$1!: 4Q\A$
MZ0)FP;&8\T(,N7]-V?7SO%2:^^!\HM+\F(XR@I&Q!W-" KDD4^
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MVZTC=!X[IZ!CKG^X,DB*:AW=%,I;&4[KP4[V(&NU4E$('EXN'T+4*QMIXC\B_H^W&4?KS?8)"-\)TNB_E:,;>
M%$B52_#BRGL^$@Y-=S0"-LV8E!();',).,.0#<:"1<15TL(SHD)V<4Q7]ZQ<
M'"]&3^]+*"H]7;V>3O %IIP.S 1$K "^@'WF"Y8B3('R,^\I"V45WG6*M=IX
MIT5)E2N_Q-KX)2K397DH&N\L-*P(+B,15'(D2&[*7'84*(5"LH(Q+E5R'CC40K)DD!#9"JNF]JN
MBJ/SBMP71*GIMD2"":)EBDBZ:!%GF"/#
M D/61FP%\\8&^NH-EWQEP>EK4WB^:DZTUL2D4O"[*?@$#7',&1*]! 6W#'&G
M*=*,4L2$M4DGFB(.H.#&U-AS4?"-=W3\,UW._/YNCY>&84NUF'\HEC):J:WA
M0E6(MARB3;?1L8*SZ(1!QD2/>,Z)U@Z1/<15'KG1 >29X4K%OML^WVMJ$3C\VOGM;Y.IMU8E3]8$L5_3O$U
M*I6,+'ED,S5&X%7E@&P-ISMGO5D*R3;."1[,'I:
M(=E=D&R"CQJJJ?*)(NP\0YSD(SW&15G24>@@M:.Y4AQ[=JZTX4 &8MOW;#V+
M3@O/8I"/S?R?G-N/=:RZ6WN01<]FGO(>&^^&?M\ZMZVC1FX==M-)^;T#=]9.
MUI?NP?PRR@!*$*@Y;#(#9%D3 .,G+.D<&8;
M*RE^N1'Y8 _K>YF5$?:G/6N8!R:*YFHM\@;GAD'\4@'
ML ^4]2Y1[:P1=-T4>4W<$^L2C3AV8EF%'5;!.FO P2I87@Z6Q12_,BQZ$[!
MR0B+N,,$N>@8HMHZI\ 63(Z\>J-GI(FL:;1.%7=80=ES9*$5E"T-91,,DPEA
M(M$,P/ 6XW
M!QI>8?9*,'N"CWNB0F)1(TD9RS4Y!;(F.J2#X"8I910A^8QY.B"M@NP[V@J_
MGEMXZ,@MVY_6W=XI3(6?[UYF-3%R,+_Y?Z[SZYOK[MU%KEO=,I';EHGF9=H_
MCK/2X0M0Z)Z'QYS#YSEK/DR;%\5Y.W_1Q^7#ZEG6Z\;:,+?SZ+Y>04O3.XX"BVAKVQN[V4&KZ1/X)+RL7V[4_XI1P/X\_S5-GP,'W9C;6K]
MGM_B_MD^A2=?%L>V6YS:1NL<_@];-WS\
MNOQL^!J=V,SA2Z'\XTVC+V]XXZ@3+'S^UK]W/L.CCTY+F3JVYZ4TG+8[N1O(
MM]B\S']L%:WV>7X--Q3E&*:EX\6@PF!!9JTF)7,6Y+^6X!Z$)D>3I"D(S8-0
M1EN"N51$)<&"98?;I;V(,4'S#,]L?R-?MOQJ[)P=X%\:XN_^QN;?]SW&=OL>\0!^QW"5;\(T\Q?#H8Y/_]/YH2]?OH
M\AF['\SF\(TR,_C>Z#;ZT<'Y-K9$5QBCMS"6LW9G2-LR+VKU2JXUN7/"'X#0
M'QWG+4*^+LXZ * =6(8B==JG10/VV^:HSV<70+5;:G5&B/&QP-^Z,'6=X?3F
MZZP_;L!SRZ? &+J][H##G'7:J7$^B&HN%\#W3GO-_A)1&!\=CN
MZ\'>!AS0=O-"]K_Z>B!_XZ^>]X9N?NAHF8 F\%JP!8]1V[%->+#>()P_&MT^32YG
MN+258"+;W_HDKG=V!H\$Z>\;%UA;4!,O PAN1BBC?C
M/9\2!XKSZ(];V7S,QFB,C7 XJH%F $B'V 25
M\+;7A:_U@2P#]6P!'E/C$::%/DSEVTZI4-'NG9=3/6#STW,W%%H H-)D&7#-
M!="Q5OQ/^R(;<:^+T"MA]A;E:[3Z/'"@!6/:]GKXYI,O-88@@WD?8,YPFL9M
MU?9P7\MC+$<_$Y3!8NO$?.-)DNVS+ND9^_=X5*WFS!Y%Y& -OR&;8+2_V>:%O>R^^O7:
M2X%TH/$9G'SY^5;@_6S(B17M,]64N/+Z>IF_;_9
M+^KB4:/5&N-DF5I,6[CC#MLA.)=^]J'G%@C 32C6*$E]_G)^U.(.W($L7C-]
M9E[TU?ZT ;!NW8YU^W.A>V$Z[0M
MU^P8K6.>X*'S8 G?0;O7')'@(M\T99\LD-.A[ WVO*MEGR$@P"P_];*I=V65
ME+)R@RT#(G83'-K_'-0EJP"3X\^Q/..M$
ME*5M:&BG=AX8?((NVIUO14DO^PT/JT#66FWAKZ0/%TPI0 ?OE'Z>Q?[3E\^3/BO0[?/C*W^+[W7! (J=$A!_
M!6M\7&.N+L^.G5X'-+<;)V\UICE@F1YGL[B3OP^* C^$EYXW3P2X=8K.1
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MDB&!*9EC,\L-)#5:,#MY>R^G][3[[!G(0'^18@ONUC]S?/P]=VYRVE/%
MZHT[I*>\+C!;R^RJUG(LF>64 I+BY!S\@7-OO5*)6%*&>A-U^V:Z-QS'OV$8
M?]I.YW+@]NA6V^9L2'U/ZR=;A]X:IH4DR$A+$#>.(YV219)%+F'B-5;IU1O%
MZ(S>8L5PFQP$P9:GC_U(BPFZ1=3KOL_HRCXLC_;C6&@&4V6TY?# Y+J[ZE:Q
MRPCK>EV0W6[67^#:8!6-(,UG@1@ZPI:6T564I9POG[OMG5&40R6K6P^IIZ(N,BB__'0##?#^1R4(9H7 RJE9^_\D>'E@@.LZR0I3PA;CE!
MEGB*HN061T)E\/K5&SZCEN%PW5\#/>B>#<,K7H]!5GEF/A>P0KN,E^BC56T4
M10*+W"Y!Z8;SAR51QLGHN:=&8&,Y(TE[L"4H5K OPALJOFBB:K43+BMC]8OZ
MSP^'@5.KK6((2P/H8B5%AGN&(M$@#T***$FN7C5M,U[)6.DN!8X]DW_?C'[CYL3\YIPAU#03F)>#0 5\ 4D/3.S$)E:F:'RT+$S4^FBI=&Q WMMB=;%/AB:'T%M5O-"#QO3\,D?Q]!K
MQKTT&O_[TL*&E\CO\#'G$>4(QW)%]_,Y]#X\_X]FVW_;.+4Y^%$_V3E,5H/]
M9R)B4AO 7?C)2=C;\]SCB /8AX!]$<#E+*]UIQ?7--IKJ_1 7*UN&?\X[ER.>V5*=\LP3#N.E&+T4?_ >JR_V*1V],_G
MRK14<3UY?A3<6*:47@5,EFFL,&M->]:-OPU_^#TTNF=->_E;HU6^>WG1[X.[
M#Z(L\P,F4EC+Y_4_'L0<*EH3A.>PPT'=F\&#!Q&)M3(B<2(KM_^9Y#5,YW^,
M:V3N9S?=EH@:97>[[4V?@,%!M)UBIY6=Q^.6P@)-_9YVNLRR1G;[>:Y'WWD6Z
M*:ZJB>9+FCC\U!+[(@J:O9W:L(?;\=SI7:# ]_TJX3RCNHM@. )^KC;@G$XR
M\47X]];Y8"4_#1?RVI='%BVBSY2;#PK$P._UB_K)6[AW_>?NOH=G[<#]/YX>
MG'[ !S^_-@_VF\=?3_YI?OTT62 &N/K/KU\77[
MX\GNZ3_'>U_>GNY^^:?YOS_?#XK#[)P#K\?UG]\.A20LA A+)H#6\]PG2(L@
MD*>.-:\ J2[@5)CTP@GV&7^']N2)29$_9X
M)V;Y?)O1_?+8['%.MN(BF#T,TYPJ-SCK!*7"[V7PNSY%*97C7!B'D3:8(F[A
M'YNP1L0&89BG202 $L&F\/M?5>?)%Z+L]^=EE;*OJ;)/D+6DK,14.^2=48AK
M%I!A3"%!39042QJ%!;(VG<^\1LI>N=-N4_]/95!$>9HUR!R]CQOM&>+?6(W'27*%I0TDZ2 )TX*8F.1#>,J&J+>3 Z%+T*NLT>4![L,4FY$*.^.)
M181[8#,A"J1QLHA+:Q+C%*<:.2P81A-]%$93Z?8]=7N"O#!)*&?$((Y]0IQQC*P2&&&-63+<
MG+L\N%I7GIS;%'WG1_2],B(']"M'=9UVN7"V+N5JFD[[G);I7
MCI@U(S+E FZUPK_;,&6C[\4*!)<$P8,I0F,355A&A4P@!'$E(G(N&H2CUP18
M#>.V)U^"D(S7Z?'T^U2XT<,Z&?LM"M=7UK7)UTS7HN  T?84@NZS@32
MRF%$$L.&"J$-!/L1T6C:.":$1PDH" 42--E$&!Q@A[H,GU-%:&@)439ZTU
M_2DXS[2F5QJ]I$9/.G$DL8&F@*Q-!O&4/++*$:1(E('PX )?A?U2.7&NOB'R /?<$CJ:DD\8E^+G=/!'FH-N[KUZU\O>./^]#9@SD=E&\!
M,ELAZ'((^FV*$Y'HL=#)(@=F8 [&P>FUE7S&A$L6;%O!2WUKD/K%:+>/4.E*NBW0$N!D_JA4Y9:3SSB
MF"3$O2? $IU!V"5%'-8F)?'JC2*U:72=J.T'DCHJJ3X0OAD"#;+UBV#__:]<
M$_EZ#]R;VCWFIMO]CELKZ"Y9RC?'-57<8>P,P]B7:.YZ5V#:P*:P9GV:PLYL
M[KKB9JUK4?Y^Z2WG*=N2#QO63J51#^B1-.]
M_<^')& J0&R1MF89DL3B-,?\-V%/C
MM'=ZO9GB<2=VC]O-$LM*)\B(*(QZR5YU>^X>)O:,H"_^'>[=83V8^>T^/?@E1I7
MB=]/0YLN;/=1&\,,]X'A!%R^;7=&V@?*-]*]7=@=^L7>*\"?#?@?+NLG'PZU
MP ZG*) +RB!.\PF.I0XI*4( N#?&90IS4R^CV>TBR>NE&\=0ICF6U&D1%"R/8?@Y<;$>2_8\LV
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MOE//&6%JE"S<;V7AVQ)5 ]1]@)XS5,H'&2RA"]VVZ@\SMS],U'V[CO-]Z]N?\>[VVV:^_]Z7]Y?UD[?'7[>WR-Z7@Q][?TX$
MMIY^OCS8/\I]=N$=/ESL[G_ ]2__Y'<1!R=P[9>WW^!^XNO)#I_51\;(D")7
M'DECB"A,M"HJ,MMUMWY=&U89 5_!6P5O$_ 6 +FL3\IZ#!H3
ML<6&6V$-U91*F)8,;\14\/:D\#81MV\=/>I)4GG-U/Y:G:S"A
M;SOMTS_[J_1WN4CCX%9!VE*0-MVF);)(C) *22P$,+:$D=%8():D%E$!80MJ
M)9!6U9987^5^Q$/!2KD?4KDG^ JQRGB?5=IQX"N@SL@0+I$D5'$C4@S69^46
M:Z3@")W^X>V&U?6'1*S1NT8JM*>=U?KQ^(BE5H_J%I/
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M+OE_^['5BMUNC.7M>^?].A/-QFGC?%"@HA,+WVSGG+MRE(/$F.RRM<19N#\*CT^I_3,;->0
MTR]MV6>SW8K]C(7U2FQ_/WR704[:4V:SUXJ/$82^"]MCW_9;UY.SWS.
M>KI2(1A"+K%R>98!"+[>3JF;RQT,BJF,KAIU#G,]^&O?RA^DDL#U8[E1KT%K
M\Y]@\9NVVX6_]E=Y=*?!LP<)5, &2LPLA6%4_2"_0WM4*O0JFVM,H@9YL/TJ
M,?!*HXHQ<.GPG<^&68/3+STM7)_62[IB$_YV]+IX%UME#F\&FZV0BU!TSSME
MO;.'5H<;A[?,\MUAUWDVVU7.;!RD>8\)WDC8\ZK=((5+S&)9K@+>;R3SH%,#
MI>QO.; +Y23'5O%?N$9&>9SC==M> 68P+'%
M?0+7V"A]=.<'O&:KE,=10O96*PPWPH& 5+G9<[).+^#S0Z88$]1Y9&P,N5D\
M1B;0@"A)W.%(B7)J]AG&;45+2GTL"U0L4(GS9I@M5X9(KZ63DGB=>(I"^Z"I
M4I$[XXFUY)!H_NK)ZU<17BN*!TZDWK&=G'S4_3MV/AT#H5^?S.D/ QD^.X%[
M$)!ID-O=QM?M';#X/_S+OG8\%_%#?VRT^_<_6QYTI WBIA/OI$J:W#^WZJVC''<4*
M:[B 8T(<%BK [X"N22DJUC1-_ _;!=W(I6$&VS1PB[PKG\(\=+-89]H.X.Q[
M?=/,71;P&HTR:WQP1:ZVZ,M4;F ?PTO/01%R#30P/_(UF6WTQY%W?C!*[%$L
M^ET(,FR53^H'38]=7[1[YV4UMORPL=H3_8/$7#-R-++R&XU_O8T0-
M>6=>E#]A7FWKLIS?9BRG/,M#K^./!U;>7";47ZH),B0T%EIXE[117&+J"->,
M"Q&,@CV7RELB0O!4<8V\^A_C<$ !>-#'>-Z ]=HNQ;B-4"3,'WU1M+76LPH4W.%(ME'. X>GV+I
M*?P#?FCE ,B_.\,JL.6*%65]QS/8-OJ0T0>^)4O#WE.61BWTFK$W*4=_YY$-
M>48E-Y-RJ
MWXN=__0:YT]IL5[^JU_K:033DXK6B6>@M[F^ NRV!17_#?MDMZS'6J1.^[3O
M5CPZZL2C7-FIV8 7"OVM]:S4X]CR<>A8**O9#'P2V2O9:YW91NASEM@*W=?+
MJK7RT1G)-#5)<6JY]L9%PX-U#B"5D??OX4SP[
M'QC(^/5UNWBUJD$74HTG]=9^:N08O7:G<31PW_0YEK>=SF56HUQ/'3[O>R.'
M(7V?CG/AXV6KY*Y+M<72WU]8QWB3G1QC&F(X?=WD3@CU9$G&001/M;
MY&M(W^<"]=^C?::2L4F0]H>>">U4\BAB!ZS=9)"FWB%.J;8^T0A$/H,TP%D-
MWR1FRW0+VKRN/P1/3,^Z=?UYIBZP.WA2GN) \8H!3Q#I?,1X=M9I_P (.H_-
MR^7*. O/C*'<,C"I:3 F@,GJDU""2Q("ZUNM(!ASG2$_;&WOW48O.7>&HY\"F#?!BYSC@M&4FA WJ 9
MU>;5&WEK$Y.^H7N#>00;\GFG 9\,_;GC_K5^<%.G[]"ZS:?RNG0N9Q2SPZ).V,H(9YC4#L/",WH86
M4Z?(Y2'[=6S8'LHB@,16..EUSTL\J0!B#D#@W>V=0XP3EC$))%1NW.6 \!MN
M"6(\,"DBM8EQH/GDML9=ZV$-O\@CC;?1=7JV-'_,PR7+*:7
M>//T8V1AN1!QVB9-M2R;C[#76DTWD+W[
MV<;KXLQV!AO"74QK%TA@5+J  4(8,5HX(/A4R2!) DF:G8QQBVG]M^WL=3[E
MF+8PX<&IY&4@+T>'_Y^]+V]J(\GV_2H*Q[WOV2^43.5259G=[SF"-KC'/2WP
M@L>#_R%R*Y M)*X68_SIWSF95:72!@ACLU@=,QBT5&5EGN5W=NI]5A1:$Y8R
MBC+=$9/K @14#N@\U3Y322B(N]1S\Q3C "SY?8XLPJOT]V-F/E!9'/P_LCDGF6.:F+
M+ !;@:=$PDM@.F1,2YE)Z>23Y\"O;6#BRP3-"TS5;FVCBL($BC)2"ACT:1?H
M1;?. 6WJ?BA:J"W2]:@HG/D
MO"B$ ^$C70K*RML$?E,I4;FG6J@\M=P!%:4)>O76IR+,$P:4XX>VV_1CW$1!
MW:Q:<$%!A77N%Q\B4>\/WR)ZVRU7& +P]9NC\MT1W9!,13+?.D?6),X 3B!X
M$D1D/B/::$$\37%\, ,HF@')T*ULR="I6F&U@T8"ZICZNZ:#?;_+U24II]("
M;.&^$'DBM:460!<@+^<\D\FUNSIA.&JW1.CSGJV7@V&D],K/U?BK))^-)7L=
MBD*K5C/'THQ:8JQ/"*!/0$"JL$1S"DJ"6IICQZ9\99.YRJAMA?#3O';B]Y94.)D1(_O3J2/ .(+@6Q29(2 ;J1*%W
M;R8!$\\R:[@,*2T*J'%)EN-\2LN24:2/VH]6IP8S?K4C[>:IP=2:-,]T:@N:
M"XU>-+ ?X/?4IM(7A5C7PKW%U. -,T5F LQ9:&FE]\ ]4G,<:ID2+;#;=$*S
M0BIP%F"-T\D/FC(*SC+P25""_\>^E/=#8.NUG2O2*NRA!9>
MVD1XHXVA2A0)%9[Y/&>EP0."]9KNE?5$V(:N(ET=@,H7-*>)D"1-%"7"H@DC
M06BEUC"5Z+0(PSW4LA2\NQ51.LUSEZ:)RREP0,JES66>:JJY-!C\O8*"-B+J
MEDG)'N5@UYH\<<2:!$24%((8F3!"07+E1>YXFB511*DM=>-:AS::O36PI&E9
M2_R "R N[C*;X]E6J]6Z*H?+#+!=T1!NH^VTN<-/Y-;%[(Q-+M>/X^:O&.(#
MQ,=2(11AW#.P!?.$2"48 2[G/@7%;8H\9&!:G25T8V^7T986
M*LVRU%N1@+++EN?KIF5O?%V7457GSI')C6>&:])*E, '"G\
M4+IP8"!)QYA+8?/]6MZNQ^M1F!7+LZ&&7B_JO;.:96)Y]XR4_K[TV]N:-($(
M:[MZC,@8,VQST%CR1CY?BX^^;8-\SCP&I7&$%:"M(O$@GQ4CG#EI7)(E*A-/
MGJ>KIXY^9^:MMH!=AG.)MU.3X%ZFX-X8Q#V4%-RRY&DJ-,I:)O\_$]VK3RZ^
M9B[*-@Y79.I&5;VV:EX[@??6)]ML$GAO5^KL[;P_LIFB/',@9JC.B/#2$LFU
M)E0YSHSE('B*)\]YOK68OC.'"F]';?_8/DKO[(EWDQ[8%?,=E4)O&B"BG=C8
MY0 EXR_<90GL_\^T<[#+.M_>7.Q]VST2ON!@/EB2VKP .@$]91(G2,8*KIU*
MK+1VODV1!A*B2A9@'5(!<%!Z#G\D5A7>%M;R^8Y+]Q:S7=*?I^SX@SJS_!5$
MV0\,VJF]"JMDAE *X8]'J#\]%O*SGM5 ^/
MN_VJ672H]2M?PO;0Z6P_^[K ,** NF@QM).&W>WILY'_K?KE=]<=G?7TQ6_=
M?MBC\*7?9V^(-YAK)1WN%]\NZ_ZDV,J$PM*_>.R*G K5 7.=<>.[^79
M%DW8RK>3+;KRO,?KG(4WX6=XXO7XH
M=9V'BL3^ZL!E?GWG@:Q[GRH%LC;$;:_2+O]\[
MB$I^)56L^<"_VL8EZU#7 QM6NORA Z34XU"!T*\ZF8Z>_78="OJNP?;7(:T;
M#UK\(8N\I;%Q<8@."\VQ[PEI+%
:^5V5>"E4MC':U_S!
MQ+996Q5CJM?.MDU$\-+8KLWUPH2WXYR9QX_T_LZ,C_ZRQH>* A0/RG2_0'OA#8R[^DUHAK<
M1G#(;3]+3.N#;M'74EHW)S1"_]V_&UG%K96XL);]-\CXGW*'$W/;OMYLVY
M)D-#Q=##RYCK9BHB?@;;5S3J&U[C6#O%+_*!C#WN+5*Y6^4O2YAKVUP2._EYMW8585,Q&%GS>-]L#(]
MI?ZHX0_L]SQLJEKKA,%DSLLM3I6 ]43/"+NJF7 _Q!Z\2I@T[\X_$!?(L1'O
MEIHY5 _)OE.9S3Q&:V(FA;GG!B\7E, 2RBLV"W#TP;0)LWPX+F,YG1-5,VUN,EM]6H.+A6Q 0%=9$<#_,2DYL[1[BX^@%PZ1
MEYH,#&;KB7[W\S0D+>*R+H#AB@:&O:*AY=[ 77YDV VZHJD)^V'LML/.T0=7
M-*>\1I?E2\>JEQ5G'AX].^=BG]U1$W2S>U8[A[PCQ7*Y!GQ?EP,$J9\]#0X&6V>7(>D]#3SB(1,@7MTQ9
M=5ZNM#+&L4E->NO&!0MVRW/^''@!V/2M&LN6M.G4F^[#O]UA]3;GWV'^'N4W
M?=F23%MK\ >1US?#_+J:&S]WY-^Q'TZ(E]K$3%* #/+9^PQ9[3P4\]%?N)[#ZQXA&C'3JA\%^R8.6Q0\OFD;
MCJV.QG/=RG("R./%K6M\%J:P&#P$S6$]63?44*QG-([P<=!\JQU;+&CQC ZC
M^S'FK59E_?T9]/7YX]+Y -$*C-0V?^2F(E3$\R[?[#-3E]3FCW=N)D@83_(N
M><8YM?=%F#6M"YU#5I_CE'XI#^BI=GL+>W"\72MT<"LLM[U
MB@ B>GG6<[1BNJOK?SRCSVI,'SL<:9YT$P\RY1P1^*,=IQN
M\9U;\:^)2LW+^]N(CAW>7"*_0-]?VB;KM20))>Z^0GY_?&\\E+CQD6@GYF2Q
M!_N. $QT6C7=Q!G[[>E8N$< W$.,'F,Q*V/#!Y,'M>F2=E<<\(G,N<5
M''S7@\IIR= ]SZ9;(BED7:Q,?ZEW#-4<2!_W"EKX"%.T@_FSTC@L:"5+@BDU]RW.#Z
MW.V5P5:0Y^9K':,Q,Y0Z8\CW#,6(U]YUK"E08=&&-.,_+3+E'4A5&BFHC;EO
MS#CUP%2X%K/XFOB:Y:1.PL4 O2=?KTC6U;4(GEQ9%)K+F*&=R2G\_54RCD':,*O26=
MD82#O*YF,F=7S1X+?B*\>JQN2,7\"ZYH P-??FD=)TA;*%2_%IP1;&3L"94B
M@%/3V-\C4E-O7\AO;:U8^L9^6R-4
M5.J&BD1@#9*AR38%PXZ8)&GBM($0?KBZ+?U4%[N035?%-*'WE!]T7]56O!4]
MD_-QVXTHJB>I7>[!O61;U[J/.6"UMXW3BD[,3P!(RV3+LF>\SVPDB=?3_[#2
M(C+<\S] 2R+%8]MH2 -#+^F>UZ7^,D-E^V]$OQ
M];*,Q8S@C)!2U/,-O_\I3]?N(5HHQ8WD/VU-8Z>_WD18+$TX*^HA2GOP]]K!G,2.:[!"F=()P<@7Q3
M^#LE"76S6P1CZ"92GS\\[ALBJ=J1DEMNV^! KTB6T57J\TY".=IGH>P!R=M&
M)Q%^NH>JAWW/K/9)F^EMP78SI3J_8^+DQ6[TZW!R*7&
M\AZBUAV]#JVY:&_6@?@_I"AWB!,R\4V#X\G\''1Q,7H9F^@#@HW(;+&MLX\A
MS]'9?KZ"F1'^J,T&F+%1&/"]Q=/O@' FU'9CAYM>O#S*XG> MF%*/7M2/@B@
M)6F85,@M4,BVY^SLLBO.AP<;>$EI*HNEGU[[DR:YS5W%-Z2-0LR^^"6$_+EQ
M,]G\8794\6P6T2:I9\99HM;JNE6-I11;EK0#1KWK!R@H\3*'_-&[^6T["\]_(TLM0]:SC>[2C*
MRP3GW-+<2&G8=<::49R3^7N*# X>;U[1V($87'V=03B?4*A)ULL 1461E8:WD?:HM\:QU:ASH>C:;
M_F*X[J2X7ZL2\&4OBU_/V: LC%:J#@[3(;&'M!B!FSBF_%FOXXJ);$#/+!A%
M?31?BN'!(.A[WBCS]>DTX[,@+#/MJ:/N>5/9*:?,5=4??G*6-"
MIL2W?L_ZL.62KF#WF*D Z;W=@J4$-\\L1URI>JDZ6A6L,A-$O*&
M!:9NKA3Q^$WCD$@S>FFP'5WIQ)_1$H1U K&4B4TH[Q9B'VQWQ+ KL@%++H0P
MC(NR:$@QOZ(!<60$B$! A!7*-3'DBF]$MV7[EG+L1HV/=6T=$6E%O@'J*LE_
M'0!JM*_C:U:R^.;I_+.9T#X(OKQY?G[6+W(21V_O(-?^>^D9-E63
M0DQ&LZ^E>%@7@^A!+_HWGS0_C1*RW[%;->)];GV=4R/Y$;EP?><)0BMQ'4NZ
M*:K$WRXEY1A@,S!]5G0\6>D::/6Z;X+<7Z]
M3M36P)5O,$28/+I%-0-*G=EQZ\$*>>\OG_ .SM>$O)^V+ILEW@BA9#I@AOR8
MER:0^.F*\E(12RT> _L#=]G",O[KXCH==^TPSH6)M_E(AB10I2WX:&6>X(>)
MB?]K77^MO2=2:R=Q%=!WU.^%, S9>:OUX;-IO "99S>DT<=
M2LY?.DV%9/#KV_8<3-1)+PT^3&MUQF[7[- ]AGEO7>":G[2&8\7A\YC$]521
M%"*EX0?>"EF7UTI"PM[LK'&@K(ALMMJC7H+.B&R#5=K":5GY;IL[956>T%V@
MZ%=TI][DQ>XQ5S,EZ=8<#@Z%V;=43#/QJ>1+1%4%NJIN-N9L'F4,K=-76M4C
MEC.Z]>/Y9P(>9^@\_4&"6\*>;8Y)5Q26K&NA9T4IV7&D=
M$S>%R8#^L$/0XJX?//>D"+&FR_I'E>5_'&U(5/[R=>M___97#B(E_))'2?0'
M5U0QN:*IU[]^9\5EZ]C\BF9W\E)5XN+-%8TEU':^,K@N\ U#NB/UOVU&4<]B
M_J7*P6\:3]:_UZC
MKC [+<4.!',C60-U'ZX(_*3P-
MPZ-?#NM.R_[YJL#YS?G%ZPQ4[MC+=Q'*NAO"4_!VJ3;G,]ZCC7W\ER4+:YH)@-=CI.I
M2"6IR"'[UW_^!PP+**#V;13[LN+\W85:?I=A $PYU.I
M;Q^RM672^;#;8N>K4[8J7)IX,<%Z]?)3CT+;2A<8-PDTN\TO E#1L6-I9O\#
ME7[F3?"?RW?.&1JX/'U-72M'GQI"3XHTGDP[_\SV\PO"MH-V9N;LE-A0E"Z:
MP=O7@IS[ :D*%!;3:Q?_@>[V@RN:R*.9!^6Q]PE3'^<'BQQT@S[>K17*/$R?
MF02JTKU>TJA^>P8Z:KJ'\',\E\_NQ5"M6-WX4C\%1=_-L9EL$];RF)_1JR_(
M]Q/ICF8"^P%:NZV$U)[I_!MS,FP5'7?*=^5*=U\.YT";8:9V?J$D<;+G26,6*E-3D;)R"A2X\HU(QR
M_C<[AW6LM,^6.B$FWHWE6U/NS9*N0.3ST_7TU" 5X+:?]D9OBY>9 )4L)P<^
M(_X[KS'-C?P;GXO*_,VHCFNGD@^,8=8H* IN*6 \4A":HIYJ/NX0?YK.M"R
M8(N?4-:6$ MOY>\W3.8>$5.J5R\]3U/T6(-Q7+M:DDN*YJ"FHR@ZGV^CV^
M+_N<<-8E[@U';A6-%3P4$9ZJ=3!<9&#+U= ,4JZDXTM_I&5&JQ15%UPQESG:
MO9(:35G'_V"MK.6((04"M'_UK&3H^&N[C$Q:D)E;J:I!K]&0[3+ /9B8U#_J/+BK4&Z':VV1"KJ1!
M5.G:FA9R5N<^)'HQ!?S9IUFG$/CUK(EB?:]8Q%/7(BKXN/;PM8S*&LEYINU.5]FHK(C"5&YYB>^2RXQ74
M-W;;KT.TB3H2"&W[:X*8*Y'CY(BF;=F2PJ_OQ2KV-^ %.&659@WKK
M#KM9IO<%6_Q(-G-)X1&@IR&=QG\,WA&P45VOSE \3Y[?X;>MM=7D!5]WLW_Y
M4Y\NG>>052ZB4%+"^N[6 7M*ES17,@E[F\'37+)D$\ZEJ5.@AWZSAHGC$(?6F\')#=4N08A*6OJ
M%0_[%##S3I:5O8$.,A9^&@:2*E*8V:%K/M9M-^N+5_K-*EN'2^5)D462OL6.
M3DQRW:V@GU?O_5ZN])?\DE-)'0B#[X>1WB1[ )+]0;N.?(D\7"WY\8 '2!+<
M]9"W)8@'[[[/8U XY:$FR6.H$ZUW"FFH@LH_/%0LP9*=L7V"0Q;1H3M?E\F
MUUT==2E#RM>/N"7M<0%6NE8 #DA7'\9X#XKT6M
MVTW#JTY'T9.6#7([8T.BU^GE3*PB]=;F^BK+7UH[^6L[Q@YL)IUC8&,N1S(V
M.3>;DP?-]VTM6TJVH=!^O;77GOK16YM(PZP6D!O7A\#G":O7FX*,9HT(]U%?
M/]OG,D^M"I5:I195JHXR@)G#7[#_12/#D$O$[S_U"S-;'M^?BXM?#N TIFT+(5]UB'.VX7Q$ANXK9LR458N6=ZN74-
M)-3[^BEX0^4OZ0HF8PW2W3D#+^=G97&FRQ-*Q)_/M&;[A!J/#QHA(0<&OKD2
MM%B:_RQ0E^ SI;*@P[_0/IA^V':3QD3YD.?G1VK.ZD>-0TL2F&\VD_>*WJ9;
MBM8_M)05MF"4IRM_"BA&=K[W5HIIJ;>.1%M.^$R.PQ;GZF9Y XFKK*3)[@A<
M-UA>]E!]D=@!72?V:.8DH[9()Q-5_.866!S8O[C?@.J*P3 LMCC,@)'8"IZ\CT="86N]#/?_-01\/06M%,[>M:9/KH?=
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M&,W_7_=&/@$>4[BMS[KBT0+SQ,1?QGU1.LLEE4YFNSRSQ+K)$FU=I=@GI6Q
M;<&4)+6A8+"8$-X1+,G+M?T.(T._TGLF'1X9)DQQ/>,A.9QX^T2PQBZG1BUM
M4,/5OCZF7K@(#RLUFOCV ;2_VW4;AC)"DNNW!1?=.P!IF,Y 2#G9F65%M\OA
M%7P-6>KYHHP\,:[P?\3>\61B+&LL7' <
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M@TKDKK&=33WP!I><2M.F]$0Q66/84B0,%0'8>65#$^D(010C6D02&ZLP[K-
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M5.XTXUTML!K&0HO3T(NM>A%],AIL50D4#X87LQ)HYMI9QBJC4K&RWD
M'A.W,5NB%8H/AQ>N208\P#AD9OJZ$K7U M^C?=4]U]XN>2VGSK0KM20'\[)/
M0'B'YTD0>\13NY#2)TE;([R8&.<=?F&$PX8;NN M(%/3B.,8M6]=GBQ
MGN]G:VM]BT@I&W='7IE*P1?$F-V%<8!WT@RDD2_)V+[N
MB8O&SSPUOU#A#5R>=Z3>-6Z6:\,Q,\8-#SW=^')O/GL^5E^IH::FWI>V4)=L
M^]M'0_BHM]+CEMS Y)2#^?S&'BMW!9%3#E: <4MVEOZLN;E6S%NK%9UGG[JO
M0GSU,Y [U.>:V(_8^[C2#<-P:D5C2<%G.(HO/I$?_X3(NM2
M*.W^JR9F6D*[1 /+.8(1-G+!95JO*.I'M^M?T3\X[U/9(#39;9"IW?Z[:40^
M[\\L$==-1YN*7QY.(C8I\V7;RHLCAT5@.H$>P.@I[[?G,DOLI87CO]>8%CH5!K'Q^5
M01,\[NT#T1JN+![(E^CJ$FKMKX)63?692EA7P_URDB]^V9G(//X5[YLI8SEB
MCQ8KM[\3.CZ^+R"U J[RZN%%%J@B)U=F:[HKLN$]PG#]F1A!A:S>3YEV2L&[&28Y)A7$#IX\[);(2OHC,]$'[ EO[?0$:(A[
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M48\@3*F+R^]A?;#E,>="MO3T<\U^BH-A2\7&M$6KYL&I.2MPH"&N#U>_4Z48I(?P.$PUWIYE:2W"V.CP:Q_OD%A\QT?I 83B_@=HT:=B3M\N_CN8
M&28WRX^B&N!G=Y&2DI+?/G@E(F)B7.X4E)W>[2"IA%3%^1I7BI,\@&8.F-A[
MQE[M!Z0-JGO@;V.EKI9RTD.@MLCQ(LF*RM+;7[PFNB4[P5X\H0+9/76*<7/4
MXF)>@9$UBH15R,HSSTS; )=W?6897OKA5L9#UKCFV1G+H+*NF#;=,=:9%VX&
M>CM5Y^JZ$/5A\'Z4\=QBT,9Q9GVQR\>O*S24-_H)39]P5NF&=__7Q)HO=SI"1E2;Q?UCKH]++LT
M+#IIVF#MZ^;9\] P9>G'N!16P@PR4NI+!@<'3R4YHOB267^+LR$BT.DG#[.8
M[E&RYQ^7$W=J7VS/O!TC5GJ'$E^'KK0ORL8;\?\M.& W;5AN$0#ON7#M\"P._%UY0,^-X&!X_8GB96>_H?S> *AKK9X]JZ'4AA4%\@+2%>;;):V4>O
M5%"H<\B/:Z=W.N, )"2HR$9E_=8Z0PRVV-H,/\H=B%Z' R3QQ6;NYW0^FX,J
ML(WSE+8GDZ>4AXHQS'W"8ZMX\_'AIYFP Q0\79^LZ2OLK.9"1*B9WZE,U8^\
M6YT+E)4Z+'%J)6'Q$
M>2H7C'&7$A"G
M6V_?T@=12TU<%G%?6I(->9:]G(7K1W/:W_?ZUB<2-!0L_:ZDY0+=X'ULTQ+W
M%W34@Y=G,<:G+$)N>+GUB+$"]39O<70)P>G-@'"=/,Q:28YA(1:ZK@(-(D+/
MO K,BM!O79*W@S+FW2LVI:9PQA':??M;M;Q#7F!((10!.?JYP;?XC&D3+9^D
M9*?4Q0B &3">&[OL4^^*!Y1>.U=47SH\W%ZCIJ&^6]MLN/VF">Q_ZH4%UKVU&Z1/T:
MT,0Y"?&=OG""5?@I_HZ[I=7?_GZ/43JF0H_'+G+ZS2>\\J)QDG9L.IUJ7$5<
MZ6U93!8XU_D9 ,'95KQM+6V!R&?_LAN;VAV!]\FR#40S]Q41O@U5XZ17,AM]
M<.N!2; ;W4RV["0\5%>LQ:0()S43S&9T.1(4?,11D6+*1/&,PDW@G":3;6N?
M]*^;2A7_+G).P(D&AY57=Q2>N3V5C7IW4+01=QO\"0RZV8#S8VG#;&OYP[4N
ME8,S4S!C:;M#V3HI&164B%8@D[^'(,]:PE
MXWMLX>!H];L'CP;U'7#7S>#TX2QYN#X/]X<'+PV_FD*PF*SUBSC5JBI[G3X@
M]Q5-7H10E^6#4S8SD]@7NN13KUA[LN :6+I_ZF2:S3\_/@;A[]$WJL'HE7C
MEQE:H!NOV5*P!YXT;M*L!X$+_JH*5"H40'D>V3:T(O%]:Q]781^6*DR,_L G
ME]4#A:W"STFHIP!+W>W99+*IVHZJ$6EWK9JE\&&H5^+6<=W"@Z,#L]*]5*VR
MH'G[4]5$KW.0]31][.MZH:5Q.)> OF5__"\YP/F?/MR\O>8E5=[^**3N0
M[SHI*&4U2W^4O,HL@?XJ+A
ML892ZQ;Q"/6WD91J#I>OVM;JC7?A2@'AW8VA:E3>I_AO7 ZT2CR2-I,
M6VIC&[X:YJ_5B&^S:]18-B-JULC8M_)=T80+=]79<:PZ0#.).F?2$-$-:8*?
M!S_EF?7(=N4 )7_3&*FS7_5CY9GYJ^@U7-16]<-MG;]"F.[#5TE]"/.KFAJ<_;AX(>^8WO#K:$)K@8?%UNSS-
M7U;J1/?'*IKM'3\8!BUBBS*2+&,@[? PCXU,%Z.NJ2*F(VO/V0)4P )ZE
M&1_ML3OAQ*7RJ;J?*31I#<\NJ:5#Z'\^T#Z!Z9XE^;5,-+V+2V8W4$A9 FA^
M=]'%JCSHDYS"^U]OR+4Z;E2V/@\PK7SF91#VCOV@[S582J]"F>/R127_X(]"154965F\!L\1M
M&
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M9ZQP2I4A57I>&B.I H\&PNY-@H5''U6HZ/G9BF9,[N5.1N7(GZ]YWCFE#N^_@XU$FQI+E[&X>.+S=+[J=$E:+&::H$
M4=1I+"/4*(RU2[P9X#DD0@5+;Y^R;J=N.V>XC ?=NJ-M/EY%BG=WGXYK>^N=
MW7\)>5 4-L$@#.[1)L#;K9%-OB.G=V.5+7D: J@;08D[+ 5_*RU:O(TV$$K5
MSA>RVURU 'GN:PST#<#C'GQ5__+:FC$X=#B4UW4M5//4,P_DO::BT]I*%-#=
MZ?"8KKFB$8#-6@X-'98+,A1>L ]0+1E-+VEW&]L^JFVK(Y<#0@;/XT7;FOHE
M.#0_JFZGR8PMBGC^TXEBQ0=;9,6Q]!G&N,]W=T=M0_=M5_5QS,_
M[V8TB+;N%P>+&8+&J<=[B*93R>P!O*]7HE=BJ.AXFWG[+?)_19[R7R/*S%S1
MO J*D\<.OKB\)R40JD\X#'^/E-^&WM((8.(X *) 1EWA%RG]"L0T$#24L_'
M@A?VN!!+!(#6)$D?.LBL0==T;AV8PN6
M+ !?OF?C0K:^D6S=*LWNQ[-ZNK[(3%3O'?4V6_0@0N5-VK5C!9KM^ J:UC6_
MU YT!$&MJ%5!D?:NE%R38^6 BKV D^ZGC+9#+(A8])'BA3D%+14#Z
M5\?7!06JGP@%:MJ/#N95)S[+L"3$5ZXC-[_TU17?(/9D.3;QLPFR ?L$FFY>
M*U\WS^ J#@./\1+2XSW;M6LC!9J6^,'J1UU%]G8;.:X_9_L7\8O;QPV4D>>Y
MX]^0J^*M!W"H1MP],_<8\W54S*3F4VE]WXE HBGK@UA#:-TCK$P&DLKI,1W/41II,;(]"4, 2E]
ML-!7,20@I34^L?E;DZC5DA!PK5X6V"M %&6;1'=*4B@X>]68SU[!357I#I6Y
M$L+2?B#E 4XKPM(XHE:Z_45OF2[3S5/M(_@8.U;BH/>$-]8R?.-BY7J\S&,Z
M4]^'QB=:@_ALY;/9'EJS=OK5@ODSL6P%,>/HC_"!-#FQC":6)5NZ3QO&NQF1
M?R5NJ>(N_C'%.),<<92)9M-&8(K!]S,S;?20,Y8"Q?VU\ =9KT[@U\_+5S+X*P:^
M6>W93\S-D,P*1UVN27MOFP(;O@NELH(H]&.!VRN+&DK;AW6M@W&:1.6=.6*@
MUT,<&ROH\1PMS_ZY@*@N VJLVRZE8$=7.'OH
M&7>XIS=(8'E_5W: &V9?+VBR@R9$QL+5&X^+ 6N#L7W>
M2=FN37E8H2ZS"/LD,WL-7J[JE7_"+1:)TP+ NY6UO_O,.
MNRE-R:C/#2"H9DVQ78&L6I14X,ZX_;#]Z7>OOQ?$.S[(@1&* :NGFL6:5%3?$/RS1DLMBKJR!*Y?A4H0>E@MJ)Q]J
M)>\"7&3]]6N'1[Z> :($;5Q8<&KAZR
M0D)6BG\ ,S(K
MU]FFNZY(R4WCD]72O=-E4WPRXM%/JG9J;XC%9W"PC;I-AT+QD*>8 L.DUX&<_/
M!%8+$NM7FN3,;:V6W!G)UVV]C ^9B+)LQ&^DSA$SWO6,1'!#WP2D-G"MS+#)
M^CF,9SL%;0HG(_P((2+=K[S?[B(5\9IX'MI_P=EP#0]*WT1R8]+RD=TT Q\EM8*L4]:3@-6L)'@M4C/-^.GHL
M@%(2L>II2 Q7]LQ8/@5H:"$CQJT%60J:V)64>,W'I1Y.;
MO&92J#1RSW/5P9%QRC#)D62*5$MX<"PSGB*)>QR7GY-[HW]8"R[V>^ ,(CM*
M 7+=-$#A;S?2K"V5[;#/#@Z&_.-;WE2$,I>A/)^;GK1:U8KW7TGZS2B;?I05DLBYMY^--2.48:SG=KHD+[IAW7;;6BKH+
M,O.9,QD<]/(Y>&%8:;171A2=UA%CSW)Z':*>N;ZIS/S#8'%LU&^IV:Z?:AI_[,MGAFGTKFV!QE[J_X
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M:TP&LM_JD-[\V?O&Y$"08?AW(M-U9890>-]WN/./<%(+U^JTP(
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MT"KVB2G-AD^T!\:X25]'--P9]>?EKS(^(Q=#YG]KC*P!ACJ?)T?CKI
MO!;BR.+UJ"M&G%R3CA-HPPF0<[B35#B1JCUKS\/E^-1YY$FJ8I+EBMU[^4_W
MK[>W^5^DVC2PJ_(P0NIPS[9>!_4*#D0GA4Z I7,ZI^8<-CF$CW$-E_^+O?<.
M:BOK]@7I=C;&-& 3#30FF6QR,M .@$5&9$2PR2 DHLBAVS9@LI$$(AIC$%E@
MHA!"8 R(#"8'B9R#R#F.^[O????KOO?-U,S4W%--C$MC75.W?XFX%J4;3OU @AV@>O\6Z 9ZPI=1$
M)Y(--_GP)P\)ZT$!Y?%:#AKK;,K'$//K$0MS36M&?QMSY@BUDPXI=TJV1
M;6?*/F!QG;X2'.JL+G2?>9&OA5#PIN1V%L)AI5/ N5YNB3F5VZ1@86YN>^F/
M-TK8FL1>[RU)H_'^C[,4\(1.ZLC7+F/\9[G EI3HC17S4Y)W7G! P?-G@2*;
MEI2%X8XB7J6Z?%]E:SIJ+6&&YQIORXL=.S4=2O-"^0N2S2]0?=[MM,A.!RO7
MLT@1$2<@M2(I1,O_;?3FJ-];6GRU,^)5O-6*Z!.LJW4[W6%B@&;6C:2UJC2
MRI;[.6FLA>UN,O,P.QP$'_/;DU8I3^["UY),K%)^"4LJE3
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MW_K[SAFW)MGV,X!2SVV$G-X8,=I(O_O@?,0A;7.Y M.L,JLGH6#
M;=S+D@_E!EIML&$R#Y;+3;HDJ'&,&C:K+G2+J-#];A T7?(\#Y7XM,1=PI9F(&^VV[T&R9<'63$.O916^#&" * C*%J#*83\N@_X-B
M=8<9?T:ZA!>@2,\*KN*$GUH_C$>J&/UT2+=7_>'!?"Q./-U'L4 "R)B3PM)"
M>:XU*)4>$5E@AG/D\M&6MKYW#/"5&@^.B:Q-2BQP.A:C-2SS)&J%#'NXU OL
MP#>0/V"6XT^Q-F,RCEZT#YK%U[J*?BVSSOLYGKTP ^8F;6>1:C-B(LX'6H0?
M94;1OCE*SHJ-1J3XV\Z",LB1GG\>EOVY'\Q8;'H-DG:#-;BJN*9$A:6K>OQ*=%Q2BGG:6YHE
M^BJ1)>3['<7.>+&29:]S>8RJB'Y+D<^1BG=J-C*U\!!N9*B3$.T\5)W-_Z1L
M9_;@#^G2M01-8P^7B7K:"36-.*!+T23 2%]!323/#)#?M46^OOIW>U)=T3QM
M^GY./96A!HX^U94A)?F>'()#;UW1]THN3L:OS
M A29>"F&[L>[\DGM4^8;34/&>=FZVYZ?\0Y&/INJP<4CMD;!DH9(D+>WIR[C
M1-IS]4D%KZ]#KRG$DHG12RJ BVZU&*X/ICHL83$$!/=&-W"0".\/CD?OVN(U
M$OVOXVLRN3("<=NC]+TWNFURD+OB9%A(>5EZ67[!3J*N2%,PFM?EM:>ZW6?'-6D*?G#9(/-[7$"P=TK2X#
MZ_-N3GEO0H)+@#%B8^?PN;:W
MQLQM,S ^,'[?W4X_7^. DS$>!AKC&!S:0?V+'1YN]7-Q&+ ]EWX._3%: IOR1/0,:J.S4JPASD8JQR4<%
M!F.P1"#,$U)-@J3P^*/_#/YK7N Y0E?^6)+)OAQM=5P1O,7>+C?KEX
MI8JB-8:'+G,M[QO]QQ:/5-)*1]"WY&5^,5Z7V$^'7@%\F'QQG,%>FG]1M.:K
MX'T'GXB55V84TXC"U!MON!N@=SB'V?DF8.E.@1Y15:ICN6X)]V&4*=/UHO
M P?+5[ST<*9S8Z5L6 &2CB#93Q&^;J@YCC3H.E#KZIU,;787+[KS"&A2,A!6
M8U)1[SF;Q3%B?)[<7@J8$,B5[K6"&=.A]V44F>Z/C)_$2=]5U+TO(,T;'NNF
M^>7+!X#&NBB4OVX=UT]>&//B]%BZ,UPAOHLP'X:Q-Q9:#\- <1LA+\AY_%.C
M\/48(V[F$KHH@/N+I?[*.G8FG2KTRA?CK>)&-7%K>RQ)0 $GV])>?50A0"N\
M]V/M__=Y[:9<.;?I5MPNJ>A.2L\+?W_L)JGB6-M[2177L,."6J<](6ENV2QA$Q->=0GSD<
M6SEKX&OPIEY7?\=RR=*]46TZWDK#,37GZU42F_'?,WD.R;YQ ^&B=B=5$TIJ
M0ZN[Z0)'1?5*^I820>09OI7!][J+Q-ZD$3*\G1@F%3.\89[WJ/,,W3#=OJ_J
MN8P$8EBHLSU9*__N_+YG2\VH1U^_(
MM?F\P,'G%9+&G2L+H"(OD DI"7=1HJ *J FT76W0 %(-!PA6DZ;A%J @>L5O
M#'AIZ+@GC@\.,*H^XH'/DH(25L 4^7[&$^Z!+FYSJ^=1D^-=%E;M$Y*F,E;Z
MCO[W7D;J2$7&"LPW4%__'$V/YB-%Q^TE]W8X(?8%N79]NRU7#WLV&PI,W?:T
M,YOG\JR7/TUA=5I]= QF"Q$QUBW\CBB0/H2F OSSCG4.]$+F]$=AX"&D'H*B
M]*:7QSVMF>$SF*YU*BI:E=[0^O?=:[1@QTT+&<1*99ZC68=T!VV^HJ^C7^4#V"-37\O/*9V%33TFDXP5..S6,,X)QA/6
M+*,++N &M!A,=",92W0*G_2@W%IFBUP]^I*;F,DOK:-'Z)GG]#4XLPL\R4$U
MV]V*77>>_JO*?Z9DAK=F[^Q_S.W"9WP<1%KD^;:<:PUV=<7.*%08](\AH]?_
MH':'KVF[WBDAP"'7X8OL0F)9&E!]#VKE,M(XZT>,H^,KG9H:W4GK[!FAG5AN
MVGT]:$.PI[ZS'+RBK3M/F$9A8[DK5D)B1#6U1+#+TEYL'Z&1&7AUY!;C6SKD
MU-?_29EZH-U-PZAZ9VWGMGG:Z/7*&GPO=CER'KGEIWR5C]ZWG?ES
MJ1MK4X)ZD@UE:
MMP?;)>2OJ6I; H%W:A[*1EUUFE])X&D0ROP"*XN.CK7.!F&A=2>130ON\0LRX6+4FAY'JJ?:
M)R]YS(0G/J1$+XP,T^H,(:4R*'V1!>[Z[1;"%D$-S UM[0<-RVE%F*J7"8%!
M_@(9N;A5D&XI_Y5H'TZV[]9^EU0=+3YB*TS7 +5MQ4'+DBZ+7<45$8*U';6&
M[V7N[V83Z%U9RC@L_-T77WP(GXH6%*(4W)6I1#N9:\6\;VL#^/V74YRS^/^G
M4YS_DU!,=6A3UHL+XZ^-U/R UXO^P@@^_D9@:%>K[FL1%Z4%&)L7K2[
M"5%F;BK3JSDVTB57=?>$3/?H?O[- \Y/A1?8-Y^4_E'KNP'>AA _K&Y"<9!8\C\@
MGO=ED*J_#U)\],4CJ!/U&V&KV3.\@B^JA]<-F]TDZK_X>LYYJ8Y"C;3ZAZ]?MCMGG9)I-[SNXFR/N\GC+-)N6F4(>
M02IY'SVC?_%#G@GK>.%E?=;^,JT=%-3.68T.P)-(K_D&( KPX5YE
MO_MO4?:3;FA@J7VD.,]B1O\JW^/Y9 F++QW8'M3G]U 5J]/P>1(AJQ2<_>OP
MOE>G='M=H3-?3:=T5XQ:8]V@/VR^-+T/Z;H^08()Y&1%)_ WENA7P.HG-3LXT-^LT#4GS%BC;GEH/;][Y:=
M@OYQZN<6Z@[)[:$K6F,"O.T'A!]TD7P?YQ3]\K4@(Q@>V#Z8=I/0R:OFH5&:
M^WJP+2DG-2F7FVM%Y%7:81<[[2MG-UD#E)7WP*',PY$ZO*""[QY)=X[LDC"/
MS!FTLJVH-BZMV[\6F=>:34\32.K7_4P.W=NI\;Y[ %! ["!'KSQ"+
M=V;GCK]O=$W_'HDTEM-TK 9#*C>)F#NPA&5K??'Q37+XICF-5(]FIR'&D/3'
MG7."=B;2*LPF [J[P>:XD01ENJC"L'S^=1*60TD\-E@"ADQ#0+HQV.H]0A&Z
M"=#_>L#AB3W_]H9NM5=P>>C/AC' *(#K-#'^'W1Z_WLD\G_/2.0?JM,)) VP
M>TU>X!99V5[Y#;=_!!"^2LID\QF%__2E<*Y=30GYS6ZXKR.NK\-3:GD2:E10RQ>:]!>#:'+/$&R
MON&[C/(.FG( 'F!Z$GTV!/>Z?7==-"F?QPLQ)JG\-B>[50JE-17:+#B/D;*Z
MS9OEWXX<"A7*=1JSM/FI3H'1"P,?9?72;=?FU C1>C+
M'AN1"HQ:I#D:4AZM^J8'/S5K&0+XEMPWA-X"!XAF8:L4:]4*;MS! [,WP.GV
M3"0648%#K^S"Q^\/XGG^%G/5F3-'!Y@4-W"<[UKH7%&L*G"[=TV'W8.=AS)4
MY\O8#M64$ZL&.Q1FS0O(+:7P>O+RK.L!G/-U7T8IAQQG4\N4N"I=7W#K-I"8
MMVZ)OJ0ZV@93T!>@,O5MM^C4F+@=Q\XQ"QS-7/&W))NUZ%MB,3^P;A6YH=VW
M >*NYUDS_?YJ^I\_,!9XYR@GJ 6U1Q=S"11PL].
MK'#UFY0Y5S27CU;AH2=IM4$;Z 9D>!02[4C/82X@2>NRTA6W[>$,WNOCL22W
M.5+F9+N?,U#J$99[CFEY-=HCB*=7
MBF-LWP#JW>EG7\OMV5^(YR5.\:]N/,1RF6Z HSM!#9X.?LCC.Q6'B=2-2U?NU"VJ],^8^FX](^>_;6A@B+14HW4%@7_J%1V;07@ SYT>BOU!FWXL+[LK
M(6J_H&,B >TQ2,]9$]#0[@"Z5563W*K*/4W+'!F;Q%_U5Q_S\7-15_ CH@;.IF_\;N^E._NY,&RH]]K:I=KG&XK,5*
M0(BV(G$UI< E6+Z4#$(;<5?+.>E>HJU:3?[2MC*C^TB5-6G>H;K_A\:#*/M)NRQY.YE)_0HUZ0%GX6
MW\@4\+4B>38X3 U4#IEL"N?.HZ;&Y^2V9L?7WE!2:&YK?$!S.4L5\#D##=42
M>0'*-(+H?+#1<
M:%3OW_?N#(PVZ^6,?KP&%AI+D/'.,]K2A'!IZI^_$[!NL&7L*I=PI/;;,OI1
M*VWOX;#\+U#1]B 9-SO+V!@_#=^Q["WRG<"/(T<.06LLCWT!PP\>BCM.[
MLPK8XJD39\VW"=^@2^Z6SST>!?:5?DU):C+]/*&.T!$]T))/>"!A\EWYA3,K
MDW_PJX/<-^AH+&I%&V!D3)O'(4:D<%H''&KH_W!5 08/BANO+,>7N03,)=7V
MT=TXN*5)3IW(R.A&R'8!_T$,=E-;J?8$W2?LM4&@*\E6Z\C]^N).&MA>T_'A
MN+RM'00S:&ZWJ?:J"&P->R=B5.5J,G3R7C.,;7#!D>XP/AF4%S0?..'+56?:
M\:6,UJ:[H3',TKS(TLLK@UVAX"N<9&U'FWY+XNO_4/#/Y?6K(8W)Q L4TH8),UO)W/ :3:U
M]A9Y4=A'2>'V?%,97Z=5))2W]S98X+;&A"'3O;.\G+S$^B"[Y<=5G]R8%$^D
MG-G\;Y?C7WOJIR[Y# 8*'+6)4F.\6YS<'M=EM [;>YF-KS+"3,QT>F^2:H^Q
M3!T3K7/K@-UE& (=1QS&7]%SP)XL.\WAABA3?PZM-GMGCRJ1*EYU22F*YA63;]C\%5_,5".>E>@.1YIO@:L\
MP:DP;;Y\U?3U!]V2@GX*807_'*[>KO)\Z_U]!FPI (RDGZY:T
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MZ]6N"0 .?-2$D+8<^C' &).K"<+>&=PZW[>X,LQQOC\\PGR=-R0-V/1&0
M>I$4.W_US__0T?\>7OK?-;STA]!E;IA0$'GG+?O1TO*WYZ9/L^]&\^P[S(19
M1/I(1<$T@LG6_%%AK8$/&R$\^45CSNLRDJCI*SB)\ H014SP2VX$!M$6<6
MKNG?_Z4"K @ !Y%339)%W[5Q-=S@&Q-TC=/2M$P _9J"BGW5[ML/@L7S
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MT5F30)>/.X/Y)>.(4]"'(K3?7KLQ??8*(CM'>()-UWQ5L1H"H(-Z7
MGO*NH+6\S!OI4@LOE+YJ3Y3X#Z=X.8*-J X_.:09S<]M%)ILD991LJ?!I. V
M/BD7VS*&8YE]C"P%M49U3-*5KO7*#>F3 2CX _BZT^I^.'[W1E<&=2=%9
(GS\_6?(PD@%8GTU8FTXC>(?%$4&O9 _^*$+O6[@*6NY8?VIR1H!\=
M=CG+:U]YD8Y10-TVFD:JGRV>O=I6HE/D[)!\FFDZ<=(RX0:JW; G>P/)9V&:I(4+ G\ &Q?[%VW]#S^'J]0B(!//4"?YS,<
M](OXW/C?,\;=K(]+-2%?FC9WUT\NKHN_G_OE07EM;;D[*991T@')=?,9/79!
M"WG2/^A'X75K"W:"5 JT\/([9V1$YLY:]/3@V$R3LO^\(WP(TDL,UBYX0?:NK9NMYH@3'S"T7!V 7'3"/9#IK3Q:LLQ
M,]*V:0WX33K2WD>S/NY+6" <87&"S]99V,TVZR8(L7D*,=R202XP]ZRC@GF'
M;IK@!*1[2_'/Z28W9C_[FZ)LJPO:^&FFM/VE\G[U9]5^P@YL-PJ?NG%\O3="
MA4.>66+R%&=QF)GC65MT",UL.6IX]=7X?-)EB7#.BQJRQGM?B+6<7C_;KY@$
M06=E]O>"8TLB*A^/3#Z7E!C7J"6'O@)*5R6Q)!ZOR_3R2*
M#('#YYWUTZ6YG,P9D2J,=B;?A
MS5YGB?K]KZYRS2:0M)%65F'1^G!8R;UC\=5X3Y1AK7S*I-R)K;W_>EN\(H=]
MHLQOK9+BY-?0[$/X)TP*W%RW>*XY0D/1HR+P."/?P<%BP(K4DX7J]$9:5Z:)!-[6ZUJLN6H@D7M0#;2H>8;IU?_
M8 XA3U Y\5X?%KH4IH0W#?1U;*YTWD4.(5U/A6P"@=IJV1_(1$P"%VTJT@',
M2X]3J70Y6C-OYBMI$N.UT*DR<<@(7!LR3TU56,12?SQA2=%8A:V:0/FM3O:-
M[QZI04"L!@1J8WW=X\^Y=*
M/D82P 0"Z+7%+3QMO5G"&LWG;;.C@5S^NMOB@)8+51[_)
MI-W^*ND#VG%/_<,:;BP+B;!#/ %<=]/041[I*D76:?:H4DJ+B;'(;$?8:\L6
M0COYRSFE0?/M"NY:[[O@M2,_)TI@FY(!.Q[O*SJI6KKK:X+'+0,M]1#;(930
MI:N@I4_G76NL2V)^^PW.T_NP>NRPO4:K9=N63(>\_Y,<5V% YSK',S;U+A=H
MH_W<]E+\^\D QK,Q4HJJ4VJ*/BM1J81Z8;$;CAAF_'OQN(5N]6*YXLR2#[
M4T,<&OKW6Z)M/U;H\&I$B"EW<(_:R1K!@6HHY=3<) #/A3HP5-QIHGT_M;<.
M;>LR_:R9\YHOUWYO/^9IOIIF.594=*^;D.5_)<*9>##7E3CF0_I2R[WLRY>>
MDPGAND'NI('AT4K&J]+J$Y9^_^8MS^G+L3BA6'Q+(+-@=($S/+7?0.@CR/)=L'17E5I66
M]WP<'P@A'0:(\J;=17IJ8'GJ3^:+Y,5N\.$3*M\R2_PU[] \H2P]#VB8? "0
M:WU5517R5/F.^L,YL_VGG^/M7N=@&8\YI)-5[0VR6P2$9$VN/P5@@IL6EGON
M-#B[8;K+/2\2/]EUD'G6%($'Q>3U TH]S4 $,*?_J%Q-$N<3_@=>O#X>8QJS
MF,CM$2C[^DC2 EC*@3*M'RW/4?IV)D-(&0)")$(*YH7*5O^%5H7=E@5OH,Q@U\X9_/R%2,,;BQ D9=)ZCI^_#
MC"Y_Y9-",M9J14U?,^.;[(8;MS1% =A&PG)G1(Q='Q3C7?9^MS*)9I'MN!9X
MH%8X-N[%CPJC8/Q3UY[4TA*-I3_:,LEED%ZJM 5ND-K'!ZX<0U%4T6KSJTV,KI8P
MD2._RQ)[ U#PVW%\RK3PSP;%<]"0":=:=R>4!5W=5HJQ?E3EC30:$*&LHP4$
M@;:_84H=7HS%%PA(\LB$/6J+G_Z/C1*?7XL$?D2%Z,$$O562487#@>KH6.N[
MO "=*'$=H!N.U_C\11_L^:A0?7"\I?VDV_N6-35"'^DP(4:*;Y,&=DL;6@9
M($[5@3>TT=B@C$G6N5@R'GSEUGG52<' MXZ#M1GEL%G0C>R+C@G)%8/*L2!7
M>\I0KA\P2LYL80MWB
MI&*W+KV),6.L*,=L$[C UQ*WO>%72"0M?8^\7WE6/'YJU,HG,VE]+M"&_]-)KWH%5H/3=R&G/CYNEFL/U"ZIGO3L!%DS1L?;
MF%:YID6?IM#Y*+/8\T:MCCIY:N4Q_W%K!/D2D"(SGGA %QNYH)S]-N%
M-6/-YS'$,BVCO8JY15&6'E)_&X-><:!;5+[K@"[WVOHBHG-@V>FN_XX!F3,T
M*ONBIOY6P[-'(N>CRK,JH]BR2ZH^*Z,S*EW:TY2%S:.>C&._D.,?;;>>+/;(
MV'<^[[3I]$MP>ZHG]PPXN%$KTW.YO^Y(8_N*2ZW7.&O*3R"_6A
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M^NIVLVP$!/('WK0E==
MK\V8LEPWGD&28]Q8F2G^T3H?Z OKQXX,'D\G?H/>\6>RYS:^.F2R:8"AE##9
M%3>.#^XVQ['L%:B-:":RH7\LV^%@1\4-7,MAG*UD2W\A!065?]YXVEJ0YUE9
M.*=1>*)I^+[ZY;]="^H\_-O"3YS_\K^_\O]_L_J9O]E%9<,1U3"GX+LPP/#UG?<[FF(AN
MK3$U?U3>]73V,:G3 40V_T<>^SL@/7A.8DTN/O4EY>?1?XY2O%E_F#9TRN 5
M"#YX;KX:),0SZG\!.(L_;XRPD0:6[+#%XPXG,?55I_7E#- .Q&&PB$6*SE'.
M&?-KL,H;+=>_;K0[@2EL5_XN:6E69,P9[VH:_+/Y6[U\T^9#S
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MM7+2_=ZZ)3@^W7KBF0;\79W-P/J\H2*>,[S4XY4G9%*<<^>@LTXBGG/NYDP/PV'VAI/.D=86E+YQQMWQK
M5S[P5,.@C'_JD6A1TE3VI'H:5.@/-EF3!/./#]")5=#B8FC(XIP^GO-FYSO1
M@'/2/!PQ:W+%Q1E3E>V9PJPS/XPCEG3:!D197O>-L;!EU/E"ZK1=>RWN1B\P
M:EP[2]N/;,2QSV_E#N>DL+1AQ$S[875&:=GSHQW-H1 7C]12!5G&Y=/9Y1$7
MM;A!*8(FH,TO%1T]>BQ$@3[3"TD<3#3Q,M(M2QX,4/UW $\?.YCI"#WT.5"%
MQ0GEKU=]Q*?M;0HY;S@(NS_0'Z7%7#5PXM+Y?<,HN;PZUB'"I6BA9>=I5FN:
M)%>QKV/:*9NSFO%.^1PB7ZV(;%OE [.$.^^!M@W2[8F%PJ-L;ITB4SA[EKDY
M#2)#WIS;,%E@ZMZ(Q?GC:$L*X\D/-S^066W5R.E??X)K6+O5(,38O.Q_ =;G
MD!&),*M6RVDH?7PEP=;22$+RHR"THW&-C2_#-3UF_1DPC8XSY'BB5C;=,6\V
M=/OD3F%&D2?4EPE&JM0!''P3_,6Y7R.H7:0B*)=$,M;K;K^D@@QSMUC4P-]Q
MGB@& <'E0$^X2YG'O+;?P/7_N!#4S-;YU+F^8XT$,2%(+\J6?]&,>Y  2'C&
M?Q'GP@I+/MA+$BZ(U@HX87 KSNY]<^8?XU\TX/$D4[D^LA3,YJ877I U;T'L
MB1!XVE^4%H-J2;>\_R=SKOZBR[@RJF1&4W=H_=G% QQ1$[&.M)9K]]$0 ?A(
M9"G-G4F3U&\G0C*\WPJ(%$6*C'GIZC@F&2$#62/CK[5I/0&+( O/0-)18^B7
M$(:[N6#GO;ZN5AKH+4BY7PX6MK>=L#=2/-+5,*9:#)G?S3
M:6[6BPH#DL4F#![I<^Q51*B9ZV".+.]CR.<6_R/@DSMCP>4&8MQA7!J A$CN
MW-5:AXK(!Y0_X?$#G [Y'_"X'URE+(10B^P=J-BK2WF]:@P=[8B7(T?'$*2<
MW8-CW8/#5?X)D7_Z (O+&R,5B99\A3$V=!X8.[N6:SUPO-VZOJ/HJP=^#H;/
M:]3T/XC]6;X8N1<1Q/SZ :8%S>-@%9)7N)(JRE.Q[QHM-^J^I(B(X5XN3BT*
MCC3"-O)UDFD458S:XSC2'"AG!9ZQ-3C-@1<9]!2W-XMC3CIA%VQW:EKK@AX@\]@-/&RRKJ[C/!GSO79._M X@'G6PU[U\MLM-8$ )O B:78"
M!*GX-R;(O\GMOL"^@X7)$L=(BL">9R"U:<*NRNUQ.730CA0*/
M%95\&JUIOWQ)Y;@D/"%-=_2I0]Z_I49TWL7X8#_%@+79J#-ZHT3;6.#B#BN8
MZ(:C0_006GVY#;'5Q>W%%G[$A99#$X>B>V=N>SP'4TDHJH=
M^#*V]5Y@:?M$HT]/EA=T"N$W\GD#9.WE*5BN^4U/NX'9KR+0GQ\G9CI80DG;
M<6,\X_7L#P5["E9H?G/7T25R")=_2'B1_%<%?%7"U-:T*K2.@M:#R*K=:DEC
MB+4I^V_.H[K$)@SYM!V=.;I@IWZ(S8*IN36L5LRJE>1_N!ZJ?4>Q6WD1
MTQE?E)G?>FA_.DJRUF]K+:T/ISG(]#)>:#UZ/A;IC.!%A\S%O+07!%Q2(<,T3:"F>+;A3.U1 $!Y
M,<-@7P*=AA6VC#T5(:[SH)G( X4AN0$__>:C]?YQ9@K;\@*!7K'\LS\B4Y.7
MJ(>="X@\DE]6R-9-"**->['Y%OD)+0VH+,1GNNQS/J7@-.B00WS]A1O!18/!
MMF7DO_3]BJ3)*7:NR8V7B54!%6B)0(!5Z>"\R/3@T8'I)55Q-O#< L]D@^*W
M%I+4]Q);T$]!77=P1*VP75(%+ /4-88669OVBN!S"W+6&8)EL-IA<(B4
ME)TW2ZXY[IP@2EX\47 \>#DV.A5!2PJ4ED5%&VW$_H8^+DC:8O]\7N=@"-Y]
MILT&3+,#P) A@(0Z32FO77B-OFNPXAK#HNA]1L,O.R,G($&Q2RH;8Y/1I3&=
MZ]09\R'$CJ+6.&/)2RIUWX+0#>+:J7*%MN?FMY:"W+2&_."ZT>1QW<[OPGCC
M.;,R;,>X5$">=N+:3F!+N1GGU2F^G,RO<+OB)H:UYX7?,G7[Q3=\3_&[V)TL
MGTS'P[*8S*+%-(5S6F"#VQ9%;:D]H^*:Q<7][M\;M4*GBKGP+8,55J7EP[UY-<,]XRZA
MM:QYRQ/"8N%I!G 07UNL(;W7OUYPH).;^6V@OAO >Y"MAWZ @B/"'5ST^3.3
M^Q'!5[,?GE+#E\YR1"^I+O+V1+O%1!ODW0ZCW2ZI\B9LL?K$"YY+JJ!V0^LP
MFY7V%\5I>&F/US+S,#9O\]L6Q\"4_3L+$KJCD-7A(K),=#AY;S[AT;$4"]/M
M7;=SI_7\2ZH*IW*O[*,Q .]$HVWM46$I(-AQ=1_6>9YM%!5!&QU'"C[;%/13
M4'E:D2PVX[N:"$J8&"6\G4I)J%C&C!Y5,%^_06^ 27.!T?(UL?8L/GP0?Y_G
M.XE2BRQ:\$9:/6?M.>F!%A5@%'6_5IAOI^%AI6]\$DVBP$U?#K>?_$ZJ'O?'
MX5#.AQP;XZ%WH H![$':>T.3S1>CXP1]7B:KZ->D9FD6$.3!G$SGP*\QQSR=
MQ,3 &S<^ ,Y[7'"75#FO4O,^*MNO.C?M1?2M-U2502=J _C[-TKG4L(S%SB^
M#:R(906>%E53.A&EN4H:4SNW1(=K#;174O<'5VFT,3!+V_SG;B9KZ6S,W[+J
MW_D=(;:W:VN',Z?[U3O:>N%+%-8IX'!5K,,286AGQ[.DA#3BZ%'Z/#WCSN8-
MC0&IFD"")"M1J7[->.;:EBHW7_SCAO^44G^(^$7;X G>8V[#)A!L\0JOR.P]
M7&5[?,&OBAHXB9/)-=P1*IWNC1J,UU9[,0O4?'AZ)^PBHW U0/E99[^GV)Q=
M*;9*'H1J8LQX(L]H-NZ363!V(H.VZ5%3(9/?.7*^ 92:,03&C]*2="%X40BT
ML,-[J++?=[A\(&6"P/;2HR?(,C)VP:G[/)]=7BV > L-V)/VBC5Z3_BI1Y,;'!;BEQ243..._:?1F!35SL3:W2#-XO*S76UR[?W#$?Z[,UN%&+E
M57@R_^!^,SW4V_2P8C^K'VT=FF.GCL\]XSW]$G$1DMV,VP\:--E32(P,@&BH
MX.0YI:UG[,@E;>90/+BX:!8A:.!FM)9>./DLAY[$(U73OYE/>B[H.NQ0#M/@
MY8G^VJ[F3/%=>YJ=/]R#0 B84$J?"7Y,9 FZMY\!.;>65KND8BLPU<^S+VCX
MLL YL<\RE!>?(TVZ/F@70XOZ
MTW,8\AWK7H?0[23,+)X[5=BE#E0&Z@4Y;=AIA(3/L1FOS-9FYNQOAY3ZE3DO
MKJ+X\(;"CP* GCB5"'0 S=X09X0Z*= 2?]?8)!X2.R8HGK609^]:D+B_T:[;
MI:% L;0LT:O)#YQ-X@ M U]^6*FULC+E*]H/WV72TY'#BC_^?$G5-:8],. _
M.3=;,)GOP.H+!['=*K![SB^J>4893@QF3"SAN$OHR:EF&D/15H[GWQ$Y\P+$\0>'L@ %Q0-$G%B,ZIY!YI:Y#OL&IW$
M0>'QAKACXCRWW!F]-IUL#>%-<*4,">'P=5#^[L>:C]@'(22=)9.:4PBFA?[]
MC,WQPYUU^BJ:,\"C>." G?HV8,L"8LG9&R_AG)1Z6X;L :0D(P^9WJ]6]EU),%M9#^UJIH7^-E@N4M+K#V52UL+X'89^DT[LHAE";SD82F'>UQUD=C7;8XU
MNQ:/84P3#.97;[C[(,"36UF)#'E6U!KQ:5OTW&IW*)B8YV#A!S-#^OENX425
M'P3SWZ#=JMB\WV[/<&I9:/L9%@
M%6I.0Z>*#S VR+3QA:#7G!6"[J YBS:*YVOW'\ XQD%IH==,-K*%;2ZIPE[S
MK+DY$$:D)5#&.B,V)\P?UF)0N1 ,O@A2.6L*LQ9GO7OEG?65'95(6B&A-;45
M+1&F\3SYA="5V#@5HGI6_'[ G 7&),);_))J7W'J1+M]V#K<[7--6MFBJ_!:
M,,4?HI"H8BDK0-PBVQ@ ME0 >AX6QC):_4F?3> (3VN!!!ZXG!)^V9,
MY4S>Z-?FMQ:L[S:T Y9D:<\K'GW=X72:DQ8FC:5(;'C%_'JN]P:UT_ZZCV-2
MZ>&:XI=%9ZL*EV*U59RVX'4ST;?[#?+AN?Y;AJZ'LJ$\76/*NHFLCJC4][$6
M*71)A2-!C9/X! W6'G2B3Q>N47-B/"3->/!'AN09K57K&$^E!O9_$:=8Q@O4
M[).MHE$*>6?97M"5>L\6L5I.HO=1?)B:G0] )FSR!3+(%\>
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MWV[7U,5G)MG_V:S>@IF8\3IIF3H7G*)VIW_J:UT&.O[RU
MN8I#LH(L5L>K?3ISFMC*.#G?HJ$0U@MX:DDF(1.(!(0.P1P((7QKH3ENFY0X'<
M@U,:6X863%>9T9^-0D1+FSML.Y7^J_S^<_+%
M@K"I^B;M*[:*Z9RBAY^"Z]E ]H=!Q9Q,"(.=&O2CKM4,Q\00C=Y% +W6^^>7
M5.*VGHH#2A9'DSNT@Y3&UF,I+L>4!!S[?KY0 ]ODTY.,?+E+*K[PV#N/&G]\
M?4K%U<&1, FA/O2TEC6O[.((UA_.'7Q/LU9;XXG+61D-6%
M:L>[.KZ_\A/=8('I@CX,@/0L5*$PU06[DT!37;HT R'76?QM;Y.7-9+0%R:#
M8:'?;3+6C'>$.UH6AEP\/.";VOJEY@+6%6"^KNU-7B'9AW.\4RR"TFM::!6W
MD\3,?5E'D@V.!O:.S/'MF^WXVA.YHM,\P:S=_<]9P#0 ,39A1,U#9/2Y)#^+
M/U\E/!DDBJ,Y=!CJ'1]';GMR\X<)J,!\/G;-C;7"4RUX.9RWC:*UOVG/5<)H
ML@MU&1Y*)-W)F4BK/( ^KXCGE2MAB)R(3X$<&(YML["_;80G+]*QW>NVN[F,-71Y_C
M&3HG,E$U,+ 9]M-P;+R'AA?X'=G.[!.(@E)>H(9*TI)
M2.\G@5%>:59="XRI59RUGMYK>2VQ+@,>.E//3!%W_B_QP94EE 1OD.-B;R+'
M/;GN@A6)A?I!I[[QIYY8Z^ %KMPT0'"A?L(O:_)$.J\T#>JT(/J]BN(E:@^O
MFL%7B2!H9 !(09MQ>&A,&U%90VS_ZJD8_D#&JN!SEP.C?NJN
MD2J2_QZ1&Z'!]SU/.7R8N\5TMU.JNJGO,_=LP=5G*L=-U25%!X?*PJ#R6
M7'VA[>J+F">5$,0YD6U3'+J0HL*%[NY$1HPWW@=\,!0:D[IEN*R+@(*_?/BH
M 0GLH$P,H9C8+$6'HLZKK.?XZNXK,,R34I?HFYZ'P!_];?5K*0Z'?A$3Y(7K(A]$G?+QM'AH%\TFLOH#SEZVM=0;\XG"(F+3
MH!-D?Z^86333BK84R'YFUG$T2116Y%N&[F&(0EJC 5(NS2INT*1&W.G^Q[I7
MFFFK ?7OB!!7@3H<8/L$K]RCH[)R%K83+!9!VCK*E&N6N=L3MAE2>W UH
M/8JM">5IX5J8;,<&KM -E)VLM1?\2&ET[4W'?.3!0O>H]%!#('2DA!Z0  D0RD$(
MD(0BA!YZ*-*E-]&?Y]YW[_O>\MZ]?]S?[S?'2,8>(8S?6"^=)8;OWY7X5*P)T?F6:?
M7"9#II=8J]-?O0_;(B?YV^!1H;58>Q.Z:1@3>PH@+]OG01VM#=]!P#C_M7UI
MUNSSY@MOEMFO6'*2VVRYX!*+E=;,)<)ST7J3?6K&@6Y'1]K^$4:VJ$,@\]8M9H8J^M>64KK:#6;NDCO+2;\PK839(&0.5Q'NWC.>F#8^TK**MKBF>#E9A
MB0GQ3^8H[0%)E&S1%C^X[+'@[K961UQOFTBS\%#>VKCMZFA%9@GZL'X.=,(%
MB9V"W)4^%#7S1F]Y\&.VC'X?QL;K;&"YZ*#WJ55]D>>'!4P+WZGZ6NEZ>:Y<>G5
MSLVKX8A9\TP']XTDHZ(UH-K%07>DVZIKG[>G%7_ H#K$UPAM)(SU]@UWR?D!
MU.-R9/RCH_[7(BH?AXB#R5.3$L##/,=FG*!U.3,%JZ@F;2BP)'"1;J]B7D)^
M7M\1_U_#Y?^O]%//PM/1569,\YJ.Q<\';P]^K:K.\7Q6,X1J0.41J:1W2H H
M\6R&4ND&X*=B:6DIX!544=XU)>W>4,\R58A@H:=&)WLF.Z)]!66W%$Q*OS';
MU\+&KJWWB"AN4E9(F_.[#%J-6#N$_4!H[[@J-IOS?!<^WA#B\#!'%8'LOVJ\I,_
M0]'94G?ZD[=/M-LN40 /:O^,$;"Z]D:'^HV8\-?D+_<4KFKF.T[GKEBYU /V
M4/Y?.^I6LNY>E2Q$_N Q:
M?XTGQ;Z@>B-[^@CHC7K/TC(&)/==K;KDC);5 X/'@M'KMGZ$X:! 1>7,(_<;
MK9>YAB-G1E0]4142Z/>X7KW/^W3T=47^'Q"76PI;&.9ZH7=E\Y?O/JRX%
M<.X=RA;MK?:0IO7)@&%1YP7UOSZ;C2&SQ5_]S:,EF^8(L2/@E3\O <
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MCHG):T_!@J.S*-
MGR]CSBFM%[#M)2%3XTF.,[/$_N.^)B7GQK/J<[6R_DFI3;)36PI+2W)"6R=+
MFE!FQ<"\6?K!T\S2=(\CI':H@2 \&HG-+)L%!I[,SUZHK>-#E"R(S>1:1GN%
MWQ$DG"\OD*\I2Y4(FMGA ;K:%RC@ *;*,%W $TJ5Z?%FK1&D$*
MD,OPB7\2_L%?OQ@&WFU6-PR(F$T,DEAXA/9^T+8"2I.J^EJH8B!L&,X-E;>\
MK@'KCA6./HCE".AIID2]-&&,ZZ^_G1V]J>:TW2YQV3LPW+277O+4#*-QM^F.CGZF3MT$%ZGY$IE>-\TCR^K2YIZ&,YJQ%Z
M)SWY])8Y""Q_FBLIN.ZZ@@1)F^KB:P-9U4IB@WZ14'TVB2(R.C":^T>DM!P:
M)XC+?($TJ7#.!+J$UOM0X(".$V!R2OU)^:"27$]9'3C4&'M1B+#1[*\4JSO&
MI\Q:DO_8KP0Y[O".UDO@ 4
M\@M4%:GUL:N!CHZU$\F?1TH-4GMT$U5%S,MSDCADW3*_QC/RV-BXQK"#1"#K
M!1!-.!+@89H8!TV+U_['SEI.(XGE_#<$UN88[6Q]8/IM'^J:4K 3SO&N%OE9
MF^_$6)H""FBX4M59N?<*FRTZAP2"A?5G0(SO%5FKBO4:$,*P\3_&VOB:9
M]N3JH,_)[86KCJ_GT\!RYJO!%A$@VCQ(H&,BONE>AUR$H8@VFH]8*"GSZH#:
M]""2<_)HU=&&*>->=LPK6NF49JVK^D>!=3#2ORU #6Z4[
M ,&3J;)U>9S))ZS\J,YX0?85_-"6W=6,?V($$PQA%1JM*)_$MFZYWODNVAV\
M1.@-,?%KFU3W+S1P^IP';\6-">/E$\9N?-9^2C,T!UX(";(YI>=KVFZHW5!Y4W>"&E0NWMN-K5G4&'
MB0;Q
MRHW:Q@'*\;Y\$C(.#E 8IY_V>0M.^L.L_$2APG7?!?L-K9%FS!AX'*(W0HS8
M0EHA":J_K$OLDSZ^FKGPFL/^&''^8P2AB=/"SC3C?OD"&XL# K"5Q;?$.13&
M2O15X>,M)T%NXU1\!/K69=SU0XS%I^0M&DJJ,TNU8$38,K.F&U"28'-GM%@V
M.VT23^S_V!_C %CU$9BM9M<:*<.9:?4*.!C1&\@\7!>UMEQ!LFN-FG@VR7VG
M2?ZXUGYWN[N]J?9)C#%C@==R.Z#U5>^.CML/JQ8D-S&.S,PW0KP=*2)?S6R)X05[B
M0Z<.LTT5\\5#4?DXPBN' V$% (YYF2KB:P'R51!R77OY+T;^J>(2VAYA.L)Z
M !F,QWY>=OTM3UZ ^NBKNB<*,
M6X&SKJ-?^36NR/F;FP6GF)3D+52GAJA@UJ9S=Z_TCZH/A7=-]6BE!W>*6E)?R3=IJ.2=4\QB3,@6UQ%!Q%Z/A<67&L?F/L)>40
MM'6:*9^;#5Y5T+I9:9L>,6+%'+H0%9J$93?YWZ53K]FE2@:&S8:Q@N7+:49KL[&Y AWF';7F&LNYV8I&;\J9^>#.[V
MQ[/_ <"YXX,-Q/"4RDWH-S9LF!:]>%;RD!N3=DMX,!/6@'FC=[-YY":X2F-X
M:AH]8ZI#R.FX7_C7WRW\LKQC;F]-!OF[N_OFYFE8Z!/=;)]^4H19BVQQ1A8P
M6?37O['4,T 4OLJ#;^YX^]O?_PP_B*)\J
M6 /1U\Y0S2DVQ&_B,=:.:D/('"5V-L>VK94&EG57882-T#>?]H\WS@_VK,8DCK?/G?I@]\0%V; :_
MVH@H&-BU"*W*_0K0GHO9:@BU.#7[&*N_?>)M7W5LH7"FWQ9;5$DG3T-S
M;:N59.;T>&*WP\2VL4P;XWN(7HZK7D(V<_88G
MB@H90F/%5L+K;WF%RM=Z5;>4B<>DC,\XM[&B,Y%;](4?H^+>K=/+;7'.'U.:
M3H-JIO/4KSVV]=\[6>*5BL'(!=-8+TPS<;76;9T,]Y>5:9B??/)+&AB^9)?D/]>!WYL')!NH07IXX;T%4"\
M6S?'J+7-2/&^^S9)^A!\Q:"^S9B;FUMX=EPSQ;L.ZF( QEKA/U"2I:D^TLLS
M 4AD;SX8J)'4',V82O74@Z7^_0+!_G.^7V<"[#AN-FXVR]HRS>1BIGE>-/%_
M8Z@7YVZ=NGBS&[-G#5(5[OA.#?3#CTAX;;UF ."H-6=@UY
MU^B1"JKZ='A%K+4=5N0(:(S1P_<:0W^,<:%D.#72U?[CW* M"M+ G-4]#5#.
M;JK1KFNXO2$QZCFK:,IV[^!V3R.BE)!S:=BZ;<,A1!)<4]*T.Y?_:(YP].H5
M;%-PD""/SH/':ET'CV:P-@&D)NSTO5KIR+A#V,.K+=R^?"#LL!;I)TW=:/!N
MW$)X^J 9[%RN?GP2,GW4IO>^X>V&&J8I'-]Z,;9#+9QT-872)=YY5@.\'=C6IIVN4*L ,2@,LW ;U$Q)B7J>KR*R
M)3@SS1"P,]<E;<\*"SMC7W;IN!SV.M("V#">6D\GHVVA(^?'=*5=2 ET_!*HOI,H7:Z
MK6.&$>[8S9I-=5I?!TUF:A>&[D"W=E!#3U_?L7%-:,=&#$B>[.K8OK^\K@:H
M6<;',HTDV=6@S2VO-/#H9_7L+VZ',*79VBP-@,4%?,K CPHKS3S2?@_'
M'7)_0Z5QW7: A: =$W!= 4TGZ4!H;2$K,-^\Y*1BE:^MZ5"9[QDA>6%6VEA)
M?]^J63)X\ERQ%+95?H]@5@6/'+]?_KMW2>B?_UT,I*T.4O\0&.'R25%^HJBF
MLK5_T8;*?"1GA92RD'&S=WP,E9.YU6$NG">E:SKGTS7V+:#QD!C"MW/C&!A+
M-V(>[;-7O?!ZT++H.TWUP'>:^3>VLWWM^4I3WR[:3[^.>_! F*B(V0.63\: ZA0(AXJY?H:\Z=,X
M/\Z5O !]?K_5Y=?"3V$E(*Y)/M%D^C_^MQH_BZLNH*E]KQJ$5P#W4[[*
M3(M9%C>_W4;PV:NH%02;8?6BAQQ/)0WI'2_O>D&(A/)\>%K/S2_,].NZM=,Y
M\U2A_'=CV_=YR7(U^E!TCRBZE;U%*]3F\-A"F2=)E?(RWH=LE=9,U&TS+OS0
M)^M?]URY>?$_M?XUVZNE@X:.G7 .9J%V,3ZK%_!JK[@.)K#@@NM=I9*5,4]?
M_FW__2^\P-MOU].5<_6GC^&K P5J22^NO3MFJAMS&9$N/\;+&QUJCDB7K:S3
MGH"%)11.D =IJ:)CZ]$]'7?O409-)
MI:/N.H)FS-]I(APNOWDTW;UR_C
M+\JR!L'MWE?1\S^W2/+*AC6?W.G3UHC1AQ^0N44D<]YQ]>\I?K3)98&94ES[
MX ]Y'@9"YVR %^*LU%ZW!K[+S> I[+L /% 26'8GA!#L%;3SYIH<,[I\YM8]7F
MBW+!?1I-HRF\#0&0%PS+Z_D&X;?,J+:5UZ_
M_U?SRU[OM. $^^[]?)^:U4?"V_2V&"U(#[X+R+Y Q%Y>#\PG/"EY0@&^$<( 4VO$!>
M^N3\)IJ46-"LTPLJ"-/+*_Y+D6[HVL]JETZ&+42L:?^2=.G&66?/7
MQK\E6(DGC42U#$I<.DJ,)N[YY,F?A0A>/L)66S#)CP4(M:-_"$35IO6
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M-\DE,WAR(9A=TF7QCR$?=8N>
M=W[JBWW]:66AI;;B?ES>DH1Z9]I^;_3
M(%_8$($)_\K[<&OUK_\F\/YTI^-8$33Y^+;PEU-Y*J!N!U"35>'5FM8KJ96_(S+O7]2'=11NZE*>@?^2@)O$54V9;T:
M[O=*(1TP6Z@)=6MC^8GCAZ/=V\*WL^:^\IB/$]AEDQ\M]BFXD/7N:_':=%;H
M&'4V[/[RG:;8Z!NW\/%PVXZF^K_A-%:D-G*8F@1
M[G*F_<;6GKWBE5.?CN!BS[,:Y W)6:"NOZ+B/[[1]:>?.TZM(0+
M:A2 >-:T4IA:W)1B9MI"W3>Y*+12:5&[T19Y_R!2;KO6:T/&+:(0PN(\IQ]Z
MWILDX9ZK(-EO':*YD)Y:S6>ZM",?_7M\Y#LS2"6M9JU!9E-V^)U8_;J9X_M]
M:4VJLPW3LG/F<_)*J:A.!^KR0(9?HVYJ=463\=RX#LG=XK[Q@M=P7?=M%CQ/7\E,C*Z?=W%BWO 0T"N45]KYI-[\)")7\A-1J"
M0HJ9G59AD(^?7"U'$LW6=$#==4M8%C4^$68S!V3QDX?; SV:%NV^VK#\\1\<
MVI.[ +;\G*]1 ,9Y].T6/3\J]ZB*&\U]>Y6[2TKZF9EV36DL9CFODLSYN!G<
MLJ@SG)"R&(X/4+K>94Z6*+Q,F#Q9=[/=JLK7 ,=D2' Z9QEV9",T6Q-C?J>8
MD+'7-]C?UUC526@M&PIN9L-L3>B;\]\7[]L
M#+<'EC_Z-RK?3?X8#JPZGTB?-PB6^[ RG'7QG88_+G7:+OZNZ(\KC*T_.$#-6*=,I1:
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M"(SG)P!:^&2C'GC?FFLL\1:)Y]>$K<#L&'5&E;G^_#_83:ZSB\8M?_6T:='G?6"BN>[L+FT@JBR(E8$J;>YI[&YFS:E&_8B87-Z5V
MAC%?L-H9X@K2]0&;49-L-TLW^.>;F_@_UH,ME.22O-OKW^%DXS="FA*KQ[U!
M%I0<0V&)8WRE3JRYK851DH49Y-(_<-UH?J FK<(W_XT193AB+M-C!GI_MV"(
MR:V3G0358K58Y344DC$+9.!M+E!<' 69%G^K6SW9&I7$^?;@(@>#C0;LIPA!
MH\)$M?A>R?&>!([AS,M.[?Z,2J>Y?G3A[4S>W5[]CE0CDR,CJ^T#R;=G1
M\>C=-:.K[%V6^XSWD'VV84I4>;3S0!_B@K42DA^:_3AS82 [H$0H'U?LH/?S
MK\G97H%;N9A:>*.(5]685X$%*72BM]"@%KM<\R )I0"]VJ&;0K7]I55SME/U
MJ>R__Z-[6:"G5:,G9VL[/0K^NA*2+-/W&N][$/&8L;+BM>9X7?<- :6HLX?5
M8O;]"0GZTF8+.GQ],)"=]L*CH[#FB\%\#X;O-*[]C>\7 D@!BY?5] 4%W[*#
M&,*&YAA/Y%O<[:(<1Z3!0GJG]EB'N[@J+E6Y=;*([X-GH&X]&EHC,D_ @[K;!@WNR ZTQEI6M!PU3$F'+A6=_#&LKYM5Q7GT
M"1--RAP.O*BM2>:PSQTSQA^E:@K?NE<6@Q25=E'.>MV&"YT0G4YD1&-A%)^U
M^J^D>;*%1E%%54FMUTQ=&>J=Q4](GC0L?:OHTV6,!Z^>T*=N88E@"W!#M8E%I;/0.@VT\Q@A?-T-#1<_*.(Z*<,MBG%!T\K_KLX8\4S3Q*[F*M'
M?O!]!7^VUHXC&J+E"LO:2'Q*2*'^,3!##'"WE.HIB
M"J^!ELR_*W[YR.M(,@G4U(KMH?4D"N_7Y$5V
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M/;J0^0SAX\/%@>"=RO5\JWB.-ELPK7L7^Y>X1L9]!?L4)K/V
M/-J(F\(/C)@^4(@6V0[H1AB\&/3TA9J^E>!R@;E;^.V65^^.F!&L=E/_?B.SC3MQ\$&%3F>K:&R%K0%_4@@<>:,ZMQF;JJI]1\#2NI2
MYRCX5_!P!.RF2GB(*#0YU5WW4+Q-'/BOIF4HVB4C6.7(X9GE8T>3!6O-\KP+
MMX#F#2D>-=.]H^Z'/+GW?+_&JS,9 UY+\OZS24=Y7+RTC%TX#U4"2H">&Q_R
MM&_W&F8K56=CL?(HP)F"*828P%Z]#"^LW1(]#\;VM_4KDOA
M%Y9%81V&CKQ%>/A">6,%3@MW4 /C."VK*JD;@(8C
MI\D7F8$IH8X\S*3LB-2IB]TT'KPAYJ-QREO]93EOXSSEJJ.M%_:6Z
MQ:FRPCTC[<8#F'6#V^S6IN8KF P@W^F@[C N>JUP7:+]!<7*L*=1?(7-LP89^%VMP$Q>QHM[5W%85W02^Q?,GHYB)1M&!\:-$.K^?UW(K'QMS+!^73PMU$'1R
M(LO-9R(=&DI %]_R_?3'=JJSL&RUDFB3UYY"'<(7^6:@B^(HN50YK!EZ)5
M\KO(4Z+W0_^]Q+/##;M$T>@PTU-WR08WYAUG^W=6J%'0Y39)&N\\B5_O&?2,
MUO!\G=KQ%MBRFF54.I#8LKZH$JXNBBVPQ]^D:N-;]S-(J7JA)<*#%\7#=Z\3
MP?O9 4_6Q+QLZ]AG6\#\FU'E"IM0P1\9L=K"S&7Y,6S/(6\^"%M7!%<>6--D
M[DFRL&O0J*5.1;&Q7HXW>:O,6#PX1IFZH6[*G=/IW/O_@*R"9IM_X:2
MT[/S2!#=%:^530E#N5*T="MOUK>UDS$!Y1&DA2TV/CW[?Q:K2NV!C_5J9[PS
MAPTISN#JE6U?J+6M>J!^SND"_FZU:RF ZQ
M+T7S;TV$I"=,._YV%T=NS#>XMBJ0 N+VB>9+ ^^*DU7!N\^)X$Q
MY2[B59QE3L3&%WR@U?7%*W.W[S0!PW$#1ZIS6"Q;/7+E8PAS-5;DXWI* R /
MM@/9U&\;\J=;QYQ*UI?^D,G^+5O>.P&DP^QK5?6"3LM]L
MWE>BJD];:SD\B!MIV)RRLU7?D-6W O0\2GP@ :QOR%D*A2SW:: !CUQB/B'9
M?T./!8AQ"3*&7"1-S?2\I0JKO^$?Q!*T!"B+Z:XQR,K%EV=F8W+*'QIBP1!X
MX5^PM95SH5)*.*/7FXB=/8@O[F;CE?]$1J(%>@D]Y-E -&^9N F$1_>_B1V9
M>NS6U!0,R[;+/K L%3U,HU@)BW/6A@R'S&;DMR>Q@%[#VRT7$K"LE8NSA8E6
M?(\]YX/G@_C=PDFI](D;1WE<^
M$IH,#L$#0F =69FM^,$C@PX'0ZI?RF'+6>+CG2%&6HM)R@R47HE
MH4%78L(SKIYD/VU0A@M09Y25D4"IJ;#[NKC4E&L=%DJSL;2'<;")G0P-.LLM
M+PE0)3P;BTIF:(DV\?F"27. F-RDULO_7TZGQWS#;%9L]+ .?D
MT5:+%<=O&QI&V/%7MEB0O$4KG&FE&$II--)%.[H(.!]J
M5%?N&6PR/+K;NRN+LY*]= :<]>HWR18RG\OZ[/!8D^6V[VTJ&7Z>QR,\U@J]
M7-EZI2VH[("S?IZW:^\L*)FU0)CF5#N]Q^P"LR(D)>C;V,)L Z'
MV]0OS*/51=,9GSXKO S3;\'95[\*Q_FOG9Y!]UPRS^7L"$\1]!9@>L$0#Q+C
MIRS4H^8#U(M>EZ_&I,.HUT[L"8>)YK;Z\2/RTVYOO(/D&IIM.8;- J !ZXV!
M$F;SY.7]B=\:$Y2O>41C@WLFNW](&G+(!:0:_+JDOZOR)!99WA O+HVXYU2#"ZC
M[:T<($FLXIO*JP!O;1$5-J8:6Z\/+]\'/7C7VK&9<5&U2[4XWA17L\H95SJ.
MU"^<3GNV'#P.==_0K7D?S74R G/XPZ^_(&0# I;834
M'$\K,_^=Y@2\,>F/;4^:_JTM7Q._%$\J6=JW,XLI=R[&,;KA&/X\& L/-6R<
M21+FW=]_S&!>RC<;L#S$*'^Z.VSM&_Q%[+!]H4ZBN#3?DVU*TL5G')@!XD84+MI&3/B3]\EDX&C,, >Q>JL>A8_]
MRRUBU<)C7B2Q(''.C1==10NHG%R2[9FF:Y#FG0NF-F\!]1,T2C,_&W&IM'"1
MZTK33 RVS:#M0:,8G8"@](P-7Y<^>:GGJ5F2/ JN2_N>#VE+Y/5DC'LMV-Y$
M;ER5[\NPO5KZU32<]/I%\%^F<.ZCI)3\V<]U4X]74O/#P^CP\$-[X%
MR!<"I5[!_O[OYK8.?JQ*.ZAU[3O-E(V"Z9;;<: 3*&HUQ.UCV&13N9V_T6NN
MXCZO<==?B!K&9WV!0S._0&5+,TAZDKQ\TA:V)H;[*P'I[T]*IG%0B(=]>OY.
MS>&#(5;;FWFV/('GGX?@M"#(#$F?-\J@D4B0SB=P"-)I@F1>Q@L2S35;8: '
MK#/+0.=A.:YRQXB)*:>8B<-AE48,65P^W3:Y=7E0"(SYE"XG-! 7UR*ENVU>
MSGEZ=YL7:RBO!?=&14V@C$BQ$1')EBT_K6>\54CG)?9QHQ*;Q1JQ"T7 Y8<9
MN>#S2C6/)R'2K8%4LF;SI_*QK467=L2LP_$I]^YJ/D\*6,S3H2>D?]O9YD4#
M;\@9I%D.@-Z^B+GC*=RP^L$%8:.P_,3Z%5R;SS0I7.@)#T<&';9_K/HKM<7F
M.E]R6[7XMD1MOULS3FB#("E#Y+?[@E989;(IKFU[;Z_!L[$
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MW CO.-H9[^ZA+(# W;A3.SI*VDY[4MHZRQ'LBXWWRZFAK]ZLBN5L#I02G%GJE1(<3[FYX\.S!OPJS%*V.S>
M4Z:MS_*T4SP1?S@K61FP]QYFI$06X^^X:2>8TE"@(ZYU>+.I'UTE,[!P_V0(
M/67+?3&TH(K>BGD<)G&P.'Z:.QDRR/(NJVM 8"JA%,=%.C,X.RL=U>65\W5X
M,A\_6[QJ6CZ3T;&IO=$7NM?J$21^=;\F^ZO(.[$PCCZJD@EP4K#M?6ZB98.(
M;WSOXN/D01]Q^W*R*Z2.&7-7NGG9I2:P8/7A#W1K[*D=D<;>0IX
MCDLZA05-AK<\58?;=[]U\=^37ME6E\M/$Q%F5SRF*Z;>' !J^CQ0-S-9TOQ<^D/ Y>DLN6LP==?K&:^W*PZ>;4
M*1= "-A@9*]KJ*N'RF7FV\RZM@!FX)T\)H'D%(,*
MK!B"V?SX]V(P3LR+2_)\\*/!C
MSO#=@<5)*@7!@/(@CK+XY/I/!_RD,B H[?%H3^GPBT.TO(:A<1P2)2Y^D@?R
MT$@ )S#%&K/T[[$YZ@%XL__N+/VS7/NT],)X;6>Q<
MU8HK,-C(A&[A'OVVY24NO(-4OY:C KT?47VM4Y>HJJ74F ZT"8_TU@K1TC/)
M9RIJ=US0FE&_>OO)\9NHE_%W&@_G\I:4^&$S]='3HAW>1%C>]2NUS&:!7^3+K3,>40\:JZWQ7XP#+3C(>S4DB717Q
M(9-S!I:K.02TZ43Q8S81F3.H;]%/:I_G,/,<=?7,60*ET]G<#(96-?OGDZ]
M]JZ9JRN6D]: /M>;U$5A
MHWRCO&12&II:2;#N^'9J_"'+T1,3R5)]LFN?Y9HWO.:Q\G23QMT,G-:_
M1W]_2-]3]:5O0/YE\+&OA)= ,]D L]*2*0SIHQ-Z8N@A T@+OW9]\-.NV4)]
M>])\;L[$3)WSFG4 ANEB*RA]^='\?]$(G*(Y%WB,YA<^D
MJ"F;IP<_YLQ"RM;#7%UW& O#UNR"!M[Q6-\^^*J[XCCD^S+6#LEOOM!?57M4->[M,NQ[B++7+HKVL
MP?%L"_M[@=QZW+2J4IH73S-7K132\1IVY5%,H"7UGW6QQ4%"+>9[5F0'LF%[
MS>4O4X/KG;ZA5PB,]%<)
MT,Q@*I40U'*OXHN=!X25(GCV5#GG^JY5"WKNP?A6>,HO_64OLJ-WG>->C 4U
M#6'&$Q5X#
MI[TI^75HM-U,(&_:,8&_VFX+1BWW5L7&;'/+L0+](5V3J6
MV1+Y9"Q:*/Z)&A&IL1FN-W=_TAT2H?Q[C^P*VOO?A
M6*_LQ)2RGTOLWJS#4TI\ZH"52PNW++..&>C)7 "_]KJQ!6]@$JCG/ RWRQ-S
M_*S35,KFC/UD-?<&DE5M&X_5B.E-';7ZN5LZE(,LY3, )$R(WK.5=GS>KH7C
M:D)CG[Y#L/4KFHT^YB]TPZW/>,'LO-PE9[,!42U;UB#KU4291NO>T06PILSK3E*8I\H[8;Z3*4X0,[?5TKXUF#YISO];/62,N"2#UC".DGYR="C7-
MGO]*Q]^1_V=^O$MTRQ N==BD5# _,^MG/Z%GJ3@= )KCUE4Z-L\JA&;,C43&98M
M:WHV^W).B4OI8U\?F3?!83?B+2WXEI0YZ*3LU:4_=\Y8.R<\GSEC9[&;WA5B+:?Q^
M--:\A&U:>&3\"R1A:3_=(I6A&;I(0Q-HIRQ%E#LQTB;EJ1-B
M?MZ7[ZBD6/@.)1G]H'?V"3S6QL:VSR4'NTL!$OXD', 7_O.@P$]%6'C7V$
M^WZG_Y_/<.\S@'-B747J@*W1I1$
MU@$4X]RHBGC_!;VB:X2#PC?A6G*AY$*<:4K;;E5=UT!9G;7?*1!RFC]N<::8
MEUIA_M\Z+/U9\:HOK'C/]!@#NXO;I,^YY_*$;+HG7_*3#?BF,':9H0
M?C_?QD.<8V$@?_,D.>.>DW^[NT#57'"%EED5U;Y=#BC\Q3< 5$%@8>X_,'CW
ML+V)*(W#V:7SM67M1 _NS&[(!V+\"M7L,Y3\L5SI_*O[YT"3PE^U3AANE*2E
MI2$BK17-,@;B6XFF8*+A">8,_;O+RHJ;B[&HA!\NW=<"7CJ+%+BT#;=]9*+Y
MWE>.C77J"AFQ2I=WX5F5[65(*LG(;N]5_% MO?DQ.(94*VA'%YN/B'3QZ$/QWEV )?L*F?7:@),"N0L
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M7,:S?(WR5%<07N6#5LOXBMJ))406)UDP<'/4"K=THF@].H4;8\NE'.$
MLA;C;#_5O[OW0PG.=Z.[LVZJNA26%D.O2O+Q\4I% $7F#GA!*)M6?0TSKB;F
MSIII2WC)],!7=($/[.!2QMKY>!U6@W7W;FNOK.H3H, _"(RV^Z A>_H(.\]G
M'?C=8@LPSD"9#>4R':,5
M+_RLA46(X N!57EVE9L;0MFV5Y_%&*G M^W>PEU:@-(6AL&R9!T1D8P__OTD
MR^!<_FBTLI,\&MIT&!&R>T 0>5D $*<^DK>&)]@%QS<)W_:GU,DS48DAU+?[
ME[=V57C;KPGB,Q'N[_.50&4YW_YX914A\&FAX@A$"AC^%18^YSC)E@NE9O#P
M,+%>_?WD# _Y(LI_ZU)M4?T"L+>T-*FVK^F:9#TY*%[J8D<?@,7$G^Y#X>EJS-E=6!M?A[.K,:$E<&&P4G]?IE
MY(FL-A4M.%)7D/O*O[,"[]+XUII=J./MW*H8=.T(5B)QIX4+535X7S^-3FW@
M6C)'KJ]'S@)Z1_'C(S<*H+^"5\ND4MN3S]Z/O10-W#_N=JHY^.0O:+AU/HE2MDF[L/1P_NP$?H,ZGC$BII _D,S!W3
M$1QEV^+M!?,SG]@4S)<"/U=6]EDVH8?\$#K>8N<,V\S1_*M461,7:5];XWB#
MB".YM9?_#UUO&=9F]KV-=CI3I[1 @>)% @0)Q1VF> B!$MR+! ^4T. RT]+B
ME@ A: L$"&X)#H,3M+B[%=>BI7W;^9WS_N5<9W][GOUA75O6O>]U[[7W=E-V
M,%R]] $Y&!<B/Z1JVYN44E>;F%\?,:FX5Y'L4;K]2=6PPC;Y/H385
M32?K= ZXJPE3/7U,XGO*4]GHU7HE2C@2]$V<4+)(6=3&AJP*B:C+4O=BJ-I'
MYY3B8AGN6HN$WTOJT4_0C'!Q"OZ=$S2$B2R0,068CD
M&+$U<"E,#C-A9'N?UB_ ]P;LJ!F=-QWSM<(2%!!.61%*<\S.;21J\.[DR83(
M*C67*+7L44Y-DFTG?.I177.W4]++/!8/W=.]AN.N B-.=O=S*
M1/%$\K7W0F+M^S9*D= GWV[!>_J$S'Q+=1'QTE8L1U9]51^C!M%H[&O#C]UV2KNU[AB:!TM\L6RK,B= @]Z7+M6#&=!#;G6TV[!8PWI<^
M_'60(LW+4OAKUTT1]<:BVNM;6\@/])IG\&/C/7(D&J) M2,FXC]N
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M"^/)1$2R>>D7X7-W=I#82APN:6.TEPO(S^LQ)Y89_SC[Z5?-4*\O!89,A/2
MOJNA23-Q>TEO:J<(LXN!Q?[Q)6G[FLI<7,)=I!5BLG]^U5/?516,U[!.D-DR
M@W&F.G@ >=7_AO)53#$NF+PR#:4N;$&1! W"ED=W\/F)*"T_.R(:AN4>3%A.
M2W5QXAU9_58+D@5\Q1$Z"&KV@JF(L6.^(]G ]P$/'&GX=E^U51:51WQCNK]]
MMZ__;X4GN0E]R1@.L'+\FFI<3S^E1!7A 1C'P/!TD?;)&=UV]!TS65KK%^^[
MI(RY793OR'?P7:NS0BG\@>,&2 (WT<(,
MJ^]S#"3K8N1W#B-HZ?4=%@3O;-M?J?/7*G]P.'QO9*4<63$,>0MFKTU T@ZV
M]XT'9/ZAHE_2[#+J%4FEY^-1E60\KXM38>"@TVI3RQ90HN;@6\^S4=#FZ
M&>KVO<%B>IU"JLE7+TVU <&KF]E1E1?SX"V?$8O]P.&J32QJI_JK0ZYONK,%
MM^6 2!0;-=P2 HD\;++E1X^HO159^R)523#A#TE5R[K2"KNH*A0-1[*KSZ@7
M5C7&SXOD.M#B78I1*#MS+$_QF\$O^VX\8*0$,%J'"P=\Z!$$.%Z5Z
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M)2\,U'-&KR:9:D;?>A913#XY,!\H-U@V.*LUUP>./TM#1JC8.^"W6ID0]Y0@BRJ"M8D4PE.4S4L6F#$3UNH^_B6I
MDR_4\QVE\U%8AV5I)=NB N1]\A]6+UN7>PYY9I30L&S&*2M>D[A=!JFZ[ \%
M$3EO)D#U(XUM(S#];6)%]BYCP^]HI=CBW;ACW0 IS--9Q?(V+IO1EW)S_A-
MOY-(6._V9OP8=$%PXV,)Y)965S!I@\">.N+B);X-XZD8"*XXMM6X]9V4-TK
MEPDZ_R/+-R+04L7O;THM7X\JRC]&DTN)W+)X2J=4][)E"Z=6@#9,
MZ_.RQG8>]@@-!L7)25F &L5/+X@)0W8U\I_@7R:T$KU=#^9L6\U)P;Q<*^72U(I7-
MZ51;E8N-/BY'V@#CBL038F;6$TFYJ47H$4>K<&R$QKFP5V.R'Q4D%10@>!]O
MW[A1L4+:T;X5)K9/8'H\]AK>L)#_GH;N0D+5G\/T855*-!%40KK?Y/8D2^3<
MHZ5@N><7%F2*V%[7';*-#N /T4/?7)MNQOZ7)#F6/:+<)\
M9]$5'.J?U;OW0(R0)C4\4Z;O"W&>$'3 W0LC12')3"Z/F[[O:6KO6)Y.N0\O
MFO+\ 4F[OL*NU;KT P:[K_5R2W*C5HJPBIN*YG/F/J[;,R?4?8833"(>^BB/8 Q;!A\?DRF
MI[?"3:7$=I:IP'\9I <]$LY>4+ERN4"-)6'/YLU"<4
M'A^,S2R[G#%(D<9R/)"O])N#3%JV?)H=+DX-#"PB#(IT;P/PH#_K*Z5=6SJ%
M+W8(_%K)G@)TM3H5%2>9T;?&DP*$.@SV(+ERTNDMQG%G]_EVO*AQFG'5-J+"P_$ 7A%=Y9BMR"-UQZX"?2FW"+Q=G>>$0%Z#
MQ=OJQ+0YL]XN]EYOF5EIOP7.FG)9\%[-F+X)GU*J\SY_&<_C]^?GZC$C>WAN
M!(!HKJU)M?A&LXATNV%\DCNOP^5U.BI2WT:J \+K#+"04U%'N$ <$X/MVXPWMA00POL6K:3Z#
M7 J32V(&P59?*CTVDF]TTS[LR1W^0ES67D,IJV$)\$9*7_K863-J>1#2_/7
MK_/Y5L0"J.AYK^XJ%4]D>NK-XFJKF0)-1"&MPH&/+?,[..Z[7:NM%]:)'I=(
M7%;8)_JSWQFZM15B$XUZ>A'SRXK61$501[KR9,"^.4@9#RE#M:>*AFF^GK94
M?3_=@C$!:&CJ3T/KS"+%+MABU^(]3ZEV?]S@)MZ;G-C?[&_V#&;IR0QV W?\
MN$&G)ZF#9DSL"^R(SR5==ZJ))BI\'\5$?A?(-:4 V\#^^O\787X;)DFTMG]5
M>Y"P$[ ^5."J0YF7B$*]VK^-Z(Q"> ?A)ZN5<0HML^_!JT97+\LKWR#E#QUF3]
MS!M=\QDGD$#^A&MCQUDU?'_WV82=D>F,'F9?%%+JX0^FS1.I2<@A?7=QL:P9
M/G*Y!STG=)H;S>T410[9):@M+R=M'M\QG_5>>^#-$XTWFB+>$S=80&K&($[S
M=D#=IS7OZANZ)ZH55':G:^40',5J?5PK!@M>_V_]1.3GVY9>LL4*;27/KRC9
MURWASHAQ"X0*:*N=76&0\NNBY,:$ZW6+#UV^=F^K.T'<=6L)W<1O:*SQ5350DI98L6V$_L%^PW5=?3BAHQ52=F-
M17][0EUNK7:_=S!PHB40QQ\OO$AABQ3A_.)!Q+9HZ#($9NE.-;IP](D(@+7[
MEO$,(&"G)B%O.@6E4EGN-PY-MC-&IT?&PZ*PM+QD [$K/>W\U0ZE_YZQ[?C(
MJ;&K[FJL]YY4>DZOX-\5*^QW./]H4TC<("1LW>M4-"V%UXT9W*N;NO"[)RTZ
MG A0?YIJ:NC#O7'\Z,6,)*O@!/\E>L-Y3CZS#7-J^V4%I),;D]LT%V2WNUOH
ML6R14"$N/C!6)\FZ[\NSTS:TJX/9S"8P]U]M]U[-D/>JU/@X/8#S<#;@QPWBP56!7WY]X;0+
M:J/O^HQ%V#_BQPW'TT;Q,[&@"-#6*=IE+/.U0O,I<;]&6!9\'M.&".62+CE6
M6S::A]K(VJ^&&Z]V5^ -[.)Q2G1$#MD%XQ$-29:8807K"J_.;Y^]E<^>5B06
M*R6>&?'F#*\OCGBDG"CDU-3DN%X7KM/-SZ$O%;C6''3Q@?T]0+':&K%9>^R[
M+;!!!Z?/!T>'_ZV^_"RT=&=O^A BECL;8IZSL$\NLV96-@G1*5&?1Q]0J%7*
MQ"]GEO-9D.!>]=W26;:>)=R]9B*@?-_A6..ZD7F"1
MWAU7]&SEL<[]-9%Q[H #9F5M0:"=XGOQ;Z>0$ZI3F+]4M@
M4U1)@&]J3+(:.5BTS)];[C9%#B<20.<#U(O7U+K87-[:9UB[@7];).8RBU$L
MFY 7F*>G?235D=[/8DG#,)Z0.QIV,:"J&S&;G_Z",47WI2E$#!<0< Z"9$#N
M'],HK&=65KJ;OJF54IL^,4^S%EKM4;NW;OG)$SHE/5%49Y%>,VT961E=&\P!
M \:P7SSXU](#_ROMC5.&!2NC5ZD17J,NY]3\
M6T*385,\:]S9.4WS*N5'E0KK7@/E3&EP&T^BU=VF_&]4Z(@#E;8CS,O:S(HB
MI>VBPSWS_Z)  VU=_C#I?PT92N#'#1Z7>RVBYOW'" $;J20PIL'=UT]E
M[)94U!+B5LA,PR.O>L!X+[)4C\7&:X&M=$!FO]
M.J)L!1I7.$6G1X4S[9*FF(AB;WQI^_",M*M;PV/9SX.YPL)&S?.;[AF80:9+
M_QXWCU+>B0V_EJ!M\L17#BZ8:+.$=P5JN'Y3-.1#['%7]&;2QV\%53_/TSO0
M;&!2#,>VI0Y&J#_F$="5C9/?]\32Z$\_N E?^!D?I\''*6@BA30*.3[KZ=61
MPK[1;ZK\7$A[A$U[U@F1JCY0(4SJ]JB*YR2TR;BJU^YW/#-3
MA\NEBEQ/5A!+L/%]#W#3B:TQ8V+!2QL8>3!FWK39MFJ(Y!#!=_@^6$+@U30Y
MA7MK__ARD?:FLO;'#:_8X!\W3OU_W/#WZ;KJECJ+D]ZTO:KZ^?WC1N7"U4RG
MXOR?9W$L MW77J<#NTGTS6_&W7%+542I3H;*@[3.2W+#PI-RW^2G3:HWKW_<
MT&9F NL!9'[/<"  $B0(.C-?5#.U]-2_FN-;>US\G"E\M>Z
M;"FM6_$,ARZ*;.EF>FO+=EGJ\YX,1R(B(CK10Y_-7LAKUDD'FKQXX9XEK.]Y7!<)>?2L Z;<'RB?TF1YIQVG>WY.E21-PYTP8\Z0&2EZ9!17HA$[
MJMGL^4ZV$#()[,7!2RIM%/,#O8;.WT[^JT,]H.[(>O$?':HT:*U#PNJ7#N7K
M#-*ZT#VR#Z9RYS&17/8VC[8^@_8&&]1957!\:G4VM'9YOZQKM!Z2_[T06%23
M,0VK7!OQRT!K/@2NJ20R-K7CL"[.E5)8#HE 3%E2D5?2ETGM,BQ]^.+D=R##
MV'EFUIZ[+T=_1U4B/]IGLB4A5@P+5!K%B  ."K"9?\0\,QXU2^\N.GO7VVQT
MF34K Q7>"4('= 3C/76,=/'_C*
M N\>+[4S5V]M+F-8Z:-*P"5SLVB/_+;LFQ:P^YQ%#C,LWO%@N ,\W'1ZH4PE,&
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M&!:7H,(!HOA^-@:)2$?^UPC/:]J"F$>[ANBK)?B5A#85\GI/K-X56#_:=OOI!]@3KYNR"@
MNA[E3683>MREX;BA'-?W>P"D58)MY.!TWM]]OM3?@2P1EU>S:^V[>V__F?9\
M][=>&GQD&L!UK52->P&%+6,NP"=!JRDJP38-@]_>-B;VIW.[#5;E ":92*7,3?XZ?:DKI?Q4E1N2HFD!+DI>R0
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MN(L9E$-:"0_7;$MXQW+\>4U_\1,)""]_,TITQ@SRU0F?8#@J34
MMK*B0CZ/+N@]IRK;4;W=T6K])2:[:1J:1,;(&(6%O];XZF[B6>>DZBI!FXY?
M8GUE(G8B%@03COHF%HMT&!K(MG7+44G9>B3QHH^Q9X85J[V[_*DQ<7#>8]!3
M04V\HGS7$=$^?60.]M1TP29K/?+1VYX RRX@..KJWIL)H.2 _
M82GO[&[$UG0.E:9Y+]R%XF49U*7T^1M2$N;#XF02;U(<@B!()__"ZB44#T4.
MX6\]>BOVK8&^;5$PM9!@\!BSCTH\&+0JLS=73.^[XB]W27AMF>)1X.=P-UQM
M@V=KD%.4*V_1G#$VDW'<2.(-KFK^LW'\RIRJVRZ4T2A])VV02[G %9UG.Y&5
M1Z'T<@.=L/)0H\-B98>K&++8-** M:KR9%7)B7"PJ+*BH.'G!_\4/@(.[Y_*S/
MIV46H:'/2;$,=*.&%V9;1[#HX5YD9,,'QD$R+]?YN/'SMQR@NV@K6C8^F?_(
MP$[[C99F9T$)HS5*+-RS/1+F#>\1Z"1M19I'G7FMJ-LJEO>MJ2M.Z;)TC]<3
M&*@. KPK:DBH3,[CG;Q0CGK(;L.N%@U2I!CS@(DG6H$__@Y%Y]) 5)8HV+=L
MMF] $Q: \T7W+MH%E"H [R*Y0WZR%]M]]Q1R>*ACH%?;Q@EVBML69Z(.C@\*
MIBW*P^>A6E#SPQZ=S%G:HA+!=&[5I ^;#D[504\:W^=YG'1WP,VT
M\/K'_03A4,! /G>,4A ZL.J>3B6#GAQL(SR[>UPE /W>1!LX="R3L\ I_K\)
MA!X[
M:_>F)328RTUF=RO-! U3/10]?^P_29EDFDF=(^="V^G1(:/#]XX5GZ-'%M65
M01F4?TS-R49DZTJY>@Z^]=W8$2HS:P+AEYX=8!.Q[Z'12D)3QBWDTBHFT&<6
M3I@AU]-OI35[IP06AM^4O"W>)^\M2;V%[_4ULKG60Y^SB5T9T5#'\A[],@3(
MFXIE3O>8P4T(4&,>T(Q)!Z:=!8KJV7M)//WZAW%3'AHV,RCK[,;59 LSL;IU
M("I(6/TNM[=7:QG;3HST:#8+@7TW"-2::=)PP9V34:
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M%8WD^2L-F$O,T(L>H,AHDB
M1%\ OUO2_AJHF?9N+>^E3,K/4+3P(%K%].>LF6L:]AW+Z#BBH?%-?:SM4Z29X!"1U^U"D1>YHAR0]C
M7!?_;Q-_AUQ=3$XUVFP;6F1\KNDU*9[-E^*^N1I"$]W5@Y3(%92PFPZ'UGU]
MR!*P?3NN0L]-EHK7A/%)UM.@RUG1&3/D'NI#DMTTT;D1D^[SX\9M/CWP@1M0
MX3;M^NW5C(D922*%5]*;7]58'BN7D;L$*$]+3<[YD\:R3)GQ@!F(--I5H A/
MSK16<-D#XV3>=&$YS,E(2]AW?$U))0T
M4X@X1#2-+]!UZR'7>JL!7CMI)632# I1;3BSBSATO;BC]ZEWY>S,![^F!HV>
MAN9T\PI8SPS/&C;55&X+;"^H)'O::+B2$8HLI\,YN*#-^S5G^S8+'[3%\!21
M2%@4)ANF3C!@OO5L"]
MWH&Y$$#=9$Y'-4WXL_^/#*._,<]I:KITW5 Q8!5S.()H4*9M+DYS,AHN"1("
M_WZ;5(1H$Z))O)46Q+GWL1E0&\WPW3C2$K$YX2%I5VF76=M;>8]GREC5#'V"
M?UJ]!)A7R91^TUOCWVIRI#-K;U(MU=33RC>:O:E)Y=X*:8CXN[!?^ZQV3'?8X]2J.$1IO\* FP_Z^5XPE:[1O]1(7>V'8D*7
MG30_M!XU0VLS&X3W5 T'Q!R\W&MY:[J6TK+;ZAK[IA3T-KU1+)NQ7GPD#UO9
MD4"R:J;
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M*IQAW34FQSU_5S*
MN["B#.4AV1[.0H1PZCJF BYJW4VR^ZYN48>_SM2GX9]P<]JY<-XYNZW-]%X<
MSL P_Y$0_=ZNBE)A82(KHQP2'3'?&6.O(ZNK$$]1N75^GF7V2/R[,U2_1)5@
M5)Z>M17.]&2@\[UW9/VDN\'K\*^)HH7NWO"OP1^80FGRXU"JHOTY\%H(](*9
M3W-9,PV>>%YK]'*R(?;KA7#4=YC
MK*U/6X\&:M^+@Z3E4;>KV6JAO<2E:>)G)&#Y"UL7Q1M_.
M6L%P O"[X4C.XRE.JLNB;7^'R%?=7P[E(%2Q "B.NMG43:#$_OE(7JN^X[6V
MM397K(UC+ =0LK:PCB3MMH[  $T]#$V=9Z/,V:%G;PT]))O![
MB%Q3!->'::#N!4
MG=U;84GRHV\L"9GTHOWQR:M.@5  OY^@LW/9>!S6%S87TY=FL4^M< \$#*#G
MM@\$-3NNRT5[GI%:B@ KIIQVG7#GHNRZOM?UH9&) (*O )]9P1_GQT?4,QT[
MOD;,#.=8P,$&$=O/K+7]]5@$HD0SDXB @J:2KE
MQ8>X< 'T"D:@C+:NZ*25?D5V)S#@??+Z2="DZBG-."]+'\.D0IN+&W%[1O#O
M\I*G82-:FNZL7=.^I
M1^7UW'T$HAB;N!]8C'5MR.Q4T\E@D"E,)^3T'YB_Z%>CEWG&+#1=>:7=SZ)"7C2#S W
M[8R6P]]9=HPP#WBP=!4BR$8/*Y]2_PF)CP[ZT&IX!@"0\]_3F6&UHJ**?U,]
MOIFU+/+B(
M:N(VW'"K'-//]FP/!^*>\@J9+HRCC/;%@=H
M^ASM)&US1A$986\O7IF(A&"9\7XZ[[K&H[,:$ @^NYBI'N^K]M
M(=M^X?\0]V@B+U475=HP*P/]21BN &@7%99=S?DBFAO]#:U16]7X-JTVZI<01%-$A)B:+29$HWLLX4*A&)OJQCL*MIG\( ] 9+3*V5/!\:VW01+@XZCHG[4?TGA>K23NX8 /\S_O
M8O)/3$3 62D*
M#]L+B*LF'.7"5H=-E1:DBOGT4:21&.J5>!+Y&'E?+H9CZ]=%?K_6T;R-6E:S
MRZ6YAQ/ ZGL>3H*.Y;SYFI^73:Z-.@C '2; L[Y:@W8G?IC.NE*2DP)%#;WA
MV+,(V+II:*E4_*(?/62I$"'8'.T\2YGAQ-G[?K*MTX6QPG^=*S,A?'4E]$ H
M(G;1ZA7IY]IRR =2LV%F_NN.:5\/LNQ;L7C(<%%BM&6BGQ5/-"8-A8Q@E]/]
M<2. 29VSJ[=M8^4H2([2Z+G>]L>)A)K]UR> C!?<8C(+$SKU35DF5HP+)WM7O*/835PO:>;1T%QI\1
M,9T] 5G%N2Y<-95*OJ[#&0_0BQ;-]JPAL/7>C =*!#,AOU;_"]1HCZ[LR08A
M*D47?4WC*_U!Q1UC'\Q>IZ$7%!#@(W9\]79YD&<3.(CC"YJLKO*6!XY2P!I9
MM%\&U0Q9=-BE0!+/HNTO'B8DP4D]"4FK6I'V?<,;&V:P."(58]][_DR6].SN
MA7LCGPR5<'"XB& @*L"$)F\PG3T_[F-KV/!"HHA=WO@,55:G-5&PBR[GTUTP
M#D=%&6J3EIX\X.KO/9VER0G+L:/
M*V\.-K-X/V1"4YJS[""Y!
M'@NO?'"KF"+OZ^+HCH@;#0!3/XX//<2;Z7XD"J;KNS\_%NGG1J\56/;)&!H
MV.%B9VR2PK%SQM>DA6F@T5^W[T\RW9QB#510)$M;=25
M59%T="_4MU(/0O%M5BPU\H5&0LZUG,0X!*6BAC9R[" /,4LJR?HQ[:F67[%4
M 9RU?MPP%15!12 I(DJ%6E+T:"K]FM@B^B< #S$^=O%2DTE@^XS@,#'*Y5T:MBB6H_;DAZ==,6FN%-:U)X]3-- Q2ZR/HXU=FB;8QNHR/2QT0L>CH0/UG ?978
M_;/>(]'"KO#>.RBCW"_%9[)II-&XZG.=9MLK^Z\@ U?Y@36+7N)(\DG1X;>?
M3GN_PWFM:@/4DF[G]6@2[+#J 0S\D/%"I@4O@NV9*_=6&L)GIE*F*XOFZKM$
M"1:CO NOD=O:_=.T$8X5CN):0];Y;]!9UPCRNK Z5&C8
M5#_\+A[I7,3L9$Y3U&[J"U(3;B#6(G9K,83IO&';6TS!H1+9]"LCEKGU^J;"
MT-U2"&(WK=AP3"'Q*>_,!9GXM)DUY2MQ.FL(#![)G>K'P6U!*EA]O>#\,SH S-DMTG-+1V^^JZ87.
M*37F9 SE-P+C+'CNY7U.S-YBA[B3<13YW]BL.TA98OG=%HL.=ILX$I%"6@IN
MDI)@%;&_KX,Q3T$H4#2,5!Y5%6V;QCQ)$]GIUQ;J\#[+(Y= )3)O6Z;J[$0T
MMA1\71_.?2%LE6E]P@#1E==O*-A ;"=C10@;>DZ^'O$G"T)
M(D*(3:^R=>Y*.%UZA,"]_,UF*S."YT,TP73\31K"781JY/%_'V&)S-DG!EX/9+A7-9>-@)9/-+V'*
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M];Z_GA-_*6/=O(BYA87A8C1KOV"%-HV.R=+%"R--W^&U3@:E3W43>V0>K$RC3 [',#,.27C>;^>C 45%J+.64
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MCE:8N%="#6G5=^/-6]\8\MH="LSI
M++J4J,8[AC-3I;\;5?(;3?!],RFM"ZG55  >K'[9BM*0R^X6,&IY0"
M_T2?NDOTE" %D9^D\+FRJJK+&:&CUPBV2%DSZ*':W7QOP;3"/9M?@$YFN@.?
MG)K6JY1D2BF^U#R9X"LX:95O?%R8_>M1&UI]P^.HR8%_?HTEY>_\G4!15RO.
M-J0Q=,JV%DY+DO0WW[^4'CU[S59<$=9<'=(="G#:V 6I4A2Y2"=//#^R'8OU
MH@[!!MBEN(SCW+&1MK)TZW1:^N6E9@G<]2M<*X!M:,*[G3-+4P/V:"EXU2Z@GGZS];%(825^$(@/>4\5*.AO7&C=]!7]*!J5XT3C8IV3??UAKYBIU.QXM#!5\+7]HG
M)<[:55-RQBKE)M%C!C*Y\BC0(W9YYHC[7]] F22M1G>=?(2+M]'+5^QLI+3Z
M;-J.LR,#!,^.HPRWU_*8ZZ9,@$O03DU3M_IN'NA+AT?@-^I")]G6[8>^LA5BVO"$N#V=OCB!0<[;.Q)P55,Q:J+9.7ZARG&Z0U?
M>+VDA0/CI6M='R=+%T/_(7/H$XP#[:8);?IQ&5-3::D^B:/^_F\"TSSW^$RH
M&X)8+4K(,EP>3[3_S/+^V>7:LOWC-+N&4>4M6WB5TOY\@96U<^;-3D2KX0LK
M.CO5T_# +X9@
MC!*FL5'+/JD,$(*(GKWKO&U-3D"Q-K;XP@FSKGFHX,N%\QBZU?FVJ/?RP8QR
MQ74X&2(ZVQ&W+6P6
MYQ:4>^B0/SXB:QF9M2#28_KNY2L9H=^RQZ>GHU/D[*,S'K\]] K,.8/%EM37
MIR^&"I2XIKT0/!M7'?PCA)I)Z7&JUVRZE4@>A^CU@C TK^QK[J>6KR4UDTSW
MA!PD32RFG[M*\O1JYA]>_IY?9$%8^7H\52J-3]+@E@^FE=^4WCS2\(Q(2H&2
M4%C.C(AX:.S^K\@XT;& @GI[@W$UEF2[3
MJ?)4I\>>@E>W.4 +*]@93IIVW_!PYLI;M@-REAL,8+]Z!VOL=F*;)U-TW%;T
MQ7$;V_AQ':R+7%U$#%>?,R#&A%+U?7&'V/UNM]ZZ(C@)ZL8UQMX.J(#U V5Q
M/?*@Z"?#*$$?P8B0/_P;71HGB!(E^?D3*1BGC+X+E416PBH9W'#F-)1A=C]OP 3-OCM\-Q3$FL1)/S3-QHM1-H@?8=XDO0+UGV:"88/JF#N
M'E62SRQAE
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MKZ6!=X14JKS+A],Q$VM#I]X.I95:0O62D:(V4CA6W?''$C]MM&[L> \^D>R:Z6HA7O6ZP?1R*M9)WQVWOM#'D
M&<1N%1.A7L5":0R '3))(70=2L4*
M2RGNY;)&U696O)UBVEMD8?N,3D>/F0BH;>JK/W> <:NS
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M"N2,'2BI3NCK^Y;*TFC^OX]H%5CY
M!#:?9F F+]2L2U[WSC9K64T-= ,%#ITOL.Y+%/UQM4CA6?23VSG&!AUXWP5M
M@0V8AU7T)O*L=(L4F0P55^_+7=YNBP\[_''C=)#(3I!C;$;<>J$]\+=:BN2F&9)EQ[-
M"0MK,+$F3:D_)+WE=P*3QQ*ILSX-[LDR%42K5R$\ZGK-BF+J+=8QPI=^,IL2
M$Q+5\8>]/,[\!87L[&2]'?M)  D'KQ 7[*"BGWZ0(AT0,>>/0OE[Z9UN&]O-
MT$!VY21IVX<2K7IJ^U #1C$C3TZ%9?/UHUC2U_2?0B%76V^\&<% ;=Z9"\BW
MU5ES].8;9[Q4'FPH:S)?K;E62-M=5KWD<&;.9U2=E%$5U+]E2H:9_#5N$#N;
MQ3YKVR&AE!+1D<)E),QQ?U50 ."$JH3)>WJ("P[B#U=1Z-*"MR5Z0MS MDU9DT]:$*^0,,57CJ)XZP
ML&TBPWDZW]!\!>L_WJ'56G0/^'FFKK1OA23A,)'6QNU^E^$#DE\(=^N+_G%T
MY@>H1MF'&GPEZ G@: H.18Y!,M:LZ<;E0->16[]2^WWW)=;?=2
M8/J@[@=( PY8;\G/%3[-GE%]_BWCEGC9GPRB+7$M.%P0Q1;_\/\2]=U136[X= ))4AO"HJT  $)O4N70)  H8-'!>D"@1!"%4@(+?30B_0.TDLHTCO2
MJ^CK.<\=W[WW?9]QWWOO-^[W_?[('VONK+WWFK\URQICSVDG?A[WUW>#4ZS
MFP^?=1?;^[K<=MD*7KB\-%KQP\M8=_*7A0'LO,VF=N)UWQP@G# 90Q*4 ZQ/B0__%D9YFGU+NKMB;
MR30X'':OBF%SF'EL8ZRGV)06JWF'WS75=0@=..+X>V/$D:[)C8\/;&.\*3Q9
MM7:9#G.N1G85+*.*)4*354,E)ET[7^W62,D95C3S\3[*(G&J\:O*KROZ6]E&XZ\LUL^@9S5)X
M@EU^\INS?.<(3Z><"))7]M2(XT*B%\;(=%Z[NR7=MQO\LE(O:V+M[%!;:#37
M#3OH+JQJ9D7)7)_E
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M?,N-)KW4Z4MRO<_)+&_(-H*RE< I$HD9R]BKLT6GT"U
M50(=4Q'NNY&LKOT;U-N2EH;?[UNDP>E2GNW,0_9QLU"U/#'6$F
MI$HLR0LH]4L,P*YGV''GUG&CJ#Y._AA]LNG7_M!\Y'B?"[ B41#.+&(L4%-!
M*1@N" 5:\\Y,6;'_IF4@NP^$6+%)?@\@S.VN/6^+B X2;W!(3Z=G:8JW^MV\
ML\?B7#!]9Z%=M8EQKE1'Y]Y'_1_D 7RCVVGIP?*8]BTC6#7@@2LFW)B* 37)7^<&V&7_-4[!#:KN>&F L6L\D[G9])W37\>GIA1>3 Z56>?O,K9RR9'+F$80
M2VA8!H0& 1.?CIC,/.OS$Y][DF9YD_>LEK.4UI'O"+,6W\SNZU5'+OB1>T,+ @8M3L=*SGMV_R+6
M?+*1Z?7:0OP2C*B 3TE4/61%&!P.DW9U[<:K>4  [&Z:S[ 6:I/(=L(>$@/G!Q:^8^?(9]U3L#J$\WS5-52X(<_.LJ*;B0KBS4B\P_5YJ
MQO448&8.0EL\F^CP(*_DJ-;X!_ESIF3F@SLW@,T'>D@"D#=>.3$B<+80O=+T
M%:16>%&O'M],TSYT5 ^CURK%V1C-&%=FI:S.RX+.>L#=)P9E+NNUVL 0G/'P
MHZTC?[I1O0#2&D"1$50CYU;@*?;J*.;%_WXR3D;V>_ZJ,9"Z%	DXV@+;RU\@=A=7_PYB]F8=9JL1I5.AJ7CK#G>%QYX878V/L5\(.B8-.KOM
M?5(>D1HH@80V\N2XWJ3(MEZ"TL&L.M\XNXO^8YBW0(14C*,P"=PL:K"VYT=O
M^JF_X8!6];:-=,[TSW*F#C7_T,E<&NS\&,3%$&2U/>$Q=_7;H-%>WG?+HHP2
MFYC>Z-C=RV]#XW)7XAL_1(QT)J7>WYHPOEF&UWY25%)H=",;E*EF$/[%X(L2
MO(WO_I?!YQN6+7*8>V9]0$V])N0 $&
M9XV\>N]S-B[L,[(W*H6-2T^E%AA$-'4UBMOWY9/J19[^R]*, X>.1?2\>N\(
M&=D:UK#-$<0L6P_]WMD7IE"6(!.OU%XJ+-*,]G1'V-\ WEO./:!"*L8M2QSZ
MS*U.UQINM%P ,YDLH@-GN[[[PTX51M=KL\X4;\8;-VY.RZGN-E_PXNB*E8IF
M)_^63M8"HO"DSV#%^
M+GL)HS4W6,9ER[@/6J,KSOWN8OE\[2<@J.\*!OQA/WB?/_1_8PE9]Y&-")Q;
M7?'Q6!BVCH'M\@!#WR;C9W>!$Z$*K$\^3#HI.A?-N-Z[#:WX;+>I9=W)?+$=
M\XJGST_+4&?$#,?\$"[0NZIUI.\P34\>MNE63W>IUIVHE^WK6'OL'#DWZ9,T
MF/K-G]Q/^">9^JRL/\#H/5)L]D%/PWSA3$Q#IX\/83_M)YDU;N'UA>I&[Y1&
M/4N_V\*X\N0,STZ(\>-XJ18!/@T;U1=5T9F=RK"7L
MF354A%,C'7X*T;Y#393R0E7L6]1+?A/G1=?7\>QH-GMLA/BJ**S.9%!IPLCC
ML2[?U9SOR&/*->+$(40:QV0IE&C
MRLIV*FZ$]G:%:5:6-$V..&180CP/C[(JBO*OPI'<=O9[8F)T:QY79-!;_J="
MY!QC_7BDO"AEL1A+D-?OH1(Z4J,ULJKV%&!EM4\XJ(C)A;J(>IFI9OR1M="9
MPBT?@6ZN#^MA;"?18P>'KF,J_6A:;22$P5P.HA**7Q'?8:BH0UH;\,G
M5V( 1>I=C2%J>V+J!,2PQ#?PR&!;3L.5W&]N,^!D2XVLZ.2YROE)K%/HP[#U.["*P#L:P_HX:].CJ_H
MN=1KAT_'-^A^C#OE*5F&]?->3OS>,E/+0VC/M%N?,+7\,Z^]2QFM>HT.-QO-4:S<$KL3Z-:0/)%:TR$8A05_[745*XI"0O=V("VCBP
M7 _" *>0PG$XZ;9L;[,0I,56;[JPUA?HP1.L;*UJ,R0F;B8[O_]C//,M&KB]
MRDJ97<5;]!W9--X.S;F@9R7)*_C$?""YY+VT!X]O>N7H@#H=65A3R
M[,P$C>89W!:)EO51"0#&F9L^Z:_YY+!K83D0]RZCOD8$JI\?3-^16L_92*]>
M)$P?V5)Z]\F;T,5JH"C-@FV2JSPX4E<%$NXWFY9KOT/M;AN1FVX%5WSM-[*T9IA /&4F))+Z,[GF"YG4HL)U_RS1ECX
M8B-/IUFD)&=.9Y<_Y&-FCM,%(28;:@B;+YV5R=,]S3\($H@Z/&85!(_M_XC,
M-R:^8=]UI.7.\"NF^6[ 'IY+?FEQ!*K!/9&CXVC4R5?+6?T\/=!R3)-M@MVR
M&$";NU 6?)W ;5 &W.%65A;E6QS=_<]*Y^Z(5C4JYHS,G
M_.0?@_N!.X %#>;X=\Z%]XR6MFUJUR@Z]J+8=[
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MXIAI/2?]CU7QZ&60JU9?E@&+%Y-+5W1[]K@8Z""X\%Q]G:"^EO<0/T*Y/X&*P%4FPN;)7#&>/%
M-,EYV@4J;)E?K9/BA1R'*7+'CZ5U2B.Z_&ASWL2#H#_);.:;^2B$>I&OID-U
M3)S>,Y1E=G\TBS*[OS"\7>@EY"A\5^R.&EL53Y'/5$S"<"?"4MV^TR1V4("7
M6TS3#1VRVQ^=O=LEB*$MSVV'2']"&\C33-R0*6J;=MZQR]]Z_YK\;=:W>]!5
M#2^$3$=06-1Y=@6,EF6)H[3;4)
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M:^WJ (P_51<8R\D(%#>?K<>;8QMS.C2#B\-S>U=H
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M34<[8&]Z<"$2A6?)"I5]] *+[8LV!.9VJ_0\M+-#H-)//+=VI;,S X<:
M?V4%;2G^17]\+7I)+>H#*BGLLJI^&ZL86Q[P_8/)>X$REGP\@)3KI"'YA#L=
MX+3TF:0HX!'ZK ?!3>8I_\M[G4DS:WR93E4R=TN$54)!PG;S,9A,WB -;E_Z
MQX&IL;^?_--W'?TXY[5&O\G&$6GO"Q2!HX.(RQ]MO^1O.#2_Y\E0*C-("-^M
MDXDF/AK\1')  L':<5?!\BT4KJ'D7WZD*>\$BKB6U*?(=)84],D5,_WP:<&_Q1TB>'!BQNKU(_!(VM,/ 0XDI0*$GS3W:EKZL4^=5VOY_2>&76E45
M5]#/V[.X/NEQ;.=NDFD*2L[NHLUP,0ME;D,POHT\8W*BNVR9+]9S1WBABZLV%3,
MYY\T6M0ZKISD\*
M9<]=*BOG2V)5>S65()?;+TE+?DL[+#Q?4+.F!T&;#Y!XV8%HA>!S'C7I9DF0
MALS-'_/&).EK@E!I1&3W9<%K)/Z6^PI3X)T#$%ZZ62(!QY2^Z]KLJO!Y662Y
M[K5"4^]*T7,DAU%?4B5\4\DJCB;@#4N4R_"PFA*-_1)K8G] #*$AI?L&S>(#?&NW'[3.EN
M7,01C^5T(R\SV[/%E./1)K>=M?%[M3VG(BZ5=#D783OF6ZG)'<=S
M+87VU4>IAOTY8 <2C/$S KIRMLL>,90&L_A)1M@I&*I<$XH6*,@?)3D!Y[WF
M&126&Q)_2%A)EDC%)-7NCC?=K@)Z:DZ^75/:@I%JT
ML[5\G<7BY7,+$N\2=:_@B$+C,YQP3]0F7?7A9N$2CVL@;8/RJGDT(![2(#VM
M2YE;K=O3(*C?,EYQ:9J> :PW*\T/+"AM+^I6&0-Y273[8J&3&\*\?B;ZH)[\/_[>)_5O5CT-_Y, 6]&NMTOTUW>@%F5[&Z&6Z
M-#BY9N^!=T[I_;5'&D?S%E+2Y#A5$S12X2 @\J!1F@Y-432"S;!.D1/?B<,>
M@KG"=@+W=3R2K+8U?I*-"Z3"ZS]\8\W.ZG"X:(^IUNA8&373+J_X,V=-9@D9
MG8 ;3]&TXHKT+]R5V'B8E6>HX6WIUYQ?VZR+&H(F>3^"NF^_K8\(,$LQ,,_G
M3G3.-BR_>[US4OE;W114E@"(W0Z]TVD8%,#(G=>C_0
M&E<-X;!#T3KK@N4.Y+J_(-/+3D3N;I_DX:9\_',_'K893!E*+04G$1R%_V<7 7]'U3[+K-$E%4@L\O-D:3CU 8-2*7,IUN=0_?ZWF4Y'J6]7L
MUA(Q]F)/K/+$IO,?>]-WEG)F4%@*1LW6U_7F&XH!J"@LL'?*OJ F2.T@*:B&
M9B=2I[^GH(4R 3J C-=Y^RC-IOO09;[8SU]RLIQ4WEP9(9J*1;_*3#:!ZN$4H\_W#NB*F@8((%'#BN:2I\#_\:_*O699[!]%
M%!/KO_6N'>:69RN! ZL>>C^D-[=^U8H8?F^KRO1/I_;O=TU_UT<7]
M&_!PZ@X_YW 30L:SF2WA ;$U" R IP//BE!^/ S.%KZPR/Q2FRY
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MF3'L7%*:>3C]BJQPXT ,V<-Y!OKB,2BV5)WZ4*-%PWT
M!OR5R8$;18"S+%S*1.D_VJUD;?W=5P4*C5:D,>XEZY(O'DF_\[\&/WI- $E5;7,CE:PF1]]
MW?IT8FT,#:1[+<RF?ABXO*6G[ON HX=-$-2!L+[
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M(C5.!=Z*T6.OO^X+R4GON(J.: AU,U"FGM@!N=% 3S@VQQ^6J!9S2XOBK+6Y&EP2_/'.AI4O@G
M/P ^+NYWQYLF\_(+<(R)@9F#T>1-VAP^R6&H3M(^'6%L--^K].]G+'"LYS4Y
M_4GFDOTBLT5J#V8=KBLSK-Z5DN(H=BB$:#_ ^DV&)JH *JN%]]OS)L]2O<,5 W5YQE*\'IKZPCJN;#H3
M+^;?$?.N9TLS0+Z,[/+7:0MHI.'O?*E6H,J,4.U\!6+338K)(]GK2D$KYG-O^@.D8+7;
MNR.:#+&E:B]9Y@=M<',-QG/E]M*>Q^X"C>P24(TN8A1[,[](I*[FZ;V?9+$A
MV8N;!O(,_U8I^59U7J:^?/#BS2?*!!FV>^]MU+G/@UQP1HHI>>7BXJ#GL_;IMFI:_4$2(J,NI:LJYE#TX1XX 6BNF?1-]SF2;6X"*]7:TQ2LH<*OM"5 AXH/X$%V3;T>7_QDK(F)\7(IWV? M64J]8_TG
M'_G4E\PIPYC2&:^H&VR+"Z@O?.C.*B?!:39L '_L.83,?E,S>MX%T#=NAU1M=
M=3H;)C2XX;^YN0.KC@^%K<_.@3&C$_RQRMJRTE8V11H\/$2Q4,9D R<,X\FT
M+HY":M$P&!/'>)<58E&XHVRT-?,M.XG>@K%=:CPK!HB^U2?&5VK6IZ&UMLVQ
M-"5X/.(*G>E<[M<;OY-/?*LG,<%Z:G'A;2P"MDP)A^6?K*XT'\J!].)J+7M)
M"B2>D4MY8Q--/W.8+6K$=(AGI;ZI+N_DNG/XO<(HY^^];B.^T> $=;6VM,3%
MJ$:;-=Q*N\)AA=5OCC?^_8> _V^A$EI_^7N/S\KR9S],Q;+U07Z-LIZ:&
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M8UQK];=IJTN+%K;.JZM00+/>VHQ\]Z5U
MYX@]!W8VT-*O<$Y2H7-R):&H!195DZ.?[_=$XH>L[ $HF;FLQR- 8R /)7(
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M9-)7_07SN#CTYZXN,]H'1]GSMLM>]^ ]UY=E$:(Q 3NWSW
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M$E?A%_,8*Q4C30<"ZBQFJN((R=9*14Q09,@17H%RG.5
M(3+RW%92[^L;?/?'K6LFZ$5O/?8B?/<^R?EVO@3HK0G"3,$.02GC@%YL1V[M
M\(>C,NZ"V'O>+(OV,\@__/K7Q %24HB*?=:2RI+W1M>"D^=3;(7#=!DU(%!(
M6CQ/!P;&G8#!)(=5__%;[4#E(IVZWEB)DVM<[JRD N9^FSP?BM4P.VS(Q-Y/3J?[QHX>!)T2[=):9
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MC1Y_JMY7/�?9]*]E_'\XP&+PYK[W$M$<"[E@S;NR3:!S, [N(YE-$1XPTY
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M15X8,2B'()&'NY*?'D].3TQ4XEG$] =MG4!KS1N (7IHI
MB*%&ZD;IN<,.0$!A5.G^MY7Y#U)"/!ZB$N_8_Z+E&Q,
M3I8DW>AD%^W'.?U@4&2D$N*57IBDU/+$UFA;$;I.[N;KQJ.&IE;NA*]PLJ*N*)'D?>
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MKO8;$ .TQ]%X6>E1*^JOFLOD3L^G$4)YVY$4A& !#LB
M)7]\IR+E6 ^-)TZ[-[\!5QR2]RM4?I!LUS6VMS*8M"%*==]Q5<-GF$@MFBV!
MS_ <#LZ#\DX_R[BNZMCY^4^:_-&'RZ[IX\X=CI*K#?$-\/.3'0+W.2?P>4IG
M61V\30$/6BZ]:9JDG&G]';,!]O@A9$[4Z#*"X"VU-IK[0U1;
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M[(A307+[U&]2"]!%R%
M6P"ENQ&,YX$28*S2G,64]O:7W=/J#O:Q8]#$F9; ]V\(6=K0V5SD%C[:6DOK
M54:XH+ ?=5]/G#6G'')+,DJF=\O>"3%AHC1]#%4BH>F[-E=T0#>@Y=]T E\+
MZ=V9C2=R9&E\5+&[ [;U:PD9XQ& @GHC"ZI+8>1CHHMCI9%M'5.G[5[#+5N,Q>Q7(X&>)3N?',^\\0&;]0YX
M2@$B'ZD2@8)'#T3+98K^0-WCCS#KX3,^7&A#U# <'7NEMM=^*?NHXDW-U/G-
M77:3N[ESHW!W-;=O&!1N<.?\0!^JP0)1QUA;46E$-76]>5EE[D-[U^\H,=%R
M<+O
M&+\=S447 F'W_[9K.1Y%+!])EI6L\M=FNA.%!R:3#"48KH>^"+U;Q'(#N3AO
M'RVV !B5$
M3I<971Y!24;*A"7@;=TLY<":JPYQW)KQ7/"\+W=A6:00BBWT]T$1+$MJ1"0G
M,@@%OG%5W@CYMOEM)4\TNPN)M^](W'+2B_A8W*=7 ]/+YWO56YK(0D.Q['.:
MTL10I0<4(0RJ;XKIR.':
ME++R+NK9&5YGH*K8]8#R"SV)1,JDXNUGWJPRY;6SEZ^\7S\D7-FIXN-$$3^H
M^E.-1-N (HMY9<=4VQK3J6][99%,)I14UKBU@$8 ETC8TMRSO=P-QX QA27F
MMOZWS%8A>8YZ2I'6"AY19IJ$4,"(3C!*
MP#X@^(\OQ:";70LD^+6:6G97"MZ!7C6S1=-DJ4
M+.I! ^/IPD;Z0$E'*DT=RDL$G)WC.0J@2'-@;I$54Z@6*33N .*"1"$3XI(3
M')25E'$Y0ZG45F["6UO#7=/5
MIY[AG$G$SZ% SH;?SN]/*S5QGWVU],S7^XPSTG/X5H&NI@\T/-DAMNVZL_A]
M3H\/+W5^HQ9J,[05]%J)[EKTLI$;[:ENI@(@Z<,HQIG+K,S"<[Q\P\SMJX?J
M&9)OY\GH3D:^7@HL^E-4YVV_L8W)($6"$(^)7B?JU'PIQB-QN?HG62&)FLW5
MY7FXOCNS K/FP4.-YZ6SK,!NA=L[M-I"R6^5M\G(;I@]61 ;;+JT9PJAH*QZ
M[WQ?([P#J:H\0Y)%8VR+1%""W1/6RZ)=?>$\7X/1+'&8F6G+P4(\T('D63%OAO:GGY!;QJ(Q?SXKT'U+#QA<%^:K,(V_N/[1?;
MB%56]M[^#KV.A_FRQ!O:E%2@4<9DI*&5,T5@VU,(Q(M^1KRDP'>EJUML&ZFL
MV"2B$+U^]K&NS;9A/?/TRV *3=(8USW=1\T G=Y 2\#Q2J/#BI7#3 !%O5VO
M\P9,,_)5@\4':*HDBC.2(A?:D$>! Z"N'":[
MRLYU?Y(]8:J>?77%$)TGEI.LA81)+U_(*U%8OB] />&^9N+0L/)MX+DUQ6\G
M%%WO2!M:4:\90$NUG:S'Y_RE.17HS;W--7#V/FR+?DQXF;O?M:8E07#XH1S<
MD2MP)W06>A<-FQWE>37JU3WU,-=#B'-QJL)--0AE_CC$0XA%(Z:S1<#*;7 1
M)!&'>;(L/^!GLH=8JK>(VOQHV4Z;5@2.M3XZ4?1:,8U4B'-L'I$[+#?]\$NR!KY:
MD5O4X(%B)"DRQE;'F15OI6P&Q?3+LCVW(^* 4D$"$+" O$.R9T!/9+AEC%?R
M;$BA/,?O@IWE+#TI#-,^@?9]/F,8X>V['6)",/Z.;UG*H6P>TRGXG/2VT?=+4[I@O@2UU4I]^Q,W_5T!S<\[]/KJZCGN2B)U/\E>#3*T
M0VL'0Z< =3/CC\TC[14IVSFZ&/S%P)Y)F[,N75].-.T?SL?&M7<(<8$<6<*ZW4'1@UFVK 3S*:
MH%VKFRI+:\WNRJJ!0 %P6G;77.F7Y?L=5YE9:^4WIR=O%#F8C
M8#_6$)B-(60_2KUB;D3TXX@A=;22RTG
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MKRX19^/>E'-K^>W@\#WX .57.W((/"
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M[OFH!.;M(=U'%4T1M/%/ O"3=T<4[:RF':@H4336>@<2H,H1S/JO!QKLE
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MD'S(U6J'XX*U+JV0\E(9MG,*@8K,H"#M*H-"0=ZBA- #NI)1\+;;AI
MP.3= R.D^7/G/9=H)U,LXR*2?);L>N:N/HA7LAC8/K,I>TZ%5
MG), @NAR!/-W=54K*AJ.B"+2I$[02071?A0B#=X@GW8<_QG6M[8#%4[80!^E
MKIB;GU K (9>7Y)(,5E#="I)^934LFGU@9=FH XX1D]02@7X<7JD;!<
M0D=]-A(GUU./033E16\*KXN(#'N'4#*V1G=62;*6Y_;^K@!$!5+CR]V?("//
M! J,&^\'UZ6X;/H;Z:6GY38/%\_.X$N]6'_)Y+)-V_<<&A]<[WSZF_Y5A9]H
MG-&?!(AIHW*+A<
M?;N",;CJ^.#!FMVR\W2PI/FDS'HE+\ZP"9=JH<]E"==9:M0_\6UDMNH5#H^O
M1@CZ-0:P> KYYAD4;^#I#6[C!P CP8.\T $UAW7RN2\&V':YR\V5F:
MIWVJ8426]?V@!N;B0ZY@6XY&H&H5NS]%^<G6$^]9TSC9@?
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M ! SB3*;@:*1NQ8+63O. J;1'0=V!?=>9->(,!GP=^1=0ISM5S^BAK!QI4-_#B7^7Y#V%E5SO>8]L;PM =[^)'=\5-K@31797]!S9*
M 4A4C>+6*_X7VG'G@*8ZPU>ZE-01G.*&":,!JQ,B_01Q=K;VCP-%!?%GS@P7
MM>S8(=.,=*:KRV@GX\G)$WFYBZ+!A4*.S?6@].^^S[Z)DC8+;N),2_,/?)2Q
M\6.)/BY=PC+S;>@-4&937F+O'%^//M04DL4EP5\#FC0^?.-E6HU#V,R$>E1.
M3$5E_23S_N([^"<9^-R17%KY1AH
M@Z6C?3S+R&32-(=D:=8+5X=5&B!EZ1J^.VB%Y/8#2NPR/T6VK3+U PQ[298N
MKRX:)A)?&>>VN17!QN7%T/,.LZ^K5G.1K8A!:WKLF6>$/?-
M6O\_-%&4T$2F">+G\X2 RBKXS-XU75X *J=_5^M;.3JJF6S5C_3YVJ
MCC?.O.Y*<_Z"&1B"&,?YWJ0"E/2JHXR^F,]^[NOK[LM0AW?FT;KM=KZ5%U8-!C8C;75Y@S0!YC8..#
MH#44C]9M%US*)/=P&@P5AXP&$-IS1[,E&3'3598BF!?;
M9+=OG"9NC2N:,-_>]I(U86L<7SVN_]U:@%F!/:#;+P>6#@@4):>4TN-4P:+N
MG-\3X7N12\#\@'$C=C1W3(8U*WK3>\VH.BZU8<*OY2#8SHD:@D&[O*M00C4M
M9B5@C>7/GL(B
M9:VB#)I\D.D$#['\.F=>"(J[_R=9;G9.8@AWM9A2M/E>/-<6S-#&/(QTHMDV
MX# P>SZ1XV!\'FVL[&,G?_C>6G8[*%?FN--D>[PKFK>I""Y84W5SLO!R?M
M?Y+U6#EY110B]V4"(H8N+6P4"8%#8]]DFA4?4(SDUC"LE5%^.XLNXL>OBYP/PZXQ1243$BN2N
MT62;U>W >'$^SDFC+@G""X(S#\>#CD">Y=X=G,J)FRP8;]#G 3B.ZBM9>D7Y6QG,+;)&4P0.9@<#0=,DL@BR(
MDZ/(.7G;)F=$,HA@JI73Z?+NL54?XZ>T1($E-3-2^?G;0H"2$1>I=I+#VG/
M&^H*;XN!C?DDU4T?S/\B:3OMK)I1\EMKM'ZU<"'!VW#L4H9M[4M1YE1]G3VB
MJ@JG.#'1O2ARU:&+X*LZ/'REIW'4DBMG]40C$'.EF[J_GG%;>[*_4HR;O+JL
M?P'5CXG!Y5[)PH\+[C$P4%"$EP6%AC-G708R$RUGLSA?=<(;.+,:I9/\W6YX
M7R2X4JI^^"'\5*0KS7.5=W,3DFK]$-P1_NB;HI6+1LC8>XUG@B_MK6G+,&$U
MFX\^&J>4OM8.O.!P$91B3F/OD634C"67+E9[R)2-ZS:O&B=110&!E?=# PN8+88CV#Z5M#:N
M%XU768_VVK^MP%#Y;O!Y(D*8IK/W.L3%S4)WV5=IW4T:,Z1*A 12%1 P;I >
MJ4&HUIZP3357ARX;1_T2H376WF*Z\"]AV^Y_.[N7A')BGG&4,B@8S+;.>GH*B_;_'3?DV(8.>^DN?%E^.
M=/;BP*6GFTP!_/ZOZLSG91U?3O>7N@?CIA:7K-YDQ4^+N
M%;(RC\8:9X[U>.(@EJO4LY84RJ8)-K,GW#M;6_R,Y%_\&&U@3 !4VJ'P6L_Q?S\GCBORIGKGJSP
M$C^V>NFNMGZO15A0THLKJ%3F5,<$N77]U&3L9Q'"@.MDGQA$; O]M<*0
ML_&A$(\>!K.8; PQT-_KY-32,B"/NZJ*J[F^6X=$OJ-!-3$RTXO"-AV3[W)=O\"TANL-=>/U?&RQ_A95OZ%:J;0J9/L
M>DG&U/=]5LMK14TY^)@+ 2O20:)Z1"I0K?6&=FV4EI)RVUV37V/BIIL7K<2J
MC,2>?Z6Y.L^=H%^7.UU^X\0_BVS!"K/])5Z^HL%MUIX;5[YWJ 6,PH/Q>\2Z
MRCR6@:SAN@'GB..5SZ1G);=\OYW1[=)@:U;NSU\D>1US69.]GT7Y-SOHOMPV
M[":MK#=Z#B+6ZPK_=( ?*16D'0HK9!5P/=>>L6DIL-GT-B#JCJ3 ;C#Y:S
M*W=%93^R[Y& 8_D J3Z???XJ/^AXLGC?]DM8IF^&*J'4T5S#>L.M<9N9GQB#
M"O3EXP,EC,0.GS3*T]2O!'*><*G[G /MK_,L-F>3@BGX,-6ZKN2<"9+1VS7"
M662%*OCCPZKBZNV:4G94HV$MC*M6#;D8BWH/',P\'@NDX!E^S\$/:Y-K0O-Z
M6L0LH%G"\==WW*'-L4(KU.Z:R#K32H!'JEY03HU+GOK<587+Z)6OOX59D)0I
M>&$U@E[-3XY96@U]:NZ\C4VWU\-;9CSQGQ:
M4%GI+7 ZWIV9D0 :ZG^\Q./G$F!YN)R(0&K\MCVJGB4LT;B,<%C$0Y*V:E;X6*\*G*X=&@@SFI7Z;3F/YF*_/
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MFBAE!=9/\_44Z+B-P-Z^&@&?C6=SY0$%ZZ_##U&8/V^"UZ_>5T?JC*P
MA10C#37)9_8P#7S7L[M1G&:I7V'W")S(K:7:HO$
M.,.;8+W5>5:X2-9ZV"MW6P:MV_MOGSXM*]<#C"E:LK,U)-_3V):\
MKY.SZ-Z(3(=/T"^X85D_D!VVI>DG_Y%C;%\KOE!'OM.?.=C85)=H&.D22K.Y
M4[&#-YAU;V>IT383]$YM#YG4[(3'&!1<<3-45]H>5R2O
MC0E5EJ6K;%U3?#6$6E%.Y:S*;?N7]#B_( ]J0F6*Q]D>4M!B&N_W]U"JVZGM
M:"/8 UQ2K1TEOTAS 8.TPE]52?[6X>QXAY)%"Q>C*HW VWHSJLN#*26\"<,M
MAMEWN"VN"+FT%FA9VRIRPZ2$9"9U>!./MFL61KMYRO>V&
MPM# Y.'Z2GG.-XE\,*F[FB!](! Z#QM(%LNMM+R7A.',,-T(4QX/R-P7VMKZ
MS#$A[U"?YW(,\U59)%>W=$V8Z0EKMRQJYT:D9/ZF?'9>Z4X;0BJ
M\S<#5(#5Y*FSX6FJG51)L*5&Z_"DR
M$>L.-E=Z#]!-L?^A7^IMG"%/0>2/2?72WOWOLV7>R4MV>]4V.8<.>-B-I$_I
MJ[J_I&&TXCU8RU9#1#Z)BI//?R+4F"5I5[X 8I8Y9/);!<'G4GZ<<["N1CK:+^_;$AKX,4.%3XW)YM5_H YXJVTR3WH[;38#8VMYM?(A!
M!96-(:;)6HU-E576WFX_0AZ!\[PN]? 0B4K)*G&#=%I+NQ$^ZXC"TZ.C%E-N:W@O=$5D<:.%Q,901W!RRJ
MG=(]T7N/T-Y&W*?MRQ-*@R&!JA4>HNR/#. FJHYC!95;=#T1.2B:/%18A&A,2G9H?*A^W?*6Y@SH'7;H D_HNA)2HA0YZK97K+,P
M?VF=9'_M\3CBBM#=^FG)]EPR91"72/[/\',FA&]F"C3UIVJ;@%(T#AKJ5P9)
M"W$XG?%AW;?XJ(0&)\!/9)6'OZ5)NEO!Y4U^;OHPGMG'**' $46=3SR]+^QY
M5@+R('MWIL("'!DWV6-S]F(G+'B(T066/8)^3Z4.$*3&M*+&R=(O2Y['9.(V
M'5YL':]] ,)!U]I'"!?GW.
M5*9+']U*"_CW.L>FWT1^7>!9[1>]JNT=/H%/D_B9?U94U,3U,A(QK:D[.]7?
MU&%"ZM'W'ZL3$RG_A5!AI;PJ?Z,+MVH3Y%P+DY0MO5D<4)V/"[X&AU):Q#*I
M3U>;"/6/Q/33OH$GV,"!PD# 9\!LZGG2^C__UWMDNFOES#*K*EBKBK).<:E%,?2]!:JKJ2.BK>WL.35
M%4&G]@$"OT@HI]CF%S*<.A_Q\(7M6LB,]P5D;C:@3@0PR-[2U$,AY9^=6$AI
M,*4N>'VW;X(0*2SUY"^<5)ECRN[CLS-WC4Q[6A$BU%S/E[ ZUE4+[B&_88S^
M@TDULUC#*07G_RQJ'J2?7E*X%!YN69GMHR3GW9;AKPM..]BWP'H#/4&Q7*FD
MDBP:XB8C;17;=(  X=W<4IZE:SIOZ&^N +G@09.%<,U7VK?&:575>=!Q,
M-I2X'L)W6^/BX]U&#V'50R1 T,Y='J4A^OMQZ:YJU)J_2'C.^VY:KBJK1D;7
MK*%!P$.ON!JD],C) #$R2 TD613'T^$A_O;/_^ 9^B,
ML%N#?+LC<^$P2>U>%Z^A"@'(J-I&E(_SW8+T6U*EV+ XI+V7VY:X0(C8ZFF*
MW$3VFJ#4A^9!_[V%$ 8%KCR9](^C_--V -XN[BG[T93MH MX2?6Y#+/%OZ]=
MG07+D]R5#)G8S,@P$S'?Z3;.L'1@8I>ETN8=T2V*?U*(3K1EYP/%3QK,K?W0
MSQ" @W7L5!V@92>::1 #AWCYC+3DN\
M>)D! TRAWB+$@]MI^ITS>WJ=.3W33B\?HP(K;N]_$./@7(=:AN,M'[Q8TXXI
M^==U?XG+?KLMIXYE07DN%MR6HV();)3VEEI:\8==M@+P2?7W8NO?99HJ304B
M$.I%U]HQVV;&V01HS/*906]7M[?[XV\ZE\4,A--9O%'9#7PJ81@0:T/$?[MA
M#)S]L@CTM 2I9$(/L2Q:?Y^/;)@^-,_[ZX[)M<\T3@^-*>JYURYSFOTRH,[U
M3_NJ-WFI"6L18_$NGN-I840ML,KK^J2"DYH?J%2Y29"&$[!OIOY;58;20%W
M4YV ;>YF7*ZA_?;-NT$3--@(K=R8>%3F9[3B#'2?8<+R+W*"QL.?:@0]E2B"
ME#5BOLE:$R GF4%I3]H[W.])=PPTMN5K-@5$Z"=.V&0+%
M*+!.HV2AJ4*&1L D1P;U^"$E92-PLH6.02X7.\WT8;GX>0N%6C:(8U)+>K!$W&#>'&>(#4#1?_8>W*,GQ:X1[3+A9L1YO?"+1%B7![]7063A+K/76Y%)8-7YPD/CG#$%;'0]
M=D@3MR /[9(5TU/R !P5A+@T:5"NJ3]H3.+P.:?]-FHTA@CL;ZWI!V_G@/&]
MN<-BM1'6M\V2H)2&>A26GSJL+&='++>9GDVT]YX:2XZ/5PW]8@!0MW,",%"PI1X2AE9FL]-_?A3%
MM+)XCS5&O:03%A-JL[>P.0Y7K/8473"G,S9Z@$N87NN9 2_K*80VQK__.;ER
MWE_^#B=+]0'[/KUIGR,X101:
M5@MI]C&*'WU[9/KI\NB0L](Y1,/46_+5'!WU9?N=W(X/:_'_Z!,@J(>&#J29
M+["K#<1F!WZ6N D22;[4#.BXY(QA25LZX$+04>PLL1(SSOWV->J]@4! -M?&
M2L9'I$5P(IM->J:XK +;98GCK4%?1E^#F *F>V\,%6* +)AK#??ZN2J
M;:$O9KS&UV"$J ,\'K?J2DW]@X'J&:)^MLA.CB-.,_K"8]T IU-$2U,5KL
MIJI9<5I[)&3T?MIS>;&@$D>)&Y[2"5<+<+9V2,\JL2
M8KF6VDM&1?K D^1#70C+A_N*]\K\#+V9O(=6A9MGQ3G8G:1M/O=OE=IF-'))
M#U1$;79G:&GQ8"E'Q4L/)6X$_OX%0QN7/QJ8M6 !:1W,(R1TKZ J
MAS#!-6^9$L9Z;VBC!*LV*M+AUU Q<45%9HOPF8H-A83N_0^9F7SXQ8IYCV!Q
M[TKZ*,#=6X]1EGQ3/?Z1@K3D$Q3-,=F*G=7ZYJYB\[1#DOU@@H?=C;+XV=+Z
M:.9GV:N&.N>&S&4#/C66W3%V 8X?U^9:=>(1-;%665]!'!>,;=5!/S1W_ABP
M6=C_&P\R#('W+#J=.=::)7&Y+^.T,I4;?GZ+&*
MADO=0+HJX]E;.1-]@\TUEY-I'D!*J*<:-JS\.G=I(XE]$&&MND]"87AP)]_$
M-LS$\6D0P=BCX7C!O;F+/?OJ%XERDLR&@;,=$0@44><\G: W+5#@MR%+3@:8
MX,^J_+(X33M3?\3&.(;NQE*,2!ZT17VC$6N%/,7%(.)WHV39N-[+U.A4&]Q0
M.^Z\10R,$(_7DI[KZ"[-U$N-ULR:C8[A>;-'V=XF(,8HCXK<6ZIH:SNNE M[G\OTPD&/3YMQ
M-W%+1EW3T/P7B4R5>9/7L?!C_)JW 1U9X]C
M;H(K%.P$2J[2=-F:$ZQ\CF2H%,=S8 :%S?FH\@N=;L#O%33I@"
M\6S%+Z_DVO /B<>ELOTU6($Y6_N#&L9]$_^3*&R;Q-EYX,U@:Y3"2BZ0#_T&
M^S&2C_](13 +X"RN,FB8OB-WQMD(Y2.JE#?7A@D8!RA9?&XT1$\-'S%%>XG$C5:^C<=^RD?&/>I8'LL?WZ4E>J#.XM8/DZS[@.O<*&0O;FA8&9T
M51*TK'@J\$.+*D09,B]SI,*:+C7^Y>)1-?ZZW.?WB4")AV=9:!E5R67G_
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M.?"'R@;S\\Y[TGU9#_J=K&U:EY3B":6\M?W?MYW>L#_DQL<8_>"P< $YQ3@NR#3ZIJI\_@/0*M!^D-507KNIMBUST#%M%XR+MS57!P@6CQ2(
M&0:.*EQ-WB;J&0]\<$HOZ,6*TYQ1W/@^R N.6-P5XA>J=A%O!\S.ASU[^QGT
MMI^S()^8,1!R1R/>!9]P /276E9E*^/3N\#]J5RD^?=IZC]2)6E[FJ806I:[
MVWYR)O3I
MLSD8/L8F;;,FLYL\#MYRK-$[/I> BI-9-V5K1,'
M@E8V/\\\[_^2IP7-$DK/DKEIHE@>K;F&3]6?H)8QD='^>?O>GL8G NYYTV%K
MSL=2AXO; >UI?Y-T\Q;U.MY/E"0^^9MMZ;Z9?7D5Y_>;YM!'
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M!L[CH'X$0+ M 9I'T>/+W]XBQ3U_3KE[QO&$*?I5
MV!9IAH=D62(YFN;I2VN8S#@0P!?.I5-8-ND-;V$%2)N*39N1Z:P2[^B_(68Q
MBH4_X=1=,/7GGBG:6UPK9RY(L>Q:1I3-M]")Y8:8&
M_/S/A X@F7E1>U,7(-93AK[3W-QW,)Z_\+T+W=P-44?4]L=IP[$Q P8EM[V,
MC[LF+(>^+L<20K&OS\9ZWQH%6Y0CO(I='-38 ,-EV7"JG;!?)!F+(&1 !&/7
M ]6/$>H.+K_1]5,L_[_OD_9(^>[]MXX]N#V;\\"[CM"]!_3\(IFYS#?,;,4*
MA;Z]X-0@SW/Q%TA/PB-3 YU*U(#KEWZ%K[AFX5_=^SOSWW96WQN7*0K ;LFH)CXZ;8H%W.T+N^M
M,-)K*EP$ #-J4F+;U/-(.6+B$XD=5PYS
M=ZE&,;!VS.#P!SJ V)+EW$7R=K(6ZMA= J8]6+S6YCLIIA+FT7W47FE<^^,#
MY*_O:<]B<"/JP,UOEP!7+X);-:O&FW/*:.X K99Y40;S_6*ZZH^HYS%3'Z^H28R
MC..9*L#I#H8%T$M)U/"M$\P.?P!SGZ=<1/.5YVNB=^:WS4G
M2P@.<2 ^TOW0$4?C(V%#*VIRO@*Y:H+:!Q5ZF1(9+P( @&!M+-"
MC/4$4.Y55IO]ZH++2TER!,6,G[-M+/H,_%$91Q4.(U0H?NKA7"Q5^):SA?#^MR,H\D!K?N2TYDG=6/C4O]MC1KFX;#QM9J%V:Z(%^>S=)BWACLF12ZK1QNB@=MJ?)1S79#1Q#WRT
MK[T6PTRG%4R\]P3?V"$4H0 !:D**0Z')I+W">]YFNHW/"ATA+&Y3NL*OUC*Z
M(BI%\3L%?QS0RRK=B=K:XNR>#\'D52_)>Q_\@:LN=,MEU&J^--'( B7E !D[
MX^DV: ,&'R'/ .#P$JMV'@MR35A"@ 91%34-&V)@V-=?8Z.2]VV
MM 685SKX;@R6/Z)_VA*&:.OX4C?3SII;OYLS;>=BRX8XK=$9:)2URZ<'#
M[K56O:+=E[FZP#O/(7?..4GWEP5)[5R''>@(],)3V#ZY)3C+;T%97[_E\N21TK8!^6RDS(^*M7
M(E6-)?GV-\EWA_BCL9J)'.[=61'KI')S%#!Q1R:NS
M8(NO,'2O01VTW'*]MM*5H($4?Z_J>>0A9,H@@.T9K=GU454HMAJM,T:LY;SU
M3/W,L\Y!.^F'X!=6AX=,KW<';.EH1;#C8;AB^^%!DSD^N]7#%S.-2MCG'1>E7WV>J(Z2\KSY[4;(@_?*S%Y+
MOSXGZ.J%*<0PEDLF0\]QEGE]:.8A%^/07)%?))TU#->/NR^U]H0GC.&6/$]3
MS:Q<$[1.JS%RV'.F4PX;?7'!9K.72F(_5^.(A!D9%_%O=>K;1'ZLNL8AD,+3
M01U"Q_)\-'7#/-0LX_>$"6/^+$#G)KEJQ:,XSDDA/W5#TWK+9 92_U<7J\_<
MOC>"M>R*-(JM[F])B0A\ )N^KU6[\A!%"AX:91D(TC':%7-J!S FK)9%/3N.J?9^
M JK.D>L;1X7*INS:J!=8\4M\%Z=WT9:M7W;1!GH5*,O@8O#TX+FP:(0!GP P
MQT@#R_;';(4MK V#CHKOW7 (T1*IZN.SE?I6;\@&F)O'PNZC9@R,Q#=M_>RV
MZ(9P_H1:17M/N"0=GZP1U
ME$YM&X%B9@NGUBJBV]RK3"KV]ONO7F_2%EO7TDZ6@(' T[?F.J=K3[EPN)A?
M)!;/YU(#"^["1=Z%1?K!" _+ >H.2FY/6F;/GH;.NG?^N=">JP19X.1K+'!S
M_1@4/MZ0LIXA ?3 &M0&?P5*SH]:";-5+/@JJ&P-L7;S7I'@V3F^S,RY
M5-2N+8?JS7T2NB>TYN*SF=EE7+*9-G(-&"*.]
M(ZPJ&&)U%L^P4_L=4SQ+JX-WW4-#S-5:IC!3[LSENUD S^-L)B\WT8TI/]I)_+^?2H6/>#:%1)#X+\K*0W
MB^&$*F$PD3U2*&LV"$T)1V67JH:F_A"*BR+??6KO)V+FN67J/H+E^.R[VH%A
M-F/":0Z+81.SXCV]K@S]*+DN%9Q?-=)]HQ3E33]&EJ_(JPOKQGQ#M:44$O2\
M+(FPV\G:I&B&FM$7/Y-3V1V17(PKD!TW=79IFN&B/!7=L;V[OR*O-LE\X+*$).8J+C@5R;ZJO%LH:S$MU%SHG)PZ$F0PREA'C#9)M%H[H)D.;>VJ
M1]R)?IK@W$-O9IY8%X"WJD.XVEE\F^>'$^HL6BC.C.:?_T&(-A2R8@LN.DA4
M_HAL ='L%_LP)FUE!Y-EQ&Z8WBMIGA?13LASKIGX8#5:"W2^X-DS\C@N9S28
M$15G">:)'6^O)H.GW3:$O7\1M!4OXWH1A%2,_QA&AFG>U]6[ZK."U%*IYTC\
M^7N:!XL0<[F-44Q^HSQ\%UFNBJR+&=)Q'\J3>^5EH^',I>[B=;X( JN=92>=
M(4=/!^>:J[V]@<)GBY2GC:75$)'%1 2PO0D>9[&' >S8_R*I>AXV;0B!;%_]
M(O&?47FWA3SQRDG>OK)T#PXO+Q]+AK=N)NGM46&F7DY7$)'!-AEAI-'C
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MBNKNJL;B]G>4A)R-NYAV,^RN-#=-I.\9<[P4=>L^'!$N4;%?2:82@P6*R6
M6SV=$<:^$I.=U$WU-&E?.0?Z(JHQ,3Z(5=:.]CL(?K XSN24.7U?<7X+P,%$
M"LDN)0T;6%"!\E,BLA0U?"M@@]O>D+?=G0)[A-O=6X^"-XS9 1=\A!6C0&13
M]FA#!7306&;:Q@UZW;4L7H=*2B;PE,%?^NNCG\="*1@H(!'?Z">Z>(#<)U8/>_Q.]\;QC:GMOG\S)JW<><# Z;$2+YA(74
M:_7R=>/]8'DSG-S_JO9SERNDT,^JR2*9&+QM64C8&:Y?T/I'L#C!,?MK.J\K
M=^N@6SXZ(FZWF+\TQV':(BQX9$T,UK8=>)G=;)=#6*>O51B%ZQQ))\\?:ZYC
M[M3(A#^JYZ-(VG2'KL_,& $\H\6?-XQMHW:2?@
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M,4[C6\AR4_15\&L<'YFI9S/9=>H>KO3W[J#=S!F$ZL.EU_V->O]\>:$8M^7Y7EV"@OK6J/<5*3S1%B2BMH ,CR,Q&P9\)
M]"PB%<#'P2'\T#QO+.DJ#L%;TM)_Q#\;("$]W>2\[^+&H!HC99PINA K][B9
M5CW:%INTG5)20%1G?@?-'[]6W<6!]\< .UXM]9ZQNB]%<[G[\2S^'HD ]Z!:
M#%<[9,7$7G(BQ<&M?:=)85R5F!W4>S6ZH+[]EBE;9Z!UBA1Z9\'12M6'OD]4
M=WUE6A3^L=PPVF0_4$(QS=D44/%]@(D_>K54N")^4I)S0TP$-> R'_K=:T_X
MF,,U&3:ZX6%^T"4.#1Y^$"N[QC\CMD![Q-3JQ0<&+O&Q^ ^(%8@*9B/"4?ZO
M3;-B.Y)1K0'/VYA/FDU=:\W,'EA*E-TKVZEE&>3\9GR\VN9_PF52A0_KG,Y_
MY2I1/9\J^H(8CE]5*4BPVF6G,'246!8N7#UPY)Y:;
MB?!^;DCT@BBS]A[KA&E&+K\,2S5;X'LFIEV;,W+?H*S7:-]F 'K.?4P
MO[VAQ33V",35DYY$KJ- 3+D!IN9QM;.LC0F1ZN7P<#PZFW%\IXI
M0XJ;3JX%]5TKQ<=E*S.<=_%O;E=1?HDK]&>BBXS\3V^P&'[,XIQ>$GN3TE.]
M+=L6QNR*[J>HP9S5U;$[.?,;OX45F'VN>6UP!G%;D@QHS,M.
M-#(?S:%SH(%?];_D\6GC4AR<##/A-LBF]?"T$M4,S_T^[Y51(RMG&PN*3W[)
MT'K-P/MUA>Y5#:74""W9^PN(F\RI<H;RF'R5*DA)F<^
M9?,A7=V:?;BZ75!FB<3.4]3\KB)Q+B@K)8LQJ)S2R:O<6@0W2;,O5:>?CSN52[(DFSQ
M-EGM"/*)6. 20GXAI@FW<\\+M# J:W0 L$/<2
M4AIXCY%/C2L)RJUHP5V&W-N+G3WWO[5)9"B>ZM1[-&16(VR.8#)KX,9C"IC+
MJU(#9*MQ>,R$%*19?SF;9SII0(S-M!3%V0? N:OG3ZXP6P1Z"W:^6]6Q#I1B
MB'X!Y!95,&3IS^;BTU*65#-X@FP$S1PCN6)*/Q?T#N_1'L17ZL>,^>;7^^LU
MRN:7ZQ;,Q.%$W43H!W7M5G$OK:*S@$%YU+V56+
M@!4CS#3FW@F&=>(U::&)X]]ITX9]G[Y^D?M J5SMOM]YOGE0AE&+O;E[C"',
MVQP D3Y/5)AG;"-3\(M1[U9>+Q00U^.V$@/Y/TG^<6.G
MD2PL?PBHQU4T9OLK?,0SOII8TP@BA6VPV?=6MICZH1F-,BA*?P,@81*:W;T!
ME+LQX]6,[#;Q^<(J0:1=2K>BL2D9XJ-R/$Z7+]LKPL[:K"N*G^7]&CUK^:CIC>AF5\0$W@BDV7]E<;<_YX< 0U?
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MAX09E,M/HU\T@;CLI$'@>=CZBY.Q$36MR T^<&C477B^?LLADIV[P9O52L#S7
MP'MEMDZ"*U$U(L_5&R3<&0WD1VE'?9H.+$LCM$;5?BD*$WX9/25J2@/BN,H^
M"C(\"Z":*L@8%JCFR.;T416
M-[Z&I5@QYF;S-%JHJ5!E-D7)0)" _<5!8Q-HO$BBDMO.SNX-Z=K9*M%*::!1
MWFVLIIX1]R*$;BD_>&M>YE"L1D>7$1I,+H&(%53'.IN!,[T&EW4^P"Y03BE%
MTEE>9%7I_X+');,$U#D9(75-_QN]AN=B
M)526C.WK.$2NCZ0;=WUBH@9+?@TQXMG975=^1YTJ!Z)V
M"=K05RV(F[Q4ZW4VMM0027VPM/SRP6YFP>X^3U/ _69UGO@5B:#0F$Q7W ^M
M2>_]539$0D],#'V7H=]++:AYR\Q&,S"=RL&AR.H=BVM:?"+5BN_O/2PHR,OR
MUW\?Z3QW1*%E/%.J,,#SU=Q\2:IT=Z6A8:.*6
MN-EE*7I_WZ)U,YH5J46INX=J;5-/;[NW"@!RM;:I\/GPW[=S%@?%X$NRX?#?
M&F(7^MMO]28DJ.)9CI3^7C5(!*T'008$O-EJUNFS&3/=TN(U-2ZYU)8],;DL
M,;RJ46**VDJ5Y(":WI3K=BM9-'!:X6,]*/)>4G?I&LOK"K!:*_0.B8/"WV0&E9
MOK8:AQFP>@!0^#]@W?_=$@]\1FOF_"'_9%Z0NY,I+V*(0WRT,3Z$ JH)_
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MCE1L-C/?I8KH&8*1^L$#X;IIN@R,\SQ +M#7X>'W:__X^;^[AG^0YFV72+1G-IR&3TZ@'9&81\^E[6A'"P$/O^-4):6+E!$_?"::EI&4Y
MO1F-."9([43FJ<.&UBL]6[QUIH=$DE6773T:DY
M JN7T9&QM;VRY! =]KUIQ^YC.)5WPX[,7BF:H9W1$/E#/1Q*3E8)V_/10$25
MQH>/R$.MM,I]I]_,Q*6I!DU++746C?08]78[Y-4^+9S,XZY^)$*/+::?L#5E
M-92D:1VYMZ1FLP*/^FI@K-N2@Z[)= )QS#2PG_+9$1-BTK 7!9
M6VU'=JJ$F]X-6E$)=!W\9;PR\'#E!_AA^@U_X $2%\, N3>NV
MSVT#C"+J4;>PD7 I+8S49=_%@D&Y1"F(2=Q?V%FU:Z]
MV"/7*G$TQZ02E"YX7.Z[T3E.O$TVW6&\+WIC%EM\0@2F-=5L=FA>[;2W;8,L
MFS"-7G?+"WQ60@$/N:0BV,7T-/$O)!0>.F-@: ]&,L*R6\DM40_=K5($Y%,K
M=B+ZORN?GY1H=UD20N^D[:47R((LD%%(,2=8F*&C4@]%R@JE9?&HV' K
M87/1S&'Z\Y5EB/O)-G(^>: - "I=I#&>YOEL[).68"F$.??/0+U0S*YH$9BL
M0KLHL:YE\&?Y&D.,"AY._W[!PN;\O*W%I24C?>/KII1I&,EJN'ZWH+;&T&+F
MMYZ#LDK9P$.#4&?JO(>=K0ICBSE[679V K]I6UI:^OZB
M=U@MV.-D=DK!Z(>T0Z:5%)[8WS'?8XM?>3-PO07A9O>/MIAS*XSC_8Z:S
MJRH\2E6]WJ)'XV'ITE<\=YFJ>:!.-OONA\&%T<_ GY!V&5>)
M.6S>ZFXCE^7[P[J]\(;J+Y(9S=LE7?OSF[SGY7L:S55P;T?;H,AR#R8]5N!K
M JR_$;5HE.6VU^6='!P^Y=K_FTXJWF/]Y_]L4EX%!'16BB)783YH"6UBZ -'
MHMQ>DEJ"*6"V5='U39,AO ;A3T7)VG<$'%+BL8!EL>/>;OJ1RZSBC2M:RC-F
MB8MSVSEF'_"Z37S[;Q/44F 3:4Y@&0PN?U(1EI-W/^V5!W/FYYS&E. J2 O=[QHDMB[/)HM0ZEU]WCUNE;J7X:XVJV%"#
MIXY\H\6" 'VPO:E(JU02X74UVF5W6G^R_OT/8<5D23YL#1I-I.2*%-NT$_5R]W)7Z[.8_6F^A%LZ6P
M<]K5./!4L2S-NW?1I=]Z[ORQ +,Q-TJ  (@WYK#F^>K?W2U-SC\OLN2;^>3)
MCA11ZR!II0\2/8-?1MA\ "FJ11?EH'A]7:3_YO6J=
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MW88\W'4);@S)!%9)@-\1^MTS1;>NR? <.G-]KV3BLW%>HQF8PE,(S>LC!
M&)<*8\WJ=Y#<4RJ.@;M>!X^*OEU78M*)$1V[71/>=>$B1%JJ2?R]%25=3'O
M,?=X5 "&9[(#7&OTJQLV0*_7!LBU5"JT&*@!UUFD,UB^"OAR%#B)Z#-<6>29
M0D@00<_S3S^4HG.?#][S_CH_C9C-,OXS#E"T2
M)$5#,,')IMUXVIA_*%02!K&GL5R44N5Q<*9,KB$8_PD"@JO)!8O-OY=$LUNK
M9[-#K=+X"$^21E!8;UWQI087/%$QYU ^5ZEHE5';,Y1X9HM =;99TLW,-
M"C_>RLH.OLU&OV*[D4\8E-UJ>1(K>G S#>R.^7LJ\H$^.L'(JG+SZL>".!=#
MK+)<]SM)Z-J+8KAM6V08Y ;-U@F,V/1[/NI3-HMTV3/I%Y97.7>G%@&UY8 .RD4! 1WMG5T54O*\P "3.R1._">GIM%:WN3'1T5D1&>LK> $D/I$G?DWM
M;9S-G;"W>IM.M 6[DC@2\>%Y+XN_
MSUMB+]NPD[+$6EU>_F)Y!U5T<'))
M!VOVK'R4+CS[K"\PD+/]U(]02"!Y? D$[[?+88E3VNR2N '6SYVV<8"80P&G
M^Y<&FKSM#P6 DR$3+46$:V0%?%=-0)\Q0BDEY W.,4,2\"!8D>3CW@:R2 IB
M&*AO*!I\K!?G2RD1R
MH.NML]Z0-Z\H!?7$]$GSQ""2#4Z5,7S"L3!T]-F%]G#N%/Y\[/F
M7J:%Q&8YS]LNN$3LS>BIG=&3AU/_ %!+ P04    " ! 7VM4Y4)(Z?.( 0!L"P( $P   &QE=2TR,#(Q
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M'3TG';4.@-#ZR/B7[M$!_W70;:-G8&1BIG6#C5:A>!>M^_3TM$XSTGI,^S6
M]CO P,G(M??@<29NH\O,^V[P*-UY^&*[V(G\&E[C#IRX\I6;02RL?/P"@D(2
MDE+2,K(JJH?4U \?.7E*6T?WM-X9$U,S48NIJV]H?-_4
MW-G5W=/;US\PB!V?^/QE\NO4]#?\XM+WY955PMKZ!E]T #W=WXY?Y(N3QM>V
MC3E@WN"+;IOO1@5.!L:]!YFXCALQ7[[!O4_ISG:>$P]?Y->PB"D;XWBOW.Q@
MY1-7P4K@-UC["V>_C[&@?XBSGQC[F:]!8 <]'6WRZ#D!*$ FI89+ W^6/\N?
MY3^@%&HXJ$7FD@[>4L3,J9VM[#UUH6MN.6E:/M>RB5Y)C\=8'; ?V[O_V,4\
M7X['5& LG J4E,XQ$GTIK*#KX
M2G>R\#05.'C3YH.U)L_E8\Q]WRT:T;CS'(.^*VU5A GL0G\IA25MPC!8"*R7
M_)A4+RJ'G!!-\RJ)7]<_W;M2THL;R&F3;UW,J L,D=OMHU@6+'YK&B%$T/.'L*3B\0?V>CM
M*Q,T->YL"'YQ%5CW"2N>#-D;VTMJF33,&M+V9%BZE;4W@7M?XT[>QM%J(;QHR 1DIS-%
M 5>=S;[R]-6 ]JU,VZ&2J?D]Y,AFNE,)/V'PRD[$\,78PCNX "$$M$;3 5 )!6XCSI>
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M;45QC\I:2I1=:1Q_ZP%H/.-BP@_&XH0(95TT5E4 *]8\QZE"F5M."]GW3]54<5*K$@U\"W&W[O9KIN]6GM2S)V
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M.J3[KIKE(^@0(SPC! DNRI&K#. <8U:.L$-
M.RU>>/]IT=$3K78,CSYGW("50DF)T!AP=AL56!?J\\954O208> LHS,52#4.
M5*4"A32)7,.'4<7AK2^6S33.?%
M,.%[YM-KD)X*O-\'6RR*LW-0"OPR%4"?B/GY]&5JX%[*ARXJ\+4!
M0OPN_?.IK(OT-LCO()&3JC,OR7>I.*/M)A16N;$52R'=PG0Q=9\G]8QG?3-*$<\M]O6X:HUGDKOTI
MA?_8.36OW.9&')04)$$%4 /H[[) YQ_(]V:2 KBVJRM?3GJZ>4>6?\%N64#
M;2K ]68^29\*[ V 4-"&E" G>OU_$>-;23"_, P>/W>U$,Y!!?;IVL)5\4+7^B(YS*+ _85SZ@U0!?WVU*!/OICW/T7+A1'[N\U
MXKIBK!?I6:]/?IY)!=HCH:M31IG@>RV.]7'T>]/NW\OH[Q\> 1^?DMP)N?="
M@TH1SH*FT@=V&JIO$9)KZ,^^;VE:(XU^^@=K[(X8/LO!D]C*ILO%48*7)2S/
M;Y/]$A(2<:&VS8%34D+\2:.&J2@-]3R\LDHI$RK_:13.TVT:FY]/3;O/,T '
M!D$2 4,%$"&0GT\-M(&3OX?$?F!PL#02M%\RKO#&N.E7>0(II2A%GE5
M?YU+>KMP:0O[@Z\44_,8C_QS*TGTS5!W<$T%%*4"_8Q4X+MJW@S6E_0(NI-V
MS4IC[U3&=?1O.W0UIPV@"=GJA_))FVQ1X*$MF'2K'RWYT:\>^A'$;C'T_5M!
M0.X/5;?XHZU76X'QOT=_?Q**GK:CE.,XL(^79?6($M'AVAF9W'L-:/3/4\1L<8_U:N_JTMUS.%<#LJL*]^@7Q=
MA<[S'!5X (_M'"(4TN
MIP*?.TC^5. 2/TU">BM1(:.+9TE':==RAF2NN%K*)YH .5$TJ< ;-IH\F93[9X#A#0W[H0)X<*00PT.8Y3_>WLEF>>NOM!L#W"[2IM#4"E8\)\QAI W\KO$E_:RM7
M]F<+S?BS)+_,\OKYP8F!K-*I/Y6#6W2BL8#FVD96*56IE*O_25S\HT4C;>4K
M%7BDBU\@!\*HP$FK^6I^L$D91[O,A7X_8\%&]*0"36F$5&OU?X\^CPK0JN;3A.$B^\4N]&<(,_D&[+,L,A+\?($FD7E,>3_A"!XZ
MU\O:145Q?G%L>OK
MD^J70Y66#.1"3,\K77CT#KBIEV)IAXC #L+,Z' \==*2P'BUD@6=JF\=N+Z\V&]ZMD/!2OW^#H;H;;&OZ<8F>JL@$Y#M
MI!.X/.0$$B!DGNO];F#5H5"4:W?Z;?1D[R*S<.R%C,C'#P5VG939$UP/.!O9
MLN$]**P/J0##%P([7LJ(9VY&D6SL62[^OB/PX.5#07[FH0/
M?;D2'4GW=8?)"AJM_4F';(=7EI1?!I$F;LW 7<_:A%E
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M.H>+HWZ$!/R]P)P:;^TVF1^?'7(#2PHY.>.L>A2J(W(/6I:
MJ']/DK4F 7YS6V[H>1U=!OI!M!8X-O!<^ SNZZP>7A$SR(=DSX@*FY.8..I_
MU-JO5G>'GB=KJFPT[XE 0 1 ?02Y"$B,+=O'/+C)!&17__01A\<(A\FT[.'T
M7<>>TGN^_RP;^4#I] SL&01WS;$>'5)]B!Q'D2.XUD(YO0STC2%%NI&J8IF6
M+@_U;JS(Y%URC('4%H?L,
M.8;T[3QD,ZI-.1 \SCSG@+.N&RP>
MK4'>S:]W?D6HQ=0DX(8$Q>[;NOI;'[KC;NDV'MM?N?W4I;,'?-(>T*V1B2HD
M QSS[%/\:@W(@!ZK '$ZR-!J(3PJAF0Z]P+1M43P/8WG1=W3T/7V6A5&>5@)
MBA?&97I^F;3[G!5UZL9)OF4R"M7N,30Z(35+4VG&%'+X)/D!%;!#121RU,UY
MC._,3=5S]L)Z6.*0=J^KJS?9@KBJ:92)\=BJ%(Q9T&1V$
MCC>&4P%'&+^?IS4Y%G[YQ:#-M/SN]>+E.B9ALT_HHR&'&[MZ:78("[N_'$JX
MC&W0VOF68>J0?5!+XSQ7.17X321\C.9$:O5S:$[A!8VI 'D(+O8;%?@N33.C
MH_K6/.>9H"3Q"C29E1^]VMGK&.+=IM-W+E8=KN:IKJ9TT,OAG40%@K>G%WJ'
M"GSF5"0CVF@^]#P=%6!1H$W5B9 %\O&FDC>)W%'1GBO)5,E)F&]$ZA
MEXEJE!#KOW, _J[!V_VR/,]%^=N1:[%^[I/*(DWV.@ZM81['K< M+=X'/RNF
MT7SH-(W4X-H_-0!_#^U5/XN+W6Y>TV)A&%_E8$\Q?IV+VZPSL38V=@0(Y3A-
M2/MF1]=Y <@?)3J_15O\-,\U,7(].DD\6;@\LO&F)>=3S[U#'RTL+E!H..=!
M-:TR+),*'%X)3>(7C=;\:<]$M1%0U:$?2\P74>17 A(XW"90.CA+"-$J==K]# &16X
MFV!!LR \=V_X"941)=P
M,]!0LJ)BPD!FI/(K$$]MP!GK=YH/WOCZ,BC
M.3)[8D["/C#/>>,<]IFCBY3N&O%&#%]_$
MKF/[/Q=1K@3ONN*3$]?T#E6"O5B;K*?H>C_NA<4I- :\M08;MAD"FP-\=]HY
M?U$U\RWP$3S^A^J)E!.K$/)
M""29H;=^ZQ6PM0O_^YV]^HN[JZ:_[.-8LC;O9?_*(N0/ZRP_[[.J9FQV#C^O
M/9KV[-SB">@V+3$R_=K&;N__(!MER$&YB55,^T#PV$@YOG0XV1/E9/DQ%NAZ/(
M@&.9T&(>4&C9*='C#LCBG1#QKN0F:AYNC6KP:F2*PJ82D 9^>V>B^%68"'9[U
MZX5>*N .&03/#>"/CJO(K+@I'#M#L#C%H%KR=)=&FIUKR\?X=Y?+#GND_O)<
MM/#?3U:HS)8_(EZB=RTA5N?"LU-XU6=?,ATZ) IL]7YU 6KRP)][?W\N:_Y?
M7];T:YS#$,U1L\6X/.$85B?D4+4&WF:19GLY-.1W#4MF9K>$G##=!<]:9?9Y
M+U#[F=]J,(2U++$CP\ &/3,_ORYFI>)R1?;5=0N/=2H0IH%9&2'$3!@.6H^_
MS21QNZX$]+TLJ.B9[5T=IP+AKZ-!K.A'8<$2DX\7A[?QR'P6BXS*LT0D$EQQ
M$S7@=@VZ=/@!@G<*YJ73;=Z[/K<=(NF_A(L+"&I:QD@\^5S(I2?^R-:.R$YI
MEBUC=CAZ=F;S@>\8W?*Z,73G))V/?V
M506^9UJZD?WXR*X94N>,8J=F0I+C.:5B5=ZP5/+[98JS=\)4I>*AVE\QXTO1
M7)L-KHGID9\!J\'/P_Q/%%&CWS0 !@M[K?'ZIN794P_^%Z2^5_FTY[_((B\1K^8B8*D+C%
M7$_6P8KLY\24%+8-H4_!N>G-Z4S_N3[+5HA.',/(4HOF@7J,!03
M104*#.NRO31/UOI>^5KG\W"JQ")UR<#CX2>V)_:#'TL&E"IUVE5*KA]<.T[3
M8!IP#'H.=K12@2]/4VGF5R1 TJ26,/N5;6[*- 1U-ZD XTY:I6Q$_V@Q?ZC6]@N4SLZ?=@;&WO(?JKBF[A_6WE]M_K?= 9L>
M@I@*QBC.*DXFJ_[0PEJ6,4[JA[WD;N*I[S:N$^^B5TRJ2Z#[C?:TZ25GGQ'1Y\+8'@@
M-PGI3\!^C42[<$3X0G'&'C$5/+V&V5::"35HUI&8-6#* /F]P39HWY(AH\U@\N'7G?VKW^L\DV7^?
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M#$]/864A;I\J0? 04+CHK@D8)DJT]Z@UC6FUKLYVFZY^;<.F^#V[+P
MOIT"^J[27 H\%8'+9&K4R*:%G*AK,G+I974F2M;=!5K+*_:,54;
M+OVZM?9?!D4M6D=+&^>8\2S>FMPKTN0G'N\(&?A]DB99#7HPMJF4N/(>";GF
M796Q"G>KSSQO?C7R@GB!TH783HY%L+@@!>#.PL.JU4-N_#HET&FADA>2I_@>
M!+(HS/4!<^?;@GCZD!2:;A8J1E&$IQ-'Y_82=31\T?P(R3,)([)(09M]0_2S
MZV=W/W]8FW02.'?!;C\G^^TGLM[OUQ^$L'KP
MFMG([T,.)JSI;MQ;YAA K\ )MX@*<,$.K>VD@V\.3">JEC0D'].8:1J:C)\T
MUOH>>WB_X?%G.P!@WBFUZENQX.1(Y]@*JT&N_>WYB=":.,('SIR&J(N9:#DX2
M'WX.E91.>'0FOGF!E4VW#%[P\O81=0N3@0>B/5W!R4+)LEQUNHG\J_&O9O+:
MH"?3V([LJJLU2VMC^U9LY3W82NJA O<2H=^:J,"2.+A:DCT%XFXFK*BF65$!
M#/^MI)>WU,#:A@:UW1.4XPUH=80Z210?-DL%\& =R%CE[_K%942XQZ&@LO9!
M@1MT?W9RUI19]ZH%\]N;Q41Q=S*$+ S-
M%FA(-18*HS"#->\H!\@I6HH$S['20/3E=C5SO&0.;]Q+A%AL_CQ4!16E=O?4
MCEE_6>Y!]!G7112%?8@< WX^2G3V:Z&UD9PH%43ZO!Z0-TWSY71W+H!=-V"O
MXM90W!W-N/)'F+$7S2_2GP]55;O-E>:VWQD7LD1 1*5B'
M\!C!U/V._XGM_Z.P_7F7Q)=)JTJ?QM[G*3Q:>$DV
MD$4[&)R+LQ4N^$;&FCS&A(F''#H^O7X1TD@!"04X[CN^_+:89_F.+E*$CACG'<_>\_,T) 4!G!FO(2"96J=+QT^^NQ")K"QK^O Q\L*=V%2T.D@#
M901I7Q*O_LIAX$<24^KHBHCRXB^,S#&*?**[JNM@Q5(^J7#L"&\W=[
M1#6Z3+<0? ^T'C3&Y)QPMNVLJ)A_38.>.2("^V.$H^J.")W0^Z^;[?WMOX0G
MY'"L2Q0V(YI8*G7+VS8OK,2-\D2$P0@GO2X_7.;S(M#&I@2",_%+NY!&?GG@
M58HT+1Y5UA[C('JB/,C'/T"_?H%6PTCW9\#L6YE+F(4$&E %C_TEEM9#;L32
M?#0<-P32@NGBTKIL[[:3]0E7OV+B8YU*S$^T&\ >[HYPLOO4=6A::2BT73I/
MR?,[&1ZJS+Y?5-9+0D**_VIOG_7@-$*W9?S- MN].+ZN&SX50_@W1MJ\K9=X
M%U$D/HX539K*E9 ?>!L2=+ZCH?7).T9S"1XM9YL.U4&=BFV_MMW;+3TC?N.V
M18]9S/CH/02 8R\=@GM//(=HA[G#AZU-P@=NS#P58)UY-^XZAK^.TAV/J* "
MBLFMTS5]N2'U)W(5PQ5FUI>@\>MR4QP$F5(,)&B4'>HZRH4TE T[.,%%WS]9:R5;+/>4
M=>653YI.X](ZK\T>Q]Z>#S"C @QPFI/"YJ)=AQ4I7 9R
M+E$G:N;X:%U+<3"\,)'0B09SOL (8E\W1-Z4W06M%@"0V*:U6.4*!VM
M,+G5O:ED6!N%CP:*JIUP?\ >R^\M3(Z1+_%QZ%!%"4+ R^F$V^\CA *J"P,D
MBG,.[[FJMR]<%]CQC$'B'EO9.,+53U-ZG6&3"KHE[6+WZS%PGFJ[(<;T,-WA/CSWI4X.\0A88PF7RJ8TH86K%1$]
MA_BL^"/ JVZ@U4>$HG/%+H_"X8O.V$2Y2H:XB#6U+,X74?UO?)Q:#@W/C:-Q
MQX:AYSO :QX$:$OUT&7(IHYPT(GVWGA6\CR?KM .=JE1 "+Z[4T.K-H"M=O#9QW0EJ]&G\*9E8:>\
M2\D>J@Q*X_87L+5EQ%6,K=C'*CML&[1^A+]G;W67JK4T2F5FR&=8I(XKQ>^S
MR;#EA5T!['!V6F^.]E8INM*LWI!?NVE1O-A+0Z+FM$SFFX9:B9+"TP>7%9Z0
MY*8]")(Z$>.PG6"-&M1QE,.O^;")>3Y! FL=<.YPX5LI@WT]-M8:\SNV:XU]
M9"XSTM[(_V/R.SF1_-0AG8 V[A7/4[^6M%U=WI.V,O(Y)#OU+
MNZ)!(M
M2A^S/L\\"2'MUB/2GO^>;:43YTZS=QK?#85NR2P3);KL*(ST-)5YN0VMJK4=
M#L$GS-'A/3&CC!2(Y?WB&"Z7AY:681_>MT 2+?9P-A,=7*\.N=]F'&N!&4)S:&;:Z9A17R/6FJZ7-:=I38Y1XK(UBZ_47#
M'5(?VV[@=B0#LH-H#@(/!36'.)
M$-+!#BV.C8_-U!B*^L$P/BS.&4-.B?4KC[+TA!:M=,J9( ?["Y5WOJY++NZD
MP?XZT$F1CH2&H,>>@GQ%@^FK4-JE'\0FZ445?I?J\7T1^
M'*9U XEU0ERIMC#Q5H=WHT]3'#]V6S31+ A##.$6UDP1!UG)(G2-
ML2._72OR$-%8T9\28NDHO3-EE6U % -K#+0@(E2 IC\>'AQ^#3Q4P"23=!RG
M7O*.,G/1\K0]F UT+&OP&F+'^7I4A'9B@CQK#86))A*X2P
M'_)?QA_F@L1%T7SC79(CVAHW&O\D6F0>T>'R-BQ.1MVH\_"^952&W3QP[J3H.Q<40UQXP^_Z.?R(;[ZENX \.?/ _:[@[1%M$G=$U+HLO*@X5PV,(2+\>[)M$_.K52
M]YT\F^+@W[B[.H[8L5F >A8OWDHDJ;-Z$&G2-V0QLPI1;;!,P 0%+R5,H6%E
M_:GY-,5F[H1^G5RE8;'!&,+Q[S%K:S1M?U>":C.\$!
MXN0W=DHW,HX@M,%")HV2V%R@F]H)Y-BZ%OA%0PYK<_1\5WJB\_QQ?B5IENO-
M!X2*MCPZ\!]^UF\0 EL61K^HMK-.]U9$)^WP_/10L\E"_GK=G=+2C(ULVI^T
M#+AF]!L&C:F>-^;7]/._H]P2#$(VU;-,YL7E/<]R[C106=T3\92'H"W1"B%/?P?I:3?NFQ=;LA*L#C7K3(MF>C_0+LU?-M%I4BF7.@?\ZS?I$SZ
MQ9#\*TD?*Z_4>+RB,G1\JN@&%_VG?,B]G$.V;)T9A>'FY54MI]+'I_,[ ]6<
M_GBAIM_R)8=-O^0H]=56>"7+5+QQGO?1=1.6X6>O%$]^^2^;O\TK@R>W6!W=
MNFJNKOU>PCEE[@H1NIQ[-%LX">' U.;<@S>OJ_@S]!UY$^;%(QM1/(1'%%9-?#,56#E(T,Z]:$F2QH5\XX@2/=#U
M18Z!P,^D47AXU
MJ&$VKEKN&U&3*/,N=MYX>STFA_&^DO"D^9J^CF$)HGVTP+?68R 'JY. "\,^
MSQBN?OZRGMB4^'FM]%&ITL4S.FJGYYHTCP  P&$;9.G&>R\!+X%3:%D;I?17
M$H=YR6=D+LG(+E+$JQD'P*,T*XR@A),70N#RV'9Z@@NFIGI7AUO1L)Q^873?
MN:[9<1;>JH-9IE$\UP& SF+F5T=_T?JFK^.3(??9+1FT7^3A'RK0^^9J^',KV=O_\0F?I&A26J$ VGEA!U@K@9_ 7HT;/VIF+/^Y
M*IB?+WW9R?&$Q%UBFHSJ&BWD8;Q(@R%G2"<(WK@[%'62,F$8Y8?!:#$5[O'S
MK$>MY)X\W95XO,IZ^$Z%JU_3\.>R;>([F^OBV[^A-EDR,QL/K._=*KTT&X*O
M;9!_I3#14A[E)E5V52_56W;JW3+CQN;,BM+K&>$XB[LOY.HUKRS;^E2WY;UJ
M75;Z-,2?8!ZY<3,YYT/?0'$/I*7-!UE8&JPE0HO2)V!A&HIXWT;S:B'DVA6&4_(?QIW9 Y!:WQ;:P.9&B?MG(/GM_MZP6I#1RX!.>^_C+*B^PFL+['>:M4KYO57*W2HKIOUGBX=>
MK",YL
M/(?CQPRM]4I/G+_/=2N_[D *HX#Z^&L0\PYT410"F_AH%$YSD'B<3V-Z^:@5)[#J6'DS-L+/EU$/T%?M.A$
M_HH3,R)GJE.!G7&T?T/AL'78 =#I#!2328/T0]E48/IB8QN(FV&#\"*6)F!S
ME?B)!F%T;[_A1*'CE9&RH.T-HS4YCK4PW&D/@A1X-P\LTIW]XI!CJ^R>N%!W
M.WOVJJ%+*855.
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M"!+\I(0*S+'@/;&E&%@@&J<''3SYK@ &/]$EAD=4XG5K#DP/[K:%W/)Q
MX5"9MXP]%9)XH83'3MQ)RUN>)Q"2IF*D#1C]#WSLU7-9DX=NR2,">GE4A,"_
M4HJ'S2%IX>TY'&WN2?IX"";>RK NEZ,>(9!DTKF<_?JD C+[U=#PD#[O)\[W
MN-(/32JG9#@+UN(RB8? FB-:S' F\E.2 U&=\%P<7P$W[E%]#AN?+\\[EM\V
M/FQH/DQ^H=$DRB?N[2$O=I)8UL'O>4"!-JG: /PLS0[IH2%^[2O.N 02]]<)
MQSD9YW&/0%$.]!N6%S1$((MSI>SI5)GN##BJTZU8W?U1MQ&!*=Z!
M8H4[23$LA'9$*18M?W W+4),[?'GD#6^GI9^4WL&ANZ9@!8WSC['(5P4,OEQ?R ^2FU#T.4^H;B7HS+')Z",,%
MDK!F59@JI:G!LV7,I0T!BYELIVG'6-3*D;Y93934;!KQ%(%K%+.^6F]S:*@>
ML0-/)T61C%BQYYHV?K2J($]QY*0"77K0JB2T;LY[*N &&3#1)N=J<>B-]?0D
M:>,//?1)1-TAF;B?:4_]]H;T\<-K] %CG3[Z5[&ZK3R1L'[=E9Q>M!.,_AN"
MD5"9GG
M8$T??J8";ZC ; ]>R)#W&UCR=<[5)99DCL_(BF[1\TB$,$\SS$><#814$/8T
M#^MS'5EP_/[&2\;D)?Y"B)\\%^66SW?KII4NGVB2O-#US.7$;W@K"5+GW%3I
MH[F7L[/@%8\!T;X5:QS[W-=PTC&X+IZMO@\YB-Q5=5F]M>(YT?ZQ\3$Y!O_P
MAB? CA*Z*W*#3JEE>-YOXZY'BD6&*-5ZUQ).W>S-->$TZTZJ!/N&^VD#6/?^
M=^9&Y'?#5?.E:A&^UB[?G*Z>6AZPF3DE /3
M 3_1:\G%R^#=[S92&%O>+HW#*8/%+I#>8YEA1\%4@!-QE_^
M"-FWG*BZ/HS)B\.V!]"R6G[OTMT2XU[_V
M0< ?/MOSDP_OC?LIMCV:?^SJBD&?Y-DP>@^6Q)(YP,!^L<6.NY4=R:2B[3L@[UHPHE:&[KWV_Y1UQ
M>L$^7%"<%3,[)^W99*KP#EX\0!FA*-&<*Y)D3"[3D"<*4# 0$0TIG,<))#:@
M/5+5\%[U7AS\]G!OMB=?:OQ-YY+X)>R/*CT?>56F_3^&IPNO>G4/LW,T\-_X>D:,/D$,.C3-5[X(KX#T\WTF_)3[W,R_$)P?O;T%$D
M-;V$/FM2:FYR9N9KBYP[=2;'M/.BH&\*-H=*A!'I.X4:[]@EHB!T=I9.!\\%-CA-R%]WY>,0S]4:>+4>0NI:BVQ<&TLY>%56Q
MSS08X>I57#)LNT8A)]+4H^S<@=0_O]SXAW[S$/6L>(&P'TWB]L4(?5D(K3I)
M/*7OF.7<=],:9F4X]MS9/LBI/RV-(Q_7_"Y(4]O.+^$ON_ ,;=TJRO>-ZTG'?D>;Y!4[!U&"Q0#]4G1RW%7HVS.(RGTBHM:!3]G!H9%
M5]W 0D(1.[LI>PBKL)+.(ANA9OVWAD:5 ?DUK#L*N;_/'I8"MIV3FW15),B'
MD;CWR:FG/EIY@ME_1@"L%Y/$F3Z&I$IZS7Q.GV\
M]WE<9U5R4\"Z36)7<[Z1N]^3,\]5<]SEX7&K'O;59 6OT4+#.R1K8@#\6C[Y
MK=91/\0XYMT@0[06DY^8T5E.08V94J-DC>D#.XY]EF;%'#4:FG6)[NSLK>V5
M$Q9VP@8)]*I?OK\MW8EI6]9N@!E@C2W#/\D,STJ\F!]>9->A,/+6^MO\A[/F
M$N,NDG&I1>&SZ%SK;\LT&2_?>>G_C0^>O>:XA^2NXL1EGLWOK0I '7\Y\$VH
M[66'*MAX)*F_]I.D(:2N)(:
MH*7(.8DQCXA>:&E, S)$"'*7=## ]=!37&;CHVGCIFR55_*H?38HUL.E9>A0
MYQ/W;7:PE*5IP.E/! @5"&VD
M15D3JI.C1:C9)!R$PH+%1C&OE)##JQ@S20Z8CH9>BS9[_V1P@_O@6W+9_ZT_OTB<2:G"/WL%$
M*(*NL.T(*2?GK"DKRMG9D$FPMR.3O-XDY_MO@P^J:T'BT*YR/<
MSZ*%TZ"SYHUYDC[66K$8KH[7[&O96.\*TSEUEF7F!B LXOEL+U0M_@,B#\5.
MKD [B.BNQ!+\+X]#0ZV:IV#<<'9_T:]8.KU0TYLI7:7IZ*2/^NN]EC:Q3UDH47(X
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M_^6C1P6?G \?%<,C*6S+&ZD?M<_)+W*ASH;;G1&V=_ 4^N.*VX(
M8_*MH<4H,KXTZG,E@8_K;/^
M&9H]@]RP8M7%B[Z)Q&NGKJN,/.BU13DLPI /ES3LGOI;X6MJID4>5O;O0>BYM^W/WFRU$9.':$*ZFY*OS<$GU@[RC$Q[O..Y"BV A*6DXZ*XB4"O+I?*,1Z('*H;@FL=+7:L
MY1A%M,%*=%Z\FL93@1P98\<^9
MX8=J;@\C0T!G=']?O9"3]! ]OF@^Z>M>F7S9A<5^$\9V;QQWCZR]'
MVA>5&1]CKNSX%[Q5461DR[(1U!'FW)?' F6<
MTTT&\HOIOFFT1A]#"=_S;(6P?XY;TK"H.:-@(#]Z*N%9DMZMP@3AB(S 6D-.
M$Z<<*O!N[2W]1"F)Y^A86$V4+5='9"1U#W]<0_
M)\H1T ?P2W4[S#5[,=TALKZ=B7?M
>'!N*/3R#^K0=Q
M9WC46!YRYN>"5.!YG577$\_:7. XG),YW1U.G'*XSC!J9.H@9<5A4(,$(Q2),TSF &F4K=SC L
M.YX;7;9VF]WZ5F?1[& ]L=WEK/&R0;$\ AD!ZI'),##*[D7[B$*#%FBYWH93#B /%5ZZB=RP(HX+O(D
M3>/$*?SP>#=S(ZO>N[.ST^L4]@2J=OQS.58CLXT/3!["=D,H!!:W.]K5Q )W
M0^X>BMP-7NU'!;^O]-1I*<57R67Y8#X6U9O[S4;J)46<<$12A !1F::#C%!
M&2X @5B)'#*222O-J/-=S8T2.DNCGJE746NL&RD,X&M'#&%0&YD<_ !SIH?S
M6 2EB('N)J6)\VX_IPJ+.RZH>?I;>;,J5T"K[]\V=%51;M0 3 I3
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M.5$ 8XZ 5&D,<:(*F3K1CD6?YAO/&^,B6IOJ1C0V0-M136#X1B:;UMHN
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M>=7H&%?1WM7(5)/8M)EQC;>U[(+^EG<.MS+(MD?JNJ>:N0^*VWAK;;-F+%@>9%#JE(@$<4
M0LX R;D"B"#]CA4HS;G5 MB^R[E]'6JKH\[L1N6A,]Q$!#6F-Y\$^Y(!EO /
MT_4XH(Y,O2^*IWTQAO"X3E26(0B^3B4:W* :*-9@V=!D91O<'.L7<'"\TV\1
M\;YCI_J:=#YYQN'G$\)S
ME_O63.\J.3"IL( 2I(413A,Q ICD&8A9%F<9QAGFUD+L_8;G]M)WLN-.@1P'
M: V_V9=@,/*K;.N^1V7SLW$3+J7,IXR!..7"8;'R(+$+/8DO$T)NM&W_7FZ_
M=S)?[W[RY;TH5S?F $'_SZA#+"!/!..I!#)-"8 D%P"KU"@P)*)(4,)2H=S$
MZH]2&]?@+59H/0J8J0133H""$@*8R@)065# TZ30OT$0
M8Z?#W9''8$)1R?&QMYM+C8SHR.3\1!BRLS_Z41IUWM8#L\'8^A!U3IC(_U'4
M(%TA'$L%TMJ.EU)_= 5J0/71N:D+\XS>_:2W>F99;Q[*%5T:/:'KE?BPTNPA
MJVTK-K1((>8,IYKPLB('$#&F?Z(98#E%G(@DI23Q2D"RZW]NM-=+N>DYWM[?KN2VK$VZVT@N#0W_ZYYNM T+
MFJ5*B@(!$2@ L19(A(NDCRSDQ8*8,O<"'(?@5+[$W4.13N/(A"U
M3D7:JZAQ*]KY%;6.V>_H7SJ:YX].)ARCD;GT3S@\]B4&@&0L4=_#Y?EMM]:Q,6]=<5_U=EC??MU)<
M/\@-O9%?I=E0T[_NECWW=/E-;F[3!8G3%"6, UB8R#3])Z YQB#E<8Z@8EQ*
M[!R9]O)^S>T[/5XHVU740ZF]7E_: 16U2$4[J*(>5I$!RR/^[>4'V"5@[N6M
MG=&4Y*((NR;VK+/N9E5^EF
MH: 2"E$(1$IB(]J; AB]ZVWW_6'O;R_;;.NH))9
M49@*4Q!) (6(]61?0,#37&2"Q 0GA>U&VI.6Y_:*M\8YIJP= G9^K\H;AI'?
MX5 (V&\'>2,QT>;.M[]:;Z+M=[G[JU[VWZU79H*\5M''
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MN^7Z4#F/W$L0,RIB8#!*2 P@9!XS&,4A(PA*90049==G".]G3W#B^,_3I
M29F?2,UI>.UV](* -H^#GQ$D;,ZB$W3+[W1ODV[[G77Z^=;?^1L\LU%IN?F;
M*3+W^G'WX_^4O8Y0V9)MO%&!O5UEZU@G!UQ&NO$&ST5TDUN^L72;\OG]:KC30R?.;8
M\S6MRNHJ>EM6?+DVES1J)'[IKG8#1S@37'$%"%EJ*>[M;LUB;KHJ* 2A4)X"C.-!'!!!"J
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MIC!@!@B&$G E)4UC!5ENMKJ*[VO0KEWKV
M#OB?/TD)C^K8^W$O"JC]V4EX8"D"B_/D[Z3K0>=XA[U,.I4[Z>3S&=OI"WW54QYDM36?
MBD:LH),D6. T)ZE4!<@%QGI]23D@C#&0L2R)&:<2Z^G82M[0K9X^NJBE'._/
MZGDFS?-\T.MXS_;>W#81V57XY 2Z=F_]16!-)66R ZBQ\6JG6Q)2KV08A\#"
M)"N/HRAD*&$:.!R6"3ZHY]S@%F:
M@H1E-"8Q)5@XQ4(\[V!NW_S.OL@8Z'7*=0"AW;M_"3 CO_-.F#B_[*<<#_J2
M'W0RZ2-(0B]-EAOMN7J9G^$_DW^W+Y>&I7XC$$E4X4
M10(984@!**0,H!3E**>0\%@YB16<[W-NKWQKLOZ.J?7FUB&^W05G.Q((C-[H
MVRT-<#MS^T$:?QB+H]KDD(5C[ $*FT5NT>^T&=[V0!QD7SO)
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MPNC<5=OVG*RMK5Q%7VCI**-\9D#LJ",GQS
MO]F8&%(1Q[S(109BB/2\BLH,D+A( "Z2E-(XYX(YE>89[FYNU+1?.]3F7NUR
MPO1[U9KLN<@ZCK;C>NMB#"=;>KG#Y[\,&T1EG!79\2Y?9G$VZ/[)==KP7=YE
M45LR-B!HG0.U%M'=C%_K>]Z1;U%U%QIE(>^-<
M==5CV.RH:_3!&)G1!L?AJD:>U_K(/64;VCU7<\ S7_,+/"!+C5-5\U:ABL]/2.9 %2B!$!IJN9@R8& 1990
M;/[?::IFU>O3-C>[U[Q^VZ9XO"\K3I>&]M[K?ZD6'.5*B*0 "32S
M.9P5@,8J UA@(V-!4"Z(;?GK$WW,C8(Z,Z/&SN;K7UMJ7Q3[%)S#[!((I+&W
MTMWQ<:J:?08![P+:I]J=K);V&I1TT^/H3DD:A-%$(]3$?,,D%S$
M '(3>4L*!HI8)%DNBB+.K;0?#IN>V^MLK(OJ%#)W<<-GH V_O9=!,?9^:,Q5?TX TA=-*'&IUD&!*H%=]3WH=)N3V^8KE+;44.?%%X[?H5W]-[Q
MS?!K5M7ZQ0N6ZUF&2C.0R40!B/2*B&58SSL21!F""$EI->6P[G%VC#5\]M.9
M[;C\.0^\W=(G*)PO>XIV'DF?6$$[=$('#Y[I=>IH0CL0CH076M[H(1Q1%X!2
MZ\T;(_*Z7$JQUI.JC9*E*>;T@VY$M:!9KDC&&> J-T?Z.0%$%@(4F9*9+"2$
MT%J-VZ*_N1%/6]K01+OLC#8U-G9F1XW=#N(&%J"?GU4%AG+LO9870=%!'R(L
MFE.)0UR*JILNA#U&0Z(0%JU,IPAA[](3.0B'VR[/"FUE]$B&<4%S"'"<)0#J
M'X&>^DG 2)&F!10Q8DYY8X==S(UZGV5!.BD2#@!I-Z6[#)Z1Z=01F8LR1.U5
M""_*$9U2B_"\FT-YHD%T"*]%4Z&;+K_4,C)OZ%VYIE*L=EN'E8ZQ "_BN@VZJQN>#N@8)4+2F%%K*QZGE;8R@6,
M [$KIYM]L]SN-I*7S2*\( E3,$6@8(0!R!@!!.4]OD",S+!6&'BDV!TZ&SBAKM?!Q.ESAZX=)LL=N<:/W8P.:%V'JOJLWDJV
M761$%PX2F2'@PW/-^9LIR75$NO7HK6X&TB)LZ
M- /4VR%$G%_M4VX'?;T/.IGT%3_E
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MCFA*"TR&.9>!7 L.A\IMMGQX36RE6T*PW8RCW6
M+K@6RK 9$CMB"8?P5"4T J#J45/# :7 !39L>IZXVH8#&(>E-UQN]LW!:9NL
M*_]\+/]UW]:>;7XAM9<+6DB$$I$#6A0F"X=R(ZJ= 8H2(E26I8E"KJ+:9WMU
M>8^FT=G>&1U5QNJK:+FW.[K;&6YJTT65"95U3.P$XSA.SW,T!*W((:$:R3*][88ZE;:K4<%=S(Z/66CVK:LV-
M5K(^!%YV%MMG]IP!>9ATPD(W,M=,B)I]*E0X]";*@KH 1:?\)SM@!E*?SC0P
M6=:3G2/]A"?+.WSKWBZ7>GV]HX
MR)RR'YYW,#?RW-OGN4MX@*#=Q.P27$9FQAXD_R.78H1-P5/.!ZYY^ZR3B4O>
M'G?QL.+MB>L\$LH/"V5W"BE)@O22#8-"$F7$=5) 8,$ 4Y)F*4:C.G83T_&PH"ULBO^_@X.:2"A\!KJ@3PH[B]^NWOO_^R
M0R\"D?Y[5%81C:HM70FZ$=&]OM!,D6XE-67HZI#-[7>ZC38F,K:J(Q.WWV4D
ME5IOS+_J=919$V_7T=9463-U&W5[-[KG57=>KYM;T>V]X>S[W93,W/!C'?'U
M[=UZ99K]_R.YVI1&N6]WU7?Z8))$:/2]O*E/^:6&1V-W4TLS&C/:*T&:Y=J1
M]79])Z-7__D?.$WC__Y=_V/]8_+?O]2I*$+>+>7V6/O+]8^#YLWM?S$!8C5*
MFEFWM Y8*E?1QWTTK\5]]563S5WB!I$]%41HY5)PE_5
M=M]]?ZQ*7@=Y-EX;H)O>]J#M?Z--UT-1H\SDH2WW*TW"NMVRVO5FS*OKE2\?
MH]W&A;Z=5I%Y$AJ76NAK<(Q5_[JGJZV>MQT;L?NJZ:^V?K,6]TTY/7WE:0N.
M=-PUM^O\+X$T",Z]G$/* R?OG4YOX)SY3U0&SEX\1G6$WS1GU7SP6;TO5W3%
M2[K\LJ[*1@!X*U>5$0?^6%;;!8(9E@AE .>8 9BQ%."",D!EGA>()5F1X'!U
M%.P-F]LLP*)DP%6T<\^\:SL'H\[#Z(^]CY%QTG&)$&S0[986+S&4(\]1@H_B
MNY6>(FSJ&4+ =4UHY"?@O+RKUQ4W0R#6TW3YHUX/
M&+V_,#/I\U@-3*4';IYL+GW>@?YDVN)J=]8\S$+X>'][]]O];?LOE9'W6*0Y
MRG$L8\#37)H:%A10F&! 9$Y((I#(4I>4=^N.9QKB=CPCR-@?:0>Z?W:IWFH_
M%.=MMQM#Y?6V
M/^Y+(#]Y[AGA1:I@!I#*"8 TBP&-H0(DHS'*!%)Z*+PT3)S,^%/1^[&BTA[<
MY#MB=IL68PS W"IY!Z:L"Z$;.5-VV(873HBU NA\WJM=,_Y97=_:W)#WM-PT
M2F89Q45!&05YD7, 85$ EN:I_@-F2<%)ANPV! 9[F=M^P#Y52=2I2DH;&CT,
MRIHY0&K'3Q<#-3(+/4_G,C:&EGX;Q"!X*M=A3Y-G Y%00E0L7$K5:C0^=SHXO:]JAG?'WXVIH?-?9'C0-731BY8SJ7T\BD/(U9
M*G*@4I%5#Z2%(%'Z#I9ZOS&B>[S\!8[\7(7X>04+L7
MW?3 +&SM31<#IBW!Z0'-025.GS;\/DE&IG3[^)ODNN%M*:L/;21.%^FLB[3!^H7P#"<^ [$=2X4#
M;F1>ZG)1@[-Q_3BF6=WDF^[:Z4-_6U[R.;#Q99&N18(Y2
MS 6 JD:62"Z:H(2%,*7I1&:LMQ
M0N0 O1W1!(9SHBS33OYSNXY:LZ-GA?FNGE;F"YAFZ@Q8V&Q3^^ZG33IUAN4@
M]]2]!?V/
M"8B6K4>U%.7=4P4$CTR%BX;Q_#'V5(,S,DW^R<;%_D!\JO&9Z)S\PG$*
M M.!$_6+FI_LH#T$"/WS]R#MA3J6?V,BX$IV;Q[FZO7CN]N[Y?I1OW0X!$4D*&&$9A$5"\\1*=\&YY[E]QXZ? _?JN%]%3SR)V&/4^7+I
M"?RIP?$]>P\ ^8N7\9T0]W_.>BNY\&1$)A+
M:6YP>'RY+A3H+T)XGG@'(#H;V$9FNT$37ICR;. YSWM6K;B17[79+OY*?Y:W
M][?MRJFN>9+&""C("@"91 "G)JY20$$0EBS&5L #3/-
M13",3"+6"%@3Q$EOA]Y]?5/OO==_>_[.'[8ZR>M\TIGN33U]00CAT[?E0RGD
M2E2-LNHN^?##K1[.[2*5K* 441#G2B^W"I@!F@F]W%(\H3'FF.<7Z&X.=SZW
M5_F9#&HD.NNO:IT$OJ2;-LBA)=#RX2(-SC-#8WE:,A+@8Y^7/%7EC-[NL6[%
MF_>9UXWQ8\ERVD$VHC[G&0->4*C3#IIAQ4[+-CP76V7%EVLC>/-9O5G?WLE5
M54]COLIZ>O/&9 ;602JUB$MWG'/-JCKO$4P*D*F)&
M&$6$**?%UT7FS(T.]]Z8A-6^/U'K4%1[U 9W@48H9W<0^D?GEV.PRH5C:KEB
MFVRD1N;1(]!'UV9/]Z;A3HM1<%^W!0$O[#KN,I.F7=<%@>]@G1>F5=^R:8W$
M12FK!2^$1$@/$<5W$D+L>QGOY
MOID^=JJTI6OD3!\U.]KRQ&)D#OIH 8!'6;$#5P.7#-NW/W$YL /'#DM]'5[B
M'EBR5Z%95]4;NMD\JO7&E JK/JW?_;PK-^VI=JIRI@H"TD28 -M, 981_?K&
M.$6#4T66N'F6#^(PO%.-^[F1D=T\[CXWR\+
M)5 AB[0 (BTH@ 717O\L398DHQBB'$"D$("F0C.%,04RIS(AK$ 2.6WO/&E]
M;B]2;5Q;<-/8Y[CK\A0YN]6(-QXCOVKV4#BO2HZZ''1=\K2'25;;]7"Y3).!89!CDS48))8>2*35D1S@1+W]VD6Q]EZ+6)SU_U%Y%C5M1XY<;CUPXI';$,]U C]<+J1[W[*#2\K^653
MFMJ?*4&*%Z:>?"( 5#@#1#$!L*24X3R1F',GG9'I;)\;Z?>/@YZ_#^TENW]#J^Y?-VL3-B->/OU?F
M^]]6"EC=7/-M^5 ?#>U"'A2$F(_\]=#&1S7T-)(2Y(S%/[Y?EL7=].V?3"97ZNJ
MY(U:)TYQ2@M3]XH)HE)KZ=QXUF;J:#MS[#EM
M8H!;M\_(C4[\H 1:1DPQ_#-8-(PZ\N&7!Y>.RK2+ 6]KYS7UOQ1TYXG^Q1UZ
M1DC*JI+R1&&POYJ:G?J_WRA;RF_RY_:UQO"?BPSQ+&49!2GF>EZ?I*8B@<"
M)!QGDBA(I55DU@4VS.V#T[A@N.-T[;[.D^B/VI?(.!/5WCB>B?J,F=T78N21
M&)G[QQH$]QA1?QC#QI)ZV#%MS*D_4 >QJ1\ +PHI-GQ2 %.(0(9IQF-!18J2VVSBX]W,3?B>V)E5)OI%.O*P>_T\Y3-7>FYYKK>R:B2HDD6>,9FJ
M @.69HF>]# *2)QSD*F4BR)."',K1M)O?(8O]8/NIBT)6:YTG[+:1G?TT? G
M*%?@G^6JKL*^?%*MQ''?L@^OY8ZD)VAC[S4:LZ+&KH [AT><#;LGV.]@VMV^
M(ZX=[.,=N^:"ZB+?UTM]1]7(/2\0+!3BD .:0*(9EBMVRP
MPRZ<7NK)DL*JGIW_GWYI5
MX,5=H\V_I9OM%)@^[VX\9%_+FW*U,NN-UU3_PCG>X,C3F2>0"89!(C2H,,DE
M($06 *:2\Y1!%K.LQ?/=RE(-/ 2:76?C8?FNWN((!J3EQNA%T(R]H_GDC6W,
MBZZWC41
MZ D<6SNH\WD:X_*B]$T:[WWIK(ZT,U'/FZOHRT;>T5)T0<6.Q^P7#)@="TTS
M"".SU6GT=[_9Q737OD0]9QK=CJ!"?AKJA<3']=T55VOQ"X4X*ODLGPPW]#J]>/K.E!W)3HG_R%3K
M [U[8ED@O,+FHEUJU+3I:X$@/,AX"]6NNX2';GQ]LS(D_:$OV]HP^/KV;B._
M:T8O'V0CKJ8G7IKYO^@5Y.8WN7DHN33<_D93?[E=%#F+4YA!P&F]$Q-SP*2(
M02(9(3%6DL9604Z![9H;T>Y=BSZLGD@AM].HOGN=5J%VL)Z(U2Y&K8_U+"MJ
MO+07N@@YY,-4_8(#.3)C_[\TAO:*)B\TEA/)GDP\IDX**2,@/R"C$K*WR;16
M1H"H+\@R1O-^*Z'3TC +E.*3KA/.N_U\!6!QAZ<
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M4\ RO(B# 03Q/Q\*P^T%54-2"784&V(^$PP(W,PYZ/Y845?48G
MXX'N7K!:CPTE6]SAQLI"EHLWY?;Q>B/IF[60BR1F,$5(@CQ+]-(T3A# B3"R
M))E :1%C3*T*_SUO>&Z,^Z8.#]3&1<8ZNY?_ *SA5_T2",:>8-EY;_TBGW)U
M0-Q8WU*_L?^"YD?0_%B_I@>-3?)2GG*A>P5/_MYO&O1AQ3D-4NM(/P0RW+3B,B2#3CD\39ET.G(97,^G*A>V
MYL>J7V6UW91&<]=H&^D>S'],'/H#7=;ULK;U]G^YNFD$8>(TQZG)/$:9F>-
MS:D$%@ID+,MCPO.$L<2%3AW[GQN/[LV/N-$$TT2YO!>- %M#IV:CT&C T%K'
MUHTU70?'CBY'A'QDGNRA72NP&3ZL?^A9?Q6]:1 /QXJ>@ 6E0U<;)N5!3X">
M$Z!O,Q>HJ['SPCG]\H%]X9Q6 ],0\U/AG&2A])(OQ=*<5IJ].2P$8#FB(*6,
M0Y'1!#,G'9OQ3)T;GX94V>IY'4)?;9Q'Q8ZRY_$ C,SN+S[V?@IKHPY+>(FU
M<#\3M_/%_(.V $PEDTQ0
MG!69RU?(J?>Y?5HZX^MMCX/Z9KTH1!NY^0"#8\?^HT$^,J4'1=N9H+U0"\JZ
M;A9,2J5>X#SG1[]&W#-:NQ!MU>7/(1=4ID#0_\0!YKP,XF2V,-#U _BW6$UOV_T#T-H<=:Y;N>#2P4RQ"7W"CS
M)/JKF_$$Z*]P"C""F*(D5B*U*C9VOJNY?4F/2FX]7C7B]\U$V)U73Z!L_[6[
M'+NIOF 3P.;^B;DGT#AI&QX/43#4S.U<..'./?,W=X'K#S[U+<
M+^5GI5N[OVU.0DS-M.=57P16&>40%$I0 $F6 4I8 3*>RC@KXB)+8Z?3%//\=+*+K9C87D<'1[A\3GYR.Y['^8QR[8XXA7VT->R[VE/
M<-T .3B.=;S=/%T ]A98+8/V^^K7^L%D@)"%-> "(Q!U#!%)#"
MZ)&GF#$F&4P*99OL<:*/N?%28V;4VGD5U9D0ZTUD;+7/ CD%Z##A!()I9'+Q
M0L@I4^0,!MY)(Z?:G2Q_Y(QC_522#OW_!X&W/.(+ N9$QWH&Q5?&V%\,F.\.8'P[!*/[
M.9XM-&'/[L[V.NUYG2T(!V=TUC=>7"JA.?G3/SS3#O\J*[EYD%67>T.751TS
ML5 2TMP4)^4D0P F' -F1@,J!DFB(!2IHS+ !=:XO& O4"RA<>GTS
M1;W,X-5;_#M9X3,2_<''SX[:)AJ3*7<::G_:B@JCU$_P
MA76L @K.]KQ4!05?X 9**'@W>>D&H>G'Y/UTL6=-!'7U;',JR66<:'?1":#3NXQNS80J);D+M&0X8:A@$*22Z@FF* C
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M5ZFM;"41%R*!+.>Y $4N4G.>DP"29@((1E"1$"5%XE8>SMN4N7UEDA%KCQOVA9YH51Y0_NXH(X9&?C=E0*:* /T74W,3)T!2
MD69QPD2JW!4G3W8W-[H\J1SH*X1R!FW+B7$P#&+K+Z34-S[I_5)?P_%V^Q>BTY:OMIF[S:UG]LRD7;'Y:))"B%"4,9&FBIVXP
M0X"2. -)J@K*,LI8@=P*TIWL:VYD\\34R%AXU=;6;O_R9;TLN5[JM?_U7M8/
MX6_'0(%0'9E^Q@#4H[3=6:@"E[<[W=_$)>[..GY8YN[\+=[U+Y_KU7U:;WM;
M4A(IC).< 22% K @9LD(4Y 4"2P*PI,<.X7"G.MP;N33*_4>'1.=;%QH$QR<
M2V0.8V_+.>$0'9UX3D(7&9NC/T:B&CN$0I?3'.YTZKJ:5A <*;!I=U^H$E-=
M(/0;/=&Z,=6DA$BY9!Q@)0N3]6'R?Y,AT6'*VQ[D14*_BN)%P
M&K% U'/H[>@G** C\\^)LD\[B%N+QRSO= *_UA8LVG0#A?'VF4S=Z
M[J3?23.E6MW4"BR[SWFM6H%1220!GJ5YU98@#Q@T%<5FDB*(X9VX;YN=Z
MG!O[[ QN5("N^KI %ONNGK!;;GF'!'-DYKD01_?]:UMLPFY3G^UUVMUH6Q .
M-IVM;_00OZM/"NO[F1O%-)8VV:@FQZ>)K.RL=1!N.PWL,)^$@VMD$ID *0=YNR"(325M
MYX>[GBCV_7M[1<+9*,2T6->!WCN5X5)A PE0D]38LY@X5(,B%=YF46?SZ7?2V9D#$,_G
M9RZW>NZ+-_.\9L?K&_W9'L2V,0<+R2E)<0$!Q1":77$,,&($% F3F. $9\Q)
M07.XN[E13VMMMX%K="VZ@^I7KQM\$OP<]_]MH(E[-[W
M<)?3[GQ;N7^P[VUWEZ\*$M,M5]M-/?5]KQ^2ZUNCNKY()$GB'*8 JEC/;2#-
M ",T!EG,%4G27%#A=-AVJJ.Y$4HM4[0U,D5&4^TJ4OJRB-:FNNH3G4#6CD%"
MX#7V&M#H..UMO(J,E='U,%8>6R'M67#C
M,\7=-W3)S7ETN;KY)+=?Y*9=85XJ(_WU56[O-ZO/JT9K:(&X
MPAG$",0XR?3223" $Q:#),Y@G,LL2X73@=K8!L^-J\X+6]?ZX3VO(^UVU/F]
MN\]X?K47M-E3X%>3;[Q640.#T4RLDPH;-)SEVL9]F&QI=3Z/R.CT/,NGPTDN7OA^ZXQT[?;!VW8]'289?[CI^Z1*93#!)](K7882.:W7K
M ?#].%P.ZXN0_$D>CUZ].8-S 'H>!FUDFCW1^0O3Y3 DYVGOS/WN1[^_KA_D
M9E4KV=W)E=#\2>^WW]>;\M_-<1N+N9Z9$P+R6AC D!6-10Y22C+(3,YFSFS/
M?\_T-;=9]=[F*P_>GF.93/'P8'Q&YD)IH0-ON3X8#P370\?!9&,\_6
M/%0G^80Y+;8$:>#(^%P+DYT;6[K2/SRVO<6_MJ2AZFNAO[J-6AF5,,TE 051
M&:@Y%@N4 Y+K_T,,$D&LJ@B=[&%N?/HT:O@JHIVA[H40GR)YGCTOQF?\V5L;
M[6OF9M>A@'$O#.D-T-3U("V!\JH!>10$B]*/3^^;O.+C4;./%7H\?J'?TO==
M*S;RF]P\E%P>ST7]1G^VL]7WVO+^;]HSK 5.*4I8(@%1,0=0J 10BCF(LQBB
MG*<,8J=4TC!FS8U!S^9H[RHXF//;UC>WE72@\;1;9T\_2B/S>-@!=5@%CMP)".O+7J
M9M,+[[AZ 7A^(]:O66_]9VJZ?T0P@P@A@
MA21($4Q9G.2H(-RM$-WY3EU>X&GJS?6%$83TJ!-B@;0=-X9%;V3ZZXR-.FNC
M5WTD6X,#'A79HQ-:0_I JJ@ HC',8EEH5&QFO\Y]CNW>5YG>K1I;(_N
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MZ/*4;'//MX@]1D>/5HR#]49=ZV(;[.BA\QQDT"V9]B6&!(*8**$(+6)6%&Y5^ 9ZFQMY[XUMY6MJMY
MG7/O*A]6@V YLPL-[=BSMA"H>I2)=T I<,5XFYXG+A[O ,9A'7F7F]U(2LAR
M\6ZUU0V]+Y=R\T;W=+/>/"X*@9 DL9[EY#@W>WVFX'!2 $24S(E@6$]Z;.CH
M1/MS(Y[&Q*BV,>J,M&.84P@.\3,.=2_SN/
M6X-@-/+K?!0>Q[7;,$[VYZ9!\)KHE-3ML7(Z"3T+P\"YY^E[)SOE/&M^_TSS
M_,5^BZO7Y7)I=HZZ$U,NRP=S0E M8HGB/,L+($46FS*)":!*8L"I(!+#.&'0
M:4%ULJ>Y$6%C:-196D5[6]W63*>QM5LG!4%L9%KT OT\V7.^1M\*_T(33F;Q\_JC5%)DYL[NMEV>L(%-MJ&)#$BSF9?-S89:50"
ME2N59$@*BISV=8&*2,SP A+$[J?TK<>[+MMAN]Z.B?J@P#63T[*4
M34HN9__Z!4A*8J8D"H  )OO=N;B<3I$XYX'X$ RZ\=]>PRN
M\=J5^>BGA>6DU[
M_ H9;F#/Z8L1>O-[/M\)7WVR_<_3%*VV/5H]AV[=_B?!L.%W@(&O31X^G)Z^
M(^$F6NE#NT%M/I[@4)!Y25.CR7$LJXS! JW5*(
MC6V8W4MKD-DZ2!30YD=DU?]EX(AK#K'Y)!F^1,)"'_BUL+.Y%<95;X.SY
MQ&$ZD5^!8:#D8G,[7BC%V!JH\XG&]K=R;C6\_B'VI[C[; ,2TU*3'L@9S  4
ML 0D*R$H($U(AG*$.;-L,'QJG+D17M][Y)"5X)K3<0Y7T[V&J]$*OLU@#Y1+
MG^ Q&'QW!SXYUM0]@<</3CKND67\5=I6^UVGQ27X%%(GB:X2(#A,:*
M"U"1 QK#%& 8 $P*O.<9B2."Z,0Y^)(?Q)]PI=X$=^7X6],S089O9U[5=C-W4ENSV&3J7KH[@8%*N?OG[R\O11-TX5
MI(]?X-CNR\XE;VJ\]/8L-(73]6J[N?
M>I-_K29)#U2+3:4&7I148%%F^A29ZY)T7;/(BQBD'.?JGW-:QD:9^P9CS8T$
M=1^8O*9%SGPEZA'!B=:B5R%IM1HU
MQ&9D/7KI#I.M2 U=&:Y)32]Q;<+>)2G?\I]$6=_T39D7"98IDXP PJ@.[M4:
ME/ L!5R4,"EDD4%J)6!_9IRY$>O.O$A/6\3LJBLN86JX.+P>J= +P-[":&?B
M3=0;Z;.C^B@*GENIGQYKXA[JHPX?-T\?_[@;&WRIUTP(WFAQ]K8"\W.75/'N
MEZA9U>@W&DE1F]? &>0 PI(#G')=;, @$B)',+9*([XXXMP88F>8?MDUK<;!
M^L&BN8TYTF9LX16_P+RQL[4CUTX@HC;IH-:9N<]6;^751W
M]QO!;W^*FMR))Y>\%G?52NL,OR9+39[)(BD)8P@S(!)=0B41 26"&4CS(N-9
M+B2F1J'D')V;&X&>RU.]Z3)3F^@ 4+35"#UABDX#\6;/%U'K=-0"=1,-H-HQ
MRTVT0ROJX7IVK0]QM1?ZVIJ](N9D\HS>1A=[&W7^&7S5W+]BGI3?7G8N)Q"/
M>R$'9Z _][)3:R9A]\(VNJT_/F_N13WL(-A\$IL%%*B(.<5 %#$&,"L$*(M2
MJYYBFBO/+_(2
MQ91+ 221J:Y;PX PR52(1!E'99)S:JD0<7* SACI2@3M:YD19'KSG8
MWZ?!&7QNA5;Z7''G87< A0'G,\U@N4
MQYQU^'1YS/F/3]*O6'=H_:ZF0BPRF&<"4@H*7$H \Q0!(G@.4 &Y+%!"%*<$
M;%2\-V1N;'Y-Z]O6H:"=B0_S9T9.4\Q*8/8*-R&ANQ$?H?F2;8@/QLRY__ 1
M9%6D)25I)G*UVLUDIXQ&\T11J2)81I'(
M4FF59#\VV-SH+\G=
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MPQHQ]ZY28TB$Z29UG2!8Y90SL9VD'W]D.[
MRYC'.F!MB#)2Z-QXI,%2_
MDRB11B7;GNR9&QGM7(KJ@_9T5\"Y;9M4/QS8+I"KY/^;6?*7.]CXAF;2!-DDIFST@[QB/.(OHB/42;3(/$(R5"G
MQ.=M[8/TM_T7_+UZ+9/E%U%7:_Y>_5NSR+.2(BDI$!"JUR*6B5I[JY4)(H24
MN;VLML9&G661IVI46NK>6!^'M3+0;D7J$)O_KN@9!6,7T3!
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M53^V/QAI[FFGBO4\1B'JW(NU7U#L6[3V+>M?,]XVOG]/+^_N3
MSE1@OOLWG23SK?U))VNBC?TI)LUJ7]\;R".[^M>/,=F>OC*@S3"A"T:L,;W>@X>V]'VR[0",J%/>VB@X#CJ?>T2B
M:M5OY3MH>T[T?3.+8.;V]9E>F7,^7QDWK:T\
M^LIWU]#1
MEFEW *\#[&@W[\K;7$*6+]IX>A&9OHML?6M?4L5V"^ZR;[CI-.9>!V?$E
MI]&]E\/5R(=I^^!NULMTB+@:QK/-)*Z_LWT2@BZ7RW73:/^;4-^+2"),XK*&"0P
MABHTET2M-UD""(6IS#/(H;GV2 #[YO92Z"HW#SYJME!>1CLWH][/OB/CJ\Z?
MWR+E;-1Z&SUQ=]<\YY7V^+<;G7,)E-?FZ;$AOA+C+XD93'3@-\;_'^;8/"GZ
MA>=ZHC3I%YYSJPSJ@#,RDE,=8M3)LJP#0C;,NPXYC.-6T_EMK:]=4^"]#A^G
M$A<\08"3/ ,0L4SKKJN(D @D!"RXP%9M4<&]]VRVD^TB[0;S?
M+W842;28*L/=JR 3$'HS*S3V]EM>UC#ZW0$S'W[:#3%K6([VQ^SOX+,MMW]E_6R8H\+DL=)618"I&E&=$]5"K!(4H 0E3E"99)QO/@I
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M/@; -3 OO3"D#@)(_J"=7.;H&HC=A(S,P#*1*[IPI^E%B*G,V>V7 T^'X'?$W9ZQC?&$Q%,X/@DD"^B=OS4DEE*
M'Y\$RU4'^?3-KBY'.;GEW#+Y[8/6B*MZ5=6[^TW3JMKS^"'J@3R9>9+%1!YAGFD[LCW2&XO
MF.,D^.=Y\KO\^2Y(6&18IB++&2AX(0!,!0,$E3G@A#!8YAE)BMA!T]/6#B,2
MF5Z8\\.*U7I=$+WBHOO;;SI=E>\BX WYU?44BG[N:U;(SF.[-X+US)GQ?9")
MF(;-3Y8!'=<+W42'67J[FR7_]4*N0'IE9FLC)N5=5XB>LZKS?1QW.-:K.T4F
M/]X*NMFU^<(2LDRF:AG-)&7.I%-BFSO""2D]2H(>+(&'-;%FL3@1KH
MAZ(WJIXJ=J%'F#&6ACL*UR$4>K]@#\[;%IS>PNAWLMG6[=FOQRV!\TCX#?A/
MC#-M.'_>T:-@?>2C=D]]4V\67^HUW[+-Y_J;J']63-S^JII%"5E9Y%JHBQ,&
M8)$@%4DP##B#C&.U$"K-#J3.#3"WY[VWL4V Z.'_)+[8T^XNG;P=*N?GC_99V\^R6-]R;7=,WWQ>6 EG::$>:%"*- 60,0JHC#E(":.2J$=<2JMD&(,Q9_C8
MMR9WTK[=EWQO]LTUS 9UBG6!A^KGVU0LKJK]/91NTH-H-%G@8S7
MM8+)N).N'2R >+Z6L+G4/O_EW2_6!B>?Y=/SV??K>M#+70T[^.GO1&]2;A8J
MXD!%@1% 2:G;E0D!=$4@R%*(8)PE4N;$-"?F"COF1ED[5W2NV<.S)DNZ.HVU
M'O3_0-J&2X-_^*MSRCS9XYH9'.>W">4[.1%,S49Y.V"FRRM_Q
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M4UW7/OC_A/JOH/MK^[2?ON,D#_6H,[MG=_Q#CK&36ITTO>#.)['Y7?R@HEY
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M1W[4V>G0IHO_TL
M4R9PFE&0<:AKJ=6LT3+/U1\X%F59"AI;-90U&'-NM+DS&;0V1P>C=Z*\%[>R
MG=$WHT'/F 9FO.OAM*8X"X"\LIG)N),2EP40SSG*YE*??38&6B>O'P\?Z5FQ
M59UH_[7YT#1;;=F7MF.2(BY:P#*'(&9"+?U*+D ID-8(+CFG:8%+9%1W$,2Z
MN5'<4&1FZ-Z3%A&ZJ?TI,1KMY$WWJR;J_-2"$IVG/KIWN'X%#(].7VIB _/L
M"\RII\8@5V(_0;3>B.:CVNRTJ+V
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MLXRM,IQ-!YX;M?56MBN/AW6SJ<6FJKO@N.YO-TXXO 3U.
M2I[A"\Q#SY [ !< -_-T;8_X392N?06.5OG:ALB,Y&M?NL-D^=J&K@SSM4TO
MN;)AY<=]UUHN>8FY4>FB=Z-XY
M^ 20AAM[5\$3>L_.#AGW!I)'SH=I%_GQ9?K@GG?S;"O(XT^Z/> '.>3/\IM8
M5>M:"_8N).O'?AP#KX_^F:$F??S'W7U. 1<^[5#O6I-5
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MVP0*WEEM6=1_ 7(S1O((9& NVEEZD(B]B5[O(7Q[ 4+[HG\S8/R6_U\8[/%>U^FIT NRJ;_"H'K,%0PS",LT YS$$,.
M^IBJZ=+L=\;>Z)C*:]ZH&3*^LT4OC#IUCJ@9""7[-_=%5*;[=U
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MO14.^^ [77YA=]CO9X'\>8=:V^=IN*O=$;I/5C
MK_&3$)*E<29 B057<6I) *:\ #BEDDF$4FQ72'1RE+F1V\[(Z#OY%=UN-_?K
M6J<]NRDIG<;5,"Z]%JW0L:@C4/9AZ!@0?D//DR--&VZ..7L48HY^V'5UM*N2
MTZ4^@V;BB.0E8I2 +$N+;M>*E)*"C)$,9Y) F.=VJZ#3 \V-$ YV=N6Z5_1L
M/XNMZ=KE>L2"KU%=1!T7#>,
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MVMS%C00_K5<_UBNQ(?7PS*7+&O\L7Y-:DA'>$>RX$#PT:?N[(&_7S2UHOA;^UXT':6
MS(@P(/*!F7 (^9-#X=L]Y)WYP]_ZHT%'X+SRH*T-DQ*A(T#/F=#U-H[%$E(*
M=9^?HJL4^TY^?24;\55HGZMEU:U%[_7"]<-JE^BH/M21LD[=Z<36%6?_I9,?
M%U!@FDA1Z!)=JE-H$, )S4',LY0GHF2"6VF2>+9O;BO*O7M]@61[QJH]C)ZZ
MJ.+AUDFMM;A/JF[/8[OUS][3:.^J%F)45MJ6F/G^0IBQ\@M._X_0Z=B]2NQ :O19?(M%
MFJD5-@&)I A F") ,48@)X3'*"^IC*TTW*\Q9FZOCR=;\YTW;8^'0\Z1Q/N7828GFOVNIUQ#;5E;6_02^T\.T,WLH'L?D][U9W7
MVZ9:B4:-ICA*-)MWO_2VLWA#ZOI1KFO=&FF1T#B3,6: R4Q7$.42X!B7H, D
M9CE$D@HC-0?#\>9&K#N3HYW-46]T-+3:7"?&!/)Q:@P 9&#V>PD,S:5V/&,Y
MD=+.E9A:R>Q8(#2BLF-RE\E$=BQ<&FKLV%QF1\=-O5E\%0]]MO_M72W: \(V
MSU?4#SKC_Y/Z.O39HQ G69$5,>!Q+ #$#(,R%PA((;(8YS#'1)B0LM6H+2;L1)R$;)Q!V
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M- &ER F(.4X30B&'I97^S^EAYL9"K6C6P+->J<725A%.OW!:
MKYI;_C_;9J.72Y_E\[/?_8)J0KUMW?#K&,=:=:O]\'
MTY76R\UR\#792TVP2Y_<(+/@NY^N7R.G[KL;!.(3_7G#C./VFGE/JKH5;/M=
MA=_;3G;@P^IAJR+O_1OMD.PA!6*493U",$;<*CJU&
MG]L+8I@,TDF%5F09?5BIUW][O'&QGP:0$ZP3.
M<_9TNXD;-2JJ[00M;W]5S2(364JS(@*U-48ZN5=/[9]?;7,M[I2.:I&
MNMNEARQBA.,DH1@(H2)FR&@&RCC&@*<\9UDJ)9(J=EYOR-(F=@YBJQ65["T.
M'F6]TAU*?HMHZU94=?^XT8ZYA,%A9MDF(G[QN9LF.'[UL9VV5IOV9$2\F]%#
M,"WZQ@8']_:Y;;X#XJ"3$" V#F/O"X3)08$_'3&''?+*X+E;@GX4/\4R[<7>
M"I9R)@H"RJR@ &90 AJKEP?/$"Y9SC.!K+9;1\::V^KQ$*;=[&.QUMXH=535
M&P/:,N2]#K[) EP'Y-S#U?.8A E.3XSW,J'H>0->:C4
M6JSZE^!?ZK4BMDVK%+2Y7?%W_]Q6#SK.[;_O*"M)QG.=KR<$@"2GH*12 @XI
M9#'#4G"K0-1R_+F136M^-+ _VCG0ZLETNT-['QSYQW:.S#@I(/*!>J!B(B1(;I6G/#;8W$CN8<--91S'P49C/J\@5>8)YR
MQLV:D$P \T,FJ=
M:.5.?.H.&,Z4&3>%Q#\P7X6 _@I- 3O\ ND(&!KQ0MH!=A"=UPNPO(\;-9Y=
MO;U^U&TFVM,ZQ7HX1C$&)2\)@$E. %'$"*1,LT0F95R8E:1:C#DW MR9?',J
MF+GI.Z,X'(N:P&]&<9Y!#K._"Q^MGFR0VK(+R?J%K@XI6M3,:=E* L
M@'C.23:77M=G?4QEC@J8EZDB'YJ42:_02H0$AV>Z-]6&VZ<\6O5?./;]N'AV6E6VJB-(G3HM#%5[GZ(]?Y7T@""1-<<%E
MCK#-NNCL2'-;#3TQ--*6WD0[6^W(YCRX9A3C!;+ Q.*$EC697$3"*X6<'VU2
MXKCH]'.ZN'R!,TFT%5Y_KU3$MFTVZQ^BWN?CZT2#K2*IU69!8EIFM,@!RZ2B
MC)PFNI1<_8VC$F60*D:QZCYN..[<".26_]3,W'>X9KWAEGE?II@;,XEO),/S
M2FMQ]%>E-X5ZFY\H8QSL]DHT-D#YIAVCL:5V!,5%M;C=\DK-
MZ<>^Y<8"904LXQP"5A"DF_\6H$R2#+ $*EIBPG0_Y\2]9T
-=2]\WK'&3%WV67X5NF:4;;:Z-K'/P\C+C!'&$I#$,-/[#0+@5/TM
M+PGE29+@6%KU73D[TMSHH3U>6&W
M(%]O+NMXQII=#F"WG4I\%_K-1E7YZ+B39O^@@XH[)$
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MUO=L3--D=B[S8;;Z]XUQX/=R9VZ?:/5<2P@M(/);2V@R\+1%
MA190'%47VEQKWY#D=_(_ZWIWW-"T>89ERE*>)@7@'*NW@TY_IT+]P;,D923C
MJ,B-MA=.WWYN[X&=<59IFV>0&^>.Z_$(?9!H"(55>Y#S'E_=!^3$K2=K^''>
MK6%GCY%/V=N$!"U9(!2P!QFXQ$
M4D!9H0)]"B5*\C2A:6(:XQN-.+<'>F>T7CW4VFS=%T*M*J*E:,/[KL6N7;&O
M.?R78WOOH 9FA9?%TSR,]X[K1.&[$;Y^ G8KB$8"=;/[3!:@6[DU#,SM+G0L
MK!&K1F>AKGA;,/UEW6QJL:DZ?<)>X?6D7B=AD,1%B4&<(JH;P"% D0K7.%/]?>SXT[%1U_EN^:3?5#USLN5  J
M(80ONYK6.5=7I)L+?O1C'=LF*/T9_]
M?YV+JY_!:D99[F %)B(O.%F3TFDXO%+-LR$F)9#3[CVGA3.?SP
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M[5^DYI\?6KWGOZD/;IH/JZYW0-N'<\%8EB,ML)P@+ "$E &L_@YBBBS
M/$%6Y.K?QMD1K[8?4.U -'0R&G@9T<=H^+G>TZAU57?J[ONB=>[J!5/G<-_?
MUI*[ WPO#'G]96<[-.>_X$3;OQ+"387?UT4 .Z=]E80#^N@U$W H^Q+9M_V9
MW^UJM27+KJ1G@?,L31E) 2L+!&"98$ QQT#]5#"*2L&Y48?E
22\J@,%H"GA]B;@_Q
MSLJ;:&>G98[&")KCS[(?C (_S>:@6&6[C?M]=<;;F=M/EO4V[MXP\^W")^VS
MW[36X.;QJUAJ5;WA4F&1"Q8G,42 8*RU=-(28 $Y($G"!=6]=I!QQMO94>;V
M>'>&1KVE3Y;NYBE8YS$=?\*](17X(0\,DGENFA>P)LI';&@*UTL!KH1Z18?G.CBX/&.PD: FFV*W05/(%IKVO!<\!'
MF^>YO\XIS_UWT'DRRO0];(+SLD/7B> _%7\%*NM&,C7Q;GZ7\(12%6T
M F"LECF$I07 "9.LH*5,2&J7#WIV+)OO\D35@:>% F^BU65E.TN83>Y1W*:S )_*S;PF&U/7G.;^>MR:,;3K8M>8 )AG.2@1I2 F-,6LQ$7!K;2 +XPWMP>Y
M;Q@YM#=ZTF+\1BOQNS3E/ ^YQ1K?#Y"3K/B=,73LL7D1F0 ]-<^/^0(]-"\"
M<+IGYN7+G'LX,2%XVPO]0]-L]8KYLU3#_5BOOFUT)AL3*JK4!)$D&
M,$I3D"!1(D84T<1&"P3C$>=&-CN#NSA"S4;4D.Z]R5JCHT9;K<(*81E/7,;>
MC'.\(AJ8=9Z"N;-6@]G9&[4&>VWA9(:-[P9.%T:=NGV3&0@GFC<97NC&/EW-
M[()2DA$B)1 X90#JVE4LN5KK(Z^74;5OHFV#4I^NVD;C3QM6VT;,([Z:UM=[-H&:;^J:),W
MF]OMYGY=5_\2?%$RP7(6QR IJ5 +!%F ,BMS]6.I[D5BM5I([5H?G1UK;H0T
M7!;?="G5370PU[;MT7F,S9C'$W*!^<85-(>&1A?A\-S$Z/QX$SXEH%WQ_A?2,4_B3^\^-
M(G;F10_*/ML:[:?(F9' %7@$?O#W4&C3;J)WO]ARRW4#@S?DH5+AE_ZR1;L/
MZ3(4H=OYJ=_?LDWU4[W4A,= Y0Q,GFNNGXXQ<7'U20>/JZA/?\PA4[MKF_(W
ML;ZKR<-]QMVN!EGJK[8NP5<1^/ $HW?#;@%A.ST")1)3B$$J
M,C5'D#% ,A8#3JC,***HE%9+LY#3,P&#SVUZS-9_ 4$/_$H8"(+TVU%[\S7>
MP[BQ]Z"7L/"W*G0$S^NJT=:&25>5C@ ]7W6ZWL:] %@WZUIPFJ RXPDH"YU/
M!U,$:$P*(+(B10E-F$BL"W_UC>?&7/O25FVJ9QW
MZ.G59;SMS28OWQVZ<*IL]\GO'25?].-[^_!0"U:UV]"M&'/S[?;KM[[>5!2I
M+#.1 U9PH37M"U"FD@*90I:Q@J0%MQ+^O#CBW![0UN!H:''4F1R]4D:K-Y]=
M::\Y\F9K"*]X!G[_13-
M1B?I-YNZ8NIO[>!_K*I-TV\J/C[3AA.\R! I_
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M?[>\@:ON%-U\6#6;NCW5VV5Y?B4;H8,QP;\(]?U<;MOHL[^Z." K4:5\9Q0
M@;,L@PA@A B 6O@/;
M [-W2AA< []4_'W1'>3%;/'RK#=F//S$ F2VL!PKDEG?P5G2L%H)WK>)U5M\
M^O^[8N@W:J2[==T=&BP2+"E.LQA(W>@:R@0!]3,')!-)')-]9:WN]4WW9YU9_U-M+._/XRS7"F;SXDIJP5 .CBI^0/91371#C#?*HJ&
MHT^MJF@'R@F51
M;<(.9OU[= 4[@M%;$[#C.]MW%OFTUH.1Y2&512U]Y;K^H<]'WZQ7O-*_[Q-B
MB8"P* L!4IZH0%M #$H:9X!QSE,)$\QB(V$=VX'G1LX[VX<)8C?1P/YH[X!E
M+CUW-A<6^98
M0S+ RVS%ZX9"8*HU \!>4NC(5[\*0H?;3RL8=.36D3[0\2<<(^WJ;E7)BA&U
MX&-LO5UIA9SHYW=EB&P&?*&8:YW/$.'LN-01G^&*7ZP@LEO,&HV]+0!IQ4<
M1T&EW=6.*4"DJO\766[%Z\??!6FV71[S^UK\OVSXH*_?ORC$?S#:J^ =Q# 6Q0B
MI066)6$DJ&0UM1T$3J24PO\[=ZV[E:1>N]
M8""Y+!AX[3R845(8=$-O4RE@V_AI9[;>XG_U1X?R;X%U&>T1\RV^8SK\U+H[
MEK"*PK(<
MD!)F+"6T*(2TRVV[-.3\,MIZG2ME<'=XIAZX)=LNN],U]V/.B]B;T99// .3
MU<[4 Y0W46_NC>:M7C7LS9(TC4YSVVG.?O]KW?UC]+O8W*]#G52:(NF5Q"X.
M.BEUF4+PG+",KW-L;].%D,VG]4;H0I*/:[)J#DG9AT>F3'%:%CP#%&49@!D6
M@&89 B*1E!%<<&PG6&TZ\-Q"OIW=NNNLLOPF:@UOZYY.UBBXLYCQU)BQ60C
M [-:$*SMF_E8 N>WW8_IX-,V!+*$Y*AED.WUUVH@G<[$>*[Q_\=*W;L]C/O\
MH'^OL^R:UX_O?HF:58WX4E=,?-6Y&UT.:2H3ED#!09YP J"$*PH)_WE!
MJ*"CVF?RO5Z3^J0VU1?U^EQM*K)#3Q';.?5<
M]3QJ6L?,4]2NGL_QE\?4LQ3XU?#O.$'F>8533M1$N8;A)\PJ$]$7PB/9B5I=Z$J0JME>_C79SCPSZNO@FWK6I\,KOBG]:K>_:@[(27 !"XU(MK[FB&P(%R'E9D%1@&&?(*1'J6LOFQDC:L:CU+!JDD#0W
MT=Z5=F]WZ(S;YHV_N35CNA>9L<"T>)BLJ^;'/5?+%Y9A,KJNMNYE\KY\@7HV
M.\S; +Y4.91!*NKA_R7(8F,#^'G18/RA^6D 96 C&UYH6502Q!NZP48GM#
M'SI[W=*)\KCD'*4@%UJ\+<>I;G6< @XS25+="SFVZB%S8HRY4>4PE/RX7MT!
M->B/Z)G,6..J;70,L2G;707)P7U%2[(#1T_J/N=<=J
MK:?_\^Z?V^HG6>K9W"=X+(0@*"\2"AA-I8J=$05J#5:"D@HILA2E'%JI;EX8
M;VZ$T2:8ZYBJ_2Z+$Q)Z^3-@#@
M5/&TR67V'0M:9 7&"$I$ %8'H
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MX\SMO:(%*ZIN8?AJN6Z:WZ(']6#M\FK;\GH0\R%S[NF!VL]R#:"E-&EO_/MJX:7K&! G"29Q(:7.=+,T[:H.2DR(324>0&@4&L/FHH2
M(%;F:A'"!$RY%:G,N?5I;USCV-S4I8'I7)N4FD-A_]@';S7Z@NU$C5J&^F@+
MJLN5O@JF!8]:"57]_'^6^C1R\S@L]=WEKCY^7W>_W$FG0XGSA C 4"X!)"P&
M.(D1H#R/11Z7S+"3VY5VS(T"GKNBHWG1VJO#CT._G.7.'5WPUW_ OL/#-1,X
MSB\33DM@)OKWF1'S4MF)9F:B*MDK9LA/7:P'.$=*8J^Y^V35L!X@&!;"^KB=
MX_*3M+(5NJ:VE9W8Q= +$F>$I$4"$JCK7W/$0,DP5F^M3* 4"RE+JQS<
@Y,YH 9'3=:W,Z-3;_4:YU-TT
CC I 9QT[OEC??I#]GM]G3#?W^KU]N'[7^O^:Y=EF.<"
M"U 690%@4E!08D2 Q*6$0@@BL/$FWJD!YO;(]B*IK9&MX+O]!L])'"_OI5V+
M3N G.!0PYEM:UP(TT5Z5/5!6.U%C*(QL,9V\;+*]HS&CAYM"HY_SI7'Q3=0_
M*]:6=B_B(F5Q^5)7ZWI@]YM:\$I]3JYK71.RX#BA<2(1B&&*%$TA
M"$K=NH 7#+("4IKAS.ZM,!?7YO<":KV*GD 3O>K ^2W2\-Q$IQFA]?0)+T2O
M.F]_:S78GAX8'H"-]),0:6AO(MKBHDO#[/AX+M-I2/US,7=&;YFY?^VL7V5S
MFV.O;\W9.#?I"WHV7I]9"\S./D=MVVI5;<1'93[_L-HHDM"%G[TRX\"+OA3T
MF;@S9'&6)KP$"<,$P(PG@$K,0(($(H401"*C_3$?QLPMX.E\ 4OM3'3P)NK<
MB8;^[,JN;>2D_4^FV=MTJBD*_ 8,/#OV4K8>8/6K7GN-0=,*UGJ [DBCUL<]
M[0\A/JQ^JE? NJY$\_FOM@.">G6H=TJM57*_;1\>EI7Z^X+#/$XE%* H*-8-
M-J7N)D= BIF .2D*&!M5+9H/.3=R'5@=K?_JVX+L#&\K;)J=Z>8[](;HEY)S
MAA@&.<^XBH])IEYZK 2,QR1+(6[X.
M49'ANU]]<_:_K=?\KVJI>)%G#"5%"CC" D!]ND1924"9$LQ8#(NRM%1J,1EV
M?ONJ@Q4]:+%#U#6?P1<"S&/0FTBH=K_8V1SNC?_,7==I@Y#6Z
M-!IXTBC2!HKGT:+5M;X2.?Y;D/J,5/]70=B]:/Y8;BJ]PMC_^Z*$)*9,ZO;)
M4&<@E(EZ,T@.$"Y*AD6)D9V$MA>KYL9IIT\^M&-CK3*BWKUHY]_@=]>F.[A,
MM6M:1. )?)'TB2!SYR'=X@JL Z=EN%CVPND;5X!Y.S"@W#+J!>54#
MV_9,V)D=T^.CV\LP6Q.G/6)>V=%B^$DIT!Z6YSSG<(>P$L#[
MWFR0"L$QIJ!(B99%@@00 5.0HASQ/"O5#U9::[8&S&U-NK,?$ /EV?\KC.:L
M9>.\D) '9CM+Y=E=(6F(7GFN*+Z($NW+=,9SAG7H
M6DE$DC%.*,@3O<-+U!\TBRD@>8K3A) <2N^-*8[-F!L_FO<[V/NR[W'@W'K4
M<0;-Z#/\O 0FT=!3$J0#Q7E$)^\_<<*4V76?. ^72^^)D;O9I]*H1>V#J#>/
M.GK?W*ZXEE!ZT*?-RH#EENMU[BUC[9DSR!
M":-J(JD*L94OBG49 K'ZGZ1(D42I<2&P5\OF1L0[YVZB!^U>>^ N=@YJS?'6
M0QV:D]['Z*%SLOTHZ=S<2YD9A^O^I_QRHLF+361@YO8_AP[ETGXGTSS-Y<4F
M=:)LF D?4*NTDB"XCV2?^!UOLB25(# -?(OO\I?;DH#O\O_-YQ-\W?Y
MR\WJ1"_SD[.[$IM(W(@K>QW5]\8Q
M-MO!](9;X%?D 3!M:'2P-(!>GQ$F7K<:QT><=$?1R/GG&X=F%SG$%UU5A=Z!
MO%M5_])QS2?EQK:NU6M[$,@LTH*D",4TB.+ BXZN@+4@[V1Q]6T<&#Z*/+[IWQA!BLYGWB.]$Z
M_64QM5A3!\!VJM6R#XSMEK"68(TM3DUO-=VRT]*Y)PM*VVL=FUVP>Q64:)E\
MD_.G9WH("$M(2E2 HJWOD;J,JLPSD&*NN9_F:6S7FNT*8^:V2;3S1<>;I@>]
M5ZM;7#6;9FO6J>8H\-LD]/38M_/P@*O?EA_7M6Q /T!VU#O%Q3T>](5+5
M_XLLM^)MU;#ENMFJ[_WA*4T01"01$.2Y+E#"C $B2@H*G# 8TRSES*I :72T
MN9&J-C9JK8U^%T3;VK:(M)0 &L77C 6]H1:8Y@: #2Q51!9$H<<$%+\2/*,C
M3JNQ8^+\D8B.T46.*[LM;?H6JGT_V#+#<BECPTJ]NN8"0K3O&(_QGU:SK
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ML=8Y(N@(N,,$[8N:0&W(1#<^9(>?'FS@OY*+CQUDAER^YH@V//HLD
MS7TO[[R0 C&&6 $X2W)%& D$99IQ@*% B/%24F35N.O$&',CBJ_B)UEN]SFE
M.ZW4QXBNZWK]EUKA._2,>0:K&4E<"59@V\_Q8CS\:9
MOMO':4=/-MXX\U%7<;V'6F^Z=$6H#TNQZ=IS#*7>%^JI9VE1YD"BF %8X!A@
MG"2@3$C&TC07.+,JO#<9=&ZL,+2YVW\:&&NK N1E#^$8R,&4,S=7%[[W!
M+9ZW)G@Z*,^9 ^196,Y@X(EUX\RA.):%L[C6-6Q9:@WRFBS;971&"ERJ6 4(
MJ2,5F6! LJ0 <=>S!^"^Q
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MO(%_RK%&R"L/F8\^*3E9@_*QOX!#$/3S4ZU]MQZJNT<%:ZL1,]4W95*QZ
M('IQ39,$*KS67\*7>VW756;1G=\WZS7^AW0K/;R. M$$YJE, $80L7+G F
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MS"ZC^/Q@TY,N(>$Y2
M'AEPXI3ERZX?)S ;7'-%(>3G71^);MNQSR+Y)#:+/,$9CQ,$1*D;ZB2X!#@5
MJ?HCHRBFB2P3EV7*^*@S7:=T!QJOJM;:\]TO7& VXQ$/J$U9+KFW='_LTQO[
M6RO9X+E\\B(N_BLISP\Y?5'E1?=/UE=>OLJ-5;[79-5(]4S>KO@W4?^L=)_Y
MS[)O.4^6'U9:1*C-TM %WZFI"U(C>)K&D#Y0"AY!=@"U9K:5[CM#(VVIS_CQ
M$AJ>H\>SPTT<.UYR^SARO'B%JY@&W1Q(YXNHJS6OV) 7_[@-<==;Y:D:5[O:G$DX40@!'2_& !3J)YF
M7N9 4(8*J<^XH%'BZODAYO8X]RFKT=(VAQCN>(SS>&5,32.1U:G
MO ]P4/5DF!\,S+JK8Q:,R-EI_G[^C20E]_7
M5\,3^/FV1L;J?3WJO?/[^O1=)WM?CSHU?%^/?]"7,K=8L?L?I/Y'?R"@DU)0
M3BC@5%+U]B88E"Q&H(RY2&-!,<-7RG,_'7!NC_H)O>F]Q8X'-A?1B:P@/>S05]8Q?LT!)>EO,]<=T5/J4J+X;19,COM:<8QQRS/
M $D9T:B<+4-M&9<
MIXJ.E[2IUU]V17J?.?MJ^S4GRCR(9M_EYM[M]L
MF\WZAZAO^4^M#]+L.H\_ONDK4:@LX[2D"* DIS-BO?4699M6J(\S2$@LPZ]*6K,C;7>T,_PFVIE^$^V-OXG>
MV!9866%L7F,5"NN)RJR\8FY5:^4"W$BYE=7M)JNX4B 2A&&8",Q8 6FOPSM2BDO$P4YSMU'S\S
MX-Q8_M!/6Y^1:I/5PZ&-CI*;*&W3-C)7>:=+V)NM>B&ICK_8#IWJ;\ D)A
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M4V/+J=.$W[HS^+S>.WB1QB67\)V\=TS617E8KP7M&
MT&^%;V*S68JVEJ?_U\]T6=UU6WB0D0(7J !Q6L8 0D1 J<4;4RESGC(N,G5O
M^W# SHJ9KO9[)W;LVB[B;O8_'9DJMS\">;!(7G?!4[/6?Q6)DRO]-=W*CS[%+ZN_BU>:V<^\="
MH"25&,6 HPP#F$,&RCR. <*EX%(0IJ"R6==>'G)NJU>/&Q<&>)LQFU\4 [/9
M*(#1G]];^6UM>-1:[G&3UQPFKRQE,.RDS&0.PW,VLKC2C8&^L7O!MSJL?T?J
M5;6Z:U2DT$KTO*V66[7L>?TX2)-NORJ+I"AB%N<9@$61 UBF$)1I+ "%.&&0
MDR1.R.*GJ.G:E)0V7_ ^B;J?;B)Z&,T+*O0!UQLN=6B4]'WO]9]K<7O8G._YA=GR)K\
MKL#8*QNZV#$I/5X!U'.^O.96SB*IZDEO0VO-RSJV;K=0NWSE@A&$L%3!+BL*
M "DL ,ZI! 2Q7/V&0"R%S>IM=+2Y+=QZ$MQ;&^W,=:K
M:+9+K7CV7OGRI:[6=5>EJC[[9=U4VHYF 5%*TCAA@&%6 H@4^5"U9 -9(5HQ
MLA*EA<,FFP_;9KKU-G2MW63?.7=SV-C9N]>EE[8.[LJO]25['^UXSG9)Y3/6=SKO1W#;[TT?:T&X[IYEE@U[7OD
MMJYUHWG]:GG]>/A(+RYR^Q>I>=?8Y;.\Y;PUA"P[7=V^<:/R:"%86@BUT 0H
M@4*%Z4RJ"#V+ 2E8C),"%R2U*AT*:.O<5JZM?8!J1Z*AL]' 6QU<#C_7>QRU
M+M\,^AT=W.XEJ:.#XY;[ 0&_+8;[!O/X#H3>7WCQZ;??; @_,7XW)0+:.^WF
M17C@CS8Y)AC2OE[MT[J_I2Y_TP6(S:Y:06:0(E8 J777(X'L[.Q+,EM++2L21C$=9VM?2 6FV3U(30O2UC=(YJ5C/L":
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M39D J9!9@7C^_Y7W;\=T>&[K[&WE+7>S/.N.F16(20@JX JJ *0%Q2P0F&0
M(YG3''-5"N:RI3X_U-QXO.U0?;M>?0=ZN+OD=B^T1V/OT^C:;9;#8!:9GUNX
M#J1L'(<\5!E->RS"-_$^/=ST#;P'U3[9O'OXCE#5*-ZOU'ISUYZ18>N'YG?7
M=2VW]36KFYJ>"\4+S##F(!<( I@2;1-FFE HYT+;BQ*5I9-GSD>(N1',Z1H(
M!WHDU"C2_#YI54F^]BLB\%6D6 M2>L(N Z%
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M#U+]'7B_E7?U0E0$0@XY4*PH38VX
M F!>(" R61*F2IKGT,U#<'*,?6MPM$296Q
MK 0R5Q) R5*]*9<2B+2459F7!2-6)P>/GCRW#[\3+FFEL^]V_Q2NX8][% B1
M/V=+_9UZVI_4U;N7_=.G3=;#_J02A[WK3U_@F3GVK.CA+E96*LX%AA@@;-)/
MD5Z)"6.Y7I-9E8J,J8QF3DEA9P::VV=Y7!W4.T9Y%EN[%3D$8I&_83^PW#.H
M+B 1-CGJWYCU=4/DHI>G2]7[TT/C^W^FXRHMH 8E[%V8W:O!J-T<
MV'%*<&0C$TP(4)WIQ@FDH-QC-_*D1.0$QG-6KO]\5K3Y.MUO?VZD2MA$D#;ZL[[S+\BS1F5
M,-.[$%.*N9004$$HH)2*"A-,"N[42".:I'.CPB?5UAM5S4]:6;#7%C3J)JV^
MYAAVIW'2JIP8G1.C=-)HW61RURZM)R9^6>SX=Q:O0&3.GL7LCZF]'V=F8E7H
M#RSM2]7QCP/Z0+7_2 .Z1Q#?= %*\_BZ^I,M=&Y3G1MRK]E_)OA:O?8QL$.S+(<71V$UV
M.*[%JQ&Q^^=-:+CL8XJA8)LHJ/@4OBM[_)R"BC:@#$05!V^?+*QHH\1A7-'J
M>H^$WJ/JI?O:ILW!C^O[?;/JF^7W'UM-^LVQ:*WAZ_6JK6YZ;8K"++>/STP[
MIE>**B>5J<*B #1$3%&A ,JQ9!7EF,'*.@DXHJ"SVP:<*G:\5_>J.V)UJ''2
MJ-P48>J53G9:7R6]WM[[@.CORN4E9"YO0.Q=P/^'D^^04#V3EV"J).QH+T.@
M?.T)IF,HQSOF\-/EA4\ XI-<\BG&"USD[6^;=5TO2@11P2L*!#:]E@B%@+$R
M!R5-$>&9-C644\'-X>'F9A9<*%';R!RHGEL+MYUK+AR(D5?64?B%*]'V!)9I
MBK*U0\ZC#-L3]:T+KSV]RX]!85D EIO&Y@)E"$E)J+).Z;$?=FXFW.FB6C][X1.^
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MUKT2H[;:0_/BY"NA1?HU @+^H;\,7^+$.#@OLW)P<0P]\24>'
MA:(7G!TV3_#,YKRE=?U)_8.:@Q+;3YOF4,3;7W+#E[7\O%ERN?MCW?VUSA8P
M+_.BJB2H\M24NI8Y8%P0D)>9-IY51;& ;G%#+SGF%S7L)4[NC_Q7*[1C
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M.GD0+,$9L)D/@)+50Z= K:W>!I)3>;[\J=\O^+K._F5_C+Y["8-<\67
MMVVZA/[EZ_7*A.&D_J6L%TS*DI1%KHTH4NKM)JL (RD%A:)(D2*#/',JQ>\C
MQ-Q8>:=#TBJ1:(&;2A7)4SVNDC_T6[+9TN6JN>3SNFY23QSWFU[S9FG"19Z-
MV':>]428/^RU>&S2RWB0,M$AH QK//H(,JV%.0*J(S-TS+/\>+3;O'8+/U2I
MS#$VYP=* F!9*D"EP  IA%2I:;+*G,I7/WGZW)BO]^KX;3.? F?'4-YP1*8>
M:R22DQD$9XND(DW[Z)Y5[_DV?OLBS+=238T5])L'COHGH%VT]-ZFCG]2[
MY8IJ@J"W_4+]]M=6KFI3M^[#LMXN$((,<4K-'M2T)9(4$%BF0,I"8(FK,L-.
MZ9L!99L;43P[#'BUR^1Y/.RF:_*_.PV;0X:]CCM+*?FV5S,Q>CHR3LC9M^.K
M%YK3R&P78SK?KO3>==,LT '9,P+^8;LN!91OVK9,X8$]ZML480AW=^1G\YCU
MRJ3P[IL3UE_UBE2W9[C>K3?7J]6#'O4_6F]/J>V]+$=Z4XR5 I#@#+!<<2!R
MCO7V.65I;NV@=!Y];LS?*9#G!YJ8>^(RU[-J*!'
MIN;YX6WO"HV*^T3.T<#X.WE+O?$;\)^Z/W,RCZJWNH<^5O^'>%9M:#JI;J78
MEZUYO;Z[UU+0=MDR/\J%JK*\B5@KI02 .86 ZD7%9"64G"AP7J"YE/2[A(O9G1UOZF)VEQ0_4U3>,%<.>6S$']NBKQ_TE
M?87/O^A&?+IOMFK=46)#:/^0YO2P%-?:$*#?Y8V\HTO3#:T7]8'>?I6;NVR1
M"RJ+G'"0$XQ,_F,%B*H8R(H,EZFV;I2P2O=^01WF1G5G-V@'*"3L,3FY^3!0
M:!.A!6.7&M :#CT@28=(LH,D.< D,: XU@)Y@1?/CJ=G_CI-N#V=W9OD7IGD
MY>8R;!V3%]!CVJHG+S=11S527E"441FE711N]?U&9X)C[9B0Z0AM3W$C0]&)_N]HNMX^=,^5&WJ\WYN"".:#P4"\((04J2PX$2U, I>8\
MEBG->5)F18HQY\(J_?#20',CME;6WN>7[*1-6G'M^.LBNL-,%1*SR)SD"YC#5L6>**RO][.+WDBU
M7$GQ2J[T#UL39/XBM]O;QHBKS7^V#9 7B)=5H:H,,%%I@PCIGZBF",!3Q%->
M,(8I=VCOZ#B\U3?P(MT>C?1))W[3YJ)M=M'U_+[:[?N,IW"OFIMA9#M'=A91
M2,@GJW@7&&9G6\@1M*!&D.W8DUH_CH \-WM<;P]%;N_H&!NE*
MW,AZNUER;%G4*AB"!:[\A2#3_!J,J$S_WRHRX3;LW.CL]!;R0/JD
M%S^AVT0KX-0-PG8N+INX<1!^D?WYU. Z]=^( /)T33D"@>W:KL,1L^$>'K8/
MF[*QAZ."S[I]N-[M>996;I:ROOZ\Z=J+?-FN^3^[^CH\Y8(P60)&3.4VE5&
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M]<)A+&\@+X>X_!_M4=A1;1U9#= V9KD'K!$-VP9-L(I3%.*!O8
MOML_?V([[4BQ8WOK^!*WK[+>;!>OS;DQN;FGF^WC1SV!U[^6]4)5/(6,I*97
M.#3'&4N J?X^E2IYF:$\Y])JCWMN@-E]GPR;:K^_NUJLFK?6Z"SI59<$8PA!44$D
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M3S6+4RSI7]=;>MO-D,T\3CEQEF;!5-,1VX(XF1MS=908C))K6C@D!WI')$^2AG@W<3-'B+\OOJZ5:-DK\H E$4.BE*D+#/]N"JKD.#^D7-C,+W -)VV
M3%--RQ/E!_@,V7\=1PK.- '<7NXO8S[_ZC
M^<*;;_O@49-\J,>B]U_=B;^,"5PUV2J?Z>;3IGG-1%/CY[,V?DPYZP6'!:05
MTBR7-*([.HCL)L&.F8)#&YF;@J :(%UL *7("6&G1G[A
ME*\!,"XG=0W=[%&U\+#[QZH?IV_?MR $Y2RO&.!9D0*(, -$P-S4K]V;F4"K7 9*@PX_(#I2@%:*?*D^)_='9Y]C9M*LEUFR*[P):4*
M(<0Q*$JF "R$ )3*"I ,9Q*)E$ONY-$^.!$
MYLB^:G2/3\@*H%88A.U7?'*D:3L5#RE[U*-X\.+1OJ?7]'ZYI;?-]M$<6I";
MGU*\6V_:+/SW=?U M4X+6E88J52"5!!M6A%I2N*9!F6(4UZ6+',D!&<)9D<6
M3]PHG0ZMVZ1.>BV:M.2N#$:OB+>7RG*FG'U6X?&?U(,5 OHQ_BPW^&)YMRRE
M>"E?EQM( YXOQP?YT>,'26M9[U;QO*002FY\[\QL)HL",$HIJ$3.A6#:3"*%
M"_<]??SL^_[#-7
M>19[Y#^D>#"99N^6)G3[8:FYX;W> *^^+_5&J36DOC:]#N6O[2LM[3\7.1,E
M2V$&5%66 "($ 98DTUL>#!GG68Z9TQ%(#QGF1@"]"ETS4*T$:+1(]FIT6Z3D
M6Z-)8E1)&EU<2T=ZS)@=HT2>A\BT$V<*W,M0^H,8MCREAQS3EJWT!^JHG.6(
M1[D[U*]Y!W:W,K$2"X0*#"E"+S!T$RV^IGYX>9
M&_GUDAXT/_9J,S, [&7O>1BX8GN%XB-E[S4/@]A$'G-/Y)SM^<&VAN!+EOO7*5M*(FW[I_>YN!9T&VL_5"0!>9+$>BYFRY78(DJ'EV
M=K!);;!+*C\WM"Y>[T<83XJ<7*_$KL[)M1#+KFT6I#DE' %)=&(KW$5UTE'Q,VWDE]E>SD=J,1"^CM""4LH)&I9326
MSN1B#T]0FK$8=E+"L8?A.?4XW.E'0@-;QQMY1_5?5]^O[]:;[?(_&EOW![$O7"K(FJ-3A&@[CZ,4L"RC0"J>EZ2$&E,9">SX6\U&X.2W
M7O3?#>;[+. #\:,$-OV0"[TC=1%AZGVJ!SPG=J\^3QD;6/VX;OKT2:$)5:TW
M=^:PQ2L]O#"YLO6UZ>2ZW#X^B]AAG.:8$UBAE#E9
ME>/$F1LO'L;Z/J[-8F4.,S6-Y1HMFF[&O7*FAU*[1= [NTZ]@%%8K^EU#CL&OO.!W%%/]6/L_]6W
MPS,NAJZ8+\(9)4H;H1S#M"O8D&HNE@CEVE#->-1"@RD;F"XTQ+ ^H'Y9I3XTQ*( .*/F>%H4O]JR-?KYX7%7Q'EYLF
M-7R?@+E >4Y@ED$@*T(!S L$*":5MLA$BE&5,D&<",!ZY+G1PJYAAJZ ZH16\XJG=Z)-7-W4"Y50E4[<'
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MG7<QDW;;,OFCY^:2LOUVU]RPY>U% O!,IBA
ML@ LK8@F8DD!9;@ L$14YJ4D2)+%2GXWM2)^[4;B
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M=5=X O3<5^'[&'?SO/5Y_&VS?KC_M)*=C40TD\D2,8 8QP#**@,8I@4H)=MDEO>0T(=&]^!UGM%,PY#-0?O#&$#+F]F$^,=*
M/_' \VL.YNZ\OY_U!D#>F)#!F[5)*UU4,*M2)0A@C%8 *B)-&R0$*$..YD_ RSHU7SP5CKGIK9:]G\F 4[;*?NJ^IT74?ADD:=9-&W^1;J['K494(
M[X5E4.UE9SOR.N$W1>XQLW@@A@VJ19!SVJA;/*"/PG(1AQI9^&U_Y'E_7HT1
MPHJJR(!@LM"F<0H!+@4"#.6X3+-*B=0IHW5HL+G1^;Z4F6U37"M([0@T%%"1
MF7"/T9/N=7%+O0U $J?U;%FPC$&6
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M0(ZJU"2Q$FV),0%R"1E+BX(2Y9;N.%JDN='*0#CW(&Q;1ZE/Z3VMEN'922=S&W^:B@(!F%18X$SD1R*/P
M@*,85A_\]%4'#@*0!WJ84L*=)DVAD5W,H5,FN=&O #=7>@9V+:?.,=8;<"8F
M#_\ZH!\A).R&7)PHL:4,+Q,X=@/H;"S9\3$CBK/\6-_J.VI3FV_[^'&]E:?.
M4A24$R5R#)20)8"D@H A!4%6\#(C>8$Q5D-M7X>I$#F"'.""2P Q5("*D@-!$&&PR%#*/'?D@^/.CLH.VPY(_3&U
MDB>-Z"%;0 Q.ANL^.AC$L5DL%+IC>C?88!6K2B-]8_+XZJ9E3Q/+
MNET027$J6 E25B$ RTP *E,,$*0B([12,BUMH[X!Y)D;V;4J]0[%7JFDURK9
MJ=5=TBN6M)I=)0>ZV8= 0TSLY1#SQ-,5F3C_=6?*/IX]\8Q-%/*>9.:<(N,!
M<1X(GH<89;+X>D!(#D/P(1_KOH V#[Z^O]](OFQ>\O;A7ZYOOAQT2-IU.NNR
MA3G.(1*4@ R1'$"!(:"4%:!2C!!(4X:X=_5;BZFJK]G">449?@NB3*':GR6
M<%D6Y;-]FD<3@8:N]5,_;];W]&) .;0G" CI5
M@X( P+HU++"'::AU@<53IFMB8*_2DW8&#K=Y^A#Z[KB?E#:XZ8HOZ>W[5;W=
M-&]6_7E]N^2/"X$QKU1! <&F/1H52/^489 *3C,.C)M^[?WH=:[.;%TB$0&NW8^_](0+OO_UV "[O=MQIYVMV]
M"QA'FWFGFST,3?'3^%?K=UKLUP_U=GVG":%+_J8BERE"'!2F:16410Y(60D
M<<4A@Y5$1%D;F.?'F1M=]:(F9BH3W@OKG%P_!*V%#1D&L-BVXP18.9B)83";
MRCSTP\[-(KR,R) E.'#W=!;@916>6'X6E_NF8M!ML
M;HH8+ 2!F2",@(I@!F"E$,!IQ@'-S28]Q8IAJX,*-H/-C3!WLAJKPTB;-.(F
MWWJ!G3,L!H"VL]Q"P1?]+($W-2(1<
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M79,/ JMC0])^-T8+
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M*:B%837PI%:'"Q3/+1&G>_T(ZJ/2/'J\8_:;'#>KW[*>KM_J
MBRYEO8 (P11IL,?D-R-^LES]GNPT2/8JN#&6PZS8\58((?M5US_G#W<&OJ_+Z1^TQF_?.M-#][P 6!C%VH[Y0HEE]
MK$]+'L<.*>\U2PY5NTIVRC5'[Y\FN_8*7C4MQK=7S24[+=VX,]BTVS'KI%,Y
M451\RCET)N;0@ >E[6#"34KJH2%]3OG!GS^B^9M:;TQ/*0U,WV)NW_=O(3!7
M C$"BKS* &22FE*G*0D6%U9$#ZQ'GM@UW:)+HT<]L$/MANHV":&0>
M?4$P/3K$A0)U%FWB[,#U:Q9G Y1-Q[C!YTS?-LY&K9.]XZQN]#/ANV8Y];OU
MYD;>=_7O/JFG=?&N33ZA^874RC:_62A&4\X+ C@O*P )K !%9094)E-)"=J!M+G.O3?O+:>;.
M;H\TP8S$7LHC38;S[F&/RIO2@^K?F%)+YZV>S?5JO/JZW>K.U>9!B@7*).&4IP-@T:Z@8!0RF)9 0
M$:D@H15VBBIZR# W2C5")@*- 0YN'R)N):+2PF@*/MJ_>( ;N"NLNQ\1-8[V!.NXIZ_\HSTS0D\T2#_IL
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M>+-PV6OW#$-SXA_FF-'WY
M(6]OS1!T];C A<)I*7. &"\ %&4*6"D%H#3%M,@*0C,K3^/IQ\]MJ>E2*0GG5)[9%[2DT=.G)!T2IWC3*235XUPB['+
MUC)[;BWOS-SKNGYH \5UWZSDJ]S<90NF],M1PA00#BMMBFHKE$*L0(X+C M:
M(9*[-;>/)NK<2"2 D^"@K.R!U@?]9(SB5\F7Y=W]K5XA]"_^+K<_UHZ1C8AO
MCX.+Z<7?B?G[C*Q>A\">GZC3$MZ5$T?R?KT[
MOLNPDBD%L$3<)-4CP'"I "H8@15&+.?*)4/M> BG=62"3+2O9HRD.VRWV[0Y
MYYN=P-(R/#T*H=C1Y[UP5\GK4&=!+ZL>-F9\/,RT(>&S:AY%?,]?Z?>%_[':
M2+[^OEK^AV8,^NN57$FU;#H?K^^D_L5GN:*W9KBN:=I"QZJD6BQDUZ1IG^X5J7YY4Z9OBMDC]GW$'Y&]ED67U=
MZR'^L=S^^+&^-2W0WJTWIX-F"P)S7HA< LV4^7'4=&17_2 ]=7#24>
MR'YU>@^\WXZ$/VKMBV*4L];.PKS(86M?R,Z=MO9^WOAZU%TE4Y32K,AE#FB&
M%("D*@%5>IH0*B'G!&><0M]BU/,L*?N\R+)7P=@32-I1V#A\(I.3*S2C:D]'
MK-MZ8I@7JSH]7'UUX$KWLS=ONER-&_E3KA[DM1#+QCO5G_M9R )R(35DM. "
MP#(M &,B TS O"H)DTQ:-8"P&6QNGWTO;[)I!;Y*:"^R.6EXWPAM?TCC(M;#
M=! :P4FW'6M77V_7K4IRZ:VJ.G0^'I=;^M%KB3A!0)-Z)[N0$O3H>3UR\(NI,Z^0[:8FOJ,?43
MVGUU+W;R>A!:7\>>+5 Q_'@7QWX)MYTM(&>\=-:W^^_8O])?3YE__TJ:<5WWXI>F '[W7PX7*?:T[\0I.Y[_'#03KW3'PFQUY[?#BV+
MG?^%!TV^_[=3[)07P/).S_/H\KMYI6[DO:G_L/K^WA20N^OR5/H^E3A/*TQ)
M 80@0AN@N (X0YD&'RF!JXSGJ5/O3YM!Y\;EG0,HP9ER"HDAQ5Q&85J;M:,D@1[)$:6J;VW9ND+D13R=GT@J:&$D3+6I3
M1L(^T^TLI,/4$@JHV"%@'XR"= W?VP9-EPEU2[3 ?[N*U/K7 #XOU
MW1O6KRT
MC5YVO6'<+-EM3X."/IFW,3#0SCM65]2"[EJM!Y]TY^H*R?/=J_/]
MGLT9
MF]%Z*&7[ ?DUDC\#JAT#C82G$0A+!M$T\/-6V+Q$%UC]HA#E\=
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MA9"NDE[JKO+BO=RT]2E\XW2G47>-?8[&:\C9?*;N5"YY!K%1& "/45",I.< T
M@Z"2144*"BDF3BUSGSY^;JR[DR[YULCG>M[U*79VMI4_(I&YTQX,]Z.J)W4.
M>RCUZ1#3'C\]J=[10=/35_E]MDW(]A7E_]34(/G#IBF.V=GXJN($2L1!4582
M0(09('F% 5'F>'MIJM62Q4^Y86O;KWA@-)<7^'#,B#N$]6;[W;0H,_E^U$B>
ML$;TI-[)[KF=&D+=[NL/A&1D*FBD!!UJ7QQ0)-RAH7BSPG$
MYA;/\+[\ZYHW?EUM77S>K%?Z1]YP5?UY?;ODC^T_O\I?VU>WICL[S4E90JE
M0;+<%"VC@)C3JQ 5VE*0A'*5.P7^'068FR&AY4_V"B1/-3 ]B(WTR;?NWT:-
MI-'#]<2 ZSS9D5),]",S57C@W0\A>*(7]GB"JQ#3'ESPA.CH2(/O]ZM7]-8DHG_Y(>5V45*LN'%@9<0[+7S53CVF]+]L4BV[^KR[F'[L)']
M'[IJ.29EZ]WRIUPH1#E&"H&2IPS S-04HE0"E**\$E )*(MQI&LEQ[\&]>ZZ
M-K6Z[/_:E\5N$@Z-/F.9U6[R?/DU^)2\",L&F(T ).J$960JM9/EA0G5";#+
MM.KVN!'-&GU:FY_JMG5M@L*FY=_Z=OW]\9J9; .^74C,4JZR A!48 "+3)I,
M  (D@1!F@F!&D7/7QK@RSXVTH_7K:[RA!P DWWH(7(,>$[Q(EI&4>;T>L<,S
MM7(Z1P&,$
M[,_^>",QT2F?2Z^"TQF>D\H.G-9Y>OUDYW).BGEX N?T!7XV^-NNL=<7N?FY
M-#Z34WSX<;WZ*6N]&VBHKV[ZL![^W61A?%QO_TUN]VZ8A90\0[+"().FKT@F
M354[QH% *,<\8P6#3B>CHTDZ-_KK%4TZ39-S9M95LE.W-:=,Y]=#,\QHJZ_9
M)H]R>^ ?=3.NX[TA=B;U+.9]0D/Z1)NWHXF^.C>UX:J&3@9_4-LXGK236L31
M07]N!\'4M%IQ
M6FEL!IW;HG&4>K87^ZI+RPV2MG=F"FQ=YF&!C>X?#X#IR.2^89 B)OJ=&?@%
MD_Z&H1A. +QPKR\YW9MP@C3\ 7NK'GMO9GQ<]79I*A__
M75)-:%U&RC .UI_M2;V'/E-]P\$GJO_K^>?Y](F3?(XGE>@_O]-_#+'FZAT)
M[U8'QA F*<^ I*:4)>0I8+S,@"I1BC'*),J\G-O'A*U7
MPK$[UUEX]QB+C\'@SV@BOPL5W[V2RL[":<=%XP%
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M3F")-)63E_E]O)_NY:8I*_S!M'N]67[_H:GAC[JU(';YH[M&W_2V3Q[5
M=")7M3$V/BQK;0Z4L,IA*O4NPP3\F,@!SCD&F"A>F*+!L&0N'WT@N>9&%CNU
MDD:OJZ31#*P5T+KUC9 OI.TFW_8Z)D9)1Z]&J"FWHZH7F,C(%!=\#M^N'NYD
MVQ8FH ,F,/!!>3:4;)/R'3$=L?EM?/VQ_K#?F0-L?*_W$QH/U
MJ3U/HC^0^NTON>'+6G[>++EL0ET?'XQ[ZY/Z]+"M]=94:.7:Z^L%8H6B$F$@
MA%0 \D("C"H.M.4((>VGIP_%=VJGNQU3QZ,\IV_MU6G27:N
M3;9SBT#20) T&%PE+0J&OPYPZ.YT#*Q-]5;9+4DS?%=BA^\O':W^U!WH._TF
M=._2@8JQ$Q"C3<8$28CA99]!(F*T";%+1HPWO&?,I<]\[ [#B.OM1[EMENHG
M18"[F"&%.*69*$#*%02P5"F@:5F!2DB:$5XQ5%J=C/(;?FZ+UD&Z
MY/<4/QK\QV:YE9^4,M[DUBO5G#BOZP=SWMFDPBS*"N8THQ10Q;6A7\H*L *F
M0)OY6.19B@JW(VF7AYP;W342:S-:M>&BSC_:G0_7%C77,KLQFP7L=FP6%LS(
M#/8$QYV?N:H
MP*Z@)='&%01EI@2 0A8 YZ6)45>R+&&E"'>RN,X--#>RV^F3
M7GSOSDU#,S%,,?'PC4PXW;C$?_^4&^;@]YQW4J]'WZ_XNL[^6%=Z]^_IO6/SYNU
M&5"\>C3=EM^O=L&X:ZX%:QIZ[(H@TK(J".4"B%1* "56@*9ZL9 HDT246546
M3N>;8@@YM[7D0,=DNTXVO9;)2FZ39:-G\MNMUO1W\V?S2ZX53GY[J)M*YK\G
MZUW0G>Z4_6^.38)BO QV-O!+3W'DY>S9[.X4;+R+[[O9_=#/KM$SZ14UE3%_
M^Z.?Y?W1BKV^4QIR0L'V18@@Z;4.EB% ?=6**.5:(E+P/RS\?EJ(Q>=H_
M2(UAXY==0)BE95Z4@,@T!3!5$E#3Q"GE&58IA5243HY2VX'GME0<&6P'HB=[
MV:_:@,68A+Z!R;"C]1@03[WS\$-W9#K@9:@BI@@.#/Z":8.7(1E.);2XW[VV
MQQI4"0969)+I90Q8&,Q*]=$%0\Z/,%D!D8M*'A84
MN7RQNY_TM2EPN*DUCWQ2#;,TX>+F3,T"DT()2!!@$NFM;RX(H+A" *5%JHJT
MP%)9=?2Y,,[DA0J'/D>;RSUW>.;T?7<$\6D/H>YD626$P*1B
M0&-(VJQ(JG@!*OTR*,P1(\2I#]JE >=&GYV\76NMYPVW/$NS7 (]981A(9C>
M27/]CY)*0*I<&ZBJXKG,D=)KF5NS]9"P3]-Q_46 M]PZ!P0S]I;Y ,48A7(L
MD0B[([XTZ+0[84L(CG; MO>Y6\$G.FIVI3+[;JM+62]R24O%N=X M,>=*%]O^IK
MNR8'\MN;@';S<-ET#@?K1"&5EX+2WJX.#NE$%O9X:)U,;2>8!HQNN^=,9GX[
MJ75HB+O=Z&F2_Z"K[?JN,?'_6"VW]>U^;KH;9<(VLCK:PH.H&QI!89!+K8!V$K9[<);
MQ'XSDOX>PQR\#$E82W!@O&F-P,N*']E_%K?X$8B)$5^OA/G7VS\?EC_IK8DI
M-P6\B:)Y7A(">%ET-9:Q2!'06WPB84D*P9TRU\\/-;=]?'-PPS0E;7XX$-:I
M'+H%Q';D$0:XV,Y07\R,R'$%Y8V"X26GCLMK/6:"4 4+ ',M;57L4P2*L-U:9HCB5CU$_*@$POP[6@E+*21Z24 FH%[
M,T4C'(MA9]27:8B '.[TM%Z,!JMM6U+J9EG_\]7C*[GB/^[HYI_-E\ *2#73
M2)#Q,@60\@J00E% ,*4I$A)6@CO9,!<&G!L)/9$W,0(G.WG]C)E+B%N:- %Q
MC!_E]8;0W;:QQ"6LA7-IT&GM'$L(CJP=V_O\J.9OL>;5[ZL4LK* H*\H$C;.@@#RG$!4*E4GN5YCG.G"M'GAYH;O>PE30Y%]6*6
M 8#M."4,;)'9Q!,Q9R*Y#$90"AD8;E+RN*SV<]JPN,.SP"#_(<7#K6P*&9ZK
M7/^5ZA\7N> I59("#(7>(D&AK12E]TX0:0.E3!'1).)4(]!ZZ+D12B]Y5TQT
MH"5#\JU1P)%D'";%CG3B0!V9A *B[%X&SQFPL)7L[(>?MAB=,RQ']>3&ULY+U9DUM)CB;ZWK\B;\WK1:7O
M2UMWCX66S-:T2B&3E)TS]X7F"SS$6Q0913*T]*\?.,D(Q:Y#\IPXKIFV:J44
M"QW+YW  #@?^Y;]__33[Y3,N5]/%_%__PO_*_O(+SM,B3^=G__J7/S[\!NXO
M__W?_NF?_N7_ ?B?S]Z]_N7%(EU\POGZE^=+#&O,OWR9KC_^\F?&U=]_*7_\Q4=#XP#L9S#\IZ!MXP
M#0RUPJ"24@K_W[-_]E%(Q[.")&,&I46&6'@!DYTVP7+&DMU\Z&PZ__L_US]B
M6.$OQ-Q\M?GGO_[EXWI]_L^__OKERY>_?HW+V5\7R[-?!6/RU\N?_LONQ[_>
M^?DO[5C243Z7)YL<(Y+L^^_34M/OU:?^K7YPO"Q-MP5FG>?,;ZVSG^ZU]6
MTT_GLZNO?5QB^=>_S/""EA:H)&&Q6C >6Y)!8D FTQ ]DX+I/R
MZ(0_FH7[5K[)R76%GRS3+XMEQB59F,NEPS+=4?Y-=.]^XM?SL*0/@O1Q.LN7
MOUU-31\Z7"]ZE.96943V7WXA[@LNEYA?;S7V(),;#M=D?W'SDWV@X<,RS%?3
M*O<=#Q(1B[$,&%E:4%P[B-9G\,S')+UQ*6-OB+B]>B=4B/91<914&T'&6UQ.
M%_GE/+^@HWN"2;H@@@#K0SUZ#8>HK0''5. E2"UBZ0T6-Y;NA G9/B8.EVSM?3];??IC-\<_$IXG(BN3%:IP"<:Y*&UP*<= R*3+Y8[=%*?30F
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M4= -(0UG1'L3;TLP>;M8K;WRIP%3Q$2.@S0Q4UA:\-PCM>D^T36A*U.A&P.:9Z+F8HD1PFXPUW
MPAX-B>LK=@-!PPG1@\4WLMKKU?SL[H83SES@VG'03'*R6DE#
M\/0WQ@1+43CI[?%7J+=7[0:!AI.=1XEQ9 A\6(9:!/7^VZ>XF$V,M(%9 FLH
MNH JTH KVZB(1VZL2GA\3N+&DMV4WW!^\W !-K+Y7WY-'\/\##>)6558*MXK
MB-P94*%D\)E[L%'XHDK)41\?-MRW!,96\@V+$))*@#$P1N@7,O">T'%CX6XU5\VG)P\7
M9A-8>%Y+61_O[^(TEO=7JQKJ\&J@L],1JEUP)!6"MV
MKQ]X"F 51S2F%"9"7Y;C$3JZP:7YM&1OHAX9.">?<)XW966S<#81.NB4L=:<
M)B+!E/];Q FT#$VXLXFZ;?9HNPGFB+A?D@0',5065/SK4()!3GK1(&A?>R
M)S1<6[8;$AI.?QXGR"90\/Y3F,V>7:RFYM\(TF30
MD@Z I=[NAVCJ,T@-R*7V3):2?%^IK7L)Z/:@L/F$Y_'";0(C[S^21W1)?=19
ME1@96",9*"(6(N,,>$1E'$9#Z._+7%Q;MQLBFD]Y'BS*1EX2?J"?G6@*K9FG
M8\[YH(GN7$,FK2 ZG7UTKG!S_#7(]16[*;_AO.;!XAM9[:]269Y,O(>TQ,/K=X-$P[G+GD3;&T#^
MY=<[DGQ-7SBJZ\R&OU?SLEA^VGS@3:([-9^Y\Q']]:!YG+HC6]$0(Y/;"UQA
MAF%F*"E$R,Y84*I0W*B5@&)<4(HGDP7_@5P>^_RCDM!;2&Z*.@(O1 P=341J
MA;92X+BE."/'_Y_M]?OOSP_H!3_N'/ZK'E7#=ZCSSW+U9P%L+Y9/..JKK\
MI^6WZ3S,TS3,WBZV#:>N,&6%*U%@!"-,)DS9FCGT"CQ9!2?K<2$?Z]A4PBIN
M%+];=+._?L79>G7YE8V4@5S2G9SWH>Y0&W)GC0\ASG""SH4BA2"GUA>R@,D2
M[F4 ^IK,UGME'GUTT0.O&SK&\3$&0\6EI>E!Z",>.W>H?SX+J]5IV=1TG'R=
MKB:"Z(\A)1 >R59FX2'4+J."&6M"SD[A8W6Y/:#G-DF- .D /3\$F:.$W@!Z
MKM/_8O$I3.<3Q!3YIMXX^ 0J&D%N%W=T[&9C3!"8^&-Y[,-A61O!RG)(7
MO4J\ &J*L3QP]>&&9D?3O@(\Y
MOD?8G(>)&A=%Q^K[MN7I2?@'X^@S+N.B)R1=<;$1TK,=&S8J'G.M/ SU=;16
M 6JX ,P:1_$_6LL?:YAT.(;N)6><\'H@]!PO\ ;LS[9V=6<<+P@?!RI*C; LL5W(,PD1P\0)FJX^FA:N]*AR:#$T'G9)$Q/0Q(;M+12+ATH%87O8FX&8#LRN>OF/ QNXQ1 5G#
M6NM(/E9$BB"=\LHZD54ICW50.!8GM\@9%R['Z/=>J!PC[ 80\SRL/I[,<_W/
MRW]<3#^'&3&S.ED_#\OEM^G\[#_#[*+V#) )A7*0!*^9AX#@I"C (KKL173:
M#)2"X@Z"@:W/9K>==( T$Y2JAUS5^\P(;%$A_D;7%\V&^!).LUX@N S
M;<-L2KUW3^3B>V$<(D?[V/7U$1;J$:K&=7SZAU5O&F@ 3:_FGXGJQ?(;L3#1
M7!7/78;DJQ%G-0$5# O:K2*[8"\
MP/-ZQ;NZ(9Y)UE*0^:NJK7T,3'(07.&U"CB&'%SMJ#0(<.XE9YR)+,,!YWB9
M-P"%A<69H2ED#4(/JOO71 ,1N$D]1JD\<,T119Q85)<"'.B$QY)2B,F1X\S >\]ZP
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MTPHOA;",#73 /4Q3"Y%:3_:I%[$W :%K@< U0^N8UE@4DG+K.TX>#;C@ J!
MQA,J(=TP1NE>5!;]M;"+5ZO#;=2YP-!%>OIR%.9]-UK8*=;\M?/RYF)/15]?77WZY$@U:;
MR+6&G*6J[=4I7C2I5JMQY*'Z9IW OX83#P,-".44@#T+J\!GX;
MOM4[8!(9?65Y073<87'B#"N;_O\A"&(M60]1U?Y'R&)]8QN%&_9>O@.1S8#O
M*%P\<%??MY)&Q-_FR?9-MOZ8DW+>7BS3Q[#"D[,E;DZ&*\8*.0*!>P&&^=KO
ME9.?F##4AR79FI0]N]WN[O[>&_LL.N[IV#.:AA7YR%BZ+% @69U^P?QA\?QB
MM:;P=+DY!2[.SV?3VO@S('FJ+"1@16\:?PH(+%.P$8R0RL642ND HFZKC9N1
M'  ] PBY@2/P^6*^$V9 3#D;:"X@@ND_.@B*+H
MLG+:#O6XY\?4C9NG'.C0ZUTM322<7F"\JK+3.>K$*+;!3;:L< 6>!4,@X-HI
M-#X^.MSVF"1EW*NL<;"LY$#0.53(#1BC>SRZXA5RY1GHX@)AW$4(=1)&B22A
M*(SECW;_[C/$&S<5.1!:CA1Y"^FHQ?SL RX_5=Q/G!5N\])-&EFO<6J_2F<=
M"%0Y<6:TY\-8E>M4-.,X#Y@#.%3H#5B932:^C@-?XGJZW#C]+[!,YYB?X9S^
MLJZE"]>D>"U='TVPSB<&/-NX<\7!>VO \Z)BS-K@0*\!]J.S&0]^.(@.
MJ+@&8/EHM'*-+6,*CR$&D"+52F:*6KSAM9!'<9DCAFB&P6-' IN)!X8#XA"J
M:@"!FR/@_KW$G&*690]DZ04HQFH+VQLX9%G]N$&[RDBB8'/
MY.,5T@"TKC$Q41J-NA#^!W8L9NK=./GA_J!GB@T!O S;4YUEOZ0\PA&:_ HH_UH88#VD,)
MF L"0\@8;X\)Z;6YVYZ(&;"Z;Q#$'"7N!N!RDO.F;WB8O0W3_&K^/)Q/R?>:
M),--T** #3G4MG<(KD@'3EC'R"1[4P8J*;Z?H''3I@.!IP_A-X"A=[@.-9OV
M,BSGY,JM3E*Z^'0Q"VO,-<^6INN)M"(D2;*Q*4B*,7V 0'(#Z;A/A5NE'QT"
M=#BBX6!<@A:%ZB$5D. [>[M(R;SQP(44>*O(%OHP7KR*=TS&BK!R^NN9>R;L%>[Y.4QTIR'J^=WM#VI#.WWFZT
M\1'7TT0>]PU6CAO =?.#GV :UR.<]#"2\_EBOEK,IKF>;L_"+,P3OO^(^+T"
M+ 3K;/ 6LG>$EZP*1%F;%_*(40KZ8@X_D&67=7H>KI4PDR&ET+5.QZBI?0-!
M,PLQ!6O1UK'SP]RFM#!]_F"HUC["'M'A62W7WRE_3]LP+*>+S<@?2TPK
MC04D:I(%)@Y.Y0+&,;+ + C?K74SK7 -*?2OVRAYD(2Q4Y"'ZW/1IW#'1L>.
M[C_FJW-,TS*E$',[.H&10Q]225!RC3!C+."5,F""+BI%E4+IE'GLAI"'R!@'
M)3VI=M&WG)N(G1Z:(I:9E#K86BG-,BA6)$0= G"&WJ=HR*$;>)+E0?/YGFK"
MQ"$FIE^A-X">>T:TE(P>6:"SV#)!I[(CD63/($E&<:#/.L5ADHL_SWR^O93\
MX_E\^TB\ 
MHAX@[@8@LYTJ^.Q>5I@6;C/?A\O$R/?/$;RF8]R$'+UPN? T3)KF$:*:&\IW
M#(#Z$GX#.+IG7ER)PG N)3!F"W$@(P617($,*%,.)E. .>"%?-.C^8Y!S9&B
M;@LLE_/BZKP4[E2 X'4=1UE?C+IZ< =-7]!*N-N-)OH'2ZNC^7H"RR&B;@ L
M][2KD@JMRD0WXR: TB25$(DAHRQ2C!F9M0/'3Z_W<W8+U&_X'386)N "@W
MC]&W87FZW#"5-P5+;W'Y_B,)=:)J)9MT!0K/M;J;N(HJ)\# (I<&M?3#U(EU
MHZ^1R.I %#SJ(?>BDN: MF%A=7*Q_KA83O\+\T1*P8+A$5*F\).D9,'92+&
MU)F'($24PSS\>9RN1E(\0P#K*!4T!Z@7T\_3C//\CB1&6Z1>"88SG,3(3.91
M09!&5!]/@I/>0]9!)Q9\*&R8[$\7ZAHY!H< 5P_J: YBVPWS:K6ZJ)LE6EUR
MSF"]2;19>.6)O ;-4_3<2%;D,-[4PS2-7:LXN*TZ0/3-@>CU]!\7]0ZYOBC?
M? /G";?%X3I&AUDE\+[.B$ZASAPS&5!SCDQ$]/(I*  .M)+0W
M[=J;@P==1VM5I%UD:C!+.TCX6JG@-'&89:  2 0UT%C<'Q,W=GEBKR#K6QEM
MX>N.!YF-\-IH4!RI3*.VL<6!9MN1 FJ2$&1I7!WGP@[W '@Y/1PF_11SM
M3G#(BM5+9&Q?75S![:JH
ML:22(B\*A*BOS82+$'GM[8":9>4+ET8-LAT?(*CGJM8L*'*PC"+0)&I+,>[!
ML>3J@&AFBE=.A8%N:QNH:NU3]S\H:-U'SF.7+-Y;F,><0E^8 Q921+(_T4%K7OI\X<%K?L(=VQT/%AH:8O,VHD,@;/:B54+B$8RL-P6
M+I1(MMN8R?^S"EKW4FVG@M9]Y#PR6-XN%_DBK2GNP^7G:<*-1+R4]?TV!V]M
M!N4P@PLZ0W)>&VZ*M;[3B=H))_=1T,B=QG&&Y&C1M@&-S6NR+0>K2WP[7SM]
M!^";"?*%\.V$#K5P07+E$0WOSXX\2,9X=N1XS=Z%R9%B;B!ENSVO.2!5?(V,T3%RK%KO3L,^4,8CCY1YCR0R
M$OQG_'.Q_/L?\^EZM6,B:0Q2:@9>U/Y$5E@(Q6I A;212M;9W+I3N/>MX8,+
MC.N4'J&P1=_2&QD"?RS#?'KQ:4=X2&B=2 F\JI&;-42XR 9X. 8K@CX' 9MP"0N\EBHVQ63%O(7#!0,GKP(10H5I;DM(C.#7.GW'C1YR%A
M1T]B;@ H[_ SSB_P-Y+2?2W&7WY-LXL\G9_5D"%W#;[J;LB"0Q%NF':E5PCHI$3KQ^8'"KBF(#
M#:U[E*SFBCF/.\+Z4D #5N8]SNA;9[_7B_LPJQ.N\Z?I?%KO3&L.X9*KP%4)
MPB+$D&H/(%O Z\*@"*:-8ZQ@MPO# ^*S+O0U5\MY#+X&4$D#0#OYM%BNI_^U
M447JF9]-ZU!U\O+6JXD.PJA <:THG@YGYR2XP 6=U0JM=RS(@1( C]/5
M7/WF,<#J405-N-EDB-?+B[2^6-)V>?XQ+,]P>>\>)>W_0^"UHYKCN!3";]KRGYU@-Z?QL6RBT,Z=O
M<#W11::H21K(#=8VT06"\)*B!.&=U3*%@7RGQ^EJKF;S&!#UJ((CX'16"]<_
M]#<"[B8_M=OSA%M;5T3@SBE0B>).7U" T5B22%+:@08.WD/,N--P^D;0D<)N
M((3[/4SGJTHXKD[G+[]69BZFJX]51J=E.]=8\1*9K7= M?LF5QI<)K,JO;9:
M:.NS&Z90]8>DC=P?N>\\0*^::,9UUW.K";2:B?[Q1SKX$2RO-+6,;"BRIAQ\@U=CH#.6;29_O##Q'\],](-
MO3]+,GU,+3<04E($@Z3!R]3+9KN69'GT&4'$4J?JA0P^)0DI>*N==%F[-%"%
M_QUBNH'M9\FL'ROM)@#SF1BH(MGZ#IR7#^$K
MDCU>+P.I;3H/RV\;@=:IQ/4"=+%)]EU))*5LG"G@)C@I
MC2,O8Y@F#C?(Z :4GR7??[B$&[ M]W=@6MUZW?GJT_GF;:[S7/B3!304K!D#7/.#U.2VIW&;KC[J2X0^M=-$Q>:-PSVR>
A
MW1#XLUQ #*FE!@[>RSFZERV=-DS46J?I[(+"Z(GA07)9[WD5)W:BM+5,@$'R
M/G'& H8\3*[D!X1U*V/]62XF^M1" R?JO>Q,4A1<%:5)(@)!^:0@^/I/781$
MAQC3,&UR[R6G&X!^EKN!XR7>(&PNT1]B?155+%A-3J52M9^A\HK4K(/A,@[V
M$.@!@KI!YV?)]/UGN1T85$^-X_ :
M>[=/^*P%,\'0]M)U>*)+=:)9J:]78D)GC<4X3.O P^@=]Y7:L!C: [ ]*;1Q
MV*YNLSGA+# >? 04GN0I9=C>! <4P93D2]##M*;?B\QQG[HU ]+CU-2LF2A\F,K>/0D=]XU="_CL184_95/7
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MDE4YVU 4BP./D=I[B.M3#AK?2\3\_FTS)-8;ZN);/D\WU8
MAOF*W+U-H>VW/^;3?US@"UREY?1\HZIJFZTU,91+GDAM/P5 WX1/N-O+G+:8RD*!$ZH&)\&#BU:!=$Q$
M$PK*@=H2[$/EN"?F4R%G;\ >J,:1>^B^72[.<;G^]G9&3)W,\\M_7$S/=V]P
M9A<9\ZOY24J+B_EZ]39\J_N^EL^EM+P@,JB6H?KH;A9M*#$D='[8K=DF<[#/$WG9VFQ
M6J^F.Z[IBSNNS[=8P?H
M]D?1N&?]D^!V)/6-#=KIZGRQ>6[]KEYN?%C\01^*8;7KL+1C2'"FBBH>I++D
MUA<1P4L60%/DEK!D;V\G5^['8Y?%QKU0>AJH]2[TD5'T#FE7;)/(+
MYO=__E'?T,[IE[[M&*)@+1OM,@1F:U^*^H@6T8/A1DOI7>"WYRO?BZ).BXW;
MOO%)4-2_T$='4:K!_T9FVX9OU7=8?ZO='I $M[W]VQK;;Q\6VV]>^@GUJM61
MU%#79ZC2!' &.6B'(2>6C'.V$[8.)F'MG< \[3<>,K=">\MNMVF_
M%XC'T#!N!\@G0>*3J:B!I,T]M:M:1A^=,K6BV8)BSD/(7M..$DESS(H/]/2X
M\:D2O5R.'B;F!H#R!M>UQ( "\/JX,#_[1FXE;8>K[G,GM/L^;^*4^UI 7!4E
M.)FCM.1MVK"9-8L)O.<1LG!.HDQ)FL$:9_5 ?R.WKP>BZ.[#O:=6:1M OM8%
MP#AO10@"9.:A$N\@6L$ )(:/!.U18 VX+6JC[4MDPPUVCB,H1R"
MFW$S? W@>W2(-+!-7B"MG*8;J=+?9[C1_SQ?;\,^24QK],Y"9@[I4 NFCHN@
MP$ZDJ)TJV:5AKJJ[4#>NF1X?0XN!%=H 2&L#W"K)T_GE.*X/N/PTG6^9X:)X
M;Z($G4N=O&5JR0C% =E%)9-$86]/WNRQ#?	(UK79N#97\J/+;%8D]F\WHG
MVWKQ2?*Z",MIF%UR.@F^<":BI8"4D;ABBK5-?(#,E2A2V!+2,,7P'8@;-X9O
M#IU]J_-8C+[ILW!)-(/CF7%#MJ1QM(8;VT
MD;<*:.]-D3^XP+@W,TUAFG3LQ^=X][4-(/4)U!RDQ"^K(,CV>/T\^8&0Y9@
M?;$!G$IU+C:Y%)[)#"6E@EAXC /5@7>A;MS@>DAT_!"(1ZJJB3#E+E>7Q2(D
MMTEQQ<=L/=@<"BCK$()V]:U%5)D5Y:T:ID'5HV2-&SB/"KE#E=/4U($'MM&N
M\O?#,F2C;]SHN FK=["Z1HY!
M;G,TG5]6^=8Q0_.+ZNPLRN77ZF2AU82I)$S,"9B@_:850,_#.
M@/2<%2VSYW:8S@V=R!MWC/:H(#Q662W'+S=G03\/Y]-UF-4IT-&*D%FTX*16
MH+3U-9'#Z5XH-4%G C)E 4TA
M$8J8P6ER0$1@T7CE$]/#Y,"[TSAN:-U T=E ZFQ@)L<#G&WG:MY_=8#!J1B+
M :TE<1AM[9Q9>W-B0EZDL4.=Z/O3VDCOD]=#%IGWI:H&/,JWVX>2JP^+D_2/
MB^D2'VQ2,$'K&,,2(#"1*V?DJ11>P$A,,49;R'D9!(3=:6RR%+TWM-SN(C:,
MZEH^S.\1Y43YS"S3#C Y:XXZ,'=EZI:
M.+B7BX28-W.KZ_->X@M/R[77OY/HDHC%&XB,@C>%F=SBD@MPSBB$#$:Q,DPZ
M\H>D-7E,]X:-.\T^^U14"\C;^1V_+9;O\/QBF3Z&%7%T\T$YN1_;+R"QNV63
M]FZ,.2BP.G#:U.1_Q"PY9):5"E[(8(>I\SZ0X"9/[<%0^@1*;2=]>=4@9G5:
M7F!<3Z)4"FN[ U[J*#UI$\2Z#[/Q4DHM0PAJ$&S>IJ3)O,]0H#M*#>V@Z;J%
MW^R*TTTSR]7+K[A,TU6=%B6$S]8C6)]JPRKBRXEHP(L22Z"=(MPP(VM^2-JX
ME14C'L7'*ZJAHWA7QOYA\2%\_7.Z_EA'%I/XR)A?C@N]5>.>>' R*@3N&+D<
MD2*O*+.%E$RV3F3$,LSCED,I'K>F8J3#>%"U-F0_+YNU?9?G?.MP7/K+VV*G
M6(OH!"<_6=:;KT2AH:-@$+RUBEGM11KHD.Y(X+CE%>-@M%>EM0/)[L*<%,&]
MSS*"2$G1D:$Y>,7HW*"#Q.G"LE####WH3N.X)1=/#,R!5-= _K&R5?^_YO4_
MA]GVA"")35-]PD;?H!UX\PO7?O(M+J>+?+< H#;Q):E<=H9[1_OH92E8D\"<
M928HM LVT6$2ZG@<02(*66=E,@]ZH.+SI^5S7 ^XY[QGPQ#YV3?0)!GI@[2A
M#LA,=)(Q1RKA#$P6): LW PTM.\HLL=UG%N"]UX*/!BMYYM-1'PO^VE-!1V+VY;R?N_OW
M%^?GLXT P^QRL.>K>5DL/VU5>.GD<:>-\=Z"U;*^LP]U>GJ(8)GET1EFTD#W
M4QT)'-=K[AF%0RBE@038JSE]%FV>MV%:F\%,5.#2U$V2+19R2!C6R0 ";%&6
M*U:TL\,D6F\1,G*KU2&4?:>4^'#)-P"<'_?B_L\PN]A\9VF@R9O7J1BY@N@)$':PS']:B[?M
MZE'9%2QF4]DE3R/5N]D,S@4/POF<=-'9AF&:31])^,CYG6;MWF&:[0W(__+K
M'7V0I_OWS;/S$_W*\H)^$9=GW_Z:%I^V:SP_??/^
M]/6K%RG_[V_L/I\__X]]/7+UZ^>__BY6^OGK_Z<).?
MU?03:>DF>N_T+MCGTW_]SL=M#G>+W$%9WSSAUS7.,^:_]#1C8S?.N-Y!DBJW
M[=.^P[=Z>38;X,4'.CV# Y>S!IVE+\+EQ =Z&]")O-[FC&QG:403N-G58
M3A>;N;9)2\V5C_6%F@/%*8;WC%@1GF'@I7A5.MVGT K7($/_N@V7!TEH!#$'
MZ'/1IW#'1L>.[C_FJW-,=&9CWLU\8B)I96(&'VH,DDL!7WP&1@AYN:_H7? ))N\;#;#G0J(ZL783)P8D)(!R%Y17$M
M;3Q.7 @<)A%_+SF-'%+'JWO1M^P; -"]4P.UT,0XMX"Z<'+R' G$A0#)9>6S
M]S[A,(,E#A[Q.!A\>E#RG9KE(R7> &JN/7;:,2!-0F$+@@NV -&L(::$D*P1
MQ<;$G!_FT+I#RK@'5?]X.4[6#8#E).=I%7^8U:NE5_-=3YH=,T$QH[V+P*PA
MY#,AP+D8@+@JS*5LA1C&UCQ*UKB9[_Y!U)\.&@#4.UR'.K7D95C.I_.SRR'R
MZ+T20:0:45!883! U,*!$\EH%9RQ::@G7_?1,VZ:NG\(]2#U!K!SDM+%IXO-
M*XQ-EKU*:(D?:S/!S[AMX[9C+$N;!5H-F?'ZB-?5%AN96/0L(9:L;1BF\J S
MB>-6 @Y@I ;130.@NXI!GM>9\KO\ZB;^B%8;Q9VKMXT4R'+TX$5$*($I9;-#
MKXLW.<
MVX$J^>_0TDAT?YR2;[OXK"22T*.7^Q4!RI% 0A"T3.
M2O*&HLB!8OF[M(SKQ@P'ED-$W0!8[BE^5X&[F!RK/>@,G=(R@;.&@>0\3+^X6$[G9]M'T9L"VC?X9?,=BA8EYSXX"V:3
M1F*Z5LQJ"R5I:0K*J WF>K\MEM?N[D[F
M^=J__@S+99BO)T8%SPW96F<+ X6: =G8 B)+X9TLZ/4MC_G^^="'D]"([W,<
MMIY2#:W8M.]='?/FP?%ZNKQG1TVRJ15UKI[FNIKK+"!XP>H $,M8\5C"4!GF
MSD0VU]+@:/LV@')&MG+O,-7X<_,BI6IF%]W>:5E66_%=3KGY]F&QP"(EMCCP8!+*D'6(7BIM<+;7MF]=NXH(IIK0G"HI7LZ5?PDF+N'R5!LR9[X
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M(4HT4$HLSDH=HBL_D.S^JQYMMV+4L$AU\AH.)
MO-;&%UV'1RC(/"O./2I_N_M  W:-/,'IZK3<6N#;]L_OF\4GS93W%)W(>N +
MXLV3$P#6U?G01DMCAWGBW(V^G\:N[8.1VW9M %4UX,G_4<>DO5RMIY_(:5U-
M,D4;VFH/ FT 5;U5[[D$'4+]"D/!AIG4?9..<0I*GAA01XB^ >#L6C_?[L%_
M:S?P5-]4H@:6:V\V5)D*048!PR?%"07.(P[S,?XBB<2I.GAACO:BC"5C5
M_/*'\/4V'T5'K@S%*-XI10%10@A>TVY10NM0BM#!#@2K^RD:IXCDR6'5@SH:
M@-7;Y>(4SI+ .-A0&_2P37?\:H4#2\6*J'WF
M@\"L*X7C5)4\,>P&45<#,/Q]L-<=(.)=R2D
MQA K9P)[OLZ[V79A]FI.
M(KOX]-T_G5#,H[EEY#5DEVOS'T.+4E3PS!_A75
M /J>+^:;I.>VE?AT]??G1,-T7?\VT=9CD,0 8\F"REY"].2]>@K)$_="/4=3QUI-J34AK UWL\J[OC'9[7DI2':M3PF&*Z3J1-U)1QA.#KG]--0"_=TCQ^ 6^P[0@^565W6:(689"Y@#,
M,U,CJ  Q&@E2LQQ2TKS$81*]/R1MI.J-)X9=OQIJ G(K) )JJO$%\39;;"*F
MEU]KC1->.@DJ*P\N1$OA&)-92)=X&>8"9%]*NX'T9[\9&51_
M_P>4V[VH[7MGPU7;77[^4Q?;W"IKA=42"/M@XA8(C@G'40N!..68\Z#],>LH4Q: /K_ >S
MT/81?0-^W>O%_(P^[=,+C.L/]#N;CJM9LFQ$,B"151X+Y69,\Z[S)40"C$W\#2]UWNU&7VJ$7K'G$E'BKD!H/PVG4_7^+J.R[Y51?+'"LO%[/6T
MX,3Z(FV* F2QJ5YQ97"JCH?7@H4@&7$YC$/3A;I&')P#$7"[HJ)O=30-L=4[
MK*::0HJ3;7^&C=JV3^+YI)@H;$0)TM4>K"E%\(DI8-XJI'UJ8AGFV?B!!#=B
MU88&8G]*:P";U6?X7K%$G"*I;?V.1+F19R:V:E(FG.$$DR@R%0M1U6&]FGGP
M.6TF:D3'AN7ZVX=EF*]"
MJBR]P%5:3L^W[>FN?7TBB[ \UJ8Q-C**7EB!&LZ0T)!+B\HP.U1)SUZ$-M?_
M]!BT#:FDIN]A=@5,H788GF\RQ*LOT_7'YQ>K]>(3K7_ U\&B+ ">SCY9I;M(PF<*.!/94
MG?C0,M?>UT2;BC$!.&-8QQW29HF2@[0+)-T]HZR
MPP/9RF"D=1Q#]
M7BRV]Q)/=[@_SMT3'_-*,ZVP6 )MJO,;I2+#)RQ(%;ES*K,TT.#O)SKF;]TV
M8@E1\:R 2;+N2L8$+@KZOE^COE
M[VE_A^5TL:F *4$9F1@96TNAD_(Q0B3Q@$!4A;X9->_D\M$*UT!#_[H-F =)
M:.2B]0!]+OH4[MCHV-']QWQUCFE:IIAW!2\NHG+&U^DBL@[6I7/:U4RB5\B0
M98-<=WJ
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M\_5T_>VT/*^_A+
MX/9_!_1CXL:UE.,AY_9CHI[5V  R?U]\QN7\VH$1%(\Y6PG)&%5K>$D^*#PX
MPWET11>TP\#P-B4COROJ6]5W&G@>(?<&ZPA4\O@$&457G("BE:L"\3L2#(X,D2O2I1Z.+Z*_NYL?0XGD)OZC]8B@TXH?<\1)0R
MD;'S"(5'0VZT1'!&2 K\6+*\:!FQJ>XMO0]Z&O+2_3 Q-P"4-XOYI\43_R_,$^+-DLLK( C/0%E.;GD]"&ZDV&A*)_2BIB3[6+W8+[[83\9LNEE70$^.%L=85
M*-9*BB=H3_F0#"06K;9&:F.'>3WW($F-W/#W@ZQ^!#\JAFI9S2TV3G+>S&)9
MO=KU.IHD;XLSFGC 3*Y'I!T15!-G#,
MW>+GSK'-)]$FH9.)@ (3!2^U:21F 8C69%%T[6KZ%(;F+FF-)/4&,3A'*F+D
MNLCW2#+4U)F"
M'LDAE22X1PIL;[^/O[_1>L?U&HGZCC=#@PBX&=!\(9XN*D^5G_5B4>]&5O/O
M1S JYW7PM6VDJ>-(&.T$[1P((RB($$8ZK_9"S0\6'&<4[Z"PZ5/$(^/F>PE2
M6JS6JSK>9C/KD/Q]$95121H*,B/Y:E($")G7!]_<>>YEC"9V ,K#*XPS(7<
M9/0DQ)&A4"<:A?FW.RRH*(R7MI9(^D!.6:T]B9E,H;#2$2_T9Q0(AT)"9,Q7%FI,P_ZH;PV.>/
M-$QV<$MPH 2;0<'J'.=Y.C\+%^N/B^6NS^^$*PPQ*0NAEJ82*XZPS!(%:6A"
M\DGQW,7M_,$R(TUZ'103Q\NS@:#W=+A>?I[4L\+?%\C8K2KB2M!; ;9;U
ME9NH8E&0:1_4PJO,]4#%F0\3-=)LU8' TY?T1SZ(KM@HB^6,V*  ZY*-:\$6
MS^A"BN1?I3J7!5F!*)*"PD*A[Y'';7B'XZC38B,-.1W@4.I?M@U8G=?3]<[?
M>H_K]6PCJNU]ULF70,K)M=_0MEBTON"9)!6E#H&#(=<,E)*UM[.+P"E88TH(
M#'*@HVL_0D<:6SK4T3:@EAH X>5#Q>]/$M_@^OEE9BA*H74H8+FF8YPIB@.E
ME)"8-L9%&R@:& 1QCU'5#5ZM9W9[EW\#6"(KG1#S:M,G[;)YWT1E(0NM!D46
MLLHY2/"NWLOS9$A*,14_3,.\>\GIAI[6$[S]2;P!V%RUTF
MD[%0T%'H$%(=+1 8F*A58LXY%H:YC7R H&[0:3T#W*?4&P#/[V$ZKT'#;GC%
MA\5]Y_6$16U"P@P630$5:SDUKR^5*2"US$06XC 56YW(ZP:LUK/*PVFD 9A=
MW='O1HF]Q26%(I_JSCG]GC9E6>CL*0!QL;X=S"Y#1$D;2*=2"DM*#31RJQ-Y
MW1D?,'M\N-YOG2--\XW7=VFKY]K5!->8[>,]I-1I&C6!)"W,Q:
MU$45GQF6>,M1[U3:M0<)W<#U,R3 GTH/#5BU^YH97_52OUO6+:SS9)DS\*1\
MG8NB@6)= 1B]0(=,.)^&<A-O9)UR5.]@FY^_<,ERSW[D.
MKD-?H!A>QRH* 3[7@1$QU=E2@DDF.Y#?9:UN5JKU--8@DFWE(F?'ST0ZX2,6
M!Z%DVHE!6HB._@CBCI:8J,_G'CD_O&/-1VS]5B-(1F-
MRD!!7?NF4;@:.*=_*H>V),Y59$<9AJNENJ&B]2S3$'(=O>!P2_S.YWJ[/9).
M"GWZ&_RZ_O %9Y_Q;_1#'VL'""5,(&LG0B#OWVH*0+W5D+Q+Z#PS*72I6MYC
MR6ZP:3V'-*2"D]\3 I5)+[VC/;
M)DWGI,3Z4#HG0)O)U?=,F($Z<8TS3"HS8YC,$;BI<^\1:;LZ@\1N"5S&K-A
M8R!_QF%2^V#C!\.D]I'[R-UDR&G(%VE]NGR/R\_3=-E0*:/F6#7K-7D)F8'W
MY"]DKLG\1R2M]]=([#X*&NGI<( V%SV*M@UHU$[:.PY6EY,(@C?%>@X!67WK
M;Q5$58<]9L%011N][Z_IT(-DC-=_ZGC-WH7)D6)N(+>X8V374JGD+!SR""*[
M""I3S.%3\)"5X%J:G+T>ILWS#3)&Q\BQ:KU;@'*@C,>>-'9I4[][A6&V;5G,
M F=66C*OKKZ)U!P<8P**CS*F:&RY_8#LF&%C#Y'12.^6XTZ3QVFDU;^F>Y#;R%J_2;C(0B9>'33DN;;W-D 1E 7!
M$P8K?,S8I+?%D
M(K<&AWEY=V SXZ>:K7A(7-B3F!O(+_T@D?_R:YI=U/X))ZL5TO_RA_!U$E.*
M1:D,PG ZZCAW$'C)$(UWI4C/BQT&20<0VTC2^T!\W%\N/IBR?NK;YZIJ)%!*"=75NET,G$HM*=WI]/, ,JJ>Z+]Y+;_?.H-I'
MB"UH?A=ZQ-HX5YH, 7F=3VMS;6SIR7WP07O/.&*G5Y\_XPRJO53VP RJ?>0W
M]A"B&].3,L':J_K,+R%%KMP;$D.N;TV#54EY%DV/0XC:FT&UE^(>G$&UCQ3'
M5O^-Z4E9UA<%1H+Q4=17> 5"U!9,1DNL$U.YO]ES#L#*J4@:DQ0FV-H+K3/O,?KV?M(:.H2_U WX'CA
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MRV(QEAQ]YSR97Q9T])?+_2G[$E]-$QZ$VTK6+EK#[_WC]EM
M 9DLRF@C1() [6Y5A688:!DD4\67.RUA]VW#<7O)YL8(]F]>CA-S ^[,[5-4
M$WT^48CIM:U-1;@C\!,WFKYF0TQUQ-4@+LPA;LM3]O Y5C
MA-Q6$]:=/60A^$(..'$O">N<%0KOL !GE@>;6-)H.AP[]WYX;M11[5J_7M7[7;9)-P')QLD J"JF629GW"*"((&YE%EAL8OONL^:[6$?QO1?:N.B5Z=)$\)$EVIM!
M>"@^^I)C [[IW6[2S^E?T_75O 7&O0WU::L)-@,)2X+/F=RJ['G"8G26P_2,
M_Q%E[4TH[-$G.4X/#>#JX9ST-0YOF5;ZT@L\7ZR(ZXD3+HC:<[&$R$"A#N#J
MLRQ+3#N.@C,W#.R.)+R]T8?#W"STK\4&0'N+N6OM@T-3^S1_!TH^=%;]=[K&-Q)7SD5(_+H@>O-V#0K(1JT
MD*S$+$TRGG7)$G9:K+UAA[TZ74?)MI%8OM[_GV0ZZTDIJPG%H0IS""!-Y* <
MFSL5DRWN4%_V-KM#=GL \H'"7)OK/ 8[R4O3NN\WWZB/EBAHMR
M]WO#/9D]C(ZG>SO;@YR.?$2[.=+NK'3U+E*JXFKV$6QPLNX&#:Z@ -3%61&B
M9ZI+UY:'5SBZN'0GK],K>;U9K''U>A'F-03X;3JGTWHZ/_N^\K;2$GE63EH%
MFT7&G7/4)%-= +'0A9)C!TZ%"$6ALJ#%.CV)' D>M>GP(L
MB^$U]W, \K+AK4GDM7 /Q;,ZF4(18R4:2"B],6A:#!$+V0/W+U=QLV=6"M_RQ0?YCEW?XN*$7A18%5T8,21=81O0@"
M?;(F1(I/.SVM&P;J/R*_.4L]-.P. 7ZO&&@ ^,\7LSH/=+GK=NV#%"H$"845
M08:#,8BV&& IA&R%T1C+( B^2P4=
M219 +E9,.5FOV= X:L&H':/5!P%R@(@;@,CWKJPOIJOUI+\YT =8 :&H#4PU[?!_J$T_)LL5PN
MON!R([2@A/6!F%$EVCKMG'Q0RPTX[\GB\Y*E&29MO0^5(S\B&\/#&DJ'/Q$^
M=[O/1!L=6@&N<&+1T^X+*=4F6Q0U1:>]S<.\*MJ/SI%]M\'P ]#L
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M5)8,@E$41SCAN.,L9=O?G-[[*!CYS?X36L9>=##V8  \OUBFCV&%
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M._'OJGNN\WBL%M+4$:JJSGHR)8++B8&P1G#/D;X==-8WT",Z1,/(
MN8/S@=NZPA^NMLL5;K?[7.UKZ12KA\"YVA9]P"4J[B]+PC/@@Q1!2C.Y=KOGV)4;6A!)>Z9*VBB:@25[PF9
MNY/2' ;H!%7TA:2;#'51*]Q+@IIR"DK6ZGF1-:"R,J.Q%A]V,Y\>2UV8GE,4
M^S1(CI#RW(.B;FSP7/F%9B^ 4KE>3A3 !1M;-%-8!_(:*\H=OW^?ON(
MZ6JSO%S>SSK>B8=Y%K.J9E](1>(IG+:5B) ,FI0+2TZUZ6GR/%US-^V
)-
MJ*@.87?#RWZH=.(II*@%1(<)E*FCAQ7)3>.Q48-]I^G:UX[-R4"7@#7
M">KH %QOUZM="\R=9GY=;O^;G&9P?!LYQEC J2KZ7FVDGP
M*BM"BR30^!BM;]/)[B7*YNX@,B4.7@39"4KI$F3W:A"8".2#&M"UN9\R%*E'
M9STP8Y4)!I/5@ZXRIC!NXR+4OT3>_=0JZA%M]\*=G#(+)COR!5( 59R#P$H5
MEBP4644A&WEJSQ#5G2$[3O$O >I(+70 J.]6(2W W4*\6WP_W_:_#XYS+U@D
MOC3)RW$+,=%?77#"95=HA'^&PF%0^TLD[#=57@>@K$??>-L:_]Z9^,(5
M8]$[0YY'H<@J%PV^T-(-)B43$G+OVZ#P29(Z.G";# 'K%NKH %>_K^*.E7LL
MW,RO<\[+I#C)AY<,BLE(RS I<)(Q5C+3BK=QU9ZF:=XVP&=!UD0*F7E8SN^;
ML%I>?2F(>7/+R,))HFK&*%\.?)!PCU6:O\X'5_6V[3Q7I[M<'?2(8_T"_\]\((ETKP'C07M &CD> #N7J"
M0EH*9A,F/J@ >_QQPE 2YYM]U PECTX:FJCKU1NOWZY#KS8F[+=[<=W9#-DA
MCLYMSC3G'&EC!-KJ:A7K,V^2*Z\#WO^/N@>@>
M\WG+8DXI)VT%"!_KS;[D$)VT@ Q%<$ALAC9YY$<0.\_1Q$P ;:/"5[\'WTTD
M'?*OCY_EVHZ6\^[P$\CK[/$-]\DSDT#O;K!B";446D+D2EH74+ <7J-#4%--
MN31<0"[$G2K%0)!9@)62G.9BHXIMFI$/(N^5;/]CT''4]C]*31WL^H=9V=TV
M)X_:)A9 "MH>%',(WI<$UK*HK=6YA$;S&9ZDJ9?)K9,!8%#H/%H;'>#J)0?D
M\+>N8,K4WRDD&%H.F3"G6P2HS9J>Q9FZ8RIU ]<]K(1,AY5*-P)C5V
M -G#O-R=X6/PV5A-D4_"\37'7"X3U,GKUO$;Q.+UT
M"[,WEV_#9O-MN?KT[^'B"A^_N/%5H.T!;$I)?
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M(+T'D8,+6*(G7WR [_/L2UXCO([1\[J%T&=&SW^L-_]-#R)G_RNNMCNE/1\Z"K%8*>04;[^[4XN[X
MPDH9B,-4QU&1)\[)D8D" P3+M+@OG=Q%/T-\K0.?#"P):
M=[[H:,!Y0T9>9%';90NP3F4;LXC!S'.,WM7-8DO,G'C#,T:!KP"?]VX.: V'
M4,CA<+NIQTR0%&7.8$HRL:08/R!F[@^I_DXNL3S\3.:F)(&!9O/PD=$H;+@ F26M;Z7
M!XC2T>R]U5]KTOC[_+'_KD)N9I."\MC99A
M*)D1#$SMUJ-$H$ KJ B\H'0F&QZ&S7*;U6C5L[F/2 N2U/('UE.ZWU=+BA1N
M7K%(+NEZ*P&ENO JIMJ3.SI(' -G4ECMAM3-/_>.#LW,&-W>/^:<3)1]=/VZ
MHYUE+(%K"5+E.O@LUIFQQ(H2T:!C/GB6!\#@X7/GC9SZDM99SP7R;.4
MQ7$;QC-OG3=CM?46,I6X^]A4GN=&LFR3@6B/E./@0,W!I@I!:1<.'Y#2^
M_*9!@&DVRJS%QC.56&<&R3V/_CF.##+T% R2\Z3(?B99(/!B0:A8)T$'F\V0
M!)!A;QL$EF93H"8%2P/Q]K<]D:#>EY^7(2XOEI??%EXFEVWDD+-BQ SY8$$'
M#+L9*]YR(*(VD9+HLB:-DEEO 0O
M*%Q)3,D<5%;*J1&;RS%0:#;*H+4"59)B%AUJ 8Y^!,/>N*)>7(DBW8)E>CZ17Q?VR6E_BW];]6"^1D
MRA(O0$NG3C9)##P* YQ'%73T)C2J-GY,2X?'IV.T_^0QR7'"[N D[5>\")>8
M/X3-Y;??:+/?UJJM5]<4X2CL\KCT%:DT5-;-O<\"#_V&]V:PIZ/MI]0$WRW6^SA?,02;C
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ME'PS9O?$RY/ )
M'A1PC 94"AJB50E$+#[HE%@0;>8!O$Q;[[9K#&X&VZ[C-#.SI_YFN\5=:ZD;
MMCZN+_*#M'DIK&+%9>"B5IY:7TL)0P*GI""[''VT?("//N!5\YY#ML%-"RF_
MYFWN^&NV@0\^VZ;7\O+M92R2(V148;D6@!->7&;@BS) QH?IK!.7L4T/O>9[
MWUT]S].V=M<=HB@L-LD,69=0$R41G%8%I/8QL()6F#9C(H92V/L^. 9#3U==
M3:BE#F[YGN3FAV^_T2-VC;X411Y.U%P8(AY(@@:<$:&.7U;(HV7'$$V.VE(H'%R;
M^2,#B.O4TAT+B,$^_W':Z0!P/Y,_L^_+98K4@T )ABU^IF#EIR]?-^L_L KEIF6<<-*61,8[LD0+
MJJ:&>DP,M'=>1NFY#J8-;)XFJM, -);6 #I%ZAV 9M?&]&WXNKP,%\O_P?RDN/;L
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M#+3C5-,!V-ZD=/7E:E>8\S7R?W;?/RF !>?>
M"18D9%7[QE.( C&8.G,:LS?$-[.Y"22GXJ#3X6?*J5S
M /QC>-8AXHM@@J78.("P@M69F1Y""1QL$2%Q9YE\V%=G'IR_Q$BG)R"SP'U2
MI9^*^M\FR3)[DIE?\')_,O3CGU]Q1=O6%>E^D2TS25&PF#)2W.?(6PK,):"8
M$H-G09DTI'7'R-?.6U;4"(2MQ=^!U_ <>PMO,:BB,\3$*%R4M$708K%@6%1"
M*Y\QMBGH?XZJ>:N0YG)+QZJC VC=M]>+[+1UZ!!DK-F?23'PPC%PA6?+F>>\
M49QSGXIYFU$UAL[1XIYZFSMK7NP$'6B&/_L,V;%GZ4[S*X"$@%.<5>8,U;YQS#49P::2(GJLV
M(^XB;(HCOFZ6"<--]<'7O9Q6M5$QV>1HF8>(-1')
M)553?RUHGI,PTAA>]  7^]F7='KZ=A(JII7LS! ACRSMA\S]41M4K,LU1QN*
M2XF2!M9U,DRFE&X'OO#?
MPW+U\WJ[?7_HA.+N3(XA$5_(3U/6E=HC4 !920581!9.I:!TFZ2;8?1U>M(T
MR4[50$,=X(ZX2(AYU[7KA;.QA2]&**])7*CJY7"MS2M8:S!9B=PSW^H\= 21
MG1XS38+ 5KKJPI6Z9FVY2A=7%+\L5R&E]=6JVO.$RS]VR0E&&8-66(*)I/65
M*>[UB42)1F>C:UL7909[52^_K]-SI(D:J32/:462>[',->=E=#7E!E*BL)9-JR)!:"DQ=8:'.NT/# @8GVV27
MC:-SWM."=CA[Y(^UT]ZK,F8GC$4]^*!VAJUA-YMQL)-:")N#!VYS).6M;F%.8+8UV3HQB#NZ5X ;?38013Z#&/WDS=V]^A;?,AK8M)E
MXC#HF@N?'5EV+7;-%GAFP40FV_0+.(7J>4]OSP?>LVFVZSW[_NS=!^(^^E;R
MY6=.MY./I'^635T$9V4Q%HSG$I0.%*TRY: P&ZV,VODD_C=MZ@NOF?;6%QR]KW\-6WA8_!U_!8^2FLS%^-])%7MRN0_DMD(
MF^5Z5YK&&,5QTF@241V;R+R"X'6!Q#PFJWPH.*AOU*"RO(,D]-*D9UI=KZ<4
M_-S(V=/]^VK[%=.R+#'O:Z&9M[NIWI!R2+3E!PE14\">4&:',A0Y;(;R,/0\
M1<9\)9X3J'8]M9S[#A!^^/:/\%_KS=N+L-WNA97H ]I1+(G/A0#HD<+]F+SB;0[Z!A#7+0A/!\>ZK:9Z -]^-/9^!-P33/'LN98^
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M 8CVQO*4M0;I- =5)(+;U5$H"KPIO"#Y86\Z;PK5+R2]W_Z%%W_@/]:K
MR\_;A5=%H:LEE:8.SQ84['LO//"2I<209$YM6H2?1O<\D4H#[)R6-W62.KO>
MI0]Q^Y\8-K_]:[T0%(2%E"1@Q2Y\^SCW4'U
M&.6]3H02Y' A/(E56 ?!6@8JU2;+UB'X.MY726%<.OO%WW,$SQ/B](G2T0I\
ME3A]M[[:++P6Y)R'5$\/!$F65J.3)&.7)6=&.F%-F^3)X^B=I\Z\2Y2.5M_K
M!"G]VT5,G'-C,@3&/"U%7R!&&X%+%Z22CL72BRVM],Y3BMXG2,>J[]6!]$VA
M-]^RJG4*A:<$B/7"E"5BU0D)ED<2O.)%-4J]/H'H>33!&)]#LX;\)U$^0($0\_KZEMV"WB9$!3P"(,P6@WHA&43 QBL11O%QMSJ0F7H8TC-;?!O4L-
M'$+)@W)NP4P2P?':WC61OZ,4D'>%($41KOZ(YS:%^J=0_'0BE51U
MH?;VL6>X"%'F((* 4ABKH[400@@6G* %JE/2)/,FT)N2BT[,W#18G4V],S?$
M?[O^4J^BPWY\Z9ZQFR6[D(ECP%C[OGOB1+H(P?)ZI*Y<,I8+88?,C7G^+3-7
M($\#I(F%V8?-VZS_6-9E\6Z]N1Y';U9IXV9^T+GQRSM4FSLS;6H\DD4(+"C(H#N8%9;!NT,SQ9UXQ[^C>Z:%P
MLA@[V&-^6M&S<'NY=[9N#)NTGD))HMWXW4"^S.K!E@'.;& 6"TFHS:7%87H&
M(<=UCIP)1=Z%F[N+^)Z\QEE$YV-T.D'27-5K;5D7 @=1S\]*KE/0VR1P/4_7
M("CY5P*E"570!:1&7!,N1%%&!,E HK&URX4#7[L "6=S8MQ$#&WGR01Y3,5&B1WWP@:3Z$IB1R2HR%J9.%N02
M'$JR'2;R4#BF4%J-53]$S^DCX^\_]2X'BMGL$R\<@G-D(G4)]$D7L"5%:YRS
M@>,9V.PDEVT"+#R>'G^ZX%^!@;AKDE+_=G2J[Y./FM:0O$QM6^."!GT2.E+(
MC &4K?.#F#8@BD<5D3,1V_1_;V-<[K(P;\5Y!W3+)+>AC@,06/LA%0,Q2PG9
M:=J+B]'U.:JZ-#-C4/%T(NR)*N@ZT?7[=3O%8*K[SVDQC.I).AM[+Y$I
M9PHIV]:.W#$JVK%$/9,K8E?'''B;ZMYVWLM/*WK6U5V&2C%%>V-VA:ZNYAYY
MH%_T]=" >4W[LHMM*LH.$-.E.1F#@4->RRD"[^!D[^?UZA,][!:T;Y/*?YB>>7%SNIY? ,X10N\ .A]QM5QO?EE?
MXLU( A=H>P_*04!D=?P+>5TR)XBH;)$\^F#;] E^1$I?@#E&OP^]W9.$W0%:
M/EQ?GOZT^K?E*G_XZ=\J*WM.%$?/O,O I*U9VA[!AUC "5^"9#P6V::%T-,T
MS9NRUP _$XF_ R!]OXOO;'&ROG96+X"60CX5-,E$Y #!1UM'!/ LVOG^W],R
M+W"F]G!.E'5W:+DWH$>P(&0]=0A6UV'LAD'(2H$E;EA&&:)JP?P^?>P6=95]&NXO';[%%J9 QE+PW.F73=3=%F8!\WJ7*<0*^7SJ^8\D<8H&6 A
M:5EKM.%SX*L'8S4U(D8![@CU= >YGV\3CSB+Q@M44#()2V5#;'BGP?B(,7G-
M$-LE6AP@:-XRA;:FZSBI=P>>=R'AFR\UY6PA-1/%)@N H5U.;#TS^VU_9K:0*A/3@
M-&>0L]8J"9>$5TW \XB4GLZ#ID'-:=+N "[?"^5MV&R^+5>?]M#WS*%AGB0C
M=]FRLD!D7M!*8#H9[9G1[?*4GJ*JIUB_A>DY00==X.GZM>^6JUHE]G:]O=S>
M];.J/:5ED#H%BG +J].?,CETP2 9U5B0Q2!5*FUJ:UXDK:=P;BID3:F-#N!U
MW]3>YMH+:W71 D3)DD(04KY3"B$%FV6R6FMLXQP=(*8GMWH:")TJ\:1P@P9*,P(R8",410>C)*RS9XVVA%J5A7<&B:C9-QUPFGEYA?:C^EI
M?^#Q^:8''S-M2OOS5#9.9_>E8/$9(D\9E'5U#\D*HD$LBJ-2OLTUT/FR37-T
M5F'VX!.K_3=9@8 J IJ0=)%:BD;5=J\EVW0,!H9DFXX1> =;S($;8^Z-,=P@
M63WRV54B'ROF@H EFB2R$RRV\G./RL,X:Z;I*/6^G(5>0H#+1"[C
M!I2CM:.4T'7D**TGG2WQP9/.;8YJ7DT>QBA-#\W#&"/V#N!S, 67VVR"1@;)
M8@)%5A>8V2.?"5D<;VC]#PLM7V,T#N SC/9LI+EK$)D$)*E0,]'
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M#@U%\RX8+0PF;@:Y$G^MF2^C5#MHYLL8.??@+1V]B!"]$)+H](Z^Y
M!(@Z1VVR5A+;- $X.ZFYX1.2P%PNA2M@+-O:.SN2F^8D:$,!6;8J^D93OH?3V-V\EE-
MUD@U732/?3*!.3'%&.*
MO0.K]>'FO1\OU^F_/WXF66Y_VFZO,"]D+%G5QG0.8^7$DOW-1H(+,CD3T:K0
MYE;R:9JZF]ER"H0F$GT75NA[7GY>_O-JF7=ZN?X!KA(NBK-:.<[!\CJ(D@4-
MSA@'I0UDH,20$6PV.0QK/PP(4Z/&OLT9.[F]QR#!(F$%H'>].S
M!1(4&!1M.8+A.I")3 *\$QD$,F925)DWFHIX]3.?BG"#^#J#T][!<
M;>M@--R^7QV*.1=H2T&C+23I=)ULK,&'XB%B+!1M1BU+&W?Y1=*Z&P-S"JBF
M5<1X9/EK9*WP4PW\)O)]U@6W=?A>N'B'N%WH:!(77E'D6&O7"],4 E@.A26&
M*@>?39NLX8>4=#?UY32OY@0Q=^$D_\=F>8GO2ZE OR9A9V+)Y;^ITEHDY2/7
M3H'-=8;79#5A[7ZX3&W<1@G-*VL0"6.5W:T74
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MF46E&]6O-K<9-_.!O^U=JF\/YO,9IWB]YP=GZOE2S71SWF3RJV*=!]&PKY[HKXP7\L5S40_+5J[&+O<&W?K3R#
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M.@.AE 3%9>6M]]8UZD'V/%WS9OPWP]))XN\73'=-IAF$=C7#N(!"BIP]
M#Q*$8*GR&'EI,]#T1=+FS?5O#ZDCE= OJA8&C9?9%6 !#2@2&3AF;!WX2U&L
M]DJ)-O623Q T;XU >P2-$GAWN/GQSZ^XVN)"9)X=E@S!(0?%? "?- ,I;*H=
M))$W.EH^2,Z\I0'-,'.,L&?.7[IEX*(R@-<,A/Q?5]O+>IJVR.37I>(31%>/
M>U7">MR+$$O$8) [XQ^D;Q],4WKA-?-F]4^ AZE%>6HN_V^-S,G-(>M"4MQ8
M"H]@- IRT8@CQQ2M?EF"U#K+$,[AT=S0,V]R?S.#[$HWV^C/ZW2IGZQ
MT(7YXE7MN4=[JK+%@$,I*'"T6CC)D24^QJ(U:"
MRT7K6)ON> 9*QP N" E):>Y4B4XR=SPL;EXS<]Y]6U@<)+JO.?JQ71MMEO" 9;"\719(OCC)"ME6Y])I_UB^>X\;03K69K M">I\T#Q<$"*AR-CX(W@2 Z+RXU&
M]T[(Q,R%#><\*6VDV:YS:6ZRW=;EL'B6N#T^OV;$PZ?+N3F6HS9Y.$H(+S0%
M*4%6P")/$$,ID#U'(R4KKR,/Y]F,R9MH_6]7^ M)\;=_X<4?^(_UZO+S=F$C
M!NUI>9#=)^L?B-9=2:,L66?MA5>\S7G)L11WE9U74SNCJR@,1&&6](D0NC#!&!"/ <4>N
MKT #KDYH*SK7ME$\LS+O?MQ5[M(Y<#=*);U#[?=5WM=!8/[QST3_=-_#U>M2
M>!TLR&N33>55/5OU"9 S;URLQWF-IL >0VY7"5/-0#B)LCI Y%.9I4(H'9TJ
MD&S .IX5N=>RS2WH6>S0/0G_M/IZ1<'#[YDL6F%$ .8DQ7E6>XC.9<"0H\W!)I_;5*VUM)>WZ577TV9Y
M*#9D=*"-(+\CF5T;$ IHE?=!>*NM;1,$?D]'QQ9O# J>G,<[7M@='!S=W%W@M-L35C
MB=1;3:N*OH"3+$!PA0=4@=E&I[2#2>PDJ#P2"^MS**9;Q+VY':"\8V^1R')'
MBQZRJAVYT!>)P:L)=).44@G*/NXJUTE7>PX.+1T
M;#%"1IO 8I*@A$0(UF0P/FKTTF$IK!G*7B1O7K^K ]7OV*MGJ85]$/8+K?OX\7RTTY[VX4)-B6A-2&C-EE6*9(@0P LPF%0C%94
M8R]_','S%II,C,1S*.WUW7U.,#-BV',;WU^>9:+$LW=35KDZ]B9 L;FV!*TM
M&82G$!25S2%H[6SC=(:6&1V[?CU;\A>>7SWT#WY9KS;?+:;K>"N1NVH5K=6
MJ,G$DR-!2Y>"+BZC$8F+C(T/T4YEH9-SW5.Q]Z1=/*N*>]K%?_AVSY*\V^ _
MKW"5ONVN9;+R*.6N4Z>HP^ZY(I:L :3])SOTFKDV5_(#B.L$C^>%S=/WL)/H
ML"=8'F)H?]PI=!^7J\^T=.^U%'$O]'O[&5$OK1BM*/(Z$"AK$6%R,&0TVVY5U*:1E,8
M#U#3R677K);N9"UUB+3]>@FHDO6:')>@JO="858PAH-VR3I'\1UO=/EUF)Z9
M^QV=K.<7@'.$T#N SD=<+=>;7]:7=_#^ZV3A-T!6O8URS^M_FVYRA]^^K?*RDUF2BZN>(V0
M5>U3*)@!SSP#J662-IHLLUFAX_$XF_ R!-L???'5^*4#N^6@>I
M_J&RK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MV26F3:,F0<=2/&\L2)RQ1F]WX'MVEYYBWS&2(&W;UF0#L(AB&
M&HIE-:.Z[O:Y-C!,PAOEDBS*_"7-\G)M
M=(FI_56;I756E"+11%6SVF,&KU4$9$9E:WVTC::?/$71O+B:0MLO N@(T7<
MH;UUOUYAWRVZ_?5JMDYE'R445TOB2Y(0L99*2.6DQYA-22TCERB<27Z!964$<[*-,WL$L?->N32!
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M@^OADIH&Q]$Y[WC2L_H.4VNM*TS^
M^.?7^R'BS5S,!^R9;#5W3(&Q.H,*M/B"TP%TJ9.#8>7GM6H
M3JZWOTXFY@3MGTY[WTP)0F=I%W5R>H8OWJ#2"IB+C# 99.U1JT%I[;,3241L
MD\_]NE*%=+0Q:24@:-I65"QD)H3V@,DE1/36A#:=M_XWI0J-P>)IJ4)CU-F!
M@_#3BDP0WC4KW'M UWT;=)W);AQDX8F5;",$)1D8@48ZJXK -L=:SQ#UFI*&
M1D%AW48O_4)L?X%2+223-CHF06172'Y" -1TA^Z%!N"8%*F
M'5/HDU ,D"PY*$7^J'>)@2BJ-I<1Q;DV8=$K37(=G-YU^C^8\)5V"S7
MU_GNVI8H308?:Q<,HI<$YA"X,TQY)V4<5FM";[B'-_K;0ZP]2<+,@RB:>U[3
MR'YN\.SI_GVU_8II69:8]RLN&A=]=!GJA'90G):=$X&!F"APY]53E?;G7 *YJ2-SQ2QZMJY&!TXS+29LQB=
M2JGZA1"UJ!64$('$%XP=#$P*,[
M2Q'E]V1UY;L?K_QAH#I"$QW ZO^["A<[PUMYV;MY,M5!PR8!JCH%SY";%^K@
M3V9TS#;IDE2;;*<#Q'0)H6-4O9Y6[AU YY?UZI\'N&"*%5/(2OMDD)96%C7!
MP$**1"9C/)CG,"0L@=6
M@BU!2FL;C9\_OF_6?RR_$PR]7=1&L=XER
M'\+F)R93H%@YR5#GE(@"07 &F6>3.3D7T;0I"9B6C^X&
M[Y[/3$ZJXO$ ]]< 7^&GW1IKB/.;M/1W5Y?D&?_XY>O%^AMNWJY7EYMEO-H5
M8/Z"?UZ^(^5&,-C'5TLLZO9W"^SJ?6SEPAAOG
M4ZBN=DN$/D_>O(58;3 XH4+Z0=EW6\7E5=@LP\6-][/0.>E4) =CD)/])U?'
M%V-!VV I
M!UFU;7\MM5TD&T56%,DY*\F 1Z[ <9*O)HD+DJQCZ5R[\9$L#$*K>[UH/8-B
M9SY.O)>=MZ^UW835]IH,.0AAOG.$-15T/P"ZW_+J&>:D$LFBBB DFCJQ1(.WG /M
M DHP+NI T'$H&O;B86?5['5AJ8',_SJUR3=W2NN;-FW+Y]JTG:F ^3BB9JIR
MGD""O91"1U9R4DF"%U;28O,)'#H!R=E2&T(GJQJ=,\]="GUC>*ZO3I%K3U:&
M[(U0IDXM0? N./ ,>7*ZI-*JY\EW=+SR8N8Q:'KR GJ\0F;<[#,N%S_CIW#Q
MX^IR>?EMEUC&=/#!R SVLF5\Q&Z6T\CR)DQ<$WU/J @0
M8N:[:;X>34X8V! O_KNGSJ?=X[6RGD1$,ROW[?K+U[#Z=H]X"@RLX"6#4+7)
M5O1$?**(P:G@C4W)OV\&CGKURR?_HF/Z&XNP3-?AGI8%6VF=Q@L\M#,HXV06Z!1>U3
M-%F:?"[8=%B$<92VA];DCQ%]!Q!ZL0S<%I39) 7:1PW*> F!2 4;R*YJ(]&J
M-OF'K[0F?Y3^Q];DCU%&!^ ZIKR[:!)7K1_W4410Z,D7$#X2.E(@OXWV;=^F
MB.RO4Y%_"@1;JZP#5!XX\<=1N#H:O%!0(HP:DMNP1*3.LD85!/D#""N
MDR.Y(_7_8AK :D[&. 1CC0M)
MNS:- )^GJ[N2BVD1=;0*NC10C_;TFQO>>K*[L+(PGHL#YT4&E70A]D0!S3PR
M;VVD#W,Y6_<)[:XFHK'C=;22YB_CJ9<'CSG\^>K+UX]77[[CRWNMLJB52;3=
MDPRSH#!(";!&L9)5,"X-J=X>]++N"AJ. 5 ;T=F?#^X33A48697$1
M6&T*K#P/X)754 H7)FN7I3V7+W:?KNX*$Z;%V=$JZ-*PO0O+S;^'BRN\/U5N
MD5-*7BH)!AT'Y1A"$.C 2B:
M;5;O[Q7\+&(@UU/0"HJJ#J-CZ,%)E\ 4YZU'0<%,F]ZHPVDY0_B6ZZ
M1-UWG0)^^';30&!1M&2V]BAF(L2:J$X^@4@99'0&@S79F#8WCH-)'(:YUWN\
M/X5FNH3Y9;6%2AYE:SXG(=VZ[!9XUDN96UC&G.3)L.F@,)'(:VUWLO
M<+I6>@Y%W^0OR]6R%GU5C=4F/:LM142U;%:99&Y:05*D[7/T%&DCC\Y)9 ^S
MX]NY<@>H;=NZM:,GO=/ODZ.EK(:!)+J8#@M1&/8PE\0@&R
M"E7Y9/+9[J0>4S<,;KU?)#33Q]P]@[_4UB3;NZY./ZW>7FTV.WF%N+Q87BYI
M[1B*@*1G#AS+M2&[5?3)"HA:RZEZGM1A
M('R]I_]3:FKFO>\^#_>ZQE[?;ZR_$$F?:S','W@]F/G#!G\+?W[8+->;>RET
M;XGFY>6"NR@RIRT_N!1H(6H)P<=ZU2LX,A88/AS6<-#434C2L,S8WJ\(YM13
M!R<=3_%84X&'="79%J(+O7> _^D:+V(LWLNL@"F)H*R+$!W3H-%Y#/6"
MQY^M>7O#CIKB]5Z&G$.S?\4&=K_@S:JO^]SY>]4]\?[9V](-D4LO'>B40"MX
MS*"EV!55>W"6)?I#6!7)2[&-[O]G[T W:K87>6E)15\@UUXJ*M>!2PH9Z!"Y
M28$G?S.<<
M&)-DBHX<+_5_V^>,T_;0]CEC1-\!A%[LV!)*B,F*0E*I-PP8#80ZGSZ(XLA;
MQF(:M3-YI>US1NE_;/N<,$>XNAO#]'V) DS=Z-H[GM-(_L9]\P= WNZ?U]MOV+:
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MRMZ7)Q)Z?"''@?':^#4Y4$Y*\D[)K] Z1I7(K6#I7+TGAM#;72>P:0$YN2L\^>>3D)M;/G:4XO\XFR.@<5/SU%V&TZ
MG6>T2M$'D&(W+\0/_&$896,D2P8X%[6F0A)0C I
M0A(BLB(S6MZF(T=/$X;/CZL7Q@R/T4H'3L83N6#>:F'K]!^G:MZJ-;0W2AD
M%<\I&:82_U^4AWF"AH@V5]&LQ1=#@Y!H"4/6P@)SAH%S&C&;!92
M-1K^_JH2+4=I>VBBY1C1=P"A%W/[E&+28Y$@N%2U&M] R"J"ETZABT;ET*:H
M\I4F6H[2_]A$RS'*Z !TPF_!R1=T[Y?=EXI9+4)?8F&@5(R0=!( BI2>!5]0MVH
MD.\^&9VXZ*>K]R%PCI;US!U9?E[_Z\?59EF/AG[?A-7RZLN>E;WU1&Z+MRQ#
M9+J \E) \+2:7.VK)FB%Z8>E=@>[K+SPFIEA<;SRUFTDV8/U>'P>KIDM,;D
MCD5'\A %G"=>G(W*QRB+#8V/DFYIZ23+:,(=YS@Q=P"4YQJGW,\+N.N-\HX$
M^N;]VY\&MU5YM][4VY.#N2UWC5:"2^@*J<'G0(Z>\B3!B+2.N0R1EV0<;[/#
M]2*!3C;7(Y$\HA]/M[#J(G>J62[&_UGGMS[Q)SA9=?]Y?N\9K-5),\ECO)A%5>5W&D^T*[
M_M$%"8V^NR3V(R8L@B("DRR%!=X5B%)S,"RGDH1+.0_I,]B M$Z9XA6W$&,BJ41. N$E
M@,#DO=3:OX'.(63"DM;4;8Q=X!L^, EV0DSN.
MKM5:#S%*_V/S(<8HHP-P'7.Y7LL'929;SNI-F2H8*>(S#H(C!K,.2:HV
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MJ]# T-LH7H-G?)4I?F,(VAF21C
M1-\!A%Y,7O"N&&NKD&RQH"+]$0/I/F?';!T<@;H-E%YI)LDH_8_-)!FCC [
M=4Q:@M"1H=.U1;4FJYZ*@D!> 5CGA?%)2=6H/>5?)Y/D% BV5ED'J'RWI$ K
M+ XV];%N#W\HYLA@\$;[@V"D2:"LDAL
M"ZXAN,18L3E'TR9&G)*+>;?@26"U[D3''>#[QW]>+2^_?<1TM5E>+G&[M^[%
M<$6>10238IVE@R1.2=$Y3]D7X91FJLU1\V%ZYL7U/NX-W/$"R'B-3)D?79O>]HV'>.[!N@'6D4F:$T]/C6@,I767+
M 8ODH$H)$&2NXUH#%U$6YL*@/)G&4Y#/U0[IF)!A&N'.C8XGQ^\&J91A5D(T
M6E_WH P^(I"W&GS Y*30TR'DM8PY'J7:06..Q\BY$["\6V\PA>UMESC%'3<9
M0:(,]6R:UDWM25@8,EYR03&L7?\HI'Q/PXPPF4:Q!Z!R@I1GQLFO8?5I7P ;
M,\6PO$!,M&:4I,TR%+*PAN<4C,E"#BM[&@2-V]=V,C[QM*WE."'VH/D]8*WG
MP:A:JE=J*2E&"T$["=['.L7;!%T&M>0HISJS_\
M>8_PD)02(GNPE7.5:_N#4(O5I*"PVTK.S:!Z_F'JO__J>0Y )E/_T5+LX,#B
M4,%83)+5:]_DJQPD"R213 Y+3HK\9,.1->YE=$M+)Z-L3[^>.E','0!E2'.G
M[])%%\6GI*(QD) "+26Y!Y=MIJV5QUP<-E-&>I0BQ2
M11\EZ+@+"@C3P0@*+K.3(85DR["8^E64*CRWVM^27?FTWGR[=JED]BA9CL!=
M<.1R9T8[#WE83MOH7"&_ZFPNPA,DOL("AS%8&V.HCU==!T[#$^G9&)AFHG84
M%2BTN8E@&\WTZ['VH9'RAY5%C-%$EWC:WQXD)8/2*&J/LYJH
MFI%\EI @&>6XQ!R*:-,P[%6518S2]M"RB#&B[P!"+V;B"V*#)Q:) 6)*N4+N
MKT /3$27I318=!NGX96618S2_]BRB#'*Z !<1^786\F$30I,%:*RJE"$9RT(
MBNRBY:+DTB8Y_:]3%G$*!%NKK -4/O8P?OAVZV/L78PE7H](M-$4C-E!%*;Z
M&*746:H&8.,F!X1I(E[]_^R]Z9)3
M2;(N^D1N%O/P$ZCAUK5JP*!J;SN_9#%X@&XG$BTIJ>(\_?50*F=EIH856B&Z
M;&^C@:0D'S[W<(_PP4'*D7(H3L;L%84K.E Z%864-NY41+7_T?L42;VE!@.!
MX.$Q/(A&.H#6GQ__6&!87BZ^OYKE7^??<#&[LY^36*D3D:OV8STF-(?@:]4!
M\2&)*RYCFY;[9\D:%V(#J7[>2@]=[-M[,U]\G2](0-N+Y86*2MD(6NH,2MH
M4:$"'Z(E5Q]XX&U@]2Q9XQZ2;6 UG!ZZ@-6?']+C9KRW#QR^4LWV0RRH2@)>10ZV:T60LI@TQ.Z>*<8ZQ-Q/60DG&+4-N@Z"AI
M=Q!-K27R.J1_8W[D;+,LZ'1]'XZ:Y"*E 6>X!5FRS59C)"?$OJ9)8]!(\.DER\[5M
M3'@0+I1B6# BMKF)W8_.G6!GS@MV#375@6.[X>[U]YO?_C]37!!1G[__CM_P
M8IU2RYRD3$F"MK7[D:D(+NIZT!N11/'*^S:!UV[T]39KM<4U6 --]82_C76M
M6VX?\[>Q8V%Y+BPH*":1_))G-Y(O?05_MUA1ES?">J$63,-J ,%*[[.>@\)00:6O4DA6]5F;L,S1(U[
MA38NR [12Z=^3-ZPPH,K4E#@0=&'TKQ H'P<)%/.:6\BEC:#JY\A:MP8;ER(
M':*73B'&Q:M9ON:'\^2=00N&TAY*RTN=Y,\9:".\*,&3J!JGK4]0-NX=V\B'
MYJ$:Z@!QCU.MNN3P8EZE^/MMIP@*GNN"68FF;ID-@=+]$$EL=:>;HTS6#4;Q^JI2_#=F->[.[T?$R88V51*@*+:5)T6%B6WD+1@SMM 5GNJ
MIH*M!/96R7$T-%X$W_%Z&A%^%WBYM0_C&RY7ZY/CSL7DJ_^9>%:2RM9#+72A
M&"(D\++^3N02K%.F/#QS'_5I[?>-O=6@#06GAG(?&4VO4EI<8I[.Z..PEGLF
MG'Y;^_R40LK29HHU@@?E= U%-5F(M O/ U
MO85(0\)D2 G_B#W'/R^O]L'E7RY7)/!K+83O5],X3]U\O!LYHWRUK:P-NDDSVV"!^CX=WZ@/<1=Y>@
MV5P;QF@3*V1"4JA0.\$T1*<8^)#1EDQ,EG_Z@/?3]JY]P/N(O@,(O=AZFC*:
MK&T!E'4C%Z^3=Q3W("S#Y(M5UK2Y3SW3/N"]]+]O'_ ^RN@ 7(3:E'$?.'7R5$O1C@FQCA1S!T!Y?!?T\]]?,3V5:+^EI/J/
MO_#B&_YK/EM])G;1DXP$ ^<])[N0J79B127@G4?Z!N'GQ
M0:B=$L\/L_\'P^*/O^83.R,=&9D.CYB5!^U%L4E8$=E.FUU:0W5#
M;R=..=B4B&*TN82[5"*.]E1
M-!XX]U;;><+SE_DEQ;XYL9A" 9DL14C2YWI]D* (=#H6Z:4ZU:"8G0CN9,O)
M:.#<6VEGBLWI-YS81.>#+0AOXKDO.[EM)-8]?YHM'!O)JL:@+SM:VU#UX.DBG;H6TG=&W\QF2VYU_1_QINJ" G$17?=^KO\(BK]M;
MTFKZ;;KZ_D ,CFD32G&UN522XK*"8%*&0OEE\"%XAVV>HAHQ-/(#P"FL9#P
M=&4'Q'!MNL'\H?953&L*NF;XS]F4/,-V9CE:JW2A5+>.(U>^4.8K*?.,P2FS
M7J=IVKQF'47VR.\&I\!T:V5VA=SM$EWS^^[KNO/C"8X14_3H&7 5/9U91H-/
M1E(JDVW!DKU,7!U9K#T#>+LS;N.SU]\=16SV%-E+XG[6A
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MMR'%E$W)@%HE4#E%<$91Z)2+Y8YE1GGRJ:[&]Z![-[2>][-H87W=VT"1
M%3&.A\_^V?Q>C/,_):1Z= 1T-YDTL6O$UU!9,U/$N1K6A3$'ZJ
MLI07+QF73]TR7O6[,D]6G$E D=6ID%Q:RBDU!U,<9RQF$U1K[W@D"UV7C^R#
MOWVOQMHHN8,#_XKRZYDE==F!*Q0(:\9*73&D2(2- X>%*LH/UT@&H#A?<+=NS=;W)V_#E>NZ$U"85Y0JX(.LBML(@E#H?441&
M$;;E)IWT>#F*FW$A?@2X]GUW:ZWI#M#^\Z9BZLXC_69TB0D^LB(L.!9+W7]D
MP,?B(%N>,FK-LVNSI.!)DKH\P$^(EGD+U76 P6T53Q\^_GF]_,,'GX1 8(83
M,Z;V3:-F@-&C39*G:-J4_#Q+5I=5EN-A<3@5CGQ/^?AN['J7%K,RRQ) VGJ;
MP'P"YXDE'7-1R@LMY"Y7[$]]?I<5CJ?'TV JZ Y&VZ[X-WPI83$FQT#+(BCW
MXP*"B A6J90*U]E'>Q"TGO[.+HL1>X';0*KJX&2]B@I^FV7\NU:%_;9<7M)G
M__R?RWI;>AU"9ZP)'4F*>\_JC#H!KO;6RV!+DD:JW&A[XR[4C7S.=I%.#Z[%
M,T#FS9*O:G%&@_&EBBV1V$STD+7@V8N8**X=!9L]9,+#XV)/X!V@I Z@MV4>
M1)&VT!D1(5J705$X"MY@ !T\$Z6XXDV;Q8\'#KEL%PAVX?".U% /&#NTI/OM
M98TSWI57^2KNH+BD_KOEJ\O5Y_EB^G\Q3Z(0):+VX+"&P89BD%B"@%P2<2)Y
MB+D16-LQU=U2Q.< -)94HY,=0F
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MV-I62_%^OB))3\/%Q?1Y.(W9 3J'ISXTRI
MW3>>65ZB"0^WA6W%WP"DC-Q>.AP$3ZV6#H* -=7QY5PS/LPU?_[[ZW2Q_L>;
M/).3A25-Z4-( D%)1'"NSD3(R>B0C)2JT7#'H5@8NQFUP2W"R34[=N_SV@@I
MUWU3<]V+"\SS!87I!:_+[6D:B^D@
M,FI]TXT*ZX,]89=P"]:EE)@E&)=&?;--&XL?1*-U\N!LB1-RK11,:@\RU^;5
MZ!Q$'1!XX"*%I')D;:;[;Z>GRXZA0Y#Q0K_%(>+O(RW=-FY*!"NR4#:RDE)H,]5B&/J['MI]#&A'4.\/
MDX'>F6CX)_UH.EM]QM<7(?W[8_I,G[7S?*_M;7:);0;F#8/DCI("9[,#LH":3_2^!8W74OD$1H6 2#G&7*8M"Z-E7&/^3
ML+V@\/S L#WTT@&HFDPSB,ARUB@!1;"@BE/@,"+DHAA7,6N+C19=_>@#P_8!
MURD&ANVCZ1[0OOUFZ..K#Q\W,S+0R\)-ML BJXU;.I*$!0.=N)9$=" >VUW?
M/D=:YU%!<_1LN_\=3)5]7@579IZ9YR)#8KF^_28>)"CT F)2"I+@3'GADP@[
MS9@_Y,N[?%/.>A6<%M(831IA05(G!E/1U>64.0C@XO&36)W7H;
M&Y:S'47[CS+(YY@P]\0(.&?,;U8;KGMAE]=M@[\NYLOEI(XZX!@M9&X,B:!P
M.I1X@L(""286B[W-OWB:FRV/!<<[V<36$Z;?9W)44MIHO C#*QH"*9G;0,:7 ..X^F.K6DEC#J
MQ;P.*3??=A%[LUT7%U_XA!/O.N@,.6(!)2V#F(4":9R4.:!F3K4SJ"8\=5G)
M1@3%0H+@D$3"6+2B6)'+2$]NQS,W\@25'\B:!@#/&=;QK;NH/LPO
M+LI\424S=#W>4Y_?NJYN)[X&JH_[:;I,%_/EY0+?E;LT?,"+6OR\)N51BK&\
M*?A!D8/UO-0R'T*8, 5\=EC;,NH2E2A9MDW]N(GQ&^[@K5]0-!!W'._=J648+BE>,T51\2+.@S/
M,CH.5@:O+T[TS*V@8+.L<,*F,=56LT
M6,VEJIVH$D>:RWWF!6M[@>L4!6O[:+K7>6J;"I*,DCE5!,@Z!$)ELGY?+VI9
M23&KF&+!_$(\N\/7=/[(VQP#N\Q3.T A'8]+NRZ?X][9$!U(+TA**I&44K&4
MPQ;K4!J-Z=AI:#]L*=FA"!M8+3T LPVJCS+BEO#R;Q"*2"CTQ3.6 LQ)LH%.0J'PAO*!T>M
MN#VOK9>'NLGVRNMN ^LU#Q1%!$.)
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M,Q Z%V:1U;KD,S/*1TQV_C+RWV"7QP&O=]-<_^WRU>7J\WQ1MS+^.2-(/1A
MO_SY;URDZ1+KQ%+\4"5ZO25]\Y-ZB[81UT2YPJ(R#%*H;U$\(023/&3GA4V6
MF>)..09B< 8[?TCJW23'!=P/';3>:/!_L3X:8W[U#1?A$ZZ#_)_(F]STS4Q\
M5"RA0U!14*!ODX.@)0?#LY;1,U0:S^SLW)W[SM_F>K?@CJ'Z0YOW_5S]9<%)
MJ3BZ*, 44TAP6H#S24*.4G@?/8K>9G(/+8*1%W'_8^AM0?M#6_O]ZX =W"37
MRBG/09MD0!6N(2IGP16,.1BO4SZWIYL]13#R=W[3U[CI^EL1O_V=;BHQ9%\(J15#LD2?59UPS**6IGF
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MR;69(,&5*<'; (S5S"]P!4XR4U>/E^(CV9?L\R7@$2M=CB^>@O3ED\\1(J6(P%I*NJVT+=Q"DR&"L
M=Y;R3?J?1KTW>]/:Y42+01#=5FV]3V=J5FCLC.$1R68#"V2]GG02/4HP)2@N
MT4KZ<9]N?OA"]U._)G;AZ=O!I0=GW^QMU$5#NK&,#CQ6:B]K)N<2/*00I&4E
M>(^=#0(=Y,7]U.^!/20.PX"@6VLX\,;AF3EL=0E5D4Z =KZVEL4$,>H$G!5K
MA>-%FH:]RNT9['+N0#M+&1<@O=C-RO%^"M
M]IY;97)L^*0Y$M=]-OIW=^O;$DO=VMU!A3<[WH;SB7"1%5T$J55K4-D7B#P9
MP*)45LE&9[NO]-J5V3X;\]M963_(^;&,ZV%5F_()+2:$$C4G<=0U$K9N"HR>
M\Z14,*5A;C1BM>2/4R-POO]X+-(VI^&U(S8*GP
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M^8"2[PFZCW0>BO9CWT"5ECV4X"<87PZ("##Z",BE#]*6NBU.6U%NX4*?<>C8X@S]0
MY#B@478&K%[LK8.NXIQK/[\-%!.YZJ:\(#>E*)3/F6?)>'*MGC;Z$$"/;>OC
MV^OX>MD+F+W8\PE*LIE./BFF0%M!J7>V$F)MFTN%2ZR%.CJ>.P-6UU4RS[XEW^T=.J3H98\/'ZZ&Y5".^BA)*=XX984%FZL%"**+JM I[*U2O U GB'JV+QKRT?_0:)\3?_FWQ.?DXS>6A!)42(IZW8^
M$Q0EDBXE'XL5XF0,WU U[K7]4/AXF*8,IH>N':<]^7!.?\P+5
M)W!"*4GAA!"@0]*@BN$0@I$@;X8LY'-S0K>/U_7XF\_J\?:NW'SASW_7
M(Q%?DU[*=+66^ZUM\,BM5'1@!X\,5$ $7^J 1X<@1',(_HBF&J-U/VI'O
M?OD2%M_O'!OU86LZ^X3$(1GD#5_11A$80W#H:J>U0HA),^ A.ALI5U>FT;B8
M'2D<]R&F&19;Z.=<4I;#[^:V?$B3]*3E[=ISD"I6E\*W3T
MFSKL@X''4V\/EG4'AQ;)XVI4PKK!J6"]]#$)/-9K9&_KA3*Q8:-T(GG&BFCS
M^'&/C)&+6X_0YWPHX?:$C$T7B5=$I-,2]+KI.A=!IR)&.H2+]JI89+G-6^X#
M0L9%QQ$J?0H:4>41*)Q Y1+&/07*$E$>$R7*QNO6D'RGZ"R21MM(]JEKUD=UFXT
M4S*P8)BCJ-Y*MQ-,Z!ON0(3^]! >3Y(P?+,,(=&QT;NO^<+;]BFI8I
M7AL,UQBSTP&X(H>JG!7@N*X0KRVKS.9@=\J/=T/(4V2,XT0&4NU\:#EW I9?
MY@M,8;G:.$,?,3OT E"2'U3!:XB8##!EI 7;6_K@^X-*_O/A_+Q?399ZFJI8-.\EY0U+QH%*B7R(Y
MZ""L H?%IARDS*S1M-KG">ODD7U(/ VIB@Z056.YZ:?9?>L0Q(133$!=ZPQ*
M2 $^8P$M3 XJILQ"&SAMHZ:3E^\A,72TT$=.MVY'GHF4N9>9V!;D3!5'A.A]
M NXQJTPY:2P[1X5H')<@^AM7]V"GU@2I[J/0#Y#>RVO\UG4V_7'[9$&YL\9)G!MKK0JY/
M>_#>2HJE*/E7B0>Q6[2QD^+O??7(JC]$'*2>$;+=IY1,O(:Z"'NRXY4LPC#V-\6'1*T=,"PQ)_PJO_
M??6EACP3)0VW,CL(RB(H^@SPTCO0/&67R*K2PX*3K>,9=_NV3LH%#M3GO*EP
M._ KNQ1^OOE]OLY]G(:W6 JC_9F)D")ZC!H\4-BOM!01K&*0DK"@,HY"L
MB?\YG.9.WA:/ ^.)57GHXF+^5QTR^/"LN#;#S1G!
ML^$4>V8P?-WN40($C1&$5IY)KWP,;78P[$MI)YG^,'!LJJ;]8>BO8#C#3[45
M_X\3HI',["+,UO_F7;GBN/:UZ!94 "C90*=A;*1<>E*F]4&!Y';
M2;YQ*EP>J[ .?.2[KUA7O\T^_3Y?+M^$Q>)[F2_J4KCEQ+)Z92.P+I]+H$25
MG>$,@BO!:L$2,VWRV*=IV@E?YDSP-9#HNP;18QN:2(]!.V:!YSHXHH9?&O%PS_P36R]V^;:=@.,Z!TXCX8X,E]>72Y+*&K=@**/P.@#"W6#LZSV[QX
MZZ7-HQD"6]QHD;84+@V(5&HQJ5,0G4?@/&%63"$WC0SV66XN)A^F:XVW+Q]]WNZ>ZJ'62:>$I$U
M72T_U8[S>OWQ=3$E7N?SO^C/R\_3K^DJR94A16>= )5J44Z)"ES.@O(3-$Y6
MJ7"[ XZ&I6HWW/7^BC"RMGHZ?>_/CYK4<=L,=8* ,A ;G*2IA0%K)&=:L_J8
MW/9(O4_0;G@[ET>!(:3>SV7KN]5G7-2A9 O\3-S;_2&UT(%CNIX3]OV7^>)/B@PH")C.
M:M_R?#E=KP1X2P'FY:(*NO:X%TPH:J.A!.5=@,@3.=XD4.C:YR[:W-OO0>1N
M8#N7Z_I6VND >'=\<_@RO7IP>(^S<%%'UKV:Y0>I]X32%:URR)!=3;?-^H&,
M&!4N*LIAO&>^-V$";=C]WO_>&),,,K$M=%1DLXV2DK58
MJ"16NV(96(=UWHC33I_[%$TGN8R&4VS+Y=J5%\KQG0:I;2C)2;+'-@-$SF6*
MYCX8>&&*YCZR[J%CMO;+["+$'S5\W=^N)P4^TZZY7=2V5/
M],KN([\.XN0GQN#P4DP2(0+WLJX"20AD$1&TR259:Y&*XJ'1SM(SFC&UEZ9WFC&UC]@[
MP,Y+@XV8B<4ZGT&Z5-=>(+$3@@>EF"A:"2]]FV[;\YPQ=0R>AE1%!\C:.NZ(
M"U54':)A-&E=)9OJG17)1R4=&0]H99MY\6P:[40\;.;(J4:T'A,^'RGF#H#RYJK&PF8/!:74XRR\8W# 9[R
ME 7(#4"WE]#/Y2GUVE*&7S7XY.W3+]PB+?F^Z^'7U!?'S=]=MV425?2_5TYBEJ_+
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M\)T*6@-+N\=X]+&17%F$0QZY$AE,JE-\N8IU'WP R5C.44;FTHF"T24
M7X?.;7^]]7DH_[J@V'KBLM#%,+*K7.W*: X48%"RA^@=_2BI1L.^M],S[CS
MT=&VOTYZ]'5;AL=9+XRW4H%*!4E*.H'W4I#[SA&54U')-L7M_4_Z&QUT1ZJK
MGR[X1YR]Q=4D>$V!)8\0D*+-]=A"5\BV@M9)6BLCEC8U8=NH&7DHX.A0VUIC3Z:])%G"8X(UQ.HNI]M;#=9UCKG6K,R<:)$AM&"#'4I.Z^C[S2O
M_;@Y4[9E(Q'3A2>GNLN+MUBML2I3?AZW05+NK\G3?S97U6
M%SXFQA-$QFOBE 0$FD^:1QY'V(<;'%RYO67%=Z_<4Q#K
MH=8@%44FJC;21*/J8&.;DBV*9UPX>28&"TYF!RHJ7Y+7SN\U\.#XUN4_8R ,)1\]2CE#3N93>/I[E
M-$CE[=,?VZ3P=D(1$=1Z3L(>XN0;/IE/9.)*77<_N#J6,0$SB9(TC+2@P&F91MHOGS&I&RC[9W
M'9&RC^@[@- 3LSI,P1!$'9Z)E'A0+ C.!T6_,TQRQE2)C=Y(SVA$REZ:WFU$
MRAYB[P [+\[E8%;EQ!@DS3RHQ"*$F#7HJ$/DJ@C7:+[7>8Y(.09/0ZJB%V3=
M;S%-/"3!=(&2ZVG/92$K$19*D39P7S0K;2*A R==G&I0W#%1T)%B[@ H0\QL
MMLH(:RR'Y$6]X[ .8K8!2K+,EW5C\WCIZB 3N)M#\4#\-!C O8\RSP2_^ZRL
M]-E++P(#6VP"Q6H-E7$*O%#H,D47.;?IF!B8D4Y<[.EPW4K)9X;QGV8X%7*/4-V9@'3] GP[
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M B*/4M>90'+;47!E?R3/[*14$-MG)
M6;Z_ KM%Z[8YM1.-G'O)2:;,4]+'0X#:=T"ABF32>&4+;[.';G<:1V['/ D0
MC];-N=29/K%_>9!BTQ<^NTG%Z3[\G&!S)L\YLU@B!#I?0:7JLB1R<,X7QBEI
M=J+-2=-P<^9->]0O\\6?LX0+$FT-*-[/E].UH9#?3E?SY"?:6^VE*I!J=8A2
M14(T1# O/#E&X2^1WX3_/8CLI%[G2/0\]&NMM-3![_(_43*7XA,'*R)E85+7:>^A9WVTB#[?XF;/#/'Z\3/IYX H\_%G#!=-OD#?4,U*83$C
MQ2^OO^0&;\+EX)PB*_,QU,/8@?.[11$ +:9(!/4'1T]OO@<_\@";ZF
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MTK]I\6,*'?/(0YS$>\#,
M_,N7^6S-QZM-ZR:%84[EC!"Y=%?+,".G:#!IYA(EEAY-FQ>OQ[2,O%GO2.T^
M!,MQHNX +!]Q,<7EZ_?77[^6S(85+;GWQDO@QI$995DE8R*=X61,B"[:U&@Q
M_--$C;P ;UCX#"7\#G#TOS6YF*TVQ%OM I4>WQKO<
MHH+D? 05,P>'/) Y*"[KOG"NVI3E[4-E)S'R@8AX!+!&ZAEYK/<#OMXOINGF
MVFR2-7+#M =;9TNKQ MXJP)X#-+ZY!U_>'.U=:CW<]_1B0OLJ.<0Z>>'6 %32BD7OP(3U1*ZHP=4)2EQY$SE7O&2Y
M-UJV?E5WC=K#(.5XL780X[P/W]>]Y+_,%[>>\EVYSRF=K%=_@;.$Z[^9:*U4
M*"I!3C;4G"% $)0@YA@3@7Y3B)T5D%# 4A)T?I3)MQN#L0UU\_
M\W G[?':Z !@ZY[_^WS]-/TVS3C+==W0W9EIWF97D&PEH:WE&)0#1>,,9 PD
M2OJ!:%0:MSN-(Z^8'1ANC70S\@W;JT^?%NN&J*OP]!Y[?Y"/7H:K<3Z3++G*
M5G- SBE@]3D!10H6W'7NB*<#C5GZN)6S102B"(%[\AJN53=4:%5DJE-D\?INUTV
MK1*OO]\I&+MZ[E8Y&UJM.?L &([K2W?!T>[
M=[D,H[(N-FK^/I]](F?ZY2>,JS_HOUG7R/H2-3/DPKUBL=:9*/"92_+H2J!"
MU#&UF4VXC9J1BR1:@^#A%)!C]=%!^/^0ATV%F_:QH#4!?!0&R/X*Q*@\9)/H
M1UQ+P=J\#FRG9UQ<':_G%X!S@-!'A,YRL;H-5C]2R!(6T_E:)I)9)TJ.4$<6
M@TJ>/+BF<-)['D,42FJ^DR^B;[B#&/K30[0\2<+(!3@G2#+-M!HGN
M3N.X1^@8(#Q641U \)XC?_4M3"_6,V;F=Y[E/\\O2'7+]2R:B?0"72F4\7(7
MZV;:!+XX!8F'F'DJVMHVC:I[$CIN5?;ISMZ!5=8!(O\7:]D1YE<4'H9/^/:R
M=F&^*U=%F>\N5\M5F&42[A5S6184G#G@N29(9%]U!Q.G T %)K,WEK4I8MR+
MS''KLYNBL9VZNL@KMK*W$> C'F_/@1H2&PHV$'*HS[;2"0BE&# 4$)=HA$=U
M0ER^3/"X%=VG1^C *NS7;S[%Z$1RG3!R#OEU=:>_S:<]63/XF8
M)7(CP84ZV)>2=XA2<1#6EL"5+UC:=$@-0O[(!=Y-87IZ_8Y<"?[NZ[H,^7^G
MJ\_W^L1^76"@;_CC)>PH<;#77I$G*,DH2L+31&L>C
M>G!-O;4>?+]O';DJO G@&LM^9%0=TQW&A8J4[VA"39W:%:(A0:8$&$R]>WW
MH5NJSO.UHY&FNFZ5N?N&\_-_+J>K[P0L%2(F%16=YHT=NI?=*Z/#[R
M9'DF]&N1$51A9%[") B.RQAUQ-1H\_PS1'7KB_;!QHZ^:&\E=' K\.JOL,BW
M[8,VR"*" 4DA(:C,&01?]PC(Y+7,J%ANT[9[CXQ>^G6/5.[#>_2#)=T!3*Y?
M.K%>A'W%V7*CCD6]/%M?1;S^?OMO-N-,UQS?LCW+[R_"[&WXN&V<,('V2RE:\#-N* ] EP/?=O8FNX [1^0#HEI6FTNW_Z<
M35?+#Q__O-[!)!GSP3E(,I 3,%9 0*V :73(2/2YT6219\D:V6F.CIIY*Q5V
M@,?WG\-L-?^R%N":D_ _BL/3B!)65;-'=MDM!G
MB!JYW[TW+ ZEOB[J&Y_>BUB+4URQ&8K2$13/CD1$ ;8N*94^^3;S#G;
M2DYW2TCWTO%3?: '"[P#U&S9I!J,#9J<+7$0*4=BP8%G:CUNDGF#P3+=9KW;
M@4MK3[EU]!B\'"GJOL!R#7?AI(F>:]#6T'$MZS.#*@:TTL7)J()JY%\>T]+=
MVM&!P'*(J'L RQV!_'Y3_1.<*:IX!ZH $TT 6:7ESKI%3P5GHHW#HRN+HD4Q!_T1,_,LMH39L.V&'V:YTD
M"!H*5T/J8G]P^2MPS=83U_,?P^Y0_FVYO-RVE?9*B)]9B
MOPK%PZH
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M, E]#,YK&5NEFV=7O'>,LQQ& QU :4LE '*TQ8D(TI*J5G%0(C&GF6=1H
M=)L[__,IWMM+R2\7[^TC\1XP\[@V*(4HM40!7AD%2@<#O@@'1E@;,:B8&\U]
M.[ ,ZY1E>WMI]^4RK'U$W1=8KFN#"E=8(I-@&=&MO$>@_\[7NS=5C$YD1U +72'J?=A\6ZQSC7S_X2+2[P>1CG16:&+6@%/=2EO;JC=J.OG]BY!<8&T4IW6+M7!^92DLFG!,5I2@Z2D^!,81 E
MUT77C0>-+@N?IJF?X+J=WSI ^MWAZ/?I?RZG>:V8JQ_@+.'$J9Q]=A&$* $4
MQ95U5@D9">=6Z&R*Q38/)CL0UT] W@)9Q^NC.XBMO>XD:%N83:J>Y['>=NDZ
M]#1"\<;9C$I*>XKX:DU,CZ6:PT%H?WEW!YGK\=H?Z-2F\[K6 85/..$Z19F$
MAIRDIAS&9@@V>4B:R8#29,G:=,OL0EV/M9?#@6H C72 LD>%]'=2#TR9">L* _WAK1J8M@S^SMQD>4QF!I*_GU!ZP$L=(/<.X+-C#Z+"Q MJ#=R7.GNO
M4/J*1D$RAM%/>%:Y47'<<)VA[38.#H^N!FH9>976$QRM?>^OB_FREME(K751
M(+3P)*\BP%/:"DS7=8K:N>@?%(QO79CUXA>-O/=O.+ ,+]:.,?(65Q.K;%!>
M.,AU"X$RD=1=9,H\')NY-T+H:T9>TWM546$'8#S]#2.OTAL6$P,)
MLH?HY:7R\*>JPZ]7V+_*>5K_DW#Q*-5D7C G@H"01!T92[_S47'@PG-E54I1
M-MI#T8ZID1?P-8B3.@% ![;P\NP:-(FAIO#0!,OK P&Y>5%[8#V3C@P_!]VH
M"F:0.4+\C"[;AU7&R ?O_4O>36_]]C*.3M)0!
M<[;+0;S[-^Z&G#.X46\HZ)'AL]T6KG9!ZZ1#8C&"X+[6*5H)@?)6D*H6GCH4
M0K@=\/+,5^P&D#.X'A]2E#T<5U>"V12;OEM\F'[ZO+JW/OSFA\O-3Y=\DIP4
M1O$,= 8+\IJ4N+@ZOB-KQSDZPWAJ^<[L^;*ZT#9&["Q.4O\\7M
M5)F'N\9K5^F--U[_S209)S*OPY(%!A)L70A1;ULD1\Q*%,,?)J%#/3P?1O!N
MZ#RC*_E3**X#?-YY>7@3ODY7UZG+!U+@XAMF8O^7R]7E F^R>ND=8\QK"-:2
M 18E:U]0@,"L4(YG(U/+L>E[D+I;E>D97>2W558OB<&R\I+^5]K;HG9,K]<;!A>3@+SG&67
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M]YN)-U>/5_??$R]D2C)08.D* Z44!X_> 1JA3/&*F%,@?;;+"W6-2_A8F)45(GS!,'6_7X^6W#9(#@MF6T I.P&OS-X
M91A#-1V!ID.A01!'Y+FY2HWJUIZB
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M :=S2@G,*+SMIM1GL&]< M%=+V+-^#X/#H#T'YP6"TLK7.7@2
MHI0>D='1)]O,C-N+S"$*QU_\LC]( :\OZO'ON'?1,0_2) /UR ,D;59CKT23W@S8ZOJW4'DL),.OD#!.1U
M77/2$(JLO_"(SB@F3*O[E[MTG),'VPC>Y
MOC=:=_&LM\29H*IW#Z"Y"I0M*W+K]!<0;'%%&UV$: .F%PCK9*O> 3J?MU-
M!WBJNTG?E7M,;9;WF&*2D#F#"+4X,WI)48(VD$665B@KO6AS[_(D2>-B:%#%
MSUMHH0,X5<==/?0?N/@RG:UUL]G@Y(,HNBZY+=;4W>*:DV0X!^&3]]&H$'VK
M ;-/D#0NG 92^>.)+P/(?\!(?'\H+1>KR8C=J EKS.IL@:O;0!TUCJ-1@2_TQ+.G0"PE821E^0-XPB.%^[8Z-C0
M_>=L^173M$PQ;\[*P!&C#QKH!..@E*7?H1:075U"BR69W>:+[X:0I\@8SV$,
MH-KYT'+N!"R_S!>UZ?9Z@ZAP4;'D%5CG2YUTY\"S+,!ZGJ)0J3@QH"_92L.(
M,!E&L5N@G=RM+B[!,W&EJ00M4J+4?)?-PP)*R$F'QE@-P!R24
M7%%>5#FX7B+U'6&Z0.T?_#BHTAE=$!N-ZM/N/B_7RY6MQ(
M:\//TRPR%XMV=%"S4G:,&Y/V)'?=RI@D$6ZNL U3>
MA!&_WY19*;*I8AB#E"T%BS8K\-%&T D-4]E(Y4K;A\\;6L9=LSE@B'6DF#L
MRKH]_^;]]_OZ0NM=(>-83DDX]:?OYXNJF;?SU:N4%NN]QEQ%Q@L"BD 2L\I!
M]$A9B"5Y)>>L]VTBKP.([>0E]$!\S$^KK [P^"LY]SLL_CFCA+=J*5\5#$^X
M<\@C&6I"*8D=].!)G"!39$EKJXIL4Z#V F&=O&$,@[,AE= )IJIQ?,"+NOKQ
MC_GOT]7TTUHY'W&UNEA+;I(3!L%\ IF] H4IT GO"]BHDF+6=R.OD
M:GPX? VKD Y0MHV'*WM9+Y_!7-MGKT+/L%A]G_@0_Q=6[\D?X^Z:&4JA@HD!!\$$#*C,+7E/2
M@9I'5[+-K-&&^@,)'J#OX.'74%!ZIU8]V5*4C0&T%)3 NY3!U^' 4M0UA#)0
M8-IL/OVSE(V;,9P"7UNZ#(;35==>\"-^JA[_MUF9+[ZL/_( A[?E0X;S;2]1
M.) ;VWS-!_Q:$\;9ISO?]P&_X>SRMOH[.L).\1I\SG5:LJ8P3 0)V88HG52R
MU67E[C0>?5OVX)NV]=9PY179$0,=30"EM00744,N/,7"Y7=(0OEJ^__XKS3XOP]?,TO5I@6*ZU
M,MF/3",,1F*V1"F@B(C$I(@0I"] /'M>A#%*M"DWZJD%
M>1#MO]!MO(^@QZZCOJ;\UO["Q;J"+U):9+0WD)+/M;P\0$0E@#D5O=-%:K'3
MB^=^;1D/R>CD'?T O6YKS3A*R&,CYS*^NIS%RQI/YF0C.0.;?W]P6)Y7+5C#TM=WKNM>$\9(E[8/F"75Z
MV6OW IE_?S--8,IX,C\3P8GK_Z[?"&M6V.+]KO1 IMEQT)SE=4$#[CD#G@03
M!5V4*3J>7Z13':Q6NO_E:0)!AI?T +A-+/7G$Q>BN&1 ,0FUY8O+CZP\\
MHPAKUD[R_=?B(Z\%_5WGO889\TW\W%6^_GLY%$5D28H9J6H;G^@8^")9U$2]
MPA$-O$Z,RXBA/N<]46TRQ S1"FCB]$.*A_2.1:>1V2Q4!"#$XCBQFSTF.R^G
M_D!?FS?8?MID3:)_"X4F86HW;M5H>.?\ H/'[<3=UR7HL$Q#)F.2U'HN)2H&&3P/ @D0[A+:_MG'YW6CS2,J/NC
M-(,KX,F_CU6"LBQ
M:4WL?'PEA71X"'YK?K9;NH^VQ[MFZ7LCUBE?+)(RU%I>I!*$4P'R6R
M[*(TRA;OC>AP$9T89A8.E3[":\9!^PYXIL!0__5UO)P;5,6#[1\=\ES^^
M@K&3W2R/D) C4U'4_E-&,N] ,RQ.)0"TQ8W4C_)UDMVB$,YB;>QM:LL#7@H#
M#:2Q:CHDM9+$@G%BC+Z)9+=SI'\BV>T BO^SG(GG@#\')CTSB8$7G[2E6[IH4X/W-?-D
MS=9$TBBMEI+#.$V-OQEGXEGB/>I,/ ?KF3L3T:I0F_,P0H<64'0@72\IAJ[D
M7!SJ8NT)->8;);PSG(GG(#DQ*7["=+>L&0;OFOO'*H47CC E,X:<@%FY
M[N(9- M2&48_-0LH"!N[>)A/##,+2^A"4@R)Y,314_^%_S7M4[F=3800Q<\%$3()EN4P=8:V.2!J^+9*A5"=*&%'$X;GQU&M.%2UTJUV9HD">_4Y8_
M0/L>5P]/H.S.0%OK5BO+I%"T""RU3V0VS NNN3:@G"F=;I.O## =!P827#,T
MBE.'SGU>TE]W$4':@\PY>T;2Y$QKS9D/X)A(-AC/H[&\B_B??72ZA/OA1=X?
MK8G%_)_/CZN[Q^M[3 ^D%M\TOV&[:QJ5,M>:N.JMK%RMS?=,](P;KFH! 9=5
M%Y%_=8#INUL_G?T,:F??N8[A':-TW[:].NA;)K%.X]!.,X
M \R*J(V6A6 5W98Y&*DA)=XE;K;+6-.E[ ]/D,&QG9@K!,=B23/?K.M=\_AP
M]P;H^XLE["H2H"A&5!-,&S+!' \,/'@&P7I(ODB=NR3VGQQHNF3_X5DR+*HS
M\&Z^:9;KEZQ-$MUB]>'J\Q4NT]U':#^LM6VE,ZK(.XM'U0$LZ34;C4[+U ,+MM(&R,[5[>(9\%FJ'48I7 )
M;>
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MOZK?]@_UOP@K_.??_@]02P$"% ,4    " ! 7VM4X@?&ZBT#   0#P  '@
M            @ $     97AH:6)I=#(Q+6QI$CK.@  "8D# !H              ( !*AX  &5X:&EB:71?,3 M-3!X,C R
M,3$R,S$N:'1M4$L! A0#%     @ 0%]K5+!R P  20H  !D
M     ( !35D  &5X:&EB:71?,C,M,7@R,#(Q,3(S,2YH=&U02P$"% ,4
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M+FAT;5!+ 0(4 Q0    ( $!?:U3&0^?[DOT# /T!)P 0              "
M 3R"  !L974M,C R,3$R,S$N:'1M4$L! A0#%     @ 0%]K5$LK6?0P&@
MKS(! !               ( !_'\$ &QE=2TR,#(Q,3(S,2YX&UL4$L! A0#%     @ 0%]K5!9#_PXJ]0  -CP+ !0
M ( !5&L+ &QE=2TR,#(Q,3(S,5]P&UL4$L%!@     0 !  100  +!@
$#     $!

end




:]9JJY]37)/+7'-R5/KPR_WKWL=U@
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M*J1;ZP?5!?;DAO\E0IV9]GBQ!F],UQAP,G#5,UD9[.Z
MA(B4,BH0@^;4V@7?3] #],'WZC
MDU+(!VPSN"UHKE1-?S#3*KSJT8!W=12\-\S'.CPWN-$D1\\FL]1_JJ^5,FGB:88*$1&A9V+Z8JHM-S\[Y51)%\.FH<( N2F/?'N)1D3HD,
M][ZA'":IH0G.>*;).H*B[=%#&OC1\2+%STD.B5]#STZ\CFRZ))]D,[Q
M>D0&%:@1I )C3T F^''B?GU\SDH2X7BZ7S2QT8+MQ@LKUQ(VF?PNNT_Y3:+S
M=LY/*N-%['8EDC./M$TY#-CE#:T61;T>'G5S>TES8\OP(>6TP);AJQ1YWEQ_
M].+H9T0$89\A0R,V0EX*.]?[;%T'Z=IP(RT/?K>>%K)A2!+@HK,]8P"8LF\:I9QHH32Q#R!(],%ZU+WYTCY&*R
M!%,(KA0VU;$)*L 5..SKRG.B1=W
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M1LL^/ 0X3R@BHJB_,E)6CXS4(,J
M&?269K"+X#9)2BFQ]#7P#"Q&>VQU*TR?*;[ ,'8Z<_A9J?L*J9=H2+BS+F!9
M1"/VF#.1 Z]7-3JJMNM'[7R*.:\W)%N'/-V)EGL^93]&%7/>?F(6PPZ7+$N7+S*G]G0$4\>>O',>41&Q\\LWYAP<
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MB>%-D:!^(N!K GCASEUMZ[+?K:DX.@2/G%'-MR:
MI/[,>HYO_D]$_/_U,YX:F0\++X3=($<3-J<-'TU#HCZ0UZ\T$+<1_@Y[5]K@
M'"6GDJ\.K$DT/O[VX*C<@<1Y:,3$^=;3QTW960' ?+DD\@I!'8=8DR)DV)'%
MB,DM3E:$>;1GF3M/./[2C1,!23*W4]5L3Z9K6F@ZI? [:HH96?"?>\W1UT^6
M1E"YT>WH#RQ-F1PD)5I\XU[JC4;:&[J4JPD9DD\UL$(W'.BRW0*+X)>#GEY4
M/V'=:M_N.]=V"J%*-B* 9EBH7'$M(KRT@C?D7(H3M!PO7!WC[T\N17,Z7^X_
M2JZ5FUA4\/8:[?.(\GB@GYF0\R8^3M:PV-8A,K2,P@-OXF?ZYZ]Q,ZDHBBG9
MB@'HT-,F/RNR%90@CK69\8)+W:W4HB,.U'^0W7&W9K.)D&RJ#AO\M)NVQDH1
M7H175+<"#Y)1>(YVE'#3:[)2*R8H1J$1N,2;>OHN)BO;R4?1RZ4!>$?=^K!0
MUXEPI8I#U2V"GM]J7G-8$/HJIL0)4TB\U "J8@;NQ-TUM*5Q,4@M]XMZBNS>
M\YTUF&Y60+AR\,CROVG:#_44/5TJ(C1<2N6=QG*W" K:"YM^'\5%ZV\:"4K"
M#XDT-I1ZX['-V,,P5W)( 4R#F%"GFYK-/B0.TU'>RR]Q83SEH5A9._NY4XU&
M"(U %#$3'
MKMP(79O>CA1L/.#!U?&.;+=B-3#2537F7^>2RFO:KE]SNKJP4;/O,+M'OX[Z
M-(*?W&'N(-8(,I^U;$2J?Y0<# 7@QVAGX=*M6S3Y8BIR;A0>:[[!>X^=A/3,PM)
M!@:T2ZAQ 3*69,$4>T^;INQ):#;I^>#^--[1/+FC!^7>"GP&[GB)/ZO>Q7Y_
M)ZZDV:4!,:5WTG+A3-"/;+D_!3,C7-3UG\@'3J1[.E5X#R[ITX^K^P.D^5'+
M_2P?Y+=;J'E5ZF>;32YP=6,5YK2,A48#9"0^)\_?(\XG4:[&UH$,Q7%6I.ST8YI'H5&#>8WX,U*B0S D3#U);-WY'VMX+-??$/S;BBE
M!+F,-]G>]G[I ^V7O:0A6<=&CVF:\7F0** 1KV!@\:K2(LX$9(BHRK5*"7;W
MGTT/O6INP#U\]Y^D5^1NI@]"RL=:^C%ITWV5A,MXKT=I)J,*I Y?3I& E.9-
M[L\7:>-B/GPBT?N%PL]]?U>4;Y$K$.L3Z#:IU\MKFK-D8LK>Z_YR$[3*13E/
M/1]ZS9X6"W<_3 B3H6H^N>ZN?)RW34OM_(3[^^2>)+7BADLPGIV7*6$O4/&@
MZ??!8RW "!$> GS-A*/U#-,RQXIP#L_" XUVL9V#"2J'S8T,5TV/N,EH[#F3&@8TGC"<,9%I/2U6X_[S1F9HY=#+7^'8\EY"39FGX8S*SXRY#_DF@#+5=-
M^T;G-+Q9N#CK\!T1^96@JPO\]N82LN_M?TE@CK:/K?)[@H0/G/
M^ON&QP2[ROU+"5L@ BO\6?=&\8!<+1<3KCO3C89^F!L\R/^O285_-(CVOY^#
M^",EYN^IN7]/8/>/]^_\_L=_>XV_)O7\K[?P10(;050YVDL]GF40G]X9:+JN
MBN'0M530V6KE5ZOA)U;$2PVYC6HT ,_\E_J*AT5+IYXHYI[G*E ])%?]08J,
M):)QB-4E0L\U>MT1K+H);.8(!YX
M3;\&':M 8]"D-D+%KOK#BHQ'0004[@!YAI9@?=TTZ4K+\\>STCKQKJ&(<"!
M3S9L L+EWS_!0?I*:$VW>I3;2T)&@@XITN]6M.KD9;][@[>OXI.-/\/7K@^2
MINQML!V.LF8Q36ZPSLFI0D#;MNENL.SG*7A4%F49CNP0.8I\TQW,>,;OZ$5WE_&CG<4/7]
MF$YV]Y>2:^>=6$NN%V1>D839'?2?%")TY@KS!5E9G!.):C3\U_+_M_G53^B@3Q5%
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M_D?P??ZZ7OJL[3E4H@UWE3!=Z/G=TF0O$X*,4
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M%AK) 'B-;HO-B2)QMP]U\CNE=TU1]@)KA>'(?N+GZW#"!%W1X
M;AQQ^BY[B=F=UUIU'C3KR)A;])[QS5='*37(V-?%G\A)ZX=Z[\M6A\K@--Y5LUH1FIZ60*SK#
M:6DK([!>63EU.A?P"/R+.P=E&4&^ CO# )Q[!UHO))EF&\#M$Y+K8!/")(:VE!IW
MO+8-0$GNL?[G$W=>'4G^M)M.CT??Q#Y"<\"=L.,>S_?E%8\S ?C#
M7P5/K9N_8,G2_[KS7.T8!W4S@<5]UU&Y5P220I$&A96,]:R!AN9#6;A=E ZD
MA6B@@_.0BNBY3=V^O^IE-#](YNR[8NPO@P+"G2%TT Z^9@ :W^W[Z^$Y^;L%
M@/F ]>.+ZEI9+\\*Y%QY/\F3\HB2[7W-#DEX07:B1UR%8Z_OR?U'ANJZE?E_A" F_SR0]O@[2?^@IEF5]*/6DC:
MW(LS_D0;J"YXS9[^EYWZOS<4_Z#47N#O]X7,PR3P#@<[KB0)-EA(?YTT;K(A
M*325F/U2&C#XMAS^VQ.*(FC9( \T$Y\P8YL6.?03!N XU>+M(;.46WGCJ)=!
M!9.G]1PJZT,=#76U ,J?SX<;/B^X7F)^+0\E]?92K?^"E3NGM?<=][ !9$50
M,V(<@G-@ -K6X_5.\F@Y9QT_)+;GNU(I'U 1,Z43(5YZKCD1<. )6W'+)ST
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M^_>'^TGOR_O=^+_[I8]>'_W+AO]!:OY0ZK_F6 =^K9XN332*7MZU*]U]$V)9#8S8>U?:S<^CH\6.CJP8;_>>#28\80#:1200)*V/M"P]$?-\QV:=+[*QGUB[:C.]U^BUXY* :?9]CY!W;H&;OZ(SP4=/%I).)%X\4G^YN$448 ZC;M :Z7=:L*(J:DJSJ@.4)M_7PR;'?PCX
M1M7:Z,L/,P[;!&W]@35/KQ8>3MN)8G#R\-K5@^XC .[+MH2%Z'JCX^?PP@>[
M:6)> [EKA<:U@KP0T5-[!IGQMI+0LH!K^-F0D)@*];OY$5>>
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MF*;QZ'R(W?;8&\K"HV\>K=]NT=[04! ,1]0S0CL)7AY!0.P0XRFT]@ZB>@68#3VN Y(*9)Z?YIR
MU+C]UN:Y^_?8AVASM[I/KW:?$TZX-V!K_>8"M^'U(@/CXU9N.4,.Z<%GK^#8
MGODFU8;R[P@2>UH#=],0E1Q'R/B0-2&O3%!A-*.@W\,'-0;S4T8.6UG"TW9RWUWN6XP8A!?Y@L1T&X)AF7_VK'T$3U6D]-_='//7X@:"SSA#3
M9V:,FKCRH2CGOC)8!!%8]%C"[C_
M?GV@6?M @G2??^%Y]YQ;O)*#<;ZPHC!;B=(E=:]5>L1C8L#[F@_F)NW@37'4
M6VO3*;,MO75Z'U.:%]J!E!_2OUW*M3.%*!MTU^PP%7T,[50"OTU;0;*M\.QF
M$9?%'(KU'L\CO2@/8/LK,SVI_C #G%RT!B!ID;ENU!W9_EAG2,<']8)+NGP]ZJ7TSNH+ET[K@&H0-
M9D]86T4,'JJ\^Q@=[QS!T6I]H[CX3^X'P_R@> W***^#OJ[^0T
M_AB?,"V1'6C0E*S/[$3_)C,;P(DBDAEA?0U.42(CIS/;,BOL$B;S,3#M8.(C
MDH.A?#W'*UBA_>QM4+B1\,H7/06J!:&Z"1%=F]8*Y_NF;.OVY?N9CI[>DRBV-6#=36J:3CHB]5Y$I_"+.Z[!QS=W7%U?%Y2)4
M@LL77DU+XQNY$F%6753U G"OUHNT]?/'W+2EB&!TE+J5G1HFT,H$)746?P/$
M<3;>(/TCB99/@X7&X-&TW7(.93CS, ';5!GX 8.6ND(_EDR=1A
M2#3D^-8!#O6H6>^:7'?OQ%/[8A8T .R=_+?(E"9'T3&ZD+OR,@/ L;4RR;,<
MDE>3/G.Y#BH"SA!\]5PTR4=E!>)*[P%6@I@&P)VVET*Z3BLZ*WK"?:&K%U@2&ZN
M\-!$&[>IY& #D2
MU@ZNEY #)E\>AM!#*4::GZZ>:0XO"\WU]CWPC37 0^ORB7\LA7O>-S&3<9@\[Q=^V47M&%MR5AN!NF,C76T6WXO*TQYD0'H*BUZW;^Z
M!J+#F-8/?1[QVV7>VX]]%L"_N/7P=+V1LTMZ:5*!&^=1Z(4]?+->JJC?VF'E
M_8*YP1PWKU-.
MI"Y#N]/02?O*W^<6YOZW*OCK(G>@B=V]J@X2%H.B H2HO6&)TOS:_]J+L2,\P<
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M#*QYSO34)@W\3>?#'(H[-2<[VB"_-K+\$8Z*57ZS]GYX)[MRYVVEHTE>\,6N]W2=G*9_@8#]I1>T#^:I\2+J5NA?^^UY+9 JE$M+
MN#N*)K1-N2QEF6 )964)'1K,@-BWQ(&7SFX^##M7;'?7#K2J<#\H*,3OJ1UF
MG'I.N?=L8I/EL8,9:;( >7_]Q.B_=!$B_
M1-DFY=!R&]G#NH!'G,G)1'7VP6Z%"EWVYF_@T.*IZMTZ^[O1BJN^J]E)^MPS
MV'+@:B91:H:E[;#WA =I<5 !$;>7A\#1DMN:*L)6>>]ZBLYE6,N!63%9_?9#
MYL+H<0^2*3EC!OMD(&P"4BUK/T4]GWY*1WAZ$?MYB'K4Y5O,VVM/M^\X?^#"GV9Z O]-]L(@,^4E,7/5<%#A;9\R;P\?BV2UQR_IAX#!
MOQ!IZ;W_HD#_H4AYO8.3,S *):*MD?)8ZH 3(';L=RF&)OE+I*.W]JA=3;IU
M(YGO![?Z+T)I^#MRW_]14WK+=MP6R3_5ZG4*(S]S$E;VT,\#\MOX%4_\FHOY
M3[7SG^R:?6)MHVKF9'?B3/D3F_,^5JYLW];"7/FOR^G
M:-.]&ZIN (4T@R9Z<-7Q.A9(-CWENP+1+2#A>#FH:]OKBVGRIBH>]UN#V,S8
M#$>]<1::*'_4W+<>V<]^L=VIBAD1[BN%2>O\1[[/*B-=LTF: 33TVLZ.S"8;E
MV;RLI,G7>^3O/-W_2/\ >,_#_<+C1PG,6(1Z; ;$LFR232YO#DY]&5A2,0'Y
MVL6UL/A)@/;TCVF65*4$'=;.C_EGLVY%EA)&9+5[I0N:3=85'>]63'T?+ _&
M;'O/JCAR-LWS13N^FM34_5'KW5!:3%D.<3]
MTN74WA/2F9]OO7?Q-KBR&9\B-+9DUFP6VO5"GO7:6XDF!V%09F$Q%QDC5
M8-V Q.)L/>AQ5_)SX-FIC= ZB8$#RO,8S,;!ROIJ\&W?Z)\S-;I-*V9OT6 W
M59>0B5=2L6@7CO&9]KJ,5LA!F*X\8GLAVN22!,@Z1BZLLE-]58J0<0M4+M9F2'F7C X=('[
M2K52D:*;10)E7&J[Q(PILM-OPSC(^83J%A$! O*)GO:*GMQ I?U*7(SGEH>T
MY=K9A#1IE9NZ]3NQX
ML_]F^)[]G$=A<*;O%X!NTUDOSW@ (Q@ _LJ>-3@I=!1E4!T."PANMT<<^+PP
M.X2::"B%)CHU)VKPLY(:G*$SG^BGJ$M3Q4MOLHPJO K7J )18O
MR2?[B1[]3O18N!SM:K,3-U^MI;6JYKUZ!B!=-P=8G74;F(2QF.CV+"*:%P66,RLIDN2\12CP>U
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M2L%=3&Y]16J>BPP$6+TVAXBO 5YH/Z Q_SRE/C(
M[0\5W7\_<2@Q)H;_*^FZ5"7<&+FOD0,*(L')YW#]X5-[*S7S&WMG/7=
MU!#IUAW60?*K(>7)4VAQT'0"G&"">@(1H"K!*=9N<*$M;+2R_51/'M3>XDL%
MV?EC[=6Z>[E'3Y_DDC]UP!!\O$!T+\D$: =_
M5 =^5'#B76%($9B"%1^-,ZLG?LSGC6['6P$GI-_=*Y%:AR7;*>AM+A?*S4'(
M0=MK3,\)-B07,0 />2!4$^#_\E RMF :O2@)(A]AQ@]<)827E>$1/?(
MNF9G1P;HOMRS!NF%=  CID[3D'0E,F*Z&N$%*[%O"2ZNLH9:\)CDSZ6HC BS
MU68M3V^C)LW^UX;!?IZ5R41QX5XP8[(,+H0#4W>=O%!*-4S"DQ14VK12Z_);
MN-L*4R8\9.[JL[^\=DQ>F?7).=&'>CT191\]#RK@&FJ3"CY4I#5L@MTK*(A"
MG*;1%Q827Q_;J2-H3V_'@^YRQ-&%R K3@K"=R<7YG]1
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M X=^0^[)/<0*D0D<]7=*B4.&93,]/9(8L8Q:F:7IY9@41YM
MY"MUG(O7(@HD&JO I(9,;"C'UY+?"/2/J]NEGC4AVW-JGW;DGZ;2Q-?CO\OX%)_A\FA-F72JXA7,:!.A"'01%Z
MBF0NLS%_4M>E]5L]S:U.,(LC.B;T0<[0E68& &=$'X-_L-YU7>V9266:S*^:
M(/9Z[]"JW=$S5![U6?]]D>"#(_L>MHX-55C7I!(/@A3?$OI&I-6#C-_.1X0.
M#C1#IB+BZ_M95'#?T,JE9;(_BG*=K3+FTATRRJ\AMEUR.;YG:1-42)-D36*V
M@W=T>C($"FHGS4HLA,,<[GFNI]#$CF[T<8A[2I1U6?:&X#,)FUBACXW[41I[4JE#\7I*;G+VZ11MS)3K,,$Z$;02
MS76U&U1.2ZMTQQD":7P]3PM1)R>
MHKNU58'/HE?QV5/;5K4L*Z?'@
M;JM#DS\+K]R9'GZC G&GN?8INC#LL09AYM:%G*3!-.&[_U35E7PV];
M9R2#22;^J[ZX#SKYK/R&*2=J4C*__U@+"H1&-Z_'AZF136;D(./;I-1&6R5%
M]OY#Y.'2B5"_,Y]B+:")LSZ'I.;% R3LS+Q+0_"(9NQ^JA/!:^P1+"2[9#*A
MLU-7//S5(?/X[5.)9("=YGJ/QP Y SK$Y@D1[=D27Q4
MT!U[J"CNG3JX5.-:YJ(!ULKS>8"CCQ?_I$LT:]'3)C CY0@=U]>8Y733 G<2
M)C$S]%"28,R-6\^&"><.HB\P <3^I>LWAN=J:=9NBHC9[X@WS?B4$TO#?__*
MI1:4_*4RWUTKK"R_JL?G?H1ZC[[6U>.(>B,SQUZGX/^.9G'U37>=_M
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M!PJ&':<"" X=K:!X!H#S;#_[W=%ONM_S?3BUG4Z*.=I9:VA7=[1JE5@PY5Y3C>G&T\"-8<=\I'?&M]/1U^3G//
M\Y.2C>D :;9L@/_>VH;2??NH$FNNU-Z0N$$EV^ >L^^9>D,LC^D"I.3O8[4-
MI[:W4I&3.MJDN\Q@& X[1,O8*F@4.Q3 P4?5;^Q9QA[3E$C/9P&OPX3VAIDKE<()-
MJ4?WZ%BUM\$ /_J?A$RUA=(HQ?N9X)JNR09(P8*I7X&ZC'9U$=-ZYCS]Z41+
MK6<03>LL]"_ 0SI&!/N.JL9[R7@367NY>FD%$=Q&]\O%19R#F8M^B+6EP74I
MK?O7XLKM\N>O2\G>MV!>96\:T0]%,KM_@6CVJ3].1(^,(V9?/+:<)3ARKUX!
M!U=6YNX^1BI:W!P1ON+;/E-8T=(0EO9'S!OD\C)53+5=Q\!K,BWIG?P_(VOEGTN^X>ZE6I"K"=O3'9$Y1$0KXOB%
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MGE[ZP0@5L:=R01!:#=S51)&\."5"M,0^J>28'J(JY/8&K]-79'=;3G_W]XHT+(&EIV]9(63]CKV[6]J/GNJ9,;-=*$.G]Y<&]6JZ7M%]
MX=0&S_Z8*1:OM^=!#?Q>TUO3B?$>/T8I>*D6FA((XZ@U4$(Z2J#7A&2Z4O0;$.Y:7:D].HYB]B8KES$U'M.;LV[+K[B
MC_GL'%EDG&1ZQOU;;Y'C=F7R6ACR"3J4=N$RR'
M ;C^8&Y];8&_F_>2G*B',K(=JE?4'LW>;I!P?1E@0.I0Y\O7Y^S%MD>2YK+2(WEY7,3=T8)7[3[DVYET]QXB%1'\-E:.DD/S_]6<_>]\-A#_D/OK
MAM(:LZ62B!DL!8"F1U5.PA09@"17'):RQPZ^^/SU4C[
M-A.\\ [U2.X[FGQJX1,J B[D&2;MAN5MY%]L/)783^%=-;)\#W:<@$]L[]PS
M7-SVO+$FIFVM>R L"%_;I =HE[=/RJ?4;8C/46WLNBJRJAJ++B-SH!>)/:TZ
M7$WO:I'UU=KNH*:"D(H,.\=1,_N[85GC4W;N/%TAMP*$")TJ0N\_.M]:/C0]
MG+)9N4 ]3B'=**L)O8![2@QZI)A9+8@Z2&[^/AX1_$BL,YO ]XX),9_!W=F2,B"19'\6#)C=%S'9IQKY4
M-RWLF!/%@V+_Y#UVG=\;1'M0PDKGMN08FP\5-(#-T7*9L1J8P->&C:)S04DC
M>DME]76#ZW=V=UX^#CL!;_&$/2!X _G_=CJC_%YX24;3-@]F5XEB^SA?F,9\
MI>OE;.COE7='F4]Q#V( /DE),\=5@F,+K9A+WS:L!!('"GHV7XEIP7=.KT]L
MDJ@,0)0@,X0THRN J!) PO-0--T)>_L_-I9>D<#6K0%7F2B+N)E/!,>:[[*ZUYKWFIMPH(C5Z;V,$Z;6R(
M\WGN6(0.^E:_NN,ZPT9/F@:RDJ\!FVW<=_H.T%QN4+A#6TU<+[;/CN2NJ%6.J]>O<^5*-'0#!F,\,;Z-4PEKERVH;%]
M8?9Y/>3K:((' W"D9/[>R]F?=#Y]9SXN (EX]X7?O6U?NMPJ"'^4[,TT>* =
MJVH&0%Y/B2YF_03] \@ /&=VVT;YKGPQ7(3,T@SBJI=Z,(T06GSF+N#U(T2J
M^GG8E1R_8HZ348?$3E5)HW!L/Z3Q=[L3[A:EU[HM#ID9(J_#0_HX"WCY
MY?)K]>"$_$2J$T6,G#B$LVYON!UJ]FFL_)".U$Q/*]AFWPS>"]
M8ML__)_M?\84N11GS?W!(QSSC>H?L<^_1.(6?/
MS1[K%.4\QXVS,XJ!V5-.>%C1V8E;M*DR0M6&+WLT7K-Y;XJ[Z]"TPPW/(/-LP>1;9HMP\Z6CS?J.Y1#]8%
MVCS0(Z[2^_I-K.O(&2UZPL3\:!1, C]Y?,QB<$N.B?/.4K[R7+IWTL?RVA:1S]A^WSS1K5OX\]]F%D"7A[L!/EBF3M90BNV'E4_T[M_H/AI+U<4F#,^RD)#-/$<]T;_OW)X
M]YG
M$#;D6/CFO*7\9'*@/5IBOG]4[CKI;*ZVNG.( C8)Y,*4. 2R;)VJ;+8:P533
M9G#NCH@\,:O7NS7K]NU+0:\IND5!(M).IW.70,5(E&4Q1_ ;S
MIB6%25Q^LRS"5<>K)U:!,/C0P)ON 4NC9Y1*,J?;EX($\@5>SH
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MJ\>A5Y+<(NA^U2S-U*;4!HM2L?+^^XW[A&TJUSH>N296@J%>8K[G"
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MZMHDS374FS-,6R]:5#!G(_+ZARJU_$*XKM\BE
MKJ+2#S!4H2E&;+-/]?,MJTBM$R[I=?/EC86CIEAU[U.9PEKF!G 98"8PD-[%
M %2'CFPW"YH=(F=\:E0D>L>>S5=[#86#U"G!$*F!I#MOQ6S/:SU9F[8]VAB9Z]*"GG]&%ADMT>&>4
MN'L%#U^FF0Z.3B(,H4[/D,#'2Q#'L6UDM,8],;PB:]/MLIW(2S+GO[V//_7-
M28JOQM3\U80O>$KQ*':> ;C5N313-FXBFU($=O!,,NVJ*,5X3"E(Y'Z#PWZ]3_(=0!F6E9#5O(\M
M SO@^ 1#^X5DVES@1C]MT['&(+1-[PBN4M6B@<-+E51D;)D>.E9YOYI6Y^&O
M"YVS$=PT%5JOSTBC/Y]L-!#>UZ(G2,B-&=)1PJT(JWWUKWY?<>DJ_-/5/;80
MGD8>LOT,J&7M,JXCWFM\M9(O,"T>A_.Y(/XN1/G]_D"-IDYQ:R.#D*WW-CJ&
M[#;&SX=RI3]^G)CT=>^U+S>Z4V"1*64*]JOT\*]VVNB?0:^Z$NNFK*EY16$8EW@]O2=]$LT.![6&GA\<,"'GP\':[WF7=Z51WS2L(_T2V;O%TIP'W%DGJXMSI>IS?M0%.AP'
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MX6WYS/>!T(_!W\,_AZRAW2AF&-#28WLU&I)6O+Z6>$.'JX^JW>EJE64OI";
MX^>;J5Z<'GMOZ/GL]\&ZNAVQ21R2DZK=>V9XHQ[)F6F+397-M,&F*IIN/#\^
M*-, N2RV6,OL97^:Z/]I^%8+COO$ &P%@G9NP[<#KOU,)XA CX\%!J()(]KT
ML3.((*KHU_%V9J\"OXTMWROO'@F)XIOIY>!%!F#?2)>.
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ME!!(>Q?[W'N.[GO>?J=G_R>8I
M<'91N/2&&BUNPZ^F1="_/R) ?*?J\YV']\"G=SE%VIW]HE79HWN.[EP]LG<)
M%W'6YK:DR.F/C1MV,0[]JIWN[QP,*M2E33K=EHL(K^ ZUE?NN
M4H]'>KQUV;@K'&OQ6Z&%>8E\4(3I[>?9 ML.%FDB/0*D-1IT9[YW#:00G'1N
M8%2/X618@:N>)64NPRY$HJST OZ*+LDA_.JIVM8=\H]JG0(9_1]=$V5&@W,'\<
MOJB7-C,CL%4H)$C 9#JYT#;8,W0>6P%'%+#%\&J;.F7 [XR&[/<1J%$$"DQ0E,E=X3V/ZRIOO%H)F]YVE;"^<'
MO3>;L-Z/>V4=4Q_;J5K43(G8\\GJNAO:>N$(VKUS%@-K,!/GM,6@%3%M+UI@
ML)/Z4+]P6P8WWS+>)
M-XJ(;#LX([.:?5PZ\!P_GY:X\_5XX[#85H5'?=%6R3'2GS*W&^^:R4HO/R",
MYT$).UOC"U&BCL*B#="VCC&_T9M8A;@G#"5VNW+$(EG@*9L/XTY&J-30PB._
M>T!UY[_G%ED5/HYFM,98Y1$,%U5)BS1E5B2B#8&W1P?M\RT'?,9\=HQWO?8V
MM^F;YV7PV^ZV9T7@#O#Q"Z\]D8[B/[)T\/2=\)28>
M0[G!@="/*U;GB-+N0,6 >X#_AF+@*G3;4$(XJKUVP[VJI.S^ZQO'[#4"'2TE
MI@OO&7OS,$FL )A]CAVM@?6A0IYRN5[21GUAD:Q^M#PTYR\%E)FG+-:<#44G
M-$;P*<,^5SJ8AN]&Z"YURH\LXE$I3I)%JZDS91>)D;K*9Q:R4Y^K\?N"H&L;
M:+Z>NSMB\F0YD#I#89NA>K\/+FR)^)9+Y5(>U>]J&&^UU%(?W[F[U7]2>P9N
M]XIJU;IQ8%,>#$%J8][+_QVO'\L4&'GRY3\CT\A*T(/0F2(":[#&/'!
M!_.@?[C\;ROV_M];'VMK KV$JE*GI)X]4X3K7EC(%7PDQ^?VT8&2-$<,85^DSD5X
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M#I*$-"%\Z5;O=+-6]\CK>##8Q6>^$'9<=.K%;JOSY?EA%\SV5]XC93NTWRBL_'D!6&
MCX_/U;V$WFTA2MVGW!K>F5WZ#A';#B!]Q,]^A06;Q^Y7>YOD!-IMC^O/@34>
MEW;\_*'2-$2(47I%Y?1:.0A>GA;47X.6:->-KO:A!.E.MZ4H=1C"1IC=4.(E
MY$IUYBD.Y(X<9*Y$YR/3A=H>HNKW./SS<7RV,B$%Z%(Z*BT(Y.L(D<^;W!1]
M9>X[X)\L#5_9,' #H:)NMT5S_/888D;.O5G8H@J6R04BF(ET;7\VE"Y,7 VB
MP9_YBJ4[TNA;WG?=-]X],NTHBBZ=PCFPRD!>I&9'RLV3:X#Y%^:H*UR5S43/\B_9WJEH39?6NE6G56H_^1PK&BN$S:%[&[^.>.P-I
M-:?3,?"LM*]([UZ(H,'4F?YSBF__DC=AG0U4/^% B@I+5T;I]H9R;?KE' CQ
M8AM,X%-W+P="@!(XO2\EGWZ'-G/S73TI
MA=*4WHUH:A_4,Z"%^,7#9%(:Q 4OERA
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MZ%O.8R#\<9+WGDS(+Y.N^/@8N-RXS-#V&6R>SN^ *T/ITG+S
MM1^CU,5O( ?KI^E<@15[?$!&DA$?V0G4/F*:4 6@NX!;L%"O-QR(^=
M9I7+,L5Z62_HD> O?QMB2[I>W[,RITT38 K!ZJ%+>ZEK
MU7C>7X=A>2N5ES?NBK.?[#3L"H'U.(.D9D0>B02&'$'NI.]SB0.Q^@Y^YU5S
M1QH8$JGE0 Q]SE%1(2>P*[]R((J7\9KXL:?@6#"'+8!'J0<
M43HVZ'K%"@\$/%9TFZ'._%:3+HID$_;JY*9&WN3[>-+)3N-; <1/11/E3:^E
MK;$^H[:QJVR%0>A3Q'1 [+*AJYB$7NUC.E$\KE(8W"MRO,X>EW]K)H.A9A?'=8P-SZCP?5!
M81D=CK_#@1Q@'J&JC8*DLE^[OIB]M^?!W>4B]"_.6Q)J-P;$-%X"C=D!#\55
MMU2);KF'33V!M9!I*[CE*+SF4=W7TV:<(I2SX9V5;>R08N4?;KK4K9
MOUJ]4@@@#3EPC>RUPBH46.DHO"/!?X&Y(GA\M:A&= 6J5ZTP(( Z9OWTM*HD
M]O,O\QQ(N]Y)NMZ'-FY1U)TMAWYT#<95NBG2D-08\!YW-=B'
MEXZ.\[HMYW3X#&\B!'&1"7<<77Z#D\WM7$MXQRLM/
M>A1]XM8V"0QOT#)Z>GO(8@I+CJ-(6-*%J.5F7XO$#
ML)&PXAIEBH"6$ B&]4X:(CJ;VFPM,/"
MH7UG-PYDJ[Z:<@^&5(W&(#[-[:KK.OYR1BQ5[=O^)D8.8HH 5XS)ABK"TO:S@
ML\X=MU=1BGS9:B_GX&?9#; \Q+.5]F=&-KYN=*?TV8.X\H>(:\II(86TZT*\
MAS1>#@4\O?E48WN5:L[C/M@G1)7>#<)R54J=[=[/'M&P0%\]CZT.W5P.1G0^
MB[6,(%.ET6-CB4+^O:L_?.'3N_G$3
MW5V)]ADWE)J.+\246@VL:1=TV,IP('S3C,M(^!3=@W%GCB&\,(C,TB[I7D-?
MD7"]O;KU/,:5A5.5X$"@RE*U[<*7*M6;/-QN@X;<9CT,)43#SYV^$,28LK$5
M=[O^$6?;[(X9W<9$6\RMWF9:[;.-C0*MI37PC/S((@1#0)-& Y'T!(8XO?.K
MW$:3K\+Y@V4"P+#0.+[H20;Y-@-%-V/O&D'"B68-1>G(!-,85_L@D\Y[AV';B//O>0450=CPRO&3"PL1"RS0H-L)Y(E#)P=W%L4)#8,>CM
M.O]ITNR*B;%3CEVYK
M"EK,.%3\A^[O9^*;,O\Z19>O3\8F88\Q4GW5'BC7U)3(*I\V6O1!
M[0="M>=?""T!\U*,QRXP(877N%V^=F41^LY7^[\3OES"N!*X'=,@D&,\W'P0
MOBW;'E0CLF76=@F1LE/"W)%3%Q\E^#]VFCG1A!"1O=_39Q[OE-ZE7G+ZZ\.!
M=!&+MRM,D_D:$+RDJOR>_O(W41N%*6@1G!P\!@R@]0*;25]G1X[B7E8&A@L.
M7DAWFVKN5]EW^%GU*8VM[R3�\ U:#S750V(1R%.FD\;Y]!0#:0/%P3>E6B?7;5F]']:9+<'N%;G8
M_ ]#:3V:MB,E3KY8CY6$'ZL $K%/,113[#ZGC:22()SJ=_,2*X^8L#FKFSLN
MDAOUEW[EOB'<=\MXQU4^)+;D?#AM% **D"(_ R]F! DG>+
M]Z.XPBA@Q&4X8\[XNNV]&(]3IX[/5)
M:7W"FAT_?/67HQQ(X58>?5&:+.5QWH=ZDB%:7:&7?60VLGB"/5QZTIX7Z)*Q
M_/(K=#ZJEE#II?EM!;[+*<]Q1+R#?/_4F,TGPH!UME&#FI I!,8SQ8&$X178
MU\049\Q+9G1![,)U%$8TW$-X!5!. DN@P3^N?I65C=J.ZL5#V2*MXX#X#%OL
M$T) 9GC&=O>WCH4' ]:.KU0GB(F'I9SO7O@&:9,AUNQ4.HJ+  $B$VB5XD ^
MK[''LY;3<0GL8P 7"6<=2-)]LD)9E!'(3//*(UI"$%*-3J)_+5N=[.@[ZOFP)&&CTK[KW
MRDTI]QBMD"@I)9"YM'QC9&C4*B;:Y_M*F?FPK[EH/<'4;4^FR996P86^HB(F
M=GYT M!\9:1Q1..>TM9,A3>L!D$+H7%#@B'-F^Y9Z>M)K:WQULO8P;NXV[KQ
MB/HSW@6I?IYE,3B;QY\A2ABY$$U$0&?53^#AZVX4?)#:+*X8_-GK=-QI&1%=@8)$DW6986;DBAB@[,F
M<2#\[527>HQK R/2CS64XFM/]#T>3'CK$5O7T'),E>G@')+ 7J^+R Z"EU<_C#QSN)\
M3LM)S9.N6)G'G;2R4M#0KV@PAU#^'$@U=X4)$\=&.?M<2[2F/*
M*VXW'< .FQ2EK@]V]JT))<<3%ADN-7*KZ2CQ6RG^IG:&:[&OUB>E&+-Q%<)'
MK49Z$\H*.FFV-Q290A(T?7Q,3L663'I*_?+)QF@BF@M^36=E^_@E0-4$():I
MRR#CV#KH>6[J'8;71@E5+.R@,@PW8_-Y#?O^7:"H8RPOTOR\1L"OUW]!7^+2
M]41YLC)J!0'_N%*@C] 9QTYXL6\%/8^3SF'>;Y '"8.I!)1U47DT72MPGG-EEKFPZF]I
M_BDZ,*=L"45)9Q-OW=1IR>)B[ZSUUOLN O3R+G13BH^,G#<]"I71XE 4(YJI^?A!/2G
M J<+6#+VP>!AR):G9[@TP!&V-,.RW/3X@/(C\"(_+/FR$SF0X' .)!/.M@!I
MM-12.U//D*4/+ 5Q((]AR5:L_>#M@ARNU1*\7P'VA,O*E1_]QY122P-VM21P
M;A)VG6;;%S="J^B=3'2@,)1&F,7#5FM+ZAG/*W9Q(";T^$ $ZQW9+PY6/E^*
M:.6^0J)%%95B"RISIC8W\011&_\G0AZ^7@Q?<-KPXL"&XY@Q4Y=/QM[$[;4Y^I#FC4#J8^ !E%MO#=HQY_D^;BK5:-?WPL]GBO@_F]
MEC-/WW"[SP-:#_ .N6A3]7B9&,&C8
ML'&YYA(3JU8A_52K*]G#)DEPRY(AV7IL=-"@EN9)]9RN$PAC"W2?MUR)50Z/
M00>)GTQ'NT\:M?AF*$U5T_^XZJT>
M34Z4 _GVH(4#V8*F=_QTU%LON 7]\S<.+UQ]38XG25@ZQW9D$.YNO_LTNMSK
M>%G9S\L7ZO7CP ;_ # &SJ:#/QWTOW\JS_Y_Z^S7/EE?X[*(^!*KM(+RFY%;
M3VW;[EIIF./I^3,1X.JO0' @&N5RS!VP<>T?#ZP%K^^ _;O.&F'%@>H.>T-BP.*)'[,4U\[6/N'&]96GSI6
M:Q/GRXM%KAO"*C2_'"OF%:NE)N/?-[,?S6V45_&-0M]T--8*G?;2-]+5/^V"
MHG6XTU-3$)X7UA]TYG]C:VY6'0"-8Z#\S C^,N['
M7M.YV#M!@*=@QQZ#,2*Q'(>U]N?XI?N?H&N;=6=-_W1P
MX.5A)C\W6%=D\Q01X<)Z8^T[Z07&92$^>F*ZL[U7MFE>5NU(.8UZOP-$DKCF
M7 ]2WU^D#_W^)GW824U4/;WS;HS /7-(1..!B]M"UL55B(0*BQJEBH_1A;/:
MP[BACJA$DR7W$/T5[83$6_:O)XO.4!^[6WFGQS.-Z"Q-[\9&H+]]W*LJY\ZC
M;E59SRS'V8E!ES*S CW>#+O#-U];]\ /36\/4IA.%J7 PE7M/N1&$F'_GCTT)]U8L5].0,G,8"CW]&)7F=_!,C^!NJQ;5$OO
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M8<7(H*WI*I I?') C^8L$>:@,"-DM%XP@RN*2&$Z*]J,+=+5+99N-GYDA3:
M5E04Y.95=NSS?C\>*4S"*;TH!0IT 05CM[*E*!M2>YTWCN9FW4IAM!ZSE/?O
M.W"\'!,$+S0$P6CHEGU5T'V%">NIC&+ :2D7MO@UX2X'TNB"W5Y_8X=ZV3N>
M604XLSS^T2PP5A9RCLGO=$])NFO"I! ?,W)V4R[0@2Z*N4/%LW;,XRD'.)#P
M>RZQN),VVOK6.<8#P[E7G\7^\DOQ2$8OSIM5#GO0ZD"T+9"K;O>/,VK,T3Z@
MW)9_'=9? C$_\6R;",]O>KLO/X>(YEL0.9"]R,$&6_GNB#Q2^WYP' Y>&/<
M_(ZU8[+VNBSASE,'CQ+O=SY![?>OZTXG7TA]M[.HXDGIW4%K%:VF&9]AN:16
M))X[[HX8ST//8R6]3>I]!>6+[S:H?^)?^J8LJC"#[SBX+#S@3ES\+*
M^[/<.ZMFAH[/2QSVAYN!-Q$B H76//JNV8G=_L0D6G_P@6,1]1C!\-C7P0\T)/I[$F1@!T65PJQ:7\-//O:_[[Y#O0CQ][. 6_\E[_3'\\\O
M/_]Z">*N#['[:1HI4##,_8LDQ7K#K72 ./HBFWGCD#7K6&.4D=MIR&%?YO16J"5RC59+5R'RWZ3KU5K$)39+H.EB#[]+-L%6A$Z$D9TH7,@
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MH]RXHX/BJ89C(EI4>":4
M?00?ZL8PAI-J%#B0TJ,HD)O=A3I<>,NZ")\\V\=4A->",VE\L8Z0*L+ >?DC
M=BRF[^[@0/C7*3M@= :]70C_+J$F_FG[)/='/&4)_V()M+/H*D28L"6C890X
M/XWH.W4"[%?H3#[U-N, ^YNB-OT%OO;R0S4#!T'P'4&1)=!U'QT@=%V_VR0*Z HDM\8-Y'DTZ_1DFX*%^([IO7=N&A<2&9)$%Z,<4@L@W,H&:FB+6FR+PYTYY
MF'D,>0XK3!C6EP;[N!A-\PR:A"T-HC@0FOP(_@PU0:IZFBUJ]^E IJ8))K\\
MP2TB)K-EQ*VW-[*@Z8O3L.KF1VE&J.7AYQ68A8S\LE4O)ZLU
MF):Z"*H=I&$7'6B&@2.'OA7F6]R/D[?OF01+=.:X1]^1PE=&LCJJ%& E.X"+&^2L*
M[&=WL'_IXEG5([L3CF_<3MV&<1Y["W)+*U1CGXGL:+BO');^WO/B/GIH_=JR
MO'KJJ8\"DS;H0/QMN?[1&A^#2(8"4BW$KQ??D5)^>_%-;2*C3[N'?@%=_Q)K
MM&X<(#PRV\J!3'S 9[OE((+X+\GLHG47!CWNVU\X9
M!D&%5N""ZFA6#FTY96^+ZQ0+?6^*D5/>XGL+4^:71?)F_0)VZSM2HCIY9Q'=
MQ'X,OW/&^]>SP -$D-ZGB&%KZ #]2_@EI2;FW#(-7^![ GGRX0Y^HF ,;.2&
M?H8ZD T!YCRDPUWVR
MD^G4(#?M@YD1WHBIC>9 D*ES0-]LC Q*R%YRJ0@M0'&8W\>X2-]JAT2,.3RK
M;63GNK"V(XZ9S(J/^VQ=C%\A2]00%H/F^PR^W>V\[]JU4.V0L?,W/Z&',N_?
M5]R\Y_#FWMFI^MXD;=;,191K\@BO3,O9_B7BB"'$5F16"7JC8'\A)8Q=+@KN12]5$I.2G8FI3/\KK5,")C&B5)=^)
M]NR;Q9!1M?T^ANM>[:WM32RZU5"R%U[/A3G3 ?_6]_<*7FQX,:\A6+H
M W&#G>) @L$+96+9USF0A<9I*'/W8_X'"+H5OK_O4RUZ'G:N+?0Q,'$DS-L+
M^PW[D\O'UGQN>38
M'MFSO$?VRS&?@S,_B#5=$CJ5S72\3Y)WN7#;-XW G_?EP$8W_D?0Y/1#BA;D
M'SPRB$677?>=(NZ/-[5/E4?8'B/(#X;D_6N"3/]%H&D26@)CQL/0P#PXTS<.
M]GE2RMDZF"!@?CLX<-X;?X;_:4K$)='"WWZVC]O7/Y[]CB%F#-]*S?@
M23#*&+!1#F7FP1AE>$^*1=AG1  .S\J!#_C [5L6VBPF-U5][%T\9,D^,]U,
MWD9Q'M*#,^QV]I?-%/.CS"J'+=MJ^HZ#OJ40?\G16&N=N+H;S0
MUL<^F $0IN070( C*JK4!HPSXDO_F&6Q!J>')6\.$2^V<0X'TMP.\B,2#SV!
M [D$73='>CREK\$UJ$W$#\%UJV7HS\O
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M^9SOLH(^O_-I]>'G-QT?ZU3(A5G^7A[WJ1FXJ,A-1?2&+?2+WB0&]E!^TNJ-ARJ/N3BE)CG
MNSSYX3:?%=/%C.NM?$[PO(@X7/?@\J73EPX_'Q,WQ^M3M+=@[B )2HGY\JCF
M?1[392_2A 430AZ0"WO1+H2FY#7NC@;3UAA=;I_,D;6B^*(DO,"5F2R7!)PY"YB4 "L9TUCQ;Y_
M-HCH(;XHB,P@6M!5GA"!%Q8'>]^07(W-BF+%#'7B.WUD[AQHD8X5]7JX^W:^
M:FOM0E^-F'??N+@4?6C)^5O5PPGBQ:(G/9VZB@1Y:P_/.(5.?1E;VKKM85+C
MBZB49T[E-BT^3^34UP:7&"[@;-M4HBX^)P:KQ^_TE-&S^.SEDL!OK!)TO1'F
M%G7&C;WJIT\I(8W6CH:Q]Z,;8/Q,G5TI=\G%E]_<.(*:.7I!Y(#WGB_5(ML.
M,@&L!2M<7<4%^@M.TL)I%AQ\$[VBGV)?]]S97ELZ!A"
M_'.(2.NI"\")GG?&NJ=]\\+>>=G+>9[XC"V,KRPRU(/)G1@_Y%ZOE2R?>=F@
M+U__R8S]@PUH)NBZ 3MHQN_UBST 09PL4XTN3W12M:-*U/TVTWMUT$XN-LIA
M/O+]9!+Z[2&^Z*?@;#D,L9<**,
MY)VQS'G;<^.:L,"W8QXG&\;[E6Y&09J4L$UP.AQ8E08F0./EDL(6GE)&FG @
M4AP(PP;E&D^YKZ7/4[B8HPC?(O2@V2@W%7-OJ**KGYF.CA"Q41Y:
MKL_4+BF(9YK*K6,JA:+'Y<21,N;0'XOA["^'\
MF]W>5'6Q26'E0CA#BBE .13E>XW>CM4G51H,J+9@]R 7C?;6/H -Z.P,.<:5
MKC'8W]<__>CSH$RK_2N]4X_S1X5=BK.5PM?Y+L-?"SOZLQ3)#B1L<'YQ N.TKV@W
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MV4<.^BO4@C_%J^#'B^-,$6/'JNYSQE!@G]G9ET$TFU4734^K[N(R[
M):/9WD^B[>T0R!Z7.F ,"\]'D+1@903:DQQ.LGXA[
M]5=@Z?18M8&E5$9IPXA;)&9 5;;NH2(_%;7K@$_#[FG;WI07!Z_;MKD,I^?&
MC)8E?O2D[\NCLH_;^]HE/#PN_D8:3E$4
M\^J110= F<'33PBP=LLQRPJQ;-T/)FQN,X:/CN^&LR_7UXZW7H9TW?.X+=\]
M:-D6JY@-<>V,QOUDLXJ3
M!]%$30@J9E..:!<(<)\_!1D!2"):LD!G./&1]0X[#4#/?4U08K>QV^NZ^$AH9.ZV8TCI88PYD,"L9=57
MPP7LW?<=J Q/P!.HNTL!Z2Q^*0;!-@>V G5"5,7?DZ.A;$O4D\TK[8:RG1M9
M5<":Q+42L/<[6.]'+H(H,(M:N=6.O=O@C0@'@IG=4*%M98$W]CM !.ET:-Y_
M ,1;($ 4^!T@%@)=3_Z*#WWE@E&2%,/=#PWDMCRM7^[%%$RB"S)%E[H#DO.?
MZS8I9C$-<11\#5N9.*)<KK+"8W["FZ$<
M3UB/?X]]F&&@0%R_F4D/3HCZ_O](I0>[_)7K]USZ 0YDIN*OR?0HT+\&;>5
M>L"&D^ /AGLV9#7]1O1)<-&';&M#L%-+1B_6[>9GFH=_JF?\,]%?\NROU&7]78TS_Q^3&'QNM_K 7Q!_[YU\*=.7\3XOZV
M_6\2T^D?'OWM#\?_ZTDD?^>CFD*;YD"BM:F+K*=P#N2*U0).&&@Z1P$/$/VB+HK&$8&"E-!:Z6;;
MP2<&9\,KXVI(ZYZXBH[8YMY>#J03IOUU_^U0=F?L/B'IT^J-F@<,SN*+Z*_B
M+L1VQ5X?'MFP;E 7YT"J+^/M@&#%K88=;!5'FG!"L5K02[V9?'#\>@CK/BVY
M?U)A7AF5EN%,,YI5-F,JFB_E?L\H>:6LM,K'OY?6%
M89^77W$F_'JN#$V[T9V/>:B!A7;#QM[ "WK?^!S/H]C!J1FU+NNB/C?IT/JX
M_;.MBX?2-1OOO(5H BJ,TP(-OD(RMT>=3O2BVXQHQGJ=B>@9 9<&)"PBZ=#E
M11&#,)Q15-9^EK,F]%BJ/ %F?8>>KL*Y^@5VSD9[A"MUHM2/FEN[*F/*.*73-1]/W>6AO
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M.X;DQOT-4S@5DJ&K.)EV4:;YC'%'ZMJ,ZU\*U\<+S%_?-( 33Q(W/.-_[6*_Q[XZXSQ_G9QT#8W<2#L/G@@
M,G3E)C6TCH_J)L5G/WJCEG0GEU4LGF"/4\#SC-2UZO-W*6+WU.(UP5>R7B62#G>NJF.]&*T%U]PJ=QO,!>\TF
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M#L>:S,"5@6K0YT]E T/@)'+?7#5J0)VB'G>(>$;O8 )2C0/;NE=GZ7Q*&T&ZBE;XD)::+FF46P9^59([K&Y8^=
M'!WHUC6V0A3U8(' "F%B#NQJ5T[#X4]=ISIWVD'GWT-2*$+O-(7HV=/*T1X)
MY3XEY3"W@".Z/+O-]7Z-#=XN:&1\_:>"9S_M)?Q<\>VO.30NNG_+\CB_Y8?,
MFGDHWF^= \H$B5T_TKIP5J\#%XG6X_)'W \6&Y6L5;:CO
MV-"Y%>N?H@_;F!;UW564'6OH=3-,8NO$@59B(D& XL*SJ.SD0KZ]YNUR;\T(B*4-J.=K2JUDR@)CF9B\0I.D6+P0<*3EPTI@4=&/-
M=G3#/0G^%5: S$=3"G;JL7'7ISB0+L^3*+C$TB*;]QSC,G,?G>%*:5L<&ZU+
M.E=W,@.XSZIP6M[;RW;H]ZV-;.N:@?/W?1=F"MM5B_-1DOIJ14=Y
MD=IZ7<=Q[$'&?8)?P,.BAO9/KB-&&KX/[CLH#;EU]TV3@7OTZQ3C,3[1FI/2
M0$5^@@&\/FFA,\1[A"!["MB'+,OKH HR90 _D'WA\HA&^J@ 0$OV*MZ6I35
MN%4+LY8F; 6'.4\*E,7#.J&K+D+@>:"Q-Y/5KV.$;ADXTRJ]4QMR_M@Z+5+?T?2>JZ=?X@/?%
M9R^Y+/*'V[?)L*1<)^:T3!.S?U,IJ,->B*9^"(D&ARDXQ>#SN,%!=S^<@:T!
ML&"P-KU45#9J&$*5JS6DO\2 0,.%)EY+ %IPJ ''I CP&?U4BF"SN@!3)NPSFN5*TETOR=_,
M@QB>FBHY)2$0TE&YCL@O(D^AUJMOGF-G4%KY4@@,N'W[HOO2:+P[IK95QCI^
ML)S WLS1^ HU_;]3M^=WJ_)#T=#^[!_]T/^4ZD/_3SY;FV'_(&/@(?Y/M[^?
M*CIN2G_\F7?X@TK(GWN'GQMO?OZL7. ?X,'_OO+4'QK^N_K[QYRHY?3-8)8U
M6WYJ%LN86"9BV*V&S9]:J\3^'@BBWF9>HE#B5<1$5WWNJUI2?*NJ"':#*XU=E.)!F#H15MXZ@QV(VXCF0
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M*,=C+DPH)U8Q7C=^/-(]E.A\H38YL@S$!6F!Q([A;II[#D
M/3XD#B082C%#$(*J,(<4R+8V)C?H AF^&M&URC:O=DZ^ZSKE.O)U?4;HO>:A
M])/,&3[W]N(S'(CZR:T>J3(A?'.Y]N" N<-SCF)1]EQH=Z  D/1SV[
MON5F>UU[&)X7Q]]/F 4$55WLWUN/?+U3%+OZ9:^2B/09 :6I,N>T;+I'[8A$
M\&'J+G][5&3Q]TY:C^1.OTNW'CING18@=-&*6 GJ1U"M;#D*W!]WUC&.D)Z2
M>OZ">>10S-E2>Z7M3[=F>-@@GN%=@0&+2Q1S]#L7J.@CQ]/SA>4^/A_$,/)?
M(C_F)\I=UX"^\(YC2B\& BL&*W),P2L<2%V7-5&[IO=.*Z7OTK'$J$>.(*AN
M=-P: +*L!=9OH">N<,2L=6.8FE#*\&@^E"4JM6P
M8+Q?0SJ*]^$3@YC9_WH)F3KPA6*#DB&]*/[9$JO&9X4^I18-&Q7_B[SWCFJJ
M>]=%0V\"TCM! 5%I*DT1"$H7$1'I B(=A(BTJ"$!E-Y!04 )2I,:*0&DA8Y8
MZ(+4%&PT22QQ:4*XB]^Y>^_?^;Y]S]UWW'W&V.>/^(Y:)J%*!UTR93AIHT5/J4S3A$IHJBAZ(1KU$__#0
MMJ6OVS(/=F*!RP1><"1%"#28#!-[?]%?"8 4W'1Z[Z270W=!JTH%)/Y+-R.6
M1X8N%M.LBR]/E2>M9F9OR,V?.,%C:==6W7]#=09&LD>"K.5IX-[K(")GP-EU
M2F'.8 0-6*J0/H!FN]\JQ<6]CN0*&7O0F
MJ#[,5DUW(3WE>Y/WMZF+]OS[#.]"$FPH6&9*%?@LQ0:L$$+&LIK_^[>02;"Z!7LQPLSSGY
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MJ#U8Z='P2C-%=K=]/P;^"M1@9C5,9&(<$$J2,^!;6F)R3Q-3MX6\CD;+Z/N>:
M5>8?;MV0V*?U?H(+Y)K\R_0#8/>(2=AV->AZV%\FSGWNKY/S=QB_R,7WOVD[
M!?\#.E#_MSY6T?\1+H"]_K]0)?E/K4J!Y/'%,II5.^7C!]U=B&S++;DG!^S8
MR_,V6<,=-V&AX_-B:EY.P-;3^(,7SYQ@/;D+N=D,)APO8>>V>J21:H!W&&5UX/LX9?5,=(SPY&."16S^
M(3&E7*<\8\F_)N'_#D7J;\W4%R%X:A?R=]I:@%H DY\IMP9KPF1&JJOVNJKC!O5E6NP7
MUVZ4/5GJ2N3+1MUG*?.B1Z%>5GOSXD="1(6$XWFRA4;H#_3^7E+1I*K^\40]
MJ( !S  ,=FV)Z$EUJ>4?")YK7I>LE&_IM/W-J-B3GG\UW>YO1V_VO
MT9)!S_@>[,X-ZQ7P4T R-Z@K!;3/M&7
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MA22A10RXJ/X#:>3M)*-#K>]:9@O);J\O14EX=G7%WCRA&E7SY8]\"FGC0%6
MM&%]1ONU?K[3D2DLAA?>0?SJ_[OMD/_(CVMH%P(&(9$@""@5C&BF+/P:AJ?!
MFLV;&Q!E@W_R"!L=;S\/841_MX7C'4]''JN!L#B(RDK4KE%XGDZWO*YP1
M'>5#_>7WXLH$=.8.K#P7MH-JF
M_.1H>=Z4]:;CA8^?4(/Q*"_/ND70=\]8=!M\,Y)NOU%0(K.W/QBP"^$!R+\N
MG)Q1H S7%&!\3GJGG+\EE"OV7#(^ZE%$J:!+ YP$[\=P,^0IFTP)RA6MBHKA
MBK 8A?9'+UZO
M5;@IZ[BB;F&QU(=.M69?(*4E*VB I7W$=7
M:T\2DTN*/]YB52&;06*@5P@93%' @BR8W'6*G"4T<-H=<+L4O*4T<,K,)554
M.8FZ3_Y!,.G7(";)4YRA&K**3? PFD3:/%EA#='!" 8]7UFPS>P\E% H0]'!
M_=/>@ -L?_ ?BX06-XQ0\%S\RMB8HO*;CU*M"NLW2O, 7L@+LUO07L+B'$UK
MIQ+I=HL(F]^FW:<49.ADG'H5Y(I._.G0F?LV-CSEWJUO65\)2*W!W!<_4H?9%7
MFVBP$E^82\0E:VXI*TKQ:>][N6QALA)[D(K?F]@S5(DD,'!.^@?C^8)L8LH?
M^A^N/7[VWG/F@;M3'>?^^4VL^KH-Z>BDEN+'T*Z:J60Y0*>OY_CB^M8:,3E'$0-OG=@8%A_1KGM?S#\E^_FOHYWW]^
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M]I]@S1E2?[EH.4"EM>+U8!N ..FF
MTXHI^=VKJJ?.1Z^(3_T\KK-3R\5M.J'AH:9U-)<(L>22*A7T:8"?![-33I&<
M64V-'Y,:QM6N/7=>Z;QPWD\RY3!KU"G#.W-6_[3Y_&\0L7]C#N/?W)P\&G;<
M/"15_]%A)29K3TP3Z+0>,#,U(N4N?39KV>E!B>'>Y83=84,,S[N^KS[0]>;Y
M-\H9KJAC((S).6.$C:"(<#(V+A*6A-)(=9J.#/;F(/<=L3AL:7#L"Z*.<)<
M17&@)I@R<$D&"S!-@LD&:FB-5?T?N>]?
MJMO\I\P5B?;"UO(@ES&M6$X;B'XJ%<.%[@-IQC7!9)CX!X"'B%Z([G?%9A +
M7K^@9&16*LW4+][$;JOW?E>$=/@\AX1*#0?//V,KGC8"$=@2**M!7FU.#*L/
M^G-=7*]A.D\J\> YR.-,6X^?4_^Z8>^ >^Q]@<+,"V]8_R5O4_^(7V>PD^^Z
MF90*+X^!0*Q?K-JDISXX HXHT'E7;;#+" DY!8]*THXV9(
M*9F6CG=NR1XA4BP-I"%S_SFA9X;H 2&$0W0GR<"6&M+#@KA#PU >?,ZTZW]-
MW(BQU*V2ZL>4+,H'[3N1>RZ6C16AS;(E]G8-PXM4+$?:O3,ZYC)PE_I['45!/Q'9Y;8&;FANN1%=U_SJY,/3O&W\[>?
M&H+$B/R_1ADL'MTRLOF1?BY09&,7TMPV,LX!?'OU+G[9'7%ZD%949#SR]&7(
MAYBDNP-7*<%MI;P+N@\"2[_0BN1+ZA2:6C.YV5HM32_6YBT1>9O__QT=\M_]
MG#Y"&3)4+**X%\T+"\%*,(PH[HFXZC4,KBVMLFT*KF-_M>"(L/$PS-"KP&NQ
M,^"P4QCD ?MS>A5M!/1/,NHM_CDZU4@*$4[+?/=3_1"!7)6&)\E._/S0R%^Y
M]LN73=7SBM;11?.A!R:RNQ"1_4)R9/5)TQ$/W"W4S4OF*-.0'G@?=YUY EF (RT,!
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MB*71:G"M+ZAN&];$UY[)XFEE S)7"L$8GA+Q5[C JUN\X]O*J]_5XU>_%3'Z#YI9N,&J4$0?'OLV>\L(,]ART
M(C]@4TN-E(K;)\@N-"P81*>O8@:WDV!<3-'@$@.@=K5;<:!(O:3X])7UHI4R
MN3HA\J&3FHHLC]CB'CUR^FC!D)&CHYD#,!88,5M>%+A#;:;U 8$D6Z$UCP-S
MRCV4%?QJL(R[N78NTT7QX*R5Z7BWY5$QGNO4/&-AI N%!AK!?GL7NT;YY
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M'<%$'>N(%OT/"[$K=NW,W75]P*,.>R=M&MT>0"2;==-,>$2HV:TNCI=XRQ/=;
MPS5K;7_;XI/[3MF]C8D#Q813$G,11KF(F9]F\OP.)JI[TO)F(MWUS@%W5]/@
M?($+'QM*E)JF0S^;^Q31_'S=$!"3@@]Q>2TU+RX*)N.)]VXBBLV!'7#L@C,H
M>83;A9F?R;N0X!#TIFO4DVJ==#UV#W>Y#'V3X^E7&[E>>^5ELBC%<%&\F;PK
M!'DP>O(6L PQZUYH<]UHY1=]6W
M[^T[F;OB=(O]IH"LN;/ON3PJ9E.'[L+@!T "P;G)B :S& F\'M*RH-;V&[$#
MU>6(-%*+-'*\YKU6996JN[4X87EA1/;5^(U!\\YS'UYA>Q7BH3(L*.F2K[.(84^
M/CS=4C..OQ)!4ZL]A5K@BX1>?*/3UA&Z$)!$>HP9>JOG\ *P(6]9#]&D[P9]
M6YM(2RL.[K2VZ>^WXQ'@>JRID=:G O^,V7*A6R(%BYG<_GN1.OV5J138JJ>O
M-V2;4/UL8;U)QNJ:C?[H%.U&'H3Q:&=MA 4!@[
M3SF&*>@F&V 7,D*0QJ'3Q3$41\V%6N/6=T@SC5KHW1_09/'L-?'#WZ7,'NW'
M%9]P.WQ:C$]X/TO)3YHR1#1RP\P;^$66B$6)(QPW1F BR)!R1+19H\VOCIX7
MSX8"0UC_=#4UU3 /Q<+T8,3ITZ?/@ -\-G.]YS4T%Z6)R-GGQCG5290<.>^=
M?MOI$6JN1&H*1LR"4MRQ\]-D[";6&YK8Q4)W"6X"3,CH@>4#!H\U/E^6T,VG
MK%N%MF=*=;TU7[%Y6?80K)@EWT+'0(ST@H$R,YR(9HA8VU/0PY@%.IBH.N7
M$ZSG8\'!%9W&QI[@P"(1T32X=JUJ+3%AH2J,Z$-UIW52Z&0H0QS#Y-VB1--*
M*=L#GON_H)OAFP/JP_4DO"2 ,<-<0,LB,ET.Y'A>B"<).[5D6KOI?G_% ?/+
M9BN4@$#]@,^T5\ (&2.,  $.W^BYN5R)O( AQ5"F#=S"&A"_Z*PK,A;SW[H>V5L49P+!+
MXZL8B3/$<0&&OI"I3AI&S/I(2D3/%#[V=F9YT$JL1ZI0/J^.;+*!
MWB6 TQG'G,(T%S#$M8A<"6IY9*YA.6\RK!^>VG,<\"MZVX M7[^>JUO2QA>B
MG4:+NEAZM32JD,><&]H./II/6$;8TWP #C#7C^UDH[U'(VQ!HLL)"Y!$!J*)
M6 ' *J)XV;Y_RHTO$#/5W?FK[Y*4;]?,/_YG+%ESW7!>WB*%1[*4 =&GR)=00$6WXAZ
MYW&D;1+W[">/@3(9G2R>MZ8?7_N5KC-H[5=':5L^*BE\>H+K_?V]+PY^@XR:
MW5GZ4_$>UH'/9A,0*L;3VY%VU)[>A84@B;?^^[8?6V[=RCWBPNF2:0H?71L+
MWL(NEC%YV>B&>ZM]!EPD=,HNI*5^!>M+VH6( N21?FK00FCQY[[*)7>UNC:]
M4!=3W9>-IVZ=4DQ7E5?]I D
M.\D0"L=6UA+KW8:2\LGJ&G\<\]!N.C;$&JQ*55P<#$8DYB]]MVJML-&;*!B
MJE^":7A6]],+)3/I:O](297Q74B YX(BL05#N9ZTV5P*SNCSIIXF*C:^OK)Y
M9K[>QZ^YR[\C8/9BI?.JV=+4H0^0]+:#L;!SY6!?U4@3"FRKC[)*<]AYLB=0
MA4$-,#[LHL,'3V :S3"^J5;XG.VD^W5=H&#SUDEH9T,
MSX
M/":9.JO;?#-'H+E+;5TX*>0-Q5FD7307O7JX
M;3I6\L<0*@\8&2X1 &Z1.K%2(& ,%?DEE+TO#5YVZ^Z][+(W^W
M,>.![[1N $N&)9>CB$9 ]
M2X.MW$#WV:$#QN_!*$Z$6'E)6P&&"W6>NMVOF8;2 &X4O7O\$3?4N'YSL,>;69_*Z&U(BNAR\P_6B^CC***
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M[+[-ZKO=1
MRA2OIK:>SN  GYQZ'=V%;^67M(/>L*@)C<=4]MS?>8 F5BYL;P73%9#G=RH9
M(O33:+]UPCZD%Q9QYS(EL9;\CO5KC++05U?5]JV'_(N%WOR2[,^67@I89(.!
M)F\DOM&&IUS$+N;1!J?*$W_U8H1[E )="Y3N?3KX8-LX?#.L5W"1C:8$O" 7UAEIJHQX)CO=CAY
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M%,=E993LY6<#U(6
M^Q<]HZ-43/*F=H;&6[:5(-?'9+<^UEQ.#RMN!RD%GYQ149;?M2!5&5OLXTJ"
M!;_T2K"3H U1KQVM(7+PA,3]P.J P^I"..T17E +]EGA_;' $;W-QY5#)$,8
M&9M51K$=@?%\:4R+@0VV3NN?<#?L\#*::L0-_'XXFGO8$_O0(XDA,T"/00U@
M>")L%TJ@:;!6P0%-WE$LW07?S*Q-DHY2QT1J00'=%6KUC:B#:B'J;611K2R".C$[Z
M$U,QDN%#52Y36LR;)%ML$>8*ICX4Y 3\98A1L8D3BDYN0YZ'!49@8OG7!>*=[?2
M;C9MM.1](F#]L-^J>54S&2T)\]8$5/08XGRK7Y- _ S9P3!.A1&AF=*9A63\
M/;PXPX%"U>D\N:)NI.K6K?.!;C!EZK!Z4SW_4GU[U9(C8
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M^/;+__5JU*U2P<9_?"'W[1PW];>N'4.M['3B0]'QGI0+^'G:9UKASI.0GY\HN/Q&
M[RJ"#6E+:<7Z^IR]FI56J>^B^B&J=J$6"!):]';CS#/&+R4NE!Z.6
M4 (]K>^,9("QC;X_*O$,^ZH+S2X;>2Y?)G9P]15G'2\GO G3JE;])''^JSF$
M;0GOG04<'DF%72?@G,PC&Q[L,UW':Q!=,C'FNQ!KZ^CV
M7-676Q=>+H[YVDQ\NQCZ7O+!-UMQ=!\BPIV/R?VQ'-UWM04ZSS:D/Y+TT[.%
M#\/O!F0.:VX^+7J])J3S;O">T6BHV+&K\7Z>6I\NL@11X8 R8S FKI
MP7M53H9AKUM(-;FR4X?T)7OR(5@-C0(CW=$V,T_:[AS9+'5X\_J@Z=B5_3G#
MIKDG+ J@2GW4UR1K=%]>,T/M!?4Q#IOL]3@"^%'[,4"IXP54GBO+%' C80>QDJX O9]:)&?
MFB(+,4]PQ2V'QE0S#EP>#Q'=%!A^,'6QM/! 1MP96CWJ,AC=-_&!MO.K=H W
M?5_P GP$QKTTOPL9N *P#7H&M5'%FJMH9DTKRD-,AY=T@]"H+GR86_P9-DCHK6I&!I5Y/]=YP7
MILZ*>VJ.>7??-6@8@,1"C#J>-G<=*'U-\N190TFTSV%_NF@OZ_,YO=.QNE>@
MEWCRW;[I8Q#MK(PWQE+7+G $3+!X/B10X%?V]]'/H_N,%>.5S3P7N0;/.#A!
M6*(C09B<6D8/ZG/=^^&&$0*JKC1/1VR<3"^(_I/PRF0?MWYS9W:-X>@0:D_K
M\.Y"X/#W:!)\2XX>M@X3Q5\73/20N#L$P^GBZQ%^<&'$I_Z^R)!37QO.N2]*
M?;0S,-UO4FG._5.4!=WXMZ=?NZAW WE6NP&,W)")QH
M.3G4C4G7IC\L;U\.9_62#Q/#37P_EZ]Q%=V]7^6'$]EVRWVU$YO^9Q>R2:*K
M(A6FNFZMPK@#'&]CTV&D@]2[ :Z.V04E@SQQ!7WX^0%:) 75'$X_A3Q*'40= RJH=RY.^>&F<(OM
MHN7Z'GE*KS APKN0P*S4%9%9!D\M4HH:.7*/>0AIU!ZP_5-&#G4Z
MH36S_]W3 W#76\M>"<.]7RVOQCEGH$71?19&QQG[=\J9^QG[=JKQWB^06A6,
MT!Z,#24KQ4!U57RN^-S,:H:2FZ$'BS>KJU8MT8I]SB[1RB@DV0>;@R8^[9&D
MX+= 2LE>1[788@'_K=RY'[$HN ]0)<,2&<&D!Y3M.'RC+W!7/.]4_OHG&9WX
M(WZMZ><,JB((1W#MQZOM1:Q^;&]B03M&=K)@X$X\?M$B"MURX9OE+M>"B8,MAD))Z_]^4-,WH
M9!!&JA[,B#I/G&->2#6B)B300*H":=R29=%LI7&>W"]I4^B+,T96G!U,[I5)
M^=0S6,J:JCH*"X4MFI D&"+?:<%SZ"!\9@<*'TY""[P-E"_OD9EBSM^,)W\Z
M'1&3<)]=\&B^WU4(E]1)=C82=MY("E0D=TMW(<'T9<4+K44 4H3RHLTZY;R5
M$L9[^ACV8-G]2PXL5^N,(5LG67LJ=S)@Q-(>U9VFI\ \"<./9&N;8+A1W,AF
MA/CM'X^MA^B;..O%2,= [\[,B:ZP8]XM+SLZ::X
MJ(MA#W!=>[@ONW"!VV_AA0+;+&AB_'J@!(%BN8$'5,73Z H([,4I-;AF_4]!
M'E=$9J^5%RW&]/VMYB7+E\C* MD!T;$G3?807 ! 9_(IKA+NE:@#>F20F3[W
M3T4:4NZNJJ2T8/@#82+;#*? S_/K'>EF]GQ0Y-S&*X],^>JX,
M=1TI#VQ0:A:9_*Q %>6[$S6RYW']F9IUFHGMS%WCZ:4EQ'U;T6-:L07"DHMA
MSH6O8JUZL15[^@#6 M\$.2(8%6]V
M5K6 2TIBBB&84XLF0G5'G]Z)"'8)_Q3W28OK0)KP29T?A $,]Q(2!MPI!02V
MAQ;:DI4GM8/=>"*W;A-M8JJUCZOY??IDYB"HG1#="6'Q\XY[=)'SK:A#B+_K
M).-4^=(&\\"[^CHU-6(@5A/N[_PD7D?*/_J:V&6(E5(L!P3EOW?#Z-5$0>"(
M($/THHEP)V2!JJJ  /7ZKL"R93/MS8+)2F&P/;, 1K\>\[=,U)>#JB9,[CDZ C6(
MX0-]]X30UO.":@*J=7]2&E04>3WU^X#3BB+U;<(]Z>X6]6=JS:ZC!C5M0M6J
M!6<']@G<.-. 8?)ZAH!4OP^%T@0I50(H:J'\ZPN8WBP>8)TPA);JT1ZM?!OR
M=$FYZZ:9?$'EE7,U.CPEISZ]-NG1"3QP;IA(P?>%XW1-J@T,;*D1@)R\GK#2L^C=;%[?6:RFYI^6WMQTWSM[^=47PY
M>1=:^ '/ B.VX)O'LW8A_MCT78B4D2'@9@?XUC/'Y17:)XTT 7W:FHY4Q,9,
MSM.XD$/WCJY4O*FY%A=?9J6@VL)?1U!$O4<+X7UW(8!*%D/\]0A! D^LW(4T
MSZ;4,X0!T"\8@1$B/IFI0)&]_3$K,3+CT/R6S_.K5Q\0A6NULSY6&_0.G4L*
MH.'A>':D'LBYB+F>DO^ I9R=A]II -N'U7ZVBSY9%^O/^1/\P@H;_'I>!;4,88,Q7]+CR[N@0@>@,D:
M6$DD=>DT?)'7U!]B)M2,B2ZZ;NA:^XHZ)ORZVMW]=NI YOG&RRNH3FP2WA<*
M:$(WD^CA7TH$*>C-1HUZLF!JB7*PZ2Q33O?N[5S +KH4_V(F5%J(W9%6XW.
M,4[H&)&]=0LB@Y> [3%4H)J:=07 >8'(?&VGIDL57K=QPG.$I,G',&YIFVKY
MZ+],"T84O2T\X-DAVJ@0_2\4]3L?L8L3!IQF6_5]EW!?,'(7LJ_XVC7AUM[M
MG2?EL5+QC1>CGJEP02).#L4LTOV9LX1]:"_;^8(A3QQZV%W+O8LR?G>K%./8
M1IDMIG5.Y2Z9A58<5"N-G5;5TCI:PWG-V-Y3!-5_.Q1#MP$Y(NH$&'0F/3P;
MNF E[^_$SO\:0,E.,1RNT;?@FMO\)4]H$:A$Y](XZKIY(-K?5JW/G3#]5IZS5%&:>SCU
MV:D :^3 8>Z#7>W
M0M[>ZS_2X-->^%3^ B@4U,KRC4\)/1^5UZ$+H=YYLJ*O80!5P:U&2CBM@-I(
M&4\UB*1"S\XQ.$K'JY9LHLEI5BVTR\RQ1"7_[KPPGH^#4K^$CW]K)3P$HQJ>
MA>%3@Q$7-!=>]_4>.,;E9,
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MO?NH]O9#$+5D^%8896[ U3.URXOD3][8^F[HD?2C:/,%EXK+CTS'
MGK2*9/3^*.4?!TZQD1RPFU(2L6@BSK-)X#&*95.YG1G\"+SYS=N/-9PP'M!^1YV,
M:"8?O@$ ^?%KNL#:0@F.TB0HXQJ\"Y'N.;6X]LV"1)>1N4JZKJ;QP4Z^[";3
M"VGL[I KVSI])$N"]I4*VYP&0>LC:/>H8":!Q3TJVK0,W#D:F"96G$S7S
M]0[X(2WV@@7I ? T,!2HT"T^NO"Z*U>LD3:B:62@2+ZY'*A;OTU(VL;>QQ4%
M2U]S47+L&UDYYK[TV]=YOR5+3\!.*TJ> 9:Q^/OH/B580#T?DT>9KAV07R3^
MY&G =(#144I5K'DB,OQ.Y7K.ND248W8QPK_\C&W[]C_6M#"4N)TXO;^OEZW$B3
M!U 9H>5W.!;I'OT=-6E8W*3RNI,C2RUXX_7I\,! L=HK5D=2=4S4JM0 R27;
MF[>+(+G_":<=\GHH4.:2#%PJ'T.'/*!-,UM2[Q;F+K98E:E5'8UJ5U3X)AC4
MGISSS/1B31F$)99#792EA"E,J&V96M]'/%RO!@GM[OR-V/G&Q12'J
M>5>UX0NJ1(MDIO8ZK+D@":4!H"]25[+*T4'!\B+/WRD6T6U;O@L?5Q^TM(J5
MR($(MK3>9('D=*Z.RP&:I.AX'#P%*L1P\'KR15K\L0X35[=>8,V!>U!GZ6%5
MD9-\V>SB7D8:2\\X9:#&\10[P?=N-"P5I!D",+^LA9'>$OVY^HC/^!=3!IKD
MPW"5U'=R0I4^&2F7!96"G*D%=DM.31/_^C;^91Q< '''HVAV]9027>]+EB2Z3"K?UVQI5UVT+H@,-
MK-6T#AF?=I=S]HG09GGV)?>(Q<57 ^Q"V68.D]K\? /ZM]>,9";5M>D.?KZM
MC:W.9>R/"8@T=\Q+=,&=B2
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MHDNV@?T!!5\72X4_TM54SU6+?EB=<#)0"R[P[H\/8 LVH=#B2,5:50BX2?/TUH+C@]+&5LOL3MGFD(N<
M5A]**AL<;>,- I\@SU+>MJ5U:;?M0KPZ]X6,590OO7_5>]Q]Q>9-V$O1U:/G
M8E^9'%&(C_S'(76LE2]*OZ .37V<8%B5N0:)V\>J-/>TNES+9N7>E\EM$'M+
MKN:.FUNP3,!F7?UJHJ0WS[[C"@YF;"S&LA N"&]N*J1,,X&A9;C\Z0DLZ;I'
MS-GW;H0Q6K+'I_W<0B_#"JX(ZS[*M+F2>IB4X96H8VK&FUS&8OP%LG4E M_B
MU)OE?"G7<[XJ=R47AJ<%&>%6'V3S':2I7GX1A!^
MBX=^$36&;XJ^J\X\B)J&R1CH$&UXO]O9&$T[4B]@Q1Z)N.L;I/%VW>.\F6.Y
M:''2W# #$AWA-+X+X8,1:Z$4FZR,7PW15&Y=K;:'VZEO\IQMIY%KZ*P[4D1^:Z
M^!S->?;5.>YRCQC2$0BGCI ^/:#ZDR32KR//D.JCYK;T==LJ7W]R6S')9<]I
MHQY1("5Q/2/'ZO-6/06B!Y@R;;G3 QUBC^]=>C-M+?:@QA2K&//Y@#%'5OC,
M7-S>Y;:\!+ >#P!.JQEN).P@>G&:Y)=&YN>ZF#_@.OD3*N4Z$N8;*7(_5^IB
MC]V[.$?[EPIW7V(= $&Z*8-WYQF2%2\*4D?/-%?!#*3NKYNNE6VDMV8:]44!
MU)[C!X7Y-,PMKD]P^>\A@@,N0\:"*E"HFX9=C9!B59/=B$EU]^_5E'Y:!#N%)S^#AV C9-6&7ZL2@N;86H
M*!@T.,K>(["$GSF3@3M2__3L-UO:#>NZ,Q:$JZ(_V$L.LSUO;6UM:LT<&UL^
MF*C$(VKWKQ$J634K,8A- 8$,Q8\XM LAVPYA9-<\9"C, NF>)W4;T:,A(1 _
M[L[RFQ"U-S5EM5H"Y5FV$83X4DPX7J-GQLR[/@.RLX'$9<@
M'K\M7&C/ZYLY;ZZJ?TN)OZ\2.T^.-?RW.GHT*Z7+EH3E0*"^#_6CP[DZ&XY=V+*2C'[6>E-YVP.R.DKE.TDAJV/]K;P%\?;&1VOFNHD
M9JM/<-D_"&G@?KEY.[4=P@:Y*A#KI$.YNPKM)X#25:!E.PW/@;Q5"6 &I-OO
MK[G2LFX>PG4Y?T2X/\V^L:Z4T>N5'99MJ3!WA*I)F]HI,-H/--M1]+*8)]:B
M;K>F^#5>29
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M6Y!5!LTTQQ?O(NN#_IP.=COI5)=K?8 W[:OEAK'T#Z='#.F=!IC?
M]@+?8 V49X_"+.;]_LW.RHFL_=[',@^?I1%5ST-864(;TQZ*$\
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M$4&_A@A-F"TV$EK>>2VO3K\8N'/9JKPIBKWFK82P2;NJV$K9#?9T
M[S<^/^?0/&&DS;@VV2)G_N>5VT:(+ME;>;0Y.4Y]T432WSI@E.7SU8/G,]YH
M&.C!WR.1RR<>E+(II1LSOO<8/^9/LXGD]KJ
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M]/']T3.\CKE)N H>HF>L&;R6M/%V8.XR5 F6--JP*HE8"@([4!$W:+M+$M
MW*?36GC">+U)E= 44R3!D?1:*34L:UN#*/AX%T),@[84;$*I ^Y40KR1,+KO
M-%*=?H(103DWX$6U)W5CXC:UN\]*RK69';SBYF8\EY_>N_]-;++I_4&/N^,NY?3G-W#)0GW\5YURCGA1W0=#CU'&&C#_Z0*$D&& ,K9/4Q)A/_Q_L??FX5#^___HB$A(]K(T
MLKS)DF0K9+380ZFL,4GVK1)&IAE+]BV$(DTE49:Q#64;C"4)V1DQ"U(89LBX
M:Q9G?*[S/=_?]_,]_YSK_'[GG#^.Z[K],=?<]^N^[]?S^5CNN5_/9R$"4_83
MLK_5B+?V9-*9MD"WM&#IV>&F!_'1_&,\NF>VN.$M83T@Q'UX)%!+YI"D 3V7
M5D;9>^NYA7,T19AP'U@0?H_&A1]>>/.KV2FMVOAX:5.>?]G,]]D!P>']#5?Z
M#A'?2?B_?3ZBG.]01KF5"LR2#9@28FS^*:(1-7Z[0>ZM@(;/^XWJ<,J_Y$[5U="GD=FA,,VJMGB''
MU& 58MK"]8PV0,QS([\%YBZM[]HLZ6#8[!FE+K24PI+.$3DBSV@_5[X+X'>Q9+PXQ
M9=#JRYL(]GS$-[X;G,M;9-6;J, $K@%[M6E762BF%?F<5 ^R 9):6DL33FX]
M^FXXJM)O7JIA<]8AIU=5Y*V4@\5QYT7N1>_-;FN9=['FV>AY&:F0I'A7\VN5[
MR]K:Z0O'6T*$P\&Q4.HU\(P!^^#KZNE^+=QPXL[?Y003E96 A%Q\O6 I:%M"?4OD2(<%(0%-KK8+F2P^D'2M&N\ %OS%O
M5,*OT)!):-$?DT.3[%&!1UJVTEM(I@2#+!7#/H;LU,+Z":".P<:L1ZYQ[B6YV,@V^-J53 (E,M=O
MQTJHP>WSEG+$<4>] >TSH&_[D8#BX%(U!R%XGK"*]016'R<>,#D B[ JS:XI
M3WO792/Z$,0;2!2>SF4?5'[#1-+*NG=!@&89Y2SC+/,F;3G1^"QZ15JELP5Z
M$%"G-(?B"/RN,4W2'P12/%U"UNVVPL_5O'3.F7OR;,&(;Q9)M1"*)/7U6/[-THL?Q8,.6RBTBK$/
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ML1,/E_%Z=ZXOQ=B4-@C%[\[$?(VD4Q1;JMQ>"#C
M')!%'Z?9IM<&YXZ*X-U\T"URD^2.D7;J6)R:_,^B
MU60D]>J_J#J/<1!^U7XI07(DSF TRF+]'WKI ?.1:B?R'1G.MMD%SYZ<%,+K0T9Q+A)O*
M&">$J9;@V,+(^%9?#GD9JL16K6&*@B%7,OTU3DHL"@E^>?SLA01$_1;-5 PQ
MBJR-9(KQT659F?!(ABFLA0X&7,CF5(L$/:&0G1LTWUA=ELWUJ>W]&8N\/U9@
MKFYI146)-TX.YD>9'CG"/08AYA/JZMD]A!HI''AFPV&44J57K(-+B2*75P7G
MJ/;6PRA1"(DK^P^>]'U^'00RNP("<>&0G5;7V%)]O<,S' -T ',LO"RC73[K
M*$ G;"C"0G'FZO3,&^!.DW?X2[+4BQ_7[FVW_6IQ##
MKKN@QQP0\H]L7NX$2]E7SOGCX7?/_>ZR"-7W,>.U^)H9J6_U/0H]:LWL9GW@
M&!9(K+064[:483BS"C[*5 _\)X\:VF.(*#^IQWC D%BL4LD+U=9*+D5JTGNG
MO9IB38]A.=@_#H0RK%90]00< 6]/]Z;"/;3&V5Q,MU&V8B!4>!DU<$QQ+$CA
MHUC/T4Y>O^[V^X*B@MYYKF9F)O<8"HAQB!"2V(ALG.K
M06B/,H]3K1>ZK>Z:\*/[Y.0XEW+TE;F?%_5OBK164VP?W1??@\6GP8OV);%F
M'FYB4\#UZ,X*#N0W=>R"\,-L_@%RFQ*0UI/_MPLQ$N%Q8%SAXRB:>98N&?C(
MXHK;?:]4_Y/,IRE%0O?D+;A:4Z1C(#;E_T&S0Y! [%YDHSB&=0$'$6GE8'YS
M%+6Z5+YN4A=8O^VR_^T768U4TUM'8SP_]V^C+=!G6-7LXS!A4M+:P )6$FY!
M>YGWZEQ@4COXLR+G=;%F\9R-[5R<7'F 1P O/[LX92BGZ& ?CQ9.-88RCF*-Z!#VC@(
M#%N/8X3XS-N:IC0T0A?R'QGZ3&A9OZ6]UQ0[M3_F+K]L>F;@5ZPO>A]B -IP
M+)OASN2<5%R;.^RVL$P@X8B>57@+]-C*D^E!X7A2AA1NJO#F6-VS-<^$=WX^
MR5DG(S]JI_&!
MLZMIDPT-&ESZWQZ5]*<_.9T=CPEK>,0/E45V\C+Y:#@2DBD6V;4+$D;H!>*'
MW@>7K#8/EN$H%MUWC9UV/"0RV3=&2Y\K<8T]JG'*.+*OID$]!L2]]O _>Y#@
M6;7M1U^J4
M<^X6RK5M3^< +>%4[(+3FF":*U-E'.EO>Y:)C'P0,:,YKH9^)_ .HI53
M?]3W./M*\$74]JW,T+T58Z9,?NHP4U:;(76>#.'XA9I085A@'S5P%Q0T12%+
MWVERM1OP6Q#"6&]A6=\EJAX5#OEUA-I'<6
MH&+ R4*\+_N@%A$]*T:RZ-A/M>\0CG$-[L%VI6S;!,:6 [L@]V<\P6[A,X&Y
MI?@WKQI.OS!.^X%C?)*!O+_^?\#]$-P5B"1JI4*%,1!>IC75(P_]RT _)^IO
M2'U97QAW<4:<@YEZ=FY\>BK H2&.27DJ 1?>!45W$_[F!F#HNZ >=+('-^!"
M776B#7=CI?T]P".506\#!YUQ0NCAE;!+*BE6?DV]/U<_"GWI2$\%I;&%
MJ,!SOE[L?L1X(:3W([$9> 'QQXKVT72L)[RK(280:J,<9F:>
M(V6([>1Z7,9]2=V"II[@X;9K4JM2FEJMS1ZH5)E1ZM>;X]?'MBC?'?ESGX5ZJ%CVRR:7=>V$JY8R?T4IAFBS6U+0S'8<-H1MKR8]V$
MM&&E-?1'RP[6%#E4%(CL1,B,&WN161'#-J,/BHZ&ZMG:7_GD'$S1?'-ATU8C
M\\(;!74=;7D0O_%!9O4DDDCD2-A(B@"M44L6\0WG:8ZE9K,B7F+ %0K8?# +>]HG&LQQ!B
M(>KH=DO3%/L4\Q)5.):M<73=IM\$=;A1JE'T\R'H3M4^HSL;SC=ED_36"%0H
M6LX=\<6P;RV/XF)XBG
M*[CR)%(XF76A-110A:Y94'78!V,9RC#%;FE*02Q#X;=HZZR#P[0HNENK*>[(&]LLC0D
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MT1^(QNE#YU7T/G$FF,8)R4IDIUJK/TW8@I6+]8+@A6\ &)I!W]_!24'@6.SLH?Q<$?K--A3(/9]$?T#;B6E5H8_2O0#')C25PE?76Y,RJA]ZW
M!G?'$
M2;4?YCBNKF% .;('?0!N#6B16C+4;8!'%0&%!:G;F@ISVT44/[=^M96LB,,V
M)TLT1YRV=#XMYM[:[^;],)(IBB66=1,2"50;;#R4&Q*@+CEN?-&;.M2+Z\9[
M?#KRK#=+6%*G(D[F2T+.W--%Q%JF&=QW81C@0!539("> GP?H*W2^\9T-_9J
M4L,O-1V3H]92JVLC=T'\/K4!)/)$M6W;B^3)B$W5:&<#,:7/3:=5-RD=+#Y6
M'C+(/A[5*+S&$J9NJ#4'K*QW'=-#>Y
M /X[V ;)):'N@Y67:WDS>G]_8985LG3_LR^I,3# T(++LEXQ?4E:XDP_:EY9
M2K"QE-[$CPS27,"D4?&9 -'*>WT(JF6I!_G Y(.4S B!]Y8RC75,2"@'080[
M"=3[4HD(%43_O% MM:WQ.?4@>V.AP4.FP<9-IK>U&:9;OJZ8S,.X7G=AZU;,
MU_R#RZ]4?H*!$P2F1"C]SEY1*(#;J@7HH8E9U-"U0_@J3H&+&OU8+.S=D'PS%5)Y@V-"UKU@ND-Q9O?P7 T7+)
MZ!29*[00M"^QV&[HD;E*R_=*OQ>-S8T8IK4)3X^^7.E4UP[":(#\N8<
M8 A\B+G_/;L'(01DE<.TK(NZ#2-[-_C.>U7WE_6&RC\FU&AK]$1^ )^V?RH+
M7\X,_)V#U8,0?^ZMH1*$'V4K/XYV=_%12^N/K=*EAH
MU;B^\G)GNE_YT@NA$O]^] A6 %;?-7^6RD*GP<7([A#G473)E@;FG!KMI.:Z
MF%*(E:+RS3LB3^SEO_$F_%NCJ_];V_6)WT("W2(6A]K>N$*53J<_=EEO_?1/O/-[Z([):[CSM*DAULNL
MO[^K''1GR]'OO[XG]F'NYT--%JN]XE$)?C#MPHKWX=KMTY\V4C'_
MM7F:A-Q$5=5V9;Y3X\B@X,C3PJ-73C=GQ[T]=D Q3LC*#&3F[>W]SN5BF?]D
MMMOL;'=M)X_(8\L1[__^NA=O3'K;6-E,\,_HI>E63BG=5E@
M64.C,]V3]O&$MX/3&>7S%,=_>UB_CWM?)1?/?:'K(PU" KC&*F\22W*T2_(^
M1:BXKKLTR_&XZ5%B&,7QY[]=8X '^%MX45KT(/12?7/AD"T]Y_NL8H-0W]>$
M6#68;-;Y?]_A?<"\#'6]3:]JZ-.K&8]^+X-B;^6Y#Y:3FUXRWVJ,9&3OW)K
M_[?^COORTTC80\"]?[)P>*&\N.]#8]\U\SY<4L[+=)GUDWF6FV/_3_7(O]U/
MJ/VH;K&\=;/C\]  E>?O7KAUO/]A^;#EEF#MNKW>[?\ZRVKMK]_Z&WY,"7<_
M/?_S_.E!T,=8Z,"3!^&?SWA.9YHY_\_[1>3_W_[?WJHODJ%]P_%(OL:R;E1R
M84B>>O4B)O_V5MTN"'8IYM,QQKV;'[^&"&N]6B5_,'\AN9E[U6:B,;O8M:$<
M]_+M4Z>(-:P8^DTKH0.%V5B;HJEK,?]_;Y-8:"[@S$<(X^K'MB86VM@K6':LI2]4HJU]^FG.!<',^#*2
MAX=O1A]Q02JQZTO;!L+E@O[V\M-0I/I:&%EM\FU!_;OEGZ--\R-KUYW2=D&X
M4TS/75!)/PW-YN;8%YHN\M\_T5O'06V^OY)JPKS84YBY
M:%>:>6T8&2RRTB0U-97S/*1ZO51+J?IAO?9BX=\D]D%-:B@9C",(P;S<:)#>
MA-\\7>ZA.!"NKIK=$< TD(+#?T4]7@:V^0PI#]2$G8<;N9QW*S+67
MWGUW?_'F[>(?M[00>G-(OW+)IS]9D@NUSB\&9F[8J9UPU:S^0/GU0&+'B2EF
M02^A"6$T"'-'^D6NE]C&F]#
MKOY$2^V"$CT!W"[((GG079+JY"^IXO0OJ/S9B!L,R=81[P7^-4=(<-Z2'W06)>?2\PP]ZE;G-W/1H
M^_JD(T6Y^U5(7@SH4U_8% U]3:/OQY%^J]MW7T+:65E/;C5ECR15
M>50@1HN2*M*PWV?^[%7[Y,28KE8,%(-:ZZ>FT=_0II+A8,89V++C%(3D#229
MCI^L+&D;EV]*8^AW_5T9R?<+2J][KFQV2_E*Y(\S;]&NW[">H0=@;O1\0)AA
MB^@&2\&MA'%G].:L0Z4 +7/:]GP)*=CNRP(._\*Q\.UAJWM*JK_NTVE9BOSR
M+XSVC50X52+&_OJN/6=8PX;&V/RKC&OPLR.M-P(7L <"I%GODJI[J^3&':4D
M:RY_>Y&4"1MR,0/K89[D.9\$]3 [#_=I;J=58TG-C__=R"KB>!&?G.=:SX45TL7+/
M1Q$*9V)&EG)#U@-?[EE% F!!WWN,043T8Z4PZ/1Y]?@.B!2FRL*,MH,C '88
MI=%\5N/LS HZ2&6SY*+):P%#DA?DMF9#,05Z!=G9B:US1#-<]VKZ&C_R)<+>
M'3L-1-3"-CIV'#]M$<=UV\::\C+A?8T&5_\Y.Z?&4E_8D(.KT\!,J0(VOR:M
MB+[:2LT8+$O=W@5Q_;S+5&S:M!X(#2>52__]4W5OQW79^>/$6GP65ORPMB)(
ME6\.2KUJGUBH1>&G-1&UUN:"JV%)MN/;*)F;L"2/5NI4RL:#_ER/D8.Q/+8%]1\W@%8Q'3(.Z;T@B%EH[U9DE!!OK=76*;XU^#>0C
MC\"<;&A#9:%E*W7^DU(&^H,:(M]Y@BPK6K**KZN'R#I5(SL/(_VRQ#G7:<%4
MUV**Y_;]->MIW80)7P20;P2>-?*'!!'=VA[^%<$;9=@1S[]^]Y$1-*L_BK'Q\%233.;;A=SLI/"C?R*U@LN>)],_[0#*R3G-@#G+X;<1#ZX%1>:"$O(QIIPF-
MY\\?^_9[[O2RPX2>OY?MIF9IQHO[W[\_M2]FEL_>9@[&#L*O<<83>*(+G5Y0
M88?VD7;8\>63$=DT8>=Z#B>4AMOSP*%YKQH^L9Y>@O!+;B2_&ZH0W&&;&D>M
M>7Z[U,T4F9V]9[MVWG8
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M@#&P^X*85N5 Q16:.R6F?3PDW.B,IM<(I:3NTXO/Y5Z1A3X*HAG)A1?Z
M0."PN .?]6CH7@*@OM$%30!3'=""B$XG::=D465J2!D:-G#3?O^*DRI:YJ)<
M:=6K.+[ &)=W43X9KKJJ*=A[X3;08ZT6G$Q=:  ZT;.(KUC!79!WVC!7Z;JQ
M3O@"5 06I^EH\ZAB\(O;A=M.?DMAO;!W11%++4 -
M2BF@BG7O@AJETMO!\ M-0('GAU\F7S<(T4<3^!
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M(C=M])__^/K:%(4D*%STRPH9X,9UI8;1#
M?P.?Z5*.:E9?DJJ?71YNBOO=K:E2>+I2^LB2OT3>TW+YU)VTU57-TU^";1Q:
M4^?GY__))Y.C]BE9EFA\[4L [;,R!JEO5; %BDD$89A-'[(F&)W0H'Y.7TZ+
M/DP-0;V[Z!GTI+2T1./S)$T-)'JZ//XVT5/<*Q9:" 5YQ@S4 JKW9;W;#N>VG"EERO?*B]>
MW;3#1AA:H\@(, ['*FJ
M=N"\1!5F^^EES7[2ZXNR?D<1#K1/LNNOA"><.!/Z =FIW:X:Z*$+R(0QW %G
M=S\3/L.I].!U=(CN[]I1%9'N4;WQ-&F-F.]F,N8Y42-6"A5J$.Z+;/Z-07:G4']GE]J^!BF[ITJX>N1=.!9KAQO4$GO ,7RF^
M,(KI!WUFK#]"&*X-!).& 17?I) 'POO\Z/=[J+RS=ID_"/89=R1];5P$93KF
ME@J4ORSO3_'J'T380;H#=T$)2&H@WUK!@JW'/!G)-)DV2/K8
M:EMN:WR_G.]!L+'CA^O4[O+E,Z^$IX63D-2KPC/"9&2OD#I1)8FMXC$-M'0;
MWBG,2OB-%(=9W!B1@39D1!K_#5O1K[$H5T /N8&!NB]-.QC$WE_2$-D&JJWG6M,
MP_CL\8]C(2K.P5KB =*V@]WYE%!I-_6H! G-A2L2UG>X?V-)V&X4)WJ.M.Y_
MRW0 ;BQH&G2;R$Y5>K6.8-H4*+Z-K;&]CI:+%RYR,S<-4__,TB05Y *[EA9Y3GALJ4S)7]@\.ON\JJKWU5=+D8#Y^
MJ.H;)VJ0/MB9,OIY5K[F+LC7?D:F%\^15,8")*3H2F,SXC5ZQ1]F]KDY+$I<
M1^E>29_<2/&AB8X\[YLY0O!?'"Y )8HQ(A =!4+2?](8%R]_6+S/57<4G,*]
M*<[U>SD32WP'J;' V:?])71 91#C;+$Z6FAB*T0?0Y:3H50I^N=GVPH*+;<&
M](N_II[9GR%R?-J!>?O
M,]]_[02_Z^MZ@_M@FTOSV9;S!<,&0%+S_X6@G:R  T5RGN&/%#&
MYM^F[8)(?YFW:$?&=2$\0%SO6+>)6.W4F]$@IHW0XUV0S]CR9)""I#H$GZXM
M8U5MXN^B"!LXC.GREQYFBN5>X8RZ'S&($D(22W=!4A2F'G$NC.04%Z*IN3"U
M7J6UL4ZI7/N1$CSZM>@YE61P8*+V(_@IQ3.7<68%R0^/V@7Q/ET5A1V>ACI?
M9*C"7H??N(!NS!WUA-=]MOK3='BN$ZW*&2:N%-/'E/:GZCM>#Y.*
M;Y=\-KV%:1T\9W>.ZHQXP/670$M;:.I"QACN+TMN5P?:=***'\>-
MA1YH,@-?KSZ\,9_U_J>H^$EL4.VX0MR/&9<;SUTM)YS5#]N-965! @@9A;XX
M+>#,%/T^=:=W[H9&JV(U\Q#M4#%U?MGA;GXM4$W>-NLP#WUJK_SBE*E1[MWD
MLT^XUP@-''?-B?0B:'U?,L($\0TET2[KADUIO4:U6]D%+7A/9FAV%S07) 9K
M#KZYJ*;TVC/';P?'#]5<8AB1AI]8@R*.<0@[KH3=Q3Y-\WWV>F!$(X.A%Z?,O:MMB#.6?\XDZ,:A\?C_QPVNIF?/;.4HWPGW3S9
M+>QT&0[5=-GDU 2$^!);,YSU^Q$$Y\$#^-YC7(*?1I&@712)I?&3OZM.D)^O
M+;9-A"AIA=_73 UQ+C'+* WW/WE*"5UN
MLEGEGR&IH*-:'=
M.P\+\9UEMB+[;**S]?L:BZU .+7*F+J,3YZH3 CQ&5)4[UP81]4S8+"+Y*4A
M@F0*4T[K\9M/0?6 AXQ1PN/9AQ>$ND5-Y@4+Y%_4ZGUF#R&X)XWWZE;=X]R^
MC)]0X:JOD$-H)M>K%5OAEZ%:6E!4IZ'77+>1XVQ(Z3<%0N!;G
M^\T<3CR#T(5;486[A!/!&+N4"B"7_"AA8CGV=[D&6F);-1A_];@R28"+U5TJ
M>3M#H=P/5W'"I(1Q#3&"$N:0&G1FH!?;0.@Q2K+E[F#+-D]LBR=GG;XG*NFL
M.,QK!0[R$W8,E]@T8,I$40FD10C5'#FS"^JNA2E:&3YU#:EX)/D&#P\VCG18
MD7HR?D7T;WS^I'-(>OD(A)C//LUJ"WX H1#P,KT0/C33YDOM37NF6& G@>/5F.++I*2T=D7V
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M!6[H^#]L\)"G[H.1-ZY15P;/90=JN@X=75JMS%S13\*^E& +(3@<$+_LKLCZ+(D#6.H88@C;8-57X
M9S-U:#>&\2=;-<-#02]MBB) H)0?2AD: 44E+I+>/B)?$+F<^,U&^MI+,O=D
MY/UYQ#?D@;PW0"S#!"C$D9WBT:\O]POXCX8T+X9A@M-SL^>JZM,:YN5HMO1B
M>@:???Q:S:^=??@[+AQ>P<@8X(D;-C()LKQ]7<+&G+G0TYQA[^TA8)GK!)Y85[_LH%W5+:L3L9:TKWJ"7
M\A2^N#>L7/>=1X5?1 WDJ'U"_L7R1M;L5,=?E72LEWV*_L.G?Q,:"D-CPZ/G
M3N]8351K5 >MOZEYT:-[S?27@N'+\T*3[?^P:M[9[S69?2"U5K& DD"^_N6A
M"6B2M0[Y[>R E70"#J?]P8.6,Y9\'^]?N5QN6#.\UZMO5
MQKT:ZVH!WZK\*!E>*^DOUU.5P3U*.:?-D\_ZAE_AE[_"EP/CH]^:PF@!_Q!B
M](9G"#WXQER:FP40ZED-0'JE7Z+#D&'AE59E;@-*!AOW%/7F2F=[L[]?6'R_
MWUW?1ORTQ0J$:D>8M>C$4J]D30]WH##8N(8M3W#J[QS\NR>C(<$Z5Q/-XS:_
MY<;!6Y(7;]SF\CXX+5/1P"J$*U?"N#FTSQ=K;!;D.:YKS_/+4>I;D_./Q"'5
M.?N1IZF (EO(LW&[UL26-A2'X?BN;HJQIG#13GA4TS*%
M(UT%#3BYB&*Z(@%K"$F5@63VM??00^L?H=C/;+"1>,A,[]"?A65[ -G'].$MJ"RNUN7*V733^<>&]!.>A@K8C_>]*^87A.RW>:IK4/K@+DT8RN9YESYG/[
MG&/4$:V_RB6G55JP<^?7N[E6H:]W0;7@M714/30A)!PE/B@TG*KW[!NTG_][
M_I-,LV8#1)2/K"A(5E5EB? _GEX&XQ].?GM@2>5(/R%N(I2I,T4'TY?Q6++_
M+HC?%P_/^FBR*HW#2,,I!)E6OJA'9 B?Z\U.$OBP
MOX>A)H+Q3B5'/:#:W.@)9I#TH=,3G&8K>%0
M%22-&;S@+CH4;2\$2R-#,C!"$<$'^6-<\GM.+L&J7,UD/)Q'O,/_N,S T!>
M&=H6L6F-0,P'LF@+Y(@,DNUA]Y[ 8Z^KH!KJ>E^31&:[A0Z8P%5SQ@9T.H7_EAUECX,['VF7*WU^^!\2.6?%*[.;XRK?WHH3OA*8 ^RG@DG0M1YJ*(X
M0O##'#3%NEY*CN4/F(V2(CP%3?//^BC52_K
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M+5-\F=)APRM\!J^1G9H0GV=Z0FH+9$AJNRKPE3_NG+S
M0N?KYVO5U:X"!>GEJE/\)RYP"QKH_7X4]O(0?N8V'?@W+RKX09Z,/XGYQ QP';@!W0O#7.FN99@ _3<>:%A*KA$3A!JMM29&B#O,=8.>1_7 5!O$83Z'
MHP64DS(QQ6KG( Z/:Q.WQ>Q;8B__^M3XI:,Y4?[P"4*#TYH,0Q)0[NY"NILK]
MM5T4\1G%PQ9P!?*A?+_PX\W#Z9-ZM-"T[5!QJ/MJ87FFCNP%6W.7C"\:EE\5
M+.=$Y0:7/MQ93MKKS<13QTI%[&/*TY =T,>(_32/%!+DV)R[.PQMU<217!:,
MH!TUT1^>&H7Q5N(Y'V(V9!3/@+7U?FN*<_UYSYFOTZSL79"O\(P!71D(9,@!
M$/IQVG &Q&>F76%V@&9D3^TMK83E7J7FY_$5/Y(?<;NUC*(SZG+,6G/P-D?S
MM?,%L,K<^ETMF9%L163G28@G-!55ARA@" )H8GP/M<#2YJHU=R
M-59"A/+&[2/F'Z:DV8V*G;RC]$D#$8,^"TPQ7!'#D/JRS%8NZM@"I/N9[KDP
MR<9Z
M#2?_!:?HA2:-.E?E#67?HPFX24DYOI+85&EWZXPT=CZCW:]S K3O +Q!B#%\J88DYT,U;I O4T_!X5F\8T)0AA+/7L]]M"
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M2UNOVFU>@>=*C 9.8/.WDI,.M8C-W\\XRA1GY7-<^&U[;KCL
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MW.3+4A!1IB:I)1CI06V>N9A Z$I'H) "\>K-+,KR,))S4_&C26BRYCG)W]WCY[$G6!*5
MF^]O\_(KIM(Y>J0[!$LLQM8E;%#ZL)&*Q:?%L%Q1QQA9#>7J%KV^$IFH
M2Q>^9!TV-U/\0"M@BNR"V/S+"X29R$NL-+@55>TW\Q25-7KS%UNTAC;9Y"WP
MM2C"RFC6HT]Y[)]NO(_O;$-PSR,M,Q ,2MDKI8MG92)#P+%XW[4_C*MP]8(>
MO&3**=3%E@D]QB\]6Y.[VLL6Y;J]JU&RVOXR,-"96Z"W+!2$6$BH#5WKI\IT
M8^LCNS;B&K'4--CDJ%NHC%FUQ_![=UCBV5NG#.=O?F\9-/QS^?,'MP#UP['G
MT7XTE12X$9$@/ _4]^"W\_-*_1OK;JX8YI<\>.*&[TIU6>;KU./3BCG..&M
M+Y6[=WQYS\'P4A3SL 6;WS>0ZC-%U!Q>VWKTB$0QXW9W%G?+F22IE[P.^%P&$;G))-P!P4+.@8B-I 2.&M
MO(GO&ZH\=FP9$D^3WROGIEF]D9+\^D'BU5/C(($3#G*X4,0 M,EI[3W#VT^_
ML*P#G%YH@D;>>^VZLN-Q-+H[S6F,$J)HI1A=I!^JKZQ@)O-E38GD4M%**^N!
M<#'/3<&U22BI0*PWEO:R&0])K'*<=/&@;P>?#)4^I>@X+3D_2KZP@0$E+\7*
M'Q;6 7[]*\:?(TS@CM],3%;9,A-,"(T;)QWXJUDK$RY$MAD4NY[:F:)Y9\NE
M'XP*SK%,O/+S;C5/V@0DR5^N6;;S[X!B0.;[&S9LXDVMLF7036/D":&Q0L(X,FAXQL8:,(AD
M7')G?_.0,-E7TY8SNM5[=X4V\,Y,XTYES/?7VB1G"UV%G8UVMY&:\U$J?
MY?#_: ;C!8B^. (^E!B:QMD]]:]+*Y6080P)+UD]I0AB7Z+I!GWNEJL[2?DR
M=R//
MW+JFYGQK<9_E1GHJ:!,\8T&<+'N/^ RFK@O/0CLO=I^&0;L4NQYF;/V3OO";U
M$EOVVX,6<.+\2=IZ[?M?M;L@[[D5@U-IJ(9YRW 9;X//B@V?1"^*Q-0(WCS
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M=].8!MR+)M KA5^B%]U>E&JL-[C?[%*27;!Y0Q#5Z]H6UMTN^ZW5BS1XLW@7Q&NL7VB1 %WC_\_!BIS0Q)$*Y.$OC:W>^C]*+PM7R5\):
MK J(E]8,FCY#54;AAO%.I/1CQ^M&M\]L:XI2M%3JVT>U2A@%CI$1P[+T>JV=
MA7"5UY_)']$$^LIU$IO?42&ID!$JN%ZCR0VDC1-5)E7)[89:$L1;;\$AYGI@M>Z6Z)X>XI&;!6VY:=_B9F
M6.?TR[ #?0P3\<5M;,/3DE\ASG:LT&BY71#SI/!C[._K\+.[H/B/$* 90KH+
M5]X%O2DA#3/E.#G;,_5B%X1K0=ZV_ZN_"SJ$)' D&;E\%Y04P>Y&_0YFR^Z"
ML,*Q>-(B#-T#L$!4&D*5*4%AM-U-@  2&O
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MA92:Q.BHV]*SCM34";DNE[LOJ8FO*@?'SLU,][/.E_]
M(>4\82[S(*:4Z*_D7D)UGBV9;3G"\N7)"7:A-P]:09/;^1G!<4< ;ZP@7SIZ
M$?C&VS,/+<#R!R)]EERKQ54B)B+7*%LPYA7B_[A(E>"IZ5N^'%XW6,3#G
M@D<4C33//T(?K]%:^:4?1\L6;'E83
M@HB=H0TU5%^6![>$[(L"M8Z^#511%T/ ?%+*^*/AWQ0/2=8GVV/&WVD-?U(P#EU
MM^S,Z0:F.?XPV!#9M+O%IN0U-Y]QC2@JX# M@F!<=;;< 5G!?#M1OLVTP2[3\H\3&%$52]'.'D!W'>B)0VC6!%A/) \#<<&B?MU$OE??[6K2
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MO?=YIM/"6SP/M'V( .(J:_PE^K
M8$:DQ>%Y>%HNJU*<6?80>^"(#
MVS7@GJ%WTFS/&]Z<,
M'8[_8OTY2_)=^CJM%SGC0:.@ZWUBVBZGV)M3%-UA:6U3*(NVEW>E+"XP:4!O54Q-';MS@B&_!3G"SR#YK
MBGZ$8U#\><<:R(V=)^WV-[L70M/CF(9+?1X(%L[97Q(>/#.TOSO[19+%L^HK
M]\5\ZO-X0K$0&LR.6>D31GG[9-%"5H=XPYO.,1Q+)L(I>$]!Z?(F>KKKT^SG
M8],!O@[^&B=7^-J[XC4J5V&;%!81LL*L *0\P8ASGIMNX0NH\R3@F6BQT-")
MS)@:BPM-BMBDT!\GN:0+XW\.!R4X.$6D:T0TV>_UWUEO'7OQ"PTXB:+^9G5Q
M7UG)1$!UXGGFYOP7?^/H$1K8 Z\.:YQ8=6!"N4SB!
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M' _2K?HD$!:8D.$I61=I_J!7%P*4$<2ONVL9I#]]%/)FMG_8-QK@8J""WS[
M3MO.+.%8LA4( U:6(_A )M^"21,]%2GPP\QX/<+9['9G=&!(-#%,6&I_B6PC
M\*&N+19?=EWI^B=M&(M&U>()CRZ@[F[!FIX@ =0P/Z^KPX@9D=J 333MT :>
ML'CJXYAG4VE'Y+,//'KW R.A?3CRYYQ FG6L=+I& ,C3V9;9Q@UT\0YP\_#:
M;&MBIRD'13>0QH]I\\XY
M+/GYC$)LAKKZB\2;VEH*\R."4V1)\DT,ANPWL#8M M%(SW+P&V-/(CTI; LF
MJ]_$B!A=)\)=/IN7/HF(R'*=[=L"SZ?[?8(L,3_<"#GL>P9$9H&.[
M2=.^#-2J##.3KI7,0P2@=[=APB 7J8RS^FG0\&'S\V7K728M^$Y/M[7Z<\&[
M+C2JZ_Z*Z120YY0SR#-2G6C ;@W43^Q=2T$WIL]^C0,B6"4 *1[+D6$:^8_/
M_IALR4@MCT[[= 90?_!9HQ 4]/.3CZF^%DX"'#.5\:>@Z<[?3KC'AS%]64=
M%)%!AN,N]^0+)EM(^+_P"^G=@HGKA;9^JJXIN?L!-VE_LW_QAFALM>*D>\H[
MH#Y&=9J)X@G',>583MRG!&DHAFD@>A<8\.,"%VS:6@3C\(%T6I).E5Y"G29M
M'^5*4Z .]G5;?%>R6O:2VO1?UMV%Y9GE9(QN6*?O\>4+TD<%([
MW''7NM(CT2([Y:FOJ!4('/AW0#W5X$V;)=ZMAW_J8YD")A7,"*>.NOR%M^\!
M#QVWX=TKC\5F5U>_OY8%;/U:G]AEY^B\#.YYK+QC$QL1$7@]4._/G\%;G:(8
MC?$S]$M&?/L?%<'XLL_!\.EL56*GW;_<$FA7^%6A.HFUMDGK>MCYJ>YCZV*>
M79.;U=G4IJ0:>JS%]-7DXGK;'2>_S)Y14.>_5O@;)'^:I]0Z\]]^\%N.)%'02CQ1/V1@"\\Q4+G!?XJ,-M8X0L,]$59SQ58
M->V\=NJY1T#^8&YNN@*FRS]KHC@M_4/YP=W_PC_"T[954.Z1]A#VG7NZ1D3C7$7E\&<
MDR,D0].8 U*G'6DA_-NG6C2YE[Q=H"!/"/*5_+8.4TS33G(<%*;? ,@]*I)U]$I
M2 &"T8^.P\"'PC+\B?HVIN"]9P67ZMP*VA6//FURJ/Z6
MX:M00_S#$>=V&*%3MF# 96PR\=7L\$IS!>XR&C"-N1E625,,5(Q/'7KI.G"K
M8E=P7X"WE>V:^\?WA[S-8Y.%C..82CSAU(5IGC#'EEN!],Z.Q-%N$4=QASE
M[;O5WY 9'8AQ@@Z.X#9 CE%4S0L451P4_44[%:9T#B,O]ON<8DMNFO>#,&7%
M7VA0'>S2EZ1J$
M":VI-;]BZQHV4 ;T!F/%1=]52>W%OSH.;]XNI,:/ C _\]AF_J0=/,FE#@TF
M:A7I'4($ED\S50:^-[+"G5JB N1R IQW*B4T_GH:ND,]Q2=K1NCA ,2$ZU <
M:5,&?%5B@9B)J,.3ZM++DID%\\9?"S$OP;/@U*J9U7-C)>?F\?*FCT-/;N_V
MSC#1]9CP.)R9E?P60($'M#C2B7U$(2LSPB!)F.CO[GL1% 2:&'\:ZYYS3C#_
MS7G?,5Z2@#"D'+_S1]3H?0ENI W=T TQAKJ!**/E(9^Y9M"O(F=03N,U!-%W):+#C$%VA<>,(^\R[U(73+\
M6>>@+O"]JFK>]C31^%-5BU@I27W$"B)$GC7NT];>V789IC_T,PXML.+W_WR?,TG XHI
ML0'+4?H!17I"$4"<8_,6+)Y6/ >V!?#VF(186SX87?99,G=(#)/HVC@>>;CR
ME;[KV6#I4JM8XLQO5B3W&7$^1G&JLY(H/DWN*728=YRB^//$ZG8P')F18S,.
M[L="*;P<\NK5+%1>]ZFAHXXW8%;WN#60J=40)+EY/#6\$$"[M_WA18IS$MCH
M&SJC1-R-&Z!$%9*F]7/=0HLD,'*/QH=T4S7<9.WF[_V->?Q 0&<%"N'[MF"9
MVY<88HQI$H116BVK"7!S'^6X193,@!&N3)GJ"N[30,G>41K%\M7NT7?N>3!Q
M14W*40IBT(!:#M1Z\;A2/5_[3M]+S<+6HU%>VN-R]Q[*-J7L?)1H[=OKZ0^_KG;O$
M3R@KCPA2B VDWD R58DG(@$X\X3*=_5PM.A$@5G.-3"OO&(PJM+M6G2>37V>
MRHT4-F;&YK;*0J/&]=K@)EU=>FN8).Z0 DZ]>A$7).2X\ZZ?7:_;)VV8%U135U8T"SS+',+
MEK3O>BG>B9MC8$3>,WNTR_)/1B76>*@E9R);7OU!+/7Z&MJ5X\%MLQ+@#9,;
M]L2QC^)Q3$(>?3?'C6YOC!(!\[J=E_T]HR-DAA^:%&GEW72PZLTXG=;QS1U$
MY]V'*T.F?FJ)^#IQU99MR-G)K;(2QJW9,B''O .0G:'/-027OO[+0FF8G6YR
M,@TX_E!5>WWB0 :L^\/RP_M'HA(@ABQ7R1,V)58@YKZ3^3C"C>)%S^?V3;EH
MD:RR9_P;BUCX[;M=T3AU_EM7S0QYGMA'^N3LTC#&D2=ZS3C0J'\Y
MEA$DN-N20ZE;0_*; VUXER,]12$"
MMJLA+M H'8F='FV"Q'DQ EHIT+4QD?F"U_EU%!^>'[^2T_!GXNVEB&,/#(HB
M]OU[]>LAH].(L>'I0-9Q[A.>$F%051V4 GII)R=XLB#;<2K,0CZA:C(:I@H\51L@6P
M?;1=9&^#Y ZYUY,-[+6XUYS J?UVGE5]*SDIBV>S%-_$C*5_+\)"+C-MX4-&7&L7:!A<_F<$[?Z.BDI\R(
MA%"RQ&!%"(;N?GL"NWJVK^Q[YV^-().">D'I+1BHW;3BRRRC\40"2BJ;SMFN2VGZ+G:[GMW^]L7U05L1W+5P0+V ;3[1EY[//@D0N@-C,\D-^/-U1ZCWVM*<"Y9+G<^O9H5IJ8\7&=
MR1@K&O07/_ 6+F=>LY9] 9=H+;Y$5N4XWUEH??=3C_7.:*#4S@BGL7'R485]'9>W8'$V:@D(4-TC9O3T"R_FUXXQ&?G/A!$!5,5;/D!FT[/D
MAZM/7*F;7Y3>/:?&<**NG:96
MHKC?/*%X=A#G_(B5'.6[4(>=%3VLE0V;.8[8 YTQ68:_?S63CD
M3BIO]._,Y3/:P?)=E?#VAQPMC170FC]IF@L7PI\X].Z=B.VCT']NW?$*]C@'
M^<^K(-ET18I]A?"!V.2;^(3ZHT@7S/0'2(Q!"67;BN_4?)3QP\&%IX'_D2EA
M]S<=Z=VC>=V]+[9#'R?(FH/F)P%GSFA:663(6UP&V/,;L7@'[RH>
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MU"W8NS#VMYW!4XK>GXT=^'/[1']#)[%^OW%]C X%AS8!"T^C4
M/J:@<57A9/?'M*6C%39'4AQR#Z>\#O7Z#T'^]?$C[PUL/^7K9WGMH_:*"ML;4JW-E8RC'I2:D[?=G*3P,TGY[ ??E]G^(%*US/?US5'XZ_Y#]
MJ8F0[]%FC@9B.-,N5=&FW/%.GO1XZ*/RO,$B2Y/>H[*VO-^[8%(_(VL>;2M(
M(X KE0A0BY39H0SJ])+JY-(LW.1ZT'(S(+JS)3.^0<_@C*FY?\),EC!6I<-,M
MT-[7Z>?0U\9+1HT-Q'_8$XDF66$A_M%?=KWQ>Y4G6]?=^N7KFSR3P\*-D@,,IFMX0GU,G6M 0D?0E'T;J8>G4)<;WMB<2W7\56VLX;WO
MJKO-_(ZWQSJ'8-$Y@?Z!GK!ME3+YC]FUW;%7O+X EN^1Z98/W<^8W=W=N>N6
M=21VI9)]\0>IOF_EKUS?$);>VPK\?O^Q(54L@E)DM(HQ*=_4.;>_<\\Y0V^67(./8YR!O&@HMQS$'B_,S[/_#=.#F;L6K]!'W?
M\=!W_T8FA/PV/* W;#'9LUU=+I"R"4\V^AM*DO#+S6/5/7=9K<'D7OVB:QD.'D9<;:VO'Q\Q;
M(Q\O^LL?Y[#KJ>&7]?UOO] ]Q2FUQ'5;\YULQL+6S5S1[B/K:YAM-SK
MJ+-O7]O^=PF;2AD2@RB+"^R,NA'HH3NE5[]L;U!UL_A-ZX-]QCU#W>&3S)W$
M%/O2%&.5Z8\1_XJX$@K+?\@>]L\_EV;2.&(C*7('=]=6,2/EQ2&8ZEV22GO;
MI?=&%_:UE2BX7]GY170GB@!#Q%NEP/[R\42*V8?P1&X3<;Z@R(R;2?:A[:!4
M@GE]!F4:-;]\H-FFP=@S]I:69[@
M.+-U09LY DZP]9>(HD2Z I/+2Z9GKNH1()@![4.?FT0JMA'.U-S/";IY>B9E
ME;TZ\]%O9UD3G2O8/2EXAJF9[/O<-<_99%M4S#OVG?E5B?N1 E4'7QPX?0$F
M#]OSH/X"OYXII4AUM";HCPKBQ.OZ-Q_W_\9^:VRPFUO<@K6K'^ ?;GY?V;"X
M702AEYA.@W4(S''.<(L@%.,Z+ @F5S6('-5K@Y,2;6E_4.B2D'(<-48V1<>\I^5#)7U-S&,Y"G&O)FQY(##\#@9Q
M+G_NV,_/H>F*##O&I6CWCW=&^)(3$A\%-(2\4@BU/D-JLR3*5; @.\=O1=&(P+T
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M=6 A0WY2WO/*Z0LR5_Z!F<%TJ#4]D_S/".]IKB&QNP3!P9<*@Q_XI*R4_
MDGA-VV'L2]#3[74V8Q%30SO']K^[^%1'.N_^8')M2?_ND@_35F@7<(T=?(TP
MM 6KQ:RM/F0ZSSO5^/J(GOUY']L]\_>
MK;AA<]PRSQ6 QUK8BQ4V);7)E-#ZRN^'@FNAGTK=;L!@O0KG!_\)[3LS"=L1
MHS-,]B&G(20(1SG&]6 \4XX5RM2B:*\Q[*OPQQC+,\>,=Z7GJ0WF9O>_,CG\
M:+JI^E:GG5J4&,Q6K^KEN&VP<3U60_>L_CNADR=VQ_QLD&/>[9R151\%E4<97SL\H'"PB-B)6D>!^XOI
M,  FVQGF[CNI$$%W;M2\VJ!T[S$CF?XF7U.X2W9'K\VM/89'UI&)>.N%<\YO
M/;NC:)3FT';_*HT'N-N82PKN7K 'R65ICSHM=IXX>.1C;#YL[B59&E3JM#K6
ME#+>VP$?:TAZ>F.DYX4_\[/NS:B'DMHPKDY7!Q]A9@LFC?2+1C+.]<5MP3S)
M$C\VD&(6;I'TU@'+D.[-F^=>HJGRKK@5JK;7Y4=ELU*#-])I 4>Z1>R*:@&Y
MA6$*DGJ9_C"OAW1OH_&>3[U
MIP(Q9@,Z.I8F8WK(\_4I<[LO:!PZ)7\Z_?A;1[X8P7]KE%'3S[9@C(A5MQ+"
M!$E9O=[?8L?UZ'+\06"BOBC WP8XZ!$PW@RS_#+R['A2LP,./Z)J4]C/_C^?
MO_:_U9P'%3BS(GI/UUYB'XV(>)HU9@Y18L@;K!
M.0#1A[>\0?0ZJ@-"#7IC.\0\-E^D_&#]17/ /)X@1*-55&<@DD$RW(*]W8*Q
M+W^INL,3?L_>CR.=:@>FD@BRG MMXW^4[/5JJK1 _ZC18=&4BZ,)+3F!Z-C6\6"2^@C V_(O@4HZN4N1?3C&H[%++=B4=-CP38K\?&3V_C')OWF
M!XUZ.XKC0U[*BARZHGZNUUBWX'8+^=PQ9W?3I6BY/3Z?SFH:7TQ3=CQG_'!B
MT[^_WM
M1!BT4@25RCE(L%"/6]A$Q9^*%J2X??8(,*27WY?\]Z'8O9,V^#.@=]^#:@[#PAPVK==,$WWXR "*F
M4WG)&SUHCLD4F6[+L1)DW=B"/8MF0GY;K&$-=)ZXXDQAXVMX>("UR!!"4E<;,.XP?:)OTIDK\3<'
MXN326[#WU[CWAJ^SO7!H$AMWAFM2DX&<;R"_,NA9FREFA0$)I6R3@$WOFA[X
M/:3D.AF!$Z:Y/.KQK_"XFC?TX#5Q8.^^#L=AI87C/8Z/$T^5\69I#7W);8@]
MF4^)G0L9D7;$X47//J66'N9VR:32[OC3PMUMSVY"M6)X#+1!=W"($*
M3"3K"F2 N'. [7$@&GK!L)+#L\#+ 2,XGT"=O16!^25->1LY-F$BC]13!-I;
M\X)^B!PT^Z)\>+M*2%P41*'6J$26&?2$(!R29
MIEIS"W^Y!T3(!3_RZ&*%[]K_]I+&Z4Z;7ALAV&\B>,RT;PLF&63%SU'CQA $
MVJ(PT+H>8191NO+7@3FE_05G(V6JZ9$+Z=2]1MEO->ZKYX@_D+[5@T(O#,]D
MLG*AM_H0QD@[R3XDZN5Y&F4O8,LHJPBZ*C/ZZ3^:\=X_:HE9S8_$LO+'+EBYA)GE&)A.0UFT/*:8)V&^*E25^W8/XU,6C(-N;+B9(\V%7P
M-RL*\HN9_'@ML-"3J=63 _8OHTSSH@KO2>W/S0I4>3C1EU\6>/?WAYX;OQ@7
ME%KZ^YEK%R53-KZ8%RAWA4_.>EFHI09=-_-5B7^9U$1'(^:=0
MA-NAB!OO);VR:@?R6 / UP;ZWR">J3\U(9,_/=7MVENLL7:-$;O7]%9#RYE1
MU[\8H\MF^U[TUNR%_<$FT>K+.=(+O33 !05QXTZS#G$. 8 GXB$8W)'3LZG:
MCJ0L!!LDGFZI-^FX3\6/7>TN
M.@K2#)_Z"E=/M%UGJOL.S>7U.MP)-.A2S/\U=/8X_
M*>^N>WE CBIM5Z%DJV!XP[W_I41\E/YV27TJTW3U,?LD;XS88+!J/K^\MG.:
MXP5:64F!6I0F4]G?2_GA,3=\FC]6=PSKWB_Y[6YH+[W/YG#?SLA'$0=BI#$=
M$.YWGB$<@GX/59'GRY$B2+\[[HC>EL184M^F5N)QV8.U4RH#.3
M;O_38^1@P8/6Y+-K69):_5;;]^S2"1,=AEPRT8OV28KU#CS,S.LF[(8V9 ^2
M&O>6ZE,Q/R"/\6F*N\0.&["WJ-&PKLX?^_7VY<4.M>@BSVXWGV$,-]L(#1[X
MMK( #8B^K17IQSG)S3#.%,>? &KBL1R5>512E$UK&5PX8#/$5D-6,;[[U^QV
M#1NI9P,[FOP?_S/HM\BJAJ_Z0O\O QO;^63,2NY_NY?@R"=25)+/V9PD^I'!@\B>
M85#'N18\.[AG7WT]*!?FKF_*3\J2G^,4\SEZ=E^
M?;F_DEC87P-JT9VJUCMF?D>< @L7#.+)P&U:;R'Z.*C#0"CX-R'JR(E/)_KB
MYZ9_KM-9#_V^_M+*5S3\QTU_BW8ISS6E^WR/*;=F50L3ZB)
M?9ES'@BO9);/E\7"D_!2S O@ 1&$^/<-\#RF7-!R?L28VZ8.CH]?ACW
M5^-]"$_(G'F*)_R;C2,,H7>2,<-RO$\>_.,6QB^O!E8N& AN1[+-I8%'L4FB _K9MN]C2 *([VQ&2.<"&X9>;Z$8 Y*59:G6AT$
MG0:ZR'L(AG;:M*^P.2K$"N&5$W^C +@]#D.CYW.WSC\QJ?[GW+R+S-B(N%KC<7//.
M?)!K;!6;Z'-9@*!*C*%_!JUVLS>2YA [ @C)]PGC) 5\=<7#/B7-Q.:
MBP,.4; OHI],1U:4T\XO&UV:*4J84R;3FK_R
M0D-W+*$5("^J%\% K99"3L$40/:@DHI@XP1I'-$Z9SOCTAO(^-9C5O6UYD6G
MWL=#?-R\YU27F5,!KUJ%KAM^V)"W2?^'>"2")Z3%MMXF#HH6*DSX6W03HFOU
M]K CH)7^;;P-P80[ <;#B6ILS&N
MTTNR8Y]57NZ"Z<-N.PPJ7)%^2!C@WC=>HPXPX/%_$*G$AB9*)3QQLZQ=0^<9
MY_!XPZ<_:-#V)L.ILZ4]74:K[?$L%:6S89>\4_^KOB] R7D(&T&;*69'0_
M4"?\Y6Z8NT/D6MNMD&O7MB_B+6H_-VZ>T!3
M;C%<2WJ'P=M,JCIK$81#DY^" %!KU#A6^EB'#GBYCRS@RR0G&+L1=U*_7P8)
MK#G.C(-7COP!3,%W]ZX6-=^
M)(P !U=$NRS_>C8H*=280G.&X6P?*L="R[ /[\L48:F^YJ:%D5*10G_(JC0P
MDR[7C17!E3LT9)Z_"U0$JCB9#R25Q-[X]'*L-[O6)V\@X^:+&#CDZ^]>X%SD
M%G= \-C9 $V\E05>EHE-6,7=:[G=/I]RK>?=$=7K^D[X]#><)PX%*WNY33 K+ (QG
MJ\SV+9 5_7DFKX",]'+BRH+H M,6%^^GKZ
MI3&VQ](5%+Z<3>I'YFK,_8NX"NIT$8%+-?>(381D>B4M>8CIS(J>XB@%:R6U
MG6*PHQ7[7(&.5HD02;?J@D _?4PY6A>#*_':_ZG_J2,:<@ &<^EV,->>[
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MZ$$DC_GE&E18E_:%YSJ]2;\.D0YNBQ-:LV,@@[.9>!23*C)C[7PV2<-Z-9Z.^%^3H=<:3/SU=TQR<-
M[QV]*HT-H:1Z[$H#^P:.CR=L#!3S1 0!S_F+3-EG-/A7 -F[=L\5D8394Y)_
MNJY]4,[D\N$4GB#G_$2;.4:,8RK+N!Y2%I#+VCDYMSP@;F_X?J=;=HKT
M;\WOG#R6* B! O]C;MNJE4Y'#ML';P4T@^9LUR6>Q$?]S"[0!R7NMWGKM?WZ
M>M([UWZU*HV!O9$_->X\2\#EROAL8.&\#P@IR#$NC@UERK^+7A!=J\87:Y3VR $KB[">F3'"6G$[8YQ?H7[";5D5=&F5*LF-PA?>>W'?P3G).3OZ0:+WK[
MZGT8S^CK[UM &Q([VUU-7I(!>U("4;(-7?&^ E?,T&TAI^'15=>(U1__Z#E<
M;GF3S;@\VVCD3[+[&+ZM"^Q'OJ=(7!5B6^'6YE5K(EAW4,HXTRL ]R,[9+$O
MTE^OSL1\W@Y%1V_?:^[(*]* )G0^ER ,RBQP+7[,&8$.+Y8]!)G5F7O_KG-M
M*!??7%2*2FBZXW]EW>OQ52]Q/S[ZG0(D]11/[ VWO U1PCDUVF"00GJ]OV$C
MN:9-+IK>BC+U ,2J.+EC'GH?KPEAGM[O[?DED_:2OA#^"_Z#UEU#+:<3XK>3
ME#\B_%3S^."P,E:R_XJU_FBKVW\$LS"<:]QL'A]OD%R;E^$DYF #1K]8
MIHE;J07D>]W[D;6LZ>)V?G1>4D*]3WGS9=X!MHV;K3.F[/@]O@'D_!=XG*O@
MRMH63&!EB;@3;Q"LP5(55Y48^Z>%]%@?G\J^2HV$[R_)>M!:JU%G+FE_K"H3
MU-I839^GS13PA/.PI+=_X[+BTDC@05..5"N$ETU-*]OZ
M\1E;,+C5#G#\+1EZ'$7,4&DX7C$AJ]JO<7,BMUA2I^K)E#^195OG'Y(=)&(3
M89=R>[1_QT9$#UK5#:\+HAFHY*E\QQZ.E?((UMC^YLU>[S=N.-7+BL3ZSD.6
M[VH&X4DDX,+:#!TYGP@%GX K$MI>]9IY\.1'FNW!0/]:UZ21]@HQG3'\U:=&?;%4L3ZUHLV^ %FDW4^B#SL5#6K7K)PE[\%[TTE[
M/@]7XGAH93 <+;KD@ U:8U627@=(#GNV^JZ=[&(:Z"M<64'=1?I8PEG50.+*
M-'UX%P>*Y..(A'VXOJZIS1=@%_L$,-5G?AHH>DJT'.W(^$JC5!WLP]Q4&3L]
MOG@NZX%-MLDCHWM\8^1Y^JPMHVR[QLM=\###(%WU\%C8FO@2406O1;Q3X=ZR:L0ZYULU:.WN-#U0ZD$^Y@64GR(JN3'O543MP7#DF-RH$&$$^>S0_R)
M_.H3%H*,F4)/MC-%,2)#-[VJ-YVAA[A0-/8-U7&:MF@XS#];9_93^%-PNPV<
M"'%#UB_NZY\$E4_?21+D^1R:+!U\E.N_I[S,OX66B$K\TB[,YZ#Z?/.12(";
MWIMN;\?YTRNP?_;$\82&MV (:+J%MF"5V4P$+ZFVA@2Y?F*R(JD+#AI,K:+9
M\O[C,L!PNL7>I_C+8_431U,&+AYR^;'YX#FR/43CU;MOS4EWIB81M8)OT2IX
M/M X,I 9>;TI\UVBL+9/VS
MQ]%!!J'/ZT8*_T&FTH!K)&H=:ZFQ"0O:6!C_^YTLC#=]'A,>(-<(N,X%+)'_
MK-V^WX4ZR>Z[:>0IFOI.=4>TRT
MOUE0!L[K4D::>:6V6N8II^]E!>>_^]?_S#3F9F_!O&L2$;7#G6Z(NPB1,:?Q
M5?V?^CZM+7V%849C<@9[$9%W5](0/WN+&Z(7^E4
M&I!1,CLS\>I9BH[A_U]R,?Q1/1+4*D^IQX+:X1"F\NL@Z_CYW;
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M"EK/8TSI?915Q(JBS<,=&6-\%CG'!F0C-7)M_#4?SCZ>*OQ#CF\'O ERBFYM#@UT"OK2T1$>+9+:?;)8:,QNS6-['=#
M&MGFK75')*/,_B^K>G_!E!+ P04    " ! 7VM4
M/Y/C$I!@ 0!2)@\ %    &QE=2TR,#(Q,3(S,5]L86(N>&UL[+UY<^,XEB_Z
M_WP*O)J(>5411A5!@@MZEAO.K29CLC/SY3)U;U2\4&"U>4NFW"3E3/>GOP 7
M2;9D":! FM7O]<1DV;((G/,#^>,YP%G^[7]\OUF".UE6^:KX]Q_0S\$/0!9\
M)?+BZM]_^/KE#888WEQ]1?"PBA# D,>,0%Q' K(%%(P$5F_15#4MN)F@
MRO]2-1^^6W%:-YB?E L\^0WS&^R_!LU'$(4P0C]_K\0/__%/ +1PE*NE_"05
M,/_]^NGMDU.27\PW?BGDE5G9C[+,5^)S3-AE63X8U4A)C)0H,5+^\U.3_7*&^)[DK?=E]2!P_2]
M-W&_:'Z0XPN\,\W9(K^(*K_7LA"R97+VEU_6:Y^O:V4*ORIB'R2U;5)>7U(I%AFDF:0*1?7A!GD819%NC76L@C
MA; ,4LX6]>967\@"?OW<2]5,/6C>'QQPJ)]XGDM9K=8EW[X);Y:'7F_ZS6;>
MA=DO!;V1U2WM+M#"&Z.AU><_=L4&1FY@! <[DO_EWW[9ZNP/_^5SH;I\;D#!
M[[W8_^^3T*[X P&7Q@Q9E8^!6O&A0&V?]DKKV*"D:,4:-;LA-60A^D4NZZK_
M!)I/H#8"6]/EGUWG_F7O[KDL>SUIR4\L7O>-7_A*VVBW-7RPCL:F/0N0>G76
MC=TOR3$0)I
M*@,8=&1[WR8*5 HSXTSKL '0"@0> "-!B 71! B\(%
MV,$!;("X !LHP X6X/<#@  T>EO0W_1UVG%)G?=^,;?G]_[?,X5M&=)N1
MS=?^G+?. Q7^46ZA\\V(9UNSUC31TS=F!PH[HV-Z>28Q9)X-YMXX>CX!W RN
MWGM[K93D=7XGWQ9<6W%?Z/=/M):?I,$Y7[;B7=9OI!Z1+C_KIWJM[^_[!U]>
MA&D4AH1RF(5I"#$/,&2$:Q,WYI2J ,E$$)<-(@\RSI?((M]<=+!]R
M3;J[Y1'(QSM?/H<>QMZOI,H+*5[(0O]0?]2W^"6OU[3,Z?)7[8R_6U75@H4Q
MIA@1*%020/V#@BSAYG0U5&D.=7?G'F\1.J%!)S4P8E^ C>#@1R/Z3\ (#]Z8
M$(Q/>L5HM6X7SO^RA(JF"=?/11)ISL,1S2 3&$&*F(K3@"8*<1?[Q?.B3&&?
MS&U)[&P2ST"/;',=S;'%W:@!?C2*_.3/MG" S:OM8#/OI+:!
M Q"/W_TNE[IOA7^2MZV_^$&]6)7EZIL4GW_[^K:XTQ]I$^*O\H;)DS8ZB!;=#SMR@]^-Y)9TY&&U
M[.S2:=9@]-?!^? [FZ;G(^?58CU#G$D-V?-A>VS?>AAQ&)5NCTQ>KFYN95&U
MVVAEJ>_-QME\<7_X5,6(4=^_+;3O9[+
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M]J)YIZ>0UZNE>'MS6Z[NVKFZ75\24H8CH6 "T
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MN#-YN<+GE<>L)Y^4TEPA>;':WUXK:IT1?M\6H%=D1VY*T3
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M(G2QNLX5:&YF6:\/Z!1J"+!3">SH9%,1K90DQ*L+P@?LZZW<7V5?'A;:(:25?U2>]0+GN$L9<0NWE^#%QKB]P38.,;X8/O30\I_H=0&3F[
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M5Y\DE_F=<=-?W&]__J*G:DR"C&A'#<8X5I"&-($J9!&+XU3%Q*EP
M[3G"S,TPVTH(C(B#S+&S%L=MPW%LR$>F2D>T!^\GG@/3*'N)@P1ZEGW$T.^9D#9 .
M*++;\NC0GX?9+*9HSN?F4$!?TZ1<;G(O7^457Z[,2BV0"I,,Z2YB_'>9V-H=W)$?F@:9JUT;@
M-I/[ NQD=6^E]F=Q.('DU;2PFWE2&\()C,?&@MO% ZMNR2OS:O@D;XUG5ERU
MH;CMO]OV1"H,2)J*"!)F\K6#+(64*@1CFB582IG2S"EVUFK6N5%2)S382.TO
M!\!N%>Q(RCNV8QLK7F!UK^#D I/?\DM6,T];.\D%C+W"1TX7N]&4D+D>GZ_+
MO+Y__9U?&U/,M*!1R%4MDPTE,3S(]\
M6AE!+R0P4MJQS),@'B<4']",SAU.J%B3Q"G5#_!!)?G/5ZN[7_2E#17\#9L?
M8?MC\_P_.>@DC_HIE?JG^N3WW!_@UT7=%#CCJU)31&/)-V=E+\U62'G_)?IX5)YH[@YCA6$1Q:OT\6\PWM\>[%1D\D/FB/>;5,(-.
MT1R9$7P Z403#O ,9@V;.28C$0>%=SG%Y;*A"8 K+J6H
M3)N:S]1T8=2?W,JROC<1/28FTU1:O#6VRB++2)H$40H#'IC.AK4LF\7NL[_C=I2E!(
M<7DG2WHE?]6#UZ\T5V^VGQ9!$O"(B  &6<(A)K& 69"D)IF:)"CB4J5.@8OS
M4&MNU#Q=I>P=E"Y CQ/H@ (-4L! M;-Y/)>RZT[WK>46VBR$G=&;Z\]Y(\ZH
MJON0=?^3U'QW4NT?I"+\D.6=VPN]$[MU 'K!
MP3A%'YSH:[L4=J_ $0 >^1WE"=L!G:N>^_-.%WF_-7QE F649@$BE3(4^DD!$NH AQF%"%I,J<
MZF\.D&%NA';X.;MH(_V;G8R-(HYA.P/6QS*(9US4QP[I>0+PS>>-*CN_;U1J
M-Y9VXHU__]*&'8]QNGX&R'Y#@@;(,6V T'"@]L*%SAC*O5/U9WXMQ=IL=1VV
M4IL"7)>WMZ7D>6/9-F5-*V-TMH9N5:UO6GOUT6.Z!_QT)!]](8YT,1]O[LDZGX\.WVZW
M]/$G.Z/#^IK7ZS(OKDPY#FW-Z,]D>==F"X:*))G27AAA*C&5>)!^ E)M,G#M
ME7$>,10ZG42=F&]N[_T'X@Y/V#R%LNVFD3?L1M\LY.?!N!@ W*+RP:X+(;"WFJ>DN)5,WK;4+79!_^U--U_2)BDC%(*DSAF$&.&
M(8FP@%DFLH3)6*C4JB^=U6QSHY+61F@E!JW(7=_DBSYUJ)';P1@\";B%(>\3
MQK$-\F= T,$L]HGD5.;MN8BZV:NV"!VS.T^.,9W]:*O. SO0^B)W GY]<[M<
MW4O94'S.ZZY,^]>AC0C\RKWM&
M_%?"H>Q[HM>F.(>V=L<&K=MK-G6(M1N:G
M^2^#O:<\Q7),Y#^/M2Q._O6Y>![QN@RJZYJD<
MN.IH$EP76.5:&\S;LMN9X,^RF&,?S$V[CNZ)A[XQ]YL[Z$VZ:=/_?(.ZE\'G
M?0)?G>&^+NO\AM;R/R5=UMX2C$S0(Z#OH76:+8 CMU,[*<8SMUBSA>ETVS7KD7P1Y>OOM](EE!
MV0@+M,5TJ[_0;1&#'Z]H7E0_G4N&1Q9D* V>"?)S$N &\U9V\*/I[_V3@=[\
MO=N''I,!3V,W,O<=$>"96>\T-*?YSF*,@7L%?2^Z%^M*SUE579'>JHGFCF*:
M)BQ.8"Q,S:98$NWZIQ1&:18%/*.)(E9!5E:SS940S$EZ7C2.:]\I*.%1&L8(*A%A
MB"/3@R3"#+(HU+RA5!1JY\2IR?63<[G<]M/TM]XDT._(ZA@[>!IA.\+P@MKH
M!T]#X!I<5^!)*$:I'K _V[/4"'A2Z:*N0Z#SQ
MQ*_#]VOS,NZ.C:K+.YHOS3'0FU79%&ANP$9IH%9E6X!VHE?>J;MDY#>=Q[6?_PONK&6?
M[K5FN2;S>)N=$O;/\1*SA-S;N\MVOJ&;/3O"F+H*==[V!MXVE-P4BF7"Y#G(
M &(A8HBC&,$L#0ED692$VAVC8>)46<5A[KF]6+:R]@ ZO2Y+8+L_- JP
M([/V0$P';!DYH^-Y$\E^_HFWE9R!V=]H.ML\_^F^/D=79J][VV"K/E#
M6R5FYX.=;[8E#-X6O#0I8Z]D^U_]^W(M\N*J;W-G7(+72FDW89%%(E6!$) &
MJ4GQH#%D*)(P%2B)(U,-QI3Z7=5T:XTS,=?(=[!&YGQC^,VH.K.
M:0#M4PF] CE1SN# &]$I)= :ER.Y?Z?'F"S)SUJ=W6P^^XN&=KY^DR]ENZVS
M8%@S::S]"I4* K%,$221]C!$RB4.0Y'A)'%K<[T=?&Y,VLH'C(#=_JIKZ^H=
MX(Z3Y;EPC,R-#D@,Z#V]K_*9C:9W!IRXJ_2^*OLMI ]\9T;1+/^]6NIA3*>-
M)AJ!$9F&G S/)1Y;C0R1?C"%H&YQ+0\
MNH^>,:IE^-TQ_V,_;S?&/");#B_5/$X#'>3^_+U*9,I1("7E&0HA3E$(B
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M'(9QX'^GU72C.O$ [<,?Q@)ZHD@(?X [!4<,0>U(G(33<).%3 Q1/
MLYUT;F\ (S?H!0>]Y";XNI<=;(5WZ$5INP:GF7\,9,<^;7QF4!WZ?(X [E3M
M/KV [-;STQ&M8ZT_;8>:K@.HHW(/&H&Z7NO.ZA_:H\O?\OKZ]7=9\KR2'\N<
MRU]+J;V,\LLU+?Y*RS]DW7RZB&3$$"8<(J7_P2&BFML3"H,8TSA-8Y2F5L5A
MW*>>&\-WTH-O6GP@._GU@Z-%!5>M!J#6*H";1H?V+_:DY+@NI_E^/+1'9OUY
M 6W_#A@/\(G>!'Z!=WHC#,/NR'O!<<#)W@[#%-U]1PP<8>!V^\VJ[%V)#VHO
M6B' D8A2E<&8L 3B*,D@4QF&69S@C&4DS$3@5JWP^(0N#\TT)0MWY34;L?DV
M9F%('[\3>%MN@GO#<.R][D?@C1CP88>)W_WJXU-.NRUMI?[>[K/=56?'N;7C
M[81ZO)?U(@SC&&.20I7&FEM82B#A*M(H"\P2'(LH<.H%>F*^N9F;#\*B-LTO
M97T!7IYH?SD(;3MF\8CAR-3R%'RCA) =PV*L +&#%C%1(&(HA3S(*,2$$4BD4Q$%$$A4'A//(
MS;CQ)]S\#*&##UPO-MA4FS&]188'U9Z[I -9;I)E>@Y"-#]O_M"I=O$PL<-4
MB^C5.;"@(_+IV:B/2[W#Q7M>ECX;UI.$?OX, YW5HLY%OES7^9W\+/FZ;-XI
MK[^W^ZAO-#1&CG7=V;.O:6E:VIM"$$W*A[9VUT6]B&F@65]QB!B/(4[2%)*(
M1C .4YY0$DB>N$6*^9!J;M;IKE*@VF@%9*<6,#Y%L6C??)YA[NP%>!Q]&\1\T=>CQBZMWIEC/;]+T>);B4INX]$J: GAF#I.$
MIV?EVDE>A$&6,9Q0R")LC/@H@"Q!(20B8B3CF"1NS0U!QSFU2;](P"GT;W'=[A$VGXR_R>_U"J_G'(@J30(B40Q&(#&*IEX@(*F&:
M<BC-&^W0VNDWNPG)G^FUNMVD#S=6=WR^O-:WYGSZY?KJE[=R++? ;[_
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MN^TFCBCL["B^26;G#Y+9\T;;"U"T6>PU_>ZXSSCF8EON2B5O5Y4)6<()3E 84BCC
M*(,X40)F/,$PI$+2-)1)RISZDIXIS]S>*IOHI;)SPTV\$N_D![13 /S+/V?:
M@OI7\\+I>MJ(OJ>-VQOGW.6T>ZE,N$@COS<.-!$RJ:6;9?NTLVR]1J!7J?FT
M5\K?R\$3NE[Y_UR9)J5X3P ^9G%?PPXC:M,:J+[?!C:\T!Z)T+.5]TTIP"A"
M).$LA!'.4A,#C*#V!"A4&2$!P0+SS&DC^OAT,
M_F ;G?B<$',F,3L@O'+4B2DGI2 []1\SC.55GE(/3%X-C9(D"!2#488PQ"EE
MD,0HAJ$0 >,)#\/ :D_WV"1S(XNGW\R/O)TI>>/V?))5'I_.RDP=T'6N)Z6VBJ:K;"J\;C-;G>73IXTZB\
M>ENTONNCD*/FCZ]H+3=-#!99D*0TB0@4 5$0TRB&3" !I32?)Q*%R31-.VU8)NJ\X_T6
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M7',CH$9RNS)??8('V<LJ/;_XQA']9"&-ZOM?W2&>=X!"1
M1+$,"JHBTXHL@"05L:DWPU(419P0JW8)8PHY-S+OMAL;@0<:CJ.LI:<]Z)%7
M:.371;LJ;:M.[S;HF-A-NQ4[1-!Y[:J> ;7S!NDY;3ZO+=7V]*DW2Q-="C]A8VNV95)-7\>+^03>"
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M6!R32/ D<2I+_6#XN3V_M9,?3C%M$>2#ZNU5,S[\K8%^TYI5\JK9MFIL9(%)%B=)#%%B*CG1)(,$
MQS$D,D6)X)G@Q,WG>3C^W)[6'?&&N2F/X+-T,8:#,O*SZX"'NU=P6&N_%OVC
M.::UQ@\KN&=)/_$U;W&N#WJ?F3H1E0D%E-5"AEB1(*0P)4$ L50*TIADD)&,
MZ8<^E&%"%X6\HK447\Z*=WU*!*M;G;2W^IX@([ZR3,!=F6M;\L=KPR#(6Q/7HK -SC0?=T]1OVN1U^VNC./;7V@CCWOS'L=G0P#LHCTT4O='.$[ =M9VYQ!\XK]SA,/RDW
MNP8SC_:([/;U\^@E;@!>",SV!4:O)*LWNV+
MY]]X=[66110G02!$!$602(@#3B!-F((\#FB:
MQ"Q*E5/+T:D$GYNA^'QU+>990V5F)5)F]$Z8X9TRV\HF$P8-C2#\#"*)QEN2
MYRH[<[W0C>&J.>OIZ.^V!9_K::SCZEB^9,;#?.1WA3^XSVASZ 3:2-T.[61X
MIJ:'3@ ]W?O0;9C!+1!-U]>R(>=/>?5'UP:67DFT$%+[ EPQ&&K3'^*8*DC#
M3, XE*9EM2"QVRR^1%;4^;;N6'ATVC:<9,OC$8FH@=B B/GIDVTEM1K
MU\&3O\7Y<9-I(+U?5NMSI-$QI8,) D:8-++2=
ME%%(5-VFGQN;[!UD>#L:.H3]V<=#9R+ZK$=$8"N\-H(F
M/AXZ MQ41T2'1)C+,=$1>!R.BHZ-,HS;WN0%+7A>7'V27&KS2D]ENJSJ$81I
M0%W5Q@]]N:15]4$=^&Y7@$%E*>(II1"'RK3E2+2YA&(.96H:\T4DBZ63:^A%
MJKDQ82.O"13;2 RV(E]85FX8<1'MN'/RI1G;G#NV*B-4TO"*GU=F]2/9I(3K
M%8AMQ75"8H("*F!*> !Q1B@D6:0@H8Q$ 0VRV*T7
MW8$YYD:=&Q%!961T8\=#&-IQW9G(C,Q<6U :\2[:FNT7X&U5K:7'$XXC*'CE
MGT/S3,HF1Q1]S W'OCKT25_=RK*^-V'(M3;]S&[7K6&8QQ%P24P9)I3 "',,
ML78U(0D9AR2.A$KB,,J0DZUE._'\.*&5NRTH73VH'>CJU\ 3HR0QW.S^J;I5[:M^.M7JP#7NA;>_2'Y=-%&'J^6Z.1K^W&:C=K&TC(2(THC#-$*F
M;;1_8YZI>W.]T5WC86:$I$&MJ2: H#7%(8H@X,J<$H8(D"3%$69I(
M)<)8NL53^!1N;LS]H,?(H_8B_3'!@/(>7M?3SGQ\KE4:^05Q_@*Y%PL: 4F_
MI89\"CAMH:(1H-TK
M:X&G2UXYM0CSR%)Y4LH_1SK**9"]Y9V?I]H+1W"EZ 7D5@=#R[9MC 11^Z13W!4C[+?O9(J^BC
M)-EYB(]=L&R@=,]=SNP\4"V*G9TYP=#^/C4U@KRF9:&GZJM>,$KB0&HG@L6*
M0QS$$61,)3 D640R%1**G'KU'IYF;G2M_<+UC0%=/\UF@7CNNL5\ E8[#CT?
MK)$)L1<0]!*.4!GD. B>^^4%W#X9.?G>H/\?J;7&"YAR 2BX%33"DA&G'#(49I"P2$#&J B0#Q-T2/_:G
MF-LKNRE1M15QT%', 2!MG9USX!G=:W%"9H#?\93RGAV(O6DF]@2>4G/?I'_R
MF[XV;'Z3^=6UMDXO[V1)K^0CE^%ML>,TO)=U6Y8DY]T )KIG\\Y"81SP,"$P
MSD0$<<@B2+*$PS!% 5.$,\T;YVWA>)-U?I1S:#N@5Q=T^N[O#^3%@RT"K33H
MM=Z,U83'N1HG4]PO0W=_GN4N>);]H&EO  _;1-Z79N2-(W_R/O-6DG?@3V\N
M^9_2WU=68>E.+T!, [
M8Y\)SP%;^XV#<3">:"O!&]9.VPOND!W9<' 8;+(M"'<%=S
MMSVI"O%23Z9?,K+@N3Q8,D:I#%-, \BSB&GJYRG,.)OWC,,-\\UQIQ$F+CJ
MV!!X]NN0#1IE^([LMEQ^=^:7T%2& 1-06ZT88II&,(NT+9LD&4,I9D0(IY8U
MAR:9F^7JW#C 'D[[G=ES0)IB;W;4Q@K' /"^/[LWT>0[M$^I>FB/]LGO#MZE
M;4I/='4Z#
MG7!^9-#512E;@9MW+15W5*]NU696\W55KVZT+,X;GL>AM]ZU] ;H^%N/+9:?
M=K#LI+T G;Q>-PVMD/&]\W=\TJFW[ZP@.+ '9W?=@&"-[MEYHX5]V3\Y[[4Z
M[<@OF^H%"X:YX&&00J2B$&+")&1IS& 88Y8R&E%.K4*XK&><&^]<'J:8"]-.
MJA/\HBOUX! $8H7]Z4TS[XB.3#S/"*9#>(UO4*>*M?$ KEOHC0M0Q^)PK,:9
M+BC'1:T'$3I.%[HS=O<2,-*JO*SJ?HE-.SL4W+:EL1Y$V
M%$5*8!(@$H4B3'G ;!G;:L:Y,79OU#2/02/VYF$ 1G"  M");D\R=MB?9FSO
MB([,V,\(ICUC>P=U(L;V :X38SL!=82Q[<:9C+&=U-IE;+<+O27,/6A(_[',
M5^5G6=[E7)HS\M; 7\0B3=,XEE (4Q$R5:')G6!01"F*9<1QRJ3;"<8P0>9W
MDK$KM:G4<&OD!E4K.."F^A3XL3V)JG[2UH\\N\2:U8)9[Q*,O CC[QT<2F-[
MM":-&J#38[IR;2Y8CIV@9B/*C.04F
M'5'>.4SIV%@#RS*9.O*?Y*V^*Z]->8[+0GR2=:YG?[4N]?!MA&S;O" .D40B
MPS"A.(8X0Q)2$48P2Q .X@#'"7W8O)R,ZV)&].9_JI >M^%W,>]\66:IX$D01E(QK9J,HA12%# HB$(D3G.C/%X6\,@43
M[+C-9EJKYXRTS]GNY"/N6W0R@G+;BNI?_CG3+^9_!3_FG4H_ =$IY<9I5BMA
M1V;>T)V&Q7IQP8^]P#^9'*D-VENA_;&7"T1>:MO;DMY+8LJO].2\-6-W.0MII(QA#&!)"$[MCK:"?+=^AB(^_ ^PLV?-O" \%TVI_>/#@ _UO?BW%>BD_J#Z.
M[@O]WC;=U3;QNYPRX_CGLOIBWC3;C)4THE$2IS%DVO&&.-'$GU$909RR"$M%
M4A5;[1B?*XH WYOU!G>I6WH\EGZ[.,ORMC^
M^WCKX>[/GX>F7]]^H"S3^OGG ;;G\Y\YG.?^EN\T][^MY4VU""03(E8!#&42
M0"Q(!#.&$0Q9FL4D9)DF52^=+3=3SHTVC[9:!+\;N4$CN*\FEEOP[9C0+Z0C
MDYX'-/UUJMP#:)H>E=MIY]&=<@\&Z[Z4^U>Z$9&0^:+MJ_&;7"[_JUA]*SY+
M6JVTY=ET3"X7*2>)(!+!6 8)Q-JP@T2@&%(D".4DRD2(;/CGY$QSHYVNE8V1
M%OYAQ 6]O&TS:>V-G86S6B(CTQ /L$>IY+$J'MH;A+,KX[$
MJ3VQ88/X.OCHV@-HC_ ++:]D?;EL[HE\57QL ]WIE5R00$5)EA&HN*00[>-&',CP<,;X^;?;J_E K3*@*TV%V"KS[E'&%9+-_3,
MPO>"/,LAA8>U\' 8X0+ER*<1AN2?+F",><*:T&VH.$AA5FE<#!C&F H#V:+3?G
MXMPEM?,R)ERHD5^$(Z^1L]/A"5FOWL>Y,DWJAG@"\+$_XFO8XVND8]>*^^V,3 [#@48838FIY(24U.3-343".8,BB1"09BP+N%-0Z
M0(:Y$?)N1$TG)]AHL=O&[*+I]-U]HXVK&1S<9+]B=MP[\CJ,S+?C+,$9\4S.
M((X4RV0OQS/%,3D#]70,D_M0PVCS"_W>)D.]6MW0O%BDVBCE@= GOS3,VOA5%MKM
M6YJC_G55M5623-;+JK@L1.,_?EQ5==FD:IL;HCO;JC;!+S*-$RRT49($YA )
M"0RS-$4PY%$:\%@%*+0Z1/(ET-P(\=-&TOYTN+H KV3%R[QI4S%CH\_;N ,*Q]&EO"US+MOW'2W$
M;1>.7LAZ03"+(I$0*'&L.55IOX_@!$$D6;] KKNIFG,3Y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MQ3Z!=ZQ,/ 2[H_6(G0:-,*P+>;7M"STJ-5'67Z^IJ5\0:N<
M+V2,,TJS&(8HC2&6"8(T( 2*#,=11AA5R&J/X^@L<^/_]]J+S+N"9,NF(-EM
MXSW>W&B?LC)B PB8D=QM+_@PQ'8;O&<#-S*5]_*90W#02'@!7AR%R'F/]B@$
M7C=>#\\TZ6[J464?;Y$>__+  .[;)M"PN&KLT=??3;2X7 0,
M3$ :T@A2E"J")!&I<#I'.CC+W/A@(V3K^UR 3D['\.F#@-H]_6?#-/+3[XR0
M>_#R,03\AB0?G&G:0.-CRNZ%#Q_]\K"'_^OG+Z:L[KJ\ORS$KZ:G66<CZZ
M03_KF4Q"EN5,904)B I-8QAGC >8*NS48.SJ?RWT^31^QKY_!U49(4&WZ
MN3O&CMBA;<<0WA QQ3BB'!(4$0@B[6MD849#Y5UO_#3
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M%@@7LZ&X,7$=F.0M(
MP>^C5.1W!S[1HQ[VG4(7@!J56N/#*.7&?^>LI!TE3K0^([/DT:5ISR%XK?^TJY+]TCA3
MIP=0O;+I.?),2K >@'O,N3Z&'%A3I3N$?5AFZ[(LM1!MCLK]]BN=^7KYC9:B
M+;WUMM!^?K.]4S7Y+5^N:?&AR7VJWJ^*.UGI&_K]NCD<2%D@PSA44 4F:SE+
M,:0II3"+!*%Q( 7'3O$9DTD^-XIOM.I*W^VJ#G9T;\J&['ROTQ\T %R %@*P
M@T'7ZJ[6*( .A@NP 4+_V$#A6/UELGO+[C4RRSMFY)?.'&\6]SHU4R^_?R_J#VB9BA"P-4D4EY%PAB ,B(4$L
M@UQR)),H(8D*%_6JIDN;$\2##F>[!U%XNAQWN$K)SS#.RKZPX.[XU\=
MYDMHUT7JM:X[-^659/4B(ID*LY3 *),88I4Q2 .A?\4XB7$H8ZIB%ZO_P!QS
ML\][$8$<$GMY"$0[\_9,:,8/>6A1V6PZ&0']V8A'M/=JS1V:9U*[ZXBBCRVD
M8U\=N%U@JG*W5I+I1-&'!D>8TP2C& I,M3D3X1!2@K2#'Z$ <1(S&3@U$SL\
MS=P>]$9*#1_X6N1UYPBU/5H&15T_@:VE;WLV8F,[HH/!\IN/?/JL/5W->E+-U/_C+555_DGQU5>1_EV*!!6%4$P74I&#:;D41
M9!1)F&0R(YBD+$R<=@"M9IT;:?2=G7:E[MH[&<$'-=$Z@;L=@WA'RJ\(]V0')@>9[AE.20%%[Z^;:U,XV)
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M3SO]+WV;>V, [I6#O0HX*66/ >UCAA]ECL&>=%^J=V?L!4U#@5D42
M!4FB]#\D8E0&C&HSTZT>TN&)7)[V:0HA/:@/_>X,U_@0K-8N\)E0C7^D=A C
M[=L>B=<P<&W\WIHJJF=U"/J'G!&CWW[C$,Q]G@3L-V>OES7UZO2G+Q]
M+?2(C^(#JM??9\U(\RO9*?I&EY
MF!=7O9V[IDMCZH8+&9(HXA3#,!48XH0'D"J$(*.QH)1134%NW9CGH=?@Q !P+8H !V8&A\S $G9<^_=BY'
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M5[7LN@XE"".52 '#1&80JK9D5"WZ:-?L496
M\*.6]B=@Y!W8WND(RI:8D(GZ)Y>GIIJ63DVKODX*(M9YQ ;Y(?EVLEJNK^R:9OKIHNRS?@]^[_]I4OO>UEAAHD>TW;$Z@?'JORQ]V(_/.E+#9[W+Y@V^B
M/:YS8'3:X;)#YLC^UHD!)MO=LE-D=V_+\HIA5N#+):VJ#^I-7NA9\N+JD^0R
MOS/Q,U_T@!_4BU59KK[)\O)[7BT8"H5,4_TFPRR"6'(%"8L$I&F8**4(1-,8S1+CE?K8NZ,HYR]6Y%BTI;I TK.^-1,T3E/%9UF9DTCQO69PIU#N$7OG5GW23DJ]W
M4!\SL_\)AM'V%_K=]&X* Y1U6^M1AIF(F8#:YJ40)X1!$E,"XX0BA)D*$ M=
MZ'=OAKG1J$DO;#J:&1$''E7LPVC'?V>!,[;QYX:+,W$]J;M7 MJ?95(B>5+)
MQX3P]!>'IERS>ELN[24MRWM-+)5QU!6&Q0\YV(?F7#BC.S3JN_G95M$%G9!)P!<::!DXJ?^#9KR3_^6IU]XN^MGGL_X;-C[#]L7G6GQYU
MD@?\I%+]4WWZBP/#E/3B-7U;7]):7C7-SEZM3"+F(@U#_:*/*(S#6#_2)&"0
M*4(A"C+*(DZ"&+M%*3TUT]P>[;VBF4VQS*;S1]^4NE/A'OS>JN :M?0DZ';V
M@!O%X(C C'
M20Q#++3[$&:F@A/C4"&:HL2$.&*K-@/;(>=&$R_D\BI?6]80V4'F^",^3-^1
MG^47K]_]^O;K7\]_//>U._+2[K[\S:-ER[XH)67K>>9188'W\P_2(W\@,['6B.>6)>P)LR2VP0B.X98B=Q
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M)4(?FE/*[YGQUM<,HQ(WINCSNKZ8[DR/"9>W'^MI'A;O&WZPIKH*%YK
MAC/]*RY9U12A7K LD5$"U/<=Z,!V*K@QCP#5L>.D,;%?&2>TL*#!O)=L'\T&H"\^.D@[.#W
M7@^/##8<1*_$-D",2?EN.$R/:?",D8;L;.A93"^P-ZO2]'Q<4!R&F: A#*((
MF8SB$&8DRB"B5%$5Q0F/0CN[ZM#P\S.D-A(VV?%]-]>^AVL%ZE5-ER[>Z",\
M;78#AF,TNE__&)PSD'#QL(BVJYR3!Q@:U! .T7VQHVS# :?-O4F_E"O[_**Z[?/NM2
M;CU7@H*,HP021%.(,RXTY<7:H M4AE",$ ]C%\H[,M?D*NA76QBMR
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M?-E&H!1M*[7KU5)?7[W^VSJO[QWC1EN!P7(KL1OS
MG<#9CN/\83FG)1_[-1_S#265PT^GFZ"
M4W[+Z^N7FJH1W_Q+01%WS3\H)>
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MSO""RLAO UM K$GCI-+';&!]\8[]JW][;/L^/?HD='!2N?Y!/_W%HZ5S3=*_1LXCVH!!A$62QB& :Q KBT!1JDB2&FG=ERK&($[>@YE,3SNT!
M/]QPJ?_M UOF5]T9XB8$UI2L:#LR]5JYMK8\L29V'KE/I,G<752X:=W]5_*H]^@(ME PIB^,(:A8S=4OT3UE&$.1)$.C?>"!QTB>5
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ME^.L_=BS0'Z6?=D!^/K:=WT2K"GV7_Z82$N(HPXEUL_4C
M$\V-I+:R@F]:6+ VTFKWIA/7H6?X,72/4G+
M\M[$L-*;U=K$\%1F$[B^EH#1I8D* =6UE#40)@U2_Z4Z #?X\8?/OWW]X:MPO;K:E7>K)<4:!YJRF8T,4MF
MP-OK^RKGC9+;ZW_N9*OTG:,=,=#N.:P*<%NNQ+K9".W_6@APJ[&_-F>*S4>=
MJKWF1O [LVFJU:Z;&;66LC3SF:]K:@0WM/Q#UC][ZEMO<;L=ZUI_[/+I>M9;
M*/&@8[W-]X?9U)>B;:E'E^;=]K9X26_SFBX7*A290$Q"*B6!&,"L@6-WINUG#W][E;A;R4^#:&<0>(!OY
M7;25L#%OS9YD)Z0_2_<$"EX-VZ?FFM2./:'P8[/UU-=]N=J77+^?UTV7@>[3
M;=Q)'W72QYR\694/8AD6*0\3PI,8"M,9 (O$-*%F!+(T3F4L%%5)-*!(K5\I
M!X093%'1]K"3N:/H&(% 4]P40[<%1E_CY]P\&'E=/6PT^(!_Y.V(LT1\YDT+
M'_">WMKP,HO[!HB)JU@M<]',V_I;GXV[M6EL(K&B),M,6'R (>8D@#1.$,QB
M%:(X5DH_5K:;(*(3P9'9=&KP[#=(?((X
MU2;)66 Z^?.VZ!SQZ4\.,9E?;ZO,KF]O?8T[V[XN9'EU_Y^T9*OR_9HO)2U?
MKLK;51O6UAW=BB"B&1$!5*G^!P<$0:9D H,XS@028:1B9,NX-A/.C75;F4$K
M-.BD!CMBVY.&%=ZG6=A$-#S\UG2B8!=TCM"P
MU3"34;&+4KMT['3=. 6,-S9&&D8TR'@, QR8+(PTAE0(!(7D@1!A'"#A%,9@
M._'<*/K=V\L7;]^]_?+V]6=P^?X5^/SEP\O_^L\/[UZ]_O1Y4\KX__GZ]LO_
MTE[QZS=O7[[]XKF4L6/CQ3& 'IG%#YUDO>"QI'#!M.)JS(AP1"DDD**2$*I7$.!.I
M5?":6;N?P=N@<.XH_,<)TI_%VJCPXD+>\Y(Q<,?8X@KYMZG:YKJ]7I>D-
M]+70(S:"M''S9H^V>A ;_\E$W'>?4+:477S]L7!ZM$@2DB(>Q#"5"8-8"@4)
M3C 4B(66R=W-^EBN[G+3RO7-JGRWJJH/15^=N/I::Q=/R[Q
MBH:#T3K]J)
M#=:=W/9.@PWHIYTNSU"._(YX'A3MW2_/:$[D@IV-JI,3YH#1$4?,9I3)G#$'
ME78=,I?+!@9*?T'L7+F10![YK;I!]^,.NM/T)!H F-_@>8?YIPVH
M=P=F+\A^P!##7C/O9?V25M?-^TQ(\>+^:V5:Z6[J\5^:7FWM?/H%EQ=K_5GW
M1^V5;,XI*0LQULX 3((P@SB."60HT[^&*. JEA0SJ],8OV+-[>5D5 )OEJMO
M79'O;8>+K3YN/.AI^>PH)5,6Z4>C%QJ&;5?KD7/.S0TKIO7ZY
M)R]PHPHA\\5K34#U_=M"VSRTZ<7[BM:T=Y=$B+(PD@QBBH7^1TA(@H3"@$6:
M*2(I0F'5,^+41',SSEI9P8ZPP$A[TG%R0_Y$5>RW>F"I$F17T7Y6;#K*FB=GFS*NO\[XV'
M]?J[.9-ONTCJ^W219!CA@$B(4U.PG(8)))(R*"A.HB0*0AY$+B0V3(RYD5JK
M!6S4 %L]-M4%=U4!G2Y] U8MA!O'#5PY.\X;?SU&YL"C2W'1@,^;,*D=;6R6
MPID2ST/2*T4.%&52RCP/KL<4>N9HPRCUDZSJ,C=WE]G1NBR:_QC:OJ-+4T_[
M\*==EF02D>3_NS6WK6-;P7V'55,V;4V7T\ *"P#N?G-N93*635$Y.=W6=
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M54^&;^]OV_D+SF(),SW'Q$00O8+/*" P1H CRC%$F!*);6M;/VEY;L37&NNCWEY[6(=6$];D/ZM$4*AH : TN2,RAX!!Q '/L56^/U*N])Q&P07+1_0$,.MMP
MZ'[2&88[+,]G%1XM7":+]/A^O?E=.[?9TG+UC?[\LJYJ@>O*5&MM3^US64!*
M,-0K,I@#B&,%2)Y3(.,"$<)%!K%53(1'WW.;C>Q,KS..=L9'VOIH9_Y5M'?
M3QG)9E3LJ&XDK$?FNA,PZ[^7JRZ633LA[:#VUDQR &T4V22;_E]$.VTX4M>MAO'>G-LW4EC&[#Z],4J2C/%L?-XESH83$($4D!1!*!!@MH*9^
M0EBF"(DI<0N<]41NFE#9!KO&.G_0[)C9$XB1F=<* 6="/>)K4,+LMS\I(1YQ
M[#GA';O$<\XF]=Q>[N:"'\T$<4>GW4;3VWO9[<=2E(@"
M "'B(BL(YX19U;CS[']V<[?:_*O>6JGVX&JW3GJ\ZG9K];Q"^^&Y>^XZ3)83
MN?' 'WLR9X'[=ATQ69F2E^O
MA"+B>5*(PL3MZS4J+2B@4*2 (RDY1Q21Q+J>Y_/&YT9DK7T^92@/)*G+G!Y:BP'!%P.;IE,K>64L7UIEI/7>,=P2+T6%WJ!
MWFPLZQ^Z?VO#[NH-R@5F$A&(8D!BK "4F0(LHQ0PK%2.W/-)[71NV6/46UR],>W6D3')MW9"WD[
MF@J(Y\CL% 9*=^E6.X#"JJN>Z7-: 50[  XT2BUO\Z0=N=2_O?E5KO3J=VDT
MB\1MN2J-L(7)4VT);D%03!&NR_(FJ3E+A8 J2$%:();$G#+NEB!@U^WL2*BQ
M^BJZ:>QNE@]/+'>D'COT+1DH.*9C$U$'YZ\].)\:W4V4 M*0$TIAVOGXLT]Z3*7S_N+VFWZZY_T(UH59C?KS=*EB:XU=2]T3:5
MK7[/AU53D6%(IGD!$Y3+3&0 2P(!9%*O$!'3?T",BX+DBDBGTX@7]69VA'JB
MUD%?B-[,3HYJU1M0KO9E#'K -,6I]M"87:"NQDGX:@$3CD#-5+' 4-HW3Y
MH<\3$,8]XFFZ>MD#G2?NGCV^>7JU=R[=^E::)AMJV3ZVVFYIGL5Q$2N0Y2P#
M4'!SE!Q3D!2&%F(NDHRY4,&ICN9&!OODAFAGJ:<^RDEL[1@A!&(CY$0,D)0H
M$%-$&.,Y$]RR,M9!V_,+@6O-LX_'?8H5(KS(*:PUH(QN@JDB5NAU88X%B?6O
MC9O8#G(]?X)DAK&>H33V:&[GBC[^O-I*;^\5U'3:_@";Y-4Y3
MP I$F@0Z5G .,D9)(E.9,&A5^M>RO[F1TYLE+6\C52ZEN(KN=\9&-T;Q@._]
MN'),E3V#NMTL,B"6(S.KU/.RBBX_J_8?WOWDRWNAK?E-;AY*+M^LJ^V;
M+J%F@7"JIXL4 9:H&$!$8ST_(A#DG(HX5D0FR&EW++!]I=\NDM+
MJG.B5G(;W;6N1ZS5;)2-C]&KLM[6<-1/"#W8=GSX@D,X,G^:^F6=:]$S\2&4RB%5LK Z0SG7T4QII#56/_[;.BU^$W4&NQ+("7QMJ>-RU*8A#0_
M/.AB&(T+B>)$XQ-3Q+"+A^1PYOK+8K+V1[EUE(=1U;>G/B+:11\XBQ@/PVBWPPD V,C/LL.J'
M9K20!54@/H_&*.%:1[I[D9"MTVZ?"ML:N.,R!6%3T[W1Z^S*N"\22FDJ8P2$
M-,=W5%% "4( "8QIG!>9%$Z!X:>[FMM4HC6O+[WMIP!\!%4[F@B#U<@T\429
MO,/LC\[0@,$3Y]$81;CW2'U
M^:?>ID[@AAGI6>6@7NC2GRH)-+LN'NL5=W?1%FC ":9&#
M)&<,0*X20!BA("4RB5-!$I0X'8$?ZV1NG]N]C=XEKQ989KE2
M16+*P-93> FPC#,0IP2Q/,TY3:W.. ?ZF-N+WIK9:-[6AD:MI?;AL:?@''[=
M X$T\ML^)C[V@<0!<)HHI/AZM2UY>6=J_-7Q3\>Q:^*A?D0WZP>Y6=4S9A/E
M:38!PL0@GP%L(!KYU)V3Q26?,;T?H7SN4L]]%',4_*&J[J5X>[_1$ZXF2.5O
M1BS[D_Q1_Z9:9)#Q+",%R C7LR+&,2 XE8 4-).,IB1CF=-VATVO&ZI7",>6VGEC?O%_MGE;G
M@!MQ.8V+'7^-A?;(-!8.:&O1MKQW*)R4*QJF1ZPY7
MX)TRZ^XGWC]SA>5P5\VY!5]:>Y"K>_E5\O7-JJZ]^V6]+/GC_FA2Q 6/F90@
M(50"F*H$4 D+(#'+5)%F&"NKG3?K'N='8K7!4<_BJZBQV96MSF%M2U(!$1R=
MFQKP_FA,'.>TU!J0P.QSKM>)2<<2A$.NL;W1?3M_7V[CT]JT3)?UDO1WW4]U
MS;?E0[E]?!8*P67.",,*%'E< %AP ?3?,ST*.>&Y7C(*O5ZQW.EW[WYNY-,O
M+]/YT-:9J;VXBCH_O$-@/,?I_!'"N.B/O?]P_\#C@E;+*]"%TXT*NA/95U-\O4S7E]KX.<=%_
M4_=-TJ; .6=*"I!*HU0N) 4XX0JHG#&4ZC_2W+HZL(\!<_NT[-6W:R>BSHMH
MYT8$HM:3J'4E:GVQ)SBOH3K_;1E[ $;^NLP8>_O/R]AC,-$'9I2QDS[-8<$4Q@)PPE, ]8,'<)$4 *=2KV-D
M06'.75,DC_;D\A9-E1_)G',ACX-HMP<2 )B1*=Y8.+XP[!D< N<_'N]KXN3'
M082"!RE)B4
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M_/S9A"ZK!ZE[LYFFFW#CNZ_RJ5)5#'P2_LL?&%-DU[O!P&P(-CZ$#->F[IR%6YWGQ:;V753@8D
MCN,"9@AD:8(!S*6>HZ9Q#C*HB%2TR FWBH4\V/4ZC2*EIL-
MEV S-DLYP>*^M#_E>MA%^$$OTRZ73SEYL+ ]>:'?:_V>EIM:RN'#ZNY^6WV4
M#W*9M8]FSF'.>9:!!%,].>*97G]B)$&:*9$@KG(*G=2W!_J:VZMN3.WD21IK
MKZ+:WBCS?/.'@+;C@$#PC?4X?-+7XD\F'U
MH*<:Z\WCL5A,F M9$%$ PI("0*I9A'&A0"I53E2J,,+";74UU-W\EDZ=M/'NMH@$I0Q!CNW-])QE
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M$Q0PE7* !*(J3S$OL)7JDENWM+!L+R3"DXO&,?-(5!-I26
M^ F@IA 3?][U'-3$3\!A*2=^ZFX_PCI4[NVJUW9U:_7<2S];]36?U9OO)J1B
MD:9)AK)4@$+F>E69)1R0HM!_35+%"R,E%SL=:'M9,3!]9PY+VO,
M/4+]PXIO)*UT+\U_RU777ZOV^4ENUZK[MV:I4R0DSRB- <&8 1ACO:*,50&H
M@@0BR'(BK/8_-_+>UJ
M]$JT3O]B'[KM,U[#W#G!*(Q^LM@"VIEO5.-WH_*U&Y5/S:CL?N&P ^"+O'TH
M_<@C,%& _2@CX11Z?P&. P'Y/JU.%J9_@7Z8X
MX0G+&) T(?JSHJ?G.*8(* 0)%07D:6HEFG&\^;E]-9IDH .?RDY[>-&U2TE&##S*1CE]U
M:?$RPXT?2\K*9;E]7"2XB(N$<[UNP=2(M#% %!( RI3E.!4%S[!?G;(G_*>USGD-1\ML@)"S+@$::X9
M T(-,8$8 Z'G-BI.&,=9X13VYF[#W(ADYT)?&M!X$3UUP\29:WMDM>V$ Z_,
ML0 ?JE(5;-SLV&CDT1B9J>P'8N?#550[<7X@W./S_*$,&[SG8<>TD7W^0!V$
M_5W0E!N%"EDNWK93YV\;NJK*)L/1E+Y>%+'*DX1!(#G* 202 6(.:7*T*BQU([;!@$=)J]0,(W,3AX(69..#01'6*62_"\W
MZX?_TK?7A/(O:'X$S8\UBPPV/ E-V+C6\8#5M7YSI3?KV]OUJCX4KG.3%C%$
M/*=*O^0DI:9T%P24%1+D<2KBC J.,J?"\\\[F-L+WMC7E(UPFZX<0&=3/KI/^7B\^_ZR>L\8TV[*AIUBV_;
M*AK5]4K44X)K\7_NJVT=H[8H1,$(3W(@8E.@3S\.@* SWS'L%3[$;$CCW%P'IE60D'L'L'JC%;8>%;[
M[J>-;G6&Y2#6U;V%"S.;/\GM-:NV&\JWBT31-,\2!E*6Z2E*2BA@!2T 2[$J
M<"(S1J@+>1WK9&XTM;.Q.:+]H[/3,3_Q*)YVU',I2B.3C#M _KG+1Q 8)V>Y
MW]'+Y"H?2R^-JHI_6NN/*"&@;?>WJVWI+
ME_W?FW/P3^OM/^2V+8O\;RF:8-?WZTVO4G*R8+ H\C1&(.5I!F"2F(P&(17VTVC2UA6_VRC;@J!
M9:%8!C GJ9XQ%SD@A&9 8JA7_'&18>QTNGFFO[E]D3ISHR?V1L9@QRV_,SA;
M[@"&0V_L#<'3P(T@_6&)2]B-PC-]3KMO: ? P3:BY6T3%V9KQ$H^K/2*X+[)
MC#5[ ]^^TU6KWK]CSV>5<'[536_?TJW<*:8M"EF8='@&"&.Q425B@+&<@"(K
M4BI4GL6)TW[E')R:&TL&*-;5"@3UX&FW][8:H'TIKQU&1PIYU3A%!JAH+V4X
M4=6WD$^LW:=@#J;.Z'OS9WP$IRLI-\*8SZ/>7$C'9E!EYV6&,EBENC%L\YMZ
M:-/*ZK.ZYGQ]OS)AHE_6RY(_-G_NM3AQC&."N  %-?4C<@3UY !R4,1*921F
MA#"GDJYVW<[M\UU;;?;6]G9?18W-T1_M?[W+:UN.A-U'+SR^(W^60D'K_*EP
M0RHHF5MV/2G=NL'QG! =[_9,1C%<^66MN5-NRTW#LWO%L>JI"%DGNI/I5SQ4E8+BJ1,"E,6DQ8<0"0QP(H3D'*4,)F3'+J%#0[T-;$_L#!M:? :,X%'&I_J;
M/.#XC./'8H_/W>)'(!]E54GY-+6S5T102\AL"B(
MB@7/73ADN+NYT4ACK2G5_23[N+(KM^&#MQV/A$-Q9"JY#$!G2K'#)2BKG.ER
M4F*Q<_\YMUC>Y2Y-\YN\HZ;-!_GW]>:?OZ_T9/>3W'Y6>W4"F4%$(4* Y04#
MD"$*&))ZKH(I)H04@E"K4#ZKWN9&+GN#HQ_:XNC>F-Q)GBW=9"#LX!XFE^ @
MCGW\-#E^]G(X07&<2!WG.)[EKMJ4-;).NCG62 W(Z)QO8S)5'6MW^B([]C?Y
MS?&NN7Z [NNZM_4*U1PQ;>1WN:IV6>H?UU73YS?ZA[W907MB>R>O\>IC WNKA?AM ';G^:0G>$$GF*XV3#KC
M] 3H^134MQEWN8QW>N6\?7QW*SJ[[ZV;]8_O=]$97CPLB29QACO4@T Q
MGA> %2@'L40$)EF1*6BUUCW3S]SHK3$UZFR-&F.CUEI[X8PA:(>Y*B!@(W.2
M)U9.$AH62'BK: RU/9F0AH6#?2T-F\LOS%?]^Z;J:I[F&TFYM
ME[^?Q\4_._7 ]7%R4_?=O$QFZH&;)_-2#Z\,52CS_?U*F"1XNKVO/BOS+PL2
MBUSB/ <04J+_4!A0DC) <5H@AN.8**=<4IM.YT8 QXLN-G9'KWY?J?JG7Z+&
M!S/'-E=<6OCRRD49HB$>FD<#H!BAD>1JND:M6'NGXA4M4GH;B?#W*@7O=
MM\I_W]!5>7_[^8<4W]9=AI YZOOM_NYN6>J?%RG/H$IX!BA*E-$\-7.4) ))A19%5OR:Z[N9%4:W&TUB:;3'3>&5V?4%>=V?:[O1:(G]\N#XOCR$ST
M$A#:[YB'A7*B+?-+(77:*;=':&"KW**1R?;*[1WJ;Y8[W.5Q9&D4DK[*._V
M?*>5_+(IN?PB-W7JQ2)3N81"\VY"H(G\U9\]EO$4D")+2*(4S')A?5HYT-'<
MN+?1 =L;&]76&J&0)K7+X8AM"%Z+T\E H(U],#D-7@ZGD8%PF^H@TA<_MX-'
M"U"&SAR';I_NN-'"B2;^D-PN4YH6,
M20*PHC& 68P X2DUQ3U0DF(HE;+>5#_=S=PH\\.;]U^CUM2H9VMDC+7?4A_
M]?R.>ABTQMYE\P+*:3_]/ [>V^D#34^VFW[>O?YFNL75?MMM7W<1[V8I_(W^
M;%;&;]>WM%PMDH+ )"4$I%C_ 1F1@%)* ,*T0*:\(Z1.V^J#O
MIB!$N]WS1V.Q8PSI,-9VVVC!$!R9("X!SWFSS J4H+MDPSU.NCUFY?SS?3&[
MF]QG%!_E#5TV)W_7/\MJ@6&<)4@J &L"2?,8,"QS@#@E!2<49]1J[76D[;G1
M16U>U)XT_V$LM*2'8[B=GR9<@,;(K[X+$$XS@A,N>T\#GKAJ?HE3/ZA4#-"ZP_IYG(D]8 1-I/:OOM3NW5[&;
MF!K;[-_!/E#GWS]/]T=^]ZP\=WKICOCI_<+UVYKL93OB0/]%._9K]Y?LS?I!
M;G9:WS"CF""D@%"%7CS'"@."LQ@D2C+,&84I)[:OV9.6Y_:BU<8YZZ0? G;^
M=?.&8>07SAH!IY?NJ+?>K]W3UB9[\8XZT7_UCE\0*FRDD4IX0S?2",1^V\B5
M, 7=KJOJ_E:*3_+G]GU9<;K\AZ2;!@81GN?XP<@(8$2G@(BVDHAP7
MRFJ>&L:\NN-I-4WRI9RGV?-J>0DBS' U,3Y9FD*",H*(#B)
MBR(C# GHMB'I;>W^BVB'7[4O_<;/=W)QD-$;?
M^G0>B.B/VIMQ].T"H!IX[]3?GHEW5B\&[G#?]?(F/17&MYK.S8;OFR6MJL^J
M/E*N]QH%RC4Z/ 8L9Z9,89'IN6\. 4I0GJ49U+]R4O8\V=/<&+.VSX3N-I$+
M+GNVYU&U8[P@6(V]Q'6"R5VI^1P$8>633_8VK:;Q.:I(G5N^9\<4 IHH!#@F2N1(D1S';OJ-H4QS>96F$77LO*A/11O?KJ+6\*AUS7%R
M%FP'"G7/[$>SY%W0='13QT"OJ,,9-
MO;8."NF157;8]CVU)FGUW:C/Z?\8U?D'NC1Z=,]5Q0630J6<@SQ)I"E6C8P^
M<@:R3&(A"TF*W.K,PJG7V5LW2!8P#74NGFWUGIFS[<;VZT>_]K4D3^;[>;,W/;]:WS&Q>
M7M\:A?D%2:40@L6@B'$"8)JF $O-6PC'17:=3LWXC)67T5+;3
W43Q^^9%'S?A@8M?]:UAP;=R[$_WSTJ
M_-9]$T!#T:'T]V!TG^9LWLQRC!-^!K3#7IZ"!<@Z.Q\_=;Z]3_;^//RZ?W#X
M]?#;']V]@USN'Y[#>;SCAY^.GW137W/GS
M%>U\@GL??$[V/QPF8>+WW'PVGVK-DL*0PF28MZ@I,5I:8KFC/E&IHAHCSWFZ
M9$+;W\2.O-CQ8SCM& %T9(K(B0< YP*)31-
M>)K":1OFGSQ/Q=9BHO3=R9Q;@NX/!JN]G@N/3F-:!%C/X3V*)K
M)<9_G'/*[Q('K0C/1#'UKIHL\RH,K-E(K+4DUIL%F$2UUGGN/4F94)CKJ8A*
M\YRH1!?.*F<<9J2S):,\UA18MSB3_+8MX%^>A6\=56Q8^$>R\!SH2)CG&4T+
M8%SGB%!>$&F<)%085EB1,RH!=&1;BQ4E=\?"OYI_: 1
M5.DRC>2M$/J[$?"XKIGWH*76G2:';&36&C+K_0+LX'FFBBSAQ*4X?SF3CDAK
M068EF6#.4)7K[%ZB4*"#0"8;8K@]8M V94 ,BH#U+(G 7LPFYP5)F ,@>F=&WY+K;R/)L 6SJ[J]WB/Y_GC=
MI"NR':9S":\:F;BN!;DRG^!>!Z:6;]/U U/K/?Q]4>/+G_K>Q,FWO^AN+V1:
M#QJMRTJZ#!G9&_&]EO@^7(#GH,CSM+ 9X90Z(BSW1,-)$98G*==IH;5@3YY3
MGBXI^_PQ%3'?D_1Y.^QYQZ[K6TG8^A5E[.,5LS\V,V C9F]?S,ZA9$$SPT3N
M2"&E((*G@AB5>5)8SY2D(LL3^^1YNJ1V\Q$)V=N2LR58GYN^16,-T&U[:JYQ
MC<8#NY[\S[
MOB^IW9OL;3CC[;(FKUDQ-]N]BL12NTTP[M)9+M]GZ/%Y!/*AK)DLCV[NM>[B.T!NE]\A6W"Y&$?YC/&).C!66P/%3OW8+*2'=<9TB@01C_$RLRP
M+<.5S[)D8C*:*20T=5@X)CWR>($GSUM/];.Y:<"_>.KG'>*VLBO*@E2?!EHW
MTGLMZ;U['B1W &JOON[M=-(CE;HL*4P"L PS04%F8QXW)=H+EV2.)5E!GSSG
MLDXT
M3L=3JQKZ;7*[?[R'\#K>H[(]T_?XC[XOIO> 8EMWZEQ:)=0V=N?D".KU];/OTL
MK]A&/OT<^32'PQ+&,BZ4(@Q@$L@GJHG,F"4,Y)-+'6,Y1_F4M.%@-_+IIO%Y
MM59X_L'-XW7WV*&Q0^[QN--
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MWL(*=_G>Z9N+PV]OON[!=3H!'[@NZ'3Z\1/@@=.7O>;(Q[UOQZ#7[9%(%#[$GO7-#I(EDGB^4O4GT>5"T>=RROQ#]W0?C&\];C6GVK980M5F
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MSEEA709\G-I4R=R:I$A3KE+J5;YAYWO&SGOO9MG9*Y-I(QUATGE@8L.)O0IB(_?[PJM/N49;0HR&1V]!K1<;RQ&8&;$PJ"K0]X3=M
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M6W]6GH?;[KNW?MP=+O.A;(38[0FQPX741I9JEC)GB'T9MG&4/ @K<7-,&W_6@_-GW7\TLFY)!4M^R'"*A\@@
MZ^$4Y5CAG<\RL+&$]U1R1[7V,K-:,)J'Y.QKP)--L<5/0R1V 9%DVEJG\P0[
ME19$Z-0090M)LDP7/-7*>9X_>2YH.V>+\9L')$C7XM8'Y-#YA<4/]4P4"169
MSKAP*5>69WEB0;B#EK?27%/\;)+)?YKLF0\>6R^D35,B\MP088TG$@Z42,]-
MG@%)&,>Q54Z;JZ1-Y:,>?[.1/P]._@@CA+%)H5-5"&Z]SI7)4I?EN4T3YN5&
M_MPS^3/O4I8^R2SE"5%)D1&AI"'&:4\RIY7B:Y]EP2H7R*=4^H\)D7@,<
MRFPA59H;G1A^1;OS35G4G8.FSPM&FZ>&.UXPDJ>9(H+[@JB"%D1RSUDAV(26-\!H4Q;UDT#2[OET<@.NZ_CK
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M74)EGFM),I]P GC.87FT) (@G4V%-C*C3YZS)&M3R3>^B ?&X' #_]6&(6HAEG)6#R@*7_G%G 9K5L(*$$W">N=DYH4H
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M98P8K@7)$L,9#F TVC1DZF.I4
MMS.AVHHOA@LVPFLCO!ZF\$JD$=HD"0/Q)'0.?U%-<^%RYK7T2;X17O=.>+V?
M%5Y".I-1!7)+&O@!8(O(-!-$0*-O$_QAIN!_^Z[I?G
MU8;N34YA$^SS_PLO5H]PJH?'W7Y82WHV:^]2CF9H*2&>_U\S_$=]$O&RX#X=E@J(,4U9/QR6 (=QBUU@Q NT(5/$]%GN3"FEPK#%4J
MIZQSUA?ZF@)VF56[7:WID1=8?OS/26)/_]W7']1D__3PHO/A+:QPE^^=OKDX
MQ-:B<)W.I]WSCP>NN[=S2#]^^OBI<_JRA\62G>VC),UE5J0YR8Q,B"BL!6"G
M4Y(PE>8^SX0I,DQ)Q*EQ2R?'E3G797E6,Z&JW3K3P]87W9OXUG^MI(O)R+WV
MPW!FMT(<['+B>*V'^\-W8R!C]V]ORX=)$ '1B4)5XD!OA 9$;##1"(=
M2";0A*.Y#^,#MY91P)D?1BIHK\G^/\HXW/#^E6=.][:/;-%E/%^+]IK[6T_' !P0,;#D]XH>
MFH@IO$5_?Q:2<^^');:1%%=1RJMD[\V137U>9+8@7F>83I90HKU)2)'S@A6&
M"Z'ED^=\#4GQQRU(BIL1Q492K'?^ M&!XZ 8K,)68QS009$1G18%T3*U,K%"
ML41_GZ3X8T92M$M1$23%>'#LX?/#UGEW?-+";RX3+NU6\YI+I,Y6:SO0WT+
M,GZS-'A:)WI4%0S:9:M,E+NJF>)JA*3CA47\5%A
M"J4+14F2&$9$:BF1.9"&3[U+'@';!MK629"JQRM/$\92O=@(O@2Y-4MAJ/5Y'X.O)$)OOC''H
MN&Z-@(9&+7T\]/X4EA;5,5;?ZV/X#'FCND^%@U7[9SA
M4?0Q7.BX=">NF]-;6*ZIE(F1PF:93'3*$J\83XWP5&]JHW^N&W'_X#/M'.RR
MO6_'M//I\U&6%TP;GA(E,[ K"X=HT:4LU0 =_L!
MNX5"3@WT.=8]_/RE9L3M5C^1M**CGI^LHJ%@1?PY'(RN23[9+TX^>SO;1U;S
M7%M58,(!*&^0W,2D1I'$%3ES"58F)D^>"[&U:H(X2,(>_ 6 OQ@#SO=?SWQ_
MA**K[X+5"? ^-%$-74- M*'4Z 7"Q(J$(0*="HE:Q &TY)]&<(MK4X^W6>Q)SKQH8TO8M9
M#3CT%L.MKN6Z\.L8R&(T'MVIC-H)"WF!ZRCK,ZOF>AO*N1;E? ,L*;7V*M5$
M9UP2P3@C*G-@:'#E)#,2#LNA)V15^XZ2<( Z>NAEJL1/MSR(K18&7Z\P/L[]
MT%<^BK,&1%LFO$8GOE? W8[!BBVCM2/T;P4$!W^\A'-OO2.\]?1EM^=;>X.M
M%N><,*Z88,_:K?.3KCUI&6^!BEH>\!L\S!>/W]R>'$]&XU8:!W>V@W35*"Q'
M9_"A"=QZ1+;X83/;PHR0/.&S]3O@H'T8L<4FF#,C=JB')=#E/
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MGN\? ]N4)P!T=+KJ--[YB'*X9*VW*$Q*/BF&EY"NEC\ ,,9#7X9Q^"ZH3
M6.SW\ZX;GU2)G8UOE=EOR?0KVHP&OZG0&7$S/T^C/1:./\IGOG^F+TY!^S*7;=/FGNX/S#KU8^/RW-;ODNZ$#Z
MVV?#;J^5H:Z@\!->#,08>04)IQUDP?A\T+KP>EAB@+\F?=_B2:UA!C.O\*B\
MGW8C=7?[%C9Q%'Q05_ '7\HQ',[W@ !!DY7E^,N$$)#1$%#0+@ 0@!,O
M!L,S?!#1V@6Q,[Y A0&?0"SUNJ?[RQ\/UH(L.!50=^PGPYO\@57O^+!@4P?!
MMHT2-2J=/RZF'WFM UC:!HGK]B8(^_:+J;&TB;[?P #A^SN'1]+ :;T%C@DO@B4K:>%9+GD6DG:NG;$SJ^*VERH)D*BUK-=F $0;E+('&G:(P4'0
M LE$PT2?P0M?IOIGP2)I (A%K/RP /&K/G)'(G$.>%32;QV"1$I3X@V*B>%*1+%F6 9SI=;WB*N(6?F\'L;S694IOT(
MDM=RA]V61D-OV&Q><-G$Y>\N:.=H*KVN1=R&9*Y%,@>[1\8C/[N4)(8;(HRR
M1&;HR<^$LMI;*7"._@DQ3H[G2.5%J+0)B.VT 60%'=$P3X1JF4F
M.DS+KFP@FFGN4^ 2YPK."]8*C?"[&XH]=/V$?<>(*[."!,!06X#\&Z-K!!SP,7
MC0:#?NBI.0R^>I3R(>D#067PB3>6V:YN4@37/SS0P-H).LQ_:SW5S\);(P^<
MA*JBCS["$>Y&N8I+5X; U<0K -.,6V8"G\7U.7W1ZL)#NBY\K7>!AX5NS[B7
MF* \.3TM@SL%[,M+#$KAQNM>ZP#6/"J9/L:5BFY_X:&>E<0!LF72@_,JWPV$
M4T5Z9IW[R]P:O]](-"'&9Y6N8C2T/H\47OO"P?1:_MHS\=GB4@?%O?%Z03$JP
M$3*5@MGI."E2;PQ(R\QRN;ZG J-KOKOHR6PX_16%CH!0&C38%:U4YXOG9U\
MDRC]/%1XVTQ<>KK<-W<_2?>?(:V;2-$^(D0Z,
M--"_1.6%!+I/><)8)G1(7T\N[X6P.L1V$-*-J^J'8TP.7\AC\PW*J8-J7^%0
M OJYLPS2D,G^NESK2UAJE4"Z7S0*DS;9I"O(*^V<'ZE,2)"86)!FT$7N)%&&
MIH3G>:%Q1H?.-+H KDH];H/,@VT&<\V[B0WX.>"2\V$W_('9>8,)FE_S:>_X
M]R 4U/K1.)"4FU);G2Q_IB\JVZNIXN\J?[GNYA+3"N83F$-2\X;N5@#FKYT#
M>Y0X52C!%-'X0R@0<%HJV',V9=Y>6=498B7H\5#*6+I'2788OZPEZ
MND(WO!Y:/J6M'OP@5^387.?.0>LONW40YM>^65VS=+>98]?P*HTD85*B 1TSZ5RQN4@DY? S*K\X$A@.'* @P ,N3?*
M%MSH K4R5[+-ECGX(QTDC]CKU'398F^6.@]W/;(OG$Q@2VFJ]Q0@"PK(?TSJZ%IGABK\A
MM73M-83HWF#L6Y2U?_"J+EW#/=N2P'$DE"JTFN4,=[E%,7VQ4>_1[4=>1U/L
M@:?*'ZSHV]8:#[6#VTR#:J.+4S/H5A5*Q -\J,!HM7=_A ]^
MF"EX/2G3;$88E JM\T?MUMD C'K\M\YKCKY84#AC.*AQ[9P=ZO[G$69#!-<"
M0'PL":VJ=:]H@NB_6G\V+C,JMEK_G*9O+*4<5'0AO:)7EGA@^7*[\CG448IV
MJ+([#=JN#NC],=##4(4:^TH,%K)$EJ8(84()\NO0A_+;X/!;4[;=3>__=_ U
MCQOXSO\QEK?XW+? N;>!*]PX.CZC,K;%<
M$V'XYB+-O)V@O$H
M/ZJ+QV+\L^IW4DF,JZZ*&DZW8$F ZT0,KVJ<4+[
MVA>O!SK/![Q*#TL0S+7++:1)>DR$G,D[N\Z-?*];IQEBEN!,M?_=C)%U(T_'JIK&Q:^[MMN'7;]@[3^_
M5[7_]TX1'5R#Q4YTZ$)4]YS&>#5.K6@D9L1.("LJS7YJNOP5VFU3C+A>G_(=
M>\2XEBX1BN0<&Y4+EA)C%=9;B%QFF3 ^P4[0RYV)R_N3-TZA-3V&:5?Q?\YF
M2%]+%#?N@'_ZJI."]P99:E%(0R3XQ/
M0\;MOBO+QQL2%U"O$D*(M+4$*F3A&0Z%XH[RS.T13+6
MENFEI@C&=9K=]ZXT3<:A02%FZTY%_;H9;=])3&RAG^N4D#:9N9<2SONC'/"4
M-,R0')L"BUPE1'.J">QSREE69,J*)\]5*K92M4 X[5A[%!JMG)V!( ^Q'72G
M52ZIL?Z*'2&##[[9H+R6/'5%Y"6.4SEU&!/*R_[VFUKUL!7#C4]WM7^_)1ML&82KER
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M'UU="T*=ZN%QMT_*.&P&:.=^.^KIC*/^88I
MUNAZM8[%'(;UW;$SV.+N.I3-2I?- .@KV^T<'RE.#4UR19RDC@A+$Z(=TR3+
M$YJSW&2N .E"+^^/T&ZZX]=T3GUG Z;;\L%O2"*0Q-[.^Z,D93GH&D-2C\B%
M:4FTE)1H.!?I"\Y<[M%A146ZM4SE(%EZ8ES7POD14Y+=??W"O]R,^N;F1S^WUP;\>1O.'6
MR*T'AT=6YM0H+DC*10KP4&3$^-R1(N?.2\V*) W4Y-ZBTV$C(J*(^&2/7,J4Q/[]*I<)$=+F1!592E3*$ZG2
M%,Z./WG.L[9<-L#Y>EEP.#C&#WL7)7.4/C3,7JO?06WGAOJ\7Y6D!#7:+MM@
MP 5'9X-H;90\A!EP !",]_UJ2M.TW^DR-EJJ]F'W@:R0EK!7>MR?-7O8Z7IU$LLL81A VL
MHYHT7;:!LRF?=:;FXHY3J4
ML@>:C>=YPI36A!84AR2"G2P]P')%E:2F2-(T+9X\3[86O6CS$N?QNLY0EI:9
M0O-&\"K0/1[\%L;XV3"=.?C"3:][')$KHE)]T:R6ZU_MU8H=C\/DD5!--"V%
MJ_S=T^MU%\>ZZADP.L14[?&P:R8U.!T!CX]B#E'##=_&#X;ZX_)[Y]T(929G
MS]IQDM@9SIT9+\D(\O[TRL=R 7>&+ZL$)\5@/5^O-SBO7JU&S4Q;XX>9,M6JVS#16.* !.8T[U>2Z:0DP;0D@[E5+@+O1'R"L
MUI=>I3.WDG]3.1;E+@C>H3^MG$!GP\%)UW2CD"ZGH'G;TV7")M+ITMII>._3
M) CF93TQJJ%KD<2QV].5/AT;6T"6EZO&=8%"K -!T^9-55NTVKD]>ZFU\U+;
MK06'5+M1=0NFM8U^N5+EA43#YN.WR_&87V;VMM'>"O?KFA>?W8BY5$1LD%4.
M?#O30YP--HV*7^6#>KPP:\:[EBWSKL4D@X5R@-VR)4G/O.:EPMO33H)NPCDZ"BT#405
MU93"U^YH4A'TM/$7?LO7ZU#4HNUK^S^F[P!L-A3=OGL7LKO&X
MG-Y5CKQI5(ZLL:12C9EGK6(R#+O4V-)(!B'X0]7*[433U:$$#)&NF>X5T8I"
M-.PUG-J@C[/*/ $A,0$*!436>DK_ : L&9\\*YNH5>.D+@D";;=>P][#(YSI
M,/WGQ;2IS#HE/>$P_HME^#(:=E3B;_70:V#':=W+RQ"XV_UZUBU1$E+_LBFC
M\P3[+-XF[F1:[V3S!<;"A5@&% B
M8+\QNB8:XT[+[3$7RT\7.W$BA$&;9?I]?:R[_5'(:1V,1EU,)42559+Y8#E(
MTZ;;0_P"UYD <6!PK>^!A^!,XD'V<#J8UG/EQAZEEYS!65KY8+C4 J#1FQ
M*%VGK4ZC21 $0A6N530(9D8K=24A1G;+[I;R\?*@WIIXL:]TZ$]ZM
MA?6L,BIKK.,S!>D:6LJ&ELM '<<^D%&]&39>?U3?&!>+^3B-8
M&X+W#8RD@4_.6Z,H_5;LYSR.ZL;H.O#6*#KCCH>#R5EU\4NJFV+YU*TDMHJF
M ZO1^W__'#9E=-(]V^W#/F L>;8NH:2G2)ZU_XJP7\Z!=?RML_/J**$X(]@+2-%
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M#_$I0L8RVH42K*?JE=^ PC&=';V1X1$J
MI\_"DX+!,!B6/0:!>(_+$:9?ELYA?UB44WLY$\K<1M>NJPPJ+U8(
M9 2S+)BM< [=X1*/^<(N-QT4<]^9-;[F+W@Z<,#[WV\NPL+ HOEK CB[3"+E
MZQYO4"\TLS(S64:M+$3A4VF=9'GNA5&6:DV/J,()J.M1S"\8DTI_J9C4<@A\ [P%W]D[/81KG)P"_CK?^Q->^_;^
MXC_?=N$]*XZTRQ*E"TLX8]@4T@JBF63$9Y9S7V38 R?BWVY_XMTVI@1(:A)K
M#"!>1T6B$J,S;S*JI?&*770V=T[>-?:WMMI
MO=C?.WBU]^?NWHM7N^\J<%:2P0V4RS+ZAFN6:X[B,ASNU>N>?'X"4_C(%(J\#\2DT:],6[J&,<'+55ZMZ5N>@3?X=NL=
M+APCFOTQVEM+(SJU0W\4G@W93EWG4-D98':".3^
M>#($> 0_^MW):9CB%9929->Z[4]=01Z*5T:-
M530&K4WWICMJCFKZG\E@K)M^YMD)5=-2>>Q>CVU"AF@LUB<)"]EJO8PNP?8,
MM)\+J\*SQ27!=;H8K(DP%)'DLG/ 57Z9]-!Y6-X<+Q+<@+I?+FXPM]BP(:?!
M!PL0$FXR*$>\Q,7&Y;WO=\*NG.]=#_/S[ST,DB,><<'"P\J0&8(TAWN_%ME'H!:B:%=J&V*^&"X2 #T;'
M0Q.%RFH(HP-HB@=]W"V32>H,R6IDW4*>Q-;K1-WQS>*= +$!GK0NOAZ/(G,T2
MT=+='>PB(.EECP&7".$"O$*]2TO&C;Z:9:CJRJ-+KUR@OZ:1.#IMP1H67.V4
M;8B_6/Q7;1U:Y;/"\+P+EPR%M[IQ,X>1L#$)IUOOUW3?(W/:X(Z(D<4F0TYU#DU*M)+0PWAN,[!8TP)SB[:E$A5P 6
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M$>=D):PI,&9DX(H]GCHBFCWF8MI7L$DP!="7;>BF8JYIZ<0*5%P;JO/1H/3$L8WVK
M**;LR#&J,\GAO@XP:F]PUH9?3L%^!V PCCE!SI_U!EAB]$4'$=JXV]C;DS[0
MPG&TPXQ4M.^YLV7!GU=/FPM&XQ.?:MUST=9#S6
M@E0RLPC^AE/O&DZ"$'Z,5T24CD?A^CR^6#X>:JAEVWB]&;M\BZ-)0?"PWD>16-GZN2U:UPSXDQM
MD6KQ1.)#M\LIZTON-O3=4P.\Y /;XM/6!Q*@K08&!X(8-RFLR
M"G+F>(!P6B._UYG<4^MX5*G'J6():AS3+@!"AER5T(\6TW?4AAQ8,
M)-&^%%)-06@-(S [:WR.S>V:3U3ACM!5#V06@/, @RN1,&OI^Z^8.(A2'L[K
M2PV'T:<4A6U[JM.BZBU\'Q$T7''9?E;'@"[/Z4*WEGXV^@CQ0Z[*D[SJKJ7.
MJ:)E!VTXO:=8L;^<'0UP=1,4^:-#K>7=[_H^[L1;^]L> G#IQJQ^O-? R
M9.+A^:,<@'_G.\"!" '[^$LT\\'$Q<)!,-)C:F8O;!*("@L<$*M)9D'IR@]B
MY:$==@UR-D#D\X?M+KO*>T25XDN"Q_T:QRDN$$H#\67]F:F3-^JM"]T%?(^+7VDVL/@EBX?5@.!Z= CP[:?T)
MG\'SWND6Q604AG2CTAJUGEID\E"9T;N8*6CZ<^?U:-&]]7[K'4A0CS*ELE#*
M0MMJW26<[!8L+P+>+L\:#J*PSBJM[OAZ
MBFEU]M_7"\8&6!%&5[X9;H0 =UC^KS6UG-:[S5
MIWX-HNV'*A>X2A_K]GJHID==URV+IIM2I=K_N2MM30F@V<069$=WU"M;%Y3E
MQ[5\*=?<:%\[2]BX_7.-"]SL.02X@^FI059];<>&/:7=5G;8G%]HV*"%%_&+
M&-KMS\9SI[62X98A=P&./II6%>/!.F,4XV2"RQU_]DK776."OP=F9KF@H^@CB[IUH5^7
MN%D2;SQ#W#W\7C_NG FM)]#Y'#.?7?D\P8LS0I&"SJ*=_Z5/SW[?01=!0PNRB),&.Q%"G!>573V.ZK!G>7+AKMDH8BL1MUI/LG"N4P6!4?E/(C.Y^^;
MWWRSTIG%%GY_@V4QS>B\>(NI]_O%Z]+>P'=?Q_W8&XRW8S.=!]*4[>?G@=8M
MC?8/X$D//A]Y410F=RFQ*4N(L#(CRLN$J,S+-)..)TX]>:ZVLNNT2FX@.R19
M."#@M:8O+1)R2#>:8KGSDUA;&8R0.8;!JX68^K0J=TKI*#5"]_)&TXE8V>X6
M8T-8Q5$**)#(@[-NOU%KC!8TUA/'*HTN\%B9-H5^V]/*,EVRAG99*=DN^[&C
MQ8BV&#Y()5[EF:+>IL"IFZY)!=JV,7>U:@50:N&Y
M<$Y :'7%F3_%X(='5TGI548Q,IRQ90!AS84-IFH^4O-@V 11+,2U*J\6TG_U
MN="LJ2BZ%NX [%S5!"V4O"'O!&.F2JI>H?EYECWV(VAZ+]T/W1%P>S"QYQTM#]]5+IB8DV$8T/T7P7IA;H@M@V9
M0D;,$@L**%H+0$+'Y>0,5$>-KBMS244!=3HF/DX9J%8S[4;87#TZ3ZNT[?;\NPT$/4UH+=,02M=D
MTVB=F2&R[#+1T@C#M9HGLEXKS1M4&%VE"A!YOHV"XV#P=WW6[^I'V"B$JQ4"
M7O_]42JE<7G"2)'RG AG,Z(+D1/+:>'!8DAM7H0FTHOEW3,PM(UT%$W*M;K7
M"R;21/$TRY4 8T7"/XQF:9ZDB54FVY#''9('&"F:*2M2*P@8(V"D>.D)O,1)
M#AS-&?Q/(5[@? E>6.PQ'A0MMB.>ZOL***#EC5IO*A_#'$&4@ O&:H]4:DRDDMDXRSU"HOI))\0V1W1F1\?Z=S9"2E.'< Q(_*B!"2$S@A
M1C0U& %6S@N!EO#B#*]%&G,^!/)C8&,ZEQ)H"=-N6AAI7+!HYA#J": V0)8U
M4(5/!J-TF9>NM1VT=]3(P<$<+]MNS6;&US !G578>2#D3J#7*RRZ.XKQMV9N
MXVC&P&;NUULJ'XYU;_"H<2X]K1ST*%[WP[9
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M6BN@ZB'Q\C5$1>];M?=%%Q@7_HSKF[;%K"H;E7-]R
M=EKYP)4#=^CK%>)PG"]=-YDYJ[#(CA[:DVJ-]'O66."FGRQ99$DO2!5SA!(X
MN>R0VUB,:BYFEE26+V^.+F96UQCA7:VHO!> *+'$>[L(HFJG:,10#202MR5R
MZ JBG-YT2IE5B'%8SV>>^MH#@V-8'B3N5JOC=?\<,$CIP:V2-?6P;@J'";:8
M/G,QIMIUKP=;T["^0
M1P#09>)5Y,( RHVKE0^ ZIRG+%7J?Q#3&LFGA
M[;3ER^_2JIF. ,ZO9=K\(,OF^ZR.OS1N"B;KGOCS$9@9O@]'#,O[8S@X[P.Q
M]D+7Z>%G[+R#N4FP>:-R///NJ!KGL;WUMK3B'3[C^Z,H:4KHV$8!.)[,OA2T
M#!8?CV._'?QZK?#AO'KZ_*=!SL5#JDH&>A?1(U;. "BILZK^*N?GNJ*
M*AFSAI)1/BR'DC?3XU?@RIH@,1,5.[:.5QPGYAC%"0FXT0WH>*ELCR&H,PQ@
MGH&G  V@#OO;[7^UN+@'*]A8"DF.'K[P;^[,3V(_7&K7SY]:[,VSY#+IS!S?"M=Y%A^F_
MX;UNZ_56XV\XB:Z.?[KO5^B?8+#T/!_Q/'U5$
M\[5_ ]W#MAJ.>"!6@XG]8?6XB1X-H=( _M>ZW=K=:?V(H9
MEOBG'PS!YOFP58&J*8;Z%]SL KC55T_:>HJ=!3!Y_5GS4EO;IR/>^-.KDE@"W)MW-4\2/]P+/0:P*
M]]2@(])M@VAQDM-9,%U*' *;@W2X@!]"659WT)MI0K0,+>#K;[7][,?>HVE6
M]":Q?4MPO@^&P\G9N+4_/-;]LIQBS@**1U6?("@G_>JOJG86D6X-?T)]*VXV<#!U-VL^R
M=V2\==R"LN](NR&N>Q?0;=,/GF#7/(R,[1LV?C#1[H $9Y@:O87_RK,8-T;C._1$)=.E;QYWMFQ_/#3
M+M_?><,.#SXG^P=OS@\/7GX.U_OTYKSS[>WGO9V.Z,P/PONT?;[WS74[!U;L
M[7P\@>^E>SM_G'0^O EKW]O9_K;WYYND\^WXZW^^'::=XR/J69;F!:!*EQDB
M9.Z)SD5.'&PW3S/87&;G$X>8UIJE1IE,.6&8UQG-4YHRGBG%F$SF1[AL#O:G
M'^SYD86CM*E(")P.'&R66P);[4@AF4LY;"_S"P>K!
MX)^.I7QSL'=]L'O;1TE"M4UD3A*.0Y?21!#M7$8RS8W&&9:>TOF#==*:G.M"
MBD0(FWL%!IQ**:-<)H57"P>[_>+%^\[[O[K'?>?UV]Y^[
M>^]>_7NW]6H/_MYM/?U[_]V[9XM#F*[Z^]:&"BVU5*\63W/]^1*66U[DF1=:
M2,MTX@U0:V&TM(5G^:K[7,TML_<1$OY3.DDIW$D4B4YDQN FWELPH%VQZCY7
M'][L?3RG5C/F%1"(\!(^[0$.)+ +6:%-D=YA+U^ 17XZ/"= -VLGV"TZP-'2
M5FAP?34L_2DZ5I_5SO#M_1?-3BF]T.LG]/X+L?:+&N39,$BFZF9]20%W61X3
M.Q45OJJ3"25NM#%YO^\7TA\//O/.GYUT[^!]TCGHB,/3#OOXX:_/'S^] HST[]-#MM=;Q$&[Z2'[
M=V__P)X??OM,]P[>?.U\.^D>?OO8.SQ]>]KYY+I['S["$[S_.E-VMF//]W8.
MOQZIS(E$:4XRR5(BBB(EAE%/K$U3R0T8\9F;5Y3^]W6W\X LF2EG=*V\2[A??+@-(*=O*.$5%-Q["
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M__GKQ)RZWOZGS^SPX#C=8R\_?3S8YH<'V)7CYP>$W7'OGX/U%9P=,)7:(
MYM&X\R[Y^O?![KCS:3?I?/M\)."$/*>:<)9H(H3C1#-M"-@'NA 9+30'6YL!
M1EG5E>.'<0J^NR;'7*:>N>IYKV/+_/1K_&P38X7K3?T
MO]OU3O@/WSO&F95S.5#S^\O6VY*EVO=!:R&F.%, SYCVN9#Z^+UKHS0+N9KFGS'A.E%:>".D\42YA).>,66%R;;EY\IQG*\4.SAT9FAJ$F]ERHU/K\ -0QEN&.UDDN5@!N726[6))MX_^72X #42
MI3TSPA,*&H6(/,^(,;8@!2NXIC;UF3-/GF^<&H^:DPV8!ZD15*>%%JDRVO!,
M,:DXUTPFVFR0QGWDY#FD064J=.; :,AT2H3,3<%S+U[,ESFFWQ
M>\3*O[Q3XR#D%9>9R-_OW/B^%(<'+<2<3C*IT+5GN#!>:)VD*JI5;H@K3$Y$RA".,(RT%)[;S!H F4^>Y_GW>V;799@'Y!;Y
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M?3ZL_K,'U:2)8QPIV#^MYIQTXR"(:OQ*YS(1(-2524T#O  N(T4X0YE3B3YWS1'_O?"VU3D(SPB *-K4<$
M@GLE,^Q@HV$YB5#*^,0QP23U5-&KTJYO0@3825YC,YVOX]]@3<0-QJ2\XB]'
M%J_@GF^."FJ,2-*,.!JZ55)'#,]3HH$1C9-
MTU*8XN3AGAX>8S_\F69#RZ3GW[OO*VEY:\)2^$([F>96T!QS&HLERDQH)>(,/^_
MO:OM;2,WPG_%,'# %3!=OK_T@X$4N5Z#-LZU<1HD7XP9OEBZR)8KV>R0L$<"2M=DF1?#@SG'D>D1%34231)!: (U(>=P_48H7J[3BY
MOW--;%4K%8'OE6O?3\[@HJB3913]Q^1RW+O<^640?=&"VOFM$J.[%@M8UZPJ
M:<@L4:V31VEDAGPAE/-*.1DPV;NVX&Y6/7!6G1SG/2UIF1P1G@.1P2(!:3P)
MP68?72B@S'S'QU\ZFH"<69:R(VA4GJ?!J3QUNU Q*.Q&\ZE&$YU,G)9J
MHVC+:#(@0*G*: %1JSR>5MC= [;,,5\!-+9WBWUS-B..]NQ[+95!&^ZD0">D
MC &SC6IH8!;RBC%H[[!)NW7TH'5T^/KM,2B'*% 31Y7,ZT@G@M8YPA77SB4A
M(?G= [/,$+UEV="YO;;98XM,:1R=3(J")0Y'4YF@&U&TU\/3_EF9*\V%E3IC
M$<,<#HK6Y;KF6J(!\NZ;?*1"1M%'F,%X\G?WI * .E!^T=
M*HY4)FW
M#4:7+>6,XN>Q4G0=%)VK6W>1[36^#J?R?-<4R[.;6\63?'V$<'OD;SBJ?Z>G
M5,UJOO<"=4==RW5'[T%+WK*9_XU,7U'^+2J5HXJ_O^;KKGV*\5_JX\OB>LRZ
M&E/AW:E.RGAOY_W'#]6V442#^Y>G>U,-T^\QY')>(^GI&A_/NKTN'KS(&[GUT)%$\;,.B?5NRXC:C+
M^$8@$R?3IS;JF$L.O:9ZHOTO\2)/X 2^4O"LU.C'U=V*D$M_/"][?1JA*#I4
MW9QQ.6O%AZH3HT:1]*RTMB@;-E?5/T_CP=:2,>4Y#<2N:V]Y8HD+WXOAE?V7XZ 8A. &(3!"#:
ME+EWS^3>?R^OI'E@,MSC9M(/RMB[9R.WJ^)J^1XRXPX^C&3YO@09SWF/-2WC
MNDB![W/5\D%]'\]A5,6H:B>Y!)/OK^UR7V*TUG7[_O49R[K8EA*,1]?KVU__T
MW_WZYNK=QP_B\^]?)&%%[+\$'XZ.T@8FN.JR-T#1/K6#*L;/E
M1!H-1";G2CZA(4Y0Q9W!:$*14E%L;=P*+:)/V!@;\$-]VG*K3?_B">LT5Q1T
M9-0D*6D4MNB.B)2S7 GS>2@(!IY!( 8R@2H9('8U@
M$)G%4D["6\7"WW%/KGDI@U5)8Q1&4BD=(*K(F'&&6N6E=M"9%6U>[*%5L7R8'%%OO0@FV+C
M>>4>38UAM,7D(L\S.\HDG#,\S^D$B::D+>OB,NU#J46N:R%01A218#")2(N2
M.&TB*7QS@2/SBH7L_%B]OU@YL$'4&!VSY38B4'9O?&31\:2RJR,9)&MU"EH%
M\+F17?BEE0@T9R=9IB06ZX@953+0-1*+W!(E [-&A%15T#.W3+N[0Z MI]6\
MA2#\]H37+CYT&U@R@PJ,$3$Z(9W1((RG@HND(M41.G.M?6"YR 4>D]$:4_8B
M(P,BF;0$M4U$..XHM!.J$ET@U
M\L@[2N]6KN7Y )%16CF9%Z_@DD@0C" 30%3*0,VMR;YU84?1^XO\*-L1(.)J
MWVQ$@&AE=NZUN&:M^RU6/O1_@7RQ'3OWQB'S(CMW$MP*H$"\$S9;6&!<4ZM.W0MF/GW@*TG;>#;2'^T$@\>EV+]$&(E(14^-=L
M D"Q!>SL1K/).FI7]
MLPYR'@,Y;[^%G(S[&6$\(\QR2O+X, ** D&AF381K&>X>^#6("S3E:Y$(1;DKMBDUYM4;'B#9>(.62
M:6=W#^B2@.Q"6&C3:F$W(2EAEFWS@>J0#9??DECGBSU&6_\/U!;<;E]60X?6
M#T;KKPNVE97&\\ B4:)DT&ON"5B#Q.D@6:(I@"\U/$QN=@;]VM=GRZ->'5)W
M2/W\&1$=4C\&J>?LZD"]U%HA45I0(@W:[ 6+2%AB&B'[0!G*JXB;[H!Z77[!
MMPK56Z(^,B487Y"?KO*583R.%^,=J CU+V[X\BL"_DHSG9"+.#HM,BC5BT'_CR(,5O5@;^>JU\^M;00,RM/R
MC2]R>\X'T ASQ_]>]L^G,MVU'$O3_[J3^6[#6C\@(V4UR:"\AY!OX7/W>S%>
M[-7J X.AKSYK] 8^G%5J">\O\IOC\OL,T\XL'-D[5U;<]LXLGZ?7\'CEYVM&L6B1-]2
MDVS)LCWCLXZELI3-OFU!)"1AAR(T(&E;^^L/+KR*) A2=H(]5-5,;)/L#Y=N
M=#<:#>#7O[UN7.,9$A]A[].)^:%_8D#/Q@[R5I].OL[O>I9TXTQML=
M0:MU8 SZ@\'^6_*Q;RTNKT#?[)U?F5<]Z^*JW[LZ[Y_U^O#,@L"R+?K/+P\S_NE)]*V+O#]R7[\NB!M_
M/SQEKQ? A\GG,,Q];=-N(:$//4A6NP\VWE"R@6D.AF9,P?"0I 3D^0'P[*0$
M)R"]8+>%?CD-?7W*7K-R^CW:AP-:$@@"@A9A .\PV=S )0C=X--)Z/T9 AP@?X6V%"UC9]_,@S6_6BSQ20PO +]$O@+7F^?
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M,/GV-AQ+T>0,L_K];3\9__WWR<'/[-+NYO;L?W\_?A'5E
MN'(FGO7[%^I,S.+_Q8A*Z! _9^%F \@.+V=HY:$E-1E>,+)Y\ !YJREVD4UG
M"XU8J0@IX>+ [)NF<-*1;[O8#PED+!7 !EX:&6@CQ39B\",#]WK['1FIQ% 6
M\3^$H=2KB7[KDD.CQH ;& #DO@=K8V099ZW^T#J,LU$I76+L$WR&7@B!YXPQ
MY0^P Y\MGHU#/\ ;2)KQLA9,KFDM4\S-L^R+( V*:22@8GTO@3VR*^F*.5BX
M#76K(J2,=(S;*-.&X/+->JYU6Y(&C\G
M!?WUJ%=+^!"]9]D)MZ\!)!YPDW>+W6\0KPC8KI$](A"TLJOO4@&YL%Q8/)[7
M0ECBKWBR1ER=S >+G9'6R.!5.HI5&5?CI]F'(]^G'>4Y#P@LD(N"W7N(4Z."
MY6)T:?$H8PLQBM_D7QB\'IPTJLJ8&#G%5#?8$#TSP\QRD9S0A7A9?/<>
M8M2N!G)YNK)X\+.Y/,4%&FF)QL]Q?=B$HN2#;@K6&/AK]O_MGR'M!IHXA0$;GWJ*L58-(TYI^EDUMZRRQ.&#+4W>SK%A:[2"TW
MS&?#HH>5P>BBY=%YI750.%:&(^?7
M!9VX2OG5\0#K5"00[Z8N\%B0B1GF+[*>&]D"^VD',2+I%.P8WJ+6GGZ
MA(0P20MH&AA4 I0;O'.S&.1-%G,C7.Z/1,A&!OK(NEQ/M["-#6#E]O)B6/1;
M5-G813.JTO%M-' 37+G"O;3,PHQ=G:,=U*XW<-$LXL4)Y-KQRBR&BAE9Q[HU
M]2/87RWT7"6(5*L-^\.B<6+$.3^#/^B@"LOWYV'>?Q9!JI:&IF46)F9%;G14
M_1P48"H%D#.#+6:5CH^NAXP>(/ ;JJB(1&H/AD.SN!0E"#O7N2VL0(Y0KOFM
M8='P"O(NJGK1\H.T2P6$7+_027_!_L93+60=X:UXSQPX
M?V@ *V?=N646!E ,SNQT B\8VOG9PQU Y!_ #>$7VAVTN]C*2S/6E2/([659:HS/"G9R!1MQ&4;(,B0=M,ZEC+L(/]%#5'*
M9*MO#52U;>?]FRGTV)GCP'.FF,HX#)#HF=\A<(,UW\JXA->42TO4T$XV0Y;:
M3\LT2Y(I!#Z/C>9+,$01T?[')33B4HY\+>_]-FEJ+?"EMM@:#$NRGYKSN(MV
MNA$S#LN..J@DN=JF(O 6@_RHTIOP*+,=C;Y:01]Y4X+_#=D6GNB;R<)%*]ZF
M=JF1[U\=N5Q9UJ"0O-)*KG+;Y$3U#.09207C3XU,%8\BV(#GCS"('HXIV?>4
MMHJ2Y8)U1FW6FPL6K4DB1[PN1PEJP,<;5H=$5; LV]$F/D(!KSST'^@@;Q*L
M(1GC#>VA-2OF&=Y[5(#>WR"^<3WETGEN#8I; 0Z5SJC>B82RFAM1U8VT[DPM
M\MH;N>H;HOY'B6X@*2/?#S=;;DN^TI*_HXQ6E"R7N@MK4-PF=*C496IBL*H<
M!:@!&\5K&Q#(S,F<0,]Y D'+;2[O4P6Y2%U:@\+J]\$BE5:)6UF#5\K@M3I*
M5RUKN<'B"<:N&]U,]/[R)"M4+D%7UJ"POME*@H2Y$UG.:26. M- %R0!7KQ,
M&/H]=9&T?*D8G?6M06&M]6!%E E,T[]2 3M*51.NWOH!VK"+,._"@#(F]JO!
MCD?YOZ-XJ55$+F>F-2@L4ATL9TG%#%&SU(6/ZM9->9L%V/[C&E!J-E.AG1S*R4)UG1XOU"2F0="'B;#@L+C95L::+JPWE
M77O0LH(BI%QM6M:PL(!4S;>.+Q*4]WCYT];!V-:%R!E]9@T;#-#*-QV.KC9A
MS%X8"+'KS:Y=8/]!O0N*Z4_XNRE!-O)67[ #W?<6E?8UDLO5N354MLD2@=N/
M5K%@**VAP:O8B^IHB$H:42T-7LVC,.[I@R?LNDM,7@!I%?ALABP7C@MK6%CL
MD:N67XQ,(4?.)KTC)/\-#H)R/E]:PL"Q2/98CZ(X.S&16.UL#.I/[U[O85$AOYD*FZ=M[A.]9#+BQ7UE"Z"XZ7
M;)19!UXE(ZV3P2LE)"W1_:Q>QO7.B&O&K0'LI*QE>^\)NBQ0P95HRO$X3M'P
M7FIE6.E\_;QO%L_%R'$\0H]5?U8RXB*.["SI]S;GK#<%E\[WS\UA,133E+5=
MC .HLZ'5N=>-T:6J_)SME3J&Y\'EM+)=>O0+!Z!(:@-3M[-
MSL[\VNHT-@F07!]:P[(CH%)VY/_HH.++=&B[T[L*Y'+5=68-"\O7>1YT6RWQ
M?Q:[_PT)\AUDLP(.Y(L$4>A2QWBF6 >C9R$7B#05@-*&?@I645UH'R#&3(
M1AZZ\^S[ZI$D?9<^B),(#N1A#:J655CGR3,R"\^>);D/W63G(PQ$_TPA
MX?.71FPK4DO=]HN^63PBBNU>B%@T9>$N!M-E!K3PW*LPI$[[A3DLSJ'*F-%%
M?[W0HP?E*M2C2;7:Q<"R"N&FM XK/;$()=\S7!/+G<;EEF\32]+,A?# '3:1:T3;DK
M Y%;KK-AR4F3)>SHHN6JZM+6:^<2++F".[>L\F7S*BX=51GOC\/3(N5PU"_#D5NE2[-X!F,&+;FW/<'K)'?V
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M EVQP9EQU87AOQXQ>PMC9D+K<#J_*%[A90')B@(4?$& '
MGTXH6^&)X8$-_'32#,-#KLML6XSQNB N^KB%!&&'->?3B1.2R"_R0UH@"D+V
MUV\$A]M/)^)S%,#-B1&(SP/28[_Y'QV\ .7G N2.
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M&,2E*' ;;H%P]KYA(OR0&HY6$VC M=M7FY^'.UGFM?0=9D&Z3;21>\3"K,,C?U0Z.@;_> D15,8R:5]G^LD\UU5T\9+J,;\N@:I=6@A8J
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M*><6XS!#J^E03(*J/A- )UHZL^,E@0WRT";7W>G)TWS-5;&4=
MF9Z-Y9;F"6Y#8J]!= QBNE%<9IXJB335;?GUH6A12-C8>R]>5Z(Z.[^P)#=@
MAV%J8.A$)#TY2BU[V4'5"EPUA::,G] : )8&F4]WBB<+E2VMI=.TO=J[(P#$'4UW6INV))
MR%RQI8M?N!]&!\$2AR1RQ611K+>!UW1DS:'W ,B*CHMD^4UN'R0$.BC_S=;%
M.PC3X'*: "MOEPJE!@UD"^RTR^W,6&V:D- (0H,F%VZ,O?>B%>*'-)NO>GE-
MC5I/ Y#::SKKSEHL_Q%3.X:(W+%1)=>S\;-P@0E;.F&H="QR([($-K=+\<\-
M>&7ZEV(N>,8);6RUC]\:4,\.RKO@#X@::H>W3W.#3=$J&1
MDKOEVW%^!X1*W6-HNQ"0,29;+(JM,5U*M!HT\@91UTC'5(24*B
MJ4N5F4%/7BAK_#7:WGJTHBSHG1MRTRC:(+*6JS,D6P.^]3:0E.44@VTD4P\F
M(@CSQG%FZW+I)--%3)-T6!T#9L52'5E*4E:;WU21!R(CT]B3FTUQZR
MJ6N 78[L1QM7ZZ;"-60:F-Q1E'Y5M]&)9!6(FD]Y1
MJ+BYZCO70I-M6OP:+]J ,6N ZT('DSM,EI B.[S9DL0.%=KWV8_L\Z*5D[)=
MML81A,3#S]1[K5=YU32:*CC:[1"M:F:+>Q]IH."JTTL4]I2H$6O*L&M,AT?S
M6'4MF09,97M6@.NB#1*'7>#EX^3!SL8@@><$X%7TK[]BYY&P]=2:JM6VD57>3'ZRJOOF4=L:M0'1MM7P5O99.4X->#,0^07;01NLS'4K)-95Y5E<>M)DLXZ,H9M^^
M)I'HNK,;E(@U<+#W#@MC\QXJGYPU#9?_*VCUE.UXBA]M-)BR,T&Q-UH&D#S"
MUV#^ MUG^(5^M):MJC; T-V2Y?-Y8R^L:1YP2J?IJ,[LKIJ_8.6=6)EO=1BS
M92>3B0E"H#1"D44
M**22'HB]Y71$R?:PUY%I.MK$J;#(D:O)_:\T4)#%4X >Z""&66T@J /14AI+C&])VM#Z*I01#4]M:$M)*''U1]=H3#II :-H+S,(#;U?O
M&99\J,%HIH[(#D8V0:%3.9&>R!96L(O8771U.<=-47YP_G$:@N:'
M93&=OA7Q*H6H=9%$6S55?E[KKB(QL?K4A[? _K%YC9&&
M5M8)E=_KJ1 J@G/1 0[RC!0)F::R?H/9G E[8C??#(=TT@D(M40>J+D,I9Y0
M S7U]UWHK\-;%]ILM$WQ"R3R9DD(-&A.;"2>DL2N.I=#1O&#W8L;Y&^Q#]S)
MD@^5.?[J0[XR)#9DU8B?&K$&/'N$@1VM;DO6"\<-%*-=ECGT!/&UFZT4=Y5J](
MK:E\9Y(/DW!LJGE4Q+#>Q225!)
M\8!&!4I-U59(!TKF5MA:YZGR^Q_L.F5N;IDDQN+0.V!4D335RR52V6;G?%,8
M3?5V>>;$E&=2LILOY/-8*:&N_$^2;HI'[HRHQ_C,DD6:YN^H0^F1F+-W%G*-
M(U;QM:8,SLHC'8-I8L5.NA^JCDS3 1Q%?WW*&GXT7I0;+)DV51)HVL)4T[Y0
M31NRP<5RG@/,+^-0N;6Y 8*>#DF\FAEEN*@= %)#I(-K6?N7TJ&)
M 9;MA&L"\:.UPZ^GM ]\ZG5LP.>?_@]02P,$%     @ 0%]K5 S'*$9"%P
M^-0  !0   !L974M,C R,3$R,S%?8V%L+GAM;-U=67,;.9)^[U^A];XNVKB/
MCNF>\-4[CO"T'+9Z>]X8.!)2;5.DIDCZV%^_"9*RJ9LB :G4$0Y9*E%5'S*_
M2F0"F8F__?W+Z?C@$_2S;CKY^1G[D3X[@$F_
M_0G!W],^S^[3YZ0
M7Y9_]&IZ]K7OCD_F!YQR?OFW_4]4!NL\940[YH@TCA*GJ2(4E 0OHY02_NOX
M)Q>XL"Q)$D5(1"J>2,@L$YVLTMXP2J-9WG3<3?[\J7P)?@8'.+C);/GCS\].
MYO.SGYX___SY\X]?0C_^<=H?/^>4BN?GGWZV_OB7*Y__+):?9LZYY\O??OOH
MK+ON@WA;]OQ?_WSW,9[ J2?=9#;WDU@>,.M^FBTOOIM&/U_*_$YGS\NGGK\Z_.WCX;NWKU\O/Q'V_>''W$,2SO.?]Z!C\_
MFW6G9V,XOW;20_[YV1@6"(4SQE= _O/F>SW_CC'Z<5R,ER)YAS^O[UBP5(0+
M7^8P2;"2S?F3Q]-XX4/CHIEI?_Z78Q]@O+PZ6LS(L?=GHW>=#]VXFW)/< >R
M];#66"Z.;H,G+_IX,.T3]&BWGAU\AF)EUB9L!3XR/H3U]#F(^<]S(+PPAC $0*JHD7
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M T*3EMP[93)OX^[N@G1H]*&JC&B!>S&!$]454HTJ[_OI&?3SK\5Q
MF[^8I#?_7G1G)4I B".<=AU3CA)F!-IO*P$1"4\$#3'9H(2CJ@E%;D,UI"BM
M C6J*:!B"'8VG77SV9JJW^?=D+Q(DD:2)6,4Y$GSUVC8.MZ
M1$,*JRI0H8K@:T;B@(]/;R<17?,C_^6;Z1I9=,<%9$48+2AL67V,WA'+@H[>
M9R>AS=K.S9B&%"%5H4(5X=>-AZ[P4MNLDD<4L6RQ20:9>*'0W7<8H+D8@;HV
M\\.U<(84!56@P/XBK[?!!Z"=#9:*MBC;/3L
M$!/%.%U,YK/W_JLO'MHDX95^ >F:85OO$TO>HB760&11A$^@B3?621>U4LZV
MB9BV!SFD>&I/YER)K1JI:N\W90R+R^!^GZ"DWR_Z>.)G\.*XA^7B^W[8(+_W0X<4555B1EO!5^'%V\DG?.ZTQY$>
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M*+N7X*MQ_IKQ,,I81%M*?':P2CQQ)ALB,OA+$"(OOG;$:9ZH,)'J/KZ*@R816B2<7D0S)X.W)@:N^W1Y"KT;L#S#W)5_J
MC>\GW>1XAD'KXK3(&%+)I(K=?(2QJ+!1X O+S3HRM4XG8H5P9:E153+^$DI:Y(PX_?^RZ]G;SR9]W1HNG5UA+IT")+KI"]1B_=
M7(1IG*"JCC@I>9>?8+5/]&XZ*UM$
MA_G(?QD%:KGP.'U;S1!I0%/G:=E%%BPEZ1W/HLTFW3V!#FE5H39_&JJL8@;(
M>J]Q8X;,+)7R.BAUP$XZ3R7U'5)S\N
MNP OYJ]\WW_%B7XE;HU1+0_4$10O3NU)*@QR#+Z!6:%6O=%!-EIPW0;>D+SR
MW3ERQ2&OKIF:D^QR*^D#1$!@80QHG,_'+#5UX!",U;RL"1I5/$!/C&>>1RNR
M%HT\KUM0#1:GJHF%.[VEKZNLS!$88F88%PAF&DC% 2LH0A0E'F!(\&
M7&J4._L=Q9 <[WJ:WUG.=7.=SA.P7DUGJ[0K;7R45D5B$Z!'5K88;#9EV]A:
MG+"#-*+-TONU<(;D--?3_?Z2;Y0$>SXX@<9&ABQ)R!;Y&!+&?$8+G**8L2D
M!]&F^N-:.$/RC.N18'_)UPR-SC#P?_/E#$.VDFVTD9/W;3+R+$0J- F@- *+
M0 *5E'BG!0U"!@AM:FBV #>\C,@:!*FME4MT^=OSR])ZAS]7ZXKR\0B__O/-
M;T(4^.OZ^5C)Q3
M*5'T]ER@G$AK2T:?*7Y!U,"3C=ZV"=BN ;.O??GO'F_ROI_F;C[*0G#+G2#9
METY%"4<80BYKS)8JY8-(M,W4L@%B2.'FOKJ_;#5VE77%#: 9X&U*Y/L:/L%X
MNJSR65NQ$0/FL\J:<*?1R9$2#2+5ABB;'%"/J*:3>
M[C>,QZ4DL-A?/R[IS>FTFW2S>1GX)SC')A5H2%02SDL1@#&<.(UTCL$'YYD4
MF;99H-L.WST#TZ?%F@8JJK=Z=3KMY]W_+<5RF"\7G8Y$C$E(I4BF'C%%'8AG
MF1.CJ#=99.E-HW7=6W'=,Y9]6G2IJ)*:,Q$Z>7&^Z'&2[2-,R?O1J7C,C*-3GD6C):WKT-PSLGU:E-A;_'57NBX-;VW EJMODCH=
M$PZ2"22G]>@FL6 )==[["$&T6NVX'=>0HMK:W*BHD6HLP0=OC(Y3%Y0UCB [
M#9&>!N*4!6(<.,F==Y:VR4&_ &/_U?SS._V*.BW9_]UD@1)?BWXZF;V$/.WA
M6_TMS-Y\P2D>Z=5-?/_U+;)B6999Z@:F2X\ ;3OT^&J/0K!1ABA0ZS$0R1/'
MMS@F(H2Q.41M8Z/JZ(:#&E)DN#L?K^XU#(,%%3>IUD#7-F/=G&UD040F)4XG
M FDC 8,9&Q$66B+$$ED6LLW.Y0V !A57UN;3?N*OQH7-!0\/PFIF)%&E1[:4
MCA.+;"3*U?H+) L[?U,O56M_ZZ13/&O^EDE!E<'BL
M=-,1@:'@8UGHL7[5#9Q2+H1JMJIR;[!#,K&[JJ]M69Q6+,V?SPUQ:,2UK
M*Z#_U$68?9R.T\BS:%6VGB@7BL^5\+WUG!*P&@18E62C:M.S=['M<^#X6;5\+7/758S_GQW616'@^SPPD.
M'2$MNME)6> _S,M^ZA(G$F89NN;)E"@=%/KG@1/@(@(U,CG1R"6Z"]J0,OJ&
M2K2Z^JVY5/(>^FZ:NGBQ/?9L'1$4AZB?^?%A7E_XY@*M)[PR"Y8R@>FDI#$D
M;:5(4%I"EJ;_'N.0X+T@SJ&DJ(S:Z#9+"94',J@=H:%R^C')4[/U[%(2:X3+
M5Y%QY3'\I<3H:(G,(JWJRJWC3%@C >/C1M[.%3"#VFP:*A/W56+5I.O9O%CU
ME0B^C)*# 7.,2[*B+1N6A
MK[M/78))FJU@?9S[^;*[WMO3,Q_1.DAF0P9##(Z:2(TFHG1:(* E^&R]3+Q5
MP_#M40YJ]>PAV=1,E97/&[L>YC+5ZG\7JPED-LI<\N"5():B%R*90N_6FD0H
M!QLEU3JGAKV'M\(XJ*CG(8G62(V/EZC_ZL7'?_SZ[O"/FGGZW^_9/$W_!OB5
MLO1+9::?G;SOIT7%Z>77WV>E>+_W7);./IB_BOQ==#S<>\##B/K) A2"0-<=73)M5
M)W? 6$H9)JE7;4Z2VA[C/1VOYB:L!=&N3)-M-%@S<+E.#-_6WC?$D"0UG.9
MI 2^:E1C8P@D&P,8LG-F=9OC$;?'6&&;K@=?%BE6_[^=7&H'?=3[!".ADXVB
MG#<8%4H"RGGA)@$2 L60M'7)M%J#V@;?P *<%ORZ)EFFMN)J[OU>PG;E0 X<
M/0Y2Y60]X4P*(FE:I@I)(D6VF<;,O&S3)6$,+ BJNX;S=<)
M5RB=:;[02&$4F"DMRB7AWI2")+2H2/I 2B/7Q'.(]G)]QPW'"]S[T4/J5=&8
M-@^AG(86:>,0Y\,P[HY7FP4C*P)51@7"G&08H[M,K.*:A A+-N@VX95YJ]EM*HKK6J^8%D8/YRUKN1,%A\0!3"PO>=
M'Y^_,B/)-= *7DVRSTW[_%*"_V!+Y[GJHFY%1<@%+L^9U
M;QO#161@*5%,/N,&04@B<<%V(B7*:&K4 N ;,5K1XJ&J)!Z+%OCJIL@:Y
M:G__ 9:G&Y2DF76..Q+;?^7W9"Z6*B].A;@XH6-3ZZ*8ZZ.:ET#
M\^9+//&38_B K\F;G"'.1TZEP*1&F=EB"GW**#VTC K5EI-++.8V&[0/.\X'
M3"CA423JHR?1FT)*83"X0;-#M=8A"6U0R(-**'G<5(H!\_T:7[,%"5IG/5V7
M_$4SEUXI68*D03.%4/3-Z@LP\>M\7WZ)-V7!*U)^FLW\9-X
M$9]SY1#*A(!D:6AOF"9.9HSK&.C28I9Z_J DO0;CD X8>?HDW9<$CT%2*QT:
M=AM+ZC^*0<1 0O2!<,MT",Z)Y-KD(^U*TMWSM=?QU='TR'\I/8I*,00^Z-=I
M__'$]_ 2"7,Q^/+!B.1!$.9+@8RC@GC 6=!SQI5#HKA&5Y@-Q!ETWK4S/GOTSJAILTMY)[0GD,=:G4M5U=6$
M14L8AV?+9,0
MJ]J21?NKJ^(Q"&?K.7G=,LQ(\"!I:5=C%$2^45?&RTB>
M0L)I;9+LI8WVE>$;6R>/B:YC[;CR["&BK^O!M[URM2GRGH>Q9
M*[XJC/A^LNMA/D^9^CIB >U%N-(\,@?]$]8MIE+X>(=,KSE]OOL
M<7]$3JZ.]?ECVO_Y^Z1;'DBZB5VPJ$0I^T4_O.RB>2!>:DY,2%((#!TAJBVP
MW_F@(6QJU-+AYMYV70E726SXO?>3;G%ZTT@=E%P;I8BQTJ*-4Y8X;1EQCE*3
MO"UY&%MH_/:G#&%[H(6Z*\JVS<'>X //U 5BI"ZG-N3BSE)+8@Y6&A.I<&T:
M5-Q\L/?>)NO;K4)PS$B"&;9-BJ]?-\A&*"J:MQ+
M<)6*=K]Y6(>?RU+T^2D(RW;WB[.S<8??CUQ*5"FF25YN!%')B!>E%)1FRCSS
MD;-P#V_H]J=5MC2WC2MY-.=%9T;KO(.<(2*!X531TXNV-ULS];C>WRW
MJ:+N[[!1M511TVK=AHD*1;W#]UKSCNU)B8=T
MK1I1HK+(VP?8Z_)E/TGOI[-Y#_.N7[8C_ ?X\?P$+[_K\OF!2AMQ*\X)ZXO+
M5>W=P_"ZSZ\6K#<42Z7V;U>K6#8:F6^ &$F5@97Z!6L>4
M+=J>-H8?CY?AM#LRD6/(\P!-9VBK:9#%R,H%C'.MDEFV2*6['
M-80YLBF7[BZ[VEE-+>OW+APQ8AQG;7U#(,.EE8 0Q2::&.L7M:_^C8I
M]O< .:@=_D=B51T-/AC%WJ,\^LV#)'I(RR.]H@VY+,)$*&<7&I3)\B ?+;33
ML52UFD=AV_5XAY2S. C>55!K0PHN2]E6^0C.6A58,"2XY=G&',7!5"(Q.GTMZ$:TI[_(]%I1Q4U),T&FT/Z9;5FE&G9)*R<]YH#L A\11%JDB&
M4NJO/PY>0A$,,F*3W& $0V56I51C;Y_&TZ_/!Q
M_I/D4F[^=/I7KJ,/P 6S002F7> L6&X81Z,1=-):X__[X:\A2N5%UBRIF)DV
M,K-81&$V>V/!"!6-^67Y0_K5V?"OL\6_?S5),%_0
M<^<0?MKY&_4KMOXU5K_%A&1*_.7K+/_\[__CIY^6EH-IFDY&^!;+3ZN__O[V
MY4VDP_'\ESS\],OJ=WZ!T8@0+SYA_NTS_NWGV?#3YQ&NO_=QBF4G^O60*RA3
MX?S/^FF_'(WI(P&9IHN(C+Z+XRKP'C%N^_3C,5]^%LM8X&(T[Q'QS<_N%>_D
M$PS[-/"-C^X![>*#V"?\%'':)]1KGWL%YQKD)L+ZD8DFT>G%#,O?WOW^M7+YT_>OWC^],FK)[\]>_'N/UZ\>/_N;KPCO"!,4@BY?*W_
MY^[/NH*1Q# <#^O\\HJ^7'U@A=(C6OPZQW'&_/-/P_RWGX>H#4\FNFQRT%)$
MG[#8@$4;B+8H,=C]L17W&OEHDJX]953GRS6G)
MJJL7#15?TE]G W0E:O"<84J"Z10GRKU_/ ][G_!B.MM)]C(%OLBZ.9?T9S#X^&>?ZGQ?_O" '>D3@9D_FSV Z_4:N^G_!
MZ ('NJB$4GN6I-!,9T#FE2R,1_0YR$BNLF^B@D[P[DL51U$Y:8D*"&$?X&\Y75AB(I+SA(C$(F5Z-; OSPB7F0Y#6(PITHLU,<0NJQR"-
MWJQ^4Q'R6$6\''\A%)/I-X(T,$*7('QF*=3)D:-B'JQ@6&(V13E!(743!5Q%
M\1@8/]BJ-QE6QS+\>OX1I\^Q( TO/YO,YK,*2FN(4D=:_:PTM X*PP!E8K)
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M@EUH!T7,EI@1A-YVJO$0JJ1
MC9-!2>DX;[14[,9TUG+HR=0-HH%9\WJ
M"1LX_*^&$(';^!;/<,B$]!WIA>8;T(>>,N+M#3O
M 4B"FEQ@40?#*.R)F:.*TK<]2^P \EX%=!2W.\X7^R:F1PV-\&(3YN]C^L@W
M%]/T$6;XY,,4%S/N)=!"BR2(()GE(3 =!/E!"8$%Z;*S*0=NPAU);GL_].P5
MT=;,/>Y%5:#K0U(:^^L_,;^?/+N8S2D(FBYFUXO/GT=#^OL D#PQ#HGQ8BPI
M%B4#GLDA!BN5]C&E4CH(H=O3'H4"&ABVP3[4L\EX,L4J5S9)HP7G0^),Y.29-A3/^)*0H=2Z*..1YS;AY>&8'ZF@3D1B _]S
M ^;R1MENM*&>SE91I(*$5FC!0G"6!5%TC-E8;)0;NQ_.1RJSAF0U\%5O]:>O
MP+2VB @1F)*IY@>27QVLJ.D 6J@<$:)MHZF. !^IF%K0T^H =KN^N=?<\1P8
MS:"2:+IB806/O-W4 -MT&HO"(4-%)$G12B,
M-+24)IN*]33P-J?R5T \4@$<:N8&1[K/)I\^#>>+[=MZTXQFL>'X XY3A6:M
MQ%P<,.F58P2RZM +YG.(*;C A6]SBGL+J$>JB+YHN*D0?ZQ";AMQL!QMLDQ0
M5,=TEIH%6L(8YP6XTCH+U\;7>$@'^R?11T\DW)1'Z.%"R#+;; %Q>2/5>AX]
M>3KD*A==+Q]0%&8<9U'8Y"&!U3(TT<46,/>1Z=$/5S=O?1QEZ!;WQ&G6FHRO
MX(&8(=F@F<,0:QJR9Z3KQ+@'B0 9HVRSA[*)Y-&P?I2)&VRP/HMSJ+LG+V Z)E=E]B2EBT\7HUJCK>ZKI.%\H)R$I&BL+H&B6"8  [(#4UZ$
M5(33!E032=R-[=&HHV<:&NQ;74&TB'MI0OL\Q8]UM^T++C/47TUF-3G]=7D/
M7P=@BS$*)"L B6E%05%T$IET611;*%:"-E5%]@3Z:"34DJ &.U@WK3"0SL5H
M7&*FE'H?'B4+P0/+ $:4:&56;21S$\NC4<619FZ[-[4USAHX:4,1@N:X"#7M
MS H63'3,>?*8/+?&F>;'^EN1/=*8M%="MD0G1Q*V#T/95="!0^M*!?_MYAA\^W3@..$(/ST8PF[TN"\D^^3J<#20-
M(D)*3 :L);1D8%"K!$MNG86?W%OZ/(VUS%Z,?BY]&"X@IBD!KHH10
M[^E9R4 +3Z%3MM:"Q"0:U34\D0:NU4Z^1PGL8^@&U+_#FLW^Y/J^ZG\N/*N!
M*E+I'"7CB@/36.NK61IND(Y;15\#MCGZN@74Z=W(8SG;7!!Z,GB#.K>7F!9#
M?KH"Y:(6,3M)CG&F ,IH8!ZT9MQ9;U)"YT2;FP);X9P]_\<;N=D9Q@+1DQ4B
M*!F<<($98W+=8J_Q$+G).9<05*RU]UI=$-G$!B<85Q!=2A"DC>3-
MLD7FLE9!,8J2.#/ULGW*QAK=+M'A.I;'1/@AYMUY5/%OOVQ8A,+:?[3I?? &
M:B[61YP/$W1H--*]$<+U#V[>%>&6<6RT2 C*B.*Y]YBEEJ9X[[A+H.E%I1G8
MJMTM$JX_H_=^";3R.YT%K0;"DEM@."DQT@IAM4-/_@)WKK3QPWKOEW#=[2&[
MO9XN'I(7Y[IOG4?1"0TM_=(%R 6GVY&+^<3(=_C?F@5*2@Q61I5P4HU$[YEUT-+>:
M+ "DC*I-KN[MN!Z9.(XR>P-7]3JZY\,OPTR3^%NR ,FV+@[P 0RB"C@Z4W+.S 5+
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M:\LLF*)3I)"F=%KZ'R+Y.S)G3LG]/N9MD32S,SDHF>5$L&@ F
M.(:0HM6P65/S!\FA/&3B[]?<+4[1;YX:=T'T@^=0[D7:W0ETAUC\-#F4)6-
M#H5%1QZPSI[DG@-G27$P(F238IM3B >?0]FS!/8Q=/,CJ56^APG).260%8Z.
M8E(E65"TZ#FE,P\QZ&).L9W\@!)J]F+IUJWC TSE'H!&%I70
M3 &JE,%F"&VNTSS0!,ICF#_2O*=)H/0Y2.$UU!.)FLA;:SS[NJB!H6\8+?UF
M8X7'G4#9$^&'F/>>$BC?O:<___/%;^_?O?[U]9L7;Y^\?TD_/3)Y'MDB<
M[()_(VG2ILB3*M(F'K07&,BC"PF\!([%)SOH\/F])TQ:[;+FQK$L)"T&*@86
M@(18G"K)&QF];^-[]9\P^1:_X/@"?Z47;EMUS+C[0EJ('C^FPRF[\NM2?J
MXLXZ3K\,$\[>349Y8&@UC;+6VE2U2:+#P""&R'BBP REM%ZUZ]^GD]GLS712:H6<7'14'IE50)H,4BV+(%2=)HE06O4?O0+B[*D^U* -
M'-2W.$/ZP(\DN>4+<)8[KA.WN--*"A1<6R3Y/I?/C?B_3,UV6SM_K
M@+0:##!9 BUVXSEX*\_8YV@QA^6U?!6T]1O.!^8HE(T-#X4%FMMQ<) UNNM40;OC$K0R)>X'=?9
M2Z%'LS=(>MP 5JLC#H1SDG.:F83WFNE$@4TH*)DU6)),2KE&;5>V@#E_^H\T
M<(,J^'\G,\PJ$)R]'K_X6L%=#&AU67WC
M-$&AJ8PY6IS*5F-Q04Y.SY'AMX[=)G^"&T"D9X'@1T-^#J;=HX.@]T>^>U/JX9CB^H%EJY6I-QK.G6";35<'O]_ 5:8:;
M3X$ #,G&($9PHC."B4*=&J
M-G6\=@!Z)"(ZSM!;!'#T%BVY95="0Z>DAA2!\5"=?R[)J1)<,V'!*V4]K;UM
M+J1?@W'V9!]NU"T4'[WANKW2RFR)\'+D+S]]KF7LB[2HE2@4]-$TI"$:%G1$
M%@7-5"IE(7R;:^?[H#Q[@32C9(M^^MFYW8%XFWTHJL"6@8R"T:.4)%D)1^@C=>Q)]"SUU!+8K8(Z>@]
MXW53KG7AE@6JFA\Q'%W,,0^L "54/='2@O!%Y>J1)F] 9\IFTKA7 =-!$E0$K5&R6M[T#T*.C_Q!#;Q'
MT9NQ?^#PPT<"\N0+3N$#_G91K?*Z+(OZO+Z8S^8P7B1-KUMTD0F$J6>>+AIR
MARCP8EXJS9(IB$)'A[)-7O*^2,]>,DVIV:*EHS=U;P-\!>_F\I>-Y!8L:=[4
MHA2^=HV.I69BQX3>68>Q37&NP_">7E=MA;"'ZGHBL4'^?%<3+5==P8$+")&A
M#&0?I6!Y @8HP984"I@VY0#V@OD#"^TXRAKD\.\ NU+_#K)4W#D>6$Z21FX$C9PG
MS[!$;DO07D.CT@4/I7SA4=G]AQOSX98OY%ZC+TZP[)(A@49@$;EERM,""UFK
MW.U*R-F7+]R+SCO+%^YCUM-5KNL ZL?TL_OQ3-VDO2_7T,1#@49@NM#LXZ6!6I='"1T0
MK>AOB?A_K-JE%N "V;CHI1<)$D25(86M#85IHO*H71)3G-D=M
MNM4=/R EZ J,TX7[/5)S(^WG4+OV6,!EA!>#=_@9EC?%_YA,__$[67*V I4,
M@E*&LR"+9MI)QZ XPU CB;MDD^W&Z=F-NE.W/N#TNS9'&'W2M\5Z?%?%IW T[HO$SU%"Z30^BLJTD:EHGDLXW2A&1L!^JN?>BYTG6X91KLP*YF
MD!48+9TKSEMFDR7_4&9D$$)B D4H*>N8&U4]N ;C,4RGA]MUYWMXNM)^SYZ\
M^X]?7[W^H\_*?M\_LW5AOQWH-^OZ*46,*"-C%MHI"H!H&)SF1-[+^MG5'VTMC5AP3'-?6"0@V'>RF0$9BT:I;CW7];O-YP_@]E'>KEJ^F=^
M^NWW&>:7X\L[WT\2K5?$/,ZV75JY/*7P*D?E9&0.:B$YQ-HR3T26I?<*54K*
M-KLBVP/^!Y$LL8^JMB1CGIK&!O4 K]]YL#XX"2"9R@(J&,^BDYQA!@S2!D5V
M>8P72>Z#RULOG^Q#1(-(\DHV^OO)6TR3<1J.\!K$]Y..%KNT3N%%J*P,"US6
M"Q'&LF!T36MW7'$TZ&*;":O%:'Y(C=Z[+!IX^<_Q\Q33<&$E^OL(%RR.\]5J
M7(/$C<'@'BQ>,Y.6/^2
M5H^T-9F\KI9D>3.",8W^ J9#&*UQ#R 4P65T]<"1!A]3K+7"@%%L)XN2KD!J
M4]RW [A_Z:MW"ALDB2VN+M9*"&26=8E2CI9CX,BD@E@KT-6].1]9 1,@\:!X
M;%3N[2:8?ZGH:(IZK");]W%?_/-B./_V%D>U=WLM_D2 EA-F)&=3* ILC"<]
M:_2YWD%3+,<25?3<6,4[[';O?, /K(7^#-^@?"P98XI0ZT$M_WME^*^&$(>C
MZ^,WQB3+=69&ZMKP)9-VLT*&W@69BDVBM+D*N!_.'UAM)R"V03G;FVB?I#2Y
M(&N2+7'X99$*I JX4!PPKU--!:*5-G"564FI(!81HV@3[75!=WK)M63X3C$=
M24^#..XFQEKS;$S_B*PP*+Z$F%U@+D-AVE&D"<8#YQGHKK!],
M-(<2TB!"VZWH-_!M4;UA"AD',4&1T5IF0DSDJR7%H@#'9 Y6UV-0E]OLC7;#
M]X/IYVB*>@S"JE>WB7 X?KZJ([/J0$7K_Z2LOU<+KLX&7"=I8TZ,2Q*_]L(P
M'Y5FZ#!'Q4VQT7=PM ]X]*,4RREH:-#*XTYMUTW2E*87F*]8:B",2)# ,.65
MJ-UJ(O-6 8O9Q@)*9N';7) ^#.^C5-P)*3Q)O/=FF:=;=[A>Q]'PP_)<:F"
M_#FD=R/RA&2:X%A Z5BRF6#66O>ZSY42. 'J5''<+HP_F)YZH:I!8Y3N>1D#]!:0
M:\?0%C*(C)EY0VNR!!YMT"%QTV97LSO&'S*OI1&%#8[B=B!=5MW?OKF+X'6,
MA>)6HPAQ=+761*UF@0E%4=:U6A3WQ_I8)+^>3&<(F$G
MV<^_50=P3J%%/5%:=#(=U+;5' LPX#)7I+1X%U&859ABC*[0>M[F0EEGC ]F
M]NJ-\SF87A!-?ERLUM0?1)QE+L"QR"BXT9G+Z2BY,"$XA
M#EC-2YL]JCNA/9AYJ3=^;]Z][I&%>?D-
M)/A+V/0^Q9A!,V= T(M&*W/,2K#,L]80I +7)BWS0,"/7VDG(++![$585\!7
MG4"CTAI-4$R46N!;N<1B?2FR#4HIBE4!VK1AW43RZ!5SE.D;; Y;%'\N(K3M-P5FOF2AFR"\A<2+2Z%P+H9:S-.$LL0'J5ODU]QSNA/7JQ]$M.
M@Z/B]?RW2AY]/WD/7_\8SC_6CB)D#IH6UUT$-C)+DP"OHJZ-J3DMP)'B@:BR
M8RG9[+S,B*T*S1R(^/%K[114-C@T7N%^7;X;9KQ<=]>NWS*I(M:$FUI9A"9<
M"G0312J>8I-:R$ES9X),C9:XC@!_%('U2E2#4^/N5AD4*4+(*C*9DJX%36K/
M+4XS,$W)WA2>I>9-)-4=XZ-752.Z&APD5YCU_W6W]0N,EG,M66"8ZK4+^@&]
M#M>_<>4WE_W4;QYPKMJFO_A*D1:#%B E9[_\7F9<-/6@=D2E"DA2>/W3%
M[6^S=Q>?/R^;!,"H?O2OH\F?+\=E,OVTIT1YW1X!G_^:U(*))IN6RQ_T;&.::7:5!*%O?E>RPT"+#D07%)7-%
M.Z%Y,=ZUV3+: '(/_+<@[$::V^'6;G"8LS?\,!Z688+Q?'6C_/T4QC,:
M*HWZOV!TL3B &<_(1U\F8?U]^ 7'8L"#MAYK,56-](?-B5X.(5GU0W)6JN34
ML(OT@:@?IZQ.QF.+\_W)'&=U&P&S& @'5F+@+%EN:@JIJ$W>!#.6HY574#Q.C1QLYU851O;6Z_).<(4O>>*- ]<'T1#O*
MZSW[IJ8R"*I<=ZS4!IQ72@F'W13B0YGB+ &NUYW(_\-/N&Z^TX'K$W=SGW0WH]#>BHE["W (VF\EUGN
M"F9!\Z[.4C,O-6$&",Q'IYGR7$8+!95O6/?W7B5WA_][#HK;A[V>F][MO*BZ
MS'"IB5Y=ZAJM'(,H<@0$R;@MGFE/>HDUX2R9I&(ABWG7I;I9KZ!.[X"UXW[R
M$(CKN7OFNB!-6><3IIJC.ER-@KZY&L7GY2A@G&$YBM&-400#F@+7PC#X&M$J
MS8*A0*0$(WF(5H@8.\BO/T2/5'OW1%G/4]_SX>SS9 :CU^7M\,/'^?O)[S-\
M59/[GLQF>-F05 JNBRZ!*>WJ]0\9Z]$_,$,1;L*2@]OZQRZ=W0
M/7KZ%>#EC;'7Y>ED.IW\B?G='[^OR]5^6P&DH#9;4PNT8%LA91 S,"FN4
M"A[$9NVIK4KH]+!'JH3^#=US2=>WF.I&Q\(&=OT!
M4S+*?)G9\7*\SAO_=3*]?I5YC3NYA#P7YKB'6DU=,0CT#@C(PDD3')>E@YB.
MP?!(U70R6G;>Q#M=6^1W[U\_^S__\?K5\Q=OWSU_\>O+9R_?7T=W5(/D;9_>
MNE7RG2/::)I<*RH%@%(,E]J%'$)2F2B4MAAP@#N;)F][4._MDS4('Y/GM180
M^3R@$O/.O"7U)BM.9\L9>( 2;*@+MS0VT-Q+OATH
M\NU2TJ&@$9'K-IG]-[$\B#3U?=B^F7YQE'F;MR@6( "#)N\=ZMB2R6Q1?0,
MI55:%(!F%S7OLT5QSS0?;M0&.]"7-XH?)"M*"7XNL:9.@UF24ZWY+6FM..\!"S0*I^S,\BSU5%K
M0GH.JF_N!2R WZB94NOYW-@3&&AKM:.EDR$Z@BO ,I\H>LR&PD=EC,9-+Z7C
M%LT>(,Y6*:4WV\E$&- E]ET.E@P'\
M$'HYSNP-[ML>7*NI@)0 T3 >G23PG-952U^F6H0N:H=>M"T@^?#+;O6\GU%8^/L8/DVF\^%_8UXW('\R'RBQ7@^5CNG@' O&2!8EHD=)KE]N4XNKY:C.7JH/AO(=N
M"U1WO(#!:T"7#/D#4$M_6$REUYB>FX(*#7:4
M1<0DLC>L2)JLM0/)0@JU^YG4BGS+).3]["@?<1JP3*^FA8?>SUHNVU=;9Z]8
MJ,4>3?$J@TF9E\8G ?=]G?4X<1]LS/N^SCJ;SK_#?Y=P#/1:+M)/DU%&Z!!K
M.R-?/6":SSF-1P:.4 -P73IM>] 3KLB!OMJ4PDX(#^3JP5YT3OHT:X^;Z@M
M*QR_CV>?,5%01'/Q\C"["ZA]K@YTXWP7G-/>#>B)JDDK.Y],!%PFHVW,+$"M
M\))+8:$$"GZ]L46JDF+L5.OK(9*_(TO_E-SO8]XFIVFK87Y/7IJ,:]RZ&*[.
M4G&:Z!A:J."PT&R'-.:@M!0Y%->HL>6ML,YX >C?[ VNEVU@6@FU"ZBF]\BV
MPKKG"@;'TS=I9?L&D\5VMC'Y"VK&EQ-0C32T$"$8VB*8-IZ&J '8,EG73/<0L(VVR8/(TNT!Z)V
ME34XU,K-JAI
M=AF.,G>+;B!;:O5U0/2C5T?QCZ)-51W3(M1=.L9A-9#J6Q&(LAJ68@\K9!.';
MU,9\N-41]^*I4W7$?8Q\FNJ(G&M17%!,ZIQIH2,OR"^(UA),47IE9"&/-Q8*8K5F(%5A4?"2@J40MM'FP4TLCXGP
M0\R[.9M?Q=;H6OM_G
M]W4Q_(A1;5P-!V,S &8*S2QY^]YG[1(4Q.2-2#H.]GM4[Y?#34XUB=,Q,"60
MK!PRX!P8:!X2I"*2;'PD_*JOR^&_5K[Q5>TC\7(\A_&'8:U'5JO__#[#7I=>Y\8R0$4)PNT69:ZH'L0^9_[*&)SWNJ=@@:^
MRFZ,L[=8C5:[S2Y3HA<9JLL45C$H-DH743'EZTWXE"(+B6O&@].H.=I8VJ2%
M'@CX$8NI/Z(:N$;/,TK"P+)2Z;O-76K0O[9()95QWX@ -,LJA4'(NZ
MIA\93N%?3HM ,'J>LY/0YJB].\:S5U$C.AH >GL9=&/L1OLI:XNF+V!Z?S;
ME9I45\H&ORY7OC]013H1ZX4)%WDMJEI8 "'(""B40VVY:]-\8D^@9Z^8EL2T
M[V0&)CBCLV7H:J()1V3>.\] >.FY"VARFUVX!W/UXQCNCS#F?5_]6 _AU63\
M@=:^3W4]?$__9K'_G!7/5B;+%/(ZD-IO@0O'G$BB"&YXEFVBH6UH'L@)W5[D
M3GHV<@-_=!/3:GNJ"ZJF!W3;<=W/(=WQO-TAA".,?CI)%"CD_#A@2D5'@1,I
M/YIH&(!0VA8G?6F3W7%**=QQ5GQCZQ;W1' \G$P7;8#7_;6P>B=),N>D
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M%-[C]&H<[W+)6J)GF#7!Y3Q0! F2&0M>TP\.N.L,M:U*;.Q$]+9:Z,?8_=<
ME'8#U/J.Q^SEZBAJD((KWM:6QYC)@8RDT*@CN7Q*N-K&UN:4[O"=NCSG;-GM
MW8@-]N,W\-U8SL0@NB1-JO=!)=8>$=6QQRQK_4F;93$U>CS%ZWX3VMD*HXWQ
M>ZX2^PX_P]*A_V,R_R[96D'^??,'IN YXT8ZPUK3[
M7%-0R!^545N=E*5 )I(GHB0PR"*R8(0/(J@8;9<:OKN?<-;L]F2X'DNDKOHT
M?8;QMQN0=)0V*&=J\1X@IP,TBS'3%".=\H2-_NSBN>WX^+,FL@^3]5@9]*:V
M)G$T_+ L+FF25ME8R6)99,D'RR#:1?6_X@6W2N6[-B]O^_RSYK$7H_58D?,Z
MIMEG'-?"RG Q_SB9KC+\!D(CQ*0= Y2A0O,D+YXH%D +*20MI6:[-&8S,69@V
M^_2W@#I[ ?1E\"UB.&J;[!)7F4Q'A(O\^#6N*SZ]R.@A17(?4CT>15Y8E$FS
MPJ'0S\@IM*+#U-[I86=+=1MS;B'\Z&VS5V30I3_Q#N?S92[;,KI1;]'#PQMN552XAYEF5Z65JQ:(F8^%C0HDJ5A
MQU1"FQ(36^&\]AT8U"[<#.GOZ^S#T%@$LH^U:EKVF454I&J32BD\:=WH F8G>&N?0A
MM7%0]L)YMG(Z 2U;5'3T#FFWE90&K#@/CKF<%HD.G,5V-K^,JDFNNU9 R%%2OJQ7AHC%U^+ 4+O>.18]_0'"I9)R
M02L.8?91L;B7D;8P=E16T2U'-[_/:?6JJU6$9 UJ2\&W44QKBJA "/I2>W0E
M":%CE[;R'1[UJ'@]UI1;J#XRXVB)9N6.O%E.[D_*'*>_X=?Y^S]Q] 7_DW[I
MXVR0N986:!*1 .3<.D,Q4G"&I> 3^L!M@B[I@WL\\JRI;V7:+1+HH9'QM:(#
M6"!JD37CJKH.*B;F190"V^Q9/9CR',?X_4<8\[[+<^SN35B W-[$
MR65P2I"W'R.+AD(4B:@+_3 :T6=GUGW,>K*FG%U _7B=6?>B
MJE-WSD/L?#(1^(C:VY HO%>U8#!PYFOIJ*"1(\\6A3'G2O[>G5G[YWX?\S;B
MG%Q23#";KRM"V%BW;SPSF?M:")63&YH4*UZ5$'A0'/HG_#J&T_E[/9*SA>XC
M+-O@BOFEI)]>S,C!F+9V$9?](U"YJQ9%)4Q]S%QCWS7G8A7DS]?C*?#
M]!'S[U,8#R\^K:"MUB?OLY7 )1,%:)8SM0L8]S1(E1?EH&CYVLA8VKJQ<\=C
M[F$SYW ")FVLUV!U7Z='+HI[O9K >/9DG'\=CF&<%O5NUDF3LZ??7N$'&+T8
MSX?S;Z_+L_JO3^\RDUDF#]=E=#V8:^!P+XGF0:GF?=H&86-H+72
MQ=DV6ZRGE<0=#L8I%;&/Q1LHX:-Y,IM/+T>_PK<;
MLDG@+<^*<=22_!Z36/ V,7#&REHUP8DVL\@!8!^)C%K3U//![EL8?UBUB.#!
MU2UJYFO;;6U0,QJL)_\;'3ZR14+,>I,5F$Q*[;2Y
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MSM";Z21?I/GKZ3N^.QO$V(;@@>R
M'[$7F9,>C=IS-+3"4_,"5HAFZT:R'4#UOE&Q$\[IMRV.9^HF[3V9^60:T!!L
M<4$P0%[[GSG-HN:1A2PYZNAB"/V%5B?F_I:]CA-1OX]U6QQH+8&M8L&2LZ28
M,C*9?60Z:\M"HE@P:RF,LCD'TR;7X1J,TT;4/5%SL[+E@7;M>9OD%,<*EX\N',50)=+P"?@?Q\3]\C[(MEW^FWP^[N!#KQD%VB=$0&9+JHP[U)F
MW#I;&R=Y\.(6DF>8_O)A\N67U25Y]L:!Y0?#WYYWXDF\_AI\<9;4>%^LU
M@J:Y=T;00^"[=%6]^\CFSU8.M>KQ_
M5M%G]%#=P8;1.G 4I:=T('DG2TM*+(5( 5YVXQN=2K_HZQ5W,K>M"Y<]J
M0=[?<#ZPJ7"PV;"DP#,M:8X%ISE3:%+D00K=J,'$5C@/XB1V'\ZWYOP>9>0&
M9ZTOQZFF.N!S7/[WY?@2X4>8?L#9P/%8*/+(S/M ,[>/AH'WOJZYV2:41;DV
M%3SNA';VBNC7^&UVYW>V6N0U]RO!HM4>#3PYSD *SH3PSDLO@3>:'1YZ;\MC
M%-&7P7N.4W;#(J&./^! QPC:*,>4A,*T*HEY&0M3Q5NN2HPY=>D1RQNLYC3F?2,"P85ZLI"$^")'2&ON<@IBAMF^Z2CVT9/\:P-WD^NJ'D
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M&H)OU&=^)Z2S%TL_QMXB@Z-V_;:NF3MC9$MW&G%L(/VK;[^KIXY.<%Z:=#2C8T9B!PE0;!=.>9J*H9&(\
MN)Q(FC$GTX'@K1]^UH0>;ZXM!![5\O3:\?'BCRM]GFN#1_ E,PG.,EV A@E"
ML&Q\SM9EQ467+*3;GO%HZ#S*>%M8/7J/;N,^2(0@P"C!O*UM D$8%DM:)$T%
M6P*0R-JT4G\PEYZ/66Z/,.9#N/3\O"I"*@?.UY)Q'+Q./
MVG3:D3_+66]O'
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MWI4NA[Y;/_R1T=N/$7L,LC='_7V@O^%\K;@B?9&:6Y:C=$P74Q47,U->*[3"L/[77IVHAWU>R(%.R5TP3;(M/."8)M
M'4.9#)B@-;@V^CD0\*F.JD\BJ%.0=M\GW>NQ;AG,F\ET7B:CX615EF:Q5>)X
M=CFKS$0NGL:6 H.L$K,I@$!9*]2W*430$>"];2.?0BN3]IPUJ%_0 >:ZRE$'
MH$V;[':&>C]==YL0OK^HCF#K7N6E;4(+(K 2R!'0J EPB98E5,%:M#YCF\+6
M]RRK.SKW/BQ5[4/2:=14\Q/IT_/+\1>V%J0S*X%/A
M+)G$:Z\02\$)^1\")!B0PN1&S5Q[@?^#KZ&-^6X0@G8:Q.XAK(]%.@SBU*OO
M_L-X,"MS:QD=(N0F&KBO6?C.P114LHBBF=.18C]9%(OUV$]B2,Y"-!0;_FA"
MWM\7.$L=[T-] _T^FXQ&,,?IJJQ\ "4U@&*%%TD+%.="M8=07*(17%@
MVEBYO.L>2=:,(JN8R#9C^7K;[^7 VGP[CQ<*:B[XB
M1FD9?6!2A,(TKZV?LO,L%.%SE+X4T:8^P&Y,/])BT!,S/9;_NQW96L\=L#5=
M)&Y#=S\+1E],=A+($32<;'I98>1:>6N83U";N1@CO2T[]$%;=LH9R^\]Q0#->/_0*$=0=X]
M3FXKU#:ZZ-%)YHL@Z(&F8DBI7M:>YW;5,]]"%*[*_9ZH$K;A[,&"NLZ
MU<^>?GLYSA>T^G][79[5?X+3SS"=?ZN#6D:S(A@E3&%!U_:1VB.+*6CF,201
M5+)6G2#Y_9@A_$@+[_WPWJ"R]'9TZVVP#MB:KL&WH;N?%?>>B+]1NK!GUAI,
MC;=BU(@IZ6"8D<2ZK@6"0I3(:HUFZY+,6G2Z_G\&BKIC83T#0>U#UOVNL:_P
M XQ>C.?#^2XC1:-"!IN8<%F3OX!V6=)?L"L>F:VP'D@U]Z>U;"9G.01C0VF#N[0%4J6,4S,,\I>M*B
M3N^ZUM.V 1TJAU#:K,7WIK3^EN3[%]H^[/5<+>(JFM_@TW*\.2HGA0-R$7A@
M.BO.P&K'M)=>>,%3=IWJ7G:J%;$-P8^P./9B_1[[GRPJ7>'GBVGZ"#-\\F&*
MBQM&FQ!7DNT"LO]JBEWAG;ZHT/%,3DY%0]]%&3N#C59KFC$5JQ,F37-9LE L
MQ3HN"/ .-:9.1T_GH)5;:A#=DU3VL7[/$GDSG>2+-'\]?8?3+\.T'#&M>(9FL_J .H
MWA>5G7!.OX@&.BS,=MV2.N+2!U ];X4[$)S'^'$\53=ROP1
M9FX^+ZRP)65F(]>G%;#C&V6QU"WPYVN),SM)2-*0JN. I:N'2,)]X3"YX+*;-S;U;8?T(
MZT3__&P1S_'JN58RH N:IL0=$TCYF4VERON?_B':?B?1\3M^#[(LZN#BQP4! UL.(]14:25D(P
MEF:Z) +W!6W4C1B_#N2'6A*.X&"+)(ZN>G$%SSIKJ@.BM@O!)J1[6@R.86HW
MZT=8N>V4L%Z;9&T;6!*K-T>95K59GB_:ZEH"GK^QBW
M5P5M>'C02O46#%0T/4M#Z!IO7)*U6;]AHK>8.V-9LP?H1%H#\>MHCC
MX/H*"U1+G5[%M-[.,\L. J2I$:>[CVG>"OR'V'QN1>6MZCTZ'(/5R%>!;B^"-C=$(VVBRY
M#SGUEQ=\>C7MP=,]KJ%/OUV_S[L,-BF<+%G5ZA>Y9JVEQ$+*BB5CDY*%7(/2
MIB[\,:C_M78V8'>+,H^N.W$=TGH?J@.H$ZV6WU$][#7R>')WSFA'$M-T5;R"
MS0B$@K54CZLUXH+A#"!H1M^S:#(*WJUG]0,62T\KX&FTL@\?#33RXI\7P_FW
M=Y@NIF3YJQ=T%\/E@<>LZV(LE:;A%D&+//GV#ZC\70?9*%"UHT@^>R[N$"#5U3()H\!D7@I.]T27-OE=R%[$=:G7IE
M:8N*CBY7L"L'$E\ML1WE=E\CZ)O5,U/9!RDCEH V?@.:L8-4NA
M5E0U7K&@LR:6%9$=8G2A34>M^Q'-G;7-[U,S^W!QFO7J>_T$+H'B/,M,;1JF
MK:&EU+O N'7:@L7D3)OFU[> ^L%7J8.XV2*;@\L-[,1V97.@"[;3KDWWO='7
M&Y-W*>1(%DXQP5R!F%/F8+,GYSP!T\5[!KS4UT05&TN4JE'$='*![+\$-=?'
M/L;?J8M_^V7#3*_HR\4/%M^O9GB+Y:?ZW]_?OKPTV9]__OF7!;"+&8YQ^N';
M7]+DTR\+HSV#V?XQR&H]GU
ML1D1)]$J_7&PUY=MAU'"-DZ TPE
MJ9D&6JBC V"&"U&221!$F^/0.X =/0EO_?@G\VMS8E[,@.S388'7NCC"%E^LCIZW.J7;"^CCDE)+
MEIJ<[]X.]S?R62ZF4_KK 'F&DK1F4=2D'5>;OH@"S"H45H L!MOT7.N.\<>2
MTH'#
M(LOE98M&+GO=$4@!C4N<#"8=>87<(PNA).80?LC;,P#T=_3YNX/2EA3Y^K=QH?GA1=X-X" PF6YG\*
M=T%JJ)T>8\Q>TV+>IFK0PY/@7=O$#U*!W=E[L-O(][-A_)"VAO??!$YHE$F"
MVX"M]CNO4O8"__SNR-*[@  N%0+=1JF!006)9*R
MG3 N2VG W,_VU76"2K*)R9K8D&TN*D%.G@N*/:I/O
M 2GK0*I:E ZZ#/;NPKP,^S)Y)E*3Z MZQ[0*D>"2:8*52@,7MC3:Y=L3Z*DV
M8DXHJI94/90=FL/!?N_]H+N12E]1NJ'T/S@I.J=-;($E@N/3(/)#$RH99""
M$AFLBN8A39SWN%=TE@K=@]T>E3G"B\'K^4>L46&;,[89);'#B%V,Q(>B^T0,WHA7&,>W(ZI)<@T770PQZ/_$'4
MT8J$$^X\OYE.R+V=?WLS@O$SPS>6.']S7_O$AX]C8(E9&
M:)0J)*.XMDH&ZW/D/CN5E30F#SH^XSB'X]I#GEQYR/=0UR9KC;.691^0:2XD
M\V@\^0& SB#XV*UGR=YNQ=W8CG6W=C[A[]/);$83;O%&Z\@$CYSI4-_1% V3
M*FJME,Y2M-GSOAW7Z:>[GE6RZ1?U2$.#[=J=Z)[DO+#[;."R"$CC9)@DS>BU
MR64T65.HY*T2]+6);>Z,WHWMQQ'+872T*3IW\>EB!.0=/,?/4Z3UN>*BOX]P
M8?IQ?O)I,IT/_WOQ_9T#&@@1O.2@6-9UN\:0ZQ?!UOP
MG?CNA=H&&<)[CN,=U#W&G:,1 [#@?$UTD$[RFJ88&!00S!4)27C'E6C3IJ#G
M@?SH@NV5Z!Y3BVOXLQ/5;SA_!I^'*M6/-!-.*9EQ2
MKF.61RV-#AECFTR-VU ]&K7T3L%->1Q=F0J'?T'F_@FW4>7,?Q^.+IST,M3T:*QN*0RRZ9 +0"*M81-
M8;LB/!4.1"-Q=&$D(>2\+!S2%>J56AGBI?:L[3H-U6;U'HK
M:WT)HU%$QT6C\G8=P-U_"D.?HNBZ*AU(3H--@]VC_UZ5I O$IKD('4#>3\I!
M[P1W%="1[-R3D(Q,RKK(F0N:9G$A-0N)%NIHQ/0'0D!#T$_
M^Y#20#>O8)Q7AX>V* ,F&Y:E$TQ'8\E/E\B,3+PL_:'TV+3U%98D6V,@3B3R3W ,FSDSPM9IC
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M^/CCON\7G3MD^<]*SYQ(5+P>:,3+I)RAW/KW\+I"3K
M0DI[DQN;I*SI-8YB.^2#J@= 5:$N1D,*JO#:/L'P-B^TW?"-;T@.SIS[EF0#
MQ32(5SPBAEOI+;?36";*:W2H$GBGZ 3/M53"209D4&6=K L\MLE'ZH_U&=*J
ML<(:1#WNPWR'JX?;P$@AC]X@XKAKM:::]=;R.L"';,"02A:Z^N$@8O',"&PW>[(YQK$2#YM1I
MI)9C)QM4=Z..5U]_VDCZDR ?VU*]Q_#E;?L4T+5/,5W'%+J &#\/LA#-^4&8
M528^^7[/\)_SQ>O:SGPU>(3?0"SD NG.]0+,JMML&162^ZD-4DT:@G1 ^0S
MO3A:JZN!,?L(U!] WX4O>',(/@VW:3Y:3\#'R4UK1H#N1!M,>^,>9]MA*Z7$
M>LZ/J%TPG'<0%%KPPCMT6LB8VQ1EGP39GLAC.UFN]5!:FSF+JT5(JU_"<@O@
MJ[P;J4SDJK;AR)[L!%LC4.1XHD>I14R>/- FO.H [J2".X#+-,O[.XQ/S;-,3I!7W)(;UQ^GSZ4&^V>Z_HWNMM
M\2D96US)UBHA,:"+RJ1$YP&6Z-RDSQ<=&.J]=B]_A"@E,L:X8L!4L>07> ^>
M)_(+K A*188AM7EF>HAE@(X M^6XR3&[:FT:5=;&WO:IE$8
MP6*V"MO4+3T":OS3[$#];ZG,'T3@+3K>;*S-5[.\1O5AOEPM<#5=K%=/OUM_
M ^G@F7]?ETC0WB_354UP6][:=-=K"5'F((* 4ABK%8,(M7,RG<"*29V29HTF
MF RYBK-GV]%4.G KRM>WFM\1["N@UYMH(A.G*R)F*-(3,NEB[2G#:!\9DQC:7[2.@SI8*0PN\P1C)]U]Q032=?5I7RUP?0]^O#R$G
M8[*15DW&8"&F"@1OZ2>S"7.Z+Q2B>ZC((1PY-)EICN<^KL^_VQ5.IC0!FS&
M<@O31278ZG(QFW^KKS8;?OGDG--& ?.6^$4N'YF^9 1KX7A!&:SKU+7ID:]X
M#NH\6'0-^JV\G:UP@#5 \^C+S<.+3.Q^AT@J2YHELCR4I-#D)*4TJN7:':5)0_
MCNOLR3"@V!^2P@T<4WJU+39W#5449420#"0:6_,X'?B:;2Z
M(,^>+JT4\I [_N#$VNN5;S(PA*9;C#A+'DA-!F62%HS<04ZNL(-EU'L.D4P:,3J:3B8N[TVG:&*:\'J//)
MM-8^8ATMH[$+J)\OK;67JCJE-NXCY]%(P$E%,M;.H<9Z4(F+:N)&LG@-)H_D
MZNA.[=!/4?F]TUJ'UWT?\1ZE=OEO&%=#U"O?_ISA:Y1WHKSWLLV2SIQEFZ-
ME:WQFNWLZ6M(*[Q@5GT7C" 26K BJ3Q1>]TZ3[
MB#%YS1#;-(3; >CP5K^W/_9-2/CJ2[5\)U(S46RRP(./9-4* UZ5"&Q=):ZR
MM[R-F[$+T?@^Q1 <>-CW=P!Y-WC)7OO'O\UGG_[ Q9<*HUBH)EX1O,_?X 93GH?G#)-P@U_/N(J\'OU_1T3.'II: %+EVHB09
MS?AZOKP]NKVVII=!
MZA28A\)J2\8L+ 2#=%C%@BP&J5)I$U]X$MIS8<>0&FCPVGS["+L)@0EK==$"
M1,D25"0%.J404K!9)JNUQC;&PA8PSX,&ATJYP="0NW>7-)EG6X"1'P6JSD8/
M(1F0,8K"@U%2MKD?GI]AL+=[R_;8P>8;_-U=<77FY[?6?%DT5K0,C.R91,'[W4$%$4D
M8:7+I4U%QS8TQPHW'ZSA+2?#09)NT?W\'J:KF%@75$TK7+?C.DXAZ^%Z>X((
M!PA]/$HD2SYL=!&"RR
MT3#PG9B>!0<&$GGS2.+ZC$O6UU:$!=!Z!2IH6J/( 8*/MO;%Y%FTZ>'V$,MS
ML08/E'*3:.%M1+?JD[O@:FH-[D)V''OP4,T]2H0#Q=[\.+B%3[ @I$$"9#7A
MXX9!R$J!)90LHPQ1C?&F>.36(V.QH8^T&[#@GV$QK6?>[V%U-18,K!VWBN1_UU0-3T(GB(Z3A7
MP&&Z>D3Q!PBZ\::_0H;).H:%W!/-D6Q3YN@G78^Z"MA(;G.;:M2Q5/_$<=]:
M\WWDV_RR_QTS?OE:9?H!%]-Y7B\XY.1"4;7TT110D?R=J)@BO>D8BBR%ECS"
MM;\-VW.Y"@;60H/7P\<17G&Y"\81_8;M*$_!ASAI.!-'=*%S$RV?N+@K;]B\>A-C,0I
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M).X&X=*[R'Z;_NMRFM?=YC9_@+.$$S**M7*<@^6U>)$%#+T.R\]?PS336O]*G^OLW(G21=8L4R@B)3)[B+LQ)$7N
MD^$Q2.-9L$_X*-L_^6QU.8"@FJ=1WROQ(;.U:,L1#->!CITD@+SB# (9,RFJ
MS!OU>3VMTJJFU_T!(F_0\.OO)(]E;1J)R_>S;5[-!&TI:+2%))VN=>4:?)WH
M%S$6\F>BEJ6-^?X/$FV#/E__N9BN\'TIE7@;TV-];)$Y>EWK
M-TG*1ZZ= IOKS64\+5RE D5A4*(H0M@F:_II;&=/AX'%WZ"9U[:ROV RYQ@=
M)%N'?42K(#HM03MD68CLM&[C%9Y$<>7 %#A4P%MB0GM'$ZOM^O$RTN=,9VN_
M@]P0XN1T54):MQ*^_N=JO@H7D^"9R4PB($]T=D7N(-99O]P97E.'4:HNS7N[
M?^/9*KNA8+?H_Z V_9U@?@E_3;].^^496$H-FSY_N?/C4.%OH4I!\<._Q%6EXMU\\GW95,2LC9@G5/2
M)A; *K\FL*@= 2($*:3/*DH4;9H2;<=SMMP84,Q;M']PP/"NB[MY5Y^FF[*0
MS:O'1!4CC$599ZX64,P@_8062A Z2LTUTVW&\W6"=_;<&%X)6Z@R<+;5)K\L
M1V<59@\^,5E]GP(!500T(>DBM12-&@X0V#IN%
MVFR"1@;)8@*%6,#9R&NA<4I:%CH;V]3QGWI?ET,NAH,EW2 M94?!>A=4/W=?
MEUYZZ];-8Q^AC]?7A0E9G/()R,'!&B)'\*QDT-;XZ K7,;;)K#_UOBX-F-!'
MU@T8\$C+"'/6AX8/3=BFP?Y>LH+9D@2)X!A74\.U_0-9HU<[)-?@Y1_6$"'GBZQ.\U
MCVI]K$670Q)>0+2>;-,Z!-'7'N4H+=8A"LYWZ^/5:9K$S=>>NZVWOPP'3#6]
M 7'%IRXP!I\.(+\6^_(*3HA"\43'@UN7ZSE)%P)3%G@6
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MX ;$4Z7]:V;!#_1&#(IAC %7O.I? $G68!
MGC+=^8%9UR:4V!GB2>2K].'&_:!"&V4T""]M!_KJII1G#7>25$J13'W(2B"H
M'"0XSJLISZW,Q5O=J)=4)WC/E"V'**%!5+JB^[C.W:;/6R/:1F=;C)#1)K"8
MR(T0$B'4UU3CHT8O'99&$RDZP7L63!E6"0T>-6\@W1K;?G7IY_U
MFBGMZ$SS)2E=$,%(YNNMFL!CU&!=1N.#Y:)1Q>D),.R)Q)^3(U@?7;4DUMO9
MU\O52]\FD^P14#\;3?;1Q4BG
MB;R"9E5)N?!,1@ 64,@4^$RNA9:1"Q&BT*ZQ3_X0U,]&DWUTL3.L,]+;V@!]
MG;M];M/WL5Z=GV5R,FJ+VDFO$(//-F=FQP9=QA"%
M6M>)I_1%'S_/%ZOZ\^OYETC?D:\[G'(C9&UIZK*H[YI_$=\=0HBTNF
MW83OH[RN<%\H?.&)")Z"!$1F=?(AX[SPMX*XJ6UOM/(SM@$ZO[$>#3^]%'*6*UHLBI!*#(V
MBZSS45&2L9F1@U%,6.Z5E(TZ8Y]2*YK3N,,.UL]X#6RZH/JY&]CTTENWMB7[
M"'V\!C8!5;)>6U!!V=I'(T PAH-VR3K').>-7A)/O8%- R;TD74#!CQLJ9$\
M)H*6$2I)+
M8HIP13F),3"!6H1H)_M\X:$/"*6^F%Y]YH>+,/M1>/0CS*BC(-BU#J'FP2B.
M%IS- 1R71@J^NH2M80+3?D!J#C5J-QNDWD^Q#4XY^8P_/L
MP24ZEA9;=(6[P?X.5U=@ZR2E^S"+8UPG%) MCP0S5DEI JR\=CP2^-"HOKT;
MP.?-J^%TT\)(OX'Y:KF\_/)US?(_EYCOP=1.*,.-)ZX/WUU+H5GY?WL_P RZJ[1T^
MX8O)JL-Y$P9-7&-N4R#1;TO/F
MZS'U/V!WNBVG^\7Z;Y.BWIR$^J  G)T(6I3@$G!Z,1W
M3I0V@=-^.)\W!0?7U$->'3S__-:&^>OK;3?F*E1T'Z[)5G/'%!BK,ZA &R(X
M'4 7EHW)A8[_ULY!)Z#/FUG#Z^HAM0Z>I?X#[D/1+'_(YNJ1TP6N<\H"="KD
MSUC: CY9!I9Y%-9*FQM-M>H%;R&9=TZW9#TII20,G%NO:[]K9E2VUD?KVPQL'9<2
M3R0DC,F(/A)O,55G(Y+-F7CGF+QZ-RCA.)J%7Y)9+UC[:U]->
MVCQ4/X%L?/MW&!W>?[ >4@$-WE3>KS[CXNXSZIU[=!MD:TVHW?%ICX0Z?$I[
M"#IGDD=@61G!G#1-.+,'V&="H]9J.M6$B $Z*ASV?4=)DNC5@8',UYQE(/T*
MIZSC0?%DG56):1:RB_W2)0;NS+"E;R,+* 4SM02K=O3U+D-(V0,KP98@I;6-
M6C4-UWV<.#9Y]?7K8O[7] M]YKO+NM_FZQ#9A[!83=/T:YBMEA/!LM6>/-M@
M; VY<@27:+VI*D<:$07Z)]C;\:M.HBMK'\U>'W M1-G@FGSH8KY*Z?++Y478
MEC^/^6\D[0VTC[A:;:)'$Z<0G4,+A9-0E""F>X\%M"@0
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M1CJKBL VU5*/@#J/M+1>3)BWT4B#2/<.:-MU;5!>^P;31QC@V6T2YX+39[(7#L.2_HH8)1LQO5Z
M)1,V>F9!9%=HO<) E/2++L6&()B4::QRG:F6W7!]9(&W4M[
M79->]Q']F&G0@AMO5@>7"UI"BP\)(&/2R-6JMIP*-GN5C]"#)]3#@+B^E\4V>B
M;8G29/"Q3M"A[R21F[U>_1-]SB#/W;?;[LA/!\;=5AI#Y@LLP:
MT!6./V?+KYBF98KYNEZL Z@^-FHW2NR",ZYA.I"JYJWD//19L!-<-"[ZZ#+(
MD.CJXW0J.A$8*$IZ!Y ?O?*OH44W@?%
M10E!.5>BP)RM1!=S,9GE075= HP0M7BYH#@E.U.:=@B4F=9 QM!L1T '<2J9Q]^/!T
M_O=A"ABIJOQ^283+B3$M$V@9+(F@SKC!HNK#B% AI%1&X\AIUJ0,RY'#%-#
MBG\(\2,NODW3NMGO1"MIM0O4(V9DHJ.63%H1^KT< M6,^0%_L*
M?93B\+>S%2YPN1ZX,"$3(3&>--@@734W#43/Z8@+P5CC0M*N37+#X[B>(2?V
M%OLHQ=@/;KMK6^]#F.:)E87Q7!PX+S(H\D8)KBB@F4?FK8WTP[%,C]M GR%M
MAE/,@!'H6@#S$.IOEU^^?KS\<@>@]UIE41L.B#JO5Y,[ZYD28 WYN5D%XU*7
MID:=ONQLM=]&G*.41=_I,;&<9"-Y%E'13?:=0[7591IHI%%6P"NKH10N3-8N2SN6&7(;US,D
MR=YB'["8>3>ZFUGSMP>-3')*R4LEP:#CH!Q#" (=6,F$UQ-BI;,UG0S)D*D(]'3/2E2!AF=P6!-
M-J;-TT-GB,^0-T,H8PMM&@1=?W#ZCO?F%-?.9P[%>EW[1%JZ2+'V#+!%8&3D
MQ;5IG]\5X3,DS0"JV,*9!F'96W;YK2-16%2!D\//BLMUP*0&GS72D:BL94QS
M9MJDX'0$^ P9<[@BMA"F0+[3]$]PRY;;
MV>O+Q6(M@!"G%R1N8K(APUQZYL"Q7+,3K:*?K("H)6?..^[P=H="-_-9^DA2(%%Y#HZH61;)\(D#1&M!:MDY%%89VW93^=;
MO^^YJ?UPH6[1?(,(ZQ;HOP3Z_80?/R.N)LSQ9)BIHY]CS6A1=:J&B&3X^)1K
M,UYO[%CVQ.-0SY9!XRAG"YT.:C1Y&]2MSO2;T/'\R]<%?JY)I=]PTR_HPP+_
M"']]6$SGBUOI,:\7F*>K"7=19$XW8' IU.E3$H*/]1E+<&0L,+P_YF?K63,@
MI+,ETS%5LX5B!X=S=X&NZ7976KD3+IQ%.HNA
M(-GDRI!OY]!XVDHY>\,2G7!@>L;P6S*I)%K'U(F)$*9
MFM6.X!V)QS/DR>F22FG#K;LXCMC4]Q!:'"#,8W?MS3B=_(:?PL6OL]5T]7U=
MZ,IT\,'(#-S$FJ'*+ 3N C =A77689.>#
MB&7 ^KJ*I#H=8?;]%I@BE16\9!"*##05/8%)G(-3P1N;DN7WG]&VZNC!!Y^A
MF@X3SH@]GI5DUBH-.=<6"B(6B%JI-7]$JJ?&_8DVS[/'\^'6S(""'K6)VFOXRD6T:>XR1K^CVRTSN%=,U@:MR=8D&5$*
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MB^"T2EGD:'4MR-\AC090!4-NBGU&Y*CI$@JDD0JST%ELJ2"0@8ZD"F5
M D^^T5#+7C"/F!QZ"&7:J>+8N:-//"TR[QA=F 8,79IU4F<$KPJ#8LCHDLH)
M+MI8,2>6D]%._]U2-OKH8FFOZP/]/J(?DQJ*<BC@!-)VV[HEO:)?/>UU19=$&"89FBM94&W";V=
M=\K&(31JK:8!CY[=HV7)\HHED7GOE"(;K#@!CH<"R+6)+*ML4J?JX.<^=WL?
M6W48J0_X8/3$3. .H'Z^N=N]5-5M]O(>8
MP3IF2I+1:-G)&CU%Y?>>NSV\[ON(]_13]CHT%3#1]K*G+[@?A'WY W= *^>O_Z;>>6(V_FB_H"L#5-
MX4<3DN 2G6W!@,]DV"I%YA*Y3 X*EV0KE60<;Q-@/Q4)G,3#3Q]F]^E/<[)4
M:N6'M^C38Y&6Q4H&6>@7Q6(&5T2 X,@5C2BR4@V=]>?:DJD5Y4=3]<#5^'_,
M5^%B<>MZG>'JZ]7S;=S 3O7)?[I>*=W<\[J\=%L(FS\B1WA)O[>BY41,6 1J
M(,M7@_)DQ$:I.1B6$UG*+N77#@_0,'=7L;["'K,Y\\NN%Y>QGMIK^L[Z#ZB'S5I(D67@T,0:#WM
M B'IL#0*F-&,V2RD4FV*H<[A9;P)(_I(_!@OXV0L2X]%@N!2U;;B!D)6$;QT
M"ETT*H"=3Y #8UD7]"J_
M-#,8ED:MU=3@Z+DQP'ZY)"\+E\N/&[-WN3YL$S/"V>2 67*H%"L.!HZ6_S?_\Z
M6TSK@^6?BS";7GZY@G9U/R&WQ5N6(3)=0'DI('@ZY5R=727HY-/W,_RW1CZ?
M^)HC1#'W5\"\C?1VVHTGD_=PKQ'^Z)D,.[[_R+D)7:1R+]N .9:MY,)G$95/
MS)$E8955 ;DH$L.^V08[H R>/Y"UMJBD Z,$N4,R)G">]DP6H7#CZ@RL-H.U
MQVA5M'O8FY4U3#L.D[B5:D/
MRPZ9XC&P6D?IGM1W-===7'Z;SS[]@8LOU]U(T<
M!,\VY)+HOAJKJGC8E;T0>4C5MPQ 7#G5.G&#&(!+(@L98AE""!F80,.B9Y[K
M9SZDYA"R'"#,$W\O9JC6 =<+^^EO;37^75L#]&/20VNDS'>6'+>60+%1"$GVU4=AAQ#=*R$-HU3
MS^&]M DC^DC\&.^E.<0L&-)I*$*LC0DS>%;-]8*\B((NE#;O%F?T7MI+AWW?
M2_LHX$3>2VM709GI!F4UAJL*1K*[:BMS,KE*UB%)U>84.>_WTD-HU%I-IUI)
M=M-"]=7%FLO5E1LIF/K85Q\ECMI9%O="J"9'9GVV-I>L1+ NN&2XLRP7)56,
M_4*HCZ$8/GH:DV2Q6$B^'HZ2!7 E.R@YJ<*87WW#
M1?B$]X4Z*3XE%8V!A+G0XKD'EVV&F#C7-?,B^[$B34] /8W040^N/!TZ&E(Y
MHX0Y?S2;_B,L/MT&^X&<9I(4K6*2&)?.6?*"HU/D!=.5$+018+G*&,@])D:,
M1*DN>)\AKP974_M (P_=8M&MTB9/.M#82\'= HU]!#UF-*D+
MKI= 8R_M=0TK[2/Z,:DA?6$*IO&0"K,V3%;VV.A;L.(,PHT]M)AWT!C'P6<2*!1
MZ,C0Z3K81--=FHHB.Y@D8YT7QB3.=A5F:AHNW
M,X)]62%?]>;BDF$VD%.M%PG>@0N96*]RRBABRJS-B;,#T#,P4(<0=8,RC#\6
M1,V"B^6K6=XTBYG./KTO6] NZS99;O^CF^9[3Z^EJ54[Y&J.8PD/0I/YB>FX
MPM1ZB.8GILS!
MRFEPSKP.R\_72$*Q46A#6F1UQAB=NM[Q ,EZC$R9'!O-8/J!X2MY[ANSC
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M]P^2U)?++]=5)-(&*6U-%N2U*PNKGGO@(&2RB6NR&;P;3']WOGKXM
MN5,M=/G1F>9-F"[^&2XNZ<-^S83>A30T(G^/P8/_O8C09DL]URKRB2:6EH6 GA:'X1U8PI'
M3J%M\Q33"=[PQ0XW G]_2^ 3)IAWAJYP%().DQJYCI(.@Z0%<]X&KO18!3-;
M 8X?41Z>/4]7.!RNFP&OV=IY[B'$M[-ON!G#LOP'ABJ,_&KU[M4_)YZ5I++U
MM01<@-(A@9?U)Y%+L$X9-SHD1#60_U?YY22&019B@FD 'A-+GF6A-KK4TFQL)I\1T(L/,+GIN^AY'D@ ]'%=2?
M,SIR5A>85_5!+:1UQ=XM:%IJD:/38%EDM4]9;6&9Z23<,@F6J/M*4DIT(MM$,BM,JC&ND
M^VXUE*G1&]^&43U
M/F\;MY6V&I3B;8%UM<.Z &MJ^>Z$=AS3MYE2[U]R@VJDA1FT$R#9? 1*.4BY
MAI0XGD0VH@[(A"BEM[)3Z>>I4><(D/CY3^BBB 4/^_/C'8OUV\/W5+/]]
M_@T7LR\_)@<1M-KALBHQUJM;"S&&DWV3
M$V.=>%LKJ3[,+PA8"A?IO6(_<:I=!*"E>;9'#C004R^$->KQ\]TRD8
MWVA60C=\SX4J#;31P'3]Q^7J,ER\N9SE&Q]-F1"TA!QJ7IDVZR5GD,DI79QS
MC+4Q/^XC>2X\.$C"#=X,URO\):3_P?S@ ,NRH-.U_6;4M$XI#3C#+__8'7'S\'!;7":Q)E<2B
ME^#129*"K^6QPH-PH13#@A&Q382V'\[G0IR&VGG()3T8EW[Y?O/C?TQQ05_R
M^?MO^ TOUBZ;S$G*E"1H6RNUF8K@HJX7H!%)%*^\;V.$=,/WO$-K#734X**Z
MS_MU.MU#O-?]WSJ ;1IIZP7W2"VJ&NC]B<-J>*6U:*;7"[2P/!<6%!23:.EM[8?]^![&EMG4Q![Z_+U?0+.:SYS>6*Y'KMT(;OFW9M
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M;U4U<&;VP/UF?DG6=$XLIE! )DNFNO2YELXD* *=CD5ZJ<;*W^X$^&KLGX)^27WT5U2"U
MHB?L"OG-=)G"15W \H_/N,!05O59WY]U9A5'&YAA!LDP'<'"<<*4(40JTY+IHG]K88BIF/(:35T.$3!W;HV]!'T
MJ*7Y'7"]=&WHI;W.-?I[B'Y,:L1H$RM%@A0JU,)A#=$I!CYDM"43^/+S=FUH
MPH@^$C]&UX:4T61M"Z"L@W8Y"^ 4]R L(ZNF6&5-FZ2H,^K:T$N'?;LV]%'
MB71MX#(++V,"9E@&A8:N4>=*S7\/)B6T.K3QH<^[:\,A-&JMIA$[37]H'_LN+!;TPS?<_XFYXP"9*<<6;-EE)PS_@
MKDLL'HCP%4EP]FFSC[[_^"M7,8!7_PZ+_.ZR[J+WY57.:XJ$B_7?6[ZZ7'V>
M+Z;_BWD2A2@1M0>'*H$R7$ L04 NB3$I>8BYD9C:+>HDPCU]^/? LS\1A3>X
MK ]>VH,%<:>*3([,C5!'=+GJ$8O,(+%@U*3>-EYLJQ6]<'<(
M53=XQ=Y[79OUO%TN+S&_G7W Q72>)\B#%QHY!%T4W1ZQWA[: :(JP='.9(F?
M%F^W+>/G)>O!2AWP';PV.2<$9;[X$F8)7\]G&Z/E:E[4.UR]G9&K@I-$?H22
MAH..GO YLE9>OY\O5N_GJOW#U.Z;YIUDU%39+/53M#[R!0K
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M*X+BDK@:-0=3'&VOD&$^=.P7Q8QFS7%.Y
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M3/20M>#9BYC((7AV5'K"^S\5)O71S=&K2;?_[BM:VI?U:I=_TA^13C[C+QZ(PVI:@0@2OKR73-&H)T$8R,6J.TWL:&
M*30'83]:LS7W\=K:DXWOMHZP[0OSQ.< G5:O4+ND\%X,ZGCUO5_W>GQ
M#UQ\X1-.:]%D5T".6/N@6 8Q"P72."ES0,U6OSI;WLAJ.2I4'E=Y/M_L_Y!7W,!1F'ZR5J;Q)C 8';B*!82! =L21"=.B'_I@+WH\9AY]+8#1J7H\M*]#IJM.2.M4;?]J2YNA
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M?[/1^$2[A%')!-(R\CL9'32!<08*7P;"[8+P\C8-I
M=%8)33>KW?0(GQ29A!2Y@-$N@)*Q@*M=>"-C0IE2R!4YV_VR6>(9;941N#K^
MMMJ#:*7.=-5\J;I7(NT*N00 <30?F2P6G.0.A*U_]]9(KS]G]&VW6N>LAW_^^AE:QHD03/*0G1?\65GB3/3?Q4;&$#D%%06:O30Z"EAP,SUI&SU#I
M(_6]&V'U+[OPN)&,8>DYX/B3L;W/IP4AI>+HH@!33"%!: '.)PDY2N%]]"A8
MFUZ^)R."E\UZ F&288DZX+R9L1W<#D<7U\HIST&;9$ 5KB$J9\$5C#D8KU,^
MMX> GB)XV;$G$(D9EJBMYOJT])XOR6UX6@K&X2DZX*BCQTO:]W3+WU^NEJLPR]/9IRM1W%O_G?_D
M%_PTG33DZ+T+ J]D2D\+)I
MG]JT)Z*H7G0=!Y!)]\(>=86O"%
M65 V)"\2ER*L]R?6&;+? E^V6,,MUH)D6S;3,.DTH_FHOV/E"?WQZ_EL
MM0AI=1DN:DM!,1%>EQ)+(>4(76>2&(C.T,EB8LDHLDMAS(GHHPO@93.>3"!E
M&))NV:S#Y.L,)8>'Z4B=Y6 ",IZ2!)<+ ^5M[7CH+$2L0@C"%N5/?[/N+X"7
MS3K69AV)I%LVZ_$R=ZX6>NN<>DM+F\Z6T[1YA1$.C8VN@%C7VX=(QU"Q$F+V
M&% (9?6)U2,]M:27#=70%!V&2%NVR#"I,@^.B@XMJA\:V7=7QB=D/BL?I0+)
M/ E<,!)XG6^I8DXB\)I>V["149,UO6R2WK?.Z%3:LDL.3T\9K(.?8A&36GV;ZSE&"XM>1T%4T/N?DL5HEG0Q[>[7O/#GR]E'P@*2M
MW?I^F1.JW\EH7TQKB_L'<^,S2N94$2"+,P2-KA9?9P2QDF)6,<6"]WK#;VVD
M^,37G* 3U%R/\S9*&+C]YJ]?OE[,OR,^@@ZY=S9$!](+6K5*M.I4+'!5K$-I
M-";=@2)/?]-/SI*!57&H=*@K8RUD:R F*U61&C"8P%H5.C(.=/T@=X
M'W*U4=^ S8SV;RMK.%$^U'9+L9;B"VLAQE3 IQ YGT\_U HEV?_Y/S
M9!"Q#]B29CNF1RCK=0F,;##@IG9X$Q%K^84#PZSRUJ:,V>U%CY>CI3-E!E+/
MSFXL#3J+7X4 YSM"@)V>UG_Y?N=Q_8 ^Y W1#-:U?"R)W>MQ;J,M/&>EO+&J
M%.N52#P3=;-VAF&:M 1V0FVU?CR".%9'E0ER1;50-6RB(21C@ G:674&2A:V
MC17?9#TGECBUYD'*V=^X%'SY86IDPGGQ13H*UP]<5)0M360RI<8C!%Z#AFUZ+!%_BR
MITZ43"UZMC^1;+6/>[Y>\E4&5J@3E'D"(7RB8Z$.]+;90M::>1U%9*VNIZ;K
M.FY.YG'WQ>D0YE22-P<6Q#H-IZ;2,I,+9%5(3X)('H.SP,E#U$4H'OB8_7P.
M6LRI)I*.2=7A;I=!*#-:=M^>9]75&TB7)1TA1?6@11TG0_7HA&MI7AW EC/9
M""ISS\F[ E]7I73(X'S&^J\UQ8U^,S?LO'@.&^"))->?@?]]2#)PINP&WM\7
M\\NO[V=X];C,) M,!@\LFIJCL#8S'0DIEVQY8E'U_VV>?N8NZC\+F
M TI[X#S86WC^^/?\"H]0UA2;)8B8R;&5$L&5PFI',Y6-=LQ@E\R/;9_]HOV#
MI#WBB/BW,_J1[.6_<+E__L66#QDJ;>(I?/>R'71FQ0LI&4.NN.-U*%A.WGDZ
M\FW!,MGR>8=F#8?5VEN]Y;UGF1+S%HI6!913'#PAH5^T+%PY*7RC.N\'6 XY
M-/Z&!1<+S"2L5\LEKDAT"Z0=]C?<_//5E_GE;#51TG KB=-!6:P%^[1!I'>@
M>&S^M11,J^DWO-DJOY,$?LDR^G?TZ"S63_^KO3(P,P?-U'AP3=&!Z00YWG226A!6%812RS3B>
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M[@:C;W\CKB?08M&,6>$Z*F$MR<$@_6>M]5,KE&-OTN^R#\AF3Y4"5##B6
M=1-RVH7SW?Q'+W42A2I(0 @AMZ"*KPW3N8+DI=/,2R/B4[&>[M]VMLIO)- !
MYWJNVRY<+FF5R^7;V0H7N%Q=F=RWL4XXR^35L40>GETWAXL0=9*0K"XJ)E9<
MZ!+@[_!59ZWLH4798![D#\=KJV=_W\S9=CP5:4OATH!(A6XWYQ1$YQ$X3Y@5
M4\A-FZS(P[&?+;N.I+X!YQS6_?&Z KBX6 .:EXR1#L:Z'MH;J_#71*3(N2T6
M-+=T"$HAR-+R9"B
MLTZ 2I)\J1(5N)P%F=!HG*S+Y%VZ#0R+ZJRY,EU-
M:I8U0YT@H QUWC*)1PL#UDC.M&8QR#:3;78 .EO.#"GH%I/+UFV7ZR/] C_7
MW*#KH'(UM GM)/D2&.8",M=\>ZTMA"0U*$Q&5"M,-2K/?@+8V1-B2,&WF*'U
MVS1$,HQ6W]_,%W_2?4E7XW1&P#[,EVM!UP;=Z9+,I-EJ4C 43"B !2-!>1<@
M<"4<$]9#B8;\0%\8D/<7@?1OE2NHDF]SJ_4$>O9,:JF8
M%D-INN1?O%J]0?JZVEYCEOI.RPA#A#FJ535KF_<.IEYTY:>$#)EZOM(Q#K:+H&+M!8;J_'O&2NB
M3?SF#HRC5;(>H,[Y4&)MD*-Y ^9Z4$4'.$WK/>\!.DZMY@$JVJ7L ^0[@MIK
MTTCOM 1=C "5BX"8,((B9\V318WL_@O/.:G[BPVPHR^X9::Z=_N
MJW@GA#.^JX<1ZX )[VM 5SC^G"V_8IJ6*5Y3N0NH/K=V-YWO@C/NG3V0JN:M
MY#S@N?X$.(TQ.QV *UOS1ZP QW4]@6I1,K,Y6#Q7Y>^XP4?5?0_Q-M+YF_D"
M4UBNKEO'1\P.O0"4=-NHX#5$3 :8LM)D;3(9+X,K_"Z&\6[Q 96S1=T'2+9!
MA>9-6.BJL'WU?62X@V
M6F"2./)C,J*/Q!LP@5#@0:H
MR-A1W$4( CF8;+--16%( :&%R4#%E%MI08AN:9\*#@P4]<(SH1V\\
MD3+W,M,R!!U2BB-"]+XV:L!X?$[S0X3\]M/? /6C-^ N*'2
MTS &C^S= C!^+&]/%=Q7X@'R&SAZ*0+HG"M@Q)T
M$)V/&A^)R@VKQ3YB&UA[_R!)?;G\6:@O2XUX="#]U:2#:B"5XD'
MTMF2+CI-M7#-YJT2AK,R^:;+/J925AZH@V^D5;
MJ5E)*KM&\P(':[5X_8FO-Y44N\JVBG=9B2 @*DTK94J#=ZZ>DU)*YVQ(J8WK
M_CBND\C,[,."^Q;Z@&)O&>J_"ZL.=IK.+M<3H'#3BF+Y*O_WY7)5!?.^W*\G
MOZGDF:"HR8K(R(7)I68UD)2BDN!TL9H%%:QK4ZTP]$K.GGA'56W+V/.]'63J
M>VJL=>W**%#()-WLAF[VY+&XG&*4;<(*S_7$&D+0+8:[W76QG>2TH#KUGLMU
MR42IWJE@1X!B'_DU5*?0.3M)
MTO8IUDI_&X"\N0RH98A)"&'B<+F?IQ%F&D*+?<0VRN/^)I6M%)-$B-4E8:!"
M0J!S)X(V&7E@*:O2ID?H2:?]['/T#BCH!O;5SO>I+KA>TGYZ::]KDL<^HA\S
M[4KJ0!LKM++(DF.VL>]UPFD_31C11^*CI?T8;X5)Z\A
M'83)G0&G17W&SEJ+5!0/;6HS3SWMIY>V.J7]]!'U$=)^F(G%.I]!ND0^:42"
M%X('I5B-'@DO?9L)+>>3]G,()X84_UAI/URHHNK[G=%UREFRJ1:PTWI5TI'Q
M@%:VJ>T\\;2?0WAPL*!WVH]-GS@?]J08Y(5S]\.#LN(9[[YO68'"6)<8<
M4[6/.[D/+J1@3."1I3OOF[N_8?#GS<1#$DP7*+DVXN.R$&6$A?_;WKO%]>-L)VN^?,.7ULA]T=_60O""/+5L'
M,5,47I)EOJRRK6WZ(SV7%C9][*E%"YL^"GSBT79=6G+[3 >V" QLJ65EK"B(
MQBGP0J'+!4/.;5J5CKR0G\(V6RGVB2;C[9GIYY60R(JN7>(KMQ@]A$*1K7ROH&J*M!3K$+\E7;X!\,A,5$8DVA$E+K1 !%(*%V#JY=
M%:WET>50VK1./0;M3V%<@U34H$*U"^9[H?(=[WK"%:;@*V)7YUP8VH!CEAZD
M-\X+451Q;>XSAJ#^*P*'!=QQ]*)G<4O>7"<1'<
MT^UD9SM(MK69#595@]%\77#_L@8]FRY6^_&$!QM+4@:*"P44DL2"8 PP*9%]
M$OHIS\DML#^%80U1T(CS^OI IE^N":$?D7Y)6ZWQY"D:%B $6P>6)L*L(EE!
MB#P48YPK;;*UQZ#]*:QJD(I&G DX=(M=OQ,DG^RDI'AW%?F:6HY59]T5JWQF
M25K>: S/(-@_A:&-H[0&LPEW@]]%9)]HY-Q+3C)BG@(3'@)$AH04)9/&*UMX
M&U9P=XS/U)8&JV/$F8)[.%M%L!R-1\BE+CKJ2&AH"\W,9MI28_&A3>1W-I3Q
M(6H?(,RGIHP?(NH$U,)$ 59K RFX(\.Q
MAZ!/26/K@NO?#,=>VNO,<#Q"]*]$4GHUR#"8.H,A@9/D^DC+2@P&F91M
M.E9?!,.QA47TD?CI&(ZF8 BB#N# #$HR!\X'17\S3'+&5(EMREK/G>'82UO=
M&(X]1/T4#$=F54Z,0=*LMM=B$4+,&G34%'^K(ERCX7;X.\>BM_5$O\5MDY*G$)477F05O:"_
MUZXL4DC2C'%^VN=KMSH4ZPM[1)I*]@5C8:JQ]C(:DS'A#'O*HQ+8/
MRUGZQWO\>CU/GP*%2O1RO,?EU1SS+_1Z3#^NATJLY+J85.HG)P5 C??$,Q6 '^[
M^N?U55[3R[Y4/^H68F$J!T91.VI#=A=DAB"= B$1O4*'=CO3OE._'1]WT:IN
M(=(1V50/(;ZB _0[;3256OC#*%72BD7OP(25OQPUN.H;\5J:S+GB)&M_Y
MJ&>D[>&B;$!P>A>^KXA6O\[F/W:@M^4^08TS,)1FL:E./>23@B[6C4RJJ :/IU6SZ#>8
M^<0DED,2&F2H@9QBA:+PR,"*X'S.VC*>FUC206@7;S/C"K\!&>F^];X+\[?S
ME0CR_3TR>#)AEFMKXWH:6J0]4LH"F<5L!0O99]5FL^F$[^+MI($:&K",7GT.
MB\7;\F<-Z:?+M_/W5Q\_+5__"^?I:N,TWWZXV'RZX)-BR)(#NR6-2#2J/MKK?Z550^.X
M'^[7)(5*70H6)*,_E.,D%F<5,!2D_1RE,VTN^SN NUB[::6 !IR@%:/M/LY?
MKKY=99SF!1GUW2H7;[,K2.:;T.;*WPVU2L] QD"BH0_(8V]B*MTQ7KS%-%+'
MCIS;H$SJBX\?Y_B15K[VO>[A_9VVOD58$[\G67*5K>: O/:H]SD!':$61>K_V9"W:'YP9R +694YM*8[#C8E,5ZN*M7F8%PR9K$'?I&
M^\+9\ B'79X<++F'C5Z\]HM6T$99*K /^[(J\@*@@&*X@.V]=3L[(
MW"9MLA?2F; )>ZEYG\4,$G<#KM!=/#>#.CL@:DHE?(CI:4B$(REM=R [5.*G
ML06FT#&/'%2=/Z0$)G",ZYKNC0E9UD*V:2=S*ALXP!H\F0GT$70+U:\"X16N
M%S=#BTQT*F>$R*5;-\R/W(;*6G))2.G1M"ES>HCE]"[B4 T]R)> G_DWJ
M:P/&:A>X9)DLL3!0UEEP*0E &Y4QD?XGVH0&]V!T8P1VFMM6P118PIG20I$&U02%*\S'S$R9I)4/JB'!-%#
M3QM83QKFTZOIQ\7MMUY]OEYB_A'>6N&\5.24N-7MO(L./%DM..45B\F$E!L5
M*1] -G2SNA7T;[/%8E(H(E,.-5A2!^V<&BN)C?90KPRG3P+R-K4M]V"QODBV]TGM<$X>^S.]?)GV:?Z5F+EV%QE2;2"W2E
M>,C/^.:Z
MBHX"DA6U[NWU04(05IE-*VF-@HS=0/Z,]@
M72.IJ44#P"U9K#96\@@W>"?D^?$4:[^&6IZHT!9PC,)4G8-2%I,(W6:G#DYS
M; %[9E8SIAI:]//;!6^B>?*"'@U&<8HU@Z'C-[@"06/Q!HW,NHW7O1/.SV 1
MO43>HLO>[A5/F&$\N=CC(HI?QI+^#EVAV/$WH F^V*Z
MO,H5RM4W_(#I>DXRQL7K?Z7/UQGSKR0C"@2_7B_7_>'+]BK6A;.3B%DB-Q)<
MD+0(B@\A2L5!6%L"5[Y@:5/F,0K\9V9IIU?IV"S^'A&;J1R,OO=SAM:WZT"EG;R!EH$T@TVG@Z5DND8Y5$9I*WY/NU
MH8WU!WNJPH.F]M1:2>=2J_#;;/J1#NLOOV!<_D[_GQ7_UI>HF=$
M 5+0B5P)5(@ZIC:C0W:A>;(*A=86,!M9$PWN]+5AVP2?<2U)*?MXDWA0$'#J2RACZQ'
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M<E?G]3?XU^HC"M%2EHS3^2FL,M4A+^"$0: SE!2C9-:->GYUP_<<
M3*6!)AK4'CS8[-:()])(HURT@%[6GF2.00S>@_8LNL*=98TX+GL /0>+&$/6
M#0H%'C74U8>;:^^;*^\\2=$3U*@AVIKA"8+D@0J!]C@="]<.L4U7[?Y8GX/A
M--90@V*!7O- >"";SX4#:JPEH3Z13Q4T2,-%*H*B.]GF[N6\1[0TLJ,66FG>
M_G]3J8Y\F1YIF-4BTQ66UB!*$PU72YCU!&3:,/@?P34J=@!#3:,D21]+E?_
M+_X*\_SCGLH&640P("U%:2IS1I*I35ED\EIF5"RW.7?NP7CZ>YR!NMTFU1XM
MXQ;A\*:8 "N[[BN)9#W$J++K/JY,:_'R^X__9C.[9+6"'\N8YG>?P_1-^')[
M+=UA34VY "U6]31,@@'&LKU5G8NF+\6*@V.*6SH2N*PS28L,E1-8+VJD<,('
MF6R;NMS+L=X#Y(7&B_R#%+)X_^&/FWZ%DC$?G(,D
M YTPQ@H(J!4PC0X9B3*G-AC>]"E,E[,O*X&LD+W[
M\,=B RVSE&H[?$#)!+U_%)3XK#TX@25E6S1W;>[#'@'U;WL:365-[DKV=>.M
M]82NV Q%Z5@#7$<+5HP"W)1*CE8(U7A8\MDT+6\4)8PC^Q87(@_[=G9!])-W
M,.^EM,/MJX^1^&DZF-OH&),60?N@"9G7=59/ $D.'Q9MHG9M<@9GW\%\9!/H
M(^B6K?U6T%YN#BP>K+.9#D*F+8$RHMZO% M%R%28+!,M[EK.-/>]4-T/E"\
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MR;VGE48HWE 0CDJ2UW\"LUB!>7YFT%_&#;BXNUL$O:<3C?V08'"'?<84^9L$R&56T#."-J74&
MG*(FJ^LE@&"TZ\G@L%'![6%PS\P\1M%!@W;9^\J:@E6,51H4,S5 4L) <,E0
MO&2L+@:UCR?:,9Y/##*&K!MTRNY8ZZ@P\8): _>ELH<*A4EH%"1C&'W"L\IM
M8I#+JCH=8B --#%B+^W:#W4/PM66]K=Y'1%HI=1:%P5""T_K+P(\14? =&WZ
MK9V+?HO)M;/][,$'7;*^QY?DV*VI'T/W!I<3JVQ07CC(.AT?#5;+&_66X&&FNDHFCP21I%+)O\#
M5(KDDB Z,#89.IB\*BIT4.[^)URZ7D>278NFSP,">"@)!$Y8_2WWQ4'+CP7%F5*/QM$RXT7-0EF^*YZ;Q%\^G#/5O0)(::
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MK7YV6-2@W.NMN2\JX+RYA$ZSZ3IX^T(*^'*]BO_HIW*][O:3HLXDB<_3;,O^'6."2OH
M?UX'"N7F$\MTS-Y$<.@W16 ^) XE&R64+$8%,YJM[(7QL-[
MQ=J#T/P<]C2J3G:8U=&)Z>Y+J/!C^%S/V0\ KG4#YJ('LW0 3
MROLIU1S!>
M.["256I%)O]>9 VQ1,EC)7+*_EGBQYYXR4;04+8[3& P0?;M5ZSUCM./O\T6
MBU=A/O]>9O-Z#;:8V%B'TV,$]+4S4F"U)RKSP VW2B0,KA&W:3^F2S:,D26^
MPQB.3BZOD]ZW8?_;OZ;D''VZ^OIZ&N+GRM"X7S^VR36MDY83+V1*,I#GY H#
MI10'C]X!&J%,\8J9S#KL#L<^_Y)-XF1RWV$L1^>*AX#^^S3-5Y?OX?/$J*@2
MYPF"K17X/EMPV2 X+9EG-ICB,[RW*<-N_;767=ELX
MP(63/- NF)VKS!SRI!P*#8(@TI;(56K$>]F'Z%G8Q!C2WE'].2BONZ(#OYO/
M$E+<_BM)X>8ZXFVYLQ].=!3<%5'O)M802
MZ0ZU#V\4L+GYW**9KJBG$Z$89IT$)"$5T \6HF ,(D8=H\@25:-V$H^@NF3#
M&%WJ.TQB.,-W3WNO0NL:3)T_?T6M:V,!R\%@XX'0!*8$;A98=WH>/C+OVU:"'5
M'6_(8%+IH>E8I7"NBE+UXCW2Z9Y*?1,T6"U99,60+$YQ:W2VD\G&[L%TK.QW
MV,9@2NAC[=)S83YEI*@OU\L+[PR$0%X?>JV"1BU5:C.@X&Q'DPWRED:2]'F.
M)BL20U04%PB1'*A,!ZE/5@/7EIM@$N>RS1YR]J/)>NGVT=%D?61\*4.=NJSI
MWZ/)CAA-ULM83C'=Z1A-7XH5JZ!J*W !03A:6\@(T1I:F[!>,<%4J]WO/@H^Z> ?*Z,TB R,4PQ42;4,DFGH\/B7/N)M.^_G9CY)X0I+9!)LK2E6WF,MT?.U+8$J1B>R[.8*/Z?Q+R,I
M_!CQGFRT%QDA/=PXB"EI4):1%4:;(3-E7>U6()EOF[5]5FH?+N0&+MZFA<#-
MOJ.Y8^3!@G6&U5FVC/8=BH^X4S N7M/'"W5OB_OQ1SO57>AJ
MN6)O3BF0G59&.4[3%2Z.G^QT^#O'&NS4$_W67"?#,A+P1"]94"50A,8P!B,+
MO8W&&#TY_/4CA=L_,O\JP^Q#-U4
M5H4)MT+[_K[F1=Z6=_3;*XJ5ZZ?O9O.J^#>SY8N4YJMY(5Q%QNO@8Q$R+5_1
MCNA1@;7H3'+.>M^F1\,18)]@AO4P>]G>H%HKJ(%/^C<2TQW(?TSGF.IWY_55
M^(0[ASSR# FE)'CD/'D2#\@46=+:JB+;!*,'@%V\K8PI^ :N:X57#?8]?JYM
MX'^?_4;B_;C*R'[ Y7)])3G)"8-@/H$DAQH44D#NO"]@HTJ>T3E@&HTK[03O
M6=C(N$IHX.KNPK2VX55:'G,E++]=?L+YNS!??I_X$'*JM_ EU(%$EA=PJ]8T
M ;E'IQVY/6U.I'Y +]YZ6BJFP"TWE/2[H,6FY8B17-ON*I;SJ=;5*!AN*+QR&
M )JK !1P2(CT"P@47Q9M=!&BC8$< /9DUV@#5#YK)_H&ODF]Z7U;[H'<9!>Z
M &MZC;87VM/R"=W@4=26T/^[*/(/,1LQ^+^7*RRLZL[-S12>D9&3;CS("2
MVD/PED/R.4B3M7/,=%$\?>L=I=-/VPJ_]]@+]A..%]^(\>7XM]Q#:R]FXWE@\)IV%^-5LM2M!)8:-VH"6O0\]LN^%US@B-$'#>2^<5#*TM]0"\BNDG&P)--M&.LY*O^1;?Q4NN\C
MWD8Z_W4VK^U[;X@8PD7%DE=@G2]UII(#S[( ZWF*0J7BQ(@[_$X,IPN41E3.
M#G4/D&R#N^%U3XAJT[6HXK;&0P@EBE(2I&:!%ID*Q$(QF[4Z8Z_UO1#EG;!X4F3J^/H<)O^/*8"
M&C@1:X+!;+&"2B))&6,BY$WZG#='^PS
M,:/6:MJ[]8S/P'Z/WW!ZC?'[WW#V<1Z^?KI*+^88CJ=?'_C"L;C7?7!O$:^=
M-84S:8IP60ED%%TJ@\PXQY*T4DX.?/?XK&NGG6]6,Z^X/SUO]+GZ]H1Z,5B@?1/_CW\
M:T*KMX4Q!M+6>9%8.W$6DT"Z%)/S/AG>Z4;I"#>H-]CSX+GUL)>'KE%;!34X
M%+=B1ZVX+5'2SBDH]E161 B2(OXLT/-"6ZD2;7RD\^&Z#=#_ &$^-=?M7N+P
MQ]827^FEUEW7
M)X/$.W8F=6TV=R%M?+@NH,:_0MD'YPFO4(:I:]9*UB2!N$2JJ4;G1-%(>]TC2EY@^M\?9]_^8_.-:SUO?EBI>:7@'\\[\37)
M.(*?#9+:B,[;#8*7KR=!)Z=RG2NHK:_SX.N !>L 6<@,C5?('JMAZ:>WEZ^?
M@]YZ2JW!^_9?[R;%"FFSX8"N#CQ>3=/13D!2SBN64*7M =,#]/9?[YZ#WGI*
M;42"7^W4O$I+U5O1JX\WE-%,3V-!,<@K(BIS# )+''A!&T6*EN6MZ\>=K:X?
M?O,E:VL$68W($JIH[@/AO-BD@P01ZF BYZL)U6FL4B,&ZUFTHH/2GI6^CI?0
MWLO>\9.IFV7_?5IF\R^;8L+5;][CUUK+/OUXYZ/C4ZQ'/6:LQ.OP-6[WPHP>U#!>/!<%>#>,)9J=8QNTZOI,A*Y
M8]O4&*G=/BIKT5!C,ZNK7"TG.I)S1)L!,#IZZ_$K*5"AN%4@5]8ISI)O^&<_GYAN*8>JGTD,9_,!B@>C/
M7"V<2/5]I-NDY^P*V$U]M8E<>^')^_6VE@/20NO5J=JGJ.EXR#;K;W=Y'O[Q>4""R6&S\
MQ<5ZW$UP9"%6 :W(@_)<0>VA!BPJS-$:"D ;C0]Z#-9S][C'UTT+PUECN9FA
MU0%,VVEI=^$\\6B7X>K:-H3!LFZ1&KH'BGDCHI(>3&&T&6J3(1:6@%LZ9*17
MV>I&.T5[Q7>=Y])8[WU$//)A_MOLK]?3^57=_S:GUP;:YA"3TB6'!$TF62LE
M"@<7!6VJ-@HM37%.\P['^X''/%FJ]Q@%S-I(;V1G^^;6X2:0N _,H@I&AP!.
MD\4JI+C1"\W 2B5"EIZID#NH]=&'7*I2QY/<"4N''M[+OJDS)VKH,.;=]H,O
M;7>3_3C^K7OK[%U.3@JCG5'DGSN?*4!RJ**(5FJVX][ZP?>/7DHD5E%7;\K[J\4_WJUQA8_()R$).L5L!./JRD7-/-9]4 =9DD^R2-^F1NPQ5!=K
M$Z.+O$5$<+^B)7)N#=9Q]+HVBV&E0%"!#EK%4E!2T!O=Q@#.INIKB*('"/.I
M[VJ[!4;J2-^DAO
MY+31[Y@^36N)P(?9Y^LJRZWTAQ09?4X!C%BU/?<*O) :Z-]:3N.YB5WR@0<>
M$K@Z@1N?-[85S>M[<4#W-6@EYY!=\
M/S@6%9EX)H_#!@3ED@"GB@!4LGAA?(K=1K6?H^8?8<%I6W$C"GXTM
MN;'9<=^G].D->4BY('+.#D@C#)12#)P/%G@R7CL6M6%=5'CO2R]=;<=+:.0W
M[[^_7R\^7;_^C&E)7OR[V5\XOVDL6">(*[(?9T2UG]HH54<'3#-9FP78++NH
M;>\#+EV%XTANY%+]UZN[R/\,\SB;O[E.GS',7\WF7V?SN_.>C'/!:\L@8)9D
M;FC >R/I),E>"Q528ETHJEV>=>E*'EV>(Q?XT_)(HK/I&N>'V?7RTZM XKJ:
MAION \B+YC7J4YJB/LL\!!<EQ)-N@$_^!2[>7W
MESA-G[Z$^3]6'J%4&65D#+)UM3=3R)78@>"=MRP7771J-CKO4607'!TW$?Z(
M>\!^?#?H;OIC=,#7]!+C$,*GN=<85Z\'C68$I32X[3B(,T1OLXFTWV5KZ\[G
MP)L<((0BN$UH?&[3&O5IC.; GU UM06%C6V(9F<7(#Z>]@
M-+>//L)O81>;(/X!Q)L4"RM:*$>+1>=O.@08"=F%* +34FZGK,:RC<>!G8&K
M<:P2MXUC1 WL]3>.+!9YH+Z5P!#SE_]X78LG%E=TMKZ>7A/\3;>BQ;)#D4@/
M$ZD/7&S;2 70KVIDA(7<5HL,>^%JL[;EXD5
MS^>5_-L"]^XGG?Q%WZVAG2.C]HFE[WNX^77](X8%_I__]?\!4$L#!!0    (
M $!?:U3:<@7A' L#  ", P 3    ;&5U+3(P,C$Q,C,Q7VYWB#*Z=Q;6]?V)[E8W=5=7=55U;5O$+'6[MKWZJH"
MAN.@HV84!L,$!@8Y&L!!< D0$T$.H#@L"@Z[LCAX" @B 7&$@V]WE^SUOUO=][_\5[?^;![^/V[/[!8Q_UV&.O
M?^SU#QZ\]Y1I\ &Q887'?_G!W?'[[G(\>.S!8\]>W_NO
MW>+2==5# "C:I]V@],*G_3('1K<"H*=!X,$;/F.L7#\-NR>\\!P7;WSR5[[U
MVY]\(@[>^*2)"J!0;<-+?)B;4)U%S9]3GPR>_(QG7OV&\>&85WG8N4^,>5:T
M#\/*)^RQ=^L8GJ;N$)RQ!>F);-N$3Z-/(4SX(04]@V-/0
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MIYRI#77>;7AJUU(4#> RU>K,90@8'ED*D-L%I3=+I//9C+*$:[%8@ CV*7Q+.\VU#Z;G/6]YMS
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M2^7F7>N9Z& C"A04P3JT*CPZ0*L(.>TNMGN(V?P8KRK/=
MJ8*^V^N*>&'/SGAV=M,]8.D=KGOAH*Q5<;LWN-@?=C-'*_3YXJKZ9,8VSF\W
MB*2*(;<[CX&>7L_W7>829\_$01KL=82H3_-U.E?W@.!*FB^M8=""U(R)P]*UZP:CX%Z#_[MNG\/N*(SSC0S-';RJO<+!XO2^I16KEO4
MQ[RNL:EKZM4 N(NBT7<:L;M3,9J@2'U=XWO+7D[&=@5MQY:_C6&3DT72+0:K
M4Z=V;U;8ML)11C]O'.6X3.5&%"%+"[0.:)@"$0*(-B\A=X;H-5/(@,0((VMN
MX[LS[=ZFWJ1Q\''8#+,):(>5X "-58<710(C(.E0TGU]-LNB#[([CW
MDY+02UAKKZ!YU#T.=N8:R6DE8'<.="22+C*XG>WCG=;(='B>^2)-#KDE%.D]
MX/+954 !U$%5D_LVU>-+B>[98UOM95F!-I,LME=SJO-,IF5H'X[7.D7R9 ZJ
M0];#<0'M>NTTF@S#R?,]8#[J*VB6]C"*I VSB UO,YDL:QGY]I
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M83F[TS'75BD>L'W?UP]PLJ.5
M>QK]2TN=F2UW(CN$*S2PUL1[C&36T2;1$[2C.G.<8&[KCCZ8,T
MQ02TLD454G$0T/E<);KL+&"3"NRFT\%P_7E0SB,L73ID2A344;F-V#'Q3;'5
M5*7[^3 ##0F45M:[0&M?R7%61"*-RECP;6^G.24-O1S1!OAP1NG074J;3.4$+:(EJ4CI6 <
M+ULT"X70%9@05V^8#ZZ&'?@CS^FRDA]UI6+(>T!M$N(T'I"#YPD'79X8>1UJ
M9RQF]'F33&',3^LDDSMM'8L7"YY//KIQB555E1VVRFH&VMB66%<5V>?0S6+C
M!G$DB4LZ7$0?9M35#IKM9F6*,PKFYV$@%.[$9HY4-Y;*G*S4):Z4O#56,[1*
MAERJM%0DM 23T2T]MO> ZYGW.W1<.0/1?LCI.A"/?D.?L493"W8G(,3@FJO,/3ANP/'W@-@,M^K8<3!'(975GI N
MMY++=:3\X;#,DPW"75+8^Z"4ZS;U;E_K+("#)C1Q&$*V*3FP1VG/EHZ&()LK
MP[)ER6[V>]HURC!UM1UHYG :U$G>K/)N.^)^ DD@RC#W@"URQ9WF922F"[F=NG7C,I54R67K0I).&!0C
MV&?_'C!5XDU[* "*@_H;+QYG!FN%\K$,=?=6I3SRRSNSJ&6G\^E
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MM[''E7TH5)QH%9.'R9QO,!BO<4'=6^=]V5]7(,(O@Q!CRC%RQ2\UMHUG"^I+GR-7..(B!$$[>02]>=LM;+CX*Y=A:)
M\_4P[@[YL).&->Y(.A:::LU+AGMW/8H$:!4Y/Y'H+;QM03!F$9*D6,]UO3-X
M63<'I0HI43.R X+R_%%GZ0O"+Q_\NP_'$-L$"(F44.%CEPUI#DZ9N2%SL>(;
M^R*37DK#W+(G;;
M-C45G,4Y!T$S)C1(716WN8SL(;->BQ=20PD04 =Q*#03,:&D%RU(]0FT,CD[
MKE80QZ+KSNV['34VHVX9SVVM.'8#]
MS06B (^5-#H6^)EB45G3W20'>A*HMM/
M+:BU)<^:EDUHG>[,PIER&7R0@U1)]?=#B=%+4P G>4@'I7.&@.L;7B]Z;^O@
MH;,NR^W%%>/JF%60*/;K61K)PN&4W5D95B?T2N3=A5$VFQOA#!/7J7>G$ENT
MYD(U/!W*([)3>XK93N5!%RCU")Y6*ULO"8[%"W[3FK$?9R\[]^X!CP,_KU2Q
M6V6 P90''85R["4F.[5L'CH02;';>K,(]1SG36T_MQWH7D
M)2NN"H<7XUQU22/E\RS1;HGV-WZH0^YZ=7)(;&!#;9*6X:]'LL5"O5RO+9 N
MV3/*01"/[X@\U *&J%QN7X6Y%Z?M^)2S <\OQE[9'\
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M,5F,I"*EJYP ^>[9=9QT* ZS40&9-9$!!D71_N UZFG').K4M:E+WA9UN\,
M,RMS[2N3NI.OD[/94UV%ZA *
M8"DI5+O="7HPY+>9(G%YD4G8/EP!1XL8\8,V@!9'.C#X/7B?6\@_B0QW: @)D#ZF, OUN-K6,JD&3? G!]
MMW.JX"@A;13BVBF2(W\EBP)Q=>B?H4Z>XP+OL4I*7I,SSH8GDP!1/#P6'!H
M*_BM*\WVNET%4VN)@G=+-WCM=
M4CH$1&R_TE99Z.B 0-\ ^=B=!Z.-=#YL";^,UTM0Q2T.9*$KMMD6]!7U8D0
M6X>P>\R1 $I 3_.\<%*2V?D)2SN#?AP/*UQ;.S?%)K,SPY%X %_8-EGTL -J!=Z3B2%F:N%<(940K),+]/ASS7!5]ZX8Y0UNM$B@G(VFQ6H9*?(
MD EAVFP\_U04Z_,&#A^MSA&HJFD*/5W9BE$'"!OV\1%<-:1_[:NXKE3M9G-5NODA=#$9#(^;(Z_0L -+
M\*6G:/P@:G!0781<[^7;$L&E\='S\2 ,10T2U"F"$YDICETR!PX.JZ7FG1@\ %9*R;@$LF]:\#>G!#C
M<%MIQZ%FWC0+77(C<6>0G&W%N5T;"Y]$MV?/6[?70*LJ+;/]@^&:.FHROKNI
M$M9$7OE->0.):ILRCZ)$;B !MTJ 0!
MG/#V!M56UJ& ^9NHSFPK?"+8#QUXAH.K'K5$#@
M94]%=6F) 9,^V=8M>W9N 3AW\ \731QKE#D=E8./#>JXF:@]6:#3/""3N K)
M9K,85Z[$>M;8\D>6,_7@Y%U94P(+?[4*.#CTKAHB\N #LCIMG0/
M6>3:@B"4!U 9EX<5'+@1D>_FG$"@)<(,PP'XGD .BYI95T!=*N17
MAS50*L/BP2/@P$ (D',78'V&%=Q8U5+OD,5=T\B F".B1.J!H.8-<@"XZN9&
MH9S'+HO5RJ9H"8^=I3M;HE\LAZ=TPTH[+Y&# 00J.93CUCJ6.;HD
M8(!?6B("5L2U-!:R;*> IC,172(2W,8]^^-$,3>AL+0O;"5/ '3L=+*BC!M%
MJ9X3&+V06R ;5XZ5#K/D&7OW8,=#DL/!%8EKW8IR9$)=MSM4^WFA
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M?U0,KJ"TQ[%UTGDFZR^Q;[YE2Q*VS[8]]*9NP @
MXE?ME9*\<>GU0O;.J[Y6;X&/E[@%WM5. !O'Y,@;<,)BC%V1>#.JC>/E*$WE21P!S@I=N
MEH& 22V^0@]CP#<#/J^E2)I4@%@XG;3DL8":36<-PU>K%)>T"+$70Y[>&?(K
M=7L6L$<3@#K!B;](< G#AXX'@H7@5:0!A'LR"!0CCE=%UL_QTAMU"P9@F.Q
M111WNTYDTI0WJ9\ MY5VB1GF*UF/4G4D"W6_DTQ @FMSE:W4SAL<9,L='&TA
M2P.+[5D(@+5VDW<@0?/"N#H57K(O5.+!B%.)[<:;&?Q]2%@N'F
MI!@?2:YS[L9\@$H+Q6GSG J7>$PETM#G]Z)##'V?6P;"<&L^AJE5HVW&21]V
M1\H@] H_H[D=!.EXN&0WQ;9FW^,KUMG8<"1"6>A>T)"X*HC1'7=#)_3'AF,@
M QU%&62Q&CJ&ZSE48VXLB?B@4_EN$/9DO CQ.$3'1\] M,,G"YIDT"V[0
M4*B9R--P:'!]CH%I"=B*,%J,KK4W<;8=/+#M!P')5A"T#\1>E"_Q4)0;:J9N
MBVG&T)[)LP9OIA:USZ#67T\F*^[P:E\#J(,I=90[8I 5F=+K?DJVW8GO=M1^
MQ=(ND-I?!EJ,Z+)6X3943
MNE^,/)-C!78\1,*@8;G)PB?+7R@TBVZ42$ *FBBC$Y+%!MSS^V:Z'F!O!6ZR
MN%K?C,-B,J/5M+"&H3TMS/^DE'TY8:I_RBY'D,06+!E>1DEX81O",?>QH4X"&>93AP)S,35AI(X+DE0DBFG$#]+!T*S5"23 5$/!K
M:,7#!TN@=;)2XN.EMX2KNUNDS.%#LY@N'I3,Z)@.6:[N9->WC4N7)13@,P(-
MYK=XN4'D3FBJ%*,I.5HXU8/#^5J(>?T!:4(>*4&F@3UC&+;"&KF]=4?
MU/"RVF>IA=,1RHE*H=B!0M_T4!Q23.//12)AE@;DS7H43KTC@[>^K.O&WL1+7/WEJN(%..&TTCAF$*"3#TO/[HNC?2KFGDGJ,U[")4>M\%
MX[:)/'LEP0HB>4=2:1;/B4QX'AY4-?=.UT@Y%(726(LY:*!(#?CST22["DS%
MCCK?R!)S-L_DI"&$#_9;)\MW"=+#T]@P\@DE\&7<),RH4PG-W#W'._,X-J?1
M09+ ..#5JF+GP)WLT]'$ZXZ[O3B1"N=V,S1;JY5^OMOA)Y
MQL;=I&+PHRNSIY():#@2Z!TOA5AD7E,_OX9XE(ZT2*]N#PK-RZBQH!^/$Y'Z
M>_. K^3%@M2BZTU3D%474Y#RF9A$%C*U&4 O:=)62!+I_+G&QI,L.W2_W>0D
MV*Y7AYMQB$JLT-?H@74WD2FEZ$&;DM(]50:T,!+ZJ,CG>.^>DY,_1Q:/9(A^
MDL/#$A8*\![P5W9W<.&N5[;RSO-P?H>E\^J(CL+
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ML?LX8KN\QDAU>I%FR%.],85]@OG3*R8TW4OVY:K8R'C
M)%D%!78#9 \;WNN5)A#9(DYZ(@?Q&49:ZVJX742JIAM6T?=*0XJ+(850$\$[&9>
MZ/)N@%^:(+-(6$T]:;OX5>6@G[8W!JLL7%Y9^\)E?07#0S+M-)HG)HN3%\\"
ME'TUS3(6A8HE9+VK\0RD]J14,8CN;$^JT"NV,BG9=,104'K$L6M]6H)Q&"0J
M;%+EL1]7V5G+K@7KQZ:Q,5O<'+MRWCO741YK5SQLZ[+TD"V(3%RJS?K1;&>+
M8%(DA6_L:]RZJ^02-"X;#T?YJ)959T6LQNTT2]Q-,FV)7,2>JM!=J$-N6C/M
M,4AO9,R5==3C
M^4S*2BXC)2--9+G3SUD"PI"J:(:UT&Z!7I\O?K%.>Z(L68"]V<,7O2;DTDYX]WJ;?"647NQ:0\?K)?3O>="KMZ=UW%A+)&A MP#\
M1#(;9K=+TNZX;\I% _VBAK/$@XGNZ*_+=.$BHBQP!4M,9XJ=[YXCU=MBD8 7
MV_.,19ZF%?XTR6.+LL^NM)=QKS&JC.Z6AH/4D:KC,W.E,,K9\*VAXO,&/8.(
M'(B1+LI^LZVVQYI.\1Y1# 9>P08JG,\\3W/I[:'_QE&!J4$Q4)J/(!A-MI5T;>!.*@8R>(M0"7;1O9J6Y-!DZ(/I%J-6&H4)%]JFC
MMW@$'4V6*<"F.>=']/E"I:.S* %*TP.+I*>;VA =0@+^[)Z]U@KVAKMW0;N;
MTUHS!MP??:80MEK0\Q5Y\AVNQYTDUU'M(,T4Z)FB3?2J&::3SZ<3B]_49EZ'
M90S5!5]!90#01U'9ZB6T+Z$=IU[TT$4FL&O8%
MS3-W38!FD)*+?+-NXTS:!)/)TI
M20F9*OA<;[JITFBUM&12/U\ \()R^JI';E2DPN)I)$ZT#.-A*ADHG6G)N 8K
M<)3SW:&HIZ/(!W P.C(S+<$6,5"YRK:UOBT7'FP&I4;)+>MSVDYZQRO'\EV6TOYPK!QK3,6AK;EB@Z-K'S8THR$
M"+MHC#Q1&1WH%E: 2-6*Q+'24).883AWZ8V'99YFUE=X U$(36PY(Y3]J33B
M*Y=FAYVH=KZA6=.,0FT0]FBCGI"T0\L2NC$'PUDF4)F+E+NTR#80G13VQ_,@
M$(UUR-VIS3M\PKN27S381%I'VXVNJNA*P69G^+!YGISV-X[M+"[[66'5DX#4
MIWF.I;ATJEB%25ET3?\*JU4":G<(QM2@K;/G(T0.H/_#)8CR+)%QG
ML;#S!8X_[OCCR M7*ZRWF5"#<"[0CAOPE9:(13[CPCA;R5 @1B2E4F&4_-;$
M;V-XX1* VD6T1P!J>MA%;;*VI&,7FNZL:Q/-R<,46#6'*BF\A!##E;&O2NY3
MFK\,, _2^D*6.DM,3R;>W1XA+83862@RC+<7UDX">9)C(UQBR?O7P,Q^ZWL;
MFM&7TRZ:,.*RQ.=V/CC-A">Y..T5MEQL<9P6*<+RMXA^6#N)ZVD%HSF^I[G^
M&F\)V$.SWB16@%!,!II!@,$S*#@Y"PO>1=0XL#IYTG+543ID<] B3^#U-3>S
M-_/E\X:]?!'4&8:2-.[*$K5(4]D92PN-G"K-52%<:6>F:ENO1=*Y(EWFFSZI
MT?XXT,=-&PKQ(BERO
M@:;U)S7N+=2/#KO+)/12$MOMCLBB3*O#! /VRP C CW" WL=KWN8;Z=,-M%C
M1MV>IYAV3JN,#1YTQL,)N4'_WJ]$/YY[ CJ79%M;%H$)1.-9,L5*@
MMNFY-;[.YZXZ9%UCR^/F/*?MACMNYD#G8$:L^X1(QQ&^":4S!F9UT!Q1,+6+
MM5IY&06&@/)0#[+.W7.>EUU0PD;/-.JKKRI,J>CK^:!3(WIXA743+R>
M^F-]HW-+W ,Q:PA#%WZ>YSV[<<>[Q^\239IHVCO<-N6V;8WS_;76<+O.S79E
M*;5.M&.O[< LD>R2*KT+:1^SV\LGFU[$>(VJ#Y T!:Y[YHRT<%BX73='SM"C
M#28,S8;$H!5GP&0KUK&X6.VN:EMRE(+(;&+_V!EQ,/S0++4O4/=*S=KE+V-4U58)$AA!TCZWK+%GI\:I2-3$Z!5(V[*"M.JYY
M0B?<>M_9+5O>".GP"5O9L>_+6),NG3&!BF;$DY>T; 26CO_3$'BE=:-50A[
M"AQGA\ $VV149I9H0S!UV^T$8%=F?:4N^[K?\R]\C;\VW0J-04"KH,7_Y$6?
MRQ-@X"Z'+MYH4UHV2X_FD$"+$J897D-%#>22@JL!Y?'F-GND2SQ#Z5\I4[':G$); YZ"Z%T*D"+>SS
M>P[9Z&'"[/D3%+6 MS^N]ZIE10+4U/L[#?!$LJU
MJ6/SK:S):V,)Q.</(" 3528[@Y:S:2H=MY1EM56KE%64HLAKJD^6H)PU#TG22J ;3P=P3-Y8I2)U>V%M5 +
MGU3:V^O349>H)<;/?.7#)6?#N&KMYNK 3W$@$RJG:CN?]*NP@S%U5.FZ@>F,AT^$R]AAB^SNO[T"Q+G)\@JH [HH(N^PW
M?G>+I%8YI,H,MOB]2T1FJ8.6BK@KB_RR ]5\:IOZ(%\RVS N_98&V9/9)>&Q
MI.?-H=[U%X0(BUT32=ZTA5GQUL+YF&?T$AJGPEG:NFA[NPRTQ)IY:&_0J8T6
MO@#JZ>XJ8O-Q(NQSA)1I ]:=,B"S[H9"+^A8HLG%;1W[',FF5R':CB%K=?,JB
M1+0K&RN$H"=5%1"W&;C%W3I;1,S?W1KK,]
MA+)Q9#FDTE6#?.EO?TX2KE65,E@3[?<&?8K)8UNN>.0P7#J= \Z-X?6CRP"]
MS:*V=V3&-I(-6.9I-AU.LJ0N6F-L*-R&:V=R;\LL#0F0QJG6X.M^"&7$*F%,
M&M?72Z*E:&TZ4T76B]W*\R@;>6^61ZUS YO+
MT-AM;=C*&NN:)U4+35@@1H-
M7A2);HDR3CG,E-:^A7-,!;UK>$X:7@"I:N><;EU>-^/B 46WV-94#O .M\_7
MB)*D(2&D=*W2M'-R:,X;BVXB ^ Z=L:J7KTH6!78MWVK/CII=;>.B*#*W]Z[\[N[9TS9=[ZKN9?XP
M+#S>^&$H320!:2N7[[$6-YH)'AR-VQ\;GI!X,L-2/Y2TR,W=1JK0W&'W,%;H
MKKO$QYM@,"7^E%N+X[=P6L,OM[4O3O+DYL!>.;;>@!O)#C;Y."J"?=[#YE&B
M=Q2YFZ>Q_1#_>.UY)P!PGMO%X;9%PTMVIO@0=C9Y^:TO/IS[FPC"!]ZH),]?
M=I.3ME/"Z .7;.]VW ">W7!CR?ZZEP?:#=V' K0;PJ)[W8MW3A&$AVS1=F[A
MARS]S'+CZ<6!/$1P$MZ0X ;_V>Q(F0?RVO<<+B[X$EB[]
M_FY_G$>PP8< ^[RB+X$]-?$Y+MSL>7GZ?L%&:1A@-!)+2F")0$
M:01"06)+/(O],N5?4H<2%D%\IP?;S&W;9ZJF+*.'51 ]B_&B])=V/6SB(0SV
M39E_D/NHO.%>+Q[&+Q4%B!(@!.%K$']_8_:2HB^''+Q4&A\LX[ID]B> TA6]1@L2WSV*_/[5X ?[U$A;/;5BT
MOMOO" 0?(N"S&Q8]+]?[!VG+J+NZ34B=%R%^,#L7O5RQ]P_O7]SB' ;/ ,\6
M?/;&!^U_#:GA#V'\X?HC4GN1U/RR&,*F^Q DM]3CYF$7
M-NTST9T-=ZLJBWWWKA10E6UWXPE/=.4+4H8B>.2$X^<&\-DZGP?Y_R6%!:'?
MWD?\#A7V?E\T$'T(0Q]1V ^WU.#_ZE);KS\BM8^8F0^;PGX05/2_1&$A\&FF?\_D-KM[@L#BF>CDQ<%(!^VE8KGV8B77RQX7H;;
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M^[L/'OOHQY]+>O#@58]_],>\\K&/>L7'OOKW/7CP,7?SQ5[SF5:]XY<=\
MW(/E\T>_XF->^=I7??PG?.P?>_(3H=__:OAU[_@# _4I/X)]DOFE?]#Z;TEY
M@_SHW_^QZSO=M^!_X5W>^DO^N/$WQ_K/;GT-_=2W$E^FJ#_^R3^L_XG#7_P>
M=FGA8X\OXKZS_[Y"=\,?R-[2>^ZJ]O
M%*]YW5O6O_\/X&__P?_AK_Z-'T*^2>OTK>I_P:?\N6]&L4_ZU>_\1V_[X__X
M2_I__
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M_;[/^IYW?.OWE+\6O^JA_[&T_EQ_"'_O2?_[/WO))W_+??]/7QXBY_JFO
M^+%/^3ONB'
MO^AQ[!O8=[[IB[[_RW_C8XO/59*/^M\?_@?S%W_CKW_-
M>_[T7PS8KWG-O_WBO_Q5WKO^P>Z=WR=_=?(+/_M'BS_U[SX;__;#9_^/;_F6
M^:EW?__7_)X_?_A'I[>_Z8O^)/:;XOK/O^D/^]__ ^_ZZ?_C-W_':O2[_?BH
MK_NM][SQJ[[Q)__03_SIM_Z-M]6W?-GFA]_]C[_A^Y337_AG;P9^\V__@R+Y\I_\P6\XOO?!%_WC
MSWOJ:>5;3\7I5Y]Y\N]^ZM?\!GWZ#Y_?_?2/_L=_\S?\[_VM+_S.N]1ONTM=
MO>=')Q3_]>]B?Z^6+.;EP6N"S^%_??CA^1>F?_%'_>B7_]KTU>_^T9_]N__B
M6(L_\*Y_]/J?/1A_R(=^@_BLK_M[;_Y&_7.^_C??^M5T^-W:W_PC""G\7/1S
MW_JW?^'_9>:]PYKL"?2Y#C@>;VUX5"\DX2,:UF@X,%[00Q*J9
M0>!J#H%4\[$%1<<'"G'UIQ8*'NRZG.*-3J@YA_G*%,]G0/$7X8!;0=Q7H$T"
M6_W32PVO@IZ[,7E82Z;A,HHC]JL1/KQQB.G5AE>J[:"6--,HF"7XN+;<4NP1
MWZ#P[_]B$?]9^#FB 3,VO'_YMT-60@48*L$^L,-Z'Q.:;90B-)R*[5@^[7":
MZ[F7P?H$X>#_>/L&&@$>'O(X;5"9R\8'@KW;&PM407=M2OXXR=8F9&^*4F7G
MLK%QTO6_S1C=^_IQ[LSA&O>#+[__&$;7L7*S)NU5S<$Y-1 0D=Y;=_
ML:K_UV"4GU3YPO5DY.:"X>()GCUPDS>?6T>.UL7K+D%$D9;.Z?.R3!
MV#YA/L!&AR>+E!SC_5G2M1QBL7;OXI)VG+\55FT.9)G?Q'3JMB);2$)M#\]JP,]O"_X<];<^&^_>_E_""L%_%'F+>9:1C
M738W-Y#RZO7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M[;;>QG4RYDV1#\L#B%,XP=E=+%OZ*/N!7=8F7*NF'.O2*-I5&EHPM>(6FCO=]*34LT&#^(RH.SK)+7$
M3LOEX88GPU0\>SML:^VTL/7-QCR_7'#BD?*HAU'NUP" ]P1GV1V;_554?UHR
MVW5[8Y420K*;C*5JCAJ<\^5+5/B8*"U->)4]!"4:%YR-E!I+S&DBCGA0\7W1^JNLPV(F LT5F^*"*17%!LN.-ECB(X-G!$*XCD$+<,[KUHE8F-_
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M8.ERL05QL4\MI";#A"]O.F;KXD+PE[#,/"=B3#3Z[@9@?7VA$R>1LHE!+1ISLQR>JVHV/%;0WXA<(NR1$/$VSG8I 04X_!,_DOK470YWR/O1
MH^G9EHDH\S()^D[-VU&7!SZ')]F^03IYTY9? '$GW"X*-O>'*)'2BJTQW6F1
M#@&ZV[K'0:4WEO"U6V:2[ Q['JP.QQFY1/46'F8>"';1V.L^I6$
MWT52?C,HQ'L/WUR$OZQ&O6OYX4$ZYY6_3^_/,G5/-CS(C1UFYO:C#Y,+<#J8
M&" F?G:;EY1+3%D6(/B(LS]8P0XOB#D93/ERC@YEN)ZF^PQ40$I[%M/_J(5I
MB8_"9=CA;CA45(;_!E'@Q#+R'69IHN10+P'CA0 EVI>5*.OJEBW6I-J=+$.'
MQ [P;/1RVSE=U5T!L74,''[1L2B)J%B&-,(6[GTJG;+IEC%Y'H>)D.-HZVE)
M*_M65Q'4'ET7^4U[RY%AB2=!>3ZW
MTT0B+#H\DBST(JK9=;!3N3(7[^FI-5P@>Y"+?/6*O>=K.#"WM>D-*6"V;_9U
MI)I>A'V50Q[9PSW/;#'^X6DSE9=2QRGE.3OMRC'=['ZF7))#\O_@U0FLJJ$4CE0%C2*DZCX]H[
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M]#MT9'2ITH>&X?V[&R+""D2/B8GN,"'UP>-[MGHX,>EOTCT;,?RW-5!N!%#'LQLFT$VSZR]":Q$38,T*%-US5ZDU6LMRE'88B
M;0F5TZ9\+=/LT_A,!/"B@>(01A'/=!==VCM#J:Y9AH[A8/ 8@P
M?7!8^A5Y8MJ*BD1L]5 /';V_/#:_*KM?S&Q]P!"/YDW\7\ +BCX];E N'PRMZ' )Y*NZX=6"P?E]UX-/YLI.$*(Y(-^/9V)
M+$GH&RUU]S#'%/[5)]A<\WX(FY;XC_6O
M; \^>9^Q)I
M_Z:ON<=PQ239L2UIP2GEY"A! 4.O?VPB+[:V86JO?P_2QUB?5\QME'3NGTN(
MF_"*L7P0!U6&+<.-%OHQ7*.'FXL:):$YMJN
M]3B^]T-EH$)Q'=77-4VIQ-%>*ZE[ZM7"2LF$J?PIRWQMFW=YPWNMLX.-7FMH
M2>D2Z-6V@IV\940&')*?)]%BB S$!#&^N8#@O?.G5GU[:UYF^[N5DW5VZJFU
M'LQ5+V[Y8 (=DG9=_2.T9,S5?'12D,/MW,2GN8^TOEFBV=$J5Y^PVV&>6Q ^
MPNY"-0"YN7"-93>\W+#T&?V^\ Y2KZ);UH'@!ML$66D":%5E!5.;GGDC#AD!
M-U?_TM+[@32P]Y]5=?]0F&3/\!L.N- N*-#.QM)6"[B7U70.#
M N=IS$HZ?)I2.SL+X4K/]12I T/CP&%J +?1WO[V"9?J42:[_[Z7JO9O^7H>
M>V##8?*&-X)VHG+A;K3PFXH_K__S*;'=D*T4N[I./Y=>?^^FT1PR1.Y^GG#H
M3R1!BH%!CO(:1_W[KJ@$DJN@1LK2WAK38L R(032WR",5?D=#'/1[O02V5)N
M)Y+3?&]#Y@WK&8:._LNQB?!NA89I!3H),HK?O#K"S5@R5 [4S98B&>V\S);X
M!7X%7JW/UA8.7-YXP%E/T]O;Y#VQR0K:%[0Y?=^TG!54I724F_Z2$_D,1
MLN4+Y565'?+6F,\-72>D!-U/8WCP[(I!_#17:H*S JL>_Q6#*75K=4/KV"D!
M2M)J;]?[CO3=2'4")MM\=#UO.1Q>.'Q*[1;X3AR-)R+*ZV7X\8IYNV&8G1>(9U?UP7:=,Q!!681F-R1N4-UI07'SFE:? AT]9U.(SZ8$L!O$YM3P2?]S T/,5$&Y6\B6P
M\>Y=OO]?%>^GJ^=[D\*MLL/C*JN9[_9(Q)BE (>74P[QQ DNP/QB'I(>2N8KS0V*.]!8/7XH-*?SEWI^>E\=[Y2K81:B^9<=
M@MT>:U26SK=W>[O!TU3[IO)K3GGEVWT%*%\BVJ],JG_Y,2YC)8TUO&I=U1Z;
M=Z5-INMCF,]-L7X[;]'YYI;*.AG\
M&\>S\=;AYN__G-+[!V-VYVX@6B23T '0[$*;G3\S54S+N"X:]O"N_Y-M3A+IL"&)P[&MU%:3!@,2E;EG @KV5@HR_U
M+/5!**FKDUU3R]G<^Q;0[@V_$'[$.=YX^MQF>0.SV],:5?X&X1%%9H.5STWE
M"R,,\[5K$>B?'VP-B'LP%LLU-4SVOUFFP>8^I*D[$!JM-/5$U)\*&JK+_R.-RZDE,NN-"8
M-]_IDE!;N/_*55'_V6X0W= Z.9*^W&Q_XL&[!P<;$<:]JQ9V Q^AJ7
M[,B6?=_7*&.;W .^.KL5Y-RD>M59/9'79L1?UN$Y6N'2LN?R#5N9>'.U[;A?
M;N5I#@J5B(>:H^-#AX6$/%L,_/7%M:#(%Y.OU4]?O_,:F_Q.)PQ9G%E75UE2'Z.OI7C1-*2^/S7IF:D)_:(QQTTP":
ME%A6/K.-0I@\EO_*4^T?[OYV?-?OZ0-^@^+$Z=:;JTN2AI!+-\O:_<".CY;K6$G
MW:?I;=L7E,T?%)#T65+0#K.8' ?-=T@>BQKKQ=UP2IVH5;73S;?NA^2;V:<,
M@3WY[GE'9YW@>WB]-!B5]AIJ^3*59V6+JHO\\O%=H+%UZMUE^"]-FLWQZJ1&=7#=MJKP\
M#/Y2:I[?O'G>4[PMTUL_.H,D; 6FZ5UT:%>Y[G%@91->I^QU6-0'*2U^XR?R
MWFC!>WX-)IVZ>^%W#W89Q^1,5>_)>4TD46OL1IG.R%/AY1LSPD^Y+(#8);^@
M?J4>+UM;^&1(KU(_]:0/ ZDR941S8>%V.DNZY;-EP-Z#/@4TRX[+G
M$"TU\/AEN38Z2.^9%M(EN**?+>4UANUV=M]7R'%O]DW2?;P]T$__ >"CWONY
M^(E";'Z([.YU65RZ?9F=>F)/+7KS/$U85[*NNG6AG:-&9(/X_BT4>
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M@.7'.W3IU\\9J/5H=_?%5<,/8M)G!3E3-O#7OXM-Z(U]K_;@8K^B+7&CLA_?_!MO /P.5=G\0<
MZ74?1MF3ZSB"3E+GAL3/-9=&T(NY" AL;SYA@. UV <:0\&"A/
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M#'>2Z=LO4QD7"G+F_W"!GN4Y4Z[>M/Y.9UQ;S" T'$:=\O=]9%@
ME8;9C)RBHFP%GG&J6^QDCBK!*ZDNAC8Q;6_#D+B1Q$UKIU8Q9!94O;GI]=;;
M]XEOGS;RJ*Y:.[@P:LS'(P)CP3LA207\I^)2@83&?8WG8H9]RFN%4X@8T\&2
MQI?5MR\TO5N#'R_1^O33()<.>3<3+ZM(=_GU\';-5\T9G9FX<9=+_J&,=*>"
MP.+63Q,<6F')1RGSP)ACPZ]:X>(7<6Q)F,Y+$W,VO 4"2KZ$>
M(;&6VW[+F2'"=:#.4V@[>I0S_$@E9Z%!$AG0F\X=?9+^J@%3^4>)IXX1EP[=6"U?J_&$:)GW_O?GD$1(>/2Z"IU&X\TI;/R^R*4A<\33!3C"?
MQOQ*1Z>34:UG7[IM56P[MG;"EO/JA(T*8Q"MR7Z,3R*^K3_^H51SG(
M]T-9_/QJ8 ,C-;LLP)>NKO-+&K\JI$"J&QJ)?GC1>[4]TJ%2K*N:(VL'1_Z1
M44Q&X4RB4[Z@L0H*QPM6Q(Q!;-^$=CTV><=Q0(N*TNRP"
M,\$$;%%K"^5F^"9"5M.MG:G6\PWH8+"-_R*T>]BEX82@#FPD\TU$"2D7^"KK
MR-P$C7IZ.4$[03"9Z8#4KGXVF^_.?=IC#L5Z&BX8Y&&;G8G\>(
MAR;Z^&B(LR!;\QM+@"G5&\L?P/?@YI5'CZ*B-@C\IO.'54K#N_U/=:LJ'3O82VQ+TA#0CIS.?U/7([W2\N9^V1<,DJJ'8W.NJU[F+$ISV
MS):R](6-:MKW4H#,*5,6!FH.=L\="Y8MAMU/CJ._TZTX6Z1USF6R"4NP:4JP
M=!H.5.?2R/NBL2N2Z_T+=9/O0"G6XO'6_*P'_9][\+J=/0/RA>):1,Y_H9#Z!-C+\15!:I_T%%>8M>EZ=3F:2(<$ X
M3B+"AU8WBO+:JTJJRC^L _?''MG C(0^YU;@9B+%^1*1\[ '0 M6)   X-J8
M(C@LN%B@HL=)\C4KP[J%>;5Y&;?(O W%>%&KZ#6 :P.]D 9P,"_-4 >NHR)4
MIEWW7/.P]>S#FG7-I*P39#_=PW;//(O]J<7S-4\IL57+9+ ](Z[7LRSU/>;2
MY',A<"'XN5).6\_$Y *>E=HQLCE, T1&#Z0&TU";5D:K0(3!BU1.09O$18H\
ML70R0/@EG*"W^P$&<%]?S;?00B(U1JZE=G_Z3WD39MS\7,SOA7*,W[J7J\Y:
MJR,77N]X"/YR9Y6Z*ZC].2%@DQ!TZ>CY7;?=;^QM6S)< V10>E/DH&/^X&;F
M=[KB8O3F2%@Z['%3N;GU[IQ?G;+2N00Q[+RL#*3LP>L,J;:@H_L)I\R"<+-J
M7XLHCA[ZX&?)!AU05]$Z9K,_-GEGWU+[9HWUL""H-D9OMI-7:(()X@6>WFRP
MT0QKMH&LFS1>LJQ(:Z^O(<,:;+3"Q%=/;$BE_@PX^B3=&_^:,O]'XA>MAK;D
MJJ!G8UY<8A X6?OU(PV5$G;W5IS&B@>0&O])U/^
M:H^+D'F_C(I<-HF%D1;_CN@)YVAU\Z/SN:9FPTCTCI-![[.JOYY86,1.Z&,N
M$1/BQ5TRAE],FP>/JFAHH,IUNIV5"Z[
MK)=-G;01 IA\X^6,?&/UPZ0R'YM-G; 1>H'.Q#&V_*>I_V2]Y=M?2R&A0SQ=
M.$L1QB#%@LE=.W$13?TQ3L-%K=8J^D*H,"!2LD=P+?U#TRW-*>^-#C;U3+CJZFY+K,V,GSO,>VNN,?7[1KRR08M$!%SHIKDF$
M<=/]F+$L43T^% NF$[[&SF*7$5<8SO(@F:\O\ 7E7!^Z1B#VD,LUDLS""_#=
MIO8<^IXJ[V5GW%RW9HG^2133:BP!QCD(NQU'6M6O.KM8>EW2Q6VRGPH%>)A'%/F6LBX^S"M8<;
MFE-H?T:M.>ZL]7>Z38OJUS
MP]1UQ;S.S;0AQU&@;!)]6?=F\%%UK+_=G^Q@7B(G]Y.YWR\_CIQG9X+$#<[)
MIZE13M%\-6$ZZEH@4I-B=W_SWO-PEL?VS1Q4#SM0,M( E!*%U+"WX>3DE>.Y
MDU21T(M!ZD>9LE+<@6QW:@GL$[)?MQ^())LZ9-\I$S> A?-LGND-PGUGR!LN
M!1AXN*S9HA")E-^YJ&.VB$=F$$FY@%4DFOL]QF>S^LZ8M3IS'M+.FD]="H<+
MYVKX.$\3CEFL-8%Z3J$0F#T/6?1T3GAG3&N5ER>0&06!1MHYL
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M(3Z#Y3&?G\>AM.9Q8#^E8%\:,/!JHQ@;>+^GP!9\+L_1+FH?:']SYT,(
M^]W@!)F#WFC!.P1^5GO\:<9H55G'P9=4>.7-^2LDW?5ZX>(K^3/F,H?*>2YX
MI<0QQ);&P7PJW'5X'@8PK).XVH'[DA%DE'*2/M1I0;%\I1A)W[D_7=WU2EY\WX_/!8_,0II'_(.T%32A08MJ"
M-?K3OZ9Q_$/Q4V%#&0V7N='_<%3%[^)D:E%:/@/+N#M40T,O1K[:,N-%/K
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M&4Z3]#7J.?#-F
M$EZ@J @%YY-V[&C_5Y?1_S_P2W&^7 O9\5 8<&KEI7K]S !SG&M^VJ-E?_(I
M-[4\,H(/3?JFH7X0:9\))>0/Y2JF6<]F[S),27_.-S[;[_[<+)
MBR3W?W4L_TQ 9ASJ!,N/*XO%/#W]=V,S\Z]6LW?,R@^)[9PF/I-X_'-$]>C.
M,^LWKV!='[(,>#J@,/:'0_$2GZ8PD;\X@Y$CU6D&LUC D<[
MWIO+4\3 D:'\(B?&F@SM^XTRI!K:G5-&?+>DSO;"ZJL)IB-/B:J#X0&1OI+*
M>O[E:44J-$PG 1C>_"X;8!\ID"4_4I]EP:F:HAZQ(-*GN8?L<=#)$X6);=?*
M<4T$".^5SLJU].'F+]2ER?<=]35.ZKORJ"S.4%!NT^BAK>XQAL ^#+1CTBK"
M:%YN7O9H+![$*'/GCQ!,Z5C9V8%(R<$HJ7.7\V[K+S$X2D:IU&-VW%'/URM'
M\!1C(/Q;4FH5,!FW=U$Z]B721?KX"L7$'B\W]H6"MMV4T#RXNNPPCPBV&BP%
MW7.+EM\U %V;N+RUT) &.AK1G=4$X[06F'YN?W;"-F'S9%TY>Y(K>,ETEY*5](;KA#UC2B=($3T3FC
M#DVO?@IQL^%@L5JMOR>0@OS2NZY?=94I]
M#^2\#EP+5^]++@#W\R;,FKCOFM3'JR_,#8&2!@>?2TYZ?*>K5=7QM#O:]^XX:;M3
MAE\,W2\6:Y%7\_AE+57F5T$&VAS,-B?BKM3PK6$+KPX W\
M"AR;VS&E:1*2J98C=I7'P"2$KT]8$^D?A_[494_+*R*PIX"+RIZO,/WZ_Z5U
M&V>3W^IYW9=J3VXRR7:^ACGUX0?*ME$QA&+*X;&R5W,;&OBMI@89:I0%O0!\
MRO+CSH?CZ5B&H,787E]3B-@SH]K2<1";G14EB
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MR6./G_T\E60LVSJ6+!9H_GX&D _9*$YLI.\8G16X-5Z>69B EDS +-\)Y$A.MWE14LR?VXD2
M:3LR'>:J'[?[3A=^UJCT50Q0_=75P =?:JZ'!LU?/59,*71$%]".Z)76#IP+
M$8>H*)&55:?\_?;=^GORKR;,3.PC[+>35+CC(A=DV'^YEA&7'695F"R&&^B*
M:A2P8;D[[_C*H;V':;^XTJHBU:X).=$O'LCD#OKJ8M%PNZ\%GG*NY0AA4Q__
MVZG>5C\,FSI(_D[WACKV(GYYM3'A8W%>,+VP:IX7?_=JT4XJ_J;0P5K;*
M64@#-V5]H409K*\1[DRE-DB[QGZ]DLI1,?(['9T6N=IDL:;E1$+"\+'DHNWC
MV#NUCIOSYF>/S6'LEG(/"[$\^D>XN3>_3728AC,37;+3_6]VC.^$F=6%U4['
M4XYE[0M=UP\3AU/M3XUEYHVGHEL7&K%>#&X-#_![((J!T0]N;ID]B%E71<:J
M"WL'E5/Z#^U__]?XQ>+$<.*4H8BCK-7.(:^./H;H(1_(SWB0C.W9,36'CX_&
MF@_R)O1J0,/F0KJ,EN1W.)K]\HZ5M*>^+%/4H(^/U>S_2
M8.%S:X"F8,E7=C=T']]*,5PO]58MU7_4A[\-MSK,7_^=SM'ES-#9)E29IGL>
M,8,%$VOS#\8P1Z5NM*)WM6/1^V*15?[MH[C<(UOK^*T5G1,33/%;_T5P4P19
M):5 *]K I=#2S\9Q/'&HI3(M["VHHTOR+C%/IH^KQE"?1QMXP0Y:W_,.G:7S
M_IBU-VDS][K&A\E)N!#\*E"S_MJZE1[3=&:PC!O+^JUL_LF,"1T$>%M'>@B,
M/-0;>;0/XK2(N3#:^_BS013:*^DCZJ#TO14>J-K+JZ[_E5V:@TJID*,"R
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ME7)$KIY@FU/8;7;08GI(,\U(NB=NY&+)DC2*GO2A<*'[WVA=V$@$+'^K-V>8.L
M/W,,NGLF%LJ/N2UO9IT+1_@K+O:7SW7$1)-D\I0^[[*<4R%/!SDL:F9'$._$CB,D<NXP8$]< 1(2A4+D6+&\PKRBN]5 ]K 0"N2L1.A4NG"-/"AIWZJ"9CA]98;5JE%. K@#Y,N1+2:VD3DST8 I2"N2K1Z,(SY:=9^4]!Z&9SX?'Q^^+L.B4_DD
MAL*0:9&/5E>_)(R+,QD9
M:<*+5K6"RPU 0PDJ9M^"E0<=+'1+R+2Z1ZL&7Q)6!)\+"_/+CWKP-^>/WMY&
M)NK7]/WMC^9O]1V*=2S;*E.F*Y?&RY=HV.CO[" ;[3&<#]E9;0 M5H_WE7-&)PYWG*:_*GYBI9
M@_F0!11?5R6:6^'>IMA"QN6#:X<]HG[)G&3&UCG*(0JUJ3E"GH!*F%><%G<0
MXAHK4E7$FGP45!9*=0(2A_;1["Q?DG_[)^ZY_PT8/:?:!HQOFIDZFAPGG#L>Y:AQO/L.YVLW,4^1P]J:U33> 7$@:&Z-$A+0BNC>N7=
MB\\<"V/W?XS(>NW@^8S)=>"$E2LQ=>$]+(U6]L
MV9(GBM^B'TWD?)BS?SR7#6\7#/"1*@,A2!1RKMG#DS7C];ELA$@SGIZOSG<&
MPB<7-WE&TA*!VJ \1P+.B@[@^H3;7Z8R^= NEOFL9FHN56I_Q7HG,@!VU^]7
MVNFAR\**440)3SB%YW=*7Z?O].!AIH0$T;/._=_>Z
M(&AT>T],X+P4U3&:9))*S)G4CPC80>E;HSK)^ZD!3=D+$':0\SA^5'.P6R?W
M3OZ,D,QMFA O 2\0U'@@\*0:9TPA^XB=!NOO0-0#U-T@YN3/@ZTRI;='$G0D
MFD,-'$^*S4M'2YU"?3O*,\I6V63$-& ^*1*HDK>)B7^\3<93@R3%L 8Q1
M8ZFPL&] >'Y?W?/I#W8!73J*FQ;C?K5(=VEE#X(C"!KBQ51^-710+06 /PAY
MADJCN1!\JY=M]AJ_TT5>2:")/&@G[9/>5_%8#.D^E^''CTEQ)1"K9'&5#&_]"U]/6W1LE2OE[*:]AZ6F[I,]XB/>TZ?LZOZZ[EG5J;L]8%
MC2Y1$"!@Y<-B>T4XJS_[M9X0V<O%%'
M'SWQFG/>;9[M6B%&6#DWW92DB03S8]B5D^4>E 4)*^%TQ&NR%A(GA[*D>'EO
M!-MT$L++'&RMC C7B@N/\\55POJ\;XC ;:U:R;MP%V$0'NVA:K38^9E\^TNO
MBA*J@XZQ9>62@F.\EU3Y[7UML<-99XOZF"B6>"716OW$J(H^!7]60T>IR,P.>EP89*LE'L3>JC.>\"*ZO[MGXM1C:8I.L":7_(WZIVG5^3'_A9D'A
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M\X.G;/E*Y$FV?= ;R+'SW5W)V6&$2&1"#L4 Z.8*'76#NVP:^&KUG:#M"
MYX;O+Z=%,V$J0* -@(%L \Y?7D-T#9Y2?P;B<>QF>*U!WR]9"=BC^_.5ZS[' M?T-
M72:.&*-;KU@+13PAULK]\_HHJ[@HB,:D(8\LC?#IG]B>_QO(;#SP;='8FHJE
M,"<4GYB^:G#0L',P8;(?6TO1 !L,.1@8E5?T-M$D+V,[$19C=F7?Z31WRLC#
M6_PV5;\&^$PEUF%$9H:5ZJC6&3["9ZC;UT5W?OUQ53[*)/_$QB&$7DW5D#;3
M)GO3I/&*YO#>Q@"9SC01.G;.E7M@MC>?+<^G>4KP3W$:/(WTF7AZ5]4V7
M/_^Q+8P^<_RFLBFV_>II@WC?Y@^3?]"[+,M4S2&;W_^<\XW]+9L/9L;[CDQY
M8?N,[22\RF.6B;'3B,<5$#BHGYK$IEFP\2R;]PS#J#]L#CO.?
M5ZR)ZD:3E?'LO_U=0F[(;&9N'"8XBY "$@9' (B[(2O,29/R_$H>+XAXX8+2
MMC^2YCW6'^A1S/!67+7#LU6:'U;-P6.6%GWG[E[)% 81E9,I7S&\VX-VD;&L
M8B'W(I$/H(459+PIF]J02\'G0(B/#[I@Q@_S%+=I5YL;.&)L+YZ@CJ"'HVB:
M@(BYE53# '7$M/WX)K%U0[YU7?[/MVZ%\.8>6(X_W[H%6L)D:Y*%!-3L[)O?
M'PU'PI$Y<9PI'US_;?A85-=/*XZOHUCDMB%%!P?UT'.F4^\=5X(?MLA1_I%:D2R5O0[&I
MRU0TACE^Z\<6^3_-/)]5R%STC6M[(HPSM1"45V^@YTAW$UAY[:4V(
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M( -D0D=%J*<(N!VIAHI^[USQS^KF_TU,'"O(;@P$L6R7V%C?[A33H.2*WW2[P^<=E30W(.VBEY*MH-
MI_=L#Z,)QZ/]N;JK*B//5*6EM5)DOY)01AW=Z*;@]KMC>P8>,L+4.6:7^B(1O@D*^ZW'[U_-M5\V*T+2%.])"QR%'3I=$=.C: T
M5=J*4'V/=YEZ6N7Y
MIE#%AXS9(YYN2=FLS%NVC^*1:2#L:]8#C98;FI8#N8QQ_J=1UWO3.):P6 G+
M"F(5?*%_@I93GX3,2$L_)FY^;G+A\K";)]F\W3H$%_+/;RXJ
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MVR!GYS*)[RWP<1"W%)LXOY#S^_8Y)TZ77T<=-E?O>!^ZJ"#B><>^
MT[U#FTXHB3V';%"M89NY(=&^N\L*EK&6YQR:-G8+^YTVT@X?O58]8G+(M4J[
MCC0R-/9US5<)[M\H6IH.ZFOPP"/DY.>,I-0 M6PIJ87>WE7:,5-X3F.IW$WN
M]F[#HAL1"4KVNOEK]CIRL!6+QZM#7[?70;F*F3!A'2\%P\+CB:3G)7[W_S:B
MWZS;/>I,#H)M2.0ZC4R2*W)[(+N^#%Z;S"WBJB.4M[$B:M)#B^4=UL\<2WU6
MN2 ;R(2KV>X,JY7=3":XH:@Z]?)O\Q'>YR%RR/S9Y&?:I6I@
MM7&FI]@LM\]/:PU+QYEKP3(W7RQ\L+AGN .QJO1H$#^+BO+]N@J;.G-"QC+M
MBROWQ''OV_#)75(>V\,44UOW;HP>V^[HH+2$;94 0E20@>W2@NA2.@00'H) 4+O[*T@
M0@A($@@D( J$7J0D(=0-TJM J*'WCG0$P>M^SSGO=\[XSC?N_>XY[WOO\U_F
M,\=(,N>:3^9:8V7^#.WGI827%"Q[/H06O]D9^CF+-V;]?15X#?^5[+S@7IIP
M9Y/X%5AL4_VN.+PE+GCGN%T[35HX9$NLB'./2-?
M4 T="]*"_^*Y&@+3BT_-IJ^4\8C72Z75."N$5?Z@U>]FHLU30BY7_N-5\K\(
M3ILIG@S[]#^'KK5:A8L+?6I)PR&*O<<8.?%%Y+!D.@'LGH/WAY05H:HV*0_Q
M_)9ZE=V1Q)9'NA*WI@A@7O_5" WXL^.C"0\9
M]6C%#NJ'N^C3O'H(<@,6711MT8K,7U$8'#RPA) P;/1.\-8'P _*K7#$R/ZG
MI7=F#/ (H^H Q:5;%S6:@HES9J0\0(61SC\X:\U(=6Y>L_U2LF)1I345QG'L\K,MI4'!H/TG_CNS0XJA9L*F=*UA[?E@4WW;8#9S.WPNPQ_[
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M^T8T^XL*UFPI,_Y]GY>.!,>:\81>]FA+CF9;W/P8E> &;PJA"IY-C8-ZL+M>G84W%A]*)ZQ_5B
M.8TA/V1!;VJ"_S=Z;@7KP#>14+-2#AEDL<2SH8/"SM8D5/!9Z^J&>F7#-1M6
ML59=">;.J:EWXXDG=""JL2J]H&&B]UE07#B^SB5#O81?_\48?B&HTQT#2^Z(
MG9NO$2GA;W5LXW340_[BBJ HZG.9ZI>11.3XKZQ2&,E8 7)7-LCA@WI*E_NV$6)X[
M0;3UTDNU5,^NP>)/P$N@=>HV#PVPT
M^>S0N-V"=&2(CCVVU*)T=+5\HFQ7 .@DYZU<098O'=GV$_8?JZ_+EGEDW9A2
MC "0_>#D(6O)\B\UIVS<@30=\H1H8;ZW"47W\IS:.^/&GZH+,B"4O"_"R'K--/ZSSM_R>EZ[\-
M[//.;HPVU9*+=G33BZU[U1) Q6;EEZ14C]_>9FH; W("KGS,Q6<+H#U;_'"U
M0?JX2P[*9V#0H%]<1.9:LOATV6A.H>8T6Z]$J[ATSY!,F(1EVXE0L=VP>GR+
M3#IOJ(U\ WOE-ZWYSK#4X)"W>M#J5"6?R_$D/,84Z32$GJG$+.^Y^ !;*JY+
M/_$Y]XT2FSU$!24M7AIHS[#*Q=D]]KD>4WK6#HUP&!X+![M/(-/]K1W?G/74
ME,&^,_BS"1[J]92&92K"7O8FV#H_(;A3YN3U'TTU=:&.5>4FZ5
MOJ.'!IY ./VBF;Y8L.U(^ORQJ/&Y$4_UG]Q(!5@?+IH66YH,[LL,;NI4#]9F
MC 7>,070&Y($UNH..DNA\-;Q\-?XL'ST,]0\^Q07R"IN3N9N5;W"\T;U@@]M
M!;.&AL-M('S,&R"I6S.:I520X_C#58!.WZ9DF>1.V<[#-B[F"7'[1HADI)$=
MSALD4*?1V=K2VE39R(J$N:C4Q&<29>L>")" *C68E_Y:2GW9U_KC4\@IE
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MJ%*NV[LE]XO4,+(8&N!;4_X\I/KXJ'6*4,\^G^VJ''FQY+J1;_LJPI'#QJ9&3FKBT
MSY?*]5MBJILU\NMI/R1PI1"&W(!.VSJGY[U83=F6,*AS:Y5:%NE0#Q8=+PR+
M082])GXZ$EJ]L)YD(#G*[7H',F
M5SM(F@4ARY=#)C15IVU"4"V\\U4/(AXTVRY9MU)#5G9H<+\1PK]8@T]0O=EU
MV1T%+VSF UC,+[(4^8(+J[,_QL -'9EZ0P5_*_M]_XT/?^FK67@Q2%6U/\6\
MP5F(YCG?*_<09"*%A""M5@MR:@WPHPWVHMW>DKG7DX4*.=3S-UOZ8)*M2--B88?D>^"
M'">I53M>DV$M14"!#$ A3BA[),R(KTXT/5("I>SZ&P.#A.FPXYK!"9STS83T_UE+M3$-R+^'5XEB"]+-*&-\CKT2T65568T:VC) 4H
M>;Y8LBFL\V&F94^[I_&;KOO!&C%ML,7)/GH@!V5M>_)3A8@<7=@#H#^\-O)*
M^NUAPK^_OBP/Q=S/:RZC;Y3^FAQ[PNV4/'B_YMWL WJ4 ?CBJ9@(3" QKY^3
MV['H&!"HE968"&/C63(^&K2;$%1076F1G<[G>ZVGGJ8,2PVZE#=YPT_WR4!$;XL7O(>J#O-Z.8 -S&$]WQ71YF
MW0(8],)NA)B68\YLR>K$U],LPW<>1MEE6#S)H[ZGRE^ Z@?45/#!? $]>%83
M8/VA!FB^O-@)9@$5FA1NT*/MP#A#D$)7&G$&;?&G9!:K@ \]H8IJ:GDDI/!F
M?*(C,8>L^L3R">ZS3IB>J8$^!3WD%PXWB=89M)0J *\HM(Y'AILOTY?45 4*SO%L8X8J\K C,:1IC\Q=Z>\_[?X<@/4T?:C*/'7FDE3
M@_-F9X;7DIR#PAQO9F;6*P8*/I9M#>F?TW"):Z]-+@?H_Z')S\_+W%TNE7L]
M\(LQ-IMFAPOQB GNY%"0/_87Q."\60!ZPJ0B\K,MYV6_;&;*W;^@L0 2?;,>&PU\!Z;9SCWKR6@$\7,X
M7_.#H*#ULIY^G:*,DV)X;N[:Z+J$3IW;N?2I"PAD2AW$
M6.7WE]#^XY^HN:TF)V6!!LYO'4R&:$9&'[/'+"]I%&[((A5K"OX#\R9"&\%Y@JH-#
MK^S&4P $BX^SP['20YG!! >!;?T0Q@CD1-?[?L4YZPZG.^NVW2,BY8FQ]N6T
MP5CM].QLMWJK ZSP9QO^\B2+6=[O#&J9,WTZZ^'>,_;6_C(Z 6A,;BW!Z]4W
M]OZ.W&E ](S+64COF1+K7MMGQ#L=N]5M9V&/6U_L-16$_R)?3(A-2RC;=41N
M6+&]&3<2W^8 S)JS]#!B7=:$NH9LD30'A+-R!SII-;]]U0>MCY<'\B*CEZU]
M/20&V$V(;K5A$XNLN)!BN5EC
MZWW=#&B(;JZ2[IM2L2$%IB[_J^7#ZK%TV2%_J]BN,*&W&OZ
MI(7L^J<3:XQWR6.>B2HH>=HAR[2O'%15+P//U8WA^"GQ]W^6)/^7<9MCVWGD
M%(F?#!B[QJ[7$QUK^JZJ;[CS[MS:ZI+E8]?7EHI:3S!^[;64=*8CUDR!=@*'
M@(W"3N:WQ<^>UI2$JB+U3M:LK9*S#2B!(J%I1&0]7609U_S.H"Q[L#Y<1@$H
M0S\XJ2YMJ@X#]$P6CU4@6,MMK*FKE0'OFSD&CEN&L!L5ONYQ2J:VM[D_=E2
MJRH/-C]0N-U$[QE0%8<1E4DBL=46A^DX\4$)5GLI4D:CD,1^L;28&&>@?6]W;#^V*+L4SZ"A.U+
M.Y;@TRN?O$3U'U.]XDQYFD55GH(4CJR!!C?QE_.T^$ 2J_?YWZERQU!?Q#Q^=26O]&,\#8#\]V?P
M([UC_5"'29L-\4NJN$DJ:5")1]#7I34S4?592GI^DKVUJ"9ZDUF3&^T$,BUL
MJC>4G-DBL)7[#X?%!=<,?JI%0^DKN%NSW@,[PW5<4=:#J O,##=M>(B5'9XK.YT:;*)KYU/DY$SI<.ML)-B\J/'W3^$7
MW/:"+5= 7AJA*84)3ENZQ_9CQG7>;I)6NQB01%12V8959SL%96MRUM'ZK[9W
MOS<%\C[]^_<0V=P"TK]EE2N5"K:N;2V5Y1P,+6P$W&BS!X45%*96#@B,C#K+
M(B"S0-6!.9#2?KP\6IZT1'?19LVE;6CO7?=?V!)W6@+F=[BR[WE1+DSKI%GJ
MS5N5Z-6)?S,S$" DV;:E:\'((KUP.JM5;,>5^M3YQEXYYXMWU#
M%;(1J1$WYZ&&:>K"A3VL-H87Z2  B-,A8
MF>#F@=)T<_M(>Y0]B2?Z3X81WI:RDSHKC\N7V=J2#&L\Q-"#2X&M"BGV ['P
M2Z;/]-']W7PSQ,&ID;;*8JQZQQ?])FS43L=9II/=PEAW*P47?U)D1>%H.6H%
M@1Y;N*2QI\KZ(.!+]O5%(79?VH8".*%G3L:596
M*#QKV)D;\U%6VTX9GM0T78;AO=7F1 @7,])>%DTO#XKB)/B-W*3%*WKD<:W'C,0 G2Y6=^=H)C7P802#8"NZFYB@LN\;HZ?C'TJ"R'Z!]I-0]$SLOG-PXS&JON?Y7R?8J@
M7O1FE <)X3?U8YT_*]W[_9^GA?\UR!/6.*&9R2/<[6OOK9];_Y9D[*,+8TD=
M(OM5I$*#O)S5WD95\,F\-G&UN*NAH2%B4^8LU%VVR\\QF@9UY!#-%V[,R;B$
M?S!=9B_:O%-NRY7RUTBS#F$.]0*9P9E!M6N'U\> A4HQ1V?NH\:^MX44%UX?
MG+Y$B%)2MC,Z=#4]Y1;Z&N;JP[PM!0Z1=C&)Z0@\0NJ/5\[O=/
ML]Y]N!8V]JR2U21.$KV$?\61NZQ]C>ET>J&/WV2+YY,Z.@)*H
MU*WO#(/WX^V#Y*@>5@8==3$>?3!(6D:!Z+720<%5R31/ 3G=K@(%N2^;YIMN
MAH3<2.-*PA?OA&Q"^'O?Q\\/?B9#:UTA%8PH/\;;WO<2(CB56/4_"1*':/-#
M<27/V'ONE'X R'_RJ#]=UU8)F!(:%SI2'1@]T1L@+Z,LQR.'A(-!0B,3C8CG
MJ,!*@F>T43J+7'SOJ(5J;^5?/'8>-(77U@WKYBOXP+GC*DO/_\)2RH@.
M/1$#SDAP*LLU(=THV3'EO-FZ;Q]IDA4 MQ!_>MT?WGIZM' 5\C&)_:Q6;,9)!OMS0QY-]3&I$+Q6 J;JV*R[7D:6[.VL1FF:N'J(@#IFL6M*FG/PY@OKU==X(NC@E'M51%L?(R7Q
M9O@V_>2@:UJ3$I6\?=9'I1JO6@&M*XPLZ837F]\9LBS_[ [B]=GR\)/07BTX
MP.1NMFVBDF!I];@(?]&ZV#0DC[D9K,X-8J^?:NR>74U7T'BQKZ[ULGG\<%CO
MSY>#)55=:^"^_%QS,+__UY!%LDDZCC' 2_T9WS27B1LAKD;8.PE4@HB%Y[8:
MN;T^VJ5W?JN3D^)ZA6AY)C3-)?MW#Z\?'B!MU/-WB%K=O\^A_FGY#&M_>)P,
M3K2C_G(-&18W1;<_0IBX0>8M!_43+1V:L)G:*)WNN,K45*;=IU<;.ZC(
M,,@9M9/9:@#I6AK%JRI5MFV["&UN-VHG>3]';V$MXW#Y.5YV,;\Q2$C0TL*G
M6=>VK7?6E])0/L:Y?@LP]@1.U(I4A/$ZU"ID"GI<9[.\4O2F1\30"23-QW_'
MTFVT!DG^*+E=8!TOF#WBLP)5@=:I;8RS'Y7YD],3WN+K;HB)Y/:HOOD2+H;+
M&[7=3OW[]):+X+/9%;A;2*JGL_*"**M!Z4=+O+2?Z+ZA#?.--/]GDD8>\ABX
M[+ZW22:?YDWY$L.=72/3/8\6NF5] , T"&H="X3+C1A1NA)O
M!_)G-% <9I#(Q.3M=%5VI8KLC?% (AV_DNJ4-T*L9HQ87V>59S7MN(7E;;PP*PLXT3*/M"&J"Q_JO^>$
M$U)._%55IE?AHY$V.9*@(_^2A8 G@=:___,T];\%%^#^ER8ES1?Z-#C>+-94JGUL5=!1FKU_5T]6H6U/15644@NE^6B(/?Y82?$WTD9 "H%%)
M;'_QD#C85-;PX,R T\-AGKTPNQX 'V2)9GY>8#0"RMDNF3&=GNO'DD3$62(W
M@MT+\R)G\>"^K46I:2$/^4@!FG*/7"\C*37(O#OJFT4#2H!X<=7+ SS8KSX^
M,!=D89.N9*.X6Y;NR<_4\2U(4 DV,#.!R\U$DHC-R1:P@M#XG.I3WLK2FJRJ
M:)[6G+D*]NRH)]K]Q#/9%6 ]=6T(XNL#%WM+\C-NKY?QK@
M5Q*(#'?W:/BB+&&Y5/)^5X]'%>:CWT1,HN@@6M=.D5,/'-N=G'>P:0V"HT]&
MT?=@7+J!_= YE_5FFI;<.A6I#_1.V\Z-"I?,C7
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MS;/YCEQ$:=(6"&LIN=9D(@!)<8Y5*+3HCS5
M0W[6=2SVS?G.()+J120/;HJ]X@> HP3:N]!2DBQ2"&^OTBXVP,2F0^.  =H-
M=)S;_";(+-5,X4YS-T7)_)$OUB'-(<-'/^;/V(M4J:DQGNDQCZ[>,NL_X<%7
ML9P9MSZ^0L\>#.],1OZA%JM8I%@"T^T(AG3UOZN\_SIFF':"
MIY];NBL7:\H.UQ58^N_72!F2L_.V=1%(\+<)*R[,+(#)V$K7(T'L6UT7;6_3
MXY[%1/&JK$,N'"3SEQ/H.P,&F9V6<;5?W=@/Z((0C-'Y)VG3?QN8_MBJ&^TZ
M8QH1!_AT*9/&SQV9,ZY>RX:J#$Z1.GP'GMWI,[<=@]
M!.D^[;YZ<6C_A-R^2FV1;<%G2(5!N>/9D&]OHZB!GB5A)?@Y&]"G?A]M__ARFDA3"\?:\?$G%
MN=T](QU5]TSI!6QI2=6#A24]]%BR/%9TVM@-<;LDRSPGZ%$\I^L*^AZ?8+O7
M4)URVH0"KU8=>5=@,7YF:[SPN%@FEV56X"2_0[YC#U/T^R[8VR%,Z'"T Y,L
M3=X:*SPNUQ5I4F6&K&?.I#E\[1ANX?L-+?^_%*4;!N7[)OB)N/)>VC"[:B""
M(/NAJP,Q3N>29Q1KI\6N.YN=#M2) CE2'^V%IB9(0/IEPJP$\^?-&_3TO'1+
MU?)I=;H\>KGO5ZII1GY02XZ[1GI><=EUS+F0 QG[4# Q3*]QW"#T5OO!\SVWT;)9\W9390I'C06KW=YWAG4G69MJF9&T8[;2E5'JX:#_
MSC9)XB)"(/N;8F;6*EHF^IVBWP;JUAT#,H&4$&Z0\;+F+C8CVNANF)2ZXP5/
M?@8&'=[RX5_\(L:Z,Z!4[MUU\YE%RDG2J6R&3Q@K7UCQ].A(-6CW;EU">.<_?=
M0UW]5'L+41J2^Y79WQE>=NE>E=7^O^UNYG\C;I82; /K6YN]']X!YL2\M4NU
MTJD&KP5U&+2EVP"S7&E!Y.S']PZ[.]QK!][NW1($R&87BQA8.LW.N['C'OG\
M6F(W^2HN\ZO,>6=8CT&N!MZ%U-O40ONX]<+Y";2YYC)'RZ[K&?;4T,BU_X?P
M%/>]",,=W90+4>PJ-<72>6^A=R=*V\K!@?*]GI"H5$Y;K=07*8%U@P]Q I!8
M'6&V0V[O^?;Y^KJ%P]*$<%.9JY_XF>IOIV$!FHT4+>T,/[.&.GZ3V5U#\];V
MI,D:;PYY^)?(A0_^JHS53T%A0W;G1Y4M^$]C(^2QJ&:MTY]9A?-<= =..X>7
M!;.ZBCGBM"$F!9TZ0@-SP+@*/D%!RO)3]_9S0/;Y+]V#H5F3Y@%8GZ$B,,N\
MB)Z)7?7LL'*_57K_)YOKCU?O'&-:K@+24IT=(B]^VJ-(3@^
M-2=WT#J_UX9S81S4:?,S"'!5H(8^^N3?;5W^O\#-JH^9'[56\4EVQ &/#X$)
MIAWDFAHR>D)QK7,%3B@7U'Z[BN:"5[)]9Q!->,DG+77_F; P[RV>('-#5"T,
MX8W-7D%#Z8XWBHI"'P8M+O;*[A2W=$(PF;%0N@/7ED3(A E^"Z[ZEH;V4)/I%*$JZ3R6E
MLS%-56;LXP1F,F)?ZAF%Q4.0V[$++L7.?0_!T?K,/XI0)#
MZ4+W=6>I&";A)[A[," WE+*4[L5A'-F.!XQS\
MS*#&?EEXJ_$;AWD].
M#.\=JSZ"/A$R_'5I.35'X8W:@S4_'>(>YNV8J91._@+^*O08_Z;KG>:'5]EK
MU=EG4ZFHQ$3%@>3BWOE21D' 70EEGCB]2OEPQE[Z9U7$I7 N"F6^B[DA)=W_\
MEK?'I6#2FT"X^YVA]]ED&+*$]WC&[JNJ_8:[)K@Z1RPB2"+HS"*QQ-3FS?7Q
MWGQMG7M'B0Z1*05OP<0!>F)D\9R,N8UZFR@K>R4KWWUS#/.2>]Y6NGLA+?>(:J=DYY
MA)]^9SB*"R,]/LSP_,Z@=MCPJ>4[PW>&P;94WJ6RQQ*\4P^_,VS[-W]G4,!\
M93M=MGO_[>GYJ-Q-C+^2I4K+;4]R1T-$+OG&:_3XC\HT2);01:NL2)\CF!D'
MOS, K[$>G9>>.YD;4Y!VZ[D/%BRL2SV>SQ\J:Q^&KH[*60EC@L=+Z>959^'-
MCJ?GEWI>A&^KCH?H9MQ6LY?(TT^4
M=Y7Y4A+XQ28>F+XHG,KI9ZV1@!.-P!LT3)\[F8IU57RJXSGD3;6\H_ANV; 5
M%=&K8'%.?I1;^IU!R%.#L<*OOJ_8N)$
M2L+O39BSO?CW*^RW6W5+Z_4E,065+&IMLY"%1\L;.OW))O.N5+>+L6Z(*[?P
MH"O^=\6N^"Q4#6 K\_#O>;JE=\Q&5DH%W[6X3H&W$WY;$E&\EB*"\]X]J#K
MKW1_?5NO V/;GG-TP1'\-^0G*#,YXVFA;! (N![B@-E5LFR(N"7QI'ZBV Q!
M]:@--J(;)KQ^:2R9WE%3*5YH:S6T[3N)+A)O\8-FS+355!3H
M/2J]+)HHDA2R2JM0:?6*KS8;';Z_3S!1,&E%Z:JJV0&#!#O=XK0/E>4F]+D?
MY-9C>1]?#,LR=@RBNT)AU_6QQ:9I6WGDADNR"YCS.T!6FPQ6>T3;9=T?]O2N
M3O'21A3U1W_W^LS)BF9]4"TM61EC2"(=FN?IV:\ZRI6YIXS*-S-#T-@ZF.A%
MD\=OVV!SH006[]K A6. 3AU=)=7;0V>O3Q)%T18_J^UH%F^X.)B6SU#O61>9_?6<;5683CK'L]% 7<%%@Y
M-#;Q>K<\F'C3W93;]K"[O?U8%9(IDW%)XQGRUB<"\#Z=;&=8" :L#
M-A(P;&)<SL/.[3
MR;"W%7SS_,6G^/'T1%$'JIB;LDNW# 8R3/JQ%^%(3;QYN#E1 W2C04LZ^@4(
M\'J08 ME(KXB3;QQHHH&;S$F_]44>+Y4^\T?-FU)[RM>SS!@<^F8YDB3R'/9
M@3/>%')EHL*9!,E+RQ!W4;]UG;17.P&KFX(=#F\K9.]F:K-09$<2IUYX +G*
M6\SDO7,IV$F*_G60]C; .-)P=M,?/VB]Y^.X A^/?];=:7PH.8 O1;4.U8>N
MRH[P7&#<[FL^'4TC^H@%KV8!6[,+_&X^&GZ2T5N5E^$UI-64/"=\$K[#M@V)WU3'XP;!9< PA83;U
MUJY]7%?\,O>GU'B8B:2BZY0
M>BM,YI2VK836;P%^X>PRW/LEV.W O#I>OP8GWV2])M'8.J)FL9_C$KDZZ+[8
MGN$H91SYU4-DU=!9*QA*E1#;34\4/*C:ZQ4[,B)RI/1^N&+QD@)_T BX*BJX
MHM7LK#"!26]=E.NAF)P]_*II__ZO9/_4_=DAZ*8(C/.(M8[:6C+[8.CFW,L!
M/Y4B=0XO-Y0M])NK^X.N39FB*.ZXT-!"O5;C*FCYUU8$!+F?@W>TE-NVAYJ6
M+8L%F(JH5Y%6W.+0Q;S;TEO//HQ)-Z 364Q:V<8IKW@TY8V5A9_4J[C*G)W 2O*$I
MLOZ.TD#HYVE%)>W>,/JPZ?@4<6'$SREMX!L'G_O)YG$65.[%D']-\>8=;9D<
M?\3[+6Y0I0UF 07+&%/TP"F+@!^FQ2$S6+N/[Q./;@W%0$S]2S+7QV"BC\]@
MX.\,6>NR)3$'O_N9'+'>NDE/V?W.L J-.+,Q>#SI@FJ_T3;-3WNO-32"[WA_=:P[
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M>*H@*.L@P(8^T3TUD3H@Y!?*0>'TTZWDB>D/%7UHM >[S6W
MEBF"R?GI!XKX F:_M9109OK50]50U=B=)/B]G
MA ]+$'-8J@F1:_<'?*I/13N.*2\+CX_KV@BY20E(,O.+S*8 /_(3'[;"Z
M_6\G?T9K:T7*T?RX>RQEES[D00.DMCK+,:=7 JGY
M;G*" 5(;A2*//Z(7,G%76KQ  E7WV,U9&7YZ<#Z:WEVS?CB1,\QAU57BBLKR
MNX;NO!<957"3 SM:L^]+A7L6+&>9*7),@;N(@0#H#0+SZB:
MA$@/S7(13ZHI3T9-$0D#Q#S193G)[L#_MK,$
M1CB%3X(WPW+U+$1?A@S#4H4413 G3] STTRZY8WU(Q,S=]7BAFZ
MYS]I?Y[.
M5/RU)V):>WBZ]>7'=):N(0]K42;$ZI>B[-4>X3\3@H_>*?"T[2/7R)(XJ
M_&FV@RF3K?*:?H+<^RZ0%Y1_<[FM90^'&*\FXNR9-^-I6?+@(0!5<#VN[C(R
M9CE\F10$EN:]>1"[$QLW*QH(+@$]9N,(OMJ[IN][(.Q9EFK"#AYPD185XJ?B
M8#4C]NEG',H. ^[WE1LQ;*/K ^$:.>4@*6EM&S>E0K"]/]QJGNC1[>QSM2;H
M+7C*(DDQ:RZ_Z7FIB,1-(NN*)_Q#725J/G;K!<53=MQZMWMUA/,PITJ/\0O$
M^IZV^&?Z3C+'F_^D9GX:EGXXZ3JG"-W=E6&[C
MYWMU423"SOMFA[AVJD57$@=3J,X;Z.RLDQO'HZ8_2=Z'5FU:34S>V SO.$-/
M&C*TJ,C]89"C$S2JR$6TTP<=9U=#]]4JUO1[S)R3.KQE/ALFW?2= ?>P1'$B
MMNX#HP=CTLU;4' U^@9?YUI<0% ,_ALI%[:6/"
M==SCPQ$W;*)Q_&#([X=[U&3]CNG30M'.O"2!["!SB93'?6
M/))TNUXNXL4_/#L5@O.%>@][ET K+ IAHR2>-4L4O_&1KD) 1X6NAIW=S'\,
M\X7\ XDI^_HP#>_JPGMTYL.2FI=P3::%/7XL
MM;P%GA8(\HE2N#>P*%P88(.I8?,7L6IO-JN.;.BRA]#6IQ]D;_;4C\@K&&)Q
MTK:;?3)RK^D(BKW@@JW$KNFZM\Q6','PI56LE$&I3-=SW[Z=&_M''[\S^-J%
M=$@%DRJLE8W%JOP_]S".3#]/=5VSO;Q\8=VPW[4:$
M!)[94,*GUKOZ10I\,YNR"705JQZ9F(_211G)^^LW>DEYN&"===/5A3^G'4GRGP*?T
M2PZ.-3Q0!<0D&*4XCHV^G0G1:6]O?4/U6"Q$D_P! S+K;LZ+JR*IQ="51'9X:CJM(Q5&!WQGB14I$^G/PXCX?$<"'X!2.P_D YHU@1PYOV'<&;D,CU^Q!
MW=L2E+.$;%"[X.A*79VE58).6%M*JZQZV"MT_O/YUPTY"9C/0$G_,KQ@8*7^
M;ZX+'P3 ?D,<12Z3EAU!VJ?43,=6^_4@)8;-CD:8ZE4R)
MI2OGLU-VF9QHC1LWOKWDX9MTM'HE;:3?V^5?7Q2)PHB9247O8V0EBM/BWV1H>"%IHE
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M;09I36N*D_Y(^J=7FVDF.J^)2[RI_[XH%FQ[3MP33HGGP8XH#O$A/DUS.
M60WKFYS<(*++4\R&"V>OWA^%HT,(2P@)2,/1GWP+5#UX,!2HJ.HJ3:=7+YE,
M#KN[':/RQ_%K-@&7F[S"U@P*OOBZH82L\26]+$..?BVP58P5_&?!M*L/%A+Y
M[AYO=L:>:!T_9C/S$Y4XN:%;:'H_>,+3TH_R("/-GO (5M.+;7#):5Q:Q$%R&0_A99C;F$
M"$*$ZZ([4$KE>A''UW0U!RU*0"2F6,V5IBW>MKB,X4H(E7?C$)G9'&F;UE,=
M&IJTNQEO_)U!?A6.R"+H"95,G;NYA*B#K[5(';1\FGQJW4,Y3PXUBOC)Q).D
MKIKY]E[ST<^;I%7H->Z?"&*L2#;2I'QZ:F
MG^Z]N,5NDE]ITI@8B.GNR#C79=A&J WB_;R&W"*GWGY=XY>FV;JH]>>$WV*X-1AM5YXPH2(,UG.S>_VUWL*Q]63=1V(CVO"99664:^^HP6!S&>,>!;9AT#Y2&[^Z2D3
M#_@?87V*/-\9-+#Y-PBNIQ1K _S"CWH]#7ZO:>2*+OWD6(F
MRCE!MGI(H4KUVH+JB3(DU\C>*$::D];W#Q>D_RI^YJ];\%U\U[2NKA>AR=A!
MYO04]SCOSS&WW,ZZV]VF]F# Y8&/:R-AB.\+JH+5 TB=4JT\^
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M485>3QIK69QIK>D:
M2DNZEIE)P06:1C&::^)9P =U#E5.:G-:F2.$*LI#CY%PXZ. G6 K"V6Q4^IZ-\L4G\*@^B914!_'
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MV7=]B&*I%<:H/(.>$BM(H;9D*L>?#:^ E)>Q#4^"5]]XB""^R:/6
MA%L<(C(,.!#%ING]1_7#^+.VOE-K?$B!]T;I%Y05KZK]=EVQ^&G"C018AF((
MENIOFD%GKAG:6G15'8?HIA=M";:TYYO%GX-?.B2.EW2N$-XZC N6B$$$U2KS
M#9=G(+.UIR+FQ)M<'@_>RL:/3Y[(KE6(K%; ^*XJC..SYZW'C?,U:A4SQS=\
M0QDK2)2'6WV$C3%DSI%-.XX
MFRNN.CPX5-]^I+S4WNLS(!NW"+L>YXQIT0M;&X%7G7UGN%K?&S]>H;SWHU-2
MBX:&'4U8]M7OTM;[E-=0'M7KA4#Q-FZ+.%J6M+3T0O-[D/J#%L&[57RJL@L3
MV>M"$?<[_OS/E8W[4 *[4*6A#L;-4AFGA)/F_0T\)#=P7)4$4)@F_"*MX5IO
MYA3I>' ]MSGH0LZD:[/X-8!6^_/.EM:>MG="CE56+50VCB8$)"[S&/B@3D#5JAV)0/LXX.B?2;\RJ!VXQ#>F(5
M#MS![A)A[3JBRL]4T.$WFO)'BRM3ALQ>6XG8B)F($V-3UZ6>Q<1^9XCIB.9Q
M"V(,T3:5N]01N;4:6TZ-+11+QKD7^R1UP<@W*?P]"AIU4@E=#?+%;H I9(TP
M5]#VV.MGV;:(0[$TK-"I0/Y5[S")>0LCC9]_^_V?\I/Q_Q.PJ?U-OFQO^#$TFQ$;Q]JZ!,3R7*-1]
M\9J+*I9\K$M#1O*=WOM/13K?R1A8%;-OU54?GH^3+I],H#::-6B0+_^F=,I.++BMT[4#\ .E"@AE,I(""A./<61L(H
MU9R-.SL!+1Z0N*P1=75_WFX1&AVR$OUG=?8Y9S"C*V;YW31%-0VJ4_-V&U?S
MK^8;R**ZA6HB01]IC&L>Y:38R5C_-^-5K_
MPNXH(E.LK1WZ3851KF>RF "$B=NT8#;3C#Y\:>R$GD(AFY[I*OL.(Z0B+
M;G-VM.]A+LL#X[,#BHC/IA>81&I%1\>$))@LINAI@I+MY6ZL?ZHB@O5-=ICW7)"+%%^D0%\>J^DI/,-(7Q=<6L$Q#5^[<]9_( ;
MOC5ND^O>%<&B)KEL'$(%>#<4%AV_JMU%M4+$R@2O>'SV_=45+51F]DF00:TYF&RD2Y
M6^\A1:4W,Y!Q[?$GM_< ']0;B6H:FHN!CY+OT5:K_<.1I/ *N!TX5_>D=MS8+@]]L:RMPZ$FX",A[F\HZ+! Y
M/- D^* V&QR4S-3772%:F1(8Y6LGD>LDC_+8?')77[- HGK<$+DW
M)4ELO9)AY:%$P+:3LNBBB'+U[MP4#4D[D./";\RKZTE6_,57A!)5?_"*:40M
M]WG8[S]6@DM$A*+S+U6)PG3RC&OU+X8[DZKJ/P$SJB+#6L'\K#"UWD_@=Q[QW5UK+D"W."L7$ &PP8L,$&D9/)&8YM#$@D R8+,#F*
M'$P^QR:8;(1 @ #9@,B(*(F, 9.3042)+'(T.0J>S[FSYMT[:[XU]WMWWIOZ
M0ZO7[JVN[NJNJE_WVE7-H1[?UL!;78>O43PG,!R[II02/"+R+6M-DI8Z,E_!
MI?"R0OS1T)B%HJQKR]2]N ;O9*?>6 G3.SU]LT+BZV$U?[T0:Y-]DHLOP Z.
M(/@U;$6_]Z,B+"QE'DK4J5)NWTHDIO9JL5B8Z?46-PO
MZ7HIJ X:\0Z"1Q9.9F:$3W*"3MKW8($H!ORFS6^CXG':RCUO34IC4D2M?U2A
M3YIT$[RS"<&QG9N5FY$FEA$9/QS-"X'*GOND,MF%J#O5> ?./QW-!RB40TQL
M+OR=EJ8*7Z5]1E*23K2KYG?EO7.'<]?E\'1KLP^S)R.QYC&,']NW:[Z4&8'!
MT1OLT=B9PAY//L?;9PG4XT\=2[K*%P&
M]P'E=Y8G)53"LO<,>Y#5ES^/RPG-4-[9W&@>,L;()52%L2]>M@I*W.X-\+U&
M?GY\8" PL%@O_5Q(>Y,]2D[.QK8^5*E7TMS';@FKGSK56XM-J1*%4*M9+#]Y
M[M"'9\!B^718^:E.'\0/LP!I=9_?#^S,F**^X1+QF%BF)LX0O;Z\,Z5[DO22E0JQ6WI
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MOR#4*I.L"L<8G(HRV32V@QQWU?/NM+=9B 3U#_U_]^HN7)GK]O:!E-@8H,.=^FH.Z37Q8A>YG[J%
M1$YZI!2$7$35#E>>&0U)AW#5TIH\8R-8LXU)F4]^HR-+(*-B^(),X99,SU)H"=6$/]'=]-06QG
M>J!7%!)6*]M3!@MD7LR"_5MSC9VIKR@OYC%YB]/>_ #>OJJ%M7BW**W.VF=,4=UI&87^PE]<0,+]TX85P)4;JM>T4Q
MYF;?T:S2,I+?%JE;=;-9?VWH[6X(Y4O[KD>#?,$<8C\_?'M07SF_@6%59+/9
MW@YA0'^A]51-J?1[L\V'[DCX:QR*8<]:X&B[F"=/FP;5CEL
M@OW=DIR4[1;7T_2+(7GZZ[RN/39]49[2F+4-.%CF07IFD_R90+?G
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MHUCI%/H]DO8?BF)TCPBK&\<=N LSLN*NIZ)#L ;.GEQ:?&]4#ZVDG:6/$UAYI??E_B=O_
M&?K5(3#^&-64/W_70X/>W=YUZO(ABM0/Y$*IME8L(BIL[,9>&6BQ:R2EJK2#
M[:$::A\CP18(CPS;::]EAB-3TYO2-0JB8V7Y0^9\4S)R<;YUW]\%L6C6%=0T
M6B]K79BJ4TJG/A(=%V4_XV\WC>3V5<>,A]'-$2"C+]M'.OE[15TVV'&]7OP;
M8 174^I6>/O22&?^I)&&/[ATC=9&T)7_W1P4.L_SC%97&0N
M@H+:@+6Y557NU-R8Z"39;VS?KB[Z=@I-"\Y&]5E2/WXQ,>VD/0MOMW ?^J+0
MY[TI?\]1WL[(49Y38PRW/*]2A[';9/J.A9?$426H,;ZBR#_BVTP ^MN@X2Y@
MY0_N$Z+@.9W9!E)C^*0*5)Q4XI39A5'YUG:L4O<5&W'-!J%A*%I@-5:IVJ-=
M[B11(8D-5#/ID2A5/C*+$F=O, EUI'.Y)A59;ICX9!IJP\TY5WE_U'4R3O-4DS@G\']WJ],CJYT;K7OV
MQ"2HE73',TY8X>VN^D]%F.!\HVJ@L6BPSCY=_W;$<3
MG::[A2951$-M1<PRI="+66[^Y@\WR=E%0).5@8+=XG1&D4F'[2A
M&9!JE IHL1N@>G1+0Y-.Y0NRH>5K>Y57TW3!LPN1:-LLUO#/:_CC]!!6SIC,
MHTWB^Q/K^WUY"F*C/[93GR!! EB5TDF3+:TGL)4:2MOPPO'["RP.E1F^';%3
M'A F6=CC?$^[I#UVX?9D*=?Q'0J:7\@]#]^7)IK<.LI*3\G O
M$Q,\9Y<>DZXHTEXT)#VJ_RK*TJ<'0"?J?"3YCMTW]/$;HM@0JWNXZ68SM>G:1$3B11M?>'1/QLK:F1S@=9L8<$O'A7E)<* W7,I<&
M6%10LT,G:"1[%7\@[IX=]=OVV;C%8J#I&TO"+&W$XF:"1)>S""'/%.**HIGH
M?L&?]AC!(3DW7NZ<^*1M7O#I\%@.(+>OS'OS=IR>XD#FA[I*8?"K!%236XN0
MX!& *%S=+\?]YSEMJF,O%[FKE;^]3O^$L[WI*R+H7C"?;&KU?[S:&Q=OND^JJLX=7@IAXCZG5^Z[-!F(O>GRV^Y9H0461CY1$WT-!T@W
M?U+4/36,+/<^S,S(\?->- 5MGD@X"<5-8D]UQ.N6FW.A9>TZ((;3I&4A@_V!
MMV_CB,0Q+O*?!E$_E;9XFM,?H>G*Q,E2>+?G)R?9C!:C%P%UYN3;;O5
M(TD-^:AT,%*3]TC5.M%B4E;9V6O-F8_4G4)RD53!&9+F\(X2)<-0,7Z%%SI?
MABNXD84SF(1PB(%>+>>-,HW<85*W$.0[6+U!X&&_*I=T0' QO')Y[<%S(=V0
ML*20K*7V%)EUMOG<3>INIRK^+6RP\?B%XQ+=MO.4WG;?OK-&PMY)E6(/H+-<
M0'X1.R^( [TD;J5KXK+%]L94>T;:5EQ&]P@$1:'!<\[R_CC)G)%;S'_5W'BS\2<5HPGW1FASC\6%R\9,
M'5S9(O8)K2:3;6H?AE5.4^11!,(V@@DB*-HK"/B(UQ1_!V)QK 9$_;!:[$(W
MG VF$#"$IUN,V%>8;JP^>\*ZM,Q?,R*-(-P4R"ZR95!7UTO4-9)T&JV $I?5<4_2;WGY?&'.^BBT_PF?5#09P,),Y5I[C[.\95B9#)
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M>+"<,72BB0U$+NZH$4SFL9$M+0K6/,2+(/_);#':CP[0S.;L-5,W+FBD#$;O#RCR;^B
M*&"AN:!3NZ+8W+VB(%>MS&[D_2@PC%Q1G!=?40RR_8=_7%^G;+NB^'58Z5P^
M](K"):3.C6T7HGU%4==\L4N>(Y]<$LE-5Q3[R5-7%#N?0CZY*'W7Y+BBJ.J\
MHCCJ_'_5LL*S[\:T7)8/O&O=&OE>EQBR)G)I1!I<1-&R%420!IOVH_42Y/>C
M)7A!8KHP.[N@A#3CH5@QM^=4/,550"$J3NX6NGU:W13.0B".VU40UU_'@;FE
M._3?*^6_5[N4'C
MVC+7H'X55^STF@HKP]S98[A?95)H$'%+ F9M)_2#Y4^65Q36Y&Y;2
MV/T;=;Y>QR=*3N>0Z4+A.UHW7WR\K>2]WNN-RS,*R5
M\P]X-&[T'%Z*7F]"Q R91\ #D[8 %HGIHY/$OF]"=<1P85.ST6!&QNS&.T+'
MW 3M[S.+[_^_1AZKM7YNZQP_8M(],=$XOF=;8Q[?*RE5^D5.P%E4@Z>_(RRC
MZ#,N1\UN0-Z7Q;+^ 9JN\$V4L!C@XY!4*0Z>
M2+C^&@KR\,F7X.-SVMI9BD#4;3>J,X2^'#/1SY3][!D=,Z-2> B ZL64RA3J
MZ/(R'6EMR:*IZ2:QB4XH?@ZYZL6TI$(]5N#*,)K\PM4$!:6_C#._XP_H'26%
MLZ+--5W] C_/M!HT;:!7A%7K2H.DA>GTA %2IHU#_"=\X],^4TNKQ_IED=<6
M-(1!Y#I,@@[#$?@PIY[1=>(WW]H+0FNC!.: ?N^"&F+W1/50++H&!:7"+3?L
MX]D@7&$L=V0W^(BF/3R93N=-LY(XGWE*FYX0$,D@[@
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MY$:H56+J/]=.8':/#F7@(>Q&_V,L+[,?,2O99U/LW#SKS%3
M:FP1(3($.,9N27&;.#X"7?9O,0."AW
MEM\KMP9UW6,TT33P%%@*L55XH8VVBV(5TK&(Q38//_-2Q[J7O#4 /;PAS/+E
MS\O/785!LA)-@4O8^?5^[@26Q(6'QFEC7W!.Z@\4:SH7Y?,&5K@QCO ;R(^:
MTJ\^B6IIE7M@.%/Z!>NPNW?6&@\$8W(;]4QJMV2+#7)4/0_&":T*O9&O,SE^
M'34ST>8FU*L;39]!\0<%@7SQ2]V&TX2$:&+CQ
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MYEWP8)976&D_,3UW@>!VW"9W>M74]%F!3Z$X4Q1G3F.-]^)0\$LFNU>[LD#3]I
M$C1>.E.A/66;\VLJYW^=3^2:?_ %N<=L'8MP+B%$'[KCMD\^0_VD)+QH^U,J
M1CQ90^K&MO*9O%'/NL4B2.
M;FW'W6TS3TT)YF\%6JUL?W6%+=C,+',ITX>3T_L\!A'U?7V=CV^^J[RJNJK\
MXY0:_>@W=LF#0OP*R/^.:*^:7GQ--DBMKRM2'0F:Z'HU5&"VK-DD B0"S1&\C9CCT!U&#!YP2+"5"DF4I[/=N,
MO"NE>H69LOHF7=E1?W:(U!],"-%BM&_02_\77?L C\5T>ZIUPH+A#C3$8GF^
M+52BX:BYH&=[>I*1TTU+/VZJX'OFC&-'[\JMT#5Z;B7,6B13CY*0/++J/4O
M\B86;>^>W.#7(7G^&HW61<[(=BA!C-WC"OX\'7I."WM"!4#QLH-T87 JD"[X
M'N!##?L31E/(Z#Z 6^A6XME_G*R0U[!2ON?#R9\=Q0OYV'5?)S/>!$&#$G.[
M3D2?:N;K]WG-G=)['UL>W>V0+ $GE$^S=O*5;^4-6M(GI<]Z4& >D%V%TH(D'T*AVC:0F??^=9-3 S.S,.'>@NG=<0Z&!
MH<"QR@:)/^7RBB)VGCC.[*UZ12$2E-4Y8JW@[-@JB:$6S9+-M?1K)"Y^]MIY
M^SPX4[1,GW^;MW27Z"Q[^UU13_112E!=<;3I!]%BP2*7.<6:JN*2C;SJKUUT
M\T!'S;K>@A=QI5S)]YB8J-+L#C-B=)H3I*35Y->(O
M$5CT1"V_5 Z/^7LG':CCCT?XA?0@YB =KB9"UN@Y;DI5EKLH'5%VP"!F-P6)
MJA-P?AC0&'DWK"OP?DN.HL=$S[[?A,D=%^P*?DQTCRVUFBZ1D%0JW[6O^G+O
M^'K>1KQ*HZ\$)A[)NB17JM]*""XU@$BWR ([%2:RS-?KB4+8#7L5'!^X:9SZ
M,L8YTFSPYC!O/G<'GWF8F>7Z0.+:43X*;\)R)S+*2D*^&_'X@G/16)_8#;*W
MF0S?0RCWO7^,G%/.GSXU<;QA&2;Q*"]-^:R*POR*XN[3T(D+^P.!)WM^KRY^3/B@]I+8&C7C
MLF^(DQ+GHR\FC(__59[_FZY)-'8%D&T_G:MG57\0$HMP0<@0N2G3U18XRD6-
MX_L;"FV&%B/ G:)2-E^Y-%7F7ZI3%WS(4A6AZ=.D7 ZOW4$QE._9[)@&PQ E
M.1=4ARH99P$63D\BTTP#EF>GC:E>E@BDR8TA;;DV>*XH?@[6R5?,@A]U?:MX
M_^ OWEF-J0$_\/T?3K?;_&SL#
MEI$YYN.BUNJU4-"T_WFQSU&#[/)?M5RQKG0^O_\7 ODIK)ZM^2DK>G4ZK=G7
M!1\9L?'0W/6%%5'=4:QTF:.5DU7BE78A%MS0XV:K@GX77L@#KM6$PF![V4?8
M[??(VL,&R'6-."]1UP*A5;1G1N%1>;07W$W#C&^0'SSV].@R*=1HT+N]$[MX
MOOACF[Z3SY7#QI @+-3GR_CFJ"S )8Y6#TC
MGR^X>G$*M3!K2>&SY2SEX71\F/ELG.MB*GTS>NF!ZH[E_1RV7]]\WF;][<=P
MKQ_',+Q>T_G\//:BNXK-3D MT=A3N5 W5SHEIR/N46[I^&SP*/156&(A2)2=
M0^R1+4^KD)?C,[X?UALN.6NEZM"A!PVC\W2-$A+$=0/,ZR+VAS'UUA%;/K2F-8&50/J1=V0:Z,U*W
M^&@?,Z)Z$X,\3-\MZWVV_F<^'4TWF6&"9$39/DG1:)\ARO
M#OY$R8Z>_1B?S4R^R[B(^=";[B%+9L5G\M/!]<&["T2RT"4JB
M_.).*#B8&!-,>*',5U=WTGWZBNBXU$UK(^WDJQP)6XS2+G5MP-1A2@[1J$+[
M#:9Q'T&MS9V5F238BI0QL'E*'0J*Y@5 @1P*7[ZTX44$YQR/YNVI1UY;WR@"
MP+>;QJ9-?2!8HEQ7A=!_)I#_7T3SY*?#ZM.BO\H!LQNS"Y0TYVRQE^%ABEKK
M;,C9T[6+O. GK1<#@_VJBSDUMYXO_JL,_XY&LZ9\7OR\-5 >^DOO:^]C3'RC
MX[OE(78,U^"])E/ 4$-$"E8K6!!Z-V*E58I%(P6:Q"FYKU$W(U)WA*7>P+-2
M6U2$"!>-?BWF]]S9C5GB&?7A\]#5<::?/E?7GCXS_=)W)-Q>:U*7;.OJO3)I
MU LCZ8\4M@-?%L4?B17*M177THV'Z; ^ 29S>\(8QP
M%! 3Z4A<+M %1O5SOS<%)('B^5P?%9=",B+M]:I'4]98*HIQ2LJUACNV0*$1
MY4?=U1+3Q=#-]12;$BFUZ3BSPLO;I]S'E;EPIT7G5YVW;\TZX0LN:891=_(*FU9E^.N32NVS!Y(R1[K
MO A0>/]VM-B3MTHSC.#ODZKQFT6.?1P)J@%UZPL6Z/K86O/!0@9H#W%I%O Z
M=/XV./Y9/IA3_(S3:*I^#B[][*A["+,K6M+KK> "J
MJ UL$8Z[H3@I*]G$K8AR(/3TK)L0S@(^B/"M.[WY6E)<4A8_\B<)<0@='
M+Q[VM9'ABS]:K7K_&*J5]S#BH36+>H'NG4'=;MXE^IT/:2O'Z6*8\?*#6S"$
MQ1:<_9RYJ%/3+R]SW0,EV.3'#A3F"FJ,&X@CE;16:)-3:,T*\;/5Y[4F97$#
M7:+S/[-#W_PWZM5_H+V[;*;:Z9_^+%XOO6R\?/SFBJ+B9'#5Z,7B]N=3\A5%
M%K+'?OBA<-_FQ4@(2.[W:J'?_ANY_S+W XS6E\'UO,Q^GBD*Y(N3K1P ^!_N
M6Y?M3<"I]5P[H#TG)RA'7>V+]ZA>@QU3WS(5,0RG2KJFQ!1^KLNK*Q)/0P<4K
MF\)W-\1^CY9*_GN0I[((."ZR:@\U[J?=J=7LD(GY_JS]0;PVO)Y?R,S/>_,'
M>-GDA@0Q3!E.B$K6K'>"?1YV0"0&DL>-&K]Z 3N;HN(,N[NLF:5%SX(BV@OA
M&HR)]]*>['&(YE%UW4%4U?QUS4.WK780\W
M96HH/!-H:N4J?Q904J6 2)U=KGV(UAX^'WQ<$=*R.L0B)II@\6L6%X=HUMT^
MWV\$-2B4_2PN9\THG34Y(6=.-9^&N0_2\O89I^',K.2Y*02I@%%0Y38<<5OW
M3RCF9]_,YR9QFP@MUG).0%4D6:/>_!CB3UR7>#(E9N?8B>>INAJ>M!;[TSVO
MTJ6/RE(/SH)4 )6NE!P_>]":VC\9W&+AN?Q"-@X"7$^MEN:4?-E/.VH"HA.-[L+L0GSW[&S&4#T>O>1KO@K%ZE#E]L
MFE>\J[V-5K+U18URFJ&5[=)-*
MJZD9!!Z^."N\/8PB 9IM]6'K)_NF_49?^D7Y:
M?*R(14K\]F>9QI0<>/%;RP^\O8O\5A[9/?UB__R*0D$)-I@K;9$V>5IP ?/[
MR>%_(OZ5/OY"TRQ+G@X=4%5<+R:;?]P=E4:FJ_1HSA]YJ->Q+_#&<@$+,"0,,OWV<
M*"Z,E+VB^'8@']QL][HQS0OM3*8O$D?.@SV8!RH,A!7%.R
M=_,==+>CCFGM,?N3+;.FS0_=3H2FGG5:^NBY*H9JLCK/EUVX2>R!M0G!:7KC
MNNDAC#>Y:GEK,7TI'D6:L?\7)?L_>!+WS])/*V([
MN GZG3(/&\*6QA\N%21E+R4J'U09D\V7)653EO=/ZDD;K(%L5(:S(?0_2
M)1H=TAS(6Z;[9 )",OK]!S]U[DJ<'LM6?C &HG!H/R-+>E5J6F\M>6'3708W
M?J_Y^[;$,QDV5YI,(4'$_#6C4C85F/__@A)3!F1(0='R'4=[K,J&;
M8V^'\GT4:X5&YAVU@&B]M1U)J62$AZO"?(+304"Y1S.;7[B> 6$M9M/)\*&>
M6<7ZM@)[Y\ [SW]6,,R[]>>0,46LJM1QQ\EH'89D*9I:T"MV\ZV,P!&#NNZC
MHG8ZSJF4:3ZN$=N#"E:QN8YGV1"%WIHE_.G7=?,3B1S=-@A3SD955325IQ$[@/6D!*$K*+$.1S1K:!D'&B6VM"3[$:=T3
M 97ULO?0@W22SGZ;C27NH6%RLO"!;YUAFZ_!M+RNW8=EB^@$%DLWL;( :W^G
MX2A;UE[1Z8\\#,-1]_HQC>K TLK779S2^;JY7"UH6A@/S"X')):A5+2M 0V(
MJ+JA..K&--B\A0JXOWEN2)PV_+ 4;"G -<8 EQ$ZG=79/C&3/H&E"='
M+J1/N_:8K-=E%EL^%U7-9VU[LY3B^3'[&5U$;6(1'Y,[K$D3H,']->&]&"GI
MJ)1L>&#+;#;JB5(\=)HR_+(D/"V?1GZ#,>0CXBM& C.[<=\+RJ:4"+/M$G4F
M4'7*$YF
M.JY_!3VYGW.>__2L93W:(A;O,14DI*D4WF%18Q_+OZMCZ9D1/]:^AM51&=9M
MY1QLQ0EJO29% Q[G=B7H^)>5CY0GRRPZV.J!Y^7OU=GW1(8C#LWZH]VTQ@0U
M=[-K$W@"Z&"N4V4Q:^;OQ]O/6JVZ40C4U+LM]Z;\-4?0E")U_IK4OFX(NQMD
M&EJ@4YE1;+_&N]M/<-P/$?W?CUVJZV40O]DAJH#\N4VT1W/45<44AYXBQ
MT,SWT&O'=X35KE.W.J"_O!8Z5W.] \'R33KB;+N^>/$]S/3YN@Z+&(+0YGFG
M)=.D#SM*HB1[P[)%Q1/C-(NWR%Z_-6Y+-,AGJ)=^-X3TT%\P F#P6%.5;KQ/
M*8MY_IB+>?D1LE
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MM/L/:+][1LZA&PDI063U> X?WA:(]@4;"N!6HFM]^$CC1*^LU^0GY*WF\\K X-\=4XD E8J)P1N9[4 [119*L"9Q95^>070
MLOKBN94*'@X;.B#?8I+1P4A!E#F?$KU'T>$5!9_?)3$6O2X+.;56S>P5;[SI
MAW/L;@]A3IA4:1]JZ)A,WTQN>'C.SP[^[(G--U]$\Q0J??$$&#FW2?[=XOV7
MCU6>,IQO*9G)UB?D;" 'RN@?&(W#HQ(N,QN<&>,]/5VRU<%,
MA>FKGIGL'$JL-SH;/VT%M]7N*<9]LISMJY%NWY\MYN1GOM @"[7:J*%'F$D>VZ)P17.N[
MB=IE&6#L)<[S]N<=53PPP([L2O/A\?2AVNC*VNZ"#9)5O6N_)+1H&T%_.5YB
MD5%XE/*$IGQ[BHRG:3X,&TRZHK##"[0J!0?HD7O=R6TGI-GH0"<5^$KRX2\6
MT[_MN1UC%3"5\E864?YGJ$.L40AX$'JJ'456ZFW9 RW6;"4>F@\OW;1:/[V+
M#-I\[CQG*'BYUHXL8?W,9,BA4<7CIW*0?U!R\EE%_VX/0UZ\"XTE1[E"\H@" A-2Z 0UTQF>8G8<\
M]>F*6JS>C(0Q U>EYTC]YHCUS=T\"Y3_/F9OL70]1=0#<$F(WF1$=22="#;/
M9@13$4+J?&/8##3'MWI_WW+J8+(]I_0P7:UTX\%SD'_Q%Q)^3+*9:(#[ZPUD&"6[#BBK&E,,0B5!_2]+4&MCV-L9HJ,X=9.O&A=1T!<$GB''3'1L&79C:'F/0F'@0ETUARX6:N\2(><"J=,OPZ#,Z%C);''OVQ
M:)B:?L 1\+:\I0/.:S,XW=S=KK5^>9]Q&V^\8>[N$L>J->+)"0\.1LL'C"^Q
MQ.'6$>PXN8O7^G'  ,6JM9*U\FX;CVVQQGY6-(@X;^,8R-)YN%2O*= W' +$
M&#-2@MD V01I)7TBFL\DI>+!(%:R8@J^N^*K]'B\%FFD[J0ES6SJL9GR3KR@.KY6$1I)"
M6>V\OS33W^' ,R=4G;DYFIKGQ\[@ON >JM?&J8I?T([)?9Q[<$[3$,ZX]"C'
M48=_4SNA?W[EA_WOH#:QJZ "Y[?7QR\4G[C72\*_,VU8DBT%9;S7F<$Y-_=Q
M_L ?/L" M#?$VQATO')$FO5\/*)!2#F3XLIR@*1K;CT[R[PUHH,-/UT^U*M4
M\+F3[=,*R"A^VVL<]#6>"NQ$#NTJ$Q'GZ=D4L;2=1OJ*-J9 Q[%[\# L#O93X
M?O;DJ,EO,()YC&Q=!UW95P2U.HA3DXYB&YTN?P.ZH WN3_>IE*.S+$RX:C%%)JNVI43R-XA'[#'?;%2(1S
MQ_UK2&C3:W+^=\9T7_HM]5<5^=97%-J) 0RD$SUH]+D@0^VD;_G3,GOSRXC^
MPBGX7*N0]B9'=Y5,GQ"6%9*Z19)%-D_ :]&HKGXC%SZH#L0W%M;5^7FYULXV>
M>DD[,&+2N[E0
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M%'8^S36]JC#J00;[G:FPZ<0>R:_]5+O-O0ORETLHXWNSW1?I).ZIDF[<&^EJ[:H7='OR]\EZ/
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M9II B5.ZS\'C36Y+L4S)+2
MY-^6Z*_6YSTSTR3SR>F2ADXA08_SH@OM>Y[7VCG#ZHK5M&2JOOL^!*O?H!$1
M$IVR''VB$I[;?U-4Z8_4R1!MHXJD9:UD:_9[M7:&K@:B()W0J+J3_--;\Z8K"
MZNM%7//R1_C!6!6YC'NOZM+]LCQP_W2'>$4Q;&!_64)/!HP9DS^!IVUG+SN!*L]L5
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M#P!)2P;]E*G_:Y)WM&M]R8_]Z0ANNMOD?8X1
M-K=N=M!,7V35A^:Q)6+AE$WXVFX5H(5EHOK9-Y"_*V\ ?@
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M+GCI?L%4T1T3E\=_RN!G!84)(WXP;$,TNP&HD\A["U2C5.U"P[99IM+ F28K,$I,_4.
M4RU2<:Z3D\S)1%&84"=3]0+!<=33.5I^IKF$]>(R\.B*XB Y[8H"'3GD]G?Z
M^1Z9AT%N^2LE(_ 2CXM+
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MG_YW2ZIKI?;GYMI+]A?SY#?'*_NSN"N*W))!LC=;\1G-D8!V%_'2@2Q1T2]\<+^H/J
M1GW4SVK^42H"TQ>S00K4?DZ*VAW&"=>JAS4;QQD;A
M4-':FN,Z24ZR9WBXQ[GDZQ\6/W/P^ZQDFIA"JM-A-LIVBGY&%:%\%R(5G_G3
M& $Y#]IE0+I)V;&Z"\0@6K IU^'&6,66.@>[3OB'ESVZ23]VE_H07 N@!GM*
M?^?XT85*2C$RM$"6(N)Q2\1%>GU6MXV^@%:2#:08[V\"IZV)7^3Y& 1UU&SO
M\YL*OFF(;[$9[FOOM1!J0A\EUPHX"+QDG'V:I?R2HZ:2=595NAZK/@>\F/Y!^(&LG\+1Z0[+$
MLD7W*>Y!ZSWS>]' H%_]>OMZ1T0YX9F^2YN%=3U>23!DGBZDJB"F*9'DL"VS%)7DO[!N2%^9L_\K>/6]0758M3Q 2W*Z\9;4(
MV_Y)'^%*_"JW;F0Z9(1SV3QVE_,K=%BK\R-1]X'WATL;05X3[;EL#HXGU"8>
MKD+)VO@CP^OKG#=]@&CMT2,VNK-X:@W-9H!:5#9.HR:AD>&UF69%KDK2H]$J
M=OD(]W,X4W D0A?LN)P!Y.4#0J$_&EH,J+MMK>!UDP[8OC2IJ/#OX7D_
M?[:(6K%V$6"46__%2,4OS;+?V,HTKI>A IRUP^KZOYA[[ZBVDB=_E!GGB W8
M9!@331(F2$3#. !&((+(V>0HL @BP]@88[(102;*! $B1X&()F7=U0!<-4<8,?+_4H9
MTZ;4Q<'0(?]!;ZN-B[-B&*TRN%/DYIYHUK/$6+E+_F@-;EVW'4KF4Q%E-T''
MCU=Z>IDUUR(&8JN'EY/2]<%$OH%A&ZWH_]P.\+]R)/)_,H_]?\;9ELP+BKN@
MUC&]$7?"?JG/IG"W?GYS&2FVQU+O^=3+R1L ^(
M\EH?9D38CDJ 8V,[![%5FA79P1PQ?[/^"7JR<,K]Q2X]?H+,8L>UO)8V5T+2
MKTOXD0Z=:4_HD+W=96L!3XA)X)1@5O1-^$2U7A87-S#RN1AMI[P"T[/@9ZP?I*G'US$@\E>/K*(+Z8A?VA<="CVCN/'W:L9!2J
M$NIESG/#M;A[6F\_*WR:]M31B%QY8+GDHML>DZ==7,YJ-22%O;H\L193E37-
M92O><_>?/-#$@F\G08BN]-&U\658NK51., 64CT\SIMAD5#(I9X=\<)@=@ #
M9.# *BH^<2$;OK>)\7G(>>4.<>[\W%BIC-4WBDJ(
MD9KK+H0Y&;65;?(ER+Q.-RN/Q6IK8U8"7"%G0X;61 YC=H+!E,8+]WT.Z?O$
M3-%1"[9&;GX@;"'=F7>'%6/*EPS/=::-HBNJ[->)G3RW5\0
M_6ZI_5>#-'J(37N88<#O@]A!PRL+(3
MR9B[8P!J3X0M0-B"$UD165A",UHYCN61L+'3$,H'2]X\$M;4K&Y@O2DR$WD#
ME<@(-%S6*10?208/K:S,Q6!7"]__U=7+',68?'OO@&$0JY?\7!H:*QM@PR;TXZD/6KE\V+-XOM=EE;1
M'.8)BYG.D#&;(CNA-V4=_&-*X0 Y%3'ZUB'<0)I81CUS^M:K$/UG^7O5[&6[
M_AGZ8/WPQ5D[P5A;/14EW#/-G'5'OFC8VY2W3C?7SFA70)J6V.GHP*]U6AA+
M"<0XRB0A01;"QV
M7CA,WD*7E&:M\[DR6D)RL)$OQJR:G0:YIK S*B5KNLJ?\M@ZKY3QE)OKKXQ$
M4-ECRI=N(\@Y)DV)M8Q> 8S]Z@OJ?@O+I:PP7^3 @E;Q:5RE&YY/B'4VEI6_*_1)
MV?:$&@9\%E2MO39@1.Y0@!8- 3 =N%QZS%B60E.).G(^VN5&%W&^XE/$IHEZ
M!#:2\TZ_8:)=,?[1.'W&(0(LK/0!LOFY]^X_>7Q""[T$OF[D[G>LNPU93UHA
M%#\.VXMCK<\X/N'B3")F'J]Y,FA^K#BN_=)MD+35=2E!I^$X%MY![G:2G6X5_L+SJ3MV*B!4SD3('NM+1$KL
M,;7#S H$BH#G8_T80]Q9"QR5)]Z'QM_\/W!>?K?4TP9^(.F,IUC[:H2:>90K
MGZQ%LM>A&0KB(N(*1)!K, %^R\HAFW>IK;9*\)9L9,R7PM#0Z.1H)\K[DQL+
MQ(2P)S0+/&"5$"&E4-A/11IG87XSW11M39(3P^2_1&F]P8A54[>[VJ7OL3W>JUV_:;$ZR9ADI@U<2OFR4\(A2=JLFYOR/8C+
M,O9CCX]%<'%5@'GF>IY@&AH<57 O<>B)']U7^A5^7
M2C!^T3[/>8+_P,@R_CYE HEZHK2M)$][ L:\)[VO?,KQO;30,UA]Q%8$',P[
M:Z..>6TKPE[6^[UQ:(O[??9$A?_M-2_K6RU@8=7BEF'A)6H10=6.3U;W.L8[
M<63ZALI.P5I@<]4%15E;_3UN,ZNY,_@&QZJ/@M?XF/"CNA+WT=K[58AS
MM5F!#C]@_$55YP*&H-\[0>)^B@4+9W6AQ?+M72I2-ZP9]6L2PJLGV>_TE0B#
M0VA9+7ENU=W)U PM_2/\T[_EN[I9\BN+RIV"2;]VT^D=C2N,KSK\)Q#1.Z.R
MV57VFT!9ZV-4SZMC@G7"\K'DB[>7-]PK68[H;'(==3[NP8&8*R9U ?C)2I!U
MW"2-GLNPT8M((X724N0DW=V.9.#B7)M. #^NPLCD%A@B_UH(LI.Y:,\H!1TH
M.W1;LC E5C@"P:5)AF8YRRC:%AQRL3O2QGINQ3O]BGH/2IXS+-84ITHV0EB6&7_>
M"3.VV*0-S6L$3^9C9Y^^3?8%=$<%'5DNR$06";''NKWB=E%A#:L;O:D%K["J
M,;_6T?5Q ^Z<87MS_N2"HCM/5%N5\2Z"/ ZD^MQLLF)E;FQLV]53 8YV'
MXQ)T[K.QH1(&'16<3SL%L/)*(;8%/&GG,MTIZS^\1S\)0C:J;W<6#,\ >1.?
M+\:_5]6K+-8M\%+X2HJ-&AE\Z*R?.?1Q2D?!]F[&4'P4].N&>+,X_1)KS,[8
M$3I35+?36_]T&=^IN^,_OS@MKA19E>AVHBC&@9$(7_"/?T E4.LV 9A$4QF'R[O+AH%]9W:_"O:LO*#ZAX?ZSUR)7[-X72V/.
M,FPN**9&.Z("CJ(O*%[:^1/1&^G=9;X\?]C\R]BR/*_S)RQ^N: (/1X]*\6P
MR,]<4'Q9O*!PK3TSC%2]U'^3YOP]R[?GO-HI8[G[WU%0L%%.HT^?2NE<4,#K
M#Z,&FV!'CTXT!^JG_&>V[]E?WKA&5K^@N/Q16^R$L;[^+/,+[YZ<#R+6E<@IN^BIPCS#MNUF15+RH1'5JG7ZWP!<<8J385G G[,2PT)M=L\EH@OW:5
M:$\ZBL:]&Q-AX.:Q,U1\B.5)YH]XT69W_]'\08P'082*8:/BVO-A+Z9DAM8P
M%..[Q5J2(<#0^%E0Z=!2[!%Z4>ML.%: 53'Z$[%W)K%WT\?""<9699SFJ4[=5V(-_;Z8>)U*XB2QVWU2-K
M%#E_OKNK]V<38W$OL=96T,Q9LT-QUV]!2H/+/=>7[G
M1M^QSG^2S]3?-S[[8.]A6U?Y>1:R#91ZQ;%Q29_L4G6;LCE=1W5JN//I7NC$US
M;='Y%:%3;/V!_@OZO(Z<>DS?+^L+1!WJR$:>=9]%#DQGXL1#T/J"W:).*1U'
M($7Z/>_3'%6(O)OUFN.E-Z1'KQH(ST9,<]+_7VSW]/>3<'B7$
MPIEAQ!UJ\,I@2ZW3Q*"HSVI:W@V56K0CR%95VQBS>JLM-2%#%GFNEC\.=S3J
M@.67.T(,<(30CB0C5H#,(B ' ASE_)%,T\.^6!A?GXN8"DB%^*4D&+FDV34S
MS,YN6F3/)?@*^4*TFM,",9CDA>1P(C'L5V3TCH# ^CK7FW\BH^?Q^R"1A3RNV&0]5+K80"O\K)"X6 A4(T%3D;."HY*CD;'C(L
M=*$*P.OC$D;1CI="2W"#5;3@#B^_/E?P/_Z-K??U/QWO/*K)ZBA.#)7V9F_+
MFR&J34-[H_7@2G ]3FPY+A:AEFQE<>EEY>$2P<%LMD@;Z>,#,XTZ_=CUM:"*LMN*JZ'#F:D]Y ,HV=I"1L6
MAP;1AR5^&RH%]YT/.@N%XY:+RI[;*3K>4<^S[)INY M#6=>&D,0+PVHK
MCKVQN>+Z7ZI$UP6)WB;,_0GIT@1/'>3*,T,OH\$M SA_O;6 S,,<'K.J,O%/
MF<:&;\P8>=49H.05H(\$BU5ICOER@M&9#M\QX^/)A'6G&+,:2ZZT&KT%>R\<
M*#!CWN[(_X#L3/:TRC(RB,BWUP2.NA$5X';40VX\>*/H
M??.VS(?YFG]4L]71]N (%D\F&0,T)JMB]IY#'74LII4]=@GA=JG7QA_]O.QS
M@M5C%HDYY@,]V-T#%:N8ZAOZ\R,>*7JOG@@VE.7Y0A+#CU)51\<49,SUAOI>
M/I<0XGC2OLT@\NHS5/6];^:JYX2\A<@N&5D>>T.+XYQFE$=N&^X&>6>S*UJK
MH=9?:IJ]@K*T!A!R8DP:$Q:>UD%#<^P#Y(8DX\>\(OIM\L0X>J\MYYF+]JX6^ =^% Z+@5%WD4;WZ;KW<
MZM;6UN[160.+S]H!6O5[ON\H'J^RNJ>0.ZJ2/-NLAUJZC
MRQ<4@YO&B%_JP^/1D^5CQ)CF&]^W_+8>+?O.<[$564@
M'T@/2 F].7;$%!B=KSSZS0JVM713R5BQ%.L?/#+\PK-GHY*@#;&-G+
MU>XP%39U8-["%M\!Q1E6',CMN\F9O",W*^H=/UR=]FP3!TPC@FM$[-K
MV>U6]2]!,3+ ;][_-BB#1'969)\DZ/)!)W49?&)-O86[66_)4D
M](?V2$,$J:]N=8  >0)61[[IUBHVV]IQ\Q,7MZE(VD8E%@%_!=@V.6LWVG"ZF/9'8I+HCEAW4C@A;K<'
M /TT60ZX$UW/>0ZUW_#O:=@^'#""/&WPF+J>\7_A@JPB]$M&_FU1+!<8C+2*
MY5244504GFEO[YIY.V 7&=4'X(MWBS17]>@X2=9D%EG75H/B,L0A.K;W4OF/PO.48%?9MW*.WX:9S(]T1<>%:+>.4$W.^
M78)!K+.#W+L2PGG[W^K"GII:'
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M[?7?)[.:*GT"^SD3WOJ]S,N#ZK6'A+/S
M;5MOUM6Y]/NK6.!6L#C#C[X_KSQ 4)]_/P@Z_6/RAD0>7E ,RHZ=#1[;
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MVH#X59_-A^,)FW^@0Y;$N5[IQ,S%/S(;""X7E9LZN58F7$EY..,],53U4H8](YY6ND&>;0-(-R(X\=M9/C
M[65O.TX9Q6,;E1)BC#0N*'9]&&8.6>+]"&>3K5);PWG<".U'OHXPIMC/ZVOR
M=SKUS QXHSY?4/BT6F;15"1DUD:<@,I3P'"YW^TA^7:>%8JR(.F6<3TI:E?C
M?L<]I5OGPBUMY]#NQ!5?HKIMHT]M-BZ6@3NBC>AQTN0T,0S;;>/QIOU6-[!F
M.U1_'1P=*6NE**;9LTW'@_HO8)'BH=8FL^0 -P13_)M*)F=*;\-;8K1%^LM5
M E\H%_(HZF=Z>+:1IN-.*'P=0D,ZT=9=BF/MQ1&["(E
M"HP^=<$KC(,M]:&GK':&_A_3R:D:\,=OOER:4JBS"(ZQ7"7'SX[8':RYS:CB
MQ\ _.H4=+.?<>O1Y4-)OXHY)+S^I<+>?0F-8KRUL1=6!.TG]I7^0-^*@]E4%
M=W)'Y1B.@R7F-0N>4X/NURU8K=Y[7#-JTK60T
MY(Y[**_0LU17% G2.79["0X2YO:AT%@\5197Q"!'A9J\0VR3>O"(="L51,:1=DP,XUK8,.\)QZ]L*M]/&\;[IQ@$^]B5;XQ7C&T3LCB+FH"R7!Z?[)\%"& =SWXR1+ W0(0
M*.L,R:)>UM5I!W6/1S,[MODR\91CN>3A(K(JO0/;ED'9$\E)7W?"HE4'JAE\
MD5JJ"; 'F^J#;O>X>77U8Q/CA+\=MMIFK1B%RW3P9E9F]I\607P3U];BJN^/
M5N8OFD=/5,5]&U33J3<5:A)AT^CEC$E@:[:([!@E0NDMK]KI(Y$B@&?O1-SX
MO\Z]U4]>BY=Y& *[H#CFG"!2+8Z/7E'I'19.#\S2QWOS.GU\F^B7PH1<_W7R
MR8^*H J42NR0T2O>^^ UB6J-MYT!WD6)EW_'03J!#\(@:-M/#QQ49B
M1P>,!9616]^&^D7-=-;NI1]C,RHMRO:D/V'<"GC491)M][.UAO<[.F,UN2A1
M!F)[L@J(;4/+G'F@5#YBY2^_4<553C5.,B)S)7T
M#Z<:XS"P/C'>@V";>,#:4A&S/ZAP>GLWXQKO/!6&&W//8/[ "P(>\9SGCM"4
M0TRXPTTCS618)C=D@\9FR>SU(_F1P?'H=8W J3^V6(
MWI+?UVVE1GFGNCW&.APO4(,ZA9T5$@4.7.
M_N:9]95>FI%)5U?_#[10GO'#X-JN^3Y<_(][@EXXN]6Z]9*U%#DM_LKR4K@0
M0.A,D47INMRNV[U$$&U&[-.DF,J?0S::MN$ XS/C4UR8@,!)'B%_7,NT46FN
M0"AY'^U0V3CJJIF9.WP]73 Y<4.CW_!##1P75N5:C9V)%:YZL=0/"!^DD[WXMK9)
M77K753EK1UJHPVUL]^0K67'I-E/G-/G*ZWXO53YTP
MZ*N3NUOO-=)3<(Q^-;AW1IEKB3;HWXM:(/5%1KGL?]%O+_:KFWN7++%;MF*L
ME4[+;URJZGM+OB8GH;#QW5SQFW_HDN"U#W5 3.7^\:T4K>0M9WE]+FXNQ^ G
M_RHLEQ,(JNJM./,>D!+9L
M7E#HIAE:0DU%ZLI%8BNU5W+"XL;X>+H^KQ;GA]YFMXA1R.N;>>$YG,H#PPFP
M]9B640N(8D[).RY=1PX"W6MSV.=W!*2^;OO8Y*Z/.^&T$Q5E!!K5HMTA]*VF/FJ-,S_1D,<71^GVC;POC U#K+;5Y@G:J6(-HYS;1\W?%3KA"YZC<
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M@)^WD^HP+/FY+)6O9%W6L!6-C[D=.K*R]J'=A'U(; OG%J1T?G_XS)3XL*_RL\H&IUVV]?_7+LD;Z(,YQO7HD\WJ0=$%
MYAP,N;= ,^6W^]*>5]=]DJ,1G\6D),=OO0KEZ D4>)!M @[FA:T"?YH()615
M#!_8*;P85]*M9[!CR#@CP^#:YKKCD:D%N;FUAJ]!.[GP+EVBDU(Y[ZSMUH$M
M=P,QEM/M6&,%=Y*,^_/SU&+*O_;2[PWU0;(EWE&Z?*L5;R'@CK F$]%Y#F6>%7]H((
M7QD*>O1["''Y=AZTDOGX3B'W)Y+R"]G#!5A)^7FS'$*0LDY93]]\1'5BEF,0
MAA#8]96^*&/(;#[UJ5;C6G8R6\XLUS(RV6!?:>OF'\K/_H6Z[XP'I<=*>6,[
M.B?>P, _L>T>*T++VINI[U\6N>6Q%N(=%;11R+C,!8EA&49@JZS$XFIN
M3O'I0MPDX.%<)%:=-6H[XQ 5E]^Y4WJ=EJ'Q>[4ST;-W'E;EQVAH?T.E%C'L.5G-Z(@.H#,R+D@7M)/UG*I<>AR%Q8& \;9'5$0E9:(N%\@H
MN,1>Y\-MWV1&AZF7P'RYG63]KR^]J"=D
M^#YJBV>J?\WFW V6=Y+3B[';9_IU1:!0.5U14%6.UOXU3MU$?8%F#_\8"-?Y
MHF;8;-68MA'G8R"9*"Y,O=C<_OA!LA='91_'$9B@C_1?8-1N.9$ F4>%BT\6
M W4[!<#"JM$0+>!<>*TY6ZO6UWF2BIC08G18VE ZQY'HL(9J+5-1CM;E3/8;
M(DBA8NR8M_!)? OVQ3$-,E^\J)7 'SOD(=3'P[/6>=A1K_5\ROL=KY[0SHM.=RRLC:@'*6Y+\#HS/[&
M/O!)\U.\G;*$@X"@@B]&(/ZN>! C]$M9]FP2
MDE,48>2'FG8/OAJ?R(#+R<&)E"R-J<:MZH53<5A!*TQ\#[05P5!Y*RM>O5)W
MMC4'W; L+V>P$#B_HH$#!>K$\1MWU#+Y>'2Z+W'2M?+^4]J5LLN=C_2J&&4R
MH:A68BTX@"Y:,UXE"=POZ=7Q:^9*RH4M3GJBNEBS"H.,LPS4RW:B-%=E=&XJ
M,X=76.(0>WEWAHX="'A$4M4\JG0"K:QIJM50B<-':[R%Q<.,*NQ5ZU6S(-45
MV [#!.,>CZS^1W1:[QP%"JP6P[[W_$E!0?8$,7ZV*NHWBC?[.F5@/-#3.F,Q
MY.;^@P WYLAZ^'B$'_>@E /%I;@T\W*:FY):F&53>+@:=Y)%U^%#!7D\KJOK
M^>- #Y=OC*OFINNY+&(-,[_9^/-SP8LF(2;SAQ]7:XA!86I::G)P*XQ@1_N>
M.IMHN6=>7S3 4T26R&1N:CJKD'Y_.%?-]TN86=W-#'AH0&  I7N@U7"B4\F#
M,-H&FHA>@-*W?Q @6V&NZ(+BY-ZEY9YZ07&&H)I>+;\$\>D#P0N*:G:=$=8+
MBI\7%)N_SL[79%(R _ZZ1[FMB-E!;VJ5V3OVR2@C(B723>\E^/$$=#?+->Y[
MMH$JIXU^DD.J?DT)^![OSDM5-!545>5HSUEMNUHM#)JQ%(9.7P%A3HKE?VP[
M3EHO/J;!]#ZK&\V:-(S< 'GQ1:9\G/CO]K<:/U.]33"
M;%E]51>),CH"O"N^+151&V$HT-*/D6C-^<19>P"LQ>"V@<'J\YA^*\'U@MZ<
MV\E8>!)J4EY3NEG8$'DBU+ZYO98SY7NN&FLT,1_/N9<7Q#E.G#96\>N=FVHU
MR,RR5"TIBB'UB:<#!5KBT$3!D]1E+I7EY:]>8TZ728,:0B
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M'&'J*V@(?4/;YI87%-&E@G#'Y%Y0%0UJ=D]FOVO5X]?@KG)PSTY1?&!*IPL]PV-T41%^JGM?/PN\*:GJZ
MK8Z^I4C+]8P/!3!*Q"-4=%A!!-BQP9R5VD>!EI<3ZA_FD6G&&7Y9?P98/UH&
MJ[?]A#:WJ@J8T0B-Y/]NDS!"C^1PMG,T
MB ?423MWMHP8RK*]'NXP]4?B1@)$4]Q3C]#UB-VALG55G@F3^8VN:8,L=[FI
MLEJA%=\>$ZRMP07$[MU:XK';Q%'A":Z0]
ML<:"7-3V#OEP1[4G,7-GU):,^VB3_[!JM9@_C5WSL,YQCA%(_](+J#Q]O>,N
MT^BDDMF;M<@\1'+VY"=TK4/;_=,$);91C9+IXSP +@N:'*WFS9I=_JTXOB
MU=T5W'[7TFIYGN\:Q*:KK:^M8AMW
ML] 2X]>=D!C+QQAZN1RL//B7V9/,,&_#B"L8J^:C)3TU_I@08Y$0HS\SJ!IB
M^]-V2X&.-^:7 LD1-)%>M7,L./G1L
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M/F5[OM( A^;F4=_RC0IQ=H7Q<@W7>=4>.DK"P5$(#9 2Y+GY+;*2
M$3R/I,PF1D6TDOT\(=?%+?9HF KB4I!LI@<"&VH/E NSR2\=MSK=@\[GPY;U
M!]_E-F2W[BW6';NSS>0>X ;#/13+XCE=*=D1=>B;DR,+[K*"Y5H39>B/;X>(
M,L*S:&F5)M,H"]D6([**W.(\+[9
M)=[>XD6\[ YN>>P7FOHZ7C>#SF@B)W*N#:RFC,$::$OAQ9"V+H
ML.4A.]\D^R[=LP?-?QLIW991_MQ6^+Z^HBZ>DU_ 0.V#8?KF!IA)PILJ.B#+
MTOS[C@C(<: O5,_+D29Q_> 9E-0W$::)PGXA$P2;3(N^*>=35?)73=\B9>QIU61,]1EFU_PQ=O1-A)N6]M
M81#;)7  Y-J0KUV%*6RPLB759JQ&;*_@QG"#WIOW_6FZ^ @\>R7CKEDD3X3,
MSF;Q%9ZF3?V7[$8_= &2'0".+SN 5()^EP_!U+S;,1B)_4D
M@9V(I=>3 (4DB]RN:,T8@U!(Z_.&"C=8<7:7THB E*?0'%J\]WGT1SP8D'24
MI<61D: _+\S>]$ODNYE])FE]_::\@MQ)*6D%0/G69I'VX@F7P9,&NN%Y*0DW
M03XD>RC\ME24L>)IKN4"Q_EU\_9)!KEP_U==_<(\&\[%&_I.U04"/%YF$\BM
M-[N[1BH;X;DDNQ%93&O]G6#WW0Y0+966:D-*P=<1.744Z>NYW@L!ZF5G+W!>
M"-+%?WEQR.A/LTZ>0.L+Q99.7%%JIL"AMW_,:-^+7S]XA$BE&/EBG;1$O)
M.C=CB5#SV&T!)\":84F>VX-DNE*XH'2WSF#
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MB[4WD'HKVAE6JW]2_69_CTY&ZOF;0TP[^Y4
M S\7;-3D?X^R8E^FB35OW-JL=#R8DPE#6*K$"'@7\!2J?OZQY?-[BH75@_I>
M3KZX[=-Z'CO53J"Q]8B2OX7B&<-(LAES,BB+F^Q2S3%MW6(3^HXA8@
M%CK.KY]?L=CYW4+C'+M!5Z0/4WV*Y=./MXRP+I"WQ3#T,\CYAI*AC.&_[<5'
M.0J@]\(($SW+;S?L*54ZHQ6-H.0VI\UDFG6=6FP#+]XP!/AI>5O,8&!=2>3/
MJM)B4@L!OER#FLJIG,P*"$-?HP-IGUL:);LEY2C=7OD)>*OJ5^#VNMV9;;RI
M-/2).L]9TM%#'>!S_#RVI:/.#D&0T.U
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MYVT;Z$']&67!G,U%AKX^$!'Q0I@HR350^B'E4:_M;
M&RJ?+.DW-> ,S(?Z;5YA("1-B\EU@.NRV^)T
M0IB.I0EHVL(LET>F/?/DSNFN^Q@ILU:UQ99[C8F:8X8J/6W"[T
M5?O3.,/<3,+^?)Y0#D/[?;30@J*544G20HNBHI=#Z>\5%['\GVL]H(F9
MCI:NS>_D@TB5@^W"[.#/75&%[RK\5@<+\Y*8E22'%PB,!S+7J[)' R R)% 7
M07 -D;K/"M'8@@@7URW6!WDE!#"T'P2]8#?*7DZM=T+NY72Z
M12@!8#[:IXN=0_37$G>$;^&$OCI,2?)Q9[8G6,V^C%&)\;C?X2_@5^1>.$_H
M%R,%X89,OR(_0+;U'H2H*=:Q[-_FE98DJ>2&OMSLXQ30*WYN8,USB.3G:P\(JA?@'H6!UVY:"N^'AXA7TO(J_-JH@NAE_[P4A--0#R&&R7'TN
M4D><]R-IFK+7MI5#)A2C=L(P!DULNP4$H=!23,J..H"5DX-E'PXSICV:)EDE5(H?V
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MTVV'Z5P-Z:&X9;1?M1&^&#I1EN BC/>23Q@?%<(FAIORM+QN<&'4Z7PN
M_TK;B7^L,!^7LLVN_TO@&Y'QGGW7H>G//J37>BE[SRD,WT'1V.
M%7J%8AXQQ6U#370+"5>3-S6ZRZS/ '(@]#MGILL?ZN.YW_0"9]*YCJTJ ;RJ
MVS2K/0_SV)7#!I*@/R:T_5[13AK(OIS\:9*Q+ILA!Q5[>^PHY^ZFC@6X
M:D#!^1EH:NK):CZGC4K! 9S)@!F6LQXO$U]OL@SRK'._AC6_W8W[O<]CYW+JG!\XR2*0H=V?9A5'A;5<7=
M_NY)9X^G%-PY:]:-\Q2MGH>9ET_8&&$(W#.K2:Z4T/A9A=S;/0Z^1I9](;DR
M'/^FKJ%X?/PZ0IT8YGU#+*YE2HDY_MZQLU[6:P^WW I,$]5<%"(F\_4_^V=MA?KR=X_>'7>UFN:8'_BQ:
M\[6?MQ/VF#>0[T>F)3RC.U[#C)H/HB@SBB19_+-FNR80SYH!J.6SF\ME4PVM&MBQHH@YV>SYU ;<7
M-YX+U@73E$1YIB*2^>6RD^ 9T0*=12^39""OQY^VQU@H/E=?"L0:;U=H?;35
M8J0B$9ERJ?Q-WVV!9&-0[/;=SR6A^4R%@H;%&RV^J+;ONX&LDHJM_ZT'^C>Y
M^N94@L(^RE8(4$"*"W6_2XY[SM+%&\J\.16-&VDH#'1Y-KVKG;WCK_TNB(^]
M"./GS('%W?T9#8SJI]X^S77C[][FS0POVD(5AWL=\( AA: 4]H_W@S*_<(+Q"3EU6Z$
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M),U496-OU1FR,9 ;
MPFV;8*?)>/LH3P 5[\8#SWI@J_XPZ@M:6U"OH_1NF*>\QP$;AEXNBUX>7/S+
M5PD1';U>^:5W/1<'Z&PY[*1-Y::7RQ'OD/RW-&[QK;54S>X/UXX7
MO)]QH[\6U==7=2#1PQ@C<, H@5PI3CBDVANN(G R=IFN4?F(WWC2J\,%_5F;^YWLZ&%\,.N8L$0?6K"K)O35G
M*]8)$PF%SF)I!49^M)^&ORU9>H:G*R(D#<,5U 9#;6,E.[KC,LU2+]$]A5
MLH\!9[^ )TT#'AK&ZFAD:.0J9*)TC_NQ7N&8GV?4F.)==5./C[+4OG,1ZXL0
M]R<"R:T&L>-"+(+3],#=&"^D!<,#)-LKR)-,!MO,<_L-HXY)+F[
MYHAWMY%OCO !=OGWP3B.$ WK$[CQ/2"U4G'6&+:B$66X(_1!49/M34$
M(:LFBSCA5"  MP4_ CM\/VT:WQ?[-(4/I2L\^+,+I5B4;>\)Q#^<%RX'[5"6S$%)JJ)S$%[PYYC8AU$H
M]A4F2_H6E7OBY9JC-(/KKZEC+.G%.WXYHA?C3Q6X?^W;H%3JLV;.VY_='UQ%
M* %>U)N^*#0:$:D9*J^9*.=ZY99OW[$G (8F^272AAQ(HWE<(V>L&WPF=_S!
M^@KQ# 6BCP0FVP^ZSGS8/0?[>='_B[SWC&IKV=)%M;<#QC;&QIAH8)L\P%#MC;D[GB0TYXN
M"D85U38U)(Y1/7JXV&7$,G32KWM;E@0X3)
M^G8G4M'1*YNJL&[VDJS([I-" Z6;J(YN@GGQ?7;Q)-?A>P0238K#U7]D4;F'5\FZC,@XAKN=)P(C%4G\RIVVX_/8.V5V:ERXY@SS*$Y%;'%6%764Z ^.UH7Z[[/9
M_;23?D8KWWQOIV0EE;?K@UF?G9TUF?NPU6P)GS!'JHM1?3-=]/RL*-&/KL\Z
M.,\V2X3;2\>14X>4R]&.SG>(\J-7XGJS;=)(!Q0PF3"; 83);M.H@TWC!P?8
M$)UBB,^&1F%8)H8^726N85XF.8&XZ,RUSMF[,Q1II[8">*:9\%
M3LEX\V^LLG=G::BOQ^R5A&U=M^I_\C9S$LH34;1&\(7[B=0,TNCU8IH]MEKA
M+>N,O9PK9RL\
MHJPS]R+(C,SA9J>X57KM5M']ITO4C]&]^GTU"/6:E\ML_65C1>*?I$0O6Y%[
M5^W?0#JT27X2Z6)',-UJ3I.PS8(ITHGKU4BRSY
M$;^6Q?J^6N6-[UK5FWELEJ\20ZDJ:%^E19O3=[[E?0Q^+-KTQ]QC
MD#EPV-AYC+Y^W/JT5S/%I5A:V&PW).VXLLU.]\@K^W5V.X9>HGG=]^;HTEN%
MF^-F8];5*'3>&)*MF$I5:;!\)*?898Y!VZ Y\^C[]OMNU;$)4G?-BB\$ +$0
M5_5.W5NIOIKOSEA#.6L/E(S%0FSKZ!Q]"%LTRRFPHNY2#.V"XR$ ,/2A1ZX(
M[4J^TI:-AJ>JIM]PP=ZI\N:-:>$)IS3Z>DG"L!"%X]+AWZL7.5UAXN^<7E#^X%/@/GO!>:O=[T/',2I&G"O3!0D-JS*
M'&U0SU+;E'>S#K<,0TH;*KKUP=XW2Q+XIU[[YZ/!!RHY83&E@O T=TJFO'<+
MK%=CN_HIAL]#(.WQ:!K:(9N4J%'!2\&Y!J3/$G;/WR1[OE4?CG^D]Y&N9^S:
M[JW?T[.&A!>\U26/SWRO@GBO*Q\7SR+'+UC JA\-[PA[#,4X$E=O(.'CHV?W
MMQI5K:9+ART:)3(,C%^0A(R5">AO%EM4]NH.^+#O"[V-R5[]M'KISP:,C99H
MYJ+EW#V$VV\/G)O?G)LRNQRNM+6 4B%=?1&-X59VH^PR2EM5C)&_'_X!^"?E
MU[*Y$&ER_<%*YR)15N7&)VW1KV+K1@:LIS6C[[,%66? 7GW*J*]T'MPU$I?G:
M4(&VJJN+._CNCW*/!'M^9J_XI4%J&KDH-M22!NI'B.(>ZUE_I=P_UJ"2H4ON"
MF=$C9[] 7Y6!JKR%TN*B$V/;>RUJ,6%:)=5ZR\LZK1V-*5'KD1;3>6PS5&P<
M(%7Y_: 93S6F64]?RQU]Y FS6:.L9&]5GY_]9H@[
M&\C@2PJ6K)* =?N\BDO- K'QDG>K(17,T6&RN>X_&992ZE+4O8_Z_C>0R0LOY>A(_$H/+K4:
ML=BHS$4]JP$JS>U@P]9<%I_!R%^F1+O>UR;O0X@'\XOFPH7,$I*X[HY/ZY2^
M/J+NGRM*/T_/_.AJ;J56JLCLO2)@%UHYPV;7/2-7\,;>^S%45;BG8C7AVV<*
M\^8)O[O::/B;0R17=3$;OI*CP,% 16%X0T\MQ0$KOTSS!&1R
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M&W)=W](7F[/;N1@9Z4A67,(S?\?=$_XKRJ1Q8?-Q>6?:>ON[ L^*9$WTAV
M]FZX- 46D31[4K"LJX;W%(7I>_X%)V<;OYL_*FT_FXP8F?(?I0H/>NO;*
MW)C<:A&4"8V@R48_]_;T?)RNKWHYW>C2,[0,=F/\WG]9[P?2T6>);+'?7VA.
M#1?#^0;<@YL0 +'?($//*F>V,WUIC&@&G48NJ?7J6"Y+L[H8)6CK_[M%[JT2
M N!^F>+\\HNN;SNU!KI)CX2J(C[(+9!1KA$,?U ;J
M]P:%U]$VQ1DE3-E32%4VMKC5:S<*D*FG@[5V1R^GS3#Y(&+]L-P+M3KZKK<9
MSVK['?CW133EK6D9@JN,&N/4D"R+5**=;OIP*^"'9VCVW__5Q/V/5G7D)Q+=
M2NS'/W;"=4VNK)(V(\9:(/254R )K2?EO63GZH$TJA./U)M(I)]E35W-]$!-\>*FMN#YF^#QR+BL456_'W%ZH=L:A0O1
MZ\8C^.WW+4=6=TMJ$ ["9D7#H0Q"K39F;^R$)JAIPVER3*?,(8H%713PARA$
MXB=U\=MJ&]WVT-7N%?S^E,=*-V8U9U,8NS#36 !R]:"+]6_T.>?%^LTS)XD=
MUVZ.B+@DT4' R5YD:;43!@4N7=95K9>Q9Q
M/=[-S;18.OCT1_%UL[;S'HCS774=WS="*]ZO:;36Q:H=%Q"/3L+1K7*O%#@X
MQ<0T-,2DCM33&*R4RC?97RF\8)XVT-!BDREL3*/5V+$Y[Y8N_T7A[#[6
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M1/*:O4WC'+0$/I/CX2N87L!TU
M5T^*[/V]'X&YMIC2G_3]4QD&\)OK$"F=&92L$J9;O/_BV;9&18UF!YC:
M1#R6R1#BVY$ ?SC]7OR7B:>ZJJC;,=DJ9,00Q:WSEHU[1/W%GF10[F+/X\:6
MT5G$IDN,H92@DMH9QG__F.ZB0&-QKLKQS&?[\NZB7?O7@Q&&W]_^/'?_EQYU
M[.2P[KBA.L3A5HV0/Y4I'8)Y'&^.OX7LKEEWNJ@
M?KPJ7ZU7U/!XQ8KBK\DEJ982P6Z>^75$9UHVX[.P#3OYR:32!W '<1TZN0N=H M^8WE[4TC,R7JB7< _O5L\JB/2VHZ&+
M/_Q,ED,S;WID[>$4&4RF'5$EP/ALT9;.HFOV6^51?[*X:.)! P8ZMD@QIK:;
M6O!D87AC+=E@VTZ[:X2/ $"@4?><$>]S1AP.WV@JM0I@+(W>);:4?OW1;.T_
M+@ )M+[4]+O?66B*(+9J9.@J7!@=DWXI_'G$QY_JO5S&K24SRXOLY=K,M/B"
M5<.Q*K/5I&@7+38VW MTK](X3NJSL?'B^JE+.1]C9JC%M/&M&2H$>QY&B/8H[I[]*K<'TR4-!8+C196Z+3$]FT5P,RV3C"Q14,1D2DWK=S7?LP
M[6DM(!M3TE=K/CSO((6IVT@.]\1H09>3%VWY%[#.]Z#C";G3L(Z"!\(+Y%!=
MBH!''/=>!?7T],7P'5X)8K3(AS(4!-?.,CZBOP( M+[;!$!=VK*-#$)(W@F9Z$J(2_$\MX2\EG0[O8SZT9>
M]9$&CSS7N[NO" "Y.TC<*5"&&UUKFW/H/9&W(;0>T-3HK;3+PD), #"J2LH3
M]=]8^PT >&2^:XRG-*B_BFI'K>3>%@Z,(0"JM]E62WU5G"9FK7R&CGB3 X]J
MAX2&#YT^??U37^0/U3WX8OK:2;I0K+-^+9@_!6SL2KF'XQVH@UL@DPOA!R?(+IG)6$BO\"8V--7,'!1NP,8?#R"I4(&WN7F9Y"0)4.=7B[57\9;I);T-.5B%QW9, R#DDCW^NPP/L*N5@8\8Q-ZBB
MU"_E;M;0^@0GQ7CU8$A]JK6O7IQ+:4A)I@9I-IVSF(^DTQ]DP+R(04>>S9B
M0M.)A9D*3A]R6\Z)[FR,$MGD B<9]W^W>B/*M:S6# ^>( !L6\I,./R#7*F%
M&\NP9^"!G!J@C'2M>M/9TN1I@6%.;PANLB;'P@N1^%:IO?OC@>E B:T' 9"H
MFZX7;X/M<7DVG6FZ!TXGLW<\1%>ZG<%RNF6FQ'R$.%R6 SR\=[10U-V='.SG
MC,%,-$N#_Q]1;0\0&<88S\A"U94)RESL\'Z
M*\R8RUPSV>-[3??[&GR<4R\81K4;[T5?LLO)>FRC^$;IMG6-+,<88?NLNT].WK,S$'MXT>UDVFC6%I@Z;%/L_POFJ[
M$3PO!VYA(&,Z)2T\]X&%0W[MR@[9#(^VH/SM8E&TX,WYJ.Q@V#1DDAK^P>$)
M/_=,/!*X_DJ1W^BNI3*E^4]T;D._>0?/>!M-QJ=H2=OHA^I9' 4?@D<^J[ *
M(3S2H"?K#ISN[-%*,=\@SOXQNG^Y(:8Y-ED7Z2-T>V6%16?_JP+
MTVN"_*ZWF>T;+*)FN37V+@W;I997Q5(0I+#=S]@PLJF!JX?"\>IU7T?
MW%495,@2VF#69T*BBU%87K*@B[F-Q:)W+U9M&E'R[0M7G=U4BA:VRS9[41A_O]XZ6(/5\>\H)/,!7D;/%B(V&DQ5^A4"'-9_EI57!ZQ)/>-
MM=.=T^JUCGV:ZM-702,Y^3V=XN,P,]WXT#VU*M'Z7AX-00R-=8U0:U;\A;"#
MS1 #(U]::+1]G&YAG&ZV@A2TE.2)_DYWS>#0".4)=6WTE\8I,1.](063)])V
M,RN)CZV7)[B &XG2":Z"%??ZOE5%!(9S9P?[CZ"!**HZ>()'0JB/>P,/"4#M@VH-+*.=JU[W:CCF;>>'%$252'8)\*[
MA*KQU\] C,;LV@:[5 [Y3..G"0!,;%I=[6#+J#-6J_EV8>&]?FWU38^4V\3(
M/9,AFX2!"#63WK$.I V'"C8"\;PM(:!ALU*M;Y<7I4D G!EHY>KV9[_M5.GJ
MUUV(W4Y9Y@ 2:_+!A*>S]^?Z?#&^>".M]72DZ B?NGT517W.A:V4:LSW>%.*
M45B?-O;SS#\7:#80ZH&#M/;2KJUP23M$@W"+\2&'CB.
M@I_J%9AR^)%8Q,&3@R68T3(R.HH]&-1+.Q(!S5A$$75MZMRYB&"IUW,'&?U=$'$ "!H^7(2+3-L5VRIS!/T%-Q7P>/[
M%=UC%:-/%\%?:>1Q_[Y(!?RB">KDJ: K&J;3Q!"[=A;C;%8N?AF'C#$Y'44\
M(Z*'R4!5!-^_/T;O@YD$A![!GU+%,6B22!I,."MHE KS\6 O:[I!^(\,4N4Z
MI;/1>>N8>5?6Y2'T2UD"H%BU7'[D3Z9TJ(;7N6%R(/T."Q,,#66ZTQ_MY8R!
MA2./(P07'P!9_(D2X=2VSS>B+/Z61@OATQF6HM@E_\RA']DE!^:M"W%6BB0K
M*9JPT=L.RE_ET  /O?_1K*"_WMI(/YOI9 !_2-&
M?D>^+_&=P6>TO@,,_Z&L1-/VW:EZI26V#1MCBQ&B")[NI[KA$-WQ;"$>:Y6D
MI*1]"TFS&'5],HEQG+/7T->E:]U"BK,5[0MR1ORT1_JPKK$_[=&U*1HQR^&Y
MR\C/+_6VFX0U_S37(46Q*&E3(.M@%-L 4=R^84]*WX-)/I$426$EKE-ZWE'(
MSZ!RB_:DXME0DSNOTM)WO%'@C64IY,=S7MW^T1?>M)S;I7/[KBP/9B73FI2R
MQ10MUTFX*$$9J.XZQ],?JEOSN$ESON7T/_[C>QA7SJ$/7QACYJVWB-=-CPXC\M[]==ER
M:)TBYNO##S#6-T*JA;A45LJ'12=5]:*6[O<*['3*9Y!!BCZGD/.\9:&N58I.
MHDQR%) J?JST"L,S$=)7NVZH48N!+BIZ5_]@[!Z_RV-U[K3>NJBOL9LS/!8;)2WK*F+UU]JGB6X$_=
MGF_[$6M= 1\&^^IJR[5+U\/+TTWL.J^>E'V._,Z<@5E14<5\GZL>Y\K[=/[&
MU]F+Y>M-&>8_WWW^LO2;5&V&T)\:DU3ORO/R]U8"P'0OXUMY('I&^N"" ) $
MQ0WEB!HE39WE7\;]JTMX\^7%P76KB*P(@!T1 H!,S V&8D19)6M=#%W2ORSQ
MFKM*LP)M@!9LTNW]UJ*)OE[?(FY(' (9/ @3(2I3R?4QCU^LSV%AH<^*Y7U6
M%ZA"+6<7<\#O8>(&A&24ZZZ:2Q/=/H8-!5N,K5P]#(V]:ELEI==)VZA/YI,)U!/YU&^LDEUS/>8:;=B
M%F+>:48&=CM#9+2'.V5*_/JUP]N,QJ#T+(=QFIDF8S98]9H[^8CIGX&D#B;1
MRG]GDOF(C$%;I&Z^;21P?.<,J=&U+1DJ1S5/X2O94JX7-'J? &@T.".32.G&
MF*Z*_@GFYJR4' /XC[\]@:/B-)\ B+P2N(J< >76?$TTTICK%\I([SH3"6H_
M\K\\@)P5$0"
MLZ:PERZ!T*Z9V\F9J5-\%%J#8V1TGZEA0UAOVIMV7_=@Z'3 (?RT4$YJUYT\
MMU&_>=6$*X[YY5^/?[SQKN$(.]CI#.&\3ZIP
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M:B*:>VU\[.;.Z"G#9Q7.T#=1"#3M<'B\8_3H/^L71E):!@GZ79IH'MQ.FKO4UYLVX%%"8
M!>4<:DM1XOJ*D^N['%/*DY#O_Y:D(4KHKI<)2B
MPA[*40&U-P2X[XQ\$E **9_^1+R?$3>4+GIQ;WT7?KXQG<*K,&Z-<=GA)I\[
MU_,-;20 D,0,(-?Y$37$/@FWW'/9L):TE&#JQM*<%=D$DNHF5*K!6+&?S#'NS$T:C&9!
M04O],;&1OMK-Q4?AF7:&W>$.AWW-JKLNMH=MJWL6)7UMG#8SZ;*V3Q [T+6)
M-+Z:>TZ&E+!QY5.3509JT:RS3_?(3O\/LHY#Y111:=XWUZS=K@ 17G.^;1K+
MXS05\@&4W,VS!&3
M\X71(OI(GTUCS42(9"':357Y$VM+0CP]\6(V Q+IS]
MZ%[5T31<[X*?;0@^D785C1C4'W]2?VW@)>]MO9ZK^)@4]!_G;YB(C!5MCWC5
M:"^EP2%-X[:(D16=YPAD-M1%S_J1?YWW$PYBUU%(EP^K&7@Q0H:W!=CD#2\V
M I?2&*JWW*-DP,M(5Y=PX8KD*T\Y-JB&3^U>TA+Z/K^]JWG[28>"] W&0$$-,Q'>>>U%_
M:580R,?WQY=MHZLN F!!5HFD;DEK6PU, +@3 'X]0F4I!$!5B>R5[*5"[.!S
M;[+??LZEVPN>'J9!?>++HV)$47W1%L=^,B\D\V:CVAB*/U;:]]&*KGMP>$O;
MO2T+VJ 53%8:4_4QH^S7#DRD)J4TV13!>"0DQ8)5AAL%5+S#FHX@-"JZAF$:*B0<2JDY[.Y+@[O[':U1_/V_^9P=Q 6@( "RPQOK!
MS%K_R>_;V)I)XS.,2N>+:$F*G;V4GB(.=6H7(9Z5]-?N$:I6A#6ONJ:/YC@:F-I'5L+0F6I$K)<\KZTHI!2KOS 68]TU34-Q
M>VG$[CTVSJ.B3";>B(9?WU2T!?UFN+0;G9NB-U$PW0T<\D] 0:*N1\LWL
M:9&D:SE7HE>%06Q0EBR"YC@$$CR?5(%^;]O5W.FMX!3[PRC6VGS5)V(K?#O;
MKIF"IB664T%5!";0MX _' Z?IQ!7H2:EV;R1'FR*_8?5HGL?2!>3MH?@>^S)Y
M)FWT^Q.\.7HA:H8B/(4!Y;&S IO:L$!>[L8Q
M<'$5YS,&?-,%0>ZM9 BQ:+!T"@_.#W@*^"E(';7'ZB<[
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M:^<
M>*H>EPPU8OT4$+T:D8)#7\3UC+JGSQ\(UT6^+M,S4#&"VGN*/)O;0@L6#:CL
M6PR'O>OY]]&_R^[#-D7V9(Y$\I%24W[Q$<.=J'YSL:J(L6"]6$\1EN,D(0]8
M\[/ZGM_"^F/T%4%%@B:U0+,1 R7-^B+8B3:-JA*<@1
MBD+(FTNA=GU*RY,114+Y-60NF/S]]W^C=E(PKQD!\*-A [3UV90 $!)H/0@=
MC,2ZE!R,$P#YU8H9G 2 Y;G=@-(YSC\WW-#F(2"4UY/T1\-V]]9GNNO_/^>K
MEH!?Y4%!DH[GH;DM!VK'O@5>8Z"26O?2R.PP8ZE2"Y!9Y5
M'VNI]$#LJ@.5DQX)T"#M&<#ZX!BE-W&]3V%&<8$/XQ]%1U.U2?3%92\?5RY@
M?;/M2ND&IV,-J]6EYR/ULWU7Y$G_M42DM"ZP_H%QQ\;$"
ML=!]U:7\[<\;?WGH^
M]ZV&\PO8LA$ ',Q"NRF/XR3JQUF(9 ]?\*I!A385LD7V9_G2ST?&XK5&LJZ@
MPBVW"SU@DSZ]DE@58QIE43.J'Z[VG/^
M2]8?,6]H6=HTX^RP'.\FU&T$O)<.$*<&EWY
M?+V_ &J3YRZNPCT6J?B*7C=;2-RKZ<#/UJY1N2,U.["^8-MTT(CN9"HEJ[[1
MPTT_DJ83,39_?++?;3!UPA)[<[\:_*/YUIZ6\V1A/:AED:@M1N$P_Q/MA_$_
M_@8Q;>,(PP=@URāRNGY!YV("69*FG$&S2&[F9/ =>[8@P.8:!74I\\_==0'\(5
M4PD C4$Q_9: AM,4D-IT'W2KRL!(P1@B34:18,)Z0E-N#_?9KH\885*4M@)'
M=23DO#$!V WQ'@U\++RZH1YIR-(UD[)GV+F6-^"XGCP_ :M=P"ZRU_>J@2SM
M%)@\H'/RHQF*\NRE4[''VW(G^QNABZ."!9P.JJHALWM^U&[_OOD$V->>/*&Z
MLNE+V=3%@CV.F]V/:P^RQL=;3='L1[F*R9M\ID(K6;PL)2SHZ+NN=KH5L%D4
M>]N8AG[.B)Q;72MYF6%5I)76/ANMBTGA,FLV>2/."3)N?0E97%/V43IL+=$P41'AF#1NADD0=(S+O5?%\('N5G=G?0/WT^@]-='G(D
MD269M@W=^[9PR:#!$,! W\[P^0"K!;Q(M-(&+CH91=1UGDH5BAVK[&T)"P5.
MQK7SFTJ,!8W0P$[WJ>Q)GU^0_I8*73&P&<.5B&&#Y53ET:^]X%_-^/[UQ";^
MM[W\(7&Z]E8%I0JNV><1BK__A.#.UHGF1N!1S]KL.N9)?(!Y^M@H12_FSBL:
M];;)TWL.0([-HH0]6FYPGS78G+B^E)@;6^\C=YDU::BY4S9VM1M0. -7O+FZ
M8W?BF5(=EI(G!#N+76I0YB.9.=P:U^3WIT[AR]PZO<^G
M>7XI/]C% G7X/+ UW$L8-#WMI)Q&JRR:<7;^O".AWTH+7U[M![)H&E:_'-'_=Z%R$[92]_UC"V?]2NATIMMYZ5XX^++8Q%TDPQ#,=MJ
MLM& T9EF2$JPINS/@,![9CY/AA8) $>0Z6'=>DD$8]YXZ $)[6JECT*,C/QOT4Z5'E/ZL@/[5C4WH@?J?OX]0$ZB.^PS'(.JK>W>\TL9 (-3!
MZ)G\N73 65I&SYUAQKE$SXPGX&CR)W(
MY=>#7C4$0.GAT"[7";,'E#2Y8^\?QN5_-L\!0/[Y%99O8N_:6+"^2FP?-N^(
MZW-@[ U]5B/ *)BXRP*3:M_F'JEF#^>42Z*FIMJF!I.I^5E!,4*MN4C!"QK1
M.%/1>@4VBOR?<9VC;YP;-T]=SX\F16Q=MN,2F:E9HJ\Q,\@-892)[+.SCD)C$D&5B^GU"T_I7NS]R';A94 N&5?L_[)G@"0P14H
MXC%.@54S/+UZG1>/"LO*XX9B&:7$XVL32C](U&?#\VL6SM)4EU5TFE0&@$A*
MS.NU@1*02:JNH8V-EHBW*U58]S^Z&:'>I+(1_6
M& C=O-!C6CN?E=CF$,X&A=LZ7007=OY8P'C <]AFME?!M[GC XL2](
MHN);K0,GYKVN-@PHNVM1/YIJ8'*:&SQ7>W+[P=IP\::NYZ7"Y%[HZ;?D>79(
M%V]@2 [\=G@\U=3.'[?CCR&H9KO-FTGD.BT:3+\-3D4DW2K[X%9B9%8+[.AQ&+9S&;/K.?T^-DHX5!^5V4E!80 /="
MPL37.5@GR)/\=XR>NXR/QU:D.4\/@5M61C:3=WXF;3E7E*OI9)5A?;-;:"X$
M6S#X<,05M8 N2*+H/\SM?8^62H;KZ00T=1"1>>V_ BLHU?MZN0-
MQ/>\#YH[S^-KX7M)195>I\?KP;GC,^Z#5[3X^S!!5%A_?(GD#R&%Z;5O+J7I
M?3]NTZO)(YU#YWX?*EHLD8DKU9]TX+*_]_;'Z)YJ+!VRC+F%&#RT(,DC/A@.
M/!P3DH>,,^*Q9%JJ>] B!\BWG$OJ]?5T]W61'2Z/6KHMMQ8ZY>0&>*BB\!(\
M4^Z4W^C(96;#Q4I"NG:.2B+4$KO][!BVSA"TZKY3/WNDT*#*JZ
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M-*-;PIB%!$-BZR4G>SFJ<6WV"=X&O9"EWW;O
MY3,*KK_PK@M].+B'U$S
M, 7+"(3ZC]A;A4MQY$T.#L=EL[#7YJ2IZ8]*WK^*EQPP=LV0%2JM-<"!MXX3
M$'M=4SG6'!U2L:ZE#A,[#I8[3W*86.]NAD"9NZM4Q!=P:E0OO2X/4OIT
MML)A&V(V#!N#9K@:14V+T][V'4AHC>&'>SI,E$=O80^XS N#@M *\
M[#X3R#YCL+V/5%1=;)5CA'U.$"[_I_/WK^76-1&0)P@>&G8[1SY781B=7><.
MI7E_222TH.%I#=:(^EALTHD6Z7K+3Y
M%"7$:1W9A*"T:1^(K=Q6P@Z1J>!9N@B HZS23XJ/+G]2\)!1(.5K9\^*2G&#
M +LKIJ+C ?SSP9S>YWD'EZK9+' #I7=-YWE<5C6:*@8.3\T&(M5MRJ >]/&UZ,-GR^V@>]_2;4
MG;^P*9IX)E)2)."'O(/.1[GE@4OO%CXY3 C$;Q( MG-;>A,,:U64>  3VU7_
MP;U+2Y7+:[GB-3>73\MVR46TKWPU?S6!GT%-UI6"ABUX+P&@'@+@32+J!X  0*8;^X9M@. 9NY%C)+'X)WYG[#X__K?&,9P(]//N
MI$/?%I"R
ML-*I)NE2YD7[1=E5HV^%G;YO5K_1GR<#=Y676_B>[G[+0B"R7EL5U]
M5)ISGGBLK6JL'#/.RX ,\BT,?H^(5*'S,\6M>IV.V@*JE^Q='+4S9-_K:Z^X
M=S[U-_PG,H5O'[<2 (_H$PB /89" @";?^/V@<"Q9S$!<'H-V+,DGZ\$0$EU
MV>YXBZ[D[X']E=Y__,T"J)GNJ1  #.>6%PP-O@K6'Y^W%*$2K4&2X?MVCP(W
MB<]6X =:>(VLW 6-Z/Z?JWF*(<#Q].WF(5Y.*FO>QM%S)WE>9OI7I\)=F_2<2[T7/O8_=-MK#XVM#[_MNO1VWXY!(S+U3VXB*G,[8_;F_)='Y-8M9*LJ
MO7,:OIEUH$B'',O9-WP=;["9!0X'0AO2[.3W03T+
MXP4KJOWVP1K;8VX,"W$GF,2JQT1=XLXZ$V78ZE/191=4W3HLQQYQ6Q0K2;^]SW6,K$H#JGU">HNSMZV M
M:_J+[&XI,/JG;3BRUYK=._;EP6:9L'29=U!$:U*F?J'3*6:?^=0YC4@;-V5'I-.-C(R=S*F7\P ,T&@<_U
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MK22C?&"JZK2]E1"/C(6%A0G?H"-2Q&'1 G#MA%QJ^X]:0
M#,B8[>WL5WZZ&F2-0E&!K,JHQ01YWNVY-SU7_1-V, ;1%JY@)QY*9#G^
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M92K()8;@;YJ#Z-=8AUTBU+
M8EQ*G;WH($]NNG3,*[MB[+IW-P2==\MI(44X/^)9,3LF3YJA#Q#-
M+6L6ROQM[SB-Z"IHI%$K;.7NQ-,>KFD'YK5"5;FUG?Q@.:V0T45;DAN0Z?,W
MVX^U:TN_&X4S-ZJM4G?NK:?2L5"["&'KZ4M#BS=H?=5JBJ".+@?]B+BBJ15C:-U&
MYF9/2R:^;&(TWX+56.(X'K 4R/=$# WZ/G=Y4+*,KSZ<)@"ZC/6+BPTA4XTW
M"8!840Q'ZZ663$IH6.K2E-Z0PFRRZE#[,?_\V]GJN1I;F"\GV<(\$-,Z I:S
M^_:UO^.?N03A@PN>)4X7.>*4AE;-Z&2EV.15RH=,!FKS45E+,36V N\^)PPZ
M5S'R22:-:9_W2EM#/^O&6_,$<*SMT4'OJMC ,IA\QRY(\]A RNL4]BD<<$KU4UW+;.X[)LYVV\(@+B&
M(NWND"RY@5*^T+=1Q:Y,W?OG-&%YY$T%:/OB3RT\-10OI4W)L DKI8YR/G3A
M!JE$1H%BY+F:$-AX0@X/&YIJXHSJC J^&AI/C$/7L5&_DNM2B?D^%OLS$B,)
M$7KL8-/-1&^/-+%7Y ]5_)E[Z0/T)#N)'/SENN-/WEVJ8F
MUU1YNQSZIS35IJ4$O^R9@D'E/#A?Q1=@VN 'S/@[ES7!TD?OQKS'D850'@)
M*=1VPTC OGT4;U0U@7YTL'G+;U<.O59E7+=X\9&[+G%ECY^'_@3Y
M\<=3K[HQ ]X=WH!%EQ%\3*3/O(Y%4LQFH=)(C2MH9VOHH5JP:A ^UP?RN;O$
M6(Z%/;5\[Y0%S#^2[OM>;=RKJ3D6JHF_M68&Q,?KN4J"*9_.^8NOP2)9A8+6
M/6QM:*S S10G_6X@;W2I@=?VJJZX!B5S_,1 7P#L1OL.-P>_-CF%
M3$JAN]!!6MF+RC4;F@"G9%KJ^^S?=1X3&9E,N7>YC^V;1UM?0!Q@4-QG5* G
MY=Q+\ /(5(Q5M:I&I*H2-L#C^ZDFNB=G$46RNTW>>#Z
M!@@"%@. K5MUC%44KE>CGWM^K9O=)R6Z
M,J_8[.*P^W(BS=A!Q?F4-)M&^+7#H9=\_FCNCE!!V>M,2@(@"4X4X_$W6:^R
MN??:7%YQN\ZHO'8  8IPGG]Q/^"WL.F7RXT, G^, LOZO\G$F=";19+GQZQ&
M)\7$=DR>5RSTTBJ!^,;A_XN]]PQK>NGZ1MG;O55$05! 0&!+#TB0$GJYE6:
MT(MTZ820(%WZ5E"DB81>L^F=2 L)=4OO2$)/ "FA!Z274%Z][_MYSG.?<[Z\
M7]X/YSISY4.N^<^5?V9FS5J_WZQ9LT#T[RZKAAIL+T:JO_6B5B^?Y2RU=UE1
M%GQ5%F9_J+'1(ZW^*&'7GP<)Z'POF2U4%.AWEJMDQ+DA#&CC5[/?=]_P;J)F
M[VUE[AL);@Q&'ONH+M"S%D5>^J R;N?93B O1-?2^K-LK%"!>3W:8YO 8=%7
MRWV"AP&UYAN3LZ\?NU:MVH;.5QH$BBS&O+T9"_X?29WO;8SL-LUZH
M$H=DA\\4#$/HS4R'PA\__VX)GS;1/GTL5&5?Z.RN&W$0D#"^+[7!O,M5%5?E
M1@V2ET^)2O#GD'Y82&M8WJB=]#/B;Y%JI$@Q>DX -8-?NDV(+MMK9SF7][0H
M>R*WDBR06ZYE>H%A=T!9OS9.*=$/,GLP [SLZZX/8)QB'(-)55S7:E9E.VG)
M^PF2M\[S 76P^.*F!S#K0A#9?K$N9956
M;-6-?P=;WG#_N]8]TL+EA4UWIW/(?/(W-F>Y3(=[)P87]*K1)-66PO1VEIF1
M]8J_I%IIP2JIWYR.8G3.'X=H7S_*3FFL]A+5)4T&"[*RB5G 664#_#]+4%P<
ME+-B9'B]&!KUD4FVI06!\"L:VR&%*YK)L%.Z'U]'SG?;J)P_Q*B-$'8XGWA%
M\TG9+31WDXM[?V0TN.U2LV.@8RN1<-BC;'X?,RIT,0L;R =;OQ9V!WX^6_O]D1,<9/9N3]K0W_46N*^
M3\Q_67SQPJ-=[<__%[C!']05X#.G9!WR=J(#C
MS^+P/M$XV$@6"M+LDBB=73OJFYYQ>=(Z?)##[XV"!J4C*^TG'>XZ62T'KA5@
MER-+*J%Y%R9U6Z$MRK801SRGJB<>G *OY%L:#0L*\"AU/?67K(,9M>4/X?A_
M(RN8+!&$ROJ^^$$$D ORRD#!G3:10PBKQ$IHI', .]_R[SH.'R6#@_,[J%3C@D\2$[':=/-A&7PP3V+#KJTXN8D]<7G>\N7
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M"P\H*I)A.RRL#S[;IQN ^ ]05&=7NN;P0'"YG+A-)S70$4MMBO(.#W8E/J-3!J@OJS_Q^KYQ;K-
M+RS8G;N,TL5?<]Y@R+A)XM!*[>S1)^^RA@S>_MS'E72K1.Z((M7BB
MC%W7$V^>[B16X_)=F=Y=!,4ZJ<0A.BAHQ^VJ7D\#V&Z6F6K>L$.Z4Q.#<-NP
MY&#*OOA@3::U4:Z"3^)X,E_T.5E$)VG_54MMJ(BBQ1%7K'*)I4CO9*6284"
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MX5-CK-\KBU98
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M*\O%N1Z"1N$%J&8AY2ANQ )OI>K*^OI!D.$*E)UZHT7
MPTR>R,.JGAD\=<@M:(,,5S8
M8CO1 ;W4KKZT_>?FK+00^Y'4WRSFP\QN#J#UI_P!0 ^6+:P*G5G!R6N-S>(S
M]=Y/5)41L&8QW>OV\E2\J&9\$;ED_UP$=F&Y8GG#!#YDU_PJ.BZA>)]DZ?@M
MM<2B;"]6>9%S5GL;M&AHASV7L9+UT\\RB_B ON?E(*L1J?\NH2"OJK1@(U#
M_8!BTT5R7PMVM8J)3?7.7T$Y)AM9&;DF6(06OBFWUU30:4%BXD7
MK%Y>ZD0J/>%&CLU/W?B_'0SDX8%A./EPT'!%\^'"['+\'P]DTE&ULRY7-#VV
MI[<'CFY
WM
M*(!L:TB5#=A&4')9_]EK4XV4X1=+XS
MK9DK=!G")WA:SJ%SU84KX!(>N!"V(R8)R0;D:,.L<3ZMG<=GG/=C
M>%"2"@/W,L?\;X+09M*F$Q_2F<87&>>8]6#0OX8XBOLG IK].SRZ$,Z@K>[
M\PW^J[J_)BM#V@[R[PNNAJVKH7*,,[<[59[ET:]41+N
MCHMSRN:FM:G#"H]FK42]\2MH(%-;276?6FV[Y1,_W!_T4[O]];+^H:F?C@>F
M-UP:$+BVE%'O]B8 7:]C+9"J_$2O%-G]\,?"OF"HG8&]7RM%!\$Y:-_$]!U0
M2P,$%     @ 0%]K5+O7?7=_ P  3@T  !D   !X;"]W;W)K&ULO5=M;],P$/XK5L0'D&@3)VW:H;;2UH&8Q*1I$_ !\<%-+JV%
M$Q?;68%?C^UD2=J\#(9&/S1Q.94; 2GR@<9.,>&5WTM0
MI[)I%)OW#^COK//:F0V1L.;L,XW5;NG,'11#0G*F;OGA/90.30U>Q)FT_^A0
MR(83!T6Y5#PME36#E&;%E?PH ]%0P&&/@E\J^*<*?1:"4B&PCA;,K%N71)'5
M0O #$D9:HYD;&QNKK;VAF=G&.R7T6ZKUU.I.YT6<,T \05>9(MF6;O3J7$I0
M$KV\!$4HDZ_0"'V\NT0O7[Q"+Q#-T#5E3.^"7+A*DS!0;E0:O"@,^CT&L8^N
M>:9V$KW-8HB/ 5S-OG+!?W#APA]$O(1HC +\&OF>CSL(K?]
MT(/WCF94P>B#SLZX(Z1?/FAY=*4@E5\'K$TJ:Q-K;=)C[3SE0M%?Q%B@M3%B
MC;U&6\%EYR85J*%%-:5^KS5I2GPY2C*$]S1I2.SREE
M1$I_3(UW\2Z@YPU&HW ^GI_P[I+RQK-NWF'%._R74&>@N@B'K1!.)PTF!=^P
MQ3?T&TX=T9U5=&?#=.]!Z$:,<@E)SA"CB2WRI$A/9M.SY4:7!\-F\!3]!"+D
M0"[/*\;S0:BU[@M"]_71A>[+G;5S#>D&Q%#=G%6VSOY#E6*O;K/>L]1I"7N2
M/^%)_I12\SZI8]*-V8"?KU)+[*,B#*:M%E.*38_$_![F?LWQ.@6BH@_*?]Q/3CPY']40-WU\2-M_ZD5T&[F
MNN.?>8U?:X?^1N78G7H8X$>FP3_51KOACX)@')SZT2'FS_OF&*XG WYD-#RM
M.F:M5J3KN=6*VE(3;WQ:T&[CQ*IS?FL/\A)%/,]4<7BMGE8?"^?VB.S6XL67
MQC416YI)Q"#1JGK*Z\T7Q>&]6"B^M^??#5>ZP.SM3G_P@# "^GW"N7I8& /5
M)]3J-U!+ P04    " ! 7VM4_GBC#(D"    "   &0   'AL+W=O?*3'AQM,%K6()ZVCP(;7FM2DH*8))PA@1D
M4V?6O[H.S7Z[X2N!2NZ-D[2J=,S0$ A448!Z]<6;H!2(Z0Q?C6:
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M:U2'IS7DX (  #,(   9    >&PO=V]R:W-H965T,YZKF9-J7=QYGHI3R*AR10$YOMD(F5&-4[GU
M5"&!)E:4<2_T_9&7498[\ZE=6\GY5.PT9SFL)%&[+*/RXP&X.,R"@&F-B(ED+
M\68F/Y*9XQL@X!!KXX'B8P\+X-PX0HR_E4^GWM((F^.C]V\V=HQE314L!/_#
M$IW.G(E#$MC0'=?/XO =JG@BXR\67-E?@J:,JQORA;R^+,GU
MU0VY(BPG3XQS/! U]33R&*]>7.W]4.X=7MA[";%+!L$M"?TPZ) O/B_W3^4>
M9J%.15BG(K3^AA?\_9(T 5*4>>@,I]2/K-Z4QWX^=+].O7V3N=_F!&Q0@PUZ
MP59":0F:2<#RT20%RG5J#XJS#9 UY+!AFH@U9UMJBD/A&<4[*=&Z*XQRMZB!
M.#X+HK28-"R"P!UU1S&LHQCV1K$0&;8>1.DE['NB$6C(WX2>=(J_L'8G9PQ
MMXTBOU5<7J.EF^OTB&ULM55=;]HP%/TK5M2'5FKS"02J$&D%
M34-JIZJHVT.U!Q-NP*H_F.V4[M_/=M(,6F"@:2_$US[GW',O_LC60CZK)8!&
MKXQR-?266J^N@T 52V!8^6(%W*R40C*L32@7@5I)P'-'8C2(P[ 7,$RXEV=N
M[E[FF:@T)1SN)5(58UC^N@$JUD,O\MXF'LABJ>U$D&: T!A4);!6P^+S "
M2JV0L?&ST?3:E):X.7Y3_^QJ-[7,L(*1H-_)7"^'7M]#X7K6MLUV0L*J4%:\@F9H377_S:]&&#$'7V$.*&$!]+2!I"X@JMG;FR
MQECC/)-BC:1%&S4[<+UQ;%,-X?9?G&II5HGAZ7QJML6\HH!$B<8PT^A\#!H3
MJB[0%7JFVK;DN"TY=GK)7CU3YH0K+2NS'35ZNC4 --' U(\#\DDKGSCY
MSA[Y6\$75QHD,[MIIG=UJ^;W'-^>LI<\"B._GP4OFTVI4>D6Z@]FRUJGM=8Y
M:&T*G B)O@H-"CW= 9N!/%1RM]7M_H^.]EKYW@D=O40E+@!A)BJ^L[VU6'^C
M<6G'3]YU]R^@+9]IZS,]R2?A)@"UTV3Z(7^<^MUW)C^"DL1/=YOLMR;[)YDL
M*BEA=R/[']+W_.B=Q<.8+8>#UN'@'P_0X*@#-#CB  4;-Z=]M>ZP7!"N$(72
ML$(_-1M?UB]!'6BQ("W K)?"'*XFL/=S^QSGOP%02P,$
M%     @ 0%]K5-PW,RG7 @  "@@  !D   !X;"]W;W)K&ULK95=;]HP%(;_BA5U4BM1$D+"1P5(*VC:I%&AHFX7TRY,<@"KCIW:
M3FG__8Z=-*)KR%II-^"O]_5S3H[MR4&J>[T',.0IXT)/O;TQ^97OZV0/&=5=
MF8/ F:U4&37853M?YPIHZD09]\,@&/@99<*;3=S82LTFLC"<"5@IHHLLH^KY
M&K@\3+V>]S)PRW9[8P?\V22G.UB#N4'.%V HX_J"7)*[]8*"WW,05U'L(Z#Z'SBT[XK;!Z0"E(":8\N>_4\6I=0-H47ND7.S][5AYG
MO2"*A]'$?VS@Z-<<_8]Q%E0AM5X,5JFP;+0QN"A[FQ,-KM1MTP_M2"-:JQ1JT^WZ7872))AO?IQKA/
M (1FLA"F":HT&QSE>QAU^W7&R]O@'XM><8YKSO&'.),"#UXSX_C-]H-N[R_$
M]C4EH7]T4]M72(-/@6ON\;$&91?@
M_%9B454=^Q[4S__L#U!+ P04    " ! 7VM4P3"4(L(#   U#@  &0   'AL
M+W=OF_:Q/'\_9L9,V,/=US\
ME&M$!8]IPN3(62NU^>BZ,EIC2F2;;Y#I+TLN4J+TJUBYKWC(&=\8WB3I:>P;BRX/RG>?DC'CF>(<($
M(V4DB/[W@%-,$J.D.?[)19UB36-8?GY2_V2=U\XLB,0I3[[36*U'SL"!&)=D
MFZA;OOL=Z1B_BB;1_89?/]1R(ME+Q-#?6!"EEV7_RF >B9-#Q:PR"W"#X
M58,P-PBMHQF9=6M&%!D/!=^!,+.UFGFPL;'6VAO*3!KOE-!?J;93X\^H8R#A
M[ L1@IB(GL/9#!6AB3R'%MS?S>#LPSE\ ,K@AB:)#KTN*^"1L491FT(_0L(O,"O )K^NKG7@!,6
M80RM7M@Y_=&%&9<2W3,$M
M4?K['$6$3%4YT;R2'[2[WF\-R+T"N7<:LJUL+;YLW>L(3Z3$2KI,M&=%3>E\
M& =MO2\?*DCZ!4G_-)+/E"QH0M7^ J9;(6KBE(D.2B1>^[(@R7X<_0K:3C7M
MH* =O)GV"V=1/7"FVRW!A-4HEP7*Y1M1JI:_?!&OL!2O9P"^=ZBJWFD(UX^Z
M\4JL+)U>1<:Z1QFKF!2T>S68I>+OOPD3)O'?NO>D-1G+5$&:RDR63[)9J:"N$?
M6H1_8H]X6:TNX$[IVFJ"!'P)GR@C+*(D@3F7U!ZE?EP_*G,P6R2H?9''S2NG
M?P5$K5% PMFJI707 F*6KDK*]!V$G@?KT(S\$[O1RX+Z7L%J!IE$MN=)V) ]
M,4*$Q?I &XFM[HQ)#D6Q.GS_A_3S@!Y:I7]BKZRL^>\5TU=8CO;-:V%\)[4L
M\Q?<*4O#?9QK>]U*,P$_7W)N7IZ,0L4-\7QOU!+ P04
M    " ! 7VM4!Y".7JD"  #O"   &0   'AL+W=OT;XK-]__O=)?@\+H5\5 D DFW*,S5Q$L3\PO-4E$!*E2MR
MR/1*+&1*49MR[:E< EU9IY1[H>_WO92RS)F.[=Q"3L>B0,XR6$BBBC2E;7*BJ60*28R(B&>.)?!Q55@'>R.
M;PQ*=30F)I6E$(_&^+2:.+XA @X1&@FJ'QNX!LZ-DN;XO1=UZIC&\7A\4+^Q
MR>MDEE3!M>#?V0J3B3-TR IB6G"\$^5'V"?4,WJ1X,K^DK+:VQ\Y)"H4BG3O
MK E2EE5/NMT7XL@A#%HY1ZE6D_G,XI%I+ACHB8?,E!4F39FMR"3I3<,KIDG"$#14YG@)1Q=49.",O(
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M_]]D#]F*J4@4&<**?-A&VH5@/U19==?*0)';CK84J/NC'2;Z1@+2;-#K
ML1!X,$R3K.\XTS]02P,$%     @ 0%]K5/WWIKLL P  30T  !D   !X;"]W
M;W)K&ULK9=1;]HP$,>_BA7MH94Z$B= H *D%52M
MTI"J5NT>ICV8Y "K3DQM![IO/SM)D]! FB)>P';N+K^S__8YHQT7+W(-H-!;
MQ&(YMM9*;:YM6P9KB(CL\ W$^LF2BX@HW14K6VX$D#!UBICM.D[?C@B-K 3UM+D7NF<7
M44(:02PICY& Y=CZ@:^GV#<.J<4SA9VLM)%)9<'YB^G_39-7B>S(!*FG/VFH5J/K8&%0EB2A*D'OOL)
M>4(]$R_@3*:_:)?;.A8*$JEXE#MK@HC&V3]YRR>BXH"[1QS4,'072R62;/@! BY""!%1J'2]1!8F^HZ?'&;KX
M=HF^(1JC.65,+Y<W4-"LK!
M.=4U:+%D=9NCZAH6E,.SJVO8 K5N"XNKQ6ZBH/=-Q\HG]-7;W/)Z/)9)^Q/,EQ\U'^577U/Z=L,MFG+ L!;JX$
M)ZG+K]UW:JA-)AFJ7;GKF@^-.1$K&DO$8*E]G(ZO\Q39W3WK*+Y)K[\+KO1E
M.FVN]?<."&.@GR\Y5^\=&ULE57;3N,P$/V54<0#
M2"6WMN&BMA*T0HM$$:*"?5CQX";3UL*7KNVT\/=K.R$*2\NE#XWMS)DYY]@9
M#[92/>L5HH$7SH0>!BMCUN=1I/,5JV0%![$693&
M<19Q0D4P&OBU.S4:R-(P*O!.@2XY)^KU$IG<#H,D>%NXI\N5<0O1:+ F2YRA
M>5C?*3N+FBP%Y2@TE0(4+H;!17(^SER\#WBDN-6M,3@E2Z& :Q(X0,
M<^,R$/O8X!@9[_C";P.'!
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M P04    " ! 7VM4G_B<.\H$   M%   &0   'AL+W=OI-T-V'Q3[0$F43
ME42'I.*TV(]?BJ(EV;JLMMLF#[$N,X=GAL,Y(F<[RK[R#<8"O"9QRB]&&R&V
MYZ;)@PU.$#?H%J?R3419@H2\96N3;QE&H7)*8A-:EF,L"S)$'LVQ6.Z>YB9(_V#Q[)>B/R!^9\MD5K_(3%E^V2R3NS1 E)@E-.
M: H8CBY&E_;Y'71R!V7Q.\$[7KL&>2@K2K_F-Q_#BY&5,\(Q#D0.@>3/"[[&
M<9PC21[/&G14CID[UJ_WZ+!G,"G%\3>,_2"@V%Z/)"(0X0EDL'NGN ]8!
MN3E>0&.N_H.=MK5&(,BXH(EVE@P2DA:_Z%4GHN8 [0X'J!W@4 ='.SA#'<;:
M83S4P=4.[E '3SMX0QU\[>"KR2JRJZ9F@02:SQC= 99;2[3\0LVO\I8S0M*\
M%)\$DV^)]!/SI:XJE(9@2;E@6!"&9:T)\ &C6&S4FT\DPN *IS@B@H.3!\08
MRDOH%)PLL$ DYJ?@'2 IN"=Q+.'XS!227#Z$&6@B5P41V$'$AN">IF+#P4T:
MXO 0P)11E:'!?6A7L!=Q@0,#./89@!:TOSPMP,F[TQ9>U\-1K&Z4Q6 4>]J-
M]&N1V.XG6CW U'&;>B'$R:4]:CHV#'';!WLGN"DYAR65$,QTC@$ @*
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MO^CDV
M^D97TZA$QAZF,O^:P >:/O_W'%::8O>+RIOEL*DYG9)C5YIC]XO.9[&1[?]H
MAU'N* 9GJY(>^Y=IC]T4'^ATB0^LQ ?VB\__[=JP*3I3PYL>_'5PK)0%]BO+
M&[?P&TW'K[=&VSILC+?:J![X>Z?V&:QW*RU67I>HP4K48+^HO=6JTS3J1=?1
M^F$E9?"MI0PV=T[O84US]8:ZQ:JY;S%KAQ8)9FMU'L5E2K-4%)O\\FEYYG6I
M3GJ.GE_9YW?%R54%4QRDW2.V)G)B8AQ)2,OP97I9<395W BZ54X^[.R#  %J?6%ED=3C);T9 D[7A-(_G+(N8A$?(K7W:2
M-:=DGC8*@P[J=OU.2%C4N+E*STWXS56\$0&+Z(2#9!.&A+_>T2!^OF[ QO;$
M9[9<"76B5^?MWHJHAH0&="=4'DQQ,=T2!0/RNJ1H6C[>]
MOT_)2S)3DM!1'/S!YF)UW1@TP)PNR"80G^/G#S0GU%/]S>(@2?^#YQS;;8#9
M)A%QF#>6$80LRC[)2SX0A0;0=S1 >0.TW\!S-,!Y WQL R]OX*4CDU%)QV%,
M!+FYXO$SX HM>U,'Z6"FK25]%JEY?Q1<_LID.W$SR:>01',PB1/!J6"JW0,+ @6YZ@C)2,75F>71WV71
M(T?T$(&'.!*K!+R+YG1>[J CAV(W'F@['G>HLL\NY-<8'O,^M(V.;X[.T"_,5S8Z)JK?Z[>'9=38-Z:^[^/"
M BF1Z^_(]7_R,NX;9%IHT.[O4391/;\ *G$9[+@,:G!YI/R)S2@8R11LBW=@
M1(*,:$V,<^"'NV"'-8*]CP3E-!'.:(=&)'#0AGOAFB#DM1VW&^QJ.>N>Y3ZX
M!,W[:":=4D(OY'V9'0'IH^14"!$X%TY^^6*2Z.X1RR&EQ86[;<]!K:#4\$S4
M;N?2*3 IYD29*O#N1;K$1&KTA+"YE12TW [&A-E10P2<_&V723&D,P?07OPG40OU)N96:*
M-^Z9,VRBH-_V'62T?,-J_3Z"S,X6.^^NGCDUT"1@0?F%"2P3T+8 UO$%)0(3
M\IKZ_2.2GW\X^9DVH2KY:0< ZUB C&PP-?*N^+450'6LP)95JAOJII!ZD?-XO2ARE36W
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MEZ^?]3*ST^UW[ ]Q;-^/!.0"6D3$A+/ZXC_4>6R]C4YF$;#DM_^QS@
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MO?Z M:E5UJM38=<;3(N>FEO1=I3C ;NG1=>K%EW74)YG^?OX-M1]AJA
M[B9[J_&!\"63%59 %[++;KLODPC/7A3,OHAXG;XZ-XV%B,/T<$7)G'(%D+\O
MXEALOZ@+[%[7O/D/4$L#!!0    ( $!?:U0J[]+Q) 0  *H/   9    >&PO
M=V]R:W-H965TV@;TD
M38!L8>PBR4/1!ZXTMHE(HDO2ZVV_OD-)UL62N-N@K1]LBIH9GC,DYW@61R%_
MJ!V )B])G*KE8*?U_KWKJG '"5..V$.*;S9")DSCH]RZ:B^!19E3$KN^YTW=
MA/%TL%ID/D?+@6<0
M00RA-B$8_CS#+<2QB80X_BB"#LHUC6-]?(K^,2./9)Z8@EL1?^>1WBT'P8!$
ML&&'6#^(XR^ 7(#*6RX5N3B$0]3=(B!B WY%8]:
M\8;<8@ U)!=WH!F/<71%OC[>D8MW0_*.\)3<\SC&Q=3"U0C= '## N9-#M/O
M@4E]2N'\B?N-;(]Y!Z) 1O22^Y],.0+=O=_./>>!NJ
M*Z'Y>M-L/7.9GU<3SYDLW.;6CGN-_Q:@!?U["G]OA5Y8EX2)X*4N;$G Y,YUDO@C8P3R?.W*M]SF]KX3.I^] >^'X%W[>7TCK6X%OYUPMYY3FPF35R5N%"[NKQ>7(L S9(^/H?6-AH[00^X
M2I"H79%^OKP6@:W9M)DT 5=*1>U2]>^45MJ6*BR;K1ORBE630J5HU"YI_[B\
MT@Z1\EM*UF5%>PM2)674KF7_08'MT*P..AU6U)GVT*FDC=JU[2?K:QYT5O__
MM=3T)R&W6#"I<_9#JO \H9\N&\SIKL\[F;TPCFG5359B\B[UG
M,\/+)_/&,'_08I_U5D]"8Z>6#7?83(,T!OA^(X0^/9@%RO9\
M]3=02P,$%     @ 0%]K5(L"'6YB P  10L  !D   !X;"]W;W)K&ULU5;=;^(X$/]71M$^4*DE(;045H#$QYVVTE:+RN[=P^D>
M3#(AOG5LSC;0O;_^QD[( @7:?3AI[P5LS^?O-_9D^ENEOYHO]I!4Y Z_Q&\>MV5N#@[)0ZJO;/*2#('(9H<#$.A>,_C8X02&<)\KC
M[\II4,=TAOOKG?=?/7@"LV &)TK\SE.;#X)N "EF;"WLD]I^P K0G?.7*&'\
M+VPKW2B 9&VL*BICRJ#@LOQGSQ41>P:MSAF#N#*(CPUNSQBT*X.V!UIFYF%-
MF67#OE9;T$Z;O+F%Y\9;$QHN71GG5I.4DYT=SJJ*,)G"3!FKT7*-5"<+'Y )
MFWO)1YXAC%%BQJV!QIPN4[H6""J#*9U)3'=2F DF852HM23-)TS44O)_2,XE
M?+(Y:IBH@BY<[N)N$!YDH@J\@L84+>/"7,$-?)E/H?'N"MXYHTE;2Y@5]DBNFA@Y!XJLF*=V2-XXL>IY@TH=VZACB*
M6R<2FKS=/+J03KNN7=O[NWVE=H[RZQ>%^.,1BP7J/R\$NJT#W5X,=*IPC5WE
M/BIC7D8OI3^11?>W[U,
MJP)&GR8/U[! :E8(G]GSJ2M0)M[QB;N6M1G>1,U>/]SLE^6$4JO9JI4..+FK
M.;G[;SAAF27#"^!?@USFU;T,^8326836O$Y
MS/[-SRT;AVM^W]]:&7B=P?D'O'?_0'^>S4CO9_TF?5>
M!]S[ <"MZ/L7.?I)GUF5V/U!USC"7.GL-]/][E-B#O<&D@+UTL]IAO*BJ:#\
MW-:G]2PX\A/0T?G8S8A^T/GNIAPP'YE>0\_!=02P,$%     @ 0%]K5-PM<;*W @
M3 @  !D   !X;"]W;W)K&ULS59=;]HP%/TK5J1)
MK=21$+ZJ"I *=.JD=8NHNCU,>S#)36+5L3/[9G3_?K83,HH@]&G:"XD_SKGG
M'M_X,MU*]:QS "0O!1=ZYN6(Y8WOZSB'@NJ>+$&8E52J@J(9JLS7I0*:.%#!
M_3 (QGY!F?#F4S<7J?E45LB9@$@1714%5;\7P.5VYO6]W<2:93G:"7\^+6D&
MCX!/9:3,R&]9$E: T$P*HB"=>;?]F^7$[G<;OC+8ZKUW8C/92/EL!Q^3F1=8
M0< A1LM S>,7+(%S2V1D_&PXO3:D!>Z_[]@_N-Q-+ANJ82GY-Y9@/O.N/9)
M2BN.:[F]AR:?D>6+)=?NEVR;O8%'XDJC+!JP45 P43_I2^/#'J _/@$(&T!X
M"!B>  P:P, E6BMS::THTOE4R2U1=K=ALR_.&X/Z- A9]#:/7!\PS-V1YR**[(R?@I(=LZ2[P]0
M;$#]Z @T; ,-.P,=4M=@HT/8*R]&K1>C?^C%W4MIKB"S_Y,4V7L$53A7
M[+>P!JR4(,WYV@B ^IA=W7K'O<%QN\[!AIUVC5N[QIT\7S '=7@9M!^_R^P-
MA3IIHTW^IT+M%G.R4,_!3A2JOWL$!_,+TRKK
MSO:7INZS#U1ES+C$(36406]BBD35O:L>H"S=];^1:)J)>\U-NP=E-YCU5$K<
M#6R ]@_$_ ]02P,$%     @ 0%]K5#GCI5>9 @  J0<  !D   !X;"]W;W)K
M&ULG55A;]HP$/TK5J1)K521$"";*D "NJJ3M@G1
M==,T[8-)+L2J8S/[&-V_W]D)*:U"MO8+L<]^S^_=8=]XK\V]+0"0/912V4E0
M(&XOP]"F!93<]O06%*WDVI0<:6HVH=T:X)D'E3*,HR@)2RY4,!W[V-),QWJ'
M4BA8&F9W9 06(E-@2X03L=;OH%;P+OMTM L;%@R48*R0BMF
M()\$L_[E(G'[_8:O O;V:,R'Q@O_;>R5M7'/ET
M;/2>&;>;V-S Y\:CR8U0KHJW:&A5$ ZGR[H@7&5LJ2T:0&& RH3L!KC$PJ]\
M%#FP.2C(!5IV=DO_I6PG@>F\WI5R VQ!>/;%  %6',&>L[,K0"ZD/1^'2&+=
MD6%:"YM7PN(3POHQ^Z05%I:]5QED3PE"-%^PS/""[%C;EDGT';MJJW'UXTHNB-VVUZ(:->J/G
ML"?>1XWWT2N\WTD4I3/:D80VJ]UGC4Y9?3'LB=6DL9J\PJJK6F>M5\#ILMO'
MG'2GH%L#W9RD+0/_1,5M"0B/7KT2S,8W \M2O5-8O0I-M.DW,__,/HO/J0]5
M;>.1IFIBG[C9"&69A)PHH]Y;JI6I&D,U0;WU;^M:([W4?EA0+P7C-M!ZKC4>
M)NZ ICM/_P)02P,$%     @ 0%]K5*:]>(@= P  ?!   !D   !X;"]W;W)K
M&ULO5A;:]LP&/TKPC!H(<268Z<7DD N&QVL$!JV
M/8P]*/;G6%2V4DE96MB/G^0X=@*)[8;.+XEU.=_ER"<'9;#EXEG&  J])BR5
M0RM6:GUOVS*((2&RR]>0ZI6(BX0H/10K6ZX%D# #)ZBI69L$>#-5G! M3W]5SHD5U$"6D"
MJ:0\10*BH37&]S/7,8!LQP\*6WGPC$PK2\Z?S>!K.+0<4Q$P")0)0?37'Y@"
M8R:2KN,E#VH5.0WP\'D?_4O6O&YF221,.?M)0Q4/K5L+A1"1#5-/?/L >4.^
MB1=P)K-/M,WW.A8*-E+Q) ?K"A*:[K[):T[$ 0![9P!N#G"; GHYH-<4X.4
M+V-FUTK&PXPH,AH(OD7"[-;1S$-&9H;6[=/4G/M"";U*-4Z-YOD1DC1$$#,$J,GG^.
MT&J<[];PZ1Z+",H[2/_\04"D.EQ]I"E--DF3 ^@7U?3;/H!)
M=4:O[L6\*4J_^6]$DM>F1-X6U=RV3F1UQE-O\E'I=T7I=S6E+]4[]8V=THB<
MUA5>D]+'YR1> _3J-(X/_!=?Q.E':AR7OH5;-ZY)34J_3N:X-"!<[4"7<]E<
MYKAT+-RZ94UJ4OIU2L>E^>!J]YD2&3?BHS00W+J#3&M2>F?U78WKU]%86@^N
M]IXC&C]4TZ7?X/8-IR9EK:1+Q\'5EO-._IKKV"V-R6W=F"8U*<_*V#ZXZ9E[
M^2,1*YI*Q"#2@9SNC1:UV%UU=P/%U]GE;\F5ODIFCS&0$(39H-&ULO9O1CILX%(9?Q8IZT4IM@HUM2)6)-)VH:J5F=]31
M="^JO7 29X)*( MFIBOMPZ\A# <"<-BK]8#2=[,2#
MO)/J?G<;Z;U1T]F'Q23#[)^K./]K?6GZR>9W8_>S,O7OIAG$02
M_?RFOT9?E=S&?QL.9Q>'L[/#T3,.][XLV7MTO0V30#7ILN^:9UVG,'F<DH,\FV*.3#(OLN3&+.\#K;_R=9XJ$D$L,BC')W+EM3P^X-)T[9-M#'*;
MLW6*;!UCML"<]$38)>F9^TT^2A]A]',NMPL9F=:+6QS&[6-YCHO#C;M;GN/Z
MN>N2X?A C'T4*T59S4I@"^J']4(M2!LM<*E0X3[4P !G3+K3(^^[/-7.H1IY
M3&4ADW$)2]7$ ?/8S/GCDMBM) $R8]J+),!2;(;I99(PP]F?*V(*J>8,9,5F
MM!I@I2\DLLNK=K( ';'3BRS 2>QV*(M;6P66RR3RE"?C0A+T'[JPWA" *;'Z4(X 5 GN3KF\;].",H94U$-D$S,5ZR7J>:<7F>FD&K.0'5BIOJ%9#RKN!'@-1GW#HTN&P3RXS
M8T@U9P"Z;0;Z2W1J5<1L8+/->M$)^&N;KXDOTZEN*3!>\QT:HK!%2UY*-74@
MN6TF^4OD:H5 &\!L]^)+V,!1)X2V\G?+0(@U6[$^*#":=FA]T-/6AS&DFC-@GIHQWY66KK7#+ /VL%Q>% =]9ARX*.^VB&$.J.4.)
M8.82T1EGSZJA#.H"Z\5H84!XUJ'1PAI,E-HB;0@ZNDA9Z?=&+U I['##->[%0.'"6=VBA\-,6BC&DFC.@
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MY6&5QY<)/N96N\!_U\S_/]5&1H]-!9.W-EN"]]^YR2D
M&20=/&1[2>S8=_>[LWWG#'=2W>L(P)"'6"1ZY$3&K,]=5R\BB)ENR34D.!)*
M%3.#7;5R]5H!6Z9"L7!]S^NY,>.),QZFWV9J/)0;(W@",T7T)HZ9>KP (7KMD*;L'VZA9+!Z\6]/\5=#& 11;^(
MHI_JZ_PEBC/!DE,R0?\3#,A3)'Y,(9Z#^GG 4+LPU#YHZ+GJS.#EPQI/1>T2
MG))/\&#(EQV(+9"I3$Q4&?+,="\U;8__=MSU6QC=;05PIP#N- '\'9A"8%F%
MF1GLEC%K(+L%9+=8$IT7$AUXPD3)KW 6 130T4!GB#*)?0O=IIYI\
M4) /#I)_-FCQ><8N,K3UXS5IAWK[,N']M\03Y+;+F8?2EE\=(5HJ;?0?YYX@
MMUC>A=1K]6M(]^6#'JX?322@(+?YC+4F ]%]!:*-E*!#.2C(3991!ZUN#>F^
M]-#F:D]-%@KHR^HSJ.'<5Q_:2/EY8Q8*KV<2X.7U;09X?\$*#L!QT,IS5/'WEB+/Y3Q;U!+
M P04    " ! 7VM4UO.^C.@#   O#@  &0   'AL+W=O@R5L27^Q9-N=-B_#6#QVCL> 81Q!!J$X+BSQ[F$,*&)E_Y-#
M8>LY),R4%DGAC @2QO-?^E8(<>;@]VH<@L(AN-:A73BT+=$B W'V[)!\(X>6)QC,9JY&K$8B*Z83'O+)\WJ)G7#\B3
MX'JGR"<>05018-XIRXS.RKA;GV9F2GFA6\!]Y(FZR,YMUO0HWT]/5 9MRQRU&US$0+,[D,\;158RZ%XP&G4XP;%<3ZI6$>HV$OMER
M!]$=W8/$\DU2D$Q$9H\?@4IE<(9":46T(&O  AZ*+:]3O7DNW/J)W;D-FZ1?
MXNXWQOJ4I+$X I 5R#T+@=1E!@47? \*.>894*T?,S='=FBCD:\FRT9Z.:3>
M60J\^TZU_H.2QZ"1QTP@)%15:(&Z4XO9]T[MSKMRP=CI_TQM
M\O]Z K,;_VY8D?Y91_7_?VNRP/3CHO1KU I.5()&*LM3:G.]7FQJ;Y:K%SP,
M7*/:J=OYS>WNOU&M7:%:32GU3UW.;VYS.'?1:L\TNT:L4_OQ?WG_*;K.HU(9
MV#J_L!6_4J7+GA-X/7]0)]2IZ?C-G:!*J)8!8J\G'!?!7/#\X'*5?J>NX3>W
MC18YV"RG-I'KM_7D][/Q0#+5)[P%\+C=<%^[C#
M&QU(8X#?-P)+<3$P$Y1WQ,F_4$L#!!0    ( $!?:U3D!]@2Y (  "0(   9
M    >&PO=V]R:W-H965T(9'.NTA+1.:]M#I0=@+UD267$D$\NTKR<8U+S<7+,F[__WM>B41[;AX
ME1F 0ON<,CEV,J6*!]>5208YEEU> --OUESD6.FIV+BR$(!3ZY13-_"\T,TQ
M84X.Q/_838R]M;@!X&=;(R1R63%^:N9?$G'CF> @$*BC +6
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M?=S=:\'IU=7N6;W>M6IG6$!G96NZP.]Z-R@T$0*S#9CQ/?K*68)EAA[WIMZ
M?DU64@G=Z[];HO?KZ'T;O7\E^C-H+9(H'=Q^7,0%>F%$':)=^F"E8F@5S8GP
M%GO=0>2^-6MXR:9?VQRA#FK402OJ,=^WPC;>@F+6QEI*CHXX_!/6=ILCUK!F
M#3_ .BGT*9J0H.U>4=U(Y4;RPQ_J**WU)V&&FKW$0QD"_7W.N#A,3H/YC
M$/\%4$L#!!0    ( $!?:U2!)_7Z[@,  $42   9    >&PO=V]R:W-H965T
M$IM9X:/IF?#QD
M&QG3%&8K++*"%-(!64
MI8C#:F1-\)2T2<>" ^R<+:6D73#9,;XZW8T%27<2&Y&J7*3XX7D@7/-[Y*1(BF+%&S
M0Q"3WY,#5Q.A:I[IMD#?]3!-D8P ^3%1'HL@8C$(]+>Q0#-. YJNT2,+(;Y&
M5W<@"8W%-;I!(B( =!&WFXA5S'Q4< 3=_O[M3 \":>=ZHF.C$WR[>IGW!.TC6H
M?Y%$RQTZM)N1G>F>; D/T8]O*B1ZD)"(_VH =4I '0.H?,##AEH>YAXN@TR$%U#2@M1R]CE=V7P[K46?S"M%LR[=8SU;,>33(EB0'-
M.1IE$^AJ,9FK:?OC$9(E\+JL]LIW]3Y'F?LEH/XG+/.T_Z:( Z_KZ,_Q6@Y*
M.H-ST_GZ3B>A-LR";?G
M3L(]H1P]D7@#Z$#Z57)>,[46*_M_@"I2WG:;Z
M5EL$['U@H5I#>Q:?[^U7=;T"[E_5>(>MUA:[V*OCLFY4/R[G?@+%1SJNM
M##[[7N;C4-T?C_P%02P,$%     @ 0%]K5 8+
MCED,"0  F5,  !D   !X;"]W;W)K&ULW9Q=<]HX
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MA4-$YC=,HC3["YX*VVX+#&7)RQY DP:2URDQ\R,;/4POTPEO5^RYFX&XIT_.*6
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M_$G9Q"14LS<.>*8!2X$#)ODS$#E@%#R;.JE^T
MR D9;V-0]DVDDN5=2(>;9R%@D^'X$<0S8P1FY?,*P6CW^LN-U[=
MR/.7C0:Z$21USPK856S6?35M2H\]*VV*HI5=9(N1TY1#]P3\/5BJQ&RD:3J@X**N'F5+GUCD5C
MJ:S]@$' *?@5TLU@MXV7QRH&,]SN]FHT56@*UV/3W?<[
M&TF;.R49H%E;@UU5W*IL"@KASJEPS1YJ(]EZJ^0H9#/8U0<;4KR(=LZ++^O(
M9@)Q-A$,Z9"YW-$UFE1U4A"*FB'TTV0:)<^4;L"A2'$H.BH.18I#T4%Q*#(
MYG(LZ29UL:3 $AT26"(#,=9XJ&@1'1(M(IT"Z^I0 2 Z, !$UG2'%-VAHZ([
M9* [I]V%RTW:LWX\*&9#Q\ALR,1L%<6J
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MK=;QJDN*1)T5)-HX+W#[X41V_]F+"K&(8Q&8HS SLI@N[KV-K;W4X.B[
M@'IM9WF%N#"S&$.0TBL?FT/.ZXZ\B3XA!WN.4^>IHAKRBN]F;&M83:QGW8AB
M';+SM=17&#,3?3JNSG,%6&3G:Z-;&Q 3?3*MVJ:K/BK6(NNQUKZ.B%>XL\8X
MUE4TYMK3V!N/8U>4=!T9%*ZYKS>)]M*!K*O/>[EU?;FK\,Q]HYDO&X_0"SQ2
M+.8VL]C71!9'!- +M_JY"H1O)6.W]*[JOJQ2VHQ578LW5743B$B]$HJ8W'W9?68SGG5U,CK%L&>(
M(&N$0U6
MN.TNOW%BM()NS9OABLB\?9T?VT18;_7B9V%BN1CL*7;S]G6J;2/!H.D=DE+X
M%*)9S]QY"@V]/9NYVW0;I*?SI!9<^N)J0V-4S.F]G#DW6 CQ%(IZ1X6BGD)1
M[Z!0U#-,I6FQ9;W_S5-DZ1T267H&;*QSL73&R2$AHV=-@IXB0>_ 2-!K(L&J
MDXKPO*,B/,] 9;TV(&PO=V]R:W-H965T0'2J9S!RV]B!L@5VQ+5:20YA?OY)LC '!L*0JV0M(KOZ_5K4=O
M1=DSCP@1\)HF&>];D1#+S[;-@XBDF#?HDF3RRYRR% O990N;+QG!H59*$]MU
MG):=XCBS!CT]-F6#'LU%$F=DRH#G:8K9>D02NNI;R-H,/,2+2*@!>]!;X@5Y
M).)I.66R9U=6PC@E&8]I!HS,^]80?9Z@IE+0$M]CLN*U-B@H,TJ?5>=+V+<<
MY1%)2""4"2S_7LB8)(FR)/WXIS1J57,JQ7I[8_TW#5Z"F6%.QC3Y$8I#&6?&/7TLB:@IN\XB"
M6RJXYRIXI8)WKH)?*OB:F0**YF&"!1[T&%T!4]+2FFIH,K6VA!]G*NZ/@LFO
ML=03@T=!@^?;D60NA#%-Y7+B6 ?D^NM2_?-/<#TA L>);-W"T^,$KJ\^P178
MP"/,"(%3]/V_..Q4]Q?CO3\9OBMF@LP6X/1RQ5FX0V4RTPVY^F,
M,--R*1QJ:H=447L9H*[?LU_J$3R4\1':E9D-QA9TO9#UW5I+7A
M"V&R2N_IFN@K$'3KU#1JN O^SA&:F(0
MC)1?#O6"M"[\;9\@X93$#@G=BH3NNX5[ [!&@PEE]R"0MRYJ[P$U""&G;<:*
MG.TQR7F_D!O@7A3UTN>]0KU/B$'*:_C>$49J!T?T,7O_%UEW8WFQ". [3G(S
M\,*U5@U2I]'=QWTHU&[L[V(&(=1H'N'&W7+C?M@^5AR-@,XWW_$L(1LJC62Y
MAT,=JP?;0B][OU%N#^N;3R"_<]O[[UH^V
M1U]TV=GWS9R<4PV:!SG<:K3VHFS7[L@I80O]UL AH'DFBLMC-5J]9PSU+7YO
M?*3>.?3=>VNF>"2YQVPA786$S*5)I]&6?K'BW:'H"+K4-_$9%?)>KYL1P3(W
ME(#\/J=4;#IJ@NKU9_ O4$L#!!0    ( $!?:U1=68< RP,  #P3   9
M>&PO=V]R:W-H965T8/K0SJ4& ;QW;
M,['=;CNSV7CBM'WH[(,,LF$"R"N).-E?OY*0P4DP(2];7HPNYWR<&Y_D,SE0
M=LIA:RC@LW\2X2:L&>3?9X1]9$
M?-^OF)S9)4H8IR3C,W4ND2?EFBD%+3$CY@<^,D8E"L;2N_4Y%LXM1QE
M$4E((!0$EH][LB!)HI"D'?\84*M\IU(\'1_1OVCGI3,;S,F")C_C4$13:V1!
M2+8X3\0-/7PEQJ&^P@MHPO4O'(RL8T&0.('$X@3!;=_1L$U
M"FY;!<\H>&T5?*/@Z\@4KN@X++' LPFC!V!*6J*I@0ZFUI;NQYG*^UHPN1M+
M/3%;RT(*\X0 W<(ZPHS 7$8QA 5-96EQK).C-SA* P/LE$3A.^ ?X"._ !EZ F4>6.^>L1ZY<$4S$7'X+ T*GP+8,A1E/-QC/.9N(^*2!#WP
MT 6XCHMJ#%JT5W=JU)>MU=&XP1NOS*ZG\;QSV55!_KAYD=&+FI3F9U)Z\3RA
M-SC;$?CUIWP7?!,DY7\W6.J7EOK:4O]_M_0"KG/!A2RP.-L9>2GZ4S."1+N\
M)TPRW#/=NEHL/!AK#Q2?WL_\'AI-[/O3^F@CM*P38,R>8/?EKR_\G0C%23!FWV\D7QOTEB7F<+4_DEU
M(M^O+\YAZ=^PT3]CYQ^,YGNXEL3QZXHHJYJH8U1BCSI.L#[[R*EN&4X'ZKLF!K5W"J=]@:.3BQ3J>'+?QK^ON..]G>R06\7*[4 Y
MM*0[8VN[NL9UPXI3VO-^B?
M*8+J5$==.-;;TM[+<[WOG/&P.M=1\\'^^Y/[1M9K=F=H6&_<>%E\&JOJGH)&
M':B&MJPW>E$-SXO!/FDKI(3M='N&0T#S3!3_J,O5L@5TJ1L?S];GJC6DVQ45
M3-%7NL)L%V<<$K*5D$YO*.UA1:NFF BZU\V+#16"IGH8$2QCHP3D_I92<9RH
M%Y0-L]E_4$L#!!0    ( $!?:U320@!',@4  %D3   9    >&PO=V]R:W-H
M965T+55LAO:@V@R4N:
M<'7=6FN]^=CIJ&@-*55ML0&.;Y9"IE3CK5QUU$8"C2TH33J!YX6=E#+>&E_9
M9_=R?"4RG3 .]Y*H+$VI?)U (K;7+;^U>_# 5FMM'G3&5QNZ@D?03YM[B7>=
M4DO,4N"*"4XD+*];-_['6W]D %;B*X.MJEP30V4AQ#=S\RF^;GG&(D@@TD8%
MQ;]GF$*2&$UHQ]^%TE:YI@%6KW?:;RUY)+.@"J8B^9W%>GW=&K9(#$N:)?I!
M;'^&@E#?Z(M$HNPOV1:R7HM$F=(B+JS!]N9 G(60WYU;M(%*QNDA)AH^D*H4M@@GVF2T;R7)-C-*(_ E4SY4TVH!)(*
M_$G8-TA>S4-.N-!$"[( [/PT8?^XRZYYX<@:K-S!5$0Q9(ZK :ZR8IPSOC(T
MS8-7H-)5%LWKX51\9B)3R"'C$B(AL=B)TE2#RX"&U.V7H>PWKOCK!CVKC>%?
MA%)D2J5\Q4&]I3)VM;G;7-N@DD^#;N#.IK T(?QN$R[(+\)D$9,VB5RI$YYD
MN-_UV[VC8GE+ZL#R06GYH-'R^7()=DM ]O.#/)A@/6#L>,029LV^*#+?Y-%I
MF2CBK*>;5&1-?.^E>&9V,W6V  Y+
MIL\)1@II6?:V(ET&#T\,QA[D'QE\*E0;GU%I[ZC1WB^,+C &^M5:^81NE3C8
MN77]O5#,N-RF&(\RC(G3VY-\B7[5KJ/<>E-B-CKAYK6'AS+ST4G O#K^OK??
MUGB-'GBR763%3?NSM"=YW)!U)67O@=-$,VQT6&JX73;Y&V=13<5-BS6K="Z]
M=G#$N9 *#Z7J&%4V:OY;LW9G]OR%XE:PJ+ ]!\IC)*=!@M+D)HIDYFS]DV*A
MPZ@Q)!(XG;8J ]8F?/M)"OQPW$\)&1.R.G;R@/_+;G_>0:
M/M\!/"2XWQ#YS3NB1SNR3"2^B B)?LXD4S'+/Z/^O(-T ?*OII7V6Q&_>61^
M3P^><_R2*PKB;6\WKU_O[&;-_E@/\/]_W2(3PIUAYG?/\[\OB/S:S:.
M_G[6^S\R[!V#T&E_>&)_+^R?S/PWQ0XY[*>^_W\<^[/"JNK>JV;GY>\'NM\\
MT8TU?^!6U7P)#=]5F/O9ZS]>#=ZHQ*V_(@DL
M425^I6'9R/P<)[_18F//'19":Y':RS50[/]& -\OA="[&[- >9HV_A=02P,$
M%     @ 0%]K5$5T<]%9 P  ; P  !D   !X;"]W;W)K&ULS5?);MLP$/V5@="##:26*"]Q MN EQ9MD:!!T^50]$!+8YNM1+HD
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M*%-:I(6S89 RGC_I?1&(B@,9G' ("X?PV*%WPJ%;.'2=T)R9D[6@FDY&4NQ
M6FN#9@TZO-X)O'DF
M)7(-^P##NWOS\2F$U@PYKIANUX4M1QTX5/L-WDV"3F_DWU65U-GT2YL#NKV2
M;J^1;A/-,YB;HV(\8WP-G[,:ZQ(Y1 /& ]*QH-&Q@O#2VD6N>A.,[T1TD05?EYC
MND3YJR%CS\L=SE\D8W/4?C4;C^+19'% =5A2';Z^;!T^/=5>T#D_TCI\KM:+
M4NM%H]9;334"Y3%AU]3N69<08(K VG*E8F]S%O;?*+%UG6'2Z%-K^F&&_-W *4U,.]70NC'
MB=V@_(,Q^0=02P,$%     @ 0%]K5"&Z09,4!   9@\  !D   !X;"]W;W)K
M&ULG5=-;]LX$/TKA-%#"S22*,E?A6W <=+= &EK
M-&WWL-@#+=,V48ET23J._WV'DB)+)I6-FD-,43/#]T;#>>3D*.1/M:-4HZ4K'.G+/7#(!CX&6&\-YOD
M_
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MN>YUL6[8LNX-33P4X?NB^B#/+K9N(^S:."%$_^QGE';:("]4674 !Y7
MP./NP._X(V12R),+:A%O5$.!1][@ JK#J,ZG ;5?0>UWA[J4T!"E/L$H)5SG
M7_GVUX'MH5-I%_R^C6R,O?X%?I=5U);K045@T)W 9^CT7X "T8QOT;U01:4N
MP(YIM"!2GJ#7'XE<.PMG8 $- [MR'%88>]A-9UC1&7:G,T\2>8"YVR?0*46=
MF(<6FL"++Q#;-F$;WE&%=]0=[[W@VZMO5&;0,U9%^7QDG/#$?(W6[3JRRR.H
M54=!P6$4UC9*@\.XXC#NR $H4%#!JK4Y]^S8D?'Q!5S;IKXM&FAQ!!;%> R&X^]J 7L6>MP
MV!WL#Y(>2'ZRFJ=PMH,2ID[HH87I*L:Q-[S$7MCU&W:CEO+%9YW$?R"4I@>"
M:K^6060QZ >UYE#BMZUPU)KZLUSB#GI9.TX8T=2$;]DJI24O)W9;&(?63G08
MC6M&3>1G]<0=Y+/J%L_M(X?L1&Q+H=VM'4:M\H+/-FL#/PH@[*&,-N!.FK71PG!HW_BY!VRZ@YFVHS_*(_T ?/QN%61Q@
MWGV<*F/6#Z4QMM-L6V&KHOW:)IJ/?L-4$L#!!0    ( $!?:U0">!VV
M'@,  $4+   9    >&PO=V]R:W-H965T//@1(O*IU6C=$U^[#M \FN2%>$YO9SJ#_?K834D")V22^0.SX
MG'O/B7U]^QO&7T4"(-$V2ZD8.(F4ZSO7%6$"&197; U4O8D9S[!40[YRQ9H#
MC@PH2]W \WINA@EUAGTS-^?#/LME2BC,.1)YEF'^-H:4;0:.[^PF%F252#WA
M#OMKO((GD,_K.5]I@%GQ0F C]IZ1EK)D[%4/
M'J*!X^F,((50:@JL_O[ !-)4,ZD\?I>D3A53 _>?=^SW1KP2L\0")BS]3B*9
M#)P;!T40XSR5"[;Y"*6@KN8+62K,+]J4:ST'A;F0+"O!*H.,T.(?;TLC]@!^
MKP$0E(#@&-!I +1+0-L(+3(SLJ98XF&?LPWB>K5BTP_&&X-6:@C5G_%)\>(N X14\2RUPR_H;>#47:S4LT!QX"E77FV;D#_\KS/M1I_'_<
M@;A.):YC)9K%,9A3=BSJ:(M/*MMSU4AI6;)G FBYT6=8GO(FM0+Q7;8J:IP4RF^.9-B
MRS>UAV@%MXU'_ 2RKC8,1LB7P
MGY8XOO=^ WMG+[,SJOJ?LLJ>O&9.Q&\\02=P+;_1:W>O(F CN;'ND)GWK[QR^4ERKK358)7,AGNWF/AMZ
M@4T(&:;:,A#S>L$),F:)3!H_:TZO"6F!V^L-^P>GW6B9$X43P;[13"^&WHT'
M&>9DQ?2C6'_$6D_/\J6"*?>$=>T;>)"NE!9E#389E)17;_):UV$+$/8/ *(:
M$.T#X@. ;@WHG@J(:T#L*E-)<75(B":C@11KD-;;L-F%*Z9#&_F4V[8_:6F^
M4H/3HWN>BA+A"WE%!>_,+,V&"/'G&IU ><):D*965W!["F!\[,+
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MN4?NW/C&ULM5A=3^,X%/TK5K4/(+%-
M['R/2B5H*2#-L!7=F7E8[8-IW#9+$G<V3E!(GX$9%=UC@&>2A/
ME#[G)_?A9<_,/2(QF?/<(9
M&='X9Q3RU67/[X&0+/ FYH]T=T?*@)S%T)?DGP
MNQ*"DA#(/#!_$\
MW:=SFA P)0S,5I@1
MKG)=K(*.K#(F\SZ S@5 )H(*^J@#W8)'Z6,]_8%N!=T\2K_IOKJIH$\^Y_SM
MYU:_T]-G9*V-_;X[_6!U0U1:56ZH*CO1U": ?](!@86X4K5N6*I75E*KHJ88R$0#IU ;Y&OS91
MB&4/ODKH)N5ZOPKST&PZ9ME>']6.%>5EM0-  >R;]CYNHL"I[-V>MK>7$+M*
MB*U/"'X5*L8S("2TN45T 0YR!7 :EM=(*K9/7E1UA6)!;V_KS/QO/Z)1&V=;
ME@(X5@ 14@!OVD#7-!7 B<*B;2N MPJ+T-T'[J7=J=+N:-,^HNF6,#D\B$R7
MM2B++@/%/4Y"5=LIS#H-APY=;B.LP$-"1$];RX
M[6(XV+23B,E)Q.U)Q)T.L9<0KTJ(ITW(S0MA\T@\*6O9S,0N[G+]3+DJ"UZ[
M:R#8;^Q)D8INL(G7:@4*U.TIU%[4?A6U?R)JT1[2I8QW795$)OM#WD'$3)&(
MFLZJAK%WX7B&)GYK?XX\84'E:?#Q3M]H8]KJ#=I5TVXF)T![WD.S'M',]_@/
MQM$V"DD:9C*M?_&5\/LJ_$\,B[)_*T<4L^69Y;FJ-J= VC#0]#G8A-HZK
MY9*1)>:DZ!87+5GY6Y1$AN5;D#H*V/+-,7V=;_5< O6#R:@HSE&,LPQ<@7^^
MD>2)L'\U(P^L!PVHGS0^VN''I=UF T<61)Y[4'8=<;<*G$X08#TY0/WH,",L
M$L%84;;,!?YSI%)#-82"_4:^X$Y>5R:=/<'9:=_J 8EKBD'@6/WG2/S
M-*QE$.IU\+,3]3UL"Y6H8M3W_".NU5H%]6+5MM';[P,  *P,   9    >&PO=V]R:W-H965TRAZH"7:
M8D.)+DG9V7_?(27+LEY(T;TD(CDS_&8X'([G)R[>9$*(0N\IR^3"2I0Z?'8<
M&24DQ=+F!Y+!RHZ+%"L8BKTC#X+@V"BES/%==^*DF&;6IEA\?R2,GQ:69YTGOM%]HO2$LYP?\)YLB'H]K 6,G,I*3%.222"L8B=\I.&&YFH@P$BEM L._(UD1QK0EX/BG
M-&I5>VK%^O?9^D_&>7!FBR59?2>G06-N+.)/F
M+SJ5LJZ%HEPJGI;*0)#2K/B/W\M U!2\28^"7RKX3851CT)0*@3&T8+,N/6$
M%5[.!3\AH:7!FOXPL3':X W-]#%NE(!5"GIJ^0MDRG,6\92@-1%HDV!!T.T&
MLB7.&4%\UUJ]0[=/1&'*Y!WZA%XW3^CVY@[=( =)O2P1S=!K1I6\KTW\EO!<
MXBR&R1L]?J&,P2G*N:/ "8WB1"7P8P'L]P![/GKAF4HD^I+%)+XVX(#W50C\
M_4&+3R2R4>#=(]_UO0Z@UNRU3F.%690S;++^SZ\@
MC9X52>5? WN-JKU&9J_1P.E3LU_7012Z4Z.KR\%QZ4W'<^=8CTTA,ZG)C$?V
MJ!*ZHAI75.-!JC7<9"($B1&D?_2&8GJD,3')D\.91PSK-<@FN""IB50=5Z!28LJ
MF-J3!GI;:.3983?[M&*??C AT"WC$JXX9HQ'> NU0'$$"REDH3F6A+.8B$[\
M:2LIO&!L!PW^MM38GG7CSRK\V2#^PY$(>'Q0EJ=;B#)4K[($P0,F%82?9OM[
M7?9IU,5=&!]?<8_")G=;*ISYXV[PL (/AW.&*\@%"L'^#NG.O\Q\0_@QCG?31W^U)\XI?'PBLIVFYG3(>;:XYXKZ_D7=O__
MLP^%WF]AA7:KTG=( 7Q/K?0NKYT7#,)_>8\2G.U-JW%H%'[H4J]*3E'SZQ,G
M+ 3.5*=70>OY_H#2[K5?S([:WB'54=R=6M^7$K$W[;"$".69
M*OJ?:K9JN1],H]F8?]2MN.DG+V:*/OX%BSW-)&)D!R9=2 L+B:(U+@:*'TQW
MN>4*>E7SF<#/"2*T *SO.)2V&PO=V]R:W-H965TX^C/;!$ -1DYBQ36FE_?'KA) +<2YM%VE?
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MCS#^&QC_VOKB#9S]@>T%"_G>#=3VSKB?6C3KK
M-'J1JR@>,(='G(-9LFK _IX@GJH$>[-F8C8>G2]#F:N78I:KB O==9"%,ES)
M8R/SV&CT>)^&>\ZWQ .C+?.C%9@2YE/OX/@Y>)#3-$&HEO[8J#@&36@9EJUV
MS,P<,UM2&88RC:4.JEK(K+IAZ)8+=;V
MK'4HA9+C1&JN&-'
M:3E4J;*ULWCMQGBG4C )8S**F710NGH#?GXGX9RP
MIDYR,NO."?K4S:R[I^E35]&%CEVS#(D^?"9W5M
MJ901K>J>ZQPMAY$*I5M.H6%365#A;,B&;: :&8.Y
MCL$V(?O8K!G!JE)=(!TBVSK.1T?@1 5LVD3 7/M@B_A]=AMQ Q5B9NJV>:QF
M8P7P>,.11MMNL1QMKGRP6?K>NS=)S759VEV1$Q7R>&F7P\NE%SK_MYU,ZE%Y
M*V-5BC]1X)KV,C#?$,"V'4%AW';:R:!:IB+*=1:UO0Z^;TZ@ZDN>
MNB:MN++#N7"C9N%^)%PP?R$.6R[P%/F"@[/'V1/_DC4%^ >\?W>"Z@IIUY8'&4Q,'I>1_+NOYT$>G>.%"^8!%S0/V
M/\AZ]>4+:19TCM^^^H5/@?&WY.^8K?R(@X L)5&[M*4%MO\\NS\1=)-\'9Q3
M(6B8'*X)]@B+ ?+^DE)Q.(D_.&8?R8?_ E!+ P04    " ! 7VM4>^ZM9&H(
M  "&+@  &0   'AL+W=OG1Z7'YVFYT>IUL61VMZFX%\FR1!]O*9
MQNGSR0B.=A]\C1Y7K/A@PFCA*[S*%V#C#Z>>!S?
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M^,B%_60I1OE_(YNQL""I;FE,)\;C([AWM'/
M]>8WZ1,WM_::7YB/K@I^\;;@_;>-?FF0>_S-XB#/0?H RCT'_K[BWX-+1I/\'XUW7'O'
MI7>RQ_LM)SR:932LW!^!NU60T1R<;=DJS:)_::C:.)5/N_19(VR,"?0;REX)9F55I4J:B\NHUX8"<'@XC%
M(,(?1%SJ$*V$V'5"[%>MC,L\WZI7A=U[-- BMDLZLQV$M<)UZG"=P\*]BC@K
MA4&I\ZHOZ7HY\#"=?A+[2W4 U(K>K:-WM='/TB3A<;8R?:1)M=O/(<&.!S'N
M!&L ; 4\K0.>:@.NBE$5()AOLVC]6*0V2D,9_@W7WR4B5_'7M!^9#1WBN.K
MO#HP3Q]8,?BG0I2'@&>5GU3R:@V<<6VR?J3\],# _0MHXFZ#E_+CL^<@X_'?
M;)-[ODIXR3T+PZ@P#F*CNKCP>G-R-:4)6E)M60/+8_W$E58QC1T1U/NQ^HZI
M Q)^FQ%U"ZH"@KTIH!L2$1ZR(\%7RB+^;M_.5(8/>WO-YNF$WG1/<))4
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M:_?!=NTY2R4"]5+DC7/F,FN]S$I=$,3*!.B'M\:VI4[ P7;M!$C% P,O$Y%5P&1!\=6]Y!DZM$W
M\-C.2J/O,"21RGU5B8XS\/+1LC%\9(WP39SH6D970(+1=M#<[ =RS@1P:3!H?PWEQ@UKC;XS !+4Q
M_@"HG0/)T4C/T8>>KX6[EEK #O&\[@'[0H6$V+/@U.M.W]2G;^*SG0@I$)">
M=M]\;I^A?DL!V=BU^XM?T7OHG/#%=(<]MFB7/I'8)%QT:;B2>&Z
M+:F1;D=*PD8FA*T-ZX8R95!]2B:(:(+"DI*QGI+G_'"^9&"6YJQ1F342?2$<
M-C.$=:%(/L9Z/GYMN^-<^.TH%N0ZW6ZS&NY]2Z(:6-NE?K1
MEF'AL-UV[$Y+BVF'VK@@T#<=R@W"(TR7E(;\:)VE2;TJBBDT2ZMRE>!>4,C6
M+EG)\MCPO-];KM4R5H;3/_\B[:J5/(N->+:2-I]-]!*6_(6=][@$DK2 #^\_
M#]T!]:LVWG,)9(I<&"-]$V0[%Y(TL/EY\A5Z27C7ZR43T,($Y ^ VCF0#(7U
M#'6H7L**SC?T4/\!#^+:EW>2O")9C!B?*CFW4\.:0"2'
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MU/9\986V^^U'9"NJWJ3QD]'B%]K70?88K7,0TP=N:(U=[B&K?O1&ULM5;;;MI
M$/V5D=6'1*+8V$!(!4@!>I.:%B5*^U#U8;$'6'4O='<(S=]W=VU<0L#J2WG
M>_&<.>?L93S<:?/3KA$)?DNA["A:$VW>Q+'-URB9;>L-*C>SU$8R*BW)+C"N0&[E9*9IPD*O1M%G6@_<,=7:_(#
M\7BX82N\1WK8S(WKQ35*P24JR[4"@\M1=--Y,^TD/B"\\97CSAZTP4M9:/W3
M=SX6HRCQC%!@3AZ"N<T
M'D6#" IW+@1,%3#5BKA:H>R==)X=;E6%MXJPHLG@/$CGRM(-TKF*2-B#/,VY!U
M6I F:><$H>F_AR<-=++:T"S@=<_@?=+6'MCXU(*Y&^$+@1"F/FN"FSPWVV/Q
MI=82O!_ _1%\'%^W^\/X\02C;LVHV\AH*AB7L.0"BQ9LE<%<&V<]K-PAA_R
MZ2GSNB_X=-/VX#2A7DVHUTCHO4]\(9P;E^XF$(P<&=(@./$5"X?;(I% ORM/
M>52B#PXY9>U>S:DDWGM!/$O/.=FOB?>;U_84PQ8PJ;?^_.Q8\'5IM 1-:S2P
M88:>3DGH-TMXQNZJ9G?5R&Y>7:YSP50+9KAT\P5,4+D6P?=;E LT/QJV^*!.
M-/BOZS=X(3[+SNVIZYK3=2.G+\%O=]3(('$3F\E_]:""
M/SKHU\]^1X[$![>\1+,*Q<^Z$^PV7WE=UJ-U@;T)9>5H?.(+;Z@>?V'*JGW+
MS(HK"P*7#C)I7[E39,I"6'9(;T(M66ARE2DTU^[C 8U_PH/T?&
M?P!02P,$%     @ 0%]K5/0,K8CJ @  RPD  !D   !X;"]W;W)K&ULI59=;]HP%/TK5K2'5MKR30(5()6R3PFM*NKV,.W!)!=B
M-;&9;:#]][.=$%*21A-[(;9SS_$Y-KGWC@^,/XD,0*+G(J=B8F52;F\<1R09
M%%C8; M4O5DS7F"IIGSCB"T'G!I0D3N^ZT9.@0FUIF.S=L^G8[:3.:%PSY'8
M%07F+S/(V6%B>=9QX8%L,JD7G.EXBS>P!/FXO>=JYM0L*2F "L(HXK">6+?>
MS=P+-,!$_"!P$(TQTE96C#WIR==T8KE:$>202$V!U6,/=Y#GFDGI^%.16O6>
M&M@<']D_&?/*S H+N&/Y3Y+*;&(-+93"&N]R^< .7Z R--!\"Z [0Z@5]!K;A>)N1
M!-VJOQ"ZFH/$)!?7Z -Z7,[1U;MK] X1BA8DS]6=B;$CE0+-XR35;K-R-_^-
MW0*T8%1F GVD*:0=^+M^O.?W$#C*>NW?/_J?^;V,_Z7I>@_X//
M_QWN]K@)ZML,#%_8?YM=/DI@9( Z&>RG_FAH!V-GWY3;$17&ME]'O5(5UJK"
M7E6/E$A(T5)B":+'Y:#F&USJL@0.F_I]UQZ;%GQ]TNHUI5U*M*Y= -
MV14]_N*:*;[0WRQNW4\0V=&9O;AE+QC8PVYWPUK3L%?3-[S%M,?;J.8977IW
MH[;LL.6M'>0'=MCMS7-/2=#M5?5=9L"1*B2J3/2Y]!IIU;O49X5L>FC?84>0
M%S4^U]>R_),LOU=691']6D"Q OZ[S^LIZ7@79QVOG5#BN/%?K,QV1 T:7VVI
MRVE4N0+XQG0+ B5L1V69\.O5NB.Y-77X;/U.=RJF>IYHRC9G@?F&4(%R6"M*
MUXY5IN!EYU!.)-N:6KIB4E5F,\Q4MP5&ULO5==;YLP%/TK%NI#*ZT!FR0D51*I7]LJM5+5K.M#M0<7;A*K8&>V:;I_
M/QL(D)2PKE6;AP3,/?>>>PR'F]%*R$>U -#H.8FY&CL+K9='KJO"!214=<02
MN+DR$S*AVIS*N:N6$FB4@9+8)9[7=Q/*N#,996O7+0G%]'8\2PCB"'4-@4U/T]P"G%L,QD>OXND3EG3 NO'
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M)47WER8<76A(U*^68MVR6#@*?0M TYL)\![2/^-"'#0<4L3=!Z^^ZO('D V;9)05DG^/@[8E 6&[Q+
M^QS=JZD:;-\3@R;A!\U:#TM:PU9:/R!<SBU_\.?X&^X,CC\9H%)974SB;HS@PPZ)8SK5ZE=650N/\)
M6E<^A8,W:QV\%+'OOWB=-(7U\$ZM*U/#[:ZV=N?7J%M9$AY^O+JD4QD/D/G)UHLLS'T06@SU&:'"_._ Z0-
M,-=G0NCUB2U0_I.9_ 502P,$%     @ 0%]K5-_9_0P4 P  ! L  !D   !X
M;"]W;W)K&ULK59K;]HP%/TK5J1)K321.#Q; 5()
MG3IMK1#L\6':!Q,NQ"*QF>V4(NW'[SH)@780*L27)'ZIW96IB+F"DB$Z3A*G- &*Y[CG4V4Z,^2(R=L+M=U=L 1,PWU=9S/*L(8@B-I6#X
M>H8 XM@RH8X_!:E3GFF!^]];]D]9\!C,E&D(9/R3STS4BB&?1?Z3
ML-9>/3&EF+7WFEP-P3 >Z^NN:_ X"W+#@GJ04_M'J*E/'J4PD2;W8@:SUP0N
MZBS%^ENQ [^2<0AAC=3I1^)[/CT@*'@_W*N04R^]JV=\C2-\WT"0KTPM0!L2
M9%<%2I._9 S/(%(@ Q!AA'^.)Z6\62IO5A)--H*A,1=UK56>W3K7M6H@]8^Y=@+7
M..%:NU3>KB3ZLDEUE))[FPP5#\E(KM&D2WK8*95TSO6P&GC(PU<*;DH%-Y5$
M]P+48D,>F)I*19[2, 9F@U4K681Z25^HMTNLWIG.!">0M'["&KJ7W6DEU5!B
MS;!A%2Y-L))')&!*XDYV66?\G2C_;&>JD=0[YF0%RAI]L,96L]<[
MQU+1":!/O:-FNGO]!,I<9&V6)J%,ABH=]J[/[G<1XY;Z(2$7N+S%Q"C
MM!AIO$NZ4?<[-1KTBK,-5WU!^=DX]#<;)"9TBG379@^
M69LF(\$RD*-YOH"[464(H#&JL(.4TUQ)VFA8>[0#2SMG0MS"T_ ]V^%>9EM5
M[4%-93>T@MJAHW$3X-]F<]S;M*_C#4K^H,SGVFY'-G-H%G:C6<:7S7R9=0(P
M]C[.3LM2K#X)GLN"N^LB
MSP]!9'P((@^@)Z/D36H,VZ-QZ_S=.7T[:P!O.6/R#=ZHQ"9H,*NY,%RVLP5/
M4R:?',*6WM"9?='=X;?K4Y;16IB[#AR3S?B:I;PNDF[5#22B7;49?X7M]>/N
M%?F0:?/!XOA]$GOY=YHD413'6$:G4Z^"*9:W.(:O
MGPW3!AY8'(CT9[G&JXUWR/-]@-7TN0[!=HIW(K93/-> ^/,&'DGBKS86!SRP
M*F"] _']<:"G_#Y1!%7%M&%/,(XD"89 +_I[-(Z1[,3P\=<'>TJB*$G\"&!^
M!5&$(? TX@BF #1@2!0UY^#>>12NSZEP\^O/Y!=02P,$%     @ 0%]K5)>*
MNQS     $P(   L   !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(
MMB6/:(7->=I3W;+T]!
M;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B
M':5_'/=8JV_W=?V-?2^+2E_T-L9LW_;[.MN(DNN_ZJVH[)55K4IN
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M/!D@.YMS !DBD.$1(=.E/7R^NK. LVLVFU\M &2$0$8G@YR,TQL &2.0\Y6PAM &0(P1R1 LYK1[L"^S0
M+S0 >H, O:$%LDK;6N$\O6;S@E>FK2Y7?5OW/CA(GV.C]#EUK1E>K=V'LK'6
MUE$0#-4'M3^RK&Y<+YOS)^[P7/790M6(G-U*B(GI9$#LDTMQ[[4E9HX!L3IN
M!==>YQ]@BA@0.^*:2\6^\*(1[+,%:Y1P;_#P,#D,B.TP%Y6V96VWFM?:*&%D
MA\AN!"\@)J:' ;$?4E-GW_[\8!LV9Y.ZM'?2OT=3 \P, V(U3*NL+@5;\N]^
MS\-$," VP9UP@6?+-;RO
MI! 02\$.LTW9V NVT\W,QM:AZWI*;-PS\P#K,L 4$1 K(A7K]GD]D&2@60:Q
M%M*F++EZ8O6*I7)=2?LV%P+\E!JT5X 9(R VQD+8F*D1SSU1V?16LT=I-FS2
M>(%=@*DDH$XWL/CS:P Q,:4$Q$H!$2@[6[J@1;^";)A' F*/H,$H.X.8F$X"
M2*NV7;5^SL4A@NHY+C=(^[%&_Q
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M0C[WYE?B2BAEFWI7##$Q^23D"[_\%
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MQ_F#XA)E7!(D3; FT#HBUY' ZXA@1P*Q(Y(="@OJ+01Z"^HM!'H+ZBT$>BOJK01Z*^JM!'HKZJT$>NOD90F!WHIZ*X'>BGHK
M@=Z*>BN!WHIZ*X'>BGHK@=Z*>BN!W@GU3@1Z)]0[$>B=4.]$H'="O1.!WFGR
MLIM [X1Z)P*]$^J="/1.J']G4!O1[V=0&]'O9U ;T>]G4!OG_QL0J"WH]Y.H+>CWDZ@MZ/>3J!W1KTS
M@=X9]F?4.Q/HG5'O3*!W1KTS@=X9]F?4.Q/HG2<_"Q+HG5'O3*!W
M1KTS@=X%]2X$>A?4NQ#H75#O0J!W0;T+@=X%]2X$>A?4NQ#H75#O\IUZ#^/G
MH0ZWGJ\U7O\[J1XOY];;Y:_+KYV3>_R*<[BO&)[_ E!+ P04    " ! 7VM4
M@]&L 2X"  !$,0  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VTUNVS 0AN&K
M&-H&EBQ2I-0BSJ;MMLVB%V E.A:L/Y!,ZMR^E)P$:)$:"5R@[\:"37*^$0=X
M=K[^_CA9OSKVW>"WR3Z$Z6.6^7IO>^/3<;)#7-F-KCY1G)S_=GNS'T75E^.\6??CL,V<;;SR>K3:>._R^G?Q5W)!DKR;,*W\/>#KW[<$ZUS9V=6M<^&KZN"L[
M=ID/CYWUZ?D2K_0X[G9M;9NQON_CD=1/SIK&[ZT-?9>>BEZ=3P[QANWI,[\X
M?RES+C#NO'7CY./$G'U_W/-(YM/K*1:R+K3G7_$E,9:^^/WL/.W&-F_,CM?[
MFC@/2A('UH2!\EI(\*TL<'2!_YAM((
M1=2<0FI.,36GH)I35,TIK.845W,*K#E%5D&155!D%119!45609%54&05%%D%
M159!D5509)44625%5DF155)DE119)45629%54F25%%DE1=:"(FM!D;6@R%I0
M9"THLA8460N*K 5%UH(B:T&155%D5119%45619%54615%%D5159%D5519%44
M635%5DV155-DU119-45639%54V35%%DU159-D;6DR%I29"TILI8464N*K"5%
MUI(B:TF1M:3(6E)DK2BR5A19*XJL%476BB)K19&U^I^R_AC'PS^.7YYI;]KA
M.3];_CQQ\PM02P$"% ,4    " ! 7VM4!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $!?:U0=%FDF
M[P   "L"   1              "  :\   !D;V-0&UL4$L! A0#%     @ 0%]K5(=T*&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5/$]MKV? P  = T  !@              ("!
MC1<  'AL+W=O)   &
M    @('K(0  >&PO=V]R:W-H965T&UL4$L! A0#%     @
M0%]K5)F8_%KY!0  ,!T  !@              ("!@2H  'AL+W=O&PO=V]R
M:W-H965T&UL4$L! A0#%     @ 0%]K5! HQ\[> @  9@8
M !D              ("![3D  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5'C,AEY>!P  R14  !D
M ("!>40  'AL+W=O&PO=V]R:W-H965T
M&UL4$L! A0#
M%     @ 0%]K5$=OW?_<%0  8$(  !D              ("!$%H  'AL+W=O
M&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5 BI
M_8@_!P  K10  !D              ("!.XX  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5#3JUIT.!@  J@X  !D
M             ("!9[   'AL+W=O&PO
M=V]R:W-H965T_2  !X;"]W;W)K&UL4$L! A0#%     @ 0%]K5%M=*&9" P  ; @  !D              ("!
M(M<  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%
M  @ 0%]K5&B'3*M$ P  M@<  !D              ("!4N   'AL+W=O&PO=V]R:W-H965TP(  %D%   9              " @=?F  !X
M;"]W;W)K&UL4$L! A0#%     @ 0%]K5+::JJ8\
M P  -0<  !D              ("!B>D  'AL+W=O&PO=V]R:W-H965T?O  !X;"]W;W)K&UL4$L! A0#%     @ 0%]K5#S[DW!J!P  %2$  !D
M         ("!T/@  'AL+W=O&PO=V]R
M:W-H965T&UL
M4$L! A0#%     @ 0%]K5$[5_3:9 P  -0@  !D              ("!Z D!
M 'AL+W=O
M2IL$   U"P  &0              @(&X#0$ >&PO=V]R:W-H965T&UL4$L! A0#%     @
M0%]K5"Y(^OJ1!0  XQ8  !D              ("!TQH! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5,JN#.GW @  $@H  !D
M     ("!GS ! 'AL+W=O&PO=V]R:W-H
M965T&UL4$L!
M A0#%     @ 0%]K5..VLT$V @  'P4  !D              ("!VSH! 'AL
M+W=O&PO=V]R:W-H965T*,,B0(    (   9              "
M@?Y  0!X;"]W;W)K&UL4$L! A0#%     @ 0%]K
M5(>G->3@ @  ,P@  !D              ("!OD,! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5,$PE"+" P  -0X
M !D              ("!H4P! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5#Z<2W:M @  [08  !D
M ("!W58! 'AL+W=O&PO=V]R:W-H965T
M 0!X;"]W;W)K&UL4$L! A0#
M%     @ 0%]K5"KOTO$D!   J@\  !D              ("!I&8! 'AL+W=O
M&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5#GC
MI5>9 @  J0<  !D              ("!AG$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5.DP%)8I P  K0P  !D
M             ("!SWX! 'AL+W=O&PO
M=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5($G]?KN P  11(  !D              ("!
M:8D! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%
M  @ 0%]K5%U9AP#+ P  /!,  !D              ("!-IL! 'AL+W=O&UL4$L! A0#%     @ 0%]K5"&Z09,4
M!   9@\  !D              ("!,:@! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 0%]K5#[>-&/[!   \Q4  !D
M         ("!R;(! 'AL+W=O&PO=V]R
M:W-H965T&UL
M4$L! A0#%     @ 0%]K5'ONK61J"   ABX  !D              ("!.,$!
M 'AL+W=O
M#04#  ":"   &0              @('9R0$ >&PO=V]R:W-H965T&UL4$L! A0#%     @
M0%]K5&9G72EB P  U0P  !D              ("!-M ! 'AL+W=O&PO=V]R:W-H965T


XML
111
report.css
IDEA: XBRL DOCUMENT

/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}



XML
112
FilingSummary.xml
IDEA: XBRL DOCUMENT




  3.22.0.1
  
  html
  278
  527
  1
  false
  81
  0
  false
  4
  
    
      false
      false
      R1.htm
      0001001 - Document - Cover Page
      Sheet
      http://www.centrusenergy.com/role/CoverPage
      Cover Page
      Cover
      1
    
    
      false
      false
      R2.htm
      0002002 - Document - Audit Information
      Sheet
      http://www.centrusenergy.com/role/AuditInformation
      Audit Information
      Notes
      2
    
    
      false
      false
      R3.htm
      1001003 - Statement - CONSOLIDATED BALANCE SHEETS
      Sheet
      http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS
      CONSOLIDATED BALANCE SHEETS
      Uncategorized
      3
    
    
      false
      false
      R4.htm
      1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)
      Sheet
      http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical
      CONSOLIDATED BALANCE SHEETS (Parenthetical)
      Cover
      4
    
    
      false
      false
      R5.htm
      1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS
      Sheet
      http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS
      CONSOLIDATED STATEMENTS OF OPERATIONS
      Statements
      5
    
    
      false
      false
      R6.htm
      1004006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
      Sheet
      http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS
      CONSOLIDATED STATEMENTS OF CASH FLOWS
      Statements
      6
    
    
      false
      false
      R7.htm
      1005007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
      Sheet
      http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT
      CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
      Statements
      7
    
    
      false
      false
      R8.htm
      2110103 - Disclosure - Cash, Cash Equivalents and Restricted Cash
      Sheet
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCash
      Cash, Cash Equivalents and Restricted Cash
      Notes
      8
    
    
      false
      false
      R9.htm
      2114104 - Disclosure - Inventories
      Sheet
      http://www.centrusenergy.com/role/Inventories
      Inventories
      Notes
      9
    
    
      false
      false
      R10.htm
      2118105 - Disclosure - Property, Plant and Equipment
      Sheet
      http://www.centrusenergy.com/role/PropertyPlantandEquipment
      Property, Plant and Equipment
      Notes
      10
    
    
      false
      false
      R11.htm
      2122106 - Disclosure - Intangible Assets
      Sheet
      http://www.centrusenergy.com/role/IntangibleAssets
      Intangible Assets
      Notes
      11
    
    
      false
      false
      R12.htm
      2126107 - Disclosure - Accounts Payable and Accrued Liabilities
      Sheet
      http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilities
      Accounts Payable and Accrued Liabilities
      Notes
      12
    
    
      false
      false
      R13.htm
      2129108 - Disclosure - Debt
      Sheet
      http://www.centrusenergy.com/role/Debt
      Debt
      Notes
      13
    
    
      false
      false
      R14.htm
      2133109 - Disclosure - Leases
      Sheet
      http://www.centrusenergy.com/role/Leases
      Leases
      Notes
      14
    
    
      false
      false
      R15.htm
      2137110 - Disclosure - Fair Value Measurements
      Sheet
      http://www.centrusenergy.com/role/FairValueMeasurements
      Fair Value Measurements
      Notes
      15
    
    
      false
      false
      R16.htm
      2141111 - Disclosure - Pension and Postretirement Health and Life Benefits
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefits
      Pension and Postretirement Health and Life Benefits
      Notes
      16
    
    
      false
      false
      R17.htm
      2152112 - Disclosure - Stock-Based Compensation
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensation
      Stock-Based Compensation
      Notes
      17
    
    
      false
      false
      R18.htm
      2163114 - Disclosure - Income Taxes
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxes
      Income Taxes
      Notes
      18
    
    
      false
      false
      R19.htm
      2170115 - Disclosure - Net Income Per Share
      Sheet
      http://www.centrusenergy.com/role/NetIncomePerShare
      Net Income Per Share
      Notes
      19
    
    
      false
      false
      R20.htm
      2178117 - Disclosure - Commitments and Contingencies
      Sheet
      http://www.centrusenergy.com/role/CommitmentsandContingencies
      Commitments and Contingencies
      Notes
      20
    
    
      false
      false
      R21.htm
      2180118 - Disclosure - Accumulated Other Comprehensive Income (Loss)
      Sheet
      http://www.centrusenergy.com/role/AccumulatedOtherComprehensiveIncomeLoss
      Accumulated Other Comprehensive Income (Loss)
      Notes
      21
    
    
      false
      false
      R22.htm
      2181119 - Disclosure - Segment Information
      Sheet
      http://www.centrusenergy.com/role/SegmentInformation
      Segment Information
      Notes
      22
    
    
      false
      false
      R23.htm
      2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)
      Sheet
      http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies
      Summary of Significant Accounting Policies (Policies)
      Policies
      23
    
    
      false
      false
      R24.htm
      2305301 - Disclosure - Revenue and Contracts with Customers (Tables)
      Sheet
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables
      Revenue and Contracts with Customers (Tables)
      Tables
      24
    
    
      false
      false
      R25.htm
      2311302 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables)
      Sheet
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashTables
      Cash, Cash Equivalents and Restricted Cash (Tables)
      Tables
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCash
      25
    
    
      false
      false
      R26.htm
      2315303 - Disclosure - Inventories (Tables)
      Sheet
      http://www.centrusenergy.com/role/InventoriesTables
      Inventories (Tables)
      Tables
      http://www.centrusenergy.com/role/Inventories
      26
    
    
      false
      false
      R27.htm
      2319304 - Disclosure - Property, Plant and Equipment (Tables)
      Sheet
      http://www.centrusenergy.com/role/PropertyPlantandEquipmentTables
      Property, Plant and Equipment (Tables)
      Tables
      http://www.centrusenergy.com/role/PropertyPlantandEquipment
      27
    
    
      false
      false
      R28.htm
      2323305 - Disclosure - Intangible Assets (Tables)
      Sheet
      http://www.centrusenergy.com/role/IntangibleAssetsTables
      Intangible Assets (Tables)
      Tables
      http://www.centrusenergy.com/role/IntangibleAssets
      28
    
    
      false
      false
      R29.htm
      2327306 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)
      Sheet
      http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesTables
      Accounts Payable and Accrued Liabilities (Tables)
      Tables
      http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilities
      29
    
    
      false
      false
      R30.htm
      2330307 - Disclosure - Debt Schedule of Debt (Tables)
      Sheet
      http://www.centrusenergy.com/role/DebtScheduleofDebtTables
      Debt Schedule of Debt (Tables)
      Tables
      30
    
    
      false
      false
      R31.htm
      2334308 - Disclosure - Leases (Tables)
      Sheet
      http://www.centrusenergy.com/role/LeasesTables
      Leases (Tables)
      Tables
      http://www.centrusenergy.com/role/Leases
      31
    
    
      false
      false
      R32.htm
      2338309 - Disclosure - Fair Value Measurements (Tables)
      Sheet
      http://www.centrusenergy.com/role/FairValueMeasurementsTables
      Fair Value Measurements (Tables)
      Tables
      http://www.centrusenergy.com/role/FairValueMeasurements
      32
    
    
      false
      false
      R33.htm
      2342310 - Disclosure - Pension and Postretirement Health and Life Benefits (Tables)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      Pension and Postretirement Health and Life Benefits (Tables)
      Tables
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefits
      33
    
    
      false
      false
      R34.htm
      2353311 - Disclosure - Stock-Based Compensation (Tables)
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensationTables
      Stock-Based Compensation (Tables)
      Tables
      http://www.centrusenergy.com/role/StockBasedCompensation
      34
    
    
      false
      false
      R35.htm
      2364313 - Disclosure - Income Taxes Income Taxes (Tables)
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables
      Income Taxes Income Taxes (Tables)
      Tables
      35
    
    
      false
      false
      R36.htm
      2371314 - Disclosure - Net Income Per Share (Tables)
      Sheet
      http://www.centrusenergy.com/role/NetIncomePerShareTables
      Net Income Per Share (Tables)
      Tables
      http://www.centrusenergy.com/role/NetIncomePerShare
      36
    
    
      false
      false
      R37.htm
      2375315 - Disclosure - Stockholders' Equity (Tables)
      Sheet
      http://www.centrusenergy.com/role/StockholdersEquityTables
      Stockholders' Equity (Tables)
      Tables
      37
    
    
      false
      false
      R38.htm
      2382316 - Disclosure - Segment Information (Tables)
      Sheet
      http://www.centrusenergy.com/role/SegmentInformationTables
      Segment Information (Tables)
      Tables
      http://www.centrusenergy.com/role/SegmentInformation
      38
    
    
      false
      false
      R39.htm
      2403401 - Disclosure - Summary of Significant Accounting Policies (Details)
      Sheet
      http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails
      Summary of Significant Accounting Policies (Details)
      Details
      http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies
      39
    
    
      false
      false
      R40.htm
      2406402 - Disclosure - Revenue and Contracts with Customers (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails
      Revenue and Contracts with Customers (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables
      40
    
    
      false
      false
      R41.htm
      2407403 - Disclosure - Revenue and Contracts with Customers (Revenue from External Customers by Geographic Areas) (Details)
      Sheet
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails
      Revenue and Contracts with Customers (Revenue from External Customers by Geographic Areas) (Details)
      Details
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables
      41
    
    
      false
      false
      R42.htm
      2408404 - Disclosure - Revenue and Contracts with Customers (Contract with Customer Asset and Liability) (Details)
      Sheet
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails
      Revenue and Contracts with Customers (Contract with Customer Asset and Liability) (Details)
      Details
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables
      42
    
    
      false
      false
      R43.htm
      2409405 - Disclosure - Revenue and Contracts with Customers Accounts Receivable (Schedule of Accounts Receivable) (Details)
      Sheet
      http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails
      Revenue and Contracts with Customers Accounts Receivable (Schedule of Accounts Receivable) (Details)
      Details
      43
    
    
      false
      false
      R44.htm
      2412406 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details)
      Sheet
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails
      Cash, Cash Equivalents and Restricted Cash (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details)
      Details
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashTables
      44
    
    
      false
      false
      R45.htm
      2413407 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Schedule of Restricted Cash) (Details)
      Sheet
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails
      Cash, Cash Equivalents and Restricted Cash (Schedule of Restricted Cash) (Details)
      Details
      http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashTables
      45
    
    
      false
      false
      R46.htm
      2416408 - Disclosure - Inventories (Schedule of Inventories) (Details)
      Sheet
      http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails
      Inventories (Schedule of Inventories) (Details)
      Details
      http://www.centrusenergy.com/role/InventoriesTables
      46
    
    
      false
      false
      R47.htm
      2417409 - Disclosure - Inventories (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/InventoriesNarrativeDetails
      Inventories (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/InventoriesTables
      47
    
    
      false
      false
      R48.htm
      2420410 - Disclosure - Property, Plant and Equipment (Tables) (Details)
      Sheet
      http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails
      Property, Plant and Equipment (Tables) (Details)
      Details
      http://www.centrusenergy.com/role/PropertyPlantandEquipmentTables
      48
    
    
      false
      false
      R49.htm
      2421411 - Disclosure - Property, Plant and Equipment (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails
      Property, Plant and Equipment (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/PropertyPlantandEquipmentTables
      49
    
    
      false
      false
      R50.htm
      2424412 - Disclosure - Schedule of Intangible Assets (Details)
      Sheet
      http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails
      Schedule of Intangible Assets (Details)
      Details
      50
    
    
      false
      false
      R51.htm
      2425413 - Disclosure - Intangible Assets Schedule of Intangible Asset Amortization (Details)
      Sheet
      http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails
      Intangible Assets Schedule of Intangible Asset Amortization (Details)
      Details
      51
    
    
      false
      false
      R52.htm
      2428414 - Disclosure - Accounts Payable and Accrued Liabilities (Details)
      Sheet
      http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails
      Accounts Payable and Accrued Liabilities (Details)
      Details
      http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesTables
      52
    
    
      false
      false
      R53.htm
      2431415 - Disclosure - Schedule of Debt (Details)
      Sheet
      http://www.centrusenergy.com/role/ScheduleofDebtDetails
      Schedule of Debt (Details)
      Details
      53
    
    
      false
      false
      R54.htm
      2432416 - Disclosure - Debt (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/DebtNarrativeDetails
      Debt (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/DebtScheduleofDebtTables
      54
    
    
      false
      false
      R55.htm
      2435417 - Disclosure - Leases (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/LeasesNarrativeDetails
      Leases (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/LeasesTables
      55
    
    
      false
      false
      R56.htm
      2436418 - Disclosure - Maturity of Operating Lease Liabilities (Details)
      Sheet
      http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails
      Maturity of Operating Lease Liabilities (Details)
      Details
      56
    
    
      false
      false
      R57.htm
      2439419 - Disclosure - Fair Value Measurements (Financial Instruments Recorded at Fair Value) (Details)
      Sheet
      http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails
      Fair Value Measurements (Financial Instruments Recorded at Fair Value) (Details)
      Details
      http://www.centrusenergy.com/role/FairValueMeasurementsTables
      57
    
    
      false
      false
      R58.htm
      2440420 - Disclosure - Fair Value Measurements (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails
      Fair Value Measurements (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/FairValueMeasurementsTables
      58
    
    
      false
      false
      R59.htm
      2443421 - Disclosure - Pension and Postretirement Health and Life Benefits (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails
      Pension and Postretirement Health and Life Benefits (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      59
    
    
      false
      false
      R60.htm
      2444422 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Changes in Projected Benefit Obligations) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Changes in Projected Benefit Obligations) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      60
    
    
      false
      false
      R61.htm
      2445423 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Net Benefit Costs) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Net Benefit Costs) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      61
    
    
      false
      false
      R62.htm
      2446424 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      62
    
    
      false
      false
      R63.htm
      2447425 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Assumptions Used) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Assumptions Used) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      63
    
    
      false
      false
      R64.htm
      2448426 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Healthcare Cost Trend Rates) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofHealthcareCostTrendRatesDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Healthcare Cost Trend Rates) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      64
    
    
      false
      false
      R65.htm
      2449427 - Disclosure - Pension and Postretirement Health and Life Benefits (Plan Asset Allocations) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails
      Pension and Postretirement Health and Life Benefits (Plan Asset Allocations) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      65
    
    
      false
      false
      R66.htm
      2450428 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Fair Value of Plan Assets) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Fair Value of Plan Assets) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      66
    
    
      false
      false
      R67.htm
      2451429 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Estimated Future Benefit Payments) (Details)
      Sheet
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails
      Pension and Postretirement Health and Life Benefits (Schedule of Estimated Future Benefit Payments) (Details)
      Details
      http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables
      67
    
    
      false
      false
      R68.htm
      2454430 - Disclosure - Stock-Based Compensation (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails
      Stock-Based Compensation (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/StockBasedCompensationTables
      68
    
    
      false
      false
      R69.htm
      2455431 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Costs) (Details)
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails
      Stock-Based Compensation (Stock-Based Compensation Costs) (Details)
      Details
      http://www.centrusenergy.com/role/StockBasedCompensationTables
      69
    
    
      false
      false
      R70.htm
      2456432 - Disclosure - Stock-Based Compensation Stock-Based Compensation (Assumptions Used in the Black-Scholes Option Pricing Model) (Details)
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails
      Stock-Based Compensation Stock-Based Compensation (Assumptions Used in the Black-Scholes Option Pricing Model) (Details)
      Details
      70
    
    
      false
      false
      R71.htm
      2457433 - Disclosure - Stock-Based Compensation Costs, Rollforward (Details)
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails
      Stock-Based Compensation Costs, Rollforward (Details)
      Details
      71
    
    
      false
      false
      R72.htm
      2458434 - Disclosure - Stock-Based Compensation (Options) (Details)
      Sheet
      http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails
      Stock-Based Compensation (Options) (Details)
      Details
      http://www.centrusenergy.com/role/StockBasedCompensationTables
      72
    
    
      false
      false
      R73.htm
      2459435 - Disclosure - Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price (Details)
      Sheet
      http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails
      Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price (Details)
      Details
      73
    
    
      false
      false
      R74.htm
      2465437 - Disclosure - Income Taxes (Details)
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxesDetails
      Income Taxes (Details)
      Details
      http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables
      74
    
    
      false
      false
      R75.htm
      2466438 - Disclosure - Income Taxes (Taxes by Jurisdiction) (Details)
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails
      Income Taxes (Taxes by Jurisdiction) (Details)
      Details
      http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables
      75
    
    
      false
      false
      R76.htm
      2467439 - Disclosure - Income Taxes (Deferred Income Taxes) (Details)
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails
      Income Taxes (Deferred Income Taxes) (Details)
      Details
      http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables
      76
    
    
      false
      false
      R77.htm
      2468440 - Disclosure - Income Taxes (Rate Reconciliation) (Details)
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails
      Income Taxes (Rate Reconciliation) (Details)
      Details
      http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables
      77
    
    
      false
      false
      R78.htm
      2469441 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details)
      Sheet
      http://www.centrusenergy.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails
      Income Taxes (Unrecognized Tax Benefits) (Details)
      Details
      http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables
      78
    
    
      false
      false
      R79.htm
      2472442 - Disclosure - Net Income Per Share (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails
      Net Income Per Share (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/NetIncomePerShareTables
      79
    
    
      false
      false
      R80.htm
      2473443 - Disclosure - Net Income Per Share (Schedule of Income Per Share) (Details)
      Sheet
      http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails
      Net Income Per Share (Schedule of Income Per Share) (Details)
      Details
      http://www.centrusenergy.com/role/NetIncomePerShareTables
      80
    
    
      false
      false
      R81.htm
      2476444 - Disclosure - Stockholders' Equity (Tables) (Details)
      Sheet
      http://www.centrusenergy.com/role/StockholdersEquityTablesDetails
      Stockholders' Equity (Tables) (Details)
      Details
      http://www.centrusenergy.com/role/StockholdersEquityTables
      81
    
    
      false
      false
      R82.htm
      2477445 - Disclosure - Stockholders' Equity (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails
      Stockholders' Equity (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/StockholdersEquityTables
      82
    
    
      false
      false
      R83.htm
      2479446 - Disclosure - Commitment and Contingencies (Details)
      Sheet
      http://www.centrusenergy.com/role/CommitmentandContingenciesDetails
      Commitment and Contingencies (Details)
      Details
      83
    
    
      false
      false
      R84.htm
      2483447 - Disclosure - Revenue by Geographic Area (Details)
      Sheet
      http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails
      Revenue by Geographic Area (Details)
      Details
      84
    
    
      false
      false
      R85.htm
      2484448 - Disclosure - Segment Information (Segment Reporting Information) (Details)
      Sheet
      http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails
      Segment Information (Segment Reporting Information) (Details)
      Details
      http://www.centrusenergy.com/role/SegmentInformationTables
      85
    
    
      false
      false
      R86.htm
      2485449 - Disclosure - Segment Information (Narrative) (Details)
      Sheet
      http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails
      Segment Information (Narrative) (Details)
      Details
      http://www.centrusenergy.com/role/SegmentInformationTables
      86
    
    
      false
      false
      All Reports
      Book
      All Reports
    
  
  
    leu-20211231.htm
    exhibit21-listofsubsidiari.htm
    exhibit_10-30x20211231.htm
    exhibit_10-50x20211231.htm
    exhibit_23-1x20211231.htm
    exhibit_31-1x20211231.htm
    exhibit_31-2x20211231.htm
    exhibit_32-1x20211231.htm
    exhibit_4-16x20211231.htm
    leu-20211231.xsd
    leu-20211231_cal.xml
    leu-20211231_def.xml
    leu-20211231_lab.xml
    leu-20211231_pre.xml
  
  
    leu-20211231_g1.jpg
    leu-20211231_g2.jpg
  
  
    http://fasb.org/us-gaap/2021-01-31
    http://xbrl.sec.gov/dei/2021q4
  
  true
  true





JSON
115
MetaLinks.json
IDEA: XBRL DOCUMENT

{
 "instance": {
  "leu-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 278,
   "dts": {
    "calculationLink": {
     "local": [
      "leu-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "leu-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "leu-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "leu-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "leu-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "leu-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 765,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 16,
    "http://xbrl.sec.gov/dei/2021q4": 7,
    "total": 23
   },
   "keyCustom": 70,
   "keyStandard": 457,
   "memberCustom": 28,
   "memberStandard": 53,
   "nsprefix": "leu",
   "nsuri": "http://www.centrusenergy.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.centrusenergy.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - Property, Plant and Equipment",
     "role": "http://www.centrusenergy.com/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122106 - Disclosure - Intangible Assets",
     "role": "http://www.centrusenergy.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Accounts Payable and Accrued Liabilities",
     "role": "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129108 - Disclosure - Debt",
     "role": "http://www.centrusenergy.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - Leases",
     "role": "http://www.centrusenergy.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137110 - Disclosure - Fair Value Measurements",
     "role": "http://www.centrusenergy.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - Pension and Postretirement Health and Life Benefits",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefits",
     "shortName": "Pension and Postretirement Health and Life Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152112 - Disclosure - Stock-Based Compensation",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163114 - Disclosure - Income Taxes",
     "role": "http://www.centrusenergy.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2170115 - Disclosure - Net Income Per Share",
     "role": "http://www.centrusenergy.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.centrusenergy.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2178117 - Disclosure - Commitments and Contingencies",
     "role": "http://www.centrusenergy.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2180118 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "role": "http://www.centrusenergy.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2181119 - Disclosure - Segment Information",
     "role": "http://www.centrusenergy.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue and Contracts with Customers (Tables)",
     "role": "http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables",
     "shortName": "Revenue and Contracts with Customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables)",
     "role": "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashTables",
     "shortName": "Cash, Cash Equivalents and Restricted Cash (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Inventories (Tables)",
     "role": "http://www.centrusenergy.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Property, Plant and Equipment (Tables)",
     "role": "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.centrusenergy.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "role": "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesTables",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - Debt Schedule of Debt (Tables)",
     "role": "http://www.centrusenergy.com/role/DebtScheduleofDebtTables",
     "shortName": "Debt Schedule of Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334308 - Disclosure - Leases (Tables)",
     "role": "http://www.centrusenergy.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338309 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.centrusenergy.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342310 - Disclosure - Pension and Postretirement Health and Life Benefits (Tables)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables",
     "shortName": "Pension and Postretirement Health and Life Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353311 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364313 - Disclosure - Income Taxes Income Taxes (Tables)",
     "role": "http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables",
     "shortName": "Income Taxes Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2371314 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://www.centrusenergy.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2375315 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.centrusenergy.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2382316 - Disclosure - Segment Information (Tables)",
     "role": "http://www.centrusenergy.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "role": "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskSupplier",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "if8e0b37bbe104648bb57c2d4887b9004_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockLiquidationPreferenceValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue and Contracts with Customers (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
     "shortName": "Revenue and Contracts with Customers (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue and Contracts with Customers (Revenue from External Customers by Geographic Areas) (Details)",
     "role": "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
     "shortName": "Revenue and Contracts with Customers (Revenue from External Customers by Geographic Areas) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "ic672884eed134083968ac4e96bdb36f7_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherDeferredCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Revenue and Contracts with Customers (Contract with Customer Asset and Liability) (Details)",
     "role": "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
     "shortName": "Revenue and Contracts with Customers (Contract with Customer Asset and Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "leu:ProvisionForLossOnContractChange",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Revenue and Contracts with Customers Accounts Receivable (Schedule of Accounts Receivable) (Details)",
     "role": "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
     "shortName": "Revenue and Contracts with Customers Accounts Receivable (Schedule of Accounts Receivable) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details)",
     "role": "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Cash, Cash Equivalents and Restricted Cash (Schedule of Cash, Cash Equivalents and Restricted Cash) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "ibe135740709e46fd80765e57b80e783d_I20200630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Schedule of Restricted Cash) (Details)",
     "role": "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails",
     "shortName": "Cash, Cash Equivalents and Restricted Cash (Schedule of Restricted Cash) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i77348c842f8b4151bb5ad53a5012255a_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "leu:SeparativeWorkUnitsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Inventories (Schedule of Inventories) (Details)",
     "role": "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails",
     "shortName": "Inventories (Schedule of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "leu:SeparativeWorkUnitsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i74c6b12685e94c2b8c2c06884800c0c4_D20180101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "leu:SeparativeWorkUnitsBorrowedInPeriodValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Inventories (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/InventoriesNarrativeDetails",
     "shortName": "Inventories (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "leu:SeparativeWorkUnitsRepaidInPeriodValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Property, Plant and Equipment (Tables) (Details)",
     "role": "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails",
     "shortName": "Property, Plant and Equipment (Tables) (Details)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Property, Plant and Equipment (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails",
     "shortName": "Property, Plant and Equipment (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Schedule of Intangible Assets (Details)",
     "role": "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails",
     "shortName": "Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Intangible Assets Schedule of Intangible Asset Amortization (Details)",
     "role": "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails",
     "shortName": "Intangible Assets Schedule of Intangible Asset Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Accounts Payable and Accrued Liabilities (Details)",
     "role": "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
     "shortName": "Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableOtherCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Schedule of Debt (Details)",
     "role": "http://www.centrusenergy.com/role/ScheduleofDebtDetails",
     "shortName": "Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i0a0e1185b1ff480180c5b5533de9f33e_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "leu:Subordinationtocreditfacilityfacilitytotal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435417 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - Maturity of Operating Lease Liabilities (Details)",
     "role": "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails",
     "shortName": "Maturity of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439419 - Disclosure - Fair Value Measurements (Financial Instruments Recorded at Fair Value) (Details)",
     "role": "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
     "shortName": "Fair Value Measurements (Financial Instruments Recorded at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i0a0e1185b1ff480180c5b5533de9f33e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440420 - Disclosure - Fair Value Measurements (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i0a0e1185b1ff480180c5b5533de9f33e_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443421 - Disclosure - Pension and Postretirement Health and Life Benefits (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444422 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Changes in Projected Benefit Obligations) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Changes in Projected Benefit Obligations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i6221fad02d4846d49570838c48b55e5c_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445423 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Net Benefit Costs) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Net Benefit Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i9424509356794074879421657050c9b6_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i9424509356794074879421657050c9b6_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i9424509356794074879421657050c9b6_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i9424509356794074879421657050c9b6_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447425 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Assumptions Used) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Assumptions Used) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i9424509356794074879421657050c9b6_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448426 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Healthcare Cost Trend Rates) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofHealthcareCostTrendRatesDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Healthcare Cost Trend Rates) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Pension and Postretirement Health and Life Benefits (Plan Asset Allocations) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Plan Asset Allocations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Fair Value of Plan Assets) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Fair Value of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "leu:DefinedBenefitPlanInvestmentsMeasuredAtNAV",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i6221fad02d4846d49570838c48b55e5c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - Pension and Postretirement Health and Life Benefits (Schedule of Estimated Future Benefit Payments) (Details)",
     "role": "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
     "shortName": "Pension and Postretirement Health and Life Benefits (Schedule of Estimated Future Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i6221fad02d4846d49570838c48b55e5c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - Stock-Based Compensation (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedStockExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Stock-Based Compensation (Stock-Based Compensation Costs) (Details)",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails",
     "shortName": "Stock-Based Compensation (Stock-Based Compensation Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedStockExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "id123acf7ac0e47e0a094a5a928226cce_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
     "role": "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "id123acf7ac0e47e0a094a5a928226cce_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - Stock-Based Compensation Stock-Based Compensation (Assumptions Used in the Black-Scholes Option Pricing Model) (Details)",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails",
     "shortName": "Stock-Based Compensation Stock-Based Compensation (Assumptions Used in the Black-Scholes Option Pricing Model) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "leu:ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i0b066a7fef5b4acab9742101182b634d_D20200101-20201231",
      "decimals": "-2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457433 - Disclosure - Stock-Based Compensation Costs, Rollforward (Details)",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
     "shortName": "Stock-Based Compensation Costs, Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i002f9c6b85d8408f8e5d24eac4c357e5_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458434 - Disclosure - Stock-Based Compensation (Options) (Details)",
     "role": "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails",
     "shortName": "Stock-Based Compensation (Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459435 - Disclosure - Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price (Details)",
     "role": "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails",
     "shortName": "Schedule of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "ia65c31105bbb4366b754735dc26d103d_I20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i12fb2f62fd584d5798a1046717f53da3_D20211001-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465437 - Disclosure - Income Taxes (Details)",
     "role": "http://www.centrusenergy.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i12fb2f62fd584d5798a1046717f53da3_D20211001-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466438 - Disclosure - Income Taxes (Taxes by Jurisdiction) (Details)",
     "role": "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails",
     "shortName": "Income Taxes (Taxes by Jurisdiction) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467439 - Disclosure - Income Taxes (Deferred Income Taxes) (Details)",
     "role": "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails",
     "shortName": "Income Taxes (Deferred Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468440 - Disclosure - Income Taxes (Rate Reconciliation) (Details)",
     "role": "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
     "shortName": "Income Taxes (Rate Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469441 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details)",
     "role": "http://www.centrusenergy.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes (Unrecognized Tax Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "ia577d550d71242538c7875a1a38bf8a6_D20211201-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "leu:StockRepurchasePricePerShare",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472442 - Disclosure - Net Income Per Share (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
     "shortName": "Net Income Per Share (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "leu:AggregateValuePreferredStockTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Cash, Cash Equivalents and Restricted Cash",
     "role": "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCash",
     "shortName": "Cash, Cash Equivalents and Restricted Cash",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473443 - Disclosure - Net Income Per Share (Schedule of Income Per Share) (Details)",
     "role": "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails",
     "shortName": "Net Income Per Share (Schedule of Income Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherPreferredStockDividendsAndAdjustments",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockDividendsAndOtherAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConversionOfStockSharesConverted1",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476444 - Disclosure - Stockholders' Equity (Tables) (Details)",
     "role": "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails",
     "shortName": "Stockholders' Equity (Tables) (Details)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i1e24f0146a634d539c3670cece821c8b_I20201231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477445 - Disclosure - Stockholders' Equity (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "leu:PreferredStockRetiredLiquidationPreference",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyRangeOfPossibleLossPortionNotAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479446 - Disclosure - Commitment and Contingencies (Details)",
     "role": "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i3df9f37547074cb7a943429d9cddcefa_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyRangeOfPossibleLossPortionNotAccrued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483447 - Disclosure - Revenue by Geographic Area (Details)",
     "role": "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails",
     "shortName": "Revenue by Geographic Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2484448 - Disclosure - Segment Information (Segment Reporting Information) (Details)",
     "role": "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails",
     "shortName": "Segment Information (Segment Reporting Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "ia60945cdb22541bda25a2d8edea3343b_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i4efad857c417413f933d1e1133ea60ea_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485449 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i4efad857c417413f933d1e1133ea60ea_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Inventories",
     "role": "http://www.centrusenergy.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "leu-20211231.htm",
      "contextRef": "i48fc3a1880b84c6680a520e9235b4e1a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 81,
   "tag": {
    "country_BE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BELGIUM",
        "terseLabel": "Belgium"
       }
      }
     },
     "localname": "BE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.centrusenergy.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "leu_AccountsPayableUnderPurchaseAgreementsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable Under Purchase Agreements, Current",
        "label": "Accounts Payable Under Purchase Agreements, Current",
        "terseLabel": "Payables under SWU purchase agreements"
       }
      }
     },
     "localname": "AccountsPayableUnderPurchaseAgreementsCurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AccountsReceivableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable [Abstract]",
        "label": "Accounts Receivable [Abstract]",
        "terseLabel": "Accounts Receivable [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableAbstract",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "xbrltype": "stringItemType"
    },
    "leu_Accruedinterestreceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued interest receivable",
        "label": "Accrued interest receivable",
        "terseLabel": "Accrued interest receivable"
       }
      }
     },
     "localname": "Accruedinterestreceivable",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Accruedleaseturnovercurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued lease turnover - current",
        "label": "Accrued lease turnover - current",
        "terseLabel": "Accrued lease turnover - current"
       }
      }
     },
     "localname": "Accruedleaseturnovercurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Accruedseverancepayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued severance payments",
        "label": "Accrued severance payments",
        "terseLabel": "Accrued severance payments"
       }
      }
     },
     "localname": "Accruedseverancepayments",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AdvancesFromCustomersChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advances from customers change",
        "label": "Advances from customers change",
        "terseLabel": "Advances from customers change"
       }
      }
     },
     "localname": "AdvancesFromCustomersChange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AdvancesFromCustomersNoncurrentChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advances from customers, noncurrent, change",
        "label": "Advances from customers, noncurrent, change",
        "terseLabel": "Advances from customers, noncurrent, change"
       }
      }
     },
     "localname": "AdvancesFromCustomersNoncurrentChange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AggregateValuePreferredStockTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Value, Preferred Stock Transactions",
        "label": "Aggregate Value, Preferred Stock Transactions",
        "terseLabel": "Aggregate Value, Preferred Stock Transactions"
       }
      }
     },
     "localname": "AggregateValuePreferredStockTransactions",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AmountsRecognizedInCurrentLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Recognized In Current Liabilities",
        "label": "Amounts Recognized In Current Liabilities",
        "negatedTerseLabel": "Amounts Recognized In Current Liabilities"
       }
      }
     },
     "localname": "AmountsRecognizedInCurrentLiabilities",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AmountsRecognizedInNoncurrentLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Recognized In Noncurrent Liabilities",
        "label": "Amounts Recognized In Noncurrent Liabilities",
        "negatedTerseLabel": "Amounts Recognized In Noncurrent Liabilities"
       }
      }
     },
     "localname": "AmountsRecognizedInNoncurrentLiabilities",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_AnnuallimitationofNOLcarryforwardsandtaxcreditsgeneratedpriortoownershipchange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual limitation of net operating loss carryforwards and tax credits generated prior to ownership change (that are not reduced by attribute reduction)",
        "label": "Annual limitation of NOL carryforwards and tax credits generated prior to ownership change",
        "terseLabel": "Annual limitation of NOL carryforwards and tax credits generated prior to ownership change"
       }
      }
     },
     "localname": "AnnuallimitationofNOLcarryforwardsandtaxcreditsgeneratedpriortoownershipchange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ApproximateNumberofPlanParticipants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Approximate Number of Plan Participants",
        "label": "Approximate Number of Plan Participants",
        "terseLabel": "Approximate Number of Plan Participants"
       }
      }
     },
     "localname": "ApproximateNumberofPlanParticipants",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "leu_AssetsandPropertySoldTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Property Sold [Table Text Block]",
        "label": "Assets and Property Sold [Table Text Block]",
        "terseLabel": "Assets and Property Sold [Table Text Block]"
       }
      }
     },
     "localname": "AssetsandPropertySoldTableTextBlock",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "leu_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "xbrltype": "stringItemType"
    },
    "leu_BoardRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Restricted Stock Units",
        "label": "Board Restricted Stock Units [Member]",
        "terseLabel": "Board Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "BoardRestrictedStockUnitsMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_BoardRestrictedStockUnitsPotentiallyConvertedToCommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board restricted stock units potentially converted to common stock shares",
        "label": "Board restricted stock units potentially converted to common stock shares",
        "terseLabel": "Board restricted stock units potentially converted to common stock shares"
       }
      }
     },
     "localname": "BoardRestrictedStockUnitsPotentiallyConvertedToCommonStockShares",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "leu_BusinessInterestExpenseCarryforward": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Interest Expense Carryforward",
        "label": "Business Interest Expense Carryforward",
        "terseLabel": "Business Interest Expense Carryforward"
       }
      }
     },
     "localname": "BusinessInterestExpenseCarryforward",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Cancellationofdebtincomefortax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cancellation of debt income for tax",
        "label": "Cancellation of debt income for tax",
        "terseLabel": "Cancellation of debt income for tax"
       }
      }
     },
     "localname": "Cancellationofdebtincomefortax",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_CashCashEquivalentsandRestrictedCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents and Restricted Cash [Abstract]",
        "label": "Cash, Cash Equivalents and Restricted Cash [Abstract]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsandRestrictedCashAbstract",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "xbrltype": "stringItemType"
    },
    "leu_Cashpaidinexchange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid in exchange",
        "label": "Cash paid in exchange",
        "terseLabel": "Cash paid in exchange"
       }
      }
     },
     "localname": "Cashpaidinexchange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_CommonStockAndWarrantIssuedInExchangeForPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock and warrant issued in exchange for preferred stock",
        "label": "Common stock and warrant issued in exchange for preferred stock [Member]",
        "terseLabel": "Common stock and warrant issued in exchange for preferred stock [Member]"
       }
      }
     },
     "localname": "CommonStockAndWarrantIssuedInExchangeForPreferredStockMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_CommonStockOwnershipEnablingPreferredStockPurchaseRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Ownership Enabling Preferred Stock Purchase Rights",
        "label": "Common Stock Ownership Enabling Preferred Stock Purchase Rights",
        "terseLabel": "Common Stock Ownership Enabling Preferred Stock Purchase Rights"
       }
      }
     },
     "localname": "CommonStockOwnershipEnablingPreferredStockPurchaseRights",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "leu_CommonStockOwnershipEnablingPreferredStockPurchaseRightsIncremental": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental",
        "label": "Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental",
        "terseLabel": "Common Stock Ownership Enabling Preferred Stock Purchase Rights, Incremental"
       }
      }
     },
     "localname": "CommonStockOwnershipEnablingPreferredStockPurchaseRightsIncremental",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "leu_CompanyPaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paid from Company assets",
        "label": "Company paid [Member]",
        "terseLabel": "Company paid [Member]"
       }
      }
     },
     "localname": "CompanyPaidMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_Companycostshareportion": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticipated company cost share portion of new government contract",
        "label": "Company cost share portion",
        "terseLabel": "Company cost share portion"
       }
      }
     },
     "localname": "Companycostshareportion",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_CompensationAndBenefitsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation and benefits payable",
        "label": "CompensationAndBenefitsPayable",
        "verboseLabel": "Compensation and benefits payable"
       }
      }
     },
     "localname": "CompensationAndBenefitsPayable",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ConsolidatedBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Balance Sheet [Abstract]",
        "label": "Consolidated Balance Sheet [Abstract]",
        "terseLabel": "Consolidated Balance Sheet [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedBalanceSheetAbstract",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "xbrltype": "stringItemType"
    },
    "leu_ContractRevenuePortionAfterNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract revenue portion after next twelve months",
        "label": "Contract revenue portion after next twelve months",
        "terseLabel": "Contract revenue portion after next twelve months"
       }
      }
     },
     "localname": "ContractRevenuePortionAfterNextTwelveMonths",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ContractServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Services Segment [Member]",
        "label": "Contract Services Segment [Member]",
        "terseLabel": "Technical Solutions Segment [Member]"
       }
      }
     },
     "localname": "ContractServicesSegmentMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_ContractWithCustomerAdvancesLiabilityCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Advances, Liability, Current",
        "label": "Contract With Customer, Advances, Liability, Current",
        "terseLabel": "Advances from customers"
       }
      }
     },
     "localname": "ContractWithCustomerAdvancesLiabilityCurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ConversionOfStockSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of Stock, Share Price",
        "label": "Conversion of Stock, Share Price",
        "terseLabel": "Conversion of Stock, Share Price"
       }
      }
     },
     "localname": "ConversionOfStockSharePrice",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "leu_DeferredCostAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Cost Additions",
        "label": "Deferred Cost Additions",
        "terseLabel": "Deferred costs, additions"
       }
      }
     },
     "localname": "DeferredCostAdditions",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredCostsCostsRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Costs, Costs Recognized",
        "label": "Deferred Costs Costs Recognized",
        "negatedTerseLabel": "Deferred costs, costs recognized"
       }
      }
     },
     "localname": "DeferredCostsCostsRecognized",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredRevenueAdditionsInPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue, additions in period",
        "label": "Deferred revenue, additions in period",
        "terseLabel": "Deferred revenue, additions in period"
       }
      }
     },
     "localname": "DeferredRevenueAdditionsInPeriod",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredRevenueAndAdvancesFromCustomersCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Revenue and Advances from Customers - Current and Noncurrent",
        "label": "Deferred Revenue and Advances from Customers - Current and Noncurrent",
        "terseLabel": "Deferred Revenue and Advances from Customers - Current and Noncurrent"
       }
      }
     },
     "localname": "DeferredRevenueAndAdvancesFromCustomersCurrentAndNoncurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredRevenueChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue change",
        "label": "Deferred revenue change",
        "terseLabel": "Deferred revenue change"
       }
      }
     },
     "localname": "DeferredRevenueChange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredTaxAssetIncreaseDecreaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Increase (Decrease), Amount",
        "label": "Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Deferred Tax Asset, Increase (Decrease), Amount"
       }
      }
     },
     "localname": "DeferredTaxAssetIncreaseDecreaseAmount",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredTaxAssetLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Lease Liability",
        "label": "Deferred Tax Asset, Lease Liability",
        "terseLabel": "Deferred Tax Asset, Lease Liability"
       }
      }
     },
     "localname": "DeferredTaxAssetLeaseLiability",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredTaxLiabilityLeaseAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Lease Asset",
        "label": "Deferred Tax Liability, Lease Asset",
        "terseLabel": "Deferred Tax Liability, Lease Asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilityLeaseAsset",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DeferredfinancingcostsincludedinaccountspayableandaccruedliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred financing costs included in accounts payable and accrued liabilities [Member]",
        "label": "Deferred financing costs included in accounts payable and accrued liabilities [Member]",
        "terseLabel": "Equity issuance costs included in accounts payable and accrued liabilities [Member]"
       }
      }
     },
     "localname": "DeferredfinancingcostsincludedinaccountspayableandaccruedliabilitiesMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_DefinedBenefitPlanInvestmentsMeasuredAtNAV": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Investments Measured at NAV",
        "label": "Defined Benefit Plan, Investments Measured at NAV",
        "terseLabel": "Defined Benefit Plan, Investments Measured at NAV"
       }
      }
     },
     "localname": "DefinedBenefitPlanInvestmentsMeasuredAtNAV",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DefinedBenefitPlanLumpSumBenefitsPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Lump Sum Benefits Paid",
        "label": "Defined Benefit Plan, Lump Sum Benefits Paid",
        "negatedTerseLabel": "Defined Benefit Plan, Lump Sum Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanLumpSumBenefitsPaid",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DirectCostsOfStockIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct Costs of Stock Issuance",
        "label": "Direct Costs of Stock Issuance",
        "terseLabel": "Direct Costs of Stock Issuance"
       }
      }
     },
     "localname": "DirectCostsOfStockIssuance",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_DisposalOfRightToUseLeaseAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal of right to use lease assets",
        "label": "Disposal of right to use lease assets [Member]",
        "terseLabel": "Disposal of right to use lease assets [Member]"
       }
      }
     },
     "localname": "DisposalOfRightToUseLeaseAssetsMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_DominionEnergySouthCarolinaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dominion Energy South Carolina",
        "label": "Dominion Energy South Carolina [Member]",
        "terseLabel": "Dominion Energy South Carolina"
       }
      }
     },
     "localname": "DominionEnergySouthCarolinaMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_EmployeeRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Restricted Stock Units",
        "label": "Employee Restricted Stock Units [Member]",
        "terseLabel": "Employee Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "EmployeeRestrictedStockUnitsMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_EmployeeRestrictedStockUnitsPotentiallyConvertedToCommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee restricted stock units potentially converted to common stock shares",
        "label": "Employee restricted stock units potentially converted to common stock shares",
        "terseLabel": "Employee restricted stock units potentially converted to common stock shares"
       }
      }
     },
     "localname": "EmployeeRestrictedStockUnitsPotentiallyConvertedToCommonStockShares",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "leu_EnergyHarborNuclearCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Energy Harbor Nuclear Corporation",
        "label": "Energy Harbor Nuclear Corporation [Member]",
        "terseLabel": "Energy Harbor Nuclear Corporation"
       }
      }
     },
     "localname": "EnergyHarborNuclearCorporationMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_EquityRelatedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Related Compensation",
        "label": "Equity Related Compensation",
        "terseLabel": "Equity Related Compensation"
       }
      }
     },
     "localname": "EquityRelatedCompensation",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ExchangeOfPreferredStockForCommonStockAndCommonStockWarrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange of preferred stock for common stock and common stock warrant",
        "label": "Exchange of preferred stock for common stock and common stock warrant",
        "terseLabel": "Exchange of preferred stock for common stock and common stock warrant"
       }
      }
     },
     "localname": "ExchangeOfPreferredStockForCommonStockAndCommonStockWarrant",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ForeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign [Member]",
        "label": "Foreign [Member]",
        "terseLabel": "Foreign [Member]",
        "verboseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_Governmentcostobligation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government cost obligation on contract",
        "label": "Government cost obligation",
        "terseLabel": "Government cost obligation"
       }
      }
     },
     "localname": "Governmentcostobligation",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Governmentcostshareportion": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anticipated government cost share portion of new contract",
        "label": "Government cost share portion",
        "terseLabel": "Government cost share portion"
       }
      }
     },
     "localname": "Governmentcostshareportion",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Governmentspendingauthorization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government spending authorization on contract",
        "label": "Government spending authorization",
        "terseLabel": "Government spending authorization"
       }
      }
     },
     "localname": "Governmentspendingauthorization",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_GrossProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Proceeds from Issuance of Common Stock",
        "label": "Gross Proceeds from Issuance of Common Stock",
        "terseLabel": "Gross Proceeds from Issuance of Common Stock"
       }
      }
     },
     "localname": "GrossProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_IncreaseDecreaseinDeferredRevenueNetofDeferredCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease in Deferred Revenue, Net of Deferred Costs",
        "label": "Increase Decrease in Deferred Revenue, Net of Deferred Costs",
        "terseLabel": "Deferred revenue, net of deferred costs \u2013 increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseinDeferredRevenueNetofDeferredCosts",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_IntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Disclosure [Abstract]",
        "label": "Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureAbstract",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "xbrltype": "stringItemType"
    },
    "leu_InventoriesOwedToCustomersAndSuppliers": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of SWU and uranium inventories owed related to the transfer of title from USEC to customer at fabricator whereby fabricator has elected to order less material from USEC than is required. Amounts owed are satisfied when fabricator orders future bulk deliveries.",
        "label": "Inventories owed to customers and suppliers",
        "terseLabel": "Inventories owed to customers and suppliers",
        "totalLabel": "Inventories owed to customers and suppliers"
       }
      }
     },
     "localname": "InventoriesOwedToCustomersAndSuppliers",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_InventoryNetOfLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory net of Liability",
        "label": "Inventory net of Liability",
        "totalLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNetOfLiability",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_KyushuElectricPowerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyushu Electric Power",
        "label": "Kyushu Electric Power [Member]",
        "terseLabel": "Kyushu Electric Power"
       }
      }
     },
     "localname": "KyushuElectricPowerMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_LowEnrichedUraniumSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Low Enriched Uranium Segment [Member]",
        "label": "Low Enriched Uranium Segment [Member]",
        "terseLabel": "Low Enriched Uranium Segment [Member]"
       }
      }
     },
     "localname": "LowEnrichedUraniumSegmentMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_Netcarryingvalueofassetsretired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net carrying value of assets retired",
        "label": "Net carrying value of assets retired",
        "terseLabel": "Net carrying value of assets retired"
       }
      }
     },
     "localname": "Netcarryingvalueofassetsretired",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_NotionalStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional stock units",
        "label": "Notional stock units [Member]",
        "terseLabel": "Notional Stock Units [Member]"
       }
      }
     },
     "localname": "NotionalStockUnitsMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_NotionalStockUnitsPerformanceConditionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional Stock Units, Performance Condition",
        "label": "Notional Stock Units, Performance Condition [Member]",
        "terseLabel": "Notional Stock Units, Performance Condition [Member]"
       }
      }
     },
     "localname": "NotionalStockUnitsPerformanceConditionMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_OperatingLeaseLiabilityDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability Decrease",
        "label": "Operating Lease Liability Decrease",
        "terseLabel": "Operating Lease, Liability, Decrease"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityDecrease",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_OperatingLeaseLiabilityIncrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Increase",
        "label": "Operating Lease, Liability, Increase",
        "terseLabel": "Operating Lease, Liability, Increase"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityIncrease",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_OperatingLossCarryforwardsNoExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, No Expiration",
        "label": "Operating Loss Carryforwards, No Expiration",
        "terseLabel": "Operating Loss Carryforwards, No Expiration"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsNoExpiration",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Operatingleaseexpenseadjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease, expense adjustment increase (decrease) expense",
        "label": "Operating lease, expense adjustment",
        "negatedTerseLabel": "Operating Lease, Expense Adjustment"
       }
      }
     },
     "localname": "Operatingleaseexpenseadjustment",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_OptionGroupOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Group One [Member]",
        "label": "Option Group One [Member]",
        "terseLabel": "Option Group One [Member]"
       }
      }
     },
     "localname": "OptionGroupOneMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_OptionGroupTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Group Two [Member]",
        "label": "Option Group Two [Member]",
        "terseLabel": "Option Group Two [Member]"
       }
      }
     },
     "localname": "OptionGroupTwoMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_OptionsWithExercisePriceGreaterThanMarketPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options with exercise price greater than market price",
        "label": "Options with exercise price greater than market price",
        "terseLabel": "Options with exercise price greater than market price"
       }
      }
     },
     "localname": "OptionsWithExercisePriceGreaterThanMarketPrice",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "leu_OtherForeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Foreign [Member]",
        "label": "Other Foreign [Member]",
        "terseLabel": "Other Foreign"
       }
      }
     },
     "localname": "OtherForeignMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_OtherfinancialassuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other financial assurance [Member]",
        "label": "Other financial assurance [Member]",
        "terseLabel": "Other financial assurance [Member]"
       }
      }
     },
     "localname": "OtherfinancialassuranceMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_PensionPlanAssetsTransferredForAnnuitization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension plan assets transferred for annuitization",
        "label": "Pension plan assets transferred for annuitization",
        "terseLabel": "Pension plan assets transferred for annuitization"
       }
      }
     },
     "localname": "PensionPlanAssetsTransferredForAnnuitization",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_PensionPlanObligationsTransferredForAnnuitization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension plan obligations transferred for annuitization",
        "label": "Pension plan obligations transferred for annuitization",
        "terseLabel": "Pension plan obligations transferred for annuitization"
       }
      }
     },
     "localname": "PensionPlanObligationsTransferredForAnnuitization",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_PerformanceConditionMinimumNetIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Condition, Minimum Net Income",
        "label": "Performance Condition, Minimum Net Income",
        "terseLabel": "Performance Condition, Minimum Net Income"
       }
      }
     },
     "localname": "PerformanceConditionMinimumNetIncome",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_PlanPaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paid from Plan Assets",
        "label": "Plan paid [Member]",
        "terseLabel": "Plan paid [Member]"
       }
      }
     },
     "localname": "PlanPaidMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_PreferredStockCarryingValuePerShare": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Carrying Value per Share",
        "label": "Preferred Stock, Carrying Value per Share",
        "terseLabel": "Preferred Stock, Carrying Value per Share"
       }
      }
     },
     "localname": "PreferredStockCarryingValuePerShare",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_PreferredStockCumulativeUndeclaredDividend": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Cumulative Undeclared Dividend",
        "label": "Preferred Stock, Cumulative Undeclared Dividend",
        "terseLabel": "Preferred Stock, Cumulative Undeclared Dividend"
       }
      }
     },
     "localname": "PreferredStockCumulativeUndeclaredDividend",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_PreferredStockLiquidationAmountPerShare": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Liquidation Amount per Share",
        "label": "Preferred Stock, Liquidation Amount per Share",
        "terseLabel": "Preferred Stock, Liquidation Amount per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationAmountPerShare",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_PreferredStockRetiredLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock Retired, Liquidation Preference",
        "label": "Preferred Stock Retired, Liquidation Preference",
        "terseLabel": "Preferred Stock Retired, Liquidation Preference"
       }
      }
     },
     "localname": "PreferredStockRetiredLiquidationPreference",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Preferredstockdividendconditionminimumcashbalanceprecedingquarter": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock dividend condition - minimum cash balance preceding quarter",
        "label": "Preferred stock dividend condition - minimum cash balance preceding quarter",
        "terseLabel": "Preferred stock dividend condition - minimum cash balance preceding quarter"
       }
      }
     },
     "localname": "Preferredstockdividendconditionminimumcashbalanceprecedingquarter",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Preferredstockdividendconditionminimumfreecashflowpreceingfourquarters": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock dividend condition - minimum free cash flow preceding four quarters",
        "label": "Preferred stock dividend condition - minimum free cash flow preceing four quarters",
        "terseLabel": "Preferred stock dividend condition - minimum free cash flow preceding four quarters"
       }
      }
     },
     "localname": "Preferredstockdividendconditionminimumfreecashflowpreceingfourquarters",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Preferredstockdividendconditionminimumnetincomeprecedingquarter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock dividend condition - minimum net income preceding quarter",
        "label": "Preferred stock dividend condition - minimum net income preceding quarter",
        "terseLabel": "Preferred stock dividend condition - minimum net income preceding quarter"
       }
      }
     },
     "localname": "Preferredstockdividendconditionminimumnetincomeprecedingquarter",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Preferredstockdividendconditionminimumpensionfunding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock dividend condition - minimum pension funding",
        "label": "Preferred stock dividend condition - minimum pension funding",
        "terseLabel": "Preferred stock dividend condition - minimum pension funding"
       }
      }
     },
     "localname": "Preferredstockdividendconditionminimumpensionfunding",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "leu_PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, plant and equipment included in accounts payable and accrued liabilities",
        "label": "Property, plant and equipment included in accounts payable and accrued liabilities [Member]",
        "terseLabel": "Property, plant and equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_PropertyPlantAndEquipmentNetCapitalExpenditures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant And Equipment, Net Capital Expenditures",
        "label": "Property, Plant And Equipment, Net Capital Expenditures",
        "terseLabel": "Property, Plant And Equipment, Net Capital Expenditures"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetCapitalExpenditures",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ProvisionForLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for loss",
        "label": "Provision for loss",
        "verboseLabel": "Provision for loss on contracts total"
       }
      }
     },
     "localname": "ProvisionForLoss",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ProvisionForLossOnContractChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for loss on contract change",
        "label": "Provision for loss on contract change",
        "terseLabel": "Provision for loss on contract change"
       }
      }
     },
     "localname": "ProvisionForLossOnContractChange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ProvisionForLossOnContractNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for loss on contract noncurrent",
        "label": "Provision for loss on contract noncurrent",
        "terseLabel": "Provision for loss on contract noncurrent"
       }
      }
     },
     "localname": "ProvisionForLossOnContractNoncurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ProvisionForLossOnContractsNoncurrentChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for loss on contracts, noncurrent, change",
        "label": "Provision for loss on contracts, noncurrent, change",
        "terseLabel": "Provision for loss on contracts, noncurrent, change"
       }
      }
     },
     "localname": "ProvisionForLossOnContractsNoncurrentChange",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ProvisionForLossOnContractsUtilized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for loss on contracts utilized",
        "label": "Provision for loss on contracts utilized",
        "terseLabel": "Provision for loss on contracts utilized"
       }
      }
     },
     "localname": "ProvisionForLossOnContractsUtilized",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Provisionforlossoncontractsnoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for loss on contracts, noncurrent",
        "label": "Provision for loss on contracts, noncurrent",
        "terseLabel": "Provision for loss on contracts, noncurrent"
       }
      }
     },
     "localname": "Provisionforlossoncontractsnoncurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ReclassificationOfEquityCompensationLiabilityToEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of equity compensation liability to equity",
        "label": "Reclassification of equity compensation liability to equity [Member]",
        "terseLabel": "Reclassification of equity compensation liability to equity [Member]"
       }
      }
     },
     "localname": "ReclassificationOfEquityCompensationLiabilityToEquityMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_ReclassificationOfStockBasedCompensationFromLiabilityToEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of stock-based compensation from liability to equity",
        "label": "Reclassification of stock-based compensation from liability to equity",
        "terseLabel": "Reclassification of stock-based compensation from liability to equity"
       }
      }
     },
     "localname": "ReclassificationOfStockBasedCompensationFromLiabilityToEquity",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ReclassificationOfStockBasedCompensationLiabilityToEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of stock-based compensation liability to equity",
        "label": "Reclassification of stock-based compensation liability to equity",
        "terseLabel": "Reclassification of stock-based compensation liability to equity"
       }
      }
     },
     "localname": "ReclassificationOfStockBasedCompensationLiabilityToEquity",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_RecognizedInAccumulatedOtherComprehensiveIncomePreTaxPriorServiceCostCredit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit",
        "label": "Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit",
        "terseLabel": "Recognized In Accumulated Other Comprehensive Income Pre Tax Prior Service Cost Credit"
       }
      }
     },
     "localname": "RecognizedInAccumulatedOtherComprehensiveIncomePreTaxPriorServiceCostCredit",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_RepaymentOfBorrowedSWUInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of borrowed SWU inventory",
        "label": "Repayment of borrowed SWU inventory [Member]",
        "terseLabel": "Repayment of borrowed SWU inventory [Member]"
       }
      }
     },
     "localname": "RepaymentOfBorrowedSWUInventoryMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_Revenuefromfirstcustomerover10percent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from first customer over 10 percent",
        "label": "Revenue from first customer over 10 percent",
        "terseLabel": "Revenue from first customer over 10 percent"
       }
      }
     },
     "localname": "Revenuefromfirstcustomerover10percent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "leu_Salepriceassetsandpropertynet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale price assets and property, net of auction fees and other costs",
        "label": "Sale price assets and property, net",
        "terseLabel": "Sale price assets and property, net"
       }
      }
     },
     "localname": "Salepriceassetsandpropertynet",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Saleproceedsincludedinaccountsreceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale proceeds included in accounts receivable",
        "label": "Sale proceeds included in accounts receivable",
        "terseLabel": "Sale proceeds included in accounts receivable"
       }
      }
     },
     "localname": "Saleproceedsincludedinaccountsreceivable",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ScheduleOfNotionalStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Notional Stock Units, Activity",
        "label": "Schedule of Notional Stock Units, Activity [Table Text Block]",
        "terseLabel": "Schedule of Notional Stock Units, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNotionalStockUnitsActivityTableTextBlock",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "leu_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsPerformanceConditionValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions",
        "label": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockAppreciationRightsPerformanceConditionValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "leu_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions",
        "label": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "leu_SeparativeWorkUnitsBorrowedInPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative work units borrowed in period, value",
        "label": "Separative work units borrowed in period, value",
        "terseLabel": "Separative work units borrowed in period, value"
       }
      }
     },
     "localname": "SeparativeWorkUnitsBorrowedInPeriodValue",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesNarrativeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_SeparativeWorkUnitsInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of separative work unit (\"SWU\") inventory. SWU is held as the SWU component of low enriched uranium. A SWU is the standard measure of uranium enrichment using a standard formula derived from the physics of enrichment. SWU costs are based on production costs and purchase costs. SWU inventory is valued at the lower of cost or market.",
        "label": "Separative work units inventory",
        "terseLabel": "Separative work units inventory"
       }
      }
     },
     "localname": "SeparativeWorkUnitsInventory",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_SeparativeWorkUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative Work Units (SWU) [Member] - SWU is a standard unit of measurement that represents the effort required to transform a given amount of natural uranium into two components: enriched uranium having a higher percentage of the uranium-235 isotope (\u201cU235\u201d) and depleted uranium having a lower percentage of U235. The SWU contained in LEU is calculated using an industry standard formula based on the physics of enrichment. The amount of enrichment deemed to be contained in LEU under this formula is commonly referred to as its SWU component and the quantity of natural uranium used in the production of LEU under this formula is referred to as its uranium component.",
        "label": "Separative Work Units [Member]",
        "terseLabel": "Separative Work Units [Member]"
       }
      }
     },
     "localname": "SeparativeWorkUnitsMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_SeparativeWorkUnitsNetOfLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "leu_InventoryNetOfLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative work units inventory net of liability",
        "label": "Separative work units net of liability",
        "terseLabel": "Separative work units net of liability"
       }
      }
     },
     "localname": "SeparativeWorkUnitsNetOfLiability",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_SeparativeWorkUnitsOwedToCustomersAndSuppliers": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "leu_InventoriesOwedToCustomersAndSuppliers",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative work units owed to customers and suppliers",
        "label": "Separative work units owed to customers and suppliers",
        "terseLabel": "Separative work units owed to customers and suppliers"
       }
      }
     },
     "localname": "SeparativeWorkUnitsOwedToCustomersAndSuppliers",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_SeparativeWorkUnitsRepaidInPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative work units repaid in period, value",
        "label": "Separative work units repaid in period, value",
        "terseLabel": "Separative work units repaid in period, value"
       }
      }
     },
     "localname": "SeparativeWorkUnitsRepaidInPeriodValue",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_SeparativeWorkUnitsValuationChangeInPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative work units valuation change in period",
        "label": "Separative work units valuation change in period",
        "terseLabel": "Separative work units valuation change in period"
       }
      }
     },
     "localname": "SeparativeWorkUnitsValuationChangeInPeriod",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Separativeworkunitsowedtoothersnoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separative work units owed to others noncurrent",
        "label": "Separative work units owed to others noncurrent",
        "terseLabel": "Separative work units owed to others noncurrent"
       }
      }
     },
     "localname": "Separativeworkunitsowedtoothersnoncurrent",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesNarrativeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_ShareBasedPaymentArrangementStockAppreciationRightPerformanceConditionActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity",
        "label": "Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementStockAppreciationRightPerformanceConditionActivityTableTextBlock",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "leu_SharesforCancelledorForfeitedAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares for Cancelled or Forfeited Awards",
        "label": "Shares for Cancelled or Forfeited Awards",
        "terseLabel": "Shares for Cancelled or Forfeited Awards"
       }
      }
     },
     "localname": "SharesforCancelledorForfeitedAwards",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "leu_StockAppreciationRightsExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Appreciation Rights Expense",
        "label": "Stock Appreciation Rights Expense",
        "terseLabel": "Stock Appreciation Rights Expense"
       }
      }
     },
     "localname": "StockAppreciationRightsExpense",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_StockAppreciationRightsSARSPerformanceConditionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Appreciation Rights (SARS), Performance Condition",
        "label": "Stock Appreciation Rights (SARS), Performance Condition [Member]",
        "terseLabel": "Stock Appreciation Rights (SARS), Performance Condition [Member]"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSPerformanceConditionMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_StockBasedCompensationPaidInCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock-based compensation paid in cash",
        "label": "Stock-based compensation paid in cash",
        "terseLabel": "Stock-based compensation paid in cash"
       }
      }
     },
     "localname": "StockBasedCompensationPaidInCash",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_StockIssuedDuringPeriodValueGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Gross",
        "label": "Stock Issued During Period, Value, Gross",
        "terseLabel": "Stock Issued During Period, Value, Gross"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueGross",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_StockIssuedDuringPeriodValueNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Net",
        "label": "Stock Issued During Period, Value, Net",
        "terseLabel": "Stock Issued During Period, Value, Net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNet",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_StockRepurchasePricePerShare": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Price per Share",
        "label": "Stock Repurchase Price per Share",
        "terseLabel": "Stock Repurchase Price per Share"
       }
      }
     },
     "localname": "StockRepurchasePricePerShare",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Subordinationtocreditfacilityfacilitymaximumnetborrowing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subordination to credit facility, facility maximum net borrowing",
        "label": "Subordination to credit facility, facility maximum net borrowing",
        "terseLabel": "Subordination to credit facility, facility maximum net borrowing"
       }
      }
     },
     "localname": "Subordinationtocreditfacilityfacilitymaximumnetborrowing",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Subordinationtocreditfacilityfacilitytotal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subordination to credit facility, facility total",
        "label": "Subordination to credit facility, facility total",
        "terseLabel": "Subordination to credit facility, facility total"
       }
      }
     },
     "localname": "Subordinationtocreditfacilityfacilitytotal",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_SummaryofSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Policies [Abstract]",
        "label": "Summary of Significant Accounting Policies [Abstract]",
        "terseLabel": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "SummaryofSignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "xbrltype": "stringItemType"
    },
    "leu_SynatomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Synatom",
        "label": "Synatom [Member]",
        "terseLabel": "Synatom"
       }
      }
     },
     "localname": "SynatomMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_TechnicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technical Solutions Segment",
        "label": "Technical Solutions Segment [Member]",
        "terseLabel": "Technical Solutions Segment [Member]"
       }
      }
     },
     "localname": "TechnicalSolutionsSegmentMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_TenLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ten Largest Customers",
        "label": "Ten Largest Customers [Member]",
        "terseLabel": "Ten Largest Customers"
       }
      }
     },
     "localname": "TenLargestCustomersMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_Totalrecognizedinnetperiodicbenefitcostsincomeandothercomprehensiveincomelosspretax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax",
        "label": "Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax",
        "terseLabel": "Total recognized in net periodic benefit costs (income) and other comprehensive income (loss), pre-tax"
       }
      }
     },
     "localname": "Totalrecognizedinnetperiodicbenefitcostsincomeandothercomprehensiveincomelosspretax",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Unsettledtransactionsreceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsettled transactions receivable",
        "label": "Unsettled transactions receivable",
        "terseLabel": "Unsettled transactions receivable"
       }
      }
     },
     "localname": "Unsettledtransactionsreceivable",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_UraniumInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of uranium inventory. Uranium is held in the form of natural uranium and as the uranium component of low enriched uranium. Uranium inventory is valued at the lower of cost or market.",
        "label": "Uranium Inventory",
        "terseLabel": "Uranium inventory"
       }
      }
     },
     "localname": "UraniumInventory",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_UraniumInventoryNetOfLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "leu_InventoryNetOfLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uranium inventory net of liability",
        "label": "Uranium inventory net of liability",
        "terseLabel": "Uranium inventory net of liability"
       }
      }
     },
     "localname": "UraniumInventoryNetOfLiability",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_UraniumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uranium [Member] - Natural uranium or the uranium component of Low Enriched Uranium (LEU).",
        "label": "Uranium [Member]",
        "terseLabel": "Uranium [Member]"
       }
      }
     },
     "localname": "UraniumMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "leu_UraniumOwedToCustomersAndSuppliers": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "leu_InventoriesOwedToCustomersAndSuppliers",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uranium owed to customers and suppliers",
        "label": "Uranium owed to customers and suppliers",
        "terseLabel": "Uranium owed to customers and suppliers"
       }
      }
     },
     "localname": "UraniumOwedToCustomersAndSuppliers",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_Uraniumfeedreceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uranium feed receivable",
        "label": "Uranium feed receivable",
        "terseLabel": "Uranium feed receivable"
       }
      }
     },
     "localname": "Uraniumfeedreceivable",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "leu_WorkerscompensationfinancialassuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers compensation financial assurance [Member]",
        "label": "Workers compensation financial assurance [Member]",
        "terseLabel": "Workers compensation financial assurance [Member]"
       }
      }
     },
     "localname": "WorkerscompensationfinancialassuranceMember",
     "nsuri": "http://www.centrusenergy.com/20211231",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r127",
      "r183",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r209",
      "r213",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r127",
      "r183",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r209",
      "r213",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r63",
      "r65",
      "r125",
      "r126",
      "r315",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r220",
      "r394",
      "r400",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r314",
      "r356",
      "r495",
      "r501",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r679",
      "r720",
      "r724",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r314",
      "r356",
      "r495",
      "r501",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r679",
      "r720",
      "r724",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r220",
      "r394",
      "r400",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r215",
      "r394",
      "r398",
      "r683",
      "r719",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r215",
      "r394",
      "r398",
      "r683",
      "r719",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r314",
      "r356",
      "r429",
      "r495",
      "r501",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r679",
      "r720",
      "r724",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r314",
      "r356",
      "r429",
      "r495",
      "r501",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r679",
      "r720",
      "r724",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r64",
      "r65",
      "r125",
      "r126",
      "r315",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r137",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r137",
      "r142",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r216",
      "r217",
      "r394",
      "r399",
      "r722",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r216",
      "r217",
      "r394",
      "r399",
      "r722",
      "r738",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r137",
      "r142",
      "r292",
      "r496",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by billing status of receivables.",
        "label": "Billing Status, Type [Axis]",
        "terseLabel": "Billing Status, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by industry of counterparty. A counterparty is the other party that participates in a financial transaction.",
        "label": "Industry of Counterparty, Type [Axis]",
        "terseLabel": "Industry of Counterparty, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.",
        "label": "Legal Entity of Counterparty, Type [Axis]",
        "terseLabel": "Legal Entity of Counterparty, Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "verboseLabel": "Accounts Payable and Accrued Liabilities [Text Block]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "auth_ref": [
      "r10",
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable, Other, Current",
        "verboseLabel": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r27",
      "r222",
      "r223"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in accumulated depreciation, depletion and amortization as a result of sale or disposal of property, plant and equipment.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment",
        "negatedTerseLabel": "Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r69",
      "r71",
      "r72",
      "r709",
      "r729",
      "r730"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r68",
      "r72",
      "r78",
      "r79",
      "r80",
      "r129",
      "r130",
      "r131",
      "r590",
      "r725",
      "r726",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r542",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Excess of capital over par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r539",
      "r540",
      "r541",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Excess of Capital over Par Value [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r504",
      "r535",
      "r544"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Allocated Share-based Compensation Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r104",
      "r260",
      "r267"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r228",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "verboseLabel": "Mortgage and asset backed securities [Member]"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r121",
      "r191",
      "r204",
      "r211",
      "r234",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r588",
      "r591",
      "r614",
      "r645",
      "r647",
      "r688",
      "r706"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r62",
      "r121",
      "r234",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r588",
      "r591",
      "r614",
      "r645",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r506",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r58",
      "r680"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed Contracts Receivable"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r40",
      "r106"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.",
        "label": "Cash and Cash Equivalents Disclosure [Text Block]",
        "terseLabel": "Cash and Cash Equivalents Disclosure"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCash"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r99",
      "r106",
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, start of period",
        "terseLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r99",
      "r615"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash [Member]"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Deferred compensation asset"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Type of Borrower [Axis]",
        "terseLabel": "Class of Financing Receivable, Type of Borrower [Axis]"
       }
      }
     },
     "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of entity or individual who borrows funds.",
        "label": "Class of Financing Receivable, Type of Borrower [Domain]",
        "terseLabel": "Class of Financing Receivable, Type of Borrower [Domain]"
       }
      }
     },
     "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r118",
      "r121",
      "r146",
      "r147",
      "r148",
      "r151",
      "r153",
      "r163",
      "r164",
      "r165",
      "r234",
      "r296",
      "r301",
      "r302",
      "r303",
      "r309",
      "r310",
      "r354",
      "r355",
      "r359",
      "r363",
      "r614",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Exercise price of warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollateralAxis": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Axis]",
        "terseLabel": "Collateral [Axis]"
       }
      }
     },
     "localname": "CollateralAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Domain]",
        "terseLabel": "Collateral [Domain]"
       }
      }
     },
     "localname": "CollateralDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r54",
      "r291",
      "r692",
      "r713"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 11)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r294",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r83",
      "r91",
      "r695",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r220",
      "r612",
      "r613",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r220",
      "r612",
      "r613",
      "r732",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r220",
      "r612",
      "r613",
      "r732",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r168",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Risk, Credit Risk, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r173",
      "r174",
      "r220",
      "r612",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskSupplier": {
     "auth_ref": [
      "r171",
      "r172",
      "r174",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of risks that arise due to the volume of business transacted with a particular supplier or reliance placed on that supplier. At a minimum, the description informs financial statement users of the general nature of the risk.",
        "label": "Concentration Risk, Supplier",
        "terseLabel": "Concentration Risk, Supplier"
       }
      }
     },
     "localname": "ConcentrationRiskSupplier",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r220",
      "r612",
      "r613",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right received from contract, including, but not limited to, advertising contract, broadcast rights, franchise agreement, lease agreement, licensing agreement, and use rights.",
        "label": "Contract-Based Intangible Assets [Member]",
        "terseLabel": "Contract-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "ContractBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractTerminationMember": {
     "auth_ref": [
      "r279",
      "r280",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Contract Termination [Member]",
        "verboseLabel": "Contract Termination [Member]"
       }
      }
     },
     "localname": "ContractTerminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r382",
      "r383",
      "r395"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Deferred revenue and advances from customers"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r382",
      "r383",
      "r395"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Advances from customers"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "negatedTerseLabel": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of Stock, Shares Converted"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r430",
      "r481",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "verboseLabel": "Corporate debt [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r86",
      "r683"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r122",
      "r570",
      "r577",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerAdvancesCurrent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current portion of prepayments received from customers for goods or services to be provided in the future.",
        "label": "Customer Advances, Current",
        "terseLabel": "Advances from customers"
       }
      }
     },
     "localname": "CustomerAdvancesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r172",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Current debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r328",
      "r335",
      "r336",
      "r338",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r20",
      "r21",
      "r120",
      "r127",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r342",
      "r343",
      "r344",
      "r345",
      "r625",
      "r689",
      "r690",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r21",
      "r339",
      "r690",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt, carrying amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r311",
      "r342",
      "r343",
      "r623",
      "r625",
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Long-term debt, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r51",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Debt instrument interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r52",
      "r120",
      "r127",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r342",
      "r343",
      "r344",
      "r345",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentInterest": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to interest.",
        "label": "Debt Instrument, Periodic Payment, Interest",
        "terseLabel": "Debt Instrument, Periodic Payment, Interest"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r52",
      "r120",
      "r127",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r342",
      "r343",
      "r344",
      "r345",
      "r371",
      "r374",
      "r375",
      "r376",
      "r622",
      "r623",
      "r625",
      "r626",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "terseLabel": "Debt, long-term and short-term, combined carrying value"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities [Member]"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r44",
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r549",
      "r550"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueAndCreditsCurrent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue or other forms of income in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer.",
        "label": "Deferred Revenue and Credits, Current",
        "terseLabel": "Deferred revenue and advances from customers"
       }
      }
     },
     "localname": "DeferredRevenueAndCreditsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Advances from customers, noncurrent"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueRevenueRecognized1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.",
        "label": "Deferred Revenue, Revenue Recognized",
        "terseLabel": "Deferred revenue, revenue recognized"
       }
      }
     },
     "localname": "DeferredRevenueRevenueRecognized1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Deferred Tax Assets, Gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Deferred Tax Assets, Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Deferred Tax Assets, Net, Current"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Deferred Tax Assets, Net of Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Deferred Tax Assets, Net Operating Loss and Credit Carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Deferred Tax Assets, Property, Plant and Equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits",
        "verboseLabel": "Deferred Tax Assets, Employee Benefits Costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "verboseLabel": "Deferred Tax Assets, Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "verboseLabel": "Deferred Tax Assets, Accrued Expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "verboseLabel": "Deferred Tax Assets, Long-Term Debt and Financing Costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r550",
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "verboseLabel": "Deferred Tax Liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs classified as other.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs",
        "verboseLabel": "Deferred Tax Liabilities, Prepaid Expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r568",
      "r569"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "terseLabel": "Deferred Tax Liabilities, Intangible Assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r23",
      "r404",
      "r405",
      "r427"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Pension benefit liabilities"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForPlanAmendment": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accumulated benefit obligation from change in existing term of defined benefit plan or initiation of new defined benefit plan.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "negatedTerseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForPlanAmendment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r419",
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedNetLabel": "Retirement benefit plans (gains) losses, net",
        "terseLabel": "Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement",
        "verboseLabel": "Defined Benefit Plan, Actuarial (Gain) Loss From Remeasurement"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAdministrationExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of administration expense of defined benefit plan which decreases plan assets. Excludes plan administration expense paid by employer.",
        "label": "Defined Benefit Plan, Plan Assets, Administration Expense",
        "negatedTerseLabel": "Defined Benefit Plan, Plan Assets, Administration Expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanAdministrationExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r406",
      "r445",
      "r475",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gains) losses, net"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r406",
      "r446",
      "r476",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Amortization of prior service costs (credits), net"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r404",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "terseLabel": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]",
        "terseLabel": "Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r454",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r414",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r458",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r421",
      "r430",
      "r432",
      "r479",
      "r481",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r440",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Expected defined benefit plan contributions for next fiscal year for qualified plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r406",
      "r444",
      "r474",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets (gains)"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r418",
      "r430",
      "r432",
      "r433",
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r404",
      "r427",
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "terseLabel": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofHealthcareCostTrendRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Information about Plan Assets [Abstract]",
        "terseLabel": "Defined Benefit Plan, Information about Plan Assets [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanInformationAboutPlanAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r406",
      "r410",
      "r443",
      "r473",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Defined Benefit Plan, Interest Cost",
        "verboseLabel": "Interest costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r441",
      "r471",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Administrative Expenses Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan cost (credit), classified as other.",
        "label": "Defined Benefit Plan, Other Cost (Credit)",
        "terseLabel": "Loss on plan changes resulting from legal settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Increase for Plan Amendment"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r423",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable": {
     "auth_ref": [
      "r430",
      "r432",
      "r437",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Table]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r429",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r408",
      "r442",
      "r472",
      "r481",
      "r482"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service costs",
        "verboseLabel": "Defined Benefit Plan, Service Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Defined Benefit Plan, Plan Assets, Payment for Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofHealthcareCostTrendRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year ultimate health care cost trend rate is expected to be reached, in YYYY format.",
        "label": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate",
        "terseLabel": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofHealthcareCostTrendRatesDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined Contribution Plan, Cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Deposits Assets, Current",
        "terseLabel": "Deposits for financial assurance"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Deposits Assets, Noncurrent",
        "terseLabel": "Deposits for surety bonds"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r104",
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "negatedTerseLabel": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails",
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r104",
      "r186"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r84",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r143",
      "r146",
      "r151",
      "r152",
      "r153",
      "r158",
      "r159",
      "r598",
      "r599",
      "r696",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss) per common share - basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share - basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r84",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r146",
      "r151",
      "r152",
      "r153",
      "r158",
      "r159",
      "r598",
      "r599",
      "r696",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss) per common share - diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "verboseLabel": "Income Per Share Calculation [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r123",
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal Statutory Income Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Deduction, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Other, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Interest Expense, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Gain on Early Extinguishment of Debt, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, State Income Tax Expense, Net of Federal Benefit, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r552",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Uncertain Tax Positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period in years of costs to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r78",
      "r79",
      "r80",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r141",
      "r162",
      "r235",
      "r370",
      "r377",
      "r539",
      "r540",
      "r541",
      "r573",
      "r574",
      "r597",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r725",
      "r726",
      "r727",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesByIndustryAxis": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.",
        "label": "Industry Sector [Axis]",
        "terseLabel": "Industry Sector [Axis]"
       }
      }
     },
     "localname": "EquitySecuritiesByIndustryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.",
        "label": "Industry Sector [Domain]",
        "terseLabel": "Industry Sector [Domain]"
       }
      }
     },
     "localname": "EquitySecuritiesIndustryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r14",
      "r19",
      "r230",
      "r705",
      "r735",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Repurchase of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r601",
      "r602",
      "r603",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r326",
      "r342",
      "r343",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r481",
      "r602",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Disclosure Items [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r601",
      "r602",
      "r604",
      "r605",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1, 2 and 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r326",
      "r430",
      "r432",
      "r437",
      "r481",
      "r602",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r326",
      "r342",
      "r343",
      "r430",
      "r432",
      "r437",
      "r481",
      "r602",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r326",
      "r342",
      "r343",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r481",
      "r602",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r601",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Deferred compensation obligation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r432",
      "r600",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share [Member]"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Schedule of Financial Instruments Recorded at Fair Value"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r326",
      "r342",
      "r343",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r481",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r609",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r250",
      "r251",
      "r252",
      "r253",
      "r337",
      "r368",
      "r595",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r764",
      "r765",
      "r766",
      "r767",
      "r772",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablePortfolioSegmentAxis": {
     "auth_ref": [
      "r236",
      "r237",
      "r241",
      "r764",
      "r765",
      "r766",
      "r767",
      "r772",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.",
        "label": "Financing Receivable Portfolio Segment [Axis]",
        "terseLabel": "Financing Receivable Portfolio Segment [Axis]"
       }
      }
     },
     "localname": "FinancingReceivablePortfolioSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablePortfolioSegmentDomain": {
     "auth_ref": [
      "r764",
      "r765",
      "r766",
      "r767",
      "r772",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.",
        "label": "Financing Receivable Portfolio Segment [Domain]",
        "terseLabel": "Financing Receivable Portfolio Segment [Domain]"
       }
      }
     },
     "localname": "FinancingReceivablePortfolioSegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r238",
      "r239",
      "r240",
      "r242",
      "r244",
      "r248",
      "r249",
      "r764",
      "r765",
      "r766",
      "r767",
      "r772",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Axis]",
        "terseLabel": "Class of Financing Receivable, Type [Axis]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": {
     "auth_ref": [
      "r764",
      "r765",
      "r766",
      "r767",
      "r772",
      "r773",
      "r774",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Class of Financing Receivable [Domain]",
        "terseLabel": "Class of Financing Receivable, Type [Domain]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Average useful life of finite-lived intangible assets",
        "verboseLabel": "Average useful life of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated intangible asset amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r261",
      "r262",
      "r266",
      "r269",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r261",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r266",
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsScheduleofIntangibleAssetAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Finite-Lived Intangible Assets, Remaining Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingencyUnrecordedAmount": {
     "auth_ref": [
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.",
        "label": "Gain Contingency, Unrecorded Amount",
        "terseLabel": "Claim filed, unrecorded gain contingency,"
       }
      }
     },
     "localname": "GainContingencyUnrecordedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnContractTermination": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.",
        "label": "Gain (Loss) on Contract Termination",
        "negatedLabel": "Accrued loss on long-term contract"
       }
      }
     },
     "localname": "GainLossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "terseLabel": "Gain (Loss) on Disposition of Property Plant Equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "terseLabel": "Gain (loss) related to litigation settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r104",
      "r346",
      "r347"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Gain on early extinguishment of debt",
        "negatedTerseLabel": "Gain on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits, Description [Abstract]",
        "terseLabel": "Retirement Benefits, Description [Abstract]"
       }
      }
     },
     "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r247",
      "r697",
      "r698",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r697",
      "r698",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r258",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization that is the governing authority of a community.",
        "label": "Government [Member]",
        "terseLabel": "Government [Member]"
       }
      }
     },
     "localname": "GovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r85",
      "r121",
      "r191",
      "r203",
      "r207",
      "r210",
      "r213",
      "r234",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r614"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit (loss)",
        "verboseLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r191",
      "r203",
      "r207",
      "r210",
      "r213",
      "r686",
      "r693",
      "r698",
      "r717"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r275",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r553",
      "r560",
      "r566",
      "r575",
      "r580",
      "r584",
      "r585",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Income Tax Examination, Penalties and Interest Accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "negatedTerseLabel": "Income Tax Examination, Penalties and Interest Expense Reduction"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r140",
      "r141",
      "r189",
      "r551",
      "r576",
      "r582",
      "r718"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision (benefit) for income taxes",
        "terseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability",
        "terseLabel": "Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r77",
      "r547",
      "r548",
      "r560",
      "r561",
      "r565",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and other liabilities \u2013 increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Payables under SWU purchase agreements \u2013 increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable \u2013 (increase) decrease"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCharges": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.",
        "label": "Increase (Decrease) in Deferred Charges",
        "terseLabel": "Deferred costs \u2013 increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Increase (Decrease) in Deferred Income Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of (a) prepayments by customers for goods or services to be provided at a later date, (b) the amount of customer money held in customer accounts, including security deposits, collateral for current or future transactions, initial payment of the cost of an acquisition or for the right to enter into a contract or agreement, (c) the increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting services yet to be performed by the reporting entity for which cash or other forms of consideration was received or recorded as a receivable, or (d) some combination of (a), (b), and (c).",
        "label": "Increase (Decrease) in Deferred Revenue and Customer Advances and Deposits",
        "terseLabel": "Deferred revenue and customer advances \u2013 increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase (Decrease) in Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Liabilities [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPensionPlanObligations": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension benefits. Includes, but is not limited to, defined benefit or defined contribution plans. Excludes other postretirement benefits.",
        "label": "Increase (Decrease) in Obligation, Pension Benefits",
        "terseLabel": "Pension and postretirement liabilities - increase (decrease)"
       }
      }
     },
     "localname": "IncreaseDecreaseInPensionPlanObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndustryOfCounterpartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The industry of the party or parties having primary responsibility to meet the obligations of the arrangement with the entity.",
        "label": "Industry of Counterparty [Domain]",
        "terseLabel": "Industry of Counterparty [Domain]"
       }
      }
     },
     "localname": "IndustryOfCounterpartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Amortizable intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r259",
      "r264"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Amortizable intangible assets, net",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r90",
      "r332",
      "r341",
      "r344",
      "r345"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r98",
      "r101",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "verboseLabel": "Accrued interest payable on debt"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r60",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/InventoriesScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r61",
      "r114",
      "r161",
      "r254",
      "r256",
      "r257",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r89",
      "r184"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalEntityTypeOfCounterpartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of the other party participating in a financial transaction.",
        "label": "Legal Entity Type of Counterparty [Domain]",
        "terseLabel": "Legal Entity Type of Counterparty [Domain]"
       }
      }
     },
     "localname": "LegalEntityTypeOfCounterpartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r48",
      "r121",
      "r205",
      "r234",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r589",
      "r591",
      "r592",
      "r614",
      "r645",
      "r646"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r121",
      "r234",
      "r614",
      "r647",
      "r691",
      "r711"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r50",
      "r121",
      "r234",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r589",
      "r591",
      "r592",
      "r614",
      "r645",
      "r646",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Liability for Uncertain Tax Positions, Noncurrent"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Litigation settlement, amount awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r325",
      "r340",
      "r342",
      "r343",
      "r690",
      "r707"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term debt, current"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r52",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyRangeOfPossibleLossPortionNotAccrued": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum amount of estimated loss and the amount recorded as of the balance sheet date.",
        "label": "Loss Contingency, Range of Possible Loss, Portion Not Accrued",
        "terseLabel": "Loss Contingency, Possible Loss Not Accrued"
       }
      }
     },
     "localname": "LossContingencyRangeOfPossibleLossPortionNotAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossOnContracts": {
     "auth_ref": [
      "r87",
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Losses recognized in the current period on contracts which are expected to generate losses, which are probable and can be reasonably estimated, in a future period.",
        "label": "Loss on Contracts",
        "negatedTerseLabel": "Loss on contracts",
        "terseLabel": "Loss on contracts"
       }
      }
     },
     "localname": "LossOnContracts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaturitiesOfSeniorDebt": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, as it matures.",
        "label": "Maturities of Senior Debt",
        "terseLabel": "Maturities of Senior Debt"
       }
      }
     },
     "localname": "MaturitiesOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual Fund [Member]"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows Used in Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Provided by (Used in) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows Provided by Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r99",
      "r102",
      "r105"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r75",
      "r76",
      "r80",
      "r82",
      "r105",
      "r121",
      "r132",
      "r134",
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r149",
      "r191",
      "r203",
      "r207",
      "r210",
      "r213",
      "r234",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r599",
      "r614",
      "r694",
      "r714"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r143",
      "r144",
      "r150",
      "r153",
      "r191",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) allocable to common stockholders",
        "totalLabel": "Net income (loss) allocable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component",
        "terseLabel": "Nonoperating components of net periodic benefit expense (income)"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonmonetaryTransactionAmountOfBarterTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of revenue and expenses for the services received and provided in a nonmonetary arrangement.",
        "label": "Nonmonetary Transaction, Amount of Barter Transaction",
        "verboseLabel": "Nonmonetary transaction, amount of barter transaction"
       }
      }
     },
     "localname": "NonmonetaryTransactionAmountOfBarterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized": {
     "auth_ref": [
      "r643"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross operating revenue recognized in a nonmonetary transaction.",
        "label": "Nonmonetary Transaction, Gross Operating Revenue Recognized",
        "terseLabel": "Revenue, nonmonetary transaction"
       }
      }
     },
     "localname": "NonmonetaryTransactionGrossOperatingRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonqualifiedPlanMember": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r467",
      "r468",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan without tax-exempt status in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Nonqualified Plan [Member]",
        "terseLabel": "Nonqualified Plan [Member]"
       }
      }
     },
     "localname": "NonqualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesIssued1": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of notes issued in noncash investing and financing activities.",
        "label": "Notes Issued",
        "terseLabel": "Conversion of interest payable-in-kind to long-term debt"
       }
      }
     },
     "localname": "NotesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r191",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails",
      "http://www.centrusenergy.com/role/MaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r633",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r629"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r636",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r635",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Operating Loss Carryforwards, Valuation Allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "auth_ref": [
      "r349",
      "r593",
      "r594",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCapitalizedPropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other long term capitalized assets related to property plant and equipment not otherwise previously categorized.",
        "label": "Other Capitalized Property Plant and Equipment [Member]",
        "terseLabel": "Other Capitalized Property Plant and Equipment [Member]"
       }
      }
     },
     "localname": "OtherCapitalizedPropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r66",
      "r69",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r69",
      "r73",
      "r74",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "verboseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r67",
      "r69",
      "r449",
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r70",
      "r78",
      "r83",
      "r551",
      "r581",
      "r583",
      "r616",
      "r619",
      "r621",
      "r695",
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDeferredCostsNet": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.",
        "label": "Other Deferred Costs, Net",
        "terseLabel": "Deferred costs associated with deferred revenue"
       }
      }
     },
     "localname": "OtherDeferredCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r21",
      "r690",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "terseLabel": "Long-term debt, interest"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Other Noncash Expense",
        "terseLabel": "Revaluation of inventory borrowing"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other (income)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r403",
      "r404",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan [Member]",
        "verboseLabel": "Postretirement Health and Life Benefits Plans [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r23",
      "r404",
      "r405",
      "r427"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.",
        "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent",
        "terseLabel": "Postretirement health and life benefit obligations"
       }
      }
     },
     "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPreferredStockDividendsAndAdjustments": {
     "auth_ref": [
      "r144",
      "r378"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of preferred stock dividends and adjustments classified as other.",
        "label": "Other Preferred Stock Dividends and Adjustments",
        "terseLabel": "Preferred Stock Dividends and Other Adjustments",
        "verboseLabel": "Distributed earnings allocable to retired preferred shares"
       }
      }
     },
     "localname": "OtherPreferredStockDividendsAndAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionNameDomain": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of other significant noncash (or part noncash) investing and financing activities required to be supplementally disclosed to enable users of the financial information to fully understand the period cash flows of the Entity in relation to the statements of financial position, income statement, and statement of changes in shareholders' equity. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Name [Domain]",
        "terseLabel": "Other Significant Noncash Transaction, Name [Domain]"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "negatedLabel": "Other Significant Noncash Transaction, Value of Consideration Given"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Received",
        "terseLabel": "Other Significant Noncash Transaction, Value of Consideration Received"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by other significant noncash transactions.",
        "label": "Other Significant Noncash Transaction [Axis]",
        "terseLabel": "Other Significant Noncash Transaction [Axis]"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionsByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentInKindPIKNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A payment in kind note accrues interest over the term of the note and is repaid at maturity or upon refinancing. A PIK loan is typically unsecured.",
        "label": "Payment in Kind (PIK) Note [Member]",
        "terseLabel": "Payment in Kind (PIK) Note [Member]"
       }
      }
     },
     "localname": "PaymentInKindPIKNoteMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.",
        "label": "Payment of Financing and Stock Issuance Costs",
        "negatedTerseLabel": "Payments for deferred issuance costs"
       }
      }
     },
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire preferred stock during the period.",
        "label": "Payments for Repurchase of Preferred Stock and Preference Stock",
        "negatedTerseLabel": "Redemption of preferred stock, net",
        "terseLabel": "Payments for Repurchase of Preferred Stock and Preference Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Payments of Stock Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Shares withheld for employee taxes"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r404",
      "r405",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.",
        "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current",
        "terseLabel": "Postretirement health and life benefit obligations - current"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r429",
      "r431",
      "r437",
      "r456",
      "r459",
      "r460",
      "r461",
      "r463",
      "r464",
      "r481",
      "r483",
      "r486",
      "r488",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Pension and Postretirement Health and Life Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r465",
      "r484",
      "r485",
      "r488",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension and Other Postretirement Plans, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r402",
      "r404",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r488",
      "r489",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan, Defined Benefit [Member]",
        "verboseLabel": "Pension Plan, Defined Benefit [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PhantomShareUnitsPSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded as phantom share or unit.",
        "label": "Phantom Share Units (PSUs) [Member]",
        "verboseLabel": "Notional Stock Units [Member]"
       }
      }
     },
     "localname": "PhantomShareUnitsPSUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r458",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class B stock or outstanding preferred class B stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class B [Member]",
        "terseLabel": "Preferred Series B [Member]"
       }
      }
     },
     "localname": "PreferredClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "auth_ref": [
      "r144",
      "r154"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends and Other Adjustments",
        "terseLabel": "Preferred Stock Dividends and Other Adjustments"
       }
      }
     },
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "terseLabel": "Preferred stock dividends, undeclared and cumulative"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r25",
      "r118",
      "r359",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share",
        "verboseLabel": "Preferred stock, liquidation preference per share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r118",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r38",
      "r39"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Proceeds from Customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from the sale of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from Sale of Property, Plant, and Equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r94",
      "r538"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product [Member]"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r733",
      "r734"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "verboseLabel": "Transaction costs"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Property, Plant and Equipment, Additions"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r742",
      "r743",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, Plant and Equipment, Gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r15",
      "r16",
      "r274",
      "r647",
      "r700",
      "r712"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r274",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r15",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r15",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForLossOnContracts": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative provision for contract losses not offset against related costs accumulated on the balance sheet.",
        "label": "Provision for Loss on Contracts",
        "terseLabel": "Provision for Loss on Contracts"
       }
      }
     },
     "localname": "ProvisionForLossOnContracts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QualifiedPlanMember": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r467",
      "r468",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Qualified Plan [Member]",
        "terseLabel": "Qualified Plan [Member]"
       }
      }
     },
     "localname": "QualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesBillingStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.",
        "label": "Receivables Billing Status [Domain]",
        "terseLabel": "Receivables Billing Status [Domain]"
       }
      }
     },
     "localname": "ReceivablesBillingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "auth_ref": [
      "r22",
      "r627",
      "r638",
      "r641",
      "r642",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.",
        "label": "Related Party Transaction, Description of Transaction",
        "terseLabel": "Related Party Transaction, Description of Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Related Party Transaction, Purchases from Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Payment of interest classified as debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r546",
      "r682",
      "r756"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Advanced technology license and decommissioning costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "verboseLabel": "Advanced Technology Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r13",
      "r106",
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash included in other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash and Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r8",
      "r17",
      "r106",
      "r112",
      "r739"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash included in other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockExpense": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.",
        "label": "Restricted Stock or Unit Expense",
        "terseLabel": "Restricted Stock or Unit Expense"
       }
      }
     },
     "localname": "RestrictedStockExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r104",
      "r278",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "netLabel": "Special charges for workforce reductions and advisory costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r377",
      "r542",
      "r647",
      "r710",
      "r728",
      "r730"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r141",
      "r235",
      "r539",
      "r540",
      "r541",
      "r573",
      "r574",
      "r597",
      "r725",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r467",
      "r468",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Axis]",
        "terseLabel": "Retirement Plan Tax Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r467",
      "r468",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Domain]",
        "terseLabel": "Retirement Plan Tax Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r454",
      "r455",
      "r458",
      "r461",
      "r466",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r182",
      "r183",
      "r202",
      "r208",
      "r209",
      "r215",
      "r216",
      "r220",
      "r393",
      "r394",
      "r683"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r397",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersTables",
      "http://www.centrusenergy.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition, Policy"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of Stock, Price Per Share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r173",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtScheduleofDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r465",
      "r466",
      "r469",
      "r470",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r151",
      "r153",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "verboseLabel": "Schedule of Income Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of a one-percentage-point increase and the effect of a one-percentage-point decrease in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs and the accumulated postretirement benefit obligation for health care benefits.",
        "label": "Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]",
        "terseLabel": "Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r261",
      "r265",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r261",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.",
        "label": "Schedule of Health Care Cost Trend Rates [Table Text Block]",
        "terseLabel": "Schedule of Health Care Cost Trend Rates [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfHealthCareCostTrendRatesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r35",
      "r36",
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Benefit Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Notional Stock Units, Performance Condition, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PropertyPlantandEquipmentTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "auth_ref": [
      "r13",
      "r112",
      "r687",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashScheduleofRestrictedCashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r13",
      "r112",
      "r687",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Restricted Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CashCashEquivalentsandRestrictedCashTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r191",
      "r194",
      "r206",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r191",
      "r194",
      "r206",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Reporting Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r506",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock awards granted to nonemployee directors that were outstanding at the beginning and end of the year, and the number of awards that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-based Payment Arrangement, Nonemployee Director Award Plan, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Nonemployee Director Award Plan, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r511",
      "r523",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Compensation, Stock Options, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r55",
      "r118",
      "r163",
      "r164",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r363",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r351",
      "r352",
      "r353",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Schedule of Stock by Class [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r220",
      "r282",
      "r286",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r191",
      "r195",
      "r207",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "terseLabel": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "verboseLabel": "Preferred Series A [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service [Member]"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Compensation [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r512",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r503",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r506",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Stock-based Compensation, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r529",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Simplified Method"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r113",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r179",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r220",
      "r258",
      "r276",
      "r282",
      "r286",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails",
      "http://www.centrusenergy.com/role/SegmentInformationSegmentReportingInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r118",
      "r121",
      "r146",
      "r147",
      "r148",
      "r151",
      "r153",
      "r163",
      "r164",
      "r165",
      "r234",
      "r296",
      "r301",
      "r302",
      "r303",
      "r309",
      "r310",
      "r354",
      "r355",
      "r359",
      "r363",
      "r370",
      "r614",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r57",
      "r78",
      "r79",
      "r80",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r141",
      "r162",
      "r235",
      "r370",
      "r377",
      "r539",
      "r540",
      "r541",
      "r573",
      "r574",
      "r597",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r725",
      "r726",
      "r727",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/DebtNarrativeDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofNetBenefitCostsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r162",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails",
      "http://www.centrusenergy.com/role/FairValueMeasurementsFinancialInstrumentsRecordedatFairValueDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesRateReconciliationDetails",
      "http://www.centrusenergy.com/role/IncomeTaxesTaxesbyJurisdictionDetails",
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofAssumptionsUsedDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofChangesinProjectedBenefitObligationsDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofDefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeDetails",
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofEstimatedFutureBenefitPaymentsDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersContractwithCustomerAssetandLiabilityDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersNarrativeDetails",
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://www.centrusenergy.com/role/RevenuebyGeographicAreaDetails",
      "http://www.centrusenergy.com/role/SegmentInformationNarrativeDetails",
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs) [Member]"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationCostsRollforwardDetails",
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationAssumptionsUsedintheBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r370",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r370",
      "r377",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationOptionsDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r370",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock issued during period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r377",
      "r505",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Restricted and other common stock issued, net of amortization"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock or Unit Option Plan Expense",
        "terseLabel": "Stock or Unit Option Plan Expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockBasedCompensationStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r25",
      "r26",
      "r370",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Stock Repurchased and Retired During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityTablesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r25",
      "r26",
      "r370",
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "terseLabel": "Stock Repurchased and Retired During Period, Value"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r121",
      "r227",
      "r234",
      "r614",
      "r647"
     ],
     "calculation": {
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r377",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r555",
      "r559",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Summary of Income Tax Contingencies [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2018Member": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2018.",
        "label": "Tax Year 2018 [Member]",
        "terseLabel": "Tax Year 2018 [Member]"
       }
      }
     },
     "localname": "TaxYear2018Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r337",
      "r368",
      "r595",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r764",
      "r765",
      "r766",
      "r767",
      "r772",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsPlanAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r279",
      "r280",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r430",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "verboseLabel": "Municipal bonds and non-U.S. government securities [Member]"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r430",
      "r699",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "verboseLabel": "US government securities [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/PensionandPostretirementHealthandLifeBenefitsScheduleofFairValueofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables, Current",
        "terseLabel": "Unbilled Receivables, Current"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/RevenueandContractswithCustomersAccountsReceivableScheduleofAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Income Tax Penalties Expense Reduction"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r166",
      "r167",
      "r169",
      "r170",
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Increase (decrease) in deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetExplanationOfChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of and reason for the change during the period in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Explanation of Change",
        "terseLabel": "Valuation Allowance, Deferred Tax Asset, Explanation of Change"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetExplanationOfChange",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/ScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareNarrativeDetails",
      "http://www.centrusenergy.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Potentially dilutive shares related to stock options"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r145",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Average number of shares outstanding, diluted",
        "verboseLabel": "Average number of shares outstanding, diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Average number of common shares outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r143",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Average number of shares outstanding, basic",
        "verboseLabel": "Average number of shares outstanding, basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.centrusenergy.com/role/NetIncomePerShareScheduleofIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred financing cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.centrusenergy.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99380358&loc=d3e7102-108593"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921830-210448"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=99385795&loc=d3e12631-108344"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.Q)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187283-122770"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "35",
   "Topic": "605",
   "URI": "http://asc.fasb.org/extlink&oid=123355788&loc=d3e57763-111642"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "35",
   "Topic": "605",
   "URI": "http://asc.fasb.org/extlink&oid=123355788&loc=d3e57777-111642"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(m)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL7495116-110257"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918703-209980"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919784-209982"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=123385986&loc=d3e32049-108421"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55302-109406"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r757": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r758": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r759": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r760": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r761": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r762": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r763": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r764": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r765": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r766": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r767": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r768": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)"
  },
  "r769": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r770": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)"
  },
  "r771": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)"
  },
  "r772": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r773": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r774": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r775": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5"
  },
  "r776": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1404"
  },
  "r777": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1404"
  },
  "r778": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)"
  },
  "r779": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(2)"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r780": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)"
  },
  "r781": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(4)"
  },
  "r782": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405"
  },
  "r783": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)"
  },
  "r784": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)"
  },
  "r785": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)"
  },
  "r786": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)"
  },
  "r787": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)"
  },
  "r788": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406"
  },
  "r789": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r790": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  }
 },
 "version": "2.1"
}



ZIP
116
0001065059-22-000012-xbrl.zip
IDEA: XBRL DOCUMENT

begin 644 0001065059-22-000012-xbrl.zip
M4$L#!!0    ( $!?:U3B!\;J+0,  ! /   >    97AH:6)I=#(Q+6QIA[%Y0M9(.1P%'").,1#B!L]PQ@S*6,70A7JY6U
M*EE9V&E!_;\#,26/"R;K9
M(&P)&#DU&+5+U1)U_$II6BF7'(2G&-EE9#LU,L4U__BGK8*$"JYU$KD.Z*D1
MLLBNC="AL8W#8J:@$RXE#UUDH5HL%6+*(ZDB$BM-'+!9Y&;);E1SL<\#+MS/*'O54XDYQ2$+UN[1B(4T 3VZ @,>XNCH
M2Z(.R$RH8%,-3-@OZMJVBCW[NMHDH^P$+*)Y#@^'W9:G;-!IST$_:_
M:_=&@_$0M'OMP;=KX/4'E]:;(+&@GB6>!#3'3+@@5)B*NP#'"77SASIA21S@
MM9/9QF8,J_\#J.Z/@Y%F:,"L%D0/R]M+E28 JPB3&
MT:E1,AY<""X"&I6[^(C0#3O;.B<[.DY\FVJ![!/5+*>27Y*Z%P,ZW>E/W9I_
M_>)$3UV<3N50AT:HSP5.9P]WH:YRD:*,9@^'%/ I&"XF"2,,B_6?2^TA=X4\
MO-/4AU+-36GNG4B)XPUB*_W]W5+=Z99=:@HK\ GH^ZO AW_=Y3W'8#3'$4N'
MU(SS!+0CP?QY-KYZ!=2_Y'PDGF.OET17*NV1+6KA0Y9/GG0J>
M)#Q8R&*5E^Q@FW>]*V9;:_,W4$L#!!0    ( $!?:U0=8?#FB1H  /KT   :
M    97AH:6)I=%\Q,"TS,'@R,#(Q,3(S,2YH=&WM/6MSVLBRW^^OF).MNVNV
M0$: P79R4D5L7&$WL7W\V.Q^NB6DPGW]WS[E_'9T=7?YWWV"@:N^S\^L.G_A%[4]O=_=(\VMT]OCIF'Z\^
M?V(MHVZRJ\#R0A$)W[/Z1OV9A1%D\/=W=EL9LR:AA_<[%Y=[.)0K5W7
M]T-N.)'SYOT[_ 1^1B%S^7H_S;E?^_6Z7)GDW\)WY^W>.
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M?D;CX^?=T[]8_T2=*GCCN']Y].GLLG>]4Y[?\)!
M]Z+ LB-VZANLOK_?:K8[C9]_:G7>FO!8LUFK[YE%7PD0PU%V(;VCVN51W:R9
M9NVZ5ZLWS4:'%7T57>"F#G%FV@JSO@[ ?T_#2 SG#Z6[[&M/OM+/O=-C^/]*
MK[3*0H *9)$5,G_(3O@@F%K!G)EF5^,X4S
MD]8OV.5T,G'G\8&JLO4Y196M=1:KC.0> " \ ,GWV&LT<3]-DV]W\U6
M07?[Z.STZJ)[=/6\NPKHJ;#!G%F>PP8\FG'NL6M/H%)W&0'-A6JCB2R/_&"B
M5L)V"HQ:)* "H!5Q2G1?9;_Y0*6UR\BWOP(6QQ/+FQ<:@P1V 5"X,_2#,0 U
M5RAD610J=D[0:DW3#^*/N3T*/6O OP'51IJ#&4PRF'AWF!5P%O A#Y"; "\9
M 5L1'O 5$'S"F5HN<#*0*E:1NS(FH@(E*O_(AGR8!R"70V_#J81\_R(.7PH4,%1Y!F.@##9R +E #$\YI8'
M1CB0:6@'8B I.9R"1)1#P1OXF)8ZQHO5#'_^R6RC&;KXDTS.[F65T$"RC74C
M?RQLD' \N)EGI)OB(!=GE]VKL\^:M2!UX]O7QJ6!/ @XDPVJ&9\ "9& I-VP
M;@(NT6^A0D=O7$S#4%@@6D%)$M,QZ$?AA(.Z!%-U\7%Z>P<.B][DA>VJ;('Z
M"EIVG5U<=EFLQQ9!8?WYI[T#N7.OF^(5FV,S$8ZRM*EI##\=?DTT?MFM,LMQD&7-Z9-EBI!'".:QOG+FPS,!
MB L/A3PZ$.V1Y=WPD+;LU>W6Z=D7=#U=]$[.+GI59 " F5# \9(L26$9<,5O
M?,06HA+^4FB\\7V'/KJUW*DU<'GV]2J;C00*@Q0I6/97SY^YW+GA3(0@+(9#
M80N]2Z!MX0;#1+!? \Y&VG*Y&A1)873L<3VH;_3/W(B@7;K25<(AIX"[7C
M:OK=/MB# HQZ4IM7#P0G',A"Z]C5NV=5#X=WS'[/^T!>-I&U'B)^$= 5"MA"
M*U!ZCU23@'X=E+)2++NA+S&WB"1<8(^L!?8)1HE6S*30O,S:\C6J"3!%.$=ULH>&43?O0N9D%%AAZI3:OB3Y!H ;G\098A*X!P-JMD!F
M(P=98!55Y/X*X0&?N)8-YV0FHM&JH1MZ:(,A;\)QK%M?.!8P(=Q)QY\.HM2T
MH/3JU^/Y<6P?K)J8>]&I9'/XLHIPBC M5W ^L_-6"B3B M'(DEH*C2J2&22
M>-K1AMP%Z\A@YQP0&@ZFPJ)/./C?!),'?J5-'CN;=VT]@HF[
MH-4PTV@L:6&Y?"!*LVYBQOG65$;:I1!R-V+SWGH6L_&I+.S5,?6'4?KSVMAW
MB>6E+IX:<*3G!9FA!90K;*V*XE.Q[@U_2V\Q>3QBZ:.T%S@X\2&"#W:L
M"N.@LL[9T=Q%WA"$9*KUKL^K;&=089?6> *38)#+ N@"L)5V[ H[@ZDF8);!
MGVB"[3@5L,H0)AXF0B]K;J5-K-@F/S:)GWH<#(,0HZ!#):H%3HO::FQ3 DAZ
MD3AHLKJ$-7/CQF A![49^+H(./PS *6ZYJ(K?B(\^)M'MJ%X;BX]9)-Q)KX,
M%AX&W+7069R;GC/PH\@?']:35ZQ!Z+O3*/^5IT^/64UGRVD/N;PP_7,4)&?H
MAM<& ;>^ULCL.[3?H1%]1YZG:!3XTYL1_K$/^L_@;]B/M <9]X5T(QV/2[Q*M@_Z#SX4/M1E
ME,?7'FBVK-!Q,R/7S/WG99GMYR3<#+K,ID&X^/777]G&#?5R8S:R,0^T\!Z^
M-9W5SO#OV9HC']@*L'' S"_5L>_Y(9A4_#&[PX1,&]1HJ25'?F2Y:;U;VE/:1EKV,V4U1#1O
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MTZ2WJ!R*''?6_[':7@.K;:-N5A!-1FEL"8\@ //H&)22/XI
M+R(. YNS(RH_7'W?:Q4IK*-]@G^B_GJ*(0L!YBC
M"*. XA(889GX(4J+#]RVX&'I<%), 8"WHFF Z5$JMQ?XX/5)F]*O88 0V)'
M',H!($AR7)W_: &44X$,?E>^IKZGD*@G52,9'<.P(SW:G
MCF9QJU]=BC^H)C%A-)&HD&QY;#L>E:)FAV$VRC?<&G[8[
M*@W\HY.;1)B<^L8# @6ODBL@829G0U$1'BLAU=?E8T)I:D[JN*V,M_;,),]P
M8@EYD&$39*&19-) UQ$!(/G.? B
M9+:"A132,\I@QI43H%(S7N)T#V,62,P;B97M&:V]Y^0@^_=QD XJ=59E(]'&
M5QCL;Y3!_@VV-;G_"&V[0(*CEG_9#LUVW88.*
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MEP_6R=PEVA!!&*4<]2E7_#YVWMQX5
M)M1]+ E'ZD8;)SPNG%?NM>QQHGKW.+/01>Y%3Z-W=<6Q)3DFGNQV$V>-9WA4,,"QZ8(H^LLF,16B'6AG.BO
M$]X4^4%W AB;!$)-V,7>;*T&L<(C@S4:!YT1X[#S_!^#[33J]7UDCJ&NPT5G
M9%+'7^^L!&C5%(UZPU1YTDGA[Q:DTRZ+F"(DTQJ,$A<2\0ADI(]%H DQ16+*
M=RQE_>-I_0ZYF]-"RPJK.F9#[:#BPGX%+<$2+A>8JB7\@WI!TB9@H;<4$:9Z
M(?.D0H_F(5(?BU6DN+E%, EXM"#*J>L&/"FRR1MK84$FO%(P3FV@J^R*@7X^U#@&C"VTD\]$D>]0N(/F)FC4[1"E$N<>OIX'$L'
MX7C3@9I883CS P/$V29HL8\4);IIEK+A L>+BBFC-:UIDTR!W3R=$2XF 2>"2TT>8
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M868].>#MSGESXLD%<^NT.H]RZS3:QGZ]O7$'3*=N'!RT-N& 4;A3U1C+8[9+:
M'G=G?2:S*# @3E@!73-%QH-1V"FCSULNY^TX-<%C>IJT,PK.\+@1I59
M%%?'X#$E-XMFBH>9Q;*]WX"#MDX9"\"3?K.\*;:3D1EVZD9+^/R8VWP\
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M^\%@\8-1!>.DF8_^KJQIN*^<<&$X$Z91B6YZ%4QY^(UFX*3FNO
M1B-?P5"7&+;R+V^,8P]6C&=7,CYOS/NGP<)2QW[HZ6H6^VB]0#:N*\SR\?1*
M2?$!63/?C\,BRX&&L?H4%(SD[ROA?,6EF'M+D;NR%'/M4LRRL*XLK-N ."E@
MUN\K$!;+1L/C'#K*1TD*_LQ7ZGVIW#_H"!3=@?Z"[>;%I)=.ML?YCZ^O*@XZ
M%!O RP#RKBA+;E1.W_:'>!CF_$;]AD&"X3E&FRQOG)U4F'),.YD
M&*99^(3;PKD#EL4=-2?$HYZYJ2_DF FGKC3/>KDPVWY-]]C:8^N>_=62%#'C^6-J_ZQNXIKKZ^MV0%_^
M_>:Z@OP A&4B6 %5JFTJ7AFI7\<\%FR=ZGOZPJD3SIW41VEYC,@]0RK56=!Q
MTDNHII/7;)'6OO*BNN1ZL*6K/M7E;1JPZUJCN4PJ\
MZ,-?,(%^E5Q7"MNQ?%#'_BW6MNB;E3GVYU[4AKY6-#VL_-JM)'50V?O7LL^-
MTTJ5\&!!*+O2ZT+[]FE6]SQIMU;63T5
M:VFHA 46S0C,!;5'>2&[NG5+C@,,.M
MC#3(FVFVX:JI=+I0-M8UB9=!,0E]U52<4+HR&JZ1H$,7JWOE%V^74_>Y[.\(
M(2H/O=7J>8%N[F6*?;%O,]L9RE#YSLU6+::IVDUL#\@APKQ7@Q_MK8*Z9=2;
M.TZE2A1"E#+:+K3O&?5.%7_N$_CPR\$6P8_=A4S _Q:!'.K<** 9H6CF[VU:
M %7N W>1+'[K .>5Q9RQHL.\MV7P;@4'C\WQ7G,;P,WZ]CD8R+^@OQZ?WU%ZI*LD'M7LSW3-QU;LSY]ZM]\(!^FOC___.G3\_.S]%R3
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M)PX@.WRD[EB.^_D'F?TYQRO5B38SK<7GOW==4[/^7O%@HZL>=]TGPTOX[[)_-[PC\%]O>'-_U^W=#^]^
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MIDQU%;+E2[;CQU^4\HFIMM1.L+?+-84B
M-=?X>Y_L_?(F-#NP"1PI9!9X/M'TK[;S;%$#Q%D";_XTV@FFBN>N"7CU'?A\
M,^IAC_!R:C_A+FVYI14R7A#'IOP-%#;+LIQGU.XSZD\= S:JT3XG9]I'\F5!
M=&:BV@$
M0'WX)ERA%M5]U[%-'3$P"^ 'CLOGJ:DC)^A6 +80T6 I\'!JZS3:F13J$4?+
MQ7%V\X![+KN#JX<[IH;_&#[1T6V_-[@7
MF24-&!EQ*"SIRB[-DD##=KB33_U/A>K]@_V;:)LF::*)F6R=L,
MDQ>L[Y*8J.I>3=1<')%MI'9[O>'#S?W@YAMW(:(C"(*,??ZBWSH=W%V")H/*]#[^)=X$Y$GUM^2UR,Y1(=X2F3>]N
M\ 5,$[!'V"O!5\IGA<1$YFMCBT9?&3NN0=TJX,S2YA[]'/UP;IC>W-(6GTV;
M(8'=]!HJZ[2E>D?%:)GOPO]&].(PD":Q0-HGWUB_UI3D6FWC55E2-E[;]M2.
M(K6:K5R/_<16[*YPFZIR+!I@@%@@..Q_?*A]6,'X9YDH[%O1.S*^&F*>[0UC
M'6:K&"0BW,Q'92^ILV5%X6M\9[[U+>K\&[Z'LS3?R_^ YVA.%FM;[,SWP^2-
MG(JC]VN_]R]@K7Y,YQE(=9UG_K.:&\&OQPP^_)B0VZ8)G?MV]
MZ.-G28%/R%+:QU^7NSDE?"V#FF2I4T@@O0'JIEZKJJ3'7$!O)6R^698IS9>%
M603:6WF:L']5J:F^S-\[B;V]H?'_IF1>B+$WBOH]Z*;]BDZ.VDU4G24CZUD&
MZ#%E)-N<+Q)CWNZ7X6]]=.;R>
M!5@,S=7:V?BC
MM%E,G1K3,=E6EY1]B[9];%0O-"Y&#^ JL7AT]XIT?[GK\]@T7(%_&#,-;F#/
MDON7W#MF>0@!N0>UOX]-O9#($+CKKB2R*S(%_<6HJZEIFB5N6CI*CW02$L
MS,ZCDQA@]V!A/!QO1,5 RXP?.1 9;0O],B095'=<1B6? S L7/P6JI8_U_X4
M%4@]/F8^_!QF4,.TB.EYP=(*R)\%*6T@L5Z61 ./[]U&\<*X!(89DZEH8CFD
M[-!]U&QXAH%YO8?>)?&HSB0L5N$!=%XE3&4CN21S<0P@'5[@:KJ/BDTWK=6K=B5I7JS4.@H-7)%Y'>#9!ZK;YW%( 0;^P?
ML: 'VG(^,#--?&4MZAO'7+?:YDJ^"%$B(+O92)^9AF'1_:BM=BZU%6N'U?K(
M=6V1R#UMC*(W7^/=Y,-@37/B%(F@1_W%S4FUJ_++4;&>YNN['!KSJV
M=:YD>)-;8PC[E%1J?8=$U=$QHQP@5K,G+LDHRI"9U#\N2ZC2-I.?I87R]QZ:(AD=N[(5:G
MIW1$L;&AP02S@_!E#(%L#+*OUU?5LPH -M?W'$< M LPD)M25&[SY8]-Q;+H
MLY3=)NA?5X?:5W)G&H^;JV3+LM3>E]XN:UQS1'9C_KTL'.,J#])((A=XSLCG
MQY0FI&]3]W%!5%DF76-FVJ;G\\0&N7,TH^0;$1,,N;\AM5:[MK-?M<\\>@UM
MJW)6"+4[M:0R75.CC6VRL[PJ=4WZ'EOXMJ2X-H=5(GSYHSQJU?&G0#K^5 O/
MRS;W==AC+\4=^352K2 C='C7O\ZWPGKZY!87\DIK&+C=^&:EO+DC>
M6'+VBAW>Z5T;BK#73Y0T$W9$XU %V6\T$Y2,@^I%A'';$F$]<-A9T8N+N_YH
ME,S #?=:(]=XO2EQXT@5>+M+J5^!G0YL?U$A(Q_/.&,EUO\;W)*>8ZSZ[NRO
M8_/SKHUYMIS"D8L1]5W?M_E9F=Y4%PKVKF=HY/H"]&1;:9U*>F$E+KB2G O/U^U'-+5R8?+L
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M6GLK+([XIOZ=>VM#=_%P,R(WK/JNB/8*X?,FQVI5A9D\.X_
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MU)0FI\A3P3;>X, ,>B=!6YMUPMNQO3?GZE\::$HRDLAH"G;$EFZ/I0W7IK@^':80I0FBYN%F@$FLT3WLP2AL0'4WZ'7S#@K*D#:-=(ZN
M]-*FEN[F%ZUW-9R_:W^)8X@@]-:QG1:& WCYO'OJPF=SF$?.ZKHHK?=<+(25
M-HBQK8378%&[I=W'TFCAAW:99Q3K:V7B16"5]3(?]/EDIU'_
M[K=!;[6E65X4%XC@M8/N>SVDD!>7_\9N[X/[/TZ00N6U7I&%8! =N4*PQP]N
M-%?/NI0BO(!(P;FOO:V3I$I'4@KXA^O1R.C3@L5>]QH'8[XUWGMX5;SN&,J;
M>_$?V]TZZ[[63]^H*S;2[5X1V\A";*-$B/UR(,3F$H/M/
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M@ 7  F !\%: WQUL!SQ1>936!N'1RN:QC^+4E!CI+O6HYNI3UH_=H$_4@6]LNG-G4?%^Q^C^JP.#]LM._
M[2[!YO./KC:;:8 2,C,]#QO-2X1KE2Z,
M> >V[C(D:9:U()>!C>WVNVQTPUO XE*I,*BZ.IN(CJ
MG =^5 XJ!/'@TW]I7&][([#QS8>J""[90HN$)24)RR8@BU[N=
M_>4U]BO8L@[1?/?E8@;1?%U!%8MY>(= K)B'
MMTT,BGEX8AZ>F(=W4@)-S,,3(7D1DA1&2%R'YTH3D16!=!-9/); NYN&]
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M3:,9LTV>^,$KN]\SFA-:JTC-?Q0S!D5(7YWL!7=
M+^Y=S&3DK\C?8U21ZD=?KN@Q*GJ,?@?M>P5K"=82K"58*Z=U7B+;C3%@%3A.
MK3;E*N>G*N.>:DB+U7#'JB_M7*G(+%IMCODVZIJL.0T0,^;;;)>'IP&6F&\C
MY*&0AT(>"GDHY*&0AT(>"GDHY*&0AWGE85.56F41A[5*O:-49)F+Q5MM,:-V
MN$7\SV^#V_[=*"=H[0Y+]!0&VO:_I[X_Y[S$^FNSOY[,.74]R7"H].@\A3!W
M[07Y*Z >-JSS*F1N4M.$N&YTTHE1+@86R76\?IUB"Z9+PL T253
M=,G<=>VB2Z;HDEF"+IG9'"+&5A797[-=J^W]J:JD'*)K)UP\P&*5EM22U3WV
MUSS* )OFFI:45Z<"B;%5.^&TSFL*5[3W6J&A&%LEQE:)L55B;-6[&5O5R!Q;
MU1!CJW*KXJP1DLW2C",YW;%5&8AME BQ8G"5&%SU(C9.<7!5?=T.#C\L!=^=
M\."J=:\M_+ 4B!6#JT1(7H3D14A>A.2_GY"\"*R+P/JI!-;%X*K]E V)9@H"
M8 &P %@ +  6  N !< "8 &P %@ +  6  N !< "8 &P %@ +  6  N !< "
M8 &P %@ +!J3E[@Q>;K(2Y45MA>%]4IY<^N1MM0I@'F01A*YH'/-]7&3B#,A?9NZCXO<;1QE5E-=4G:X
ME882^>)\(ZHL*R&UQOM'[F](K=6N*8)&2PV,H%%!HV4'YC1I-#=X^6A4=,X3
MZQ"=\\0Q/7%,[Y2.Z2$HIO&/#V93IK0SUO1)IT7K#:7=:4PZ:KW>T119'6OM
MYI_U#V\_VM=I29UM1_M66U*\#9GWYHQZJ"+)G3/3[$T!WWR$N
M?3+A&SY\VZ">[IIS1JJ:;1!#\]FMUZ9%/=^Q86T==@'(@%VG%H5O)"XKH-+J
ME?#B!)9$@*/-)S 3J">1+K$='RR8*OVF4Q#]V@P'0N ;ECW1<55:X$\=%T U
M<('F;&Y19O;#&C&*QF#PV$O@R\X8R D6:I!GTY]R,&<)II-("#7S1]&0AG#\!)C>7J501 $#<H)^,STVB^AA1$#7 .: REU3GW)-
M0_6I#1 _@  \*!M][]^$.M?7X1V1G>KDHE)^G(^017
MH?KE/D+SPV43G-HJQ[%/SF 3+.\CF;C.++$%"6*#;^K4\_BFC6F!4' Q8%#=
MX4SV.3*1Z(>?.35QAQVVODA4%TMEA1+9E"GGI!S4X6<095XD*PTZMYQ%)%DT
MHC2!H_4IVN+=GB++UR$!]C1/UPQ&L4!SEJ,S&UKS<7-1\RFM92+)[76*.T&A,*>&B12"B!#NW/7M(A28:/TWJ$T
MW0?>!C9A60\44I/ FJ""Y$$ 9^DKX2>"\;/P%WD/S+#0=-V9S2W3FQ*E'D9G
MC$3L1BK6.T>[/Q%(XEJ)K9@YHL P*R:HYM(7/,Z53IM'<&FRG;CWX[*MP[?=
M9KP>7/5']\.;/E$*):XJN:,>:$"#$=&5J5,;9$@7C"2#&4IWE!7KD;/HTDTP
M&X/8&=U<5P'FVL?(!;H)_;,[^AB ZG+\C\XU<,-&>- LM
ML(2AKV'0,AG=#(.CW-'#^PSGV0;/SF">K\478R1BJ+$#>44U(S;A@#G^&5@+
MKDQ PQ/"[,3XZ? SLQ)A7Z@1,Q5YGE)[A:MBPP^^X/,0L1>,9Z;O+P,^ "2\
MX:P7/>:? 9B6X:L_GC(WKC)>JS1N"&7):]]&E-!6@P7);X"BX5CIRR8>.
M403S61/0CDR.:'6AN*$I4N3BC@%%4"85,
M/NP+E=\GM4)5/M-DRCGI/FNN06X#5Y]B"3[/?"*71T$17?, S1X2_Q!4(*K]
MVE*1QA1HQ%=5M01DF).!!!F2>N&69T(O/8'%";3G<>T")&G:9]Y'E,4S#>PM
M4[-X7AO5%\\8V!1CPRB2F7VX#.Z%>0D,)Z!(AT<$]C(7SF-\S#",!"=*\P0Y
M)R\(4CX)4BXPPO7A9T;)Z$;XIA^$6;8H-Q4EI-!%\/A!)3)W/(]ROPAHLU=5
MZZM9-0V^,!M;"W8"RH0':Y;%H&)?!Z-E8.P)!0[7 7^DZ9C
MP@^]I"B:O1JY1H:X<9XH<^YBIG@+:=4:4BT/:17$.;AQVL<" U0I9'6D>A/1
M,!RSQ.0HHIY;"]WB.699P6=FB3+F9+[O?1F79E_:4KN.:&"UBIPWET57Z5UB
MN4HC<)/QPO>Y/7IIMB=BFRA*%4M=%HO".@(O+$5X)GA4U+%M:KWW[3%*LST1
M]X3E0B,?^2>8LU_! 0D54%(]X68=5CUNV?W5^5-R<056PJ;KDV;![LD%M3]YMFPYE]KH8UCL1V) (H:;5EF8!!_"21
M97)@-ULT;)'POJ5T^6S/>U"8W@2CP*Q>"V6O$V4_JLXSYD3CR!#XRHX-*&3I
M2-Q=+'T"?WSI/B@=[-.@>606^ '(9Y#<&$J.\Y5X8M7<:BN%"VXU^"# XYW"
M6Q+%SS^-\:!@9S[=&D<=@W]/>[K?=$L=/[Q
M XS-^.3LR_#V(S^C$T9)37OB:I[O!KH?N)2<4>E1JA!X#J?7"FM)Y3H6_!0F
MR?'L7&#Q9/!*J%0IE'!%XC4OX;;+D7CE4I3R,S!84K N1Z-J"T[/^K*<*::\
M=[.=V=B*&>L]J81FUE:4IY@J+QMUBCKX)Q^RF&H/9<4#'HO,S="B.'N-RKJ
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M3")$]%X*2B\==DLL!%83"LI:/D$<'S^\8#C2^;ECS\HK=8YD26U_K=22+G2X4\8X$>EUEO3!FOD/AA3
M+!F^K2HR\32,CN(!X.(R03LI!VY0-0I->+R,ZI):-<*U.;8%4R\34Z57&59)
M;;87$EV+-0*:S9SQ5C6J+)-_/0I;8L_2F2,?+(I2R([2X2>8(T$V!>T=@O;B
M@MYTNPY5"H^0EH(D3UZ=E7&%+Q>QGL">T8D:QBXUKS *SPJI-<)9U^D@^69:?_AS8\UUO$_U4%6LQ?A@)!EU[!$[UBPX.+>K_C0
MQ% 9O#O1?9D/ AMSYHW%G:1(RBXMEVM*-%.8S2!=GEQF@TP!KY8V]^CGZ(=S
MP_1 *BP^FS8WD/"F\_3F9IAX; /YY?"@<4N6VK4:GC7& :B^$;TX/(8LL6/(
MT:36U+6Z5%,[&Z_*DK+QVK:G=FI2O;7YUN1CV\JEC^'U-7T:N9:Q1XEG)LVD,^C1N8;I*FQSY84^J;?!
M(RS;1HD^6Z5L2"7Z;)U"GRWUN^BSE2FVRU#^\,+\GYZDD#T')HJ(]K[O1-YI
MF &WO63 F(6A35NW FRXSV\[E20SS?,*CT<<&J[V#(OB/;H2+YK!THB7:I6AA=/NTGV]
M)$(&?$/AH98'F $SC_3N[R]A>R:!.S:]*1<:^.@GW->98YO@1+/YL0@E? ;$
M%3SBUM@&LXGP6H@H?B,KS9TN/(["J%_Y+*$5/8FD9)(>C]&+7C2P??KH,FR'
M+3[N6??S<-=-+R)-0R)= "7^%2]%GN,L]APC>9>F\2*G7FYM$&-PS&K62@9G
M3+''^\1Q9[2H6J6B,_#;\!;2 +,E"T7/KOCI@7TT=LT];L\4[_-^HI2JO, "[PM$.G$9"ICX@38^HZG#LRE-(M5
M&(@SN%0.,GV!8I0,DT90S!LIAID =.:,3F@7%K9R0
M?H3T7\-LTOQ<&YMQ$GPF)/,!^"QI=_()1IX7#6V8.R:W#6.I'+BV\\1GSB<:
MFPRZOY-N[T*M]G^IOF4OE<+""KLRDRS7*O' ZQ]_J+7/V:QKZNK862\5X0I;
M\95#)&T/06?-*7FS[=7(9O$C+^ 4@CGJC[,<=1]'ZG+_/4;0
M3J&?.5L^=\PB?/#31XD0
M-GP'HS>I5AY+>#%V$T7WTG,4$M$>S#T^4X;">.[H>IAGTT[ *O*6KQZBCGS/
M9UK*.;WM=$5^C;RV'*P0>2\$?M$"?X5OG+B^<2,B\<&8,;T>=]%)7
M^QNM]#6JQ&,AH[D*ZW6IRPB]QZ5RZODL+V!2P)ZW%,#+N3:I$P+IN0R@%B;F
M8\ ! 3FZE3&R<(&/Q*B^BV'MN[@+[!U],NGSP0]3O=(-*NY,,'=KV$F-1/?<
M5;R5*H.1/MD:$8['":3 X]6E"UJE$;7L;I:PG&8:QHQMS(]^K"2:W22EQ$K3
MF^):NK#XS&%:NI1WVWC_EDJJ08,@\.QFQ,PFN48#QMKI&&$K=6/&QG*&7DVIGR^_G>A
MB?.2$8_G83HY47+%\X";D\F,UR;,)DAE/:*,M!OG-TJAJ%YSO'_ME+S*G:QE63E_'D'5H$'LX+@*? M\LA<0IEX"//&3GR/'$MXGEK&(@
MP7BO8KP!>I#,HDVX^['!B^P5S+]2.F?R&30W:'Q6G) L2QY3V)OD_:6@H7(Q
MFJ=/*=8_8T,338=O& S1<5WZ#/8 O8WD+N!/[A.*.0-+JD&DP1?&BZ0Y5@I,
M"S5Y?&[U O>)FI:UA5T'=\/+48)!4[]14GF$_A!'/M^SO!7,JJC],M#:J3S?V$CK]64>Q9?.W/.CUD%;TL!TJR
M*DE/F\!MFFN$Q9OAV=@PP8_VK(]Q_%=GP4IJT7=7#[%BC:EI!^PH==ER8:^P
MW/DDUSKD7GX-;]HNA1
MRYIJZF&W4=.;,BLS_L+OJ-Z^8+C2<)YM,F(]!$#@DK/?OXQX.ZJH'I1HCQJ>
MIR#/4U.?5J)F/&&N I8)OLV,:AX[S!9P:]8F5&.IVR?-"FARH=RJQ9-QB?@S
MV+;>%"$V>%5&)/09FC0"2P+H-' V,1[E\0Q)XMX$GCSZ5T#9Z3O>UNH;>)OK
MATPNZ(SU30AC?7R?N -:207&MR_,3I:E6J3 +]"9?,VVI-J65@CRM_:BTX+B^&?;1U^"/XFTQ/#[##5K1T
MIIQ!!U>6:TI2 AZ.!!))?8+#.9XTU\3?//XK *93UP[5.KPR!'H1.D"\:D]:
M)0X&QG(+@"*I;6A17L.C2X##XZ$S$UO2X L0-* <"P@4B(_BYIRU/A+8&WR$
M2PQM@8$&TW&C_@CAL_@B)ADXQM $=^GYFW#WXU?X4Y<"%]4^DC'R IY:>>$5
MX2_P-9_&/)5E\", MD0&@*JS&
MK<0$LJ0)/*,5TL02DA!G?!HCHW.*?X<5S.%AJ9"C(FFR)-.5=VH$UO<55CT%
MN6BA;(R1R/DJ29N\!YUC(^-8"Q 17:!51U]N+H &! 0,X(5><$R\3N![G"47
MT98M2<*EX7:!)+! ?K,9+QKQ0=;#RH!8;=[[8DF+:)\:!I([>^+<\?&*QD0U
M\%Y8A1(1LY2A^3F6L5T
M&@!ML9HS[%.,GZ?R\'A8.,K4XX[JKH,-/Y;/DX1I6(1IV"3;FX*7&<_",#R4
M88A2/YLN0#(].=83Y;S+8A LV\WE,L_A@Z!=5C"'/0.('3[.8X]C5:W11Y$M
M@I*#7XX][17G&HVR9=L!+WS?D^E%XAZ[,4265+)9)7]JU]:LA0L=*=-/64=Y=*.)$3
M-:^(7K94GCI_D5\+$D?;-Z9L(<\=.H3%A7VQ*%F12&$QWTH_/F!>[K/<]$;]
M9+JB%(&Y5U\1R
MGC&\>:H(%VQ_7+:/\L$K>4DP=7A[?G!<)H&ME_C4FJB8+F5IL:B8/H6*Z?KW
M5S%=_G!O*5>X/K#[^$M4<(G=&<6A/399'@B*_!TLO;VZZF$/W^''*/4!]BJH
M,$PC)3*7?9ZJ_8VE:A,IC-#G/.O_=CWZ&!TM2F54=6UN^EJOW2'X.]Z/ND#2F=:W-RCB\%)C]WR2X!9'ASP0[$9
M*MXUUC <&!UQ F )K#=\-K8^Q6 K]\3CP":7P;@
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M3 LC:6%1HTM#T@,GU=+T*(W%.O8#B3O/)L[71E795%EJ?A7BT]&P*"VS1(1&GA=9RND'4Y)(?/ZOP;61$M80)I;3>=^=Y)
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M&+QP!A_1N4]GR.*,PX52S\_A]:,S^)O),:O)J]*4[K '-@E/ &L40
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M0GS>$8F/MR!Q[50T/\$P=9W@<8K.@N=CNIU#MY_>!QY73S^_&UNM)C7R16P5["Q01I69
M#N>"*7<*1'^MN?HTBC2I)5KP!ODAS.+M9K$B"[/X@'081]+B606@BW%LA&E'
MC98V&\T2$T6BO3 VJ+,,C*-:U3'F0&]D\!SJ951&M'#L8]5NNS
M;GA&]RZ:AH?JJ#>\>J_BOO3EKCF%/9.:0C@=5SAE(OPD\'Q"PBDNNXE=AO2(
M\VPO00BHDFR?$% %"JB:$%!'L)Z87*(9(BGLL\M&H"L= .IO9*1A .3="JOU
MB=3\LY,055\6))16C5!Q1V_-^Y(63CM=!A-SN@(^3+KG,Y.O#N9IQ&<
M!CH+9FBQJ;),_L5:L#]<'B2\TV3ML5\$;+V+[390SW'S%:F.^[NRG]$P@ \_
M-\L48$MO%-\:B)="O=85-M\MEJ2]XZ'YN[7FPK
MD%!KRD0]W-O3R,(VM6P859%37NVP73N;>,2:\H\HFSU+?B6\K7_ET)/8V1,_
MXX@_4\^S@<-^]=>J*C<5;'" (V.&*+A(%^ (;#9JY&S8N\=3:?5")]A7\'3B
MLE6^1^<:T]O:8)B
MHW^@NJK=Y^RT6  *1S( @\*T61%6Y
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M/DZM/ #L9L449(IL%+0)RQ'L19 "8#NZO+.GL4=Y'C6T_-;L/D51
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M+A%M@*2'F2"0FL!6TW,!M
M@N(SZ'JG-6/5@=--)L&Q' =N&?],=Z252RISG!YQ)F8[GYB-DTG$DL-TDM =
MT.2#1KW!>&B[4>H-^D,OC:R1Y:7I.$JBP3A-W7'TNZTV:2KUUD;(0XX?M(*6
M>H:U?]]SC&&_DJ=[FLC,MRWK1ZU1G4Y25DKECRO[]K>%>0A&^$;A14Q*5O@#
MA=6M2%8U4XE?I$YRNBG]AK/68A_M8Y8S[I]8S7=:2_24%#0_^.]"6J" )>YA
MS0I2ONL)E2==(*=IJRCHG^C;CG+23/#>S:X_+Z"S\MF0&NZ^J..W8\YSV0,H%..JJEHA/WAP-G
MU&O_[5'?'73_EN6YX_? 4I@I+GPK("B1;PZJY_+*J-?9EJM0J,#(E[+\IGE+
MFNOABO X>WMB#ZQ3V^ZUUP''7*5$W1I=(E-:DC*F)%=;_#M'=5QJ(:8IQI+N
ML$0A:GJTKE-UD=7E(#G+@>V0W\%HJ2OX'NPS&F= J@H)%VU14-%&V[;T7PR
M)VK\W^K_.SD;3<]_>^(-3T4SPHK3&/#(P,C$Q,C,Q+FAT;>U:;6\;-Q+^?K^"57") ^A=
MLF/)CH%$5A#AVB0PU$O[Z4#MJ>66Y$K6_?I[AEQ9KXF=NG54HP$B:Y?#
MX0SGX3-#BN<_7'[L#7_]U&<3-U7LT\]O?QST6*E2JWUN]6JUR^$E>S_\Z4?6
MKM8;;&AX:J63.N6J5NM_*+'2Q+FL6ZO-Y_/JO%759EP;7M5(5;NFM+:B&KNX
M='%.;_ I>'SQC_,?*A5VJ:-\*E+'(B.X$S'+K4S'[',L[#6K5 JIGLX61HXG
MCC7KS2;[K,VUG/'0[J13XF*IY[P6GL]K?I#SD8X7%^>QG#$9OR[)Y+33X4W>
MJK>:K]KB-.*C=J?>2%J=T,J7,EQVO4NE4+797.D
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MRK^83E@/LVARR_JI,.,%4H/)JD!7Y\E&K7EP47O++6*%P$P7[#K53 5%J%4H*JDKET$SAH,Q%Y TEO!M-T##=GZ!:ST6)]&IXT
M+EM_'5P*EL@4D2<0K2)=!B@ACF:SUB[3!'3#J;K%]TCE,70"36MA+0.)TJ@%
MRP &PC'A6ZD54 N,V*VAL19B7S:722)7$  Z-2#DA[/>GHC;"4N4GMLE=(T8
M2^M0P$/_9MHPM.Q8&] 75>Y@D2CQ2N-XR,1K&@Z!D8Z $ Y&?VP"'!)4$7Z\7[P!MZ^2P07O$7QX*:D^J
MG0;-PZ6PF"F$T&?#N_%5ID0=\=S>OPMES)$ 5HJ10@[6N8$"<-A,6L^,D!*I
MUT/[AA6GKO.R$8I[\!5)> 6@1&D@,RE H^
M4Z2D"44ETK=?KM;G>L^CV@H8Y,#;U"GC0'V4*T[T#[>\$:LR #U"4;%>"^';
M2) @&!K]1?P@1CYX<(\."-RM]BZX[TUM.QB_/RG>&^I8'C,9$X*YU2DG]N<6
MZ*P;EA:<1Z,'6E@K&Z)K9:Y/,C>%0UEN,@#=
M^DHFBK2)O0&^X!T+[+10WBRH162TD$@$Q7S -!:7D1Z^Z AVM:%8'>G?33 DT5@?$ (+'@UA'@7*K39+\I W[*%Q&_@
M42H!=!3EAJ"PEF\W]$VU=7A#Q]#08B.H^"U'HH;2HQWA!#@&JVW)%69B\R7\
MJ42Z>0KU,E@RX?:V("$^]+@7L4\4WON"Q!=,R6NABB.*+?GR R;DP2@_]/W<
M<96%,]C=S]^QL?*'B_$2I>45>1"7K:-FQ2,4_6^H$'8*4-C%47XZ;>QM.O8O
MH&PZE=1QJIGEIB"9M\]R.@"F1HB6SQE\K?)?S%;[F$R1[P>1KYTX.7
M?^^9'C:"7U-N# 66SXZ^-/2GG
M$[*GGW4/;S?S!LDU,>"4,O::PG,@8.2/J@N\E0,Z9#K3:B8H9:5\7)RXFX(V
MQ313>B'0.I_H0)1\ \U WP.S=_4N4#B==?V9V;GS.Y^B=00T"E/!'"N>6=%=
M?CD#DV>*+[HR]3/E.YUM HQ^FY]11D!R+R#EH12:BY_MV\U.M5X/ QO\CYW8 3B"SC$_(D>6]IWF+C>
MN9OB/?X[UG_"2OY^3GTR*..H1O&%4F\B1<+Z-R+*Z3"$?0S;D=T0UWSF^L:;
M1UL7T#(=;N!UPUGX3.Q<25LM'I\9ZZLN?(05E+O=+G?<8BL^PYTZ?[OOXO]0
M2P,$%     @ 0%]K5 =>_=D1"   D"@  !D   !E>&AI8FET7S,Q+3)X,C R
M,3$R,S$N:'1M[5IK<]NX%?W>7X%5IHDSH[=D.Y8=SSBR/=$T:V>\:M-^ZD#D
MI82:)+@ *47]]3T7H"S)4F)GO]^(>G'L X>2G\^O^\!\?+\0D
M3V+Q\:_O/@SZHE)K-#YU^HW&^?!-/@KKJ-6&M+]3 /*Z0[*VHU:[RF$X7
M_9PT_/-)PPUR,M+A_/0D5%.APK<5]6;4W6_*]HB"HTXW:A\>=2AHMB-JMHFZ
M46OTSQ:,;*"Z;V/S>4QO*XE*:Q/B\7O==OUP/\N/9RK,)[U6L_GGBJMZ>A+I
M-,=X!NW]5]_-1F\V>Y'@(DG<^S>J#3$4Z_U)ONC/.M?W P'EX/^V7!P?26N
M+T7__>#B4EP.KLZN^H.S#WB%THN;IWK]K\+F*IK_U[WL;O7RY8O60?-X]^T<
M5,7'B8I5)J[KXI?Y=J[[P[/N/?F^FFO5]GH:!F,@I
M"4-313,DAWRBK)!I6L@8+S-MG?!*Z,6:IB0:J1]C"!5BJ#.1<&1
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M]EF#L+MS(!RN1>R5+0%6BB&F$1U%"H][]K4+Y$!(0PXR@( :Q<2A%02+S\%$IF,2
M9Z"NFR)&C59'UEK[>^2M:.V'_LD_*A;\J<U)1B4
M@[>Y42:!^J"()=,_W')&+&4 6GA1L:J%\&U$7!$,C?84/HF1=Q[[
M">Y'4]L&QA]/BH^&.I;'5(6,8&EU*IG]I07Z6:8RK*4)%Q #Z)4<8:>=SUD9
M;!N6%YQ#HP.:7RMK55=DKDLRGTN'LL)D +IU2B8(M F= 4[PC@D[+TQCP:D,//^\41WL$*H]95],95PX7N.04Q1!<:HI@F6W*$?HD$